<SEC-DOCUMENT>0001639691-20-000111.txt : 20201029
<SEC-HEADER>0001639691-20-000111.hdr.sgml : 20201029
<ACCEPTANCE-DATETIME>20201029145813
ACCESSION NUMBER:		0001639691-20-000111
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		90
CONFORMED PERIOD OF REPORT:	20200930
FILED AS OF DATE:		20201029
DATE AS OF CHANGE:		20201029

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LivaNova PLC
		CENTRAL INDEX KEY:			0001639691
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				981268150
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37599
		FILM NUMBER:		201272139

	BUSINESS ADDRESS:	
		STREET 1:		20 EASTBOURNE TERRACE
		CITY:			LONDON
		STATE:			X0
		ZIP:			W2 6LG
		BUSINESS PHONE:		4402033250662

	MAIL ADDRESS:	
		STREET 1:		20 EASTBOURNE TERRACE
		CITY:			LONDON
		STATE:			X0
		ZIP:			W2 6LG

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Sand Holdco Plc
		DATE OF NAME CHANGE:	20150420

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Sand Holdco Ltd
		DATE OF NAME CHANGE:	20150415
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>livn-20200930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:152b0760-94f0-4bb0-b0a2-1db31ab2058d,g:fb466a4e-c2f9-40f5-a132-8d0db9b26e35,d:1bf75d3d05544b2db4639291692ac57a--><html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:livn="http://www.livanova.cyberonics.com/20200930" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>livn-20200930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80L2ZyYWc6Mzg4NmRjNDRkZjk3NGJkZmIzN2EyMWRhZWNiMWYwMGUvdGFibGU6N2QyZDU2YTNmOWU5NGYwZTkwMDQ3N2VjMjUyMDg5YjkvdGFibGVyYW5nZTo3ZDJkNTZhM2Y5ZTk0ZjBlOTAwNDc3ZWMyNTIwODliOV80LTEtMS0xLTA_8e475c0f-0e18-434d-adc2-a232bb62cda0">false</ix:nonNumeric><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80L2ZyYWc6Mzg4NmRjNDRkZjk3NGJkZmIzN2EyMWRhZWNiMWYwMGUvdGFibGU6N2QyZDU2YTNmOWU5NGYwZTkwMDQ3N2VjMjUyMDg5YjkvdGFibGVyYW5nZTo3ZDJkNTZhM2Y5ZTk0ZjBlOTAwNDc3ZWMyNTIwODliOV81LTEtMS0xLTA_f65a4013-b83a-4a7f-a8d1-f2839f2ce674">2020</ix:nonNumeric><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80L2ZyYWc6Mzg4NmRjNDRkZjk3NGJkZmIzN2EyMWRhZWNiMWYwMGUvdGFibGU6N2QyZDU2YTNmOWU5NGYwZTkwMDQ3N2VjMjUyMDg5YjkvdGFibGVyYW5nZTo3ZDJkNTZhM2Y5ZTk0ZjBlOTAwNDc3ZWMyNTIwODliOV82LTEtMS0xLTA_1528e7da-3f81-4306-9493-012505d16d8f">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80L2ZyYWc6Mzg4NmRjNDRkZjk3NGJkZmIzN2EyMWRhZWNiMWYwMGUvdGFibGU6N2QyZDU2YTNmOWU5NGYwZTkwMDQ3N2VjMjUyMDg5YjkvdGFibGVyYW5nZTo3ZDJkNTZhM2Y5ZTk0ZjBlOTAwNDc3ZWMyNTIwODliOV84LTEtMS0xLTA_f6e2d167-139b-4fcf-b2b0-74eadecd69f8">0001639691</ix:nonNumeric><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80L2ZyYWc6Mzg4NmRjNDRkZjk3NGJkZmIzN2EyMWRhZWNiMWYwMGUvdGFibGU6N2QyZDU2YTNmOWU5NGYwZTkwMDQ3N2VjMjUyMDg5YjkvdGFibGVyYW5nZTo3ZDJkNTZhM2Y5ZTk0ZjBlOTAwNDc3ZWMyNTIwODliOV85LTEtMS0xLTA_c9bac9f9-acaf-49c0-ba97-68b9552cc40e">12/31</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i5ffd59ecf9044f8eb3cf977b8db8a6a7_D20200701-20200930" decimals="6" name="livn:DebtInstrumentExchangeableConversionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82MS9mcmFnOmQwOGIwMWJhOWFjMDQ3ODVhYTViYmQyODBlMzUzZmY4L3RleHRyZWdpb246ZDA4YjAxYmE5YWMwNDc4NWFhNWJiZDI4MGUzNTNmZjhfOTQ_4e36198b-3b4d-4e70-9fe7-0357b260d047">0.016398</ix:nonFraction><ix:nonNumeric contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMi0wLTEtMS0wL3RleHRyZWdpb246NzBlNmI4NTFhNzBkNDhmYTgzNmM5ZmZkOGQwOTVkZGZfMTY_2f7bdef0-ddd7-4bfa-ad80-21e764af2e97">us-gaap:AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RhYmxlOmI3NzhiMTYwZjg5NTQzN2ViODlhMTA0NWE0NGFmNzdjL3RhYmxlcmFuZ2U6Yjc3OGIxNjBmODk1NDM3ZWI4OWExMDQ1YTQ0YWY3N2NfMS0wLTEtMS0wL3RleHRyZWdpb246OWNhMDIzMjU1YjY2NDBkN2I1NDUzOTBiNjY0ZTMzZDNfMTQ_421ad1dc-77dd-457b-948b-627f349609b2">us-gaap:AccountingStandardsUpdate201613Member</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="livn-20200930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ib5c4b96ff27e4ddeb062ecd5ba74027a_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcd0778524454cafb95c52ee8c85dc02_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="gbpPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ic94ddff991844d7bb182464410e337c2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cb9957d3e1b407bb88290f6a94e712e_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f504bd55c7f46eabe71635e913521f3_D20190612-20190612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:MiamiInstrumentsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-12</xbrli:startDate><xbrli:endDate>2019-06-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69653e79e7a64b74bafe17de62d7f7e7_I20190612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:MiamiInstrumentsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8f318fd9c2147bba4d88a7c4b055ba5_D20190612-20190612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">livn:DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:MiamiInstrumentsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-12</xbrli:startDate><xbrli:endDate>2019-06-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08c3b67a02214a92852d8412d52b746a_D20180430-20180430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">livn:CRMBusinessFranchiseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-30</xbrli:startDate><xbrli:endDate>2018-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ab5cac60220483ca5a3b38de23752fc_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">livn:CRMBusinessFranchiseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f970e37f06645c8bb2539c0ce87edde_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">livn:ReorganizationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7f12aa7ec264fe2ab35709629de067f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">livn:ReorganizationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8aeacf1e4fc34783813482eebf05252b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">livn:ReorganizationPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12f68e91043344bb9a9cb86689638ce5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">livn:ReorganizationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99471d80dbd54b8ca36fd7bd75e616dd_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">livn:ReorganizationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8925322bbe234c77aa2e0c9256cd4f36_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">livn:ReorganizationPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89e139d91fc8464a99b88353610cdeb2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">livn:ReorganizationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf00cfbfb795463ab27948e6d4c4253d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">livn:ReorganizationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i970f46cb12124b12bfb14bea4df49ada_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">livn:ReorganizationPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i013558d2b17c4355a92da0429952dd67_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f84b9a1406f4d1a801a8a1795c932dc_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2fad0d02b3e4a0ab6a60f67969ec28b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i197004b99655439cada3d2fa6e98f33e_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36f208ad6ec8402f80aac6618e1de718_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9faf33d672ba42d18cdfe76fdead2b2d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c4ddeb948eb4c4dbe320a14c7ae3792_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac495534370345098798ba8c26b009ac_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21d96c5da2404625a9ee4885a17ebf0c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc2e1e69df7e4a1d8c750a08dcb83a44_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i753478d430024138b30d3d04687e7eb7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e6560d12b2f434fa22d653edaa72cd8_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4743b9cbc8b413f864fd07a5e2fad89_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:ProductLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafea0951c2c545c9aa85f9c8daadd17f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:RespicardiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60b29926fecf4b70b1dc7c7cd0baf605_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:RespicardiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51565454f75d4bebb38194ffedb9b20a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:ALungTechnologiesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2185fe191cce4a66865bde068329982b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:ALungTechnologiesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic98b76cf08a64b6da1b29b2c251fc766_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:CeribellInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf583348934e447b97b6b58fd72f1047_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:CeribellInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i985d7bd469a442c080589425a8443701_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:ShiraTronicsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c5ecded17b340c89b0e638f6ae6ffc2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:ShiraTronicsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia943f93887004f2e973f75f871756f34_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:MDStartIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddd07ea8a3bb43fcaa80fd42e2b6af83_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:MDStartIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7070af18fef45169cea3d61e672378d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:RainbowMedicalLtd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i128dd12840304fb7a5186325c995dc74_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:RainbowMedicalLtd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cc59c39d408424fa8ec43642bdefae4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:HighlifeS.A.S.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67e02e6f525d49d79d1e1378eefccbaa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:HighlifeS.A.S.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43bc731c38504f9a9bf794876a9512db_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cfb30f9c2da4bd98ce29047f95daaf6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib244d5c1647445c98706515b46ea2376_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">livn:RespicardiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90db8675b50e452bb4dbe535ff672f26_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">livn:RespicardiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i798dba76d2144cabb6adb775c4a1aa5f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">livn:ALungTechnologiesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">livn:ConvertibleNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i282f7e855f164edab83c60ade72f1e8f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">livn:ALungTechnologiesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">livn:ConvertibleNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c6523bc48a447b5869e52fba0cea6f3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0d8e86523634968b1908339ac891144_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff29d74ec51a43d3b79a5db568d853f2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfefd2b87cb44284867538a460fdec64_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibad74017afa848158b4bcf23299630ba_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia53cdeb7e70b46e0a9df7e343e1c8dc7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i549d9fe1d5694fea83f1cb9a0116d9c3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf3cde6d556f43229f6017b4b0296fb3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99ea2a2977bf428dbe55a0a62f1d8f39_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">livn:CappedCallMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i477ef411a1da4a87828daf96a443478a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">livn:CappedCallMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i604c8c94f78e401b9a10ebc3406a262d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">livn:CappedCallMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic71b0960ca5b40b79de0620646d77218_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">livn:CappedCallMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1920c569d03f4b2981551f7c9fa3f2dc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i651e6f1d58d6444c89e41097aa3c93d2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb5a207f947a447b8d9aaf5128bccb8e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic60029069ad0424ebdeeedac7260aaf9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7955e6392f00489b9c7c6bd1a5a7b4a6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bb02064dc544327a00b12a199681a45_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i223528d062ef4c2d8c27572caa395a07_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a279cef16854d728efd76005ca4b872_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i148d72eb7ca9457d9c7534140ff8b8e6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3dabef6c1fc45838407928a7edc982a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dab210d1ff74635af037320edfe69b2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7515b98bfc884d4c8e81ba14f06c1998_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i874c5b66a97e468981139b4c21d7eefa_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e3b083fb0b3450ea7ce586ffdd675e6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8a2fef709db4b8e8534fc2dc8e08119_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19e9ceed79d04c9eb93f32768de95ec9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f293b751409438c9ba2c7b3dc48dffc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6b52afe363e4fe9a4d0f3237689efc2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2aba2a40c6324508a183965eccf45b95_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa9c677be2ba4b7080abc459f6cb49e2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c78a1ebb503459eb3095a7afc63295b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7db9636c721460b95675081b95ae6b6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95ed7028bea74431b97651e632a47b6b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcbcc74327d845ba8fc6a1532ba4b344_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib087b2c401cc4c3d8384b3a48fcd1329_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i692bbffae945465da30a96cc3773a545_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic71ba4ba85c34d5486646e473787face_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e6eaa19ee7d48d686b0f7478549e4f3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41752121b3454d50a55318982c498675_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cdbf2725d5841b0b9507ecf33848425_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a4cad9c20ed4f459594fbf97ec48b93_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2ae71915c9d485e834f0858c4a5ae25_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f78b59175ef4d758e415b5cbed5ac3f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4305df4a64bd48dba371c408205ef499_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">livn:EmbeddedExchangeFeatureLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i209b72ec61d040dfb2b194e845cf7edb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c92b7d80ea24dacb640f577505291f1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">livn:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90c6c409fa4549c790424875b8e5a217_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf2d496c991846f780a3d8de11e7596e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c3d799108834231aa07131c4ffa94a6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">livn:EmbeddedExchangeFeatureLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i945ca206fc8d4168be118ba472cf5c62_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdae3dc9ec2145e495befafb9bcf5123_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">livn:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6822c11b4df4397a32236603772252c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79abffac68b242c5a0a7017c3bb651d2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5458476260ce4943a87b849a8aacd1c1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">livn:EmbeddedExchangeFeatureLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90160a4003a147ac85584baddfa6bbdf_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic11bd09e203746298506602f823386cf_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">livn:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1595ac59e1649c287f1756d28d46854_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="distributor"><xbrli:measure>livn:distributor</xbrli:measure></xbrli:unit><xbrli:context id="if4a3c8bc06cb468c81b9eb54252c7358_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6716b0b0e633453e9726f2030e08c1ca_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24d1ba33f5dd45c0b73177d207d4550c_I20200617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">livn:A2020CashExchangeableSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ieb3ff6598aa94f57ad92e35964f81c74_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputStockPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">livn:CappedCallMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia12648082fc04c6b8edae66b0ae67c39_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputStockPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib19ca95e55f0441faf04ebd6116fa0b8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dabcab920e744a7b4327517400decdd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">livn:CappedCallMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62afb2ec706c47af855bd1dcaf827f5c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d29459e1a0a41f687a10f5ab9c54a04_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic98623a8908a479b94a28994eb16d56b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:TandemLifeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34cc075f863646e699af91319f899885_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:TandemLifeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i383d011df36a41baa36003172177eb6b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:MiamiInstrumentsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd04c511e4ce4ac08b831ad0578c95f0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:MiamiInstrumentsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbc2f3772dba467592c17b9ecdbc0bc9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:DrilltexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i252c36e7add342399b1424bfe704c832_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:DrilltexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if59480dc9b4f411782c729fa14047400_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10357ff0c2724f06bbfa2eec022e8b72_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52334654e869489ca143b061165476f4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2536974de9b486d9e0ef01bd6a67045_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26486ea04b234f2e927248919c447802_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputRiskadjustedDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">livn:ValuationTechniqueMonteCarloSimulationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d05cd06a8bf4c379ecc9d10bbb2d201_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputRiskadjustedDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">livn:ValuationTechniqueMonteCarloSimulationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a7bf4141731447ba120d2c607bf1fc2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputCreditRiskDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">livn:ValuationTechniqueMonteCarloSimulationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6291433582a64ddb8a18340f917f581e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputCreditRiskDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">livn:ValuationTechniqueMonteCarloSimulationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79119020499f4051aaa48c43f75c5b81_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">livn:ValuationTechniqueMonteCarloSimulationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputRevenueVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d800c2cae0e47849fbae2bf9df0853f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">livn:ValuationTechniqueMonteCarloSimulationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48e773110abb48db81e64c019f74f83d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:TandemLifeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d623187030142ffa015b3317a9e5d79_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:TandemLifeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f11911900f44e6a9bb586049722bb34_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:TandemLifeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae66d9458a004d28af2aca3b7976b3f0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:TandemLifeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4826f8772764dcca66860adeb782fae_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:MiamiInstrumentsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6697817a4014449f80da5eda0856fefd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:MiamiInstrumentsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0aa9d51eaa804f9bbf6db6abe1aab758_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:MiamiInstrumentsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i459d7f911ab44762922172ee4898a00b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:MiamiInstrumentsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3245df3db3cb48138c8bb4d23daee5c4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85cd7d93641d4805ad2cd66461498397_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieafa762dc91e4ea5b61fb8d13b092c3a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45371aa600b04a59940ecd80e4ec31cc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb27b6a99b3143aba0d74fd775949dfe_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie42f7909e6db412aa3041faa1788bd39_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i289e4abd6f78419f8f33d7774b970fca_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:BankofAmericaMerrillLynchBancoMultiploS.A.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibee8d98cf1eb433cb1a0301b339983bc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:BankofAmericaMerrillLynchBancoMultiploS.A.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36c4db63cfaf444f879c55013695c930_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:BankofAmericaMerrillLynchBancoMultiploS.A.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa72db626bbd480cb89d6345d833dd4d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:MediocreditoItalianoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i586947e97ff14c64ab8231790955f4c6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:MediocreditoItalianoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1080464791c844d79de57c27a7ff3ff6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:MediocreditoItalianoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc989c83ebe44970836e50ad98670002_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:MediocreditoItalianoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe7864f0b2ec45bd8a718ff4690bb0d1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:BankofAmericaU.SMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77803437d5944d49a41f07e2364e792a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:BankofAmericaU.SMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dc1230e32264a72921d8a08c4c63984_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:BankofAmericaU.SMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5ac265b05414cd791492f4617219f2e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:DebtFacility2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib89aab9bd0424c12919f50bff87ea646_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:DebtFacility2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d873ce62a3742a390dae8762e636c14_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:EuropeanInvestmentBank2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4afcc088bc84e9aa4e4191bfefcc218_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:EuropeanInvestmentBank2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87d4c0b95a4e4fe294e383610676bf94_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:EuropeanInvestmentBank2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i774fcbadcb514ffb99380b94b3c9864e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:EuropeanInvestmentBank2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a882a55bae3450ab4104c69d32cbe64_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic874c4d0e00049b4a599f3482a07d919_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib86600fe8d314ce3bbf5074a7b1877ac_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6ca57cb331747069aa1e6f1b22dd36d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6b26cfd42a14eae84e4cde0f4855b55_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i222517d76090477aa98b1abaaae6b229_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic387d566a4a047a4abc670c43b8f310a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50324d744dcd4a44b4764e5523cc1cce_I20200610"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf2a05cfe98047578281e694de92f942_D20200610-20200610"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-10</xbrli:startDate><xbrli:endDate>2020-06-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i545ddcc4502f4443a3f1a3a772c175dc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96351578f5c9420c994226ab0fb578bb_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1401125337584d3cb2556f5344879ff5_I20200617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie66d4c341b7f42f0b9c74ad3972a82cb_D20200617-20200617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-17</xbrli:startDate><xbrli:endDate>2020-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ffd59ecf9044f8eb3cf977b8db8a6a7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i444306b422a649ef948af581cd5b4f06_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>livn:claim</xbrli:measure></xbrli:unit><xbrli:context id="i17a5d78945d143a89628f9c4af1abbc5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">livn:CappedCallMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibec415e111624e90a65386d8ccfeb185_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e616a092dd14267a1ec789a805bdb80_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i950b10f7b07943f2aec8cb421632f276_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">livn:ForeignExchangeandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a94651f8023444cba196300adc7abcd_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">livn:ForeignExchangeandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64e57c8edaa1477d881db72e4c50172e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">livn:ForeignExchangeandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0efb92ce20cb40c3829d2008a9aee0a0_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">livn:ForeignExchangeandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i649606b21180421ebd128add525a4018_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic43de1d78774468cbbd002d32d130ae7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96a7d1296872411baf7843151d3b8798_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e21c8f995c24e08b7f442b0d2e9f153_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib51f3bb185c74b338b8ef92535cb08f2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i249fe1f728d5471fa1555fe39c4bfefe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iceda4563a5cf43d4b3bb9b89365c4c20_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1925dad241b4aad82804e153bd1d891_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7100fe2c632148de9c37fb8985d42d30_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic334fc4aef0a4ba39603d81e0f99657a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54a9f60e897042dabf6cfd3734d2ec73_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7af1f95c61944858b003c6c933d18f4e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">livn:ForeignExchangeandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1948e41e49f1497390be627047b5251a_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">livn:ForeignExchangeandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d2ccb840b50403f8fc4f14ac40d2d79_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e3cfd47324747a59764c08500c16de3_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ee46b672ebd4d8bae5042f234b05104_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7438dabb55a44445b30dbd44a361b2f4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae52b02ee83b438bb79bd0edc64a3be1_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7aee89dbb9cd451d93a65f546dc5d74e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">livn:ForeignExchangeandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecc073aeadb743fe846108c910b49974_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">livn:ForeignExchangeandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffc8dde6780b4135bdbe52a6f7da8dda_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia84ea03c48e54abfb6747a6de26f6116_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7abd6989d6846e99b0a4c7ee504321d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5331125ba8a94b0fbfcb5387185e5869_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa29b64fff8949389d46c6f12d455215_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd587e00f53f4c9184d615617e686bcd_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b35bd5fd55a4b69b147d5820c42e6d7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc095689f6144f4ea7254b0bb872766c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f55df33738d44e1ba296c8eb88269a1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22945e43bf0c46a2a590bd5b5d61f00f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i930e2a8fddf64cb1b8979187598b1cd4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09a77749f8b64a04b0150d233c3084e4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2bca75c3d294e0eaa5aa2c0d20d66ac_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">livn:CappedCallMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43f7ebc0918b4360bae6ce12a9368d0d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">livn:DerivativeLiabilitiesNoncurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c0f04c520c14a329fc827c4e8389951_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id58204573a634e6ca3cf75d337baefe3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">livn:DerivativeLiabilitiesNoncurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i007ee0b9e8934174994f5d86e0bb6e6d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i990fa7277e80490b9cfb6a6d1b9d78f4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75a2980d9bdb44a792b41575bc1a46ba_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">livn:DerivativeLiabilitiesNoncurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52618d0ff8d74edb8b26a424dd5945e5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06b91b912b3c479ca956a6a0c95f7567_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d1c0b4a1d3f448aa2bc219f0184bf4d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2bfe101df98424ab800c282d00e7116_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd8a5acd53214b2b9194da6aedc036eb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cd90438d14b4f0c8370dc4b8d777673_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="non-conformity"><xbrli:measure>livn:non-conformity</xbrli:measure></xbrli:unit><xbrli:context id="i8e2eef5d48ff4b9bb6fe18d873c6d803_I20150827"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:FDAWarningLetterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-08-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e7e31e16f08494b91383db437aa83e5_D20190329-20190329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:ProductLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-29</xbrli:startDate><xbrli:endDate>2019-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib86a229e06c94877bea66e161b156052_D20190701-20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:ProductLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc438c9935fb4d298a4744c265489040_D20200101-20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:ProductLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i822d6a83e0f24f4e85072aba1aaa8ce1_I20201029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia92f7ea6fe5141b3a709c569c6f57200_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:ProductLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dfb8d93c33740aab82c128a023695f0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:ProductLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id94164334ffb44b9adc73f1e3a4a759e_D20120101-20120131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">livn:SNIAs.p.aMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:SNIAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-01-01</xbrli:startDate><xbrli:endDate>2012-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i4922d7cf37464b6088c833375aa28ff9_D20160401-20160401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:SNIAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-04-01</xbrli:startDate><xbrli:endDate>2016-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd123abeb5064944877aad0f41f3b289_D20200930-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:SNIAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-30</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9108f299f5642e3ab27bd8eabbe0df9_I20190305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0767ecfc4434c7c8ba7c0a26e46ab4a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="installment"><xbrli:measure>livn:installment</xbrli:measure></xbrli:unit><xbrli:context id="i42ece6a951c243ed95e1890dcca64a65_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">livn:RegionalInternalRevenueOfficeofLombardyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:ThreatenedLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="notice"><xbrli:measure>livn:notice</xbrli:measure></xbrli:unit><xbrli:context id="i2a8c70677248473d83cfc005358a6167_I20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">livn:RegionalInternalRevenueOfficeofLombardyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieed6906313d54138b062d2f1a35a9599_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">livn:RegionalInternalRevenueOfficeofLombardyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i774b2c58712345bab82956aa91ba877a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">livn:RegionalInternalRevenueOfficeofLombardyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f8533c39b7f41078d1b3a8bcc766b96_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1478be27f8e34765a887baf8c6538b31_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5443a67444ea416485c37b991988f6fb_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id34d4656788a44fd81611969a787b29b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie93c1f60108b48a3a6733d851a357ebe_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b57b2b83dd54d149c591d8fbbb18813_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i772e55ea562149ffb5fc638d38caf1ad_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae4dac957e404f989a0f0e8abd6471a0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9a83943fc464403a7d5089f8b33a871_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11762dbaa1ed49eb94d45dbf0e1eca9d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c3477a39b584e26aca4ae04d6bcdc27_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67841b9ab95c44768c3ad97a56b3bfa8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdffa7f2634f4108a1118eab5e5b8ac5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42ea28428d684a9cacaefaa3e6dd1b9e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbbfbf1476804a928a5c7aef5fa053f0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i646772a5bff64501b5ff80d29c70951d_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ee5111b458142f6a8d38873421f58fc_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i901bf76852a3483e827718cf605968da_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37e2013ed189474aab9c13d2000c9cc9_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6767353b5d7549d18ff983e40ed7a527_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia64252b3f99d4b618cfb4816f6ff303e_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81d68c28a9ae4f16b06014531f6d4332_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71221703b9ac4249a6c037f96c6fd8a2_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f027e9798fa4ca0934d00d9bb263410_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c602e5b577142efafee2537813d0b56_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe68740e4f2a4fd1984ecc22362196b1_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cbb04514b7b4f2dbc2888e6954040c0_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ea24a03159448d282159becae6e7f97_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2b13270d7694a2899d0fd79a80d5739_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd4e32d70c90404db0418fec4b835d7a_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief427b70c02847b5b1c5f0f93bfab969_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdff871ce34c40e09563d35dccbeece4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f92e675a9a74c8ebf70114e14995425_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f678b8291d0499489325ab4fb979196_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14244109275c4b71acdb26ad86c70caa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fc22053772446cd9092b2ea318f9022_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibeb25415374f4786a2efe54934478bee_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i602472901bc5472da9591b20d9734683_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2e3b203d4b44ef49fe6a6a87e78b48a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ed16dbbc5fd4b1285afa69aff2e6594_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84001a93f52c4e74984ff02516c7b75c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecd6db286ef0474c8967169d3455a2e9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i357c72c25b924030994b1bf08eb695cb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11b5dc862856494ba736bb256c91320d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b2edf297198406494036b93de529988_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5433f056524a44659bef554cefff1704_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia85d1e0c436c415abf0ffabd07459791_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5223aa7b849840fb8494719b938ff2b2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia86697a40b714160b0bee988340e85a0_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie10c500eacef4aaf8fc597afbc3d45b5_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d1519f3a2b54a76abca9ca793ca5b66_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i585b337eb45c4a659b1ee03c596606d8_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bbc378fed9842a5b7a3214c4db31cbb_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73b9ebabb9a742feaf7a7a83f366667e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1125b67f1c85426d9cd1a530fb32d7b6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a275a7257a24e82a86ff4fa4e50516e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98e7648a0a8345a3b1986dfb798ac9de_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0977771516644bab2772f34d2437e3d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd262b92e2af4f3f98cd4f5c03def298_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28ed0d61b46b4daaa86046342354f4b2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefddf94f87084dd1ade6648ea605cf0c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b7762a5b5f04bec8a312789ceeb2bd4_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i340d4173e28147f58686dee1587f9750_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id48df069b0704c3581b5adc77e251cb0_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4561e95c0c8449a78e98f5d3fc5b92c3_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief162d0a6831435c9c447ec4cb5cc4f1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5acbf636460b4e198f468c31a3c1be2d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i225c9725da49473d854e8f083baa2603_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic23be7d8ac3c4b778a9d24d166906ab1_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i546f2452d51d4bdc881efe5cc5c05a8d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia56cee55c4cf43099b9e98160544d49b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a0fca2fdff64694bb24e3e060fd6dc8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib638c02dde7843eab3f4573d6585314d_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i427900b1e7d84e50b571679ab1cabaad_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:MarketbasedPerformanceRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7c014275f2d405ab23766c236149138_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:MarketbasedPerformanceRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32d2a1a2778b49afb67fef2675c88931_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:MarketbasedPerformanceRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d8cecc1dece477e9a955468c571ae1e_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:MarketbasedPerformanceRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65ec3dbf2057421c8affe016c664ea78_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:OperatingPerformancebasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19cf82e1376d4f11840e7da277a74cd5_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:OperatingPerformancebasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e416e9ef1f14ac2bc887e06f9aebbf6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:OperatingPerformancebasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a670137ff2a451782f99f45ef40a8f6_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:OperatingPerformancebasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bb32345ef6842089919448a35175b29_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id526b3c20a2d42d5abba8504d3816294_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97785f256ae3470b9f482c61dec5e68a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d45641764344e17bb094a058ba9942c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0dced88ae604075b207e4543f4c306f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92991d08bea7415da6b40d6cf2dfe885_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id411cf0d82944320a5787d8a7f2ebfe8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:MarketbasedPerformanceRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaa1e1cbda504307b64e2b6e1037f051_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:OperatingPerformancebasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a0a4786b53a409786262fe990c43c5a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20801a9a959b4964abe3933a95ed2cae_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45c62bd5d99d4fce99db5761c61d6e17_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4379082406654f39a39e859cda18b46a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>livn:segment</xbrli:measure></xbrli:unit><xbrli:unit id="geographic_region"><xbrli:measure>livn:geographic_region</xbrli:measure></xbrli:unit><xbrli:context id="i876852bfed184662a8f0d97d8bcaa96c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe5844e1c9474606816d00972d05d123_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62b84cedd45d40678d48897ca51541e3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba81a1a74dfe49b8aa3eb8f99114e275_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i048767aa111f4c9fb0f1ac8f9d147073_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98d0d7d6789f427ea18447a9ecab0429_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45c1d64c7a40486b9179d7e170cbe2f9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7329b87ee254e179498f3ab5d4c1188_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e91c84eafce45e9b7b415a5813b4a82_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a6de0e9e7b442a3a978cd51f4294ab4_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a14281cb8974824bd527e86f10ab2bb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i067bb22836894b95b391f0d0acb63f85_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i998e5f95302b4aeda2b81e2447e7d338_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i492977f4fcc14476974fcd6784642170_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic21d9046e8e54eb08111e039c3cd30c2_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14ea489aa03e4679ae969ce4f20eeec8_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31a3762e4349432987b7c4352fec5b98_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a02318bfa3347cc8505a8b9b72252cb_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i512e1cbc1dbf402a8182f4c49af7e088_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86e615fd4f804099b338c2d68fd98684_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b2e5a703d0d4e0da33993ef6e8b10d7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaebed4d2a7214242b9cdae043b3e1395_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d314c195032448da84bdf91257809f5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fad8409ffa449c3a2dcd5303e70034a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73bb4237240a4e3fb606e9efd3f84f99_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1965860a1d8443d8fd1255f6745e510_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37b3bf78b8684a9a85fa49b6161b9c2e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic43242093f884cfa9804e7b602317c98_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9863d6e831c3445b8abe8ec63dd71610_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifea8fbd4f8a842768f18f1cb7d62556d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3691f9031c3d4c0baaccadab036cdb47_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d14b893f6a8433790639cb04398340d_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9f0e21d42994c2d9c4ad4c9cc1386b3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37a57e73f7074cc2b478dc7848ff6ebb_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c228cdd25fa46dc846f886d32efa18b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4cde2101963426a8246337e1a0c076a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f2ccc2749c2492885274416414af440_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24e4350fe7d9437184b7909a2aae9e1f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i993975a651dd4a8da309a2bc9be5ccaf_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13437c9318a542149d8e4b9ace7af3f8_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69ff964a5f854ebbbe1ea60e0e626bb6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i718f682704d94fc694e5d005c83a53e9_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b0092809fe14757a77ae4181720814e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30054fec7a044c3195b0a1f4a0c95929_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a8df61046d04836b659e7543314d52b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c55bcd90e9a4aacbf366789e82e6f95_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f292902eb0549ab833ee3de080de1ba_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83af8f7348324741a33b045e553554c3_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60f6642d17aa4014ad54b108c471cdcd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c95775accb649a2a43367af2881bd1e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ba01b8c48ef4056a693c9fd38968b66_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i455f04a75540413cb77b07c862e31aa6_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa815b9dabb542e1ae17525ed43b6edd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb31194759654532b6d3c7273756b4f0_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee15933e70114ffda536e4ce711dad1d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6dd5ea4b1ca4e18a2fcdea83a107830_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2e41838e4174c11abc94d3fb48a1fb4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaadc304289f4da0b546e3b00fcd58c1_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ab86d3d6d0f49dca6f89b85afbdfa63_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92e6ec3e0d984c9f86c920f967033463_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6605f2db15da497784c8273e981148a5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1255365af20d4f3d8de0bd8332901b23_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4a5a9acdf1b466d8d5cd9e19d1f3cb1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5546f850f727425d90f293dbf898907b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4b98b0523e7492f935ed61439c44ac7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd5e3ac54bd741a5a9a5b5f8105a08ae_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib713c27b02154444b1b13648efdc2cb9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90c55e2ec6ed42bc805a2d2a55c5c015_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bfaac3413d149e8a37153945f6a6c4d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2d1490e739647a987879cf6b41a8714_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i576c2f526c3d4a9b9c2a3777ca6ae531_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i647ae223232c4e10957d4e6ecf102def_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d864c92f8184a1b8fc7aa74c911e9d5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3b6505d7e924fd996331218487159c5_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c978d524b454407894936f54228ed99_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i685896438be142c1b5cc2e440c305db2_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e5933b714be422fb3a8dbdb558b63d0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8fcde1e652d443a977756769f311eb0_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad0023589bcb4062a7f6ee3b1663620e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i177a57ba7c1e481b80517501c4f324c5_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9869e96a35ca485f87925c8da417cf1d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d7442c704eb4389bdc5b405e968fa81_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib304e38586c34d63aeb55253400f5dfc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic91a56d11d8a4a7994c72db8fe11c1d9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e8a04ec819f4cecb0b4d32157f3793c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i750cd8c7e43c4c11ab8974d496e7bb2f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb3170768056425eb10ca95b859602e3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic51b2b23224546d29ccce9fe55170242_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26b3c5a9534a4fe29e2597bb3c79e85a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6da06d9c9f8f4561b0149e510d196cdf_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i533727d94e6d4a939f7d8a3366ee1c2c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d8d758d27874054949a7da21f2f2b51_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdd4df75ecee4768ac486e5f62873b27_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i555f859b9cc045aa906e26d5ebfeda55_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72a6c2813b9a4c7a8ef3258c3a0d53e6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e3947b9663c4dd195e33fed5b54ba85_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37c0fa19eea047a2936735006bf189fc_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97f2df041b5e4467941d20a0fed11b0d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c740fe5919f452f8b72fcc2fa97e743_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1ba6be74fbf4cd8a64b5aff3d82ca29_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e834100347f4225a07ea71d1272445b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82d6d51022114ec88eb0d11a4a6ff932_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i621fac9415c54f6a87f88d3a519eb1f0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie26338ab822548b58c3b31da34f31dd8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21249aea88bf443ba021a32669ad704b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic77fdf65e1a94d118f6cb9b70082f469_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50dafb81ae7249f0b00a89f30fa949b6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbd1000ed3de4516a0195c708a123de5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia01b97a86f2f4fb9ad100afbeb3977ab_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie035b1af1b6244959d04c1e0f44038a5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ed94ea4037647e09c43b0db147a2453_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3dabd6f2807465da694560fc9777ec8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dde44e6ca6c4af39265921b98826424_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67e83bb326504f55b272768962da8016_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibedca0f603bd4bd6a1d7eb72407a0f05_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c3b8ff212bf4e7789a78c902e1ca14e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e0cc6d97d2c44baa25cccb561c0a434_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8d1a426602f4eb09beb15214ebfd323_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11591753270141129f271d60eea42105_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25fe44ba33a444a484626a29cce0642c_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001639691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i1bf75d3d05544b2db4639291692ac57a_1"></div><div style="min-height:36pt;width:100%"><div style="margin-bottom:6pt;text-indent:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Washington, D.C. 20549</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">_________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Form <ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTE1_6d671cec-7650-4f14-948c-88b8e9190865">10-Q</ix:nonNumeric> </span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:125%">(Mark One)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTI1_17eb74cc-e4c3-4d2d-9bb8-978344f6c03e">&#9745;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">For the quarterly period ended: <ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yNDg_a536447f-0a27-4abf-b337-dc52b2b6242e">September&#160;30, 2020</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTEy_2367b4d1-581a-4dd6-9b35-915d94bb8e50">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">For the transition period from _______________ to _______________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Commission file number: <ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTI2_fac42b86-25fa-40e2-84d2-e1d1c0f4ebb2">001-37599</ix:nonNumeric> </span></div><div style="text-align:center"><img src="livn-20200930_g1.jpg" alt="livn-20200930_g1.jpg" style="height:54px;width:242px;"/></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:125%"><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8zODQ4MjkwNjk5MzQ0_fcb3c8e8-5aae-4e0b-9135-5700434a20d4">LivaNova PLC</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTI3_644d362f-35c0-4a09-b6ff-be5792cf5893">England and Wales</ix:nonNumeric> </span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">...................</span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTIz_e5db4872-e876-4759-a24b-02bd8e8d7667">98-1268150</ix:nonNumeric></span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(State or other jurisdiction of </span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">..........</span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(I.R.S. Employer</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">incorporation or organization) </span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">........</span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Identification No.)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTE2_742408dc-15f6-4b24-ba10-803e4d01b204">20 Eastbourne Terrace</ix:nonNumeric>, <ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTE3_615e4e5a-3735-4921-b310-1ee1b67f1f42">London</ix:nonNumeric>, <ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTE4_2443e641-d92f-4d1d-9547-1c2035862b3f">United Kingdom</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTEz_e6dc773c-a9d7-4488-abb6-d6b8c40eb21d">W2 6LG</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Address of principal executive offices) </span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">.......................</span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Zip Code)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:125%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">(<ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:CountryRegion" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTE5_fd598441-2519-41cb-af15-8100f267f569">44</ix:nonNumeric>) (<ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTI0_20bf4d65-8f90-4a51-ba72-601dfe3fab52">0</ix:nonNumeric>) <ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTE0_46348ae1-5deb-4da5-8972-e6ad07516551">203 325-0660</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Securities registered pursuant to Section 12(b) of the Act</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:10.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGFibGU6NmUxMGQxNWUyMTA1NDY3MmE0MzA5MzVjMjg0YWFiMjgvdGFibGVyYW5nZTo2ZTEwZDE1ZTIxMDU0NjcyYTQzMDkzNWMyODRhYWIyOF8xLTEtMS0xLTA_4c0b6917-6af0-4466-92d8-469be112c85c">Ordinary Shares&#160;- &#163;1.00&#160;par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGFibGU6NmUxMGQxNWUyMTA1NDY3MmE0MzA5MzVjMjg0YWFiMjgvdGFibGVyYW5nZTo2ZTEwZDE1ZTIxMDU0NjcyYTQzMDkzNWMyODRhYWIyOF8xLTItMS0xLTA_3e390888-1fa8-425f-8a29-9620aa70267f">LIVN</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGFibGU6NmUxMGQxNWUyMTA1NDY3MmE0MzA5MzVjMjg0YWFiMjgvdGFibGVyYW5nZTo2ZTEwZDE1ZTIxMDU0NjcyYTQzMDkzNWMyODRhYWIyOF8xLTMtMS0xLTA_48d59eb2-cc14-426a-b405-3901e2730924">NASDAQ Global Market</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;<ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTIw_2fb80dea-ebbf-45bd-bde6-425ab4dad356">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#9744;</span></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTIx_e54fd1b6-fbaf-4b5b-9691-054244091c06">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#9744;</span></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:125%">&#160;</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGFibGU6OTI4ODJmY2VkNzViNDZiZjljNmY4MjY1OTdkMGViZGMvdGFibGVyYW5nZTo5Mjg4MmZjZWQ3NWI0NmJmOWM2ZjgyNjU5N2QwZWJkY18wLTAtMS0xLTA_1340b91c-1b7e-4adf-ac4d-374a82f2ee3d">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGFibGU6OTI4ODJmY2VkNzViNDZiZjljNmY4MjY1OTdkMGViZGMvdGFibGVyYW5nZTo5Mjg4MmZjZWQ3NWI0NmJmOWM2ZjgyNjU5N2QwZWJkY18xLTMtMS0xLTA_7a701c3e-2688-46cc-af8d-830bc28b3b24">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGFibGU6OTI4ODJmY2VkNzViNDZiZjljNmY4MjY1OTdkMGViZGMvdGFibGVyYW5nZTo5Mjg4MmZjZWQ3NWI0NmJmOWM2ZjgyNjU5N2QwZWJkY18yLTEtMS0xLTA_befec33f-e5d4-4b6a-8c1c-140cf23f143c">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTIy_a8af6ea1-7180-43e2-b7e3-b5cd6caafc9a">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#9745;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.047%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at October 27, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGFibGU6YzgyNDY1OGI5OTg3NDU1OThhODIyN2UyMTIyZTFmZTUvdGFibGVyYW5nZTpjODI0NjU4Yjk5ODc0NTU5OGE4MjI3ZTIxMjJlMWZlNV8xLTAtMS0xLTA_d0dfc065-5961-424b-ab08-76286aa1b8e2">Ordinary Shares&#160;- &#163;1.00&#160;par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5c4b96ff27e4ddeb062ecd5ba74027a_I20201027" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGFibGU6YzgyNDY1OGI5OTg3NDU1OThhODIyN2UyMTIyZTFmZTUvdGFibGVyYW5nZTpjODI0NjU4Yjk5ODc0NTU5OGE4MjI3ZTIxMjJlMWZlNV8xLTEtMS0xLTA_58ee5959-11cb-4adf-a12a-eb4064eb811c">48,596,417</ix:nonFraction></span></td></tr></table></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-indent:9pt"><span><br/></span></div></div></div><div id="i1bf75d3d05544b2db4639291692ac57a_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">LIVANOVA PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">TABLE OF CONTENTS</span></div><div style="margin-bottom:17pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.159%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART&#160;I. FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PAGE NO.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_10">Note About Forward Looking Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_10">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_16">Item&#160;1</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_16">Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_16">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_19">Condensed Consolidated Statements of Income (Loss)</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_19">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_22">Condensed Consolidated Statements of Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_22">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_25">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_25">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_28">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_28">8</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_31">Notes to the Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_31">9</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_94">Item&#160;2</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_94">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_94">31</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_124">Item&#160;3</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_124">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_124">40</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_127">Item&#160;4</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_127">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_127">41</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART&#160;II. OTHER INFORMATION</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_133">Item&#160;1</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_133">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_133">42</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_136">Item 1A</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_136">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_136">42</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_139">Item 2</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_139">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_139">43</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_142">Item 3</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_142">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_142">43</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_145">Item 4</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_145">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_145">43</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_148">Item 5</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_148">Other Information</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_148">43</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_151">Item 6</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_151">Exhibits</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1bf75d3d05544b2db4639291692ac57a_151">44</a></span></div></td></tr></table></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In this Quarterly Report on Form 10-Q, &#8220;LivaNova,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to LivaNova PLC and its consolidated subsidiaries.</span></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">This report may contain references to our proprietary intellectual property, including among others:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:14.5pt">Trademarks for our VNS therapy systems, the VNS Therapy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#160;System, the VITARIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#160;System and our proprietary pulse generator products: Model 102 (Pulse</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">), Model 102R (Pulse Duo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">), Model 103 (Demipulse</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">), Model 104 (Demipulse Duo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">), Model 105 (AspireHC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">), Model 106 (AspireSR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">), Model 1000 (SenTiva</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">) and Model 8103 (Symmetry</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:14.5pt">Trademarks for our Cardiopulmonary product systems: S5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> heart-lung machine, S3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> heart-lung machine, Inspire</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, Heartlink</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, XTRA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> Autotransfusion System, 3T Heater-Cooler</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, Connect&#8482; and Revolution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:14.5pt">Trademarks for our line of surgical tissue and mechanical valve replacements and repair products: Mitroflow</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, Crown PRT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, Solo Smart&#8482;, Perceval</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, Miami Instruments&#8482;, Top Hat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, Reduced Series Aortic Valves&#8482;, Carbomedics&#160;Carbo-Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, Carbo-Seal Valsalva</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, Carbomedics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Standard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, Orbis&#8482; and Optiform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, MEMO 4D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, AnnuloFlo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, AnnuloFlex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, Bicarbon Slimline&#8482;, Bicarbon Fitline&#8482; and Bicarbon Overline</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:14.5pt">Trademarks for our advanced circulatory support systems: TandemLife</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, TandemHeart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, TandemLung</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, ProtekDuo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, and LifeSPARC&#8482;.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:14.5pt">Trademarks for our obstructive sleep apnea system: ImThera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> and Aura6000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:110%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">.</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These trademarks and trade names are the property of LivaNova or the property of our consolidated subsidiaries and are protected under applicable intellectual property laws. Solely for convenience, our trademarks and tradenames referred to in this Quarterly Report on Form 10-Q may appear without the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> symbols, but such references are not intended to indicate in any way that we will not assert, to the fullest extent under applicable law, our rights to these trademarks and tradenames.</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">________________________________________</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2</span></div></div></div><div id="i1bf75d3d05544b2db4639291692ac57a_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">NOTE ABOUT FORWARD LOOKING STATEMENTS</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Certain statements in this Quarterly Report on Form 10-Q, other than purely historical information, are &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). These statements include, but are not limited to, LivaNova&#8217;s plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, our actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as &#8220;may,&#8221; &#8220;could,&#8221; &#8220;seek,&#8221; &#8220;guidance,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;likely,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;plan,&#8221; &#8220;intend,&#8221; &#8220;forecast,&#8221; &#8220;foresee&#8221; or variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based on estimates and assumptions that, while considered reasonable by LivaNova and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements. There are a number of risks, uncertainties and other important factors, many of which are beyond our control, that could cause our actual results to differ materially from the forward-looking statements contained in this Quarterly Report on Form 10-Q, and include but are not limited to the risks and uncertainties summarized below:</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our common stock price;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">activist investors causing disruptions to the business;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our profitability;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory activities and announcements, including the failure to obtain regulatory approvals for our new products;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">effectiveness of our internal controls over financial reporting;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuations in future quarterly operating results;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to comply with, or changes in, laws, regulations or administrative practices affecting government regulation of our products, including, but not limited to, U.S. Food and Drug Administration (&#8220;FDA&#8221;) laws and regulations;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to establish, expand or maintain market acceptance of our products for the treatment of our approved indications;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any legislative or administrative reform to the healthcare system, including the U.S. Medicare or Medicaid systems or international reimbursement systems, that significantly reduces reimbursement for our products or procedures or denies coverage for such products or procedures or enhances coverage for competitive products or procedures, as well as adverse decisions by administrators of such systems on coverage or reimbursement issues relating to our products;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to maintain the current regulatory approvals for our products&#8217; approved indications;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to obtain or maintain coverage and reimbursement for our products&#8217; approved indications;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unfavorable results from clinical studies;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">variations in sales and operating expenses relative to estimates;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our dependence on certain suppliers and manufacturers to provide certain materials, components and contract services necessary for the production of our products;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product liability, intellectual property, shareholder-related, environmental-related, income tax and other litigation, disputes, losses and costs;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">protection, expiration and validity of our intellectual property;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in technology, including the development of superior or alternative technology or devices by competitors;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition from providers of alternative medical therapies, such as pharmaceutical companies and providers of cannabis;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cyber-attacks or other disruptions to our information technology systems;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to comply with applicable U.S. laws and regulations, including federal and state privacy and security laws and regulations;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to comply with applicable non-U.S. laws and regulations;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">non-U.S. operational and economic risks and concerns;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to attract or retain key personnel;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure of new acquisitions to further our strategic objectives or strengthen our existing businesses;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">losses or costs from pending or future lawsuits and governmental investigations;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in accounting rules that adversely affect the characterization of our consolidated financial position, results of operations or cash flows;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in customer spending patterns;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued volatility in the global market and worldwide economic conditions, including volatility caused by Brexit and/or changes to existing trade agreements and relationships between the U.S. and other countries;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks relating to the outbreak and spread of COVID-19 around the world;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in tax laws, including changes related to Brexit, or exposure to additional income tax liabilities;</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">harsh weather or natural disasters that interrupt our business operations or the business operations of our hospital-customers; and</span></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure of the market to adopt new therapies or to adopt new therapies quickly.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other factors that could cause our actual results to differ from our projected results are described in (1) &#8220;Part II, Item 1A. Risk Factors&#8221; and elsewhere in this and our other Quarterly Reports on Form 10-Q, (2) our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (&#8220;2019 Form 10-K&#8221;), (3) our reports and registration statements filed and furnished from time to time with the Securities and Exchange Commission (&#8220;SEC&#8221;) and (4) other announcements we make from time to time.</span></div><div style="margin-bottom:9pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date hereof. We undertake no obligation to update or revise any forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise. You should read the following discussion and analysis in conjunction with our unaudited condensed consolidated financial statements and related notes included elsewhere in this report. Operating results for the three and nine months ended September 30, 2020 are not necessarily indicative of future results, including the full fiscal year. You should also refer to our &#8220;Annual Consolidated Financial Statements,&#8221; &#8220;Notes&#8221; thereto, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and &#8220;Risk Factors&#8221; contained in our 2019 Form 10-K and in our Quarterly Reports on Form 10-Q.</span></div><div style="margin-bottom:6pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Financial Information and Currency of Financial Statements</span></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">All of the financial information included in this quarterly report has been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S.&#8221; and such principles, &#8220;U.S. GAAP&#8221;). The reporting currency of our condensed consolidated financial statements is U.S. dollars.</span></div><div style="margin-bottom:3pt;text-indent:9pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">________________________________________</span></div><div style="margin-bottom:3pt;text-indent:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4</span></div></div></div><div id="i1bf75d3d05544b2db4639291692ac57a_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">PART&#160;I. FINANCIAL INFORMATION</span></div><div id="i1bf75d3d05544b2db4639291692ac57a_16"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Item 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Financial Statements</span></div><div id="i1bf75d3d05544b2db4639291692ac57a_19"></div><div style="margin-bottom:3pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">LIVANOVA PLC AND SUBSIDIARIES</span></div><div style="margin-bottom:3pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)</span></div><div style="margin-bottom:3pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(UNAUDITED)</span></div><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(In thousands, except per share amounts)</span></div><div style="margin-bottom:14pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.514%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.771%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMi0yLTEtMS0w_73888873-6a4a-4d55-96d6-4ac9e317fe47">240,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMi00LTEtMS0w_b708328e-9382-47e1-9ef8-8f3124367f91">268,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMi02LTEtMS0w_8bc058b9-ea56-4c10-9446-ba851a70384e">664,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMi04LTEtMS0w_d377c8b8-f694-4d55-97d7-1559c16bb4f5">796,580</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales - exclusive of amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNC0yLTEtMS0w_3c494328-33f4-4842-883a-eb214c2b6909">86,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNC00LTEtMS0w_f4269994-2a54-47e4-be17-5ebec55d06bc">86,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNC02LTEtMS0w_78ab5cf2-a4a4-4cea-87ef-8566c6764bc7">212,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNC04LTEtMS0w_a0515660-9afc-4b75-8ec6-0ef7d1abd07a">245,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product remediation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:ProductRemediationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNS0yLTEtMS0w_4ee2cd9c-dde5-42f1-91e6-0402c67bfb59">1,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="livn:ProductRemediationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNS00LTEtMS0w_4dd8cc1c-327e-4d3d-ad2a-63275283f9de">3,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:ProductRemediationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNS02LTEtMS0w_876a489e-8711-4a10-bff9-2f6b297bf7c1">6,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="livn:ProductRemediationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNS04LTEtMS0w_6121828e-ff49-4d5e-9f4e-8c5d6c6f8825">11,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNi0yLTEtMS0w_6fc0b15e-df01-492f-880d-77633f057de0">99,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNi00LTEtMS0w_a220c84e-6359-4ba7-93af-7a588788ed89">123,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNi02LTEtMS0w_58aadc6b-1d66-4820-a122-ccdb3a2dff72">317,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNi04LTEtMS0w_cd37e210-e63b-43dd-b872-89ab6c91047c">375,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNy0yLTEtMS0w_1894f19e-8cb2-44bf-b4ba-ce132a5fa62f">47,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNy00LTEtMS0w_95c1b65b-9c5f-4faf-832f-8c41596b0dd1">45,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNy02LTEtMS0w_be1464c1-c341-42c7-a9cc-6beb3c4d0fe0">108,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNy04LTEtMS0w_81812ebe-529d-4cd2-bdcc-1a950f7e4312">124,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger and integration expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfOC0yLTEtMS0w_410f3ba4-cfa6-4882-8b2f-1d5773aa6413">1,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfOC00LTEtMS0w_bbea17b6-0fb7-46bd-ae5c-d6e1412adda7">6,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfOC02LTEtMS0w_16e2d4e6-0087-4684-85e4-5ab20b387844">6,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfOC04LTEtMS0w_f245bda2-a174-4c7f-883d-e3d8de8ea3b9">14,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfOS0yLTEtMS0w_51e276c7-6d8a-4d46-ba78-96bbad1124c5">349</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfOS00LTEtMS0w_6d61241a-d12c-4556-b2fc-531916e21bc3">698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfOS02LTEtMS0w_20353d4b-d98e-459c-b9dd-66691a3e81c1">2,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfOS04LTEtMS0w_58f247fc-59e8-4f7b-b68e-d543c1ecc08c">4,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTAtMi0xLTEtMA_4497b3af-0cd8-4827-9d7f-e20074f54d73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTAtNC0xLTEtMA_1a586335-7607-4365-a6ef-57c9476b6b83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTAtNi0xLTEtMA_7dd77c0e-1da5-4e14-ae6d-e23539cd3a71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTAtOC0xLTEtMA_a44ac694-e92e-4248-a301-5a247294b480">50,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTEtMi0xLTEtMA_3f15f84a-40a8-4be9-88fc-bd1bb4551bac">9,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTEtNC0xLTEtMA_437a3866-bfe2-4733-8947-32284d6a4d01">11,146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTEtNi0xLTEtMA_1ff6b7ed-4377-45cf-89d5-fe2477436772">29,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTEtOC0xLTEtMA_a22fe9c1-576e-43b8-8f5b-c10e86a1438c">29,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation provision, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTItMi0xLTEtMA_9f88bcbd-b53b-4177-b69c-91d1f7571665">2,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTItNC0xLTEtMA_7d8e20ff-579c-4ba1-82dd-9688b84d73be">33,834</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTItNi0xLTEtMA_c480b62a-666d-416d-9cc0-8d633fe096d2">3,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTItOC0xLTEtMA_3e9e870c-dbd6-4674-9db7-2440c8e1f185">33,834</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) income from continuing operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTMtMi0xLTEtMA_6ecde5c0-be1c-44b0-a0b0-d3eec2e0e7c5">7,508</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTMtNC0xLTEtMA_015ae59d-e870-4570-8c10-ae5dd613cd3d">25,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTMtNi0xLTEtMA_42a94055-c103-4c6e-bc7f-42769339656d">22,137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTMtOC0xLTEtMA_dbd14566-bf92-48dc-b308-121942e12f6f">24,894</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTQtMi0xLTEtMA_c3e2d1f7-7dda-44d1-aaab-1c75552ca42b">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTQtNC0xLTEtMA_7ebebaf7-30e0-4b17-b09d-bc56ba8175fa">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTQtNi0xLTEtMA_b8995a7c-7182-49e8-b8e4-f8edd9e33d33">482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTQtOC0xLTEtMA_4fd3ee71-4bee-45ed-86f1-c7a814ff2aae">624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTUtMi0xLTEtMA_e8feb6b0-8216-421f-8634-9b6ad49ed445">14,673</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTUtNC0xLTEtMA_3633f422-eb0d-4af4-934d-05f9ada07e12">4,774</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTUtNi0xLTEtMA_8078332b-499f-4aff-b1c7-72aa2db8790e">25,237</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTUtOC0xLTEtMA_fe8a1d57-f7bd-4856-a616-8a2432596371">10,490</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange and other gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTYtMi0xLTEtMA_b2e30b56-d158-454a-bc85-970bd1b309fb">3,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" name="livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTYtNC0xLTEtMA_27f1cbfb-15a1-4aeb-9b81-f8f39286b720">327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" name="livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTYtNi0xLTEtMA_f9bf53b6-0a28-40f6-9fae-ca403106354d">507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" name="livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTYtOC0xLTEtMA_9d394663-ffae-4049-b0e9-376d6258a05b">795</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from continuing operations before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTctMi0xLTEtMA_56b9bdcf-62bb-4dea-a10c-86e2a37046b4">18,714</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTctNC0xLTEtMA_59820116-7741-4755-a3df-d8efe4999768">21,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTctNi0xLTEtMA_c3bd8974-e870-4785-a4c8-63c5815f9058">46,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTctOC0xLTEtMA_c08c2024-4ccf-4b83-9fb1-0a5fde6257b3">35,555</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTgtMi0xLTEtMA_42efe157-8dfd-4740-809b-8079f40939de">3,990</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTgtNC0xLTEtMA_fd6d1f5f-db04-4507-b535-fd1838333fc3">10,653</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTgtNi0xLTEtMA_d9384950-edc5-44b4-b290-efb0bec4b521">17,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTgtOC0xLTEtMA_83e3529f-b9ed-40a4-9ec2-aa6eca8e192d">23,431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses from equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTktMi0xLTEtMA_8f1810c8-6760-40a2-b0f5-9f2db7a4fa6e">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTktNC0xLTEtMA_dfc905b2-45e7-48b0-bd09-dd9be88c3003">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTktNi0xLTEtMA_7b86fbec-e152-48ff-bdc2-050b6be55dd4">221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTktOC0xLTEtMA_fdd0c4fd-a3e6-4f4e-b8ea-f35b17a12284">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from continuing operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjAtMi0xLTEtMA_a909fdd8-0b4e-479f-87d2-1c9b31fb8291">14,772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjAtNC0xLTEtMA_1dd611b0-1c5a-4afe-bb34-d36d20188cd1">32,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjAtNi0xLTEtMA_bb64ec94-a9b8-4412-8565-6d3a5245f02a">64,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjAtOC0xLTEtMA_9057c294-abe4-4cfd-a628-db4fc1e2c5cd">12,124</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjEtMi0xLTEtMA_b3b5526e-dd18-4a68-a279-cf4514ed193b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjEtNC0xLTEtMA_128cdabb-331c-4bd9-b06c-9006cd7dab75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjEtNi0xLTEtMA_86279b8a-7c37-4203-99b8-348776150362">995</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjEtOC0xLTEtMA_a1f8a0b0-3a5c-4565-8da2-c89dcfdec55e">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjItMi0xLTEtMA_62d4444f-bda9-41ba-94f9-ea814f7a8224">14,772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjItNC0xLTEtMA_23004a56-ac1d-48a4-8bb8-33fcb6b13313">32,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjItNi0xLTEtMA_635074bc-a9e9-40e7-ba28-e8d326e22514">65,182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjItOC0xLTEtMA_d6745ced-29f1-4712-b0c6-4fb84dd893e7">11,946</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic (loss) income per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjUtMi0xLTEtMA_ca14f938-018e-41bd-b63e-cb1f3e436fb7">0.30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjUtNC0xLTEtMA_6f249268-f626-49bf-a35a-c02367953753">0.66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjUtNi0xLTEtMA_3d6ea665-6e2a-45d4-b076-8b8eb821343a">1.32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjUtOC0xLTEtMA_364db6a9-c458-43be-95a6-14302687eeca">0.25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjYtMi0xLTEtMA_a8406609-9d63-4df6-b2af-d97a3bb29357">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="2" format="ixt:zerodash" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjYtNC0xLTEtMA_127a54e9-16db-426b-b5e8-06cd90602fd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjYtNi0xLTEtMA_c182d87a-9ade-4420-a085-5898b4b67d5e">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="2" format="ixt:zerodash" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjYtOC0xLTEtMA_daa81265-9396-459d-bcbb-407a1ac066d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjctMi0xLTEtMA_12898ac2-9844-4ba6-9c90-5d5d35346123">0.30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjctNC0xLTEtMA_21fcb6d1-b757-44cb-beab-6e6cb7469eca">0.66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjctNi0xLTEtMA_541c6346-2649-4554-9731-c012cef26a36">1.34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjctOC0xLTEtMA_25ea5db0-50ff-4421-a9d0-26071411febf">0.25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted (loss) income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzAtMi0xLTEtMA_3897a58f-e29e-4026-ad8c-d5274e72a7fe">0.30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzAtNC0xLTEtMA_0cc79f80-5dbe-40ee-8388-4f990296a641">0.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzAtNi0xLTEtMA_85f0f279-0e54-47e0-a60c-e6e52e6925ce">1.32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzAtOC0xLTEtMA_3e67bd86-b2af-4434-882a-7af6ca25307f">0.25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzEtMi0xLTEtMA_48c3385b-7934-4020-9f6b-56ce81a9548f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="2" format="ixt:zerodash" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzEtNC0xLTEtMA_b33234f1-a860-4bb1-956b-ca4de2cac0ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzEtNi0xLTEtMA_bc25a112-0ffb-4f06-a2de-434abd09a848">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="2" format="ixt:zerodash" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzEtOC0xLTEtMA_692f9905-b21a-42c2-8150-3e1d3c9a64f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzItMi0xLTEtMA_f2c027d2-0863-44f0-9f7c-f3244cdceb5e">0.30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzItNC0xLTEtMA_a5469d56-3dff-4e89-8ef8-2cf30c63db49">0.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzItNi0xLTEtMA_c4775589-d91c-4031-9dff-aef8bbb8f354">1.34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzItOC0xLTEtMA_b2f9f0e1-4735-440c-bfef-42295f7edd4c">0.25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing basic (loss) income per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzQtMi0xLTEtMA_7c12ae20-5425-46ae-9a24-6d7438a1c00f">48,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzQtNC0xLTEtMA_20fa9c19-c84b-4422-b11f-45da877d668f">48,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzQtNi0xLTEtMA_f940caa2-b821-40ac-b59a-4eaa0ba5e816">48,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzQtOC0xLTEtMA_7a902816-50d9-4dca-9274-41d27987fe23">48,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing diluted (loss) income per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzUtMi0xLTEtMA_2f1ca099-a984-421b-9980-ba0f38b9d446">48,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzUtNC0xLTEtMA_8f204425-d664-4c9d-bd00-bf7bed9df27c">48,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzUtNi0xLTEtMA_88b24c58-6904-4e85-961e-a63894781df1">48,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzUtOC0xLTEtMA_71544a00-085a-4b2d-88ee-e2cb847924d4">48,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">See accompanying notes to the condensed consolidated financial statements</span></div><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">5</span></div></div></div><div id="i1bf75d3d05544b2db4639291692ac57a_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="margin-bottom:3pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">LIVANOVA PLC AND SUBSIDIARIES</span></div><div style="margin-bottom:3pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">CONDENSED CONSOLIDATED STATEMENTS OF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">COMPREHENSIVE INCOME (LOSS)</span></div><div style="margin-bottom:3pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(UNAUDITED)</span></div><div style="margin-bottom:3pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(In thousands)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:34.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfMi0yLTEtMS0w_62d4444f-bda9-41ba-94f9-ea814f7a8224">14,772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfMi00LTEtMS0w_23004a56-ac1d-48a4-8bb8-33fcb6b13313">32,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfMi02LTEtMS0w_635074bc-a9e9-40e7-ba28-e8d326e22514">65,182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfMi04LTEtMS0w_d6745ced-29f1-4712-b0c6-4fb84dd893e7">11,946</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized gain (loss) on derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNC0yLTEtMS0w_987ca709-b32a-4695-b8c1-94363c736385">1,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNC00LTEtMS0w_a50753c0-b8ab-4143-a21a-2ee248706882">870</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNC02LTEtMS0w_28a51827-8c94-486b-80ad-c4240f824f4e">1,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNC04LTEtMS0w_5ac079db-e727-4308-8bde-71406b946d7d">665</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNS0yLTEtMS0w_903e626a-8a28-440e-82ca-cd018d0c6a81">393</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNS00LTEtMS0w_5eca29ce-87c7-4d67-8e10-fd787566c1ab">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNS02LTEtMS0w_2ca22d6e-50a9-4b73-9f18-79ea10b2d773">314</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNS04LTEtMS0w_dd784584-04f7-47f9-8858-be13f08d56ac">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNi0yLTEtMS0w_67f06007-0484-4840-ab1d-f6d4d4678a14">1,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNi00LTEtMS0w_d3b6d93d-7a56-43bc-84d6-852c4a1dc195">661</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNi02LTEtMS0w_9fdf2e05-059b-4b1e-80a2-b6d292451a80">999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNi04LTEtMS0w_98fc3fd2-36f4-4ac2-97fb-47a98398a106">506</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNy0yLTEtMS0w_6e3698d1-5760-4f52-b2a3-be613fd1eae9">23,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNy00LTEtMS0w_f315b07e-c3fe-43de-b2b2-3d97ae2fabe5">27,775</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNy02LTEtMS0w_4dd50b66-1305-4eb0-8b5b-481806973171">8,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNy04LTEtMS0w_1e775ea0-bf75-4147-8ca2-bab5b88e3269">16,628</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfOC0yLTEtMS0w_2dfa516d-c37c-436a-8844-94fe9655e7a4">24,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfOC00LTEtMS0w_c64f1fdd-8476-4fd0-bce8-e8e4b98bd4a3">28,436</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfOC02LTEtMS0w_77972933-119a-4c89-94c3-306582d456b4">9,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfOC04LTEtMS0w_4ed744b4-2ac6-46ac-8c2b-2cdfe9129e02">17,134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfOS0yLTEtMS0w_5bdf1727-1278-41d6-8242-a36d07776d43">9,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfOS00LTEtMS0w_8be83b49-c4cd-4023-83f3-4c51ef13e8cc">3,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfOS02LTEtMS0w_042ef546-d713-46d0-99b9-18808f0bc9a3">56,175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfOS04LTEtMS0w_7bf49585-3d01-4886-991c-0c44e7f22465">29,080</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">See accompanying notes to the condensed consolidated financial statements</span></div><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">6</span></div></div></div><div id="i1bf75d3d05544b2db4639291692ac57a_25"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="margin-bottom:3pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIVANOVA PLC AND SUBSIDIARIES</span></div><div style="margin-bottom:3pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONDENSED CONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BALANCE SHEETS</span></div><div style="margin-bottom:3pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(UNAUDITED)</span></div><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands, except share amounts)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.986%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.131%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.135%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 5.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Current Assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMy0yLTEtMS0w_bd73e834-7132-4d7c-a3bf-5761dee589f6">227,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMy00LTEtMS0w_345cd795-5b80-45a0-a47f-27248cfad935">61,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance of $<ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNC0wLTEtMS0wL3RleHRyZWdpb246MThjOGMxNWIyMTM2NGQ4ZmJjNDBhNTM3MjgyNWJjNmVfNDU_fde24d94-d4a0-4e7e-9d4a-b9b66ca36779">16,241</ix:nonFraction> at September 30, 2020 and $<ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNC0wLTEtMS0wL3RleHRyZWdpb246MThjOGMxNWIyMTM2NGQ4ZmJjNDBhNTM3MjgyNWJjNmVfNjk_75238c56-0c18-4daa-acb4-caacf7eb4414">13,105</ix:nonFraction> at December 31, 2019</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNC0yLTEtMS0w_7202a229-cd7d-4f1a-9116-2152ff5bee48">191,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNC00LTEtMS0w_49135421-d868-48a8-89db-b5f02f0eed35">257,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNS0yLTEtMS0w_ca34fcd1-b8e1-4a63-a7f7-934d15f7a4ed">178,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNS00LTEtMS0w_f2e3b82e-c6a5-485b-a2d5-715edfd81198">164,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and refundable taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNi0yLTEtMS0w_4c53dd4f-6b15-4b46-bde3-ce2a129803cc">43,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNi00LTEtMS0w_beaf040f-3042-4fc5-bcb3-f22578d87698">37,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNy0yLTEtMS0w_0174f6c7-b374-4bd2-b24b-5f17faf3123d">32,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNy00LTEtMS0w_b80ced88-b0d3-4bbb-8d28-c2f4b899f79b">28,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Current Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfOC0yLTEtMS0w_4e16d892-76a1-4e30-af3e-49b40115b7a6">673,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfOC00LTEtMS0w_7e64f0bc-da45-4c39-a99d-c18a671a3f62">549,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfOS0yLTEtMS0w_07aeef33-720f-4d20-b713-24d87ce7c22c">190,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfOS00LTEtMS0w_7d327cfa-475a-42c4-9c20-68a40bb9f31e">181,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTAtMi0xLTEtMA_3a9598a9-4df7-4b6f-9fb0-13c9d37f80e9">918,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTAtNC0xLTEtMA_3f57ae20-e302-4120-b351-3e916eb0c98e">915,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTEtMi0xLTEtMA_46da2dc5-6d6e-4c4f-8861-d53ce36f161f">583,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTEtNC0xLTEtMA_11419dc7-05e5-48e1-a8e3-d696688214d0">607,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTItMi0xLTEtMA_d8a094ea-ecfa-4786-92dc-878b36178b78">52,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTItNC0xLTEtMA_5f8d4b4e-68df-45e8-9884-dc4ac3dc3307">54,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTMtMi0xLTEtMA_7f057dfe-1c81-4ad6-95c4-ddc21ca28447">30,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTMtNC0xLTEtMA_e2609067-213a-4a69-9ac1-603012baa6fe">27,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTQtMi0xLTEtMA_4c0859c8-7720-4907-a66a-a0e6b0e526e4">22,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTQtNC0xLTEtMA_c9bfb83f-1d5b-469b-915a-296041ac9424">68,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTUtMi0xLTEtMA_ff715312-ef2b-48b2-a97f-af86c55baeb9">49,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTUtNC0xLTEtMA_e45d6884-9364-434c-a572-b1af3f99d24d">7,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTYtMi0xLTEtMA_6865815c-0532-47a4-8f76-e394da67a3ec">2,521,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTYtNC0xLTEtMA_4db120ee-e600-4565-8bb9-f8428fba3547">2,411,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current debt obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTktMi0xLTEtMA_9b758d72-836e-44ce-9955-ebb5ff9476d4">13,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTktNC0xLTEtMA_511ad651-00bb-4b04-b2d6-73862f0f74e7">77,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjAtMi0xLTEtMA_39e3e57e-8b3c-466b-8bd3-764d7c56d7e2">71,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjAtNC0xLTEtMA_1a6272c8-de2b-4b99-9543-2f06ddfb0f4c">85,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjEtMi0xLTEtMA_14733a44-0579-49c5-9b95-ed73d69f6566">98,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjEtNC0xLTEtMA_4e16cc75-f865-40a4-bcdb-a70595decd74">120,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current litigation provision liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualCarryingValueCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjItMi0xLTEtMA_92e3cb35-99e7-4497-b0e8-94c19a23eb0d">34,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualCarryingValueCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjItNC0xLTEtMA_21a4a7d3-7b6a-462a-bd8d-ea8598432d08">146,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjMtMi0xLTEtMA_2e1e0e81-c772-472a-8212-323d3d2cdfac">10,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjMtNC0xLTEtMA_d5abb643-c80a-4e7f-9831-abd67b84c729">12,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued employee compensation and related benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjQtMi0xLTEtMA_acd36841-55e0-40fc-b22a-88f17265ac63">52,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjQtNC0xLTEtMA_005aa986-9225-40ae-a232-3c7b065ed38f">70,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Current Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjUtMi0xLTEtMA_f07c98f0-5b6d-4096-b854-203524366b1e">281,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjUtNC0xLTEtMA_bfbe64ad-6050-4ed8-b200-97a866be3e3e">512,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjYtMi0xLTEtMA_2c9e0638-caa2-42b3-a520-45a63b0246e4">637,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjYtNC0xLTEtMA_eee1b82a-0b7d-405c-871f-ff7dc731e23f">260,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjctMi0xLTEtMA_e7803fd5-306c-4aae-a89e-1a3d2e875d2d">79,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjctNC0xLTEtMA_48c76a15-3bdc-4502-96fc-08139bd56597">114,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation provision liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualCarryingValueNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjgtMi0xLTEtMA_4e0e061d-9482-4a59-bb35-385123e171ec">11,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualCarryingValueNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjgtNC0xLTEtMA_39e8de90-fdca-43b4-8105-efef28db41d0">24,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjktMi0xLTEtMA_3061d102-cdcb-431e-beda-8c1de2494bab">28,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjktNC0xLTEtMA_ec736d2b-0e56-4b89-8c9f-ac63f6e1bc57">32,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzAtMi0xLTEtMA_c0d22597-b81c-4279-90d1-29703603c61b">43,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzAtNC0xLTEtMA_4d318182-d71b-4b9e-803d-e5f0711670c0">46,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term employee compensation and related benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzEtMi0xLTEtMA_cfab0ea5-9292-499d-8898-40d994c784e4">23,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzEtNC0xLTEtMA_6cfded1e-f4a6-4f60-9745-7b1e7ad7ee97">22,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzItMi0xLTEtMA_afc52a9f-cc0f-494a-badc-83fdc4b78384">59,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzItNC0xLTEtMA_98a8b4bb-5473-465e-ba30-9c53b4aee660">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzMtMi0xLTEtMA_b55e8c06-07af-4a93-afe7-6562955ea508">6,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzMtNC0xLTEtMA_8bc13327-d785-4b24-8738-0a6b23ff46c1">15,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzQtMi0xLTEtMA_b9c8ee27-75d0-480f-becb-85eb4a462ec9">1,170,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzQtNC0xLTEtMA_567aa86b-f8dd-494b-adee-57af0f6b1ee5">1,028,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzUtMi0xLTEtMA_b8816143-c6bd-4f8a-839e-9951cba0cdef"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzUtNC0xLTEtMA_2af9a29a-3903-42c1-9fa3-471df75f0dd7"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Stockholders&#8217; Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ordinary Shares, &#163;<ix:nonFraction unitRef="gbpPerShare" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjFlMWFhOWU2ZGNlNjRhNzRiN2NlYjdlMTM0ZTQ5NDBlXzIx_a79f4b9c-59b6-4c5f-9591-818d46a775b9"><ix:nonFraction unitRef="gbpPerShare" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjFlMWFhOWU2ZGNlNjRhNzRiN2NlYjdlMTM0ZTQ5NDBlXzIx_ac81ebf2-9947-4564-a157-916336804812">1.00</ix:nonFraction></ix:nonFraction> par value: unlimited shares authorized; <ix:nonFraction unitRef="shares" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjFlMWFhOWU2ZGNlNjRhNzRiN2NlYjdlMTM0ZTQ5NDBlXzY0_1293ec01-010a-4f56-b2d3-12f27981a1f3">49,402,628</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjFlMWFhOWU2ZGNlNjRhNzRiN2NlYjdlMTM0ZTQ5NDBlXzg1_52d907d4-def4-4728-941e-10129bcbb919">48,596,417</ix:nonFraction> shares outstanding at September 30, 2020; <ix:nonFraction unitRef="shares" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjFlMWFhOWU2ZGNlNjRhNzRiN2NlYjdlMTM0ZTQ5NDBlXzEyNQ_97e83f5b-fab3-45f4-9d41-ffac36be14ce">49,411,016</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjFlMWFhOWU2ZGNlNjRhNzRiN2NlYjdlMTM0ZTQ5NDBlXzE0Ng_c935756b-0ae3-4daa-8045-664e5fcb9fc0">48,443,830</ix:nonFraction> shares outstanding at December 31, 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzctMi0xLTEtMA_ada93424-9b70-4206-9769-6cedacd36e8e">76,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzctNC0xLTEtMA_91cca2d2-0c68-46b2-b213-a7303213ff23">76,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzgtMi0xLTEtMA_10f97444-2b46-44da-87be-906c00915bba">1,758,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzgtNC0xLTEtMA_62222782-4ff9-41c2-9feb-e1d33d2240cb">1,734,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzktMi0xLTEtMA_ee83454c-527b-4c45-a0f8-58cf9f3fc2df">10,385</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzktNC0xLTEtMA_6d2a8a92-ca85-4819-92e9-e4c9379ea2c0">19,392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDAtMi0xLTEtMA_ddd9be1a-fae5-4e6e-83fc-8d3cb87bbc52">472,576</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDAtNC0xLTEtMA_092c5037-4ff6-4da7-b864-d58b635ee002">406,755</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock at cost, <ix:nonFraction unitRef="shares" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOjIxNzA2NTdhNmY3NDQ2YTQ5YWQyYTM1M2Q4MDI1NjQ5XzI4_b42db590-d1d3-425f-b079-88e63171bd65">806,211</ix:nonFraction> ordinary shares at September 30, 2020; <ix:nonFraction unitRef="shares" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOjIxNzA2NTdhNmY3NDQ2YTQ5YWQyYTM1M2Q4MDI1NjQ5XzY1_99268987-e737-4f6a-bee7-a2ba52696a42">967,186</ix:nonFraction> ordinary shares at December 31, 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDEtMi0xLTEtMA_1ef42a05-d7e0-4ab8-8424-e6e75e139e75">1,053</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDEtNC0xLTEtMA_c2917f55-2a06-46d3-8ead-96a3d71e47e0">1,263</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDItMi0xLTEtMA_2056aeb1-ef0c-4c4d-be62-b9fd3e0be102">1,350,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDItNC0xLTEtMA_01605ce4-a958-43fa-b0fc-05c10b6e759e">1,383,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDMtMi0xLTEtMA_1789972f-885a-4db9-909e-ff4afaf9ddb9">2,521,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDMtNC0xLTEtMA_d5211b53-e19b-4eca-998a-77127ecef55d">2,411,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">See accompanying notes to the condensed consolidated financial statements</span></div><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">7</span></div></div></div><div id="i1bf75d3d05544b2db4639291692ac57a_28"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">LIVANOVA PLC AND SUBSIDIARIES</span></div><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">CONDENSED CONSOLIDATED STATEMENTS OF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">CASH FLOWS</span></div><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(UNAUDITED)</span></div><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(In thousands)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.710%"><tr><td style="width:1.0%"></td><td style="width:66.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.161%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.164%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Activities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMy0yLTEtMS0w_531ccb63-e41c-46cd-b024-3db204ba79f7">65,182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMy00LTEtMS0w_9c952639-4c7c-4b2d-a546-6a53ec8f1bef">11,946</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash items included in net loss:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax expense (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNS0yLTEtMS0w_1601948a-d427-46a6-a062-4e1536e3930d">41,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNS00LTEtMS0w_e08917eb-74a5-474c-afb3-a904e399234b">26,422</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remeasurement of contingent consideration to fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNi0yLTEtMS0w_72180580-5aaf-427d-ad57-9bafeea32828">31,176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNi00LTEtMS0w_6ff4b055-ab01-4dcd-b3c7-443045f75d75">2,425</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNy0yLTEtMS0w_a8d2f84f-57b4-4e6c-8a6c-46a2fbeb957b">29,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNy00LTEtMS0w_bd627b1f-9c7a-4b0c-9ad7-edbceda0a6f2">29,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfOC0yLTEtMS0w_f7701f17-b893-4d83-a496-0c0fca31dd89">26,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfOC00LTEtMS0w_fa7b3bcb-b2be-44d9-806d-23b81d12c43f">24,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfOS0yLTEtMS0w_40a12e0f-7560-452d-9f2d-799c05a406d4">22,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfOS00LTEtMS0w_89fb788f-c178-4885-886a-4723170a2c0d">23,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remeasurement of derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:RemeasurementOfCappedCallAndEmbeddedExchangeFeature" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTAtMi0xLTEtMA_f9c9b9a1-8fbe-44bb-a016-8d4e4d7f299a">17,654</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="livn:RemeasurementOfCappedCallAndEmbeddedExchangeFeature" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTAtNC0xLTEtMA_3202863a-bbea-4490-9f83-bd4f9a4bf3f1">2,948</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of operating lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTEtMi0xLTEtMA_932d5273-63a6-4147-b81a-c016ea9ace61">9,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTEtNC0xLTEtMA_7ca5cf58-4ac4-4e2d-9ae8-aceb4e13f93f">8,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment of intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTMtMi0xLTEtMA_9410367c-fdff-43bb-ace5-be02f9ca1621">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTMtNC0xLTEtMA_fa927ef7-7482-488a-8c9d-218f4487edb5">50,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTUtMi0xLTEtMA_3122a3a8-a8dd-4de1-98db-cd837ca9d293">5,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTUtNC0xLTEtMA_260c4558-fb4a-4723-bd69-eb15bd640201">7,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTctMi0xLTEtMA_a29e996d-d7c8-4d18-89c5-f7a7dc96cf31">65,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTctNC0xLTEtMA_49d15c1d-84ea-45de-9d3a-e36ae0261e89">5,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTgtMi0xLTEtMA_f44e0277-3b12-4c8e-b6a5-495fe8652c79">12,141</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTgtNC0xLTEtMA_05c9b792-8809-4284-96cb-38d0360d5c77">18,181</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current and non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTktMi0xLTEtMA_50c281cf-f765-467f-bfbf-2dd3cce0da50">15,360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTktNC0xLTEtMA_ba0f1c87-a14d-4578-9007-9809d5038db5">9,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued current and non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjAtMi0xLTEtMA_6469fec1-3ebb-4863-8be5-9572d2e984d7">49,547</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjAtNC0xLTEtMA_b673ff07-16cc-4e1f-8cc1-9c350d425265">28,964</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjEtMi0xLTEtMA_f0345b81-9dab-4e8c-bb51-4687c76aa896">615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjEtNC0xLTEtMA_d7272e53-5e25-4c2b-b09a-e55a3a80daf2">14,367</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation provision liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:IncreaseDecreaseInLitigationProvisionLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjItMi0xLTEtMA_b4d4db71-c6ba-435c-8127-c6db59697da8">124,158</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="livn:IncreaseDecreaseInLitigationProvisionLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjItNC0xLTEtMA_f01449da-4b19-4e7f-9788-4af6ba9e27fc">140,823</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring reserve</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInRestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjMtMi0xLTEtMA_655feeff-f15e-430c-a86f-1a5bb0c5583c">1,194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInRestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjMtNC0xLTEtMA_2de4cd50-1313-4e81-87d2-2d3f76c5f3ff">6,766</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjQtMi0xLTEtMA_276fd868-78cd-4551-bc9b-8968881b1926">116,407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjQtNC0xLTEtMA_6be20588-560a-44b3-b855-1e3503cbe767">94,008</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjYtMi0xLTEtMA_df6e0add-b483-4fcf-b442-01008252dcd2">28,445</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjYtNC0xLTEtMA_611a2524-1c95-44be-abd6-af9d132754cd">16,801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:PurchasesOfInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjctMi0xLTEtMA_0fffa8f4-4830-4160-94cf-ec3ee62ad6b1">3,175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" name="livn:PurchasesOfInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjctNC0xLTEtMA_b2ac6499-78e8-45cc-9f79-c34a72999868">287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loans to investees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireNotesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjgtMi0xLTEtMA_9611fbbc-b469-427e-a32e-785e7f0013ae">2,250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireNotesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjgtNC0xLTEtMA_10cd3260-9f3f-4abe-9796-41a9b6e7f9fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjktMi0xLTEtMA_803a66d4-541a-4a56-b157-b8a1f1503843">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjktNC0xLTEtMA_998b4dfb-83ca-4f12-b2da-08d5ddcb983a">10,750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzAtMi0xLTEtMA_5f5a3c88-fd39-48df-8e60-345df8faff22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzAtNC0xLTEtMA_0f485300-dc33-493e-a703-bf5883cc863e">3,186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzItMi0xLTEtMA_1cf50c4b-68e0-4e79-961b-84171d6adcc9">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzItNC0xLTEtMA_6c742d9f-02dc-4217-bce7-b1a9af6340bb">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzMtMi0xLTEtMA_5b0f9f2a-8406-44a7-9713-d0d96c40ecb2">33,337</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzMtNC0xLTEtMA_e26ce6f1-a8cd-4c93-a60d-339d71ab4fa5">30,519</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from long-term debt obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzUtMi0xLTEtMA_c6960f04-188f-4b6b-b0ff-b1d8416735db">886,899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzUtNC0xLTEtMA_1eb42d33-8596-403b-adde-75965b67952f">193,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of long-term debt obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzYtMi0xLTEtMA_44b71a23-ddef-4905-9c21-6f4a59c144a0">481,360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzYtNC0xLTEtMA_89ed63ce-fed9-40b5-a5c4-b18259ec2781">12,330</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from short term borrowings (maturities greater than 90 days)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzctMi0xLTEtMA_7166ff47-171e-4f23-a984-e295eb58c5cf">46,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzctNC0xLTEtMA_8597ae75-e8c6-425d-847c-2a64e88e05e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of short term borrowings (maturities greater than 90 days)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzgtMi0xLTEtMA_1c0eb4e4-5e97-4d68-8537-628ae5c7063d">44,838</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzgtNC0xLTEtMA_bc75e280-9afc-4615-b8df-00c68a828e5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of capped call</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzktMi0xLTEtMA_a3277a90-1c1c-4842-8563-49ef82f5b0b6">43,096</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzktNC0xLTEtMA_c877a79c-4f1b-43c1-8348-e78352a22504">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDAtMi0xLTEtMA_529486be-6e0f-4a0c-b767-4102decc993b">20,412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDAtNC0xLTEtMA_4d64380c-dbac-4fc1-9ef5-2ac882f59359">3,795</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing adjustment payment for sale of CRM business</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:PaymentForDispositionOfBusinessClosingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDEtMi0xLTEtMA_08905518-5c38-44d2-b7bc-1c232569d53b">14,891</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="livn:PaymentForDispositionOfBusinessClosingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDEtNC0xLTEtMA_5407568f-5b81-4557-bc19-ceb071be4aa5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payment of contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDItMi0xLTEtMA_0c65216b-7e86-4efc-89e2-3e638504eab2">8,860</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDItNC0xLTEtMA_8a4417b8-6b7c-4ed2-8d7c-307c1833eed7">17,989</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares repurchased from employees for minimum tax withholding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDMtMi0xLTEtMA_7892fe33-5f54-4f59-89bc-389890fff9bf">5,277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDMtNC0xLTEtMA_85f06b46-2545-4b87-b524-3fddd85eb450">6,183</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from share issuances under ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDQtMi0xLTEtMA_5d21ba0d-5ef0-46c9-8e30-6c555cd6a35a">2,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDQtNC0xLTEtMA_498c685d-0c14-4dba-a15c-5da5b145b7e3">2,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in short-term borrowing, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDUtMi0xLTEtMA_355ac296-7851-4d7f-8c1c-a0c98a2780f5">1,043</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDUtNC0xLTEtMA_3181fa28-021c-425b-800f-5796fcca35a1">2,173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDctMi0xLTEtMA_a5054aa0-c0d6-4426-88bf-f7a410386286">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDctNC0xLTEtMA_f7b1c0b3-b758-4fe6-9d61-2c4a79222262">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDgtMi0xLTEtMA_5bfd4cc5-1b15-4bfd-b0e8-b6ecf96ad816">315,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDgtNC0xLTEtMA_39619e55-82ca-4d1d-944b-169ef8c8990f">153,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDktMi0xLTEtMA_591e6703-fd70-45d6-852e-bc9359bf4db4">491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDktNC0xLTEtMA_13159553-2db0-4f3d-a0ec-4ed7803fe123">1,105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNTAtMi0xLTEtMA_89d929ef-d9f1-4ac7-85fc-d5a06234d104">166,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNTAtNC0xLTEtMA_a8bc9386-62ca-4275-bda7-8f105c3f2c6c">28,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNTEtMi0xLTEtMA_f3108375-8211-407e-b8f8-fecb629a9d80">61,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic94ddff991844d7bb182464410e337c2_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNTEtNC0xLTEtMA_dbfc3c0d-c48e-4c0c-ab07-65e9ef5e95b3">47,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNTItMi0xLTEtMA_e21d5c8d-1311-4ad6-8119-9bd11a02b00b">227,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cb9957d3e1b407bb88290f6a94e712e_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNTItNC0xLTEtMA_518f1556-df5d-4a49-8b6f-a6f13283bf54">75,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">See accompanying notes to the condensed consolidated financial statements</span></div><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">8</span></div></div></div><div id="i1bf75d3d05544b2db4639291692ac57a_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIVANOVA PLC AND SUBSIDIARIES</span></div><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div id="i1bf75d3d05544b2db4639291692ac57a_34"></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8zNC9mcmFnOjZhNmE1Yjg2ODFjODRlZWVhZmE1NTcxN2FlYTFhOTJiL3RleHRyZWdpb246NmE2YTViODY4MWM4NGVlZWFmYTU1NzE3YWVhMWE5MmJfMzg0ODI5MDcwMDIyMg_6409b096-0680-46fb-8dc6-50f4b8a7673e" continuedAt="i2d4cd84e7c304903bf21be581bdf4264" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 1. Unaudited Condensed Consolidated Financial Statements </span></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8zNC9mcmFnOjZhNmE1Yjg2ODFjODRlZWVhZmE1NTcxN2FlYTFhOTJiL3RleHRyZWdpb246NmE2YTViODY4MWM4NGVlZWFmYTU1NzE3YWVhMWE5MmJfMjczOA_d0a93c42-6bb3-4572-9cda-05d706bff35f" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Basis of Presentation </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The accompanying condensed consolidated financial statements of LivaNova as of, and for the three and nine months ended September 30, 2020 and 2019, have been prepared in accordance with U.S. GAAP for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. The accompanying condensed consolidated balance sheet of LivaNova at December 31, 2019 has been derived from audited financial statements contained in our 2019 Form 10-K, but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, the condensed consolidated financial statements reflect all adjustments (consisting of only normal recurring adjustments) considered necessary for a fair statement of the operating results of LivaNova and its subsidiaries, for the three and nine months ended September 30, 2020, and are not necessarily indicative of the results that may be expected for the year ending December 31, 2020. The financial information presented herein should be read in conjunction with the audited consolidated financial statements and notes thereto accompanying our 2019 Form 10-K.</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Recent Developments Regarding COVID-19</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Due to the COVID-19 pandemic (&#8220;COVID-19&#8221;), we have experienced and may continue to experience significant and unpredictable reductions in the demand for our products as healthcare customers have diverted medical resources and priorities towards the treatment of COVID-19. In addition, public health bodies have delayed elective procedures during the COVID-19 pandemic, which has negatively impacted the usage of our products, including the number of Neuromodulation procedures. Further, some people are avoiding seeking treatment for non-COVID-19 emergency procedures, which has also negatively impacted the demand for our products. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We are seeing signs of stabilization in certain geographies as elective surgeries resume and expect this trend to continue on a global basis during the fourth quarter of 2020. We expect elective procedure recovery rates to vary by country, and to be impacted by COVID-19 case volumes, hospital occupancy and staffing levels, patient&#8217;s willingness to re-book previously deferred procedures, travel restrictions, transportation limitations, quarantine restrictions, economic uncertainty and potential COVID-19 resurgence. </span></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8zNC9mcmFnOjZhNmE1Yjg2ODFjODRlZWVhZmE1NTcxN2FlYTFhOTJiL3RleHRyZWdpb246NmE2YTViODY4MWM4NGVlZWFmYTU1NzE3YWVhMWE5MmJfMzg0ODI5MDcwMDIyMQ_22d393d1-4982-4c72-b654-8c2eb6ce621f" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Reclassifications</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We have reclassified certain prior period amounts for comparative purposes. These reclassifications did not have a material effect on our financial condition, results of operations or cash flows.</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Significant Accounting Policies</span></div></ix:nonNumeric><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><ix:continuation id="i2d4cd84e7c304903bf21be581bdf4264">Our significant accounting policies are detailed in &#8220;Note 2. Basis of Presentation, Use of Accounting Estimates and Significant Accounting Policies&#8221; and &#8220;Note 3. Revenue Recognition&#8221; of our 2019 Form 10-K.</ix:continuation> </span></div><div style="text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_37"></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8zNy9mcmFnOjY1MzY5MmNkYzg4ZDQ5NjQ5ZjU5OGYzMWNjZjMxOGY1L3RleHRyZWdpb246NjUzNjkyY2RjODhkNDk2NDlmNTk4ZjMxY2NmMzE4ZjVfMzg0ODI5MDY5ODczNA_ec491498-544a-41bd-b96f-70b58fc4b9e5" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 2. Business Combinations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Miami Instruments </span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On June 12, 2019, we acquired the minimally invasive cardiac surgery instruments business from Miami Instruments, LLC (&#8220;Miami Instruments&#8221;) for cash consideration of up to&#160;$<ix:nonFraction unitRef="usd" contextRef="i1f504bd55c7f46eabe71635e913521f3_D20190612-20190612" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8zNy9mcmFnOjY1MzY5MmNkYzg4ZDQ5NjQ5ZjU5OGYzMWNjZjMxOGY1L3RleHRyZWdpb246NjUzNjkyY2RjODhkNDk2NDlmNTk4ZjMxY2NmMzE4ZjVfMTk5_2da87bda-b4f9-48df-a90b-7b0e6e7d73bd">17.0</ix:nonFraction> million. The related operations have been integrated into our Cardiovascular segment as a part of our Heart Valves business. Cash of&#160;$<ix:nonFraction unitRef="usd" contextRef="i69653e79e7a64b74bafe17de62d7f7e7_I20190612" decimals="-5" format="ixt:numdotdecimal" name="livn:BusinessCombinationUpfrontCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8zNy9mcmFnOjY1MzY5MmNkYzg4ZDQ5NjQ5ZjU5OGYzMWNjZjMxOGY1L3RleHRyZWdpb246NjUzNjkyY2RjODhkNDk2NDlmNTk4ZjMxY2NmMzE4ZjVfMzI3_6ccc8b88-e9dc-4f5d-aa82-6415687f9d9d">10.8</ix:nonFraction> million&#160;was paid at closing with up to&#160;$<ix:nonFraction unitRef="usd" contextRef="i69653e79e7a64b74bafe17de62d7f7e7_I20190612" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8zNy9mcmFnOjY1MzY5MmNkYzg4ZDQ5NjQ5ZjU5OGYzMWNjZjMxOGY1L3RleHRyZWdpb246NjUzNjkyY2RjODhkNDk2NDlmNTk4ZjMxY2NmMzE4ZjVfMzYx_47a1cd0b-ed7b-4733-9177-eb88558e3407">6.0</ix:nonFraction> million&#160;in contingent consideration based on achieving certain milestones. The purchase price allocation for the Miami Instruments acquisition was finalized during the second quarter of 2020 and resulted in no measurement period adjustments. In connection with this acquisition, we recognized $<ix:nonFraction unitRef="usd" contextRef="id8f318fd9c2147bba4d88a7c4b055ba5_D20190612-20190612" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8zNy9mcmFnOjY1MzY5MmNkYzg4ZDQ5NjQ5ZjU5OGYzMWNjZjMxOGY1L3RleHRyZWdpb246NjUzNjkyY2RjODhkNDk2NDlmNTk4ZjMxY2NmMzE4ZjVfNjQ5_7cbda0c3-f3e7-40dc-9912-62e374b0de5c">14.7</ix:nonFraction> million in developed technology and in-process research and development (&#8220;IPR&amp;D&#8221;) intangible assets and $<ix:nonFraction unitRef="usd" contextRef="i69653e79e7a64b74bafe17de62d7f7e7_I20190612" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8zNy9mcmFnOjY1MzY5MmNkYzg4ZDQ5NjQ5ZjU5OGYzMWNjZjMxOGY1L3RleHRyZWdpb246NjUzNjkyY2RjODhkNDk2NDlmNTk4ZjMxY2NmMzE4ZjVfNzQ4_c97ab84b-8dfe-4518-8722-10892427b7eb">1.5</ix:nonFraction> million in goodwill.</span></div></ix:nonNumeric><div style="text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_40"></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80MC9mcmFnOmVlMmEwYmY0ZDg1OTRiYmFiNWI3NjEzOWZmMGFjNTVhL3RleHRyZWdpb246ZWUyYTBiZjRkODU5NGJiYWI1Yjc2MTM5ZmYwYWM1NWFfMzg0ODI5MDY5NzczMQ_efab8da1-a45b-4e5c-9aae-7c1ed50e4171" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 3. Discontinued Operations </span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On April 30, 2018, we completed the sale of our Cardiac Rhythm Management (&#8220;CRM&#8221;) business to MicroPort Cardiac Rhythm B.V. and MicroPort Scientific Corporation (&#8220;MicroPort&#8221;) for total cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="i08c3b67a02214a92852d8412d52b746a_D20180430-20180430" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80MC9mcmFnOmVlMmEwYmY0ZDg1OTRiYmFiNWI3NjEzOWZmMGFjNTVhL3RleHRyZWdpb246ZWUyYTBiZjRkODU5NGJiYWI1Yjc2MTM5ZmYwYWM1NWFfMjIx_1bdc69b4-236a-4f29-8893-b59d506ff480">195.9</ix:nonFraction> million, less cash transferred of $<ix:nonFraction unitRef="usd" contextRef="i08c3b67a02214a92852d8412d52b746a_D20180430-20180430" decimals="-5" format="ixt:numdotdecimal" name="livn:BusinessCombinationConsiderationTransferredCashTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80MC9mcmFnOmVlMmEwYmY0ZDg1OTRiYmFiNWI3NjEzOWZmMGFjNTVhL3RleHRyZWdpb246ZWUyYTBiZjRkODU5NGJiYWI1Yjc2MTM5ZmYwYWM1NWFfMjUw_7b214fd4-4cb3-438f-bc4b-754a208592a8">9.2</ix:nonFraction> million, subject to a closing working capital adjustment. In March 2020, we finalized the working capital adjustment and as a result, made a $<ix:nonFraction unitRef="usd" contextRef="i4ab5cac60220483ca5a3b38de23752fc_D20200101-20200331" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80MC9mcmFnOmVlMmEwYmY0ZDg1OTRiYmFiNWI3NjEzOWZmMGFjNTVhL3RleHRyZWdpb246ZWUyYTBiZjRkODU5NGJiYWI1Yjc2MTM5ZmYwYWM1NWFfMzg2_3a439553-0f80-4398-9007-c201697e18fb">16.4</ix:nonFraction> million payment to MicroPort during the first quarter of 2020 and incurred an additional $<ix:nonFraction unitRef="usd" contextRef="i4ab5cac60220483ca5a3b38de23752fc_D20200101-20200331" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80MC9mcmFnOmVlMmEwYmY0ZDg1OTRiYmFiNWI3NjEzOWZmMGFjNTVhL3RleHRyZWdpb246ZWUyYTBiZjRkODU5NGJiYWI1Yjc2MTM5ZmYwYWM1NWFfNDcw_d4b0610d-c62e-4847-9e8c-18efe96a3c59">1.0</ix:nonFraction> million loss on sale, net of a $<ix:nonFraction unitRef="usd" contextRef="i4ab5cac60220483ca5a3b38de23752fc_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80MC9mcmFnOmVlMmEwYmY0ZDg1OTRiYmFiNWI3NjEzOWZmMGFjNTVhL3RleHRyZWdpb246ZWUyYTBiZjRkODU5NGJiYWI1Yjc2MTM5ZmYwYWM1NWFfNDk2_cca36e57-e490-4e6b-bb3f-0d80e317f05b">0.1</ix:nonFraction>&#160;million tax benefit.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_46"></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RleHRyZWdpb246ZTg1Yzg4MTgwMmQ1NDYyMWI1Y2RhODkyOTVkOTMwYTRfMzg0ODI5MDY5NzgyOQ_76a40e67-6981-43e7-8474-50f149ea14e6" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 4. Restructuring</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We initiate restructuring plans to leverage economies of scale, streamline distribution and logistics, and strengthen operational and administrative effectiveness in order to reduce overall costs. Costs associated with these plans were reported as restructuring expenses in the operating results of our condensed consolidated statements of income (loss). </span></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RleHRyZWdpb246ZTg1Yzg4MTgwMmQ1NDYyMWI1Y2RhODkyOTVkOTMwYTRfNjAy_2d2695db-4d2a-42fe-9ff4-724620aa96f4" escape="true"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides a reconciliation of the beginning and ending balance of the accruals and other reserves recorded in connection with our restructuring plans included within accrued liabilities and other and other long-term liabilities on the condensed consolidated balance sheet (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:49.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Severance and Other Termination Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f970e37f06645c8bb2539c0ce87edde_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfMS0yLTEtMS0w_b775852f-aab1-4f17-a09d-cc1e595c9e3c">4,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7f12aa7ec264fe2ab35709629de067f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfMS00LTEtMS0w_4062e48e-a53a-407e-8ce6-daf89915a092">1,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aeacf1e4fc34783813482eebf05252b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfMS02LTEtMS0w_f772e64b-cc4b-4851-b808-19c00ad87658">5,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12f68e91043344bb9a9cb86689638ce5_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfMi0yLTEtMS0w_58d84067-4a6b-4d3b-b089-c5f54bf431d2">2,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99471d80dbd54b8ca36fd7bd75e616dd_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfMi00LTEtMS0w_60ace299-42d9-4b2f-bcf8-b6493a320f6a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8925322bbe234c77aa2e0c9256cd4f36_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfMi02LTEtMS0w_f2c1d173-7719-471f-95b7-62e4c6b7949b">2,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12f68e91043344bb9a9cb86689638ce5_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfMy0yLTEtMS0w_480db3ed-531f-4ab3-9d97-123a34b62dbb">4,880</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99471d80dbd54b8ca36fd7bd75e616dd_D20200101-20200930" decimals="-3" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfMy00LTEtMS0w_07801deb-066e-4f0a-950f-d956a0d4329d">792</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8925322bbe234c77aa2e0c9256cd4f36_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfMy02LTEtMS0w_2b02b381-0c4f-4028-b794-f0b5779da860">5,672</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e139d91fc8464a99b88353610cdeb2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfNC0yLTEtMS0w_2f346274-4a13-4781-a484-1bcf589444e1">1,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf00cfbfb795463ab27948e6d4c4253d_I20200930" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfNC00LTEtMS0w_7d7ff45b-933d-4ca5-8d66-ebe18895b182">608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i970f46cb12124b12bfb14bea4df49ada_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfNC02LTEtMS0w_c3a118dd-3797-478f-98c9-46f3142623b8">1,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:right"><span><br/></span></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RleHRyZWdpb246ZTg1Yzg4MTgwMmQ1NDYyMWI1Y2RhODkyOTVkOTMwYTRfNTk5_fcfa55a9-6df6-4a3e-8a46-f00d4e016054" escape="true"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table presents restructuring expense by reportable segment (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:34.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i013558d2b17c4355a92da0429952dd67_D20200701-20200930" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfMi0yLTEtMS0w_b8914b56-c94b-4650-bbf6-3d6aade0c97d">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f84b9a1406f4d1a801a8a1795c932dc_D20190701-20190930" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfMi00LTEtMS0w_2675fc26-8014-430f-ace8-dd42bace5d46">783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2fad0d02b3e4a0ab6a60f67969ec28b_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfMi02LTEtMS0w_5ff9574f-ec4c-4602-8eba-e796feb098f0">1,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i197004b99655439cada3d2fa6e98f33e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfMi04LTEtMS0w_336f89a4-862b-47a0-ab41-8f80b696b279">1,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f208ad6ec8402f80aac6618e1de718_D20200701-20200930" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfMy0yLTEtMS0w_2184d5a7-b987-4201-aef2-7f7b8c7183e5">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9faf33d672ba42d18cdfe76fdead2b2d_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfMy00LTEtMS0w_225405c6-a744-412f-a712-8b799687fbfd">171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c4ddeb948eb4c4dbe320a14c7ae3792_D20200101-20200930" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfMy02LTEtMS0w_db489576-9a26-4327-85fe-e4edb92a09d3">851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac495534370345098798ba8c26b009ac_D20190101-20190930" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfMy04LTEtMS0w_1f569eb5-73a3-4edb-8579-99ff4640b272">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21d96c5da2404625a9ee4885a17ebf0c_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfNC0yLTEtMS0w_054d0dd2-f27a-4544-a0ec-321211e4d989">401</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc2e1e69df7e4a1d8c750a08dcb83a44_D20190701-20190930" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfNC00LTEtMS0w_faaacec1-464a-4ca5-8d5b-09eb11602cfd">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i753478d430024138b30d3d04687e7eb7_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfNC02LTEtMS0w_fb84ce06-c650-4350-b1f1-ef46b92dcd52">91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e6560d12b2f434fa22d653edaa72cd8_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfNC04LTEtMS0w_656582aa-3724-4703-bd88-a0d7c61afcb8">2,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfNS0yLTEtMS0w_9e423d1d-eae9-4da9-9863-0d208c864a3d">349</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfNS00LTEtMS0w_f971cc02-a84c-42e2-8f5b-f869080ead6e">698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfNS02LTEtMS0w_ced6d134-2f0e-4277-a37f-10ae0ce82804">2,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfNS04LTEtMS0w_df08941b-23f2-4741-873a-1bd2bacfac1c">4,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_49"></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="livn:ProductRemediationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RleHRyZWdpb246YWViYjFiMTc5MDJlNGRhNWEzOWM1MTlmM2E0NGQ3NDRfMzg0ODI5MDcwMTg3NA_f06925a5-4406-4566-97de-b85e20e115d3" continuedAt="i422011e6d4974587b9e9dd63d1fa0a9e" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 5. Product Remediation Liability</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On December 29, 2015, we received an FDA Warning Letter (the &#8220;Warning Letter&#8221;) alleging certain violations of FDA regulations applicable to medical device manufacturing at our Munich, Germany and Arvada, Colorado facilities. On October 13, 2016, the CDC and FDA separately released safety notifications regarding 3T Heater-Cooler devices in response to which we issued a Field Safety Notice Update for U.S. users of our 3T Heater-Cooler devices to proactively and voluntarily contact facilities to facilitate implementation of the CDC and FDA recommendations.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">At December 31, 2016, we recognized a liability for a product remediation plan related to our 3T Heater-Cooler device (&#8220;3T device&#8221;). The remediation plan consists primarily of a modification of the 3T device design to include internal sealing and the addition of a vacuum system to new and existing devices. These changes are intended to address regulatory actions and to reduce further the risk of possible dispersion of aerosols from 3T devices in the operating room. We concluded that it was probable that a liability had been incurred upon management&#8217;s approval of the plan and the commitments made by management to various regulatory authorities globally in November and December 2016, and furthermore, the cost associated with the plan was reasonably estimable. The deployment of this solution for commercially distributed devices has been dependent upon final validation and verification of the design changes and approval or clearance by regulatory authorities worldwide. It is reasonably possible that our estimate of the remediation liability could materially change in future periods due to the various significant assumptions involved such as customer behavior, market reaction and the timing of approvals or clearance by regulatory authorities worldwide.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In April 2017, we obtained CE Mark in Europe for the design change, and in May 2017 we completed our first vacuum canister and internal sealing upgrade on a customer-owned device. In October 2018, the FDA concluded that we could commence the vacuum canister and internal sealing upgrade program in the U.S., and on February 25, 2020, LivaNova received clearance for K191402, a 510(k) for the 3T devices that addressed issues contained in the 2015 Warning Letter along with design changes that further mitigate the potential risk of aerosolization. Concurrent with this clearance, (1) 3T devices manufactured in accordance with K191402 will not be subjected to the import alert previously issued by the FDA and (2) LivaNova initiated a correction to distribute the updated Operating Instructions cleared under K191402. We continue to implement the vacuum canister and internal sealing upgrade program in as many countries as possible until all devices are upgraded.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:continuation id="i422011e6d4974587b9e9dd63d1fa0a9e"><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> As a second part of the remediation plan, we continue to offer a no-charge deep disinfection service (deep cleaning service) for 3T device users as we receive the required regulatory approvals. The deep disinfection service was rolled out in Europe in the second half of 2015, and in April 2018, the FDA agreed to allow us to move forward with the deep cleaning service in the U.S., thereby adding to the growing list of countries around the world in which we offer this service. Finally, we continue to offer the loaner program for 3T devices, initiated in the fourth quarter of 2016, to provide existing 3T device users with a new loaner 3T device at no charge pending regulatory approval and implementation of the vacuum system addition and deep disinfection service worldwide. </span></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="livn:ScheduleofProductRemediationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RleHRyZWdpb246YWViYjFiMTc5MDJlNGRhNWEzOWM1MTlmM2E0NGQ3NDRfNDY0OQ_e37abf05-16ea-449d-9d33-5b1e6a1d7aa2" escape="true"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides a reconciliation of the beginning and ending balance of the product remediation liability included within accrued liabilities and other on the condensed consolidated balance sheet (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="livn:ProductRemediationNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RhYmxlOmIzNzhmMDRmNzU1MzRhNmFiZDNmNDFkODA5MzM3ZjVjL3RhYmxlcmFuZ2U6YjM3OGYwNGY3NTUzNGE2YWJkM2Y0MWQ4MDkzMzdmNWNfMC0yLTEtMS0w_2789956e-af4f-417a-b034-31cbaf16372e">3,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:ProductRemediationAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RhYmxlOmIzNzhmMDRmNzU1MzRhNmFiZDNmNDFkODA5MzM3ZjVjL3RhYmxlcmFuZ2U6YjM3OGYwNGY3NTUzNGE2YWJkM2Y0MWQ4MDkzMzdmNWNfMS0yLTEtMS0w_af59d5b4-6b94-45b2-bd8f-b5294eb8cde0">2,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remediation activity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:ProductRemediationPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RhYmxlOmIzNzhmMDRmNzU1MzRhNmFiZDNmNDFkODA5MzM3ZjVjL3RhYmxlcmFuZ2U6YjM3OGYwNGY3NTUzNGE2YWJkM2Y0MWQ4MDkzMzdmNWNfMi0yLTEtMS0w_8e4115b9-b110-4a36-8c94-987fd3d3a58c">3,982</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in foreign currency exchange rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" name="livn:ProductRemediationForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RhYmxlOmIzNzhmMDRmNzU1MzRhNmFiZDNmNDFkODA5MzM3ZjVjL3RhYmxlcmFuZ2U6YjM3OGYwNGY3NTUzNGE2YWJkM2Y0MWQ4MDkzMzdmNWNfMy0yLTEtMS0w_1114fcdf-7351-4554-947b-67be249c4651">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:ProductRemediationNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RhYmxlOmIzNzhmMDRmNzU1MzRhNmFiZDNmNDFkODA5MzM3ZjVjL3RhYmxlcmFuZ2U6YjM3OGYwNGY3NTUzNGE2YWJkM2Y0MWQ4MDkzMzdmNWNfNC0yLTEtMS0w_3ee73966-9c26-4336-90de-fc1827df3486">1,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We recognized product remediation expenses of $<ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="livn:ProductRemediationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RleHRyZWdpb246YWViYjFiMTc5MDJlNGRhNWEzOWM1MTlmM2E0NGQ3NDRfNDAzMA_238d18c1-b8af-4588-89d8-10865a2c3521">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="livn:ProductRemediationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RleHRyZWdpb246YWViYjFiMTc5MDJlNGRhNWEzOWM1MTlmM2E0NGQ3NDRfNDAzNw_1c9598b6-b789-402c-a046-db45d6805ab9">3.1</ix:nonFraction> million during the three months ended September 30, 2020 and 2019, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="livn:ProductRemediationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RleHRyZWdpb246YWViYjFiMTc5MDJlNGRhNWEzOWM1MTlmM2E0NGQ3NDRfNDA2Mg_2fee82e2-0d19-4fa5-807a-ac82caeb2b7a">6.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="livn:ProductRemediationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RleHRyZWdpb246YWViYjFiMTc5MDJlNGRhNWEzOWM1MTlmM2E0NGQ3NDRfNDA2OQ_23b71730-10ec-44b6-9262-2255c2775ce4">11.1</ix:nonFraction> million during the nine months ended September 30, 2020 and 2019, respectively. Product remediation expenses include internal labor costs, costs to remediate certain inspectional observations made by the FDA at our Munich facility and costs associated with the incorporation of the modification of the 3T device design into the next generation 3T device. These costs and related legal costs are expensed as incurred and are not included within the product remediation liability presented above. At September&#160;30, 2020, our balance sheet includes a&#160;$<ix:nonFraction unitRef="usd" contextRef="ia4743b9cbc8b413f864fd07a5e2fad89_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RleHRyZWdpb246YWViYjFiMTc5MDJlNGRhNWEzOWM1MTlmM2E0NGQ3NDRfNDU0MQ_a9f4cf8d-7a27-4807-870f-8a4a02ece91f">46.3</ix:nonFraction> million&#160;provision related to litigation involving our 3T device. For further information, please refer to &#8220;Note 10. Commitments and Contingencies.&#8221;</span></div></ix:continuation><div style="text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_52"></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:InvestmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RleHRyZWdpb246YzkyNTJmMzA2OWFjNDgwM2I1MjUzMjNhNGU1YmFmODdfMzg0ODI5MDY5OTEyMg_8b9778d9-f054-4954-8463-a231a3c544de" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 6. Investments</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table details the carrying value of our investments in equity securities of non-consolidated affiliates without readily determinable fair values for which we do not exert significant influence over the investee. These equity investments are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. <ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RleHRyZWdpb246YzkyNTJmMzA2OWFjNDgwM2I1MjUzMjNhNGU1YmFmODdfMTg5OQ_cf6ff2b3-da7b-4d42-b943-44dc6fdfdbbe" continuedAt="i1f09185e891d4b24a3d8797f1cd98ff6" escape="true">The below equity investments are included in investments on the condensed consolidated balance sheets (in thousands):</ix:nonNumeric></span></div><ix:continuation id="i1f09185e891d4b24a3d8797f1cd98ff6"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:58.371%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity Investments Without Readily Determinable Fair Values</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Respicardia Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafea0951c2c545c9aa85f9c8daadd17f_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMS0yLTEtMS0w_76dcca31-3bd0-41a7-8432-a3c6ed22c273">17,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60b29926fecf4b70b1dc7c7cd0baf605_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMS00LTEtMS0w_be7acf77-f31e-4161-8318-78bbe8ce4894">17,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALung Technologies, Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51565454f75d4bebb38194ffedb9b20a_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMi0yLTEtMS0w_cbcd1bf1-8993-44af-97a7-d150a203fafc">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2185fe191cce4a66865bde068329982b_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMi00LTEtMS0w_d294bf02-4dd2-4393-b480-9771b7e05c83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceribell, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic98b76cf08a64b6da1b29b2c251fc766_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMy0yLTEtMS0w_8edc6f04-032c-4ed2-b0f3-89209d2405ea">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf583348934e447b97b6b58fd72f1047_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMy00LTEtMS0w_64507087-0b16-4d9e-bb92-94034f07bb15">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ShiraTronics, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i985d7bd469a442c080589425a8443701_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfNC0yLTEtMS0w_f6df3bca-5b95-4852-9c21-8a03b562223f">2,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5ecded17b340c89b0e638f6ae6ffc2_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfNC00LTEtMS0w_8504c162-4ce8-41f9-bd0b-95b12f88b1cb">2,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MD Start II</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia943f93887004f2e973f75f871756f34_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfNS0yLTEtMS0xNzA4_dc2fec31-9b14-4761-9ec3-90fd1a7e6470">1,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddd07ea8a3bb43fcaa80fd42e2b6af83_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfNS00LTEtMS0xNzA4_49750130-6a0b-468f-bf77-c8ecbc035279">1,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rainbow Medical Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7070af18fef45169cea3d61e672378d_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfNS0yLTEtMS0w_ad670935-4db8-4c81-bd97-ff2610b963b3">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i128dd12840304fb7a5186325c995dc74_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfNS00LTEtMS0w_1804998f-7e65-497d-a9d9-6c17697c9ed9">1,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Highlife S.A.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cc59c39d408424fa8ec43642bdefae4_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfNy0yLTEtMS0w_711395c1-1446-4ec0-8570-ab4b25ed538d">1,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67e02e6f525d49d79d1e1378eefccbaa_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfNy00LTEtMS0w_65afcba0-1bb5-41ed-b8f1-888d68d5a116">1,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43bc731c38504f9a9bf794876a9512db_I20200930" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfOC0yLTEtMS0w_ee996330-ec03-447e-9b2c-4805d1bfc884">770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cfb30f9c2da4bd98ce29047f95daaf6_I20191231" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfOC00LTEtMS0w_bd0f1c2f-df1f-4b63-b46c-af2ce169674c">770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfOS0yLTEtMS0w_2b86763c-7ad7-466d-90d3-2adf03738669">29,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfOS00LTEtMS0w_aa3a95e7-ceb5-4adc-bd00-79031324e595">26,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMTAtMi0xLTEtMA_f5765c66-b1a3-480a-aa05-16e4d43bdd7f">414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMTAtNC0xLTEtMA_3b2034df-a328-42e0-aa6b-99c1ddc3c62c">451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMTEtMi0xLTEtMA_9421b9b1-9437-42a9-88ae-5b5fde3aac1b">30,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMTEtNC0xLTEtMA_27c39834-2f1d-4e07-b6ec-a69ca9680347">27,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Respicardia Inc. (&#8220;Respicardia&#8221;) is a privately funded U.S. company developing an implantable device designed to restore a more natural breathing pattern during sleep in patients with central sleep apnea by transvenously stimulating the phrenic nerve. We have a loan outstanding to Respicardia, with a carrying amount of $<ix:nonFraction unitRef="usd" contextRef="ib244d5c1647445c98706515b46ea2376_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RleHRyZWdpb246YzkyNTJmMzA2OWFjNDgwM2I1MjUzMjNhNGU1YmFmODdfODk0_99e4055a-2eb9-4c6c-81fa-053473207d72">0.8</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$<ix:nonFraction unitRef="usd" contextRef="i90db8675b50e452bb4dbe535ff672f26_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RleHRyZWdpb246YzkyNTJmMzA2OWFjNDgwM2I1MjUzMjNhNGU1YmFmODdfOTAx_aa6249f9-8c39-40a0-86e5-ddcb58fbbc27">0.6</ix:nonFraction> million as of September&#160;30, 2020 and December 31, 2019, respectively, which is included in prepaid expenses and other current assets on the condensed consolidated balance sheet.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">During the first quarter of 2020, we invested in ALung Technologies, Inc. (&#8220;ALung&#8221;). ALung is a privately held medical device company focused on creating advanced medical devices for treating respiratory failure. ALung&#8217;s Hemolung Respiratory Assist System is a dialysis-like alternative or supplement to mechanical ventilation which removes carbon dioxide directly from the blood in patients with acute respiratory failure. During the second quarter of 2020, we provided a convertible loan to ALung for $<ix:nonFraction unitRef="usd" contextRef="i798dba76d2144cabb6adb775c4a1aa5f_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesReceivableGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RleHRyZWdpb246YzkyNTJmMzA2OWFjNDgwM2I1MjUzMjNhNGU1YmFmODdfMTUzNA_2b361ef2-4469-46fc-ab2e-367ce15d7254">2.0</ix:nonFraction>&#160;million, due July 10, 2021. As of September&#160;30, 2020, the carrying amount of the loan was $<ix:nonFraction unitRef="usd" contextRef="i282f7e855f164edab83c60ade72f1e8f_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RleHRyZWdpb246YzkyNTJmMzA2OWFjNDgwM2I1MjUzMjNhNGU1YmFmODdfMTgwNw_9b619324-d7ce-40f6-986e-fdddc617d915">2.0</ix:nonFraction> million, which is included in prepaid expenses and other current assets on the condensed consolidated balance sheet.</span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_55"></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMzg0ODI5MDcwMjYwMQ_6980e13e-0803-4aa4-8302-b1326d752e9e" continuedAt="i077916323cac4f3ead140c55eeb19cee" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 7. Fair Value Measurements</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We review the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain securities within the fair value hierarchy. There were no transfers between Level 1, Level 2, or Level 3 during the nine months ended September 30, 2020 and 2019.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfNTM0NQ_9ef7688f-1e23-4d7b-8da7-12f8f0f3ba0f" escape="true"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following tables provide information by level for assets and liabilities that are measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;Value Measurements Using Inputs Considered as:</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets - designated as cash flow hedges (foreign currency exchange rate &#8220;FX&#8221;)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c6523bc48a447b5869e52fba0cea6f3_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMy0yLTEtMS0w_35b1dcab-706f-4557-b9f5-ed9f6d0ce7a8">1,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0d8e86523634968b1908339ac891144_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMy00LTEtMS0w_17596ff2-3423-431e-a413-e550959f11ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff29d74ec51a43d3b79a5db568d853f2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMy02LTEtMS0w_435e7d24-82f4-454e-a256-545a336aefc2">1,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfefd2b87cb44284867538a460fdec64_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMy04LTEtMS0w_cb39851f-880a-4352-bcb9-57ee4fd5c21a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets - freestanding instruments (FX)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad74017afa848158b4bcf23299630ba_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNC0yLTEtMS0w_9637e335-9108-4180-adde-1b661a88d8e6">4,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53cdeb7e70b46e0a9df7e343e1c8dc7_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNC00LTEtMS0w_19e962cc-51a7-4362-a76d-85770d100d8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i549d9fe1d5694fea83f1cb9a0116d9c3_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNC02LTEtMS0w_3b070539-f463-4b51-a042-e76cd034561a">4,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf3cde6d556f43229f6017b4b0296fb3_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNC04LTEtMS0w_3c14d505-43f2-4697-bef3-920cc84b0496">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets - capped call derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ea2a2977bf428dbe55a0a62f1d8f39_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNS0yLTEtMS0w_1af3b9df-3c06-4084-9286-5ed0ccf1873d">38,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477ef411a1da4a87828daf96a443478a_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNS00LTEtMS0w_8a85b65a-eef9-42dc-a53e-82f9e571819c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i604c8c94f78e401b9a10ebc3406a262d_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNS02LTEtMS0w_26c90407-c253-4d08-959d-fc980940031b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71b0960ca5b40b79de0620646d77218_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNS04LTEtMS0w_6f4ce28f-785c-496c-873b-72eea0ba61c9">38,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1920c569d03f4b2981551f7c9fa3f2dc_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReceivablesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNi0yLTEtMS0w_e273e496-4b97-4992-90cc-73068cf7955f">2,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i651e6f1d58d6444c89e41097aa3c93d2_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ReceivablesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNi00LTEtMS0w_2cb70e52-0cdf-4bd3-a7d4-a0487710137a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb5a207f947a447b8d9aaf5128bccb8e_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ReceivablesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNi02LTEtMS0w_0ceae1cc-cfd9-4190-815a-f869232afb75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic60029069ad0424ebdeeedac7260aaf9_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReceivablesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNi04LTEtMS0w_16b5a90e-acca-4bb9-b24c-e6d5cb41d9ba">2,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1920c569d03f4b2981551f7c9fa3f2dc_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNy0yLTEtMS0w_fdf2e9e2-59db-44c2-ac6f-57dec6b3aa88">47,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i651e6f1d58d6444c89e41097aa3c93d2_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNy00LTEtMS0w_e56e9939-bd8b-48ee-adfa-bfbb9dca38f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb5a207f947a447b8d9aaf5128bccb8e_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNy02LTEtMS0w_fb40721b-2a79-4234-a49a-e3d803e1e4aa">5,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic60029069ad0424ebdeeedac7260aaf9_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNy04LTEtMS0w_eed3cabb-be4b-4726-bbf3-f811fec9ff31">41,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - freestanding instruments (interest rate swaps)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7955e6392f00489b9c7c6bd1a5a7b4a6_I20200930" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTEtMi0xLTEtMA_90019866-0f68-493c-9402-d635ed64b98e">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb02064dc544327a00b12a199681a45_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTEtNC0xLTEtMA_189eb7cf-6afd-4f9e-bd61-47d8a19bfd6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223528d062ef4c2d8c27572caa395a07_I20200930" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTEtNi0xLTEtMA_505dd3e3-d113-4c12-807f-7c833668bbf5">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a279cef16854d728efd76005ca4b872_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTEtOC0xLTEtMA_f10a4101-a0f2-4c9c-8891-253d52e7014f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - freestanding instruments (FX) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad74017afa848158b4bcf23299630ba_I20200930" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTItMi0xLTEtMA_87e95021-5ae4-43b2-9d1b-f8c901c30690">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53cdeb7e70b46e0a9df7e343e1c8dc7_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTItNC0xLTEtMA_42d6423e-04d5-488b-9903-e2fa766b1459">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i549d9fe1d5694fea83f1cb9a0116d9c3_I20200930" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTItNi0xLTEtMA_a8c83f1f-1041-431b-92bf-6590413aca6c">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf3cde6d556f43229f6017b4b0296fb3_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTItOC0xLTEtMA_ba835604-7d80-4e51-ae6b-c342c0f54f78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - embedded exchange feature</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148d72eb7ca9457d9c7534140ff8b8e6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTMtMi0xLTEtMA_a2f87088-d760-45b6-9de3-edfbf948501c">59,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3dabef6c1fc45838407928a7edc982a_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTMtNC0xLTEtMA_e92769ab-c473-476f-8847-60bff359bcdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dab210d1ff74635af037320edfe69b2_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTMtNi0xLTEtMA_8dc82cd6-62e5-4d89-8201-db407e9f05b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7515b98bfc884d4c8e81ba14f06c1998_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTMtOC0xLTEtMA_c7abd5e2-9f9e-4747-8f32-53abc1556948">59,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i874c5b66a97e468981139b4c21d7eefa_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTQtMi0xLTEtMzA3Ng_01b90eb1-78cf-4c79-818a-f54e92f7202e">1,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e3b083fb0b3450ea7ce586ffdd675e6_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTQtNC0xLTEtMzA3OA_7fac008a-2064-4f0c-b16f-337b9986b400">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a2fef709db4b8e8534fc2dc8e08119_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTQtNi0xLTEtMzA4MA_f0096e54-bf5c-4051-9fae-1813a512f86e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e9ceed79d04c9eb93f32768de95ec9_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTQtOC0xLTEtMjMxOA_065e284d-2056-435d-81a7-1612661c5a70">1,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration arrangements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1920c569d03f4b2981551f7c9fa3f2dc_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTQtMi0xLTEtMA_4c28a022-ce7b-4ff9-97a0-02f3d4138a17">96,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i651e6f1d58d6444c89e41097aa3c93d2_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTQtNC0xLTEtMA_33a5a19b-a281-483d-aec1-72b4a47ad32e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb5a207f947a447b8d9aaf5128bccb8e_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTQtNi0xLTEtMA_38950dfb-dea0-491a-97c9-d204344a103a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic60029069ad0424ebdeeedac7260aaf9_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTQtOC0xLTEtMA_eacc933e-fba3-4206-8c8b-c5fbf38bac2c">96,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1920c569d03f4b2981551f7c9fa3f2dc_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTUtMi0xLTEtMA_c8975e77-3528-4288-852a-cb1766ddcf60">157,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i651e6f1d58d6444c89e41097aa3c93d2_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTUtNC0xLTEtMA_196e9ff5-4d5b-4c3a-8c59-4101946d68d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb5a207f947a447b8d9aaf5128bccb8e_I20200930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTUtNi0xLTEtMA_abbf1ed2-a4c6-47de-a612-df4d6f866247">224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic60029069ad0424ebdeeedac7260aaf9_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTUtOC0xLTEtMA_de8132e4-e937-4a80-be94-08a5f5a1b6fa">156,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;Value Measurements Using Inputs Considered as:</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets - designated as cash flow hedges (FX)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f293b751409438c9ba2c7b3dc48dffc_I20191231" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMy0yLTEtMS0w_b6b27383-7755-4bdc-8193-b13a66e6f5e0">535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6b52afe363e4fe9a4d0f3237689efc2_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMy00LTEtMS0w_7babca43-011d-4860-84bd-042d6d4b95db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aba2a40c6324508a183965eccf45b95_I20191231" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMy02LTEtMS0w_792113f5-bce4-4f57-a6b4-dc560c475984">535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa9c677be2ba4b7080abc459f6cb49e2_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMy04LTEtMS0w_86201b90-e08b-41fb-b9fc-8b3536fb0d4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets - freestanding instruments (FX)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c78a1ebb503459eb3095a7afc63295b_I20191231" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfNC0yLTEtMS0w_162df00d-876d-4437-a048-8cc675523eb1">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7db9636c721460b95675081b95ae6b6_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfNC00LTEtMS0w_c5cd9332-a240-4fc5-a29a-68eb7ccb6885">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95ed7028bea74431b97651e632a47b6b_I20191231" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfNC02LTEtMS0w_89e1eae9-f7ec-4f7b-95d9-fbcdca62d816">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcbcc74327d845ba8fc6a1532ba4b344_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfNC04LTEtMS0w_21d91523-12e0-490f-a71f-3a4251f245f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib087b2c401cc4c3d8384b3a48fcd1329_I20191231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfNS0yLTEtMS0w_9c2e12f5-de5a-4529-9a46-607867d6ec25">561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i692bbffae945465da30a96cc3773a545_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfNS00LTEtMS0w_591140b5-48a7-485d-8fc2-a6717b70232d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71ba4ba85c34d5486646e473787face_I20191231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfNS02LTEtMS0w_5f06436e-a875-4cd4-9635-291cf89ba0c0">561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e6eaa19ee7d48d686b0f7478549e4f3_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfNS04LTEtMS0w_498d35cd-d6b5-4ad2-a415-b5348724df1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - designated as cash flow hedges (FX)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f293b751409438c9ba2c7b3dc48dffc_I20191231" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfOC0yLTEtMS0w_d51e7f5c-8b1e-422e-9ca7-6df9c94d4a49">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6b52afe363e4fe9a4d0f3237689efc2_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfOC00LTEtMS0w_9881d1d0-a5ca-4883-a225-877faf383518">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aba2a40c6324508a183965eccf45b95_I20191231" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfOC02LTEtMS0w_a23c03e2-742d-4d21-b9ae-3d92cbe3d2ad">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa9c677be2ba4b7080abc459f6cb49e2_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfOC04LTEtMS0w_51ac823a-961e-4886-bfaa-af77a36a54dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - designated as cash flow hedges (interest rate swaps)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41752121b3454d50a55318982c498675_I20191231" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfOS0yLTEtMS0w_fabb684b-1c14-423b-84ce-b472f1e67ac4">374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cdbf2725d5841b0b9507ecf33848425_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfOS00LTEtMS0w_0fbdb451-48d5-4aa4-a4b1-57c993fc898f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a4cad9c20ed4f459594fbf97ec48b93_I20191231" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfOS02LTEtMS0w_39747586-8618-4f99-a1fe-6c7455710cb4">374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ae71915c9d485e834f0858c4a5ae25_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfOS04LTEtMS0w_826c5d1b-0b39-4a60-b922-8a635cae1d59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - freestanding instruments (FX) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c78a1ebb503459eb3095a7afc63295b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTAtMi0xLTEtMA_209a27e8-5fc7-40ce-846f-1cb1c482eae8">3,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7db9636c721460b95675081b95ae6b6_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTAtNC0xLTEtMA_f1ab9efc-14da-4efc-9a48-377fa11668f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95ed7028bea74431b97651e632a47b6b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTAtNi0xLTEtMA_aea966c2-941a-402a-9f25-630dc500b708">3,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcbcc74327d845ba8fc6a1532ba4b344_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTAtOC0xLTEtMA_4613f89d-71fb-4eed-b001-60929b4b0744">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration arrangements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib087b2c401cc4c3d8384b3a48fcd1329_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTEtMi0xLTEtMA_5e203290-44cf-435e-bab0-de43332e7f6f">137,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i692bbffae945465da30a96cc3773a545_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTEtNC0xLTEtMA_e257c3e5-122f-4717-8548-e3d6d9320526">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71ba4ba85c34d5486646e473787face_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTEtNi0xLTEtMA_04372f72-d1ed-46a1-b02c-3ddf736cf26d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e6eaa19ee7d48d686b0f7478549e4f3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTEtOC0xLTEtMA_39d0ee05-d399-45bd-8c81-dbbd2ea456f7">137,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib087b2c401cc4c3d8384b3a48fcd1329_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTItMi0xLTEtMA_a103dad5-fd7e-4cdc-9c49-5eaed0045689">141,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i692bbffae945465da30a96cc3773a545_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTItNC0xLTEtMA_3370bbab-23f0-4f33-a4e1-16c412cee641">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71ba4ba85c34d5486646e473787face_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTItNi0xLTEtMA_0ce9c156-e612-45a0-b045-a9eddbc9149c">3,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e6eaa19ee7d48d686b0f7478549e4f3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTItOC0xLTEtMA_e61f7362-61de-44f3-afd3-43837294979e">137,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:continuation id="i077916323cac4f3ead140c55eeb19cee" continuedAt="ic4b9ec108b3d422c84420ee88367d1da"><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfNTMzOQ_ddacd1c6-f7e2-4b5e-8a7a-aea099b22076" escape="true"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides a reconciliation of the beginning and ending balances of our recurring fair value measurements, using significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capped Call Derivative Asset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Embedded Exchange Feature Derivative Liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Derivative Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability Arrangements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Convertible Notes Receivable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f78b59175ef4d758e415b5cbed5ac3f_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMS0yLTEtMS0w_3972b68a-3fb0-4bb1-86c7-08303a08c8f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4305df4a64bd48dba371c408205ef499_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMS00LTEtMS0w_129e79f6-54bf-4642-8203-761e86538f9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i209b72ec61d040dfb2b194e845cf7edb_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMS02LTEtMS0zMDky_f1d070ab-469b-4795-93b3-747fa82e75f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c92b7d80ea24dacb640f577505291f1_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMS02LTEtMS0w_2adba7d5-964d-4d28-942c-bf6efb03640e">137,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90c6c409fa4549c790424875b8e5a217_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMS04LTEtMS0w_3588cf8f-4d99-438e-811d-1aca5592c7e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf2d496c991846f780a3d8de11e7596e_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMi0yLTEtMS0w_fa92417d-c473-4dfb-9436-66a26fb4268c">43,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c3d799108834231aa07131c4ffa94a6_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMi00LTEtMS0w_184e0cc6-2a43-4c51-a43a-5e3957eda22d">74,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i945ca206fc8d4168be118ba472cf5c62_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMi02LTEtMS0yMzU5_4dd4d7ef-e66d-4edf-a0d6-e1334f1bd23a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdae3dc9ec2145e495befafb9bcf5123_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMi02LTEtMS0w_8475eda7-813a-421b-aa1e-b6a8d3681266">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6822c11b4df4397a32236603772252c_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMi04LTEtMS0w_2c5a09fd-bf67-4776-a2fb-a935d0d5c8bc">2,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf2d496c991846f780a3d8de11e7596e_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMy0yLTEtMS0w_56ad2a83-3fd1-47ea-bbb6-f7adbcc70287">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c3d799108834231aa07131c4ffa94a6_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMy00LTEtMS0w_e938c9c2-c917-41d3-8403-2cba4b1f4234">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i945ca206fc8d4168be118ba472cf5c62_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMy02LTEtMS0zMzEw_b81dd69b-e42b-4140-bcad-5cd3acde6936">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdae3dc9ec2145e495befafb9bcf5123_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMy02LTEtMS0w_09dbe7cf-354c-4c77-8f1a-06939e48a15c">9,868</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6822c11b4df4397a32236603772252c_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMy04LTEtMS0w_b8f46cdc-149a-44cc-ad50-6550ef8d9c20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) (3) (4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf2d496c991846f780a3d8de11e7596e_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNC0yLTEtMS0w_007e5a9e-ed58-420e-9bbb-f2d613f696be">4,097</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c3d799108834231aa07131c4ffa94a6_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNC00LTEtMS0w_48954fb1-2db3-4b06-a889-2d485f63c384">15,553</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i945ca206fc8d4168be118ba472cf5c62_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNC02LTEtMS0zMzEw_c422b9eb-ee78-4ca8-b146-169bab57d5d3">1,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdae3dc9ec2145e495befafb9bcf5123_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNC02LTEtMS0w_4331e47e-14ae-4d3f-b6d7-1120c530a843">31,176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6822c11b4df4397a32236603772252c_D20200101-20200930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNC04LTEtMS0w_bcb6c810-f4f8-48f0-9340-4559b5d258f2">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in foreign currency exchange rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf2d496c991846f780a3d8de11e7596e_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNS0yLTEtMS0w_652ffa06-8dd7-4435-bb14-3bcd93f3b968">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c3d799108834231aa07131c4ffa94a6_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNS00LTEtMS0w_8bcbeb8b-1945-4bc0-ad90-94e93df76d27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i945ca206fc8d4168be118ba472cf5c62_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNS02LTEtMS0zMzEw_47c33321-663c-4529-8445-1864c2f920d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdae3dc9ec2145e495befafb9bcf5123_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNS02LTEtMS0w_158c763e-985f-46ce-a5ed-d30c385d15a9">131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6822c11b4df4397a32236603772252c_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNS04LTEtMS0w_5b7f1ef0-5848-4c8c-8d5f-05cc5e836e4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79abffac68b242c5a0a7017c3bb651d2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNi0yLTEtMS0w_3af8c76f-d102-48f6-be44-fe7939d6269e">38,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5458476260ce4943a87b849a8aacd1c1_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNi00LTEtMS0w_7ccf4a91-7aa3-485a-aadc-f9270b413326">59,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90160a4003a147ac85584baddfa6bbdf_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNi02LTEtMS0zMDkw_cb6813bb-47b0-4a86-a1e6-7c0b28537c6d">1,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11bd09e203746298506602f823386cf_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNi02LTEtMS0w_2b03b411-0bfd-4318-a0d4-d23b0c9d8ce6">96,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1595ac59e1649c287f1756d28d46854_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNi04LTEtMS0w_821bcda3-5942-4fb0-a2af-564ca3bcc240">2,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79abffac68b242c5a0a7017c3bb651d2_I20200930" decimals="-3" format="ixt:zerodash" name="livn:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNy0yLTEtMS0w_c973a221-de25-46c0-9872-68e3fb8cae5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5458476260ce4943a87b849a8aacd1c1_I20200930" decimals="-3" format="ixt:zerodash" name="livn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNy00LTEtMS0w_57c4f8cf-1225-4bd0-87d5-af05d0143e8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90160a4003a147ac85584baddfa6bbdf_I20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNy02LTEtMS0yMzcy_41df1947-6e8f-4430-9f7f-ae1e78432eab">1,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11bd09e203746298506602f823386cf_I20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNy02LTEtMS0w_d8eeacb4-d8ed-4d04-8ef9-d5691101edf4">16,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1595ac59e1649c287f1756d28d46854_I20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNy04LTEtMS0w_08d2e30c-8d94-4b93-b91b-e5eace3d0ca8">2,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79abffac68b242c5a0a7017c3bb651d2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfOC0yLTEtMS0w_76df6936-1c95-4bf9-9a04-e024239c276f">38,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5458476260ce4943a87b849a8aacd1c1_I20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfOC00LTEtMS0w_0bd894be-9702-4a58-b2fa-bcf9227f4b11">59,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90160a4003a147ac85584baddfa6bbdf_I20200930" decimals="-3" name="livn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfOC02LTEtMS0zMDkw_f582deac-a580-461e-8092-48ac071283fa">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11bd09e203746298506602f823386cf_I20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfOC02LTEtMS0w_37cdf6dc-daac-420c-889d-d334af93b0dc">79,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1595ac59e1649c287f1756d28d46854_I20200930" decimals="-3" name="livn:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfOC04LTEtMS0w_86597c84-d808-4ed6-bd38-6c9cecad698a">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:2pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">During the nine months ended September 30, 2020, we paid $<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfNzI3_a50c8af2-caa8-4f29-ad08-f9e96c453785">8.8</ix:nonFraction> million under the contingent consideration arrangement for the acquisition of CardiacAssist, Inc., doing business as TandemLife (&#8220;TandemLife&#8221;). Additionally, we made final payments under contingent consideration arrangements resulting from the acquisitions of <ix:nonFraction unitRef="distributor" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="livn:NumberOfDistributorsAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMzg0ODI5MDcwMzAyOQ_8e5634be-0ca7-4ac0-976c-02a63cc78135">two</ix:nonFraction> distributors. </span></div><div style="margin-bottom:2pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">The contingent consideration change in fair value during the nine months ended September 30, 2020 is primarily due to a <ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" format="ixt-sec:durwordsen" name="livn:BusinessCombinationMilestoneAchievementPeriodOfDelay" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMzg0ODI5MDcwMzAzMg_3eac03fd-2bbf-4f46-b651-404ccf57d5c1">one-year</ix:nonNumeric> delay in the projected achievement of a certain regulatory milestone and timing of sales-based earnout payments for ImThera Medical Inc. (&#8220;ImThera&#8221;), and the impact of an increase in discount rates utilized in the valuation of contingent consideration. Refer to the tables below for further information regarding the fair value measurements of contingent consideration.</span></div><div style="margin-bottom:2pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">During the nine months ended September 30, 2020, the contingent consideration change in fair value resulted in a decrease of $<ix:nonFraction unitRef="usd" contextRef="if4a3c8bc06cb468c81b9eb54252c7358_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMTU0MA_ccbdaa4e-967b-44d0-86c6-e0de8657452d">19.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6716b0b0e633453e9726f2030e08c1ca_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMTU0Nw_c028cc7e-d278-409d-8e90-2bc665c1e698">12.0</ix:nonFraction> million recorded to cost of sales - exclusive of amortization and research and development, respectively.</span></div><div style="margin-bottom:6pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Changes in the fair value of the embedded exchange feature derivative and capped call derivatives are recognized in foreign exchange and other gains (losses) in the condensed consolidated statements of income (loss).</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Embedded Exchange Feature and Capped Call Derivatives</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In June 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i24d1ba33f5dd45c0b73177d207d4550c_I20200617" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMTk0NA_e7c242bd-bfcf-41c6-8c63-af24862609d3">287.5</ix:nonFraction>&#160;million in cash exchangeable senior notes and entered into related capped call transactions. The cash exchangeable senior notes include an embedded exchange feature that is bifurcated from the cash exchangeable senior notes. Please refer to &#8220;Note 8. Financing Arrangements&#8221; for further details. The embedded exchange feature derivative is measured at fair value using a binomial lattice model and discounted cash flows that utilize observable and unobservable market data. The capped call derivative is measured at fair value using the Black-Scholes model utilizing observable and unobservable market data, including stock price, remaining contractual term, expected volatility, risk-free interest rate and expected dividend yield, as applicable.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The embedded exchange feature and capped call derivatives are classified as Level 3 as the Company uses historical volatility and implied volatility from options traded to determine expected stock price volatility which is an unobservable input that is significant to the valuation. In general, an increase in our stock price or stock price volatility would increase the fair value of the embedded exchange feature and capped call derivatives which would result in an increase in expense. As time to the expiration of the derivatives decreases with passage of time, the fair value of the derivatives would decrease. The future impact on net income depends on how significant inputs such as stock price, stock price volatility and time to the expiration of the derivatives change in relation to other inputs.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The stock price volatility as of September&#160;30, 2020 was <ix:nonFraction unitRef="number" contextRef="ieb3ff6598aa94f57ad92e35964f81c74_I20200930" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMzYwMg_1d6fcad7-dedf-4f19-b7a7-95ad58e8878b"><ix:nonFraction unitRef="number" contextRef="ia12648082fc04c6b8edae66b0ae67c39_I20200930" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMzYwMg_98430bce-48d4-4b1b-b753-1adb1d7a8b4d">37</ix:nonFraction></ix:nonFraction>%. As of September&#160;30, 2020, a 10% lower volatility, holding other inputs constant, would result in approximate fair value for the embedded exchange feature derivative of $<ix:nonFraction unitRef="usd" contextRef="ib19ca95e55f0441faf04ebd6116fa0b8_I20200930" decimals="-5" format="ixt:numdotdecimal" name="livn:SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMzc1OA_288e03da-d6f4-4c48-9b6f-28ebc4342267">42.4</ix:nonFraction> million and a 10% higher volatility, holding other inputs constant, would result in approximate fair value of $<ix:nonFraction unitRef="usd" contextRef="ib19ca95e55f0441faf04ebd6116fa0b8_I20200930" decimals="-5" format="ixt:numdotdecimal" name="livn:SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMzg2Mw_c78e917c-83a7-4400-a11f-9b5cef442a0c">76.4</ix:nonFraction> million. As of September&#160;30, 2020, a 10% lower volatility, holding other inputs constant would result in approximate fair value for the capped call derivatives of $<ix:nonFraction unitRef="usd" contextRef="i8dabcab920e744a7b4327517400decdd_I20200930" decimals="-5" format="ixt:numdotdecimal" name="livn:SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfNDAwNQ_1bdf44bc-771b-47cd-8b1b-17e473960c0c">29.3</ix:nonFraction> million and a 10% higher volatility, holding other inputs constant, would result in approximate fair value of $<ix:nonFraction unitRef="usd" contextRef="i8dabcab920e744a7b4327517400decdd_I20200930" decimals="-5" format="ixt:numdotdecimal" name="livn:SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfNDExMA_f668dd49-ff1e-4de0-ae29-95d37a1bf88b">42.3</ix:nonFraction> million.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:continuation id="ic4b9ec108b3d422c84420ee88367d1da"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Contingent Consideration Arrangements</span></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfNTM0NA_0ba57e07-5bb7-47ee-b5ad-5dd694b4b404" escape="true"><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides the fair value of our Level 3 contingent consideration arrangements by acquisition (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.301%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ImThera</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62afb2ec706c47af855bd1dcaf827f5c_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfMS0yLTEtMS0w_c6e50446-bc31-435a-b016-3f939e6fb608">79,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d29459e1a0a41f687a10f5ab9c54a04_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfMS00LTEtMS0w_9df39929-eaa2-4f90-9766-47ef52761ba4">113,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TandemLife</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic98623a8908a479b94a28994eb16d56b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfMi0yLTEtMS0w_364a385a-22ce-446f-8c31-41e1c9f51066">11,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34cc075f863646e699af91319f899885_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfMi00LTEtMS0w_6e1059f8-7745-43f3-997c-bf28b90fb688">17,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miami Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383d011df36a41baa36003172177eb6b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfMy0yLTEtMS0w_2f820e87-d10d-4719-9804-c648fb833613">4,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd04c511e4ce4ac08b831ad0578c95f0_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfMy00LTEtMS0w_acdfaba4-19f0-45f7-b97e-96b822165861">5,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drilltex</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbc2f3772dba467592c17b9ecdbc0bc9_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfNC0yLTEtMS0w_c41baaad-c1d8-4503-882f-733b0b601adc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i252c36e7add342399b1424bfe704c832_I20191231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfNC00LTEtMS0w_7ba45170-ce47-4586-b6d1-3167e4630e5a">294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if59480dc9b4f411782c729fa14047400_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfNS0yLTEtMS0w_898ab87f-519d-43bc-818e-198ba4e5587b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10357ff0c2724f06bbfa2eec022e8b72_I20191231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfNS00LTEtMS0w_8b39acd0-3c60-4324-9707-f623c09b7d6a">903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic60029069ad0424ebdeeedac7260aaf9_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfNi0yLTEtMS0w_b23f296f-40f7-47fd-a807-c0a51867676f">96,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e6eaa19ee7d48d686b0f7478549e4f3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfNi00LTEtMS0w_e631adbb-a0f6-4433-b8fc-84d633f895e0">137,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The ImThera business combination involved contingent consideration arrangements composed of potential cash payments upon the achievement of a certain regulatory milestone and a sales-based earnout associated with sales of products. The sales-based earnout is valued using projected sales from our internal strategic plan. <ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfNTMzMw_fadbd4b6-e28c-49c8-9199-b8ba1b125540" continuedAt="ia4edaf4bd9cf46ea8116376113d797d8" escape="true">Both arrangements are Level 3 fair value measurements and include the following significant unobservable inputs as of September&#160;30, 2020:</ix:nonNumeric></span></div><ix:continuation id="ia4edaf4bd9cf46ea8116376113d797d8"><div style="margin-bottom:14pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.946%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.484%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.192%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ImThera Acquisition</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ranges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory milestone-based payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52334654e869489ca143b061165476f4_I20200930" decimals="3" name="livn:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc3NmEyMTZlMjhjNzRkMDU4ZTRkNzE3MWM1YWUwZmRhL3RhYmxlcmFuZ2U6Nzc2YTIxNmUyOGM3NGQwNThlNGQ3MTcxYzVhZTBmZGFfMS02LTEtMS0w_7c93210a-e960-440e-be95-3f8a8f24085b">8.3</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie2536974de9b486d9e0ef01bd6a67045_I20200930" decimals="2" name="livn:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc3NmEyMTZlMjhjNzRkMDU4ZTRkNzE3MWM1YWUwZmRhL3RhYmxlcmFuZ2U6Nzc2YTIxNmUyOGM3NGQwNThlNGQ3MTcxYzVhZTBmZGFfMi02LTEtMS0w_430d79b0-177e-4171-8992-87a457ca6d60">85</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected payment year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-based earnout</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monte Carlo simulation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-adjusted discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26486ea04b234f2e927248919c447802_I20200930" decimals="3" name="livn:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc3NmEyMTZlMjhjNzRkMDU4ZTRkNzE3MWM1YWUwZmRhL3RhYmxlcmFuZ2U6Nzc2YTIxNmUyOGM3NGQwNThlNGQ3MTcxYzVhZTBmZGFfNS02LTEtMS0w_bd7a8493-0ade-4800-9806-69ab3e367d10">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7d05cd06a8bf4c379ecc9d10bbb2d201_I20200930" decimals="3" name="livn:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc3NmEyMTZlMjhjNzRkMDU4ZTRkNzE3MWM1YWUwZmRhL3RhYmxlcmFuZ2U6Nzc2YTIxNmUyOGM3NGQwNThlNGQ3MTcxYzVhZTBmZGFfNS04LTEtMS0w_e6779036-6daa-4f3f-9c60-676f59d51dae">12.5</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit risk discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6a7bf4141731447ba120d2c607bf1fc2_I20200930" decimals="3" name="livn:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc3NmEyMTZlMjhjNzRkMDU4ZTRkNzE3MWM1YWUwZmRhL3RhYmxlcmFuZ2U6Nzc2YTIxNmUyOGM3NGQwNThlNGQ3MTcxYzVhZTBmZGFfNi02LTEtMS0w_82ef8504-cfc2-4f66-94b1-56354c9a3cdb">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6291433582a64ddb8a18340f917f581e_I20200930" decimals="3" name="livn:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc3NmEyMTZlMjhjNzRkMDU4ZTRkNzE3MWM1YWUwZmRhL3RhYmxlcmFuZ2U6Nzc2YTIxNmUyOGM3NGQwNThlNGQ3MTcxYzVhZTBmZGFfNi04LTEtMS0w_a9e5f5b4-468f-4d23-8c19-caf36a930abe">9.2</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i79119020499f4051aaa48c43f75c5b81_I20200930" decimals="3" name="livn:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc3NmEyMTZlMjhjNzRkMDU4ZTRkNzE3MWM1YWUwZmRhL3RhYmxlcmFuZ2U6Nzc2YTIxNmUyOGM3NGQwNThlNGQ3MTcxYzVhZTBmZGFfNy02LTEtMS0w_b12c7bd5-2671-4f7f-a6e0-d0646a00468b">32.5</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1d800c2cae0e47849fbae2bf9df0853f_I20200930" decimals="2" name="livn:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc3NmEyMTZlMjhjNzRkMDU4ZTRkNzE3MWM1YWUwZmRhL3RhYmxlcmFuZ2U6Nzc2YTIxNmUyOGM3NGQwNThlNGQ3MTcxYzVhZTBmZGFfOC02LTEtMS0w_31f4b9ca-9cb3-4788-8201-d130413b8e01">85</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected years of earnout</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The TandemLife business combination involved a contingent consideration arrangement composed of potential cash payments upon the achievement of certain regulatory milestones. The arrangement is a Level 3 fair value measurement and includes the following significant unobservable inputs as of September&#160;30, 2020:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:29.939%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.170%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.175%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TandemLife Acquisition</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ranges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory milestone-based payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48e773110abb48db81e64c019f74f83d_I20200930" decimals="3" name="livn:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjgwMGExNDAxNzhmZTQ0YTY4Y2VlYTc0ZTA1NDdiOTM1L3RhYmxlcmFuZ2U6ODAwYTE0MDE3OGZlNDRhNjhjZWVhNzRlMDU0N2I5MzVfMS02LTEtMS0w_1a5d0c1c-03f8-4667-bd0c-8324ab3a3245">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5d623187030142ffa015b3317a9e5d79_I20200930" decimals="3" name="livn:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjgwMGExNDAxNzhmZTQ0YTY4Y2VlYTc0ZTA1NDdiOTM1L3RhYmxlcmFuZ2U6ODAwYTE0MDE3OGZlNDRhNjhjZWVhNzRlMDU0N2I5MzVfMS04LTEtMS0w_b4dabc82-623d-4ed5-9a1c-f9d0dbc8d350">7.7</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3f11911900f44e6a9bb586049722bb34_I20200930" decimals="2" name="livn:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjgwMGExNDAxNzhmZTQ0YTY4Y2VlYTc0ZTA1NDdiOTM1L3RhYmxlcmFuZ2U6ODAwYTE0MDE3OGZlNDRhNjhjZWVhNzRlMDU0N2I5MzVfMi02LTEtMS0w_6a8340e0-68e9-4664-a8fa-f7a0de0ae874">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iae66d9458a004d28af2aca3b7976b3f0_I20200930" decimals="2" name="livn:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjgwMGExNDAxNzhmZTQ0YTY4Y2VlYTc0ZTA1NDdiOTM1L3RhYmxlcmFuZ2U6ODAwYTE0MDE3OGZlNDRhNjhjZWVhNzRlMDU0N2I5MzVfMi04LTEtMS0w_8be8281e-4a49-45ce-9b71-a9997b68dea9">100</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected payment years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Miami Instruments business combination involved a contingent consideration arrangement composed of potential cash payments upon the achievement of certain regulatory milestones. The arrangement is a Level 3 fair value measurement and includes the following significant unobservable inputs as of September&#160;30, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:29.939%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.170%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.175%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Miami Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ranges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory milestone-based payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia4826f8772764dcca66860adeb782fae_I20200930" decimals="3" name="livn:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmJmMWVhZDMzNzdjZDRlMDk4M2NlNGUwZDkxYzM5NDY0L3RhYmxlcmFuZ2U6YmYxZWFkMzM3N2NkNGUwOTgzY2U0ZTBkOTFjMzk0NjRfMS02LTEtMS0w_2de87424-19dd-4b2d-a4de-ec8fc9fe11fa">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6697817a4014449f80da5eda0856fefd_I20200930" decimals="3" name="livn:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmJmMWVhZDMzNzdjZDRlMDk4M2NlNGUwZDkxYzM5NDY0L3RhYmxlcmFuZ2U6YmYxZWFkMzM3N2NkNGUwOTgzY2U0ZTBkOTFjMzk0NjRfMS04LTEtMS0w_d292a5e0-8601-4d4f-ae4d-a60fa3d60250">7.7</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0aa9d51eaa804f9bbf6db6abe1aab758_I20200930" decimals="2" name="livn:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmJmMWVhZDMzNzdjZDRlMDk4M2NlNGUwZDkxYzM5NDY0L3RhYmxlcmFuZ2U6YmYxZWFkMzM3N2NkNGUwOTgzY2U0ZTBkOTFjMzk0NjRfMi02LTEtMS0w_4bd1dcc1-88cd-4d0a-9a11-425b39f4cd88">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i459d7f911ab44762922172ee4898a00b_I20200930" decimals="2" name="livn:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmJmMWVhZDMzNzdjZDRlMDk4M2NlNGUwZDkxYzM5NDY0L3RhYmxlcmFuZ2U6YmYxZWFkMzM3N2NkNGUwOTgzY2U0ZTBkOTFjMzk0NjRfMi04LTEtMS0w_ab576ae5-f056-48b4-a24f-b7e38e29d3ea">95</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected payment years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr></table></div></ix:continuation></ix:continuation><div style="text-indent:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">14</span></div></div></div><div id="i1bf75d3d05544b2db4639291692ac57a_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMzg0ODI5MDcwNjU4Nw_427e5450-4eb7-4782-a9f0-452c259e1af8" continuedAt="i48bc0702696541e0919b39157b1fdd2d" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 8. Financing Arrangements</span></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfODU5NA_b65f6447-4cd4-4059-b6ca-76f28d1bbb94" escape="true"><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The carrying amount of our long-term debt as of September&#160;30, 2020 and December 31, 2019 was as follows (in thousands, except interest rates):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.030%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.198%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Senior Secured Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3245df3db3cb48138c8bb4d23daee5c4_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMS0yLTEtMS0w_79b9c0d9-d452-4329-8d0e-cb2ef0ed9731">422,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd7d93641d4805ad2cd66461498397_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMS00LTEtMS0w_d52a9df1-689b-4d61-91ee-ca610f256860">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">LIBOR (<ix:nonFraction unitRef="number" contextRef="ieafa762dc91e4ea5b61fb8d13b092c3a_I20200930" decimals="INF" name="livn:DebtInstrumentLIBORFloorRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMS04LTEtMS0wL3RleHRyZWdpb246ZTRiYTYyODA4NWUyNGI2ODlkNzJlNTE5ODZlZDk5OGRfMTI_42d09835-0e1b-4df5-b860-0b5ce43afecb">1</ix:nonFraction>% Floor)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i45371aa600b04a59940ecd80e4ec31cc_D20200101-20200930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMS0xMC0xLTEtMA_c577b052-f634-447d-9c58-c0683b9435ee">6.50</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Cash Exchangeable Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb27b6a99b3143aba0d74fd775949dfe_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMi0yLTEtMS0w_944cdb45-5a0b-4398-b378-d6164b0ff6e4">208,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie42f7909e6db412aa3041faa1788bd39_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMi00LTEtMS0w_8be411f2-779b-46c3-aad1-3a58aa100496">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icb27b6a99b3143aba0d74fd775949dfe_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMi04LTEtMS0w_d760bb1f-f371-4a9e-895f-17404deb856b">3.00</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank of America Merrill Lynch Banco M&#250;ltiplo S.A.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i289e4abd6f78419f8f33d7774b970fca_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMy0yLTEtMS0w_07d5cbaf-820c-4a62-aacf-f28fb63eb8f3">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibee8d98cf1eb433cb1a0301b339983bc_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMy00LTEtMS0w_e8d22c4b-d231-41dd-8dc7-b5091d2996e4">8,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i36c4db63cfaf444f879c55013695c930_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMy04LTEtMS0w_a9d9b4e1-705b-44d5-91d9-cb566ae52c4a">5.61</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mediocredito Italiano</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa72db626bbd480cb89d6345d833dd4d_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNC0yLTEtMS0w_fba785e2-55bf-47ce-aff0-76fbd130c90b">5,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i586947e97ff14c64ab8231790955f4c6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNC00LTEtMS0w_6d0b2f92-de94-4af4-974d-7f7846c19cab">6,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1080464791c844d79de57c27a7ff3ff6_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNC04LTEtMS0w_5121ca11-7058-42d4-9ab6-842f9f5e57e0">0.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idc989c83ebe44970836e50ad98670002_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNC0xMC0xLTEtMA_7df27c41-8fc8-409e-bed5-3c5e2f26f272">2.77</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank of America, U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe7864f0b2ec45bd8a718ff4690bb0d1_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNS0yLTEtMS0w_25887131-c7c2-4007-9822-469e21ff061e">2,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77803437d5944d49a41f07e2364e792a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNS00LTEtMS0w_687f6f3d-b52f-4c27-82d2-b925600d0802">2,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9dc1230e32264a72921d8a08c4c63984_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNS04LTEtMS0w_6197d7be-c5bc-43c3-ad77-1ca65072d661">2.08</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Debt Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ac265b05414cd791492f4617219f2e_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNi0yLTEtMS0w_31e3e155-f986-4f52-b866-bd847d87e23b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib89aab9bd0424c12919f50bff87ea646_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNi00LTEtMS0w_6353391e-eed9-458e-848a-a603ac6ef843">184,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 European Investment Bank</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d873ce62a3742a390dae8762e636c14_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNy0yLTEtMS0w_766d72a4-c376-4943-a850-572aac29bda1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4afcc088bc84e9aa4e4191bfefcc218_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNy00LTEtMS0w_6c7a4cea-422b-480b-874e-d1d3afb62360">103,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014 European Investment Bank</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87d4c0b95a4e4fe294e383610676bf94_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfOC0yLTEtMS0w_6613c565-3449-4148-84d2-2ad9f4657c6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774fcbadcb514ffb99380b94b3c9864e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfOC00LTEtMS0w_32c4f31b-0084-4a2f-9416-e4d603dabd7d">28,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a882a55bae3450ab4104c69d32cbe64_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfOS0yLTEtMS0w_767d66d2-c70e-45cf-8058-94f5ac9d675a">1,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic874c4d0e00049b4a599f3482a07d919_I20191231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfOS00LTEtMS0w_43a4121f-15c0-4f4e-9aa3-f404b8efc7e8">965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term facilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMTAtMi0xLTEtMA_cd1c6e55-d458-4972-beeb-7dc02077291c">646,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMTAtNC0xLTEtMA_687c8107-42ee-4c2f-8f03-08b0723858d1">333,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMTEtMi0xLTEtMA_694d9447-b4d0-44fa-91e1-29d2714f3006">9,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMTEtNC0xLTEtMA_b2b7a345-e2a6-44fa-8163-3be8725381ac">73,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMTItMi0xLTEtMA_e17549c3-1bf6-4b34-b087-b984a8f3a24b">637,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMTItNC0xLTEtMA_fcee3039-5b55-4db5-80fc-3d8915cdb008">260,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Revolving Credit</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The outstanding principal amount of our short-term unsecured revolving credit agreements and other agreements with various banks was $<ix:nonFraction unitRef="usd" contextRef="ib86600fe8d314ce3bbf5074a7b1877ac_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjcz_cbaf0ca2-6bf6-46f4-8738-f99233c967da">4.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib6ca57cb331747069aa1e6f1b22dd36d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjgw_2d2cf2e9-6ede-4239-9810-b8f22b9fe883">4.2</ix:nonFraction> million, at September&#160;30, 2020 and December 31, 2019, respectively, with interest rates ranging from <ix:nonFraction unitRef="number" contextRef="if6b26cfd42a14eae84e4cde0f4855b55_I20200930" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMzQ1_484285e7-bc64-4d82-853b-582831bf47fd">3.21</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i222517d76090477aa98b1abaaae6b229_I20200930" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMzUx_cdf3c333-ab60-4ec1-994c-95ac4addb3e2">7.20</ix:nonFraction>% and loan terms ranging from overnight to <ix:nonNumeric contextRef="ic387d566a4a047a4abc670c43b8f310a_D20200101-20200930" format="ixt-sec:durmonth" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMzg4_6a3b5f21-91a8-4a23-b9b1-b673535f47ac">10</ix:nonNumeric> months, as of September&#160;30, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">2020 Senior Secured Term Loan</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On June 10, 2020, we entered into a $<ix:nonFraction unitRef="usd" contextRef="i50324d744dcd4a44b4764e5523cc1cce_I20200610" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNDY4_9d49343a-0ff0-4d99-836e-adb5d687bc0b">450.0</ix:nonFraction>&#160;million <ix:nonNumeric contextRef="i50324d744dcd4a44b4764e5523cc1cce_I20200610" format="ixt-sec:durwordsen" name="us-gaap:LongTermDebtTerm" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMzg0ODI5MDcwNzM1Nw_b6c98876-d16d-475a-81e1-408ba53be7b5">five-year</ix:nonNumeric> senior secured term loan (the &#8220;Term Loan&#8221;) through our wholly owned subsidiary LivaNova USA Inc., with funds managed by affiliates of Ares Management Corporation, as administrative agent and collateral agent, resulting in cash proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="idf2a05cfe98047578281e694de92f942_D20200610-20200610" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNzMy_5cb6b30a-e6bb-458b-b622-ef12ed52fda0">421.7</ix:nonFraction>&#160;million, net of discounts and issuance costs. The obligations under the Term Loan are guaranteed on a senior secured basis by each of LivaNova&#8217;s existing and future wholly owned material subsidiaries, and are secured by a perfected first priority security interest in substantially all tangible and intangible assets of LivaNova and certain U.S. and UK subsidiaries of LivaNova, subject in each case to certain exceptions contained in the Term Loan. Borrowings under the Term Loan bear interest at a variable annual rate equal to the three-month LIBOR rate (subject to a <ix:nonFraction unitRef="number" contextRef="ieafa762dc91e4ea5b61fb8d13b092c3a_I20200930" decimals="INF" name="livn:DebtInstrumentLIBORFloorRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMTI5OA_beee2e30-f8bd-45a3-b71a-497a1d702600">1</ix:nonFraction>% floor), plus an applicable margin of <ix:nonFraction unitRef="number" contextRef="i45371aa600b04a59940ecd80e4ec31cc_D20200101-20200930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMTMzOA_9d0decd5-6a50-456c-844c-64fa56f80076">6.5</ix:nonFraction>% per annum. The effective interest rate of the Term Loan at September&#160;30, 2020 was <ix:nonFraction unitRef="number" contextRef="i3245df3db3cb48138c8bb4d23daee5c4_I20200930" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMTY0OTI2NzQ1MTk1MA_e5fa5256-6477-411a-8750-f34803532e39">9.0</ix:nonFraction>%. The Term Loan will mature on June&#160;30, 2025 and includes certain affirmative, negative and financial covenants. <ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="livn:ScheduleOfDebtCovenantsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfODYwMA_049adc4a-6ce1-4047-8cef-7bc7153aca38" continuedAt="i499b156d3d164b468dfe3e05332eb9db" escape="true">The financial covenants under the Term Loan state (i) the net revenue of LivaNova PLC, LivaNova USA, Inc. and any restricted subsidiaries on a consolidated basis shall not be lower than $<ix:nonFraction unitRef="usd" contextRef="i545ddcc4502f4443a3f1a3a772c175dc_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="livn:DebtInstrumentCovenantMinimumNetRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMTYzOA_7987ce4f-cf12-4fe7-8da9-7f7e3928198b">700</ix:nonFraction>&#160;million for each trailing 12 month period, such threshold to decrease pro rata (not below $<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="livn:DebtInstrumentCovenantMinimumProRataNetRevenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMTcyMw_214456e3-0e0a-46e0-8015-c5cad2ab2ed6">550</ix:nonFraction>&#160;million) upon prepayments of the Term Loan made by LivaNova USA, Inc. out of the proceeds of certain asset sales, and (ii) the total secured leverage ratio (as defined in the debt agreement) for LivaNova PLC, LivaNova USA, Inc. and any restricted subsidiaries on a consolidated basis shall not be greater than the applicable ratio set forth below:</ix:nonNumeric></span></div><div style="margin-bottom:9pt"><ix:continuation id="i499b156d3d164b468dfe3e05332eb9db"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Test Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Secured Leverage Ratio</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 Quarters ending June 30, 2020 through each fiscal quarter thereafter until (and including) the fiscal quarter ending June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="3" name="livn:DebtInstrumentCovenantSecuredLeverageRatioPeriodOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOmQ0MzIwMjE5MTY3OTRjZjNiMzUzZWQ3MzIyMWQzYWZkL3RhYmxlcmFuZ2U6ZDQzMjAyMTkxNjc5NGNmM2IzNTNlZDczMjIxZDNhZmRfMS0yLTEtMS0w_1e48971a-b2e7-45bd-ac68-5406f3cff227">5.625</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 Quarters ending September 30, 2021 and ending each fiscal quarter thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="1" name="livn:DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOmQ0MzIwMjE5MTY3OTRjZjNiMzUzZWQ3MzIyMWQzYWZkL3RhYmxlcmFuZ2U6ZDQzMjAyMTkxNjc5NGNmM2IzNTNlZDczMjIxZDNhZmRfMi0yLTEtMS0w_11034521-214f-44b2-a06f-be96f5a4e1e5">4.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00</span></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Debt discounts and issuance costs related to the Term Loan were approximately $<ix:nonFraction unitRef="usd" contextRef="i50324d744dcd4a44b4764e5523cc1cce_I20200610" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjE0OA_d1e0879a-31bf-437b-86c5-9529c2583ba9">28.3</ix:nonFraction>&#160;million and included various legal, bank and accounting fees. Amortization of debt discount and issuance costs was $<ix:nonFraction unitRef="usd" contextRef="i96351578f5c9420c994226ab0fb578bb_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMTY0OTI2NzQ1MTc4OA_7698a678-1976-4f5c-9045-2446e309d277">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i545ddcc4502f4443a3f1a3a772c175dc_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjc0ODc3OTA3OTQ1MA_4ba698b3-4534-4464-b890-eed0c0670058">1.3</ix:nonFraction> million for the three and nine months ended September 30, 2020, respectively, and was included in interest expense on the condensed consolidated statement of income (loss).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">2020 Cash Exchangeable Senior Notes </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On June 17, 2020, our wholly-owned subsidiary, LivaNova USA, Inc., issued $<ix:nonFraction unitRef="usd" contextRef="i1401125337584d3cb2556f5344879ff5_I20200617" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjUxNg_0af091d6-a002-44b3-8fe8-07d3d3219456">287.5</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i1401125337584d3cb2556f5344879ff5_I20200617" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjU0OQ_8f1cb2f7-7b1c-4a67-a208-c46c72e9094b">3.00</ix:nonFraction>% cash exchangeable senior notes (the &#8220;Notes&#8221;) by private placement to qualified institutional buyers pursuant to Rule </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:continuation id="i48bc0702696541e0919b39157b1fdd2d" continuedAt="i5eebc140fba4402899688fc43ab44e4b"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">144A under the Securities Act of 1933, as amended. The sale of the Notes resulted in approximately $<ix:nonFraction unitRef="usd" contextRef="ie66d4c341b7f42f0b9c74ad3972a82cb_D20200617-20200617" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjc2OA_66c21308-4e3d-40d6-b356-403059a667ce">278.0</ix:nonFraction>&#160;million in net proceeds to the Company after deducting issuance costs. Interest is payable semiannually in arrears on June 15 and December 15 of each year, beginning on December 15, 2020. The effective interest rate of the Notes at September&#160;30, 2020 was <ix:nonFraction unitRef="number" contextRef="icb27b6a99b3143aba0d74fd775949dfe_I20200930" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMTY0OTI2NzQ1MjAxNQ_07e4629c-10f7-443a-9bf1-4fb245aef2cc">9.9</ix:nonFraction>%. The Notes mature on December&#160;15, 2025 unless earlier exchanged, repurchased, or redeemed.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Debt discounts and issuance costs related to the Notes were approximately $<ix:nonFraction unitRef="usd" contextRef="i1401125337584d3cb2556f5344879ff5_I20200617" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMzE1OA_508bb115-b681-4ae0-98de-7b09bec286c2">82.0</ix:nonFraction>&#160;million and included $<ix:nonFraction unitRef="usd" contextRef="i1401125337584d3cb2556f5344879ff5_I20200617" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMzE3NA_1db6cfee-52fd-4cd5-8727-db340159285f">75.0</ix:nonFraction>&#160;million of discount attributable to the embedded exchange feature, discussed below, and $<ix:nonFraction unitRef="usd" contextRef="i1401125337584d3cb2556f5344879ff5_I20200617" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMzI1Nw_bc022e1c-660c-489e-9368-d518c494a105">7.0</ix:nonFraction>&#160;million of allocated issuance costs to the Notes related to legal, bank and accounting fees. Amortization of debt discount and issuance costs was $<ix:nonFraction unitRef="usd" contextRef="i5ffd59ecf9044f8eb3cf977b8db8a6a7_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMTY0OTI2NzQ1MTc5NQ_8669da83-3e9d-4157-9364-6512767a3cf4">3.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i444306b422a649ef948af581cd5b4f06_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjc0ODc3OTA3OTQ3NQ_0fa4cdb3-f614-4ba1-b183-2d9aa0ade218">3.4</ix:nonFraction> million for the three and nine months ended September 30, 2020 and is included in interest expense on the condensed consolidated statement of income (loss).</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Notes are exchangeable at the option of the holders only under certain circumstances and solely into cash in an amount based on the trading prices of LivaNova&#8217;s ordinary shares during a related observation period. The Notes are not exchangeable into ordinary shares of LivaNova or any other security under any circumstances. The initial exchange rate for the Notes is 16.3980 ordinary shares per $1,000 principal amount of Notes (equivalent to an initial exchange price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i1401125337584d3cb2556f5344879ff5_I20200617" decimals="INF" name="livn:DebtInstrumentOptionToExchangePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNDAzMw_66e946cd-813c-48ec-b23c-9416bbb02899">60.98</ix:nonFraction> per share). The exchange rate is subject to adjustment in certain circumstances, as set forth in the indenture governing the Notes.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Company may redeem the Notes at its option, on or after June 20, 2023, in whole or in part, if the last reported sale price per ordinary share has been at least <ix:nonFraction unitRef="number" contextRef="i444306b422a649ef948af581cd5b4f06_D20200101-20200930" decimals="INF" name="livn:DebtInstrumentRedemptionPricePercentageOfExchangePrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNDMzMg_c8c4ba4f-3efc-4843-8181-adb075736100">130</ix:nonFraction>% of the exchange price then in effect for at least <ix:nonFraction unitRef="claim" contextRef="icb27b6a99b3143aba0d74fd775949dfe_I20200930" decimals="INF" name="livn:DebtInstrumentRedemptionThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNDM4NQ_54b61604-98f0-4e0e-be56-6987b1c8a574">20</ix:nonFraction> trading days (whether or not consecutive), including the trading day immediately preceding the date on which the Company provides notice of redemption, during any <ix:nonFraction unitRef="claim" contextRef="icb27b6a99b3143aba0d74fd775949dfe_I20200930" decimals="INF" name="livn:DebtInstrumentRedemptionThresholdConsecutiveTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNDU1MQ_1f9c72f8-2c12-4c21-aa75-e7022de17cd7">30</ix:nonFraction> consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="i444306b422a649ef948af581cd5b4f06_D20200101-20200930" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNDc0MQ_31c8c747-f90c-47d0-8e10-5e949ae66f80">100</ix:nonFraction>% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. Additionally, the Company may redeem the Notes at its option, prior to December 15, 2025, in whole but not in part, in connection with certain tax-related events.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Embedded Exchange Feature</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The embedded exchange feature of the Notes requires bifurcation from the Notes and is accounted for as a derivative liability. The fair value of the Notes&#8217; embedded exchange feature derivative at the time of issuance was $<ix:nonFraction unitRef="usd" contextRef="i1401125337584d3cb2556f5344879ff5_I20200617" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNTI4MA_3ac0ea3c-4d2c-40ba-8bb9-f8f6ce1df71f">75.0</ix:nonFraction>&#160;million and was recorded as debt discount on the Notes. This discount is amortized as interest expense using the effective interest method over the term of the Notes. The Notes&#8217; embedded exchange feature derivative is carried on the condensed consolidated balance sheets at its estimated fair value and is adjusted at the end of each reporting period, with unrealized gain or loss reflected in the consolidated statements of income (loss). The fair value of the embedded exchange feature derivative liability was $<ix:nonFraction unitRef="usd" contextRef="icb27b6a99b3143aba0d74fd775949dfe_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjc0ODc3OTA3OTQ5Mw_98b311a6-6ac6-4c38-bf28-80015534421b">59.4</ix:nonFraction> million as of September&#160;30, 2020. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Capped Call Transactions</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In connection with the pricing of the Notes, the Company entered into privately negotiated capped call transactions with certain of the initial purchasers of the Notes or their respective affiliates. The capped call transactions cover, subject to anti-dilution adjustments substantially similar to those applicable to the Notes, the number of LivaNova&#8217;s ordinary shares underlying the Notes and are expected generally to offset any cash payments the Company is required to make upon exchange of the Notes in excess of the principal amount thereof in the event that the market value per ordinary share, as measured under the capped call transactions, is greater than the strike price of the capped call transactions, with such offset being subject to an initial cap price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8dabcab920e744a7b4327517400decdd_I20200930" decimals="INF" name="livn:DerivativeCapPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNjYyMQ_37737e4d-a3d5-45f1-955b-a0a95269ba2d">100.00</ix:nonFraction> per share. The aggregate cost of the capped calls derivative assets was $<ix:nonFraction unitRef="usd" contextRef="i17a5d78945d143a89628f9c4af1abbc5_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeCostOfHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNjY5Ng_d7b7d425-5a48-434f-abb7-5ff3d4ab97f5">43.1</ix:nonFraction>&#160;million. The capped call transactions expire on December 15, 2025 and must be settled in cash. The capped calls are carried on the condensed consolidated balance sheets as a derivative asset at their estimated fair value and are adjusted at the end of each reporting period, with unrealized gain or loss reflected in the condensed consolidated statement of income (loss). The fair value of capped call derivative assets was $<ix:nonFraction unitRef="usd" contextRef="i8dabcab920e744a7b4327517400decdd_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjc0ODc3OTA3OTQ4NA_1d66d6f6-4b37-43a8-8571-6595595f8d22">39.0</ix:nonFraction> million as of September&#160;30, 2020.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The current and non-current classification is evaluated at each balance sheet date and may change depending on whether any exchange conditions are met. As of September&#160;30, 2020, no exchange conditions have been met and the Notes, embedded exchange feature derivative liability, and the capped call derivative assets are classified as non-current. Please refer to &#8220;Note 7. Fair Value Measurements&#8221; for details on the valuation of the embedded exchange feature derivative liability and capped call derivative assets.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Extinguishment of Debt</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Company used the net proceeds from the Term Loan, together with a portion of the net proceeds of the Notes, after fees, discounts, commissions and other expenses, to repay outstanding indebtedness under the Company&#8217;s 2017 European Investment Bank loan, 2014 European Investment Bank loan, Banca Nazionale del Lavoro S.p.A loan, and 2019 Debt Facility and related </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:continuation id="i5eebc140fba4402899688fc43ab44e4b"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">expenses. The Company repaid approximately $<ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfODA1Mw_6aae5c73-5f42-493b-9035-e77487929542">528.0</ix:nonFraction>&#160;million in aggregate outstanding principal, accrued interest and associated fees, including breakage fees and legal fees. The Company recognized a loss on debt extinguishment of $<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfODIyNg_c9062f96-d739-46dc-962f-fa913527ad68">1.4</ix:nonFraction>&#160;million during the nine months ended September 30, 2020. The loss on debt extinguishment was recognized in foreign exchange and other losses in the condensed consolidated statements of income (loss).</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The remainder of the proceeds from the concurrent financing transactions were used to pay the cost of capped call transactions and for general corporate purposes.</span></div></ix:continuation><div style="margin-bottom:6pt;text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_64"></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfMzg0ODI5MDcwMjUwMA_b8d28efc-b9a5-43ca-86c7-e7289cd8daef" continuedAt="i88fa7f6d812b463d9d1e1cf2a93020ef" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 9. Derivatives and Risk Management</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Due to the global nature of our operations, we are exposed to foreign currency exchange rate fluctuations. We enter into FX derivative contracts to reduce the impact of foreign currency exchange rate fluctuations on earnings and cash flow. We are also exposed to equity price risk in connection with our Notes, including exchange and settlement provisions based on the price of our ordinary shares at exchange or maturity of the Notes. In addition, the capped call transactions associated with the Notes also include settlement provisions that are based on the price of our ordinary shares, subject to a capped price per share.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We measure all outstanding derivatives each period end at fair value and report the fair value as either financial assets or liabilities on the condensed consolidated balance sheets. We do not enter into derivative contracts for speculative purposes. At inception of the contract, the derivative is designated as either a freestanding derivative or a hedge. Derivatives that are not designated as hedging instruments are referred to as freestanding derivatives with changes in fair value included in earnings.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfNTA4MQ_9b045889-444a-480e-afef-c77b71c06616" escape="true">If the derivative qualifies for hedge accounting, changes in the fair value of the derivative will be recorded in&#160;accumulated other comprehensive income (&#8220;AOCI&#8221;) until the hedged item is recognized in earnings upon settlement/termination. FX derivative gains and losses in AOCI are reclassified to our condensed consolidated statements of income (loss) as shown in the tables below. We evaluate hedge effectiveness at inception. Cash flows from derivative contracts are reported as operating activities on our condensed consolidated statements of cash flows.</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Freestanding FX Derivative Contracts</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The gross notional amount of FX derivative contracts not designated as hedging instruments outstanding at September&#160;30, 2020 and December 31, 2019 was $<ix:nonFraction unitRef="usd" contextRef="ibec415e111624e90a65386d8ccfeb185_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfMjE2MA_ca1218a4-1df7-487b-a91a-47b177624425">332.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0e616a092dd14267a1ec789a805bdb80_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfMjE2Nw_c2a748ea-91b8-4691-a20f-ad0cd9f06784">338.0</ix:nonFraction> million, respectively. These derivative contracts are designed to offset the FX effects in earnings of various intercompany loans and trade receivables. We recorded net (losses) gains for these freestanding derivatives of $(<ix:nonFraction unitRef="usd" contextRef="i950b10f7b07943f2aec8cb421632f276_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfMjM4NA_125fd9a9-1a4e-457b-b919-d98317cda768">11.7</ix:nonFraction>) million and $<ix:nonFraction unitRef="usd" contextRef="i6a94651f8023444cba196300adc7abcd_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfMjM5MQ_9d3a06d3-37d8-434b-98d1-aaf64b63dc7d">3.1</ix:nonFraction> million for the three months ended September 30, 2020 and 2019, respectively, and $(<ix:nonFraction unitRef="usd" contextRef="i64e57c8edaa1477d881db72e4c50172e_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfMjQxNg_d22bfc4f-5a0f-436d-9666-ff952b541bae">4.8</ix:nonFraction>) million and $<ix:nonFraction unitRef="usd" contextRef="i0efb92ce20cb40c3829d2008a9aee0a0_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfMjQyMw_d7eba4f7-9ced-4b3a-b5ab-f61610caaf85">6.8</ix:nonFraction> million for the nine months ended September 30, 2020 and 2019, respectively. These (losses) and gains are included in foreign exchange and other gains (losses) on our condensed consolidated statement of income (loss).</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Counterparty Credit Risk</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We are exposed to credit risk in the event of non-performance by the counterparties to our derivatives at maturity. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The two counterparties to the capped call transactions are financial institutions. To limit our credit risk, we selected financial institutions with a minimum long-term investment grade credit rating. Our exposure to the credit risk of the counterparties is not secured by any collateral.  If a counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings, with a claim equal to our exposure at that time under the capped call transactions with that counterparty.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">To manage credit risk with respect to our other derivatives, the Company selects and periodically reviews counterparties based on credit ratings, limits its exposure with respect to each counterparty, and monitors the market positions. However, if one or more of these counterparties were in a liability position to the Company and were unable to meet their obligations, any transactions with the counterparty could be subject to early termination, which could result in substantial losses for the Company.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:continuation id="i88fa7f6d812b463d9d1e1cf2a93020ef" continuedAt="i72f30b3b7016448b943e572526930dc5"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cash Flow Hedges</span></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfNTEwMQ_7b215bb7-18ad-41df-b41b-5e8ad1150a2a" escape="true"><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The gross notional amounts of open derivative contracts designated as cash flow hedges at September&#160;30, 2020 and December 31, 2019 were as follows (in thousands):</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Derivative Contract</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts to be exchanged for British Pounds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i649606b21180421ebd128add525a4018_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfMS0yLTEtMS0w_ec8ee9d0-55be-4365-b499-0108f0003176">7,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic43de1d78774468cbbd002d32d130ae7_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfMS00LTEtMS0w_30b03886-0f92-4ca4-80c3-a7d328e538c0">10,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts to be exchanged for Japanese Yen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96a7d1296872411baf7843151d3b8798_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfMi0yLTEtMS0w_beacb10c-1618-41c1-8ae0-b62d714064c5">16,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e21c8f995c24e08b7f442b0d2e9f153_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfMi00LTEtMS0w_ca630da2-b13a-44d9-90b1-382baeb44316">25,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts to be exchanged for Euros</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib51f3bb185c74b338b8ef92535cb08f2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfMy0yLTEtMS0w_b0e0ff04-0532-4f69-8abe-32b99eb16348">36,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i249fe1f728d5471fa1555fe39c4bfefe_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfMy00LTEtMS0w_67474fb3-bffc-4987-bc2d-75a68b1d6bea">48,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceda4563a5cf43d4b3bb9b89365c4c20_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfNC0yLTEtMS0w_a20f11ce-4f13-4a70-883a-1a221d26a948">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1925dad241b4aad82804e153bd1d891_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfNC00LTEtMS0w_170279d5-0584-4a68-b2d1-3c0270d6f3ce">22,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7100fe2c632148de9c37fb8985d42d30_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfNS0yLTEtMS0w_7a94675f-cdfd-4c7e-b028-53bb4b5911ab">60,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic334fc4aef0a4ba39603d81e0f99657a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfNS00LTEtMS0w_99ceb148-b931-4d0a-aea9-b260d791c5bd">106,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Interest rate swap contracts were de-designated upon the repayment of the 2014 European Investment Bank loan. Refer to &#8220;Note 8. Financing Arrangements.&#8221;</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfNTEwMg_694060fe-2fd5-4588-b52f-4ae5ce3e334c" escape="true"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">After-tax net loss associated with derivatives designated as cash flow hedges recorded in the ending balance of AOCI and the amount expected to be reclassified to earnings in the next twelve months are as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Derivative Contract</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After-Tax Net Gain in AOCI as of September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After-Tax Net Gain in AOCI as of Amount Expected to be Reclassified to Earnings in Next 12 Months</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54a9f60e897042dabf6cfd3734d2ec73_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjVjMjU2M2JkNzJhNzRhMzM4ZDEyN2UwYjVlZTFkYWZlL3RhYmxlcmFuZ2U6NWMyNTYzYmQ3MmE3NGEzMzhkMTI3ZTBiNWVlMWRhZmVfMS0yLTEtMS0w_b201c245-d939-4b2e-821e-702e4a05a86e">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54a9f60e897042dabf6cfd3734d2ec73_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjVjMjU2M2JkNzJhNzRhMzM4ZDEyN2UwYjVlZTFkYWZlL3RhYmxlcmFuZ2U6NWMyNTYzYmQ3MmE3NGEzMzhkMTI3ZTBiNWVlMWRhZmVfMS00LTEtMS0w_e81eea28-5fd6-4eb2-acf7-dfdda0e15324">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pre-tax gains (losses) for derivative contracts designated as cash flow hedges recognized in other comprehensive income (loss) (&#8220;OCI&#8221;) and the amount reclassified to earnings from AOCI were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.148%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Derivative Contract</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location in Earnings of Reclassified Gain or Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains Recognized in OCI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Losses) Gains Reclassified from AOCI to Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Losses Recognized in OCI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (Losses) Reclassified from AOCI to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange and other gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7af1f95c61944858b003c6c933d18f4e_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfMy00LTEtMS0w_c02b5f6e-059c-496a-ac4a-1f466c6b3783">1,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7af1f95c61944858b003c6c933d18f4e_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfMy02LTEtMS0w_ee0be224-6717-4876-b4c5-a0cd6db7ca51">692</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1948e41e49f1497390be627047b5251a_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfMy04LTEtMS0w_1af8fae5-8de9-4f51-b5f2-f90c756b3fe3">689</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1948e41e49f1497390be627047b5251a_D20190701-20190930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfMy0xMC0xLTEtMA_7557308c-e788-4087-8199-90ae97750c0b">963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d2ccb840b50403f8fc4f14ac40d2d79_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNC00LTEtMS0w_50a4f89d-da47-45bc-ae3f-6b119ff6c533">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d2ccb840b50403f8fc4f14ac40d2d79_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNC02LTEtMS0w_3c1c839b-b68d-4d41-a792-aaee3b9218d4">534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3cfd47324747a59764c08500c16de3_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNC04LTEtMS0w_79086c82-a25e-43ae-93eb-1a0e5bbb280b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e3cfd47324747a59764c08500c16de3_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNC0xMC0xLTEtMA_7741ecb6-4f25-416e-83db-c50722d68022">742</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ee46b672ebd4d8bae5042f234b05104_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNS04LTEtMS0w_5c499b2e-4de5-46c3-ae2e-663368e074d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ee46b672ebd4d8bae5042f234b05104_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNS0xMC0xLTEtMA_b228d960-8b25-4fba-b5a7-b276d96c62a1">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7438dabb55a44445b30dbd44a361b2f4_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNi00LTEtMS0w_4a184715-4209-404e-91a4-54eb47d8b9e6">1,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7438dabb55a44445b30dbd44a361b2f4_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNi02LTEtMS0w_f45fc390-681c-463b-98cb-47ab2b8ed851">158</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae52b02ee83b438bb79bd0edc64a3be1_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNi04LTEtMS0w_513536c4-8fd1-412f-8f0b-784fba7c3de5">689</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae52b02ee83b438bb79bd0edc64a3be1_D20190701-20190930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNi0xMC0xLTEtMA_2dac8350-7e3b-4626-9b5f-821bdaf05f3d">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.148%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Derivative Contract</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location in Earnings of Reclassified Gain or Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains Recognized in OCI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Losses) Gains Reclassified from AOCI to Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains Recognized in OCI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (Losses) Reclassified from AOCI to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange and other gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aee89dbb9cd451d93a65f546dc5d74e_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfMy00LTEtMS0w_7fafd6c5-fb1a-4285-bc8d-aa25dfc5a78a">632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7aee89dbb9cd451d93a65f546dc5d74e_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfMy02LTEtMS0w_6e9478ea-facb-4681-b3c2-4dc93986a8a3">777</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecc073aeadb743fe846108c910b49974_D20190101-20190930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfMy04LTEtMS0w_3ffff93b-837c-443d-993b-96e57f5e2f99">933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecc073aeadb743fe846108c910b49974_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfMy0xMC0xLTEtMA_acdf49ec-b685-4cd7-b19a-410cccd669a4">3,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc8dde6780b4135bdbe52a6f7da8dda_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNC00LTEtMS0w_bd5a0b09-8fe1-41f9-b281-59319d922371">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc8dde6780b4135bdbe52a6f7da8dda_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNC02LTEtMS0w_d54b70ec-eda2-4102-9e97-362b46df0a4f">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia84ea03c48e54abfb6747a6de26f6116_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNC04LTEtMS0w_65c33298-17bd-4e23-929a-cd233c666b48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia84ea03c48e54abfb6747a6de26f6116_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNC0xMC0xLTEtMA_e8534201-81d2-44b1-83ce-0c51f0cd26a9">1,470</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7abd6989d6846e99b0a4c7ee504321d_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNS00LTEtMS0w_59c1f2d1-3d16-45c4-867c-3e30416eea25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7abd6989d6846e99b0a4c7ee504321d_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNS02LTEtMS0w_e47c0bc3-ebea-4e28-a51a-e5ebb2d7c6cd">113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5331125ba8a94b0fbfcb5387185e5869_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNS04LTEtMS0w_fd056f04-7ecb-4da4-8ae2-778eab33e4cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5331125ba8a94b0fbfcb5387185e5869_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNS0xMC0xLTEtMA_0d7c57ff-be52-4028-a689-8f1eb4700f58">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa29b64fff8949389d46c6f12d455215_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNi00LTEtMS0w_ca9924b0-b792-4836-a2fb-44896903dfa0">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa29b64fff8949389d46c6f12d455215_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNi02LTEtMS0w_4805acfd-9df7-4af4-b2ad-aee0fe804806">681</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd587e00f53f4c9184d615617e686bcd_D20190101-20190930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNi04LTEtMS0w_a9109df3-9745-4f60-a216-01ff6519e927">933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd587e00f53f4c9184d615617e686bcd_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNi0xMC0xLTEtMA_12a1fc21-2915-4cc1-a329-7f276ae098bc">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:continuation id="i72f30b3b7016448b943e572526930dc5"><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We offset fair value amounts associated with our derivative instruments on our condensed consolidated balance sheets that are executed with the same counterparty under master netting arrangements. Our netting arrangements include a right to set off or net together purchases and sales of similar products in the settlement process.</span></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfNTA4NA_12ef723a-d0c3-4c8e-8590-4f075a458fbb" escape="true"><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following tables present the fair value and the location of derivative contracts reported on the condensed consolidated balance sheets (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:27.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.491%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.493%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b35bd5fd55a4b69b147d5820c42e6d7_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfMi00LTEtMS0w_f2c09d8d-f1e2-470a-a1ee-71f5f6c5dcf9">1,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc095689f6144f4ea7254b0bb872766c_I20200930" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfMy00LTEtMS0xNjA1_1fc9042a-ef5c-4131-a4b9-3649d8bd00fd">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f55df33738d44e1ba296c8eb88269a1_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfMy00LTEtMS0w_c44befa5-f1b9-4436-9717-7713de27a818">1,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22945e43bf0c46a2a590bd5b5d61f00f_I20200930" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfNS04LTEtMS0w_305f53f0-3618-4a40-9f9c-73865477f588">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i930e2a8fddf64cb1b8979187598b1cd4_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfNi00LTEtMS0w_37dd2738-5dae-40ed-807c-fcb08dd47f96">4,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09a77749f8b64a04b0150d233c3084e4_I20200930" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfNi04LTEtMS0w_6e612e36-fbc7-46a8-920b-4fdb9a8f1593">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expense and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i930e2a8fddf64cb1b8979187598b1cd4_I20200930" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfOC04LTEtMS0xNjEw_de41e291-b4f9-4333-aca0-229a33563e77">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capped call derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2bca75c3d294e0eaa5aa2c0d20d66ac_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfNy00LTEtMS0w_f5d92e13-2556-4f01-ae72-4f30b5371de6">38,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Embedded exchange feature</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term derivative liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43f7ebc0918b4360bae6ce12a9368d0d_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfOC04LTEtMS0w_2ced269a-a02c-4ce5-bd60-4e62574b9f75">59,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c0f04c520c14a329fc827c4e8389951_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfMTEtOC0xLTEtMjMwNQ_91f6cd35-139e-4c5e-9fbd-8539184001f1">1,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term derivative liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id58204573a634e6ca3cf75d337baefe3_I20200930" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfMTItOC0xLTEtMjMwNQ_c550d397-6449-4364-a9fc-36cdd8c4fc2b">190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007ee0b9e8934174994f5d86e0bb6e6d_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfOS00LTEtMS0w_459c7e28-4a73-4c1a-b9e6-fca822e3845f">43,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007ee0b9e8934174994f5d86e0bb6e6d_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfOS04LTEtMS0w_defe6e3d-26a4-45e8-a129-abd2faa88ae6">60,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfMTAtNC0xLTEtMA_b0fa96e4-f2f4-444e-9b43-c65c24d3f570">44,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfMTAtOC0xLTEtMA_b859cea5-2821-4419-a0b5-80deebcd125f">60,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:27.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.491%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.493%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i990fa7277e80490b9cfb6a6d1b9d78f4_I20191231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfMi04LTEtMS0w_52385ccd-340a-405b-98aa-71d2de1aa6f7">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term derivative liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75a2980d9bdb44a792b41575bc1a46ba_I20191231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfMy04LTEtMS0w_6af53117-744b-42b6-bf75-569b12f4ff75">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52618d0ff8d74edb8b26a424dd5945e5_I20191231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfNC00LTEtMS0w_47781e1f-b730-4740-a539-ba3a51d4d6eb">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b91b912b3c479ca956a6a0c95f7567_I20191231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfNC04LTEtMS0w_23e5516a-df77-4293-b63d-317d233d9c9d">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b91b912b3c479ca956a6a0c95f7567_I20191231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfNS00LTEtMS0w_6fc94ca9-77f5-434a-bf72-7b7287092f7f">387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d1c0b4a1d3f448aa2bc219f0184bf4d_I20191231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfNi00LTEtMS0w_199d947f-c93c-4f1f-8923-865132ccf075">535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d1c0b4a1d3f448aa2bc219f0184bf4d_I20191231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfNi04LTEtMS0w_3055febc-4c61-4aae-83a4-630330a4c98a">543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bfe101df98424ab800c282d00e7116_I20191231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfOC00LTEtMS0w_5c9b1b35-40e5-4de8-9948-10d843851b8b">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bfe101df98424ab800c282d00e7116_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfOC04LTEtMS0w_30304eb4-be58-4d94-9992-f15f1d5b0c3a">3,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8a5acd53214b2b9194da6aedc036eb_I20191231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfOS04LTEtMS0w_59fb1f79-50e5-449a-88d1-4921c03df32d">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cd90438d14b4f0c8370dc4b8d777673_I20191231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfMTAtNC0xLTEtMA_5a7b7a5e-83e3-4e73-a234-f365a14802f6">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cd90438d14b4f0c8370dc4b8d777673_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfMTAtOC0xLTEtMA_7baebae6-e0b4-4aba-8f31-bd454786db7d">3,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfMTEtNC0xLTEtMA_fce5fa55-f656-48ed-a06a-90468641730d">561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfMTEtOC0xLTEtMA_f8e38123-b539-4b18-a4a4-293afcc76e50">3,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">For the classification of inputs used to evaluate the fair value of our derivatives, refer to &#8220;Note 7. Fair Value Measurements.&#8221;</span></div></ix:nonNumeric></ix:continuation><div style="padding-right:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">19</span></div></div></div><div id="i1bf75d3d05544b2db4639291692ac57a_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMzg0ODI5MDcxNTg3Mw_e6f6cfc3-8b70-4e71-ace2-27300a5369e7" continuedAt="i6da4f70ce5d44c49a0288958724a982d" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 10. Commitments and Contingencies</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">FDA Warning Letter</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On December&#160;29, 2015, the FDA issued a Warning Letter alleging certain violations of FDA regulations applicable to medical device manufacturers at our Munich, Germany and Arvada, Colorado facilities. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The FDA inspected the Munich facility from August 24, 2015 to August 27, 2015 and the Arvada facility from August 24, 2015 to September 1, 2015. On August&#160;27, 2015, the FDA issued a Form 483 identifying <ix:nonFraction unitRef="non-conformity" contextRef="i8e2eef5d48ff4b9bb6fe18d873c6d803_I20150827" decimals="INF" format="ixt-sec:numwordsen" name="livn:LossContingencyNumberofObservedNonConformities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfNDMy_6a9e4f85-0c56-43c0-8377-28357d4f069d">two</ix:nonFraction> observed non-conformities with certain regulatory requirements at the Munich facility. We did not receive a Form 483 in connection with the FDA&#8217;s inspection of the Arvada facility. Following the receipt of the Form 483, we provided written responses to the FDA describing corrective and preventive actions that were underway or to be taken to address the FDA&#8217;s observations at the Munich facility. The Warning Letter responded in part to our responses and identified other alleged violations related to the manufacture of our 3T Heater-Cooler device that were not previously included in the Form 483. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Warning Letter further stated that our 3T devices and other devices we manufactured at our Munich facility were subject to refusal of admission into the U.S. until resolution of the issues set forth by the FDA in the Warning Letter. The FDA had informed us that the import alert was limited to the 3T devices, but that the agency reserved the right to expand the scope of the import alert if future circumstances warranted such action. The Warning Letter did not request that existing users cease using the 3T device, and manufacturing and shipment of all of our products other than the 3T device were unaffected by the import limitation. To help clarify these issues for current customers, we issued an informational Customer Letter in January 2016 and that same month agreed with the FDA on a process for shipping 3T devices to existing U.S. users pursuant to a certificate of medical necessity program. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Finally, the Warning Letter stated that premarket approval applications for Class III devices to which certain Quality System regulation deviations identified in the Warning Letter were reasonably related would not be approved until the violations had been corrected; however, this restriction applied only to the Munich and Arvada facilities, which do not manufacture or design devices subject to Class III premarket approval. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On February 25, 2020, LivaNova received clearance for K191402, a 510(k) for the 3T devices that addressed issues contained in the 2015 Warning Letter along with design changes that further mitigate the potential risk of aerosolization. Concurrent with this clearance, (1) 3T devices manufactured in accordance with K191402 will not be subjected to the import alert and (2) LivaNova initiated a correction to distribute the updated Operating Instructions cleared under K191402.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We continue to work diligently to remediate the FDA&#8217;s inspectional observations for the Munich facility, as well as the additional issues identified in the Warning Letter. We take these matters seriously and intend to respond timely and fully to the FDA&#8217;s requests. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">CDC and FDA Safety Communications and Company Field Safety Notice</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On October 13, 2016, the CDC and the FDA separately released safety notifications regarding the 3T devices. The CDC&#8217;s Morbidity and Mortality Weekly Report (&#8220;MMWR&#8221;) and Health Advisory Notice (&#8220;HAN&#8221;) reported that tests conducted by the CDC and its affiliates indicate that there appears to be genetic similarity between both patient and 3T device strains of the non-tuberculous mycobacterium (&#8220;NTM&#8221;) bacteria M. chimaera isolated in hospitals in Iowa and Pennsylvania. Citing the geographic separation between the two hospitals referenced in the investigation, the report asserts that 3T devices manufactured prior to August 18, 2014 could have been contaminated during the manufacturing process. The CDC&#8217;s HAN and FDA&#8217;s Safety Communication, issued contemporaneously with the MMWR report, each assess certain risks associated with 3T devices and provide guidance for providers and patients. The CDC notification states that the decision to use the 3T device during a surgical operation is to be taken by the surgeon based on a risk approach and on patient need. Both the CDC&#8217;s and FDA&#8217;s communications confirm that 3T devices are critical medical devices and enable doctors to perform life-saving cardiac surgery procedures. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Also on October 13, 2016, concurrent with the CDC&#8217;s HAN and FDA&#8217;s Safety Communication, we issued a Field Safety Notice Update for U.S. users of 3T devices to proactively and voluntarily contact facilities to aid in implementation of the CDC and FDA recommendations. In the fourth quarter of 2016, we initiated a program to provide existing 3T device users with a new loaner 3T device at no charge pending regulatory approval and implementation of additional risk mitigation strategies worldwide, including a vacuum canister and internal sealing upgrade program and a deep disinfection service. This loaner program is available on a global basis. We anticipate that this program will continue until we are able to address customer needs through a broader solution that includes implementation of the risk mitigation strategies described above. We are currently implementing the vacuum and sealing upgrade program in as many countries as possible until all devices are upgraded. On October 11, 2018, after review of information provided by us, the FDA concluded that we could commence the vacuum and </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:continuation id="i6da4f70ce5d44c49a0288958724a982d" continuedAt="i2bd47128ea114c1c968439f48dbd00aa"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">sealing upgrade program in the U.S., and on February 25, 2020, LivaNova received clearance for K191402, a 510(k) for the 3T devices that addressed issues contained in the 2015 Warning Letter along with design changes that further mitigate the potential risk of aerosolization. Furthermore, we continue to offer a no-charge deep disinfection service (deep cleaning service) for 3T device users as we receive the required regulatory approvals. The deep disinfection service was rolled out in Europe in the second half of 2015, and on April 12, 2018, the FDA agreed to allow us to move forward with the deep cleaning service in the U.S. thereby adding to the growing list of countries around the world in which we offer this service. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On December&#160;31, 2016, we recognized a liability for our product remediation plan related to our 3T device. We concluded that it was probable that a liability had been incurred upon management&#8217;s approval of the plan and the commitments made by management to various regulatory authorities globally in November and December 2016, and furthermore, the cost associated with the plan was reasonably estimable. At September&#160;30, 2020, the product remediation liability was $<ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-5" format="ixt:numdotdecimal" name="livn:ProductRemediationNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfNjY5Mg_d40f0612-9717-4a4b-80dc-c22d60a30ed2">1.7</ix:nonFraction> million. Refer to &#8220;Note 5. Product Remediation Liability&#8221; for additional information.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Litigation</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Product Liability</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Company is currently involved in litigation involving our 3T device. The litigation includes a class action complaint in the U.S. District Court for the Middle District of Pennsylvania, federal multi-district litigation in the U.S. District Court for the Middle District of Pennsylvania, various U.S. state court cases and cases in jurisdictions outside the U.S. The class action, filed in February 2016, consists of all Pennsylvania residents who underwent open heart surgery at WellSpan York Hospital and Penn State Milton S. Hershey Medical Center between 2011 and 2015 and who currently are asymptomatic for NTM infection.&#160;Members of the class seek declaratory relief that the 3T devices are defective and unsafe for intended uses, medical monitoring, damages, and attorneys&#8217; fees.&#160;</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On March 29, 2019, we announced a settlement framework that provides for a comprehensive resolution of the personal injury cases pending in the multi-district litigation in U.S. federal court, the related class action pending in federal court, as well as certain cases in state courts across the United States. The agreement, which makes no admission of liability, is subject to certain conditions, including acceptance of the settlement by individual claimants and provides for a total payment of up to $<ix:nonFraction unitRef="usd" contextRef="i9e7e31e16f08494b91383db437aa83e5_D20190329-20190329" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfODA2Mg_c4e690be-8c7f-4b55-92ef-81593fc77f61">225</ix:nonFraction> million to resolve the claims covered by the settlement. Per the agreed-upon terms, the first payment of $<ix:nonFraction unitRef="usd" contextRef="ib86a229e06c94877bea66e161b156052_D20190701-20190731" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PaymentsForLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfODE2Mg_7ca78688-d74b-41bc-b2b5-080f4827d3c9">135</ix:nonFraction> million was paid into a qualified settlement fund in July 2019 and the second payment of $<ix:nonFraction unitRef="usd" contextRef="ibc438c9935fb4d298a4744c265489040_D20200101-20200131" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PaymentsForLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfODI0Ng_6070fcac-b885-4836-b671-212f1f8eb0e8">90</ix:nonFraction> million was paid in January 2020. Cases covered by the settlement are being dismissed as amounts are disbursed to individual plaintiffs from the qualified settlement fund.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cases in state courts in the U.S. and in jurisdictions outside the U.S. continue to progress. As of October&#160;29, 2020, including the cases encompassed in the settlement framework described above that have not yet been dismissed, we are aware of approximately <ix:nonFraction unitRef="claim" contextRef="i822d6a83e0f24f4e85072aba1aaa8ce1_I20201029" decimals="0" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfODY1Nw_3039faaa-17b6-4fcc-9acc-8fd688737984">85</ix:nonFraction>&#160;filed and unfiled claims worldwide, with the majority of the claims in various federal or state courts throughout the United States. This includes cases that have settled but have not yet been dismissed. The complaints generally seek damages and other relief based on theories of strict liability, negligence, breach of express and implied warranties, failure to warn, design and manufacturing defect, fraudulent and negligent misrepresentation or concealment, unjust enrichment, and violations of various state consumer protection statutes. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">At September&#160;30, 2020, the provision for these matters was $<ix:nonFraction unitRef="usd" contextRef="ia4743b9cbc8b413f864fd07a5e2fad89_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfOTI0Ng_a2610cee-c747-47e9-b710-189ffa419983">46.3</ix:nonFraction> million. While the amount accrued represents our best estimate, the actual liability for resolution of these matters may vary from our estimate. </span></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTg2MzE_117f8768-dd30-4654-932e-b7c189bf009f" escape="true"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The changes in the litigation provision liability during the nine months ended September 30, 2020 are as follows (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.375%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Litigation Provision Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation provision liability at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia92f7ea6fe5141b3a709c569c6f57200_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RhYmxlOmM5N2RkNzc3NDhhNTRiNGJhYjBkM2QxZWY3ZDdmMzFlL3RhYmxlcmFuZ2U6Yzk3ZGQ3Nzc0OGE1NGI0YmFiMGQzZDFlZjdkN2YzMWVfMS0yLTEtMS0w_f5f7898f-f692-4dc5-ad41-1314733e8add">170,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dfb8d93c33740aab82c128a023695f0_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RhYmxlOmM5N2RkNzc3NDhhNTRiNGJhYjBkM2QxZWY3ZDdmMzFlL3RhYmxlcmFuZ2U6Yzk3ZGQ3Nzc0OGE1NGI0YmFiMGQzZDFlZjdkN2YzMWVfMi0yLTEtMS0w_8f29382b-1b32-4907-8edb-280188452e67">128,128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dfb8d93c33740aab82c128a023695f0_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:LossContingencyAccrualAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RhYmxlOmM5N2RkNzc3NDhhNTRiNGJhYjBkM2QxZWY3ZDdmMzFlL3RhYmxlcmFuZ2U6Yzk3ZGQ3Nzc0OGE1NGI0YmFiMGQzZDFlZjdkN2YzMWVfMy0yLTEtMS0w_e2361859-fbfa-404b-9e27-523870c2e000">3,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dfb8d93c33740aab82c128a023695f0_D20200101-20200930" decimals="-3" name="livn:LossContingencyAccrualForeignCurrencyAdjustmentsAndOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RhYmxlOmM5N2RkNzc3NDhhNTRiNGJhYjBkM2QxZWY3ZDdmMzFlL3RhYmxlcmFuZ2U6Yzk3ZGQ3Nzc0OGE1NGI0YmFiMGQzZDFlZjdkN2YzMWVfNC0yLTEtMS0w_6ce23769-0623-4e28-a8d4-8c6900674a45">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation provision liability at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4743b9cbc8b413f864fd07a5e2fad89_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RhYmxlOmM5N2RkNzc3NDhhNTRiNGJhYjBkM2QxZWY3ZDdmMzFlL3RhYmxlcmFuZ2U6Yzk3ZGQ3Nzc0OGE1NGI0YmFiMGQzZDFlZjdkN2YzMWVfNS0yLTEtMS0w_194045fd-a8c0-4cb6-8496-c29d5c38d9d6">46,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of litigation liability at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4743b9cbc8b413f864fd07a5e2fad89_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualCarryingValueCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RhYmxlOmM5N2RkNzc3NDhhNTRiNGJhYjBkM2QxZWY3ZDdmMzFlL3RhYmxlcmFuZ2U6Yzk3ZGQ3Nzc0OGE1NGI0YmFiMGQzZDFlZjdkN2YzMWVfNi0yLTEtMS0w_5561c814-9d5e-4bb9-8d58-73d2e0f5039a">34,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of litigation provision liability at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4743b9cbc8b413f864fd07a5e2fad89_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualCarryingValueNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RhYmxlOmM5N2RkNzc3NDhhNTRiNGJhYjBkM2QxZWY3ZDdmMzFlL3RhYmxlcmFuZ2U6Yzk3ZGQ3Nzc0OGE1NGI0YmFiMGQzZDFlZjdkN2YzMWVfNy0yLTEtMS0w_fa8ca03a-22a1-4881-b7dc-f981c3b28b55">11,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:continuation id="i2bd47128ea114c1c968439f48dbd00aa" continuedAt="i2808b7729d4b49eaad401d01cb8982d3"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Environmental Liability</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our subsidiary, Sorin S.p.A. (&#8220;Sorin&#8221;) was created as a result of a spin-off (the &#8220;Sorin spin-off&#8221;) from SNIA S.p.A. (&#8220;SNIA&#8221;) in January 2004. SNIA subsequently became insolvent and the Italian Ministry of the Environment and the Protection of Land and Sea (the &#8220;Italian Ministry of the Environment&#8221;), sought compensation from SNIA for remediation costs relating to the environmental damage at chemical sites previously operated by SNIA&#8217;s other subsidiaries.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In September 2011 and July 2014, the Bankruptcy Court of Udine and the Bankruptcy Court of Milan, respectively, held (in proceedings to which we are not parties) that the Italian Ministry of the Environment and other Italian government agencies (the &#8220;Public Administrations&#8221;) were not creditors of either SNIA or its subsidiaries in connection with their claims in the Italian insolvency proceedings. The Public Administrations appealed and in January 2016, the Court of Udine rejected the appeal. The Public Administrations has appealed that decision to the Supreme Court. Meanwhile, the Bankruptcy Court of Milan&#8217;s decision has been appealed.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In January 2012, SNIA filed a civil action against Sorin in the Civil Court of Milan asserting joint liability of a parent and a spun-off company. The Public Administrations intervened in the proceeding, with a claim for environmental damages of approximately $<ix:nonFraction unitRef="usd" contextRef="id94164334ffb44b9adc73f1e3a4a759e_D20120101-20120131" decimals="-9" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesSoughtValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTA4NjI_c8790bb0-e641-464a-9e12-1a791e576e0c">4</ix:nonFraction> billion. On April 1, 2016, the Court of Milan dismissed all legal actions of SNIA and of the Public Administrations further requiring the Public Administrations to pay Sorin approximately &#8364;<ix:nonFraction unitRef="eur" contextRef="i4922d7cf37464b6088c833375aa28ff9_D20160401-20160401" decimals="-3" format="ixt:numdotdecimal" name="livn:ReimbursedLegalFees" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTEwNDU_663d522e-02e9-4edf-9df3-3924c6bd9017">292,000</ix:nonFraction>&#160;(approximately $<ix:nonFraction unitRef="usd" contextRef="ifd123abeb5064944877aad0f41f3b289_D20200930-20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:ReimbursedLegalFees" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTEwNjM_63dbec7f-2e36-4648-b9cf-a8b24c9eaed7">342,000</ix:nonFraction> as of September&#160;30, 2020)&#160;for legal fees. The Public Administrations appealed the 2016 Decision to the Court of Appeal of Milan, and on March 5, 2019, the Court of Appeal issued a partial decision on the merits declaring Sorin/LivaNova jointly liable with SNIA for SNIA&#8217;s environmental liabilities in an amount up to the fair value of the net worth received by Sorin because of the Sorin spin-off, an estimated &#8364;<ix:nonFraction unitRef="eur" contextRef="id9108f299f5642e3ab27bd8eabbe0df9_I20190305" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTE0NjE_ca1dc4eb-3a71-4c39-ba3c-60dc94a62149">572.1</ix:nonFraction> million&#160;(approximately $<ix:nonFraction unitRef="usd" contextRef="if0767ecfc4434c7c8ba7c0a26e46ab4a_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTE0Nzk_36e15651-c073-4f3b-8757-a263d9651827">669.1</ix:nonFraction> million as of September&#160;30, 2020). Additionally the Court issued a separate order, staying the proceeding until a panel of three experts can assess the environmental damages, the costs of clean-up, and the costs that the Public Administrations has already borne for the clean-up of the sites to allow the Court to decide on the second claim of the Public Administration against LivaNova, (i.e., to refund the Public Administrations for the SNIA environmental liabilities). Both LivaNova and the Public Administrations have appealed the decision to the Italian Supreme Court (Corte di Cassazione). </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We have not recognized an expense in connection with this matter because any potential loss is not currently probable or reasonably estimable. In addition, we cannot reasonably estimate a range of potential loss, if any, that may result from this matter.</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Patent Litigation</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On May 11, 2018, Neuro and Cardiac Technologies LLC (&#8220;NCT&#8221;), a non-practicing entity, filed a complaint in the United States District Court for the Southern District of Texas asserting that the VNS Therapy System, when used with the SenTiva Model 1000 generator, infringes the claims of U.S. Patent No. 7,076,307 owned by NCT. The complaint requests damages that include a royalty, costs, interest, and attorneys&#8217; fees. On September 13, 2018, we petitioned the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office (the &#8220;Patent Office&#8221;) for an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">inter partes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">review (&#8220;IPR&#8221;) of the validity of the &#8216;307 patent, and on May 18, 2020, the Patent Office issued a Final Written Decision determining that all challenged claims are unpatentable. NCT is appealing the Final Written Decision. On March 24, 2020, we were granted our request for an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">ex parte </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">reexamination of the &#8216;307 patent, and in August, the Patent Office issued a Non-Final Rejection of all of the &#8216;307 claims. The Court has stayed the litigation pending the outcome of the IPR appeal proceeding. We have not recognized an expense in connection with this matter because any potential loss is not currently probable or reasonably estimable. In addition, we cannot reasonably estimate a range of potential loss, if any, that may result from this matter. </span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Contract Litigation</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On November 25, 2019, LivaNova received notice of a lawsuit initiated by former members of Caisson Interventional, LLC (&#8220;Caisson&#8221;), a subsidiary of the Company acquired in 2017. The lawsuit, Todd J. Mortier, as Member Representative of the former Members of Caisson Interventional, LLC v. LivaNova USA, Inc., is currently pending in the United States District Court for the District of Minnesota. The complaint alleges (i) breach of contract, (ii) breach of the covenant of good faith and fair dealing and (iii) unjust enrichment in connection with the Company&#8217;s operation of Caisson&#8217;s Transcatheter Mitral Valve Replacement (&#8220;TMVR&#8221;) program and the Company&#8217;s November 20, 2019 announcement that it was ending the TMVR program at the end of 2019. The lawsuit seeks damages arising out of the 2017 acquisition agreement, including various regulatory milestone payments. We intend to vigorously defend this claim. The Company has not recognized an expense related to this matter because any potential loss is not currently probable or reasonably estimable. In addition, we cannot reasonably estimate a range of potential loss, if any, that may result from this matter.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:continuation id="i2808b7729d4b49eaad401d01cb8982d3"><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Tax Litigation</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In a tax audit report received on October 30, 2009, the Regional Internal Revenue Office of Lombardy (the &#8220;Internal Revenue Office&#8221;) informed Sorin Group Italia S.r.l. that, among several issues, it was disallowing in part a tax-deductible write down of the investment in the U.S. company, Cobe Cardiovascular Inc., which Sorin Group Italia S.r.l. recognized in 2002 and deducted in <ix:nonFraction unitRef="installment" contextRef="i42ece6a951c243ed95e1890dcca64a65_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="livn:IncomeTaxExaminationNumberofInstallments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTUyNjY_86493b10-9ba4-4350-a024-2fb51b1f6424">five</ix:nonFraction> equal installments, beginning in 2002. In December 2009, the Internal Revenue Office issued notices of assessment for 2004. In December 2010 and October 2011, the Internal Revenue Office issued notices of assessment for 2005 and 2006, respectively. We challenged all <ix:nonFraction unitRef="notice" contextRef="i42ece6a951c243ed95e1890dcca64a65_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="livn:LossContingencyNumberofAssessments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTU1MzY_1b441153-f03a-4972-a103-8529fff3e84f">three</ix:nonFraction> notices of assessment (for 2004, 2005 and 2006) before the relevant Provincial Tax Courts.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The total amount of losses in dispute was &#8364;<ix:nonFraction unitRef="eur" contextRef="i42ece6a951c243ed95e1890dcca64a65_I20200930" decimals="-5" format="ixt:numdotdecimal" name="livn:IncomeTaxExaminationOperatingLossesUnderDispute" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTcxMDk_c66bfc37-ecb0-45e6-a190-0c17da6875c1">62.6</ix:nonFraction> million (approximately $<ix:nonFraction unitRef="usd" contextRef="i42ece6a951c243ed95e1890dcca64a65_I20200930" decimals="-5" format="ixt:numdotdecimal" name="livn:IncomeTaxExaminationOperatingLossesUnderDispute" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTcxMjc_f08953b3-e3c0-487c-aca0-252e26853474">73.2</ix:nonFraction> million as of September&#160;30, 2020). On May 31, 2019, we filed an application to settle the litigation according to law N. 136/2018 and paid the required settlement balance of &#8364;<ix:nonFraction unitRef="eur" contextRef="i2a8c70677248473d83cfc005358a6167_I20190531" decimals="-5" format="ixt:numdotdecimal" name="livn:IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTc2ODg_7b74060c-3e94-49c8-a6c3-38c872542913">1.9</ix:nonFraction> million. As per law N. 136/2018, the Italian Revenue Agency reviewed the settlement and accepted the application by default on July 31, 2020. We recognized a benefit of &#8364;<ix:nonFraction unitRef="eur" contextRef="ieed6906313d54138b062d2f1a35a9599_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMzg0ODI5MDcxNzU1OA_d3a708c1-0027-4d30-8bf8-88c322498be4">5.4</ix:nonFraction>&#160;million, approximately $<ix:nonFraction unitRef="usd" contextRef="ieed6906313d54138b062d2f1a35a9599_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMzg0ODI5MDcxNzU3Mg_ee242bcc-1c4c-4521-932c-325adb549a1a">6.5</ix:nonFraction>&#160;million, during the third quarter of 2020 as compared to the previously recognized reserve for an uncertain tax position of &#8364;<ix:nonFraction unitRef="eur" contextRef="i774b2c58712345bab82956aa91ba877a_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTY0OTI2NzQ2MTY4OQ_270c3534-88b7-49ae-a9ec-35bdd38f1237">15.5</ix:nonFraction> million. The difference of &#8364;<ix:nonFraction unitRef="eur" contextRef="i774b2c58712345bab82956aa91ba877a_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMzg0ODI5MDcxNzU4Ng_d6776982-eb8a-4269-85fe-ee67f3f46546">10.1</ix:nonFraction>&#160;million (approximately $<ix:nonFraction unitRef="usd" contextRef="i774b2c58712345bab82956aa91ba877a_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMzg0ODI5MDcxNzYwMQ_10b1ee91-586e-4dc1-8544-d87f87dfa2cb">11.8</ix:nonFraction>&#160;million as of September 30, 2020) was a fully valued deferred tax asset for net operating losses, the reversal of which does not impact the condensed consolidated statement of income (loss). </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Other Matters</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Additionally, we are the subject of various pending or threatened legal actions and proceedings that arise in the ordinary course of our business. These matters are subject to many uncertainties and outcomes that are not predictable and that may not be known for extended periods of time. Since the outcome of these matters cannot be predicted with certainty, the costs associated with them could have a material adverse effect on our consolidated net income, financial position or liquidity.</span></div></ix:continuation><div style="text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_70"></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RleHRyZWdpb246ZjczNzE4ZTIyYzU0NDA5MDkyNDc2OTgxYzk1NjVhYWJfMzg0ODI5MDY5Nzc1MA_9f94000d-4e13-4f70-ae53-bc99aaa01ee8" continuedAt="ie565809daf1b4fb5a32cf72df3df5d14" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 11. Stockholders&#8217; Equity</span></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RleHRyZWdpb246ZjczNzE4ZTIyYzU0NDA5MDkyNDc2OTgxYzk1NjVhYWJfMzg0ODI5MDY5Nzc0OQ_e91b4799-2ecc-4687-b1b2-79bc1e25b33b" continuedAt="i847dfa8220204df591f7ef6d791c8c57" escape="true"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The tables below present the condensed consolidated statement of stockholders&#8217; equity as of and for the three and nine months ended September 30, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.970%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.290%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares - Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f8533c39b7f41078d1b3a8bcc766b96_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMS0yLTEtMS0w_d25cee26-cbb8-41f9-bbfa-f0d37df666ab">49,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f8533c39b7f41078d1b3a8bcc766b96_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMS00LTEtMS0w_c60dcd58-60d8-42ae-a4e4-56654703f9e7">76,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1478be27f8e34765a887baf8c6538b31_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMS02LTEtMS0w_53fa02f0-b944-4a6f-b87b-e87dd1d68767">1,750,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5443a67444ea416485c37b991988f6fb_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMS04LTEtMS0w_b10cbc57-6e2d-440b-a1da-39c1f58d8e1d">1,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id34d4656788a44fd81611969a787b29b_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMS0xMC0xLTEtMA_9fae0e6d-2748-4c8f-97b0-c982980af419">35,089</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie93c1f60108b48a3a6733d851a357ebe_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMS0xMi0xLTEtMA_f996f700-066a-4829-ab75-9d54caf86d97">457,804</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b57b2b83dd54d149c591d8fbbb18813_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMS0xNC0xLTEtMA_ebf2235a-25ea-4a12-b170-498e2095c136">1,333,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i772e55ea562149ffb5fc638d38caf1ad_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMi02LTEtMS0w_d9e6d363-da7b-42a8-a4bb-cd7163838591">7,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4dac957e404f989a0f0e8abd6471a0_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMi04LTEtMS0w_4914396a-8f01-49c9-b154-b2977e7c4d5a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMi0xNC0xLTEtMA_bc05ab71-2334-412e-90ec-c934d9cd233e">7,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation of shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="INF" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMy0yLTEtMS0zMTA2_cdc77a8e-8e41-410c-8872-049b3aeb4223">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9a83943fc464403a7d5089f8b33a871_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMy0xMi0xLTEtMA_35eeaa63-a262-4263-93d3-20a78aec9a57">14,772</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMy0xNC0xLTEtMA_f11ca183-d5fc-4baf-b66a-6dcab609abf0">14,772</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11762dbaa1ed49eb94d45dbf0e1eca9d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNC0xMC0xLTEtMA_61276178-b5d6-4f16-8643-04b3cf1ecef6">24,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNC0xNC0xLTEtMA_9da9629f-befd-48c2-950c-f378b253f299">24,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c3477a39b584e26aca4ae04d6bcdc27_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNS0yLTEtMS0w_0d3eef56-f9f7-4bfd-8540-4b6ff7f8af98">49,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c3477a39b584e26aca4ae04d6bcdc27_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNS00LTEtMS0w_00db5d6d-c229-44fd-937a-5bedd95f121d">76,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67841b9ab95c44768c3ad97a56b3bfa8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNS02LTEtMS0w_6e691833-6c55-49b2-90eb-d7af6c49dbd5">1,758,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdffa7f2634f4108a1118eab5e5b8ac5_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNS04LTEtMS0w_c0d8995e-9caf-40f1-accf-f713ad2fed04">1,053</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42ea28428d684a9cacaefaa3e6dd1b9e_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNS0xMC0xLTEtMA_4d296f50-933c-4087-b122-7335e4e72a5b">10,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbbfbf1476804a928a5c7aef5fa053f0_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNS0xMi0xLTEtMA_a0a3fb86-723a-41e0-a9c2-4a160e73f7ae">472,576</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNS0xNC0xLTEtMA_1da25a1e-795a-4607-b592-c9cb6f2e691f">1,350,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i646772a5bff64501b5ff80d29c70951d_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNy0yLTEtMS0w_2170aaab-a58a-4d9e-8673-e8967b91fabb">49,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i646772a5bff64501b5ff80d29c70951d_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNy00LTEtMS0w_d3ee6693-e630-4258-ae46-5e8e94b9b8fa">76,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ee5111b458142f6a8d38873421f58fc_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNy02LTEtMS0w_0a57f10b-45b5-448f-8928-3d3eba4c2c63">1,717,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i901bf76852a3483e827718cf605968da_I20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNy04LTEtMS0w_ce577cd2-694f-4626-ac25-acb5f045cb73">1,292</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37e2013ed189474aab9c13d2000c9cc9_I20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNy0xMC0xLTEtMA_0ad8ac53-ee28-4119-9149-849197b26221">13,174</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6767353b5d7549d18ff983e40ed7a527_I20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNy0xMi0xLTEtMA_7d20c004-1396-4133-b45f-10ee0cb6e2fe">295,643</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia64252b3f99d4b618cfb4816f6ff303e_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNy0xNC0xLTEtMA_6abd7d6e-5e96-46f7-b237-3ecc1997730b">1,483,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i81d68c28a9ae4f16b06014531f6d4332_D20190701-20190930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfOC0yLTEtMS0w_f7b24591-9a97-440d-9e9e-09ced8df005b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71221703b9ac4249a6c037f96c6fd8a2_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfOC02LTEtMS0w_00972052-9ad3-4858-971b-fec70fdf149b">8,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f027e9798fa4ca0934d00d9bb263410_D20190701-20190930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfOC04LTEtMS0w_37801cfc-0f7b-45b5-bf61-365957984a3a">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfOC0xNC0xLTEtMA_d3f21435-8817-454d-8e2f-41ce77064fb1">8,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c602e5b577142efafee2537813d0b56_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfOS0xMi0xLTEtMA_95346789-0d8b-4b5b-9b46-3f61b2b47f9a">32,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfOS0xNC0xLTEtMA_347b4df9-533c-4b49-9ae9-8b338741ba9a">32,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe68740e4f2a4fd1984ecc22362196b1_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTAtMTAtMS0xLTA_f07f1f32-eb19-4678-982c-0cfe457c6c6f">28,436</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTAtMTQtMS0xLTA_5deb0b44-f794-4d3d-ba8c-bcb596fe064b">28,436</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3cbb04514b7b4f2dbc2888e6954040c0_I20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtMi0xLTEtMA_1b1522c0-4b81-4efa-a30c-b65773e80003"><ix:nonFraction unitRef="shares" contextRef="i3cbb04514b7b4f2dbc2888e6954040c0_I20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtMi0xLTEtMA_99dacb3f-480b-49df-8ec7-79611001f8fc">49,381</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cbb04514b7b4f2dbc2888e6954040c0_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtNC0xLTEtMA_8509de0f-e71d-4afb-ba42-169086efd624"><ix:nonFraction unitRef="usd" contextRef="i3cbb04514b7b4f2dbc2888e6954040c0_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtNC0xLTEtMA_fbdc6e9d-825d-4d8f-bad9-671428a6e376">76,217</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ea24a03159448d282159becae6e7f97_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtNi0xLTEtMA_b95f88a4-4f2d-4b66-aef3-d1f9351fc3e1"><ix:nonFraction unitRef="usd" contextRef="i5ea24a03159448d282159becae6e7f97_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtNi0xLTEtMA_e7f5de5e-8acb-4a01-b3b0-b54355244bda">1,725,482</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic2b13270d7694a2899d0fd79a80d5739_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtOC0xLTEtMA_b42437a8-578e-4e43-b67c-c608419e0f6c"><ix:nonFraction unitRef="usd" contextRef="ic2b13270d7694a2899d0fd79a80d5739_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtOC0xLTEtMA_bbda78e6-b068-49dc-884c-058edece54fd">1,282</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd4e32d70c90404db0418fec4b835d7a_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtMTAtMS0xLTA_850bf423-ada2-436c-863f-ddc109827f94"><ix:nonFraction unitRef="usd" contextRef="idd4e32d70c90404db0418fec4b835d7a_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtMTAtMS0xLTA_f83c9a1f-160d-444a-903e-ae3ea500756e">41,610</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief427b70c02847b5b1c5f0f93bfab969_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtMTItMS0xLTA_70d3641a-9681-480e-9c87-aca19ecf2dad"><ix:nonFraction unitRef="usd" contextRef="ief427b70c02847b5b1c5f0f93bfab969_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtMTItMS0xLTA_fac56d3b-f80d-4622-9496-68530fbaba82">263,525</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cb9957d3e1b407bb88290f6a94e712e_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtMTQtMS0xLTA_a40a891a-d8f7-4aa7-ad57-ac3bbc35971b"><ix:nonFraction unitRef="usd" contextRef="i7cb9957d3e1b407bb88290f6a94e712e_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtMTQtMS0xLTA_f45e8ac1-be3f-4a64-b628-18af37aa54ab">1,495,282</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:continuation id="ie565809daf1b4fb5a32cf72df3df5d14"><ix:continuation id="i847dfa8220204df591f7ef6d791c8c57"><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.970%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.290%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares - Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdff871ce34c40e09563d35dccbeece4_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMS0yLTEtMS0w_d6a77f9a-ccf7-4e2e-87ba-97e4b6ff48c5">49,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdff871ce34c40e09563d35dccbeece4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMS00LTEtMS0w_82d7236f-5553-4d71-8127-60b10c77dd02">76,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f92e675a9a74c8ebf70114e14995425_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMS02LTEtMS0w_af15cf12-bf70-45e8-b825-cab655e8bb3b">1,734,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f678b8291d0499489325ab4fb979196_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMS04LTEtMS0w_6f1073bf-7146-49df-abe6-c25e57ca315a">1,263</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14244109275c4b71acdb26ad86c70caa_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMS0xMC0xLTEtMA_b341b772-1e50-4653-a31a-0519af3a4ee7">19,392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fc22053772446cd9092b2ea318f9022_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMS0xMi0xLTEtMA_437ce250-1282-41c9-a6a5-8448c5fb282b">406,755</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMS0xNC0xLTEtMA_8c9fbaf8-ee95-4e41-94d6-cf2b2d036fc0">1,383,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMi0wLTEtMS0wL3RleHRyZWdpb246NzBlNmI4NTFhNzBkNDhmYTgzNmM5ZmZkOGQwOTVkZGZfMTY_2f7bdef0-ddd7-4bfa-ad80-21e764af2e97">ASU No. 2016-13</span> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibeb25415374f4786a2efe54934478bee_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMi0xMi0xLTEtMA_9947b64a-bd48-4812-b219-629174bd84fa">639</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i602472901bc5472da9591b20d9734683_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMi0xNC0xLTEtMA_b7eea104-96da-4bad-81a6-585faa7f295f">639</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2e3b203d4b44ef49fe6a6a87e78b48a_D20200101-20200930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMy0yLTEtMS0w_c4753247-cbd4-4468-a7d6-cca27f0e0e2d">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2e3b203d4b44ef49fe6a6a87e78b48a_D20200101-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMy00LTEtMS0w_ed2d4f33-7e43-49b3-82c2-4caefbae5314">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ed16dbbc5fd4b1285afa69aff2e6594_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMy02LTEtMS0w_2eb5cadd-c92a-48a6-b0b8-9dbb3e1e8707">23,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84001a93f52c4e74984ff02516c7b75c_D20200101-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMy04LTEtMS0w_6e55e8ce-6353-4d5b-bfa4-2620622eec76">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMy0xNC0xLTEtMA_f9136b04-bb06-40bd-b511-1eb2cf2ef12d">23,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation of shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="INF" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNC0yLTEtMS0zMTA4_974dab07-9b8b-41f4-8704-9a39c3fbe459">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecd6db286ef0474c8967169d3455a2e9_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNC0xMi0xLTEtMA_ed424ac7-8ac6-4bbf-a14f-af53b8a4caa4">65,182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNC0xNC0xLTEtMA_5122dbf3-8bae-4ce0-8a1e-20945af40244">65,182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i357c72c25b924030994b1bf08eb695cb_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNS0xMC0xLTEtMA_1d096099-f89e-4a19-abe5-7ca9435fafaa">9,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNS0xNC0xLTEtMA_ccbb2ff5-4b4b-4d83-b0ed-0e9d669d040e">9,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c3477a39b584e26aca4ae04d6bcdc27_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNi0yLTEtMS0w_0d3eef56-f9f7-4bfd-8540-4b6ff7f8af98">49,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c3477a39b584e26aca4ae04d6bcdc27_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNi00LTEtMS0w_00db5d6d-c229-44fd-937a-5bedd95f121d">76,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67841b9ab95c44768c3ad97a56b3bfa8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNi02LTEtMS0w_6e691833-6c55-49b2-90eb-d7af6c49dbd5">1,758,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdffa7f2634f4108a1118eab5e5b8ac5_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNi04LTEtMS0w_c0d8995e-9caf-40f1-accf-f713ad2fed04">1,053</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42ea28428d684a9cacaefaa3e6dd1b9e_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNi0xMC0xLTEtMA_4d296f50-933c-4087-b122-7335e4e72a5b">10,385</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbbfbf1476804a928a5c7aef5fa053f0_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNi0xMi0xLTEtMA_a0a3fb86-723a-41e0-a9c2-4a160e73f7ae">472,576</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNi0xNC0xLTEtMA_a8075a64-93c3-4b3f-a609-4df30586264d">1,350,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i11b5dc862856494ba736bb256c91320d_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOC0yLTEtMS0w_2c5d9c7e-a8cd-43c6-ab65-ec1c285f0195">49,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11b5dc862856494ba736bb256c91320d_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOC00LTEtMS0w_69dc1a22-5a10-4fba-9db3-78c187f846be">76,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2edf297198406494036b93de529988_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOC02LTEtMS0w_3fe2017c-64fa-4bb2-bc69-d36be392af17">1,705,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5433f056524a44659bef554cefff1704_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOC04LTEtMS0w_b0f8f76f-a1f8-4575-8735-69164f3c623e">1,462</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia85d1e0c436c415abf0ffabd07459791_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOC0xMC0xLTEtMA_690fbc57-de5c-4556-9aba-be1ea7ba974f">24,476</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5223aa7b849840fb8494719b938ff2b2_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOC0xMi0xLTEtMA_b5718b0b-0295-49ad-bb5f-b9c0c170ba5c">251,579</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic94ddff991844d7bb182464410e337c2_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOC0xNC0xLTEtMA_63d72c61-a0b6-4ea2-b290-395ffea9b4b6">1,503,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia86697a40b714160b0bee988340e85a0_D20190101-20190930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOS0yLTEtMS0w_b65ba890-c4b2-422b-9ebc-f10f2c68eefa">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia86697a40b714160b0bee988340e85a0_D20190101-20190930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOS00LTEtMS0w_386ce3cf-2496-44c3-8fb6-e9551198ce35">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie10c500eacef4aaf8fc597afbc3d45b5_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOS02LTEtMS0w_bfde20e2-b0b7-4dc7-8179-a15aa9844a3a">20,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d1519f3a2b54a76abca9ca793ca5b66_D20190101-20190930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOS04LTEtMS0w_1e2626da-6277-43b4-8363-f6cc02b5957d">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOS0xNC0xLTEtMA_0ce1acc5-2cd3-4450-aa89-7cd3e55a179d">20,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i585b337eb45c4a659b1ee03c596606d8_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTAtMTItMS0xLTA_04e54b02-2d93-45a1-8582-650fa4588665">11,946</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTAtMTQtMS0xLTA_6b71d259-bed5-48fe-a590-afc953e912e9">11,946</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bbc378fed9842a5b7a3214c4db31cbb_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTEtMTAtMS0xLTA_3d228988-83a1-432d-84ab-8b12f7ccbb5e">17,134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTEtMTQtMS0xLTA_46fc1af0-6296-4887-b0f1-7e0c40f676a3">17,134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3cbb04514b7b4f2dbc2888e6954040c0_I20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItMi0xLTEtMA_1b1522c0-4b81-4efa-a30c-b65773e80003"><ix:nonFraction unitRef="shares" contextRef="i3cbb04514b7b4f2dbc2888e6954040c0_I20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItMi0xLTEtMA_99dacb3f-480b-49df-8ec7-79611001f8fc">49,381</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cbb04514b7b4f2dbc2888e6954040c0_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItNC0xLTEtMA_8509de0f-e71d-4afb-ba42-169086efd624"><ix:nonFraction unitRef="usd" contextRef="i3cbb04514b7b4f2dbc2888e6954040c0_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItNC0xLTEtMA_fbdc6e9d-825d-4d8f-bad9-671428a6e376">76,217</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ea24a03159448d282159becae6e7f97_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItNi0xLTEtMA_b95f88a4-4f2d-4b66-aef3-d1f9351fc3e1"><ix:nonFraction unitRef="usd" contextRef="i5ea24a03159448d282159becae6e7f97_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItNi0xLTEtMA_e7f5de5e-8acb-4a01-b3b0-b54355244bda">1,725,482</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic2b13270d7694a2899d0fd79a80d5739_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItOC0xLTEtMA_b42437a8-578e-4e43-b67c-c608419e0f6c"><ix:nonFraction unitRef="usd" contextRef="ic2b13270d7694a2899d0fd79a80d5739_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItOC0xLTEtMA_bbda78e6-b068-49dc-884c-058edece54fd">1,282</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd4e32d70c90404db0418fec4b835d7a_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItMTAtMS0xLTA_850bf423-ada2-436c-863f-ddc109827f94"><ix:nonFraction unitRef="usd" contextRef="idd4e32d70c90404db0418fec4b835d7a_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItMTAtMS0xLTA_f83c9a1f-160d-444a-903e-ae3ea500756e">41,610</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief427b70c02847b5b1c5f0f93bfab969_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItMTItMS0xLTA_70d3641a-9681-480e-9c87-aca19ecf2dad"><ix:nonFraction unitRef="usd" contextRef="ief427b70c02847b5b1c5f0f93bfab969_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItMTItMS0xLTA_fac56d3b-f80d-4622-9496-68530fbaba82">263,525</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cb9957d3e1b407bb88290f6a94e712e_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItMTQtMS0xLTA_a40a891a-d8f7-4aa7-ad57-ac3bbc35971b"><ix:nonFraction unitRef="usd" contextRef="i7cb9957d3e1b407bb88290f6a94e712e_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItMTQtMS0xLTA_f45e8ac1-be3f-4a64-b628-18af37aa54ab">1,495,282</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Refer to &#8220;Note 17. New Accounting Pronouncements&#8221;</span></div></ix:continuation><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RleHRyZWdpb246ZjczNzE4ZTIyYzU0NDA5MDkyNDc2OTgxYzk1NjVhYWJfNDgy_41ae2a59-e896-49bb-bade-fe8b61e64c24" escape="true"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The table below presents the change in each component of AOCI, net of tax, and the reclassifications out of AOCI into net income for the nine months ended September 30, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Unrealized Gain (Loss) on Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments Gain (Loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73b9ebabb9a742feaf7a7a83f366667e_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMS0yLTEtMS0w_288c8e11-1ce8-4777-98eb-51bad7f23a67">513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1125b67f1c85426d9cd1a530fb32d7b6_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMS00LTEtMS0w_c0c9819f-b3da-48ee-a54e-36d575724014">19,905</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14244109275c4b71acdb26ad86c70caa_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMS02LTEtMS0w_3cbebec2-3b4f-4f11-8e1f-71a3991e8844">19,392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a275a7257a24e82a86ff4fa4e50516e_D20200101-20200930" decimals="-3" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMi0yLTEtMS0w_472b380d-3235-46f8-9dd7-727034602932">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e7648a0a8345a3b1986dfb798ac9de_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMi00LTEtMS0w_419ba7b1-be1b-4c24-970a-c4ee84663772">8,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMi02LTEtMS0w_92f5ef85-7206-4162-91f6-1467822b47a6">8,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a275a7257a24e82a86ff4fa4e50516e_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMy0yLTEtMS0w_e2910d67-c065-411d-8dae-383a3fdc3e81">152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e7648a0a8345a3b1986dfb798ac9de_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMy00LTEtMS0w_70e15612-29e8-4291-a6da-b875e98982ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMy02LTEtMS0w_5f8e2082-54b7-475f-b138-813fbe577d9a">152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a275a7257a24e82a86ff4fa4e50516e_D20200101-20200930" decimals="-3" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNC0yLTEtMS0w_da2280ae-5e74-4469-b998-38f7db463d2d">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e7648a0a8345a3b1986dfb798ac9de_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNC00LTEtMS0w_662fc593-1cc6-406b-82bb-c475b5e69844">8,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNC02LTEtMS0w_27975081-16e9-40e9-b6bc-ec8a03bc816d">8,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of loss from accumulated other comprehensive loss, before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a275a7257a24e82a86ff4fa4e50516e_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNS0yLTEtMS0w_ddd3d131-0f81-4862-9ba9-b792a54bc844">681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e7648a0a8345a3b1986dfb798ac9de_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNS00LTEtMS0w_f723efbe-73f2-49d2-937d-64b43929686d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNS02LTEtMS0w_9ddb44d4-b1f0-4c9c-b8b1-dd8398736bd7">681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a275a7257a24e82a86ff4fa4e50516e_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNi0yLTEtMS0w_103348cc-63e2-4642-8fd3-597cf03c0060">162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e7648a0a8345a3b1986dfb798ac9de_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNi00LTEtMS0w_83d29c46-4fd2-4b69-a21d-8c750d43342c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNi02LTEtMS0w_ac38472b-bfaa-4027-8550-c831dbbaf093">162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of loss from accumulated other comprehensive loss, after tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a275a7257a24e82a86ff4fa4e50516e_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNy0yLTEtMS0w_48dee3ab-2215-42b1-a5e9-a2faffb941d0">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e7648a0a8345a3b1986dfb798ac9de_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNy00LTEtMS0w_6dad24b9-b3d2-4c0b-a038-a4ce1be296c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNy02LTEtMS0w_52f02571-2416-4fb7-a76d-37c842af5847">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a275a7257a24e82a86ff4fa4e50516e_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfOC0yLTEtMS0w_4012e3b5-a80b-4733-9e85-7585faee3c48">999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e7648a0a8345a3b1986dfb798ac9de_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfOC00LTEtMS0w_0e0b024d-c389-4fef-b3db-cdace581fad6">8,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfOC02LTEtMS0w_63c4e44b-e73e-4424-b0ed-de284df166b8">9,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0977771516644bab2772f34d2437e3d_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfOS0yLTEtMS0w_cb83ef62-6339-407e-bddc-903a91f9a840">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd262b92e2af4f3f98cd4f5c03def298_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfOS00LTEtMS0w_157fc030-6b9c-4ec3-9b21-18f1792869bb">11,897</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42ea28428d684a9cacaefaa3e6dd1b9e_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfOS02LTEtMS0w_f4073d25-fbed-4a8b-bc33-4f12324c1560">10,385</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28ed0d61b46b4daaa86046342354f4b2_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTEtMi0xLTEtMA_08d8aa04-813a-4dd0-9696-7503a47188fa">944</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefddf94f87084dd1ade6648ea605cf0c_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTEtNC0xLTEtMA_f9c1841c-1d39-474a-896b-352e9a547ce3">23,532</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia85d1e0c436c415abf0ffabd07459791_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTEtNi0xLTEtMA_3f3281a3-578e-4e46-921b-a99570c9d2bf">24,476</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b7762a5b5f04bec8a312789ceeb2bd4_D20190101-20190930" decimals="-3" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTItMi0xLTEtMA_e7071bce-bc65-4ec1-944a-75e7bb1d60ae">933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i340d4173e28147f58686dee1587f9750_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTItNC0xLTEtMA_203b7f69-d655-44ba-8ef6-ce25a3a77fd5">16,628</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTItNi0xLTEtMA_61a1f1f6-4d7d-4b4b-8eb8-6f0f18296bd3">15,695</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b7762a5b5f04bec8a312789ceeb2bd4_D20190101-20190930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTMtMi0xLTEtMA_44cec627-a673-4295-b426-e597d0273721">224</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i340d4173e28147f58686dee1587f9750_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTMtNC0xLTEtMA_aeb332cd-1156-42cc-b41e-3bb0771234c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTMtNi0xLTEtMA_6d714485-3d0e-44ef-a27c-1ee1e7f46035">224</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b7762a5b5f04bec8a312789ceeb2bd4_D20190101-20190930" decimals="-3" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTQtMi0xLTEtMA_865da662-cef5-4948-a347-efc82ec92867">709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i340d4173e28147f58686dee1587f9750_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTQtNC0xLTEtMA_0483c96d-7839-4c98-a469-75b8406270f1">16,628</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTQtNi0xLTEtMA_95490a53-172a-4358-8ad6-0d2ee5120c3c">15,919</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of gain from accumulated other comprehensive loss, before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b7762a5b5f04bec8a312789ceeb2bd4_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTUtMi0xLTEtMA_4509b5e9-ad88-4834-bda0-dec6fd7d7431">1,598</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i340d4173e28147f58686dee1587f9750_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTUtNC0xLTEtMA_5850a18c-479d-49ab-8970-62e24fb76e78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTUtNi0xLTEtMA_97fa1df4-dc28-4880-b030-68308f4f2704">1,598</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b7762a5b5f04bec8a312789ceeb2bd4_D20190101-20190930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTYtMi0xLTEtMA_1d272633-5c7b-4c26-988c-246cdaa1c9a6">383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i340d4173e28147f58686dee1587f9750_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTYtNC0xLTEtMA_d1be111f-0340-4612-90e5-5bb84ff38b39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTYtNi0xLTEtMA_a9038b67-60d3-43d6-9361-855f33152d8d">383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of gain from accumulated other comprehensive loss, after tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b7762a5b5f04bec8a312789ceeb2bd4_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTctMi0xLTEtMA_47bc25b8-68f9-4881-b0f0-6efbeabc7acb">1,215</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i340d4173e28147f58686dee1587f9750_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTctNC0xLTEtMA_0115e5b9-43ea-4e5a-8979-8a6c467f5bce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTctNi0xLTEtMA_d3585bc2-406d-4d9d-b0dc-4d0411aad6df">1,215</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b7762a5b5f04bec8a312789ceeb2bd4_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTgtMi0xLTEtMA_f37b6237-5592-44a6-aaf5-0c7ce0a16603">506</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i340d4173e28147f58686dee1587f9750_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTgtNC0xLTEtMA_d6177efc-adf0-4148-a3d4-5597e8582850">16,628</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTgtNi0xLTEtMA_b5a7249b-8956-4128-bdab-a2d59d4ebcac">17,134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id48df069b0704c3581b5adc77e251cb0_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTktMi0xLTEtMA_69e65fef-10c2-4620-b99e-6e9d57f8deac">1,450</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4561e95c0c8449a78e98f5d3fc5b92c3_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTktNC0xLTEtMA_d327c17b-0539-46ca-b097-14e1615eff45">40,160</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd4e32d70c90404db0418fec4b835d7a_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTktNi0xLTEtMA_1ff1cd72-b49e-4358-91fd-680840683095">41,610</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Taxes are not provided for foreign currency translation adjustments as translation adjustments are related to earnings that are intended to be reinvested in the countries where earned.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">24</span></div></div></div><div id="i1bf75d3d05544b2db4639291692ac57a_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RleHRyZWdpb246MjhhODhlNzE4YmUzNDc0MWI5Yjk4YzYyNGQxZWZlZTRfMzg0ODI5MDY5ODI4OQ_04ad643f-49af-42d2-ba4a-a2382294da93" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 12. Stock-Based Incentive Plans </span></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RleHRyZWdpb246MjhhODhlNzE4YmUzNDc0MWI5Yjk4YzYyNGQxZWZlZTRfMTAzOA_434c8c64-c65f-4555-a904-741fdc647ec8" continuedAt="i1d80817cc34749dcb286fdc9e5ef3e3f" escape="true"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Stock-based incentive plans compensation expense is as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.918%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service-based restricted stock units (&#8220;RSUs&#8221;)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief162d0a6831435c9c447ec4cb5cc4f1_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfMi0yLTEtMS0w_54f79543-06a1-444b-839f-a16df74a2dc5">4,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5acbf636460b4e198f468c31a3c1be2d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfMi00LTEtMS0w_c207bcfa-196f-4fe0-ab76-532cee420470">3,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225c9725da49473d854e8f083baa2603_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfMi02LTEtMS0w_a7fe8ab1-90a7-4dc1-9339-34797a238752">13,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic23be7d8ac3c4b778a9d24d166906ab1_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfMi04LTEtMS0w_6ff6ce14-0355-4f62-a5b1-4d1ceae135f7">10,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service-based stock appreciation rights (&#8220;SARs&#8221;)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i546f2452d51d4bdc881efe5cc5c05a8d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfMy0yLTEtMS0w_911119e9-05c9-4db6-ad1c-31c03f56f12e">3,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia56cee55c4cf43099b9e98160544d49b_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfMy00LTEtMS0w_13e1faf7-6bf9-46e7-b40f-29ba88b9abfa">2,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a0fca2fdff64694bb24e3e060fd6dc8_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfMy02LTEtMS0w_972cba88-ca43-4942-b668-be0fcde953f8">9,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib638c02dde7843eab3f4573d6585314d_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfMy04LTEtMS0w_76c098e0-7e9a-4cdd-a7ce-166a38028ed8">7,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market performance-based restricted stock units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i427900b1e7d84e50b571679ab1cabaad_D20200701-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNC0yLTEtMS0w_387696d6-2073-421f-a729-cbfc2a673a59">814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7c014275f2d405ab23766c236149138_D20190701-20190930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNC00LTEtMS0w_8de0b4f4-c1b2-4bb7-9d3c-05c46aa97747">757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32d2a1a2778b49afb67fef2675c88931_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNC02LTEtMS0w_c11a7d4a-dc37-4d84-88ed-72b2139ef42f">2,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d8cecc1dece477e9a955468c571ae1e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNC04LTEtMS0w_7e45aa8e-4f97-4277-a9e5-374274ff1e24">2,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating performance-based restricted stock units </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65ec3dbf2057421c8affe016c664ea78_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNS0yLTEtMS0w_9b49a016-110d-4ddb-80dd-b0f62aa55d88">962</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19cf82e1376d4f11840e7da277a74cd5_D20190701-20190930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNS00LTEtMS0w_1aee5019-1904-4a28-bb76-0f276385a55e">983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e416e9ef1f14ac2bc887e06f9aebbf6_D20200101-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNS02LTEtMS0w_f3d754fa-fd4d-49a8-8a7d-a509147d2c37">882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a670137ff2a451782f99f45ef40a8f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNS04LTEtMS0w_977c8b44-e296-45cb-a54d-af5c065c0c2c">2,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee share purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb32345ef6842089919448a35175b29_D20200701-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNi0yLTEtMS0w_cca2e767-2428-4f4c-8f0c-af93baa38369">337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id526b3c20a2d42d5abba8504d3816294_D20190701-20190930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNi00LTEtMS0w_2be78324-1d86-41cb-af2a-36a3968aead3">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97785f256ae3470b9f482c61dec5e68a_D20200101-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNi02LTEtMS0w_9a6291cc-f644-4894-8552-83ede90ac1bf">894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d45641764344e17bb094a058ba9942c_D20190101-20190930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNi04LTEtMS0w_6bab5827-5418-46c6-ab24-43bbab510e87">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNy0yLTEtMS0w_c936c6fb-d16c-4d3b-964d-c8244cd34386">7,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNy00LTEtMS0w_f4c9348b-a30d-404f-8e43-7c356f144e46">8,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNy02LTEtMS0w_97196dbe-ce0a-4811-9745-9aea5fc486e7">26,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNy04LTEtMS0w_77a18c02-9419-43cd-a3ff-6e98815f19c8">24,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">During the nine months ended September 30, 2020, we issued stock-based compensatory awards with terms approved by the Compensation Committee of our Board of Directors. The awards with service conditions generally vest ratably over <ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RleHRyZWdpb246MjhhODhlNzE4YmUzNDc0MWI5Yjk4YzYyNGQxZWZlZTRfMjc3_7a4b828f-9545-4ee5-b13d-6a44bc818f36">four years</ix:nonNumeric>, subject to forfeiture unless service conditions are met. Market performance-based awards cliff vest after <ix:nonNumeric contextRef="i32d2a1a2778b49afb67fef2675c88931_D20200101-20200930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RleHRyZWdpb246MjhhODhlNzE4YmUzNDc0MWI5Yjk4YzYyNGQxZWZlZTRfMzg3_00881ad7-3267-4b50-99cc-ccee96ae3bad">three years</ix:nonNumeric> subject to the rank of our total shareholder return for the <ix:nonNumeric contextRef="i427900b1e7d84e50b571679ab1cabaad_D20200701-20200930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RleHRyZWdpb246MjhhODhlNzE4YmUzNDc0MWI5Yjk4YzYyNGQxZWZlZTRfMzg0ODI5MDY5ODI5NA_accc563f-edcc-4d6e-b476-efdf4cd6730a">three-year</ix:nonNumeric> period ending December 31, 2022 relative to the total shareholder returns for a peer group of companies. Operating performance-based awards cliff vest after <ix:nonNumeric contextRef="i2e416e9ef1f14ac2bc887e06f9aebbf6_D20200101-20200930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RleHRyZWdpb246MjhhODhlNzE4YmUzNDc0MWI5Yjk4YzYyNGQxZWZlZTRfNjE1_e8b94243-f4e7-4755-97c2-ce7cfda01607">three years</ix:nonNumeric> subject to the achievement of certain thresholds of cumulative adjusted free cash flow for the <ix:nonNumeric contextRef="i2e416e9ef1f14ac2bc887e06f9aebbf6_D20200101-20200930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RleHRyZWdpb246MjhhODhlNzE4YmUzNDc0MWI5Yjk4YzYyNGQxZWZlZTRfMzg0ODI5MDY5ODI5NQ_d30d2fbe-ef34-4e57-a3c0-bd9ceff29ed8">three year</ix:nonNumeric> period ending December 31, 2022. Compensation expense related to awards granted during 2020 for the three and nine months ended September 30, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RleHRyZWdpb246MjhhODhlNzE4YmUzNDc0MWI5Yjk4YzYyNGQxZWZlZTRfODIw_8d935d2e-0af5-4885-8450-5f411493c10b">3.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RleHRyZWdpb246MjhhODhlNzE4YmUzNDc0MWI5Yjk4YzYyNGQxZWZlZTRfODI3_6954da3f-6989-491c-9fb6-618f357e4c29">6.6</ix:nonFraction> million, respectively.</span></div><ix:continuation id="i1d80817cc34749dcb286fdc9e5ef3e3f"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Stock-based compensation agreements issued during the nine months ended September 30, 2020, representing potential shares and their weighted average grant date fair values by type follows (shares in thousands, fair value in dollars):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:63.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service-based SARs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a0fca2fdff64694bb24e3e060fd6dc8_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmZjMDI1OTRjODE1ZTRhMzFhM2I0YjYyNWRkMzE1YTI5L3RhYmxlcmFuZ2U6ZmMwMjU5NGM4MTVlNGEzMWEzYjRiNjI1ZGQzMTVhMjlfMi0yLTEtMS0w_89a7b730-cb09-4dfd-b5c4-1de00f0afb30">1,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic0dced88ae604075b207e4543f4c306f_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmZjMDI1OTRjODE1ZTRhMzFhM2I0YjYyNWRkMzE1YTI5L3RhYmxlcmFuZ2U6ZmMwMjU5NGM4MTVlNGEzMWEzYjRiNjI1ZGQzMTVhMjlfMi00LTEtMS0w_c9a2c31f-742f-427c-bdef-281ee39c862a">15.73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service-based RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i225c9725da49473d854e8f083baa2603_D20200101-20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmZjMDI1OTRjODE1ZTRhMzFhM2I0YjYyNWRkMzE1YTI5L3RhYmxlcmFuZ2U6ZmMwMjU5NGM4MTVlNGEzMWEzYjRiNjI1ZGQzMTVhMjlfMy0yLTEtMS0w_7015c605-a9bd-4ce0-b678-6df8eab499f1">599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i92991d08bea7415da6b40d6cf2dfe885_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmZjMDI1OTRjODE1ZTRhMzFhM2I0YjYyNWRkMzE1YTI5L3RhYmxlcmFuZ2U6ZmMwMjU5NGM4MTVlNGEzMWEzYjRiNjI1ZGQzMTVhMjlfMy00LTEtMS0w_196c6c39-763b-49bc-931b-00b88b17888a">44.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market performance-based RSUs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i32d2a1a2778b49afb67fef2675c88931_D20200101-20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmZjMDI1OTRjODE1ZTRhMzFhM2I0YjYyNWRkMzE1YTI5L3RhYmxlcmFuZ2U6ZmMwMjU5NGM4MTVlNGEzMWEzYjRiNjI1ZGQzMTVhMjlfNC0yLTEtMS0w_9838889a-93f9-4ddc-afae-c0e12efaba92">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id411cf0d82944320a5787d8a7f2ebfe8_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmZjMDI1OTRjODE1ZTRhMzFhM2I0YjYyNWRkMzE1YTI5L3RhYmxlcmFuZ2U6ZmMwMjU5NGM4MTVlNGEzMWEzYjRiNjI1ZGQzMTVhMjlfNC00LTEtMS0w_e4284637-160c-4aaf-bb35-fdbfbc069522">39.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating performance-based RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2e416e9ef1f14ac2bc887e06f9aebbf6_D20200101-20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmZjMDI1OTRjODE1ZTRhMzFhM2I0YjYyNWRkMzE1YTI5L3RhYmxlcmFuZ2U6ZmMwMjU5NGM4MTVlNGEzMWEzYjRiNjI1ZGQzMTVhMjlfNS0yLTEtMS0w_5f955cc3-6d9d-4ded-8404-f38872a35af9">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaaa1e1cbda504307b64e2b6e1037f051_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmZjMDI1OTRjODE1ZTRhMzFhM2I0YjYyNWRkMzE1YTI5L3RhYmxlcmFuZ2U6ZmMwMjU5NGM4MTVlNGEzMWEzYjRiNjI1ZGQzMTVhMjlfNS00LTEtMS0w_684cf472-9267-491b-8ea5-72fc148a91ba">43.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:nonNumeric><div style="text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_79"></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfMzg0ODI5MDcwMDA1OQ_b10e2826-6d61-42dd-846a-a52169deb1eb" continuedAt="i0b4291447d5f4977b104b40414c99141" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 13. Income Taxes</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our effective income tax rate from continuing operations for the three and nine months ended September 30, 2020 was <ix:nonFraction unitRef="number" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfNzI_98d93a35-3d46-4330-835b-90e517f91a2e">21.3</ix:nonFraction>% and (<ix:nonFraction unitRef="number" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfNzk_9c20b4b2-988d-48da-aed5-d4873239029f">37.9</ix:nonFraction>)% compared with (<ix:nonFraction unitRef="number" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfOTY_6f14bc8c-939c-4538-96c7-b2c53caaf17b">49.6</ix:nonFraction>)% and <ix:nonFraction unitRef="number" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfMTAz_f7d90111-bb0d-41f8-9980-75099c280d9b">65.9</ix:nonFraction>% for the three and nine months ended September 30, 2019, respectively. Our effective income tax rate fluctuates based on, among other factors, changes in pretax income in countries with varying statutory tax rates, changes in valuation allowances, changes in tax credits and incentives, and changes in unrecognized tax benefits associated with uncertain tax positions. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We continually assess the realizability of our worldwide deferred tax asset and valuation allowance positions, and when the need arises, we establish or release valuation allowances accordingly.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Compared with the three months ended September 30, 2019, the change in the effective tax rate for the three months ended September 30, 2020 was primarily attributable to a discrete tax benefit due to the release of the uncertain tax position upon the settlement of tax litigation in Italy offset by a valuation allowance for certain jurisdictions outside the U.S., as compared to a U.S. federal tax benefit from a return to provision reconciliation, partially offset by the establishment of a valuation allowance for a portion of the U.S. federal and state net operating losses during the three months ended September 30, 2019. We established valuation allowances as it is more likely than not that we will be unable to realize the related historical deferred tax assets.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Compared with the nine months ended September 30, 2019, the change in the effective tax rate for the nine months ended September 30, 2020 was primarily attributable to a $<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="livn:IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfMTA4NQ_43bda678-f511-40b3-9ba2-70e621a321bc">42.4</ix:nonFraction> million realized discrete tax benefit related to the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) and the discrete tax benefit due to the release of the uncertain tax position upon the settlement of tax litigation in Italy offset by the establishment of a $<ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwardsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfMTIzMQ_add8992e-715e-4fce-89f4-5c9c42548b71">74.5</ix:nonFraction>&#160;million valuation allowance for the U.K. and </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:continuation id="i0b4291447d5f4977b104b40414c99141"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">other jurisdictions outside the U.S., as compared to a release of uncertain tax positions and a U.S. federal tax benefit from a return to provision reconciliation, partly offset by the establishment of a valuation allowance for a portion of the U.S. federal and state net operating losses and attributes during the nine months ended September 30, 2019. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We operate in multiple jurisdictions throughout the world, and our tax returns are periodically audited or subjected to review by tax authorities. As a result, there is an uncertainty in income taxes recognized in our financial statements. Tax benefits totaling $<ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfMTA5OTUxMTYzMDYwMA_9f259c3c-6681-4875-8cd8-777089a96f45">4.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfMTc4MQ_7187ece9-d822-416d-a608-fc4215a4fcdd">12.9</ix:nonFraction> million were unrecognized as of September&#160;30, 2020 and December 31, 2019, respectively. It is reasonably possible that, within the next twelve months, due to the settlement of uncertain tax positions with various tax authorities and the expiration of statutes of limitations, unrecognized tax benefits could decrease by up to approximately $<ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfMjA3MQ_f054fd36-0bc5-4c9f-a6eb-495123387fd8">0.7</ix:nonFraction> million.</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We monitor income tax developments in countries where we conduct business. On March 27, 2020, the U.S. enacted the CARES Act which provided for a 5-year loss carryback for losses incurred in 2018-2020. We recorded a discrete tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="livn:IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfMjMxNQ_43bda678-f511-40b3-9ba2-70e621a321bc">42.4</ix:nonFraction> million to account for the effect of the CARES Act during the nine months ended September 30, 2020. Further regulations and notices as well as state legislative changes addressing conformity to the CARES Act are still pending.</span></div></ix:continuation><div style="text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_82"></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RleHRyZWdpb246OWU1ZmJhNzA1MzJmNDgwZmIzNzE4NDU3YTI4NDk5ZmZfMzg0ODI5MDY5NzY0NQ_07e7e20d-2ca0-4118-a3f0-869ab57c4346" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 14. Earnings Per Share </span></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RleHRyZWdpb246OWU1ZmJhNzA1MzJmNDgwZmIzNzE4NDU3YTI4NDk5ZmZfNDA1_a36fd85c-f5e4-410f-951d-7525a343a9e3" escape="true"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Reconciliation of the shares used in the basic and diluted earnings per share computations for the three and nine months ended September 30, 2020 and 2019 are as follows (in thousands):</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMi0yLTEtMS0xMzQ2_8b83dfc5-e8f9-4d2d-9324-a7adbf5df443">48,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMi00LTEtMS03Mjc_20fa9c19-c84b-4422-b11f-45da877d668f">48,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMi02LTEtMS0xMzUz_8f69c654-b31f-4bd4-9efd-d3354292b175">48,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMi04LTEtMS03MzM_7a902816-50d9-4dca-9274-41d27987fe23">48,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add effects of share-based compensation instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMy0yLTEtMS0xNDEz_ddd7a3c1-dde1-4162-8b77-5f8ba9b700b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMy00LTEtMS0xNDE1_c265c2eb-999e-4e65-ae44-291cf04333ce">425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMy02LTEtMS0xNDE3_9788738c-d076-43c9-95f3-a17190134f60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMy04LTEtMS0xNDE5_044b05f5-2967-444c-b884-2d875f7a6ea7"><ix:nonFraction unitRef="shares" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMy04LTEtMS0xNDE5_1b208725-4024-456f-bd7a-d0ea2440b485">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average&#160;shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMi0yLTEtMS0w_695ebc30-f835-4c22-b6b9-ff3854aeabed">48,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMi00LTEtMS0w_8f204425-d664-4c9d-bd00-bf7bed9df27c">48,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMi02LTEtMS0w_fcb76de2-6cfe-4388-b600-29cd23019bf1">48,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMi04LTEtMS0w_71544a00-085a-4b2d-88ee-e2cb847924d4">48,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Excluded from the computation of diluted earnings per share were stock options, SARs and restricted share units totaling <ix:nonFraction unitRef="shares" contextRef="i9a0a4786b53a409786262fe990c43c5a_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RleHRyZWdpb246OWU1ZmJhNzA1MzJmNDgwZmIzNzE4NDU3YTI4NDk5ZmZfMjU4_0c8db8b8-9b7c-4a30-af72-046162b218b8">4.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i20801a9a959b4964abe3933a95ed2cae_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RleHRyZWdpb246OWU1ZmJhNzA1MzJmNDgwZmIzNzE4NDU3YTI4NDk5ZmZfMjY1_4983da09-d10a-44f0-9816-3f9fb6e58884">1.4</ix:nonFraction> million for the three months ended September 30, 2020 and 2019, respectively, and <ix:nonFraction unitRef="shares" contextRef="i45c62bd5d99d4fce99db5761c61d6e17_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RleHRyZWdpb246OWU1ZmJhNzA1MzJmNDgwZmIzNzE4NDU3YTI4NDk5ZmZfMjkw_5e1f3ad0-b6bc-4a0d-9ef3-c4b669d12f82">4.2</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i4379082406654f39a39e859cda18b46a_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RleHRyZWdpb246OWU1ZmJhNzA1MzJmNDgwZmIzNzE4NDU3YTI4NDk5ZmZfMjk3_e99932e6-92fc-4c6e-aea8-a6a97bbd2a31">3.2</ix:nonFraction> million for the nine months ended September 30, 2020 and 2019, respectively, because to include them would have been anti-dilutive under the treasury stock method.</span></div></ix:nonNumeric></ix:nonNumeric><div style="padding-right:27pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_85"></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RleHRyZWdpb246YmRhNjliNWY3NmI4NDkzMTg4OGFmM2VlZGRlNTg0ZGJfMzg0ODI5MDcwMDE3OQ_e61373f6-c943-452b-a0de-49993d40da78" continuedAt="iabc22abd9c9d40bb964b989be15880b8" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 15. Geographic and Segment Information </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We identify operating segments based on the way we manage, evaluate and internally report our business activities for purposes of allocating resources, developing and executing our strategy, and assessing performance. We have <ix:nonFraction unitRef="segment" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RleHRyZWdpb246YmRhNjliNWY3NmI4NDkzMTg4OGFmM2VlZGRlNTg0ZGJfMjM1_e22077af-192b-49e5-a78c-7deb2b5eb841">two</ix:nonFraction> reportable segments: Cardiovascular and Neuromodulation.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Cardiovascular segment generates its revenue from the development, production and sale of cardiopulmonary products, heart valves and related products and advanced circulatory support. Cardiopulmonary products include oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae and other related accessories. Heart valves include mechanical heart valves, tissue heart valves, related repair products and minimally invasive surgical instruments. Advanced circulatory support includes temporary life support controllers and product kits that can include a combination of pumps, oxygenators, and cannulae. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our Neuromodulation segment generates its revenue from the design, development and marketing of neuromodulation therapy systems for the treatment of drug-resistant epilepsy, difficult-to-treat depression (&#8220;DTD&#8221;) and obstructive sleep apnea. Neuromodulation products include the VNS Therapy System, which consists of an implantable pulse generator, a lead that connects the generator to the vagus nerve, and other accessories. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8220;Other&#8221; includes corporate shared service expenses for finance, legal, human resources, information technology and corporate business development.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Net sales of our reportable segments include revenues from the sale of products they each develop and manufacture or distribute. We define segment income as operating income before merger and integration, restructuring and amortization of intangibles.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:continuation id="iabc22abd9c9d40bb964b989be15880b8" continuedAt="i66d6ecf093fe400ab1e56534ff3e1f84"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We operate under&#160;<ix:nonFraction unitRef="geographic_region" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="livn:NumberofGeographicRegionsinwhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RleHRyZWdpb246YmRhNjliNWY3NmI4NDkzMTg4OGFmM2VlZGRlNTg0ZGJfMTc3OQ_0e3c0408-62fd-4d13-ae88-944ee7a10cc2">three</ix:nonFraction>&#160;geographic regions: U.S., Europe, and Rest of World. <ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RleHRyZWdpb246YmRhNjliNWY3NmI4NDkzMTg4OGFmM2VlZGRlNTg0ZGJfMjc1MA_3d8f4781-a010-48ad-b804-43affa425412" continuedAt="i49c0d133cb114e22b98505ecc5aa0292" escape="true">The table below presents net sales by operating segment and geographic region (in thousands):</ix:nonNumeric></span></div><ix:continuation id="i49c0d133cb114e22b98505ecc5aa0292"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.514%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.771%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiopulmonary</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i876852bfed184662a8f0d97d8bcaa96c_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMy0yLTEtMS0w_702f481f-6dc4-4ac3-b2cc-088f2c4d3617">33,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5844e1c9474606816d00972d05d123_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMy00LTEtMS0w_a2d5bb46-36e2-4f0e-b2b8-69452a5416aa">39,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b84cedd45d40678d48897ca51541e3_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMy02LTEtMS0w_8df2f90b-4df7-4a10-81d9-0a7ef81d9536">96,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba81a1a74dfe49b8aa3eb8f99114e275_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMy04LTEtMS0w_b8f67c1b-c144-4d5a-b150-ce39afc8bcfe">119,580</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i048767aa111f4c9fb0f1ac8f9d147073_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNC0yLTEtMS0w_8eea1033-bfa5-4670-834b-050b3c0d7209">29,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98d0d7d6789f427ea18447a9ecab0429_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNC00LTEtMS0w_6c026618-d508-4b33-9e72-00687c1ad2a0">30,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45c1d64c7a40486b9179d7e170cbe2f9_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNC02LTEtMS0w_da5df4cd-4cab-4bb7-940e-df1dbe13fba7">87,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7329b87ee254e179498f3ab5d4c1188_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNC04LTEtMS0w_ff822ba2-8b95-44f6-a843-f8e55d77ded5">99,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e91c84eafce45e9b7b415a5813b4a82_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNS0yLTEtMS0w_7ace39d0-34c3-432a-a9e9-93e08b2394ca">43,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a6de0e9e7b442a3a978cd51f4294ab4_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNS00LTEtMS0w_9c5417b5-fcb1-474f-b137-697462c91033">50,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a14281cb8974824bd527e86f10ab2bb_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNS02LTEtMS0w_e44ce631-7dd4-4328-8f90-ed25c1a8a541">140,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i067bb22836894b95b391f0d0acb63f85_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNS04LTEtMS0w_e9a96c5c-b4d1-4768-9398-05e1ffa2611c">152,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i998e5f95302b4aeda2b81e2447e7d338_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNi0yLTEtMS0w_4c60aaf4-53c0-4701-96d1-42dd73d74c30">107,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i492977f4fcc14476974fcd6784642170_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNi00LTEtMS0w_94f61f12-7890-4149-aedd-96ed890c46b0">120,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic21d9046e8e54eb08111e039c3cd30c2_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNi02LTEtMS0w_82d902f9-1e69-47a5-b3d1-69d3e0a07285">324,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14ea489aa03e4679ae969ce4f20eeec8_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNi04LTEtMS0w_12f6894a-8b5f-46b5-b087-2ace2893b177">372,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Heart Valves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31a3762e4349432987b7c4352fec5b98_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfOC0yLTEtMS0w_b28e36ca-ab9d-4fdc-870d-5fee157eff85">3,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a02318bfa3347cc8505a8b9b72252cb_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfOC00LTEtMS0w_fece0467-931a-489f-9559-c828a7e18704">4,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i512e1cbc1dbf402a8182f4c49af7e088_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfOC02LTEtMS0w_4d6a14ad-c6c5-4483-b969-4876f50a7d34">8,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86e615fd4f804099b338c2d68fd98684_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfOC04LTEtMS0w_2427c2f9-357d-4728-bdb3-7539763080c0">13,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b2e5a703d0d4e0da33993ef6e8b10d7_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfOS0yLTEtMS0w_e46c5602-c084-4f53-94ad-37b8631fa123">7,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaebed4d2a7214242b9cdae043b3e1395_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfOS00LTEtMS0w_2815f9f9-c2d6-4533-bb6f-f1a4c46e1a7f">9,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d314c195032448da84bdf91257809f5_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfOS02LTEtMS0w_f4317f56-f1d0-4da4-b797-a12231ea69ab">22,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fad8409ffa449c3a2dcd5303e70034a_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfOS04LTEtMS0w_79b8690d-239d-4798-9eaf-caca22c0d58b">30,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73bb4237240a4e3fb606e9efd3f84f99_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTAtMi0xLTEtMA_61f80086-48cc-41f3-9b9f-99bb5d89c3ef">10,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1965860a1d8443d8fd1255f6745e510_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTAtNC0xLTEtMA_40a7ed3e-4ec1-42ce-a58f-d7c840964614">14,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37b3bf78b8684a9a85fa49b6161b9c2e_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTAtNi0xLTEtMA_f86d034e-8d1f-4147-81cd-0094d2c2af66">32,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic43242093f884cfa9804e7b602317c98_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTAtOC0xLTEtMA_c66b75cf-fcee-4323-a33f-f0555c0ff891">43,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9863d6e831c3445b8abe8ec63dd71610_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTEtMi0xLTEtMA_d9fdc76e-b4d1-447f-b16d-b5704008af82">21,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifea8fbd4f8a842768f18f1cb7d62556d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTEtNC0xLTEtMA_7f07fe89-4e94-481f-bb8b-4294195c74a3">28,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3691f9031c3d4c0baaccadab036cdb47_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTEtNi0xLTEtMA_5e8e5720-1793-4cf3-abec-bfd2fec1daa4">63,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d14b893f6a8433790639cb04398340d_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTEtOC0xLTEtMA_d50d7218-e848-4838-b760-e87d0759f99d">87,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Advanced Circulatory Support</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9f0e21d42994c2d9c4ad4c9cc1386b3_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTMtMi0xLTEtMA_ad0b43ea-c628-4385-9ab2-6479b3243b6a">12,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37a57e73f7074cc2b478dc7848ff6ebb_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTMtNC0xLTEtMA_efd2c218-8943-46a1-b422-2a7cedcd1023">6,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c228cdd25fa46dc846f886d32efa18b_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTMtNi0xLTEtMA_613d687d-f3c1-4245-b8ec-376f471ee0a1">28,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4cde2101963426a8246337e1a0c076a_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTMtOC0xLTEtMA_dfaa35bb-a6fb-4244-8365-39f904f38888">22,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f2ccc2749c2492885274416414af440_D20200701-20200930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTQtMi0xLTEtMA_e41f2ede-4e35-46f0-81e3-aa8db6af2636">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24e4350fe7d9437184b7909a2aae9e1f_D20190701-20190930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTQtNC0xLTEtMA_80db6075-083d-4732-8e2d-5bb773adb257">186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i993975a651dd4a8da309a2bc9be5ccaf_D20200101-20200930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTQtNi0xLTEtMA_83a61158-a68c-4990-a76b-fe4af0d1b383">835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13437c9318a542149d8e4b9ace7af3f8_D20190101-20190930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTQtOC0xLTEtMA_3f99ae89-00d6-4c92-a7e3-31ab1c750f85">497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69ff964a5f854ebbbe1ea60e0e626bb6_D20200701-20200930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTUtMi0xLTEtMA_85dfcf04-1102-4807-bf30-258a3641fc86">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718f682704d94fc694e5d005c83a53e9_D20190701-20190930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTUtNC0xLTEtMA_4b7062b3-43f6-43ef-9fd4-c0fd8c8810a5">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b0092809fe14757a77ae4181720814e_D20200101-20200930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTUtNi0xLTEtMA_78c59954-535f-4e41-b588-5ca5f21e2e98">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30054fec7a044c3195b0a1f4a0c95929_D20190101-20190930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTUtOC0xLTEtMA_99d61961-5991-4a42-8db3-f1b9225b2d33">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a8df61046d04836b659e7543314d52b_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTYtMi0xLTEtMA_a39938f0-cda5-456b-93f8-534783f4108a">12,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c55bcd90e9a4aacbf366789e82e6f95_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTYtNC0xLTEtMA_aaffe59e-3401-44d4-bb9d-c821403edf92">6,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f292902eb0549ab833ee3de080de1ba_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTYtNi0xLTEtMA_25c4dc11-6222-4ef9-9bf1-bddcb9232dc8">29,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83af8f7348324741a33b045e553554c3_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTYtOC0xLTEtMA_292e3a60-5623-4b50-a0c2-ca393a374763">23,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60f6642d17aa4014ad54b108c471cdcd_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTgtMi0xLTEtMA_2ac785a9-7d51-4d9f-b508-a594fed8bfd2">49,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c95775accb649a2a43367af2881bd1e_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTgtNC0xLTEtMA_d58dd0db-881c-480b-8513-317f80943a8d">49,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ba01b8c48ef4056a693c9fd38968b66_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTgtNi0xLTEtMA_9e5626b0-38c1-4414-b6f5-f3f94b42557d">133,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i455f04a75540413cb77b07c862e31aa6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTgtOC0xLTEtMA_51c6002f-927d-41c1-8410-30d90e3837db">155,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa815b9dabb542e1ae17525ed43b6edd_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTktMi0xLTEtMA_8a8f781e-69fb-415e-84bf-6ef50b7a4fdb">38,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb31194759654532b6d3c7273756b4f0_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTktNC0xLTEtMA_9d1c15c7-e6d5-4e7e-9d04-e8dd6fc480c3">39,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee15933e70114ffda536e4ce711dad1d_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTktNi0xLTEtMA_cf32033c-68a1-4fe4-89d8-4c9fd68d4e80">111,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dd5ea4b1ca4e18a2fcdea83a107830_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTktOC0xLTEtMA_fb8caab7-0092-42ba-9a52-d10e3ce0fb2d">131,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2e41838e4174c11abc94d3fb48a1fb4_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjAtMi0xLTEtMA_db7f3690-2f70-41bc-a8cf-ef61fde0369b">53,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadc304289f4da0b546e3b00fcd58c1_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjAtNC0xLTEtMA_e857879b-ca4b-408c-8314-1825a9213949">65,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ab86d3d6d0f49dca6f89b85afbdfa63_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjAtNi0xLTEtMA_67ad3b46-f955-4275-bdc8-3c941387c90a">173,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92e6ec3e0d984c9f86c920f967033463_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjAtOC0xLTEtMA_1d5cb947-c5d0-47ac-9a21-5ebdb2019ef9">196,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i013558d2b17c4355a92da0429952dd67_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjEtMi0xLTEtMA_96698931-d14c-4763-bd7e-b2ad3ec89666">140,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f84b9a1406f4d1a801a8a1795c932dc_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjEtNC0xLTEtMA_b75415f7-9c80-4733-837a-9714c4ffeddc">155,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2fad0d02b3e4a0ab6a60f67969ec28b_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjEtNi0xLTEtMA_4a9d8b6f-e246-4bd0-a3ff-8cf44aab656a">417,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i197004b99655439cada3d2fa6e98f33e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjEtOC0xLTEtMA_0b1bf2c1-8cb8-4103-ae6c-9301a7fc015d">483,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Neuromodulation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6605f2db15da497784c8273e981148a5_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjMtMi0xLTEtMA_1f3cae68-caca-4e70-8576-968ae7a0ccf3">79,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1255365af20d4f3d8de0bd8332901b23_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjMtNC0xLTEtMA_aef810c1-ec21-4db3-b92e-c453c0eeea81">88,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4a5a9acdf1b466d8d5cd9e19d1f3cb1_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjMtNi0xLTEtMA_7abc1277-3b17-4f7d-a02b-b16b6f554312">197,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5546f850f727425d90f293dbf898907b_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjMtOC0xLTEtMA_48bdd693-0cb7-4c2a-9082-529b7d98c166">245,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4b98b0523e7492f935ed61439c44ac7_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjQtMi0xLTEtMA_a6afbefe-1aec-4ecb-8801-4c57bde4ec4a">10,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd5e3ac54bd741a5a9a5b5f8105a08ae_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjQtNC0xLTEtMA_d4b3dafb-da2e-4f1a-8d10-99ab12832c7e">10,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib713c27b02154444b1b13648efdc2cb9_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjQtNi0xLTEtMA_14ad104c-0d14-4a4c-908a-a76a1a47cc30">27,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90c55e2ec6ed42bc805a2d2a55c5c015_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjQtOC0xLTEtMA_92684d33-8eed-4ad4-a6a0-83c4fcbd9ce6">34,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bfaac3413d149e8a37153945f6a6c4d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjUtMi0xLTEtMA_4de9a1a4-ad5d-4d20-bcb2-571302f297b3">8,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2d1490e739647a987879cf6b41a8714_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjUtNC0xLTEtMA_43a435bd-49eb-4f13-9abb-91b5e1238677">13,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i576c2f526c3d4a9b9c2a3777ca6ae531_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjUtNi0xLTEtMA_8b7fe038-fe81-4d2c-9e37-b4c488127c1d">20,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i647ae223232c4e10957d4e6ecf102def_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjUtOC0xLTEtMA_4ed6968e-cb88-4501-9050-fc8c3684a9c2">31,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f208ad6ec8402f80aac6618e1de718_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjYtMi0xLTEtMA_8a6bcbbd-6ed6-4c25-9ff5-1ccba03052a0">98,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9faf33d672ba42d18cdfe76fdead2b2d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjYtNC0xLTEtMA_a1fe0869-e284-4228-b87e-5d00d8865a30">112,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c4ddeb948eb4c4dbe320a14c7ae3792_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjYtNi0xLTEtMA_9f3d20f6-9025-4ef6-9514-41f4762e0a4d">245,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac495534370345098798ba8c26b009ac_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjYtOC0xLTEtMA_d9e6868f-eb30-407d-9c26-245c13765bf4">311,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21d96c5da2404625a9ee4885a17ebf0c_D20200701-20200930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjctMi0xLTEtMA_513fcb01-7e45-420e-a968-e1cf48be3e92">797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc2e1e69df7e4a1d8c750a08dcb83a44_D20190701-20190930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjctNC0xLTEtMA_103ccbae-d220-40fb-9d06-d417cca17706">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i753478d430024138b30d3d04687e7eb7_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjctNi0xLTEtMA_e1a515fd-96c5-451a-882b-f2f346c5c7b9">1,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e6560d12b2f434fa22d653edaa72cd8_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjctOC0xLTEtMA_b82fcd2d-4d3c-4e33-a595-7280ec3951b4">1,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d864c92f8184a1b8fc7aa74c911e9d5_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjktMi0xLTEtMA_e80b333f-04b4-4636-8c3f-b4cad0edaac5">128,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3b6505d7e924fd996331218487159c5_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjktNC0xLTEtMA_b3405973-d342-4ab2-bb5e-c106ba107a7f">138,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c978d524b454407894936f54228ed99_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjktNi0xLTEtMA_2e952fde-0bc6-4211-ba7a-7b4ccc110bfe">330,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685896438be142c1b5cc2e440c305db2_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjktOC0xLTEtMA_06a7db5e-fd2b-4405-85f5-1f18725cafd0">401,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5933b714be422fb3a8dbdb558b63d0_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzAtMi0xLTEtMA_ba83fda5-3fff-4178-b37c-68417fee0637">48,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8fcde1e652d443a977756769f311eb0_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzAtNC0xLTEtMA_5d191b8e-3c57-4da5-a438-ec7e898af8e6">50,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad0023589bcb4062a7f6ee3b1663620e_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzAtNi0xLTEtMA_4aaf2878-a742-4649-8b96-d39227813082">138,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i177a57ba7c1e481b80517501c4f324c5_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzAtOC0xLTEtMA_bf7367f6-d755-4fec-b3da-e78929db31b0">165,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9869e96a35ca485f87925c8da417cf1d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzEtMi0xLTEtMA_6f3a6c94-d2a9-43c2-bad8-b16a30d1576e">62,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d7442c704eb4389bdc5b405e968fa81_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzEtNC0xLTEtMA_2b986764-ad06-4921-bae0-ac3db091c8f1">79,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib304e38586c34d63aeb55253400f5dfc_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzEtNi0xLTEtMA_ec8f46b8-71ed-4aa9-8c62-31fdfb5c8a64">195,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic91a56d11d8a4a7994c72db8fe11c1d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzEtOC0xLTEtMA_2fa17dca-36bc-461d-86a4-cc80a94fbe38">229,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzItMi0xLTEtMA_3cc4e663-6b7a-4e5e-83c3-1594e8a1b0c4">240,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzItNC0xLTEtMA_36860cdf-1d05-4163-9841-32eee3791741">268,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzItNi0xLTEtMA_a07241e4-5a8a-4b60-9631-d424d85f6f80">664,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzItOC0xLTEtMA_fb9d5398-dbbc-4a5d-85f5-bb84da4cb861">796,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Europe sales include those countries in which we have a direct sales presence, whereas European countries in which we sell through distributors are included in Rest of World. </span></div><div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">No&#160;single customer represented over&#160;10%&#160;of our consolidated net sales. No&#160;country&#8217;s net sales exceeded&#160;10%&#160;of our consolidated sales except for the U.S.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:continuation id="i66d6ecf093fe400ab1e56534ff3e1f84"><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RleHRyZWdpb246YmRhNjliNWY3NmI4NDkzMTg4OGFmM2VlZGRlNTg0ZGJfMjc0NA_9ce32a67-dfdb-4305-9944-5724aba4f6fa" escape="true"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The table below presents a reconciliation of segment income from continuing operations to consolidated (loss) income from continuing operations before tax (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e8a04ec819f4cecb0b4d32157f3793c_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMi0yLTEtMS0w_84c7cc01-f8cc-4db7-99d2-14a4475da903">7,311</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i750cd8c7e43c4c11ab8974d496e7bb2f_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMi00LTEtMS0w_f4fb2621-062d-4bec-9377-c0412eb786d5">36,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb3170768056425eb10ca95b859602e3_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMi02LTEtMS0w_c473ecbf-9681-4733-bfaa-9ac614ea6874">8,037</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic51b2b23224546d29ccce9fe55170242_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMi04LTEtMS0w_212b3605-2ef1-49f1-88f7-794253964a09">47,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26b3c5a9534a4fe29e2597bb3c79e85a_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMy0yLTEtMS0w_048cfd4c-3cef-4966-ad34-7978d968b0cf">21,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6da06d9c9f8f4561b0149e510d196cdf_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMy00LTEtMS0w_42c58451-51bb-42e3-8d44-59411c1c68c0">30,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i533727d94e6d4a939f7d8a3366ee1c2c_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMy02LTEtMS0w_bf936305-0398-4fe7-8929-c323b0d763c3">82,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d8d758d27874054949a7da21f2f2b51_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMy04LTEtMS0w_a7dedeae-d3c3-4861-875b-729866e3e40d">52,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibdd4df75ecee4768ac486e5f62873b27_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNC0yLTEtMS0w_8158df01-aac7-4483-bb0b-3ef098bf39b2">10,921</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i555f859b9cc045aa906e26d5ebfeda55_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNC00LTEtMS0w_62a04047-a531-41e4-8302-de07d7d2d39e">21,869</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72a6c2813b9a4c7a8ef3258c3a0d53e6_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNC02LTEtMS0w_1a6714ee-7ba6-41d9-aeb3-61645a14e24f">58,407</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e3947b9663c4dd195e33fed5b54ba85_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNC04LTEtMS0w_1a4a52cf-1f29-46c7-9a2f-62045c7af676">75,845</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reportable segment income from continuing operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37c0fa19eea047a2936735006bf189fc_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNS0yLTEtMS0w_ed9d360d-97ae-4fee-902c-3d724dce9b72">2,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97f2df041b5e4467941d20a0fed11b0d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNS00LTEtMS0w_e34aac11-8718-4e07-8599-83e50ed25a89">44,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c740fe5919f452f8b72fcc2fa97e743_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNS02LTEtMS0w_0551f1c3-6aa9-49a3-ada0-f8847bc3fb32">15,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ba6be74fbf4cd8a64b5aff3d82ca29_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNS04LTEtMS0w_e079cfbc-382a-4081-a371-adfbfc39a580">23,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger and integration expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37c0fa19eea047a2936735006bf189fc_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNi0yLTEtMS0w_93f15802-dc36-4aed-8263-edb1fc634d46">1,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97f2df041b5e4467941d20a0fed11b0d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNi00LTEtMS0w_044bf8cf-446f-4070-a344-f393528c38f4">6,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c740fe5919f452f8b72fcc2fa97e743_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNi02LTEtMS0w_a37df917-3ed8-488a-9a49-017f55da407f">6,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ba6be74fbf4cd8a64b5aff3d82ca29_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNi04LTEtMS0w_c49411a1-d4f5-48e8-92fb-89bad36e03d5">14,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37c0fa19eea047a2936735006bf189fc_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNy0yLTEtMS0w_45272b39-b13d-4e01-93c7-0c03abcde02a">349</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97f2df041b5e4467941d20a0fed11b0d_D20190701-20190930" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNy00LTEtMS0w_f14a0dfe-19b3-4da7-932a-e4c516e87908">698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c740fe5919f452f8b72fcc2fa97e743_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNy02LTEtMS0w_e4179a71-f733-4cb1-abb6-3ea0b9eaf68e">2,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ba6be74fbf4cd8a64b5aff3d82ca29_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNy04LTEtMS0w_13fbf31a-0d1f-4af5-bfbc-e3c43d1bb1ec">4,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37c0fa19eea047a2936735006bf189fc_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfOC0yLTEtMS0w_932b5a8f-c07a-4ec4-89d0-95277fe772e8">9,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97f2df041b5e4467941d20a0fed11b0d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfOC00LTEtMS0w_c7c28751-5658-4e67-9371-9f82a965ee82">11,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c740fe5919f452f8b72fcc2fa97e743_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfOC02LTEtMS0w_7c4272e9-0744-4585-9101-0e5f9d389f9b">29,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ba6be74fbf4cd8a64b5aff3d82ca29_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfOC04LTEtMS0w_11dc6fa3-4c72-4132-a838-cf14f29147d1">29,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) income from continuing operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37c0fa19eea047a2936735006bf189fc_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfOS0yLTEtMS0w_1a09b2d8-5bd6-4a67-afc2-1bf89b59a63b">7,508</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97f2df041b5e4467941d20a0fed11b0d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfOS00LTEtMS0w_8ea8917c-b68c-49d5-ba6a-38b6fb3cf65c">25,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c740fe5919f452f8b72fcc2fa97e743_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfOS02LTEtMS0w_737f7ba8-c5f9-4dfe-a022-9ab68efd0c16">22,137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1ba6be74fbf4cd8a64b5aff3d82ca29_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfOS04LTEtMS0w_f8828395-156c-40b1-97df-bd32ade3c761">24,894</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTAtMi0xLTEtMA_c3e2d1f7-7dda-44d1-aaab-1c75552ca42b">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTAtNC0xLTEtMA_7ebebaf7-30e0-4b17-b09d-bc56ba8175fa">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTAtNi0xLTEtMA_b8995a7c-7182-49e8-b8e4-f8edd9e33d33">482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTAtOC0xLTEtMA_4fd3ee71-4bee-45ed-86f1-c7a814ff2aae">624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTEtMi0xLTEtMA_e8feb6b0-8216-421f-8634-9b6ad49ed445">14,673</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTEtNC0xLTEtMA_3633f422-eb0d-4af4-934d-05f9ada07e12">4,774</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTEtNi0xLTEtMA_8078332b-499f-4aff-b1c7-72aa2db8790e">25,237</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTEtOC0xLTEtMA_fe8a1d57-f7bd-4856-a616-8a2432596371">10,490</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange and other gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTItMi0xLTEtMA_b2e30b56-d158-454a-bc85-970bd1b309fb">3,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" name="livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTItNC0xLTEtMA_27f1cbfb-15a1-4aeb-9b81-f8f39286b720">327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" name="livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTItNi0xLTEtMA_f9bf53b6-0a28-40f6-9fae-ca403106354d">507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" name="livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTItOC0xLTEtMA_9d394663-ffae-4049-b0e9-376d6258a05b">795</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from continuing operations before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTMtMi0xLTEtMA_56b9bdcf-62bb-4dea-a10c-86e2a37046b4">18,714</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTMtNC0xLTEtMA_59820116-7741-4755-a3df-d8efe4999768">21,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTMtNi0xLTEtMA_c3bd8974-e870-4785-a4c8-63c5815f9058">46,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTMtOC0xLTEtMA_c08c2024-4ccf-4b83-9fb1-0a5fde6257b3">35,555</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Assets by segment are as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e834100347f4225a07ea71d1272445b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfMS0yLTEtMS0w_a4ad9bbb-614b-4a92-96e3-1139976261eb"><ix:nonFraction unitRef="usd" contextRef="i7e834100347f4225a07ea71d1272445b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfMS0yLTEtMS0w_f03561c1-c8f7-4f94-a3fb-7d4a3752e704">1,463,523</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82d6d51022114ec88eb0d11a4a6ff932_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfMS00LTEtMS0w_4c47bf65-24e5-48cb-8835-9b4792cd0f38">1,546,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i621fac9415c54f6a87f88d3a519eb1f0_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfMi0yLTEtMS0w_8d4d2464-0883-4717-98c1-bbffd6c83ef5"><ix:nonFraction unitRef="usd" contextRef="i621fac9415c54f6a87f88d3a519eb1f0_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfMi0yLTEtMS0w_b2e5dd9e-b9d9-41f7-bb5d-66a3c5abd969">668,899</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie26338ab822548b58c3b31da34f31dd8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfMi00LTEtMS0w_44e8e413-9a49-49b6-ab8e-aeb8a51c0ba2">749,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21249aea88bf443ba021a32669ad704b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfMy0yLTEtMS0w_760bd744-2956-4521-b15c-9b7214690f9f"><ix:nonFraction unitRef="usd" contextRef="i21249aea88bf443ba021a32669ad704b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfMy0yLTEtMS0w_c4418813-ef18-4e25-b206-f80a521df412">389,326</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic77fdf65e1a94d118f6cb9b70082f469_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfMy00LTEtMS0w_f199adb5-6e97-4930-97bd-7704e589a17e">116,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfNC0yLTEtMS0w_1887e9ca-06ea-4e81-ac32-06a51356666f"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfNC0yLTEtMS0w_786b787b-3f72-4a30-a6b1-14d83d93dcb5">2,521,748</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfNC00LTEtMS0w_8eab19cd-5c36-4284-842d-2e04ec1fb633">2,411,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Capital expenditures by segment are as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.477%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e8a04ec819f4cecb0b4d32157f3793c_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfMi0yLTEtMS0w_1a9e49d6-9580-41e3-9a88-311fdf74a054">7,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i750cd8c7e43c4c11ab8974d496e7bb2f_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfMi00LTEtMS0w_c80eda15-9e84-4c9f-9ccd-0b4900645cf2">5,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb3170768056425eb10ca95b859602e3_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfMi02LTEtMS0w_e2c65f54-db6b-4f4c-ab59-4a519e284c14">17,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic51b2b23224546d29ccce9fe55170242_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfMi04LTEtMS0w_695bfa9e-a03e-40c9-8b22-171ff2da62db">13,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26b3c5a9534a4fe29e2597bb3c79e85a_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfMy0yLTEtMS0w_fcc6091b-dd86-49d3-a99a-d7f59ce450ae">1,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6da06d9c9f8f4561b0149e510d196cdf_D20190701-20190930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfMy00LTEtMS0w_7352282c-9a67-4d95-834c-2824f0c918a2">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i533727d94e6d4a939f7d8a3366ee1c2c_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfMy02LTEtMS0w_7dd4103e-c8c9-4dba-8b62-7349d8df045c">7,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d8d758d27874054949a7da21f2f2b51_D20190101-20190930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfMy04LTEtMS0w_6cfa5794-c58b-4454-af7f-0e901c2b4382">666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdd4df75ecee4768ac486e5f62873b27_D20200701-20200930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfNC0yLTEtMS0w_dbff32cc-7010-430e-9a3c-6d43658d4312">967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i555f859b9cc045aa906e26d5ebfeda55_D20190701-20190930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfNC00LTEtMS0w_26af7064-1c32-4f02-8503-c9b0aaebd7a5">691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72a6c2813b9a4c7a8ef3258c3a0d53e6_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfNC02LTEtMS0w_114e3282-ac9c-4501-ad25-42f964585eb0">3,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e3947b9663c4dd195e33fed5b54ba85_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfNC04LTEtMS0w_461a4108-fe46-4f01-9b01-458ca2980015">2,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37c0fa19eea047a2936735006bf189fc_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfNS0yLTEtMS0w_54cc7239-7dc7-4397-b04f-10de41ba1037">9,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97f2df041b5e4467941d20a0fed11b0d_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfNS00LTEtMS0w_e944d8a6-29f8-4459-aad7-8f0e9ffff74a">6,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c740fe5919f452f8b72fcc2fa97e743_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfNS02LTEtMS0w_55144a20-b61f-4255-8a41-51682bdfccc4">28,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ba6be74fbf4cd8a64b5aff3d82ca29_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfNS04LTEtMS0w_16801681-83ce-468f-bde1-d9ce22fd18da">16,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RleHRyZWdpb246YmRhNjliNWY3NmI4NDkzMTg4OGFmM2VlZGRlNTg0ZGJfMjczOA_18914644-db06-4012-93f5-ab512a0e1442" escape="true"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The changes in the carrying amount of goodwill by segment for the nine months ended September 30, 2020 were as follows (in thousands):</span></div><div style="margin-bottom:15pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.302%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Neuromodulation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50dafb81ae7249f0b00a89f30fa949b6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjVkNjJmMzZjNzViNDQxNmM5N2U5YWMwMzRkNWI3N2EzL3RhYmxlcmFuZ2U6NWQ2MmYzNmM3NWI0NDE2Yzk3ZTlhYzAzNGQ1Yjc3YTNfMS0yLTEtMS0w_90b44ac7-1a31-47dc-be55-6adc24e4b570">398,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbd1000ed3de4516a0195c708a123de5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjVkNjJmMzZjNzViNDQxNmM5N2U5YWMwMzRkNWI3N2EzL3RhYmxlcmFuZ2U6NWQ2MmYzNmM3NWI0NDE2Yzk3ZTlhYzAzNGQ1Yjc3YTNfMS00LTEtMS0w_18a676c1-5a92-45e9-ab68-74e76dc5664f">517,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjVkNjJmMzZjNzViNDQxNmM5N2U5YWMwMzRkNWI3N2EzL3RhYmxlcmFuZ2U6NWQ2MmYzNmM3NWI0NDE2Yzk3ZTlhYzAzNGQ1Yjc3YTNfMS02LTEtMS0w_27fc7fb6-ac36-4c1c-8ef0-2a6467fbc60a">915,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia01b97a86f2f4fb9ad100afbeb3977ab_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjVkNjJmMzZjNzViNDQxNmM5N2U5YWMwMzRkNWI3N2EzL3RhYmxlcmFuZ2U6NWQ2MmYzNmM3NWI0NDE2Yzk3ZTlhYzAzNGQ1Yjc3YTNfNC0yLTEtMS0w_8a2d969f-85aa-4681-8cb9-5e1cef7df43e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie035b1af1b6244959d04c1e0f44038a5_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjVkNjJmMzZjNzViNDQxNmM5N2U5YWMwMzRkNWI3N2EzL3RhYmxlcmFuZ2U6NWQ2MmYzNmM3NWI0NDE2Yzk3ZTlhYzAzNGQ1Yjc3YTNfNC00LTEtMS0w_bc62f1b7-701e-463b-9afa-647a084bf428">2,684</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjVkNjJmMzZjNzViNDQxNmM5N2U5YWMwMzRkNWI3N2EzL3RhYmxlcmFuZ2U6NWQ2MmYzNmM3NWI0NDE2Yzk3ZTlhYzAzNGQ1Yjc3YTNfNC02LTEtMS0w_4faaa716-5b77-4a94-a90a-26d5a272705e">2,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed94ea4037647e09c43b0db147a2453_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjVkNjJmMzZjNzViNDQxNmM5N2U5YWMwMzRkNWI3N2EzL3RhYmxlcmFuZ2U6NWQ2MmYzNmM3NWI0NDE2Yzk3ZTlhYzAzNGQ1Yjc3YTNfNS0yLTEtMS0w_5007627e-7d0c-49da-ae52-fd36c802cbab">398,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3dabd6f2807465da694560fc9777ec8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjVkNjJmMzZjNzViNDQxNmM5N2U5YWMwMzRkNWI3N2EzL3RhYmxlcmFuZ2U6NWQ2MmYzNmM3NWI0NDE2Yzk3ZTlhYzAzNGQ1Yjc3YTNfNS00LTEtMS0w_49cac7a9-954a-4414-ad59-e552f86f2798">519,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjVkNjJmMzZjNzViNDQxNmM5N2U5YWMwMzRkNWI3N2EzL3RhYmxlcmFuZ2U6NWQ2MmYzNmM3NWI0NDE2Yzk3ZTlhYzAzNGQ1Yjc3YTNfNS02LTEtMS0w_a9e1f8fd-ee6d-43e6-8db4-e92545a6a242">918,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RleHRyZWdpb246YmRhNjliNWY3NmI4NDkzMTg4OGFmM2VlZGRlNTg0ZGJfMjczOQ_0d51cfa5-af3c-47e4-b04b-6145658ebbe1" escape="true"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Property, plant and equipment, net by geography are as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dde44e6ca6c4af39265921b98826424_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU4ZjdmMzEwYzJiZTQwZWU4ZmM0ZjIzYjFiYTg1ZjI3L3RhYmxlcmFuZ2U6ZThmN2YzMTBjMmJlNDBlZThmYzRmMjNiMWJhODVmMjdfMS0yLTEtMS0w_5d9100d8-9dcf-4f14-a0d2-e7317982a5b8">64,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67e83bb326504f55b272768962da8016_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU4ZjdmMzEwYzJiZTQwZWU4ZmM0ZjIzYjFiYTg1ZjI3L3RhYmxlcmFuZ2U6ZThmN2YzMTBjMmJlNDBlZThmYzRmMjNiMWJhODVmMjdfMS00LTEtMS0w_afb7dfc5-40f9-4fcb-a722-7df33355de36">61,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibedca0f603bd4bd6a1d7eb72407a0f05_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU4ZjdmMzEwYzJiZTQwZWU4ZmM0ZjIzYjFiYTg1ZjI3L3RhYmxlcmFuZ2U6ZThmN2YzMTBjMmJlNDBlZThmYzRmMjNiMWJhODVmMjdfMi0yLTEtMS0w_6c6a3c96-d27a-465a-9375-f5fba3f84647">116,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c3b8ff212bf4e7789a78c902e1ca14e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU4ZjdmMzEwYzJiZTQwZWU4ZmM0ZjIzYjFiYTg1ZjI3L3RhYmxlcmFuZ2U6ZThmN2YzMTBjMmJlNDBlZThmYzRmMjNiMWJhODVmMjdfMi00LTEtMS0w_43894dd9-4086-4b36-b94e-823bf850e4e2">110,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e0cc6d97d2c44baa25cccb561c0a434_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU4ZjdmMzEwYzJiZTQwZWU4ZmM0ZjIzYjFiYTg1ZjI3L3RhYmxlcmFuZ2U6ZThmN2YzMTBjMmJlNDBlZThmYzRmMjNiMWJhODVmMjdfMy0yLTEtMS0w_dcfbc90c-7f3f-4dcb-b376-39aa862d07d7">9,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d1a426602f4eb09beb15214ebfd323_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU4ZjdmMzEwYzJiZTQwZWU4ZmM0ZjIzYjFiYTg1ZjI3L3RhYmxlcmFuZ2U6ZThmN2YzMTBjMmJlNDBlZThmYzRmMjNiMWJhODVmMjdfMy00LTEtMS0w_05df8c92-16bf-4d69-aac6-1169e88223bb">9,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU4ZjdmMzEwYzJiZTQwZWU4ZmM0ZjIzYjFiYTg1ZjI3L3RhYmxlcmFuZ2U6ZThmN2YzMTBjMmJlNDBlZThmYzRmMjNiMWJhODVmMjdfNC0yLTEtMS0w_86a194bd-12ec-4fa8-8557-3c32853fde34">190,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU4ZjdmMzEwYzJiZTQwZWU4ZmM0ZjIzYjFiYTg1ZjI3L3RhYmxlcmFuZ2U6ZThmN2YzMTBjMmJlNDBlZThmYzRmMjNiMWJhODVmMjdfNC00LTEtMS0w_86e33674-2be9-4c02-a218-8995c6ea302b">181,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">28</span></div></div></div><div id="i1bf75d3d05544b2db4639291692ac57a_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RleHRyZWdpb246ZmNiMTBiOGY0ZjBiNDkxZmIzNjk4YjdhYTE1Y2JkNTNfMzg0ODI5MDY5ODA2NA_e9834ea6-bf99-4ee4-946e-73774fef5d79" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 16. Supplemental Financial Information</span></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RleHRyZWdpb246ZmNiMTBiOGY0ZjBiNDkxZmIzNjk4YjdhYTE1Y2JkNTNfNjA0_43a36819-5cff-4dd5-abe0-e29e28eb63bc" escape="true"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Inventories consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOmJhYzg0ZGY4YTM0ZDRjZTg5MWRiYjUyMTFjNTMxNjkyL3RhYmxlcmFuZ2U6YmFjODRkZjhhMzRkNGNlODkxZGJiNTIxMWM1MzE2OTJfMS0yLTEtMS0w_e66e40ad-e89b-4864-b62c-86b9fbaf852f">48,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOmJhYzg0ZGY4YTM0ZDRjZTg5MWRiYjUyMTFjNTMxNjkyL3RhYmxlcmFuZ2U6YmFjODRkZjhhMzRkNGNlODkxZGJiNTIxMWM1MzE2OTJfMS00LTEtMS0w_611fbb77-4827-49d4-8f7a-20aa025d9f9b">45,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOmJhYzg0ZGY4YTM0ZDRjZTg5MWRiYjUyMTFjNTMxNjkyL3RhYmxlcmFuZ2U6YmFjODRkZjhhMzRkNGNlODkxZGJiNTIxMWM1MzE2OTJfMi0yLTEtMS0w_6f32b1e8-6cdc-4d34-a820-c85908b8bf2c">18,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOmJhYzg0ZGY4YTM0ZDRjZTg5MWRiYjUyMTFjNTMxNjkyL3RhYmxlcmFuZ2U6YmFjODRkZjhhMzRkNGNlODkxZGJiNTIxMWM1MzE2OTJfMi00LTEtMS0w_4d95c2d5-55a1-45bc-9335-e9f2c5d56c68">14,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOmJhYzg0ZGY4YTM0ZDRjZTg5MWRiYjUyMTFjNTMxNjkyL3RhYmxlcmFuZ2U6YmFjODRkZjhhMzRkNGNlODkxZGJiNTIxMWM1MzE2OTJfMy0yLTEtMS0w_45092075-fa62-465b-97b2-1a912ee89cb2">110,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOmJhYzg0ZGY4YTM0ZDRjZTg5MWRiYjUyMTFjNTMxNjkyL3RhYmxlcmFuZ2U6YmFjODRkZjhhMzRkNGNlODkxZGJiNTIxMWM1MzE2OTJfMy00LTEtMS0w_c3b29bd3-c92e-4c77-954b-8ce88215c66e">104,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOmJhYzg0ZGY4YTM0ZDRjZTg5MWRiYjUyMTFjNTMxNjkyL3RhYmxlcmFuZ2U6YmFjODRkZjhhMzRkNGNlODkxZGJiNTIxMWM1MzE2OTJfNC0yLTEtMS0w_85657380-01be-466f-b877-c76a665e2440">178,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOmJhYzg0ZGY4YTM0ZDRjZTg5MWRiYjUyMTFjNTMxNjkyL3RhYmxlcmFuZ2U6YmFjODRkZjhhMzRkNGNlODkxZGJiNTIxMWM1MzE2OTJfNC00LTEtMS0w_f82caeec-6a27-4d46-8b6c-08c0d2036fc3">164,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">As of September&#160;30, 2020 and December 31, 2019, inventories include adjustments totaling $<ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InventoryValuationReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RleHRyZWdpb246ZmNiMTBiOGY0ZjBiNDkxZmIzNjk4YjdhYTE1Y2JkNTNfMjUw_d65f73c6-97e7-44f8-8537-d5c870688f46">14.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InventoryValuationReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RleHRyZWdpb246ZmNiMTBiOGY0ZjBiNDkxZmIzNjk4YjdhYTE1Y2JkNTNfMjU3_34bdec84-5266-4e2b-9e15-d93d8d85babd">12.7</ix:nonFraction> million, respectively, to record balances at lower of cost or net realizable value.</span></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RleHRyZWdpb246ZmNiMTBiOGY0ZjBiNDkxZmIzNjk4YjdhYTE1Y2JkNTNfNjA1_7bcf1d56-54be-4fa7-9727-a7b7cece1cb2" escape="true"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accrued liabilities and other consisted of the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMS0yLTEtMS0xNTQ3_49d536e7-b8fb-47e9-9f99-da387c0ed096">16,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMS00LTEtMS0xNTQ3_4a8fb9e3-2130-42c9-9c3b-7f61dca64c25">22,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and administrative costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMi0yLTEtMS0zMDA0_ac0c789c-6145-471e-8da6-08d991b140f4">14,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMi00LTEtMS0zMDA0_76963798-e7dd-4318-94f8-639854d30fa1">11,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMi0yLTEtMS0xNTQ3_5cc89def-eb65-4d85-87ec-e32ea6b4087a">11,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMi00LTEtMS0xNTQ3_6bbacd80-19f1-4bd7-933d-80375ab8755b">11,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfNC0yLTEtMS0w_dcc12555-08ee-4fcc-b325-c55e55d8db33">7,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfNC00LTEtMS0w_210b3b98-00a0-420e-812a-b3c7ff58f06e">6,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:ResearchAndDevelopmentCostsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfNS0yLTEtMS0w_e6759877-109d-48af-afc5-54db209bfcac">5,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="livn:ResearchAndDevelopmentCostsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfNS00LTEtMS0w_fe2f6aac-db76-4898-abcf-18f603d19796">5,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provisions for agents, returns and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:ProvisionforAgentsReturnsandOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfNi0yLTEtMS0w_07d66619-4635-4eb0-a2be-ded3f7c2af9a">3,772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="livn:ProvisionforAgentsReturnsandOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfNi00LTEtMS0w_53e3f505-b59f-4163-bda0-a812692d3484">3,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring related liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:RestructuringRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfOC0yLTEtMS0w_3662f04a-1e8d-4701-b319-6516114778cd">1,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="livn:RestructuringRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfOC00LTEtMS0w_c9923904-8e37-45fb-b786-5ab3ed9dd1a5">4,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product remediation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:ProductRemediation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfOS0yLTEtMS0w_4bca347b-bfd1-4d53-b09c-63ac5f8d2a8b">1,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="livn:ProductRemediation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfOS00LTEtMS0w_7ba4ba44-c0a8-4dda-89db-36603aa9b3c5">3,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative contract liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="livn:DerivativeContractLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMTAtMi0xLTEtMjc5Ng_ff602494-ad7b-4ab5-aae3-9df07e5987d6">1,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="livn:DerivativeContractLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMTAtNC0xLTEtMjc5Ng_c160455b-710e-4dba-a3f6-9ec91aca8f2a">3,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRM purchase price adjustment payable to MicroPort Scientific Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:zerodash" name="livn:BusinessAcquisitionsPurchasePriceAllocation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMTAtMi0xLTEtMA_0c3f554a-3d14-49fc-8192-8eddac68b15e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="livn:BusinessAcquisitionsPurchasePriceAllocation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMTAtNC0xLTEtMA_89ef7220-03cd-4b93-abf7-24baab68378a">14,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMTEtMi0xLTEtMA_52cd1847-3450-4ca4-9d04-8e978b65bdc3">34,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMTEtNC0xLTEtMA_cc6a2eb2-2a31-419b-99cc-d309aa4e143e">33,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMTItMi0xLTEtMA_330edc82-ced4-4adf-909f-32ac77cbf5cb">98,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMTItNC0xLTEtMA_4f298fc1-8157-4878-966a-6e96a00a614a">120,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Refer to &#8220;Note 7. Fair Value Measurements&#8221;</span></div><div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Refer to &#8220;Note 4. Restructuring&#8221;</span></div><div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Refer to &#8220;Note 5. Product Remediation Liability&#8221;</span></div><div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Refer to &#8220; Note 9. Derivatives and Risk Management&#8221;</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">As of&#160;September&#160;30, 2020&#160;and&#160;December 31, 2019, contract liabilities of&#160;$<ix:nonFraction unitRef="usd" contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RleHRyZWdpb246ZmNiMTBiOGY0ZjBiNDkxZmIzNjk4YjdhYTE1Y2JkNTNfNDYy_10236a65-87e2-4ebd-8069-4616e7fd83cd">9.5</ix:nonFraction> million&#160;and&#160;$<ix:nonFraction unitRef="usd" contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RleHRyZWdpb246ZmNiMTBiOGY0ZjBiNDkxZmIzNjk4YjdhYTE1Y2JkNTNfNDY5_1e1bbd11-9999-4198-9c9e-97047510fd18">8.6</ix:nonFraction> million, respectively, are included within accrued liabilities and other long-term liabilities on the condensed consolidated balance sheets.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">29</span></div></div></div><div id="i1bf75d3d05544b2db4639291692ac57a_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RleHRyZWdpb246OWRiYzhiM2U1NTljNGFiOWI0N2E3ODFiNmRmNWVjNTNfMzg0ODI5MDY5NzY5Ng_00889461-9856-41d3-86de-a17da89fc3f4" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 17. New Accounting Pronouncements </span></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RleHRyZWdpb246OWRiYzhiM2U1NTljNGFiOWI0N2E3ODFiNmRmNWVjNTNfNDYw_3ae676ee-1ab6-45fa-968b-3b6d2927bc4f" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Adoption of New Accounting Pronouncements</span></div><ix:nonNumeric contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RleHRyZWdpb246OWRiYzhiM2U1NTljNGFiOWI0N2E3ODFiNmRmNWVjNTNfNDY5_0d076685-0a46-4b05-acde-004305582fdd" continuedAt="i0029d169d2084adcbe89c4330a7611b6" escape="true"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides a description of our adoption of new Accounting Standards Updates (&#8220;ASUs&#8221;) issued by the FASB and the impact of the adoption on our condensed financial statements:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:19.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issue Date &amp; Standard</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date of Adoption</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effect on Financial Statements or Other Significant Matters</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2016</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RhYmxlOmI3NzhiMTYwZjg5NTQzN2ViODlhMTA0NWE0NGFmNzdjL3RhYmxlcmFuZ2U6Yjc3OGIxNjBmODk1NDM3ZWI4OWExMDQ1YTQ0YWY3N2NfMS0wLTEtMS0wL3RleHRyZWdpb246OWNhMDIzMjU1YjY2NDBkN2I1NDUzOTBiNjY0ZTMzZDNfMTQ_421ad1dc-77dd-457b-948b-627f349609b2">ASU No. 2016-13</span>, Financial Instruments&#8212;Credit Losses (Topic 326)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. We adopted the update effective<br/>January 1, 2020, applying this standard to our accounts receivable by use of a provision matrix approach. This approach utilizes historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We recognized the following cumulative-effect adjustments, including to retained earnings, upon adoption at January 1, 2020:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net decreased $<ix:nonFraction unitRef="usd" contextRef="i11591753270141129f271d60eea42105_I20200101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RhYmxlOmI3NzhiMTYwZjg5NTQzN2ViODlhMTA0NWE0NGFmNzdjL3RhYmxlcmFuZ2U6Yjc3OGIxNjBmODk1NDM3ZWI4OWExMDQ1YTQ0YWY3N2NfMS02LTEtMS0wL3RleHRyZWdpb246OTVhYjgwZDJhMWVlNDEzZDhjYjI0OWY5NDFjNzUxZjlfMTY0_8ddfe692-e408-4a27-b0b0-f035655b828d">0.6</ix:nonFraction> million and accumulated deficit increased $<ix:nonFraction unitRef="usd" contextRef="i25fe44ba33a444a484626a29cce0642c_I20200101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RhYmxlOmI3NzhiMTYwZjg5NTQzN2ViODlhMTA0NWE0NGFmNzdjL3RhYmxlcmFuZ2U6Yjc3OGIxNjBmODk1NDM3ZWI4OWExMDQ1YTQ0YWY3N2NfMS02LTEtMS0wL3RleHRyZWdpb246OTVhYjgwZDJhMWVlNDEzZDhjYjI0OWY5NDFjNzUxZjlfMjAx_a29f5978-9ce8-435e-bbb7-96f01d156b85">0.6</ix:nonFraction> million.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2017</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2017-04,&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This update removes step 2 of the goodwill impairment test that compares the implied fair value of goodwill with its carrying amount. Instead, an impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge will be recorded by the amount a reporting unit&#8217;s carrying amount exceeds its fair value.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There was no material impact to our consolidated financial statements as a result of adopting this ASU.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2018-13, Fair Value Measurement (Topic 820): Changes to the Disclosure Requirements for Fair Value Measurement</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This update removes, modifies and adds certain disclosure requirements related to fair value measurements.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There was no material impact to our consolidated financial statements as a result of adopting this ASU.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2018-15, Intangibles&#8212;Goodwill and Other&#8212;Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This update clarifies and aligns the accounting for implementation costs for hosting arrangements with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There was no material impact to our consolidated financial statements as a result of adopting this ASU.</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Future Adoption of New Accounting Pronouncements</span></div><ix:continuation id="i0029d169d2084adcbe89c4330a7611b6"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides a description of future adoptions of new accounting standards that may have an impact on our financial statements when adopted:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:22.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issue Date &amp; Standard</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected Date of Adoption</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effect on Financial Statements or Other Significant Matters</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">August 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2018-14, Compensation&#8212;Retirement Benefits&#8212;Defined Benefit Plans&#8212;General</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Subtopic 715-20): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Changes to the Disclosure Requirements for Defined Benefit Plans</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This update adds and removes certain disclosure requirements related to defined benefit plans. This ASU is to be implemented on a retrospective basis for all periods presented with early adoption permitted.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We do not expect the adoption of this update to have a material effect on our condensed consolidated financial statement disclosures.</span></td></tr></table></div></ix:continuation></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">30</span></div></div></div><div id="i1bf75d3d05544b2db4639291692ac57a_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%"> Management&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Discussion and Analysis of Financial Condition and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Results of Operations</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following discussion and analysis should be read in conjunction with our condensed consolidated financial statements and related notes which appear elsewhere in this document and with our 2019 Form 10-K. Our discussion and analysis may contain forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of certain factors, including those set forth under &#8220;Risk Factors&#8221; in Item 1A of our 2019 Form 10-K, as updated and supplemented by our Quarterly Reports on Form 10-Q, including in Part 2, Item 1A and elsewhere in this Quarterly Report on Form 10-Q. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The capitalized terms used below have been defined in the notes to our condensed consolidated financial statements. In the following text, the terms &#8220;LivaNova,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to LivaNova PLC and its consolidated subsidiaries.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_97"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">COVID-19</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Due to the COVID-19 pandemic, we have experienced and may continue to experience significant and unpredictable reductions in the demand for our products as healthcare customers have diverted medical resources and priorities towards the treatment of COVID-19.  In addition, public health bodies have delayed elective procedures during the COVID-19 pandemic, which has negatively impacted the usage of our products, including the number of Neuromodulation procedures. Further, some people are avoiding seeking treatment for non-COVID-19 emergency procedures, which has also negatively impacted the demand for our products. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">While the ultimate health and economic impact of the COVID-19 pandemic is highly uncertain, our sales and operating results for the third quarter of 2020 were materially adversely impacted. We are seeing signs of stabilization in certain geographies as elective surgeries resume and expect this trend to continue on a global basis during the fourth quarter of 2020. We expect elective procedure recovery rates to vary by country, and to be impacted by COVID-19 case volumes, hospital occupancy and staffing levels, patient&#8217;s willingness to re-book previously deferred procedures, travel restrictions, transportation limitations, quarantine restrictions, economic uncertainty and potential COVID-19 resurgence. Further cancellations or delays could materially adversely impact our business, results of operations and overall financial performance.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our business operations have been affected by a range of external factors related to the COVID-19 pandemic that are not within our control. For example, many jurisdictions have imposed a wide range of restrictions on the physical movement of our employees and vendors to limit the spread of COVID-19. If the COVID-19 pandemic has a substantial impact on our employees or vendors attendance or productivity, our operations may suffer, and in turn our results of operations and overall financial performance may be harmed. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">During the second quarter of 2020 the majority of our RECOVER clinical study sites and their corresponding surgical centers were completely closed, though we continued to maintain engagement, including activating more sites for enrollment and also, identifying and consenting patients at existing sites. During the third quarter, sites and surgical centers began to open and currently 90% are completely open. We presently expect implants to continue to return during the fourth quarter of 2020 as study sites are able to progress consented patients and will resume more fully in 2021. However, there can be no assurance that there will not be additional closures of such sites in the future.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Additionally, our ANTHEM-HFrEF international pivotal trial was temporarily paused in March due to COVID-19 restrictions after randomizing just over 200 patients. During the second quarter of 2020, we were able to re-initiate enrollment and screening activities in more than half of the sites and continue to progress as we monitor relevant conditions at medical centers participating in the trial.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We have taken numerous steps, and will continue to take further actions, in our approach to addressing the COVID-19 pandemic. We have successfully implemented our business continuity plans, and our management team is responding to changes in our environment quickly and effectively. We have not closed any of our manufacturing plants. Additionally, the supply of raw materials and the distribution of finished products remain operational with no known or foreseen constraints. As a result of the COVID-19 pandemic, we instructed employees at many of our facilities across the globe to work from home on a temporary basis and have implemented travel restrictions. We have incurred additional expenses in connection with our response to the COVID-19 pandemic, including manufacturing inefficiencies and costs related to enabling our employees to support our customers while working remotely. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We believe that implementing cost reduction efforts will help us mitigate the impact that reduced revenues may have on our fiscal 2020 operating income. We are reducing expenses by evaluating whether projects and initiatives are critical to meet the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">current needs of the Company, protecting strategic priorities for future growth, reducing discretionary spending and tightening management of personnel costs.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Given the dynamic nature of these circumstances, the full impact of the COVID-19 pandemic on our ongoing business, results of operations and overall financial performance cannot be reasonably estimated at this time.</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">For further discussion on COVID-19, refer to &#8220;Part II, Item 1A. Risk Factors&#8221; in this Quarterly Report on Form 10-Q.</span></div><div style="text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_100"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Business Overview</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We are a public limited company organized under the laws of England and Wales, headquartered in London, England. We are a global medical device company focused on the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems throughout the world. Working closely with medical professionals in the fields of Cardiovascular and Neuromodulation, we design, develop, manufacture and sell innovative therapeutic solutions that are consistent with our mission to improve our patients&#8217; quality of life, increase the skills and capabilities of healthcare professionals and minimize healthcare costs.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LivaNova is comprised of two reportable segments: Cardiovascular and Neuromodulation, corresponding to our primary therapeutic areas. Other corporate activities include corporate shared service expenses for finance, legal, human resources, information technology and corporate business development.</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">For further information regarding our business segments, historical financial information and our methodology for the presentation of financial results, please refer to the condensed consolidated financial statements and accompanying notes of this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_103"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cardiovascular</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our Cardiovascular segment is engaged in the development, production and sale of cardiopulmonary products, heart valves and advanced circulatory support products. Cardiopulmonary products include oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae and other related accessories. Heart valves include mechanical heart valves, tissue heart valves, related repair products and minimally invasive surgical instruments. Advanced circulatory support includes temporary life support controllers and product kits that can include a combination of pumps, oxygenators, and cannulae. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Product Remediation</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On December&#160;29, 2015, the FDA issued a Warning Letter alleging certain violations of FDA regulations applicable to medical device manufacturers at our Munich, Germany and Arvada, Colorado facilities and issued inspectional observations on FDA&#8217;s Form-483 applicable to our Munich, Germany facility.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Warning Letter further stated that our 3T devices and other devices we manufactured at our Munich facility are subject to refusal of admission into the U.S. until resolution of the issues set forth by the FDA in the Warning Letter. The FDA informed us that the import alert was limited to the 3T devices, but that the agency reserved the right to expand the scope of the import alert if future circumstances warranted such action. The Warning Letter did not request that existing users cease using the 3T device, and manufacturing and shipment all of our products other than the 3T device were unaffected by the import limitation. To help clarify these issues for current customers, we issued an informational Customer Letter in January 2016 and that same month agreed with the FDA on a process for shipping 3T devices to existing U.S. users pursuant to a certificate of medical necessity program.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Finally, the Warning Letter stated that premarket approval applications for Class III devices to which certain Quality System regulation deviations identified in the Warning Letter were reasonably related would not be approved until the violations had been corrected; however, this restriction applied only to the Munich and Arvada facilities, which do not manufacture or design devices subject to Class III premarket approval.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On February 25, 2020, LivaNova received clearance for K191402, a 510(k) for the 3T devices that addressed issues contained in the 2015 Warning Letter along with design changes that further mitigate the potential risk of aerosolization. Concurrent with this clearance, (1) 3T devices manufactured in accordance with K191402 will not be subjected to the import alert and (2) LivaNova initiated a correction to distribute the updated Operating Instructions cleared under K191402.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We continue to work diligently to remediate the FDA&#8217;s inspectional observations for the Munich facility, as well as the additional issues identified in the Warning Letter. We take these matters seriously and intend to respond timely and fully to the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">FDA&#8217;s requests.&#160;For further information refer to &#8220;Note 10. Commitments and Contingencies&#8221; in our condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Product Liability</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Company is currently involved in litigation involving our 3T device. The litigation includes a class action complaint in the U.S. District Court for the Middle District of Pennsylvania, federal multi-district litigation in the U.S. District Court for the Middle District of Pennsylvania, various U.S. state court cases and cases in jurisdictions outside the U.S. The class action, filed in February 2016, consists of all Pennsylvania residents who underwent open heart surgery at WellSpan York Hospital and Penn State Milton S. Hershey Medical Center between 2011 and 2015 and who currently are asymptomatic for NTM infection.&#160;Members of the class seek declaratory relief that the 3T devices are defective and unsafe for intended uses, medical monitoring, damages, and attorneys&#8217; fees.&#160;</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On March 29, 2019, we announced a settlement framework that provides for a comprehensive resolution of the personal injury cases pending in the multi-district litigation in U.S. federal court, the related class action pending in federal court, as well as certain cases in state courts across the United States. The agreement, which makes no admission of liability, is subject to certain conditions, including acceptance of the settlement by individual claimants and provides for a total payment of up to $225 million to resolve the claims covered by the settlement. Per the agreed-upon terms, the first payment of $135 million was paid into a qualified settlement fund in July 2019 and the second payment of $90 million was paid in January 2020. Cases covered by the settlement are being dismissed as amounts are disbursed to individual plaintiffs from the qualified settlement fund.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cases in state courts in the U.S. and in jurisdictions outside the U.S. continue to progress. As of October&#160;29, 2020, including the cases encompassed in the settlement framework described above that have not yet been dismissed, we are aware of approximately 85&#160;filed and unfiled claims worldwide, with the majority of the claims in various federal or state courts throughout the United States. This includes cases that have settled but have not yet been dismissed. The complaints generally seek damages and other relief based on theories of strict liability, negligence, breach of express and implied warranties, failure to warn, design and manufacturing defect, fraudulent and negligent misrepresentation or concealment, unjust enrichment, and violations of various state consumer protection statutes. </span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">At September&#160;30, 2020, the provision for these matters was $46.3&#160;million. While the amount accrued represents our best estimate, the actual liability for resolution of these matters may vary from our estimate.</span></div><div style="text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_106"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Cardiopulmonary</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In April 2020, the U.S. Food and Drug Administration issued temporary guidance that permitted several of our cardiopulmonary products to be used for Extracorporeal Membrane Oxygenation (&#8220;ECMO&#8221;) therapy greater than six hours to temporarily expand the availability of devices to address the COVID-19 pandemic. Product indications for use have been modified accordingly for many products within our Cardiopulmonary and Advanced Circulatory Support portfolios.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Also in April 2020, our Bi-Flow ECMO cannula received CE Mark for ECMO procedures where femoral artery cannulation can be applied. Bi-Flow previously received CE Mark in 2019 for cardiac surgery procedures requiring femoral artery cannulation. Now validated for up to 29 days of use, Bi-Flow ECMO is designed to reduce the risk of limb ischemia for patients receiving ECMO.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Heart Valves</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In July 2020, we announced that the advanced Perceval Plus sutureless surgical aortic heart valve is available for commercial release in Europe, having successfully completed a one-year limited launch with initial real-world clinical data gathering. This next-generation valve facilitates minimally invasive cardiac surgery to make sutureless aortic valve replacement available to a wide patient population. Key innovations with Perceval Plus include the anticalcification treatment for valve durability, along with design changes intended to improve patient outcomes.</span></div><div style="text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_109"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Neuromodulation</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our Neuromodulation segment designs, develops and markets Neuromodulation therapy for the treatment of drug-resistant epilepsy, DTD and obstructive sleep apnea. We are also developing and conducting clinical testing of the VITARIA System for treating heart failure through vagus nerve stimulation.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Depression</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In February 2020, we announced a research collaboration with Verily, an Alphabet company, to capture measures of depression within our RECOVER clinical study. Through this initial research collaboration, LivaNova and Verily aim to gather quantitative data on patient behavior using technology and analytics developed by Verily to further understand depressive episodes and a patient&#8217;s response to treatment. RECOVER clinical sites will have the ability to offer patients the Verily Study Watch, a wearable device designed to capture physiological and environmental data for clinical research, and a Verily mobile phone application. These complementary approaches are expected to help investigators better understand the impact of depression and its treatment on study participants&#8217; lives in a more objective and multi-dimensional manner.</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In March 2020, our VNS Therapy System, Symmetry received CE mark approval for DTD, and our first two patients outside the U.S. to receive Symmetry were implanted shortly thereafter.</span></div><div style="text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_112"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Significant Accounting Policies and Critical Accounting Estimates&#160;</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In addition to our critical accounting policies provided in &#8220;Part II, Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in our 2019 Form 10-K, refer to &#8220;Significant Accounting Policies&#8221; within &#8220;Note 1. Unaudited Condensed Consolidated Financial Statements&#8221; included in this Quarterly Report on Form 10-Q. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The accompanying unaudited condensed consolidated financial statements of LivaNova and its consolidated subsidiaries have been prepared in accordance with U.S. GAAP on an interim basis. </span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">New accounting pronouncements are disclosed in &#8220;Note 17. New Accounting Pronouncements&#8221; contained in the condensed consolidated financial statements in this Quarterly Report on Form 10-Q.</span></div><div style="text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_115"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Other</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Brexit</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On January 31, 2020, the UK departed from the EU (in a move commonly referred to as &#8220;Brexit&#8221;), and the UK entered a transition period that is scheduled to end on December 31, 2020. During the transition period, the UK will cease to be an EU member but the trading relationship will remain the same under the EU's rules. Although the long-term effects of Brexit will depend on any agreements the UK makes to retain access to the EU markets, Brexit has created additional uncertainties that may ultimately result in new regulatory costs and challenges for medical device companies and increased restrictions on imports and exports throughout Europe. This could adversely affect our ability to conduct and expand our operations in Europe and may have an adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Passage of the withdrawal bill does not change the application of existing tax laws and does not establish a clear framework for what the ultimate outcome of the transition period will be. Various tax reliefs and exemptions that apply to transactions between EU Member States under existing tax laws may cease to apply to transactions between the UK and EU Member States when the transition period is over. It is unclear at this stage if or when any new tax treaties between the UK and the EU or individual EU Member States will replace those reliefs and exemptions. It is also unclear at this stage what financial, trade and legal implications will ensue from Brexit and how Brexit may ultimately affect us, our customers, suppliers, vendors, or our industry.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We and several of our wholly owned subsidiaries that are domiciled either in the UK, various EU Member States, or in the U.S., are party to intercompany transactions and agreements under which we receive various tax reliefs and exemptions in accordance with applicable international tax laws, treaties and regulations. If certain treaties applicable to our transactions and agreements change materially, Brexit may have a material adverse impact on our future financial results and results of operations. We continue to monitor and assess the potential impact of this event and explore possible tax-planning strategies that may mitigate or eliminate potential adverse impacts.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We will not account for the impact of Brexit in our income tax provisions until there are material changes in tax laws or treaties between the UK and other countries.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">European Union State Aid Challenge</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On October 26, 2017, the European Commission (&#8220;EC&#8221;) announced that an investigation would be opened with respect to the UK&#8217;s controlled foreign company (&#8220;CFC&#8221;) rules for the period January 1, 2013 through December 31, 2018. Under the CFC rules, financing profits of entities controlled by UK parent companies are taxed when the funding originates in the UK, or Significant People Functions relating to the financing are located in the UK. The provisions under investigation provide group finance exemptions related to the profits of entities involved in financing of the non-UK group activities. On April 2, 2019, the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">EC concluded that &#8220;when financing income from a foreign group company, channeled through an offshore subsidiary, is financed with UK connected capital and there are no UK activities involved in generating the finance profits, the group finance exemption is justified and does not constitute State aid under EU rules.&#8221; However, in relation to Significant People Functions, &#8220;when financing income from a foreign group company, channeled through an offshore subsidiary, derives from UK activities, the group finance exemption is not justified and constitutes State aid under EU rules.&#8221; Her Majesty&#8217;s Revenue and Customs (&#8220;HMRC&#8221;) has stated that they do not consider the timing and form of the UK&#8217;s exit from the EU will have a practical impact on the requirement to recover the alleged aid. On June 14, 2019, the UK filed an appeal to the Commission&#8217;s decision. On July 5, 2019, HMRC began the first step in the recovery process to identify beneficiaries and sent letters asking for information. Based upon our assessment of the technical arguments as to whether the exemption is State aid, together with no UK activities involved in our financing, no uncertain tax position reserve has been recognized related to this matter. Furthermore, in December 2019, we amended our 2017 tax return filing to avail ourselves of different rules to determine UK taxation, which are not subject to the EU decision. We filed our 2018 tax return similarly, and therefore, we do not believe that the EU state aid decision will result in a material liability.</span></div><div style="text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_118"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </span></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table summarizes our condensed consolidated results of operations (in thousands):</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.434%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,083&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664,686&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796,580&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales - exclusive of amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product remediation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317,424&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger and integration expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation provision, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,834)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,834)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) income from continuing operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,508)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,761&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,137)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,894)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,673)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,774)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,237)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,490)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange and other gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(795)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from continuing operations before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,714)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,465&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,385)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,555)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,990)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses from equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from continuing operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,772)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,187)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,124)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(995)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,772)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,118&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,182)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,946)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Net Sales</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The table below presents net sales by operating segment and geographic region (in thousands, except for percentages):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiopulmonary</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,580&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,014&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,623&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372,163&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Heart Valves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,877&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Advanced Circulatory Support</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,542&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,097&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,878&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417,482&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,161&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Neuromodulation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,408&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,543&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,277&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,461&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,913&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,083&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,610&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664,686&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796,580&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Europe sales include those countries in which we have a direct sales presence, whereas European countries in which we sell through distributors are included in &#8220;Rest of World.&#8221; </span></div><div style="text-indent:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The table below presents segment income from continuing operations (in thousands, except for percentages):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,311)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,037)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,921)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,869)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,407)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,845)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reportable segment income from continuing operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,321&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,850&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,704&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">For a reconciliation of segment income from continuing operations to (loss) income from continuing operations before tax refer to &#8220;Note 15. Geographic and Segment Information&#8221; in the condensed consolidated financial statements in this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:6pt;padding-right:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Cardiovascular</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cardiovascular net sales for the three and nine months ended September 30, 2020 compared to the three and nine months ended September 30, 2019 decreased 9.4% and 13.6%, respectively, largely due to the impact of COVID-19. The decline in net sales for the three and nine month periods were due to declines in Cardiopulmonary sales of 10.7% and 12.8%, respectively. Cardiopulmonary sales of $107.2 million and $324.6 million for the three and nine months ended September 30, 2020 were negatively impacted by declines in HLM and oxygenator sales. HLM sales were negatively impacted due to COVID-19 impacts on hospital budgets for capital equipment, while Oxygenator sales were negatively impacted by a decline of non-emergent cardiac surgery procedures globally. Heart Valves sales of $21.1 million and $63.8 million for the three and nine months ended September 30, 2020 declined by $7.7 million and $24.1 million, respectively, primarily due to declines in sales of Perceval and other tissue valves due to a decline in cardiac surgery procedures globally due to COVID-19. Advanced Circulatory Support sales of $12.5 million and $29.0 million for the three and nine months ended September 30, 2020 increased 91.9% and 25.8%, respectively, resulting from the full U.S. commercial release of LifeSPARC during the third quarter of 2020.  </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cardiovascular operating income for the three and nine months ended September 30, 2020 compared to the three and nine months ended September 30, 2019 decreased primarily due to the receipt of insurance recovery proceeds related to the litigation involving our 3T device of $33.8 million during the three months ended September 30, 2019 as well as a decline in net sales, as discussed above, partially offset by a decrease in 3T legal expenses.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Neuromodulation</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Neuromodulation net sales for the three and nine months ended September 30, 2020 compared to the three and nine months ended September 30, 2019 decreased 12.6% and 21.2%, respectively. The decrease in net sales for the three and nine months ended September 30, 2020 was primarily due to declines in both new patient and end of service implants globally as patients and physicians delayed implant procedures due to COVID-19.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Neuromodulation operating income for the three months ended September 30, 2020 compared to the three months ended September 30, 2019 decreased primarily related to a decline in net sales, as discussed above. Neuromodulation operating income for the nine months ended September 30, 2020 increased compared to the nine months ended September 30, 2019 due to an increase in operating income resulting from the net impact of the change in fair value of contingent consideration arrangements of $28.0 million as well as a $50.3 million impairment of an IPR&amp;D asset during the nine months ended September 30, 2019, partially offset by overall declines in net sales.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cost of Sales and Expenses</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The table below presents our comparative cost of sales and significant expenses as a percentage of sales:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.388%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales - exclusive of amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product remediation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger and integration expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation provision, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cost of Sales - Exclusive of Amortization</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cost of sales consisted primarily of direct labor, allocated manufacturing overhead and the acquisition cost of raw materials and components. Cost of sales as a percentage of net sales for the three and nine months ended September 30, 2020 compared to the three and nine months ended September 30, 2019 increased primarily due to product mix and unfavorable manufacturing variances of $7.0 million and $13.0 million for the three and nine months ended September 30, 2020, respectively, due to the decline in demand resulting from COVID-19 with these increases for the nine months ended September 30,2020 compared to the nine months ending September 30, 2019 partially offset by a decrease in cost of sales resulting from the net impact of the change in fair value of sales-based contingent consideration arrangements of $18.3 million. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Selling, General and Administrative</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">SG&amp;A expenses consisted of sales, marketing, general and administrative activities. SG&amp;A expenses as a percentage of net sales for the three months ended September 30, 2020 compared to the three months ended September 30, 2019 decreased primarily due to sales and marketing cost reductions resulting from COVID-19 as well as a decrease in 3T legal expenses, the settlement of tax litigation that resulted in the reversal of a tax penalty of $4.3 million in the third quarter of 2020 and cost containment actions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Merger and Integration (&#8220;M&amp;I&#8221;) Expenses</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">M&amp;I expenses consist primarily of costs associated with computer systems integration efforts, organizational structure integration, synergy and tax planning. M&amp;I expenses as a percentage of net sales for the three months ended September 30, 2020 compared to the three months ended September 30, 2019 decreased primarily due to the completion of certain integration activities associated with our merger and acquisitions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Research and Development (&#8220;R&amp;D&#8221;) Expenses</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">R&amp;D expenses consist of product design and development efforts, clinical study programs and regulatory activities, which are essential to our strategic portfolio initiatives, including DTD, obstructive sleep apnea and heart failure. R&amp;D expenses as a percentage of net sales for the three months ended September 30, 2020 compared to the three months ended September 30, 2019 increased primarily due to a decline in net sales as well as an increase in R&amp;D expense resulting from the net impact of changes in fair value of milestone-based contingent consideration arrangements of $6.3 million, partially offset by $2.8 million in R&amp;D expenses incurred in the prior year period associated with the Company&#8217;s former TMVR program, the impact of COVID-19 on our clinical studies, as well as a decrease in certain 2019 costs for increased investment in Epilepsy.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Impairment of Intangible Assets</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">During the second quarter of 2019, we determined that LivaNova would experience a delay in the estimated commercialization date of the Company&#8217;s obstructive sleep apnea product currently under development. This delay constituted a triggering event that required an impairment evaluation of the IPR&amp;D asset arising from the ImThera acquisition. Based on the assessment performed, we determined that the IPR&amp;D asset was impaired and as a result, recorded an impairment of $50.3 million, which is included in our Neuromodulation segment. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Litigation Provision, Net</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In July 2019, we entered into agreements with our insurance carriers to recover $33.8 million under our product liability insurance policies related to the litigation involving our 3T device. The insurance recovery was received and recognized during the third quarter of 2019.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Income Taxes</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LivaNova PLC is domiciled and resident in the UK. Our subsidiaries conduct operations and earn income in numerous countries and are subject to the laws of taxing jurisdictions within those countries, and the income tax rates imposed in the tax jurisdictions in which our subsidiaries conduct operations vary. As a result of the changes in the overall level of our income, the earnings mix in various jurisdictions and the changes in tax laws, our consolidated effective income tax rate may vary substantially from one reporting period to another. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our effective income tax rate from continuing operations for the three and nine months ended September 30, 2020 was 21.3% and (37.9)% compared with (49.6)% and 65.9% for the three and nine months ended September 30, 2019, respectively. Our effective income tax rate fluctuates based on, among other factors, changes in pretax income in countries with varying statutory tax rates, changes in valuation allowances, changes in tax credits and incentives, and changes in unrecognized tax benefits associated with uncertain tax positions. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We continually assess the realizability of our worldwide deferred tax asset and valuation allowance positions, and when the need arises, we establish or release valuation allowances accordingly.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Compared with the three months ended September 30, 2019, the change in the effective tax rate for the three months ended September 30, 2020 was primarily attributable to a discrete tax benefit due to the release of the uncertain tax position upon the settlement of tax litigation in Italy offset by a valuation allowance for certain jurisdictions outside the U.S., as compared to a U.S. federal tax benefit from a return to provision reconciliation, partially offset by the establishment of a valuation allowance for a portion of the U.S. federal and state net operating losses during the three months ended September 30, 2019. We established valuation allowances as is more likely than not that we will be unable to realize the related historical deferred tax assets.</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Compared with the nine months ended September 30, 2019, the change in the effective tax rate for the nine months ended September 30, 2020 was primarily attributable to a $42.4 million realized discrete tax benefit related to the CARES Act and the discrete tax benefit due to the release of the uncertain tax position upon the settlement of tax litigation in Italy offset by the establishment of a $74.5&#160;million valuation allowance for the U.K. and other jurisdictions outside the U.S., as compared to a release of uncertain tax positions and a U.S. federal tax benefit from a return to provision reconciliation, partly offset by the establishment of a valuation allowance for a portion of the U.S. federal and state net operating losses and attributes during the nine months ended September 30, 2019. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_121"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Liquidity and Capital Resources</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In June 2020, we raised combined net proceeds of $699.7 million from our Term Loan and Notes borrowings. Additionally, we utilized the combined net proceeds to repay $525.4 million of aggregate outstanding principal. Refer to &#8220;Note 8. Financing Arrangements&#8221; in the condensed consolidated financial statements in this Quarterly Report on Form 10-Q for additional information regarding our debt and debt transactions. As of September&#160;30, 2020, our cash and cash equivalents was $227.8 million.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Based on our current business plan, we believe that our existing cash and cash equivalents, future cash generated from operations and borrowing under our current debt facilities will be sufficient to fund our expected operating needs, working capital requirements, R&amp;D opportunities, capital expenditures, and debt service requirements over the twelve-month period beginning from the issuance date of these condensed consolidated financial statements. Our liquidity could be adversely impacted by the factors affecting future operating results, including those referred to in &#8220;Part II, Item 1A. Risk Factors&#8221; in the 2019 Form 10-K as supplemented by the factors referred to in &#8220;Part II, Item 1A, Risk Factors&#8221; in our Quarterly Reports on Form 10-Q.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160; No provision has been made for income taxes on unremitted earnings of our foreign controlled subsidiaries (non-UK subsidiaries) as of September&#160;30, 2020. In the event of the distribution of those earnings in the form of dividends, a sale of the subsidiaries or certain other transactions, we may be liable for income taxes. However, the tax liability on future distributions should not be significant as most jurisdictions with unremitted earnings have various participation exemptions or no withholding tax.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cash Flows</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Net cash and cash equivalents provided by (used in) operating, investing and financing activities and the net increase in the balance of cash and cash equivalents were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.149%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.150%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116,407)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94,008)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,337)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,519)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,109&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Operating Activities</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cash used in operating activities during the nine months ended September 30, 2020 increased by $22.4 million as compared to the same prior-year period. The increase is primarily due to a decrease in net income adjusted for non-cash items, partially offset by improved working capital management.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Investing Activities</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cash used in investing activities during the nine months ended September 30, 2020 increased $2.8 million as compared to the same prior-year period. The increase is primarily due to an increase in purchases of property, plant and equipment of $11.6 million and the purchase of an investment and loans to investees totaling $5.1 million, partially offset by $10.8 million in cash paid for acquisitions and $3.2 million for purchases of intangible assets in 2019.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Financing Activities</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cash provided by financing activities during the nine months ended September 30, 2020 increased $162.2 million as compared to the same prior-year period. The increase is primarily due to an increase in net borrowings and associated costs of $210.8 million and a decrease in payments of contingent consideration of $9.1 million, partially offset by the purchase of a capped call associated with our Notes of $43.1 million and a closing adjustment payment for the sale of our former CRM business of $14.9 million.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">As of September&#160;30, 2020, we did not have any off-balance sheet arrangements.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Contractual Obligations</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Except for the financing transactions discussed in &#8220;Note 8. Financing Arrangements,&#8221; we had no material changes in our contractual commitments and obligations from amounts listed under &#8220;Part II, Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources&#8221; in our 2019 Form 10-K.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_124"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Item&#160;3.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We are exposed to certain market risks as part of our ongoing business operations, including risks from foreign currency exchange rates, equity price risk, interest rate risks and concentration of procurement suppliers that could adversely affect our consolidated financial position, results of operations or cash flows. We manage these risks through regular operating and financing activities and, at certain times, derivative financial instruments. Quantitative and qualitative disclosures about these risks are included in this Quarterly Report on Form 10-Q in &#8220;Part I, Note 9. Derivatives and Risk Management,&#8221; &#8220;Part I, Item 2. Management&#8217;s Discussion and Analysis of Financial Conditions and Results of Operations&#8221; and &#8220;Part II, Item 1A. Risk Factors,&#8221; and in our 2019 Form 10-K in &#8220;Part II, Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and &#8220;Part I, Item 1A. Risk Factors.&#8221; </span></div><div style="text-indent:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">40</span></div></div></div><div id="i1bf75d3d05544b2db4639291692ac57a_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Item 4.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Controls and Procedures</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Disclosure Controls and Procedures</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">(a)&#160;Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We maintain a system of disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act, that are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. This information is also accumulated and communicated to management, including our Chief Executive Officer (&#8220;CEO&#8221;) and Chief Financial Officer (&#8220;CFO&#8221;), as appropriate, to allow timely decisions regarding required disclosure. Our management, under the supervision and with the participation of our CEO and CFO, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the most recent fiscal quarter reported herein. Based on that evaluation, our CEO and CFO concluded that our disclosure controls and procedures were effective as of&#160;September&#160;30, 2020.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">(b)&#160;Changes in Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-5(f) under the Exchange Act) occurred during the quarter ended September&#160;30, 2020&#160;that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">41</span></div></div></div><div id="i1bf75d3d05544b2db4639291692ac57a_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">PART II. OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_133"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Item 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Legal Proceedings</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">For a description of our material pending legal and regulatory proceedings and settlements, refer to &#8220;Note 10. Commitments and Contingencies&#8221; in our condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.</span></div><div style="text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_136"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Factors</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">There have been no material changes in our risk factors from those disclosed in Part I, Item 1A to our 2019 Annual Report on Form 10-K or in Part II Item 1A in our Quarterly Report on Form 10-Q for the period ended March 31, 2020 and June 30, 2020, except as noted below. Those risk factors disclosed in addition to the other information set forth in this report, could materially affect our business, financial condition, or results of operations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Risks Related to our Business</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">Shareholder activists could cause a disruption to our business.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In mid-October 2020, an activist investor indicated its concerns with, among other things, our capital allocation, reporting transparency on sub segment operating margins, corporate governance and leadership. In the future, our business, operating results or financial condition could be adversely affected because activist proposals can be a significant distraction for our management and employees and may require us to expend significant time and resources. Shareholder activists may create uncertainty for our employees, investors and customers, additional risk and uncertainties with respect to our financial position, operations, strategies and management, and may adversely affect our ability to attract and retain key employees. Any perceived uncertainties as to our future direction also may affect the market price and volatility of our securities.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Risks Related to COVID-19</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:125%">COVID-19 has had, and we expect will continue to have, an adverse effect on our business, results of operations, financial condition and cash flows, the nature and extent of which are uncertain and unpredictable.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The continuing global spread of COVID-19, including corresponding preventative and precautionary measures that we and other businesses, communities and governments are taking to mitigate the spread of the disease, has led to unprecedented restrictions on, disruptions in, and other related impacts on business. In addition to travel restrictions put in place in early 2020, countries, states and governments may continue to close borders, impose prolonged quarantines or other restrictions and requirements on travel, and further limit our ability to conduct business in-person as we did prior to COVID-19.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Per &#8220;Recent Developments Regarding COVID-19&#8221; within &#8220;Note 1. Unaudited Condensed Consolidated Financial Statements&#8221; and &#8220;COVID-19&#8221; under &#8220;Item 2. Management&#8217;s Discussion and Analysis of Financial Conditions and Results of Operations,&#8221; our sales and operating results for the third quarter of 2020 were materially adversely impacted.  While we are seeing signs of stabilization in certain geographies as elective surgeries resume and expect this trend to continue on a global basis during the fourth quarter of 2020, recovery rates may vary and the ultimate health and economic impact of COVID-19 is uncertain.  In certain geographies, hospital systems continue to prioritize treatment of COVID-19 patients and otherwise comply with government guidelines, thereby resulting in the suspension or cancellation of elective medical procedures, which has caused a reduction in sales of these products. To the extent individuals and hospital systems continue to de-prioritize, delay or cancel these procedures, or if unemployment or loss of insurance coverage adversely impacts an individual&#8217;s ability to pay for our products and services, our business, cash flows, financial condition and results of operations will continue to be negatively affected. Further, the COVID-19 pandemic is straining hospital systems around the world, resulting in adverse financial impacts to those systems that could result in reduced future expenditures for our products.  Clinical trials generally have paused or slowed enrollment due to facility closures and governmental restrictions, which will delay enrollment and timelines, and although many facilities have begun to reopen, there can be no assurance that there will not be additional closures in the future.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">As we noted in &#8220;COVID-19&#8221; under &#8220;Item 2. Management&#8217;s Discussion and Analysis of Financial Conditions and Results of Operations,&#8221; we have not closed any of our manufacturing plants. The supply of raw materials and the distribution of finished products remain operational with no known or foreseen constraints.  Regardless, there can be no assurance that any of our facilities will not need to shut down in the future, or that the supply of components, raw materials, and services may be interrupted or insufficient as a direct result of the COVID-19 outbreak.  Any disruption of our operations or those of our suppliers could impact our sales and operating results.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In addition, COVID-19 has impacted and may further impact the global economy and capital markets, including by negatively impacting demand for our products, foreign currency exchange rates, and interest rates, each of which may adversely impact our business. We could experience loss of sales and profits due to delayed payments or insolvency of healthcare professionals, hospitals and other customers, suppliers and vendors facing liquidity issues. As a result, we may be compelled to take additional measures to preserve our cash flow.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Finally, COVID-19 could adversely impact our ability to retain key employees and the continued service and availability of skilled personnel necessary to run our productions and operations, including our executive officers and other members of our management team, as well as the ability of our third-party suppliers, manufacturers, distributors and vendors to retain their key employees. To the extent our management or other personnel are impacted in significant numbers by COVID-19 and are not available to perform their job duties, we could experience delays in, or the suspension of, our manufacturing operations, research and product development activities, regulatory work streams, clinical development programs and other important commercial functions.</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">While the impact of COVID-19 has had, and we expect it to continue to have, an adverse effect on our business, results of operations, financial condition and cash flows, the nature and extent of such impact is uncertain and unpredictable. For more information on the impact of COVID-19 on the Company and LivaNova&#8217;s mitigation measures, please refer to &#8220;Recent Developments Regarding COVID-19&#8221; within &#8220;Note 1. Unaudited Condensed Consolidated Financial Statements,&#8221; &#8220;COVID-19&#8221; under &#8220;Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; Part I, Item 1A to our 2019 Annual Report on Form 10-K, and Part II, Item 1A in our Quarterly Reports on Form 10-Q.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_139"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="padding-right:36pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">None.</span></div><div style="margin-bottom:3pt;padding-right:36pt;text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_142"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Item 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Defaults Upon Senior Securities</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">None.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_145"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Item 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Mine Safety Disclosures</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Not applicable.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span><br/></span></div><div id="i1bf75d3d05544b2db4639291692ac57a_148"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Item 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Other Information</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Disclosure Pursuant to Section 13(r) of the Exchange Act of 1934</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Section 13(r) of the Exchange Act requires issuers to disclose in their quarterly reports certain types of dealings with Iran, including transactions or dealing with government-owned entities, even when those activities are lawful and do not involve U.S. persons. One of our non-U.S. subsidiaries currently sells medical devices, including cardiac surgery and cardiopulmonary products, to privately held distributors in Iran.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We have limited visibility into the identity of these distributors&#8217; customers in Iran. It is possible that their customers include entities, such as government-owned hospitals or sub-distributors, that are owned or controlled directly or indirectly by the Iranian government. To the best of our knowledge at this time, we do not have any contracts or commercial arrangements with the Iranian government.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our gross revenues and net profits attributable to the above-mentioned Iranian activities were $2.3 million and $0.8 million for the three months ended September 30, 2020, respectively, and $6.3 million and $2.3 million for the nine months ended September 30, 2020, respectively.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We believe our activities are consistent with applicable law, including U.S., EU, and other applicable sanctions laws, though such laws are complex and continue to evolve rapidly. We intend to continue our business in Iran.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">43</span></div></div></div><div id="i1bf75d3d05544b2db4639291692ac57a_151"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Item 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Exhibits</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The exhibits marked with the asterisk symbol (*) are filed or furnished (in the case of Exhibit 32.1) with this Quarterly Report on Form 10-Q. The exhibits marked with the cross symbol (&#8224;) are management contracts or compensatory plans or arrangements filed pursuant to Item 601(b)(10)(iii) of Regulation S-K.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:6.513%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Document Description</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="livn-20200930xex101.htm">10.1*&#8224;</a></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Long Term Incentive Plan Restricted Stock Unit Award Agreement</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="livn-20200930xex102.htm">10.2*&#8224;</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Long Term Incentive Plan Performance Stock Unit Award Agreement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="livn-20200930xex103.htm">10.3*&#8224;</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Long Term Incentive Plan Stock Appreciation Right Award Agreement</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="livn-20200930xex311.htm">31.1*</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Executive Officer of LivaNova PLC pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="livn-20200930xex312.htm">31.2*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Financial Officer of LivaNova PLC pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="livn-20200930xex321.htm">32.1*</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Executive Officer and Chief Financial Officer of LivaNova PLC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interactive Data Files Pursuant to Rule 405 of Regulation S-T formatted in Inline XBRL: (i) the Condensed Consolidated Statements of Income (Loss) for the three and nine months ended September 30, 2020 and September  30, 2019, (ii) the Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2020 and September 30, 2019, (iii) the Condensed Consolidated Balance Sheet as of September 30, 2020 and December 31, 2019, (iv) the Condensed Consolidated Statements of Cash Flows for the  nine months ended September 30 2020 and September 30, 2019, and (vi) the Notes to the Condensed Consolidated Financial Statements</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">44</span></div></div></div><div id="i1bf75d3d05544b2db4639291692ac57a_154"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-indent:9pt"><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">SIGNATURE</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:6pt;text-indent:47.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:521.25pt"><tr><td style="width:1.0pt"></td><td style="width:108.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:34.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:372.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIVANOVA PLC</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: October 29, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ DAMIEN MCDONALD</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Damien McDonald</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:521.25pt"><tr><td style="width:1.0pt"></td><td style="width:108.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:34.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:372.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIVANOVA PLC</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: October 29, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ THAD HUSTON</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thad Huston</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">45</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>livn-20200930xex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i14591648de4d4181ad2b5502294de875_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT 10.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">LIVANOVA PLC</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2015 INCENTIVE AWARD SUB-PLAN</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RESTRICTED STOCK UNIT AWARD GRANT NOTICE</font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LivaNova PLC, a public limited company incorporated under the laws of England and Wales (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), pursuant to its 2015 Incentive Award Plan (including where relevant the Sub-Plan for UK Participants and&#47;or the Sub-Plan for France), as amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Sub-Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), hereby grants to the holder listed below (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) the number of Restricted Stock Units (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) set forth below.  The RSUs are subject to the terms and conditions set forth in this Restricted Stock Unit Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and the Restricted Stock Unit Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Sub-Plan (including or as replaced by any local sub-plan referred to in the Foreign Appendix) and the special provisions for Participant&#8217;s country of residence, if any, attached here as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Foreign Appendix</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) each of which is incorporated herein by reference.  Unless otherwise defined herein, the terms defined in (or by reference in) the Sub-Plan shall have the same defined meanings in the Grant Notice and the Agreement.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:28.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Participant&#58; </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;__________________&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Grant Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;__________________&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Number of RSUs&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:3pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;___________&#93; </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Vesting Schedule&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to t terms and conditions of this Agreement, the RSUs will vest as follows&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;__________________&#93;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By clicking the &#8220;ACCEPT&#8221; button, the Participant and the Company agree to be bound by the terms and conditions of the Sub-Plan, the Agreement, the Foreign Appendix, if applicable, and this Grant Notice all of which the Participant can access through a link from the Grant Notice.  The Participant has reviewed the Sub-Plan, the Agreement, the Foreign Appendix, if applicable, and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to electronically signing the Grant Notice and fully understands all provisions of this Grant Notice, the Agreement, the Foreign Appendix, if applicable, and the Sub-Plan.  Shares subject to RSUs that become vested will be distributed in accordance with the Agreement (including, without limitation, Section 2.3 of the Agreement).  The Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Sub-Plan, this Grant Notice, the Foreign Appendix, if applicable or the Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By clicking &#34;ACCEPT&#34; you confirm that you understand and agree to be bound by the provisions below. This will apply where the Company elects that any tax liability arising in respect of your RSUs shall be satisfied pursuant to Section 2.5(a)(v).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I understand that by clicking &#8216;Accept,&#8217; I am instructing Merrill Lynch to execute my order to sell shares of LivaNova plc common stock at market price to obtain cash for payment of any withholding taxes due as a result of the vesting or payment of my restricted stock unit (&#8220;RSU&#8221;) equity award(s) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(&#8220;Tax&#8221;), including any previously vested RSU awards that are currently pending settlement (1) or outstanding unvested RSU awards (2). This instruction will only be valid for my limited purpose brokerage account at Merrill Lynch and will not be valid for any other broker dealer. Merrill Lynch will sell an amount of shares on the next trading day after the vest or payment date of my RSU equity award(s) based on dividing the sum of the Tax and estimated sales commissions and fees, plus 2% to help ensure that enough shares are sold to cover the Tax (i.e., &#91;Tax + commissions + fees&#93; x 1.02) by the closing share price on the trading day prior to the sale date. If the initial sale does not result in sufficient cash to pay my Tax, Merrill Lynch will sell additional shares at market price based on dividing the sum of the residual unpaid Tax and estimated commissions and fees, plus 6% to ensure that enough shares are sold to cover the Tax (i.e., &#91;residual unpaid Tax + commissions + fees&#93; x 1.06) by the then current market price. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Any residual cash after payment of the Tax, commissions and fees will be deposited into my Merrill Lynch brokerage account. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Merrill Lynch may execute my order&#58; (a) in a single transaction or multiple transactions during the course of the trading day, or (b) it may aggregate my order with other orders for other sellers of LivaNova plc securities, execute them as a block or in multiple smaller transactions, and allocate an average price to each seller. I understand that this instruction will not be accepted by Merrill Lynch and my order will not be executed until I open my limited purpose brokerage account. I also understand that this order will be executed in my limited purpose account and will be subject to the terms and conditions that I agree to for that account. The current terms and conditions of the limited purpose account can be found on Benefits Online&#174;. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I permit Merrill Lynch to discuss with and disclose to LivaNova plc any information relating to my account for the purposes of this transaction. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">You must also check your W-9 or W-8 tax certification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">to confirm it will be in effect on the sale date(s). </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(1) You can view previously vested awards that are currently pending settlement by accessing the Pending Activity page located within the Grant Information Dropdown on Benefits Online&#174;. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(2) You can view outstanding unvested awards by accessing the Grant Detail page which is accessible when viewing additional details of an award from the Grant Summary page on Benefits Online&#174;. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">You can view the current status of your W-9 or W-8 by accessing the Participant&#47;Tax Profile page located within the Individual&#47;Plan Information Dropdown on Benefits Online&#174;.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.176%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i14591648de4d4181ad2b5502294de875_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TO RESTRICTED STOCK UNIT AWARD GRANT NOTICE</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RESTRICTED STOCK UNIT AWARD AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the Grant Notice to which this Agreement is attached, the Company has granted to Participant the number of RSUs set forth in the Grant Notice.  </font></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE I.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GENERAL</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Capitalized terms not specifically defined herein shall have the meanings specified in the Sub-Plan or the Grant Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Incorporation of Terms of Sub-Plan and Foreign Appendix</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The RSUs and the Shares issued to Participant hereunder are subject to the terms and conditions set forth in this Agreement, the Sub-Plan and the Foreign Appendix, if applicable, each of which is incorporated herein by reference.  In the event of any inconsistency between the Sub-Plan and&#47;or this Agreement, the terms of the Sub-Plan shall control. In the event of any inconsistency between the Sub-Plan and&#47;or this Agreement with the Foreign Appendix, the terms of the Foreign Appendix shall control.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE II.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AWARD OF RESTRICTED STOCK UNITS AND DIVIDEND EQUIVALENTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Award of RSUs and Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;In consideration of Participant&#8217;s past and&#47;or continued employment with the Company or a Subsidiary and for other good and valuable consideration, effective as of the grant date set forth in the Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Company has granted to Participant the number of RSUs set forth in the Grant Notice, upon the terms and conditions set forth in the Grant Notice, the Sub-Plan, this Agreement and the Foreign Appendix, if applicable, subject to adjustment as provided in Section 13 of the Sub-Plan.  Each RSU represents the right to receive one Share or, at the option of the Company, an amount of cash as set forth in Section 2.3(b), in either case, at the times and subject to the conditions set forth herein.  However, unless and until the RSUs have vested, Participant will have no right to the payment of any Shares subject thereto.  Prior to the actual delivery of any Shares, the RSUs will represent an unsecured obligation of the Company, payable only from the general assets of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Company hereby grants to Participant an Award of Dividend Equivalents with respect to each RSU granted pursuant to the Grant Notice for all ordinary cash dividends which are paid to all or substantially all holders of the outstanding Shares between the Grant Date and the date when the applicable RSU is distributed or paid to Participant or is forfeited or expires.  The Dividend Equivalents for each RSU shall be equal to the amount of cash which is paid as a dividend on one Share.  All such Dividend Equivalents shall be credited to Participant and be deemed to be reinvested in additional RSUs as of the date of payment of any such dividend based on the Fair Market Value of a Share on such date.  Each additional RSU which results from such deemed reinvestment of Dividend Equivalents granted hereunder shall be subject to the same vesting, distribution or payment, adjustment and other provisions which apply to the underlying RSU to which such additional RSU relates.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting of RSUs and Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Subject to Participant&#8217;s continued employment with the Company or a Subsidiary on each applicable vesting date and subject to the terms of this Agreement, the RSUs shall vest in such amounts and at such times as are set forth in the Grant Notice.  Each additional RSU which results from deemed reinvestments of Dividend Equivalents pursuant to Section 2.1(b) hereof shall vest whenever the underlying RSU to which such additional RSU relates vests.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In the event Participant incurs a Termination of Service, except as may be otherwise provided by the Administrator or as set forth in a written agreement between Participant and the Company, Participant shall immediately forfeit any and all RSUs and Dividend Equivalents granted under this Agreement which have not vested or do not vest on or prior to the date on which such Termination of Service occurs, and Participant&#8217;s rights in any such RSUs and Dividend Equivalents which are not so vested shall lapse and expire.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;In the event a Participant incurs a Termination of Service due to an Approved Retirement, the Participant&#8217;s outstanding RSUs will not be forfeited upon such Approved Retirement, but instead outstanding RSUs shall continue to vest on the date(s) set out in the Grant Notice (provided all other terms which apply to the RSUs are met, including the terms regarding restricted activities set forth below). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Approved Retirement&#8221; means a Termination of Service designated by the Committee, in its absolute discretion, as an Approved Retirement.&#160; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In exercising its discretion in designating a Termination of Service as an Approved Retirement, the Committee will strongly consider management recommendations based on each specific situation including the Participant's expressed commitment at the time of Termination of Service to cease any form of full-time paid work (including, but not limited to, self-employment&#59; agency work&#59; or employment), Participant's tenure of service, performance records throughout the Participant's employment or engagement&#160; by the Company or its Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event the Company determines that a Participant who incurs a Termination of Service designated as an Approved Retirement commits a material breach of any fiduciary, confidentiality, non-disclosure, non-competition, non-solicitation, non-interference, non-disparagement obligations to the Company or its Subsidiaries (including without limitation, the Participant&#8217;s engagement in any Prohibited Activities), any portion of the RSUs unvested at such time shall be immediately forfeited for no consideration.&#160; For the purposes of this Section 2.2.(c), &#8220;Prohibited Activities&#8221; shall mean the activities that are prohibited pursuant to any confidentiality agreement or covenant not to compete, not to solicit or hire employees, not to solicit or disrupt business relations, not to disparage the Company, its Subsidiaries or any of its or their officers and employees or any similar restrictions set out in any employment, severance or other written agreement then in effect between the Participant and the Company or one of its Subsidiaries. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If no such agreement containing such restrictions is then in effect, the Participant will be deemed to be engaged in &#8220;Prohibited Activities&#8221; if the Participant, during the term of his or her employment or engagement or in the period during which any RSUs remain unvested following his or her Termination of Service, engages in any employment or business activities for him or herself or on behalf of any enterprise in any capacity or owns any interest in any entity which competes or is competitive with the business of the Company or any Subsidiary&#160; in any country in which the Company or its Subsidiaries </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">operate, in each case with which the Participant has been materially involved or for which the Participant was responsible in the 12 months immediately before his or her Termination of Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;In the event of a Change in Control that occurs following the Measure Date, the RSUs, to the extent not forfeited or otherwise vested immediately prior to such Change in Control, shall become fully vested immediately prior to, but subject to the consummation of, such Change in Control, subject to the Participant&#8217;s continuous employment with the Company or a Subsidiary through such Change in Control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Distribution or Payment of RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Participant&#8217;s RSUs shall be distributed in Shares (either in book-entry form or otherwise) or, at the option of the Company, paid in an amount of cash as set forth in Section 2.3(b), in either case, as soon as administratively practicable following the vesting of the applicable RSU pursuant to Section&#160;2.2 and the Grant Notice, and, in any event, within sixty (60) days following such vesting (for the avoidance of doubt, this deadline is intended to comply with the &#8220;short-term deferral&#8221; exemption from Section 409A of the Code).  Notwithstanding the foregoing, the Company may delay a distribution or payment in settlement of RSUs if it reasonably determines that such payment or distribution will violate Federal securities laws or any other Applicable Law, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such distribution or payment shall be made at the earliest date at which the Company reasonably determines that the making of such distribution or payment will not cause such violation, as required by Treasury Regulation Section 1.409A-2(b)(7)(ii), and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that no payment or distribution shall be delayed under this Section 2.3(a) if such delay will result in a violation of Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In the event that the Company determines in its discretion that due to regulatory or administrative needs it will make payment of Participant&#8217;s RSUs in cash, the amount of cash payable with respect to each RSU shall be equal to the Fair Market Value of a Share on the day immediately preceding the applicable distribution or payment date set forth in Section&#160;2.3(a).  All distributions made in Shares shall be made by the Company in the form of whole Shares, and any fractional share shall be distributed in cash in an amount equal to the value of such fractional share determined based on the Fair Market Value as of the date immediately preceding the date of such distribution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions to Issuance of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Company shall not be required to issue or deliver any certificate or certificates for any Shares or to cause any Shares to be held in book-entry form prior to the fulfillment of all of the following conditions&#58;  (A) the admission of the Shares to listing on all stock exchanges on which such Shares are then listed, (B) the completion of any registration or other qualification of the Shares under any state or federal law or under rulings or regulations of the Securities and Exchange Commission or other governmental regulatory body, which the Administrator shall, in its absolute discretion, deem necessary or advisable, and (C) the obtaining of any approval or other clearance from any state or federal governmental agency that the Administrator shall, in its absolute discretion, determine to be necessary or advisable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding any other provision of this Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Company and its Subsidiaries have the authority to deduct or withhold, or require Participant to remit to the Company or the applicable Subsidiary, an amount sufficient to satisfy any applicable federal, state, local and foreign taxes (including income tax, employees&#8217; (and at the discretion of the Company, employer&#8217;s) National Insurance contributions, social security contributions and the employee portion of any FICA obligation, or any equivalent taxes in any jurisdiction) required by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:120%">law to be withheld, paid or otherwise arising with respect to any taxable event arising pursuant to this Agreement, including the grant or vesting of any RSUs, the settlement of the RSUs on vesting in either Shares or cash and the sale of any of the Shares (any a &#8220;</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Tax Liability</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company and its Subsidiaries may withhold or Participant may make such payment in one or more of the forms specified below&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;by cash or check made payable to the Company or the Subsidiary with respect to which the withholding obligation arises&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;by the deduction of such amount from other compensation payable to Participant&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;with respect to any withholding taxes arising in connection with the distribution of the RSUs, by the Company withholding a net number of vested Shares otherwise issuable pursuant to the RSUs having a then current Fair Market Value not exceeding the amount necessary to satisfy the Tax Liability based on the minimum applicable statutory rates for such Tax Liability or such other rate as does not result in adverse accounting consequences for the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;with respect to any withholding taxes arising in connection with the distribution of the RSUs, with the consent of the Administrator, by tendering to the Company vested Shares having a then current Fair Market Value not exceeding the amount necessary to satisfy the Tax Liability based on the minimum applicable statutory rates for such Tax Liability or such other rate as does not result in adverse accounting consequences for the Company&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;with respect to any withholding taxes arising in connection with the distribution of the RSUs, through the delivery of a notice that Participant has placed a market sell order with a broker acceptable to the Company with respect to Shares then issuable to Participant pursuant to the RSUs, and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the Company or the Subsidiary with respect to which the Tax Liability arises in satisfaction of such Tax Liability&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that payment of such proceeds is then made to the Company or the applicable Subsidiary at such time as may be required by the Administrator, but in any event not later than the settlement of such sale&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vi)&#160;&#160;&#160;&#160;in any combination of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Company shall not be obligated to deliver any certificate representing Shares issuable with respect to the RSUs to, or to cause any such Shares to be held in book-entry form by, Participant or his or her legal representative unless and until Participant or his or her legal representative shall have paid or otherwise satisfied in full the amount of all federal, state, local and foreign taxes applicable with respect to the taxable income of Participant resulting from the vesting or settlement of the RSUs or any other taxable event related to the RSUs, provided that no payment shall be delayed under this Section 2.5(d) if such delay will result in a violation of Section 409A of the Code. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;With respect to any Tax Liability arising in connection with the RSUs, in the event Participant fails to provide timely payment of all sums required pursuant to Section&#160;2.5(a), the Company shall have the right and option, but not the obligation, to treat such failure as an election by Participant to satisfy all or any portion of Participant&#8217;s required payment obligation pursuant to Section&#160;2.5(a)(ii) or Section&#160;2.5(a)(iii) above, or any combination of the foregoing as the Company may determine to be appropriate. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;In the event any Tax Liability arising in connection with the RSUs will be satisfied under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Section&#160;2.5(a)(iii)</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then the Company may elect to instruct any brokerage firm determined acceptable to the Company for such purpose to sell on Participant&#8217;s behalf a whole number of shares from those Shares then issuable to Participant pursuant to the RSUs as the Company determines to be appropriate to generate cash proceeds sufficient to satisfy the Tax Liability and to remit the proceeds of such sale to the Company or the Subsidiary.  Participant&#8217;s acceptance of this Award constitutes Participant&#8217;s instruction and authorization to the Company and such brokerage firm to complete the transactions described in this Section 2.5(d), including the transactions described in the previous sentence, as applicable.  The Company may refuse to issue any Shares in settlement of the RSUs to Participant until the foregoing Tax Liability is satisfied,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that no payment shall be delayed under this Section 2.5(d) if such delay will result in a violation of Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Participant is ultimately liable and responsible for and indemnifies the Company and each Subsidiary against all Tax Liability arising in connection with the RSUs, regardless of any action the Company or any Subsidiary takes with respect to any tax withholding obligations that arise in connection with the RSUs.  Neither the Company nor any Subsidiary makes any representation or undertaking regarding the treatment of any tax withholding in connection with the awarding, vesting or payment of the RSUs or the subsequent sale of Shares.  The Company and the Subsidiaries do not commit and are under no obligation to structure the RSUs to reduce or eliminate any Tax Liability.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Rights as Shareholder.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Neither Participant nor any person claiming under or through Participant will have any of the rights or privileges of a shareholder of the Company in respect of any Shares deliverable hereunder unless and until certificates representing such Shares (which may be in book-entry form) will have been issued and recorded on the records of the Company or its transfer agents or registrars, and delivered to Participant (including through electronic delivery to a brokerage account).  Except as otherwise provided herein, after such issuance, recordation and delivery, Participant will have all the rights of a shareholder of the Company with respect to such Shares, including, without limitation, the right to receipt of dividends and distributions on such Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Compensation Recoupment Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The grant of this Award is subject to the terms of the LivaNova Compensation Recoupment Policy, as it may provide from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require the Participant to repay or forfeit cash or equity awards, including this Award, or any ordinary shares or other cash or property received with respect to this and other awards, including any value received from a disposition of the ordinary shares acquired upon payment in respect of the awards.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE III.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OTHER PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Administrator shall have the power to interpret the Sub-Plan, the Grant Notice, this Agreement and the Foreign Appendix, if applicable, and to adopt such rules for the administration, interpretation and application of the Sub-Plan, the Grant Notice, this Agreement and the Foreign Appendix, if applicable, as are consistent therewith and to interpret, amend or revoke any such rules.  All actions taken and all interpretations and determinations made by the Administrator will be final and binding upon Participant, the Company and all other interested persons.  To the extent allowable pursuant to Applicable Law, no member of the Committee or the Board will be personally liable for any action, determination or interpretation made with respect to the Sub-Plan, the Grant Notice, this Agreement or the Foreign Appendix, if applicable.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">RSUs Not Transferable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The RSUs may not be sold, pledged, assigned or transferred in any manner other than by will or the laws of descent and distribution, unless and until the Shares underlying the RSUs have been issued, and all restrictions applicable to such Shares have lapsed.  No RSUs or any interest or right therein or part thereof shall be liable for the debts, contracts or engagements of Participant or his or her successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy), and any attempted disposition thereof shall be null and void and of no effect, except to the extent that such disposition is permitted by the preceding sentence.  Notwithstanding the foregoing, with the consent of the Administrator, the RSUs may be transferred to certain persons or entities related to the Participant, including but not limited to members of Participant&#8217;s family, charitable institutions or trusts or other entities whose beneficiaries or beneficial owners are members of Participant&#8217;s family or to such other persons or entities as may be expressly approved by the Administrator, pursuant to any such conditions and procedures the Administrator may require.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Administrator may accelerate the vesting of all or a portion of the RSUs in such circumstances as it, in its sole discretion, may determine.  Participant acknowledges that the RSUs and the Shares subject to the RSUs are subject to adjustment, modification and termination in certain events as provided in this Agreement and the Sub-Plan, including Section 13 of the Sub-Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of the Company at the Company&#8217;s principal office, and any notice to be given to Participant shall be addressed to Participant at Participant&#8217;s last address reflected on the Company&#8217;s records.  By a notice given pursuant to this Section 3.4, either party may hereafter designate a different address for notices to be given to that party.  Any notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Titles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.   The laws of the State of Delaware shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Conformity to Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Participant acknowledges that the Sub-Plan, the Grant Notice, this Agreement and the Foreign Appendix, if applicable, are intended to conform to the extent necessary with all Applicable Laws, including, without limitation, the provisions of the Securities Act and the Exchange Act, and any and all regulations and rules promulgated thereunder by the Securities and Exchange Commission, and state securities laws and regulations and to the extent deemed applicable by the Administrator, the provisions of the Listing Rules of the London Stock Exchange published by the UK Listing Authority. Notwithstanding anything herein to the contrary, the Sub-Plan shall be administered, and the RSUs are granted, only in such a manner as to conform to Applicable Law.  To the extent permitted by Applicable Law, the Sub-Plan and this Agreement shall be deemed amended to the extent necessary to conform to Applicable Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment, Suspension and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  To the extent permitted by the Sub-Plan, this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">time or from time to time by the Administrator or the Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">, provided however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, except as may otherwise be provided by the Sub-Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect the RSUs in any material way without the prior written consent of Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company.  Subject to the restrictions on transfer set forth in Section 3.2 and the Sub-Plan, this Agreement shall be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Limitations Applicable to Section 16 Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding any other provision of the Sub-Plan or this Agreement, if Participant is subject to Section 16 of the Exchange Act, the Sub-Plan, the RSUs (including RSUs which result from the deemed reinvestment of Dividend Equivalents), the Dividend Equivalents, the Grant Notice, this Agreement and the Foreign Appendix, if applicable, shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule.  To the extent permitted by Applicable Law, this Agreement shall be deemed amended to the extent necessary to conform to such applicable exemptive rule.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Not a Contract of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Nothing in this Agreement or in the Sub-Plan shall confer upon Participant any right to continue to serve as an employee of the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the employment of Participant at any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and Participant. Neither the Sub-Plan, the Grant Notice, the Foreign Appendix, if applicable, nor this Agreement afford the Participant any rights to compensation or damages, including for loss of or potential loss that the Participant may suffer as a result of the termination of the Sub-Plan, lapse of the RSUs or the termination of the Participant&#8217;s employment with the Company. Neither the Sub-Plan, the Grant Notice, this Agreement nor the Foreign Appendix, if applicable, afford the Participant any rights to compensation or damages including for loss or potential loss that the Participant may suffer as a result of the termination of the Sub-Plan, lapse of the RSU or the termination of the Participant&#8217;s employment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">RSUs Not Part of Employment Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The RSUs and the Shares subject to the RSUs are extraordinary items that do not constitute part of normal or expected wages or salary for any purposes, including, but not limited to, calculation of any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, holiday pay, long-service awards, pension or retirement benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company, the employer, its parent, or any Subsidiary or affiliate of the Company. In addition, Participant acknowledges that by electronically signing the Grant Notice and this Agreement that the grant of the Award is at the Company&#8217;s sole discretion based on the Sub-Plan, and does not entitle the Participant to further grant(s) of Awards, nor to claim for further grant(s) of Awards, in respect of the Sub-Plan or any other award(s) under any other plan or program maintained by the Company or any Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.13&#160;&#160;&#160;&#160;Data Protection</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. By electronically signing the Grant Notice and this Agreement, the Participant acknowledges and agrees that&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the Company, a Subsidiary or the Participant&#8217;s employer are permitted to hold and process personal information (including sensitive personal information) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) about the Participant as part of their personnel and other business records and may use such information for the purpose of managing and administering the Sub-Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Company, a Subsidiary or the Participant&#8217;s employer may disclose the Data (as described in (a) above) to third parties in the event that such disclosure is in the Company&#8217;s view required for the proper conduct of the Sub-Plan. The Company may also make the Data available to public authorities where required under locally applicable law. These recipients may be located in the United States, the European Economic Area, or elsewhere, which the Participant separately and expressly consents to, accepting that outside the European Economic Area, data protection laws are less protective than within&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;they may, at any time, review Data, require any necessary amendments to it or withdraw their consent herein by contacting the Company in writing, however, the Participant withdrawing their consent may affect their ability to participate in the Sub-Plan and receive the benefits intended pursuant to the Grant Notice and this Agreement&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Data will only be held as long as necessary to implement, administer and manage the Participant&#8217;s participation in the Sub-Plan and any subsequent claims or rights&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;this section applies to any information held, used or disclosed in any medium.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Sub-Plan, the Grant Notice and this Agreement (including any exhibit&#160;hereto) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company, the Subsidiaries and Participant with respect to the subject matter hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Award is not intended to constitute &#8220;nonqualified deferred compensation&#8221; within the meaning of Section 409A of the Code (together with any Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the date hereof, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  However, notwithstanding any other provision of the Sub-Plan, the Grant Notice, this Agreement or the Foreign Appendix, if applicable, if at any time the Administrator determines that this Award (or any portion thereof) may be subject to Section 409A, the Administrator shall have the right in its sole discretion (without any obligation to do so or to indemnify Participant or any other person for failure to do so) to adopt such amendments to the Sub-Plan, the Grant Notice or this Agreement, or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, as the Administrator determines are necessary or appropriate for this Award either to be exempt from the application of Section 409A or to comply with the requirements of Section 409A. Notwithstanding anything herein to the contrary, no provision of the Sub-Plan shall be interpreted or construed to transfer any liability for failure to comply with the requirements of Section&#160;409A from Participant or any other person to the Company or any of its Subsidiaries, employees or agents.  Without limiting the foregoing and notwithstanding anything contained herein to the contrary, to the extent required in order to avoid an accelerated or additional tax under Section 409A, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to this Agreement during the six-month period immediately following the Participant&#8217;s separation from service shall instead be paid on the first business day after the date that is six months following the Participant&#8217;s separation from service (or, if earlier, the Participant&#8217;s date of death).  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement Severable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In the event that any provision of the Grant Notice or this Agreement is held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of the Grant Notice or this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Limitation on Participant&#8217;s Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Participation in the Sub-Plan confers no rights or interests other than as herein provided.  This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust.  Neither the Sub-Plan nor any underlying program, in and of itself, has any assets.  Participant shall have only the rights of a general unsecured creditor of the Company with respect to amounts credited and benefits payable, if any, with respect to the RSUs and Dividend Equivalents, and rights no greater than the right to receive Shares or cash as a general unsecured creditor with respect to the RSUs, as and when settled pursuant to the terms hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.18&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Grant Notice may be executed in one or more counterparts, including by way of any electronic signature, subject to Applicable Law, each of which shall be deemed an original and all of which together shall constitute one instrument.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.19&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Special Provisions for RSUs Granted to Participants Outside the U.S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  If Participant performs services for the Company or any Subsidiary outside of the United States, the RSUs shall be subject to the special provisions, if any, for Participant&#8217;s country of residence, as set forth in the Foreign Appendix.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;If Participant relocates to one of the countries included in the Foreign Appendix during the life of this Award, the special provisions for such country shall apply to Participant, to the extent the Company determines that the application of such provisions is necessary or advisable in order to comply with local law or facilitate the administration of the Sub-Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Company reserves the right to impose other requirements on this Award and any Shares received upon settlement of the RSUs, to the extent the Company determines it is necessary or advisable in order to comply with local laws or facilitate the administration of the Sub-Plan, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.20&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Broker-Assisted Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In the event of any broker-assisted sale of Shares in connection with the payment of withholding taxes as provided in Section 2.5(a)(iii) or Section 2.5(d)&#58; (A) any Shares to be sold through a broker-assisted sale will be sold on the day the tax withholding obligation arises or as soon thereafter as practicable&#59; (B) such Shares may be sold as part of a block trade with other participants in the Sub-Plan in which all participants receive an average price&#59; (C) Participant will be responsible for all broker&#8217;s fees and other costs of sale, and Participant agrees to indemnify and hold the Company harmless from any losses, costs, damages, or expenses relating to any such sale&#59; (D) to the extent the proceeds of such sale exceed the applicable tax withholding obligation, the Company agrees to pay such excess in cash to Participant as soon as reasonably practicable&#59; (E) Participant acknowledges that the Company or its designee is under no obligation to arrange for such sale at any particular price, and that the proceeds of any such sale may not be sufficient to satisfy the applicable tax withholding obligation&#59; and (F) in the event the proceeds of such sale are insufficient to satisfy the applicable tax withholding obligation, Participant agrees to pay immediately upon demand to the Company or its Subsidiary with respect to which the withholding obligation arises an amount in cash sufficient to satisfy any remaining portion of the Company&#8217;s or the applicable Subsidiary&#8217;s withholding obligation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">* * * * *</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT B</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">TO RESTRICTED STOCK UNIT AWARD GRANT NOTICE</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SPECIAL PROVISIONS FOR RESTRICTED STOCK UNITS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GRANTED TO PARTICIPANTS OUTSIDE THE U.S.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Exhibit B includes special terms and conditions applicable to Participants in the countries below.  These terms and conditions are in addition to those set forth in the RSU Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and the Sub-Plan and to the extent there are any inconsistencies between these terms and conditions and those set forth in the Agreement or the Sub-Plan, these terms and conditions shall prevail.  Any capitalized term used in this Exhibit B without definition shall have the meaning ascribed to such term in the Sub-Plan or the Agreement, if applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Foreign Appendix also includes information relating to exchange control and other issues of which Participant should be aware with respect to his or her participation in the Sub-Plan.  The information is based on the exchange control, securities and other laws in effect in the respective countries as at May 2017.  Such laws are often complex and change frequently.  As a result, the Company strongly recommends that Participant not rely on the information herein as the only source of information relating to the consequences of participation in the Sub-Plan because the information may be out of date at the time the RSUs are settled or any Shares acquired under the Sub-Plan are sold.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, the information is general in nature and may not apply to the particular situation of Participant, and the Company is not in a position to assure Participant of any particular result.  Accordingly, Participant is advised to seek appropriate professional advice as to how the relevant laws in his or her country may apply to his or her situation.  Finally, if Participant is a citizen or resident of a country other than the one in which he or she is currently working, the information contained herein may not be applicable to Participant.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">AUSTRALIA</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A copy of the Sub-Plan is enclosed with this Grant Notice and Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">The Sub-Plan, the Agreement and this Grant Notice do not constitute financial advice</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any advice given by the Company in relation to the Grant Notice, the Agreement, the Sub-Plan, the RSUs or the Shares does not constitute financial advice and does not take into account your objectives, financial situation and needs.  In considering the RSUs and the amount of cash and&#47;or Shares that you will receive on vesting of the RSUs, you should consider the risk factors that could affect the performance of the Company and the value of RSUs and Shares, which value can increase or decrease from time to time, and the amount of any Tax Liability.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You should carefully consider these risks in light of your investment objectives, financial situation and particular needs (including financial and tax issues).  You should seek professional guidance from your stockbroker, solicitor, accountant, financial adviser or other independent professional adviser before deciding whether to acquire RSUs or Shares.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">How to calculate values in Australian dollars</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Your RSUs will vest in accordance with the Grant Notice and the Agreement (which require certain conditions to be met) and are subject to a four year graded vesting schedule. The RSUs may result in Shares or cash being given to you, in accordance with the Grant Notice. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You will not be required to pay any amount for the RSUs or any Shares that will be issued to you upon vesting. However the amount of cash or number of Shares you receive will depend on the market price of Shares at the time and the amount of any Tax Liability in connection with the grant and vesting of the RSUs and the issue of any Shares. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You can ascertain the market price of a Share in the Company in United States Dollars (&#8220;USD&#8221;) from time to time by visiting either&#58; </font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the Company&#8217;s website (http&#58;&#47;&#47;www.livanova.com&#47;investor-relations&#47;stock-information)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the NASDAQ website (http&#58;&#47;&#47;www.nasdaq.com&#47;symbol&#47;livn).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To determine the market value of a Share in Australian Dollars (&#8220;AUD&#8221;), you will need to apply the prevailing USD&#160;&#58;&#160;AUD exchange rate.  For example, if the exchange rate is 1&#160;USD&#160;&#58;&#160;1.5&#160;AUD, and one share of Common Stock has a value of USD $1 on the NASDAQ, its equivalent value will be AUD $1.50.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">CANADA</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Unless otherwise determined by the Administrator, Participant&#8217;s RSUs shall only be distributed in Shares (either in book-entry form or otherwise), and no portion of the Participant&#8217;s RSUs shall be payable to the Participant in cash. </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">CHINA</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Unless otherwise determined by the Administrator, Participant&#8217;s RSUs shall only be settled in cash, and no portion of the Participant&#8217;s RSUs shall be distributed in Shares. </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">FRANCE</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">If the Participant is employed by a French subsidiary of the Group, the terms and conditions provided in the French Sub-Plan will apply, in addition to the terms set out below. References in the Agreement to &#8220;Sub-Plan&#8221; shall be references to the &#8220;French Sub-Plan&#8221;. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Participant&#8217;s RSUs shall only be distributed in Shares (either in book-entry form or otherwise), and no portion of the Participant&#8217;s RSUs shall be payable to the Participant in cash.  Participant cannot benefit from any Dividend Equivalent provided for under Sections 2.1 and 2.2 of the Agreement.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">The following paragraph is inserted at Section 2.7 of the Agreement</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">2.7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Holding Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#58; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:5.8pt">In accordance with section 6 of the French Sub-Plan, Shares delivered to the Participant prior to the end of the second anniversary of the Grant Date cannot be transferred prior to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">the first anniversary of their Delivery Date (i.e., the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Holding Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;) (as such terms are defined in the French Sub-Plan).</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:5.18pt">In the event that the Participant does not comply with section 2.7(a) of the Agreement, the Participant will only be responsible for reimbursing the French Subsidiary for any tax liability which is has or will incur as a result of such non-compliance, excluding for the avoidance of doubt any employer social security contributions. The Participant agrees to indemnify and keep indemnified the French Subsidiary in respect of such a tax liability. </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:5.8pt">If the Participant wishes to transfer Shares during the Holding Period, the Participant must give written notice of the proposed transfer</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> to &#91;the Company&#93; as s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">oon as reasonably practicable, and in any event at least 3 business days in advance of the proposed transfer.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:5.18pt">The Participant acknowledges that if the Participant wishes to sell Shares during the Holding Period, such sale will be undertaken by Merrill Lynch through the Participant&#8217;s limited purpose brokerage account at Merrill Lynch and will not be valid for any other broker dealer. The Participant acknowledges that such sale will be subject to sales commission and fees, which will be deducted from the sale proceeds and the residual balance will be deposited in the Participant&#8217;s Merrill Lynch brokerage account. </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:5.8pt">The Participant acknowledges that Merrill Lynch may execute such order&#58; (a) in a single transaction or multiple transactions during the course of the trading day, or (b) it may aggregate the order with other orders for other sellers of LivaNova plc securities, execute them as a block or in multiple smaller transactions, and allocate an average price to each seller. The Participant further acknowledges that the sale instruction will not be accepted by Merrill Lynch and the order will not be executed until the Participant opens a limited purpose brokerage account. The Participant acknowledges that the order will be executed in their limited purpose account and will be subject to the terms and conditions that they agree to for that account. The current terms and conditions of the limited purpose account can be found on Benefits Online&#174;. </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:7.02pt">The Participant agrees that Merrill Lynch may discuss with and disclose to LivaNova plc any information relating to their account for the purposes of any sale transaction.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Section 3.13 shall be deleted in its entirety and replaced by the following&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant&#8217;s personal &#8220;Data&#8221; (as defined below) by the Company for the exclusive purpose of implementing, administering and managing Participant&#8217;s participation in the Sub-Plan. Participant understands that the Company holds certain personal information about Participant&#58; Participant&#8217;s name, home address and telephone number, date of birth, employee identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all options or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in Participant&#8217;s favor, for the purpose of implementing, administering and managing the Sub-Plan (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Participant understands that Data will be transferred to such stock plan service providers as may be selected by the Company which are assisting the Company with the implementation, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">administration and management of the Sub-Plan. Participant understands that the recipients of the Data may be located in the United States or elsewhere (and, if Participant is a resident of a member state of the European Union, may be outside the European Economic Area) and that the recipient&#8217;s country (e.g., the United States) may have different data privacy laws and protections than Participant&#8217;s country. Participant understands that he or she may request a list with the names and addresses of all recipients of the Data by contacting his or her local human resources representative.  Participant authorizes the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Sub-Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing Participant&#8217;s participation in the Sub-Plan.  Participant understands that Data will be held only as long as is necessary to implement, administer and manage Participant&#8217;s participation in the Sub-Plan.  The Company may also make the Data available to public authorities where required under locally applicable law.  Participant understands that he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing Participant&#8217;s local human resources representative.  Participant understands, however, that refusing or withdrawing consent may affect Participant&#8217;s ability to participate in the Sub-Plan.  For more information on the consequences of refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local human resources representative.  This Section applies to information held, used or disclosed in any medium.</font></div><div style="margin-bottom:10pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">GERMANY</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Definition of &#8220;Tax Liability&#8221; in Section 2.5&#58; </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">For the avoidance of doubt, the definition of &#8220;Tax Liability&#8221; shall only include the employee portions of the social security contributions. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">The following sentence is inserted at Section 3.1 of the Agreement</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">For the avoidance of doubt, the Administrator&#8217;s decisions and interpretations shall be subject to reasonable discretion.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">The heading of Section 3.12 shall be supplemented and read as follows&#58; </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Section 3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">RSUs Not Part of Employment Compensation, No Legal Claim to Grant(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Section 3.13 shall be deleted in its entirety and replaced by the following&#58;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Section 3.13   Consent to Personal Data Processing and Transfer. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">By signing these terms and conditions, Participant acknowledges and agrees that&#58; </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;the Company and the Participant&#8217;s employer may collect, store, process and use certain personal data of Participant and may further transfer them to Cyberonics, Inc., a wholly-owned subsidiary of LivaNova PLC, located at 100 Cyberonics Blvd, Houston, TX 77058, U.S.A., and Certent, Inc., the Company&#8217;s equity compensation management vendor, located at 1548 Eureka Rd., Suite 100, Roseville, CA 95661, U.S.A., and Merrill Lynch, Pierce, Fenner &#38; Smith, Incorporated, a wholly-owned subsidiary of Bank of America Corporation, the Company&#8217;s broker </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">for equity compensation management and transactions, located at World Financial Center, 220 Vesey Street, New York, NY 10281 for the exclusive purpose of implementing, administering, managing and accounting Participant&#8217;s participation in the Sub-Plan&#59; </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;personal data of Participant are&#58; first name&#47;s and last name, birth date, gender, family status, home address, job title, working location, e-mail addresses and phone numbers, social security and tax numbers, tax class, cash compensation and equity award compensation (the &#8220;Data&#8221;)&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:35.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;this section applies to any Data held, used or disclosed in any medium&#59; </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:70.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(d)&#160;&#160;&#160;&#160;the Data will be transferred to the locations listed in subparagraph (a) above, and locations outside of the European Economic Area who provide for a lesser level of data protection than locations within&#59; </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:70.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(e)&#160;&#160;&#160;&#160;Data will only be held as long as necessary to implement, administer, manage and account Participant&#8217;s participation in the Sub-Plan and any subsequent claims or rights&#59; </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(f) &#160;&#160;&#160;&#160;the consent to the personal data processing as described in this Section 3.13 is entirely voluntary and can be withdrawn at any time&#59; Participant is advised, however, that missing consent in written form may affect his ability to participate in the Sub-Plan and receive benefits intended pursuant to the Grant Notice, the Agreement and the Foreign Appendix. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Name of Participant&#58; &#160;&#160;&#160;&#160;___________________________</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Place&#47;Date&#58; _____________________________________</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Participant&#8217;s Signature&#58; ___________________________</font></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">UNITED KINGDOM</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">The following paragraph is inserted as Section 2.5 (f) of the Agreement</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Participant agrees that if the Participant does not pay his&#47;her employer or the Company does not withhold from the Participant the full amount of any Tax Liability within ninety (90) days after the end of the tax year in which the Tax Liability occurred, or such other period specified in Section 222 (1)(c) of Income Tax (Earnings and Pensions) Act 2003, then the amount that should have been withheld shall constitute a loan owed by the Participant to the employer, effective 90 days after the end of the tax year in which the Tax Liability occurred. The Participant agrees that the loan will bear interest at the official rate of HMRC and will be immediately due and repayable by the Participant, and the Company and&#47;or the employer may recover it at any time thereafter by&#58; (a) withholding the funds from salary, bonus or any other funds due to the Participant by the Company or the employer&#59; (b) withholding the Shares issued upon vesting and settlement of the RSUs or from the cash proceeds from the sale of Shares&#59; or (c) demanding cash or a cheque from the Participant. The Participant also authorizes the Company to delay the issuance of any Shares to the Participant unless and until the loan is repaid in full.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>livn-20200930xex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i8ffad72acd48453dbdeac623252b0fae_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">LIVANOVA PLC</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2015 INCENTIVE AWARD SUB-PLAN</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PERFORMANCE STOCK UNIT AWARD GRANT NOTICE</font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LivaNova PLC, a public limited company incorporated under the laws of England and Wales (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), pursuant to its 2015 Incentive Award Plan (including where relevant the Sub-Plan for UK Participants and&#47;or the Sub-Plan for France), as amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Sub-Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), hereby grants to the holder listed below (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) the number of Performance Stock Units (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) set forth below.  The PSUs are subject to the terms and conditions set forth in this Performance Stock Unit Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and the Performance Stock Unit Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Sub-Plan (including or as replaced by any local sub-plan referred to in the Foreign Appendix) and the special provisions for Participant&#8217;s country of residence, if any, attached here as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Foreign Appendix</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) each of which is incorporated herein by reference.  Unless otherwise defined herein, the terms defined in (or by reference in) the Sub-Plan shall have the same defined meanings in the Grant Notice and the Agreement.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:28.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Participant&#58; </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;__________________&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Grant Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;__________________&#93;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Number of PSUs&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:3pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;___________&#93; </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Vesting Schedule&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;__________________&#93;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By clicking the &#8220;ACCEPT&#8221; button, the Participant and the Company agree to be bound by the terms and conditions of the Sub-Plan, the Agreement, the Foreign Appendix, if applicable, and this Grant Notice all of which the Participant can access through a link from the Grant Notice.  The Participant has reviewed the Sub-Plan, the Agreement, the Foreign Appendix, if applicable, and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to electronically signing the Grant Notice and fully understands all provisions of this Grant Notice, the Agreement, the Foreign Appendix, if applicable, and the Sub-Plan.  Shares subject to PSUs that become vested will be distributed in accordance with the Agreement (including, without limitation, Section 2.3 of the Agreement).  The Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Sub-Plan, this Grant Notice, the Foreign Appendix, if applicable or the Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By clicking &#34;ACCEPT&#34; you confirm that you understand and agree to be bound by the provisions below. This will apply where the Company elects that any tax liability arising in respect of your PSUs shall be satisfied pursuant to Section 2.5(a)(v).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I understand that by clicking &#8216;Accept,&#8217; I am instructing Merrill Lynch to execute my order to sell shares of LivaNova plc common stock at market price to obtain cash for payment of any withholding taxes due as a result of the vesting or payment of my performance stock unit (&#8220;PSU&#8221;) equity award(s) (&#8220;Tax&#8221;), including any previously vested PSU awards that are currently pending settlement (1) or outstanding unvested PSU awards (2). This instruction will only be valid for my limited purpose brokerage account at Merrill Lynch and will not be valid for any other broker dealer. Merrill Lynch will </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sell an amount of shares on the next trading day after the vest or payment date of my PSU equity award(s) based on dividing the sum of the Tax and estimated sales commissions and fees, plus 2% to help ensure that enough shares are sold to cover the Tax (i.e., &#91;Tax + commissions + fees&#93; x 1.02) by the closing share price on the trading day prior to the sale date. If the initial sale does not result in sufficient cash to pay my Tax, Merrill Lynch will sell additional shares at market price based on dividing the sum of the residual unpaid Tax and estimated commissions and fees, plus 6% to ensure that enough shares are sold to cover the Tax (i.e., &#91;residual unpaid Tax + commissions + fees&#93; x 1.06) by the then current market price. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Any residual cash after payment of the Tax, commissions and fees will be deposited into my Merrill Lynch brokerage account. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Merrill Lynch may execute my order&#58; (a) in a single transaction or multiple transactions during the course of the trading day, or (b) it may aggregate my order with other orders for other sellers of LivaNova plc securities, execute them as a block or in multiple smaller transactions, and allocate an average price to each seller. I understand that this instruction will not be accepted by Merrill Lynch and my order will not be executed until I open my limited purpose brokerage account. I also understand that this order will be executed in my limited purpose account and will be subject to the terms and conditions that I agree to for that account. The current terms and conditions of the limited purpose account can be found on Benefits Online&#174;. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I permit Merrill Lynch to discuss with and disclose to LivaNova plc any information relating to my account for the purposes of this transaction. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">You must also check your W-9 or W-8 tax certification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">to confirm it will be in effect on the sale date(s). </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(1) You can view previously vested awards that are currently pending settlement by accessing the Pending Activity page located within the Grant Information Dropdown on Benefits Online&#174;. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(2) You can view outstanding unvested awards by accessing the Grant Detail page which is accessible when viewing additional details of an award from the Grant Summary page on Benefits Online&#174;. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">You can view the current status of your W-9 or W-8 by accessing the Participant&#47;Tax Profile page located within the Individual&#47;Plan Information Dropdown on Benefits Online&#174;.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.176%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i8ffad72acd48453dbdeac623252b0fae_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TO PERFORMANCE STOCK UNIT AWARD GRANT NOTICE</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PERFORMANCE STOCK UNIT AWARD AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the Grant Notice to which this Agreement is attached, the Company has granted to Participant the number of PSUs set forth in the Grant Notice.  </font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE I.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GENERAL</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Capitalized terms not specifically defined herein shall have the meanings specified in the Sub-Plan or the Grant Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Incorporation of Terms of Sub-Plan and Foreign Appendix</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The PSUs and the Shares issued to Participant hereunder are subject to the terms and conditions set forth in this Agreement, the Sub-Plan and the Foreign Appendix, if applicable, each of which is incorporated herein by reference.  In the event of any inconsistency between the Sub-Plan and&#47;or this Agreement, the terms of the Sub-Plan shall control. In the event of any inconsistency between the Sub-Plan and&#47;or this Agreement with the Foreign Appendix, the terms of the Foreign Appendix shall control.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE II.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AWARD OF PERFORMANCE STOCK UNITS AND DIVIDEND EQUIVALENTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Award of PSUs and Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;In consideration of Participant&#8217;s past and&#47;or continued employment with the Company or a Subsidiary and for other good and valuable consideration, effective as of the grant date set forth in the Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Company has granted to Participant the number of PSUs set forth in the Grant Notice, upon the terms and conditions set forth in the Grant Notice, the Sub-Plan, this Agreement and the Foreign Appendix, if applicable, subject to adjustment as provided in Section 13 of the Sub-Plan.  Each PSU represents the right to receive one Share or, at the option of the Company, an amount of cash as set forth in Section 2.3(b), in either case, at the times and subject to the conditions set forth herein.  However, unless and until the PSUs have vested, Participant will have no right to the payment of any Shares subject thereto.  Prior to the actual delivery of any Shares, the PSUs will represent an unsecured obligation of the Company, payable only from the general assets of the Company.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Company hereby grants to Participant an Award of Dividend Equivalents with respect to each PSU granted pursuant to the Grant Notice for all ordinary cash dividends which are paid to all or substantially all holders of the outstanding Shares between the Grant Date and the date when the applicable PSU is distributed or paid to Participant or is forfeited or expires.  The Dividend Equivalents for each PSU shall be equal to the amount of cash which is paid as a dividend on one Share.  All such Dividend Equivalents shall be credited to Participant and be deemed to be reinvested in additional PSUs as of the date of payment of any such dividend based on the Fair Market Value of a Share on such date.  Each additional PSU which results from such deemed reinvestment of Dividend Equivalents granted hereunder shall be subject to the same vesting, distribution or payment, adjustment and other provisions which apply to the underlying PSU to which such additional PSU relates.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting of PSUs and Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Subject to Participant&#8217;s continued employment with the Company or a Subsidiary on each applicable vesting date and subject to the terms of this Agreement, the PSUs shall vest in such amounts and at such times as are set forth in the Grant Notice.  Each additional PSU which results from deemed reinvestments of Dividend Equivalents pursuant to Section 2.1(b) hereof shall vest whenever the underlying PSU to which such additional PSU relates vests.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In the event Participant incurs a Termination of Service, except as may be otherwise provided by Section 2.2(c), the Administrator or as set forth in a written agreement between Participant and the Company, Participant shall immediately forfeit any and all PSUs and Dividend Equivalents granted under this Agreement which have not vested or do not vest on or prior to the date on which such Termination of Service occurs, and Participant&#8217;s rights in any such PSUs and Dividend Equivalents which are not so vested shall lapse and expire. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;In the event a Participant incurs a Termination of Service due to an Approved Retirement, the Participant&#8217;s outstanding PSUs will not be forfeited upon such Approved Retirement, but instead outstanding PSUs shall continue to vest on the date(s) set out in the Grant Notice (provided all other terms which apply to the PSUs are met, including the terms regarding restricted activities set forth below). &#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Approved Retirement&#8221; means a Termination of Service designated by the Committee, in its absolute discretion, as an Approved Retirement.&#160; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;In exercising its discretion in designating a Termination of Service as an Approved Retirement, the Committee will strongly consider management recommendations based on each specific situation including the Participant's expressed commitment at the time of Termination of Service to cease any form of full-time paid work (including, but not limited to, self-employment&#59; agency work&#59; or employment), Participant's tenure of service, performance records throughout the Participant's employment or engagement&#160; by the Company or its Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;In the event the Company determines that a Participant who incurs a Termination of Service designated as an Approved Retirement commits a material breach of any fiduciary, confidentiality, non-disclosure, non-competition, non-solicitation, non-interference, non-disparagement obligations to the Company or its Subsidiaries (including without limitation, the Participant&#8217;s engagement in any Prohibited Activities), any portion of the PSUs unvested at such time shall be immediately forfeited for no consideration.&#160; For the purposes of this Section 2.2.c), &#8220;Prohibited Activities&#8221; shall mean the activities that are prohibited pursuant to any confidentiality agreement or covenant not to compete, not to solicit or hire employees, not to solicit or disrupt business relations, not to disparage the Company, its Subsidiaries or any of its or their officers and employees or any similar restrictions set out in any employment, severance or other written agreement then in effect between the Participant and the Company or one of its Subsidiaries. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;If no such agreement containing such restrictions is then in effect, the Participant will be deemed to be engaged in &#8220;Prohibited Activities&#8221; if the Participant, during the term of his or her employment or engagement or in the period during which any PSUs remain unvested following his or her Termination of Service, engages in any employment or business activities for him or herself or on behalf of any enterprise in any capacity or owns any interest in any entity which competes or is competitive with the business of the Company or any Subsidiary&#160; in any country in which the Company or its Subsidiaries </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">operate, in each case with which the Participant has been materially involved or for which the Participant was responsible in the 12 months immediately before his or her Termination of Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;In the event of a Change in Control that occurs following the Measure Date, the PSUs, to the extent not forfeited or otherwise vested immediately prior to such Change in Control, shall become fully vested immediately prior to, but subject to the consummation of, such Change in Control, subject to the Participant&#8217;s continuous employment with the Company or a Subsidiary through such Change in Control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Distribution or Payment of PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Participant&#8217;s PSUs shall be distributed in Shares (either in book-entry form or otherwise) or, at the option of the Company, paid in an amount of cash as set forth in Section 2.3(b), in either case, as soon as administratively practicable following the vesting of the applicable PSU pursuant to Section&#160;2.2 and the Grant Notice, and, in any event, within sixty (60) days following such vesting (for the avoidance of doubt, this deadline is intended to comply with the &#8220;short-term deferral&#8221; exemption from Section 409A of the Code).  Notwithstanding the foregoing, the Company may delay a distribution or payment in settlement of PSUs if it reasonably determines that such payment or distribution will violate Federal securities laws or any other Applicable Law, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such distribution or payment shall be made at the earliest date at which the Company reasonably determines that the making of such distribution or payment will not cause such violation, as required by Treasury Regulation Section 1.409A-2(b)(7)(ii), and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that no payment or distribution shall be delayed under this Section 2.3(a) if such delay will result in a violation of Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In the event that the Company determines in its discretion that due to regulatory or administrative needs it will make payment of Participant&#8217;s PSUs in cash, the amount of cash payable with respect to each PSU shall be equal to the Fair Market Value of a Share on the day immediately preceding the applicable distribution or payment date set forth in Section&#160;2.3(a).  All distributions made in Shares shall be made by the Company in the form of whole Shares, and any fractional share shall be distributed in cash in an amount equal to the value of such fractional share determined based on the Fair Market Value as of the date immediately preceding the date of such distribution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions to Issuance of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Company shall not be required to issue or deliver any certificate or certificates for any Shares or to cause any Shares to be held in book-entry form prior to the fulfillment of all of the following conditions&#58;  (A) the admission of the Shares to listing on all stock exchanges on which such Shares are then listed, (B) the completion of any registration or other qualification of the Shares under any state or federal law or under rulings or regulations of the Securities and Exchange Commission or other governmental regulatory body, which the Administrator shall, in its absolute discretion, deem necessary or advisable, and (C) the obtaining of any approval or other clearance from any state or federal governmental agency that the Administrator shall, in its absolute discretion, determine to be necessary or advisable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding any other provision of this Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Company and its Subsidiaries have the authority to deduct or withhold, or require Participant to remit to the Company or the applicable Subsidiary, an amount sufficient to satisfy any applicable federal, state, local and foreign taxes (including income tax, employees&#8217; (and at the discretion of the Company, employer&#8217;s) National Insurance contributions, social security contributions and the employee portion of any FICA obligation, or any equivalent taxes in any jurisdiction) required by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:120%">law to be withheld, paid or otherwise arising with respect to any taxable event arising pursuant to this Agreement, including the grant or vesting of any PSUs, the settlement of the PSUs on vesting in either Shares or cash and the sale of any of the Shares (any a &#8220;</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Tax Liability</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company and its Subsidiaries may withhold or Participant may make such payment in one or more of the forms specified below&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;by cash or check made payable to the Company or the Subsidiary with respect to which the withholding obligation arises&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;by the deduction of such amount from other compensation payable to Participant&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;with respect to any withholding taxes arising in connection with the distribution of the PSUs, by the Company withholding a net number of vested Shares otherwise issuable pursuant to the PSUs having a then current Fair Market Value not exceeding the amount necessary to satisfy the Tax Liability based on the minimum applicable statutory rates for such Tax Liability or such other rate as does not result in adverse accounting consequences for the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;with respect to any withholding taxes arising in connection with the distribution of the PSUs, with the consent of the Administrator, by tendering to the Company vested Shares having a then current Fair Market Value not exceeding the amount necessary to satisfy the Tax Liability based on the minimum applicable statutory rates for such Tax Liability or such other rate as does not result in adverse accounting consequences for the Company&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;with respect to any withholding taxes arising in connection with the distribution of the PSUs, through the delivery of a notice that Participant has placed a market sell order with a broker acceptable to the Company with respect to Shares then issuable to Participant pursuant to the PSUs, and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the Company or the Subsidiary with respect to which the Tax Liability arises in satisfaction of such Tax Liability&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that payment of such proceeds is then made to the Company or the applicable Subsidiary at such time as may be required by the Administrator, but in any event not later than the settlement of such sale&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vi)&#160;&#160;&#160;&#160;in any combination of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Company shall not be obligated to deliver any certificate representing Shares issuable with respect to the PSUs to, or to cause any such Shares to be held in book-entry form by, Participant or his or her legal representative unless and until Participant or his or her legal representative shall have paid or otherwise satisfied in full the amount of all federal, state, local and foreign taxes applicable with respect to the taxable income of Participant resulting from the vesting or settlement of the PSUs or any other taxable event related to the PSUs, provided that no payment shall be delayed under this Section 2.5(d) if such delay will result in a violation of Section 409A of the Code. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;With respect to any Tax Liability arising in connection with the PSUs, in the event Participant fails to provide timely payment of all sums required pursuant to Section&#160;2.5(a), the Company shall have the right and option, but not the obligation, to treat such failure as an election by Participant to satisfy all or any portion of Participant&#8217;s required payment obligation pursuant to Section&#160;2.5(a)(ii) or Section&#160;2.5(a)(iii) above, or any combination of the foregoing as the Company may determine to be appropriate. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;In the event any Tax Liability arising in connection with the PSUs will be satisfied under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Section&#160;2.5(a)(iii)</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then the Company may elect to instruct any brokerage firm determined acceptable to the Company for such purpose to sell on Participant&#8217;s behalf a whole number of shares from those Shares then issuable to Participant pursuant to the PSUs as the Company determines to be appropriate to generate cash proceeds sufficient to satisfy the Tax Liability and to remit the proceeds of such sale to the Company or the Subsidiary.  Participant&#8217;s acceptance of this Award constitutes Participant&#8217;s instruction and authorization to the Company and such brokerage firm to complete the transactions described in this Section 2.5(d), including the transactions described in the previous sentence, as applicable.  The Company may refuse to issue any Shares in settlement of the PSUs to Participant until the foregoing Tax Liability is satisfied,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that no payment shall be delayed under this Section 2.5(d) if such delay will result in a violation of Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Participant is ultimately liable and responsible for and indemnifies the Company and each Subsidiary against all Tax Liability arising in connection with the PSUs, regardless of any action the Company or any Subsidiary takes with respect to any tax withholding obligations that arise in connection with the PSUs.  Neither the Company nor any Subsidiary makes any representation or undertaking regarding the treatment of any tax withholding in connection with the awarding, vesting or payment of the PSUs or the subsequent sale of Shares.  The Company and the Subsidiaries do not commit and are under no obligation to structure the PSUs to reduce or eliminate any Tax Liability.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Rights as Shareholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Neither Participant nor any person claiming under or through Participant will have any of the rights or privileges of a shareholder of the Company in respect of any Shares deliverable hereunder unless and until certificates representing such Shares (which may be in book-entry form) will have been issued and recorded on the records of the Company or its transfer agents or registrars, and delivered to Participant (including through electronic delivery to a brokerage account).  Except as otherwise provided herein, after such issuance, recordation and delivery, Participant will have all the rights of a shareholder of the Company with respect to such Shares, including, without limitation, the right to receipt of dividends and distributions on such Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Compensation Recoupment Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The grant of this Award is subject to the terms of the LivaNova Compensation Recoupment Policy, as it may provide from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require the Participant to repay or forfeit cash or equity awards, including this Award, or any ordinary shares or other cash or property received with respect to this and other awards, including any value received from a disposition of the ordinary shares acquired upon payment in respect of the awards.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE III.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OTHER PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Administrator shall have the power to interpret the Sub-Plan, the Grant Notice, this Agreement and the Foreign Appendix, if applicable, and to adopt such rules for the administration, interpretation and application of the Sub-Plan, the Grant Notice, this Agreement and the Foreign Appendix, if applicable, as are consistent therewith and to interpret, amend or revoke any such rules.  All actions taken and all interpretations and determinations made by the Administrator will be final and binding upon Participant, the Company and all other interested persons.  To the extent allowable pursuant to Applicable Law, no member of the Committee or the Board will be personally liable for any action, determination or interpretation made with respect to the Sub-Plan, the Grant Notice, this Agreement or the Foreign Appendix, if applicable.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">PSUs Not Transferable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The PSUs may not be sold, pledged, assigned or transferred in any manner other than by will or the laws of descent and distribution, unless and until the Shares underlying the PSUs have been issued, and all restrictions applicable to such Shares have lapsed.  No PSUs or any interest or right therein or part thereof shall be liable for the debts, contracts or engagements of Participant or his or her successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy), and any attempted disposition thereof shall be null and void and of no effect, except to the extent that such disposition is permitted by the preceding sentence.  Notwithstanding the foregoing, with the consent of the Administrator, the PSUs may be transferred to certain persons or entities related to the Participant, including but not limited to members of Participant&#8217;s family, charitable institutions or trusts or other entities whose beneficiaries or beneficial owners are members of Participant&#8217;s family or to such other persons or entities as may be expressly approved by the Administrator, pursuant to any such conditions and procedures the Administrator may require.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Administrator may accelerate the vesting of all or a portion of the PSUs in such circumstances as it, in its sole discretion, may determine.  Participant acknowledges that the PSUs and the Shares subject to the PSUs are subject to adjustment, modification and termination in certain events as provided in this Agreement and the Sub-Plan, including Section 13 of the Sub-Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of the Company at the Company&#8217;s principal office, and any notice to be given to Participant shall be addressed to Participant at Participant&#8217;s last address reflected on the Company&#8217;s records.  By a notice given pursuant to this Section 3.4, either party may hereafter designate a different address for notices to be given to that party.  Any notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Titles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.   The laws of the State of Delaware shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Conformity to Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Participant acknowledges that the Sub-Plan, the Grant Notice, this Agreement and the Foreign Appendix, if applicable, are intended to conform to the extent necessary with all Applicable Laws, including, without limitation, the provisions of the Securities Act and the Exchange Act, and any and all regulations and rules promulgated thereunder by the Securities and Exchange Commission, and state securities laws and regulations and to the extent deemed applicable by the Administrator, the provisions of the Listing Rules of the London Stock Exchange published by the UK Listing Authority. Notwithstanding anything herein to the contrary, the Sub-Plan shall be administered, and the PSUs are granted, only in such a manner as to conform to Applicable Law.  To the extent permitted by Applicable Law, the Sub-Plan and this Agreement shall be deemed amended to the extent necessary to conform to Applicable Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment, Suspension and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  To the extent permitted by the Sub-Plan, this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">time or from time to time by the Administrator or the Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">, provided however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, except as may otherwise be provided by the Sub-Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect the PSUs in any material way without the prior written consent of Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company.  Subject to the restrictions on transfer set forth in Section 3.2 and the Sub-Plan, this Agreement shall be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Limitations Applicable to Section 16 Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding any other provision of the Sub-Plan or this Agreement, if Participant is subject to Section 16 of the Exchange Act, the Sub-Plan, the PSUs (including PSUs which result from the deemed reinvestment of Dividend Equivalents), the Dividend Equivalents, the Grant Notice, this Agreement and the Foreign Appendix, if applicable, shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule.  To the extent permitted by Applicable Law, this Agreement shall be deemed amended to the extent necessary to conform to such applicable exemptive rule.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Not a Contract of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Nothing in this Agreement or in the Sub-Plan shall confer upon Participant any right to continue to serve as an employee of the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the employment of Participant at any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and Participant. Neither the Sub-Plan, the Grant Notice, the Foreign Appendix, if applicable, nor this Agreement afford the Participant any rights to compensation or damages, including for loss of or potential loss that the Participant may suffer as a result of the termination of the Sub-Plan, lapse of the PSUs or the termination of the Participant&#8217;s employment with the Company. Neither the Sub-Plan, the Grant Notice, this Agreement nor the Foreign Appendix, if applicable, afford the Participant any rights to compensation or damages including for loss or potential loss that the Participant may suffer as a result of the termination of the Sub-Plan, lapse of the PSU or the termination of the Participant&#8217;s employment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">PSUs Not Part of Employment Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The PSUs and the Shares subject to the PSUs are extraordinary items that do not constitute part of normal or expected wages or salary for any purposes, including, but not limited to, calculation of any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, holiday pay, long-service awards, pension or retirement benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company, the employer, its parent, or any Subsidiary or affiliate of the Company. In addition, Participant acknowledges that by electronically signing the Grant Notice and this Agreement that the grant of the Award is at the Company&#8217;s sole discretion based on the Sub-Plan, and does not entitle the Participant to further grant(s) of Awards, nor to claim for further grant(s) of Awards, in respect of the Sub-Plan or any other award(s) under any other plan or program maintained by the Company or any Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Data Protection</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. By electronically signing the Grant Notice and this Agreement, the Participant acknowledges and agrees that&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the Company, a Subsidiary or the Participant&#8217;s employer are permitted to hold and process personal information (including sensitive personal information) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) about the Participant as part of their personnel and other business records and may use such information for the purpose of managing and administering the Sub-Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Company, a Subsidiary or the Participant&#8217;s employer may disclose the Data (as described in (a) above) to third parties in the event that such disclosure is in the Company&#8217;s view required for the proper conduct of the Sub-Plan. The Company may also make the Data available to public authorities where required under locally applicable law. These recipients may be located in the United States, the European Economic Area, or elsewhere, which the Participant separately and expressly consents to, accepting that outside the European Economic Area, data protection laws are less protective than within&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;they may, at any time, review Data, require any necessary amendments to it or withdraw their consent herein by contacting the Company in writing, however, the Participant withdrawing their consent may affect their ability to participate in the Sub-Plan and receive the benefits intended pursuant to the Grant Notice and this Agreement&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Data will only be held as long as necessary to implement, administer and manage the Participant&#8217;s participation in the Sub-Plan and any subsequent claims or rights&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;this section applies to any information held, used or disclosed in any medium.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Sub-Plan, the Grant Notice and this Agreement (including any exhibit&#160;hereto) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company, the Subsidiaries and Participant with respect to the subject matter hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Award is not intended to constitute &#8220;nonqualified deferred compensation&#8221; within the meaning of Section 409A of the Code (together with any Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the date hereof, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  However, notwithstanding any other provision of the Sub-Plan, the Grant Notice, this Agreement or the Foreign Appendix, if applicable, if at any time the Administrator determines that this Award (or any portion thereof) may be subject to Section 409A, the Administrator shall have the right in its sole discretion (without any obligation to do so or to indemnify Participant or any other person for failure to do so) to adopt such amendments to the Sub-Plan, the Grant Notice or this Agreement, or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, as the Administrator determines are necessary or appropriate for this Award either to be exempt from the application of Section 409A or to comply with the requirements of Section 409A. Notwithstanding anything herein to the contrary, no provision of the Sub-Plan shall be interpreted or construed to transfer any liability for failure to comply with the requirements of Section&#160;409A from Participant or any other person to the Company or any of its Subsidiaries, employees or agents.   Without limiting the foregoing and notwithstanding anything contained herein to the contrary, to the extent required in order to avoid an accelerated or additional tax under Section 409A, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to this Agreement during the six-month period immediately following the Participant&#8217;s separation from service shall instead be paid on the first business day after the date that is six months following the Participant&#8217;s separation from service (or, if earlier, the Participant&#8217;s date of death). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement Severable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In the event that any provision of the Grant Notice or this Agreement is held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of the Grant Notice or this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Limitation on Participant&#8217;s Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Participation in the Sub-Plan confers no rights or interests other than as herein provided.  This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust.  Neither the Sub-Plan nor any underlying program, in and of itself, has any assets.  Participant shall have only the rights of a general unsecured creditor of the Company with respect to amounts credited and benefits payable, if any, with respect to the PSUs and Dividend Equivalents, and rights no greater than the right to receive Shares or cash as a general unsecured creditor with respect to the PSUs, as and when settled pursuant to the terms hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.18&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Grant Notice may be executed in one or more counterparts, including by way of any electronic signature, subject to Applicable Law, each of which shall be deemed an original and all of which together shall constitute one instrument.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.19&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Special Provisions for PSUs Granted to Participants Outside the U.S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  If Participant performs services for the Company or any Subsidiary outside of the United States, the PSUs shall be subject to the special provisions, if any, for Participant&#8217;s country of residence, as set forth in the Foreign Appendix.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;If Participant relocates to one of the countries included in the Foreign Appendix during the life of this Award, the special provisions for such country shall apply to Participant, to the extent the Company determines that the application of such provisions is necessary or advisable in order to comply with local law or facilitate the administration of the Sub-Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Company reserves the right to impose other requirements on this Award and any Shares received upon settlement of the PSUs, to the extent the Company determines it is necessary or advisable in order to comply with local laws or facilitate the administration of the Sub-Plan, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.20&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Broker-Assisted Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In the event of any broker-assisted sale of Shares in connection with the payment of withholding taxes as provided in Section 2.5(a)(iii) or Section 2.5(d)&#58; (A) any Shares to be sold through a broker-assisted sale will be sold on the day the tax withholding obligation arises or as soon thereafter as practicable&#59; (B) such Shares may be sold as part of a block trade with other participants in the Sub-Plan in which all participants receive an average price&#59; (C) Participant will be responsible for all broker&#8217;s fees and other costs of sale, and Participant agrees to indemnify and hold the Company harmless from any losses, costs, damages, or expenses relating to any such sale&#59; (D) to the extent the proceeds of such sale exceed the applicable tax withholding obligation, the Company agrees to pay such excess in cash to Participant as soon as reasonably practicable&#59; (E) Participant acknowledges that the Company or its designee is under no obligation to arrange for such sale at any particular price, and that the proceeds of any such sale may not be sufficient to satisfy the applicable tax withholding obligation&#59; and (F) in the event the proceeds of such sale are insufficient to satisfy the applicable tax withholding obligation, Participant agrees to pay immediately upon demand to the Company or its Subsidiary with respect to which the withholding obligation arises an amount in cash sufficient to satisfy any remaining portion of the Company&#8217;s or the applicable Subsidiary&#8217;s withholding obligation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">* * * * *</font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT B</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">TO PERFORMANCE STOCK UNIT award GRANT NOTICE</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SPECIAL PROVISIONS FOR PERFORMANCE STOCK UNITS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GRANTED TO PARTICIPANTS OUTSIDE THE U.S.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Exhibit B includes special terms and conditions applicable to Participants in the countries below.  These terms and conditions are in addition to those set forth in the PSU Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and the Sub-Plan and to the extent there are any inconsistencies between these terms and conditions and those set forth in the Agreement or the Sub-Plan, these terms and conditions shall prevail.  Any capitalized term used in this Exhibit B without definition shall have the meaning ascribed to such term in the Sub-Plan or the Agreement, if applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Foreign Appendix also includes information relating to exchange control and other issues of which Participant should be aware with respect to his or her participation in the Sub-Plan.  The information is based on the exchange control, securities and other laws in effect in the respective countries as at May 2017.  Such laws are often complex and change frequently.  As a result, the Company strongly recommends that Participant not rely on the information herein as the only source of information relating to the consequences of participation in the Sub-Plan because the information may be out of date at the time the PSUs are settled or any Shares acquired under the Sub-Plan are sold.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, the information is general in nature and may not apply to the particular situation of Participant, and the Company is not in a position to assure Participant of any particular result.  Accordingly, Participant is advised to seek appropriate professional advice as to how the relevant laws in his or her country may apply to his or her situation.  Finally, if Participant is a citizen or resident of a country other than the one in which he or she is currently working, the information contained herein may not be applicable to Participant.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">AUSTRALIA</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A copy of the Sub-Plan is enclosed with this Grant Notice and Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">The Sub-Plan, the Agreement and this Grant Notice do not constitute financial advice</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any advice given by the Company in relation to the Grant Notice, the Agreement, the Sub-Plan, the PSUs or the Shares does not constitute financial advice and does not take into account your objectives, financial situation and needs.  In considering the PSUs and the amount of cash and&#47;or Shares that you will receive on vesting of the PSUs, you should consider the risk factors that could affect the performance of the Company and the value of PSUs and Shares, which value can increase or decrease from time to time, and the amount of any Tax Liability.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You should carefully consider these risks in light of your investment objectives, financial situation and particular needs (including financial and tax issues).  You should seek professional guidance from your stockbroker, solicitor, accountant, financial adviser or other independent professional adviser before deciding whether to acquire PSUs or Shares.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">How to calculate values in Australian dollars</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Your PSUs will vest in accordance with the Grant Notice and the Agreement (which require certain conditions to be met) and are subject to a four year graded vesting schedule. The PSUs may result in Shares or cash being given to you, in accordance with the Grant Notice. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You will not be required to pay any amount for the PSUs or any Shares that will be issued to you upon vesting. However the amount of cash or number of Shares you receive will depend on the market price of Shares at the time and the amount of any Tax Liability in connection with the grant and vesting of the PSUs and the issue of any Shares. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You can ascertain the market price of a Share in the Company in United States Dollars (&#8220;USD&#8221;) from time to time by visiting either&#58; </font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the Company&#8217;s website (http&#58;&#47;&#47;www.livanova.com&#47;investor-relations&#47;stock-information)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the NASDAQ website (http&#58;&#47;&#47;www.nasdaq.com&#47;symbol&#47;livn).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To determine the market value of a Share in Australian Dollars (&#8220;AUD&#8221;), you will need to apply the prevailing USD&#160;&#58;&#160;AUD exchange rate.  For example, if the exchange rate is 1&#160;USD&#160;&#58;&#160;1.5&#160;AUD, and one share of Common Stock has a value of USD $1 on the NASDAQ, its equivalent value will be AUD $1.50.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">CANADA</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Unless otherwise determined by the Administrator, Participant&#8217;s PSUs shall only be distributed in Shares (either in book-entry form or otherwise), and no portion of the Participant&#8217;s PSUs shall be payable to the Participant in cash. </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">CHINA</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Unless otherwise determined by the Administrator, Participant&#8217;s PSUs shall only be settled in cash, and no portion of the Participant&#8217;s PSUs shall be distributed in Shares. </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">FRANCE</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">If the Participant is employed by a French subsidiary of the Group, the terms and conditions provided in the French Sub-Plan will apply, in addition to the terms set out below. References in the Agreement to &#8220;Sub-Plan&#8221; shall be references to the &#8220;French Sub-Plan&#8221; and references in the Agreement to Performance Stock Units (PSU) shall be references to Restricted Stock Units (RSU) per the French Sub-Plan</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Participant&#8217;s PSUs shall only be distributed in Shares (either in book-entry form or otherwise), and no portion of the Participant&#8217;s PSUs shall be payable to the Participant in cash.  Participant cannot benefit from any Dividend Equivalent provided for under Sections 2.1 and 2.2 of the Agreement.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">The following paragraph is inserted at Section 2.7 of the Agreement</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">2.7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Holding Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#58; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:5.8pt">In accordance with section 6 of the French Sub-Plan, Shares delivered to the Participant prior to the end of the second anniversary of the Grant Date cannot be transferred prior to the first anniversary of their Delivery Date (i.e., the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Holding Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;) (as such terms are defined in the French Sub-Plan).</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:5.18pt">In the event that the Participant does not comply with section 2.7(a) of the Agreement, the Participant will only be responsible for reimbursing the French Subsidiary for any tax liability which is has or will incur as a result of such non-compliance, excluding for the avoidance of doubt any employer social security contributions. The Participant agrees to indemnify and keep indemnified the French Subsidiary in respect of such a tax liability. </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:5.8pt">If the Participant wishes to transfer Shares during the Holding Period, the Participant must give written notice of the proposed transfer to the Company as soon as reasonably practicable, and in any event at least 3 business days in advance of the proposed transfer.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:5.18pt">The Participant acknowledges that if the Participant wishes to sell Shares during the Holding Period, such sale will be undertaken by Merrill Lynch through the Participant&#8217;s limited purpose brokerage account at Merrill Lynch and will not be valid for any other broker dealer. The Participant acknowledges that such sale will be subject to sales commission and fees, which will be deducted from the sale proceeds and the residual balance will be deposited in the Participant&#8217;s Merrill Lynch brokerage account. </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:5.8pt">The Participant acknowledges that Merrill Lynch may execute such order&#58; (a) in a single transaction or multiple transactions during the course of the trading day, or (b) it may aggregate the order with other orders for other sellers of LivaNova plc securities, execute them as a block or in multiple smaller transactions, and allocate an average price to each seller. The Participant further acknowledges that the sale instruction will not be accepted by Merrill Lynch and the order will not be executed until the Participant opens a limited purpose brokerage account. The Participant acknowledges that the order will be executed in their limited purpose account and will be subject to the terms and conditions that they agree to for that account. The current terms and conditions of the limited purpose account can be found on Benefits Online&#174;. </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:7.02pt">The Participant agrees that Merrill Lynch may discuss with and disclose to LivaNova plc any information relating to their account for the purposes of any sale transaction.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Section 3.13 shall be deleted in its entirety and replaced by the following&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant&#8217;s personal &#8220;Data&#8221; (as defined below) by the Company for the exclusive purpose of implementing, administering and managing Participant&#8217;s participation in the Sub-Plan. Participant understands that the Company holds certain personal information about Participant&#58; Participant&#8217;s name, home address and telephone number, date of birth, employee identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all options or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">outstanding in Participant&#8217;s favor, for the purpose of implementing, administering and managing the Sub-Plan (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Participant understands that Data will be transferred to such stock plan service providers as may be selected by the Company which are assisting the Company with the implementation, administration and management of the Sub-Plan. Participant understands that the recipients of the Data may be located in the United States or elsewhere (and, if Participant is a resident of a member state of the European Union, may be outside the European Economic Area) and that the recipient&#8217;s country (e.g., the United States) may have different data privacy laws and protections than Participant&#8217;s country. Participant understands that he or she may request a list with the names and addresses of all recipients of the Data by contacting his or her local human resources representative.  Participant authorizes the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Sub-Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing Participant&#8217;s participation in the Sub-Plan.  Participant understands that Data will be held only as long as is necessary to implement, administer and manage Participant&#8217;s participation in the Sub-Plan.  The Company may also make the Data available to public authorities where required under locally applicable law.  Participant understands that he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing Participant&#8217;s local human resources representative.  Participant understands, however, that refusing or withdrawing consent may affect Participant&#8217;s ability to participate in the Sub-Plan.  For more information on the consequences of refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local human resources representative.  This Section applies to information held, used or disclosed in any medium.</font></div><div style="margin-bottom:10pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">GERMANY</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Definition of &#8220;Tax Liability&#8221; in Section 2.5&#58; </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">For the avoidance of doubt, the definition of &#8220;Tax Liability&#8221; shall only include the employee portions of the social security contributions. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">The following sentence is inserted at Section 3.1 of the Agreement</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">For the avoidance of doubt, the Administrator&#8217;s decisions and interpretations shall be subject to reasonable discretion.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">The heading of Section 3.12 shall be supplemented and read as follows&#58; </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Section 3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">PSUs Not Part of Employment Compensation, No Legal Claim to Grant(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Section 3.13 shall be deleted in its entirety and replaced by the following&#58;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Section 3.13   Consent to Personal Data Processing and Transfer. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">By signing these terms and conditions, Participant acknowledges and agrees that&#58; </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;the Company and the Participant&#8217;s employer may collect, store, process and use certain personal data of Participant and may further transfer them to Cyberonics, Inc., a wholly-owned subsidiary of LivaNova PLC, located at 100 Cyberonics Blvd, Houston, TX 77058, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">U.S.A., and Certent, Inc., the Company&#8217;s equity compensation management vendor, located at 1548 Eureka Rd., Suite 100, Roseville, CA 95661, U.S.A., and Merrill Lynch, Pierce, Fenner &#38; Smith, Incorporated, a wholly-owned subsidiary of Bank of America Corporation, the Company&#8217;s broker for equity compensation management and transactions, located at World Financial Center, 220 Vesey Street, New York, NY 10281 for the exclusive purpose of implementing, administering, managing and accounting Participant&#8217;s participation in the Sub-Plan&#59; </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;personal data of Participant are&#58; first name&#47;s and last name, birth date, gender, family status, home address, job title, working location, e-mail addresses and phone numbers, social security and tax numbers, tax class, cash compensation and equity award compensation (the &#8220;Data&#8221;)&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:35.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;this section applies to any Data held, used or disclosed in any medium&#59; </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:70.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%"> (d)&#160;&#160;&#160;&#160;the Data will be transferred to the locations listed in subparagraph (a) above, and locations outside of the European Economic Area who provide for a lesser level of data protection than locations within&#59; </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:70.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(e)&#160;&#160;&#160;&#160;Data will only be held as long as necessary to implement, administer, manage and account Participant&#8217;s participation in the Sub-Plan and any subsequent claims or rights&#59; </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%"> (f) &#160;&#160;&#160;&#160;the consent to the personal data processing as described in this Section 3.13 is entirely voluntary and can be withdrawn at any time&#59; Participant is advised, however, that missing consent in written form may affect his ability to participate in the Sub-Plan and receive benefits intended pursuant to the Grant Notice, the Agreement and the Foreign Appendix. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Name of Participant&#58; &#160;&#160;&#160;&#160;___________________________</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Place&#47;Date&#58; _____________________________________</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Participant&#8217;s Signature&#58; ___________________________</font></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">UNITED KINGDOM</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">The following paragraph is inserted as Section 2.5 (f) of the Agreement</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Participant agrees that if the Participant does not pay his&#47;her employer or the Company does not withhold from the Participant the full amount of any Tax Liability within ninety (90) days after the end of the tax year in which the Tax Liability occurred, or such other period specified in Section 222 (1)(c) of Income Tax (Earnings and Pensions) Act 2003, then the amount that should have been withheld shall constitute a loan owed by the Participant to the employer, effective 90 days after the end of the tax year in which the Tax Liability occurred. The Participant agrees that the loan will bear interest at the official rate of HMRC and will be immediately due and repayable by the Participant, and the Company and&#47;or the employer may recover it at any time thereafter by&#58; (a) withholding the funds from salary, bonus or any other funds due to the Participant by the Company or the employer&#59; (b) withholding the Shares issued upon vesting and settlement of the PSUs or from the cash proceeds from </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the sale of Shares&#59; or (c) demanding cash or a cheque from the Participant. The Participant also authorizes the Company to delay the issuance of any Shares to the Participant unless and until the loan is repaid in full.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>livn-20200930xex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="iaee45b8b84094890a9d3ffb2564bfa1e_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT 10.3</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">LIVANOVA PLC</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2015 INCENTIVE AWARD SUB-PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">STOCK APPRECIATION RIGHT GRANT NOTICE AND </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">STOCK APPRECIATION RIGHT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LivaNova PLC, a public limited company incorporated under the laws of England and Wales (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), pursuant to its 2015 Incentive Award Plan (including where relevant the Sub-Plan for UK Participants), as amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Sub-Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), hereby grants to the holder listed below (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) an award of stock appreciation rights over the number of ordinary shares of the Company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) set forth below (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Upon exercise, each SAR represents the right to receive an amount equal to the Fair Market Value of one Share on the date of exercise less the Exercise Price per Share set forth below.  Payment of such amount shall be in cash, Shares (based on their Fair Market Value as of the date the SAR is exercised) or a combination of both, as determined by the Administrator.   The SARs are subject to the terms and conditions set forth in this SAR Grant Notice (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the SAR Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Sub-Plan and the special provisions for Participant&#8217;s country of residence, if any, attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Foreign Appendix</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), each of which is incorporated herein by reference.  Unless otherwise defined herein, the terms defined in (or by reference in) the Sub-Plan shall have the same defined meanings in this Grant Notice and the Agreement.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:31.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Participant&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:700;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline"> </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;__________________&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Grant Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;__________________&#93;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Exercise Price Per Share&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">$&#91;______&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Total Number of Shares Subject to SARs&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;___________________&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Expiration Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;__________________&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Vesting Schedule&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to the terms and conditions of the Agreement, the SARs shall vest as follows&#58; </font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#91;__________________&#93;</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By clicking the &#8220;ACCEPT&#8221; button, the Participant and the Company agree to be bound by the terms and conditions of the Sub-Plan, the Agreement, the Foreign Appendix, if applicable, and this Grant Notice all of which the Participant can access through a link from the Grant Notice.  The Participant has reviewed the Sub-Plan, the Agreement, the Foreign Appendix, if applicable, and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to electronically signing the Grant Notice and this Agreement and fully understands all provisions of this Grant Notice, the Agreement, the Foreign Appendix, if applicable, and the Sub-Plan.  The Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Sub-Plan, this Grant Notice, the Foreign Appendix, if applicable or the Agreement.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By clicking &#34;ACCEPT&#34; you confirm that you understand and agree to be bound by the provisions below. This will apply where the Company elects that any tax liability arising in respect of your SARs shall be satisfied pursuant to Section 4.5(a)(v) of the Agreement.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I understand that by clicking &#8216;Accept,&#8217; I am instructing Merrill Lynch to execute my order to sell shares of LivaNova plc common stock at market price to obtain cash for payment of any withholding taxes due as a result of the vesting or payment of my stock appreciation rights (&#34;SARs&#34;) equity award(s) (&#8220;Tax&#8221;), including any previously vested SAR awards that are currently pending settlement (1) or outstanding unvested SAR awards (2). This instruction will only be valid for my limited purpose brokerage account at Merrill Lynch and will not be valid for any other broker dealer. Merrill Lynch will sell an amount of shares on the next trading day after the vest or payment date of my SAR equity award(s) based on dividing the sum of the Tax and estimated sales commissions and fees, plus 2% to help ensure that enough shares are sold to cover the Tax (i.e., &#91;Tax + commissions + fees&#93; x 1.02) by the closing share price on the trading day prior to the sale date. If the initial sale does not result in sufficient cash to pay my Tax, Merrill Lynch will sell additional shares at market price based on dividing the sum of the residual unpaid Tax and estimated commissions and fees, plus 6% to ensure that enough shares are sold to cover the Tax (i.e., &#91;residual unpaid Tax + commissions + fees&#93; x 1.06) by the then current market price. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Any residual cash after payment of the Tax, commissions and fees will be deposited into my Merrill Lynch brokerage account. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Merrill Lynch may execute my order&#58; (a) in a single transaction or multiple transactions during the course of the trading day, or (b) it may aggregate my order with other orders for other sellers of LivaNova plc securities, execute them as a block or in multiple smaller transactions, and allocate an average price to each seller. I understand that this instruction will not be accepted by Merrill Lynch and my order will not be executed until I open my limited purpose brokerage account. I also understand that this order will be executed in my limited purpose account and will be subject to the terms and conditions that I agree to for that account. The current terms and conditions of the limited purpose account can be found on Benefits Online&#174;. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I permit Merrill Lynch to discuss with and disclose to LivaNova plc any information relating to my account for the purposes of this transaction. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">You must also check your W-9 or W-8 tax certification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">to confirm it will be in effect on the sale date(s). </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(1) You can view previously vested awards that are currently pending settlement by accessing the Pending Activity page located within the Grant Information Dropdown on Benefits Online&#174;. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(2) You can view outstanding unvested awards by accessing the Grant Detail page which is accessible when viewing additional details of an award from the Grant Summary page on Benefits Online&#174;. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">You can view the current status of your W-9 or W-8 by accessing the Participant&#47;Tax Profile page located within the Individual&#47;Plan Information Dropdown on Benefits Online&#174;.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="iaee45b8b84094890a9d3ffb2564bfa1e_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TO STOCK APPRECIATION RIGHT GRANT NOTICE</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">STOCK APPRECIATION RIGHT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the Stock Appreciation Right Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) to which this Stock Appreciation Right Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) is attached, LivaNova PLC, a public limited company incorporated under the laws of England and Wales (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) has granted to Participant Stock Appreciation Rights (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) under the Company&#8217;s 2015 Incentive Award Plan (including where relevant the Sub-Plan for UK Participants), as amended from time to time (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Sub-Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34;) over the number of Shares set forth in the Grant Notice.  </font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE I.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GENERAL</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Capitalized terms not specifically defined herein shall have the meanings specified in the Sub-Plan or the Grant Notice.  For purposes of this Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;&#8220;Disability&#8221; shall be defined as in Participant&#8217;s employment letter or agreement with the Company or a Subsidiary, as amended from time to time, or if Participant is not a party to such a letter or agreement or such letter or agreement does not contain such a definition, shall mean Participant&#8217;s inability to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that can be expected to last for a continuous period of not less than 12 months.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Incorporation of Terms of Sub-Plan and Foreign Appendix</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The SARs and the Shares issued to the Participant hereunder are subject to the terms and conditions set forth in the Sub-Plan and the Foreign Appendix, if applicable, each of which is incorporated herein by reference, as well as this Agreement.  In the event of any inconsistency between the Sub-Plan and this Agreement, the terms of the Sub-Plan shall control.  In the event of any inconsistency between the Sub-Plan and&#47;or this Agreement with the Foreign Appendix, the terms of the Foreign Appendix shall control.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE II.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GRANT OF SARS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Grant of SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In consideration of Participant&#8217;s past and&#47;or continued employment with the Company or a Subsidiary and for other good and valuable consideration, effective as of the grant date set forth in the Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Company has granted to Participant the SARs over the aggregate number of Shares set forth in the Grant Notice, upon the terms and conditions set forth in the Grant Notice, the Sub-Plan, the Foreign Appendix, if applicable, and this Agreement, subject to adjustment as provided in Section 13.2 of the Sub-Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise Price.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  The exercise price per share of the Shares covered by the SARs (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) shall be as set forth in the Grant Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Consideration to the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In consideration of the grant of the SARs by the Company, Participant agrees to render faithful and efficient services to the Company or any Subsidiary. Nothing in the Sub-Plan, the Grant Notice, the Foreign Appendix, if applicable or this Agreement shall confer upon Participant any right to continue in the employ of the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the Company and the Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the employment of Participant at any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and Participant.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE III.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PERIOD OF EXERCISABILITY</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Commencement of Exercisability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Subject to Participant&#8217;s continued employment with the Company or a Subsidiary on each applicable vesting date and subject to Sections 3.1(b), (c), (d), 3.2 and 3.3 hereof, the SARs shall become vested and exercisable in such amounts and at such times as are set forth in the Grant Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In the event a Participant incurs a Termination of Service due to an Approved Retirement, the Participant&#8217;s outstanding SARs will not be forfeited upon such Approved Retirement, but instead outstanding SARs shall continue to vest on the date(s) set out in the Grant Notice (provided all other terms which apply to the SARs are met, including the terms regarding restricted activities set forth below). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Approved Retirement&#8221; means a Termination of Service designated by the Committee, in its absolute discretion, as an Approved Retirement.&#160; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;In exercising its discretion in designating a Termination of Service as an Approved Retirement, the Committee will strongly consider management recommendations based on each specific situation including the Participant's expressed commitment at the time of Termination of Service to cease any form of full-time paid work (including, but not limited to, self-employment&#59; agency work&#59; or employment), Participant's tenure of service, performance records throughout the Participant's employment or engagement&#160; by the Company or its Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;In the event the Company determines that a Participant who incurs a Termination of Service designated as an Approved Retirement commits a material breach of any fiduciary, confidentiality, non-disclosure, non-competition, non-solicitation, non-interference, non-disparagement obligations to the Company or its Subsidiaries (including without limitation, the Participant&#8217;s engagement in any Prohibited Activities), any portion of the SARs unvested at such time shall be immediately forfeited for no consideration.&#160; For the purposes of this Section  3.1(b), &#8220;Prohibited Activities&#8221; shall mean the activities that are prohibited pursuant to any confidentiality agreement or covenant not to compete, not to solicit or hire employees, not to solicit or disrupt business relations, not to disparage the Company, its Subsidiaries or any of its or their officers and employees or any similar restrictions set out in any employment, severance or other written agreement then in effect between the Participant and the Company or one of its Subsidiaries. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If no such agreement containing such restrictions is then in effect, the Participant will be deemed to be engaged in &#8220;Prohibited Activities&#8221; if the Participant, during the term of his or her employment or engagement or in the period during which any SARs remain unvested following his or her Termination of Service, engages in any employment or business activities for him or herself or on behalf of any enterprise in any capacity or owns any interest in any entity which competes or is competitive with the business of the Company or any Subsidiary&#160; in any country in which the Company or its Subsidiaries operate, in each case with which the Participant has been materially involved or for which the Participant was responsible in the 12 months immediately before his or her Termination of Service..</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;In the event of a Change in Control that occurs following the Grant Date, the SARs shall become fully vested and exercisable immediately prior to, but subject to the consummation of, such Change in Control, subject to Participant&#8217;s continuous employment with the Company or a Subsidiary through such Change in Control. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;In the event of Participant&#8217;s Termination of Service due to Participant&#8217;s death or Disability, the SARs shall become fully vested and exercisable upon such Termination of Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Unless otherwise determined by the Administrator or as set forth in a written agreement between Participant and the Company, except as provided in Section 3.1(b), any portion of the SARs that has not become vested and exercisable on or prior to the date of Participant&#8217;s Termination of Service shall be forfeited on the date of Participant&#8217;s Termination of Service and shall not thereafter become vested or exercisable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Duration of Exercisability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The installments provided for in the vesting schedule set forth in the Grant Notice are cumulative.  Each such installment that becomes vested and exercisable pursuant to the vesting schedule set forth in the Grant Notice shall remain vested and exercisable until it becomes unexercisable under Section 3.3 hereof. Once the SARs become unexercisable, they shall be forfeited immediately.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Expiration of SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The SARs may not be exercised to any extent by anyone after the first to occur of the following events&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The expiration date set forth in the Grant Notice&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Except in the case of an Approved Retirement or as the Administrator may otherwise approve, the expiration of three months from the date of Participant&#8217;s Termination of Service for any reason.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE IV.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXERCISE </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Person Eligible to Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  During the lifetime of Participant, only Participant may exercise the SARs.  After the death of Participant, any exercisable portion of the SARs may, prior to the time when the SARs become unexercisable under Section 3.3 hereof, be exercised by Participant&#8217;s personal representative or by any person empowered to do so under the deceased Participant&#8217;s will or under the then applicable laws of descent and distribution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Partial Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Any exercisable portion of the SARs or all of the SARs, if then wholly exercisable, may be exercised in whole or in part at any time prior to the time when the SARs or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">portion thereof becomes unexercisable under Section 3.3 hereof.  However, the SARs shall not be exercisable with respect to fractional shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Manner of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The SARs, or any exercisable portion thereof, may be exercised solely by delivery to the Secretary of the Company (or any third party administrator or other person or entity designated by the Company), during regular business hours, of all of the following prior to the time when the SARs or such portion thereof become unexercisable under Section 3.3 hereof&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;An exercise notice in a form specified by the Administrator, stating that the SARs or portion thereof is thereby exercised, such notice complying with all applicable rules established by the Administrator&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The payment of any applicable Tax Liability in accordance with Section 4.5&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Any other written representations or documents as may be required in the Administrator&#8217;s sole discretion to effect compliance with Applicable Law&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;In the event the SARs or portion thereof shall be exercised pursuant to Section 4.1 hereof by any person or persons other than Participant, appropriate proof of the right of such person or persons to exercise the SARs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding any of the foregoing, the Administrator shall have the right to specify all conditions of the manner of exercise, which conditions may vary by country and which may be subject to change from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Time of Settlement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.   The Shares or cash payable upon exercise of the SARs or any portion thereof shall be provided to Participant within 60 days following the date of exercise of the SARs or such portion.  Any such cash shall be payable in a lump sum. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding any other provision of this Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Company and its Subsidiaries have the authority to deduct or withhold, or require Participant to remit to the Company or the applicable Subsidiary, an amount sufficient to satisfy any applicable federal, state, local and foreign taxes (including income tax, employees&#8217; (and at the discretion of the Company, employer&#8217;s) National Insurance contributions, social security contributions and the employee portion of any FICA obligation, or any equivalent taxes in any jurisdiction) required by law to be withheld, paid or otherwise arising with respect to any taxable event arising pursuant to this Agreement, including the grant, vesting or exercise of the SARs, the settlement of the SARs on exercise in either Shares or cash and the sale of any of the Shares (any a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Tax Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  The Company and its Subsidiaries may withhold or Participant may make such payment in one or more of the forms specified below&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;by cash or check made payable to the Company or the Subsidiary with respect to which the withholding obligation arises&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;by the deduction of such amount from other compensation payable to Participant&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;by the Company withholding a net number of Shares issuable upon the exercise of the SARs having a then current Fair Market Value or, if the SARs are settled in cash, an amount of the cash payment made with respect to the SARs, in each case not exceeding the amount necessary to satisfy </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Tax Liability based on the minimum applicable statutory rates for such Tax Liability or such other rate as does not result in adverse accounting consequences for the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;with the consent of the Administrator, by tendering to the Company Shares having a then current Fair Market Value not exceeding the amount necessary to satisfy the Tax Liability based on the minimum applicable statutory rates for such Tax Liability or such other rate as does not result in adverse accounting consequences for the Company&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;if the Administrator determines to settle the SARs in Shares, through the delivery of a notice that Participant has placed a market sell order with a broker acceptable to the Company with respect to any Shares then issuable to Participant upon exercise of the SARs, and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the Company or the Subsidiary with respect to which the Tax Liability arises in satisfaction of such Tax Liability&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that payment of such proceeds is then made to the Company or the applicable Subsidiary at such time as may be required by the Administrator, but in any event not later than the settlement of such sale&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vi)&#160;&#160;&#160;&#160;in any combination of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Company shall not be obligated to deliver any cash or any certificate representing Shares issuable with respect to the exercise of the SARs to, or to cause any such Shares to be held in book-entry form by, Participant or his or her legal representative unless and until Participant or his or her legal representative shall have paid or otherwise satisfied in full the amount of all federal, state, local and foreign taxes applicable with respect to the taxable income of Participant resulting from the exercise of the SARs or any other taxable event related to the SARs&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that no payment shall be delayed under this Section 4.5(b) if such delay would result in a violation of Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;With respect to any Tax Liability arising in connection with the SARs, in the event Participant fails to provide timely payment of all sums required pursuant to Section 4.5(a), the Company shall have the right and option, but not the obligation, to treat such failure as an election by Participant to satisfy all or any portion of Participant&#8217;s required payment obligation pursuant to Section 4.5(a)(ii) or Section 4.5(a)(iii) above, or any combination of the foregoing as the Company may determine to be appropriate.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;In the event any Tax Liability arising in connection with the SARs will be satisfied under Section 4.5(a)(iii), then the Company may elect to instruct any brokerage firm determined acceptable to the Company for such purpose to sell on Participant&#8217;s behalf a whole number of shares from those Shares then issuable upon the exercise of the SARs as the Company determines to be appropriate to generate cash proceeds sufficient to satisfy the Tax Liability and to remit the proceeds of such sale to the Company or the Subsidiary.  Participant&#8217;s acceptance of this Award constitutes Participant&#8217;s instruction and authorization to the Company and such brokerage firm to complete the transactions described in this Section 4.5(d).  In the event of any such broker-assisted sale of Shares&#58; (a) any Shares to be sold through a broker-assisted sale will be sold on the day the tax withholding obligation arises, or as soon thereafter as practicable&#59; (b) such Shares may be sold as part of a block trade with other participants in the Sub-Plan in which all participants receive an average price&#59; (c) Participant will be responsible for all broker&#8217;s fees and other costs of sale, and Participant agrees to indemnify and hold the Company harmless from any losses, costs, damages or expenses relating to any such sale&#59; (d) to the extent the proceeds of such sale exceed the applicable Tax Liability, the Company agrees to pay such excess in cash to Participant as soon as reasonably practicable&#59; (e) Participant acknowledges that the Company or its designee is under no obligation to arrange for such sale at any particular price, and that the proceeds of any such sale may not </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be sufficient to satisfy the applicable Tax Liability&#59; and (f) in the event the proceeds of such sale are insufficient to satisfy the applicable Tax Liability, Participant agrees to pay immediately upon demand to the Company or the Subsidiary an amount in cash sufficient to satisfy any remaining portion of the Tax Liability.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Participant is ultimately liable and responsible for and indemnifies the Company and each Subsidiary against all Tax Liability arising in connection with the SARs, regardless of any action the Company or any Subsidiary takes with respect to any tax withholding obligations that arise in connection with the SARs.  Neither the Company nor any Subsidiary makes any representation or undertaking regarding the treatment of any Tax Liability in connection with the awarding, vesting or exercise of the SARs or the subsequent sale of Shares.  The Company and the Subsidiaries do not commit and are under no obligation to structure the SARs to reduce or eliminate any Tax Liability.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions to Issuance of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  If the Administrator determines to settle any SARs in Shares, the Company shall not be required to issue or deliver any Shares upon the exercise of such SARs prior to fulfillment of all of the following conditions&#58; (a) the admission of such Shares to listing on all stock exchanges on which such Shares are then listed, (b) the completion of any registration or other qualification of such Shares under any state or federal law or under rulings or regulations of the Securities and Exchange Commission or other governmental regulatory body that the Administrator shall, in its absolute discretion, deem necessary or advisable, (c) the obtaining of any approval or other clearance from any state or federal governmental agency that the Administrator shall, in its absolute discretion, determine to be necessary or advisable and (d) the receipt of full payment of any applicable withholding tax in accordance with Section&#160;4.5 by the Company or its Subsidiary with respect to which the applicable withholding obligation arises.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Rights as Shareholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Neither Participant nor any person claiming under or through Participant will have any of the rights or privileges of a shareholder of the Company, including, without limitation, voting rights and rights to dividends, in respect of any of the Shares subject to the SARs unless and until certificates representing such Shares (which may be in book-entry form) will have been issued and recorded on the records of the Company or its transfer agents or registrars and delivered to Participant (including through electronic delivery to a brokerage account).  No adjustment shall be made for a dividend or other right for which the record date is prior to the date of such issuance, recordation and delivery, except as provided in Section 13 of the Sub-Plan.  Except as otherwise provided herein, if the Administrator determines to settle the SARs in Shares, after such issuance, recordation and delivery, Participant will have all the rights of a shareholder of the Company with respect to such Shares, including, without limitation, the right to receipt of dividends and distributions on such shares. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Compensation Recoupment Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The grant of this Award is subject to the terms of the LivaNova Compensation Recoupment Policy, as it may provide from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require the Participant to repay or forfeit cash or equity awards, including this Award, or any ordinary shares or other cash or property received with respect to this and other awards, including any value received from a disposition of the ordinary shares acquired upon payment in respect of the awards.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE V.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OTHER PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Administrator shall have the power to interpret the Sub-Plan, the Grant Notice, the Foreign Appendix, if applicable, and this Agreement and to adopt such rules for the administration, interpretation and application of the Sub-Plan, the Grant Notice, the Foreign Appendix, if applicable, and this Agreement as are consistent therewith and to interpret, amend or revoke any such rules.  All actions taken and all interpretations and determinations made by the Administrator will be final and binding upon Participant, the Company and all other interested persons.  To the extent allowable pursuant to Applicable Law, no member of the Committee or the Board will be personally liable for any action, determination or interpretation made with respect to the Sub-Plan, the Grant Notice, the Foreign Appendix, if applicable, or this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">SARs Not Transferable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Without limiting the generality of any other provision hereof, the SARs shall be subject to the restrictions on transferability set forth in Section 11 of the Sub-Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Administrator may accelerate the vesting of all or a portion of the SARs in such circumstances as it, in its sole discretion, may determine.  Participant acknowledges that the SARs are subject to adjustment, modification and termination in certain events as provided in this Agreement and the Sub-Plan, including Section 13 of the Sub-Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of the Company at the Company&#8217;s principal office, and any notice to be given to Participant shall be addressed to Participant at Participant&#8217;s last address reflected on the Company&#8217;s records.  By a notice given pursuant to this Section 5.4, either party may hereafter designate a different address for notices to be given to that party.  Any notice shall be deemed duly given when sent via email or when sent by reputable overnight courier or by certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Titles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The laws of the State of Delaware shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Conformity to Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Participant acknowledges that the Sub-Plan, the Grant Notice, the Foreign Appendix, if applicable, and this Agreement are intended to conform to the extent necessary with all Applicable Laws, including, without limitation, the provisions of the Securities Act and the Exchange Act, and any and all regulations and rules promulgated thereunder by the Securities and Exchange Commission and state securities laws and regulations.  Notwithstanding anything herein to the contrary, the Sub-Plan shall be administered, and the SARs are granted and may be exercised, only in such a manner as to conform to Applicable Law.  To the extent permitted by Applicable Law, the Sub-Plan and this Agreement shall be deemed amended to the extent necessary to conform to Applicable Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment, Suspension and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  To the extent permitted by the Sub-Plan, this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">at any time or from time to time by the Administrator or the Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">, provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, except as may otherwise be provided by the Sub-Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect the SARs in any material way without the prior written consent of Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company.  Subject to the restrictions on transfer set forth in Section 11 of the Sub-Plan, this Agreement shall be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Limitations Applicable to Section 16 Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding any other provision of the Sub-Plan or this Agreement, if Participant is subject to Section 16 of the Exchange Act, the Sub-Plan, the SARs, the Grant Notice, the Foreign Appendix, if applicable, and this Agreement shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule.  To the extent permitted by Applicable Law, this Agreement shall be deemed amended to the extent necessary to conform to such applicable exemptive rule.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Not a Contract of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Nothing in this Agreement or in the Sub-Plan shall confer upon Participant any right to continue to serve as an Employee of the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the employment of Participant at any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and Participant. Neither the Sub-Plan, the Grant Notice, the Foreign Appendix, if applicable, nor this Agreement afford the Participant any rights to compensation or damages, including for loss of or potential loss that the Participant may suffer by reason of being unable to exercise the SAR as a result of the termination of the Sub-Plan, lapse of the SARs or the termination of the Participant&#8217;s employment with the Company. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">SARs Not Part of Employment Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The SARs and the Shares subject to the SAR are extraordinary items that do not constitute part of normal or expected wages or salary for any purposes, including, but not limited to, calculation of any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, holiday pay, long-service awards, pension or retirement benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company, the employer, its parent, or any Subsidiary or affiliate of the Company. In addition, Participant acknowledges that by electronically signing the Grant Notice and this Agreement that the grant of the Award is at the Company&#8217;s sole discretion based on the Sub-Plan, and does not entitle the Participant to further grant(s) of Awards, nor to claim for further grant(s) of Awards, in respect of the Sub-Plan or any other award(s) under any other plan or program maintained by the Company or any Subsidiary. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Data Protection</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. By electronically signing the Grant Notice and this Agreement, the Participant acknowledges and agrees that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the Company, a Subsidiary or the Participant&#8217;s employer are permitted to hold and process personal information (including sensitive personal information) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) about the Participant as part of their personnel and other business records and may use such information for the purpose of managing and administering the Sub-Plan&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Company, a Subsidiary or the Participant&#8217;s employer may disclose the Data (as described in (a) above) to third parties in the event that such disclosure is in the Company&#8217;s view required for the proper conduct of the Sub-Plan. The Company may also make the Data available to public authorities where required under locally applicable law. These recipients may be located in the United States, the European Economic Area, or elsewhere, which the Participant separately and expressly consents to, accepting that outside the European Economic Area, data protection laws are less protective than within&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;they may, at any time, review Data, require any necessary amendments to it or withdraw their consent herein by contacting the Company in writing, however, the Participant withdrawing their consent may affect their ability to participate in the Sub-Plan and receive the benefits intended pursuant to the Grant Notice and this Agreement&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Data will only be held as long as necessary to implement, administer and manage the Participant&#8217;s participation in the Sub-Plan and any subsequent claims or rights&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;this section applies to any information held, used or disclosed in any medium.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Sub-Plan, the Grant Notice and this Agreement (including any exhibit&#160;hereto) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company, the Subsidiaries and Participant with respect to the subject matter hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Award is not intended to constitute &#8220;nonqualified deferred compensation&#8221; within the meaning of Section 409A of the Code (together with any Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the date hereof, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  However, notwithstanding any other provision of the Sub-Plan, the Grant Notice, the Foreign Appendix, if applicable, or this Agreement, if at any time the Administrator determines that this Award (or any portion thereof) may be subject to Section 409A, the Administrator shall have the right in its sole discretion (without any obligation to do so or to indemnify Participant or any other person for failure to do so) to adopt such amendments to the Sub-Plan, the Grant Notice or this Agreement, or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, as the Administrator determines are necessary or appropriate for this Award either to be exempt from the application of Section 409A or to comply with the requirements of Section 409A. Notwithstanding anything herein to the contrary, no provision of the Sub-Plan shall be interpreted or construed to transfer any liability for failure to comply with the requirements of Section&#160;409A from Participant or any other person to the Company or any of its Subsidiaries, employees or agents.  Without limiting the foregoing and notwithstanding anything contained herein to the contrary, to the extent required in order to avoid an accelerated or additional tax under Section 409A, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to this Agreement during the six-month period immediately following the Participant&#8217;s separation from service shall instead be paid on the first business day after the date that is six months following the Participant&#8217;s separation from service (or, if earlier, the Participant&#8217;s date of death).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement Severable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In the event that any provision of the Grant Notice or this Agreement is held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of the Grant Notice or this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Limitation on Participant&#8217;s Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Participation in the Sub-Plan confers no rights or interests other than as herein provided.  This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust.  Neither the Sub-Plan nor any underlying program, in and of itself, has any assets.  Participant shall have only the rights of a general unsecured creditor of the Company with respect to amounts credited and benefits payable, if any, with respect to the SARs, and rights no greater than the right to receive Shares or cash as a general unsecured creditor with respect to the SARs, as and when exercised pursuant to the terms hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Grant Notice may be executed in one or more counterparts, including by way of any electronic signature, subject to Applicable Law, each of which shall be deemed an original and all of which together shall constitute one instrument.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Special Provisions for SARs Granted to Participants Outside the U.S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  If Participant performs services for the Company outside of the United States, the SARs shall be subject to the special provisions, if any, for Participant&#8217;s country of residence, as set forth in the Foreign Appendix.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;If Participant relocates to one of the countries included in the Foreign Appendix during the life of this Option, the special provisions for such country shall apply to Participant, to the extent the Company determines that the application of such provisions is necessary or advisable in order to comply with local law or facilitate the administration of the Sub-Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Company reserves the right to impose other requirements on this Award and any Shares received upon exercise of the SARs, to the extent the Company determines it is necessary or advisable in order to comply with local laws or facilitate the administration of the Sub-Plan, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Broker-Assisted Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In the event of any broker-assisted sale of Shares in connection with the payment of withholding taxes as provided in Section 4.5(a)(iii) or Section 4.5(d)&#58; (A) any Shares to be sold through a broker-assisted sale will be sold on the day the tax withholding obligation arises or as soon thereafter as practicable&#59; (B) such Shares may be sold as part of a block trade with other participants in the Sub-Plan in which all participants receive an average price&#59; (C) Participant will be responsible for all broker&#8217;s fees and other costs of sale, and Participant agrees to indemnify and hold the Company harmless from any losses, costs, damages, or expenses relating to any such sale&#59; (D) to the extent the proceeds of such sale exceed the applicable tax withholding obligation, the Company agrees to pay such excess in cash to Participant as soon as reasonably practicable&#59; (E) Participant acknowledges that the Company or its designee is under no obligation to arrange for such sale at any particular price, and that the proceeds of any such sale may not be sufficient to satisfy the applicable tax withholding obligation&#59; and (F) in the event the proceeds of such sale are insufficient to satisfy the applicable tax withholding obligation, Participant agrees to pay immediately upon demand to the Company or its Subsidiary with respect to which the withholding obligation arises an amount in cash sufficient to satisfy any remaining portion of the Company&#8217;s or the applicable Subsidiary&#8217;s withholding obligation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">* * * *</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="iaee45b8b84094890a9d3ffb2564bfa1e_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT B</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">TO STOCK APPRECIATION RIGHT GRANT NOTICE</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SPECIAL PROVISIONS FOR SARS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GRANTED TO PARTICIPANTS OUTSIDE THE U.S.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> includes special terms and conditions applicable to Participants in the countries below.  These terms and conditions are in addition to those set forth in the SAR Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and the Sub-Plan and to the extent there are any inconsistencies between these terms and conditions and those set forth in the Agreement or the Sub-Plan, these terms and conditions shall prevail.  Any capitalized term used in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> without definition shall have the meaning ascribed to such term in the Sub-Plan or the Agreement, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Foreign Appendix also includes information relating to exchange control and other issues of which Participant should be aware with respect to his or her participation in the Sub-Plan.  The information is based on the exchange control, securities and other laws in effect in the respective countries as of May 2017.  Such laws are often complex and change frequently.  As a result, the Company strongly recommends that Participant not rely on the information herein as the only source of information relating to the consequences of participation in the Sub-Plan because the information may be out of date at the time the SARs are exercised or any Shares acquired under the Sub-Plan are sold.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, the information is general in nature and may not apply to the particular situation of Participant, and the Company is not in a position to assure Participant of any particular result.  Accordingly, Participant is advised to seek appropriate professional advice as to how the relevant laws in his or her country may apply to his or her situation.  Finally, if Participant is a citizen or resident of a country other than the one in which he or she is currently working, the information contained herein may not be applicable to Participant.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">AUSTRALIA</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A copy of the Sub-Plan is </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">enclosed</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with this Grant Notice and Agreement. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">The Sub-Plan, the Agreement and this Grant Notice do not constitute financial advice</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any advice given by the Company in relation to the Grant Notice, the Agreement, the Sub-Plan, the SARs or the Shares does not constitute financial advice and does not take into account your objectives, financial situation and needs.  In considering the SARs and the amount of cash and&#47;or Shares that you will receive on exercise of the SARs, subject to satisfaction of vesting conditions, you should consider the risk factors that could affect the performance of the Company and the value of SARs and Shares, which value can increase or decrease from time to time, and the amount of any Tax Liability.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You should carefully consider these risks in light of your investment objectives, financial situation and particular needs (including financial and tax issues).  You should seek professional guidance from your stockbroker, solicitor, accountant, financial adviser or other independent professional adviser before deciding whether to acquire SARs or Shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">How to calculate values in Australian dollars</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Your SARs will vest in accordance with the Grant Notice and the Agreement (which require certain conditions to be met) and are subject to a four year graded vesting schedule. The SARs may result in Shares or cash being given to you, in accordance with the Grant Notice. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You will not be required to pay any amount for the SARs or any Shares that will be issued to you upon vesting. However the amount of cash or number of Shares you receive will depend on the market price of Shares at the time, the Exercise Price per Share set out in the Grant Notice, and the amount of any Tax Liability in connection with the grant and exercise of the SARs and the issue of any Shares. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You can ascertain the market price of a Share in the Company in United States Dollars (&#8220;USD&#8221;) from time to time by visiting either&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the Company&#8217;s website (http&#58;&#47;&#47;www.livanova.com&#47;investor-relations&#47;stock-information)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the NASDAQ website (http&#58;&#47;&#47;www.nasdaq.com&#47;symbol&#47;livn).</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To determine the Exercise Price for a SAR or the market value of a Share in Australian Dollars (&#8220;AUD&#8221;), you will need to apply the prevailing USD&#160;&#58;&#160;AUD exchange rate.  For example, if the exchange rate is 1&#160;USD&#160;&#58;&#160;1.5&#160;AUD, and one share of Common Stock has a value of USD $1 on the NASDAQ, its equivalent value will be AUD $1.50.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">CANADA</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Unless otherwise determined by the Administrator, Participant&#8217;s SARs shall only be distributed in Shares (either in book-entry form or otherwise), and no portion of the Participant&#8217;s SARs shall be payable to the Participant in cash. </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">CHINA</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Unless otherwise determined by the Administrator, Participant&#8217;s SARs shall only be settled in cash, and no portion of the participant&#8217;s SARs shall be distributed in Shares. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">FRANCE</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Section 6.13 shall be deleted in its entirety and replaced by the following&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant&#8217;s personal &#8220;Data&#8221; (as defined below) by the Company for the exclusive purpose of implementing, administering and managing Participant&#8217;s participation in the Sub-Plan. Participant understands that the Company holds certain personal information about Participant&#58; Participant&#8217;s name, home address and telephone number, date of birth, employee identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all options or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in Participant&#8217;s favor, for the purpose of implementing, administering and managing the Sub-Plan (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Participant understands that Data will be transferred to such stock plan service providers as may be selected by the Company which are assisting the Company with the implementation, administration and management of the Sub-Plan. Participant understands that the recipients of the Data </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">may be located in the United States or elsewhere (and, if Participant is a resident of a member state of the European Union, may be outside the European Economic Area) and that the recipient&#8217;s country (e.g., the United States) may have different data privacy laws and protections than Participant&#8217;s country. Participant understands that he or she may request a list with the names and addresses of all recipients of the Data by contacting his or her local human resources representative.  Participant authorizes the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Sub-Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing Participant&#8217;s participation in the Sub-Plan.  Participant understands that Data will be held only as long as is necessary to implement, administer and manage Participant&#8217;s participation in the Sub-Plan.  The Company may also make the Data available to public authorities where required under locally applicable law.  Participant understands that he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing Participant&#8217;s local human resources representative.  Participant understands, however, that refusing or withdrawing consent may affect Participant&#8217;s ability to participate in the Sub-Plan.  For more information on the consequences of refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local human resources representative.  This Section applies to information held, used or disclosed in any medium.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">GERMANY</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Definition of &#8220;Tax Liability&#8221; in Section 4.5&#58; </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">For the avoidance of doubt, the definition of &#8220;Tax Liability&#8221; shall only include the employee portions of the social security contributions.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">The following sentence is inserted at Section 5.1 of the Agreement</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;For the avoidance of doubt, the Administrator&#8217;s decisions and interpretations shall be subject to reasonable discretion. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">The heading of Section 5.12 shall be supplemented and reads as follows&#58; </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Section 5.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">SARs Not Part of Employment Compensation, No Legal Claim to Grant(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Section 5.13 shall be deleted in its entirety and replaced by the following&#58;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">Section 5.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">Consent to Personal Data Processing and Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">By signing these terms and conditions, Participant acknowledges and agrees that&#58; </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;the Company and the Participant&#8217;s employer may collect, store, process and use certain personal data of Participant and may further transfer them to Cyberonics, Inc., a wholly-owned subsidiary of LivaNova PLC, located at 100 Cyberonics Blvd, Houston, TX 77058, U.S.A., and Certent, Inc., the Company&#8217;s equity compensation management vendor, located at 1548 Eureka Rd., Suite 100, Roseville, CA 95661, U.S.A., and Merrill Lynch, Pierce, Fenner &#38; Smith, Incorporated, a wholly-owned subsidiary of Bank of America Corporation, the Company&#8217;s broker </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">for equity compensation management and transactions, located at World Financial Center, 220 Vesey Street, New York, NY 10281 for the exclusive purpose of implementing, administering, managing and accounting Participant&#8217;s participation in the Sub-Plan&#59; </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;personal data of Participant are&#58; first name&#47;s and last name, birth date, gender, family status, home address, job title, working location, e-mail addresses and phone numbers, social security and tax numbers, tax class, cash compensation and equity award compensation (the &#8220;Data&#8221;)&#59;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;this section applies to any Data held, used or disclosed in any medium&#59; </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%"> (d)&#160;&#160;&#160;&#160;the Data will be transferred to the locations listed in subparagraph (a) above, and locations outside of the European Economic Area who provide for a lesser level of data protection than locations within&#59; </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(e)&#160;&#160;&#160;&#160;Data will only be held as long as necessary to implement, administer, manage and account Participant&#8217;s participation in the Sub-Plan and any subsequent claims or rights&#59; </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%"> (f) &#160;&#160;&#160;&#160;the consent to the personal data processing as described in this Section 5.13 is entirely voluntary and can be withdrawn at any time&#59; Participant is advised, however, that missing consent in written form may affect his ability to participate in the Sub-Plan and receive benefits intended pursuant to the Grant Notice, the Agreement and the Foreign Appendix. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Name of Participant&#58; &#160;&#160;&#160;&#160;___________________________</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Place&#47;Date&#58; _____________________________________</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Participant&#8217;s Signature&#58; ___________________________</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">ITALY</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">The definition of &#8220;Disability&#8221; in Section 1.1 (a) of the Agreement shall be deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall be defined as in Participant&#8217;s employment letter or agreement with the Company or a Subsidiary, as amended from time to time, or if Participant is not a party to such a letter or agreement or such letter or agreement does not contain such a definition, shall mean Participant&#8217;s inability to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment duly determined pursuant to applicable laws.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">UNITED KINGDOM</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">The definition of &#8220;Disability&#8221; in Section 1.1 (a) of the Agreement shall be deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall be defined as in Participant&#8217;s employment letter or agreement with the Company or a Subsidiary, as amended from time to time, or if Participant is not a party to such a letter or agreement or such letter or agreement does not contain such a definition, shall mean a condition, that, in the opinion of the Administrator, has a long-term adverse effect on the day-to-day activities of a Participant.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">The following paragraph is inserted as Section 4.5 (f) of the Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Participant agrees that if the Participant does not pay his&#47;her employer or the Company does not withhold from the Participant the full amount of any Tax Liability within ninety (90) days after the end of the tax year in which the Tax Liability occurred, or such other period specified in Section 222 (1)(c) of Income Tax (Earnings and Pensions) Act 2003, then the amount that should have been withheld shall constitute a loan owed by the Participant to the employer, effective 90 days after the end of the tax year in which the Tax Liability occurred. The Participant agrees that the loan will bear interest at the official rate of HMRC and will be immediately due and repayable by the Participant, and the Company and&#47;or the employer may recover it at any time thereafter by&#58; (a) withholding the funds from salary, bonus or any other funds due to the Participant by the Company or the employer&#59; (b) withholding the Shares issued upon vesting and exercise of the SARs or from the cash proceeds from the sale of Shares&#59; or (c) demanding cash or a cheque from the Participant. The Participant also authorizes the Company to delay the issuance of any Shares to the Participant unless and until the loan is repaid in full.  </font></div><div style="margin-bottom:10pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>livn-20200930xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i305d5e6432da40e9846a5603e80fbba9_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">EXHIBIT 31.1</font></div><div style="margin-bottom:6pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">CERTIFICATION</font></div><div style="margin-bottom:6pt;text-indent:18pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Damien McDonald, certify that&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended September&#160;30, 2020 of LivaNova PLC and its consolidated subsidiaries&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter  (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Date&#58;&#160;&#160;October&#160;29, 2020 </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:47.137%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.663%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; DAMIEN MCDONALD</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Damien McDonald</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>livn-20200930xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ia1b74a6470d845d69735026fcfba1400_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">EXHIBIT 31.2</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">CERTIFICATION</font></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Thad Huston, certify that&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended September&#160;30, 2020 of LivaNova PLC and its consolidated subsidiaries&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter  (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Date&#58;&#160;&#160;October&#160;29, 2020 </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:47.137%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.663%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; THAD HUSTON</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thad Huston</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:center;text-indent:18pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-indent:18pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>livn-20200930xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i4258e5f8860b4cc799165026543667b0_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">EXHIBIT 32.1</font></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">CERTIFICATION OF THE</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">CHIEF EXECUTIVE OFFICER AND</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">CHIEF FINANCIAL OFFICER</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">OF LIVANOVA PLC</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">PURSUANT TO 18 U.S.C. SECTION&#160;1350</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">Each of Damien McDonald, Chief Executive Officer of LivaNova PLC (the &#8220;Company&#8221;), and Thad Huston, Chief Financial Officer of the Company, each hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:29.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">(a)&#160;&#160;the Quarterly Report on Form 10-Q of the Company and its consolidated subsidiaries for the quarter ended September&#160;30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:29.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">(b)&#160;&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; October 29, 2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; DAMIEN MCDONALD</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Damien McDonald</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="margin-bottom:11pt;margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; October 29, 2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; THAD HUSTON</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thad Huston</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as a part of this report or on a separate disclosure document.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-indent:18pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>livn-20200930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:152b0760-94f0-4bb0-b0a2-1db31ab2058d,g:fb466a4e-c2f9-40f5-a132-8d0db9b26e35-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:livn="http://www.livanova.cyberonics.com/20200930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.livanova.cyberonics.com/20200930">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="livn-20200930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="livn-20200930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="livn-20200930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="livn-20200930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.livanova.cyberonics.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofIncomeLoss" roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss">
        <link:definition>1001002 - Statement - Condensed Consolidated Statements of Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1003004 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1004005 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="UnauditedCondensedConsolidatedFinancialStatements" roleURI="http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatements">
        <link:definition>2101101 - Disclosure - Unaudited Condensed Consolidated Financial Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="UnauditedCondensedConsolidatedFinancialStatementsPolicies" roleURI="http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatementsPolicies">
        <link:definition>2202201 - Disclosure - Unaudited Condensed Consolidated Financial Statements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://www.livanova.cyberonics.com/role/BusinessCombinations">
        <link:definition>2103102 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsNarrativeDetails" roleURI="http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails">
        <link:definition>2404401 - Disclosure - Business Combinations - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperations" roleURI="http://www.livanova.cyberonics.com/role/DiscontinuedOperations">
        <link:definition>2105103 - Disclosure - Discontinued Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsNarrativeDetails" roleURI="http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails">
        <link:definition>2406402 - Disclosure - Discontinued Operations (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Restructuring" roleURI="http://www.livanova.cyberonics.com/role/Restructuring">
        <link:definition>2107104 - Disclosure - Restructuring</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringTables" roleURI="http://www.livanova.cyberonics.com/role/RestructuringTables">
        <link:definition>2308301 - Disclosure - Restructuring (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringRestructuringandRelatedCostsDetails" roleURI="http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails">
        <link:definition>2409403 - Disclosure - Restructuring Restructuring and Related Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringRestructuringExpensebySegmentDetails" roleURI="http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails">
        <link:definition>2410404 - Disclosure - Restructuring Restructuring Expense by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductRemediationLiability" roleURI="http://www.livanova.cyberonics.com/role/ProductRemediationLiability">
        <link:definition>2111105 - Disclosure - Product Remediation Liability</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductRemediationLiabilityTables" roleURI="http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityTables">
        <link:definition>2312302 - Disclosure - Product Remediation Liability (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductRemediationLiabilityDetails" roleURI="http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails">
        <link:definition>2413405 - Disclosure - Product Remediation Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.livanova.cyberonics.com/role/Investments">
        <link:definition>2114106 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.livanova.cyberonics.com/role/InvestmentsTables">
        <link:definition>2315303 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDetails" roleURI="http://www.livanova.cyberonics.com/role/InvestmentsDetails">
        <link:definition>2416406 - Disclosure - Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurements">
        <link:definition>2117107 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsTables">
        <link:definition>2318304 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>2419407 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsContingentConsiderationReconciliationDetails" roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails">
        <link:definition>2420408 - Disclosure - Fair Value Measurements - Contingent Consideration Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2421409 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails" roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails">
        <link:definition>2422410 - Disclosure - Fair Value Measurements - Fair Value of Contingent Consideration by Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsLevel3ValuationsDetails" roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails">
        <link:definition>2423411 - Disclosure - Fair Value Measurements - Level 3 Valuations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangements" roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangements">
        <link:definition>2124108 - Disclosure - Financing Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangementsTables" roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangementsTables">
        <link:definition>2325305 - Disclosure - Financing Arrangements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangementsScheduleofDebtDetails" roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails">
        <link:definition>2426412 - Disclosure - Financing Arrangements Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangementsNarrativeDetails" roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails">
        <link:definition>2427413 - Disclosure - Financing Arrangements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangementsLeverageRatiosDetails" roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangementsLeverageRatiosDetails">
        <link:definition>2428414 - Disclosure - Financing Arrangements - Leverage Ratios (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandRiskManagement" roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagement">
        <link:definition>2129109 - Disclosure - Derivatives and Risk Management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandRiskManagementTables" roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementTables">
        <link:definition>2330306 - Disclosure - Derivatives and Risk Management (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandRiskManagementNarrativeDetails" roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails">
        <link:definition>2431415 - Disclosure - Derivatives and Risk Management Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandRiskManagementDerivativeNotionalAmountsDetails" roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails">
        <link:definition>2432416 - Disclosure - Derivatives and Risk Management Derivative Notional Amounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails" roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails">
        <link:definition>2433417 - Disclosure - Derivatives and Risk Management Amount of Gain (Loss) Recognized in OCI and Income Statement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails" roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails">
        <link:definition>2434418 - Disclosure - Derivatives and Risk Management Fair Value of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.livanova.cyberonics.com/role/CommitmentsandContingencies">
        <link:definition>2135110 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesTables">
        <link:definition>2336307 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNarrativeDetails" roleURI="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails">
        <link:definition>2437419 - Disclosure - Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesScheduleofProductLiabilityDetails" roleURI="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails">
        <link:definition>2438420 - Disclosure - Commitments and Contingencies - Schedule of Product Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.livanova.cyberonics.com/role/StockholdersEquity">
        <link:definition>2139111 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.livanova.cyberonics.com/role/StockholdersEquityTables">
        <link:definition>2340308 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStatementofStockholdersEquityDetails" roleURI="http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails">
        <link:definition>2441421 - Disclosure - Stockholders' Equity Statement of Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityComprehensiveIncomeDetails" roleURI="http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails">
        <link:definition>2442422 - Disclosure - Stockholders' Equity (Comprehensive Income) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedIncentivePlans" roleURI="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlans">
        <link:definition>2143112 - Disclosure - Stock-Based Incentive Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedIncentivePlansTables" roleURI="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansTables">
        <link:definition>2344309 - Disclosure - Stock-Based Incentive Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedIncentivePlansCompensationExpenseDetails" roleURI="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails">
        <link:definition>2445423 - Disclosure - Stock-Based Incentive Plans (Compensation Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedIncentivePlansExecutedAgreementsDetails" roleURI="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails">
        <link:definition>2446424 - Disclosure - Stock-Based Incentive Plans (Executed Agreements) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.livanova.cyberonics.com/role/IncomeTaxes">
        <link:definition>2147113 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.livanova.cyberonics.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2448425 - Disclosure - Income Taxes Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.livanova.cyberonics.com/role/EarningsPerShare">
        <link:definition>2149114 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.livanova.cyberonics.com/role/EarningsPerShareTables">
        <link:definition>2350310 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" roleURI="http://www.livanova.cyberonics.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails">
        <link:definition>2451426 - Disclosure - Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareNarrativeDetails" roleURI="http://www.livanova.cyberonics.com/role/EarningsPerShareNarrativeDetails">
        <link:definition>2452427 - Disclosure - Earnings Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeographicandSegmentInformation" roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformation">
        <link:definition>2153115 - Disclosure - Geographic and Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeographicandSegmentInformationTables" roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationTables">
        <link:definition>2354311 - Disclosure - Geographic and Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeographicandSegmentInformationSegmentInfoDetails" roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails">
        <link:definition>2455428 - Disclosure - Geographic and Segment Information Segment Info (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails" roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails">
        <link:definition>2456429 - Disclosure - Geographic and Segment Information Changes in Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeographicandSegmentInformationGeographicAreasDetails" roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationGeographicAreasDetails">
        <link:definition>2457430 - Disclosure - Geographic and Segment Information Geographic Areas (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformation" roleURI="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformation">
        <link:definition>2158116 - Disclosure - Supplemental Financial Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationTables" roleURI="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationTables">
        <link:definition>2359312 - Disclosure - Supplemental Financial Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationSummaryofInventoryDetails" roleURI="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofInventoryDetails">
        <link:definition>2460431 - Disclosure - Supplemental Financial Information (Summary of Inventory) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails" roleURI="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails">
        <link:definition>2461432 - Disclosure - Supplemental Financial Information (Summary of Accrued Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://www.livanova.cyberonics.com/role/NewAccountingPronouncements">
        <link:definition>2162117 - Disclosure - New Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncementsTables" roleURI="http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsTables">
        <link:definition>2363313 - Disclosure - New Accounting Pronouncements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncementsDetails" roleURI="http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsDetails">
        <link:definition>2464433 - Disclosure - New Accounting Pronouncements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="livn_FDAWarningLetterMember" abstract="true" name="FDAWarningLetterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_LossContingencyAccrualAdjustments" abstract="false" name="LossContingencyAccrualAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_IncomeTaxExaminationOperatingLossesUnderDispute" abstract="false" name="IncomeTaxExaminationOperatingLossesUnderDispute" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_OperatingPerformancebasedRestrictedStockUnitsMember" abstract="true" name="OperatingPerformancebasedRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue" abstract="false" name="SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_ForeignExchangeandOtherMember" abstract="true" name="ForeignExchangeandOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo" abstract="false" name="DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="livn_DebtInstrumentCovenantMinimumNetRevenue" abstract="false" name="DebtInstrumentCovenantMinimumNetRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_ReorganizationPlansMember" abstract="true" name="ReorganizationPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_IncreaseDecreaseInLitigationProvisionLiability" abstract="false" name="IncreaseDecreaseInLitigationProvisionLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_ProductRemediationAbstract" abstract="true" name="ProductRemediationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="livn_LossContingencyNumberofObservedNonConformities" abstract="false" name="LossContingencyNumberofObservedNonConformities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="livn_ResearchAndDevelopmentCostsPayableCurrent" abstract="false" name="ResearchAndDevelopmentCostsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_RespicardiaMember" abstract="true" name="RespicardiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_ProductRemediationNet" abstract="false" name="ProductRemediationNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_SNIAMember" abstract="true" name="SNIAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature" abstract="false" name="RemeasurementOfCappedCallAndEmbeddedExchangeFeature" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue" abstract="false" name="FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_ProductRemediationExpense" abstract="false" name="ProductRemediationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_HighlifeS.A.S.Member" abstract="true" name="HighlifeS.A.S.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_PurchasesOfInvestments" abstract="false" name="PurchasesOfInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_CeribellInc.Member" abstract="true" name="CeribellInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_ReimbursedLegalFees" abstract="false" name="ReimbursedLegalFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays" abstract="false" name="DebtInstrumentRedemptionThresholdConsecutiveTradingDays" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="livn_TandemLifeMember" abstract="true" name="TandemLifeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_ProductRemediationPayments" abstract="false" name="ProductRemediationPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_ScheduleOfDebtCovenantsTableTextBlock" abstract="false" name="ScheduleOfDebtCovenantsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="livn_DebtInstrumentCovenantMinimumProRataNetRevenues" abstract="false" name="DebtInstrumentCovenantMinimumProRataNetRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_CardiopulmonaryMember" abstract="true" name="CardiopulmonaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_MeasurementInputRevenueVolatilityMember" abstract="true" name="MeasurementInputRevenueVolatilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_ALungTechnologiesInc.Member" abstract="true" name="ALungTechnologiesInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_LossContingencyNumberofAssessments" abstract="false" name="LossContingencyNumberofAssessments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="livn_DrilltexMember" abstract="true" name="DrilltexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_DebtInstrumentLIBORFloorRate" abstract="false" name="DebtInstrumentLIBORFloorRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="livn_BusinessAcquisitionsPurchasePriceAllocation" abstract="false" name="BusinessAcquisitionsPurchasePriceAllocation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_HeartValvesMember" abstract="true" name="HeartValvesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_DerivativeLiabilitiesNoncurrentMember" abstract="true" name="DerivativeLiabilitiesNoncurrentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_NeuromodulationSegmentMember" abstract="true" name="NeuromodulationSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_NumberofGeographicRegionsinwhichEntityOperates" abstract="false" name="NumberofGeographicRegionsinwhichEntityOperates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements" abstract="false" name="IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther" abstract="false" name="LossContingencyAccrualForeignCurrencyAdjustmentsAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice" abstract="false" name="DebtInstrumentRedemptionPricePercentageOfExchangePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="livn_LocationsExcludingTheUnitedStatesAndEuropeMember" abstract="true" name="LocationsExcludingTheUnitedStatesAndEuropeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_NumberOfDistributorsAcquired" abstract="false" name="NumberOfDistributorsAcquired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="livn_DebtInstrumentOptionToExchangePricePerShare" abstract="false" name="DebtInstrumentOptionToExchangePricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="livn_BankofAmericaU.SMember" abstract="true" name="BankofAmericaU.SMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_PaymentForDispositionOfBusinessClosingAdjustment" abstract="false" name="PaymentForDispositionOfBusinessClosingAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_EuropeanInvestmentBank2017Member" abstract="true" name="EuropeanInvestmentBank2017Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember" abstract="true" name="DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_CRMBusinessFranchiseMember" abstract="true" name="CRMBusinessFranchiseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_DebtFacility2019Member" abstract="true" name="DebtFacility2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_IncomeTaxExaminationNumberofInstallments" abstract="false" name="IncomeTaxExaminationNumberofInstallments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="livn_MediocreditoItalianoMember" abstract="true" name="MediocreditoItalianoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_ShiraTronicsInc.Member" abstract="true" name="ShiraTronicsInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_ContingentConsiderationLiabilityMember" abstract="true" name="ContingentConsiderationLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_ProductRemediation" abstract="false" name="ProductRemediation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_BusinessCombinationUpfrontCosts" abstract="false" name="BusinessCombinationUpfrontCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_ValuationTechniqueMonteCarloSimulationMember" abstract="true" name="ValuationTechniqueMonteCarloSimulationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_DebtInstrumentRedemptionThresholdTradingDays" abstract="false" name="DebtInstrumentRedemptionThresholdTradingDays" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="livn_MeasurementInputRiskadjustedDiscountRateMember" abstract="true" name="MeasurementInputRiskadjustedDiscountRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_RegionalInternalRevenueOfficeofLombardyMember" abstract="true" name="RegionalInternalRevenueOfficeofLombardyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue" abstract="false" name="FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_EuropeanInvestmentBank2014Member" abstract="true" name="EuropeanInvestmentBank2014Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_CardiovascularSegmentMember" abstract="true" name="CardiovascularSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" abstract="false" name="OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_RestructuringRelatedLiabilities" abstract="false" name="RestructuringRelatedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_MeasurementInputProbabilityofPaymentMember" abstract="true" name="MeasurementInputProbabilityofPaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_ProductRemediationTextBlock" abstract="false" name="ProductRemediationTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="livn_ProductRemediationAdjustments" abstract="false" name="ProductRemediationAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_MeasurementInputCreditRiskDiscountRateMember" abstract="true" name="MeasurementInputCreditRiskDiscountRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_DerivativeContractLiabilities" abstract="false" name="DerivativeContractLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct" abstract="false" name="IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome" abstract="false" name="ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_ImTheraMedicalInc.Member" abstract="true" name="ImTheraMedicalInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_ProductLiabilityMember" abstract="true" name="ProductLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_CappedCallMember" abstract="true" name="CappedCallMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_A2020CashExchangeableSeniorNotesMember" abstract="true" name="A2020CashExchangeableSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_MarketbasedPerformanceRestrictedStockUnitMember" abstract="true" name="MarketbasedPerformanceRestrictedStockUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_DerivativeCapPricePerShare" abstract="false" name="DerivativeCapPricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="livn_ConvertibleNotesReceivableMember" abstract="true" name="ConvertibleNotesReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_EmbeddedExchangeFeatureLiabilityMember" abstract="true" name="EmbeddedExchangeFeatureLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_RainbowMedicalLtd.Member" abstract="true" name="RainbowMedicalLtd.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue" abstract="false" name="SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_MeasurementInputStockPriceVolatilityMember" abstract="true" name="MeasurementInputStockPriceVolatilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_BusinessCombinationContingentConsiderationMeasurementInput" abstract="false" name="BusinessCombinationContingentConsiderationMeasurementInput" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member" abstract="true" name="BankofAmericaMerrillLynchBancoMultiploS.A.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_SNIAs.p.aMember" abstract="true" name="SNIAs.p.aMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodOne" abstract="false" name="DebtInstrumentCovenantSecuredLeverageRatioPeriodOne" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="livn_BusinessCombinationConsiderationTransferredCashTransferred" abstract="false" name="BusinessCombinationConsiderationTransferredCashTransferred" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_MiamiInstrumentsLLCMember" abstract="true" name="MiamiInstrumentsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_ProductRemediationForeignCurrencyTranslationGainLoss" abstract="false" name="ProductRemediationForeignCurrencyTranslationGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="livn_AdvancedCirculatorySupportMember" abstract="true" name="AdvancedCirculatorySupportMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_MDStartIIMember" abstract="true" name="MDStartIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="livn_BusinessCombinationMilestoneAchievementPeriodOfDelay" abstract="false" name="BusinessCombinationMilestoneAchievementPeriodOfDelay" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="livn_DebtInstrumentExchangeableConversionRatio" abstract="false" name="DebtInstrumentExchangeableConversionRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="livn_ScheduleofProductRemediationTableTextBlock" abstract="false" name="ScheduleofProductRemediationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="livn_ProvisionforAgentsReturnsandOther" abstract="false" name="ProvisionforAgentsReturnsandOther" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>livn-20200930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:152b0760-94f0-4bb0-b0a2-1db31ab2058d,g:fb466a4e-c2f9-40f5-a132-8d0db9b26e35-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CoverPage" xlink:type="simple" xlink:href="livn-20200930.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss" xlink:type="simple" xlink:href="livn-20200930.xsd#CondensedConsolidatedStatementsofIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_474e56d0-8bab-46d2-819b-3736f3d9d63a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7e70e7fa-16d5-4d68-adf1-c5d9226fdc0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_474e56d0-8bab-46d2-819b-3736f3d9d63a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7e70e7fa-16d5-4d68-adf1-c5d9226fdc0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_20ef593b-64be-4bc5-abb0-145284a1929d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_474e56d0-8bab-46d2-819b-3736f3d9d63a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_20ef593b-64be-4bc5-abb0-145284a1929d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationExpense_4dbd18b5-cdbf-4bbc-9211-16d9339db656" xlink:href="livn-20200930.xsd#livn_ProductRemediationExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_474e56d0-8bab-46d2-819b-3736f3d9d63a" xlink:to="loc_livn_ProductRemediationExpense_4dbd18b5-cdbf-4bbc-9211-16d9339db656" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_dc371dc6-a26c-4732-8454-745d6b79ca23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_474e56d0-8bab-46d2-819b-3736f3d9d63a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_dc371dc6-a26c-4732-8454-745d6b79ca23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_cd6ec853-6d01-4f78-8ec0-299cc712c1f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_474e56d0-8bab-46d2-819b-3736f3d9d63a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_cd6ec853-6d01-4f78-8ec0-299cc712c1f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_2a3eab23-ddc4-451c-8be1-6b9a52d328fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_474e56d0-8bab-46d2-819b-3736f3d9d63a" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_2a3eab23-ddc4-451c-8be1-6b9a52d328fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_1922b989-8114-41fb-8a87-f3e1f33f286e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_474e56d0-8bab-46d2-819b-3736f3d9d63a" xlink:to="loc_us-gaap_RestructuringCharges_1922b989-8114-41fb-8a87-f3e1f33f286e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_c01a730a-b2b7-46e8-87fb-e4a11ebeca67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_474e56d0-8bab-46d2-819b-3736f3d9d63a" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_c01a730a-b2b7-46e8-87fb-e4a11ebeca67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_0b06cf48-bb18-41e1-9475-3bcdaf37301d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_474e56d0-8bab-46d2-819b-3736f3d9d63a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_0b06cf48-bb18-41e1-9475-3bcdaf37301d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_829a7e57-2a05-4f03-a08e-c94d4f2077ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_474e56d0-8bab-46d2-819b-3736f3d9d63a" xlink:to="loc_us-gaap_LitigationSettlementExpense_829a7e57-2a05-4f03-a08e-c94d4f2077ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a099921c-34e6-434e-bd34-769a13b8ff5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_76167918-858b-40fb-8f3c-8fbfd8d7bec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_a099921c-34e6-434e-bd34-769a13b8ff5f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_76167918-858b-40fb-8f3c-8fbfd8d7bec6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_d6413213-b6d0-48ec-b215-b9ae2a4d2e95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_a099921c-34e6-434e-bd34-769a13b8ff5f" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_d6413213-b6d0-48ec-b215-b9ae2a4d2e95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_127c2629-a474-4a13-9642-a0f5d34ef7d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_57558a00-bfff-4651-aec7-2ed992f0df90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_127c2629-a474-4a13-9642-a0f5d34ef7d7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_57558a00-bfff-4651-aec7-2ed992f0df90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_edf9b004-14fa-4844-9a76-9f187d03f176" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_127c2629-a474-4a13-9642-a0f5d34ef7d7" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_edf9b004-14fa-4844-9a76-9f187d03f176" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_e03b5bc1-2e9b-4d66-b75b-49b7dfb152b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cea9643b-e307-419f-81b7-ac8884c59fdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_e03b5bc1-2e9b-4d66-b75b-49b7dfb152b1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cea9643b-e307-419f-81b7-ac8884c59fdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6e7f68ec-6127-45a8-b3be-40f7feedd461" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_e03b5bc1-2e9b-4d66-b75b-49b7dfb152b1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6e7f68ec-6127-45a8-b3be-40f7feedd461" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_12a13a44-a378-474d-91b6-ee0dca9384e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_e03b5bc1-2e9b-4d66-b75b-49b7dfb152b1" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_12a13a44-a378-474d-91b6-ee0dca9384e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bb5adb45-4b1c-4d76-bdbc-0b1a747bd38c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_48ab2cda-ae38-46cf-aaf2-9b7fbf63b4a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_bb5adb45-4b1c-4d76-bdbc-0b1a747bd38c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_48ab2cda-ae38-46cf-aaf2-9b7fbf63b4a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_f261a0fd-dcde-4928-a05a-6a50a1fef985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_bb5adb45-4b1c-4d76-bdbc-0b1a747bd38c" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_f261a0fd-dcde-4928-a05a-6a50a1fef985" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0a1965ca-e30e-47d2-a47f-ea3f841aa4ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4521971a-ae42-4b95-b6ed-0ef0c38f37ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0a1965ca-e30e-47d2-a47f-ea3f841aa4ba" xlink:to="loc_us-gaap_OperatingIncomeLoss_4521971a-ae42-4b95-b6ed-0ef0c38f37ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_ee487ea8-c017-4213-b7d3-2de6e370e291" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0a1965ca-e30e-47d2-a47f-ea3f841aa4ba" xlink:to="loc_us-gaap_InvestmentIncomeInterest_ee487ea8-c017-4213-b7d3-2de6e370e291" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ad1a0368-2e54-4929-b1bc-a13eaa8b1e1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0a1965ca-e30e-47d2-a47f-ea3f841aa4ba" xlink:to="loc_us-gaap_InterestExpense_ad1a0368-2e54-4929-b1bc-a13eaa8b1e1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome_5b76a985-1e31-4652-81f1-5663ed932733" xlink:href="livn-20200930.xsd#livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0a1965ca-e30e-47d2-a47f-ea3f841aa4ba" xlink:to="loc_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome_5b76a985-1e31-4652-81f1-5663ed932733" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="livn-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_50d729c7-4fd2-4b61-930c-321acfb13c67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_19c0e001-813b-40ab-81cf-63adf797310a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_50d729c7-4fd2-4b61-930c-321acfb13c67" xlink:to="loc_us-gaap_NetIncomeLoss_19c0e001-813b-40ab-81cf-63adf797310a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6121b87c-56a3-41b1-99f7-fff493a6d3d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_50d729c7-4fd2-4b61-930c-321acfb13c67" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6121b87c-56a3-41b1-99f7-fff493a6d3d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a906fb21-cd3f-4398-8710-e66758f5b984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_666106cd-c2d5-4e9c-8f5c-4cecd8c30483" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a906fb21-cd3f-4398-8710-e66758f5b984" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_666106cd-c2d5-4e9c-8f5c-4cecd8c30483" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1866df8f-f74c-490f-865d-8d33a3c00fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a906fb21-cd3f-4398-8710-e66758f5b984" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1866df8f-f74c-490f-865d-8d33a3c00fc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_5a9622b6-136d-495a-bd04-935aac36c583" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_b5ffc433-1184-4bdc-9368-1c80a9c075fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_5a9622b6-136d-495a-bd04-935aac36c583" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_b5ffc433-1184-4bdc-9368-1c80a9c075fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_2a7a5001-f7de-41b3-a02b-1a37835dd199" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_5a9622b6-136d-495a-bd04-935aac36c583" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_2a7a5001-f7de-41b3-a02b-1a37835dd199" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="livn-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8748c074-a862-4b57-bb91-c957fc7c859c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_e21dd5a5-2b4d-40e2-827f-c32077a5f30a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8748c074-a862-4b57-bb91-c957fc7c859c" xlink:to="loc_us-gaap_DebtCurrent_e21dd5a5-2b4d-40e2-827f-c32077a5f30a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_c22febe8-8a8b-43d3-82e7-cc72b5fc2d27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8748c074-a862-4b57-bb91-c957fc7c859c" xlink:to="loc_us-gaap_AccountsPayableCurrent_c22febe8-8a8b-43d3-82e7-cc72b5fc2d27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_da0549d0-1103-4e64-93ae-f4378bb7c4e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8748c074-a862-4b57-bb91-c957fc7c859c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_da0549d0-1103-4e64-93ae-f4378bb7c4e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_6b5974d4-31ad-483a-bc84-c2a2296636d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8748c074-a862-4b57-bb91-c957fc7c859c" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_6b5974d4-31ad-483a-bc84-c2a2296636d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_6cf5ffd2-ef05-4a05-b26b-b5974db6eca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8748c074-a862-4b57-bb91-c957fc7c859c" xlink:to="loc_us-gaap_TaxesPayableCurrent_6cf5ffd2-ef05-4a05-b26b-b5974db6eca7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ac82f8fc-c274-49fa-b44e-ce8688e1c181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8748c074-a862-4b57-bb91-c957fc7c859c" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ac82f8fc-c274-49fa-b44e-ce8688e1c181" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ef482f6c-a399-44c8-8fcb-43b9bbe36a62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_56f8f62c-e1ab-4cf3-84f4-fef2de6568d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ef482f6c-a399-44c8-8fcb-43b9bbe36a62" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_56f8f62c-e1ab-4cf3-84f4-fef2de6568d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_5509a0ef-ab22-4464-9b29-2dd51ffbf77d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ef482f6c-a399-44c8-8fcb-43b9bbe36a62" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_5509a0ef-ab22-4464-9b29-2dd51ffbf77d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_761c4665-ccec-426a-9573-67c65c1381d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ef482f6c-a399-44c8-8fcb-43b9bbe36a62" xlink:to="loc_us-gaap_InventoryNet_761c4665-ccec-426a-9573-67c65c1381d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_80b37b05-6575-41d3-9bda-1af3a98e368a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ef482f6c-a399-44c8-8fcb-43b9bbe36a62" xlink:to="loc_us-gaap_PrepaidTaxes_80b37b05-6575-41d3-9bda-1af3a98e368a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_06707a4b-f460-4d3e-9986-5bd69845bf81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ef482f6c-a399-44c8-8fcb-43b9bbe36a62" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_06707a4b-f460-4d3e-9986-5bd69845bf81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_66e97566-d78e-44d8-bd97-30c4f643b009" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_478da77d-d8fe-4d8f-a49d-54ac5349d17b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_66e97566-d78e-44d8-bd97-30c4f643b009" xlink:to="loc_us-gaap_CommonStockValue_478da77d-d8fe-4d8f-a49d-54ac5349d17b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_6e2ea6fe-028c-48d7-a3ee-348193ffa305" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_66e97566-d78e-44d8-bd97-30c4f643b009" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_6e2ea6fe-028c-48d7-a3ee-348193ffa305" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_01495145-7dcf-4a29-83ec-876f33dad993" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_66e97566-d78e-44d8-bd97-30c4f643b009" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_01495145-7dcf-4a29-83ec-876f33dad993" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2f7c84fc-8009-458d-8dd1-d17aa3189148" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_66e97566-d78e-44d8-bd97-30c4f643b009" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2f7c84fc-8009-458d-8dd1-d17aa3189148" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_1faf55f8-ee11-4a1e-bde0-ea9982a2a272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_66e97566-d78e-44d8-bd97-30c4f643b009" xlink:to="loc_us-gaap_TreasuryStockValue_1faf55f8-ee11-4a1e-bde0-ea9982a2a272" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_12c2cfbc-3694-477d-90ec-73e8405fb788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c3b72533-96d6-4097-8636-0d0fa2183214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_12c2cfbc-3694-477d-90ec-73e8405fb788" xlink:to="loc_us-gaap_AssetsCurrent_c3b72533-96d6-4097-8636-0d0fa2183214" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e44782c9-0aa8-45fa-8623-3927671e62e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_12c2cfbc-3694-477d-90ec-73e8405fb788" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e44782c9-0aa8-45fa-8623-3927671e62e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1aa6e3b6-7fd3-4a54-a547-821a9ffa892d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_12c2cfbc-3694-477d-90ec-73e8405fb788" xlink:to="loc_us-gaap_Goodwill_1aa6e3b6-7fd3-4a54-a547-821a9ffa892d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d6861385-8d86-45eb-960b-cc6478193eb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_12c2cfbc-3694-477d-90ec-73e8405fb788" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d6861385-8d86-45eb-960b-cc6478193eb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7f939bad-3926-4ba4-ac1c-67ed176a0773" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_12c2cfbc-3694-477d-90ec-73e8405fb788" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7f939bad-3926-4ba4-ac1c-67ed176a0773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_e4310c09-121f-4d80-897c-ff757635011c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_12c2cfbc-3694-477d-90ec-73e8405fb788" xlink:to="loc_us-gaap_Investments_e4310c09-121f-4d80-897c-ff757635011c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_6c796852-ff81-437c-83f3-610fce6f4906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_12c2cfbc-3694-477d-90ec-73e8405fb788" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_6c796852-ff81-437c-83f3-610fce6f4906" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_44486648-6f0a-4ff4-9204-ce1d68e1e168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_12c2cfbc-3694-477d-90ec-73e8405fb788" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_44486648-6f0a-4ff4-9204-ce1d68e1e168" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_1095b383-cb74-4f46-b5bf-d73d697d1d84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_31068cb3-faee-448b-be9f-7997a6690fe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1095b383-cb74-4f46-b5bf-d73d697d1d84" xlink:to="loc_us-gaap_Liabilities_31068cb3-faee-448b-be9f-7997a6690fe0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_ae323321-d65f-4499-aad0-2e13af2105d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1095b383-cb74-4f46-b5bf-d73d697d1d84" xlink:to="loc_us-gaap_CommitmentsAndContingencies_ae323321-d65f-4499-aad0-2e13af2105d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3e6bc154-d35b-4616-b7be-ab85fe26fed7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1095b383-cb74-4f46-b5bf-d73d697d1d84" xlink:to="loc_us-gaap_StockholdersEquity_3e6bc154-d35b-4616-b7be-ab85fe26fed7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_04f33dac-1093-44b4-9fd2-a7115b714e9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7bfd6e02-71ae-4046-8ce2-42e501430a3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_04f33dac-1093-44b4-9fd2-a7115b714e9f" xlink:to="loc_us-gaap_LiabilitiesCurrent_7bfd6e02-71ae-4046-8ce2-42e501430a3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_65e1d4a5-9554-4b16-b4b6-3f1cea738aad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_04f33dac-1093-44b4-9fd2-a7115b714e9f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_65e1d4a5-9554-4b16-b4b6-3f1cea738aad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_93d77eae-6e91-4ef2-b837-799b949c49f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_04f33dac-1093-44b4-9fd2-a7115b714e9f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_93d77eae-6e91-4ef2-b837-799b949c49f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_ba92a5d2-743e-4255-b114-db04a4f3dc8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_04f33dac-1093-44b4-9fd2-a7115b714e9f" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_ba92a5d2-743e-4255-b114-db04a4f3dc8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5c8d94eb-6353-4cb5-8617-6ddc8c96950e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_04f33dac-1093-44b4-9fd2-a7115b714e9f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5c8d94eb-6353-4cb5-8617-6ddc8c96950e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_637eaa8f-25cb-4c0c-96dc-026212f6d666" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_04f33dac-1093-44b4-9fd2-a7115b714e9f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_637eaa8f-25cb-4c0c-96dc-026212f6d666" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_aeffb18d-4775-4c04-b954-1f05d8e11c77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_04f33dac-1093-44b4-9fd2-a7115b714e9f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_aeffb18d-4775-4c04-b954-1f05d8e11c77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_350744b3-963f-484c-91d0-b51d9801a2d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_04f33dac-1093-44b4-9fd2-a7115b714e9f" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_350744b3-963f-484c-91d0-b51d9801a2d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a27ee2fb-bb48-451f-b2e1-6f00353e12b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_04f33dac-1093-44b4-9fd2-a7115b714e9f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a27ee2fb-bb48-451f-b2e1-6f00353e12b0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="livn-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="livn-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63b37932-7584-48eb-80ff-9738152997fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_47b09174-e684-4625-b1b0-d7bbcdb7eca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63b37932-7584-48eb-80ff-9738152997fb" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_47b09174-e684-4625-b1b0-d7bbcdb7eca6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_3e8293ca-66a8-471d-ba2f-d1204f5afab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63b37932-7584-48eb-80ff-9738152997fb" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_3e8293ca-66a8-471d-ba2f-d1204f5afab4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths_03e6e74a-beba-4e7c-ab43-b230efc39889" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63b37932-7584-48eb-80ff-9738152997fb" xlink:to="loc_us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths_03e6e74a-beba-4e7c-ab43-b230efc39889" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths_627134c7-6e26-43b5-9045-91ec92c53468" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63b37932-7584-48eb-80ff-9738152997fb" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths_627134c7-6e26-43b5-9045-91ec92c53468" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_50ac6538-1d0c-45c4-a40e-c66bdb602bc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63b37932-7584-48eb-80ff-9738152997fb" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_50ac6538-1d0c-45c4-a40e-c66bdb602bc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f8141f33-e4b4-4723-a253-115c18940b52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63b37932-7584-48eb-80ff-9738152997fb" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f8141f33-e4b4-4723-a253-115c18940b52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_PaymentForDispositionOfBusinessClosingAdjustment_0bc33c28-b535-4710-8faf-a97670e1eac5" xlink:href="livn-20200930.xsd#livn_PaymentForDispositionOfBusinessClosingAdjustment"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63b37932-7584-48eb-80ff-9738152997fb" xlink:to="loc_livn_PaymentForDispositionOfBusinessClosingAdjustment_0bc33c28-b535-4710-8faf-a97670e1eac5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_8bca3815-e8dc-456a-9161-77bf0dbab314" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63b37932-7584-48eb-80ff-9738152997fb" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_8bca3815-e8dc-456a-9161-77bf0dbab314" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0d930e01-97bb-4fd5-b23c-c214244f1452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63b37932-7584-48eb-80ff-9738152997fb" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0d930e01-97bb-4fd5-b23c-c214244f1452" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_3be2b138-a1d5-4bff-b5d4-175c62230fa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63b37932-7584-48eb-80ff-9738152997fb" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_3be2b138-a1d5-4bff-b5d4-175c62230fa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_c0441bb1-eed0-4d99-84b2-25e39bbf3fea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63b37932-7584-48eb-80ff-9738152997fb" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_c0441bb1-eed0-4d99-84b2-25e39bbf3fea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_1477eeae-d676-4dfc-a1e4-7c8e22e25374" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63b37932-7584-48eb-80ff-9738152997fb" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_1477eeae-d676-4dfc-a1e4-7c8e22e25374" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4bca852d-6124-4476-ad1a-3f5bdba15e73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_39874b71-108c-4698-8e23-d9fc62322b3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4bca852d-6124-4476-ad1a-3f5bdba15e73" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_39874b71-108c-4698-8e23-d9fc62322b3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_PurchasesOfInvestments_e85410b2-ef47-4823-bf79-4a666be16141" xlink:href="livn-20200930.xsd#livn_PurchasesOfInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4bca852d-6124-4476-ad1a-3f5bdba15e73" xlink:to="loc_livn_PurchasesOfInvestments_e85410b2-ef47-4823-bf79-4a666be16141" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable_0abfc794-f378-4ecf-bbc2-5a69ede4ef72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4bca852d-6124-4476-ad1a-3f5bdba15e73" xlink:to="loc_us-gaap_PaymentsToAcquireNotesReceivable_0abfc794-f378-4ecf-bbc2-5a69ede4ef72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_843ef3a1-59ed-4ff5-af0c-a95c272c94da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4bca852d-6124-4476-ad1a-3f5bdba15e73" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_843ef3a1-59ed-4ff5-af0c-a95c272c94da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_5243ce4e-5ee1-4343-b1ba-bcba11290d33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4bca852d-6124-4476-ad1a-3f5bdba15e73" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_5243ce4e-5ee1-4343-b1ba-bcba11290d33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e4340311-7c83-4393-a44f-e5cf2d845659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4bca852d-6124-4476-ad1a-3f5bdba15e73" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e4340311-7c83-4393-a44f-e5cf2d845659" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5b1d3347-90fe-4d23-a998-aa64184f4739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ee45a96-de27-40eb-a260-d5b63262f15e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5b1d3347-90fe-4d23-a998-aa64184f4739" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ee45a96-de27-40eb-a260-d5b63262f15e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ef6761b6-7d22-48d3-89a8-6930c146a124" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5b1d3347-90fe-4d23-a998-aa64184f4739" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ef6761b6-7d22-48d3-89a8-6930c146a124" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_407244a0-b629-40d4-8696-9489176d4021" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5b1d3347-90fe-4d23-a998-aa64184f4739" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_407244a0-b629-40d4-8696-9489176d4021" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_37f5c9e1-1522-4c04-ab3b-d492b2ea5175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5b1d3347-90fe-4d23-a998-aa64184f4739" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_37f5c9e1-1522-4c04-ab3b-d492b2ea5175" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_759847eb-3982-4673-b3ba-7a2b992cd646" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dfb17165-67bb-44ad-8b4e-f5f8147f0197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_759847eb-3982-4673-b3ba-7a2b992cd646" xlink:to="loc_us-gaap_NetIncomeLoss_dfb17165-67bb-44ad-8b4e-f5f8147f0197" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f6546ae3-71bb-4ec1-8de7-fb78c7002c5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_759847eb-3982-4673-b3ba-7a2b992cd646" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f6546ae3-71bb-4ec1-8de7-fb78c7002c5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9c9fe977-c9ce-4961-b5a7-057ef3ca5231" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_759847eb-3982-4673-b3ba-7a2b992cd646" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9c9fe977-c9ce-4961-b5a7-057ef3ca5231" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_cfbb1a6f-8bee-406f-8da6-e9ec3fef3c1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_759847eb-3982-4673-b3ba-7a2b992cd646" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_cfbb1a6f-8bee-406f-8da6-e9ec3fef3c1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ca07c368-3d3d-41af-a1f7-6f257b43af74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_759847eb-3982-4673-b3ba-7a2b992cd646" xlink:to="loc_us-gaap_ShareBasedCompensation_ca07c368-3d3d-41af-a1f7-6f257b43af74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_0329dc01-486c-4c2d-93e5-0e8c62c55250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_759847eb-3982-4673-b3ba-7a2b992cd646" xlink:to="loc_us-gaap_Depreciation_0329dc01-486c-4c2d-93e5-0e8c62c55250" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature_0038df09-435a-488b-8591-35f3d9af88ec" xlink:href="livn-20200930.xsd#livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_759847eb-3982-4673-b3ba-7a2b992cd646" xlink:to="loc_livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature_0038df09-435a-488b-8591-35f3d9af88ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_d6f81038-057f-4c28-b92c-fce936379162" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_759847eb-3982-4673-b3ba-7a2b992cd646" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_d6f81038-057f-4c28-b92c-fce936379162" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_da99b215-9bfa-4380-ad68-f9bc64c73ce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_759847eb-3982-4673-b3ba-7a2b992cd646" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_da99b215-9bfa-4380-ad68-f9bc64c73ce1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_7362bbbe-6235-4a14-af84-b025913f0ee8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_759847eb-3982-4673-b3ba-7a2b992cd646" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_7362bbbe-6235-4a14-af84-b025913f0ee8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fc1d3c9e-f1e5-4db3-b188-d33947899302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_759847eb-3982-4673-b3ba-7a2b992cd646" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fc1d3c9e-f1e5-4db3-b188-d33947899302" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_393765ab-bb65-4f73-949e-1193c53232ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_759847eb-3982-4673-b3ba-7a2b992cd646" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_393765ab-bb65-4f73-949e-1193c53232ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5cf1956a-432d-4067-9ed0-7438f2aa86e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_759847eb-3982-4673-b3ba-7a2b992cd646" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5cf1956a-432d-4067-9ed0-7438f2aa86e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_42e061bc-c1c5-450b-902e-7c603f4095ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_759847eb-3982-4673-b3ba-7a2b992cd646" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_42e061bc-c1c5-450b-902e-7c603f4095ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_2b41ce1a-4ff3-4230-800d-fa0cb2f64a74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_759847eb-3982-4673-b3ba-7a2b992cd646" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_2b41ce1a-4ff3-4230-800d-fa0cb2f64a74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_IncreaseDecreaseInLitigationProvisionLiability_c03cf0d0-1af6-48bb-8d3d-e6e1ecb9b857" xlink:href="livn-20200930.xsd#livn_IncreaseDecreaseInLitigationProvisionLiability"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_759847eb-3982-4673-b3ba-7a2b992cd646" xlink:to="loc_livn_IncreaseDecreaseInLitigationProvisionLiability_c03cf0d0-1af6-48bb-8d3d-e6e1ecb9b857" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInRestructuringReserve_9cd28808-4fe7-4103-a163-47b80be2a789" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInRestructuringReserve"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_759847eb-3982-4673-b3ba-7a2b992cd646" xlink:to="loc_us-gaap_IncreaseDecreaseInRestructuringReserve_9cd28808-4fe7-4103-a163-47b80be2a789" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatements" xlink:type="simple" xlink:href="livn-20200930.xsd#UnauditedCondensedConsolidatedFinancialStatements"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatementsPolicies" xlink:type="simple" xlink:href="livn-20200930.xsd#UnauditedCondensedConsolidatedFinancialStatementsPolicies"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatementsPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/BusinessCombinations" xlink:type="simple" xlink:href="livn-20200930.xsd#BusinessCombinations"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/BusinessCombinations" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#BusinessCombinationsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DiscontinuedOperations" xlink:type="simple" xlink:href="livn-20200930.xsd#DiscontinuedOperations"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/DiscontinuedOperations" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#DiscontinuedOperationsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/Restructuring" xlink:type="simple" xlink:href="livn-20200930.xsd#Restructuring"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/Restructuring" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/RestructuringTables" xlink:type="simple" xlink:href="livn-20200930.xsd#RestructuringTables"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/RestructuringTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#RestructuringRestructuringandRelatedCostsDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#RestructuringRestructuringExpensebySegmentDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/ProductRemediationLiability" xlink:type="simple" xlink:href="livn-20200930.xsd#ProductRemediationLiability"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/ProductRemediationLiability" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityTables" xlink:type="simple" xlink:href="livn-20200930.xsd#ProductRemediationLiabilityTables"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#ProductRemediationLiabilityDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/Investments" xlink:type="simple" xlink:href="livn-20200930.xsd#Investments"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/Investments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/InvestmentsTables" xlink:type="simple" xlink:href="livn-20200930.xsd#InvestmentsTables"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/InvestmentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/InvestmentsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#InvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/InvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_de7edcc3-0308-4da4-92d4-0ca2867ce65a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_512ba8fe-ac5d-4cd9-839e-4c2d252907fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_de7edcc3-0308-4da4-92d4-0ca2867ce65a" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_512ba8fe-ac5d-4cd9-839e-4c2d252907fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_273ead90-2ad6-4721-8a72-34270644e934" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_de7edcc3-0308-4da4-92d4-0ca2867ce65a" xlink:to="loc_us-gaap_EquityMethodInvestments_273ead90-2ad6-4721-8a72-34270644e934" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_96328584-13f0-4a45-8d1a-1b500eab2e04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0b4dab9f-e58f-4f51-a624-f0870a6f74f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_96328584-13f0-4a45-8d1a-1b500eab2e04" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0b4dab9f-e58f-4f51-a624-f0870a6f74f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_17b129c2-1a8c-486b-8c33-fcf9ffff0f08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_96328584-13f0-4a45-8d1a-1b500eab2e04" xlink:to="loc_us-gaap_DerivativeLiabilities_17b129c2-1a8c-486b-8c33-fcf9ffff0f08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_69c615cd-fbf5-4f39-b5ca-d9061da8907e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_87c60cca-76ce-4c7b-bed6-ae8c9e174e84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_69c615cd-fbf5-4f39-b5ca-d9061da8907e" xlink:to="loc_us-gaap_DerivativeAssets_87c60cca-76ce-4c7b-bed6-ae8c9e174e84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFairValueDisclosure_d298544e-3de1-442c-84ef-cf1726fc4024" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_69c615cd-fbf5-4f39-b5ca-d9061da8907e" xlink:to="loc_us-gaap_ReceivablesFairValueDisclosure_d298544e-3de1-442c-84ef-cf1726fc4024" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurementsContingentConsiderationReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurementsLevel3ValuationsDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangements" xlink:type="simple" xlink:href="livn-20200930.xsd#FinancingArrangements"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/FinancingArrangements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangementsTables" xlink:type="simple" xlink:href="livn-20200930.xsd#FinancingArrangementsTables"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/FinancingArrangementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FinancingArrangementsScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_3de7c5f7-e99c-4876-ab42-758379cca9d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_3cb44034-485f-4d70-b3df-40f051dba583" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_3de7c5f7-e99c-4876-ab42-758379cca9d7" xlink:to="loc_us-gaap_LongTermDebtCurrent_3cb44034-485f-4d70-b3df-40f051dba583" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_1ceab5ec-9b6d-4d88-99a5-a81c63b0f2a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_3de7c5f7-e99c-4876-ab42-758379cca9d7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_1ceab5ec-9b6d-4d88-99a5-a81c63b0f2a7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FinancingArrangementsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangementsLeverageRatiosDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FinancingArrangementsLeverageRatiosDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/FinancingArrangementsLeverageRatiosDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagement" xlink:type="simple" xlink:href="livn-20200930.xsd#DerivativesandRiskManagement"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagement" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementTables" xlink:type="simple" xlink:href="livn-20200930.xsd#DerivativesandRiskManagementTables"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#DerivativesandRiskManagementNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#DerivativesandRiskManagementDerivativeNotionalAmountsDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="livn-20200930.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="livn-20200930.xsd#CommitmentsandContingenciesTables"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#CommitmentsandContingenciesScheduleofProductLiabilityDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_9df10dc9-0e55-4a48-b7e2-7560873e3a00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_c753ce75-c28f-4556-a9ec-3ffac3415914" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue_9df10dc9-0e55-4a48-b7e2-7560873e3a00" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_c753ce75-c28f-4556-a9ec-3ffac3415914" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_b06f3022-4f42-4c67-b30f-96c5eb51b78a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue_9df10dc9-0e55-4a48-b7e2-7560873e3a00" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_b06f3022-4f42-4c67-b30f-96c5eb51b78a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockholdersEquity" xlink:type="simple" xlink:href="livn-20200930.xsd#StockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/StockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="livn-20200930.xsd#StockholdersEquityTables"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/StockholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#StockholdersEquityStatementofStockholdersEquityDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#StockholdersEquityComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a52b04af-dc68-47a8-92bf-f2966bdebe9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_24477f80-37c0-4479-838f-e97b53f956ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a52b04af-dc68-47a8-92bf-f2966bdebe9e" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_24477f80-37c0-4479-838f-e97b53f956ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_eebc055c-e089-44b0-a185-a4c6aa1fea55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a52b04af-dc68-47a8-92bf-f2966bdebe9e" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_eebc055c-e089-44b0-a185-a4c6aa1fea55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_bd87a4c6-2b44-49a8-81d5-11c59c2f030c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_ec534c79-1235-410f-9707-8dabebcd49d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_bd87a4c6-2b44-49a8-81d5-11c59c2f030c" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_ec534c79-1235-410f-9707-8dabebcd49d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_eca57e96-18ba-4474-b9a8-ae5b3251abee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_bd87a4c6-2b44-49a8-81d5-11c59c2f030c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_eca57e96-18ba-4474-b9a8-ae5b3251abee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_fc25b045-a947-46a5-9377-011cf72cda8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_510308ae-d456-4b9d-a3b2-de9304b1990e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_fc25b045-a947-46a5-9377-011cf72cda8e" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_510308ae-d456-4b9d-a3b2-de9304b1990e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_ddaa68c4-4d99-4c60-9755-c9d43ad35d2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_fc25b045-a947-46a5-9377-011cf72cda8e" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_ddaa68c4-4d99-4c60-9755-c9d43ad35d2d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlans" xlink:type="simple" xlink:href="livn-20200930.xsd#StockBasedIncentivePlans"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansTables" xlink:type="simple" xlink:href="livn-20200930.xsd#StockBasedIncentivePlansTables"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#StockBasedIncentivePlansCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#StockBasedIncentivePlansExecutedAgreementsDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/IncomeTaxes" xlink:type="simple" xlink:href="livn-20200930.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#IncomeTaxesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/EarningsPerShare" xlink:type="simple" xlink:href="livn-20200930.xsd#EarningsPerShare"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/EarningsPerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="livn-20200930.xsd#EarningsPerShareTables"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/EarningsPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6118c775-c478-4a7c-9c72-084feef810be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c5bc2246-eedf-478f-a6f4-f5af24b12e4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6118c775-c478-4a7c-9c72-084feef810be" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c5bc2246-eedf-478f-a6f4-f5af24b12e4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_fa3766b1-2cdb-4870-8704-414c0c5d9ee7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6118c775-c478-4a7c-9c72-084feef810be" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_fa3766b1-2cdb-4870-8704-414c0c5d9ee7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/EarningsPerShareNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#EarningsPerShareNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/EarningsPerShareNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformation" xlink:type="simple" xlink:href="livn-20200930.xsd#GeographicandSegmentInformation"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationTables" xlink:type="simple" xlink:href="livn-20200930.xsd#GeographicandSegmentInformationTables"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#GeographicandSegmentInformationSegmentInfoDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationGeographicAreasDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#GeographicandSegmentInformationGeographicAreasDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationGeographicAreasDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformation" xlink:type="simple" xlink:href="livn-20200930.xsd#SupplementalFinancialInformation"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationTables" xlink:type="simple" xlink:href="livn-20200930.xsd#SupplementalFinancialInformationTables"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofInventoryDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#SupplementalFinancialInformationSummaryofInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b6d3979d-ec17-4241-be76-4717a5ae8a40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_a1fb7faf-e687-4609-bb59-4ee23bade525" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b6d3979d-ec17-4241-be76-4717a5ae8a40" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_a1fb7faf-e687-4609-bb59-4ee23bade525" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_f46e50eb-6c7e-43d0-9196-aea7d949aea0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b6d3979d-ec17-4241-be76-4717a5ae8a40" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_f46e50eb-6c7e-43d0-9196-aea7d949aea0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a43cc943-feca-42d4-ab9f-3d50a4a71fde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b6d3979d-ec17-4241-be76-4717a5ae8a40" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a43cc943-feca-42d4-ab9f-3d50a4a71fde" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_1ee0c092-cb2c-45bd-9605-a84229faf865" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_51398f3b-3f2a-43d3-bfa3-f60c6c41ebce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1ee0c092-cb2c-45bd-9605-a84229faf865" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_51398f3b-3f2a-43d3-bfa3-f60c6c41ebce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_d2b8213a-8f9c-4d84-8aef-5d4402d5e4e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1ee0c092-cb2c-45bd-9605-a84229faf865" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_d2b8213a-8f9c-4d84-8aef-5d4402d5e4e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_4e758fcf-a0a9-4c9e-aba5-8a2d822eccd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1ee0c092-cb2c-45bd-9605-a84229faf865" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_4e758fcf-a0a9-4c9e-aba5-8a2d822eccd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a8234d74-3db0-4408-a0a3-a663a7a49bd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1ee0c092-cb2c-45bd-9605-a84229faf865" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a8234d74-3db0-4408-a0a3-a663a7a49bd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ResearchAndDevelopmentCostsPayableCurrent_b173aa90-f682-425b-a864-c9fa4f5793e0" xlink:href="livn-20200930.xsd#livn_ResearchAndDevelopmentCostsPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1ee0c092-cb2c-45bd-9605-a84229faf865" xlink:to="loc_livn_ResearchAndDevelopmentCostsPayableCurrent_b173aa90-f682-425b-a864-c9fa4f5793e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProvisionforAgentsReturnsandOther_37d7558f-3d99-4469-b0fb-3dffce67c450" xlink:href="livn-20200930.xsd#livn_ProvisionforAgentsReturnsandOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1ee0c092-cb2c-45bd-9605-a84229faf865" xlink:to="loc_livn_ProvisionforAgentsReturnsandOther_37d7558f-3d99-4469-b0fb-3dffce67c450" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_RestructuringRelatedLiabilities_e4deb4d4-01ac-4d2e-ad57-45d7c2c83008" xlink:href="livn-20200930.xsd#livn_RestructuringRelatedLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1ee0c092-cb2c-45bd-9605-a84229faf865" xlink:to="loc_livn_RestructuringRelatedLiabilities_e4deb4d4-01ac-4d2e-ad57-45d7c2c83008" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediation_b00dbfd4-2b91-41fb-97b0-549ad6672d3b" xlink:href="livn-20200930.xsd#livn_ProductRemediation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1ee0c092-cb2c-45bd-9605-a84229faf865" xlink:to="loc_livn_ProductRemediation_b00dbfd4-2b91-41fb-97b0-549ad6672d3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DerivativeContractLiabilities_fd0f3c22-e868-48a9-b1d6-8279fd71b729" xlink:href="livn-20200930.xsd#livn_DerivativeContractLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1ee0c092-cb2c-45bd-9605-a84229faf865" xlink:to="loc_livn_DerivativeContractLiabilities_fd0f3c22-e868-48a9-b1d6-8279fd71b729" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BusinessAcquisitionsPurchasePriceAllocation_52ae40b6-1f96-4c7f-976b-cc73e5602207" xlink:href="livn-20200930.xsd#livn_BusinessAcquisitionsPurchasePriceAllocation"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1ee0c092-cb2c-45bd-9605-a84229faf865" xlink:to="loc_livn_BusinessAcquisitionsPurchasePriceAllocation_52ae40b6-1f96-4c7f-976b-cc73e5602207" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_02e3c95d-8475-4a52-a65d-75e52625062b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1ee0c092-cb2c-45bd-9605-a84229faf865" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_02e3c95d-8475-4a52-a65d-75e52625062b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="livn-20200930.xsd#NewAccountingPronouncements"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/NewAccountingPronouncements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsTables" xlink:type="simple" xlink:href="livn-20200930.xsd#NewAccountingPronouncementsTables"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#NewAccountingPronouncementsDetails"/>
  <link:calculationLink xlink:role="http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>livn-20200930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:152b0760-94f0-4bb0-b0a2-1db31ab2058d,g:fb466a4e-c2f9-40f5-a132-8d0db9b26e35-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CoverPage" xlink:type="simple" xlink:href="livn-20200930.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/CoverPage" xlink:type="extended" id="i4de545ace2b74fd4a20c7c8760318b49_CoverPage"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss" xlink:type="simple" xlink:href="livn-20200930.xsd#CondensedConsolidatedStatementsofIncomeLoss"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss" xlink:type="extended" id="i4143d6d69ffa4ad29be9aec84054f44f_CondensedConsolidatedStatementsofIncomeLoss"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="livn-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended" id="i6140eefa2a8342b191ec73a69aeffa93_CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="livn-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended" id="i6052596af237446292f3c48624dd1ecc_CondensedConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="livn-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="ib7f169428b1141aab709aec0c5c8c337_CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="livn-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended" id="i53fb524adab340e4870434f12852193c_CondensedConsolidatedStatementsofCashFlows"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatements" xlink:type="simple" xlink:href="livn-20200930.xsd#UnauditedCondensedConsolidatedFinancialStatements"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatements" xlink:type="extended" id="i6d49f98b0c7344f1847d7ac712caa50e_UnauditedCondensedConsolidatedFinancialStatements"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatementsPolicies" xlink:type="simple" xlink:href="livn-20200930.xsd#UnauditedCondensedConsolidatedFinancialStatementsPolicies"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatementsPolicies" xlink:type="extended" id="id90c7d7e54dc48aa831c9d8165db719a_UnauditedCondensedConsolidatedFinancialStatementsPolicies"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/BusinessCombinations" xlink:type="simple" xlink:href="livn-20200930.xsd#BusinessCombinations"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/BusinessCombinations" xlink:type="extended" id="i8549aeb85cbc44b5beba5f8d2ca44290_BusinessCombinations"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#BusinessCombinationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails" xlink:type="extended" id="i32feb6214b7c453daa436f84d226d2fd_BusinessCombinationsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_452f8b08-f415-46a9-90ba-2de9ead9a166" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a895c958-50b5-41d0-adc7-515390aa2ad5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_452f8b08-f415-46a9-90ba-2de9ead9a166" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a895c958-50b5-41d0-adc7-515390aa2ad5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BusinessCombinationUpfrontCosts_26af5934-e021-49b8-82f0-9496cfe3137a" xlink:href="livn-20200930.xsd#livn_BusinessCombinationUpfrontCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_452f8b08-f415-46a9-90ba-2de9ead9a166" xlink:to="loc_livn_BusinessCombinationUpfrontCosts_26af5934-e021-49b8-82f0-9496cfe3137a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_cd42d026-2abb-482b-bad8-1d79bcf07506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_452f8b08-f415-46a9-90ba-2de9ead9a166" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_cd42d026-2abb-482b-bad8-1d79bcf07506" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_891690ae-fb14-4037-a464-752a7afeef34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_452f8b08-f415-46a9-90ba-2de9ead9a166" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_891690ae-fb14-4037-a464-752a7afeef34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b5c098bc-f753-49d3-bfa3-a6d1a8209800" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_452f8b08-f415-46a9-90ba-2de9ead9a166" xlink:to="loc_us-gaap_Goodwill_b5c098bc-f753-49d3-bfa3-a6d1a8209800" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0b2dc261-5b92-41e3-997f-e70a05a6da2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_452f8b08-f415-46a9-90ba-2de9ead9a166" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0b2dc261-5b92-41e3-997f-e70a05a6da2a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_34d7b0a8-5339-4918-a06a-aa2bf34699ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0b2dc261-5b92-41e3-997f-e70a05a6da2a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_34d7b0a8-5339-4918-a06a-aa2bf34699ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_34d7b0a8-5339-4918-a06a-aa2bf34699ee_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34d7b0a8-5339-4918-a06a-aa2bf34699ee" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_34d7b0a8-5339-4918-a06a-aa2bf34699ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50862f68-fb4e-407a-b15a-d38b85f22974" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34d7b0a8-5339-4918-a06a-aa2bf34699ee" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50862f68-fb4e-407a-b15a-d38b85f22974" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MiamiInstrumentsLLCMember_84c41346-e244-4b28-90b8-ebb31bbb4a21" xlink:href="livn-20200930.xsd#livn_MiamiInstrumentsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50862f68-fb4e-407a-b15a-d38b85f22974" xlink:to="loc_livn_MiamiInstrumentsLLCMember_84c41346-e244-4b28-90b8-ebb31bbb4a21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_39519c61-7987-4860-bff9-d97bae9ed11d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0b2dc261-5b92-41e3-997f-e70a05a6da2a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_39519c61-7987-4860-bff9-d97bae9ed11d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_39519c61-7987-4860-bff9-d97bae9ed11d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_39519c61-7987-4860-bff9-d97bae9ed11d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_39519c61-7987-4860-bff9-d97bae9ed11d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_284a9268-943b-4bc8-9090-0c6086d58d06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_39519c61-7987-4860-bff9-d97bae9ed11d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_284a9268-943b-4bc8-9090-0c6086d58d06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember_a98cd6ba-d22d-4359-b1ef-287a6e3f14b9" xlink:href="livn-20200930.xsd#livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_284a9268-943b-4bc8-9090-0c6086d58d06" xlink:to="loc_livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember_a98cd6ba-d22d-4359-b1ef-287a6e3f14b9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DiscontinuedOperations" xlink:type="simple" xlink:href="livn-20200930.xsd#DiscontinuedOperations"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/DiscontinuedOperations" xlink:type="extended" id="i7da75c6bff4a4602814f7e550c561b2a_DiscontinuedOperations"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#DiscontinuedOperationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails" xlink:type="extended" id="ia9d3704d515f4c2b867efbf768d47920_DiscontinuedOperationsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f8cdf356-f774-4e5b-9ede-b2299973c821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_331e9608-6493-4b7e-9aa9-d656784d89ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f8cdf356-f774-4e5b-9ede-b2299973c821" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_331e9608-6493-4b7e-9aa9-d656784d89ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BusinessCombinationConsiderationTransferredCashTransferred_c96d441c-b42c-4be4-afd6-0192d56a27ab" xlink:href="livn-20200930.xsd#livn_BusinessCombinationConsiderationTransferredCashTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f8cdf356-f774-4e5b-9ede-b2299973c821" xlink:to="loc_livn_BusinessCombinationConsiderationTransferredCashTransferred_c96d441c-b42c-4be4-afd6-0192d56a27ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax_95e50d82-172e-4f4a-ba4e-46063432e716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f8cdf356-f774-4e5b-9ede-b2299973c821" xlink:to="loc_us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax_95e50d82-172e-4f4a-ba4e-46063432e716" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_6e497f6b-b582-43a4-8dfc-2467c7d91d58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f8cdf356-f774-4e5b-9ede-b2299973c821" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_6e497f6b-b582-43a4-8dfc-2467c7d91d58" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_3d5ffdd0-f1c1-4cd0-bea6-352c213356d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f8cdf356-f774-4e5b-9ede-b2299973c821" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_3d5ffdd0-f1c1-4cd0-bea6-352c213356d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_edd7d92b-556f-4863-b351-0e54d6f51759" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f8cdf356-f774-4e5b-9ede-b2299973c821" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_edd7d92b-556f-4863-b351-0e54d6f51759" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_67ea7394-ba0a-457e-a1d7-4e8dd28a6b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_edd7d92b-556f-4863-b351-0e54d6f51759" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_67ea7394-ba0a-457e-a1d7-4e8dd28a6b58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_67ea7394-ba0a-457e-a1d7-4e8dd28a6b58_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_67ea7394-ba0a-457e-a1d7-4e8dd28a6b58" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_67ea7394-ba0a-457e-a1d7-4e8dd28a6b58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f0bb835d-610a-4810-bf06-69c80a606a71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_67ea7394-ba0a-457e-a1d7-4e8dd28a6b58" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f0bb835d-610a-4810-bf06-69c80a606a71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CRMBusinessFranchiseMember_bc15a784-e9f5-4013-94ea-5754cdf75df5" xlink:href="livn-20200930.xsd#livn_CRMBusinessFranchiseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f0bb835d-610a-4810-bf06-69c80a606a71" xlink:to="loc_livn_CRMBusinessFranchiseMember_bc15a784-e9f5-4013-94ea-5754cdf75df5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_51859b0f-98d2-458a-8c2e-a26a84f34722" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_edd7d92b-556f-4863-b351-0e54d6f51759" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_51859b0f-98d2-458a-8c2e-a26a84f34722" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_51859b0f-98d2-458a-8c2e-a26a84f34722_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_51859b0f-98d2-458a-8c2e-a26a84f34722" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_51859b0f-98d2-458a-8c2e-a26a84f34722_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_d44e86f2-5c0b-42ca-b746-203085833ae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_51859b0f-98d2-458a-8c2e-a26a84f34722" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_d44e86f2-5c0b-42ca-b746-203085833ae1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_e01692e8-dd65-4aa4-b4dc-18c36e278a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_d44e86f2-5c0b-42ca-b746-203085833ae1" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_e01692e8-dd65-4aa4-b4dc-18c36e278a16" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/Restructuring" xlink:type="simple" xlink:href="livn-20200930.xsd#Restructuring"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/Restructuring" xlink:type="extended" id="i9588ce2bccdf4852b88ecd762266f9f1_Restructuring"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/RestructuringTables" xlink:type="simple" xlink:href="livn-20200930.xsd#RestructuringTables"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/RestructuringTables" xlink:type="extended" id="i0333ab9865d245f7a91152f637839e09_RestructuringTables"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#RestructuringRestructuringandRelatedCostsDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails" xlink:type="extended" id="i3e5b124cf88744a99fa8c16bc36dd05a_RestructuringRestructuringandRelatedCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_60a894b8-7228-49f6-a866-bcf883f5891a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_905ed640-ccea-4ed7-b62d-e6c09237d955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_60a894b8-7228-49f6-a866-bcf883f5891a" xlink:to="loc_us-gaap_RestructuringReserveRollForward_905ed640-ccea-4ed7-b62d-e6c09237d955" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_763b43a9-620f-4687-8f6b-dec4135cc7ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_905ed640-ccea-4ed7-b62d-e6c09237d955" xlink:to="loc_us-gaap_RestructuringReserve_763b43a9-620f-4687-8f6b-dec4135cc7ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c027009d-e14a-41fb-b281-885545d8c1cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_905ed640-ccea-4ed7-b62d-e6c09237d955" xlink:to="loc_us-gaap_RestructuringCharges_c027009d-e14a-41fb-b281-885545d8c1cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_d8fdcef1-4b5b-4cb9-826a-5d8111194b23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_905ed640-ccea-4ed7-b62d-e6c09237d955" xlink:to="loc_us-gaap_PaymentsForRestructuring_d8fdcef1-4b5b-4cb9-826a-5d8111194b23" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_49e0c709-378d-4eea-a27d-fe1da6ad4803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b1a7d48b-7928-4331-91b8-d8d9ed335769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_60a894b8-7228-49f6-a866-bcf883f5891a" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b1a7d48b-7928-4331-91b8-d8d9ed335769" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_6fa365e5-3013-4d91-8d48-c3a196c68993" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b1a7d48b-7928-4331-91b8-d8d9ed335769" xlink:to="loc_us-gaap_RestructuringPlanAxis_6fa365e5-3013-4d91-8d48-c3a196c68993" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_6fa365e5-3013-4d91-8d48-c3a196c68993_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_6fa365e5-3013-4d91-8d48-c3a196c68993" xlink:to="loc_us-gaap_RestructuringPlanDomain_6fa365e5-3013-4d91-8d48-c3a196c68993_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_41d907a5-d2ee-4624-87af-b6aae7303129" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_6fa365e5-3013-4d91-8d48-c3a196c68993" xlink:to="loc_us-gaap_RestructuringPlanDomain_41d907a5-d2ee-4624-87af-b6aae7303129" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ReorganizationPlansMember_50c82705-5ce4-408a-ad46-13ac2f27ef5c" xlink:href="livn-20200930.xsd#livn_ReorganizationPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_41d907a5-d2ee-4624-87af-b6aae7303129" xlink:to="loc_livn_ReorganizationPlansMember_50c82705-5ce4-408a-ad46-13ac2f27ef5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_26045514-1390-4ba1-8c8f-b5931d55b21f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b1a7d48b-7928-4331-91b8-d8d9ed335769" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_26045514-1390-4ba1-8c8f-b5931d55b21f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_26045514-1390-4ba1-8c8f-b5931d55b21f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_26045514-1390-4ba1-8c8f-b5931d55b21f" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_26045514-1390-4ba1-8c8f-b5931d55b21f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_03f56f64-5154-49a3-b51d-5e8265f26bf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_26045514-1390-4ba1-8c8f-b5931d55b21f" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_03f56f64-5154-49a3-b51d-5e8265f26bf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_088417cf-f415-4cc0-8a59-6e169792dbe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_03f56f64-5154-49a3-b51d-5e8265f26bf0" xlink:to="loc_us-gaap_EmployeeSeveranceMember_088417cf-f415-4cc0-8a59-6e169792dbe3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_bd3add2e-1228-4c55-a07a-b23266143ba7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_03f56f64-5154-49a3-b51d-5e8265f26bf0" xlink:to="loc_us-gaap_OtherRestructuringMember_bd3add2e-1228-4c55-a07a-b23266143ba7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#RestructuringRestructuringExpensebySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails" xlink:type="extended" id="i0c3389cc8ac44b85bda7f6558d8db20d_RestructuringRestructuringExpensebySegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_f2019caa-d1c4-4b09-96c0-d989f75fe758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_f2e78353-a9d3-4fc0-925a-51e55490ece3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f2019caa-d1c4-4b09-96c0-d989f75fe758" xlink:to="loc_us-gaap_RestructuringCharges_f2e78353-a9d3-4fc0-925a-51e55490ece3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a990dd14-9f80-43ac-b7fa-448d69fe5490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f2019caa-d1c4-4b09-96c0-d989f75fe758" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a990dd14-9f80-43ac-b7fa-448d69fe5490" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_759ef6e1-0c5e-4c97-aba5-dbd19ba37018" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a990dd14-9f80-43ac-b7fa-448d69fe5490" xlink:to="loc_srt_ConsolidationItemsAxis_759ef6e1-0c5e-4c97-aba5-dbd19ba37018" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_759ef6e1-0c5e-4c97-aba5-dbd19ba37018_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_759ef6e1-0c5e-4c97-aba5-dbd19ba37018" xlink:to="loc_srt_ConsolidationItemsDomain_759ef6e1-0c5e-4c97-aba5-dbd19ba37018_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2cc9d64a-c74b-41a3-a42e-254bb460f26a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_759ef6e1-0c5e-4c97-aba5-dbd19ba37018" xlink:to="loc_srt_ConsolidationItemsDomain_2cc9d64a-c74b-41a3-a42e-254bb460f26a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_7ed8db88-71f3-41bb-b454-8eeece0571e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2cc9d64a-c74b-41a3-a42e-254bb460f26a" xlink:to="loc_us-gaap_OperatingSegmentsMember_7ed8db88-71f3-41bb-b454-8eeece0571e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_d2ad926c-84ec-4575-a6b9-3ffa8546a685" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2cc9d64a-c74b-41a3-a42e-254bb460f26a" xlink:to="loc_us-gaap_CorporateNonSegmentMember_d2ad926c-84ec-4575-a6b9-3ffa8546a685" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9cb47417-9f68-478e-8a42-85b5d6aed1d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a990dd14-9f80-43ac-b7fa-448d69fe5490" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9cb47417-9f68-478e-8a42-85b5d6aed1d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9cb47417-9f68-478e-8a42-85b5d6aed1d3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9cb47417-9f68-478e-8a42-85b5d6aed1d3" xlink:to="loc_us-gaap_SegmentDomain_9cb47417-9f68-478e-8a42-85b5d6aed1d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_43f1fecb-2247-46f8-a7e0-20f111e920f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9cb47417-9f68-478e-8a42-85b5d6aed1d3" xlink:to="loc_us-gaap_SegmentDomain_43f1fecb-2247-46f8-a7e0-20f111e920f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CardiovascularSegmentMember_c42ff708-1358-4fe5-9e31-cb9caffd23ba" xlink:href="livn-20200930.xsd#livn_CardiovascularSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_43f1fecb-2247-46f8-a7e0-20f111e920f9" xlink:to="loc_livn_CardiovascularSegmentMember_c42ff708-1358-4fe5-9e31-cb9caffd23ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_NeuromodulationSegmentMember_ca4d3e55-6f2b-4529-8298-59eaffe6a853" xlink:href="livn-20200930.xsd#livn_NeuromodulationSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_43f1fecb-2247-46f8-a7e0-20f111e920f9" xlink:to="loc_livn_NeuromodulationSegmentMember_ca4d3e55-6f2b-4529-8298-59eaffe6a853" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/ProductRemediationLiability" xlink:type="simple" xlink:href="livn-20200930.xsd#ProductRemediationLiability"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/ProductRemediationLiability" xlink:type="extended" id="i5a8166e43b614f1bb57188d6914dd626_ProductRemediationLiability"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityTables" xlink:type="simple" xlink:href="livn-20200930.xsd#ProductRemediationLiabilityTables"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityTables" xlink:type="extended" id="ic5d7260b8ff34334bae08944486964e2_ProductRemediationLiabilityTables"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#ProductRemediationLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails" xlink:type="extended" id="ic9e1565719c14b81bfcabeeb2a21dbb5_ProductRemediationLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems_29f04941-7a7b-4e28-8a7e-1861a381e7a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_d5682a88-f9fb-4bc5-aea3-905ce95371eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_29f04941-7a7b-4e28-8a7e-1861a381e7a4" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_d5682a88-f9fb-4bc5-aea3-905ce95371eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable_9595cd14-5b1d-4503-9e61-dd786c74b5cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductLiabilityContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_29f04941-7a7b-4e28-8a7e-1861a381e7a4" xlink:to="loc_us-gaap_ProductLiabilityContingencyTable_9595cd14-5b1d-4503-9e61-dd786c74b5cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_9e870b0a-6f51-4cce-8594-557a986ed582" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_9595cd14-5b1d-4503-9e61-dd786c74b5cc" xlink:to="loc_srt_LitigationCaseAxis_9e870b0a-6f51-4cce-8594-557a986ed582" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9e870b0a-6f51-4cce-8594-557a986ed582_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_9e870b0a-6f51-4cce-8594-557a986ed582" xlink:to="loc_srt_LitigationCaseTypeDomain_9e870b0a-6f51-4cce-8594-557a986ed582_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_3e458e0d-fdb5-438c-bed2-53bc2fdcdbfb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_9e870b0a-6f51-4cce-8594-557a986ed582" xlink:to="loc_srt_LitigationCaseTypeDomain_3e458e0d-fdb5-438c-bed2-53bc2fdcdbfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductLiabilityMember_f96aaf6f-cb37-4c69-a560-74b4901f4e18" xlink:href="livn-20200930.xsd#livn_ProductLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_3e458e0d-fdb5-438c-bed2-53bc2fdcdbfb" xlink:to="loc_livn_ProductLiabilityMember_f96aaf6f-cb37-4c69-a560-74b4901f4e18" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/Investments" xlink:type="simple" xlink:href="livn-20200930.xsd#Investments"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/Investments" xlink:type="extended" id="ic6f9e91cce044328987b24fc3b9b5ae5_Investments"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/InvestmentsTables" xlink:type="simple" xlink:href="livn-20200930.xsd#InvestmentsTables"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/InvestmentsTables" xlink:type="extended" id="i5330ec1de5064a97a4b2e4353c781359_InvestmentsTables"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/InvestmentsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#InvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/InvestmentsDetails" xlink:type="extended" id="i1f45c00c47964a5289d9390ea5d69f19_InvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8586e50b-1999-442e-a490-ea77e91591a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c14d11c4-088d-43a3-9bd2-d4542f10d244" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8586e50b-1999-442e-a490-ea77e91591a2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c14d11c4-088d-43a3-9bd2-d4542f10d244" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ca1cdae4-4ee5-4970-9727-d073775003c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8586e50b-1999-442e-a490-ea77e91591a2" xlink:to="loc_us-gaap_EquityMethodInvestments_ca1cdae4-4ee5-4970-9727-d073775003c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_af29c411-c321-4ee4-8616-fc675b37bd07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8586e50b-1999-442e-a490-ea77e91591a2" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_af29c411-c321-4ee4-8616-fc675b37bd07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_431362e9-646d-457f-b40b-2a45900d4797" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8586e50b-1999-442e-a490-ea77e91591a2" xlink:to="loc_us-gaap_NotesReceivableNet_431362e9-646d-457f-b40b-2a45900d4797" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableGross_28b78ba9-9e6a-4962-9414-0a8f9178ba45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8586e50b-1999-442e-a490-ea77e91591a2" xlink:to="loc_us-gaap_NotesReceivableGross_28b78ba9-9e6a-4962-9414-0a8f9178ba45" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bed31cb3-5330-44ea-99bc-6e4c6e3527c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8586e50b-1999-442e-a490-ea77e91591a2" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bed31cb3-5330-44ea-99bc-6e4c6e3527c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d6748ea4-017e-4e79-94f1-e4ea307fc04a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bed31cb3-5330-44ea-99bc-6e4c6e3527c8" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d6748ea4-017e-4e79-94f1-e4ea307fc04a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d6748ea4-017e-4e79-94f1-e4ea307fc04a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d6748ea4-017e-4e79-94f1-e4ea307fc04a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d6748ea4-017e-4e79-94f1-e4ea307fc04a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d6748ea4-017e-4e79-94f1-e4ea307fc04a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_RespicardiaMember_4b62053b-8426-4b63-a238-e23733454998" xlink:href="livn-20200930.xsd#livn_RespicardiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:to="loc_livn_RespicardiaMember_4b62053b-8426-4b63-a238-e23733454998" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ALungTechnologiesInc.Member_e1b356be-5fb6-4b84-9bdf-5bbbfd041653" xlink:href="livn-20200930.xsd#livn_ALungTechnologiesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:to="loc_livn_ALungTechnologiesInc.Member_e1b356be-5fb6-4b84-9bdf-5bbbfd041653" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CeribellInc.Member_667a8a49-1b18-4fa3-9a4f-b68233b9319a" xlink:href="livn-20200930.xsd#livn_CeribellInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:to="loc_livn_CeribellInc.Member_667a8a49-1b18-4fa3-9a4f-b68233b9319a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ShiraTronicsInc.Member_aa5ccda3-fe8b-44bb-a84e-aab4d568f50f" xlink:href="livn-20200930.xsd#livn_ShiraTronicsInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:to="loc_livn_ShiraTronicsInc.Member_aa5ccda3-fe8b-44bb-a84e-aab4d568f50f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MDStartIIMember_9a6d0c66-45fa-4280-b325-118a5de754fd" xlink:href="livn-20200930.xsd#livn_MDStartIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:to="loc_livn_MDStartIIMember_9a6d0c66-45fa-4280-b325-118a5de754fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_RainbowMedicalLtd.Member_59e8c27d-0ac0-4862-a6ec-01e0e814d049" xlink:href="livn-20200930.xsd#livn_RainbowMedicalLtd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:to="loc_livn_RainbowMedicalLtd.Member_59e8c27d-0ac0-4862-a6ec-01e0e814d049" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_HighlifeS.A.S.Member_cdeb39eb-7fe8-4ca3-9994-e000b1d0d3f6" xlink:href="livn-20200930.xsd#livn_HighlifeS.A.S.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:to="loc_livn_HighlifeS.A.S.Member_cdeb39eb-7fe8-4ca3-9994-e000b1d0d3f6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_OtherMember_c30f8ecd-a894-4f6a-a429-82ba3737c482" xlink:href="livn-20200930.xsd#livn_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:to="loc_livn_OtherMember_c30f8ecd-a894-4f6a-a429-82ba3737c482" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_5b3ff69e-e57e-47f6-8f45-b7cd21c17737" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bed31cb3-5330-44ea-99bc-6e4c6e3527c8" xlink:to="loc_srt_CounterpartyNameAxis_5b3ff69e-e57e-47f6-8f45-b7cd21c17737" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5b3ff69e-e57e-47f6-8f45-b7cd21c17737_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_5b3ff69e-e57e-47f6-8f45-b7cd21c17737" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5b3ff69e-e57e-47f6-8f45-b7cd21c17737_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3ba0c23-1ae9-4234-a984-0ee5f7ffb9de" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_5b3ff69e-e57e-47f6-8f45-b7cd21c17737" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3ba0c23-1ae9-4234-a984-0ee5f7ffb9de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_RespicardiaMember_8b76a13d-ff7c-4b15-9179-cc33010375a5" xlink:href="livn-20200930.xsd#livn_RespicardiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3ba0c23-1ae9-4234-a984-0ee5f7ffb9de" xlink:to="loc_livn_RespicardiaMember_8b76a13d-ff7c-4b15-9179-cc33010375a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ALungTechnologiesInc.Member_a667caaf-0ff8-46c5-a36f-24aaf4c6952c" xlink:href="livn-20200930.xsd#livn_ALungTechnologiesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3ba0c23-1ae9-4234-a984-0ee5f7ffb9de" xlink:to="loc_livn_ALungTechnologiesInc.Member_a667caaf-0ff8-46c5-a36f-24aaf4c6952c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6984afb1-9d2a-40fb-a93e-3837b8553cc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bed31cb3-5330-44ea-99bc-6e4c6e3527c8" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6984afb1-9d2a-40fb-a93e-3837b8553cc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_6984afb1-9d2a-40fb-a93e-3837b8553cc0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6984afb1-9d2a-40fb-a93e-3837b8553cc0" xlink:to="loc_us-gaap_RelatedPartyDomain_6984afb1-9d2a-40fb-a93e-3837b8553cc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_79bfe844-63f7-48b9-88dd-c898cc0561ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6984afb1-9d2a-40fb-a93e-3837b8553cc0" xlink:to="loc_us-gaap_RelatedPartyDomain_79bfe844-63f7-48b9-88dd-c898cc0561ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_3f25501e-2a99-4b0e-bd8c-f1262a08eab6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_79bfe844-63f7-48b9-88dd-c898cc0561ba" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_3f25501e-2a99-4b0e-bd8c-f1262a08eab6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_43ae4b17-6f18-4bc8-9293-e6bfd5e15ea6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bed31cb3-5330-44ea-99bc-6e4c6e3527c8" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_43ae4b17-6f18-4bc8-9293-e6bfd5e15ea6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_43ae4b17-6f18-4bc8-9293-e6bfd5e15ea6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_43ae4b17-6f18-4bc8-9293-e6bfd5e15ea6" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_43ae4b17-6f18-4bc8-9293-e6bfd5e15ea6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_692ff6da-f82f-4e2d-96b0-27c13036575b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_43ae4b17-6f18-4bc8-9293-e6bfd5e15ea6" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_692ff6da-f82f-4e2d-96b0-27c13036575b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_6ce71bc5-e721-4cc4-b620-3dcb099748bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_692ff6da-f82f-4e2d-96b0-27c13036575b" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_6ce71bc5-e721-4cc4-b620-3dcb099748bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_78d2c16f-5ce1-4ba0-8e79-963a8e0b9d90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bed31cb3-5330-44ea-99bc-6e4c6e3527c8" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_78d2c16f-5ce1-4ba0-8e79-963a8e0b9d90" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_78d2c16f-5ce1-4ba0-8e79-963a8e0b9d90_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_78d2c16f-5ce1-4ba0-8e79-963a8e0b9d90" xlink:to="loc_us-gaap_ReceivableTypeDomain_78d2c16f-5ce1-4ba0-8e79-963a8e0b9d90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_ebd4e590-0da5-4ec0-a842-f66f6eb30e0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_78d2c16f-5ce1-4ba0-8e79-963a8e0b9d90" xlink:to="loc_us-gaap_ReceivableTypeDomain_ebd4e590-0da5-4ec0-a842-f66f6eb30e0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ConvertibleNotesReceivableMember_7e42e3b4-c99e-4936-b711-e3d20ba7ecb4" xlink:href="livn-20200930.xsd#livn_ConvertibleNotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_ebd4e590-0da5-4ec0-a842-f66f6eb30e0d" xlink:to="loc_livn_ConvertibleNotesReceivableMember_7e42e3b4-c99e-4936-b711-e3d20ba7ecb4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurements" xlink:type="extended" id="icc3639e517c6443ea67f68e4818b2abc_FairValueMeasurements"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurementsTables" xlink:type="extended" id="i8f1f2c2677e34e569cc8e151059cc3ba_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended" id="ifdda89977cff4663ad71f5fb49cb58c0_FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0496e19a-01e7-41b6-833a-10cad35c4369" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_af555a40-9d0b-4e8a-b9d1-f9a84cc65ba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0496e19a-01e7-41b6-833a-10cad35c4369" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_af555a40-9d0b-4e8a-b9d1-f9a84cc65ba9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_6a98f04a-6f3f-485d-bf81-aabdb575be3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_af555a40-9d0b-4e8a-b9d1-f9a84cc65ba9" xlink:to="loc_us-gaap_DerivativeAssets_6a98f04a-6f3f-485d-bf81-aabdb575be3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFairValueDisclosure_fa2a382e-e8b0-4d41-bcb4-aa86d320cb04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_af555a40-9d0b-4e8a-b9d1-f9a84cc65ba9" xlink:to="loc_us-gaap_ReceivablesFairValueDisclosure_fa2a382e-e8b0-4d41-bcb4-aa86d320cb04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_9f79db41-ec2e-4866-8088-fd737213c81a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_af555a40-9d0b-4e8a-b9d1-f9a84cc65ba9" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_9f79db41-ec2e-4866-8088-fd737213c81a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_127e1924-7f60-4760-a6a2-957ffd077ade" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0496e19a-01e7-41b6-833a-10cad35c4369" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_127e1924-7f60-4760-a6a2-957ffd077ade" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_a92d0fb4-e2d6-448d-bbc4-bea50acd202d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_127e1924-7f60-4760-a6a2-957ffd077ade" xlink:to="loc_us-gaap_DerivativeLiabilities_a92d0fb4-e2d6-448d-bbc4-bea50acd202d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_989d9410-cd52-480e-8aaa-8973529c83cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_127e1924-7f60-4760-a6a2-957ffd077ade" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_989d9410-cd52-480e-8aaa-8973529c83cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_d257067b-882d-4aa4-9a42-2a0025f2f2e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_127e1924-7f60-4760-a6a2-957ffd077ade" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_d257067b-882d-4aa4-9a42-2a0025f2f2e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8fa56db8-1ae6-40db-af1f-ae25074482c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0496e19a-01e7-41b6-833a-10cad35c4369" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8fa56db8-1ae6-40db-af1f-ae25074482c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0359320e-1170-4d14-abf3-b159829ec7b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8fa56db8-1ae6-40db-af1f-ae25074482c0" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0359320e-1170-4d14-abf3-b159829ec7b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0359320e-1170-4d14-abf3-b159829ec7b7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0359320e-1170-4d14-abf3-b159829ec7b7" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0359320e-1170-4d14-abf3-b159829ec7b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_827fb84d-3b94-4e12-9616-c1d0eb98e7a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0359320e-1170-4d14-abf3-b159829ec7b7" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_827fb84d-3b94-4e12-9616-c1d0eb98e7a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_9b53d6bc-3157-4170-86c6-dd5bf1fc4a20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_827fb84d-3b94-4e12-9616-c1d0eb98e7a1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_9b53d6bc-3157-4170-86c6-dd5bf1fc4a20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ebaaf3dc-653d-4415-b14a-595949a34d05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8fa56db8-1ae6-40db-af1f-ae25074482c0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ebaaf3dc-653d-4415-b14a-595949a34d05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ebaaf3dc-653d-4415-b14a-595949a34d05_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ebaaf3dc-653d-4415-b14a-595949a34d05" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ebaaf3dc-653d-4415-b14a-595949a34d05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7eb1df58-e87e-4212-9fb8-a0f2703d0d0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ebaaf3dc-653d-4415-b14a-595949a34d05" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7eb1df58-e87e-4212-9fb8-a0f2703d0d0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_40ca1acf-24cf-4c9d-93d8-f534fdab8c89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7eb1df58-e87e-4212-9fb8-a0f2703d0d0e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_40ca1acf-24cf-4c9d-93d8-f534fdab8c89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_24ae7434-b61c-47cc-bbfb-763eefbdbd4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7eb1df58-e87e-4212-9fb8-a0f2703d0d0e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_24ae7434-b61c-47cc-bbfb-763eefbdbd4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_91873b22-e517-455b-a612-c2023f90e12a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7eb1df58-e87e-4212-9fb8-a0f2703d0d0e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_91873b22-e517-455b-a612-c2023f90e12a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0b152fbd-e8b9-41e7-94f5-4fb7ca01e3ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8fa56db8-1ae6-40db-af1f-ae25074482c0" xlink:to="loc_us-gaap_HedgingDesignationAxis_0b152fbd-e8b9-41e7-94f5-4fb7ca01e3ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0b152fbd-e8b9-41e7-94f5-4fb7ca01e3ee_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_0b152fbd-e8b9-41e7-94f5-4fb7ca01e3ee" xlink:to="loc_us-gaap_HedgingDesignationDomain_0b152fbd-e8b9-41e7-94f5-4fb7ca01e3ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_abe6caec-d712-4a72-8155-798bd2b0e133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_0b152fbd-e8b9-41e7-94f5-4fb7ca01e3ee" xlink:to="loc_us-gaap_HedgingDesignationDomain_abe6caec-d712-4a72-8155-798bd2b0e133" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5b8b3c4e-53ed-475e-ac67-936f96a258f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_abe6caec-d712-4a72-8155-798bd2b0e133" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5b8b3c4e-53ed-475e-ac67-936f96a258f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_8145320e-70f0-49ce-b4a5-708b5273e777" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_abe6caec-d712-4a72-8155-798bd2b0e133" xlink:to="loc_us-gaap_NondesignatedMember_8145320e-70f0-49ce-b4a5-708b5273e777" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_acc92698-f872-4387-9aae-efe48c201162" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8fa56db8-1ae6-40db-af1f-ae25074482c0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_acc92698-f872-4387-9aae-efe48c201162" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_acc92698-f872-4387-9aae-efe48c201162_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_acc92698-f872-4387-9aae-efe48c201162" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_acc92698-f872-4387-9aae-efe48c201162_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9999533a-e712-4875-8674-736bfd340001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_acc92698-f872-4387-9aae-efe48c201162" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9999533a-e712-4875-8674-736bfd340001" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_3efc98fc-8c7e-47e0-aff2-f3cc3a71e96a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9999533a-e712-4875-8674-736bfd340001" xlink:to="loc_us-gaap_ForeignExchangeContractMember_3efc98fc-8c7e-47e0-aff2-f3cc3a71e96a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CappedCallMember_89df2410-ee48-4a5d-a358-e86afd884739" xlink:href="livn-20200930.xsd#livn_CappedCallMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9999533a-e712-4875-8674-736bfd340001" xlink:to="loc_livn_CappedCallMember_89df2410-ee48-4a5d-a358-e86afd884739" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_02fd6259-b6d3-4fbb-8edd-1cb998335c9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9999533a-e712-4875-8674-736bfd340001" xlink:to="loc_us-gaap_InterestRateContractMember_02fd6259-b6d3-4fbb-8edd-1cb998335c9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_2662d1f0-651b-4f44-bd1e-f5cdcd076c80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9999533a-e712-4875-8674-736bfd340001" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_2662d1f0-651b-4f44-bd1e-f5cdcd076c80" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_938901fe-5690-40ae-886a-46c983f62ddc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9999533a-e712-4875-8674-736bfd340001" xlink:to="loc_us-gaap_OtherContractMember_938901fe-5690-40ae-886a-46c983f62ddc" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurementsContingentConsiderationReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails" xlink:type="extended" id="i4365b21bdb354cb7b91295a3d014b8aa_FairValueMeasurementsContingentConsiderationReconciliationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a59ba545-7212-4371-947f-744fa90888f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a59ba545-7212-4371-947f-744fa90888f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_72706057-73a3-4a2e-9f0b-8a1d3682cf55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a59ba545-7212-4371-947f-744fa90888f7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_72706057-73a3-4a2e-9f0b-8a1d3682cf55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_7300a6c2-52de-47b7-9096-48ba39c0400c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a59ba545-7212-4371-947f-744fa90888f7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_7300a6c2-52de-47b7-9096-48ba39c0400c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_f5a2f483-d5b4-441f-8422-87cf3e0bc323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a59ba545-7212-4371-947f-744fa90888f7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_f5a2f483-d5b4-441f-8422-87cf3e0bc323" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_e16efcc5-707b-41e9-a121-6019d2794a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a59ba545-7212-4371-947f-744fa90888f7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_e16efcc5-707b-41e9-a121-6019d2794a1d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_51e4883d-3b48-44e4-abc3-c602de30f512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a59ba545-7212-4371-947f-744fa90888f7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_51e4883d-3b48-44e4-abc3-c602de30f512" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1fd5c670-85ba-444f-a467-76181df92d80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue_a6f0cfd9-f6c0-497e-85a3-6402f119f113" xlink:href="livn-20200930.xsd#livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue_a6f0cfd9-f6c0-497e-85a3-6402f119f113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue_e9c8b20e-3b8d-4c79-ae60-f66a95ec5acc" xlink:href="livn-20200930.xsd#livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue_e9c8b20e-3b8d-4c79-ae60-f66a95ec5acc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7b9495c4-138b-4a12-b16b-e46697154059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7b9495c4-138b-4a12-b16b-e46697154059" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_36c0ad26-48be-45e1-8d55-0e58bf78f9cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7b9495c4-138b-4a12-b16b-e46697154059" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_36c0ad26-48be-45e1-8d55-0e58bf78f9cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_0912a675-cf00-495f-95f7-a307fe78717d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7b9495c4-138b-4a12-b16b-e46697154059" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_0912a675-cf00-495f-95f7-a307fe78717d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_25ceef6a-dc92-4b21-b8ec-a5294e316f71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7b9495c4-138b-4a12-b16b-e46697154059" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_25ceef6a-dc92-4b21-b8ec-a5294e316f71" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_a2f006b4-0b2b-467f-a530-d384e7acca77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7b9495c4-138b-4a12-b16b-e46697154059" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_a2f006b4-0b2b-467f-a530-d384e7acca77" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_f1a0e48c-b510-4e1f-abae-e529a1551f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7b9495c4-138b-4a12-b16b-e46697154059" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_f1a0e48c-b510-4e1f-abae-e529a1551f3b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_e577bd15-4fb0-4d5a-bf66-210bec5bedd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue_ea9a071d-8823-4f3c-8d9b-5105740e6f4c" xlink:href="livn-20200930.xsd#livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue_ea9a071d-8823-4f3c-8d9b-5105740e6f4c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue_499d5f85-d351-43d5-9a4b-3d8defae7b7d" xlink:href="livn-20200930.xsd#livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue_499d5f85-d351-43d5-9a4b-3d8defae7b7d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_a075b812-1478-4924-9a7a-945d10583d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_a075b812-1478-4924-9a7a-945d10583d4e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_NumberOfDistributorsAcquired_ae68d713-dd1e-42af-b5fd-370e46de8291" xlink:href="livn-20200930.xsd#livn_NumberOfDistributorsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_livn_NumberOfDistributorsAcquired_ae68d713-dd1e-42af-b5fd-370e46de8291" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BusinessCombinationMilestoneAchievementPeriodOfDelay_10c6c5cb-4061-4976-83cb-989b77a8e2cf" xlink:href="livn-20200930.xsd#livn_BusinessCombinationMilestoneAchievementPeriodOfDelay"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_livn_BusinessCombinationMilestoneAchievementPeriodOfDelay_10c6c5cb-4061-4976-83cb-989b77a8e2cf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_59f1b329-8ce3-4855-91a0-b1ab5ddab940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_59f1b329-8ce3-4855-91a0-b1ab5ddab940" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc037298-5a07-41ba-8fcc-427da8c812bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc037298-5a07-41ba-8fcc-427da8c812bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ddc74381-35e6-41da-80ec-e68f32402542" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc037298-5a07-41ba-8fcc-427da8c812bb" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ddc74381-35e6-41da-80ec-e68f32402542" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ddc74381-35e6-41da-80ec-e68f32402542_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ddc74381-35e6-41da-80ec-e68f32402542" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ddc74381-35e6-41da-80ec-e68f32402542_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9586eebd-090e-4b29-a8ef-fa8e1f68655d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ddc74381-35e6-41da-80ec-e68f32402542" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9586eebd-090e-4b29-a8ef-fa8e1f68655d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_e3b5ca72-e00e-4bd9-b628-30a0a5904384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_9586eebd-090e-4b29-a8ef-fa8e1f68655d" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_e3b5ca72-e00e-4bd9-b628-30a0a5904384" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eefeecc0-e2a2-4f46-8cd0-669f5a5efa12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc037298-5a07-41ba-8fcc-427da8c812bb" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eefeecc0-e2a2-4f46-8cd0-669f5a5efa12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eefeecc0-e2a2-4f46-8cd0-669f5a5efa12_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eefeecc0-e2a2-4f46-8cd0-669f5a5efa12" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eefeecc0-e2a2-4f46-8cd0-669f5a5efa12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9038e1e-476f-4968-acde-83c1a14342fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eefeecc0-e2a2-4f46-8cd0-669f5a5efa12" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9038e1e-476f-4968-acde-83c1a14342fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_61cccf67-e884-4db7-a46b-ba735b235730" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9038e1e-476f-4968-acde-83c1a14342fc" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_61cccf67-e884-4db7-a46b-ba735b235730" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_03b9470f-2cce-4d69-a8e8-3d382be98f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc037298-5a07-41ba-8fcc-427da8c812bb" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_03b9470f-2cce-4d69-a8e8-3d382be98f99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_03b9470f-2cce-4d69-a8e8-3d382be98f99_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_03b9470f-2cce-4d69-a8e8-3d382be98f99" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_03b9470f-2cce-4d69-a8e8-3d382be98f99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d4c1bf77-e275-4bef-8ef9-65654f8ab0fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_03b9470f-2cce-4d69-a8e8-3d382be98f99" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d4c1bf77-e275-4bef-8ef9-65654f8ab0fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_3f9dd840-c0a2-40a5-8652-c7c91824ac85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d4c1bf77-e275-4bef-8ef9-65654f8ab0fb" xlink:to="loc_us-gaap_CostOfSalesMember_3f9dd840-c0a2-40a5-8652-c7c91824ac85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_989d464a-b206-4a2f-b816-f6ab356358d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d4c1bf77-e275-4bef-8ef9-65654f8ab0fb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_989d464a-b206-4a2f-b816-f6ab356358d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_3b541ae6-5c25-4a57-925a-2721c5724e33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc037298-5a07-41ba-8fcc-427da8c812bb" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_3b541ae6-5c25-4a57-925a-2721c5724e33" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3b541ae6-5c25-4a57-925a-2721c5724e33_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_3b541ae6-5c25-4a57-925a-2721c5724e33" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3b541ae6-5c25-4a57-925a-2721c5724e33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_751c9ca1-05a9-4dee-b136-d9bd10b9635b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_3b541ae6-5c25-4a57-925a-2721c5724e33" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_751c9ca1-05a9-4dee-b136-d9bd10b9635b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_2715c943-3896-4b27-807d-b5efbb2249bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_751c9ca1-05a9-4dee-b136-d9bd10b9635b" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_2715c943-3896-4b27-807d-b5efbb2249bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_cae24f16-c1e2-4a16-a602-a5158a2b6f94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_751c9ca1-05a9-4dee-b136-d9bd10b9635b" xlink:to="loc_us-gaap_NotesReceivableMember_cae24f16-c1e2-4a16-a602-a5158a2b6f94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_743fdc95-19da-4b11-85df-2adf108638b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc037298-5a07-41ba-8fcc-427da8c812bb" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_743fdc95-19da-4b11-85df-2adf108638b1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_743fdc95-19da-4b11-85df-2adf108638b1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_743fdc95-19da-4b11-85df-2adf108638b1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_743fdc95-19da-4b11-85df-2adf108638b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_18202230-440d-4327-b840-fa5c4548039e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_743fdc95-19da-4b11-85df-2adf108638b1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_18202230-440d-4327-b840-fa5c4548039e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_EmbeddedExchangeFeatureLiabilityMember_c87ca2b5-7936-4884-9955-faa1b8b6d4e2" xlink:href="livn-20200930.xsd#livn_EmbeddedExchangeFeatureLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_18202230-440d-4327-b840-fa5c4548039e" xlink:to="loc_livn_EmbeddedExchangeFeatureLiabilityMember_c87ca2b5-7936-4884-9955-faa1b8b6d4e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_36a689cd-dcd7-4805-aa92-ac9a9192499e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_18202230-440d-4327-b840-fa5c4548039e" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_36a689cd-dcd7-4805-aa92-ac9a9192499e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ContingentConsiderationLiabilityMember_636fe354-ed8a-45c6-bda5-6c1f3c471297" xlink:href="livn-20200930.xsd#livn_ContingentConsiderationLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_18202230-440d-4327-b840-fa5c4548039e" xlink:to="loc_livn_ContingentConsiderationLiabilityMember_636fe354-ed8a-45c6-bda5-6c1f3c471297" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="i9e0ed9071c744b15afcbcebdec497ce7_FairValueMeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_13b0a885-e9ec-428a-a211-1ebfc7913a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a997f008-664c-4cec-b44a-a4096897b24c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_13b0a885-e9ec-428a-a211-1ebfc7913a9f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a997f008-664c-4cec-b44a-a4096897b24c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_64bfb9ec-4a86-4227-a624-8fad54228f90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_13b0a885-e9ec-428a-a211-1ebfc7913a9f" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_64bfb9ec-4a86-4227-a624-8fad54228f90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue_87383163-690c-4801-bf53-013c427ed98f" xlink:href="livn-20200930.xsd#livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_13b0a885-e9ec-428a-a211-1ebfc7913a9f" xlink:to="loc_livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue_87383163-690c-4801-bf53-013c427ed98f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue_ed34d295-ac14-4e28-b4cf-26342bd60d9c" xlink:href="livn-20200930.xsd#livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_13b0a885-e9ec-428a-a211-1ebfc7913a9f" xlink:to="loc_livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue_ed34d295-ac14-4e28-b4cf-26342bd60d9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fc34d42e-21c1-43d5-b144-61ecac3123cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_13b0a885-e9ec-428a-a211-1ebfc7913a9f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fc34d42e-21c1-43d5-b144-61ecac3123cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_7a15376c-3afe-4e63-a21f-6fc3e55f70e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fc34d42e-21c1-43d5-b144-61ecac3123cd" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_7a15376c-3afe-4e63-a21f-6fc3e55f70e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_7a15376c-3afe-4e63-a21f-6fc3e55f70e2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_7a15376c-3afe-4e63-a21f-6fc3e55f70e2" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_7a15376c-3afe-4e63-a21f-6fc3e55f70e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_6df05de8-2a38-4696-b2b0-0cd55a6ed17a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_7a15376c-3afe-4e63-a21f-6fc3e55f70e2" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_6df05de8-2a38-4696-b2b0-0cd55a6ed17a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MeasurementInputStockPriceVolatilityMember_e937068d-0141-4f57-bd19-f0d72384e746" xlink:href="livn-20200930.xsd#livn_MeasurementInputStockPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6df05de8-2a38-4696-b2b0-0cd55a6ed17a" xlink:to="loc_livn_MeasurementInputStockPriceVolatilityMember_e937068d-0141-4f57-bd19-f0d72384e746" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_97373159-9092-4e12-80ba-1160313b3c47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fc34d42e-21c1-43d5-b144-61ecac3123cd" xlink:to="loc_us-gaap_DebtInstrumentAxis_97373159-9092-4e12-80ba-1160313b3c47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_97373159-9092-4e12-80ba-1160313b3c47_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_97373159-9092-4e12-80ba-1160313b3c47" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_97373159-9092-4e12-80ba-1160313b3c47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0bb6c8a2-3948-4e53-b7d1-69d7f6c3592e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_97373159-9092-4e12-80ba-1160313b3c47" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0bb6c8a2-3948-4e53-b7d1-69d7f6c3592e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_A2020CashExchangeableSeniorNotesMember_7111a2e8-4e6d-4943-bd0a-88d0c9164bef" xlink:href="livn-20200930.xsd#livn_A2020CashExchangeableSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0bb6c8a2-3948-4e53-b7d1-69d7f6c3592e" xlink:to="loc_livn_A2020CashExchangeableSeniorNotesMember_7111a2e8-4e6d-4943-bd0a-88d0c9164bef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5f1ea960-bc15-453f-93a1-6e6d4a7421f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fc34d42e-21c1-43d5-b144-61ecac3123cd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5f1ea960-bc15-453f-93a1-6e6d4a7421f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5f1ea960-bc15-453f-93a1-6e6d4a7421f8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5f1ea960-bc15-453f-93a1-6e6d4a7421f8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5f1ea960-bc15-453f-93a1-6e6d4a7421f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cd7e1149-80da-49ef-a791-64c52a895000" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5f1ea960-bc15-453f-93a1-6e6d4a7421f8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cd7e1149-80da-49ef-a791-64c52a895000" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_cf7c4d2f-8611-4acf-b903-48de28906b4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_cd7e1149-80da-49ef-a791-64c52a895000" xlink:to="loc_us-gaap_SeniorNotesMember_cf7c4d2f-8611-4acf-b903-48de28906b4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4835056d-194c-4fe8-b26c-1fdb41ad37b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fc34d42e-21c1-43d5-b144-61ecac3123cd" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4835056d-194c-4fe8-b26c-1fdb41ad37b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4835056d-194c-4fe8-b26c-1fdb41ad37b8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4835056d-194c-4fe8-b26c-1fdb41ad37b8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4835056d-194c-4fe8-b26c-1fdb41ad37b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6fbbc6ea-3fd9-40aa-abaa-caf08e7ebb72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4835056d-194c-4fe8-b26c-1fdb41ad37b8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6fbbc6ea-3fd9-40aa-abaa-caf08e7ebb72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_e8d1a7a7-a0b3-485c-9795-5363c166ab0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6fbbc6ea-3fd9-40aa-abaa-caf08e7ebb72" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_e8d1a7a7-a0b3-485c-9795-5363c166ab0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CappedCallMember_0cd87e9c-7e7c-4910-8c40-bce8bbf54593" xlink:href="livn-20200930.xsd#livn_CappedCallMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6fbbc6ea-3fd9-40aa-abaa-caf08e7ebb72" xlink:to="loc_livn_CappedCallMember_0cd87e9c-7e7c-4910-8c40-bce8bbf54593" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails" xlink:type="extended" id="ib34927d825d146b793828618a3bf5c5e_FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_74055d5e-de42-4ef5-b722-9e951e55e0eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8e474da5-ba1f-4115-8fe3-8e68aecdab8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_74055d5e-de42-4ef5-b722-9e951e55e0eb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8e474da5-ba1f-4115-8fe3-8e68aecdab8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4d297a1f-f65e-4744-9a8d-53bc4c053cc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_74055d5e-de42-4ef5-b722-9e951e55e0eb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4d297a1f-f65e-4744-9a8d-53bc4c053cc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8072e451-d186-45ab-958b-3817926769d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_74055d5e-de42-4ef5-b722-9e951e55e0eb" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8072e451-d186-45ab-958b-3817926769d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d7e797b1-c80d-4bee-aeba-5f62ac359fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8072e451-d186-45ab-958b-3817926769d7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d7e797b1-c80d-4bee-aeba-5f62ac359fe5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d7e797b1-c80d-4bee-aeba-5f62ac359fe5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d7e797b1-c80d-4bee-aeba-5f62ac359fe5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d7e797b1-c80d-4bee-aeba-5f62ac359fe5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fb2c24f7-7ceb-499f-81ed-0251a762fc91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d7e797b1-c80d-4bee-aeba-5f62ac359fe5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fb2c24f7-7ceb-499f-81ed-0251a762fc91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ImTheraMedicalInc.Member_8c9709ba-bc22-4262-995d-52fc78e4381c" xlink:href="livn-20200930.xsd#livn_ImTheraMedicalInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fb2c24f7-7ceb-499f-81ed-0251a762fc91" xlink:to="loc_livn_ImTheraMedicalInc.Member_8c9709ba-bc22-4262-995d-52fc78e4381c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_TandemLifeMember_0dd9b95d-f13e-4cd3-99a8-bf730f9122af" xlink:href="livn-20200930.xsd#livn_TandemLifeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fb2c24f7-7ceb-499f-81ed-0251a762fc91" xlink:to="loc_livn_TandemLifeMember_0dd9b95d-f13e-4cd3-99a8-bf730f9122af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MiamiInstrumentsLLCMember_ee4cdf61-b762-41e2-9639-a03bc29e731a" xlink:href="livn-20200930.xsd#livn_MiamiInstrumentsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fb2c24f7-7ceb-499f-81ed-0251a762fc91" xlink:to="loc_livn_MiamiInstrumentsLLCMember_ee4cdf61-b762-41e2-9639-a03bc29e731a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DrilltexMember_275001ed-9f6f-43b1-a1cd-bdf0139a90b0" xlink:href="livn-20200930.xsd#livn_DrilltexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fb2c24f7-7ceb-499f-81ed-0251a762fc91" xlink:to="loc_livn_DrilltexMember_275001ed-9f6f-43b1-a1cd-bdf0139a90b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_OtherMember_3174f5f8-efb2-4068-a901-3ae2ab73ffd5" xlink:href="livn-20200930.xsd#livn_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fb2c24f7-7ceb-499f-81ed-0251a762fc91" xlink:to="loc_livn_OtherMember_3174f5f8-efb2-4068-a901-3ae2ab73ffd5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d356fade-2fea-49a5-8727-cb7e4af2ecf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8072e451-d186-45ab-958b-3817926769d7" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d356fade-2fea-49a5-8727-cb7e4af2ecf4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d356fade-2fea-49a5-8727-cb7e4af2ecf4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d356fade-2fea-49a5-8727-cb7e4af2ecf4" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d356fade-2fea-49a5-8727-cb7e4af2ecf4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_74de2b08-84b8-48cd-a326-7a5f306504b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d356fade-2fea-49a5-8727-cb7e4af2ecf4" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_74de2b08-84b8-48cd-a326-7a5f306504b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_9cc104c2-acbd-4a1c-b46c-1c9b09204c60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_74de2b08-84b8-48cd-a326-7a5f306504b3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_9cc104c2-acbd-4a1c-b46c-1c9b09204c60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c3b6e172-47f3-4555-8b7f-9f2ea5a226af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8072e451-d186-45ab-958b-3817926769d7" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c3b6e172-47f3-4555-8b7f-9f2ea5a226af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3b6e172-47f3-4555-8b7f-9f2ea5a226af_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c3b6e172-47f3-4555-8b7f-9f2ea5a226af" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3b6e172-47f3-4555-8b7f-9f2ea5a226af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dccd4415-43a2-4874-b027-71f1dc7bb335" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c3b6e172-47f3-4555-8b7f-9f2ea5a226af" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dccd4415-43a2-4874-b027-71f1dc7bb335" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_fd0863db-f8ab-4dc8-9589-84e3a00e8661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dccd4415-43a2-4874-b027-71f1dc7bb335" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_fd0863db-f8ab-4dc8-9589-84e3a00e8661" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurementsLevel3ValuationsDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails" xlink:type="extended" id="if71a9c4cf2514de99ec625968b481283_FairValueMeasurementsLevel3ValuationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_10f7b5ac-a023-462f-beb6-883e930ffa4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BusinessCombinationContingentConsiderationMeasurementInput_3d5b4654-5a15-402c-a7b0-8420284d80da" xlink:href="livn-20200930.xsd#livn_BusinessCombinationContingentConsiderationMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_10f7b5ac-a023-462f-beb6-883e930ffa4d" xlink:to="loc_livn_BusinessCombinationContingentConsiderationMeasurementInput_3d5b4654-5a15-402c-a7b0-8420284d80da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e8ee71ae-d27b-4e3f-a11e-415dcc5bbb7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_10f7b5ac-a023-462f-beb6-883e930ffa4d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e8ee71ae-d27b-4e3f-a11e-415dcc5bbb7f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d88ed94d-3a1b-48f9-8cd0-f24945260020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e8ee71ae-d27b-4e3f-a11e-415dcc5bbb7f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d88ed94d-3a1b-48f9-8cd0-f24945260020" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d88ed94d-3a1b-48f9-8cd0-f24945260020_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d88ed94d-3a1b-48f9-8cd0-f24945260020" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d88ed94d-3a1b-48f9-8cd0-f24945260020_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5266323-682b-4385-972f-0c7eccea2650" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d88ed94d-3a1b-48f9-8cd0-f24945260020" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5266323-682b-4385-972f-0c7eccea2650" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ImTheraMedicalInc.Member_811e94b9-6b19-4797-933a-4826b4d1e704" xlink:href="livn-20200930.xsd#livn_ImTheraMedicalInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5266323-682b-4385-972f-0c7eccea2650" xlink:to="loc_livn_ImTheraMedicalInc.Member_811e94b9-6b19-4797-933a-4826b4d1e704" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_TandemLifeMember_9d12907b-baac-43f1-b147-029bcda19c19" xlink:href="livn-20200930.xsd#livn_TandemLifeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5266323-682b-4385-972f-0c7eccea2650" xlink:to="loc_livn_TandemLifeMember_9d12907b-baac-43f1-b147-029bcda19c19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MiamiInstrumentsLLCMember_99832d3e-320b-48ef-a044-2db1ad8c7261" xlink:href="livn-20200930.xsd#livn_MiamiInstrumentsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5266323-682b-4385-972f-0c7eccea2650" xlink:to="loc_livn_MiamiInstrumentsLLCMember_99832d3e-320b-48ef-a044-2db1ad8c7261" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_def95800-00b0-4824-8231-f0ded558a0b4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e8ee71ae-d27b-4e3f-a11e-415dcc5bbb7f" xlink:to="loc_srt_RangeAxis_def95800-00b0-4824-8231-f0ded558a0b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_def95800-00b0-4824-8231-f0ded558a0b4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_def95800-00b0-4824-8231-f0ded558a0b4" xlink:to="loc_srt_RangeMember_def95800-00b0-4824-8231-f0ded558a0b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1a5ce42d-47f7-4a67-874e-a228f0f4a216" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_def95800-00b0-4824-8231-f0ded558a0b4" xlink:to="loc_srt_RangeMember_1a5ce42d-47f7-4a67-874e-a228f0f4a216" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_20f2b23e-9356-4efd-80ad-77d12e3afe8d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1a5ce42d-47f7-4a67-874e-a228f0f4a216" xlink:to="loc_srt_MinimumMember_20f2b23e-9356-4efd-80ad-77d12e3afe8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4fd17091-34f7-4cf9-9674-ca916c7c1fd0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1a5ce42d-47f7-4a67-874e-a228f0f4a216" xlink:to="loc_srt_MaximumMember_4fd17091-34f7-4cf9-9674-ca916c7c1fd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_33571e47-ddcc-4839-8f07-dbe0039f94eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e8ee71ae-d27b-4e3f-a11e-415dcc5bbb7f" xlink:to="loc_us-gaap_ValuationTechniqueAxis_33571e47-ddcc-4839-8f07-dbe0039f94eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_33571e47-ddcc-4839-8f07-dbe0039f94eb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_33571e47-ddcc-4839-8f07-dbe0039f94eb" xlink:to="loc_us-gaap_ValuationTechniqueDomain_33571e47-ddcc-4839-8f07-dbe0039f94eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_23006942-f2a5-48d1-94e7-c8a454eda043" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_33571e47-ddcc-4839-8f07-dbe0039f94eb" xlink:to="loc_us-gaap_ValuationTechniqueDomain_23006942-f2a5-48d1-94e7-c8a454eda043" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_8724e04c-da90-48c3-8913-f795a746d1b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_23006942-f2a5-48d1-94e7-c8a454eda043" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_8724e04c-da90-48c3-8913-f795a746d1b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ValuationTechniqueMonteCarloSimulationMember_6e365a09-f5fe-4131-b2cd-ae709fb066ff" xlink:href="livn-20200930.xsd#livn_ValuationTechniqueMonteCarloSimulationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_23006942-f2a5-48d1-94e7-c8a454eda043" xlink:to="loc_livn_ValuationTechniqueMonteCarloSimulationMember_6e365a09-f5fe-4131-b2cd-ae709fb066ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7bec3e2b-6239-431e-bc3f-e8a2f8ebc496" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e8ee71ae-d27b-4e3f-a11e-415dcc5bbb7f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7bec3e2b-6239-431e-bc3f-e8a2f8ebc496" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7bec3e2b-6239-431e-bc3f-e8a2f8ebc496_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7bec3e2b-6239-431e-bc3f-e8a2f8ebc496" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7bec3e2b-6239-431e-bc3f-e8a2f8ebc496_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6cbd5843-45bb-4188-bd05-01672ade372b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7bec3e2b-6239-431e-bc3f-e8a2f8ebc496" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6cbd5843-45bb-4188-bd05-01672ade372b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_c4a4c286-219c-405d-8086-246be09ad285" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6cbd5843-45bb-4188-bd05-01672ade372b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_c4a4c286-219c-405d-8086-246be09ad285" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_24929589-cf73-418e-8910-1d2b6d1636a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e8ee71ae-d27b-4e3f-a11e-415dcc5bbb7f" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_24929589-cf73-418e-8910-1d2b6d1636a2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_24929589-cf73-418e-8910-1d2b6d1636a2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_24929589-cf73-418e-8910-1d2b6d1636a2" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_24929589-cf73-418e-8910-1d2b6d1636a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1b4671a4-9e31-48d1-bd00-64e001ff4738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_24929589-cf73-418e-8910-1d2b6d1636a2" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1b4671a4-9e31-48d1-bd00-64e001ff4738" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_2e0dd377-a196-4121-8fda-7c7a75915685" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1b4671a4-9e31-48d1-bd00-64e001ff4738" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_2e0dd377-a196-4121-8fda-7c7a75915685" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MeasurementInputProbabilityofPaymentMember_2667144e-285e-4113-a56a-c39694a19394" xlink:href="livn-20200930.xsd#livn_MeasurementInputProbabilityofPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1b4671a4-9e31-48d1-bd00-64e001ff4738" xlink:to="loc_livn_MeasurementInputProbabilityofPaymentMember_2667144e-285e-4113-a56a-c39694a19394" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MeasurementInputRiskadjustedDiscountRateMember_5c9e71c0-5660-4eb7-9927-00d5270478f7" xlink:href="livn-20200930.xsd#livn_MeasurementInputRiskadjustedDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1b4671a4-9e31-48d1-bd00-64e001ff4738" xlink:to="loc_livn_MeasurementInputRiskadjustedDiscountRateMember_5c9e71c0-5660-4eb7-9927-00d5270478f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MeasurementInputCreditRiskDiscountRateMember_2490cb02-c814-460c-89d9-1b87d4f3ace5" xlink:href="livn-20200930.xsd#livn_MeasurementInputCreditRiskDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1b4671a4-9e31-48d1-bd00-64e001ff4738" xlink:to="loc_livn_MeasurementInputCreditRiskDiscountRateMember_2490cb02-c814-460c-89d9-1b87d4f3ace5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MeasurementInputRevenueVolatilityMember_816774ac-55a1-4b7e-bddb-6eb1707148fd" xlink:href="livn-20200930.xsd#livn_MeasurementInputRevenueVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1b4671a4-9e31-48d1-bd00-64e001ff4738" xlink:to="loc_livn_MeasurementInputRevenueVolatilityMember_816774ac-55a1-4b7e-bddb-6eb1707148fd" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangements" xlink:type="simple" xlink:href="livn-20200930.xsd#FinancingArrangements"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/FinancingArrangements" xlink:type="extended" id="i9c1c0375f108436db94b1b693af25e0f_FinancingArrangements"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangementsTables" xlink:type="simple" xlink:href="livn-20200930.xsd#FinancingArrangementsTables"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/FinancingArrangementsTables" xlink:type="extended" id="idec071a7351b4177b0f6c398bbd412d4_FinancingArrangementsTables"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FinancingArrangementsScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails" xlink:type="extended" id="i6f38d2145440449abf499d2b6eab3754_FinancingArrangementsScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_da1cfc66-36ed-4d3b-88c9-8532ce8c82fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e8ea67da-5ed4-436b-9d06-83c363777e82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da1cfc66-36ed-4d3b-88c9-8532ce8c82fc" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e8ea67da-5ed4-436b-9d06-83c363777e82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_6b520a98-32c5-4fc0-9952-08d87d59ec63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da1cfc66-36ed-4d3b-88c9-8532ce8c82fc" xlink:to="loc_us-gaap_LongTermDebtCurrent_6b520a98-32c5-4fc0-9952-08d87d59ec63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e6cad13e-5285-4844-bacc-222e3565401d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da1cfc66-36ed-4d3b-88c9-8532ce8c82fc" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e6cad13e-5285-4844-bacc-222e3565401d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentLIBORFloorRate_a78662ae-65b1-4ed4-a644-c9174e84769f" xlink:href="livn-20200930.xsd#livn_DebtInstrumentLIBORFloorRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da1cfc66-36ed-4d3b-88c9-8532ce8c82fc" xlink:to="loc_livn_DebtInstrumentLIBORFloorRate_a78662ae-65b1-4ed4-a644-c9174e84769f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1a642446-31d2-44d3-b755-96b5bdcb62b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da1cfc66-36ed-4d3b-88c9-8532ce8c82fc" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1a642446-31d2-44d3-b755-96b5bdcb62b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_17eb0c07-8f75-4479-9b3a-6d410ee8935d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da1cfc66-36ed-4d3b-88c9-8532ce8c82fc" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_17eb0c07-8f75-4479-9b3a-6d410ee8935d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f59b2d4a-257f-4bd6-a164-86bc6db0ebe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da1cfc66-36ed-4d3b-88c9-8532ce8c82fc" xlink:to="loc_us-gaap_DebtInstrumentTable_f59b2d4a-257f-4bd6-a164-86bc6db0ebe9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_632ad5b7-9bf5-45cf-89c4-b1ba20a2ee54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f59b2d4a-257f-4bd6-a164-86bc6db0ebe9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_632ad5b7-9bf5-45cf-89c4-b1ba20a2ee54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_632ad5b7-9bf5-45cf-89c4-b1ba20a2ee54_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_632ad5b7-9bf5-45cf-89c4-b1ba20a2ee54" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_632ad5b7-9bf5-45cf-89c4-b1ba20a2ee54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_20c29f15-323a-4030-b67d-264f62b28436" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_632ad5b7-9bf5-45cf-89c4-b1ba20a2ee54" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_20c29f15-323a-4030-b67d-264f62b28436" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_e5d76dc4-c063-461a-906b-6a7f09034594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_20c29f15-323a-4030-b67d-264f62b28436" xlink:to="loc_us-gaap_SecuredDebtMember_e5d76dc4-c063-461a-906b-6a7f09034594" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_34f10671-1292-408a-926a-34543d0bcade" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_20c29f15-323a-4030-b67d-264f62b28436" xlink:to="loc_us-gaap_SeniorNotesMember_34f10671-1292-408a-926a-34543d0bcade" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_22850ec0-461a-43ca-8f93-ed71c40031a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_20c29f15-323a-4030-b67d-264f62b28436" xlink:to="loc_us-gaap_LoansPayableMember_22850ec0-461a-43ca-8f93-ed71c40031a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_9686337f-0a32-4331-ab28-63a647594082" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_20c29f15-323a-4030-b67d-264f62b28436" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_9686337f-0a32-4331-ab28-63a647594082" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_c85f06bd-31b4-4e7d-bd09-fc59340e3727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f59b2d4a-257f-4bd6-a164-86bc6db0ebe9" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_c85f06bd-31b4-4e7d-bd09-fc59340e3727" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_c85f06bd-31b4-4e7d-bd09-fc59340e3727_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_c85f06bd-31b4-4e7d-bd09-fc59340e3727" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_c85f06bd-31b4-4e7d-bd09-fc59340e3727_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_d8f0a6e9-c6fa-40d4-a709-ab523b2fd066" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_c85f06bd-31b4-4e7d-bd09-fc59340e3727" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_d8f0a6e9-c6fa-40d4-a709-ab523b2fd066" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member_8d27c29b-2c9d-4851-978b-65cbda26c391" xlink:href="livn-20200930.xsd#livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_d8f0a6e9-c6fa-40d4-a709-ab523b2fd066" xlink:to="loc_livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member_8d27c29b-2c9d-4851-978b-65cbda26c391" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MediocreditoItalianoMember_9cf5d1ac-fc4c-4dd5-81da-2c60af23804e" xlink:href="livn-20200930.xsd#livn_MediocreditoItalianoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_d8f0a6e9-c6fa-40d4-a709-ab523b2fd066" xlink:to="loc_livn_MediocreditoItalianoMember_9cf5d1ac-fc4c-4dd5-81da-2c60af23804e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BankofAmericaU.SMember_49a6a723-0d85-4aab-86ae-3c8b3299c364" xlink:href="livn-20200930.xsd#livn_BankofAmericaU.SMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_d8f0a6e9-c6fa-40d4-a709-ab523b2fd066" xlink:to="loc_livn_BankofAmericaU.SMember_49a6a723-0d85-4aab-86ae-3c8b3299c364" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtFacility2019Member_ec6c98eb-7db6-47c4-a88f-0a0fba956c57" xlink:href="livn-20200930.xsd#livn_DebtFacility2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_d8f0a6e9-c6fa-40d4-a709-ab523b2fd066" xlink:to="loc_livn_DebtFacility2019Member_ec6c98eb-7db6-47c4-a88f-0a0fba956c57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_EuropeanInvestmentBank2017Member_6bdb2a53-7dff-49ba-8bb4-9983c0f8cbfb" xlink:href="livn-20200930.xsd#livn_EuropeanInvestmentBank2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_d8f0a6e9-c6fa-40d4-a709-ab523b2fd066" xlink:to="loc_livn_EuropeanInvestmentBank2017Member_6bdb2a53-7dff-49ba-8bb4-9983c0f8cbfb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_EuropeanInvestmentBank2014Member_c30a7b6e-e141-4426-8985-1e44c8c1fbba" xlink:href="livn-20200930.xsd#livn_EuropeanInvestmentBank2014Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_d8f0a6e9-c6fa-40d4-a709-ab523b2fd066" xlink:to="loc_livn_EuropeanInvestmentBank2014Member_c30a7b6e-e141-4426-8985-1e44c8c1fbba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_01c44b36-32ad-4020-8b5a-e127187d6a1b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f59b2d4a-257f-4bd6-a164-86bc6db0ebe9" xlink:to="loc_srt_RangeAxis_01c44b36-32ad-4020-8b5a-e127187d6a1b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_01c44b36-32ad-4020-8b5a-e127187d6a1b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_01c44b36-32ad-4020-8b5a-e127187d6a1b" xlink:to="loc_srt_RangeMember_01c44b36-32ad-4020-8b5a-e127187d6a1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d9e497fc-0d96-4605-a098-e03043d2c426" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_01c44b36-32ad-4020-8b5a-e127187d6a1b" xlink:to="loc_srt_RangeMember_d9e497fc-0d96-4605-a098-e03043d2c426" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8df617c6-6b29-452a-91b2-9599896a5efb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d9e497fc-0d96-4605-a098-e03043d2c426" xlink:to="loc_srt_MinimumMember_8df617c6-6b29-452a-91b2-9599896a5efb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1213637b-1465-4658-9db1-5539c66b951c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d9e497fc-0d96-4605-a098-e03043d2c426" xlink:to="loc_srt_MaximumMember_1213637b-1465-4658-9db1-5539c66b951c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ea868fbd-7460-4e06-8c16-b60ffd3b9f23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f59b2d4a-257f-4bd6-a164-86bc6db0ebe9" xlink:to="loc_us-gaap_VariableRateAxis_ea868fbd-7460-4e06-8c16-b60ffd3b9f23" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ea868fbd-7460-4e06-8c16-b60ffd3b9f23_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_ea868fbd-7460-4e06-8c16-b60ffd3b9f23" xlink:to="loc_us-gaap_VariableRateDomain_ea868fbd-7460-4e06-8c16-b60ffd3b9f23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_a7295783-b0e4-4352-b7fe-12cd3e82141c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_ea868fbd-7460-4e06-8c16-b60ffd3b9f23" xlink:to="loc_us-gaap_VariableRateDomain_a7295783-b0e4-4352-b7fe-12cd3e82141c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_7a610926-0542-45e5-b3a4-539487acea8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_a7295783-b0e4-4352-b7fe-12cd3e82141c" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_7a610926-0542-45e5-b3a4-539487acea8a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FinancingArrangementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails" xlink:type="extended" id="i935722f6d6d34ad1be40004dff193bd5_FinancingArrangementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_d05480e0-680d-481d-87f4-756631ceead8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_ShortTermBorrowings_d05480e0-680d-481d-87f4-756631ceead8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c30f2a43-d509-4210-82ec-568b0a197997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c30f2a43-d509-4210-82ec-568b0a197997" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_a914d1c7-666f-44e5-a614-ae7bda35d020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DebtInstrumentTerm_a914d1c7-666f-44e5-a614-ae7bda35d020" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_d2602415-2443-422d-abf2-24905a5a3cfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_d2602415-2443-422d-abf2-24905a5a3cfc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm_ad4f7aba-d64d-4cfc-8f66-3ee3bacebe5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_LongTermDebtTerm_ad4f7aba-d64d-4cfc-8f66-3ee3bacebe5c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_57df022b-6dab-48d5-98b1-d7e5fa0ed751" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_57df022b-6dab-48d5-98b1-d7e5fa0ed751" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentLIBORFloorRate_0d9515d4-28a6-4487-970b-0f310cb00886" xlink:href="livn-20200930.xsd#livn_DebtInstrumentLIBORFloorRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_livn_DebtInstrumentLIBORFloorRate_0d9515d4-28a6-4487-970b-0f310cb00886" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a4eaa699-2be3-41a2-9b2e-39375d6e6ff2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a4eaa699-2be3-41a2-9b2e-39375d6e6ff2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentCovenantMinimumNetRevenue_87b6a9f7-936c-4520-b4be-5820b51171a0" xlink:href="livn-20200930.xsd#livn_DebtInstrumentCovenantMinimumNetRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_livn_DebtInstrumentCovenantMinimumNetRevenue_87b6a9f7-936c-4520-b4be-5820b51171a0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentCovenantMinimumProRataNetRevenues_5e88af0f-32a4-41db-ad8d-d5704273d24a" xlink:href="livn-20200930.xsd#livn_DebtInstrumentCovenantMinimumProRataNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_livn_DebtInstrumentCovenantMinimumProRataNetRevenues_5e88af0f-32a4-41db-ad8d-d5704273d24a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_4e8bd3c0-ddea-41a1-89d1-3f120c49077d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_4e8bd3c0-ddea-41a1-89d1-3f120c49077d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_40a6550e-a462-46b1-bbec-7e54ad00ff8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_40a6550e-a462-46b1-bbec-7e54ad00ff8c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b0931f27-4d85-455d-98b3-79829485eba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b0931f27-4d85-455d-98b3-79829485eba9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_3ec1e1c2-f772-40ee-8c92-f77d882d99da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_bc0ef966-1a2b-4199-906b-b6efede36999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_bc0ef966-1a2b-4199-906b-b6efede36999" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_333506c7-5357-47c2-bf14-9da6a590bec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_333506c7-5357-47c2-bf14-9da6a590bec4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentExchangeableConversionRatio_74664bb6-9b3e-435d-bf9c-87ca6de474da" xlink:href="livn-20200930.xsd#livn_DebtInstrumentExchangeableConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_livn_DebtInstrumentExchangeableConversionRatio_74664bb6-9b3e-435d-bf9c-87ca6de474da" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentOptionToExchangePricePerShare_328b11cd-65ce-4f06-9ec7-ee474267bf00" xlink:href="livn-20200930.xsd#livn_DebtInstrumentOptionToExchangePricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_livn_DebtInstrumentOptionToExchangePricePerShare_328b11cd-65ce-4f06-9ec7-ee474267bf00" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice_efc7ce54-5c14-4baa-afe4-6986bd7ae5b8" xlink:href="livn-20200930.xsd#livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice_efc7ce54-5c14-4baa-afe4-6986bd7ae5b8" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentRedemptionThresholdTradingDays_cb78a60f-4c14-4989-abb1-faaa03b0568d" xlink:href="livn-20200930.xsd#livn_DebtInstrumentRedemptionThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_livn_DebtInstrumentRedemptionThresholdTradingDays_cb78a60f-4c14-4989-abb1-faaa03b0568d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays_6ba89a5a-7414-4f81-8c88-1e9e8e1864b0" xlink:href="livn-20200930.xsd#livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays_6ba89a5a-7414-4f81-8c88-1e9e8e1864b0" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_75a05bed-f1b8-4797-a32a-59cbed8f2aa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_75a05bed-f1b8-4797-a32a-59cbed8f2aa9" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_9130968a-c8f3-4dc0-8908-d2f303d91e84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_9130968a-c8f3-4dc0-8908-d2f303d91e84" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DerivativeCapPricePerShare_1b965e48-b7c5-4ee1-9c39-7ea6bc828313" xlink:href="livn-20200930.xsd#livn_DerivativeCapPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_livn_DerivativeCapPricePerShare_1b965e48-b7c5-4ee1-9c39-7ea6bc828313" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCostOfHedge_64416a71-3b0d-468f-8e54-630c83be553b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCostOfHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DerivativeCostOfHedge_64416a71-3b0d-468f-8e54-630c83be553b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_c8f74be5-3947-4ebe-bf12-1ad94c4b413e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DerivativeAssets_c8f74be5-3947-4ebe-bf12-1ad94c4b413e" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_d5550723-1191-49d4-9ce8-cb230c7c6736" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_RepaymentsOfDebt_d5550723-1191-49d4-9ce8-cb230c7c6736" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3f43cabc-cdc2-4f72-bae1-10cdde0fa056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3f43cabc-cdc2-4f72-bae1-10cdde0fa056" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_792eb119-1dec-4d7e-bd75-0cba9a99acd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DebtInstrumentTable_792eb119-1dec-4d7e-bd75-0cba9a99acd4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_366e1577-5a41-40cf-9052-531084a15cc2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_792eb119-1dec-4d7e-bd75-0cba9a99acd4" xlink:to="loc_srt_RangeAxis_366e1577-5a41-40cf-9052-531084a15cc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_366e1577-5a41-40cf-9052-531084a15cc2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_366e1577-5a41-40cf-9052-531084a15cc2" xlink:to="loc_srt_RangeMember_366e1577-5a41-40cf-9052-531084a15cc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_107ca5ad-b8c5-47c5-b4a1-dabb8cc064bf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_366e1577-5a41-40cf-9052-531084a15cc2" xlink:to="loc_srt_RangeMember_107ca5ad-b8c5-47c5-b4a1-dabb8cc064bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e41b59fd-dbac-447a-9f95-0095e6404d18" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_107ca5ad-b8c5-47c5-b4a1-dabb8cc064bf" xlink:to="loc_srt_MinimumMember_e41b59fd-dbac-447a-9f95-0095e6404d18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cd983414-9762-4f40-a016-d9bc3b3d53a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_107ca5ad-b8c5-47c5-b4a1-dabb8cc064bf" xlink:to="loc_srt_MaximumMember_cd983414-9762-4f40-a016-d9bc3b3d53a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a02053db-2a74-4c44-a8d9-0548df5d914a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_792eb119-1dec-4d7e-bd75-0cba9a99acd4" xlink:to="loc_us-gaap_CreditFacilityAxis_a02053db-2a74-4c44-a8d9-0548df5d914a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a02053db-2a74-4c44-a8d9-0548df5d914a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_a02053db-2a74-4c44-a8d9-0548df5d914a" xlink:to="loc_us-gaap_CreditFacilityDomain_a02053db-2a74-4c44-a8d9-0548df5d914a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c91406b4-43ab-4511-bf5b-63d0c2a1f795" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_a02053db-2a74-4c44-a8d9-0548df5d914a" xlink:to="loc_us-gaap_CreditFacilityDomain_c91406b4-43ab-4511-bf5b-63d0c2a1f795" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1d7e9d4e-bd33-4f5a-973b-26aab8519eae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c91406b4-43ab-4511-bf5b-63d0c2a1f795" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1d7e9d4e-bd33-4f5a-973b-26aab8519eae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1deffb2f-6dc5-4508-bc35-137b60c9ce29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_792eb119-1dec-4d7e-bd75-0cba9a99acd4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1deffb2f-6dc5-4508-bc35-137b60c9ce29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1deffb2f-6dc5-4508-bc35-137b60c9ce29_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1deffb2f-6dc5-4508-bc35-137b60c9ce29" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1deffb2f-6dc5-4508-bc35-137b60c9ce29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f97a20bc-06ae-4313-ada1-8ca3e26714c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1deffb2f-6dc5-4508-bc35-137b60c9ce29" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f97a20bc-06ae-4313-ada1-8ca3e26714c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_ad5e8435-a092-4dfb-9aa5-52264f4f5f5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f97a20bc-06ae-4313-ada1-8ca3e26714c9" xlink:to="loc_us-gaap_SeniorNotesMember_ad5e8435-a092-4dfb-9aa5-52264f4f5f5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_0df0f31e-fd61-49e4-8a14-8047c0070282" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f97a20bc-06ae-4313-ada1-8ca3e26714c9" xlink:to="loc_us-gaap_SecuredDebtMember_0df0f31e-fd61-49e4-8a14-8047c0070282" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_b4c8a5cd-584f-48dd-ab0a-ce9494835d1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_792eb119-1dec-4d7e-bd75-0cba9a99acd4" xlink:to="loc_us-gaap_VariableRateAxis_b4c8a5cd-584f-48dd-ab0a-ce9494835d1c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b4c8a5cd-584f-48dd-ab0a-ce9494835d1c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_b4c8a5cd-584f-48dd-ab0a-ce9494835d1c" xlink:to="loc_us-gaap_VariableRateDomain_b4c8a5cd-584f-48dd-ab0a-ce9494835d1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_396339bf-12f6-490a-a401-6845bd581a5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_b4c8a5cd-584f-48dd-ab0a-ce9494835d1c" xlink:to="loc_us-gaap_VariableRateDomain_396339bf-12f6-490a-a401-6845bd581a5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_8fac2632-2f42-485c-a14a-647531520fb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_396339bf-12f6-490a-a401-6845bd581a5e" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_8fac2632-2f42-485c-a14a-647531520fb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e43207de-c017-4395-9b4f-e4ece90d1d56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_792eb119-1dec-4d7e-bd75-0cba9a99acd4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e43207de-c017-4395-9b4f-e4ece90d1d56" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e43207de-c017-4395-9b4f-e4ece90d1d56_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e43207de-c017-4395-9b4f-e4ece90d1d56" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e43207de-c017-4395-9b4f-e4ece90d1d56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_dddb44bc-b81f-48b2-9e36-b7a9ddcccbed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e43207de-c017-4395-9b4f-e4ece90d1d56" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_dddb44bc-b81f-48b2-9e36-b7a9ddcccbed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CappedCallMember_b31ef92f-284d-4822-b3ee-f1b9209c23eb" xlink:href="livn-20200930.xsd#livn_CappedCallMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dddb44bc-b81f-48b2-9e36-b7a9ddcccbed" xlink:to="loc_livn_CappedCallMember_b31ef92f-284d-4822-b3ee-f1b9209c23eb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangementsLeverageRatiosDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FinancingArrangementsLeverageRatiosDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/FinancingArrangementsLeverageRatiosDetails" xlink:type="extended" id="i07b24d890de24e5980c1f6f1bd35cc3d_FinancingArrangementsLeverageRatiosDetails"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagement" xlink:type="simple" xlink:href="livn-20200930.xsd#DerivativesandRiskManagement"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagement" xlink:type="extended" id="i8840517489654cbcb5c84c45c2ed6196_DerivativesandRiskManagement"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementTables" xlink:type="simple" xlink:href="livn-20200930.xsd#DerivativesandRiskManagementTables"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementTables" xlink:type="extended" id="ic2c5115b2f954010b62b3c82b25dcfcc_DerivativesandRiskManagementTables"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#DerivativesandRiskManagementNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails" xlink:type="extended" id="ia4cfabdacc0a405b8c85ff4c185d584c_DerivativesandRiskManagementNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_47fde123-fd88-473c-ba68-aa583d7a3c20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_1f6890f0-987a-4e04-b7bd-1ec3b5791a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_47fde123-fd88-473c-ba68-aa583d7a3c20" xlink:to="loc_us-gaap_DerivativeNotionalAmount_1f6890f0-987a-4e04-b7bd-1ec3b5791a0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_14f867ca-e6f4-4d81-b245-1696467afe5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_47fde123-fd88-473c-ba68-aa583d7a3c20" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_14f867ca-e6f4-4d81-b245-1696467afe5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c57fd0c2-ee95-4c09-8e26-44c3daf173c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_47fde123-fd88-473c-ba68-aa583d7a3c20" xlink:to="loc_us-gaap_DerivativeTable_c57fd0c2-ee95-4c09-8e26-44c3daf173c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_69921f58-4688-4ba3-a855-7dcd6cc4dfbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c57fd0c2-ee95-4c09-8e26-44c3daf173c8" xlink:to="loc_us-gaap_HedgingDesignationAxis_69921f58-4688-4ba3-a855-7dcd6cc4dfbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_69921f58-4688-4ba3-a855-7dcd6cc4dfbb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_69921f58-4688-4ba3-a855-7dcd6cc4dfbb" xlink:to="loc_us-gaap_HedgingDesignationDomain_69921f58-4688-4ba3-a855-7dcd6cc4dfbb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0f86ed6f-38c1-4cc7-9e28-45c66868c0b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_69921f58-4688-4ba3-a855-7dcd6cc4dfbb" xlink:to="loc_us-gaap_HedgingDesignationDomain_0f86ed6f-38c1-4cc7-9e28-45c66868c0b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_3d7ef933-4d3a-4c83-b56b-17f1158673f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_0f86ed6f-38c1-4cc7-9e28-45c66868c0b8" xlink:to="loc_us-gaap_NondesignatedMember_3d7ef933-4d3a-4c83-b56b-17f1158673f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e9ac3013-7671-46d8-94af-671d1bc5c1e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c57fd0c2-ee95-4c09-8e26-44c3daf173c8" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e9ac3013-7671-46d8-94af-671d1bc5c1e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e9ac3013-7671-46d8-94af-671d1bc5c1e4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e9ac3013-7671-46d8-94af-671d1bc5c1e4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e9ac3013-7671-46d8-94af-671d1bc5c1e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_65b64740-b9a4-457a-a28f-dfc376825059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e9ac3013-7671-46d8-94af-671d1bc5c1e4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_65b64740-b9a4-457a-a28f-dfc376825059" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ForeignExchangeandOtherMember_0d7191c1-0adb-4d7f-811e-869adc736127" xlink:href="livn-20200930.xsd#livn_ForeignExchangeandOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_65b64740-b9a4-457a-a28f-dfc376825059" xlink:to="loc_livn_ForeignExchangeandOtherMember_0d7191c1-0adb-4d7f-811e-869adc736127" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f4e5794e-1707-48f9-b333-d17fa3050e3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c57fd0c2-ee95-4c09-8e26-44c3daf173c8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f4e5794e-1707-48f9-b333-d17fa3050e3d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f4e5794e-1707-48f9-b333-d17fa3050e3d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f4e5794e-1707-48f9-b333-d17fa3050e3d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f4e5794e-1707-48f9-b333-d17fa3050e3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3305cdf6-1886-437e-ac76-f9ee419361c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f4e5794e-1707-48f9-b333-d17fa3050e3d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3305cdf6-1886-437e-ac76-f9ee419361c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f5e5e1a1-1fc4-48d1-a1d2-de2853197b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3305cdf6-1886-437e-ac76-f9ee419361c0" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f5e5e1a1-1fc4-48d1-a1d2-de2853197b88" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#DerivativesandRiskManagementDerivativeNotionalAmountsDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails" xlink:type="extended" id="iaba4e6bac6c54a2f9a5122b28b4f57c2_DerivativesandRiskManagementDerivativeNotionalAmountsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_aa0b77b1-d3e4-4ad2-ab23-4318acb97c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_e3cd8d61-627d-4ecd-b012-ec93d0454eb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_aa0b77b1-d3e4-4ad2-ab23-4318acb97c2a" xlink:to="loc_us-gaap_DerivativeNotionalAmount_e3cd8d61-627d-4ecd-b012-ec93d0454eb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ab4b446c-e148-41f3-a2b9-102eb0ba2d9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_aa0b77b1-d3e4-4ad2-ab23-4318acb97c2a" xlink:to="loc_us-gaap_DerivativeTable_ab4b446c-e148-41f3-a2b9-102eb0ba2d9b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_96d78d3e-5ae0-4660-8266-bece441473c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ab4b446c-e148-41f3-a2b9-102eb0ba2d9b" xlink:to="loc_us-gaap_HedgingDesignationAxis_96d78d3e-5ae0-4660-8266-bece441473c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_96d78d3e-5ae0-4660-8266-bece441473c1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_96d78d3e-5ae0-4660-8266-bece441473c1" xlink:to="loc_us-gaap_HedgingDesignationDomain_96d78d3e-5ae0-4660-8266-bece441473c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5bed95f2-b134-47fe-885a-a231e121d5a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_96d78d3e-5ae0-4660-8266-bece441473c1" xlink:to="loc_us-gaap_HedgingDesignationDomain_5bed95f2-b134-47fe-885a-a231e121d5a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_77332308-108e-4a9d-ac94-9ffcccc7781c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5bed95f2-b134-47fe-885a-a231e121d5a0" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_77332308-108e-4a9d-ac94-9ffcccc7781c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2e9790b3-72e3-42e9-afae-e6d865ac7b32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ab4b446c-e148-41f3-a2b9-102eb0ba2d9b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2e9790b3-72e3-42e9-afae-e6d865ac7b32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2e9790b3-72e3-42e9-afae-e6d865ac7b32_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2e9790b3-72e3-42e9-afae-e6d865ac7b32" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2e9790b3-72e3-42e9-afae-e6d865ac7b32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_99f47454-51d7-476b-a39f-5dd591f6dce4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2e9790b3-72e3-42e9-afae-e6d865ac7b32" xlink:to="loc_us-gaap_HedgingRelationshipDomain_99f47454-51d7-476b-a39f-5dd591f6dce4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_e52e16e4-1a47-463c-a9f8-7911d91262a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_99f47454-51d7-476b-a39f-5dd591f6dce4" xlink:to="loc_us-gaap_CashFlowHedgingMember_e52e16e4-1a47-463c-a9f8-7911d91262a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f0ad6fa4-d1a5-419e-b0ed-2e07d1fcb416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ab4b446c-e148-41f3-a2b9-102eb0ba2d9b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f0ad6fa4-d1a5-419e-b0ed-2e07d1fcb416" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f0ad6fa4-d1a5-419e-b0ed-2e07d1fcb416_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f0ad6fa4-d1a5-419e-b0ed-2e07d1fcb416" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f0ad6fa4-d1a5-419e-b0ed-2e07d1fcb416_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_db2347da-4419-4255-ace0-b0290fcf22e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f0ad6fa4-d1a5-419e-b0ed-2e07d1fcb416" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_db2347da-4419-4255-ace0-b0290fcf22e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_9fdba410-d265-42e6-9c36-da605e22a3c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_db2347da-4419-4255-ace0-b0290fcf22e1" xlink:to="loc_us-gaap_ForeignExchangeContractMember_9fdba410-d265-42e6-9c36-da605e22a3c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_1cdc13be-32be-44db-8902-3dd6e751ae24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_db2347da-4419-4255-ace0-b0290fcf22e1" xlink:to="loc_us-gaap_InterestRateSwapMember_1cdc13be-32be-44db-8902-3dd6e751ae24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_1f2aa6b8-e274-4ecd-a848-483d2449de58" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ab4b446c-e148-41f3-a2b9-102eb0ba2d9b" xlink:to="loc_srt_CurrencyAxis_1f2aa6b8-e274-4ecd-a848-483d2449de58" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_1f2aa6b8-e274-4ecd-a848-483d2449de58_default" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_1f2aa6b8-e274-4ecd-a848-483d2449de58" xlink:to="loc_currency_AllCurrenciesDomain_1f2aa6b8-e274-4ecd-a848-483d2449de58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_12a0d1be-9213-4fe6-a8e4-c83dd84e1745" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_1f2aa6b8-e274-4ecd-a848-483d2449de58" xlink:to="loc_currency_AllCurrenciesDomain_12a0d1be-9213-4fe6-a8e4-c83dd84e1745" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_db56f679-aa69-43a2-8bd4-2c78ecc4c34c" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_GBP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_12a0d1be-9213-4fe6-a8e4-c83dd84e1745" xlink:to="loc_currency_GBP_db56f679-aa69-43a2-8bd4-2c78ecc4c34c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_ecd744c9-992c-4840-8eaf-b30ab4de8176" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_12a0d1be-9213-4fe6-a8e4-c83dd84e1745" xlink:to="loc_currency_JPY_ecd744c9-992c-4840-8eaf-b30ab4de8176" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_622acf98-9b7b-464e-b0ea-968e49169280" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_12a0d1be-9213-4fe6-a8e4-c83dd84e1745" xlink:to="loc_currency_EUR_622acf98-9b7b-464e-b0ea-968e49169280" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails" xlink:type="extended" id="i3a321302852f49cf9e49a1738fd6a8b4_DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d50ee6c1-88db-466c-a883-d3377b4ef463" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_5a509bf5-5d2a-4414-b294-649e0bc6d4fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d50ee6c1-88db-466c-a883-d3377b4ef463" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_5a509bf5-5d2a-4414-b294-649e0bc6d4fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d6685bd3-eb46-4106-b627-a8ad8ab1527a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d50ee6c1-88db-466c-a883-d3377b4ef463" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d6685bd3-eb46-4106-b627-a8ad8ab1527a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_bf7af7e5-9f83-4159-be3a-76a018c9a5eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d50ee6c1-88db-466c-a883-d3377b4ef463" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_bf7af7e5-9f83-4159-be3a-76a018c9a5eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_632d897b-155b-4de4-8279-2d6c8f6773c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d50ee6c1-88db-466c-a883-d3377b4ef463" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_632d897b-155b-4de4-8279-2d6c8f6773c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_69061af2-2569-4974-a8f2-7c702c296732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d50ee6c1-88db-466c-a883-d3377b4ef463" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_69061af2-2569-4974-a8f2-7c702c296732" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_13be35cc-dd03-40a0-99aa-4df9df20d22f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_69061af2-2569-4974-a8f2-7c702c296732" xlink:to="loc_us-gaap_HedgingDesignationAxis_13be35cc-dd03-40a0-99aa-4df9df20d22f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_13be35cc-dd03-40a0-99aa-4df9df20d22f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_13be35cc-dd03-40a0-99aa-4df9df20d22f" xlink:to="loc_us-gaap_HedgingDesignationDomain_13be35cc-dd03-40a0-99aa-4df9df20d22f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2268fbd8-8c88-44b2-ad0f-cf5d5cc2ba26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_13be35cc-dd03-40a0-99aa-4df9df20d22f" xlink:to="loc_us-gaap_HedgingDesignationDomain_2268fbd8-8c88-44b2-ad0f-cf5d5cc2ba26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1d4abdee-d980-4062-aa5d-87c03003be6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_2268fbd8-8c88-44b2-ad0f-cf5d5cc2ba26" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1d4abdee-d980-4062-aa5d-87c03003be6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_349850e5-48a6-48f4-93fb-67b8c2c74a01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_69061af2-2569-4974-a8f2-7c702c296732" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_349850e5-48a6-48f4-93fb-67b8c2c74a01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_349850e5-48a6-48f4-93fb-67b8c2c74a01_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_349850e5-48a6-48f4-93fb-67b8c2c74a01" xlink:to="loc_us-gaap_HedgingRelationshipDomain_349850e5-48a6-48f4-93fb-67b8c2c74a01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_644063bb-366b-40fc-9ff8-e805555913be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_349850e5-48a6-48f4-93fb-67b8c2c74a01" xlink:to="loc_us-gaap_HedgingRelationshipDomain_644063bb-366b-40fc-9ff8-e805555913be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_38c27ecb-fc39-45af-b9ca-32d3b662961e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_644063bb-366b-40fc-9ff8-e805555913be" xlink:to="loc_us-gaap_CashFlowHedgingMember_38c27ecb-fc39-45af-b9ca-32d3b662961e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_34dd76de-1732-4c71-a81e-ebb593756544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_69061af2-2569-4974-a8f2-7c702c296732" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_34dd76de-1732-4c71-a81e-ebb593756544" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_34dd76de-1732-4c71-a81e-ebb593756544_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_34dd76de-1732-4c71-a81e-ebb593756544" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_34dd76de-1732-4c71-a81e-ebb593756544_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e4e9135f-1de4-41da-8b0b-68b12c4cc8a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_34dd76de-1732-4c71-a81e-ebb593756544" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e4e9135f-1de4-41da-8b0b-68b12c4cc8a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_1550d41c-b3c7-41f7-b1da-8334a8c317f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e4e9135f-1de4-41da-8b0b-68b12c4cc8a3" xlink:to="loc_us-gaap_ForeignExchangeContractMember_1550d41c-b3c7-41f7-b1da-8334a8c317f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_68924b83-b35c-4308-ba2c-a746cd945fe4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e4e9135f-1de4-41da-8b0b-68b12c4cc8a3" xlink:to="loc_us-gaap_InterestRateSwapMember_68924b83-b35c-4308-ba2c-a746cd945fe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_aefecce7-8cb9-4253-90b0-5184cb5a6140" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_69061af2-2569-4974-a8f2-7c702c296732" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_aefecce7-8cb9-4253-90b0-5184cb5a6140" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_aefecce7-8cb9-4253-90b0-5184cb5a6140_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_aefecce7-8cb9-4253-90b0-5184cb5a6140" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_aefecce7-8cb9-4253-90b0-5184cb5a6140_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dc34677f-fea8-4732-9ad3-151e5f0fd09b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_aefecce7-8cb9-4253-90b0-5184cb5a6140" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dc34677f-fea8-4732-9ad3-151e5f0fd09b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ForeignExchangeandOtherMember_62954408-c969-45d2-b72a-3dbe98046d8c" xlink:href="livn-20200930.xsd#livn_ForeignExchangeandOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dc34677f-fea8-4732-9ad3-151e5f0fd09b" xlink:to="loc_livn_ForeignExchangeandOtherMember_62954408-c969-45d2-b72a-3dbe98046d8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_636926c5-77e5-4df6-8452-33fe9c149ff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dc34677f-fea8-4732-9ad3-151e5f0fd09b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_636926c5-77e5-4df6-8452-33fe9c149ff7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_c28aefe9-9aa8-404d-b09b-32bdc0c6b69d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dc34677f-fea8-4732-9ad3-151e5f0fd09b" xlink:to="loc_us-gaap_InterestExpenseMember_c28aefe9-9aa8-404d-b09b-32bdc0c6b69d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails" xlink:type="extended" id="ia20acfa706d94fc09f6952c2dcdebb65_DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_d09849cf-829b-4660-8971-a5b1888f3b73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_cadd2f4a-a8ea-45e1-90ce-0eb47dceeee8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_d09849cf-829b-4660-8971-a5b1888f3b73" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_cadd2f4a-a8ea-45e1-90ce-0eb47dceeee8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e22bb1c5-c861-4d84-8452-6f4dc5ff3334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_d09849cf-829b-4660-8971-a5b1888f3b73" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e22bb1c5-c861-4d84-8452-6f4dc5ff3334" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b7c509d4-8745-455d-b8ab-5df472c9ca73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_d09849cf-829b-4660-8971-a5b1888f3b73" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b7c509d4-8745-455d-b8ab-5df472c9ca73" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_6c6ea401-a554-4388-9588-c8a1dd8ef2b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b7c509d4-8745-455d-b8ab-5df472c9ca73" xlink:to="loc_us-gaap_HedgingDesignationAxis_6c6ea401-a554-4388-9588-c8a1dd8ef2b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6c6ea401-a554-4388-9588-c8a1dd8ef2b1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_6c6ea401-a554-4388-9588-c8a1dd8ef2b1" xlink:to="loc_us-gaap_HedgingDesignationDomain_6c6ea401-a554-4388-9588-c8a1dd8ef2b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a74412b8-6eee-49e9-ae89-8b46e3b5c76b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_6c6ea401-a554-4388-9588-c8a1dd8ef2b1" xlink:to="loc_us-gaap_HedgingDesignationDomain_a74412b8-6eee-49e9-ae89-8b46e3b5c76b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6d99ce1a-aa99-488e-8668-99412d0d15f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_a74412b8-6eee-49e9-ae89-8b46e3b5c76b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6d99ce1a-aa99-488e-8668-99412d0d15f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_93315254-f2e8-4ee6-8d35-549996e32692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_a74412b8-6eee-49e9-ae89-8b46e3b5c76b" xlink:to="loc_us-gaap_NondesignatedMember_93315254-f2e8-4ee6-8d35-549996e32692" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c644c31f-6da6-4098-9b8c-1897a9d56175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b7c509d4-8745-455d-b8ab-5df472c9ca73" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c644c31f-6da6-4098-9b8c-1897a9d56175" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c644c31f-6da6-4098-9b8c-1897a9d56175_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c644c31f-6da6-4098-9b8c-1897a9d56175" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c644c31f-6da6-4098-9b8c-1897a9d56175_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_131b0347-9b7e-4877-b623-ff5d2a5704bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c644c31f-6da6-4098-9b8c-1897a9d56175" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_131b0347-9b7e-4877-b623-ff5d2a5704bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_5f1031f6-6002-4251-a570-14cda9a2eba2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_131b0347-9b7e-4877-b623-ff5d2a5704bf" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_5f1031f6-6002-4251-a570-14cda9a2eba2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_cacaa3cb-2238-4998-8a14-745c329e8588" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_131b0347-9b7e-4877-b623-ff5d2a5704bf" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_cacaa3cb-2238-4998-8a14-745c329e8588" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DerivativeLiabilitiesNoncurrentMember_64e9a792-c0ba-4893-a047-551f93b7cc4e" xlink:href="livn-20200930.xsd#livn_DerivativeLiabilitiesNoncurrentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_131b0347-9b7e-4877-b623-ff5d2a5704bf" xlink:to="loc_livn_DerivativeLiabilitiesNoncurrentMember_64e9a792-c0ba-4893-a047-551f93b7cc4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_25bee94e-c19a-48fe-890e-299fedcb2952" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_131b0347-9b7e-4877-b623-ff5d2a5704bf" xlink:to="loc_us-gaap_OtherAssetsMember_25bee94e-c19a-48fe-890e-299fedcb2952" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_50b9dcf8-da61-4186-967d-c293a95d2599" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b7c509d4-8745-455d-b8ab-5df472c9ca73" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_50b9dcf8-da61-4186-967d-c293a95d2599" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_50b9dcf8-da61-4186-967d-c293a95d2599_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_50b9dcf8-da61-4186-967d-c293a95d2599" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_50b9dcf8-da61-4186-967d-c293a95d2599_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_afcc4511-d2cb-4b28-a799-bd5378fae6d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_50b9dcf8-da61-4186-967d-c293a95d2599" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_afcc4511-d2cb-4b28-a799-bd5378fae6d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_7177a812-62fa-45e2-a7cc-8111d040f297" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_afcc4511-d2cb-4b28-a799-bd5378fae6d1" xlink:to="loc_us-gaap_InterestRateContractMember_7177a812-62fa-45e2-a7cc-8111d040f297" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_e464fd36-99bf-41ec-943c-53be33545301" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_afcc4511-d2cb-4b28-a799-bd5378fae6d1" xlink:to="loc_us-gaap_ForeignExchangeContractMember_e464fd36-99bf-41ec-943c-53be33545301" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CappedCallMember_e9959edf-90c2-4c21-8365-f713c8f9b27a" xlink:href="livn-20200930.xsd#livn_CappedCallMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_afcc4511-d2cb-4b28-a799-bd5378fae6d1" xlink:to="loc_livn_CappedCallMember_e9959edf-90c2-4c21-8365-f713c8f9b27a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_99ebd0b8-3df6-4f63-9928-62790c7e1334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_afcc4511-d2cb-4b28-a799-bd5378fae6d1" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_99ebd0b8-3df6-4f63-9928-62790c7e1334" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_ea8e584a-2bc1-400a-b5aa-c0efba962368" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_afcc4511-d2cb-4b28-a799-bd5378fae6d1" xlink:to="loc_us-gaap_OtherContractMember_ea8e584a-2bc1-400a-b5aa-c0efba962368" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="livn-20200930.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/CommitmentsandContingencies" xlink:type="extended" id="i4e4734f4614a42a696c52da54806a4c4_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="livn-20200930.xsd#CommitmentsandContingenciesTables"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesTables" xlink:type="extended" id="i6189107d113b4df685275f4c27456fda_CommitmentsandContingenciesTables"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended" id="i5b9941e2102e44208a92094b1deffcf7_CommitmentsandContingenciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_LossContingencyNumberofObservedNonConformities_90c52f00-bce8-435c-ba48-e1d7af4c7d35" xlink:href="livn-20200930.xsd#livn_LossContingencyNumberofObservedNonConformities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_livn_LossContingencyNumberofObservedNonConformities_90c52f00-bce8-435c-ba48-e1d7af4c7d35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationNet_69782142-1d39-4a10-913a-0d71a2d6bf7d" xlink:href="livn-20200930.xsd#livn_ProductRemediationNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_livn_ProductRemediationNet_69782142-1d39-4a10-913a-0d71a2d6bf7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_cfef18b1-a1a6-4890-b364-2e793ddb47d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_cfef18b1-a1a6-4890-b364-2e793ddb47d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_b0d1ed54-c478-459f-aa3f-54abd0ea9760" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_b0d1ed54-c478-459f-aa3f-54abd0ea9760" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_d03f483a-24ad-48d5-a84f-a3ed0ddd0f21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_d03f483a-24ad-48d5-a84f-a3ed0ddd0f21" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_885f59cb-2924-4fe9-b26e-abae7edf4fc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_885f59cb-2924-4fe9-b26e-abae7edf4fc8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_c6ccd8af-d0de-4625-926b-8f57a3855625" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_c6ccd8af-d0de-4625-926b-8f57a3855625" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ReimbursedLegalFees_2938576f-6580-40dd-9581-f033c125d10e" xlink:href="livn-20200930.xsd#livn_ReimbursedLegalFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_livn_ReimbursedLegalFees_2938576f-6580-40dd-9581-f033c125d10e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_7b4bca84-ce21-49a5-8a5f-8d4108f327e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_7b4bca84-ce21-49a5-8a5f-8d4108f327e4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_IncomeTaxExaminationOperatingLossesUnderDispute_161ad020-3b05-43fd-8fdd-3e72f49156b3" xlink:href="livn-20200930.xsd#livn_IncomeTaxExaminationOperatingLossesUnderDispute"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_livn_IncomeTaxExaminationOperatingLossesUnderDispute_161ad020-3b05-43fd-8fdd-3e72f49156b3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_IncomeTaxExaminationNumberofInstallments_af2c436a-f033-45ae-8794-65eb30c7285b" xlink:href="livn-20200930.xsd#livn_IncomeTaxExaminationNumberofInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_livn_IncomeTaxExaminationNumberofInstallments_af2c436a-f033-45ae-8794-65eb30c7285b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_LossContingencyNumberofAssessments_0794ce75-88f5-4294-b867-e686f17d1b3b" xlink:href="livn-20200930.xsd#livn_LossContingencyNumberofAssessments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_livn_LossContingencyNumberofAssessments_0794ce75-88f5-4294-b867-e686f17d1b3b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements_7b364da6-ce69-463e-972e-6d5f0e084ef8" xlink:href="livn-20200930.xsd#livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements_7b364da6-ce69-463e-972e-6d5f0e084ef8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_9f53feff-f639-4423-9098-6ed6091d91c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_9f53feff-f639-4423-9098-6ed6091d91c1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6f50254d-3608-49b2-ac7b-1b35f999d669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6f50254d-3608-49b2-ac7b-1b35f999d669" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1f8d5242-5470-4be2-9f02-419747e62872" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1f8d5242-5470-4be2-9f02-419747e62872" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_0beb2063-b1a2-4903-8a78-5603376e9edb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_OtherCommitmentsTable_0beb2063-b1a2-4903-8a78-5603376e9edb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_85c075f4-1ad7-436a-905f-ac24edea881a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_0beb2063-b1a2-4903-8a78-5603376e9edb" xlink:to="loc_srt_LitigationCaseAxis_85c075f4-1ad7-436a-905f-ac24edea881a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_85c075f4-1ad7-436a-905f-ac24edea881a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_85c075f4-1ad7-436a-905f-ac24edea881a" xlink:to="loc_srt_LitigationCaseTypeDomain_85c075f4-1ad7-436a-905f-ac24edea881a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_6908d3ab-0056-40ed-b123-5520edba1cbb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_85c075f4-1ad7-436a-905f-ac24edea881a" xlink:to="loc_srt_LitigationCaseTypeDomain_6908d3ab-0056-40ed-b123-5520edba1cbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_FDAWarningLetterMember_f2600422-aaac-4998-a512-dd6437d67a2b" xlink:href="livn-20200930.xsd#livn_FDAWarningLetterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_6908d3ab-0056-40ed-b123-5520edba1cbb" xlink:to="loc_livn_FDAWarningLetterMember_f2600422-aaac-4998-a512-dd6437d67a2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductLiabilityMember_f06e48c9-3e8f-42ce-9952-25c4b26e2124" xlink:href="livn-20200930.xsd#livn_ProductLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_6908d3ab-0056-40ed-b123-5520edba1cbb" xlink:to="loc_livn_ProductLiabilityMember_f06e48c9-3e8f-42ce-9952-25c4b26e2124" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_SNIAMember_2f7cfdf2-d387-4cae-8e7c-3e65efc0c666" xlink:href="livn-20200930.xsd#livn_SNIAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_6908d3ab-0056-40ed-b123-5520edba1cbb" xlink:to="loc_livn_SNIAMember_2f7cfdf2-d387-4cae-8e7c-3e65efc0c666" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a155360f-35dd-49f4-8528-124361a7c91e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_0beb2063-b1a2-4903-8a78-5603376e9edb" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a155360f-35dd-49f4-8528-124361a7c91e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a155360f-35dd-49f4-8528-124361a7c91e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a155360f-35dd-49f4-8528-124361a7c91e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a155360f-35dd-49f4-8528-124361a7c91e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c90fcdf1-70e3-41e5-83c9-c3064cc65efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a155360f-35dd-49f4-8528-124361a7c91e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c90fcdf1-70e3-41e5-83c9-c3064cc65efe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a34e9e98-c43b-4105-b504-9f9f0c412ffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c90fcdf1-70e3-41e5-83c9-c3064cc65efe" xlink:to="loc_us-gaap_SubsequentEventMember_a34e9e98-c43b-4105-b504-9f9f0c412ffd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_258dc51c-6986-40b1-8514-422dca470f11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_0beb2063-b1a2-4903-8a78-5603376e9edb" xlink:to="loc_us-gaap_LitigationStatusAxis_258dc51c-6986-40b1-8514-422dca470f11" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_258dc51c-6986-40b1-8514-422dca470f11_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_258dc51c-6986-40b1-8514-422dca470f11" xlink:to="loc_us-gaap_LitigationStatusDomain_258dc51c-6986-40b1-8514-422dca470f11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_a92c79b0-e3c1-4bc3-b7b7-de9f2a304dca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_258dc51c-6986-40b1-8514-422dca470f11" xlink:to="loc_us-gaap_LitigationStatusDomain_a92c79b0-e3c1-4bc3-b7b7-de9f2a304dca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ThreatenedLitigationMember_87d1a7b2-5fdd-4da0-8634-dd6407784287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ThreatenedLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_a92c79b0-e3c1-4bc3-b7b7-de9f2a304dca" xlink:to="loc_us-gaap_ThreatenedLitigationMember_87d1a7b2-5fdd-4da0-8634-dd6407784287" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_65d786bb-48ee-444f-b706-e8251bf6c5cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_a92c79b0-e3c1-4bc3-b7b7-de9f2a304dca" xlink:to="loc_us-gaap_PendingLitigationMember_65d786bb-48ee-444f-b706-e8251bf6c5cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3e962464-89c1-4a06-940b-1c1775376e4e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_0beb2063-b1a2-4903-8a78-5603376e9edb" xlink:to="loc_dei_LegalEntityAxis_3e962464-89c1-4a06-940b-1c1775376e4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3e962464-89c1-4a06-940b-1c1775376e4e_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_3e962464-89c1-4a06-940b-1c1775376e4e" xlink:to="loc_dei_EntityDomain_3e962464-89c1-4a06-940b-1c1775376e4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b4eae528-2534-4415-9a36-946c33b0c862" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_3e962464-89c1-4a06-940b-1c1775376e4e" xlink:to="loc_dei_EntityDomain_b4eae528-2534-4415-9a36-946c33b0c862" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_SNIAs.p.aMember_e32a95d2-1225-4c5d-ab1f-10348b91a02c" xlink:href="livn-20200930.xsd#livn_SNIAs.p.aMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_b4eae528-2534-4415-9a36-946c33b0c862" xlink:to="loc_livn_SNIAs.p.aMember_e32a95d2-1225-4c5d-ab1f-10348b91a02c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_03bd74da-2ee6-4c39-90d3-3a78a32772c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_0beb2063-b1a2-4903-8a78-5603376e9edb" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_03bd74da-2ee6-4c39-90d3-3a78a32772c6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_03bd74da-2ee6-4c39-90d3-3a78a32772c6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_03bd74da-2ee6-4c39-90d3-3a78a32772c6" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_03bd74da-2ee6-4c39-90d3-3a78a32772c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_fe2af561-ea80-404a-ae3e-100afc6d46c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_03bd74da-2ee6-4c39-90d3-3a78a32772c6" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_fe2af561-ea80-404a-ae3e-100afc6d46c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_RegionalInternalRevenueOfficeofLombardyMember_b500a29f-39eb-4574-8330-9b439d151d14" xlink:href="livn-20200930.xsd#livn_RegionalInternalRevenueOfficeofLombardyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_fe2af561-ea80-404a-ae3e-100afc6d46c1" xlink:to="loc_livn_RegionalInternalRevenueOfficeofLombardyMember_b500a29f-39eb-4574-8330-9b439d151d14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e94c28c3-91ac-4e2e-8138-5b2999623b64" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_0beb2063-b1a2-4903-8a78-5603376e9edb" xlink:to="loc_srt_RangeAxis_e94c28c3-91ac-4e2e-8138-5b2999623b64" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e94c28c3-91ac-4e2e-8138-5b2999623b64_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e94c28c3-91ac-4e2e-8138-5b2999623b64" xlink:to="loc_srt_RangeMember_e94c28c3-91ac-4e2e-8138-5b2999623b64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cafa57ed-cc77-45e7-8e15-e721447ca282" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e94c28c3-91ac-4e2e-8138-5b2999623b64" xlink:to="loc_srt_RangeMember_cafa57ed-cc77-45e7-8e15-e721447ca282" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c6239c84-ece7-4b2b-908a-fd7ea47597a0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cafa57ed-cc77-45e7-8e15-e721447ca282" xlink:to="loc_srt_MaximumMember_c6239c84-ece7-4b2b-908a-fd7ea47597a0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#CommitmentsandContingenciesScheduleofProductLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails" xlink:type="extended" id="i71f65742514b4bdf8898446a0233605e_CommitmentsandContingenciesScheduleofProductLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_96198bea-8ed7-4b55-943a-751ccab20b9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualRollForward_dca15d21-1e85-4cfa-bccb-9c32447390e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_96198bea-8ed7-4b55-943a-751ccab20b9d" xlink:to="loc_us-gaap_LossContingencyAccrualRollForward_dca15d21-1e85-4cfa-bccb-9c32447390e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_8afec213-ee3c-48d4-862f-82f89104a681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_dca15d21-1e85-4cfa-bccb-9c32447390e0" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_8afec213-ee3c-48d4-862f-82f89104a681" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_c02d868e-6aee-4907-b4ea-53db3ebb2969" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_dca15d21-1e85-4cfa-bccb-9c32447390e0" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_c02d868e-6aee-4907-b4ea-53db3ebb2969" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_LossContingencyAccrualAdjustments_66846ad4-6936-46fe-80d6-bb09c471cb13" xlink:href="livn-20200930.xsd#livn_LossContingencyAccrualAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_dca15d21-1e85-4cfa-bccb-9c32447390e0" xlink:to="loc_livn_LossContingencyAccrualAdjustments_66846ad4-6936-46fe-80d6-bb09c471cb13" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther_82262a41-1a56-419c-861d-5eecb435a701" xlink:href="livn-20200930.xsd#livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_dca15d21-1e85-4cfa-bccb-9c32447390e0" xlink:to="loc_livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther_82262a41-1a56-419c-861d-5eecb435a701" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_5c1e4a41-3dd5-40b7-ac5b-4e4a187025a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_7e7c5f78-fef2-4cf5-b225-9e4ce33991b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_dca15d21-1e85-4cfa-bccb-9c32447390e0" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_7e7c5f78-fef2-4cf5-b225-9e4ce33991b8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_5464f2d6-aa1e-4dec-9f44-e33cdda1f6a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_dca15d21-1e85-4cfa-bccb-9c32447390e0" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_5464f2d6-aa1e-4dec-9f44-e33cdda1f6a1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_6b506416-9651-45dd-94dc-383ab5cc9649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_96198bea-8ed7-4b55-943a-751ccab20b9d" xlink:to="loc_us-gaap_LossContingenciesTable_6b506416-9651-45dd-94dc-383ab5cc9649" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6393f5ac-ea57-4e0d-bf4f-1d88b17a991a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6b506416-9651-45dd-94dc-383ab5cc9649" xlink:to="loc_srt_LitigationCaseAxis_6393f5ac-ea57-4e0d-bf4f-1d88b17a991a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_6393f5ac-ea57-4e0d-bf4f-1d88b17a991a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_6393f5ac-ea57-4e0d-bf4f-1d88b17a991a" xlink:to="loc_srt_LitigationCaseTypeDomain_6393f5ac-ea57-4e0d-bf4f-1d88b17a991a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_bf39dc90-75be-4e01-bb60-f46711f9637e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_6393f5ac-ea57-4e0d-bf4f-1d88b17a991a" xlink:to="loc_srt_LitigationCaseTypeDomain_bf39dc90-75be-4e01-bb60-f46711f9637e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductLiabilityMember_946f114a-9227-4db6-8a13-82dbabae7e4e" xlink:href="livn-20200930.xsd#livn_ProductLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf39dc90-75be-4e01-bb60-f46711f9637e" xlink:to="loc_livn_ProductLiabilityMember_946f114a-9227-4db6-8a13-82dbabae7e4e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockholdersEquity" xlink:type="simple" xlink:href="livn-20200930.xsd#StockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/StockholdersEquity" xlink:type="extended" id="i0a0e9f9205bd49cd9d1a117c8ceeeb3a_StockholdersEquity"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="livn-20200930.xsd#StockholdersEquityTables"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/StockholdersEquityTables" xlink:type="extended" id="i905557401bc649038e7f54ee03fd7185_StockholdersEquityTables"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#StockholdersEquityStatementofStockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails" xlink:type="extended" id="i3515c7e042a440d79ec924c330cd34a4_StockholdersEquityStatementofStockholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_28eaacff-1a60-480d-b58d-e5a6a5e03c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_28eaacff-1a60-480d-b58d-e5a6a5e03c6e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_b5353a2b-69ae-4ab6-ae87-75498c62c982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:to="loc_us-gaap_CommonStockSharesIssued_b5353a2b-69ae-4ab6-ae87-75498c62c982" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8a3d9ba6-80d1-41ea-8316-025a0e035f69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:to="loc_us-gaap_StockholdersEquity_8a3d9ba6-80d1-41ea-8316-025a0e035f69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5b42e74a-a270-478b-93a0-72474c33d483" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5b42e74a-a270-478b-93a0-72474c33d483" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_30d67578-4e12-4629-a174-8370944c6169" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_30d67578-4e12-4629-a174-8370944c6169" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_268b29c6-7c45-4390-ad83-aa7f4bf88b28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_268b29c6-7c45-4390-ad83-aa7f4bf88b28" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4b077e9a-94cc-44dc-b723-a3198b97952c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:to="loc_us-gaap_NetIncomeLoss_4b077e9a-94cc-44dc-b723-a3198b97952c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_538e633c-d838-4e46-84e4-335b3db5bbd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_538e633c-d838-4e46-84e4-335b3db5bbd2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_51576ded-f94f-4894-8290-b1b1de21de5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c472d5d2-78f9-40d2-bc89-27ccfda78966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_82e95706-dce7-4f0e-bb63-d800733407d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_28eaacff-1a60-480d-b58d-e5a6a5e03c6e" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_82e95706-dce7-4f0e-bb63-d800733407d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_9f52a074-38d1-4798-8cde-3ac2da7b6fa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_28eaacff-1a60-480d-b58d-e5a6a5e03c6e" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_9f52a074-38d1-4798-8cde-3ac2da7b6fa9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b41c560a-13df-4993-858d-02a0e1defd83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9f52a074-38d1-4798-8cde-3ac2da7b6fa9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b41c560a-13df-4993-858d-02a0e1defd83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b41c560a-13df-4993-858d-02a0e1defd83_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b41c560a-13df-4993-858d-02a0e1defd83" xlink:to="loc_us-gaap_EquityComponentDomain_b41c560a-13df-4993-858d-02a0e1defd83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b7ffb966-246d-46d3-92db-0f385ac4beae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b41c560a-13df-4993-858d-02a0e1defd83" xlink:to="loc_us-gaap_EquityComponentDomain_b7ffb966-246d-46d3-92db-0f385ac4beae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_760f5460-f54f-4abb-8c85-8940b0fadcd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b7ffb966-246d-46d3-92db-0f385ac4beae" xlink:to="loc_us-gaap_CommonStockMember_760f5460-f54f-4abb-8c85-8940b0fadcd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_18f83d58-aaa8-4a09-828b-5a8dbcad1a55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b7ffb966-246d-46d3-92db-0f385ac4beae" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_18f83d58-aaa8-4a09-828b-5a8dbcad1a55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_21c0e90c-2937-4f35-bce9-99e96e5a95a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b7ffb966-246d-46d3-92db-0f385ac4beae" xlink:to="loc_us-gaap_TreasuryStockMember_21c0e90c-2937-4f35-bce9-99e96e5a95a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3072e61-49e6-4140-a5d1-c51c132c83b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b7ffb966-246d-46d3-92db-0f385ac4beae" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3072e61-49e6-4140-a5d1-c51c132c83b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_30bd6fd6-8685-466d-b55f-0fb77bfd3a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b7ffb966-246d-46d3-92db-0f385ac4beae" xlink:to="loc_us-gaap_RetainedEarningsMember_30bd6fd6-8685-466d-b55f-0fb77bfd3a8f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2f7ec616-3586-42ab-aa31-6f9cfc13e4cd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9f52a074-38d1-4798-8cde-3ac2da7b6fa9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2f7ec616-3586-42ab-aa31-6f9cfc13e4cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_2f7ec616-3586-42ab-aa31-6f9cfc13e4cd_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2f7ec616-3586-42ab-aa31-6f9cfc13e4cd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_2f7ec616-3586-42ab-aa31-6f9cfc13e4cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_af1702d8-589a-4722-91e2-1d7ca8210a1d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2f7ec616-3586-42ab-aa31-6f9cfc13e4cd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_af1702d8-589a-4722-91e2-1d7ca8210a1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_831d5823-8d1b-4766-8c00-1d808a3a3ad0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_af1702d8-589a-4722-91e2-1d7ca8210a1d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_831d5823-8d1b-4766-8c00-1d808a3a3ad0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#StockholdersEquityComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails" xlink:type="extended" id="i88c04b3cd0234615b0a4ef04247d9a9f_StockholdersEquityComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bb0e7b6b-50cb-4fb6-9794-36a59f8a7f27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bb0e7b6b-50cb-4fb6-9794-36a59f8a7f27" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6ce06053-b11e-491f-8e4b-c28d9a3ce57d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:to="loc_us-gaap_StockholdersEquity_6ce06053-b11e-491f-8e4b-c28d9a3ce57d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_066695de-6b31-4ef7-9f14-9439604d95ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_066695de-6b31-4ef7-9f14-9439604d95ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_231a3888-eb3b-44b0-a6d3-bf9b86a0ca65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_231a3888-eb3b-44b0-a6d3-bf9b86a0ca65" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_40a8de91-d35f-4267-af41-0280022dfaa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_40a8de91-d35f-4267-af41-0280022dfaa9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_5ffba87b-a207-4c02-83c2-5a5af5ac6f22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_5ffba87b-a207-4c02-83c2-5a5af5ac6f22" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_7ff03310-69bc-499c-80b5-65f36d008beb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_7ff03310-69bc-499c-80b5-65f36d008beb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_5c28e9fa-9d14-4a48-8bb2-2b409a3cc209" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_5c28e9fa-9d14-4a48-8bb2-2b409a3cc209" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_16df45f4-c7cd-4c5c-8cd6-22e7ea209b94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_16df45f4-c7cd-4c5c-8cd6-22e7ea209b94" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0aa79096-1347-4a33-8064-2974b1e88eed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a113b09a-d7b1-4f46-943f-97bb8a6b1af5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bb0e7b6b-50cb-4fb6-9794-36a59f8a7f27" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a113b09a-d7b1-4f46-943f-97bb8a6b1af5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c1db9762-db72-48f6-b194-230efc6ec0a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a113b09a-d7b1-4f46-943f-97bb8a6b1af5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c1db9762-db72-48f6-b194-230efc6ec0a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c1db9762-db72-48f6-b194-230efc6ec0a1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c1db9762-db72-48f6-b194-230efc6ec0a1" xlink:to="loc_us-gaap_EquityComponentDomain_c1db9762-db72-48f6-b194-230efc6ec0a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_233cb239-f957-40da-9b9b-17a4431c1db6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c1db9762-db72-48f6-b194-230efc6ec0a1" xlink:to="loc_us-gaap_EquityComponentDomain_233cb239-f957-40da-9b9b-17a4431c1db6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f854f69e-8942-4052-8e5a-51a878296a7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_233cb239-f957-40da-9b9b-17a4431c1db6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f854f69e-8942-4052-8e5a-51a878296a7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0fcbfc22-fd3e-4d5f-8a05-c1dfa281f855" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f854f69e-8942-4052-8e5a-51a878296a7e" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0fcbfc22-fd3e-4d5f-8a05-c1dfa281f855" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_da1c7df6-7c8e-4f68-9984-f708cadd48cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f854f69e-8942-4052-8e5a-51a878296a7e" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_da1c7df6-7c8e-4f68-9984-f708cadd48cb" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlans" xlink:type="simple" xlink:href="livn-20200930.xsd#StockBasedIncentivePlans"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlans" xlink:type="extended" id="if4173f1430ff4e07a67d7f331bd20a8f_StockBasedIncentivePlans"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansTables" xlink:type="simple" xlink:href="livn-20200930.xsd#StockBasedIncentivePlansTables"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansTables" xlink:type="extended" id="ibb73f5804c134608b12e6ffd844b45f1_StockBasedIncentivePlansTables"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#StockBasedIncentivePlansCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails" xlink:type="extended" id="idaeca7b3ea864d3aa6345c861161b6f6_StockBasedIncentivePlansCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5a1b7c94-29b5-4145-9524-4b874400c7e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_659f599c-88ba-4e3b-8ec0-16769cdcf440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5a1b7c94-29b5-4145-9524-4b874400c7e2" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_659f599c-88ba-4e3b-8ec0-16769cdcf440" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5cc54c8b-af43-4416-830a-639de7ef0251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5a1b7c94-29b5-4145-9524-4b874400c7e2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5cc54c8b-af43-4416-830a-639de7ef0251" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_de0fd291-2375-49dd-9917-b61e7adfa429" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5a1b7c94-29b5-4145-9524-4b874400c7e2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_de0fd291-2375-49dd-9917-b61e7adfa429" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d4068707-e0eb-49d2-81ea-36c6b109f2cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5a1b7c94-29b5-4145-9524-4b874400c7e2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d4068707-e0eb-49d2-81ea-36c6b109f2cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5f6c0c4c-3331-412a-9c0c-2fdd12b69ceb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d4068707-e0eb-49d2-81ea-36c6b109f2cf" xlink:to="loc_us-gaap_AwardTypeAxis_5f6c0c4c-3331-412a-9c0c-2fdd12b69ceb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5f6c0c4c-3331-412a-9c0c-2fdd12b69ceb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5f6c0c4c-3331-412a-9c0c-2fdd12b69ceb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5f6c0c4c-3331-412a-9c0c-2fdd12b69ceb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f507150-7022-4500-b8e9-9025498bc4e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5f6c0c4c-3331-412a-9c0c-2fdd12b69ceb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f507150-7022-4500-b8e9-9025498bc4e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2323a677-d9c5-4ba6-b314-99655b2aeb46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f507150-7022-4500-b8e9-9025498bc4e2" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2323a677-d9c5-4ba6-b314-99655b2aeb46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_b4ab5895-2b03-4c75-9530-d65b406d2e30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f507150-7022-4500-b8e9-9025498bc4e2" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_b4ab5895-2b03-4c75-9530-d65b406d2e30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MarketbasedPerformanceRestrictedStockUnitMember_0ee11906-ac8b-49f3-984d-07528abbf83d" xlink:href="livn-20200930.xsd#livn_MarketbasedPerformanceRestrictedStockUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f507150-7022-4500-b8e9-9025498bc4e2" xlink:to="loc_livn_MarketbasedPerformanceRestrictedStockUnitMember_0ee11906-ac8b-49f3-984d-07528abbf83d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_OperatingPerformancebasedRestrictedStockUnitsMember_817bcb51-74e2-4328-b98a-73eac6e2bd1d" xlink:href="livn-20200930.xsd#livn_OperatingPerformancebasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f507150-7022-4500-b8e9-9025498bc4e2" xlink:to="loc_livn_OperatingPerformancebasedRestrictedStockUnitsMember_817bcb51-74e2-4328-b98a-73eac6e2bd1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d73936c4-6f36-4c5f-acba-ee958ed949f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f507150-7022-4500-b8e9-9025498bc4e2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d73936c4-6f36-4c5f-acba-ee958ed949f9" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#StockBasedIncentivePlansExecutedAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails" xlink:type="extended" id="ic066601866e843458222b214abcfd934_StockBasedIncentivePlansExecutedAgreementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_853e8f5e-cc20-4a07-8d08-43f078eb2543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8f4825b4-7b49-4303-8180-f5e066205886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_853e8f5e-cc20-4a07-8d08-43f078eb2543" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8f4825b4-7b49-4303-8180-f5e066205886" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_81e0c200-1c2f-43e2-99fc-cc0c4e64a6bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_853e8f5e-cc20-4a07-8d08-43f078eb2543" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_81e0c200-1c2f-43e2-99fc-cc0c4e64a6bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_610a6714-5034-42b6-bd53-5c58604da29f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_853e8f5e-cc20-4a07-8d08-43f078eb2543" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_610a6714-5034-42b6-bd53-5c58604da29f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f4b6035b-9b59-4163-ba7e-c1ee3faf3faa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_610a6714-5034-42b6-bd53-5c58604da29f" xlink:to="loc_us-gaap_AwardTypeAxis_f4b6035b-9b59-4163-ba7e-c1ee3faf3faa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f4b6035b-9b59-4163-ba7e-c1ee3faf3faa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f4b6035b-9b59-4163-ba7e-c1ee3faf3faa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f4b6035b-9b59-4163-ba7e-c1ee3faf3faa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06d22520-ff41-403e-85e2-8fbd9a7dd50e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f4b6035b-9b59-4163-ba7e-c1ee3faf3faa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06d22520-ff41-403e-85e2-8fbd9a7dd50e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_15b2f222-0387-4e7c-b095-b071f3f072ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06d22520-ff41-403e-85e2-8fbd9a7dd50e" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_15b2f222-0387-4e7c-b095-b071f3f072ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_af5e2282-ce4e-47ce-a08b-a0b2ae183323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06d22520-ff41-403e-85e2-8fbd9a7dd50e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_af5e2282-ce4e-47ce-a08b-a0b2ae183323" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MarketbasedPerformanceRestrictedStockUnitMember_6deb26a8-8310-4b0a-bf1d-f73b5cbc47b7" xlink:href="livn-20200930.xsd#livn_MarketbasedPerformanceRestrictedStockUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06d22520-ff41-403e-85e2-8fbd9a7dd50e" xlink:to="loc_livn_MarketbasedPerformanceRestrictedStockUnitMember_6deb26a8-8310-4b0a-bf1d-f73b5cbc47b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_OperatingPerformancebasedRestrictedStockUnitsMember_01eb627d-a26b-4811-9b8b-241c468e3eac" xlink:href="livn-20200930.xsd#livn_OperatingPerformancebasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06d22520-ff41-403e-85e2-8fbd9a7dd50e" xlink:to="loc_livn_OperatingPerformancebasedRestrictedStockUnitsMember_01eb627d-a26b-4811-9b8b-241c468e3eac" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/IncomeTaxes" xlink:type="simple" xlink:href="livn-20200930.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/IncomeTaxes" xlink:type="extended" id="icc0dd1b4713d416fac90d77eeff4f662_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i296df3f7ff704a0a8fc213cfb28c147e_IncomeTaxesNarrativeDetails"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/EarningsPerShare" xlink:type="simple" xlink:href="livn-20200930.xsd#EarningsPerShare"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/EarningsPerShare" xlink:type="extended" id="ia1911159519441c08e1ce00d82138758_EarningsPerShare"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="livn-20200930.xsd#EarningsPerShareTables"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/EarningsPerShareTables" xlink:type="extended" id="iafaa28d9091341d1a0ae3d8ab1ed89ef_EarningsPerShareTables"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="extended" id="if8209c027b2449f184473090686df29a_EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/EarningsPerShareNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#EarningsPerShareNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/EarningsPerShareNarrativeDetails" xlink:type="extended" id="i5fcf96de66a240d89085476e6ebd8a8b_EarningsPerShareNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a059638f-d8d2-4bef-97c9-8ebbe135375d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4bc82773-2bc7-440c-a108-db1f79392ab7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a059638f-d8d2-4bef-97c9-8ebbe135375d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4bc82773-2bc7-440c-a108-db1f79392ab7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c169e928-b131-49d9-955b-0f642637d92f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a059638f-d8d2-4bef-97c9-8ebbe135375d" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c169e928-b131-49d9-955b-0f642637d92f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dc5117f8-3f86-4a23-9506-ade8f07223b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c169e928-b131-49d9-955b-0f642637d92f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dc5117f8-3f86-4a23-9506-ade8f07223b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_dc5117f8-3f86-4a23-9506-ade8f07223b7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dc5117f8-3f86-4a23-9506-ade8f07223b7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_dc5117f8-3f86-4a23-9506-ade8f07223b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c03147b4-554b-4697-ac9b-a0baa5123de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dc5117f8-3f86-4a23-9506-ade8f07223b7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c03147b4-554b-4697-ac9b-a0baa5123de1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_937c07dc-ece1-4927-a411-e15c95739219" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c03147b4-554b-4697-ac9b-a0baa5123de1" xlink:to="loc_us-gaap_StockCompensationPlanMember_937c07dc-ece1-4927-a411-e15c95739219" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformation" xlink:type="simple" xlink:href="livn-20200930.xsd#GeographicandSegmentInformation"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformation" xlink:type="extended" id="i11497305863a4411b1276998b0a9b675_GeographicandSegmentInformation"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationTables" xlink:type="simple" xlink:href="livn-20200930.xsd#GeographicandSegmentInformationTables"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationTables" xlink:type="extended" id="icbfb5f4f02dc47a592c0326da221eb16_GeographicandSegmentInformationTables"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#GeographicandSegmentInformationSegmentInfoDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails" xlink:type="extended" id="ic6e3bb9c6c3b40c9bfa9f45ee93d5e5e_GeographicandSegmentInformationSegmentInfoDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_c1dc1a50-9b1d-423d-9bbf-166636baa321" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_NumberOfReportableSegments_c1dc1a50-9b1d-423d-9bbf-166636baa321" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_NumberofGeographicRegionsinwhichEntityOperates_5e4e2bf6-1115-46cd-9d3e-4f0758479ed4" xlink:href="livn-20200930.xsd#livn_NumberofGeographicRegionsinwhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_livn_NumberofGeographicRegionsinwhichEntityOperates_5e4e2bf6-1115-46cd-9d3e-4f0758479ed4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c89e412d-21e1-4722-8200-1be62f5430ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c89e412d-21e1-4722-8200-1be62f5430ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations_20a2a72e-a96d-407e-94a9-b17d347e3956" xlink:href="livn-20200930.xsd#livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations_20a2a72e-a96d-407e-94a9-b17d347e3956" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_10baab7f-8180-4587-97d5-22395e4cb05a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_10baab7f-8180-4587-97d5-22395e4cb05a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_b9ad6dd6-5385-4032-b4da-fbd9662c52b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_RestructuringCharges_b9ad6dd6-5385-4032-b4da-fbd9662c52b2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_e914bc7a-60e0-4c33-a757-922a264fe9ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_e914bc7a-60e0-4c33-a757-922a264fe9ef" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f1835683-c02a-49a2-9d77-cfd31c340237" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_OperatingIncomeLoss_f1835683-c02a-49a2-9d77-cfd31c340237" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_bdb8298c-f985-48cd-8f04-2c58731b8959" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_InvestmentIncomeInterest_bdb8298c-f985-48cd-8f04-2c58731b8959" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_a21bebe2-a398-46d0-a9fa-63135e9405a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_InterestExpense_a21bebe2-a398-46d0-a9fa-63135e9405a4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome_e0bb46b2-b46f-4f62-9230-1a7be65deaa3" xlink:href="livn-20200930.xsd#livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome_e0bb46b2-b46f-4f62-9230-1a7be65deaa3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f8b45e52-8424-441e-b6d0-22250d13d461" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f8b45e52-8424-441e-b6d0-22250d13d461" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b36fc27a-4c3e-4f04-b693-3b0c6f4cc098" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_Assets_b36fc27a-4c3e-4f04-b693-3b0c6f4cc098" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_22836383-2e57-4236-ac33-b7ae4913f5e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_22836383-2e57-4236-ac33-b7ae4913f5e6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b047a770-002d-4d58-89f1-ec5c5950e2b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b047a770-002d-4d58-89f1-ec5c5950e2b1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8db685c5-1235-41a8-91d1-822f3c129bf8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b047a770-002d-4d58-89f1-ec5c5950e2b1" xlink:to="loc_srt_ProductOrServiceAxis_8db685c5-1235-41a8-91d1-822f3c129bf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8db685c5-1235-41a8-91d1-822f3c129bf8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_8db685c5-1235-41a8-91d1-822f3c129bf8" xlink:to="loc_srt_ProductsAndServicesDomain_8db685c5-1235-41a8-91d1-822f3c129bf8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_36ef6964-def0-4edc-8502-24d4c83b2e26" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_8db685c5-1235-41a8-91d1-822f3c129bf8" xlink:to="loc_srt_ProductsAndServicesDomain_36ef6964-def0-4edc-8502-24d4c83b2e26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CardiopulmonaryMember_0912e15c-24cf-48a5-b623-82a57d604d8a" xlink:href="livn-20200930.xsd#livn_CardiopulmonaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_36ef6964-def0-4edc-8502-24d4c83b2e26" xlink:to="loc_livn_CardiopulmonaryMember_0912e15c-24cf-48a5-b623-82a57d604d8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_HeartValvesMember_f2750be3-af80-4746-b721-f7d1c4a2e77a" xlink:href="livn-20200930.xsd#livn_HeartValvesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_36ef6964-def0-4edc-8502-24d4c83b2e26" xlink:to="loc_livn_HeartValvesMember_f2750be3-af80-4746-b721-f7d1c4a2e77a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_AdvancedCirculatorySupportMember_eb0f0e0d-ba5c-4de6-8dbe-23fe3606bc88" xlink:href="livn-20200930.xsd#livn_AdvancedCirculatorySupportMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_36ef6964-def0-4edc-8502-24d4c83b2e26" xlink:to="loc_livn_AdvancedCirculatorySupportMember_eb0f0e0d-ba5c-4de6-8dbe-23fe3606bc88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d384bd76-0292-472f-8c8e-af575379efb4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b047a770-002d-4d58-89f1-ec5c5950e2b1" xlink:to="loc_srt_StatementGeographicalAxis_d384bd76-0292-472f-8c8e-af575379efb4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d384bd76-0292-472f-8c8e-af575379efb4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_d384bd76-0292-472f-8c8e-af575379efb4" xlink:to="loc_srt_SegmentGeographicalDomain_d384bd76-0292-472f-8c8e-af575379efb4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cde765b0-f515-477f-841d-d1e4c2789627" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_d384bd76-0292-472f-8c8e-af575379efb4" xlink:to="loc_srt_SegmentGeographicalDomain_cde765b0-f515-477f-841d-d1e4c2789627" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_884af861-dda3-4e0a-a104-54255c39d63d" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cde765b0-f515-477f-841d-d1e4c2789627" xlink:to="loc_country_US_884af861-dda3-4e0a-a104-54255c39d63d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_7184039c-90cc-40e8-a34f-3515f8ba431a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cde765b0-f515-477f-841d-d1e4c2789627" xlink:to="loc_srt_EuropeMember_7184039c-90cc-40e8-a34f-3515f8ba431a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_LocationsExcludingTheUnitedStatesAndEuropeMember_8e4b31b2-8266-49f5-ae60-3ccc07e5af94" xlink:href="livn-20200930.xsd#livn_LocationsExcludingTheUnitedStatesAndEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cde765b0-f515-477f-841d-d1e4c2789627" xlink:to="loc_livn_LocationsExcludingTheUnitedStatesAndEuropeMember_8e4b31b2-8266-49f5-ae60-3ccc07e5af94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_32c79a2e-306e-41fc-a9e4-849ecc223205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b047a770-002d-4d58-89f1-ec5c5950e2b1" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_32c79a2e-306e-41fc-a9e4-849ecc223205" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_32c79a2e-306e-41fc-a9e4-849ecc223205_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_32c79a2e-306e-41fc-a9e4-849ecc223205" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_32c79a2e-306e-41fc-a9e4-849ecc223205_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_e5d9e444-c6e5-4b28-9b51-2e5aca06be3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_32c79a2e-306e-41fc-a9e4-849ecc223205" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_e5d9e444-c6e5-4b28-9b51-2e5aca06be3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember_b4d53452-1247-43ca-8523-93c101763a10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_e5d9e444-c6e5-4b28-9b51-2e5aca06be3c" xlink:to="loc_us-gaap_SegmentContinuingOperationsMember_b4d53452-1247-43ca-8523-93c101763a10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_42759a07-ec45-44bd-9ec8-8e88fe94f2ef" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b047a770-002d-4d58-89f1-ec5c5950e2b1" xlink:to="loc_srt_ConsolidationItemsAxis_42759a07-ec45-44bd-9ec8-8e88fe94f2ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_42759a07-ec45-44bd-9ec8-8e88fe94f2ef_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_42759a07-ec45-44bd-9ec8-8e88fe94f2ef" xlink:to="loc_srt_ConsolidationItemsDomain_42759a07-ec45-44bd-9ec8-8e88fe94f2ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a7ac0560-aab4-4ef5-8484-d791d9ea81a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_42759a07-ec45-44bd-9ec8-8e88fe94f2ef" xlink:to="loc_srt_ConsolidationItemsDomain_a7ac0560-aab4-4ef5-8484-d791d9ea81a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_bc69e667-cce5-4147-916e-edbe7f6744df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a7ac0560-aab4-4ef5-8484-d791d9ea81a3" xlink:to="loc_us-gaap_OperatingSegmentsMember_bc69e667-cce5-4147-916e-edbe7f6744df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_3f9ba52b-1559-43db-8632-39b2472b3918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a7ac0560-aab4-4ef5-8484-d791d9ea81a3" xlink:to="loc_us-gaap_CorporateNonSegmentMember_3f9ba52b-1559-43db-8632-39b2472b3918" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_148d978e-a26e-4068-81c3-e9bedd4475be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b047a770-002d-4d58-89f1-ec5c5950e2b1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_148d978e-a26e-4068-81c3-e9bedd4475be" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_148d978e-a26e-4068-81c3-e9bedd4475be_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_148d978e-a26e-4068-81c3-e9bedd4475be" xlink:to="loc_us-gaap_SegmentDomain_148d978e-a26e-4068-81c3-e9bedd4475be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e24129c2-03be-4e5d-b8e5-f486803daccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_148d978e-a26e-4068-81c3-e9bedd4475be" xlink:to="loc_us-gaap_SegmentDomain_e24129c2-03be-4e5d-b8e5-f486803daccc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CardiovascularSegmentMember_160e975b-fd0e-4743-b07f-6570d0f4e0f1" xlink:href="livn-20200930.xsd#livn_CardiovascularSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e24129c2-03be-4e5d-b8e5-f486803daccc" xlink:to="loc_livn_CardiovascularSegmentMember_160e975b-fd0e-4743-b07f-6570d0f4e0f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_NeuromodulationSegmentMember_a48489e7-7e97-401e-b8dd-3fba9f859d1d" xlink:href="livn-20200930.xsd#livn_NeuromodulationSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e24129c2-03be-4e5d-b8e5-f486803daccc" xlink:to="loc_livn_NeuromodulationSegmentMember_a48489e7-7e97-401e-b8dd-3fba9f859d1d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails" xlink:type="extended" id="i776cdfaf40eb4367b83a50c918c9cbd1_GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_50ac128b-3124-4143-8d50-938984511c97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_992c5172-fc4b-490b-82b1-142bc37d4416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_50ac128b-3124-4143-8d50-938984511c97" xlink:to="loc_us-gaap_GoodwillRollForward_992c5172-fc4b-490b-82b1-142bc37d4416" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c6039783-eb79-46f9-95fd-32d27ff44d8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_992c5172-fc4b-490b-82b1-142bc37d4416" xlink:to="loc_us-gaap_Goodwill_c6039783-eb79-46f9-95fd-32d27ff44d8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_9a5db13c-3a02-4690-91bd-9dd8c842c319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_992c5172-fc4b-490b-82b1-142bc37d4416" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_9a5db13c-3a02-4690-91bd-9dd8c842c319" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f6a21412-ef9a-4159-8bef-684ba651ef01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b56136a9-faa4-40f4-a44f-566f05a84eb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_50ac128b-3124-4143-8d50-938984511c97" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b56136a9-faa4-40f4-a44f-566f05a84eb6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b86e91fb-d703-44dc-b107-4fb5d49a0a05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b56136a9-faa4-40f4-a44f-566f05a84eb6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b86e91fb-d703-44dc-b107-4fb5d49a0a05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b86e91fb-d703-44dc-b107-4fb5d49a0a05_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b86e91fb-d703-44dc-b107-4fb5d49a0a05" xlink:to="loc_us-gaap_SegmentDomain_b86e91fb-d703-44dc-b107-4fb5d49a0a05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d7057f0b-b39b-4e91-8687-9a4dd7b30056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b86e91fb-d703-44dc-b107-4fb5d49a0a05" xlink:to="loc_us-gaap_SegmentDomain_d7057f0b-b39b-4e91-8687-9a4dd7b30056" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_NeuromodulationSegmentMember_15b72620-f6f8-4bfa-9cbb-852a9a579e71" xlink:href="livn-20200930.xsd#livn_NeuromodulationSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d7057f0b-b39b-4e91-8687-9a4dd7b30056" xlink:to="loc_livn_NeuromodulationSegmentMember_15b72620-f6f8-4bfa-9cbb-852a9a579e71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CardiovascularSegmentMember_2e66ce7a-6bcc-4860-984a-c11b48bc758e" xlink:href="livn-20200930.xsd#livn_CardiovascularSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d7057f0b-b39b-4e91-8687-9a4dd7b30056" xlink:to="loc_livn_CardiovascularSegmentMember_2e66ce7a-6bcc-4860-984a-c11b48bc758e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationGeographicAreasDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#GeographicandSegmentInformationGeographicAreasDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationGeographicAreasDetails" xlink:type="extended" id="i2c3b450e325b480ca1ed7e4e96acb1f0_GeographicandSegmentInformationGeographicAreasDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6cd23539-e9c2-496b-882d-7882562c1119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_99b36601-1f8b-42d7-b823-844525a08f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6cd23539-e9c2-496b-882d-7882562c1119" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_99b36601-1f8b-42d7-b823-844525a08f91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_391ad36d-9a00-4fe1-8229-28e812af5041" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6cd23539-e9c2-496b-882d-7882562c1119" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_391ad36d-9a00-4fe1-8229-28e812af5041" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_bb4ff9a5-92da-4abf-bdb6-7678eb3d1052" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_391ad36d-9a00-4fe1-8229-28e812af5041" xlink:to="loc_srt_StatementGeographicalAxis_bb4ff9a5-92da-4abf-bdb6-7678eb3d1052" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_bb4ff9a5-92da-4abf-bdb6-7678eb3d1052_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_bb4ff9a5-92da-4abf-bdb6-7678eb3d1052" xlink:to="loc_srt_SegmentGeographicalDomain_bb4ff9a5-92da-4abf-bdb6-7678eb3d1052_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5c705c68-545e-4bdb-8762-b05da6a3a5ec" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_bb4ff9a5-92da-4abf-bdb6-7678eb3d1052" xlink:to="loc_srt_SegmentGeographicalDomain_5c705c68-545e-4bdb-8762-b05da6a3a5ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d4f92238-312a-47b4-b3a5-ad2476a5442c" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5c705c68-545e-4bdb-8762-b05da6a3a5ec" xlink:to="loc_country_US_d4f92238-312a-47b4-b3a5-ad2476a5442c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_a96ccfda-ab88-4369-94a3-1f66ecb6f6ba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5c705c68-545e-4bdb-8762-b05da6a3a5ec" xlink:to="loc_srt_EuropeMember_a96ccfda-ab88-4369-94a3-1f66ecb6f6ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_LocationsExcludingTheUnitedStatesAndEuropeMember_def412e9-d9fa-4949-a778-b4ccc66bf0ea" xlink:href="livn-20200930.xsd#livn_LocationsExcludingTheUnitedStatesAndEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5c705c68-545e-4bdb-8762-b05da6a3a5ec" xlink:to="loc_livn_LocationsExcludingTheUnitedStatesAndEuropeMember_def412e9-d9fa-4949-a778-b4ccc66bf0ea" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformation" xlink:type="simple" xlink:href="livn-20200930.xsd#SupplementalFinancialInformation"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformation" xlink:type="extended" id="iaa27bd1867be408dac04a5d1a6795850_SupplementalFinancialInformation"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationTables" xlink:type="simple" xlink:href="livn-20200930.xsd#SupplementalFinancialInformationTables"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationTables" xlink:type="extended" id="if782c7d746204e48991488db03785818_SupplementalFinancialInformationTables"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofInventoryDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#SupplementalFinancialInformationSummaryofInventoryDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofInventoryDetails" xlink:type="extended" id="i5d0f68a50fb246e3abc44addb8db16d5_SupplementalFinancialInformationSummaryofInventoryDetails"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails" xlink:type="extended" id="ifcc527ed9c394f848150db844a48f8cb_SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="livn-20200930.xsd#NewAccountingPronouncements"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/NewAccountingPronouncements" xlink:type="extended" id="ie32c3a6e3b184fa2bd3a4bba26f03283_NewAccountingPronouncements"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsTables" xlink:type="simple" xlink:href="livn-20200930.xsd#NewAccountingPronouncementsTables"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsTables" xlink:type="extended" id="i860f8a89b24e41328f9e1ecfca8a081a_NewAccountingPronouncementsTables"/>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#NewAccountingPronouncementsDetails"/>
  <link:definitionLink xlink:role="http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsDetails" xlink:type="extended" id="ic2cc863587814d94afb5c220e04a0d3f_NewAccountingPronouncementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_aa1fec5f-18a4-4f8c-abc4-d4001faf992b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d0e83ec4-af97-4147-abbd-a31358689057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_aa1fec5f-18a4-4f8c-abc4-d4001faf992b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d0e83ec4-af97-4147-abbd-a31358689057" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_06ae8366-dff8-4ac1-92af-031db1fe8cba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_aa1fec5f-18a4-4f8c-abc4-d4001faf992b" xlink:to="loc_us-gaap_StockholdersEquity_06ae8366-dff8-4ac1-92af-031db1fe8cba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_ba849949-47d5-42da-849f-841e69848716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_aa1fec5f-18a4-4f8c-abc4-d4001faf992b" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_ba849949-47d5-42da-849f-841e69848716" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0b8e41c4-2ed3-444e-8fab-43ebb369cf21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_aa1fec5f-18a4-4f8c-abc4-d4001faf992b" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0b8e41c4-2ed3-444e-8fab-43ebb369cf21" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2110a1c4-e473-43dd-937b-d4d8a92836e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0b8e41c4-2ed3-444e-8fab-43ebb369cf21" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2110a1c4-e473-43dd-937b-d4d8a92836e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2110a1c4-e473-43dd-937b-d4d8a92836e5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2110a1c4-e473-43dd-937b-d4d8a92836e5" xlink:to="loc_us-gaap_EquityComponentDomain_2110a1c4-e473-43dd-937b-d4d8a92836e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_002a0fe1-ebbd-4c11-8ffa-5f0744f3e3ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2110a1c4-e473-43dd-937b-d4d8a92836e5" xlink:to="loc_us-gaap_EquityComponentDomain_002a0fe1-ebbd-4c11-8ffa-5f0744f3e3ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9b2fa0e7-44e3-4171-b562-487a646ffc62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_002a0fe1-ebbd-4c11-8ffa-5f0744f3e3ea" xlink:to="loc_us-gaap_RetainedEarningsMember_9b2fa0e7-44e3-4171-b562-487a646ffc62" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>livn-20200930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:152b0760-94f0-4bb0-b0a2-1db31ab2058d,g:fb466a4e-c2f9-40f5-a132-8d0db9b26e35-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c7d58e87-2746-4229-878f-ca5c29b9dea0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_848f8241-0d53-4312-bd10-cbada88a5b1d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_5ffd32e2-63e9-4f87-bd48-242039e5ac42_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_34bdc15e-9664-4ace-8358-7b0be091c0bc_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_f1d7f0fa-2b4e-4878-97ce-fa7978f10520_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation of shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Retired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesRetired" xlink:to="lab_us-gaap_TreasuryStockSharesRetired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_db89e91a-d7ad-4ce7-85ed-a08e8e5edb3f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_HighlifeS.A.S.Member_6da6276c-eb60-463c-bdc3-5c21a351831e_terseLabel_en-US" xlink:label="lab_livn_HighlifeS.A.S.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Highlife S.A.S.</link:label>
    <link:label id="lab_livn_HighlifeS.A.S.Member_label_en-US" xlink:label="lab_livn_HighlifeS.A.S.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Highlife S.A.S. [Member]</link:label>
    <link:label id="lab_livn_HighlifeS.A.S.Member_documentation_en-US" xlink:label="lab_livn_HighlifeS.A.S.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Highlife S.A.S. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_HighlifeS.A.S.Member" xlink:href="livn-20200930.xsd#livn_HighlifeS.A.S.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_HighlifeS.A.S.Member" xlink:to="lab_livn_HighlifeS.A.S.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_288b08ee-fce5-4f05-b8a7-4341809f2b4a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_3daa1c7a-b804-4634-9d8a-17b8abccb58c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct_e833b131-046a-4ff4-8501-ed5ecfe1f570_negatedTerseLabel_en-US" xlink:label="lab_livn_IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit, CARES Act</link:label>
    <link:label id="lab_livn_IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct_label_en-US" xlink:label="lab_livn_IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Income Tax Expense (Benefit), CARES Act</link:label>
    <link:label id="lab_livn_IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct_documentation_en-US" xlink:label="lab_livn_IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Income Tax Expense (Benefit), CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct" xlink:href="livn-20200930.xsd#livn_IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct" xlink:to="lab_livn_IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_07cecdb5-cb49-474e-818e-c0c03c1814b3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherContractMember_4e083a1c-4ee2-4b9c-a32e-58dc9f32dc79_terseLabel_en-US" xlink:label="lab_us-gaap_OtherContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other derivatives</link:label>
    <link:label id="lab_us-gaap_OtherContractMember_label_en-US" xlink:label="lab_us-gaap_OtherContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherContractMember" xlink:to="lab_us-gaap_OtherContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_4ee79a07-91fe-4dac-9fa5-65573ffeb4b9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b5f9b38a-5fb0-46d7-b996-e2793b5c8f34_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_62227b45-77dc-45e5-81e2-40174a769209_terseLabel_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of embedded derivative liability</link:label>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Derivative, Fair Value of Embedded Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:to="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_OperatingPerformancebasedRestrictedStockUnitsMember_70045420-3b86-4229-b541-f2e666a868b6_terseLabel_en-US" xlink:label="lab_livn_OperatingPerformancebasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating performance-based restricted stock units</link:label>
    <link:label id="lab_livn_OperatingPerformancebasedRestrictedStockUnitsMember_label_en-US" xlink:label="lab_livn_OperatingPerformancebasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Performance-based Restricted Stock Units [Member]</link:label>
    <link:label id="lab_livn_OperatingPerformancebasedRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_livn_OperatingPerformancebasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Performance-based Restricted Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_OperatingPerformancebasedRestrictedStockUnitsMember" xlink:href="livn-20200930.xsd#livn_OperatingPerformancebasedRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_OperatingPerformancebasedRestrictedStockUnitsMember" xlink:to="lab_livn_OperatingPerformancebasedRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_194af204-92bd-48f3-a066-ba95891b8cb0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_5a445074-a485-4214-a4fd-e15feb26fcd8_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c3cfa5c5-64ff-4ec1-b8fb-6cee880915a8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5f0c1bde-65e3-4dd2-8afd-7dd051efabb6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_91f96aed-867f-4d76-bdb0-ce687e2d2868_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_7ea11159-88eb-4402-8481-856ed6d95add_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_76987926-7f69-4e22-9eaa-4b4b912ea1fb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives and Risk Management</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_d681dc0b-8230-4d1e-8fe1-726323cabe38_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome_0c5d2561-0aa6-4e3d-b5ef-ab6613025e9c_verboseLabel_en-US" xlink:label="lab_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange and other gains (losses)</link:label>
    <link:label id="lab_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome_58f58338-983d-43c1-9949-d01e15a0ff20_terseLabel_en-US" xlink:label="lab_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange and other gains (losses)</link:label>
    <link:label id="lab_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome_label_en-US" xlink:label="lab_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss) and Other Nonoperating Income</link:label>
    <link:label id="lab_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome_documentation_en-US" xlink:label="lab_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss) and Other Nonoperating Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome" xlink:href="livn-20200930.xsd#livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome" xlink:to="lab_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_50379544-c337-4594-aea9-5797521d910d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term debt obligations</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d364928d-093c-4f36-8576-90ece4d3b5b1_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating (loss) income from continuing operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_786d4f73-b9c6-46fd-9d9e-9896485420f7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating (loss) income from continuing operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_ddd43f1f-ab1a-40cc-85da-59e0099393c1_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_63dd3f3b-6435-4254-be8c-f5c55cced922_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_97afcaca-2ad3-4bb2-8387-4890ff2d944d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_96f221fd-ab79-43cd-9634-9c4236080a24_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_63aba13f-c0e2-4f25-8958-d385bc301ae6_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_025f2b9a-28f0-4a1a-874e-e5e99759d68a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_ad8c03c4-df3c-4bac-9cab-bf27d4bc4d51_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal and administrative costs</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_4476b811-d970-4036-b2a0-e6204063be3f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_2f4ea940-98fc-4495-a07a-f1df0624f43b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2aebcab-75ef-4656-898f-9b8df8c31f83_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_4ba4a27e-1b74-4e53-9911-627d862994d7_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 10)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_dfd060eb-5927-497c-907d-7a863eeaeccd_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_acca3ca2-21c1-4e79-bfae-fc0e81fffff5_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9c047f3e-4580-4e35-88f8-eebec8ddcbed_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement, vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_0f3d8ac7-430a-44a1-a132-bb5d360ded0a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_EuropeanInvestmentBank2017Member_31481e0f-6c11-4943-95a4-83e3616f8513_terseLabel_en-US" xlink:label="lab_livn_EuropeanInvestmentBank2017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 European Investment Bank</link:label>
    <link:label id="lab_livn_EuropeanInvestmentBank2017Member_label_en-US" xlink:label="lab_livn_EuropeanInvestmentBank2017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Investment Bank, 2017 [Member]</link:label>
    <link:label id="lab_livn_EuropeanInvestmentBank2017Member_documentation_en-US" xlink:label="lab_livn_EuropeanInvestmentBank2017Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Investment Bank, 2017 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_EuropeanInvestmentBank2017Member" xlink:href="livn-20200930.xsd#livn_EuropeanInvestmentBank2017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_EuropeanInvestmentBank2017Member" xlink:to="lab_livn_EuropeanInvestmentBank2017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue_b7015342-ff8a-4359-9150-48f3ff1df35a_terseLabel_en-US" xlink:label="lab_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion at period end</link:label>
    <link:label id="lab_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue_label_en-US" xlink:label="lab_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Non-current Liability Value</link:label>
    <link:label id="lab_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue_documentation_en-US" xlink:label="lab_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Non-current Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue" xlink:href="livn-20200930.xsd#livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue" xlink:to="lab_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_22ad95e7-1aa3-41cd-b72d-19e21dd42cec_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_fa491a7f-39a2-4eef-82ca-67ce6052c927_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_IncreaseDecreaseInLitigationProvisionLiability_c5001a1a-5660-4118-a890-dcf14ee543c3_negatedTerseLabel_en-US" xlink:label="lab_livn_IncreaseDecreaseInLitigationProvisionLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation provision liability</link:label>
    <link:label id="lab_livn_IncreaseDecreaseInLitigationProvisionLiability_label_en-US" xlink:label="lab_livn_IncreaseDecreaseInLitigationProvisionLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Litigation Provision Liability</link:label>
    <link:label id="lab_livn_IncreaseDecreaseInLitigationProvisionLiability_documentation_en-US" xlink:label="lab_livn_IncreaseDecreaseInLitigationProvisionLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Litigation Provision Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_IncreaseDecreaseInLitigationProvisionLiability" xlink:href="livn-20200930.xsd#livn_IncreaseDecreaseInLitigationProvisionLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_IncreaseDecreaseInLitigationProvisionLiability" xlink:to="lab_livn_IncreaseDecreaseInLitigationProvisionLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_948bf5c9-799e-4dc6-b979-486dde755091_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_ac924b8f-a488-44be-86f7-8b75886383d3_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ProductRemediationForeignCurrencyTranslationGainLoss_d8684624-eb6c-4886-b660-6a3c5021b494_terseLabel_en-US" xlink:label="lab_livn_ProductRemediationForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of changes in foreign currency exchange rates</link:label>
    <link:label id="lab_livn_ProductRemediationForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_livn_ProductRemediationForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:label id="lab_livn_ProductRemediationForeignCurrencyTranslationGainLoss_documentation_en-US" xlink:label="lab_livn_ProductRemediationForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationForeignCurrencyTranslationGainLoss" xlink:href="livn-20200930.xsd#livn_ProductRemediationForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ProductRemediationForeignCurrencyTranslationGainLoss" xlink:to="lab_livn_ProductRemediationForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_70066bc2-5e2c-4ea5-b60e-b1a631b51874_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_004414d6-70a2-4e4f-98ff-99b37eac685f_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service-based stock appreciation rights (&#8220;SARs&#8221;)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_TandemLifeMember_cdf234de-8f83-4276-a3cf-d3675e49d066_terseLabel_en-US" xlink:label="lab_livn_TandemLifeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TandemLife</link:label>
    <link:label id="lab_livn_TandemLifeMember_label_en-US" xlink:label="lab_livn_TandemLifeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TandemLife [Member]</link:label>
    <link:label id="lab_livn_TandemLifeMember_documentation_en-US" xlink:label="lab_livn_TandemLifeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TandemLife [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_TandemLifeMember" xlink:href="livn-20200930.xsd#livn_TandemLifeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_TandemLifeMember" xlink:to="lab_livn_TandemLifeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_76af520b-435a-437d-bf45-589d960598aa_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductLiabilityContingencyLineItems_bf3af564-1c45-431e-82c5-d68e419e3310_terseLabel_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductLiabilityContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems" xlink:to="lab_us-gaap_ProductLiabilityContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_f3532ffe-5672-455d-9701-a4798432091b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_fd5d3a84-b649-4a46-9180-4c2cf38e3870_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_8f512329-41ba-4f94-9681-b1099cb2200d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_231c9fef-7a3b-4850-b01f-01ad4e0ec204_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_1912830e-821b-48dd-9b73-6456c5a63b39_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember_9900d580-75c9-40a5-a736-5deee9e7bc42_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments, Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember_label_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments, Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:to="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_23a0ae49-4af9-4901-84cb-fe431b68ac8c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for legal settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice_50c46acc-46eb-43e5-be22-930df11fa35f_terseLabel_en-US" xlink:label="lab_livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price, percentage of exchange price</link:label>
    <link:label id="lab_livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice_label_en-US" xlink:label="lab_livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage Of Exchange Price</link:label>
    <link:label id="lab_livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice_documentation_en-US" xlink:label="lab_livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage Of Exchange Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice" xlink:href="livn-20200930.xsd#livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice" xlink:to="lab_livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5c943d53-2c33-4d6e-aeba-1be7173c7df5_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_50df7188-3f8b-4cdd-969e-c0a8d9297c6a_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_0b7b6151-f0ba-416c-849f-93ea641512e8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b97aab99-2860-4254-8ca6-a25f7047bad4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_A2020CashExchangeableSeniorNotesMember_c03a2445-c596-48ee-8539-308a00a3aaa0_terseLabel_en-US" xlink:label="lab_livn_A2020CashExchangeableSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Cash Exchangeable Senior Notes</link:label>
    <link:label id="lab_livn_A2020CashExchangeableSeniorNotesMember_label_en-US" xlink:label="lab_livn_A2020CashExchangeableSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Cash Exchangeable Senior Notes [Member]</link:label>
    <link:label id="lab_livn_A2020CashExchangeableSeniorNotesMember_documentation_en-US" xlink:label="lab_livn_A2020CashExchangeableSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Cash Exchangeable Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_A2020CashExchangeableSeniorNotesMember" xlink:href="livn-20200930.xsd#livn_A2020CashExchangeableSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_A2020CashExchangeableSeniorNotesMember" xlink:to="lab_livn_A2020CashExchangeableSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_2b110cda-7027-4688-82b5-709c81836531_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_0863f839-2d0b-49a2-9e63-96af34a6e50e_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths_5a6a22c1-6e61-4fd7-b954-5ca03d16deac_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of short term borrowings (maturities greater than 90 days)</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-term Debt, Maturing in More than Three Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_c62768c8-4ffb-4984-9e7a-2d894b2bdaa3_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_92f9dd71-b490-45cc-bf7f-9b0ef77737ee_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityMeasurementInput_f4202554-c772-40eb-ac41-f251e4affe75_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, measurement input</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityMeasurementInput" xlink:to="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_497c4d0c-9fa5-42f1-b77a-ef3404303088_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, par value (in pounds per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_6e0af412-fab6-43e5-80dc-4c24c196a09a_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_d83f12bf-1281-4a4f-9c29-e2333f20c65e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_993c61fe-2d21-428a-92af-f8353aab2d53_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ee9cc446-208e-4172-9784-b2d25934ae58_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_f1e8ef94-4bf5-4157-b0bf-cc847b3d5042_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_label_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_4cfc66b7-c2f9-44a3-9a71-243432e8e8b0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_c2cdac5d-a328-4f22-87a9-6e9dee09f89d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_792389ae-5dff-4798-ada3-8505faa91af4_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_MeasurementInputRiskadjustedDiscountRateMember_b59546e7-4f5a-478f-a7ec-2cf75b73351b_terseLabel_en-US" xlink:label="lab_livn_MeasurementInputRiskadjustedDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-adjusted discount rate</link:label>
    <link:label id="lab_livn_MeasurementInputRiskadjustedDiscountRateMember_label_en-US" xlink:label="lab_livn_MeasurementInputRiskadjustedDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk-adjusted Discount Rate [Member]</link:label>
    <link:label id="lab_livn_MeasurementInputRiskadjustedDiscountRateMember_documentation_en-US" xlink:label="lab_livn_MeasurementInputRiskadjustedDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk-adjusted Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MeasurementInputRiskadjustedDiscountRateMember" xlink:href="livn-20200930.xsd#livn_MeasurementInputRiskadjustedDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_MeasurementInputRiskadjustedDiscountRateMember" xlink:to="lab_livn_MeasurementInputRiskadjustedDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths_58f3d08f-e828-4832-a7ac-6336e9921e05_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short term borrowings (maturities greater than 90 days)</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-term Debt, Maturing in More than Three Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths" xlink:to="lab_us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_14e89374-a0d0-48cb-9c52-650b185a791c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_6dc342fd-6a6f-4723-8e12-d2c6e875bf07_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bb2288d3-07f2-44a4-a02c-b05b04817ae2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_ae8ed63c-acc7-4be2-9936-8ed700048f81_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_44c689a8-35a2-4198-aa6d-9050de866b9f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_4cae0b44-8d47-45eb-b3f9-6f5f2a8f9fc0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a86d59c3-9c8e-4739-a9ce-ecbfc7f9cca9_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_b5efb6cb-d94b-451a-86d7-0ffafcf6078c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_b8c9b73c-8cfe-4f80-ab44-d223f8bff27b_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_BusinessCombinationConsiderationTransferredCashTransferred_c4bb8655-c924-4095-ba31-432f27c3f81a_terseLabel_en-US" xlink:label="lab_livn_BusinessCombinationConsiderationTransferredCashTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred, cash</link:label>
    <link:label id="lab_livn_BusinessCombinationConsiderationTransferredCashTransferred_label_en-US" xlink:label="lab_livn_BusinessCombinationConsiderationTransferredCashTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Cash Transferred</link:label>
    <link:label id="lab_livn_BusinessCombinationConsiderationTransferredCashTransferred_documentation_en-US" xlink:label="lab_livn_BusinessCombinationConsiderationTransferredCashTransferred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Cash Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BusinessCombinationConsiderationTransferredCashTransferred" xlink:href="livn-20200930.xsd#livn_BusinessCombinationConsiderationTransferredCashTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_BusinessCombinationConsiderationTransferredCashTransferred" xlink:to="lab_livn_BusinessCombinationConsiderationTransferredCashTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_e6cb3370-4e5b-45d1-bc55-040b4d878287_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ProductRemediation_66ef5d3e-7923-435d-bf71-946ac3835b44_terseLabel_en-US" xlink:label="lab_livn_ProductRemediation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product remediation</link:label>
    <link:label id="lab_livn_ProductRemediation_label_en-US" xlink:label="lab_livn_ProductRemediation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation</link:label>
    <link:label id="lab_livn_ProductRemediation_documentation_en-US" xlink:label="lab_livn_ProductRemediation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediation" xlink:href="livn-20200930.xsd#livn_ProductRemediation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ProductRemediation" xlink:to="lab_livn_ProductRemediation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_3f9687e4-f320-404a-8503-99cec54d2922_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation provision liability</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_56393147-6dfa-4c05-9a86-3d2886c985bd_periodEndLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion of litigation provisions liability at period end</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Accrual, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_e66a80a0-9e83-4d7a-8a80-e64c3c380ed8_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireNotesReceivable_5bf88ba5-c65c-41f8-9a89-7d974a8e4171_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans to investees</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireNotesReceivable_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireNotesReceivable" xlink:to="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_6e3eb457-29a7-4ddd-88c4-b0b18a36bdc6_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_2584a819-889d-411f-b48d-252850d8d2cf_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_00561dcf-cf54-4610-9fc5-05d08bb2b902_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_3f229c2a-7810-4775-8708-123d26f6a20b_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_bdaafbcd-16e5-4226-b51a-f8d6b5d090ad_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_DrilltexMember_3b6951b5-4f8b-423f-9c5b-3fb10a70a384_terseLabel_en-US" xlink:label="lab_livn_DrilltexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drilltex</link:label>
    <link:label id="lab_livn_DrilltexMember_label_en-US" xlink:label="lab_livn_DrilltexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drilltex [Member]</link:label>
    <link:label id="lab_livn_DrilltexMember_documentation_en-US" xlink:label="lab_livn_DrilltexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drilltex [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DrilltexMember" xlink:href="livn-20200930.xsd#livn_DrilltexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_DrilltexMember" xlink:to="lab_livn_DrilltexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_af00bf18-2dd7-4227-98d4-e8a02603600e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_BusinessCombinationMilestoneAchievementPeriodOfDelay_64c9eda0-d074-48c7-8a85-43d8b381bd00_terseLabel_en-US" xlink:label="lab_livn_BusinessCombinationMilestoneAchievementPeriodOfDelay" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of delay</link:label>
    <link:label id="lab_livn_BusinessCombinationMilestoneAchievementPeriodOfDelay_label_en-US" xlink:label="lab_livn_BusinessCombinationMilestoneAchievementPeriodOfDelay" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Milestone Achievement, Period Of Delay</link:label>
    <link:label id="lab_livn_BusinessCombinationMilestoneAchievementPeriodOfDelay_documentation_en-US" xlink:label="lab_livn_BusinessCombinationMilestoneAchievementPeriodOfDelay" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Milestone Achievement, Period Of Delay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BusinessCombinationMilestoneAchievementPeriodOfDelay" xlink:href="livn-20200930.xsd#livn_BusinessCombinationMilestoneAchievementPeriodOfDelay"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_BusinessCombinationMilestoneAchievementPeriodOfDelay" xlink:to="lab_livn_BusinessCombinationMilestoneAchievementPeriodOfDelay" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_8978febd-c8e9-4313-9aca-003fd3cb36d1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (Losses) Reclassified from AOCI to Earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_d14594e6-b4e7-41b6-9411-385b2ddc700a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_d3bc6cc4-dfa9-453d-91a9-df8fc44fc1fd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3c537aa6-d4e5-4cea-87c6-fad9d247fcd8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_EuropeanInvestmentBank2014Member_d2adc2fd-046a-4534-8017-03a127e81cfe_terseLabel_en-US" xlink:label="lab_livn_EuropeanInvestmentBank2014Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 European Investment Bank</link:label>
    <link:label id="lab_livn_EuropeanInvestmentBank2014Member_label_en-US" xlink:label="lab_livn_EuropeanInvestmentBank2014Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Investment Bank, 2014 [Member]</link:label>
    <link:label id="lab_livn_EuropeanInvestmentBank2014Member_documentation_en-US" xlink:label="lab_livn_EuropeanInvestmentBank2014Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Investment Bank, 2014</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_EuropeanInvestmentBank2014Member" xlink:href="livn-20200930.xsd#livn_EuropeanInvestmentBank2014Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_EuropeanInvestmentBank2014Member" xlink:to="lab_livn_EuropeanInvestmentBank2014Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_bc27f92b-5deb-438a-8771-47b290677cd8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Arrangements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_358bf8b6-0d8c-409b-880b-d5717a462e6a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3ca0205e-313d-4b02-8542-b8548c713f2b_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SG&amp;A</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_BusinessCombinationContingentConsiderationMeasurementInput_12f9c837-1684-4971-9bad-cdda7d40b49d_terseLabel_en-US" xlink:label="lab_livn_BusinessCombinationContingentConsiderationMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement input</link:label>
    <link:label id="lab_livn_BusinessCombinationContingentConsiderationMeasurementInput_label_en-US" xlink:label="lab_livn_BusinessCombinationContingentConsiderationMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Measurement Input</link:label>
    <link:label id="lab_livn_BusinessCombinationContingentConsiderationMeasurementInput_documentation_en-US" xlink:label="lab_livn_BusinessCombinationContingentConsiderationMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BusinessCombinationContingentConsiderationMeasurementInput" xlink:href="livn-20200930.xsd#livn_BusinessCombinationContingentConsiderationMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_BusinessCombinationContingentConsiderationMeasurementInput" xlink:to="lab_livn_BusinessCombinationContingentConsiderationMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_fe7a17b9-355e-403e-9b38-4d39185b6b2c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_8dab61e1-89e7-40cd-9a46-dd0bbfd490e3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Basic and Diluted Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bceb1833-b191-47f2-b0df-00e3fb7cef7c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_73fbb36c-6517-4950-a499-253bbd5932a3_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total at beginning period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d276fa4e-f962-4c70-bded-31d4f59a2dea_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total at period end</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ae18b045-4035-46bf-bf42-9879fd18ba3e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_961b02f9-7c68-4148-93d0-8eddc2c3217c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_da715792-952c-44c5-99dc-ebe96276bc70_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_5f9d3ba6-ed1a-4eec-a016-9ede94080068_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_7f314ef2-d0e7-4bc8-9c57-a405117fd5c6_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement, compensation cost</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_08c5917d-dd6d-4f3c-96e4-7e88ecf91c2f_negatedLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualPayments" xlink:to="lab_us-gaap_LossContingencyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_MDStartIIMember_a0966ca2-b18b-48a3-9c6e-5dca51517993_terseLabel_en-US" xlink:label="lab_livn_MDStartIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MD Start II</link:label>
    <link:label id="lab_livn_MDStartIIMember_label_en-US" xlink:label="lab_livn_MDStartIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MD Start II [Member]</link:label>
    <link:label id="lab_livn_MDStartIIMember_documentation_en-US" xlink:label="lab_livn_MDStartIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MD Start II [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MDStartIIMember" xlink:href="livn-20200930.xsd#livn_MDStartIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_MDStartIIMember" xlink:to="lab_livn_MDStartIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_3991fbe6-c419-4bf9-9add-5f1400dcdd1e_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_493bcb39-51b0-4f30-8e52-e96c80c8ede2_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_f9adea87-de20-4e77-92ec-1ceee70fc4ea_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ShiraTronicsInc.Member_fb93d05f-85c5-474d-a951-d0a3dae27b0b_terseLabel_en-US" xlink:label="lab_livn_ShiraTronicsInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ShiraTronics, Inc.</link:label>
    <link:label id="lab_livn_ShiraTronicsInc.Member_label_en-US" xlink:label="lab_livn_ShiraTronicsInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ShiraTronics, Inc. [Member]</link:label>
    <link:label id="lab_livn_ShiraTronicsInc.Member_documentation_en-US" xlink:label="lab_livn_ShiraTronicsInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ShiraTronics, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ShiraTronicsInc.Member" xlink:href="livn-20200930.xsd#livn_ShiraTronicsInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ShiraTronicsInc.Member" xlink:to="lab_livn_ShiraTronicsInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_8b914153-b6d7-4506-8848-9c1dc0984c71_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_acaefd7d-0b72-4e4a-a812-84ea690505a1_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of loss from accumulated other comprehensive loss, after tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_499bb983-1003-4781-a3c9-4e0aac47db35_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_15c66372-2f1f-4b98-9fa3-806925f85892_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_93a9d97d-8acc-419c-8e9e-5e6b3cef8466_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_BusinessAcquisitionsPurchasePriceAllocation_dab04ed9-62bc-4a28-b931-f5035ed5f686_terseLabel_en-US" xlink:label="lab_livn_BusinessAcquisitionsPurchasePriceAllocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CRM purchase price adjustment payable to MicroPort Scientific Corporation</link:label>
    <link:label id="lab_livn_BusinessAcquisitionsPurchasePriceAllocation_label_en-US" xlink:label="lab_livn_BusinessAcquisitionsPurchasePriceAllocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions, Purchase Price Allocation</link:label>
    <link:label id="lab_livn_BusinessAcquisitionsPurchasePriceAllocation_documentation_en-US" xlink:label="lab_livn_BusinessAcquisitionsPurchasePriceAllocation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions, Purchase Price Allocation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BusinessAcquisitionsPurchasePriceAllocation" xlink:href="livn-20200930.xsd#livn_BusinessAcquisitionsPurchasePriceAllocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_BusinessAcquisitionsPurchasePriceAllocation" xlink:to="lab_livn_BusinessAcquisitionsPurchasePriceAllocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_5fec2582-12d1-44d1-9ff5-665d4c5ec6c4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ScheduleofProductRemediationTableTextBlock_13735c90-d08c-4494-bf8b-d7c9cd2d1125_terseLabel_en-US" xlink:label="lab_livn_ScheduleofProductRemediationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingencies</link:label>
    <link:label id="lab_livn_ScheduleofProductRemediationTableTextBlock_label_en-US" xlink:label="lab_livn_ScheduleofProductRemediationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Remediation [Table Text Block]</link:label>
    <link:label id="lab_livn_ScheduleofProductRemediationTableTextBlock_documentation_en-US" xlink:label="lab_livn_ScheduleofProductRemediationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Remediation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ScheduleofProductRemediationTableTextBlock" xlink:href="livn-20200930.xsd#livn_ScheduleofProductRemediationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ScheduleofProductRemediationTableTextBlock" xlink:to="lab_livn_ScheduleofProductRemediationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_574a6059-f34c-4361-84b4-aec47aa9d029_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation provision, net</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ProvisionforAgentsReturnsandOther_f95837e9-4608-4d37-858b-fdd94a744004_terseLabel_en-US" xlink:label="lab_livn_ProvisionforAgentsReturnsandOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions for agents, returns and other</link:label>
    <link:label id="lab_livn_ProvisionforAgentsReturnsandOther_label_en-US" xlink:label="lab_livn_ProvisionforAgentsReturnsandOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Agents, Returns and Other</link:label>
    <link:label id="lab_livn_ProvisionforAgentsReturnsandOther_documentation_en-US" xlink:label="lab_livn_ProvisionforAgentsReturnsandOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Agents, Returns and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProvisionforAgentsReturnsandOther" xlink:href="livn-20200930.xsd#livn_ProvisionforAgentsReturnsandOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ProvisionforAgentsReturnsandOther" xlink:to="lab_livn_ProvisionforAgentsReturnsandOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent_0e79d693-c22c-462e-a753-1ff518b08470_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current litigation provision liability</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent_a266c946-2634-4b45-af6f-77e89b20af5a_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion of litigation liability at period end</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_74afee42-b386-4b88-9e99-86d4f20e3059_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_260f92c6-a595-4b79-9adb-ab87d8ba38e8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_HeartValvesMember_2110e1e9-d022-4ec7-8429-b348e3f40db6_terseLabel_en-US" xlink:label="lab_livn_HeartValvesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heart Valves</link:label>
    <link:label id="lab_livn_HeartValvesMember_label_en-US" xlink:label="lab_livn_HeartValvesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heart Valves [Member]</link:label>
    <link:label id="lab_livn_HeartValvesMember_documentation_en-US" xlink:label="lab_livn_HeartValvesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heart Valves [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_HeartValvesMember" xlink:href="livn-20200930.xsd#livn_HeartValvesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_HeartValvesMember" xlink:to="lab_livn_HeartValvesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b5a5499-987a-432b-bcc0-20a0f68a9bc7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_RespicardiaMember_e0c54a21-59ad-4f0e-848f-3abebe350f8d_terseLabel_en-US" xlink:label="lab_livn_RespicardiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Respicardia Inc.</link:label>
    <link:label id="lab_livn_RespicardiaMember_label_en-US" xlink:label="lab_livn_RespicardiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Respicardia [Member]</link:label>
    <link:label id="lab_livn_RespicardiaMember_documentation_en-US" xlink:label="lab_livn_RespicardiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Respicardia [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_RespicardiaMember" xlink:href="livn-20200930.xsd#livn_RespicardiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_RespicardiaMember" xlink:to="lab_livn_RespicardiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_79daf41b-f55e-41fd-96ac-87731615dcfd_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_DebtInstrumentExchangeableConversionRatio_241701ba-2d3f-4db1-b00b-d3f81a1c89d1_terseLabel_en-US" xlink:label="lab_livn_DebtInstrumentExchangeableConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, exchangeable, conversion ratio</link:label>
    <link:label id="lab_livn_DebtInstrumentExchangeableConversionRatio_label_en-US" xlink:label="lab_livn_DebtInstrumentExchangeableConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Exchangeable, Conversion Ratio</link:label>
    <link:label id="lab_livn_DebtInstrumentExchangeableConversionRatio_documentation_en-US" xlink:label="lab_livn_DebtInstrumentExchangeableConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Exchangeable, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentExchangeableConversionRatio" xlink:href="livn-20200930.xsd#livn_DebtInstrumentExchangeableConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_DebtInstrumentExchangeableConversionRatio" xlink:to="lab_livn_DebtInstrumentExchangeableConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_fa089007-81ea-45a6-b84f-51ad4e8f63a3_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_88ac47ab-b47d-49a2-bc9d-75f03fd4af88_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_cffdc350-c599-4404-a326-c0d21fad55e4_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_972c0abb-c7ba-4bf1-a215-ba67649a8ea7_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of tax benefit</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_bee87a80-bcf8-4ddd-af00-17571710a9fc_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingenciesRollForward_e0a63df6-eeb5-494e-8e40-b4cb7fb32657_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingenciesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Environmental Loss Contingencies [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingenciesRollForward_label_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingenciesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Environmental Loss Contingencies [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingenciesRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingenciesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForEnvironmentalLossContingenciesRollForward" xlink:to="lab_us-gaap_AccrualForEnvironmentalLossContingenciesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_541e19b5-b913-4851-aff0-30e09c9b8188_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_034e0692-091b-41bd-804c-603d002f51e9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_51311638-5c47-4d21-b39a-77576dae84fd_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add effects of share-based compensation instruments (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_aedd090b-418c-4162-8194-08748506e561_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_RainbowMedicalLtd.Member_b4bec03e-d4a1-4b8b-b727-01b951c6fc0c_terseLabel_en-US" xlink:label="lab_livn_RainbowMedicalLtd.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rainbow Medical Ltd.</link:label>
    <link:label id="lab_livn_RainbowMedicalLtd.Member_label_en-US" xlink:label="lab_livn_RainbowMedicalLtd.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rainbow Medical Ltd. [Member]</link:label>
    <link:label id="lab_livn_RainbowMedicalLtd.Member_documentation_en-US" xlink:label="lab_livn_RainbowMedicalLtd.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rainbow Medical Ltd. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_RainbowMedicalLtd.Member" xlink:href="livn-20200930.xsd#livn_RainbowMedicalLtd.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_RainbowMedicalLtd.Member" xlink:to="lab_livn_RainbowMedicalLtd.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_28651a35-53ae-435a-a8a6-48a9c8c2a89e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_61a94ba8-751f-4ee0-8555-997fde2933d9_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_NumberOfDistributorsAcquired_503683e4-9c62-4cd6-baa6-9145b3d34989_terseLabel_en-US" xlink:label="lab_livn_NumberOfDistributorsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of distributors acquired</link:label>
    <link:label id="lab_livn_NumberOfDistributorsAcquired_label_en-US" xlink:label="lab_livn_NumberOfDistributorsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Distributors Acquired</link:label>
    <link:label id="lab_livn_NumberOfDistributorsAcquired_documentation_en-US" xlink:label="lab_livn_NumberOfDistributorsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Distributors Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_NumberOfDistributorsAcquired" xlink:href="livn-20200930.xsd#livn_NumberOfDistributorsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_NumberOfDistributorsAcquired" xlink:to="lab_livn_NumberOfDistributorsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_34510378-9f89-4129-b653-100eb52bba72_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_d46b3c82-1d0c-4eb8-9c0e-389ef72a3a14_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue_69fe1b5f-23bf-466b-9e49-d71582c6b9f2_terseLabel_en-US" xlink:label="lab_livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">10 percent decrease in stock price volatility, fair value</link:label>
    <link:label id="lab_livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue_label_en-US" xlink:label="lab_livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis Of Fair Value, 10 Percent Decrease In Stock Price Volatility, Fair Value</link:label>
    <link:label id="lab_livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue_documentation_en-US" xlink:label="lab_livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis Of Fair Value, 10 Percent Decrease In Stock Price Volatility, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue" xlink:href="livn-20200930.xsd#livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue" xlink:to="lab_livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_94c212e6-ca5b-4f3d-ba9b-956852718e15_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_fb70f6c4-1d67-4435-be1c-b2fa31ee47cc_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss from discontinued operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:to="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_21cc8699-1ec7-445d-b918-58074ae42b5a_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_0a390dc0-8c50-4f9f-a0e2-6a1d69c67074_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_7fb71e81-2a0d-493e-82c1-84b82f0b5909_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_c2a73f8c-4b8b-49c4-a185-441aa0412211_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_8df3af62-b10f-4a61-bf8f-2c5363cdadc2_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_4aae610b-0e6c-4c67-81ed-b2e4a6c797d7_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_4ad58a57-4702-4678-9e38-e728e41d7b8a_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_DebtInstrumentRedemptionThresholdTradingDays_70d6bf60-81f7-4b03-bd47-465572cbac2b_terseLabel_en-US" xlink:label="lab_livn_DebtInstrumentRedemptionThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption, threshold trading days</link:label>
    <link:label id="lab_livn_DebtInstrumentRedemptionThresholdTradingDays_label_en-US" xlink:label="lab_livn_DebtInstrumentRedemptionThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Threshold Trading Days</link:label>
    <link:label id="lab_livn_DebtInstrumentRedemptionThresholdTradingDays_documentation_en-US" xlink:label="lab_livn_DebtInstrumentRedemptionThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentRedemptionThresholdTradingDays" xlink:href="livn-20200930.xsd#livn_DebtInstrumentRedemptionThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_DebtInstrumentRedemptionThresholdTradingDays" xlink:to="lab_livn_DebtInstrumentRedemptionThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ProductRemediationPayments_f0636e85-8af1-4730-9a2b-41ded934ecba_negatedTerseLabel_en-US" xlink:label="lab_livn_ProductRemediationPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remediation activity</link:label>
    <link:label id="lab_livn_ProductRemediationPayments_label_en-US" xlink:label="lab_livn_ProductRemediationPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation, Payments</link:label>
    <link:label id="lab_livn_ProductRemediationPayments_documentation_en-US" xlink:label="lab_livn_ProductRemediationPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationPayments" xlink:href="livn-20200930.xsd#livn_ProductRemediationPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ProductRemediationPayments" xlink:to="lab_livn_ProductRemediationPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_ebebb8f6-59dd-47b2-bdad-b648660fdda1_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and refundable taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_995d3ef7-dd18-4e90-b161-d337adbff7c3_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_91a355c0-c9db-4e01-a657-f5fc5d5d15db_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax_d3be5585-f8d4-42f4-bb24-785e38e8e4d7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital adjustment</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Amount of Adjustment to Prior Period Gain (Loss) on Disposal, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_23008a65-cbd9-4367-960c-aa384ac399e5_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic and Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_a86bf1ce-a771-4923-b3cf-309d3524d508_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_23eedd21-828d-4d1d-ab42-9c6ca21c2b10_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_cdd56f05-8941-4a6d-a2e0-70a0e112b786_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_80824812-d78b-4e02-b2cd-f89e84be4eaa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_d6b45567-3a40-4595-a3b5-477bc473cd57_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_LossContingencyNumberofAssessments_18c4e409-520d-4a76-8bd5-9a66ecf3798e_terseLabel_en-US" xlink:label="lab_livn_LossContingencyNumberofAssessments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of notice of assessments</link:label>
    <link:label id="lab_livn_LossContingencyNumberofAssessments_label_en-US" xlink:label="lab_livn_LossContingencyNumberofAssessments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Assessments</link:label>
    <link:label id="lab_livn_LossContingencyNumberofAssessments_documentation_en-US" xlink:label="lab_livn_LossContingencyNumberofAssessments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Assessments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_LossContingencyNumberofAssessments" xlink:href="livn-20200930.xsd#livn_LossContingencyNumberofAssessments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_LossContingencyNumberofAssessments" xlink:to="lab_livn_LossContingencyNumberofAssessments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_b7be265b-1650-44fb-800c-07a71fbad04f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6aeb2381-18c3-4867-82b7-480bb81c2663_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_09f9a026-a72c-41e1-899d-4f94f600f04d_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_c84c25f5-53d0-4b4a-9eca-d8039693ea8e_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales - exclusive of amortization</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_JPY_388c50bd-4ca3-4101-ad49-e0ab71faaae1_terseLabel_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:label id="lab_currency_JPY_label_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_JPY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_JPY" xlink:to="lab_currency_JPY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_4d1ce896-c7bc-4efb-8a17-aadeaf67684c_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_CeribellInc.Member_ca199b9f-7eee-4113-b50b-90d43704a023_terseLabel_en-US" xlink:label="lab_livn_CeribellInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceribell, Inc.</link:label>
    <link:label id="lab_livn_CeribellInc.Member_label_en-US" xlink:label="lab_livn_CeribellInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceribell, Inc. [Member]</link:label>
    <link:label id="lab_livn_CeribellInc.Member_documentation_en-US" xlink:label="lab_livn_CeribellInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceribell, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CeribellInc.Member" xlink:href="livn-20200930.xsd#livn_CeribellInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_CeribellInc.Member" xlink:to="lab_livn_CeribellInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_ef24e45a-4f2a-4e9e-ba7a-b4dbf8b884af_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_87b37f4a-6bbd-4708-80c5-17fc665742f7_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:to="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_884de956-0d49-4111-9f2f-445b49abc009_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of New Accounting Pronouncements and Changes in Accounting Principles</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_abaa8426-68ea-491a-915f-f410bb730bd5_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_7e2dd610-c4ba-4a42-9609-1d52eb36a677_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_4e1a8bbb-c2a8-4dbc-a657-f3d33deaca72_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_d0a462b7-9e8e-4417-aa1f-87e1378cbe06_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation sought</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_1c24e173-d051-48d4-9f78-159dcbc63df2_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_015ba728-2181-43e6-ba0f-42e322972082_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1da400c1-35c9-40e7-a392-d60d368edc92_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_d93cf45d-b57a-47f7-a9bf-f2fc379a3dcc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from share issuances under ESPP</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_11be213f-a9e1-4804-a4d2-4d6a5ead76c1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_e92d9aaf-bb59-4726-b827-183b6af2144e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in unrealized gain (loss) on derivatives</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_11cee898-c156-428a-a3e6-a5bf33d580b5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (Losses) Recognized in OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_03caffa2-5501-4130-b54f-c5a064ec9f67_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1acc62c0-9c64-4f37-b86c-655a9436ec09_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_e9281ddb-7964-4227-9a97-694a7a3aa3fe_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_BankofAmericaU.SMember_fd62a038-ce3f-4b36-b94c-e2c878674902_terseLabel_en-US" xlink:label="lab_livn_BankofAmericaU.SMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank of America, U.S.</link:label>
    <link:label id="lab_livn_BankofAmericaU.SMember_label_en-US" xlink:label="lab_livn_BankofAmericaU.SMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank of America, U.S [Member]</link:label>
    <link:label id="lab_livn_BankofAmericaU.SMember_documentation_en-US" xlink:label="lab_livn_BankofAmericaU.SMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank of America, U.S [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BankofAmericaU.SMember" xlink:href="livn-20200930.xsd#livn_BankofAmericaU.SMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_BankofAmericaU.SMember" xlink:to="lab_livn_BankofAmericaU.SMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_a327654e-f92c-4cf8-ac48-423a84af5cec_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ProductRemediationNet_c64f5931-10b0-45d3-b4b2-55c9dc582b46_periodStartLabel_en-US" xlink:label="lab_livn_ProductRemediationNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_livn_ProductRemediationNet_41528d83-6fb8-441d-9721-1b2c0f74326a_periodEndLabel_en-US" xlink:label="lab_livn_ProductRemediationNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_livn_ProductRemediationNet_15471941-6e1e-41a7-93dc-d0d21a7a043b_terseLabel_en-US" xlink:label="lab_livn_ProductRemediationNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product remediation</link:label>
    <link:label id="lab_livn_ProductRemediationNet_label_en-US" xlink:label="lab_livn_ProductRemediationNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation, Net</link:label>
    <link:label id="lab_livn_ProductRemediationNet_documentation_en-US" xlink:label="lab_livn_ProductRemediationNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationNet" xlink:href="livn-20200930.xsd#livn_ProductRemediationNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ProductRemediationNet" xlink:to="lab_livn_ProductRemediationNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_04a0dce2-b70d-411f-a5e8-0fb3bcb04fa8_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_bd8ad1c7-be1b-4b57-92e6-0f8de6c904f5_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_a36f23ca-ad46-4cce-9f8e-b6dee0a2155e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_8b012fa9-2952-418c-bcbb-61c1a659e5b9_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_d6ca7f26-fb2b-46c7-b9f2-ce027bb63643_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_04f91f42-0271-469e-9a0b-c06a63a7c541_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_f8cb72d2-50cb-4753-b48f-8e9d177c99f3_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration paid</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_5f1f42b0-ff60-4fe4-8ad2-4ccbad321ed7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue_cdebeea1-c2d3-45db-b6de-5ec81b8669bd_terseLabel_en-US" xlink:label="lab_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion at period end</link:label>
    <link:label id="lab_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue_label_en-US" xlink:label="lab_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Current Asset Value</link:label>
    <link:label id="lab_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue_documentation_en-US" xlink:label="lab_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Current Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue" xlink:href="livn-20200930.xsd#livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue" xlink:to="lab_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_f0d27932-6b1f-4bff-ab85-9df310b4fe5e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_10fd5834-64c6-4df0-a66c-23dc4e77a8d3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_ec13d865-b19f-4225-add9-83f6181b4a8c_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_CRMBusinessFranchiseMember_0cdf1788-6656-47c5-87fd-ff913b6b37ac_terseLabel_en-US" xlink:label="lab_livn_CRMBusinessFranchiseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CRM Business Franchise</link:label>
    <link:label id="lab_livn_CRMBusinessFranchiseMember_label_en-US" xlink:label="lab_livn_CRMBusinessFranchiseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CRM Business Franchise [Member]</link:label>
    <link:label id="lab_livn_CRMBusinessFranchiseMember_documentation_en-US" xlink:label="lab_livn_CRMBusinessFranchiseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CRM Business Finance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CRMBusinessFranchiseMember" xlink:href="livn-20200930.xsd#livn_CRMBusinessFranchiseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_CRMBusinessFranchiseMember" xlink:to="lab_livn_CRMBusinessFranchiseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_fde89fd1-4066-41f9-9471-360a0decb1db_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_c4d28985-83a1-4209-9797-1c164cf02c61_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_label_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:to="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6a77c369-d1fc-4103-b237-f9bb7e4d4404_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_d6d274a4-40d6-43e7-a79d-e213054684e3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_1131e5ac-44bf-4311-af1e-141e22aa4ad1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:to="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_831c9bb1-3980-4d2a-ab09-190aabf2d340_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7077febf-c92b-4b44-8e54-36bd025ba4f3_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) income from continuing operations before tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a5f340d6-3640-483d-a4dd-ab21558eea9a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash items included in net loss:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_0023abfa-5ded-4a3a-b88d-d7042e91ad49_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_b0f38f4b-c827-4fe3-8e17-3741cf542f96_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger and integration expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_a3c32227-adbb-4390-b6b1-a8e7254d1a4a_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger and integration expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_ac805f2a-deaa-41f6-bafa-6ec295adf12f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_223d9efc-2930-4287-9ee1-8eac084d11d2_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_96fd9750-7e6c-4a09-bf79-60542ef4e597_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_fe63cbca-2541-452c-90f6-c61b4c2e45f2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ReorganizationPlansMember_99b73bf5-3e83-4c67-b2ce-d4004d145ac2_terseLabel_en-US" xlink:label="lab_livn_ReorganizationPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reorganization Plans</link:label>
    <link:label id="lab_livn_ReorganizationPlansMember_label_en-US" xlink:label="lab_livn_ReorganizationPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reorganization Plans [Member]</link:label>
    <link:label id="lab_livn_ReorganizationPlansMember_documentation_en-US" xlink:label="lab_livn_ReorganizationPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reorganization Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ReorganizationPlansMember" xlink:href="livn-20200930.xsd#livn_ReorganizationPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ReorganizationPlansMember" xlink:to="lab_livn_ReorganizationPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_e58aaae6-1986-4ba6-b1bb-25ff3a3bdc7d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_512849bb-7616-41f5-aec5-2f2f9cc673d5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_DebtInstrumentCovenantMinimumNetRevenue_9e774e7b-7c26-4dbb-88ed-f05d0adee442_terseLabel_en-US" xlink:label="lab_livn_DebtInstrumentCovenantMinimumNetRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum net revenue</link:label>
    <link:label id="lab_livn_DebtInstrumentCovenantMinimumNetRevenue_label_en-US" xlink:label="lab_livn_DebtInstrumentCovenantMinimumNetRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Minimum Net Revenue</link:label>
    <link:label id="lab_livn_DebtInstrumentCovenantMinimumNetRevenue_documentation_en-US" xlink:label="lab_livn_DebtInstrumentCovenantMinimumNetRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Minimum Net Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentCovenantMinimumNetRevenue" xlink:href="livn-20200930.xsd#livn_DebtInstrumentCovenantMinimumNetRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_DebtInstrumentCovenantMinimumNetRevenue" xlink:to="lab_livn_DebtInstrumentCovenantMinimumNetRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_BusinessCombinationUpfrontCosts_63838da9-3848-46a4-aeaa-5d0143f49b11_terseLabel_en-US" xlink:label="lab_livn_BusinessCombinationUpfrontCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_livn_BusinessCombinationUpfrontCosts_label_en-US" xlink:label="lab_livn_BusinessCombinationUpfrontCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Upfront Costs</link:label>
    <link:label id="lab_livn_BusinessCombinationUpfrontCosts_documentation_en-US" xlink:label="lab_livn_BusinessCombinationUpfrontCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Upfront Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BusinessCombinationUpfrontCosts" xlink:href="livn-20200930.xsd#livn_BusinessCombinationUpfrontCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_BusinessCombinationUpfrontCosts" xlink:to="lab_livn_BusinessCombinationUpfrontCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_ce7867c2-7f2d-4c75-b469-a068350c8db1_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_6ecbdced-5644-4fcc-9146-7f28f89095bd_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_79da649a-7ef9-4e2d-bf4f-162a654d9e9d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_99ef69d0-adef-4253-a335-632ffd3ff967_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b3fe5817-f68d-44d2-b96b-12c58aa08f74_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_de5ed30f-fe4b-4b22-9e4e-5757722b302c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in short-term borrowing, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9fca6d82-668b-4858-a0e2-a6caf307a3c9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b5954987-316d-4e06-9ad0-d4203a448d9a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_42cd542e-49ce-4dd8-8172-91b264955b09_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_976bde34-3fbe-4d3d-8145-de8bb684be0f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_f680ec43-2f7a-4fa0-91f5-f4da98c0f3ce_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discounts and issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue_97ff7575-b64b-4a13-b7ef-201366ec63c1_terseLabel_en-US" xlink:label="lab_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion at period end</link:label>
    <link:label id="lab_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue_label_en-US" xlink:label="lab_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Non-current Asset Value</link:label>
    <link:label id="lab_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue_documentation_en-US" xlink:label="lab_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Non-current Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue" xlink:href="livn-20200930.xsd#livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue" xlink:to="lab_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember_1c61ebda-0ee7-4b82-a82b-c003500be51d_terseLabel_en-US" xlink:label="lab_livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology and in process research and development</link:label>
    <link:label id="lab_livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember_label_en-US" xlink:label="lab_livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights and In Process Research and Development [Member]</link:label>
    <link:label id="lab_livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember_documentation_en-US" xlink:label="lab_livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights and In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember" xlink:href="livn-20200930.xsd#livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember" xlink:to="lab_livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_6ce559e9-bf2e-44a0-a032-6dc64735c7ae_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_a9da854e-07d5-45c8-9866-902e2f58a2cb_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ProductLiabilityMember_62ecd4d3-0f25-453e-98cf-30438d7caa20_terseLabel_en-US" xlink:label="lab_livn_ProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability</link:label>
    <link:label id="lab_livn_ProductLiabilityMember_label_en-US" xlink:label="lab_livn_ProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability [Member]</link:label>
    <link:label id="lab_livn_ProductLiabilityMember_documentation_en-US" xlink:label="lab_livn_ProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductLiabilityMember" xlink:href="livn-20200930.xsd#livn_ProductLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ProductLiabilityMember" xlink:to="lab_livn_ProductLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_5c460408-416a-4878-8a60-bf7edd2243d5_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ReimbursedLegalFees_d5dafdd2-2070-411d-a4ea-3e09e21c6449_terseLabel_en-US" xlink:label="lab_livn_ReimbursedLegalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reimbursed legal fees</link:label>
    <link:label id="lab_livn_ReimbursedLegalFees_label_en-US" xlink:label="lab_livn_ReimbursedLegalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reimbursed Legal Fees</link:label>
    <link:label id="lab_livn_ReimbursedLegalFees_documentation_en-US" xlink:label="lab_livn_ReimbursedLegalFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reimbursed Legal Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ReimbursedLegalFees" xlink:href="livn-20200930.xsd#livn_ReimbursedLegalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ReimbursedLegalFees" xlink:to="lab_livn_ReimbursedLegalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_c85ddfd7-6625-41e8-b69a-53e23332869b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-Tax Net Loss in AOCI as of period end</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_DebtFacility2019Member_f8d34cca-8efc-4d17-8ec5-4d60450026b2_terseLabel_en-US" xlink:label="lab_livn_DebtFacility2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Debt Facility</link:label>
    <link:label id="lab_livn_DebtFacility2019Member_label_en-US" xlink:label="lab_livn_DebtFacility2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Facility, 2019 [Member]</link:label>
    <link:label id="lab_livn_DebtFacility2019Member_documentation_en-US" xlink:label="lab_livn_DebtFacility2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Facility, 2019 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtFacility2019Member" xlink:href="livn-20200930.xsd#livn_DebtFacility2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_DebtFacility2019Member" xlink:to="lab_livn_DebtFacility2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_6c6b86f0-1e94-4eb6-b138-740e994361f0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_LossContingencyNumberofObservedNonConformities_bfc86247-c8a7-4a24-9026-968af111702f_terseLabel_en-US" xlink:label="lab_livn_LossContingencyNumberofObservedNonConformities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of observed non-conformities</link:label>
    <link:label id="lab_livn_LossContingencyNumberofObservedNonConformities_label_en-US" xlink:label="lab_livn_LossContingencyNumberofObservedNonConformities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Observed Non-Conformities</link:label>
    <link:label id="lab_livn_LossContingencyNumberofObservedNonConformities_documentation_en-US" xlink:label="lab_livn_LossContingencyNumberofObservedNonConformities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Observed Non-Conformities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_LossContingencyNumberofObservedNonConformities" xlink:href="livn-20200930.xsd#livn_LossContingencyNumberofObservedNonConformities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_LossContingencyNumberofObservedNonConformities" xlink:to="lab_livn_LossContingencyNumberofObservedNonConformities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_d4cd28cc-5ad4-456b-9013-e4f826024f18_totalLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income before reclassifications, net of tax</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_DerivativeCapPricePerShare_eaf46bfa-6f6d-4d35-9e4c-d2ed449d786c_terseLabel_en-US" xlink:label="lab_livn_DerivativeCapPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, cap price per share</link:label>
    <link:label id="lab_livn_DerivativeCapPricePerShare_label_en-US" xlink:label="lab_livn_DerivativeCapPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cap Price Per Share</link:label>
    <link:label id="lab_livn_DerivativeCapPricePerShare_documentation_en-US" xlink:label="lab_livn_DerivativeCapPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cap Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DerivativeCapPricePerShare" xlink:href="livn-20200930.xsd#livn_DerivativeCapPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_DerivativeCapPricePerShare" xlink:to="lab_livn_DerivativeCapPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_82ac60e1-a984-461d-b03c-05e4b3d305e8_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7d39e5c7-f498-4ea4-8517-a65c719a52c4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_b99541c5-4760-415e-9727-83f5bdbe0863_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_FDAWarningLetterMember_1cfc6534-9e65-4a43-a92e-d6f50aabd6f3_terseLabel_en-US" xlink:label="lab_livn_FDAWarningLetterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FDA Warning Letter</link:label>
    <link:label id="lab_livn_FDAWarningLetterMember_label_en-US" xlink:label="lab_livn_FDAWarningLetterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FDA Warning Letter [Member]</link:label>
    <link:label id="lab_livn_FDAWarningLetterMember_documentation_en-US" xlink:label="lab_livn_FDAWarningLetterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FDA Warning Letter [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_FDAWarningLetterMember" xlink:href="livn-20200930.xsd#livn_FDAWarningLetterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_FDAWarningLetterMember" xlink:to="lab_livn_FDAWarningLetterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_75e9c675-2b27-47a1-824c-bd1a485e2857_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_b3420d81-6301-4b1a-8438-37aaa0bc0815_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_MeasurementInputProbabilityofPaymentMember_38dc0ee9-1874-4d29-b659-7da3f0a004cb_terseLabel_en-US" xlink:label="lab_livn_MeasurementInputProbabilityofPaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probability of payment</link:label>
    <link:label id="lab_livn_MeasurementInputProbabilityofPaymentMember_label_en-US" xlink:label="lab_livn_MeasurementInputProbabilityofPaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability of Payment [Member]</link:label>
    <link:label id="lab_livn_MeasurementInputProbabilityofPaymentMember_documentation_en-US" xlink:label="lab_livn_MeasurementInputProbabilityofPaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability of Payment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MeasurementInputProbabilityofPaymentMember" xlink:href="livn-20200930.xsd#livn_MeasurementInputProbabilityofPaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_MeasurementInputProbabilityofPaymentMember" xlink:to="lab_livn_MeasurementInputProbabilityofPaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_d23bd2ab-1d48-4337-bb3a-a2cc44e21c0a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation provision liability</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_d1e30c8b-278a-412a-ae87-3f43bb10186e_periodStartLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total litigation provision liability at beginning of period</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_b2b3ad2c-4766-4ae6-b30f-c5068c51a23a_periodEndLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total litigation provision liability at end of period</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_9b894d60-d1ed-4b67-8f31-5fc073aa5df0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses from equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_IncomeTaxExaminationNumberofInstallments_8fc16fb0-e534-44d5-875a-f8dee7f3763b_terseLabel_en-US" xlink:label="lab_livn_IncomeTaxExaminationNumberofInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of equal installments</link:label>
    <link:label id="lab_livn_IncomeTaxExaminationNumberofInstallments_label_en-US" xlink:label="lab_livn_IncomeTaxExaminationNumberofInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Number of Installments</link:label>
    <link:label id="lab_livn_IncomeTaxExaminationNumberofInstallments_documentation_en-US" xlink:label="lab_livn_IncomeTaxExaminationNumberofInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Number of Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_IncomeTaxExaminationNumberofInstallments" xlink:href="livn-20200930.xsd#livn_IncomeTaxExaminationNumberofInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_IncomeTaxExaminationNumberofInstallments" xlink:to="lab_livn_IncomeTaxExaminationNumberofInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_84a6a3c4-3980-4c56-a0e6-e909f1d6ecbb_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_35a31cac-4911-434f-ae5d-2f7a23e34f69_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_AdvancedCirculatorySupportMember_150d09e0-e022-441d-bc17-ed591d2214df_terseLabel_en-US" xlink:label="lab_livn_AdvancedCirculatorySupportMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Circulatory Support</link:label>
    <link:label id="lab_livn_AdvancedCirculatorySupportMember_label_en-US" xlink:label="lab_livn_AdvancedCirculatorySupportMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Circulatory Support [Member]</link:label>
    <link:label id="lab_livn_AdvancedCirculatorySupportMember_documentation_en-US" xlink:label="lab_livn_AdvancedCirculatorySupportMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Circulatory Support [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_AdvancedCirculatorySupportMember" xlink:href="livn-20200930.xsd#livn_AdvancedCirculatorySupportMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_AdvancedCirculatorySupportMember" xlink:to="lab_livn_AdvancedCirculatorySupportMember" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_DebtInstrumentOptionToExchangePricePerShare_4a7025b4-ab4f-444c-ad8b-143fb979c94c_terseLabel_en-US" xlink:label="lab_livn_DebtInstrumentOptionToExchangePricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to exchange, price per share</link:label>
    <link:label id="lab_livn_DebtInstrumentOptionToExchangePricePerShare_label_en-US" xlink:label="lab_livn_DebtInstrumentOptionToExchangePricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Option To Exchange, Price Per Share</link:label>
    <link:label id="lab_livn_DebtInstrumentOptionToExchangePricePerShare_documentation_en-US" xlink:label="lab_livn_DebtInstrumentOptionToExchangePricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Option To Exchange, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentOptionToExchangePricePerShare" xlink:href="livn-20200930.xsd#livn_DebtInstrumentOptionToExchangePricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_DebtInstrumentOptionToExchangePricePerShare" xlink:to="lab_livn_DebtInstrumentOptionToExchangePricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_CappedCallMember_270ce6b7-d90e-4c89-b09e-f0c850e50027_terseLabel_en-US" xlink:label="lab_livn_CappedCallMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capped call derivatives</link:label>
    <link:label id="lab_livn_CappedCallMember_label_en-US" xlink:label="lab_livn_CappedCallMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capped Call [Member]</link:label>
    <link:label id="lab_livn_CappedCallMember_documentation_en-US" xlink:label="lab_livn_CappedCallMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capped Call</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CappedCallMember" xlink:href="livn-20200930.xsd#livn_CappedCallMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_CappedCallMember" xlink:to="lab_livn_CappedCallMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_db48abdc-1da1-486c-a828-a4e93005b889_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_56e2e410-6b53-48ac-80f8-5b1e21786d9e_totalLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI and without Readily Determinable Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:to="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_b37d0b70-8085-46f3-9efe-c16624255b5c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax expense</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_175a47c1-323c-481a-bd9a-9c9439413393_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_147f1a0a-f3be-46c2-9399-d0d4e2e8f28b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_67164a5f-25e3-4384-828f-85b864734513_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_dca35a5f-3d8c-40cd-b83f-4e02f6eaae56_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ac4b34b8-bc03-4192-84ff-d4fa2bce9f68_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased from employees for minimum tax withholding</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_da6addd5-aea8-4fe9-a44c-7464333e0da3_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_PurchasesOfInvestments_0ba5063e-5ada-4bc7-9b03-421192ac7529_negatedTerseLabel_en-US" xlink:label="lab_livn_PurchasesOfInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investments</link:label>
    <link:label id="lab_livn_PurchasesOfInvestments_label_en-US" xlink:label="lab_livn_PurchasesOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases Of Investments</link:label>
    <link:label id="lab_livn_PurchasesOfInvestments_documentation_en-US" xlink:label="lab_livn_PurchasesOfInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases Of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_PurchasesOfInvestments" xlink:href="livn-20200930.xsd#livn_PurchasesOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_PurchasesOfInvestments" xlink:to="lab_livn_PurchasesOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_397495fe-0da4-4df1-9f06-f2789d54610f_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_fed6752e-d28a-454b-aeb3-3804b3e06fbf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCostOfHedge_38723a03-09b7-409c-954c-9e30c17b7274_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeCostOfHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, cost of hedge</link:label>
    <link:label id="lab_us-gaap_DerivativeCostOfHedge_label_en-US" xlink:label="lab_us-gaap_DerivativeCostOfHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cost of Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCostOfHedge" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCostOfHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCostOfHedge" xlink:to="lab_us-gaap_DerivativeCostOfHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_dcb3b8e9-bf4c-4da7-afb7-4e63491e5e61_verboseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Information</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_ab3ea5e7-52f1-40c1-b3a5-8ba381b10431_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_37cf76ff-f354-4e75-bf8d-357daff645d4_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_b62b037a-1d8c-4836-92c9-9a2a192eb1e3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_303e4f68-9648-4588-be60-20c7db293f4e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvesteeMember" xlink:to="lab_us-gaap_EquityMethodInvesteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ALungTechnologiesInc.Member_4e8f9aa5-0e7a-46a3-ac30-485969bba790_terseLabel_en-US" xlink:label="lab_livn_ALungTechnologiesInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALung Technologies, Inc.</link:label>
    <link:label id="lab_livn_ALungTechnologiesInc.Member_label_en-US" xlink:label="lab_livn_ALungTechnologiesInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALung Technologies, Inc. [Member]</link:label>
    <link:label id="lab_livn_ALungTechnologiesInc.Member_documentation_en-US" xlink:label="lab_livn_ALungTechnologiesInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALung Technologies, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ALungTechnologiesInc.Member" xlink:href="livn-20200930.xsd#livn_ALungTechnologiesInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ALungTechnologiesInc.Member" xlink:to="lab_livn_ALungTechnologiesInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_151824b9-888f-4fed-85b4-6f4b31c8b397_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Provision Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loss Contingencies by Contingency [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:to="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_54711301-fbff-44c6-9f26-8c8a74596b8f_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_88e373c9-4d13-4722-8237-4b9976cbcc79_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_9071e560-08ef-4bc2-8f7c-ce863a3dcace_verboseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_ddd1a855-809f-44c9-9d5a-42bbef5fa8a7_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">As of beginning period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_74f5e816-d5b5-4266-831c-5b6519d361a8_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total at period end</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_d8e14635-7db4-4b5b-ac3f-ff477d5914cd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_281fe42a-3b0a-428e-bcf2-6874b41aa058_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_dfda5b6c-3e59-4ce0-98f3-bb2da24a0f85_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales - exclusive of amortization</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_8b8d8c28-0d8f-490e-9917-e910322bc8aa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_79f17295-f2f5-45d3-97c1-1221a994313f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_773b00d3-f410-4e47-ac9b-1efe55d0f517_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_936e0fd8-b788-4013-9bd9-f9439dd8669b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending claims, number</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_9c966a88-3c5f-4c2b-82be-1d588dbf94a3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_LocationsExcludingTheUnitedStatesAndEuropeMember_5dad37e8-eb54-4929-b76d-9b13cc8e4f92_terseLabel_en-US" xlink:label="lab_livn_LocationsExcludingTheUnitedStatesAndEuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_livn_LocationsExcludingTheUnitedStatesAndEuropeMember_label_en-US" xlink:label="lab_livn_LocationsExcludingTheUnitedStatesAndEuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Locations Excluding The United States And Europe [Member]</link:label>
    <link:label id="lab_livn_LocationsExcludingTheUnitedStatesAndEuropeMember_documentation_en-US" xlink:label="lab_livn_LocationsExcludingTheUnitedStatesAndEuropeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Locations Excluding The United States And Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_LocationsExcludingTheUnitedStatesAndEuropeMember" xlink:href="livn-20200930.xsd#livn_LocationsExcludingTheUnitedStatesAndEuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_LocationsExcludingTheUnitedStatesAndEuropeMember" xlink:to="lab_livn_LocationsExcludingTheUnitedStatesAndEuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_43403c8d-8601-44d1-ace7-1fcadb370986_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_247fe699-7c00-4bf8-9c9f-56604c42c499_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_CardiovascularSegmentMember_e97a2b96-2fa4-472a-8e0d-a6ac0aa87ba7_terseLabel_en-US" xlink:label="lab_livn_CardiovascularSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular</link:label>
    <link:label id="lab_livn_CardiovascularSegmentMember_label_en-US" xlink:label="lab_livn_CardiovascularSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular Segment [Member]</link:label>
    <link:label id="lab_livn_CardiovascularSegmentMember_documentation_en-US" xlink:label="lab_livn_CardiovascularSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CardiovascularSegmentMember" xlink:href="livn-20200930.xsd#livn_CardiovascularSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_CardiovascularSegmentMember" xlink:to="lab_livn_CardiovascularSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_0d3e7d23-ea63-40da-a910-cb9761335bf5_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_fcc2adfb-cb91-43cf-8e64-08470dfe4b4e_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo_8c8d8b4a-42e4-41e6-bee5-1de6003dc8d2_terseLabel_en-US" xlink:label="lab_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured leverage ratio, period two</link:label>
    <link:label id="lab_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo_label_en-US" xlink:label="lab_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Secured Leverage Ratio, Period Two</link:label>
    <link:label id="lab_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo_documentation_en-US" xlink:label="lab_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Secured Leverage Ratio, Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo" xlink:href="livn-20200930.xsd#livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo" xlink:to="lab_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_9d1f46e8-2578-47e7-9f1c-ebe093f95ebc_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue_a674b306-de3c-4d13-b87c-b082f1cdaa58_terseLabel_en-US" xlink:label="lab_livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">10 percent increase in stock price volatility, fair value</link:label>
    <link:label id="lab_livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue_label_en-US" xlink:label="lab_livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis Of Fair Value, 10 Percent Increase In Stock Price Volatility, Fair Value</link:label>
    <link:label id="lab_livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue_documentation_en-US" xlink:label="lab_livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis Of Fair Value, 10 Percent Increase In Stock Price Volatility, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue" xlink:href="livn-20200930.xsd#livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue" xlink:to="lab_livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_2d3f30a5-9a02-4ed4-9cba-6bff29074095_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_5296ed68-e175-4304-b642-de913fdaf296_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_7e3a704d-76f2-4596-ac0f-2b3157f9edde_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_de40e490-71fb-43a6-8ebd-a646ff067ea5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_7885b8a4-f93d-4a95-85e5-fc28e63e6b66_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_MarketbasedPerformanceRestrictedStockUnitMember_05dd5767-8b1a-41cd-bc5b-303abd803895_terseLabel_en-US" xlink:label="lab_livn_MarketbasedPerformanceRestrictedStockUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market performance-based restricted stock units</link:label>
    <link:label id="lab_livn_MarketbasedPerformanceRestrictedStockUnitMember_label_en-US" xlink:label="lab_livn_MarketbasedPerformanceRestrictedStockUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market-based Performance Restricted Stock Unit [Member]</link:label>
    <link:label id="lab_livn_MarketbasedPerformanceRestrictedStockUnitMember_documentation_en-US" xlink:label="lab_livn_MarketbasedPerformanceRestrictedStockUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market-based Performance Restricted Stock Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MarketbasedPerformanceRestrictedStockUnitMember" xlink:href="livn-20200930.xsd#livn_MarketbasedPerformanceRestrictedStockUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_MarketbasedPerformanceRestrictedStockUnitMember" xlink:to="lab_livn_MarketbasedPerformanceRestrictedStockUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_d92247f6-e9b8-4502-8e7e-d5c5b33036a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Derivative Instruments in Statement of Financial Position</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays_7b6fd8eb-6d40-4fd4-988f-07b1c9938548_terseLabel_en-US" xlink:label="lab_livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption, threshold consecutive trading days</link:label>
    <link:label id="lab_livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays_label_en-US" xlink:label="lab_livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Threshold Consecutive Trading Days</link:label>
    <link:label id="lab_livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays_documentation_en-US" xlink:label="lab_livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays" xlink:href="livn-20200930.xsd#livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays" xlink:to="lab_livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_4d7a8c00-6862-4209-8fed-38dcb34a8c07_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9c85c924-ce02-4e46-a238-a717cf1a90dc_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e110e911-2033-454f-b3c1-f891342b29e9_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_eca2aa16-6442-476e-a650-f76548854830_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_bc80d1f6-16f6-42c0-82fc-19db11e8374f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Stock Options, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_81f96160-1662-4745-82ce-47a065c6d165_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_87c14a16-ea57-4c3a-b765-21390cea705f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_GBP_e245eac7-3aef-4d86-93c9-0e8d5b46ef7f_terseLabel_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom, Pounds</link:label>
    <link:label id="lab_currency_GBP_label_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom, Pounds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_GBP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_GBP" xlink:to="lab_currency_GBP" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_329621d3-6c1b-4ea8-82a4-dcef17d9f731_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_MeasurementInputCreditRiskDiscountRateMember_f60a23b1-8f4f-4cac-b8c3-dc71353149b2_terseLabel_en-US" xlink:label="lab_livn_MeasurementInputCreditRiskDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit risk discount rate</link:label>
    <link:label id="lab_livn_MeasurementInputCreditRiskDiscountRateMember_label_en-US" xlink:label="lab_livn_MeasurementInputCreditRiskDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Credit Risk Discount Rate [Member]</link:label>
    <link:label id="lab_livn_MeasurementInputCreditRiskDiscountRateMember_documentation_en-US" xlink:label="lab_livn_MeasurementInputCreditRiskDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Credit Risk Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MeasurementInputCreditRiskDiscountRateMember" xlink:href="livn-20200930.xsd#livn_MeasurementInputCreditRiskDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_MeasurementInputCreditRiskDiscountRateMember" xlink:to="lab_livn_MeasurementInputCreditRiskDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_9ee16f21-6e88-40ef-a305-a83c88539c6a_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_fc9bc7f8-a08f-451e-b1fe-bc05e926af9e_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement, amount awarded to other party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_ade2b56c-320e-4e76-b2bd-ad22d2b2c7d4_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_971eccd6-57a3-4a36-8749-8d9221c3ed1d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_8d3dee01-9e95-44c7-87ca-eda9007bf3ff_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_57de3119-a0fc-49d5-ae02-0fc33bc184b0_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_c3fb6cd4-677f-450b-9926-7c2f9b5f04b4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs, net</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_660e3216-2b71-4128-b126-c5a5ff74443a_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_92b272d9-9f8b-4d43-9cca-adff85cecb27_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of contingent consideration to fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_SNIAs.p.aMember_3a3e9738-422e-4d07-8e33-8c61592da880_terseLabel_en-US" xlink:label="lab_livn_SNIAs.p.aMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SNIA s.p.a</link:label>
    <link:label id="lab_livn_SNIAs.p.aMember_label_en-US" xlink:label="lab_livn_SNIAs.p.aMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SNIA s.p.a [Member]</link:label>
    <link:label id="lab_livn_SNIAs.p.aMember_documentation_en-US" xlink:label="lab_livn_SNIAs.p.aMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SNIA s.p.a [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_SNIAs.p.aMember" xlink:href="livn-20200930.xsd#livn_SNIAs.p.aMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_SNIAs.p.aMember" xlink:to="lab_livn_SNIAs.p.aMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8ab301b9-e6ea-4ee4-83e2-8dbc536eb73c_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, potential decrease amount</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_LossContingencyAccrualAdjustments_ec82368c-ce50-4a05-8e22-ebdb8602c85c_terseLabel_en-US" xlink:label="lab_livn_LossContingencyAccrualAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_livn_LossContingencyAccrualAdjustments_label_en-US" xlink:label="lab_livn_LossContingencyAccrualAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Adjustments</link:label>
    <link:label id="lab_livn_LossContingencyAccrualAdjustments_documentation_en-US" xlink:label="lab_livn_LossContingencyAccrualAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_LossContingencyAccrualAdjustments" xlink:href="livn-20200930.xsd#livn_LossContingencyAccrualAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_LossContingencyAccrualAdjustments" xlink:to="lab_livn_LossContingencyAccrualAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_386a2988-cbce-46db-aa6f-6b8ef5d699e4_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Expected to be Reclassified to Earnings in Next 12 Months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3087eaa4-977c-4c16-a616-ae22c951537f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a10f69c9-e3a5-4248-803d-db263a852945_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_542325fb-c154-4dde-8cf7-4c40b0ea36ab_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_ad938708-b911-42cd-850c-658933415bec_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ScheduleOfDebtCovenantsTableTextBlock_3573cb48-621a-46f9-9269-20f74b2d729d_terseLabel_en-US" xlink:label="lab_livn_ScheduleOfDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Covenants</link:label>
    <link:label id="lab_livn_ScheduleOfDebtCovenantsTableTextBlock_label_en-US" xlink:label="lab_livn_ScheduleOfDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Debt Covenants [Table Text Block]</link:label>
    <link:label id="lab_livn_ScheduleOfDebtCovenantsTableTextBlock_documentation_en-US" xlink:label="lab_livn_ScheduleOfDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Debt Covenants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ScheduleOfDebtCovenantsTableTextBlock" xlink:href="livn-20200930.xsd#livn_ScheduleOfDebtCovenantsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ScheduleOfDebtCovenantsTableTextBlock" xlink:to="lab_livn_ScheduleOfDebtCovenantsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_8416c6f9-1b01-4c5e-b698-55a2a6b0bcf5_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_ff30913a-9c50-4d74-863a-5ef0e51abf06_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_e182b5cd-2d66-4bf0-af1f-0a3371f2e7a9_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_61a28e68-ecc7-426a-bd6a-3bcfbe2b33bd_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance of $16,241 at September 30, 2020 and $13,105 at December 31, 2019</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_6824e869-c208-4781-a590-5878ce7ad9b8_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_MiamiInstrumentsLLCMember_05e414ee-3218-4dd2-adab-fe4fd4f57165_terseLabel_en-US" xlink:label="lab_livn_MiamiInstrumentsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Miami Instruments</link:label>
    <link:label id="lab_livn_MiamiInstrumentsLLCMember_label_en-US" xlink:label="lab_livn_MiamiInstrumentsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Miami Instruments, LLC [Member]</link:label>
    <link:label id="lab_livn_MiamiInstrumentsLLCMember_documentation_en-US" xlink:label="lab_livn_MiamiInstrumentsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Miami Instruments, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MiamiInstrumentsLLCMember" xlink:href="livn-20200930.xsd#livn_MiamiInstrumentsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_MiamiInstrumentsLLCMember" xlink:to="lab_livn_MiamiInstrumentsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ResearchAndDevelopmentCostsPayableCurrent_cfeb245c-d8d8-4779-84e1-94ef31e540f1_terseLabel_en-US" xlink:label="lab_livn_ResearchAndDevelopmentCostsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development costs</link:label>
    <link:label id="lab_livn_ResearchAndDevelopmentCostsPayableCurrent_label_en-US" xlink:label="lab_livn_ResearchAndDevelopmentCostsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Costs Payable, Current</link:label>
    <link:label id="lab_livn_ResearchAndDevelopmentCostsPayableCurrent_documentation_en-US" xlink:label="lab_livn_ResearchAndDevelopmentCostsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ResearchAndDevelopmentCostsPayableCurrent" xlink:href="livn-20200930.xsd#livn_ResearchAndDevelopmentCostsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ResearchAndDevelopmentCostsPayableCurrent" xlink:to="lab_livn_ResearchAndDevelopmentCostsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_e1d13b9b-dcb4-4947-883f-7fe22ec03817_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_178b9085-7b10-4487-974d-db736655ea32_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualRollForward_aed4c290-58dd-45c0-8824-8b3a539a2df7_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Provision Liability</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward" xlink:to="lab_us-gaap_LossContingencyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_EmbeddedExchangeFeatureLiabilityMember_1a6f909f-b517-48d8-9473-dbae131d30a6_terseLabel_en-US" xlink:label="lab_livn_EmbeddedExchangeFeatureLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Exchange Feature Derivative Liability</link:label>
    <link:label id="lab_livn_EmbeddedExchangeFeatureLiabilityMember_label_en-US" xlink:label="lab_livn_EmbeddedExchangeFeatureLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Exchange Feature Liability [Member]</link:label>
    <link:label id="lab_livn_EmbeddedExchangeFeatureLiabilityMember_documentation_en-US" xlink:label="lab_livn_EmbeddedExchangeFeatureLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Exchange Feature Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_EmbeddedExchangeFeatureLiabilityMember" xlink:href="livn-20200930.xsd#livn_EmbeddedExchangeFeatureLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_EmbeddedExchangeFeatureLiabilityMember" xlink:to="lab_livn_EmbeddedExchangeFeatureLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_DebtInstrumentLIBORFloorRate_944eda90-a147-41bb-aa8a-9ab4f60b926d_terseLabel_en-US" xlink:label="lab_livn_DebtInstrumentLIBORFloorRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR floor rate</link:label>
    <link:label id="lab_livn_DebtInstrumentLIBORFloorRate_label_en-US" xlink:label="lab_livn_DebtInstrumentLIBORFloorRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, LIBOR Floor Rate</link:label>
    <link:label id="lab_livn_DebtInstrumentLIBORFloorRate_documentation_en-US" xlink:label="lab_livn_DebtInstrumentLIBORFloorRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, LIBOR Floor Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentLIBORFloorRate" xlink:href="livn-20200930.xsd#livn_DebtInstrumentLIBORFloorRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_DebtInstrumentLIBORFloorRate" xlink:to="lab_livn_DebtInstrumentLIBORFloorRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_bc1f1010-e2ce-485a-855a-aeb9c5bb3ebc_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_cbd5fa67-9125-4045-a714-cbdb93c7b948_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_73f0b4da-eed2-4e4f-b9a0-29acb7d3bc08_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_f2bdc227-5bce-4276-aaee-5e63ea122870_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments and other</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_d4f11381-e969-472b-aef3-f4a8c05a7754_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_ee82e86b-24aa-409c-aaa9-7007d3abbb65_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning</link:label>
    <link:label id="lab_us-gaap_Goodwill_d75b706c-d1ab-43ae-851f-d3d96be3ddae_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_b3a782b6-0839-4042-923b-74894b91d39f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ConvertibleNotesReceivableMember_3a2df482-11bc-4f55-8b44-ddc831c04628_terseLabel_en-US" xlink:label="lab_livn_ConvertibleNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Receivable</link:label>
    <link:label id="lab_livn_ConvertibleNotesReceivableMember_label_en-US" xlink:label="lab_livn_ConvertibleNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Receivable [Member]</link:label>
    <link:label id="lab_livn_ConvertibleNotesReceivableMember_documentation_en-US" xlink:label="lab_livn_ConvertibleNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ConvertibleNotesReceivableMember" xlink:href="livn-20200930.xsd#livn_ConvertibleNotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ConvertibleNotesReceivableMember" xlink:to="lab_livn_ConvertibleNotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5c810c85-5082-4b6d-9842-9b3b776c02e8_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_aa2874ea-6779-4cc2-8eea-8881cb63d04f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_3be8812c-3a81-4b6b-b1c4-4b3553d72340_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock_a3a1ac9a-9c14-4240-9b55-34eeecea3ee9_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3021e842-bbbe-49d8-89f5-416a6a1306ac_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_43acbeef-537b-436d-9d04-5358e240f315_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total asset derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_b2484fef-4d51-4bb8-9462-29e96203ae82_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodOne_58bf9da1-5cd3-4aaf-ab6c-74552b3c298c_terseLabel_en-US" xlink:label="lab_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured leverage ratio, period one</link:label>
    <link:label id="lab_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodOne_label_en-US" xlink:label="lab_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Secured Leverage Ratio, Period One</link:label>
    <link:label id="lab_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodOne_documentation_en-US" xlink:label="lab_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Secured Leverage Ratio, Period One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodOne" xlink:href="livn-20200930.xsd#livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodOne" xlink:to="lab_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_f41aeb73-c64f-4c6c-b445-d8dcabe82628_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_81400e8a-9c7f-408f-8012-30213c6f06f4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_036287d0-62ff-4e39-92de-37f62cd7944c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_6d2417a0-42a8-4003-a770-d9f4e5a505c9_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_03fe173b-e604-45bf-bd4d-7967427881be_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of capped call</link:label>
    <link:label id="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Derivative Instrument, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:to="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b5113933-eea3-4393-a5ec-9e897dff67f8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_e85544f8-1ae4-4ea6-a88c-31ce3f616484_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_48868e4c-1f0b-4e2c-ae81-d7044ff83c73_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_f6972edf-1a3d-49de-99d5-f0531c515096_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTerm_ef86dd14-fb5d-41a5-8829-423a845dc63e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, term</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTerm_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTerm" xlink:to="lab_us-gaap_LongTermDebtTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4ba866fc-006e-4937-bd7b-0c71dc7d6f77_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_1311d00a-aede-4ead-a64a-294021593b96_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_07dce501-99a4-4d0b-a7b3-2b724749fc5a_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_92025632-e172-4139-9d9f-620b77175ccb_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther_044dba6a-9271-41b2-bf67-cb91c7c6bfc7_terseLabel_en-US" xlink:label="lab_livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FX and other</link:label>
    <link:label id="lab_livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther_label_en-US" xlink:label="lab_livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Accrual, Foreign Currency Adjustments, And Other</link:label>
    <link:label id="lab_livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther_documentation_en-US" xlink:label="lab_livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Accrual, Foreign Currency Adjustments, And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther" xlink:href="livn-20200930.xsd#livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther" xlink:to="lab_livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_36042cd0-c8af-4335-ac5e-6314413aa0e7_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_869b640a-a2ca-4de2-a1e8-0698bef3f0e1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_422996a9-8c2d-41d1-a4cf-5adde4391373_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in computing diluted (loss) income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6d95971e-2609-4b39-9237-5a5299cc9ff5_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_0ccb6e1b-fac2-448e-a9ac-b66ad62bc0d0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_80110828-71ed-404d-8755-1cd2a87afd94_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ProductRemediationAdjustments_16cf20ac-2b22-4cb3-a750-52b57329e33e_terseLabel_en-US" xlink:label="lab_livn_ProductRemediationAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_livn_ProductRemediationAdjustments_label_en-US" xlink:label="lab_livn_ProductRemediationAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation, Adjustments</link:label>
    <link:label id="lab_livn_ProductRemediationAdjustments_documentation_en-US" xlink:label="lab_livn_ProductRemediationAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation, Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationAdjustments" xlink:href="livn-20200930.xsd#livn_ProductRemediationAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ProductRemediationAdjustments" xlink:to="lab_livn_ProductRemediationAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_cd52c6a9-013f-41a3-a614-2478638c1460_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_NumberofGeographicRegionsinwhichEntityOperates_4d286537-f181-43bd-91a9-e0f8b0def2e6_terseLabel_en-US" xlink:label="lab_livn_NumberofGeographicRegionsinwhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of geographic regions in which entity operates</link:label>
    <link:label id="lab_livn_NumberofGeographicRegionsinwhichEntityOperates_label_en-US" xlink:label="lab_livn_NumberofGeographicRegionsinwhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Geographic Regions in which Entity Operates</link:label>
    <link:label id="lab_livn_NumberofGeographicRegionsinwhichEntityOperates_documentation_en-US" xlink:label="lab_livn_NumberofGeographicRegionsinwhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Geographic Regions in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_NumberofGeographicRegionsinwhichEntityOperates" xlink:href="livn-20200930.xsd#livn_NumberofGeographicRegionsinwhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_NumberofGeographicRegionsinwhichEntityOperates" xlink:to="lab_livn_NumberofGeographicRegionsinwhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_9445fb22-a321-4af9-bd14-715a74daa86d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_c867e06f-f74d-45ec-b2b2-e1fa6c4b04cc_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term employee compensation and related benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_294bcdb7-5292-4f40-b183-474e7aa85371_verboseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_6b65e0ff-a888-4a00-a4a0-49a5c49509a4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_2cbb073b-a87b-4e45-ac54-facbe8d78b88_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_1e622a55-c11d-48f9-bccf-325dfcaf9c29_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt obligations</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_e3e427ee-cec2-4766-b614-d0d6085f11f2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for obsolescence</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_b9348192-aa79-4a38-8a81-f34260584903_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_5027bfab-266d-41ec-a697-845f0a62fb69_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_5a58e050-4882-4c96-aed0-55a18bfa15fa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDepreciationAndAmortization" xlink:to="lab_us-gaap_OtherDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_1c391b38-1854-45e2-93a1-93624466750d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_f6f23687-3c39-4d7e-a938-802e3559f9b8_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_60955284-7423-4099-8fe1-eb13ca6e1641_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_350d1511-2843-4653-97d6-ea88461fab3e_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares, &#163;1.00 par value: unlimited shares authorized; 49,402,628 shares issued and 48,596,417 shares outstanding at September 30, 2020; 49,411,016 shares issued and 48,443,830 shares outstanding at December 31, 2019</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fb255a35-0740-420f-9b97-91a51fa2168d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_80637775-eb66-4982-b412-08411a0826a0_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ProductRemediationTextBlock_6e78ae31-bab6-40ce-a1c5-94df69b765cd_terseLabel_en-US" xlink:label="lab_livn_ProductRemediationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation Liability</link:label>
    <link:label id="lab_livn_ProductRemediationTextBlock_label_en-US" xlink:label="lab_livn_ProductRemediationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation [Text Block]</link:label>
    <link:label id="lab_livn_ProductRemediationTextBlock_documentation_en-US" xlink:label="lab_livn_ProductRemediationTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationTextBlock" xlink:href="livn-20200930.xsd#livn_ProductRemediationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ProductRemediationTextBlock" xlink:to="lab_livn_ProductRemediationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CountryRegion_be7323ce-e5fe-4485-890f-399aba94c6cc_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_31ff743d-c3c8-44b8-a48f-6528eb9a9397_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_4efb2414-8a2a-4573-adef-689f61251197_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt obligations</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAdditions_8b57e552-8a57-4721-8918-faa6d7ced2ba_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAdditions_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_e9973835-70d8-42ce-a4c1-12ed8c36909c_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_cefa4ba7-269f-40b9-9dd4-bee0620aa63d_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_SNIAMember_b0ba6524-a9e2-4df3-a96b-76a9469847d1_terseLabel_en-US" xlink:label="lab_livn_SNIAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SNIA</link:label>
    <link:label id="lab_livn_SNIAMember_label_en-US" xlink:label="lab_livn_SNIAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SNIA [Member]</link:label>
    <link:label id="lab_livn_SNIAMember_documentation_en-US" xlink:label="lab_livn_SNIAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SNIA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_SNIAMember" xlink:href="livn-20200930.xsd#livn_SNIAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_SNIAMember" xlink:to="lab_livn_SNIAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_3ebb562f-1fe0-4e2a-9eac-1ebe14aca90d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_a24950b8-1d57-47ed-a541-8ae943211779_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_1df6ef1f-4a60-48f5-bebb-bac03dd30272_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_db135777-d5fe-447a-b583-5d084d1e0b17_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1a59d7ec-b67b-4345-ab97-42a5a8588dca_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_0231cd1e-0283-456c-89c6-331bd49d61d8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c67c3dc5-1168-4716-9c6b-00915a269346_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_eb58c7a1-182c-4203-adf3-fe01866800f6_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_02d6253b-257b-4b74-ba1e-d33b6d0ccb7d_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ContingentConsiderationLiabilityMember_360ad545-b5e2-4303-9a05-fec32913f82f_terseLabel_en-US" xlink:label="lab_livn_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability Arrangements</link:label>
    <link:label id="lab_livn_ContingentConsiderationLiabilityMember_label_en-US" xlink:label="lab_livn_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability [Member]</link:label>
    <link:label id="lab_livn_ContingentConsiderationLiabilityMember_documentation_en-US" xlink:label="lab_livn_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ContingentConsiderationLiabilityMember" xlink:href="livn-20200930.xsd#livn_ContingentConsiderationLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ContingentConsiderationLiabilityMember" xlink:to="lab_livn_ContingentConsiderationLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue_32197a1d-7234-4c48-b518-34edf5d2700b_terseLabel_en-US" xlink:label="lab_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion at period end</link:label>
    <link:label id="lab_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue_label_en-US" xlink:label="lab_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Current Liability Value</link:label>
    <link:label id="lab_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue_documentation_en-US" xlink:label="lab_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Current Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue" xlink:href="livn-20200930.xsd#livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue" xlink:to="lab_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ebef374a-b1f2-4d0b-94e9-73714feda850_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_77b0b4b0-1c3f-4fe5-bda9-b030e489db45_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_75a31a39-2630-4cde-bf0c-cfba4a3ee7de_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_5f9a0fe5-fb12-4d1a-b26e-8558f577aceb_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_f7d99411-7306-429d-b65a-51ca534e759c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_e4dbf057-ccc9-4b9d-a1f7-d461e84bbf83_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_58e371bc-a2f3-49d0-a030-f9f5b9fcd37b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_75657062-6754-4174-a34f-e31cc92417be_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_5bd690e4-7008-40a1-bfaa-8f154ce702b5_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_c509f751-75d5-446a-a14a-6932653d2fb6_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_011cb260-b169-495e-ab52-38473b09a251_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3f6a32bd-82ca-4d0f-9e53-8e7f12be600d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_447accc2-fe66-4b85-b3bf-e8415d10f029_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_ad8b78e2-ee50-4914-a936-97bf564bfbeb_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_e41dfff8-79b3-4a87-bc1f-ed458ad181a0_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounted cash flow</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesFairValueDisclosure_eea6a5d1-a152-405a-81ed-8b7a777e47cb_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ReceivablesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesFairValueDisclosure" xlink:to="lab_us-gaap_ReceivablesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_a52e30d1-46c6-4495-9b5e-ebc14ad18470_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTextBlock_8b136c53-8fdb-44b2-9725-6bf85095189f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTextBlock" xlink:to="lab_us-gaap_InvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_dbbf49bb-11e7-45b1-85fc-350f8c0d7710_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2025a88e-27a1-4b0f-bdd5-10ba2e5eaa70_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_4055349b-cd0e-4c22-80ad-21e970b21096_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_838b403c-f52e-4894-bc1c-f6c381686031_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued employee compensation and related benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_70150d5c-14cc-4a6c-8730-188db0a50066_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_44791fa2-209d-490e-a925-1d60ca7effa7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_ac013d77-ca27-4de6-a041-e1aac72c1e2f_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service-based restricted stock units (&#8220;RSUs&#8221;)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_a0b92f0c-ea4b-42ca-b153-74c050045a89_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c01c88d3-b666-4710-b3de-c754a6b8e3e1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableNet_6cc3e318-4744-4ab3-aac2-8ae963382168_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding loans</link:label>
    <link:label id="lab_us-gaap_NotesReceivableNet_label_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableNet" xlink:to="lab_us-gaap_NotesReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_6b5e0d0a-c276-4f68-9098-e55890769500_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations_42ce04f9-5c28-4b99-85cd-88739b7aa2d3_terseLabel_en-US" xlink:label="lab_livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total reportable segment income from continuing operations</link:label>
    <link:label id="lab_livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Loss) Included In Segment Income (Loss) From Continuing Operations</link:label>
    <link:label id="lab_livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations_documentation_en-US" xlink:label="lab_livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Loss) Included In Segment Income (Loss) From Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" xlink:href="livn-20200930.xsd#livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" xlink:to="lab_livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_61ba6a6f-689e-432d-ac67-27d5064cd6ca_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share amount (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature_22418ff2-9337-4282-880c-1daec04bc539_negatedLabel_en-US" xlink:label="lab_livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of derivative instruments</link:label>
    <link:label id="lab_livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature_label_en-US" xlink:label="lab_livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement Of Capped Call And Embedded Exchange Feature</link:label>
    <link:label id="lab_livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature_documentation_en-US" xlink:label="lab_livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement Of Capped Call And Embedded Exchange Feature</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature" xlink:href="livn-20200930.xsd#livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature" xlink:to="lab_livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_3d715edf-66c8-4cd0-a75b-147d74157cfc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ProductRemediationAbstract_327efe8d-532e-4d4d-b1b1-65f1a6e7e8b3_terseLabel_en-US" xlink:label="lab_livn_ProductRemediationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation [Abstract]</link:label>
    <link:label id="lab_livn_ProductRemediationAbstract_label_en-US" xlink:label="lab_livn_ProductRemediationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation [Abstract]</link:label>
    <link:label id="lab_livn_ProductRemediationAbstract_documentation_en-US" xlink:label="lab_livn_ProductRemediationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationAbstract" xlink:href="livn-20200930.xsd#livn_ProductRemediationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ProductRemediationAbstract" xlink:to="lab_livn_ProductRemediationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_e93c57e6-650e-43a9-8db5-a2b6da6a6bd8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements_839db629-1d42-42a7-a893-5fa382918705_terseLabel_en-US" xlink:label="lab_livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Application pending approval, payments for legal settlements</link:label>
    <link:label id="lab_livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements_label_en-US" xlink:label="lab_livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Application Pending Approval, Payments for Legal Settlements</link:label>
    <link:label id="lab_livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements_documentation_en-US" xlink:label="lab_livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Application Pending Approval, Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements" xlink:href="livn-20200930.xsd#livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements" xlink:to="lab_livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_a0b43204-8b0a-4bc2-8bb6-ccfd849518b2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in AOCI</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_46d497f6-1aa0-425a-82a5-ec2ea2699e59_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_cb5a0102-e245-4bc4-94de-dc61bf2c26b7_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_e18e7925-5504-4b69-84f0-8fe8bdd3a13c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Derivative Contracts Designated Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_eda3f641-317d-4308-b08f-0f8f21a5682c_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Incentive Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_849f48d7-e8a3-4912-b200-f5d84dc654ca_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_eb997bc9-6ac4-40d1-b6c8-4f5dbf7ec82c_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_6b991b55-3188-42f4-9a71-ce01f24efc73_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_e2432234-24ba-4b0a-a448-a8872532bbc2_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_RegionalInternalRevenueOfficeofLombardyMember_c643dd39-ec0d-4073-832a-9d170560ae0a_terseLabel_en-US" xlink:label="lab_livn_RegionalInternalRevenueOfficeofLombardyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regional Internal Revenue Office of Lombardy</link:label>
    <link:label id="lab_livn_RegionalInternalRevenueOfficeofLombardyMember_label_en-US" xlink:label="lab_livn_RegionalInternalRevenueOfficeofLombardyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regional Internal Revenue Office of Lombardy [Member]</link:label>
    <link:label id="lab_livn_RegionalInternalRevenueOfficeofLombardyMember_documentation_en-US" xlink:label="lab_livn_RegionalInternalRevenueOfficeofLombardyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regional Internal Revenue Office of Lombardy [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_RegionalInternalRevenueOfficeofLombardyMember" xlink:href="livn-20200930.xsd#livn_RegionalInternalRevenueOfficeofLombardyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_RegionalInternalRevenueOfficeofLombardyMember" xlink:to="lab_livn_RegionalInternalRevenueOfficeofLombardyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f1b13486-3f46-4664-b6d4-ee9cc53f0af9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_7595c2b7-7686-4274-8dba-62b8c19b829c_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_2dbe2373-c4d5-45fe-bf2e-0d7ad79e422c_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_1f7e091b-6109-4c73-b3ab-1523cf89900c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_68488351-4e89-429e-b659-d605068789c7_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_RestructuringRelatedLiabilities_8222f940-4562-4100-8759-214c095191f1_terseLabel_en-US" xlink:label="lab_livn_RestructuringRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring related liabilities</link:label>
    <link:label id="lab_livn_RestructuringRelatedLiabilities_label_en-US" xlink:label="lab_livn_RestructuringRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related Liabilities</link:label>
    <link:label id="lab_livn_RestructuringRelatedLiabilities_documentation_en-US" xlink:label="lab_livn_RestructuringRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_RestructuringRelatedLiabilities" xlink:href="livn-20200930.xsd#livn_RestructuringRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_RestructuringRelatedLiabilities" xlink:to="lab_livn_RestructuringRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_f7e798d6-2803-44f1-8f1b-f305c04f7609_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_d8007256-e62c-4321-880b-10f953898065_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_367e2d52-e1a9-4c72-9ca1-52910523cebc_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring expenses</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_50ca8a57-dc25-4210-9d4c-019eb6083e69_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_64dc8b74-0131-4638-bd23-d218decb67e2_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_141ffa6a-9b21-430a-b929-e524354a669a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, net of settlement payment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_CardiopulmonaryMember_6c43fa2e-1425-467f-b127-e3e91d547008_terseLabel_en-US" xlink:label="lab_livn_CardiopulmonaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiopulmonary</link:label>
    <link:label id="lab_livn_CardiopulmonaryMember_label_en-US" xlink:label="lab_livn_CardiopulmonaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiopulmonary [Member]</link:label>
    <link:label id="lab_livn_CardiopulmonaryMember_documentation_en-US" xlink:label="lab_livn_CardiopulmonaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiopulmonary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CardiopulmonaryMember" xlink:href="livn-20200930.xsd#livn_CardiopulmonaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_CardiopulmonaryMember" xlink:to="lab_livn_CardiopulmonaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_DerivativeContractLiabilities_8f7cce61-6d29-4d05-bc48-d54866df8816_terseLabel_en-US" xlink:label="lab_livn_DerivativeContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative contract liabilities</link:label>
    <link:label id="lab_livn_DerivativeContractLiabilities_label_en-US" xlink:label="lab_livn_DerivativeContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract Liabilities</link:label>
    <link:label id="lab_livn_DerivativeContractLiabilities_documentation_en-US" xlink:label="lab_livn_DerivativeContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DerivativeContractLiabilities" xlink:href="livn-20200930.xsd#livn_DerivativeContractLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_DerivativeContractLiabilities" xlink:to="lab_livn_DerivativeContractLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_f7b75278-d9fa-4167-80aa-a0d0bdd5ba02_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of loss from accumulated other comprehensive loss, before tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_862d09c4-8d16-44ca-aac0-3178de37f92b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_c66fa418-cd04-4aee-80ca-53305d90fdae_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c614f992-76b1-4286-9f90-6d0f639e7933_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_8154db0a-a93d-46fa-9636-061ba9da230c_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_6ba8830e-28a5-4afa-a4a7-44341ae9aabe_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_NeuromodulationSegmentMember_991ded9a-1289-48ae-ad5d-4786e06a3ed1_terseLabel_en-US" xlink:label="lab_livn_NeuromodulationSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuromodulation</link:label>
    <link:label id="lab_livn_NeuromodulationSegmentMember_label_en-US" xlink:label="lab_livn_NeuromodulationSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuromodulation Segment [Member]</link:label>
    <link:label id="lab_livn_NeuromodulationSegmentMember_documentation_en-US" xlink:label="lab_livn_NeuromodulationSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuromodulation Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_NeuromodulationSegmentMember" xlink:href="livn-20200930.xsd#livn_NeuromodulationSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_NeuromodulationSegmentMember" xlink:to="lab_livn_NeuromodulationSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_b5596076-7f43-4921-b731-886e6b70e513_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableMember_a3f60354-094a-46e8-aea6-27785231ff93_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable</link:label>
    <link:label id="lab_us-gaap_NotesReceivableMember_label_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableMember" xlink:to="lab_us-gaap_NotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_45606bcb-fd0e-449a-8611-f082490e08d7_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_MeasurementInputStockPriceVolatilityMember_ac53d993-7b41-4b22-aa35-c2a35dcd9281_terseLabel_en-US" xlink:label="lab_livn_MeasurementInputStockPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Stock Price Volatility</link:label>
    <link:label id="lab_livn_MeasurementInputStockPriceVolatilityMember_label_en-US" xlink:label="lab_livn_MeasurementInputStockPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Stock Price Volatility [Member]</link:label>
    <link:label id="lab_livn_MeasurementInputStockPriceVolatilityMember_documentation_en-US" xlink:label="lab_livn_MeasurementInputStockPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Stock Price Volatility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MeasurementInputStockPriceVolatilityMember" xlink:href="livn-20200930.xsd#livn_MeasurementInputStockPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_MeasurementInputStockPriceVolatilityMember" xlink:to="lab_livn_MeasurementInputStockPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b239f0c3-818a-40ce-91d7-d39ee6677c5d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_c201e58e-73f6-471a-be35-7c0c89c2bffa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_e54929ba-d39b-4829-b1fe-dc1952d0a862_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of possible loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_0f011e44-b1b1-49a2-91e4-a047753d3ed9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price, percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_3b0be6de-85e5-4869-97ab-29d525818f3f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_8a2ff7df-ef90-4acb-ad0b-86949205ee4d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_5af8b118-c9af-4f61-9296-b77ffc0d9983_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_17013b8b-2538-40cc-bb94-a9e02ea3e10c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_eb6a72d1-2509-4a2d-b4b7-7190203f8153_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_43911c74-c14b-473b-906b-1d205f7875f6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_PaymentForDispositionOfBusinessClosingAdjustment_d55d943a-d250-4b44-b636-78928fb61178_negatedTerseLabel_en-US" xlink:label="lab_livn_PaymentForDispositionOfBusinessClosingAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing adjustment payment for sale of CRM business</link:label>
    <link:label id="lab_livn_PaymentForDispositionOfBusinessClosingAdjustment_label_en-US" xlink:label="lab_livn_PaymentForDispositionOfBusinessClosingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment For Disposition Of Business, Closing Adjustment</link:label>
    <link:label id="lab_livn_PaymentForDispositionOfBusinessClosingAdjustment_documentation_en-US" xlink:label="lab_livn_PaymentForDispositionOfBusinessClosingAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment For Disposition Of Business, Closing Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_PaymentForDispositionOfBusinessClosingAdjustment" xlink:href="livn-20200930.xsd#livn_PaymentForDispositionOfBusinessClosingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_PaymentForDispositionOfBusinessClosingAdjustment" xlink:to="lab_livn_PaymentForDispositionOfBusinessClosingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_e03dc396-71bd-412c-a2b0-73d17fba58ae_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of changes in foreign currency exchange rates</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_e1e315a6-0e93-4213-983f-994411187eb8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_8ac5aece-8967-48c1-b27d-f347e6a80b91_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_c9709121-f668-48bf-b907-dbe9fcc9d7ae_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Derivative Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments, Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:to="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ImTheraMedicalInc.Member_31d1a02a-554c-4533-9777-d5f05c830545_terseLabel_en-US" xlink:label="lab_livn_ImTheraMedicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ImThera</link:label>
    <link:label id="lab_livn_ImTheraMedicalInc.Member_label_en-US" xlink:label="lab_livn_ImTheraMedicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ImThera Medical, Inc. [Member]</link:label>
    <link:label id="lab_livn_ImTheraMedicalInc.Member_documentation_en-US" xlink:label="lab_livn_ImTheraMedicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ImThera Medical, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ImTheraMedicalInc.Member" xlink:href="livn-20200930.xsd#livn_ImTheraMedicalInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ImTheraMedicalInc.Member" xlink:to="lab_livn_ImTheraMedicalInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db12d679-b1a1-4e1a-b505-7e49d6da7165_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_9072f098-6e13-4148-ade9-d333bc0590a9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_DerivativeLiabilitiesNoncurrentMember_c4c40859-d050-4ff5-9bc0-e25b23c2bdac_terseLabel_en-US" xlink:label="lab_livn_DerivativeLiabilitiesNoncurrentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term derivative liability</link:label>
    <link:label id="lab_livn_DerivativeLiabilitiesNoncurrentMember_label_en-US" xlink:label="lab_livn_DerivativeLiabilitiesNoncurrentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liabilities, Noncurrent [Member]</link:label>
    <link:label id="lab_livn_DerivativeLiabilitiesNoncurrentMember_documentation_en-US" xlink:label="lab_livn_DerivativeLiabilitiesNoncurrentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DerivativeLiabilitiesNoncurrentMember" xlink:href="livn-20200930.xsd#livn_DerivativeLiabilitiesNoncurrentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_DerivativeLiabilitiesNoncurrentMember" xlink:to="lab_livn_DerivativeLiabilitiesNoncurrentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_04a7217b-1a0b-4dab-bd8d-2ad079aefac2_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Compensation Plan</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableGross_354f545a-b30e-4a1c-badf-9150f5aa8666_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable gross</link:label>
    <link:label id="lab_us-gaap_NotesReceivableGross_label_en-US" xlink:label="lab_us-gaap_NotesReceivableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableGross" xlink:to="lab_us-gaap_NotesReceivableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_DebtInstrumentCovenantMinimumProRataNetRevenues_d1fe9d93-a43e-4873-b19e-0a03d5319035_terseLabel_en-US" xlink:label="lab_livn_DebtInstrumentCovenantMinimumProRataNetRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum pro rata net revenue</link:label>
    <link:label id="lab_livn_DebtInstrumentCovenantMinimumProRataNetRevenues_label_en-US" xlink:label="lab_livn_DebtInstrumentCovenantMinimumProRataNetRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Minimum Pro Rata Net Revenues</link:label>
    <link:label id="lab_livn_DebtInstrumentCovenantMinimumProRataNetRevenues_documentation_en-US" xlink:label="lab_livn_DebtInstrumentCovenantMinimumProRataNetRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Minimum Pro Rata Net Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentCovenantMinimumProRataNetRevenues" xlink:href="livn-20200930.xsd#livn_DebtInstrumentCovenantMinimumProRataNetRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_DebtInstrumentCovenantMinimumProRataNetRevenues" xlink:to="lab_livn_DebtInstrumentCovenantMinimumProRataNetRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_16464a16-3321-46b2-a0ac-c2a86699cc9a_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_278424dc-87cf-4f8f-b491-40e6d55bf2ab_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (loss) income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bd408e6d-6caa-4159-8245-a0cd3f5c54ef_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_e9744f24-141b-4941-b09b-e3635eece1a8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductLiabilityContingencyTable_9602891c-9695-443d-8b0c-1da5d652c8f7_terseLabel_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_ProductLiabilityContingencyTable_label_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductLiabilityContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable" xlink:to="lab_us-gaap_ProductLiabilityContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_97513304-66c4-4bba-b6ce-b8bc26822fa9_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_3515c3dd-2ab5-4871-a342-949eb11ade1a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of changes in foreign currency exchange rates</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_59534233-c3e8-4b87-bc5c-604ac88e3171_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_5766a8f2-58e0-4be2-ba8b-06d2f640efb4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee share purchase plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_de65e766-d89a-41e2-9d94-9fefeea60794_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_OtherMember_3ffcbaf3-7cb3-46f7-b35d-c0b14ef59458_terseLabel_en-US" xlink:label="lab_livn_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_livn_OtherMember_label_en-US" xlink:label="lab_livn_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_livn_OtherMember_documentation_en-US" xlink:label="lab_livn_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_OtherMember" xlink:href="livn-20200930.xsd#livn_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_OtherMember" xlink:to="lab_livn_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_58cd695b-6e2c-4e23-b2e8-c86d782ec969_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in computing basic (loss) income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0b0dc193-5b4d-4a60-8074-2e74a2c6b307_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_553d2312-093b-423c-aa39-553d9ef879ef_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_660e00f8-56db-4543-8436-5aeebc9df7e3_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_f07231b5-1c02-4074-90ff-5191dfc539bb_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_cd4dcb81-104c-4431-ac0a-d8b361bd7fd0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued current and non-current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_68beaa00-002f-40f5-b5fc-dd7c482f1b23_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_35dd1ac7-afe1-4e65-afea-293b943d5869_terseLabel_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded exchange feature</link:label>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_label_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Derivative Financial Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:to="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_2e3925cb-e9f8-48e4-8345-9827c63eab3f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance and Other Termination Costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_8fbab325-e9b9-46a1-919b-d4dcbb816383_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_7b703c74-52b1-4c66-b7bd-9c228c558035_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_eec0d786-d997-496f-a6a6-d4de27828dfc_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unaudited Condensed Consolidated Financial Statements</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_0d9c9e0b-53a9-4da4-8f87-b4143859518a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dcb6c367-52c7-4692-b4c0-682351e9ebc6_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c5246c4c-e1b7-4083-9aba-94d442aba8da_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_eaf5bc93-eecc-4947-82e0-33668a7806d7_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e6c6b0ac-6fd3-4967-826b-c2505a34b47b_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_f069e1ac-a007-49fa-82df-0d385fe42e5a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_a1c6b990-c403-49fc-8151-afd6ddf3784e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_8c902cb0-1249-48a8-aea4-7f6b20194184_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities and other</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_aae6afb4-1a00-4c5b-b9d7-af15dad19c27_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_dddd75a9-89a9-41ac-a439-5cfbda6b1743_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_593827fb-87db-486d-87f6-5a02c457dfdb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_3c233071-a4db-417d-9d16-d67acf14cf94_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_MediocreditoItalianoMember_cbaf1832-e49b-474c-b06a-665c15811239_terseLabel_en-US" xlink:label="lab_livn_MediocreditoItalianoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mediocredito Italiano</link:label>
    <link:label id="lab_livn_MediocreditoItalianoMember_label_en-US" xlink:label="lab_livn_MediocreditoItalianoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mediocredito Italiano [Member]</link:label>
    <link:label id="lab_livn_MediocreditoItalianoMember_documentation_en-US" xlink:label="lab_livn_MediocreditoItalianoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mediocredito Italiano [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MediocreditoItalianoMember" xlink:href="livn-20200930.xsd#livn_MediocreditoItalianoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_MediocreditoItalianoMember" xlink:to="lab_livn_MediocreditoItalianoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_8cd48411-9f8d-48d3-b78f-dedc45696f1b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_IncomeTaxExaminationOperatingLossesUnderDispute_300729c9-3254-45c1-8f87-9cd7205caf11_terseLabel_en-US" xlink:label="lab_livn_IncomeTaxExaminationOperatingLossesUnderDispute" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses under dispute</link:label>
    <link:label id="lab_livn_IncomeTaxExaminationOperatingLossesUnderDispute_label_en-US" xlink:label="lab_livn_IncomeTaxExaminationOperatingLossesUnderDispute" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Operating Losses Under Dispute</link:label>
    <link:label id="lab_livn_IncomeTaxExaminationOperatingLossesUnderDispute_documentation_en-US" xlink:label="lab_livn_IncomeTaxExaminationOperatingLossesUnderDispute" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Operating Losses Under Dispute</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_IncomeTaxExaminationOperatingLossesUnderDispute" xlink:href="livn-20200930.xsd#livn_IncomeTaxExaminationOperatingLossesUnderDispute"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_IncomeTaxExaminationOperatingLossesUnderDispute" xlink:to="lab_livn_IncomeTaxExaminationOperatingLossesUnderDispute" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ValuationTechniqueMonteCarloSimulationMember_b7818705-0592-45e3-81e5-40b619678575_terseLabel_en-US" xlink:label="lab_livn_ValuationTechniqueMonteCarloSimulationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monte Carlo simulation</link:label>
    <link:label id="lab_livn_ValuationTechniqueMonteCarloSimulationMember_label_en-US" xlink:label="lab_livn_ValuationTechniqueMonteCarloSimulationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Monte Carlo Simulation [Member]</link:label>
    <link:label id="lab_livn_ValuationTechniqueMonteCarloSimulationMember_documentation_en-US" xlink:label="lab_livn_ValuationTechniqueMonteCarloSimulationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Monte Carlo Simulation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ValuationTechniqueMonteCarloSimulationMember" xlink:href="livn-20200930.xsd#livn_ValuationTechniqueMonteCarloSimulationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ValuationTechniqueMonteCarloSimulationMember" xlink:to="lab_livn_ValuationTechniqueMonteCarloSimulationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_1f68dda1-1c70-408c-8ef9-5afe682f8c19_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Tax Effect of Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:to="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_f6384e2f-f95b-47e3-a4c1-1e67b91d1269_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_a427b94a-fc5a-4bdd-ad1c-81569671f8ac_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Beginning and Ending Balances of Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_051e95a2-2d18-48a1-bca9-0d4fbcf784d8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_2d73cae0-ce4b-4bcc-bbf2-484766cccbdf_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term facilities</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_35f969a9-ed84-4f9b-9445-4f676f4cd632_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_86943b41-634b-4e95-ac5c-9c4d30b1bb12_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_1bce407f-a0d5-4b5d-a8b3-d1e8698dd9f4_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_134537e1-41d5-41ff-b166-aabc953de59b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current and non-current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ThreatenedLitigationMember_39bc37df-907e-4f96-8032-1b17acf8a300_terseLabel_en-US" xlink:label="lab_us-gaap_ThreatenedLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threatened Litigation</link:label>
    <link:label id="lab_us-gaap_ThreatenedLitigationMember_label_en-US" xlink:label="lab_us-gaap_ThreatenedLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threatened Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ThreatenedLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ThreatenedLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ThreatenedLitigationMember" xlink:to="lab_us-gaap_ThreatenedLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_74bc8aab-24e2-425a-8a96-22ae0bd358b8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_df52a448-7d3d-401f-a18b-283a8721d7d4_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_d1c788ea-f634-4c85-a89e-c903e17f570f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liability derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_9c816fd5-f8f2-45d0-a5ea-b2ff66c123e9_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_196a8fbd-0fbe-4934-b95b-ffa59a615583_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member_a9240a66-e263-42c4-b768-9dfae06fd2b4_terseLabel_en-US" xlink:label="lab_livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank of America Merrill Lynch Banco M&#250;ltiplo S.A.</link:label>
    <link:label id="lab_livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member_label_en-US" xlink:label="lab_livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank of America Merrill Lynch Banco Multiplo S.A. [Member]</link:label>
    <link:label id="lab_livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member_documentation_en-US" xlink:label="lab_livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank of America Merrill Lynch Banco Multiplo S.A. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member" xlink:href="livn-20200930.xsd#livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member" xlink:to="lab_livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_aa95983f-89e4-4673-a60d-ea47c4e6728b_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_136789a5-bf50-4599-afb7-4d4fb33b5d5e_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_917e894d-0f0b-40dd-a232-2dbb9e1a246c_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_MeasurementInputRevenueVolatilityMember_2544b291-6552-487e-ac42-8bcd85ce0fbb_terseLabel_en-US" xlink:label="lab_livn_MeasurementInputRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue volatility</link:label>
    <link:label id="lab_livn_MeasurementInputRevenueVolatilityMember_label_en-US" xlink:label="lab_livn_MeasurementInputRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Revenue Volatility [Member]</link:label>
    <link:label id="lab_livn_MeasurementInputRevenueVolatilityMember_documentation_en-US" xlink:label="lab_livn_MeasurementInputRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Revenue Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MeasurementInputRevenueVolatilityMember" xlink:href="livn-20200930.xsd#livn_MeasurementInputRevenueVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_MeasurementInputRevenueVolatilityMember" xlink:to="lab_livn_MeasurementInputRevenueVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_5b22e820-8787-4ba6-9266-d779e3ee3065_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_1a76b33a-da25-4d31-bca1-0bcc0fa8c064_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_cf974d65-7461-4215-a8c3-a599f8f2584a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_910c0f5e-1ef0-434f-b71d-77712e6aa718_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_dc120b37-76ff-487e-a5b2-0588e65ae468_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_cab9638f-63db-443d-b540-6c9103e4b53c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_96170d58-01b5-42c2-93df-08c44abfbf65_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_0ee9b806-aa31-4f9d-81c2-11b52eb24298_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_94bb12c1-dd7f-4de8-a4f9-b1a1865186e9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_29466145-dc76-46e2-b50b-8670201b21f4_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInRestructuringReserve_770f3b71-128a-45ba-b3b0-7fd602cc070b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInRestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInRestructuringReserve_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInRestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInRestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInRestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInRestructuringReserve" xlink:to="lab_us-gaap_IncreaseDecreaseInRestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_638c7069-d9aa-4d6b-8e20-2f86103d8e9e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Expense by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ProductRemediationExpense_c1c67051-3b0f-4482-8231-24c9f78930a3_terseLabel_en-US" xlink:label="lab_livn_ProductRemediationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product remediation</link:label>
    <link:label id="lab_livn_ProductRemediationExpense_9461e740-0c43-4632-b2e6-9ab8747a2667_verboseLabel_en-US" xlink:label="lab_livn_ProductRemediationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product remediation expense</link:label>
    <link:label id="lab_livn_ProductRemediationExpense_label_en-US" xlink:label="lab_livn_ProductRemediationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation Expense</link:label>
    <link:label id="lab_livn_ProductRemediationExpense_documentation_en-US" xlink:label="lab_livn_ProductRemediationExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationExpense" xlink:href="livn-20200930.xsd#livn_ProductRemediationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ProductRemediationExpense" xlink:to="lab_livn_ProductRemediationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_827ccfef-d5d8-4d64-ad5a-cb433cd3d55c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_8beaabe1-1be5-47ed-80a2-2f94492e43b4_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_6461750c-849d-437a-bc08-bc109c29e7d2_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income before reclassifications, before tax</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_73817b1e-b196-4e26-bf6c-51e021e84a43_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentContinuingOperationsMember_ff8264e4-e7ed-44e4-8ecb-2dea538de2da_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentContinuingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing Operations</link:label>
    <link:label id="lab_us-gaap_SegmentContinuingOperationsMember_label_en-US" xlink:label="lab_us-gaap_SegmentContinuingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentContinuingOperationsMember" xlink:to="lab_us-gaap_SegmentContinuingOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_01b657d7-dbf4-4c1a-991b-e25e9d234833_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock at cost, 806,211 ordinary shares at September 30, 2020; 967,186 ordinary shares at December 31, 2019</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_5b3c085a-b6e3-4452-a3bf-e23167450603_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_935202dc-6145-4310-9ecb-9b5e891674cc_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_148f3d0c-7bc9-4f86-b584-0393312b914e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_livn_ForeignExchangeandOtherMember_02c7be2e-231c-4944-ace9-0790eace61e5_terseLabel_en-US" xlink:label="lab_livn_ForeignExchangeandOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange and other gains (losses)</link:label>
    <link:label id="lab_livn_ForeignExchangeandOtherMember_label_en-US" xlink:label="lab_livn_ForeignExchangeandOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange and Other [Member]</link:label>
    <link:label id="lab_livn_ForeignExchangeandOtherMember_documentation_en-US" xlink:label="lab_livn_ForeignExchangeandOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ForeignExchangeandOtherMember" xlink:href="livn-20200930.xsd#livn_ForeignExchangeandOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_livn_ForeignExchangeandOtherMember" xlink:to="lab_livn_ForeignExchangeandOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_c64c8e07-b978-49a4-a0af-3258d8521d51_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_62b5597f-3949-475b-a2b8-1439a4737986_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fa136d00-47ba-4476-a0e2-c369531ee5ad_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption of New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_8637abf6-f75d-4673-8e0d-45e28870f917_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_ddceddb2-5ef3-4f22-91de-8528a9f5fd6d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_5da03333-a5bc-4694-af3b-e9217cb58b95_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (loss) income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>livn-20200930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:152b0760-94f0-4bb0-b0a2-1db31ab2058d,g:fb466a4e-c2f9-40f5-a132-8d0db9b26e35-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CoverPage" xlink:type="simple" xlink:href="livn-20200930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_3b0518f2-9261-419a-a47f-76d242b094a4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_DocumentType_3b0518f2-9261-419a-a47f-76d242b094a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_4f114436-c680-4620-8b5a-772b83b23bec" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_DocumentQuarterlyReport_4f114436-c680-4620-8b5a-772b83b23bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d3284fbf-1d3b-4e35-a59b-3540e5ed83b6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_DocumentPeriodEndDate_d3284fbf-1d3b-4e35-a59b-3540e5ed83b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_d6ac5b43-e23a-49cb-a37c-4b21f7bf8964" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_DocumentTransitionReport_d6ac5b43-e23a-49cb-a37c-4b21f7bf8964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_2e8637b1-5294-4f54-9634-d131fe9fbf5f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_EntityFileNumber_2e8637b1-5294-4f54-9634-d131fe9fbf5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b24bdecf-e23a-49da-9db9-0b8b497f537c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_EntityRegistrantName_b24bdecf-e23a-49da-9db9-0b8b497f537c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7e61c426-8333-4a53-b16b-35298aac56d7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7e61c426-8333-4a53-b16b-35298aac56d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_c8cab8c9-b60b-4a3d-a709-d41872e9cfe4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_EntityTaxIdentificationNumber_c8cab8c9-b60b-4a3d-a709-d41872e9cfe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_c1999a24-7abe-4b7d-b371-c73fec7cca55" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_EntityAddressAddressLine1_c1999a24-7abe-4b7d-b371-c73fec7cca55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2e05700c-f901-4510-9b15-b69d2279c0ce" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_EntityAddressCityOrTown_2e05700c-f901-4510-9b15-b69d2279c0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_8b00aa55-532a-453d-8ce9-85cdd50f8071" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_EntityAddressCountry_8b00aa55-532a-453d-8ce9-85cdd50f8071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9e294229-62b1-43e5-8053-93c91c01b05b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_EntityAddressPostalZipCode_9e294229-62b1-43e5-8053-93c91c01b05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_1c35413d-eb41-4748-9695-ccbcb575c97f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_CountryRegion_1c35413d-eb41-4748-9695-ccbcb575c97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_bb02ef4d-9cce-47e3-a033-49e551640b04" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_CityAreaCode_bb02ef4d-9cce-47e3-a033-49e551640b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_aac24d37-baa7-49ab-9ccf-69c14485aeff" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_LocalPhoneNumber_aac24d37-baa7-49ab-9ccf-69c14485aeff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0cec324e-1017-449d-b813-ed11f6db2d97" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_Security12bTitle_0cec324e-1017-449d-b813-ed11f6db2d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_33b1deea-2e7f-4a08-ad49-cdc64aa6c404" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_TradingSymbol_33b1deea-2e7f-4a08-ad49-cdc64aa6c404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_aa3d633f-218a-47e0-b8c4-86ff2e0ffbbc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_SecurityExchangeName_aa3d633f-218a-47e0-b8c4-86ff2e0ffbbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_8345bf18-b73e-474b-b691-dd10b4eab806" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_EntityCurrentReportingStatus_8345bf18-b73e-474b-b691-dd10b4eab806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_1743944e-3bd7-45b0-86c5-89a33b2aae10" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_EntityInteractiveDataCurrent_1743944e-3bd7-45b0-86c5-89a33b2aae10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_15947668-af95-4776-a05e-fcafb8010077" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_EntityFilerCategory_15947668-af95-4776-a05e-fcafb8010077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_0b863613-f721-40b0-bbb4-5745f0c9b703" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_EntitySmallBusiness_0b863613-f721-40b0-bbb4-5745f0c9b703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_a42b9efc-89d7-4b52-95db-035a9c7a6780" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_EntityEmergingGrowthCompany_a42b9efc-89d7-4b52-95db-035a9c7a6780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_ed019e6d-600c-4488-ba3c-53e8479aa4e0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_EntityShellCompany_ed019e6d-600c-4488-ba3c-53e8479aa4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_4844f294-d944-4dd2-886f-99d885af02e7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_4844f294-d944-4dd2-886f-99d885af02e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e72eaa03-a990-4619-8f9d-536e0ae98b84" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_AmendmentFlag_e72eaa03-a990-4619-8f9d-536e0ae98b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_7752e2bb-21be-4f53-827b-56449befec2e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_DocumentFiscalYearFocus_7752e2bb-21be-4f53-827b-56449befec2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_bd4c801e-3cd2-4d9e-9b56-5bf55ad7724f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_DocumentFiscalPeriodFocus_bd4c801e-3cd2-4d9e-9b56-5bf55ad7724f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_46b76ee1-251b-4f55-9017-de89f631a3e9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_EntityCentralIndexKey_46b76ee1-251b-4f55-9017-de89f631a3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_15764913-9d0b-4e60-8ea2-24878ee00581" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec265346-5cc1-4177-90a8-2f66382c5a19" xlink:to="loc_dei_CurrentFiscalYearEndDate_15764913-9d0b-4e60-8ea2-24878ee00581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss" xlink:type="simple" xlink:href="livn-20200930.xsd#CondensedConsolidatedStatementsofIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_8f2fec3b-d3c4-44c7-a925-de6f124a7429" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a8aa2332-0a8a-45e0-8f9f-3583f228c200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8f2fec3b-d3c4-44c7-a925-de6f124a7429" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a8aa2332-0a8a-45e0-8f9f-3583f228c200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_d843667e-bfeb-4350-8435-36a6d30c83ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8f2fec3b-d3c4-44c7-a925-de6f124a7429" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_d843667e-bfeb-4350-8435-36a6d30c83ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3933d1d8-3131-440e-a5da-f4c9bc07d0a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d843667e-bfeb-4350-8435-36a6d30c83ba" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3933d1d8-3131-440e-a5da-f4c9bc07d0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationExpense_485d112d-1893-43aa-a868-67ce1aa460cf" xlink:href="livn-20200930.xsd#livn_ProductRemediationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d843667e-bfeb-4350-8435-36a6d30c83ba" xlink:to="loc_livn_ProductRemediationExpense_485d112d-1893-43aa-a868-67ce1aa460cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3655aff5-a320-4b55-ae1e-315b5772ce56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d843667e-bfeb-4350-8435-36a6d30c83ba" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3655aff5-a320-4b55-ae1e-315b5772ce56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_3aa43b6d-0325-453e-988b-d6d56d14363a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d843667e-bfeb-4350-8435-36a6d30c83ba" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_3aa43b6d-0325-453e-988b-d6d56d14363a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_1f6a70e8-f18a-40ca-af72-984dc5f88458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d843667e-bfeb-4350-8435-36a6d30c83ba" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_1f6a70e8-f18a-40ca-af72-984dc5f88458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_1dc31b81-b892-4e28-8e83-dc281cc09e46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d843667e-bfeb-4350-8435-36a6d30c83ba" xlink:to="loc_us-gaap_RestructuringCharges_1dc31b81-b892-4e28-8e83-dc281cc09e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_5c7c9962-5f26-451b-b091-ab419646f6aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d843667e-bfeb-4350-8435-36a6d30c83ba" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_5c7c9962-5f26-451b-b091-ab419646f6aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d7391c8f-3812-483e-9a04-6425facee654" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d843667e-bfeb-4350-8435-36a6d30c83ba" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d7391c8f-3812-483e-9a04-6425facee654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_1d192265-6278-4bde-b6a9-60b839670d23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d843667e-bfeb-4350-8435-36a6d30c83ba" xlink:to="loc_us-gaap_LitigationSettlementExpense_1d192265-6278-4bde-b6a9-60b839670d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2a1e7c29-054a-4f59-85c4-05a2bea133ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d843667e-bfeb-4350-8435-36a6d30c83ba" xlink:to="loc_us-gaap_OperatingIncomeLoss_2a1e7c29-054a-4f59-85c4-05a2bea133ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_4e39233e-4fa4-4b52-a1d0-18b16210de12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8f2fec3b-d3c4-44c7-a925-de6f124a7429" xlink:to="loc_us-gaap_InvestmentIncomeInterest_4e39233e-4fa4-4b52-a1d0-18b16210de12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_678816d2-7445-4b44-a474-a540c4fc785d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8f2fec3b-d3c4-44c7-a925-de6f124a7429" xlink:to="loc_us-gaap_InterestExpense_678816d2-7445-4b44-a474-a540c4fc785d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome_83d75415-b58f-4982-b15b-4adf9c5cf829" xlink:href="livn-20200930.xsd#livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8f2fec3b-d3c4-44c7-a925-de6f124a7429" xlink:to="loc_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome_83d75415-b58f-4982-b15b-4adf9c5cf829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f13455a6-6601-4220-bc48-498cbb324a5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8f2fec3b-d3c4-44c7-a925-de6f124a7429" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f13455a6-6601-4220-bc48-498cbb324a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_83d3f3fa-2926-4668-96c3-d79078336f09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8f2fec3b-d3c4-44c7-a925-de6f124a7429" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_83d3f3fa-2926-4668-96c3-d79078336f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ed2f65b0-e807-4d93-bcba-9b8ec6d861b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8f2fec3b-d3c4-44c7-a925-de6f124a7429" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ed2f65b0-e807-4d93-bcba-9b8ec6d861b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_5f323483-1201-42bb-94ec-e675377a0f53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8f2fec3b-d3c4-44c7-a925-de6f124a7429" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_5f323483-1201-42bb-94ec-e675377a0f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_581e71b4-e950-40cd-9c94-17cdaec15f3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8f2fec3b-d3c4-44c7-a925-de6f124a7429" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_581e71b4-e950-40cd-9c94-17cdaec15f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_788b0b77-6e8f-4a8e-86f6-eea58d759b7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8f2fec3b-d3c4-44c7-a925-de6f124a7429" xlink:to="loc_us-gaap_NetIncomeLoss_788b0b77-6e8f-4a8e-86f6-eea58d759b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_ba8fa9c3-fe46-4a9d-a6d6-314852404dba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8f2fec3b-d3c4-44c7-a925-de6f124a7429" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_ba8fa9c3-fe46-4a9d-a6d6-314852404dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_59b7b9fd-0756-44bd-ac0f-0d3fd95d9e13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_ba8fa9c3-fe46-4a9d-a6d6-314852404dba" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_59b7b9fd-0756-44bd-ac0f-0d3fd95d9e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_72f1484c-2c23-4294-a49b-35711c847e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_ba8fa9c3-fe46-4a9d-a6d6-314852404dba" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_72f1484c-2c23-4294-a49b-35711c847e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_72f48a23-b248-41d2-931c-9bc7da016e27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_ba8fa9c3-fe46-4a9d-a6d6-314852404dba" xlink:to="loc_us-gaap_EarningsPerShareBasic_72f48a23-b248-41d2-931c-9bc7da016e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_5e9eca7b-108c-4177-8409-8198b744a01d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8f2fec3b-d3c4-44c7-a925-de6f124a7429" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_5e9eca7b-108c-4177-8409-8198b744a01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_36aab5c5-7df8-480b-994e-7be04e12684f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5e9eca7b-108c-4177-8409-8198b744a01d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_36aab5c5-7df8-480b-994e-7be04e12684f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_e3d6b867-4ab7-4119-99bd-7de50c2fbc65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5e9eca7b-108c-4177-8409-8198b744a01d" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_e3d6b867-4ab7-4119-99bd-7de50c2fbc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_673f6db0-67d7-4d54-89dc-6c442c6cdffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5e9eca7b-108c-4177-8409-8198b744a01d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_673f6db0-67d7-4d54-89dc-6c442c6cdffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7f9fe3a8-c1ad-4485-b298-ea58dd13c69b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8f2fec3b-d3c4-44c7-a925-de6f124a7429" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7f9fe3a8-c1ad-4485-b298-ea58dd13c69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9da29777-618f-4f42-ad05-b39e524c17d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8f2fec3b-d3c4-44c7-a925-de6f124a7429" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9da29777-618f-4f42-ad05-b39e524c17d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="livn-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_56a42b9f-e3d1-4a55-95a4-2d01660213a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cf08af27-6674-451f-879f-564cbbd9bb4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_56a42b9f-e3d1-4a55-95a4-2d01660213a4" xlink:to="loc_us-gaap_NetIncomeLoss_cf08af27-6674-451f-879f-564cbbd9bb4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_92068f28-818f-4fee-8138-f4f88d5c5f4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_56a42b9f-e3d1-4a55-95a4-2d01660213a4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_92068f28-818f-4fee-8138-f4f88d5c5f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_029dfe20-bc2a-4040-b7b0-718f2e1b3119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_92068f28-818f-4fee-8138-f4f88d5c5f4a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_029dfe20-bc2a-4040-b7b0-718f2e1b3119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_1d62a6b3-f3a7-44d1-bedb-c3d6d8983930" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_92068f28-818f-4fee-8138-f4f88d5c5f4a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_1d62a6b3-f3a7-44d1-bedb-c3d6d8983930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_123df820-2251-465e-a044-8f26d850c7f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_92068f28-818f-4fee-8138-f4f88d5c5f4a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_123df820-2251-465e-a044-8f26d850c7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2fe9990d-2d4d-4c04-8f04-1745de765390" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_92068f28-818f-4fee-8138-f4f88d5c5f4a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2fe9990d-2d4d-4c04-8f04-1745de765390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9d54b89c-77b2-4cc0-b99b-fc73c4b69a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_92068f28-818f-4fee-8138-f4f88d5c5f4a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9d54b89c-77b2-4cc0-b99b-fc73c4b69a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_cf03a563-a02b-420d-a0b1-a9cd1bbea9ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_56a42b9f-e3d1-4a55-95a4-2d01660213a4" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_cf03a563-a02b-420d-a0b1-a9cd1bbea9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="livn-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d056cc6b-adac-4063-8fda-849cb29a2e11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_3413e921-b2df-4b17-bd5a-ea70659041f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d056cc6b-adac-4063-8fda-849cb29a2e11" xlink:to="loc_us-gaap_AssetsAbstract_3413e921-b2df-4b17-bd5a-ea70659041f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_eb96d7ec-2bb7-46aa-be5b-9da29afaccf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3413e921-b2df-4b17-bd5a-ea70659041f1" xlink:to="loc_us-gaap_AssetsCurrentAbstract_eb96d7ec-2bb7-46aa-be5b-9da29afaccf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_071d1ab8-ae27-418b-89d8-6ac107bc8ad9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_eb96d7ec-2bb7-46aa-be5b-9da29afaccf8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_071d1ab8-ae27-418b-89d8-6ac107bc8ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_99a816dd-2aee-4ee4-879c-b0b35fc89659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_eb96d7ec-2bb7-46aa-be5b-9da29afaccf8" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_99a816dd-2aee-4ee4-879c-b0b35fc89659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1162ca1a-571c-4c24-939b-d4a6fb7f85e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_eb96d7ec-2bb7-46aa-be5b-9da29afaccf8" xlink:to="loc_us-gaap_InventoryNet_1162ca1a-571c-4c24-939b-d4a6fb7f85e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_888dc080-979c-4700-84c2-5c1b5aaa10d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_eb96d7ec-2bb7-46aa-be5b-9da29afaccf8" xlink:to="loc_us-gaap_PrepaidTaxes_888dc080-979c-4700-84c2-5c1b5aaa10d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_daa41b4a-bf9c-4933-bacc-b5892720f881" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_eb96d7ec-2bb7-46aa-be5b-9da29afaccf8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_daa41b4a-bf9c-4933-bacc-b5892720f881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_674a2963-bde8-4c19-8a65-edf618a074e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_eb96d7ec-2bb7-46aa-be5b-9da29afaccf8" xlink:to="loc_us-gaap_AssetsCurrent_674a2963-bde8-4c19-8a65-edf618a074e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_41454f24-fc4c-422b-ae96-4dcd96f025b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3413e921-b2df-4b17-bd5a-ea70659041f1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_41454f24-fc4c-422b-ae96-4dcd96f025b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2767a47b-3cd3-4f0c-875d-6a1e1c5cd490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3413e921-b2df-4b17-bd5a-ea70659041f1" xlink:to="loc_us-gaap_Goodwill_2767a47b-3cd3-4f0c-875d-6a1e1c5cd490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_861821e0-38b7-41f9-81a0-7c2351653ba4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3413e921-b2df-4b17-bd5a-ea70659041f1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_861821e0-38b7-41f9-81a0-7c2351653ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b6616198-83cf-4c82-afaa-55861d1ea65a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3413e921-b2df-4b17-bd5a-ea70659041f1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b6616198-83cf-4c82-afaa-55861d1ea65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_92024c13-d042-4c2e-b9ee-65a4787ff026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3413e921-b2df-4b17-bd5a-ea70659041f1" xlink:to="loc_us-gaap_Investments_92024c13-d042-4c2e-b9ee-65a4787ff026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_c8baaa2c-1cca-40a1-9e1a-372cdb8c3892" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3413e921-b2df-4b17-bd5a-ea70659041f1" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_c8baaa2c-1cca-40a1-9e1a-372cdb8c3892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d0a8aa4b-84aa-4796-919d-ece425388dff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3413e921-b2df-4b17-bd5a-ea70659041f1" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d0a8aa4b-84aa-4796-919d-ece425388dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_cc89a67e-ca99-4ae7-b22d-d03168765d71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3413e921-b2df-4b17-bd5a-ea70659041f1" xlink:to="loc_us-gaap_Assets_cc89a67e-ca99-4ae7-b22d-d03168765d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbe7ae53-b5fa-45ff-85c5-76c532978856" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d056cc6b-adac-4063-8fda-849cb29a2e11" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbe7ae53-b5fa-45ff-85c5-76c532978856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_ffaf05d2-8e29-40ba-82b9-b16e37b96f12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbe7ae53-b5fa-45ff-85c5-76c532978856" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_ffaf05d2-8e29-40ba-82b9-b16e37b96f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_b6ed0646-c770-47d7-a795-f68cbee24d3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ffaf05d2-8e29-40ba-82b9-b16e37b96f12" xlink:to="loc_us-gaap_DebtCurrent_b6ed0646-c770-47d7-a795-f68cbee24d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_13056a0a-94bd-44ca-9c45-a8e49b0da1c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ffaf05d2-8e29-40ba-82b9-b16e37b96f12" xlink:to="loc_us-gaap_AccountsPayableCurrent_13056a0a-94bd-44ca-9c45-a8e49b0da1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_1e687c57-ae38-4efd-b60f-97a5347adf9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ffaf05d2-8e29-40ba-82b9-b16e37b96f12" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_1e687c57-ae38-4efd-b60f-97a5347adf9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_5ce59469-a412-4b6a-aeca-7c20cb487e47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ffaf05d2-8e29-40ba-82b9-b16e37b96f12" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_5ce59469-a412-4b6a-aeca-7c20cb487e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_e97fd7ab-fcae-4617-a77c-d099d23f2be6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ffaf05d2-8e29-40ba-82b9-b16e37b96f12" xlink:to="loc_us-gaap_TaxesPayableCurrent_e97fd7ab-fcae-4617-a77c-d099d23f2be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d44db71f-3f9b-4159-ad64-b85097458d40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ffaf05d2-8e29-40ba-82b9-b16e37b96f12" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d44db71f-3f9b-4159-ad64-b85097458d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_54452e59-2634-476a-8c66-78ad0c5e648f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ffaf05d2-8e29-40ba-82b9-b16e37b96f12" xlink:to="loc_us-gaap_LiabilitiesCurrent_54452e59-2634-476a-8c66-78ad0c5e648f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_b77b0919-5065-402d-85ad-e486f56d9493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbe7ae53-b5fa-45ff-85c5-76c532978856" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_b77b0919-5065-402d-85ad-e486f56d9493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f7a25d1d-d14b-4361-8b4b-6229db742133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbe7ae53-b5fa-45ff-85c5-76c532978856" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f7a25d1d-d14b-4361-8b4b-6229db742133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_3e8a538b-910d-4b0d-a1a8-44bc82145db6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbe7ae53-b5fa-45ff-85c5-76c532978856" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_3e8a538b-910d-4b0d-a1a8-44bc82145db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0314066b-0a5c-49f9-8e2e-e5070d4b38c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbe7ae53-b5fa-45ff-85c5-76c532978856" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0314066b-0a5c-49f9-8e2e-e5070d4b38c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3061335f-6787-4c0b-8fdc-02513dfca5fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbe7ae53-b5fa-45ff-85c5-76c532978856" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3061335f-6787-4c0b-8fdc-02513dfca5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_a0ade736-ba39-49c5-ba9f-f8efdf3653f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbe7ae53-b5fa-45ff-85c5-76c532978856" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_a0ade736-ba39-49c5-ba9f-f8efdf3653f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_dbcc65d2-411e-402f-ad82-fedba6d3058f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbe7ae53-b5fa-45ff-85c5-76c532978856" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_dbcc65d2-411e-402f-ad82-fedba6d3058f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ab176bd9-974f-44ab-9750-aa8644264f9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbe7ae53-b5fa-45ff-85c5-76c532978856" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ab176bd9-974f-44ab-9750-aa8644264f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ef8e8775-ed90-4415-a80e-ecf8645e1a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbe7ae53-b5fa-45ff-85c5-76c532978856" xlink:to="loc_us-gaap_Liabilities_ef8e8775-ed90-4415-a80e-ecf8645e1a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_562f1a03-616f-44e6-82ee-ab32f3477762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbe7ae53-b5fa-45ff-85c5-76c532978856" xlink:to="loc_us-gaap_CommitmentsAndContingencies_562f1a03-616f-44e6-82ee-ab32f3477762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_3e197d4e-a5a0-4d42-a7d0-f3d2724fc76e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbe7ae53-b5fa-45ff-85c5-76c532978856" xlink:to="loc_us-gaap_StockholdersEquityAbstract_3e197d4e-a5a0-4d42-a7d0-f3d2724fc76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_14847435-60c0-47ea-bb9b-be931a526cfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e197d4e-a5a0-4d42-a7d0-f3d2724fc76e" xlink:to="loc_us-gaap_CommonStockValue_14847435-60c0-47ea-bb9b-be931a526cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5c753489-67ef-42f6-b1d7-0e1f19241baa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e197d4e-a5a0-4d42-a7d0-f3d2724fc76e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5c753489-67ef-42f6-b1d7-0e1f19241baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5e009a59-c7be-49f5-800e-cabbcf661968" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e197d4e-a5a0-4d42-a7d0-f3d2724fc76e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5e009a59-c7be-49f5-800e-cabbcf661968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4f4ac7f1-ffd0-48a3-a6ea-839586b47833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e197d4e-a5a0-4d42-a7d0-f3d2724fc76e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4f4ac7f1-ffd0-48a3-a6ea-839586b47833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_0e9e084e-5338-4b2d-9cc3-4d7c6b9e269b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e197d4e-a5a0-4d42-a7d0-f3d2724fc76e" xlink:to="loc_us-gaap_TreasuryStockValue_0e9e084e-5338-4b2d-9cc3-4d7c6b9e269b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7356a622-697a-491e-a5c2-b8e64e723322" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e197d4e-a5a0-4d42-a7d0-f3d2724fc76e" xlink:to="loc_us-gaap_StockholdersEquity_7356a622-697a-491e-a5c2-b8e64e723322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f9dd40e3-bffe-4da0-b24a-b5c925d402c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbe7ae53-b5fa-45ff-85c5-76c532978856" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_f9dd40e3-bffe-4da0-b24a-b5c925d402c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="livn-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_9cd2c829-749f-49df-ba6f-18799c3ae6d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_27158a79-f150-4f54-9b51-662faeca33db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9cd2c829-749f-49df-ba6f-18799c3ae6d7" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_27158a79-f150-4f54-9b51-662faeca33db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_dee1d04a-e239-4c08-b099-835d886d756a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9cd2c829-749f-49df-ba6f-18799c3ae6d7" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_dee1d04a-e239-4c08-b099-835d886d756a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_daf6d9d4-d17b-433e-aedc-f306f3166f74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9cd2c829-749f-49df-ba6f-18799c3ae6d7" xlink:to="loc_us-gaap_CommonStockSharesIssued_daf6d9d4-d17b-433e-aedc-f306f3166f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9ccdd2e8-5228-4f85-bcca-ac4b9f0e3cb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9cd2c829-749f-49df-ba6f-18799c3ae6d7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_9ccdd2e8-5228-4f85-bcca-ac4b9f0e3cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_3fe738e6-df6c-4c34-b09d-8186d93a279d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9cd2c829-749f-49df-ba6f-18799c3ae6d7" xlink:to="loc_us-gaap_TreasuryStockShares_3fe738e6-df6c-4c34-b09d-8186d93a279d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="livn-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_ed086d30-f928-4c4e-865b-7309de4e9bff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_493c7005-9edc-4c6a-848c-274e36c04634" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ed086d30-f928-4c4e-865b-7309de4e9bff" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_493c7005-9edc-4c6a-848c-274e36c04634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4c38a5c3-6fd3-4abb-9520-5822083e316d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_493c7005-9edc-4c6a-848c-274e36c04634" xlink:to="loc_us-gaap_NetIncomeLoss_4c38a5c3-6fd3-4abb-9520-5822083e316d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4f2e2c09-5ed2-4f98-8bc6-becc0da134cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_493c7005-9edc-4c6a-848c-274e36c04634" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4f2e2c09-5ed2-4f98-8bc6-becc0da134cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bbd57e42-88ff-4e32-94af-b297c4986a92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4f2e2c09-5ed2-4f98-8bc6-becc0da134cb" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bbd57e42-88ff-4e32-94af-b297c4986a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a8d7e334-419a-497b-8293-cf9d38a98e23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4f2e2c09-5ed2-4f98-8bc6-becc0da134cb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a8d7e334-419a-497b-8293-cf9d38a98e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_3b79ea0a-b3ca-4b35-8922-0d419882cbb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4f2e2c09-5ed2-4f98-8bc6-becc0da134cb" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_3b79ea0a-b3ca-4b35-8922-0d419882cbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2625ce71-5f92-4d6a-8201-1fd2897ab202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4f2e2c09-5ed2-4f98-8bc6-becc0da134cb" xlink:to="loc_us-gaap_ShareBasedCompensation_2625ce71-5f92-4d6a-8201-1fd2897ab202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_0bf9c71f-6f63-4b93-83e9-23aac1a41c58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4f2e2c09-5ed2-4f98-8bc6-becc0da134cb" xlink:to="loc_us-gaap_Depreciation_0bf9c71f-6f63-4b93-83e9-23aac1a41c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature_9ef814e4-577c-4822-b447-26d9ab3d288c" xlink:href="livn-20200930.xsd#livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4f2e2c09-5ed2-4f98-8bc6-becc0da134cb" xlink:to="loc_livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature_9ef814e4-577c-4822-b447-26d9ab3d288c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_064977f8-8683-4da8-a8e8-08681694b277" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4f2e2c09-5ed2-4f98-8bc6-becc0da134cb" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_064977f8-8683-4da8-a8e8-08681694b277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_6f97aa39-f49e-41fb-ba3a-b8d2b063d053" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4f2e2c09-5ed2-4f98-8bc6-becc0da134cb" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_6f97aa39-f49e-41fb-ba3a-b8d2b063d053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_450751f6-4d54-4add-9be2-b1f2b6e0e9ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4f2e2c09-5ed2-4f98-8bc6-becc0da134cb" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_450751f6-4d54-4add-9be2-b1f2b6e0e9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_224341f9-d35a-4ca2-ab1b-a0d9b1308d81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4f2e2c09-5ed2-4f98-8bc6-becc0da134cb" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_224341f9-d35a-4ca2-ab1b-a0d9b1308d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4adff810-ba47-4356-b797-cd872345ec59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_224341f9-d35a-4ca2-ab1b-a0d9b1308d81" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4adff810-ba47-4356-b797-cd872345ec59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1d1897af-b353-45bb-926b-fcc1eb0b4e4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_224341f9-d35a-4ca2-ab1b-a0d9b1308d81" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1d1897af-b353-45bb-926b-fcc1eb0b4e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_516582d7-5772-4202-ac56-ca99e99b8bc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_224341f9-d35a-4ca2-ab1b-a0d9b1308d81" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_516582d7-5772-4202-ac56-ca99e99b8bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_46ba0e97-4fe2-44d5-8623-6d0867ad9bb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_224341f9-d35a-4ca2-ab1b-a0d9b1308d81" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_46ba0e97-4fe2-44d5-8623-6d0867ad9bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_49f8b0fd-54c2-47c4-83d3-e248ba3b7318" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_224341f9-d35a-4ca2-ab1b-a0d9b1308d81" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_49f8b0fd-54c2-47c4-83d3-e248ba3b7318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_IncreaseDecreaseInLitigationProvisionLiability_42c9cec6-151c-4537-93b0-0bd11b0c8d6a" xlink:href="livn-20200930.xsd#livn_IncreaseDecreaseInLitigationProvisionLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_224341f9-d35a-4ca2-ab1b-a0d9b1308d81" xlink:to="loc_livn_IncreaseDecreaseInLitigationProvisionLiability_42c9cec6-151c-4537-93b0-0bd11b0c8d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInRestructuringReserve_eedbfa28-5671-46b9-829d-2fb7dcd0ac2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInRestructuringReserve"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_224341f9-d35a-4ca2-ab1b-a0d9b1308d81" xlink:to="loc_us-gaap_IncreaseDecreaseInRestructuringReserve_eedbfa28-5671-46b9-829d-2fb7dcd0ac2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f2f84c8-b459-4733-aa9b-543ff8d0cef0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_493c7005-9edc-4c6a-848c-274e36c04634" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f2f84c8-b459-4733-aa9b-543ff8d0cef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_04cebc25-d79f-492e-96d3-5d082eda9c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ed086d30-f928-4c4e-865b-7309de4e9bff" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_04cebc25-d79f-492e-96d3-5d082eda9c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_29001c36-b5d5-47fc-a759-4f8b90259073" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_04cebc25-d79f-492e-96d3-5d082eda9c5a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_29001c36-b5d5-47fc-a759-4f8b90259073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_PurchasesOfInvestments_b977806b-daa2-4314-8499-e1124792459c" xlink:href="livn-20200930.xsd#livn_PurchasesOfInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_04cebc25-d79f-492e-96d3-5d082eda9c5a" xlink:to="loc_livn_PurchasesOfInvestments_b977806b-daa2-4314-8499-e1124792459c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable_63fdf05a-d6f6-4f2e-9dbc-0cc97864ed07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_04cebc25-d79f-492e-96d3-5d082eda9c5a" xlink:to="loc_us-gaap_PaymentsToAcquireNotesReceivable_63fdf05a-d6f6-4f2e-9dbc-0cc97864ed07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7602c40f-2e81-4df4-9f51-711bb43ebe9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_04cebc25-d79f-492e-96d3-5d082eda9c5a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7602c40f-2e81-4df4-9f51-711bb43ebe9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_11532af6-41de-47ec-a8fd-934cc0535c43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_04cebc25-d79f-492e-96d3-5d082eda9c5a" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_11532af6-41de-47ec-a8fd-934cc0535c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3cf04c88-026a-4065-8613-2e1068390e58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_04cebc25-d79f-492e-96d3-5d082eda9c5a" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3cf04c88-026a-4065-8613-2e1068390e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a72f76d7-815f-44a7-bd1f-4e152cc25259" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_04cebc25-d79f-492e-96d3-5d082eda9c5a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a72f76d7-815f-44a7-bd1f-4e152cc25259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e41ee602-6f33-427c-a3c8-582c077ea34b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ed086d30-f928-4c4e-865b-7309de4e9bff" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e41ee602-6f33-427c-a3c8-582c077ea34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e3dbb95f-3822-4edb-8602-00380f18413d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e41ee602-6f33-427c-a3c8-582c077ea34b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e3dbb95f-3822-4edb-8602-00380f18413d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_86dbcf17-0ea2-4945-ad98-e65f0c740bc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e41ee602-6f33-427c-a3c8-582c077ea34b" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_86dbcf17-0ea2-4945-ad98-e65f0c740bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths_331d85ea-c638-479e-8db8-476d9903b8e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e41ee602-6f33-427c-a3c8-582c077ea34b" xlink:to="loc_us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths_331d85ea-c638-479e-8db8-476d9903b8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths_d96d6c25-1513-4288-9249-810e6aadd881" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e41ee602-6f33-427c-a3c8-582c077ea34b" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths_d96d6c25-1513-4288-9249-810e6aadd881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_6e1c664e-d78c-486a-8f86-cac436a9a821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e41ee602-6f33-427c-a3c8-582c077ea34b" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_6e1c664e-d78c-486a-8f86-cac436a9a821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_90915f2b-880a-4531-b93b-cb3b11d9d17c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e41ee602-6f33-427c-a3c8-582c077ea34b" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_90915f2b-880a-4531-b93b-cb3b11d9d17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_PaymentForDispositionOfBusinessClosingAdjustment_dd54c777-4a92-45d2-9116-fd3c627e7174" xlink:href="livn-20200930.xsd#livn_PaymentForDispositionOfBusinessClosingAdjustment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e41ee602-6f33-427c-a3c8-582c077ea34b" xlink:to="loc_livn_PaymentForDispositionOfBusinessClosingAdjustment_dd54c777-4a92-45d2-9116-fd3c627e7174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_a7d91ab6-1393-443e-b200-5f8ce75fb20f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e41ee602-6f33-427c-a3c8-582c077ea34b" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_a7d91ab6-1393-443e-b200-5f8ce75fb20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0908afbf-79e0-4a80-b141-2459ce68d341" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e41ee602-6f33-427c-a3c8-582c077ea34b" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0908afbf-79e0-4a80-b141-2459ce68d341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_59ae6774-b607-4232-930e-4d47cf6f0b94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e41ee602-6f33-427c-a3c8-582c077ea34b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_59ae6774-b607-4232-930e-4d47cf6f0b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_8f236484-058d-424d-81fb-88a21f74c6e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e41ee602-6f33-427c-a3c8-582c077ea34b" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_8f236484-058d-424d-81fb-88a21f74c6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_81e1a042-c355-4856-bf5c-70d5fb987409" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e41ee602-6f33-427c-a3c8-582c077ea34b" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_81e1a042-c355-4856-bf5c-70d5fb987409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_daef55b4-4702-4054-952a-60c907800d64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e41ee602-6f33-427c-a3c8-582c077ea34b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_daef55b4-4702-4054-952a-60c907800d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_db82cfae-f8ac-4555-b083-0f8244ef8712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ed086d30-f928-4c4e-865b-7309de4e9bff" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_db82cfae-f8ac-4555-b083-0f8244ef8712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e0f66e88-dbdd-45ac-8ce7-b5c1d8ec4737" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ed086d30-f928-4c4e-865b-7309de4e9bff" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e0f66e88-dbdd-45ac-8ce7-b5c1d8ec4737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_52eabc53-a494-40cb-aae3-12390df67f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ed086d30-f928-4c4e-865b-7309de4e9bff" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_52eabc53-a494-40cb-aae3-12390df67f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b2a24381-a942-4945-a87c-0413d99c3724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ed086d30-f928-4c4e-865b-7309de4e9bff" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b2a24381-a942-4945-a87c-0413d99c3724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatements" xlink:type="simple" xlink:href="livn-20200930.xsd#UnauditedCondensedConsolidatedFinancialStatements"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_77265e96-2aba-4e12-957d-f9da68020bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_d2d6f84b-066e-4c9b-a736-9e9b05fb439b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_77265e96-2aba-4e12-957d-f9da68020bf3" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_d2d6f84b-066e-4c9b-a736-9e9b05fb439b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatementsPolicies" xlink:type="simple" xlink:href="livn-20200930.xsd#UnauditedCondensedConsolidatedFinancialStatementsPolicies"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_22c7df9e-525f-4c15-96ce-420b859e1519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4ec000f7-2cff-4cc3-b8f4-250d11516812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22c7df9e-525f-4c15-96ce-420b859e1519" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4ec000f7-2cff-4cc3-b8f4-250d11516812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_107804ca-2443-4c3d-ac59-cc76606dbdff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22c7df9e-525f-4c15-96ce-420b859e1519" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_107804ca-2443-4c3d-ac59-cc76606dbdff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_0faf25ac-90d8-48ce-8023-28be834f17f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22c7df9e-525f-4c15-96ce-420b859e1519" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_0faf25ac-90d8-48ce-8023-28be834f17f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2e93410e-2b79-4da6-b355-5c84fc1e3f6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22c7df9e-525f-4c15-96ce-420b859e1519" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2e93410e-2b79-4da6-b355-5c84fc1e3f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/BusinessCombinations" xlink:type="simple" xlink:href="livn-20200930.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_8f15a646-f3bc-4a19-9e4e-28272f3adb9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_a6bb0c12-53c9-4c00-9f14-be3e1c37ecc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_8f15a646-f3bc-4a19-9e4e-28272f3adb9c" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_a6bb0c12-53c9-4c00-9f14-be3e1c37ecc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#BusinessCombinationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_7521dd9f-8fe9-4437-bd6d-1ec6bd01e17a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0b2dc261-5b92-41e3-997f-e70a05a6da2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7521dd9f-8fe9-4437-bd6d-1ec6bd01e17a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0b2dc261-5b92-41e3-997f-e70a05a6da2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_34d7b0a8-5339-4918-a06a-aa2bf34699ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0b2dc261-5b92-41e3-997f-e70a05a6da2a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_34d7b0a8-5339-4918-a06a-aa2bf34699ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50862f68-fb4e-407a-b15a-d38b85f22974" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34d7b0a8-5339-4918-a06a-aa2bf34699ee" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50862f68-fb4e-407a-b15a-d38b85f22974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MiamiInstrumentsLLCMember_84c41346-e244-4b28-90b8-ebb31bbb4a21" xlink:href="livn-20200930.xsd#livn_MiamiInstrumentsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50862f68-fb4e-407a-b15a-d38b85f22974" xlink:to="loc_livn_MiamiInstrumentsLLCMember_84c41346-e244-4b28-90b8-ebb31bbb4a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_39519c61-7987-4860-bff9-d97bae9ed11d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0b2dc261-5b92-41e3-997f-e70a05a6da2a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_39519c61-7987-4860-bff9-d97bae9ed11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_284a9268-943b-4bc8-9090-0c6086d58d06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_39519c61-7987-4860-bff9-d97bae9ed11d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_284a9268-943b-4bc8-9090-0c6086d58d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember_a98cd6ba-d22d-4359-b1ef-287a6e3f14b9" xlink:href="livn-20200930.xsd#livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_284a9268-943b-4bc8-9090-0c6086d58d06" xlink:to="loc_livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember_a98cd6ba-d22d-4359-b1ef-287a6e3f14b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_452f8b08-f415-46a9-90ba-2de9ead9a166" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0b2dc261-5b92-41e3-997f-e70a05a6da2a" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_452f8b08-f415-46a9-90ba-2de9ead9a166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a895c958-50b5-41d0-adc7-515390aa2ad5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_452f8b08-f415-46a9-90ba-2de9ead9a166" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a895c958-50b5-41d0-adc7-515390aa2ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BusinessCombinationUpfrontCosts_26af5934-e021-49b8-82f0-9496cfe3137a" xlink:href="livn-20200930.xsd#livn_BusinessCombinationUpfrontCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_452f8b08-f415-46a9-90ba-2de9ead9a166" xlink:to="loc_livn_BusinessCombinationUpfrontCosts_26af5934-e021-49b8-82f0-9496cfe3137a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_cd42d026-2abb-482b-bad8-1d79bcf07506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_452f8b08-f415-46a9-90ba-2de9ead9a166" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_cd42d026-2abb-482b-bad8-1d79bcf07506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_891690ae-fb14-4037-a464-752a7afeef34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_452f8b08-f415-46a9-90ba-2de9ead9a166" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_891690ae-fb14-4037-a464-752a7afeef34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b5c098bc-f753-49d3-bfa3-a6d1a8209800" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_452f8b08-f415-46a9-90ba-2de9ead9a166" xlink:to="loc_us-gaap_Goodwill_b5c098bc-f753-49d3-bfa3-a6d1a8209800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DiscontinuedOperations" xlink:type="simple" xlink:href="livn-20200930.xsd#DiscontinuedOperations"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/DiscontinuedOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_aabdf5a4-1df2-4c5f-a6bb-a3cf279c089b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_637513a7-303f-4168-9580-fb9ee93c1b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_aabdf5a4-1df2-4c5f-a6bb-a3cf279c089b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_637513a7-303f-4168-9580-fb9ee93c1b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#DiscontinuedOperationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_f56007b0-fe53-438e-9dd3-5f47ef087ba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_edd7d92b-556f-4863-b351-0e54d6f51759" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_f56007b0-fe53-438e-9dd3-5f47ef087ba1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_edd7d92b-556f-4863-b351-0e54d6f51759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_67ea7394-ba0a-457e-a1d7-4e8dd28a6b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_edd7d92b-556f-4863-b351-0e54d6f51759" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_67ea7394-ba0a-457e-a1d7-4e8dd28a6b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f0bb835d-610a-4810-bf06-69c80a606a71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_67ea7394-ba0a-457e-a1d7-4e8dd28a6b58" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f0bb835d-610a-4810-bf06-69c80a606a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CRMBusinessFranchiseMember_bc15a784-e9f5-4013-94ea-5754cdf75df5" xlink:href="livn-20200930.xsd#livn_CRMBusinessFranchiseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f0bb835d-610a-4810-bf06-69c80a606a71" xlink:to="loc_livn_CRMBusinessFranchiseMember_bc15a784-e9f5-4013-94ea-5754cdf75df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_51859b0f-98d2-458a-8c2e-a26a84f34722" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_edd7d92b-556f-4863-b351-0e54d6f51759" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_51859b0f-98d2-458a-8c2e-a26a84f34722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_d44e86f2-5c0b-42ca-b746-203085833ae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_51859b0f-98d2-458a-8c2e-a26a84f34722" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_d44e86f2-5c0b-42ca-b746-203085833ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_e01692e8-dd65-4aa4-b4dc-18c36e278a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_d44e86f2-5c0b-42ca-b746-203085833ae1" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_e01692e8-dd65-4aa4-b4dc-18c36e278a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f8cdf356-f774-4e5b-9ede-b2299973c821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_edd7d92b-556f-4863-b351-0e54d6f51759" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f8cdf356-f774-4e5b-9ede-b2299973c821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_331e9608-6493-4b7e-9aa9-d656784d89ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f8cdf356-f774-4e5b-9ede-b2299973c821" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_331e9608-6493-4b7e-9aa9-d656784d89ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BusinessCombinationConsiderationTransferredCashTransferred_c96d441c-b42c-4be4-afd6-0192d56a27ab" xlink:href="livn-20200930.xsd#livn_BusinessCombinationConsiderationTransferredCashTransferred"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f8cdf356-f774-4e5b-9ede-b2299973c821" xlink:to="loc_livn_BusinessCombinationConsiderationTransferredCashTransferred_c96d441c-b42c-4be4-afd6-0192d56a27ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax_95e50d82-172e-4f4a-ba4e-46063432e716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f8cdf356-f774-4e5b-9ede-b2299973c821" xlink:to="loc_us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax_95e50d82-172e-4f4a-ba4e-46063432e716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_6e497f6b-b582-43a4-8dfc-2467c7d91d58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f8cdf356-f774-4e5b-9ede-b2299973c821" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_6e497f6b-b582-43a4-8dfc-2467c7d91d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_3d5ffdd0-f1c1-4cd0-bea6-352c213356d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f8cdf356-f774-4e5b-9ede-b2299973c821" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_3d5ffdd0-f1c1-4cd0-bea6-352c213356d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/Restructuring" xlink:type="simple" xlink:href="livn-20200930.xsd#Restructuring"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/Restructuring" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_3a03684c-6f12-493b-b223-a46c3d288fce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_aed9ea7f-d386-4203-abb0-6f6ca7cbbf98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_3a03684c-6f12-493b-b223-a46c3d288fce" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_aed9ea7f-d386-4203-abb0-6f6ca7cbbf98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/RestructuringTables" xlink:type="simple" xlink:href="livn-20200930.xsd#RestructuringTables"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/RestructuringTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b95a13f8-873b-47a1-adc7-180576468471" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_93ca608d-6a68-4c85-b19f-358b12bf7343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b95a13f8-873b-47a1-adc7-180576468471" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_93ca608d-6a68-4c85-b19f-358b12bf7343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_ac59481c-0c16-417b-98e5-0820dbe0fb68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b95a13f8-873b-47a1-adc7-180576468471" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_ac59481c-0c16-417b-98e5-0820dbe0fb68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#RestructuringRestructuringandRelatedCostsDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_3804350d-7ca7-43f6-9593-23b5ea60a8f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b1a7d48b-7928-4331-91b8-d8d9ed335769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_3804350d-7ca7-43f6-9593-23b5ea60a8f1" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b1a7d48b-7928-4331-91b8-d8d9ed335769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_6fa365e5-3013-4d91-8d48-c3a196c68993" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b1a7d48b-7928-4331-91b8-d8d9ed335769" xlink:to="loc_us-gaap_RestructuringPlanAxis_6fa365e5-3013-4d91-8d48-c3a196c68993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_41d907a5-d2ee-4624-87af-b6aae7303129" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_6fa365e5-3013-4d91-8d48-c3a196c68993" xlink:to="loc_us-gaap_RestructuringPlanDomain_41d907a5-d2ee-4624-87af-b6aae7303129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ReorganizationPlansMember_50c82705-5ce4-408a-ad46-13ac2f27ef5c" xlink:href="livn-20200930.xsd#livn_ReorganizationPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_41d907a5-d2ee-4624-87af-b6aae7303129" xlink:to="loc_livn_ReorganizationPlansMember_50c82705-5ce4-408a-ad46-13ac2f27ef5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_26045514-1390-4ba1-8c8f-b5931d55b21f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b1a7d48b-7928-4331-91b8-d8d9ed335769" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_26045514-1390-4ba1-8c8f-b5931d55b21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_03f56f64-5154-49a3-b51d-5e8265f26bf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_26045514-1390-4ba1-8c8f-b5931d55b21f" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_03f56f64-5154-49a3-b51d-5e8265f26bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_088417cf-f415-4cc0-8a59-6e169792dbe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_03f56f64-5154-49a3-b51d-5e8265f26bf0" xlink:to="loc_us-gaap_EmployeeSeveranceMember_088417cf-f415-4cc0-8a59-6e169792dbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_bd3add2e-1228-4c55-a07a-b23266143ba7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_03f56f64-5154-49a3-b51d-5e8265f26bf0" xlink:to="loc_us-gaap_OtherRestructuringMember_bd3add2e-1228-4c55-a07a-b23266143ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_60a894b8-7228-49f6-a866-bcf883f5891a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b1a7d48b-7928-4331-91b8-d8d9ed335769" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_60a894b8-7228-49f6-a866-bcf883f5891a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_905ed640-ccea-4ed7-b62d-e6c09237d955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_60a894b8-7228-49f6-a866-bcf883f5891a" xlink:to="loc_us-gaap_RestructuringReserveRollForward_905ed640-ccea-4ed7-b62d-e6c09237d955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_763b43a9-620f-4687-8f6b-dec4135cc7ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_905ed640-ccea-4ed7-b62d-e6c09237d955" xlink:to="loc_us-gaap_RestructuringReserve_763b43a9-620f-4687-8f6b-dec4135cc7ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c027009d-e14a-41fb-b281-885545d8c1cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_905ed640-ccea-4ed7-b62d-e6c09237d955" xlink:to="loc_us-gaap_RestructuringCharges_c027009d-e14a-41fb-b281-885545d8c1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_d8fdcef1-4b5b-4cb9-826a-5d8111194b23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_905ed640-ccea-4ed7-b62d-e6c09237d955" xlink:to="loc_us-gaap_PaymentsForRestructuring_d8fdcef1-4b5b-4cb9-826a-5d8111194b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_49e0c709-378d-4eea-a27d-fe1da6ad4803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_905ed640-ccea-4ed7-b62d-e6c09237d955" xlink:to="loc_us-gaap_RestructuringReserve_49e0c709-378d-4eea-a27d-fe1da6ad4803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#RestructuringRestructuringExpensebySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d59d15f7-02b3-4380-8cc7-9a0cf749d1bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a990dd14-9f80-43ac-b7fa-448d69fe5490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d59d15f7-02b3-4380-8cc7-9a0cf749d1bb" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a990dd14-9f80-43ac-b7fa-448d69fe5490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_759ef6e1-0c5e-4c97-aba5-dbd19ba37018" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a990dd14-9f80-43ac-b7fa-448d69fe5490" xlink:to="loc_srt_ConsolidationItemsAxis_759ef6e1-0c5e-4c97-aba5-dbd19ba37018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2cc9d64a-c74b-41a3-a42e-254bb460f26a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_759ef6e1-0c5e-4c97-aba5-dbd19ba37018" xlink:to="loc_srt_ConsolidationItemsDomain_2cc9d64a-c74b-41a3-a42e-254bb460f26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_7ed8db88-71f3-41bb-b454-8eeece0571e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2cc9d64a-c74b-41a3-a42e-254bb460f26a" xlink:to="loc_us-gaap_OperatingSegmentsMember_7ed8db88-71f3-41bb-b454-8eeece0571e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_d2ad926c-84ec-4575-a6b9-3ffa8546a685" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2cc9d64a-c74b-41a3-a42e-254bb460f26a" xlink:to="loc_us-gaap_CorporateNonSegmentMember_d2ad926c-84ec-4575-a6b9-3ffa8546a685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9cb47417-9f68-478e-8a42-85b5d6aed1d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a990dd14-9f80-43ac-b7fa-448d69fe5490" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9cb47417-9f68-478e-8a42-85b5d6aed1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_43f1fecb-2247-46f8-a7e0-20f111e920f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9cb47417-9f68-478e-8a42-85b5d6aed1d3" xlink:to="loc_us-gaap_SegmentDomain_43f1fecb-2247-46f8-a7e0-20f111e920f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CardiovascularSegmentMember_c42ff708-1358-4fe5-9e31-cb9caffd23ba" xlink:href="livn-20200930.xsd#livn_CardiovascularSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_43f1fecb-2247-46f8-a7e0-20f111e920f9" xlink:to="loc_livn_CardiovascularSegmentMember_c42ff708-1358-4fe5-9e31-cb9caffd23ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_NeuromodulationSegmentMember_ca4d3e55-6f2b-4529-8298-59eaffe6a853" xlink:href="livn-20200930.xsd#livn_NeuromodulationSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_43f1fecb-2247-46f8-a7e0-20f111e920f9" xlink:to="loc_livn_NeuromodulationSegmentMember_ca4d3e55-6f2b-4529-8298-59eaffe6a853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_f2019caa-d1c4-4b09-96c0-d989f75fe758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a990dd14-9f80-43ac-b7fa-448d69fe5490" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_f2019caa-d1c4-4b09-96c0-d989f75fe758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_f2e78353-a9d3-4fc0-925a-51e55490ece3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f2019caa-d1c4-4b09-96c0-d989f75fe758" xlink:to="loc_us-gaap_RestructuringCharges_f2e78353-a9d3-4fc0-925a-51e55490ece3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/ProductRemediationLiability" xlink:type="simple" xlink:href="livn-20200930.xsd#ProductRemediationLiability"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/ProductRemediationLiability" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationAbstract_d624e6fa-b371-40a6-a83e-9fd4d9714fc8" xlink:href="livn-20200930.xsd#livn_ProductRemediationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationTextBlock_ad7f082f-c48a-4091-b352-d2f5439a3556" xlink:href="livn-20200930.xsd#livn_ProductRemediationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_livn_ProductRemediationAbstract_d624e6fa-b371-40a6-a83e-9fd4d9714fc8" xlink:to="loc_livn_ProductRemediationTextBlock_ad7f082f-c48a-4091-b352-d2f5439a3556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityTables" xlink:type="simple" xlink:href="livn-20200930.xsd#ProductRemediationLiabilityTables"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationAbstract_838910c5-ae23-4c19-a9f9-ce788fcdb492" xlink:href="livn-20200930.xsd#livn_ProductRemediationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ScheduleofProductRemediationTableTextBlock_c36db064-3600-4b52-aade-29ec70966e20" xlink:href="livn-20200930.xsd#livn_ScheduleofProductRemediationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_livn_ProductRemediationAbstract_838910c5-ae23-4c19-a9f9-ce788fcdb492" xlink:to="loc_livn_ScheduleofProductRemediationTableTextBlock_c36db064-3600-4b52-aade-29ec70966e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#ProductRemediationLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationAbstract_d1608883-e921-4177-8126-7f2799409e1c" xlink:href="livn-20200930.xsd#livn_ProductRemediationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingenciesRollForward_d1f24ef0-0cba-4ccb-b6d2-fa3ad543201e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingenciesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_livn_ProductRemediationAbstract_d1608883-e921-4177-8126-7f2799409e1c" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingenciesRollForward_d1f24ef0-0cba-4ccb-b6d2-fa3ad543201e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationNet_d55b7cb0-523a-423c-87ea-9087015dfe01" xlink:href="livn-20200930.xsd#livn_ProductRemediationNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccrualForEnvironmentalLossContingenciesRollForward_d1f24ef0-0cba-4ccb-b6d2-fa3ad543201e" xlink:to="loc_livn_ProductRemediationNet_d55b7cb0-523a-423c-87ea-9087015dfe01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationAdjustments_0e9f55dc-b768-4c6c-9dcb-24d38e3e5666" xlink:href="livn-20200930.xsd#livn_ProductRemediationAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccrualForEnvironmentalLossContingenciesRollForward_d1f24ef0-0cba-4ccb-b6d2-fa3ad543201e" xlink:to="loc_livn_ProductRemediationAdjustments_0e9f55dc-b768-4c6c-9dcb-24d38e3e5666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationPayments_6a36fd6a-e637-4eb2-b844-f305dcecf49f" xlink:href="livn-20200930.xsd#livn_ProductRemediationPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccrualForEnvironmentalLossContingenciesRollForward_d1f24ef0-0cba-4ccb-b6d2-fa3ad543201e" xlink:to="loc_livn_ProductRemediationPayments_6a36fd6a-e637-4eb2-b844-f305dcecf49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationForeignCurrencyTranslationGainLoss_c5968a1b-0676-4845-85e7-727b51c6ff79" xlink:href="livn-20200930.xsd#livn_ProductRemediationForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccrualForEnvironmentalLossContingenciesRollForward_d1f24ef0-0cba-4ccb-b6d2-fa3ad543201e" xlink:to="loc_livn_ProductRemediationForeignCurrencyTranslationGainLoss_c5968a1b-0676-4845-85e7-727b51c6ff79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationNet_02b6ffaa-4cb7-4071-aac4-2942eadc79e3" xlink:href="livn-20200930.xsd#livn_ProductRemediationNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccrualForEnvironmentalLossContingenciesRollForward_d1f24ef0-0cba-4ccb-b6d2-fa3ad543201e" xlink:to="loc_livn_ProductRemediationNet_02b6ffaa-4cb7-4071-aac4-2942eadc79e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationExpense_a68588e7-f8c1-46c7-9190-44bb81645ab7" xlink:href="livn-20200930.xsd#livn_ProductRemediationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_livn_ProductRemediationAbstract_d1608883-e921-4177-8126-7f2799409e1c" xlink:to="loc_livn_ProductRemediationExpense_a68588e7-f8c1-46c7-9190-44bb81645ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable_9595cd14-5b1d-4503-9e61-dd786c74b5cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductLiabilityContingencyTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_livn_ProductRemediationAbstract_d1608883-e921-4177-8126-7f2799409e1c" xlink:to="loc_us-gaap_ProductLiabilityContingencyTable_9595cd14-5b1d-4503-9e61-dd786c74b5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_9e870b0a-6f51-4cce-8594-557a986ed582" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_9595cd14-5b1d-4503-9e61-dd786c74b5cc" xlink:to="loc_srt_LitigationCaseAxis_9e870b0a-6f51-4cce-8594-557a986ed582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_3e458e0d-fdb5-438c-bed2-53bc2fdcdbfb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_9e870b0a-6f51-4cce-8594-557a986ed582" xlink:to="loc_srt_LitigationCaseTypeDomain_3e458e0d-fdb5-438c-bed2-53bc2fdcdbfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductLiabilityMember_f96aaf6f-cb37-4c69-a560-74b4901f4e18" xlink:href="livn-20200930.xsd#livn_ProductLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_3e458e0d-fdb5-438c-bed2-53bc2fdcdbfb" xlink:to="loc_livn_ProductLiabilityMember_f96aaf6f-cb37-4c69-a560-74b4901f4e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems_29f04941-7a7b-4e28-8a7e-1861a381e7a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_9595cd14-5b1d-4503-9e61-dd786c74b5cc" xlink:to="loc_us-gaap_ProductLiabilityContingencyLineItems_29f04941-7a7b-4e28-8a7e-1861a381e7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_d5682a88-f9fb-4bc5-aea3-905ce95371eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_29f04941-7a7b-4e28-8a7e-1861a381e7a4" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_d5682a88-f9fb-4bc5-aea3-905ce95371eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/Investments" xlink:type="simple" xlink:href="livn-20200930.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_022a7e38-f137-4d63-aa81-b43617a61073" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock_996385fe-d0e5-451c-8a6c-bceee60ba9e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_022a7e38-f137-4d63-aa81-b43617a61073" xlink:to="loc_us-gaap_InvestmentTextBlock_996385fe-d0e5-451c-8a6c-bceee60ba9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/InvestmentsTables" xlink:type="simple" xlink:href="livn-20200930.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_762a413d-e318-441c-b280-e9ddb67d07d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock_b157d14e-0535-43da-8012-d8616e236966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_762a413d-e318-441c-b280-e9ddb67d07d2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock_b157d14e-0535-43da-8012-d8616e236966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/InvestmentsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#InvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/InvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_9623e7e8-c6ec-47fb-96eb-f5d4639fe29d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bed31cb3-5330-44ea-99bc-6e4c6e3527c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_9623e7e8-c6ec-47fb-96eb-f5d4639fe29d" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bed31cb3-5330-44ea-99bc-6e4c6e3527c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d6748ea4-017e-4e79-94f1-e4ea307fc04a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bed31cb3-5330-44ea-99bc-6e4c6e3527c8" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d6748ea4-017e-4e79-94f1-e4ea307fc04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d6748ea4-017e-4e79-94f1-e4ea307fc04a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_RespicardiaMember_4b62053b-8426-4b63-a238-e23733454998" xlink:href="livn-20200930.xsd#livn_RespicardiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:to="loc_livn_RespicardiaMember_4b62053b-8426-4b63-a238-e23733454998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ALungTechnologiesInc.Member_e1b356be-5fb6-4b84-9bdf-5bbbfd041653" xlink:href="livn-20200930.xsd#livn_ALungTechnologiesInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:to="loc_livn_ALungTechnologiesInc.Member_e1b356be-5fb6-4b84-9bdf-5bbbfd041653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CeribellInc.Member_667a8a49-1b18-4fa3-9a4f-b68233b9319a" xlink:href="livn-20200930.xsd#livn_CeribellInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:to="loc_livn_CeribellInc.Member_667a8a49-1b18-4fa3-9a4f-b68233b9319a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ShiraTronicsInc.Member_aa5ccda3-fe8b-44bb-a84e-aab4d568f50f" xlink:href="livn-20200930.xsd#livn_ShiraTronicsInc.Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:to="loc_livn_ShiraTronicsInc.Member_aa5ccda3-fe8b-44bb-a84e-aab4d568f50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MDStartIIMember_9a6d0c66-45fa-4280-b325-118a5de754fd" xlink:href="livn-20200930.xsd#livn_MDStartIIMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:to="loc_livn_MDStartIIMember_9a6d0c66-45fa-4280-b325-118a5de754fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_RainbowMedicalLtd.Member_59e8c27d-0ac0-4862-a6ec-01e0e814d049" xlink:href="livn-20200930.xsd#livn_RainbowMedicalLtd.Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:to="loc_livn_RainbowMedicalLtd.Member_59e8c27d-0ac0-4862-a6ec-01e0e814d049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_HighlifeS.A.S.Member_cdeb39eb-7fe8-4ca3-9994-e000b1d0d3f6" xlink:href="livn-20200930.xsd#livn_HighlifeS.A.S.Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:to="loc_livn_HighlifeS.A.S.Member_cdeb39eb-7fe8-4ca3-9994-e000b1d0d3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_OtherMember_c30f8ecd-a894-4f6a-a429-82ba3737c482" xlink:href="livn-20200930.xsd#livn_OtherMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_23d3c4fd-0601-4aae-b341-6f8f7cf518aa" xlink:to="loc_livn_OtherMember_c30f8ecd-a894-4f6a-a429-82ba3737c482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_5b3ff69e-e57e-47f6-8f45-b7cd21c17737" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bed31cb3-5330-44ea-99bc-6e4c6e3527c8" xlink:to="loc_srt_CounterpartyNameAxis_5b3ff69e-e57e-47f6-8f45-b7cd21c17737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3ba0c23-1ae9-4234-a984-0ee5f7ffb9de" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_5b3ff69e-e57e-47f6-8f45-b7cd21c17737" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3ba0c23-1ae9-4234-a984-0ee5f7ffb9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_RespicardiaMember_8b76a13d-ff7c-4b15-9179-cc33010375a5" xlink:href="livn-20200930.xsd#livn_RespicardiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3ba0c23-1ae9-4234-a984-0ee5f7ffb9de" xlink:to="loc_livn_RespicardiaMember_8b76a13d-ff7c-4b15-9179-cc33010375a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ALungTechnologiesInc.Member_a667caaf-0ff8-46c5-a36f-24aaf4c6952c" xlink:href="livn-20200930.xsd#livn_ALungTechnologiesInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3ba0c23-1ae9-4234-a984-0ee5f7ffb9de" xlink:to="loc_livn_ALungTechnologiesInc.Member_a667caaf-0ff8-46c5-a36f-24aaf4c6952c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6984afb1-9d2a-40fb-a93e-3837b8553cc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bed31cb3-5330-44ea-99bc-6e4c6e3527c8" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6984afb1-9d2a-40fb-a93e-3837b8553cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_79bfe844-63f7-48b9-88dd-c898cc0561ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6984afb1-9d2a-40fb-a93e-3837b8553cc0" xlink:to="loc_us-gaap_RelatedPartyDomain_79bfe844-63f7-48b9-88dd-c898cc0561ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_3f25501e-2a99-4b0e-bd8c-f1262a08eab6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_79bfe844-63f7-48b9-88dd-c898cc0561ba" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_3f25501e-2a99-4b0e-bd8c-f1262a08eab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_43ae4b17-6f18-4bc8-9293-e6bfd5e15ea6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bed31cb3-5330-44ea-99bc-6e4c6e3527c8" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_43ae4b17-6f18-4bc8-9293-e6bfd5e15ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_692ff6da-f82f-4e2d-96b0-27c13036575b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_43ae4b17-6f18-4bc8-9293-e6bfd5e15ea6" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_692ff6da-f82f-4e2d-96b0-27c13036575b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_6ce71bc5-e721-4cc4-b620-3dcb099748bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_692ff6da-f82f-4e2d-96b0-27c13036575b" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_6ce71bc5-e721-4cc4-b620-3dcb099748bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_78d2c16f-5ce1-4ba0-8e79-963a8e0b9d90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bed31cb3-5330-44ea-99bc-6e4c6e3527c8" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_78d2c16f-5ce1-4ba0-8e79-963a8e0b9d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_ebd4e590-0da5-4ec0-a842-f66f6eb30e0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_78d2c16f-5ce1-4ba0-8e79-963a8e0b9d90" xlink:to="loc_us-gaap_ReceivableTypeDomain_ebd4e590-0da5-4ec0-a842-f66f6eb30e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ConvertibleNotesReceivableMember_7e42e3b4-c99e-4936-b711-e3d20ba7ecb4" xlink:href="livn-20200930.xsd#livn_ConvertibleNotesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_ebd4e590-0da5-4ec0-a842-f66f6eb30e0d" xlink:to="loc_livn_ConvertibleNotesReceivableMember_7e42e3b4-c99e-4936-b711-e3d20ba7ecb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8586e50b-1999-442e-a490-ea77e91591a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_bed31cb3-5330-44ea-99bc-6e4c6e3527c8" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8586e50b-1999-442e-a490-ea77e91591a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c14d11c4-088d-43a3-9bd2-d4542f10d244" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8586e50b-1999-442e-a490-ea77e91591a2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c14d11c4-088d-43a3-9bd2-d4542f10d244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ca1cdae4-4ee5-4970-9727-d073775003c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8586e50b-1999-442e-a490-ea77e91591a2" xlink:to="loc_us-gaap_EquityMethodInvestments_ca1cdae4-4ee5-4970-9727-d073775003c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_af29c411-c321-4ee4-8616-fc675b37bd07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8586e50b-1999-442e-a490-ea77e91591a2" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_af29c411-c321-4ee4-8616-fc675b37bd07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_431362e9-646d-457f-b40b-2a45900d4797" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8586e50b-1999-442e-a490-ea77e91591a2" xlink:to="loc_us-gaap_NotesReceivableNet_431362e9-646d-457f-b40b-2a45900d4797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableGross_28b78ba9-9e6a-4962-9414-0a8f9178ba45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8586e50b-1999-442e-a490-ea77e91591a2" xlink:to="loc_us-gaap_NotesReceivableGross_28b78ba9-9e6a-4962-9414-0a8f9178ba45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cb0dd19c-2ca3-492c-8629-4d1f1f6a60fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_b3b38f0d-4b09-485b-af94-73d28bfb99a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cb0dd19c-2ca3-492c-8629-4d1f1f6a60fe" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_b3b38f0d-4b09-485b-af94-73d28bfb99a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0bbae235-af0a-454d-9ac4-8e8b0a8bc49e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_bc321215-e111-45d3-b45a-936d09866074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0bbae235-af0a-454d-9ac4-8e8b0a8bc49e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_bc321215-e111-45d3-b45a-936d09866074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_b5c61c82-1f9f-4582-878e-e4a4eb8e177d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0bbae235-af0a-454d-9ac4-8e8b0a8bc49e" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_b5c61c82-1f9f-4582-878e-e4a4eb8e177d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_4ea6af6d-0db8-463c-a556-37fa7fe793b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0bbae235-af0a-454d-9ac4-8e8b0a8bc49e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_4ea6af6d-0db8-463c-a556-37fa7fe793b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_a202354d-beb8-40db-b274-bcc6b4adff38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0bbae235-af0a-454d-9ac4-8e8b0a8bc49e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_a202354d-beb8-40db-b274-bcc6b4adff38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_161af0d0-37c8-4f62-ac28-739e5162b59d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8fa56db8-1ae6-40db-af1f-ae25074482c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_161af0d0-37c8-4f62-ac28-739e5162b59d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8fa56db8-1ae6-40db-af1f-ae25074482c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0359320e-1170-4d14-abf3-b159829ec7b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8fa56db8-1ae6-40db-af1f-ae25074482c0" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0359320e-1170-4d14-abf3-b159829ec7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_827fb84d-3b94-4e12-9616-c1d0eb98e7a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0359320e-1170-4d14-abf3-b159829ec7b7" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_827fb84d-3b94-4e12-9616-c1d0eb98e7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_9b53d6bc-3157-4170-86c6-dd5bf1fc4a20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_827fb84d-3b94-4e12-9616-c1d0eb98e7a1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_9b53d6bc-3157-4170-86c6-dd5bf1fc4a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ebaaf3dc-653d-4415-b14a-595949a34d05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8fa56db8-1ae6-40db-af1f-ae25074482c0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ebaaf3dc-653d-4415-b14a-595949a34d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7eb1df58-e87e-4212-9fb8-a0f2703d0d0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ebaaf3dc-653d-4415-b14a-595949a34d05" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7eb1df58-e87e-4212-9fb8-a0f2703d0d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_40ca1acf-24cf-4c9d-93d8-f534fdab8c89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7eb1df58-e87e-4212-9fb8-a0f2703d0d0e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_40ca1acf-24cf-4c9d-93d8-f534fdab8c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_24ae7434-b61c-47cc-bbfb-763eefbdbd4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7eb1df58-e87e-4212-9fb8-a0f2703d0d0e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_24ae7434-b61c-47cc-bbfb-763eefbdbd4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_91873b22-e517-455b-a612-c2023f90e12a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7eb1df58-e87e-4212-9fb8-a0f2703d0d0e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_91873b22-e517-455b-a612-c2023f90e12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0b152fbd-e8b9-41e7-94f5-4fb7ca01e3ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8fa56db8-1ae6-40db-af1f-ae25074482c0" xlink:to="loc_us-gaap_HedgingDesignationAxis_0b152fbd-e8b9-41e7-94f5-4fb7ca01e3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_abe6caec-d712-4a72-8155-798bd2b0e133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_0b152fbd-e8b9-41e7-94f5-4fb7ca01e3ee" xlink:to="loc_us-gaap_HedgingDesignationDomain_abe6caec-d712-4a72-8155-798bd2b0e133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5b8b3c4e-53ed-475e-ac67-936f96a258f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_abe6caec-d712-4a72-8155-798bd2b0e133" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5b8b3c4e-53ed-475e-ac67-936f96a258f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_8145320e-70f0-49ce-b4a5-708b5273e777" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_abe6caec-d712-4a72-8155-798bd2b0e133" xlink:to="loc_us-gaap_NondesignatedMember_8145320e-70f0-49ce-b4a5-708b5273e777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_acc92698-f872-4387-9aae-efe48c201162" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8fa56db8-1ae6-40db-af1f-ae25074482c0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_acc92698-f872-4387-9aae-efe48c201162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9999533a-e712-4875-8674-736bfd340001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_acc92698-f872-4387-9aae-efe48c201162" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9999533a-e712-4875-8674-736bfd340001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_3efc98fc-8c7e-47e0-aff2-f3cc3a71e96a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9999533a-e712-4875-8674-736bfd340001" xlink:to="loc_us-gaap_ForeignExchangeContractMember_3efc98fc-8c7e-47e0-aff2-f3cc3a71e96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CappedCallMember_89df2410-ee48-4a5d-a358-e86afd884739" xlink:href="livn-20200930.xsd#livn_CappedCallMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9999533a-e712-4875-8674-736bfd340001" xlink:to="loc_livn_CappedCallMember_89df2410-ee48-4a5d-a358-e86afd884739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_02fd6259-b6d3-4fbb-8edd-1cb998335c9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9999533a-e712-4875-8674-736bfd340001" xlink:to="loc_us-gaap_InterestRateContractMember_02fd6259-b6d3-4fbb-8edd-1cb998335c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_2662d1f0-651b-4f44-bd1e-f5cdcd076c80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9999533a-e712-4875-8674-736bfd340001" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_2662d1f0-651b-4f44-bd1e-f5cdcd076c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_938901fe-5690-40ae-886a-46c983f62ddc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherContractMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9999533a-e712-4875-8674-736bfd340001" xlink:to="loc_us-gaap_OtherContractMember_938901fe-5690-40ae-886a-46c983f62ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0496e19a-01e7-41b6-833a-10cad35c4369" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8fa56db8-1ae6-40db-af1f-ae25074482c0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0496e19a-01e7-41b6-833a-10cad35c4369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_af555a40-9d0b-4e8a-b9d1-f9a84cc65ba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0496e19a-01e7-41b6-833a-10cad35c4369" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_af555a40-9d0b-4e8a-b9d1-f9a84cc65ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_6a98f04a-6f3f-485d-bf81-aabdb575be3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_af555a40-9d0b-4e8a-b9d1-f9a84cc65ba9" xlink:to="loc_us-gaap_DerivativeAssets_6a98f04a-6f3f-485d-bf81-aabdb575be3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFairValueDisclosure_fa2a382e-e8b0-4d41-bcb4-aa86d320cb04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_af555a40-9d0b-4e8a-b9d1-f9a84cc65ba9" xlink:to="loc_us-gaap_ReceivablesFairValueDisclosure_fa2a382e-e8b0-4d41-bcb4-aa86d320cb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_9f79db41-ec2e-4866-8088-fd737213c81a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_af555a40-9d0b-4e8a-b9d1-f9a84cc65ba9" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_9f79db41-ec2e-4866-8088-fd737213c81a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_127e1924-7f60-4760-a6a2-957ffd077ade" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0496e19a-01e7-41b6-833a-10cad35c4369" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_127e1924-7f60-4760-a6a2-957ffd077ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_a92d0fb4-e2d6-448d-bbc4-bea50acd202d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_127e1924-7f60-4760-a6a2-957ffd077ade" xlink:to="loc_us-gaap_DerivativeLiabilities_a92d0fb4-e2d6-448d-bbc4-bea50acd202d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_989d9410-cd52-480e-8aaa-8973529c83cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_127e1924-7f60-4760-a6a2-957ffd077ade" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_989d9410-cd52-480e-8aaa-8973529c83cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_d257067b-882d-4aa4-9a42-2a0025f2f2e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_127e1924-7f60-4760-a6a2-957ffd077ade" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_d257067b-882d-4aa4-9a42-2a0025f2f2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurementsContingentConsiderationReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3e6af121-8feb-42c1-aa1d-2c557ca06e82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc037298-5a07-41ba-8fcc-427da8c812bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3e6af121-8feb-42c1-aa1d-2c557ca06e82" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc037298-5a07-41ba-8fcc-427da8c812bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ddc74381-35e6-41da-80ec-e68f32402542" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc037298-5a07-41ba-8fcc-427da8c812bb" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ddc74381-35e6-41da-80ec-e68f32402542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9586eebd-090e-4b29-a8ef-fa8e1f68655d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ddc74381-35e6-41da-80ec-e68f32402542" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9586eebd-090e-4b29-a8ef-fa8e1f68655d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_e3b5ca72-e00e-4bd9-b628-30a0a5904384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_9586eebd-090e-4b29-a8ef-fa8e1f68655d" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_e3b5ca72-e00e-4bd9-b628-30a0a5904384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eefeecc0-e2a2-4f46-8cd0-669f5a5efa12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc037298-5a07-41ba-8fcc-427da8c812bb" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eefeecc0-e2a2-4f46-8cd0-669f5a5efa12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9038e1e-476f-4968-acde-83c1a14342fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eefeecc0-e2a2-4f46-8cd0-669f5a5efa12" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9038e1e-476f-4968-acde-83c1a14342fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_61cccf67-e884-4db7-a46b-ba735b235730" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9038e1e-476f-4968-acde-83c1a14342fc" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_61cccf67-e884-4db7-a46b-ba735b235730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_03b9470f-2cce-4d69-a8e8-3d382be98f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc037298-5a07-41ba-8fcc-427da8c812bb" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_03b9470f-2cce-4d69-a8e8-3d382be98f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d4c1bf77-e275-4bef-8ef9-65654f8ab0fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_03b9470f-2cce-4d69-a8e8-3d382be98f99" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d4c1bf77-e275-4bef-8ef9-65654f8ab0fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_3f9dd840-c0a2-40a5-8652-c7c91824ac85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d4c1bf77-e275-4bef-8ef9-65654f8ab0fb" xlink:to="loc_us-gaap_CostOfSalesMember_3f9dd840-c0a2-40a5-8652-c7c91824ac85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_989d464a-b206-4a2f-b816-f6ab356358d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d4c1bf77-e275-4bef-8ef9-65654f8ab0fb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_989d464a-b206-4a2f-b816-f6ab356358d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_3b541ae6-5c25-4a57-925a-2721c5724e33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc037298-5a07-41ba-8fcc-427da8c812bb" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_3b541ae6-5c25-4a57-925a-2721c5724e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_751c9ca1-05a9-4dee-b136-d9bd10b9635b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_3b541ae6-5c25-4a57-925a-2721c5724e33" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_751c9ca1-05a9-4dee-b136-d9bd10b9635b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_2715c943-3896-4b27-807d-b5efbb2249bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_751c9ca1-05a9-4dee-b136-d9bd10b9635b" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_2715c943-3896-4b27-807d-b5efbb2249bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_cae24f16-c1e2-4a16-a602-a5158a2b6f94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_751c9ca1-05a9-4dee-b136-d9bd10b9635b" xlink:to="loc_us-gaap_NotesReceivableMember_cae24f16-c1e2-4a16-a602-a5158a2b6f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_743fdc95-19da-4b11-85df-2adf108638b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc037298-5a07-41ba-8fcc-427da8c812bb" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_743fdc95-19da-4b11-85df-2adf108638b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_18202230-440d-4327-b840-fa5c4548039e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_743fdc95-19da-4b11-85df-2adf108638b1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_18202230-440d-4327-b840-fa5c4548039e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_EmbeddedExchangeFeatureLiabilityMember_c87ca2b5-7936-4884-9955-faa1b8b6d4e2" xlink:href="livn-20200930.xsd#livn_EmbeddedExchangeFeatureLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_18202230-440d-4327-b840-fa5c4548039e" xlink:to="loc_livn_EmbeddedExchangeFeatureLiabilityMember_c87ca2b5-7936-4884-9955-faa1b8b6d4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_36a689cd-dcd7-4805-aa92-ac9a9192499e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_18202230-440d-4327-b840-fa5c4548039e" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_36a689cd-dcd7-4805-aa92-ac9a9192499e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ContingentConsiderationLiabilityMember_636fe354-ed8a-45c6-bda5-6c1f3c471297" xlink:href="livn-20200930.xsd#livn_ContingentConsiderationLiabilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_18202230-440d-4327-b840-fa5c4548039e" xlink:to="loc_livn_ContingentConsiderationLiabilityMember_636fe354-ed8a-45c6-bda5-6c1f3c471297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc037298-5a07-41ba-8fcc-427da8c812bb" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a59ba545-7212-4371-947f-744fa90888f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a59ba545-7212-4371-947f-744fa90888f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_72706057-73a3-4a2e-9f0b-8a1d3682cf55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a59ba545-7212-4371-947f-744fa90888f7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_72706057-73a3-4a2e-9f0b-8a1d3682cf55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_7300a6c2-52de-47b7-9096-48ba39c0400c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a59ba545-7212-4371-947f-744fa90888f7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_7300a6c2-52de-47b7-9096-48ba39c0400c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_f5a2f483-d5b4-441f-8422-87cf3e0bc323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a59ba545-7212-4371-947f-744fa90888f7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_f5a2f483-d5b4-441f-8422-87cf3e0bc323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_e16efcc5-707b-41e9-a121-6019d2794a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a59ba545-7212-4371-947f-744fa90888f7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_e16efcc5-707b-41e9-a121-6019d2794a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_51e4883d-3b48-44e4-abc3-c602de30f512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a59ba545-7212-4371-947f-744fa90888f7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_51e4883d-3b48-44e4-abc3-c602de30f512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1fd5c670-85ba-444f-a467-76181df92d80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a59ba545-7212-4371-947f-744fa90888f7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1fd5c670-85ba-444f-a467-76181df92d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue_a6f0cfd9-f6c0-497e-85a3-6402f119f113" xlink:href="livn-20200930.xsd#livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue_a6f0cfd9-f6c0-497e-85a3-6402f119f113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue_e9c8b20e-3b8d-4c79-ae60-f66a95ec5acc" xlink:href="livn-20200930.xsd#livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue_e9c8b20e-3b8d-4c79-ae60-f66a95ec5acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7b9495c4-138b-4a12-b16b-e46697154059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7b9495c4-138b-4a12-b16b-e46697154059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_36c0ad26-48be-45e1-8d55-0e58bf78f9cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7b9495c4-138b-4a12-b16b-e46697154059" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_36c0ad26-48be-45e1-8d55-0e58bf78f9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_0912a675-cf00-495f-95f7-a307fe78717d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7b9495c4-138b-4a12-b16b-e46697154059" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_0912a675-cf00-495f-95f7-a307fe78717d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_25ceef6a-dc92-4b21-b8ec-a5294e316f71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7b9495c4-138b-4a12-b16b-e46697154059" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_25ceef6a-dc92-4b21-b8ec-a5294e316f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_a2f006b4-0b2b-467f-a530-d384e7acca77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7b9495c4-138b-4a12-b16b-e46697154059" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_a2f006b4-0b2b-467f-a530-d384e7acca77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_f1a0e48c-b510-4e1f-abae-e529a1551f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7b9495c4-138b-4a12-b16b-e46697154059" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_f1a0e48c-b510-4e1f-abae-e529a1551f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_e577bd15-4fb0-4d5a-bf66-210bec5bedd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7b9495c4-138b-4a12-b16b-e46697154059" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_e577bd15-4fb0-4d5a-bf66-210bec5bedd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue_ea9a071d-8823-4f3c-8d9b-5105740e6f4c" xlink:href="livn-20200930.xsd#livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue_ea9a071d-8823-4f3c-8d9b-5105740e6f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue_499d5f85-d351-43d5-9a4b-3d8defae7b7d" xlink:href="livn-20200930.xsd#livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue_499d5f85-d351-43d5-9a4b-3d8defae7b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_a075b812-1478-4924-9a7a-945d10583d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_a075b812-1478-4924-9a7a-945d10583d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_NumberOfDistributorsAcquired_ae68d713-dd1e-42af-b5fd-370e46de8291" xlink:href="livn-20200930.xsd#livn_NumberOfDistributorsAcquired"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_livn_NumberOfDistributorsAcquired_ae68d713-dd1e-42af-b5fd-370e46de8291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BusinessCombinationMilestoneAchievementPeriodOfDelay_10c6c5cb-4061-4976-83cb-989b77a8e2cf" xlink:href="livn-20200930.xsd#livn_BusinessCombinationMilestoneAchievementPeriodOfDelay"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_livn_BusinessCombinationMilestoneAchievementPeriodOfDelay_10c6c5cb-4061-4976-83cb-989b77a8e2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_59f1b329-8ce3-4855-91a0-b1ab5ddab940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1d869ecb-d7fd-404a-ac9b-c5e2354d2715" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_59f1b329-8ce3-4855-91a0-b1ab5ddab940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_00ebe587-4e9c-45aa-bca2-25e43c7e634f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fc34d42e-21c1-43d5-b144-61ecac3123cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_00ebe587-4e9c-45aa-bca2-25e43c7e634f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fc34d42e-21c1-43d5-b144-61ecac3123cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_7a15376c-3afe-4e63-a21f-6fc3e55f70e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fc34d42e-21c1-43d5-b144-61ecac3123cd" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_7a15376c-3afe-4e63-a21f-6fc3e55f70e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_6df05de8-2a38-4696-b2b0-0cd55a6ed17a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_7a15376c-3afe-4e63-a21f-6fc3e55f70e2" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_6df05de8-2a38-4696-b2b0-0cd55a6ed17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MeasurementInputStockPriceVolatilityMember_e937068d-0141-4f57-bd19-f0d72384e746" xlink:href="livn-20200930.xsd#livn_MeasurementInputStockPriceVolatilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6df05de8-2a38-4696-b2b0-0cd55a6ed17a" xlink:to="loc_livn_MeasurementInputStockPriceVolatilityMember_e937068d-0141-4f57-bd19-f0d72384e746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_97373159-9092-4e12-80ba-1160313b3c47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fc34d42e-21c1-43d5-b144-61ecac3123cd" xlink:to="loc_us-gaap_DebtInstrumentAxis_97373159-9092-4e12-80ba-1160313b3c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0bb6c8a2-3948-4e53-b7d1-69d7f6c3592e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_97373159-9092-4e12-80ba-1160313b3c47" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0bb6c8a2-3948-4e53-b7d1-69d7f6c3592e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_A2020CashExchangeableSeniorNotesMember_7111a2e8-4e6d-4943-bd0a-88d0c9164bef" xlink:href="livn-20200930.xsd#livn_A2020CashExchangeableSeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0bb6c8a2-3948-4e53-b7d1-69d7f6c3592e" xlink:to="loc_livn_A2020CashExchangeableSeniorNotesMember_7111a2e8-4e6d-4943-bd0a-88d0c9164bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5f1ea960-bc15-453f-93a1-6e6d4a7421f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fc34d42e-21c1-43d5-b144-61ecac3123cd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5f1ea960-bc15-453f-93a1-6e6d4a7421f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cd7e1149-80da-49ef-a791-64c52a895000" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5f1ea960-bc15-453f-93a1-6e6d4a7421f8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cd7e1149-80da-49ef-a791-64c52a895000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_cf7c4d2f-8611-4acf-b903-48de28906b4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_cd7e1149-80da-49ef-a791-64c52a895000" xlink:to="loc_us-gaap_SeniorNotesMember_cf7c4d2f-8611-4acf-b903-48de28906b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4835056d-194c-4fe8-b26c-1fdb41ad37b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fc34d42e-21c1-43d5-b144-61ecac3123cd" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4835056d-194c-4fe8-b26c-1fdb41ad37b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6fbbc6ea-3fd9-40aa-abaa-caf08e7ebb72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4835056d-194c-4fe8-b26c-1fdb41ad37b8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6fbbc6ea-3fd9-40aa-abaa-caf08e7ebb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_e8d1a7a7-a0b3-485c-9795-5363c166ab0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6fbbc6ea-3fd9-40aa-abaa-caf08e7ebb72" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_e8d1a7a7-a0b3-485c-9795-5363c166ab0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CappedCallMember_0cd87e9c-7e7c-4910-8c40-bce8bbf54593" xlink:href="livn-20200930.xsd#livn_CappedCallMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6fbbc6ea-3fd9-40aa-abaa-caf08e7ebb72" xlink:to="loc_livn_CappedCallMember_0cd87e9c-7e7c-4910-8c40-bce8bbf54593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_13b0a885-e9ec-428a-a211-1ebfc7913a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_fc34d42e-21c1-43d5-b144-61ecac3123cd" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_13b0a885-e9ec-428a-a211-1ebfc7913a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a997f008-664c-4cec-b44a-a4096897b24c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_13b0a885-e9ec-428a-a211-1ebfc7913a9f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a997f008-664c-4cec-b44a-a4096897b24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_64bfb9ec-4a86-4227-a624-8fad54228f90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_13b0a885-e9ec-428a-a211-1ebfc7913a9f" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_64bfb9ec-4a86-4227-a624-8fad54228f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue_87383163-690c-4801-bf53-013c427ed98f" xlink:href="livn-20200930.xsd#livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_13b0a885-e9ec-428a-a211-1ebfc7913a9f" xlink:to="loc_livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue_87383163-690c-4801-bf53-013c427ed98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue_ed34d295-ac14-4e28-b4cf-26342bd60d9c" xlink:href="livn-20200930.xsd#livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_13b0a885-e9ec-428a-a211-1ebfc7913a9f" xlink:to="loc_livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue_ed34d295-ac14-4e28-b4cf-26342bd60d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2f1341a4-501a-4ac6-8dcc-9c0b6fa33bf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8072e451-d186-45ab-958b-3817926769d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2f1341a4-501a-4ac6-8dcc-9c0b6fa33bf4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8072e451-d186-45ab-958b-3817926769d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d7e797b1-c80d-4bee-aeba-5f62ac359fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8072e451-d186-45ab-958b-3817926769d7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d7e797b1-c80d-4bee-aeba-5f62ac359fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fb2c24f7-7ceb-499f-81ed-0251a762fc91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d7e797b1-c80d-4bee-aeba-5f62ac359fe5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fb2c24f7-7ceb-499f-81ed-0251a762fc91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ImTheraMedicalInc.Member_8c9709ba-bc22-4262-995d-52fc78e4381c" xlink:href="livn-20200930.xsd#livn_ImTheraMedicalInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fb2c24f7-7ceb-499f-81ed-0251a762fc91" xlink:to="loc_livn_ImTheraMedicalInc.Member_8c9709ba-bc22-4262-995d-52fc78e4381c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_TandemLifeMember_0dd9b95d-f13e-4cd3-99a8-bf730f9122af" xlink:href="livn-20200930.xsd#livn_TandemLifeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fb2c24f7-7ceb-499f-81ed-0251a762fc91" xlink:to="loc_livn_TandemLifeMember_0dd9b95d-f13e-4cd3-99a8-bf730f9122af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MiamiInstrumentsLLCMember_ee4cdf61-b762-41e2-9639-a03bc29e731a" xlink:href="livn-20200930.xsd#livn_MiamiInstrumentsLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fb2c24f7-7ceb-499f-81ed-0251a762fc91" xlink:to="loc_livn_MiamiInstrumentsLLCMember_ee4cdf61-b762-41e2-9639-a03bc29e731a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DrilltexMember_275001ed-9f6f-43b1-a1cd-bdf0139a90b0" xlink:href="livn-20200930.xsd#livn_DrilltexMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fb2c24f7-7ceb-499f-81ed-0251a762fc91" xlink:to="loc_livn_DrilltexMember_275001ed-9f6f-43b1-a1cd-bdf0139a90b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_OtherMember_3174f5f8-efb2-4068-a901-3ae2ab73ffd5" xlink:href="livn-20200930.xsd#livn_OtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fb2c24f7-7ceb-499f-81ed-0251a762fc91" xlink:to="loc_livn_OtherMember_3174f5f8-efb2-4068-a901-3ae2ab73ffd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d356fade-2fea-49a5-8727-cb7e4af2ecf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8072e451-d186-45ab-958b-3817926769d7" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d356fade-2fea-49a5-8727-cb7e4af2ecf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_74de2b08-84b8-48cd-a326-7a5f306504b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d356fade-2fea-49a5-8727-cb7e4af2ecf4" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_74de2b08-84b8-48cd-a326-7a5f306504b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_9cc104c2-acbd-4a1c-b46c-1c9b09204c60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_74de2b08-84b8-48cd-a326-7a5f306504b3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_9cc104c2-acbd-4a1c-b46c-1c9b09204c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c3b6e172-47f3-4555-8b7f-9f2ea5a226af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8072e451-d186-45ab-958b-3817926769d7" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c3b6e172-47f3-4555-8b7f-9f2ea5a226af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dccd4415-43a2-4874-b027-71f1dc7bb335" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c3b6e172-47f3-4555-8b7f-9f2ea5a226af" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dccd4415-43a2-4874-b027-71f1dc7bb335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_fd0863db-f8ab-4dc8-9589-84e3a00e8661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dccd4415-43a2-4874-b027-71f1dc7bb335" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_fd0863db-f8ab-4dc8-9589-84e3a00e8661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_74055d5e-de42-4ef5-b722-9e951e55e0eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8072e451-d186-45ab-958b-3817926769d7" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_74055d5e-de42-4ef5-b722-9e951e55e0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8e474da5-ba1f-4115-8fe3-8e68aecdab8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_74055d5e-de42-4ef5-b722-9e951e55e0eb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8e474da5-ba1f-4115-8fe3-8e68aecdab8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4d297a1f-f65e-4744-9a8d-53bc4c053cc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_74055d5e-de42-4ef5-b722-9e951e55e0eb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4d297a1f-f65e-4744-9a8d-53bc4c053cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FairValueMeasurementsLevel3ValuationsDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6b506431-f37f-4651-9b41-f4f52cdfd66f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e8ee71ae-d27b-4e3f-a11e-415dcc5bbb7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6b506431-f37f-4651-9b41-f4f52cdfd66f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e8ee71ae-d27b-4e3f-a11e-415dcc5bbb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d88ed94d-3a1b-48f9-8cd0-f24945260020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e8ee71ae-d27b-4e3f-a11e-415dcc5bbb7f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d88ed94d-3a1b-48f9-8cd0-f24945260020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5266323-682b-4385-972f-0c7eccea2650" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d88ed94d-3a1b-48f9-8cd0-f24945260020" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5266323-682b-4385-972f-0c7eccea2650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ImTheraMedicalInc.Member_811e94b9-6b19-4797-933a-4826b4d1e704" xlink:href="livn-20200930.xsd#livn_ImTheraMedicalInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5266323-682b-4385-972f-0c7eccea2650" xlink:to="loc_livn_ImTheraMedicalInc.Member_811e94b9-6b19-4797-933a-4826b4d1e704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_TandemLifeMember_9d12907b-baac-43f1-b147-029bcda19c19" xlink:href="livn-20200930.xsd#livn_TandemLifeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5266323-682b-4385-972f-0c7eccea2650" xlink:to="loc_livn_TandemLifeMember_9d12907b-baac-43f1-b147-029bcda19c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MiamiInstrumentsLLCMember_99832d3e-320b-48ef-a044-2db1ad8c7261" xlink:href="livn-20200930.xsd#livn_MiamiInstrumentsLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5266323-682b-4385-972f-0c7eccea2650" xlink:to="loc_livn_MiamiInstrumentsLLCMember_99832d3e-320b-48ef-a044-2db1ad8c7261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_def95800-00b0-4824-8231-f0ded558a0b4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e8ee71ae-d27b-4e3f-a11e-415dcc5bbb7f" xlink:to="loc_srt_RangeAxis_def95800-00b0-4824-8231-f0ded558a0b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1a5ce42d-47f7-4a67-874e-a228f0f4a216" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_def95800-00b0-4824-8231-f0ded558a0b4" xlink:to="loc_srt_RangeMember_1a5ce42d-47f7-4a67-874e-a228f0f4a216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_20f2b23e-9356-4efd-80ad-77d12e3afe8d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1a5ce42d-47f7-4a67-874e-a228f0f4a216" xlink:to="loc_srt_MinimumMember_20f2b23e-9356-4efd-80ad-77d12e3afe8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4fd17091-34f7-4cf9-9674-ca916c7c1fd0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1a5ce42d-47f7-4a67-874e-a228f0f4a216" xlink:to="loc_srt_MaximumMember_4fd17091-34f7-4cf9-9674-ca916c7c1fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_33571e47-ddcc-4839-8f07-dbe0039f94eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e8ee71ae-d27b-4e3f-a11e-415dcc5bbb7f" xlink:to="loc_us-gaap_ValuationTechniqueAxis_33571e47-ddcc-4839-8f07-dbe0039f94eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_23006942-f2a5-48d1-94e7-c8a454eda043" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_33571e47-ddcc-4839-8f07-dbe0039f94eb" xlink:to="loc_us-gaap_ValuationTechniqueDomain_23006942-f2a5-48d1-94e7-c8a454eda043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_8724e04c-da90-48c3-8913-f795a746d1b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_23006942-f2a5-48d1-94e7-c8a454eda043" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_8724e04c-da90-48c3-8913-f795a746d1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ValuationTechniqueMonteCarloSimulationMember_6e365a09-f5fe-4131-b2cd-ae709fb066ff" xlink:href="livn-20200930.xsd#livn_ValuationTechniqueMonteCarloSimulationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_23006942-f2a5-48d1-94e7-c8a454eda043" xlink:to="loc_livn_ValuationTechniqueMonteCarloSimulationMember_6e365a09-f5fe-4131-b2cd-ae709fb066ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7bec3e2b-6239-431e-bc3f-e8a2f8ebc496" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e8ee71ae-d27b-4e3f-a11e-415dcc5bbb7f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7bec3e2b-6239-431e-bc3f-e8a2f8ebc496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6cbd5843-45bb-4188-bd05-01672ade372b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7bec3e2b-6239-431e-bc3f-e8a2f8ebc496" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6cbd5843-45bb-4188-bd05-01672ade372b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_c4a4c286-219c-405d-8086-246be09ad285" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6cbd5843-45bb-4188-bd05-01672ade372b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_c4a4c286-219c-405d-8086-246be09ad285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_24929589-cf73-418e-8910-1d2b6d1636a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e8ee71ae-d27b-4e3f-a11e-415dcc5bbb7f" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_24929589-cf73-418e-8910-1d2b6d1636a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1b4671a4-9e31-48d1-bd00-64e001ff4738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_24929589-cf73-418e-8910-1d2b6d1636a2" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1b4671a4-9e31-48d1-bd00-64e001ff4738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_2e0dd377-a196-4121-8fda-7c7a75915685" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1b4671a4-9e31-48d1-bd00-64e001ff4738" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_2e0dd377-a196-4121-8fda-7c7a75915685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MeasurementInputProbabilityofPaymentMember_2667144e-285e-4113-a56a-c39694a19394" xlink:href="livn-20200930.xsd#livn_MeasurementInputProbabilityofPaymentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1b4671a4-9e31-48d1-bd00-64e001ff4738" xlink:to="loc_livn_MeasurementInputProbabilityofPaymentMember_2667144e-285e-4113-a56a-c39694a19394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MeasurementInputRiskadjustedDiscountRateMember_5c9e71c0-5660-4eb7-9927-00d5270478f7" xlink:href="livn-20200930.xsd#livn_MeasurementInputRiskadjustedDiscountRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1b4671a4-9e31-48d1-bd00-64e001ff4738" xlink:to="loc_livn_MeasurementInputRiskadjustedDiscountRateMember_5c9e71c0-5660-4eb7-9927-00d5270478f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MeasurementInputCreditRiskDiscountRateMember_2490cb02-c814-460c-89d9-1b87d4f3ace5" xlink:href="livn-20200930.xsd#livn_MeasurementInputCreditRiskDiscountRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1b4671a4-9e31-48d1-bd00-64e001ff4738" xlink:to="loc_livn_MeasurementInputCreditRiskDiscountRateMember_2490cb02-c814-460c-89d9-1b87d4f3ace5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MeasurementInputRevenueVolatilityMember_816774ac-55a1-4b7e-bddb-6eb1707148fd" xlink:href="livn-20200930.xsd#livn_MeasurementInputRevenueVolatilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1b4671a4-9e31-48d1-bd00-64e001ff4738" xlink:to="loc_livn_MeasurementInputRevenueVolatilityMember_816774ac-55a1-4b7e-bddb-6eb1707148fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_10f7b5ac-a023-462f-beb6-883e930ffa4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_e8ee71ae-d27b-4e3f-a11e-415dcc5bbb7f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_10f7b5ac-a023-462f-beb6-883e930ffa4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BusinessCombinationContingentConsiderationMeasurementInput_3d5b4654-5a15-402c-a7b0-8420284d80da" xlink:href="livn-20200930.xsd#livn_BusinessCombinationContingentConsiderationMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_10f7b5ac-a023-462f-beb6-883e930ffa4d" xlink:to="loc_livn_BusinessCombinationContingentConsiderationMeasurementInput_3d5b4654-5a15-402c-a7b0-8420284d80da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangements" xlink:type="simple" xlink:href="livn-20200930.xsd#FinancingArrangements"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/FinancingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cba58fc7-49fa-40ed-bb2f-7d30e81a4699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_6755ae5d-b841-41e2-ad2a-5d4cd19c2b9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cba58fc7-49fa-40ed-bb2f-7d30e81a4699" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_6755ae5d-b841-41e2-ad2a-5d4cd19c2b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangementsTables" xlink:type="simple" xlink:href="livn-20200930.xsd#FinancingArrangementsTables"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/FinancingArrangementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f5bef0be-b6f9-4836-a9ee-e261314c14ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_12b92cbf-8991-4acf-9c80-e7a3d46b36a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f5bef0be-b6f9-4836-a9ee-e261314c14ff" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_12b92cbf-8991-4acf-9c80-e7a3d46b36a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ScheduleOfDebtCovenantsTableTextBlock_cb8239da-d0b5-4d21-b122-0f145de2f7c2" xlink:href="livn-20200930.xsd#livn_ScheduleOfDebtCovenantsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f5bef0be-b6f9-4836-a9ee-e261314c14ff" xlink:to="loc_livn_ScheduleOfDebtCovenantsTableTextBlock_cb8239da-d0b5-4d21-b122-0f145de2f7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FinancingArrangementsScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e8c319d9-b3b6-4cd9-8141-ed094be0c6ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f59b2d4a-257f-4bd6-a164-86bc6db0ebe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e8c319d9-b3b6-4cd9-8141-ed094be0c6ee" xlink:to="loc_us-gaap_DebtInstrumentTable_f59b2d4a-257f-4bd6-a164-86bc6db0ebe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_632ad5b7-9bf5-45cf-89c4-b1ba20a2ee54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f59b2d4a-257f-4bd6-a164-86bc6db0ebe9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_632ad5b7-9bf5-45cf-89c4-b1ba20a2ee54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_20c29f15-323a-4030-b67d-264f62b28436" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_632ad5b7-9bf5-45cf-89c4-b1ba20a2ee54" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_20c29f15-323a-4030-b67d-264f62b28436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_e5d76dc4-c063-461a-906b-6a7f09034594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_20c29f15-323a-4030-b67d-264f62b28436" xlink:to="loc_us-gaap_SecuredDebtMember_e5d76dc4-c063-461a-906b-6a7f09034594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_34f10671-1292-408a-926a-34543d0bcade" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_20c29f15-323a-4030-b67d-264f62b28436" xlink:to="loc_us-gaap_SeniorNotesMember_34f10671-1292-408a-926a-34543d0bcade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_22850ec0-461a-43ca-8f93-ed71c40031a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_20c29f15-323a-4030-b67d-264f62b28436" xlink:to="loc_us-gaap_LoansPayableMember_22850ec0-461a-43ca-8f93-ed71c40031a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_9686337f-0a32-4331-ab28-63a647594082" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_20c29f15-323a-4030-b67d-264f62b28436" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_9686337f-0a32-4331-ab28-63a647594082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_c85f06bd-31b4-4e7d-bd09-fc59340e3727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f59b2d4a-257f-4bd6-a164-86bc6db0ebe9" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_c85f06bd-31b4-4e7d-bd09-fc59340e3727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_d8f0a6e9-c6fa-40d4-a709-ab523b2fd066" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_c85f06bd-31b4-4e7d-bd09-fc59340e3727" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_d8f0a6e9-c6fa-40d4-a709-ab523b2fd066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member_8d27c29b-2c9d-4851-978b-65cbda26c391" xlink:href="livn-20200930.xsd#livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_d8f0a6e9-c6fa-40d4-a709-ab523b2fd066" xlink:to="loc_livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member_8d27c29b-2c9d-4851-978b-65cbda26c391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MediocreditoItalianoMember_9cf5d1ac-fc4c-4dd5-81da-2c60af23804e" xlink:href="livn-20200930.xsd#livn_MediocreditoItalianoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_d8f0a6e9-c6fa-40d4-a709-ab523b2fd066" xlink:to="loc_livn_MediocreditoItalianoMember_9cf5d1ac-fc4c-4dd5-81da-2c60af23804e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BankofAmericaU.SMember_49a6a723-0d85-4aab-86ae-3c8b3299c364" xlink:href="livn-20200930.xsd#livn_BankofAmericaU.SMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_d8f0a6e9-c6fa-40d4-a709-ab523b2fd066" xlink:to="loc_livn_BankofAmericaU.SMember_49a6a723-0d85-4aab-86ae-3c8b3299c364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtFacility2019Member_ec6c98eb-7db6-47c4-a88f-0a0fba956c57" xlink:href="livn-20200930.xsd#livn_DebtFacility2019Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_d8f0a6e9-c6fa-40d4-a709-ab523b2fd066" xlink:to="loc_livn_DebtFacility2019Member_ec6c98eb-7db6-47c4-a88f-0a0fba956c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_EuropeanInvestmentBank2017Member_6bdb2a53-7dff-49ba-8bb4-9983c0f8cbfb" xlink:href="livn-20200930.xsd#livn_EuropeanInvestmentBank2017Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_d8f0a6e9-c6fa-40d4-a709-ab523b2fd066" xlink:to="loc_livn_EuropeanInvestmentBank2017Member_6bdb2a53-7dff-49ba-8bb4-9983c0f8cbfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_EuropeanInvestmentBank2014Member_c30a7b6e-e141-4426-8985-1e44c8c1fbba" xlink:href="livn-20200930.xsd#livn_EuropeanInvestmentBank2014Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_d8f0a6e9-c6fa-40d4-a709-ab523b2fd066" xlink:to="loc_livn_EuropeanInvestmentBank2014Member_c30a7b6e-e141-4426-8985-1e44c8c1fbba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_01c44b36-32ad-4020-8b5a-e127187d6a1b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f59b2d4a-257f-4bd6-a164-86bc6db0ebe9" xlink:to="loc_srt_RangeAxis_01c44b36-32ad-4020-8b5a-e127187d6a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d9e497fc-0d96-4605-a098-e03043d2c426" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_01c44b36-32ad-4020-8b5a-e127187d6a1b" xlink:to="loc_srt_RangeMember_d9e497fc-0d96-4605-a098-e03043d2c426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8df617c6-6b29-452a-91b2-9599896a5efb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d9e497fc-0d96-4605-a098-e03043d2c426" xlink:to="loc_srt_MinimumMember_8df617c6-6b29-452a-91b2-9599896a5efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1213637b-1465-4658-9db1-5539c66b951c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d9e497fc-0d96-4605-a098-e03043d2c426" xlink:to="loc_srt_MaximumMember_1213637b-1465-4658-9db1-5539c66b951c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ea868fbd-7460-4e06-8c16-b60ffd3b9f23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f59b2d4a-257f-4bd6-a164-86bc6db0ebe9" xlink:to="loc_us-gaap_VariableRateAxis_ea868fbd-7460-4e06-8c16-b60ffd3b9f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_a7295783-b0e4-4352-b7fe-12cd3e82141c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_ea868fbd-7460-4e06-8c16-b60ffd3b9f23" xlink:to="loc_us-gaap_VariableRateDomain_a7295783-b0e4-4352-b7fe-12cd3e82141c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_7a610926-0542-45e5-b3a4-539487acea8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_a7295783-b0e4-4352-b7fe-12cd3e82141c" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_7a610926-0542-45e5-b3a4-539487acea8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_da1cfc66-36ed-4d3b-88c9-8532ce8c82fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f59b2d4a-257f-4bd6-a164-86bc6db0ebe9" xlink:to="loc_us-gaap_DebtInstrumentLineItems_da1cfc66-36ed-4d3b-88c9-8532ce8c82fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e8ea67da-5ed4-436b-9d06-83c363777e82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da1cfc66-36ed-4d3b-88c9-8532ce8c82fc" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e8ea67da-5ed4-436b-9d06-83c363777e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_6b520a98-32c5-4fc0-9952-08d87d59ec63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da1cfc66-36ed-4d3b-88c9-8532ce8c82fc" xlink:to="loc_us-gaap_LongTermDebtCurrent_6b520a98-32c5-4fc0-9952-08d87d59ec63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e6cad13e-5285-4844-bacc-222e3565401d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da1cfc66-36ed-4d3b-88c9-8532ce8c82fc" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e6cad13e-5285-4844-bacc-222e3565401d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentLIBORFloorRate_a78662ae-65b1-4ed4-a644-c9174e84769f" xlink:href="livn-20200930.xsd#livn_DebtInstrumentLIBORFloorRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da1cfc66-36ed-4d3b-88c9-8532ce8c82fc" xlink:to="loc_livn_DebtInstrumentLIBORFloorRate_a78662ae-65b1-4ed4-a644-c9174e84769f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1a642446-31d2-44d3-b755-96b5bdcb62b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da1cfc66-36ed-4d3b-88c9-8532ce8c82fc" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1a642446-31d2-44d3-b755-96b5bdcb62b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_17eb0c07-8f75-4479-9b3a-6d410ee8935d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da1cfc66-36ed-4d3b-88c9-8532ce8c82fc" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_17eb0c07-8f75-4479-9b3a-6d410ee8935d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FinancingArrangementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0c3e2100-65e6-446b-a870-249a2c9598ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_792eb119-1dec-4d7e-bd75-0cba9a99acd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0c3e2100-65e6-446b-a870-249a2c9598ec" xlink:to="loc_us-gaap_DebtInstrumentTable_792eb119-1dec-4d7e-bd75-0cba9a99acd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_366e1577-5a41-40cf-9052-531084a15cc2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_792eb119-1dec-4d7e-bd75-0cba9a99acd4" xlink:to="loc_srt_RangeAxis_366e1577-5a41-40cf-9052-531084a15cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_107ca5ad-b8c5-47c5-b4a1-dabb8cc064bf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_366e1577-5a41-40cf-9052-531084a15cc2" xlink:to="loc_srt_RangeMember_107ca5ad-b8c5-47c5-b4a1-dabb8cc064bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e41b59fd-dbac-447a-9f95-0095e6404d18" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_107ca5ad-b8c5-47c5-b4a1-dabb8cc064bf" xlink:to="loc_srt_MinimumMember_e41b59fd-dbac-447a-9f95-0095e6404d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cd983414-9762-4f40-a016-d9bc3b3d53a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_107ca5ad-b8c5-47c5-b4a1-dabb8cc064bf" xlink:to="loc_srt_MaximumMember_cd983414-9762-4f40-a016-d9bc3b3d53a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a02053db-2a74-4c44-a8d9-0548df5d914a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_792eb119-1dec-4d7e-bd75-0cba9a99acd4" xlink:to="loc_us-gaap_CreditFacilityAxis_a02053db-2a74-4c44-a8d9-0548df5d914a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c91406b4-43ab-4511-bf5b-63d0c2a1f795" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_a02053db-2a74-4c44-a8d9-0548df5d914a" xlink:to="loc_us-gaap_CreditFacilityDomain_c91406b4-43ab-4511-bf5b-63d0c2a1f795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1d7e9d4e-bd33-4f5a-973b-26aab8519eae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c91406b4-43ab-4511-bf5b-63d0c2a1f795" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1d7e9d4e-bd33-4f5a-973b-26aab8519eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1deffb2f-6dc5-4508-bc35-137b60c9ce29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_792eb119-1dec-4d7e-bd75-0cba9a99acd4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1deffb2f-6dc5-4508-bc35-137b60c9ce29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f97a20bc-06ae-4313-ada1-8ca3e26714c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1deffb2f-6dc5-4508-bc35-137b60c9ce29" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f97a20bc-06ae-4313-ada1-8ca3e26714c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_ad5e8435-a092-4dfb-9aa5-52264f4f5f5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f97a20bc-06ae-4313-ada1-8ca3e26714c9" xlink:to="loc_us-gaap_SeniorNotesMember_ad5e8435-a092-4dfb-9aa5-52264f4f5f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_0df0f31e-fd61-49e4-8a14-8047c0070282" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f97a20bc-06ae-4313-ada1-8ca3e26714c9" xlink:to="loc_us-gaap_SecuredDebtMember_0df0f31e-fd61-49e4-8a14-8047c0070282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_b4c8a5cd-584f-48dd-ab0a-ce9494835d1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_792eb119-1dec-4d7e-bd75-0cba9a99acd4" xlink:to="loc_us-gaap_VariableRateAxis_b4c8a5cd-584f-48dd-ab0a-ce9494835d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_396339bf-12f6-490a-a401-6845bd581a5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_b4c8a5cd-584f-48dd-ab0a-ce9494835d1c" xlink:to="loc_us-gaap_VariableRateDomain_396339bf-12f6-490a-a401-6845bd581a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_8fac2632-2f42-485c-a14a-647531520fb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_396339bf-12f6-490a-a401-6845bd581a5e" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_8fac2632-2f42-485c-a14a-647531520fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e43207de-c017-4395-9b4f-e4ece90d1d56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_792eb119-1dec-4d7e-bd75-0cba9a99acd4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e43207de-c017-4395-9b4f-e4ece90d1d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_dddb44bc-b81f-48b2-9e36-b7a9ddcccbed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e43207de-c017-4395-9b4f-e4ece90d1d56" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_dddb44bc-b81f-48b2-9e36-b7a9ddcccbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CappedCallMember_b31ef92f-284d-4822-b3ee-f1b9209c23eb" xlink:href="livn-20200930.xsd#livn_CappedCallMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dddb44bc-b81f-48b2-9e36-b7a9ddcccbed" xlink:to="loc_livn_CappedCallMember_b31ef92f-284d-4822-b3ee-f1b9209c23eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_792eb119-1dec-4d7e-bd75-0cba9a99acd4" xlink:to="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_d05480e0-680d-481d-87f4-756631ceead8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_ShortTermBorrowings_d05480e0-680d-481d-87f4-756631ceead8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c30f2a43-d509-4210-82ec-568b0a197997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c30f2a43-d509-4210-82ec-568b0a197997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_a914d1c7-666f-44e5-a614-ae7bda35d020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DebtInstrumentTerm_a914d1c7-666f-44e5-a614-ae7bda35d020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_d2602415-2443-422d-abf2-24905a5a3cfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_d2602415-2443-422d-abf2-24905a5a3cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm_ad4f7aba-d64d-4cfc-8f66-3ee3bacebe5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_LongTermDebtTerm_ad4f7aba-d64d-4cfc-8f66-3ee3bacebe5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_57df022b-6dab-48d5-98b1-d7e5fa0ed751" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_57df022b-6dab-48d5-98b1-d7e5fa0ed751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentLIBORFloorRate_0d9515d4-28a6-4487-970b-0f310cb00886" xlink:href="livn-20200930.xsd#livn_DebtInstrumentLIBORFloorRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_livn_DebtInstrumentLIBORFloorRate_0d9515d4-28a6-4487-970b-0f310cb00886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a4eaa699-2be3-41a2-9b2e-39375d6e6ff2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a4eaa699-2be3-41a2-9b2e-39375d6e6ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentCovenantMinimumNetRevenue_87b6a9f7-936c-4520-b4be-5820b51171a0" xlink:href="livn-20200930.xsd#livn_DebtInstrumentCovenantMinimumNetRevenue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_livn_DebtInstrumentCovenantMinimumNetRevenue_87b6a9f7-936c-4520-b4be-5820b51171a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentCovenantMinimumProRataNetRevenues_5e88af0f-32a4-41db-ad8d-d5704273d24a" xlink:href="livn-20200930.xsd#livn_DebtInstrumentCovenantMinimumProRataNetRevenues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_livn_DebtInstrumentCovenantMinimumProRataNetRevenues_5e88af0f-32a4-41db-ad8d-d5704273d24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_4e8bd3c0-ddea-41a1-89d1-3f120c49077d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_4e8bd3c0-ddea-41a1-89d1-3f120c49077d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_40a6550e-a462-46b1-bbec-7e54ad00ff8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_40a6550e-a462-46b1-bbec-7e54ad00ff8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b0931f27-4d85-455d-98b3-79829485eba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b0931f27-4d85-455d-98b3-79829485eba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_3ec1e1c2-f772-40ee-8c92-f77d882d99da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_bc0ef966-1a2b-4199-906b-b6efede36999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_bc0ef966-1a2b-4199-906b-b6efede36999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_333506c7-5357-47c2-bf14-9da6a590bec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_333506c7-5357-47c2-bf14-9da6a590bec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentExchangeableConversionRatio_74664bb6-9b3e-435d-bf9c-87ca6de474da" xlink:href="livn-20200930.xsd#livn_DebtInstrumentExchangeableConversionRatio"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_livn_DebtInstrumentExchangeableConversionRatio_74664bb6-9b3e-435d-bf9c-87ca6de474da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentOptionToExchangePricePerShare_328b11cd-65ce-4f06-9ec7-ee474267bf00" xlink:href="livn-20200930.xsd#livn_DebtInstrumentOptionToExchangePricePerShare"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_livn_DebtInstrumentOptionToExchangePricePerShare_328b11cd-65ce-4f06-9ec7-ee474267bf00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice_efc7ce54-5c14-4baa-afe4-6986bd7ae5b8" xlink:href="livn-20200930.xsd#livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice_efc7ce54-5c14-4baa-afe4-6986bd7ae5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentRedemptionThresholdTradingDays_cb78a60f-4c14-4989-abb1-faaa03b0568d" xlink:href="livn-20200930.xsd#livn_DebtInstrumentRedemptionThresholdTradingDays"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_livn_DebtInstrumentRedemptionThresholdTradingDays_cb78a60f-4c14-4989-abb1-faaa03b0568d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays_6ba89a5a-7414-4f81-8c88-1e9e8e1864b0" xlink:href="livn-20200930.xsd#livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays_6ba89a5a-7414-4f81-8c88-1e9e8e1864b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_75a05bed-f1b8-4797-a32a-59cbed8f2aa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_75a05bed-f1b8-4797-a32a-59cbed8f2aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_9130968a-c8f3-4dc0-8908-d2f303d91e84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_9130968a-c8f3-4dc0-8908-d2f303d91e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DerivativeCapPricePerShare_1b965e48-b7c5-4ee1-9c39-7ea6bc828313" xlink:href="livn-20200930.xsd#livn_DerivativeCapPricePerShare"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_livn_DerivativeCapPricePerShare_1b965e48-b7c5-4ee1-9c39-7ea6bc828313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCostOfHedge_64416a71-3b0d-468f-8e54-630c83be553b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCostOfHedge"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DerivativeCostOfHedge_64416a71-3b0d-468f-8e54-630c83be553b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_c8f74be5-3947-4ebe-bf12-1ad94c4b413e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_DerivativeAssets_c8f74be5-3947-4ebe-bf12-1ad94c4b413e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_d5550723-1191-49d4-9ce8-cb230c7c6736" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_RepaymentsOfDebt_d5550723-1191-49d4-9ce8-cb230c7c6736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3f43cabc-cdc2-4f72-bae1-10cdde0fa056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b6af18-06ab-4b42-b040-b3dd8374d031" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3f43cabc-cdc2-4f72-bae1-10cdde0fa056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/FinancingArrangementsLeverageRatiosDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#FinancingArrangementsLeverageRatiosDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/FinancingArrangementsLeverageRatiosDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_50a55d04-9b32-4a04-8733-5744f6ea4f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodOne_11ee9c61-ba59-4c1b-8537-d2839ce272cb" xlink:href="livn-20200930.xsd#livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodOne"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_50a55d04-9b32-4a04-8733-5744f6ea4f7c" xlink:to="loc_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodOne_11ee9c61-ba59-4c1b-8537-d2839ce272cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo_13d6f22d-8755-46a9-aa5a-d9180c9005e6" xlink:href="livn-20200930.xsd#livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_50a55d04-9b32-4a04-8733-5744f6ea4f7c" xlink:to="loc_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo_13d6f22d-8755-46a9-aa5a-d9180c9005e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagement" xlink:type="simple" xlink:href="livn-20200930.xsd#DerivativesandRiskManagement"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c4d0ef25-3bdf-4d24-bf3b-990426fff8ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_d4fe4621-b002-4f25-9189-5c971c8198ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c4d0ef25-3bdf-4d24-bf3b-990426fff8ea" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_d4fe4621-b002-4f25-9189-5c971c8198ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementTables" xlink:type="simple" xlink:href="livn-20200930.xsd#DerivativesandRiskManagementTables"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_84882c9f-c0a8-4967-be84-8f1fd2584d8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_fc0e8630-e5e7-4d69-9b7a-3d4f85116ccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_84882c9f-c0a8-4967-be84-8f1fd2584d8c" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_fc0e8630-e5e7-4d69-9b7a-3d4f85116ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_bb963a34-1be2-447b-b897-721b1ae61159" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_84882c9f-c0a8-4967-be84-8f1fd2584d8c" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_bb963a34-1be2-447b-b897-721b1ae61159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_15f30452-3f88-4145-ba2f-185d818f0021" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_84882c9f-c0a8-4967-be84-8f1fd2584d8c" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_15f30452-3f88-4145-ba2f-185d818f0021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#DerivativesandRiskManagementNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e06e96b2-a58e-4561-bc9c-2a6899b12610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c57fd0c2-ee95-4c09-8e26-44c3daf173c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e06e96b2-a58e-4561-bc9c-2a6899b12610" xlink:to="loc_us-gaap_DerivativeTable_c57fd0c2-ee95-4c09-8e26-44c3daf173c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_69921f58-4688-4ba3-a855-7dcd6cc4dfbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c57fd0c2-ee95-4c09-8e26-44c3daf173c8" xlink:to="loc_us-gaap_HedgingDesignationAxis_69921f58-4688-4ba3-a855-7dcd6cc4dfbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0f86ed6f-38c1-4cc7-9e28-45c66868c0b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_69921f58-4688-4ba3-a855-7dcd6cc4dfbb" xlink:to="loc_us-gaap_HedgingDesignationDomain_0f86ed6f-38c1-4cc7-9e28-45c66868c0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_3d7ef933-4d3a-4c83-b56b-17f1158673f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_0f86ed6f-38c1-4cc7-9e28-45c66868c0b8" xlink:to="loc_us-gaap_NondesignatedMember_3d7ef933-4d3a-4c83-b56b-17f1158673f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e9ac3013-7671-46d8-94af-671d1bc5c1e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c57fd0c2-ee95-4c09-8e26-44c3daf173c8" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e9ac3013-7671-46d8-94af-671d1bc5c1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_65b64740-b9a4-457a-a28f-dfc376825059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e9ac3013-7671-46d8-94af-671d1bc5c1e4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_65b64740-b9a4-457a-a28f-dfc376825059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ForeignExchangeandOtherMember_0d7191c1-0adb-4d7f-811e-869adc736127" xlink:href="livn-20200930.xsd#livn_ForeignExchangeandOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_65b64740-b9a4-457a-a28f-dfc376825059" xlink:to="loc_livn_ForeignExchangeandOtherMember_0d7191c1-0adb-4d7f-811e-869adc736127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f4e5794e-1707-48f9-b333-d17fa3050e3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c57fd0c2-ee95-4c09-8e26-44c3daf173c8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f4e5794e-1707-48f9-b333-d17fa3050e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3305cdf6-1886-437e-ac76-f9ee419361c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f4e5794e-1707-48f9-b333-d17fa3050e3d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3305cdf6-1886-437e-ac76-f9ee419361c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f5e5e1a1-1fc4-48d1-a1d2-de2853197b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3305cdf6-1886-437e-ac76-f9ee419361c0" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f5e5e1a1-1fc4-48d1-a1d2-de2853197b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_47fde123-fd88-473c-ba68-aa583d7a3c20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c57fd0c2-ee95-4c09-8e26-44c3daf173c8" xlink:to="loc_us-gaap_DerivativeLineItems_47fde123-fd88-473c-ba68-aa583d7a3c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_1f6890f0-987a-4e04-b7bd-1ec3b5791a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_47fde123-fd88-473c-ba68-aa583d7a3c20" xlink:to="loc_us-gaap_DerivativeNotionalAmount_1f6890f0-987a-4e04-b7bd-1ec3b5791a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_14f867ca-e6f4-4d81-b245-1696467afe5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_47fde123-fd88-473c-ba68-aa583d7a3c20" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_14f867ca-e6f4-4d81-b245-1696467afe5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#DerivativesandRiskManagementDerivativeNotionalAmountsDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9e0095d9-7850-4dbd-a354-ea9ec59bb34e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ab4b446c-e148-41f3-a2b9-102eb0ba2d9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9e0095d9-7850-4dbd-a354-ea9ec59bb34e" xlink:to="loc_us-gaap_DerivativeTable_ab4b446c-e148-41f3-a2b9-102eb0ba2d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_96d78d3e-5ae0-4660-8266-bece441473c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ab4b446c-e148-41f3-a2b9-102eb0ba2d9b" xlink:to="loc_us-gaap_HedgingDesignationAxis_96d78d3e-5ae0-4660-8266-bece441473c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5bed95f2-b134-47fe-885a-a231e121d5a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_96d78d3e-5ae0-4660-8266-bece441473c1" xlink:to="loc_us-gaap_HedgingDesignationDomain_5bed95f2-b134-47fe-885a-a231e121d5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_77332308-108e-4a9d-ac94-9ffcccc7781c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5bed95f2-b134-47fe-885a-a231e121d5a0" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_77332308-108e-4a9d-ac94-9ffcccc7781c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2e9790b3-72e3-42e9-afae-e6d865ac7b32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ab4b446c-e148-41f3-a2b9-102eb0ba2d9b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2e9790b3-72e3-42e9-afae-e6d865ac7b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_99f47454-51d7-476b-a39f-5dd591f6dce4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2e9790b3-72e3-42e9-afae-e6d865ac7b32" xlink:to="loc_us-gaap_HedgingRelationshipDomain_99f47454-51d7-476b-a39f-5dd591f6dce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_e52e16e4-1a47-463c-a9f8-7911d91262a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_99f47454-51d7-476b-a39f-5dd591f6dce4" xlink:to="loc_us-gaap_CashFlowHedgingMember_e52e16e4-1a47-463c-a9f8-7911d91262a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f0ad6fa4-d1a5-419e-b0ed-2e07d1fcb416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ab4b446c-e148-41f3-a2b9-102eb0ba2d9b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f0ad6fa4-d1a5-419e-b0ed-2e07d1fcb416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_db2347da-4419-4255-ace0-b0290fcf22e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f0ad6fa4-d1a5-419e-b0ed-2e07d1fcb416" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_db2347da-4419-4255-ace0-b0290fcf22e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_9fdba410-d265-42e6-9c36-da605e22a3c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_db2347da-4419-4255-ace0-b0290fcf22e1" xlink:to="loc_us-gaap_ForeignExchangeContractMember_9fdba410-d265-42e6-9c36-da605e22a3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_1cdc13be-32be-44db-8902-3dd6e751ae24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_db2347da-4419-4255-ace0-b0290fcf22e1" xlink:to="loc_us-gaap_InterestRateSwapMember_1cdc13be-32be-44db-8902-3dd6e751ae24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_1f2aa6b8-e274-4ecd-a848-483d2449de58" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ab4b446c-e148-41f3-a2b9-102eb0ba2d9b" xlink:to="loc_srt_CurrencyAxis_1f2aa6b8-e274-4ecd-a848-483d2449de58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_12a0d1be-9213-4fe6-a8e4-c83dd84e1745" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_1f2aa6b8-e274-4ecd-a848-483d2449de58" xlink:to="loc_currency_AllCurrenciesDomain_12a0d1be-9213-4fe6-a8e4-c83dd84e1745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_db56f679-aa69-43a2-8bd4-2c78ecc4c34c" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_GBP"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_12a0d1be-9213-4fe6-a8e4-c83dd84e1745" xlink:to="loc_currency_GBP_db56f679-aa69-43a2-8bd4-2c78ecc4c34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_ecd744c9-992c-4840-8eaf-b30ab4de8176" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_JPY"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_12a0d1be-9213-4fe6-a8e4-c83dd84e1745" xlink:to="loc_currency_JPY_ecd744c9-992c-4840-8eaf-b30ab4de8176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_622acf98-9b7b-464e-b0ea-968e49169280" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_EUR"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_12a0d1be-9213-4fe6-a8e4-c83dd84e1745" xlink:to="loc_currency_EUR_622acf98-9b7b-464e-b0ea-968e49169280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_aa0b77b1-d3e4-4ad2-ab23-4318acb97c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ab4b446c-e148-41f3-a2b9-102eb0ba2d9b" xlink:to="loc_us-gaap_DerivativeLineItems_aa0b77b1-d3e4-4ad2-ab23-4318acb97c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_e3cd8d61-627d-4ecd-b012-ec93d0454eb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_aa0b77b1-d3e4-4ad2-ab23-4318acb97c2a" xlink:to="loc_us-gaap_DerivativeNotionalAmount_e3cd8d61-627d-4ecd-b012-ec93d0454eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8bb2fe19-3612-4a16-94cb-5df0e5b9e5f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_69061af2-2569-4974-a8f2-7c702c296732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8bb2fe19-3612-4a16-94cb-5df0e5b9e5f0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_69061af2-2569-4974-a8f2-7c702c296732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_13be35cc-dd03-40a0-99aa-4df9df20d22f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_69061af2-2569-4974-a8f2-7c702c296732" xlink:to="loc_us-gaap_HedgingDesignationAxis_13be35cc-dd03-40a0-99aa-4df9df20d22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2268fbd8-8c88-44b2-ad0f-cf5d5cc2ba26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_13be35cc-dd03-40a0-99aa-4df9df20d22f" xlink:to="loc_us-gaap_HedgingDesignationDomain_2268fbd8-8c88-44b2-ad0f-cf5d5cc2ba26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1d4abdee-d980-4062-aa5d-87c03003be6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_2268fbd8-8c88-44b2-ad0f-cf5d5cc2ba26" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1d4abdee-d980-4062-aa5d-87c03003be6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_349850e5-48a6-48f4-93fb-67b8c2c74a01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_69061af2-2569-4974-a8f2-7c702c296732" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_349850e5-48a6-48f4-93fb-67b8c2c74a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_644063bb-366b-40fc-9ff8-e805555913be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_349850e5-48a6-48f4-93fb-67b8c2c74a01" xlink:to="loc_us-gaap_HedgingRelationshipDomain_644063bb-366b-40fc-9ff8-e805555913be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_38c27ecb-fc39-45af-b9ca-32d3b662961e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_644063bb-366b-40fc-9ff8-e805555913be" xlink:to="loc_us-gaap_CashFlowHedgingMember_38c27ecb-fc39-45af-b9ca-32d3b662961e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_34dd76de-1732-4c71-a81e-ebb593756544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_69061af2-2569-4974-a8f2-7c702c296732" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_34dd76de-1732-4c71-a81e-ebb593756544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e4e9135f-1de4-41da-8b0b-68b12c4cc8a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_34dd76de-1732-4c71-a81e-ebb593756544" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e4e9135f-1de4-41da-8b0b-68b12c4cc8a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_1550d41c-b3c7-41f7-b1da-8334a8c317f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e4e9135f-1de4-41da-8b0b-68b12c4cc8a3" xlink:to="loc_us-gaap_ForeignExchangeContractMember_1550d41c-b3c7-41f7-b1da-8334a8c317f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_68924b83-b35c-4308-ba2c-a746cd945fe4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e4e9135f-1de4-41da-8b0b-68b12c4cc8a3" xlink:to="loc_us-gaap_InterestRateSwapMember_68924b83-b35c-4308-ba2c-a746cd945fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_aefecce7-8cb9-4253-90b0-5184cb5a6140" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_69061af2-2569-4974-a8f2-7c702c296732" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_aefecce7-8cb9-4253-90b0-5184cb5a6140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dc34677f-fea8-4732-9ad3-151e5f0fd09b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_aefecce7-8cb9-4253-90b0-5184cb5a6140" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dc34677f-fea8-4732-9ad3-151e5f0fd09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ForeignExchangeandOtherMember_62954408-c969-45d2-b72a-3dbe98046d8c" xlink:href="livn-20200930.xsd#livn_ForeignExchangeandOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dc34677f-fea8-4732-9ad3-151e5f0fd09b" xlink:to="loc_livn_ForeignExchangeandOtherMember_62954408-c969-45d2-b72a-3dbe98046d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_636926c5-77e5-4df6-8452-33fe9c149ff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dc34677f-fea8-4732-9ad3-151e5f0fd09b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_636926c5-77e5-4df6-8452-33fe9c149ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_c28aefe9-9aa8-404d-b09b-32bdc0c6b69d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dc34677f-fea8-4732-9ad3-151e5f0fd09b" xlink:to="loc_us-gaap_InterestExpenseMember_c28aefe9-9aa8-404d-b09b-32bdc0c6b69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d50ee6c1-88db-466c-a883-d3377b4ef463" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_69061af2-2569-4974-a8f2-7c702c296732" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d50ee6c1-88db-466c-a883-d3377b4ef463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_5a509bf5-5d2a-4414-b294-649e0bc6d4fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d50ee6c1-88db-466c-a883-d3377b4ef463" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_5a509bf5-5d2a-4414-b294-649e0bc6d4fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d6685bd3-eb46-4106-b627-a8ad8ab1527a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d50ee6c1-88db-466c-a883-d3377b4ef463" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d6685bd3-eb46-4106-b627-a8ad8ab1527a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_bf7af7e5-9f83-4159-be3a-76a018c9a5eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d50ee6c1-88db-466c-a883-d3377b4ef463" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_bf7af7e5-9f83-4159-be3a-76a018c9a5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_632d897b-155b-4de4-8279-2d6c8f6773c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d50ee6c1-88db-466c-a883-d3377b4ef463" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_632d897b-155b-4de4-8279-2d6c8f6773c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a76fcace-9f7f-4c56-a779-3d8472d05283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b7c509d4-8745-455d-b8ab-5df472c9ca73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a76fcace-9f7f-4c56-a779-3d8472d05283" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b7c509d4-8745-455d-b8ab-5df472c9ca73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_6c6ea401-a554-4388-9588-c8a1dd8ef2b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b7c509d4-8745-455d-b8ab-5df472c9ca73" xlink:to="loc_us-gaap_HedgingDesignationAxis_6c6ea401-a554-4388-9588-c8a1dd8ef2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a74412b8-6eee-49e9-ae89-8b46e3b5c76b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_6c6ea401-a554-4388-9588-c8a1dd8ef2b1" xlink:to="loc_us-gaap_HedgingDesignationDomain_a74412b8-6eee-49e9-ae89-8b46e3b5c76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6d99ce1a-aa99-488e-8668-99412d0d15f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_a74412b8-6eee-49e9-ae89-8b46e3b5c76b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6d99ce1a-aa99-488e-8668-99412d0d15f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_93315254-f2e8-4ee6-8d35-549996e32692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_a74412b8-6eee-49e9-ae89-8b46e3b5c76b" xlink:to="loc_us-gaap_NondesignatedMember_93315254-f2e8-4ee6-8d35-549996e32692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c644c31f-6da6-4098-9b8c-1897a9d56175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b7c509d4-8745-455d-b8ab-5df472c9ca73" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c644c31f-6da6-4098-9b8c-1897a9d56175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_131b0347-9b7e-4877-b623-ff5d2a5704bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c644c31f-6da6-4098-9b8c-1897a9d56175" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_131b0347-9b7e-4877-b623-ff5d2a5704bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_5f1031f6-6002-4251-a570-14cda9a2eba2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_131b0347-9b7e-4877-b623-ff5d2a5704bf" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_5f1031f6-6002-4251-a570-14cda9a2eba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_cacaa3cb-2238-4998-8a14-745c329e8588" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_131b0347-9b7e-4877-b623-ff5d2a5704bf" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_cacaa3cb-2238-4998-8a14-745c329e8588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DerivativeLiabilitiesNoncurrentMember_64e9a792-c0ba-4893-a047-551f93b7cc4e" xlink:href="livn-20200930.xsd#livn_DerivativeLiabilitiesNoncurrentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_131b0347-9b7e-4877-b623-ff5d2a5704bf" xlink:to="loc_livn_DerivativeLiabilitiesNoncurrentMember_64e9a792-c0ba-4893-a047-551f93b7cc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_25bee94e-c19a-48fe-890e-299fedcb2952" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_131b0347-9b7e-4877-b623-ff5d2a5704bf" xlink:to="loc_us-gaap_OtherAssetsMember_25bee94e-c19a-48fe-890e-299fedcb2952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_50b9dcf8-da61-4186-967d-c293a95d2599" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b7c509d4-8745-455d-b8ab-5df472c9ca73" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_50b9dcf8-da61-4186-967d-c293a95d2599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_afcc4511-d2cb-4b28-a799-bd5378fae6d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_50b9dcf8-da61-4186-967d-c293a95d2599" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_afcc4511-d2cb-4b28-a799-bd5378fae6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_7177a812-62fa-45e2-a7cc-8111d040f297" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_afcc4511-d2cb-4b28-a799-bd5378fae6d1" xlink:to="loc_us-gaap_InterestRateContractMember_7177a812-62fa-45e2-a7cc-8111d040f297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_e464fd36-99bf-41ec-943c-53be33545301" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_afcc4511-d2cb-4b28-a799-bd5378fae6d1" xlink:to="loc_us-gaap_ForeignExchangeContractMember_e464fd36-99bf-41ec-943c-53be33545301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CappedCallMember_e9959edf-90c2-4c21-8365-f713c8f9b27a" xlink:href="livn-20200930.xsd#livn_CappedCallMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_afcc4511-d2cb-4b28-a799-bd5378fae6d1" xlink:to="loc_livn_CappedCallMember_e9959edf-90c2-4c21-8365-f713c8f9b27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_99ebd0b8-3df6-4f63-9928-62790c7e1334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_afcc4511-d2cb-4b28-a799-bd5378fae6d1" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_99ebd0b8-3df6-4f63-9928-62790c7e1334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_ea8e584a-2bc1-400a-b5aa-c0efba962368" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherContractMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_afcc4511-d2cb-4b28-a799-bd5378fae6d1" xlink:to="loc_us-gaap_OtherContractMember_ea8e584a-2bc1-400a-b5aa-c0efba962368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_d09849cf-829b-4660-8971-a5b1888f3b73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b7c509d4-8745-455d-b8ab-5df472c9ca73" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_d09849cf-829b-4660-8971-a5b1888f3b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_cadd2f4a-a8ea-45e1-90ce-0eb47dceeee8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_d09849cf-829b-4660-8971-a5b1888f3b73" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_cadd2f4a-a8ea-45e1-90ce-0eb47dceeee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e22bb1c5-c861-4d84-8452-6f4dc5ff3334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_d09849cf-829b-4660-8971-a5b1888f3b73" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e22bb1c5-c861-4d84-8452-6f4dc5ff3334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="livn-20200930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d58d86a0-7272-4f77-848b-5c19851bc2d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_32139852-de59-4ccf-8f2a-7ab774280cc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d58d86a0-7272-4f77-848b-5c19851bc2d1" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_32139852-de59-4ccf-8f2a-7ab774280cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="livn-20200930.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a1472b6b-163a-451a-b402-ad35f3425536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_0c4b2d76-9188-4a33-855a-f2c9091f107c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a1472b6b-163a-451a-b402-ad35f3425536" xlink:to="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_0c4b2d76-9188-4a33-855a-f2c9091f107c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e870673c-308b-4571-988c-bccd102ce674" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_0beb2063-b1a2-4903-8a78-5603376e9edb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e870673c-308b-4571-988c-bccd102ce674" xlink:to="loc_us-gaap_OtherCommitmentsTable_0beb2063-b1a2-4903-8a78-5603376e9edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_85c075f4-1ad7-436a-905f-ac24edea881a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_0beb2063-b1a2-4903-8a78-5603376e9edb" xlink:to="loc_srt_LitigationCaseAxis_85c075f4-1ad7-436a-905f-ac24edea881a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_6908d3ab-0056-40ed-b123-5520edba1cbb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_85c075f4-1ad7-436a-905f-ac24edea881a" xlink:to="loc_srt_LitigationCaseTypeDomain_6908d3ab-0056-40ed-b123-5520edba1cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_FDAWarningLetterMember_f2600422-aaac-4998-a512-dd6437d67a2b" xlink:href="livn-20200930.xsd#livn_FDAWarningLetterMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_6908d3ab-0056-40ed-b123-5520edba1cbb" xlink:to="loc_livn_FDAWarningLetterMember_f2600422-aaac-4998-a512-dd6437d67a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductLiabilityMember_f06e48c9-3e8f-42ce-9952-25c4b26e2124" xlink:href="livn-20200930.xsd#livn_ProductLiabilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_6908d3ab-0056-40ed-b123-5520edba1cbb" xlink:to="loc_livn_ProductLiabilityMember_f06e48c9-3e8f-42ce-9952-25c4b26e2124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_SNIAMember_2f7cfdf2-d387-4cae-8e7c-3e65efc0c666" xlink:href="livn-20200930.xsd#livn_SNIAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_6908d3ab-0056-40ed-b123-5520edba1cbb" xlink:to="loc_livn_SNIAMember_2f7cfdf2-d387-4cae-8e7c-3e65efc0c666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a155360f-35dd-49f4-8528-124361a7c91e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_0beb2063-b1a2-4903-8a78-5603376e9edb" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a155360f-35dd-49f4-8528-124361a7c91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c90fcdf1-70e3-41e5-83c9-c3064cc65efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a155360f-35dd-49f4-8528-124361a7c91e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c90fcdf1-70e3-41e5-83c9-c3064cc65efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a34e9e98-c43b-4105-b504-9f9f0c412ffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c90fcdf1-70e3-41e5-83c9-c3064cc65efe" xlink:to="loc_us-gaap_SubsequentEventMember_a34e9e98-c43b-4105-b504-9f9f0c412ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_258dc51c-6986-40b1-8514-422dca470f11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_0beb2063-b1a2-4903-8a78-5603376e9edb" xlink:to="loc_us-gaap_LitigationStatusAxis_258dc51c-6986-40b1-8514-422dca470f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_a92c79b0-e3c1-4bc3-b7b7-de9f2a304dca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_258dc51c-6986-40b1-8514-422dca470f11" xlink:to="loc_us-gaap_LitigationStatusDomain_a92c79b0-e3c1-4bc3-b7b7-de9f2a304dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ThreatenedLitigationMember_87d1a7b2-5fdd-4da0-8634-dd6407784287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ThreatenedLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_a92c79b0-e3c1-4bc3-b7b7-de9f2a304dca" xlink:to="loc_us-gaap_ThreatenedLitigationMember_87d1a7b2-5fdd-4da0-8634-dd6407784287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_65d786bb-48ee-444f-b706-e8251bf6c5cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_a92c79b0-e3c1-4bc3-b7b7-de9f2a304dca" xlink:to="loc_us-gaap_PendingLitigationMember_65d786bb-48ee-444f-b706-e8251bf6c5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3e962464-89c1-4a06-940b-1c1775376e4e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_0beb2063-b1a2-4903-8a78-5603376e9edb" xlink:to="loc_dei_LegalEntityAxis_3e962464-89c1-4a06-940b-1c1775376e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b4eae528-2534-4415-9a36-946c33b0c862" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_3e962464-89c1-4a06-940b-1c1775376e4e" xlink:to="loc_dei_EntityDomain_b4eae528-2534-4415-9a36-946c33b0c862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_SNIAs.p.aMember_e32a95d2-1225-4c5d-ab1f-10348b91a02c" xlink:href="livn-20200930.xsd#livn_SNIAs.p.aMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_b4eae528-2534-4415-9a36-946c33b0c862" xlink:to="loc_livn_SNIAs.p.aMember_e32a95d2-1225-4c5d-ab1f-10348b91a02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_03bd74da-2ee6-4c39-90d3-3a78a32772c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_0beb2063-b1a2-4903-8a78-5603376e9edb" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_03bd74da-2ee6-4c39-90d3-3a78a32772c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_fe2af561-ea80-404a-ae3e-100afc6d46c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_03bd74da-2ee6-4c39-90d3-3a78a32772c6" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_fe2af561-ea80-404a-ae3e-100afc6d46c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_RegionalInternalRevenueOfficeofLombardyMember_b500a29f-39eb-4574-8330-9b439d151d14" xlink:href="livn-20200930.xsd#livn_RegionalInternalRevenueOfficeofLombardyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_fe2af561-ea80-404a-ae3e-100afc6d46c1" xlink:to="loc_livn_RegionalInternalRevenueOfficeofLombardyMember_b500a29f-39eb-4574-8330-9b439d151d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e94c28c3-91ac-4e2e-8138-5b2999623b64" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_0beb2063-b1a2-4903-8a78-5603376e9edb" xlink:to="loc_srt_RangeAxis_e94c28c3-91ac-4e2e-8138-5b2999623b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cafa57ed-cc77-45e7-8e15-e721447ca282" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e94c28c3-91ac-4e2e-8138-5b2999623b64" xlink:to="loc_srt_RangeMember_cafa57ed-cc77-45e7-8e15-e721447ca282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c6239c84-ece7-4b2b-908a-fd7ea47597a0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cafa57ed-cc77-45e7-8e15-e721447ca282" xlink:to="loc_srt_MaximumMember_c6239c84-ece7-4b2b-908a-fd7ea47597a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_0beb2063-b1a2-4903-8a78-5603376e9edb" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_LossContingencyNumberofObservedNonConformities_90c52f00-bce8-435c-ba48-e1d7af4c7d35" xlink:href="livn-20200930.xsd#livn_LossContingencyNumberofObservedNonConformities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_livn_LossContingencyNumberofObservedNonConformities_90c52f00-bce8-435c-ba48-e1d7af4c7d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediationNet_69782142-1d39-4a10-913a-0d71a2d6bf7d" xlink:href="livn-20200930.xsd#livn_ProductRemediationNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_livn_ProductRemediationNet_69782142-1d39-4a10-913a-0d71a2d6bf7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_cfef18b1-a1a6-4890-b364-2e793ddb47d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_cfef18b1-a1a6-4890-b364-2e793ddb47d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_b0d1ed54-c478-459f-aa3f-54abd0ea9760" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_b0d1ed54-c478-459f-aa3f-54abd0ea9760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_d03f483a-24ad-48d5-a84f-a3ed0ddd0f21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_d03f483a-24ad-48d5-a84f-a3ed0ddd0f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_885f59cb-2924-4fe9-b26e-abae7edf4fc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_885f59cb-2924-4fe9-b26e-abae7edf4fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_c6ccd8af-d0de-4625-926b-8f57a3855625" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_c6ccd8af-d0de-4625-926b-8f57a3855625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ReimbursedLegalFees_2938576f-6580-40dd-9581-f033c125d10e" xlink:href="livn-20200930.xsd#livn_ReimbursedLegalFees"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_livn_ReimbursedLegalFees_2938576f-6580-40dd-9581-f033c125d10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_7b4bca84-ce21-49a5-8a5f-8d4108f327e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_7b4bca84-ce21-49a5-8a5f-8d4108f327e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_IncomeTaxExaminationOperatingLossesUnderDispute_161ad020-3b05-43fd-8fdd-3e72f49156b3" xlink:href="livn-20200930.xsd#livn_IncomeTaxExaminationOperatingLossesUnderDispute"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_livn_IncomeTaxExaminationOperatingLossesUnderDispute_161ad020-3b05-43fd-8fdd-3e72f49156b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_IncomeTaxExaminationNumberofInstallments_af2c436a-f033-45ae-8794-65eb30c7285b" xlink:href="livn-20200930.xsd#livn_IncomeTaxExaminationNumberofInstallments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_livn_IncomeTaxExaminationNumberofInstallments_af2c436a-f033-45ae-8794-65eb30c7285b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_LossContingencyNumberofAssessments_0794ce75-88f5-4294-b867-e686f17d1b3b" xlink:href="livn-20200930.xsd#livn_LossContingencyNumberofAssessments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_livn_LossContingencyNumberofAssessments_0794ce75-88f5-4294-b867-e686f17d1b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements_7b364da6-ce69-463e-972e-6d5f0e084ef8" xlink:href="livn-20200930.xsd#livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements_7b364da6-ce69-463e-972e-6d5f0e084ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_9f53feff-f639-4423-9098-6ed6091d91c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_9f53feff-f639-4423-9098-6ed6091d91c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6f50254d-3608-49b2-ac7b-1b35f999d669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6f50254d-3608-49b2-ac7b-1b35f999d669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1f8d5242-5470-4be2-9f02-419747e62872" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_a49cf224-bb88-4c09-8271-ccaf43fcc353" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1f8d5242-5470-4be2-9f02-419747e62872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#CommitmentsandContingenciesScheduleofProductLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_adcfc6c2-6467-4162-bd00-b3790fa23fbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_6b506416-9651-45dd-94dc-383ab5cc9649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_adcfc6c2-6467-4162-bd00-b3790fa23fbf" xlink:to="loc_us-gaap_LossContingenciesTable_6b506416-9651-45dd-94dc-383ab5cc9649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6393f5ac-ea57-4e0d-bf4f-1d88b17a991a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6b506416-9651-45dd-94dc-383ab5cc9649" xlink:to="loc_srt_LitigationCaseAxis_6393f5ac-ea57-4e0d-bf4f-1d88b17a991a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_bf39dc90-75be-4e01-bb60-f46711f9637e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_6393f5ac-ea57-4e0d-bf4f-1d88b17a991a" xlink:to="loc_srt_LitigationCaseTypeDomain_bf39dc90-75be-4e01-bb60-f46711f9637e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductLiabilityMember_946f114a-9227-4db6-8a13-82dbabae7e4e" xlink:href="livn-20200930.xsd#livn_ProductLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf39dc90-75be-4e01-bb60-f46711f9637e" xlink:to="loc_livn_ProductLiabilityMember_946f114a-9227-4db6-8a13-82dbabae7e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_96198bea-8ed7-4b55-943a-751ccab20b9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6b506416-9651-45dd-94dc-383ab5cc9649" xlink:to="loc_us-gaap_LossContingenciesLineItems_96198bea-8ed7-4b55-943a-751ccab20b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualRollForward_dca15d21-1e85-4cfa-bccb-9c32447390e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_96198bea-8ed7-4b55-943a-751ccab20b9d" xlink:to="loc_us-gaap_LossContingencyAccrualRollForward_dca15d21-1e85-4cfa-bccb-9c32447390e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_8afec213-ee3c-48d4-862f-82f89104a681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_dca15d21-1e85-4cfa-bccb-9c32447390e0" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_8afec213-ee3c-48d4-862f-82f89104a681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_c02d868e-6aee-4907-b4ea-53db3ebb2969" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_dca15d21-1e85-4cfa-bccb-9c32447390e0" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_c02d868e-6aee-4907-b4ea-53db3ebb2969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_LossContingencyAccrualAdjustments_66846ad4-6936-46fe-80d6-bb09c471cb13" xlink:href="livn-20200930.xsd#livn_LossContingencyAccrualAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_dca15d21-1e85-4cfa-bccb-9c32447390e0" xlink:to="loc_livn_LossContingencyAccrualAdjustments_66846ad4-6936-46fe-80d6-bb09c471cb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther_82262a41-1a56-419c-861d-5eecb435a701" xlink:href="livn-20200930.xsd#livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_dca15d21-1e85-4cfa-bccb-9c32447390e0" xlink:to="loc_livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther_82262a41-1a56-419c-861d-5eecb435a701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_5c1e4a41-3dd5-40b7-ac5b-4e4a187025a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_dca15d21-1e85-4cfa-bccb-9c32447390e0" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_5c1e4a41-3dd5-40b7-ac5b-4e4a187025a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_7e7c5f78-fef2-4cf5-b225-9e4ce33991b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_dca15d21-1e85-4cfa-bccb-9c32447390e0" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_7e7c5f78-fef2-4cf5-b225-9e4ce33991b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_5464f2d6-aa1e-4dec-9f44-e33cdda1f6a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_dca15d21-1e85-4cfa-bccb-9c32447390e0" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_5464f2d6-aa1e-4dec-9f44-e33cdda1f6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockholdersEquity" xlink:type="simple" xlink:href="livn-20200930.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_273c3383-c7be-4f51-9c0f-18bee50b23b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7d68b8f4-9b8e-4bd1-a696-bec53cb1c77e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_273c3383-c7be-4f51-9c0f-18bee50b23b6" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7d68b8f4-9b8e-4bd1-a696-bec53cb1c77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="livn-20200930.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0294737c-0be3-466b-a353-0e004c9b00e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_79036f20-34bd-4da0-98d4-95f9dc37333e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0294737c-0be3-466b-a353-0e004c9b00e6" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_79036f20-34bd-4da0-98d4-95f9dc37333e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8afdf2db-36e6-4a55-b5e5-a68559213755" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0294737c-0be3-466b-a353-0e004c9b00e6" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8afdf2db-36e6-4a55-b5e5-a68559213755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#StockholdersEquityStatementofStockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_019a2a2c-6428-4f6d-ab2e-1986d6d0d356" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_9f52a074-38d1-4798-8cde-3ac2da7b6fa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_019a2a2c-6428-4f6d-ab2e-1986d6d0d356" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_9f52a074-38d1-4798-8cde-3ac2da7b6fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b41c560a-13df-4993-858d-02a0e1defd83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9f52a074-38d1-4798-8cde-3ac2da7b6fa9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b41c560a-13df-4993-858d-02a0e1defd83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b7ffb966-246d-46d3-92db-0f385ac4beae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b41c560a-13df-4993-858d-02a0e1defd83" xlink:to="loc_us-gaap_EquityComponentDomain_b7ffb966-246d-46d3-92db-0f385ac4beae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_760f5460-f54f-4abb-8c85-8940b0fadcd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b7ffb966-246d-46d3-92db-0f385ac4beae" xlink:to="loc_us-gaap_CommonStockMember_760f5460-f54f-4abb-8c85-8940b0fadcd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_18f83d58-aaa8-4a09-828b-5a8dbcad1a55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b7ffb966-246d-46d3-92db-0f385ac4beae" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_18f83d58-aaa8-4a09-828b-5a8dbcad1a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_21c0e90c-2937-4f35-bce9-99e96e5a95a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b7ffb966-246d-46d3-92db-0f385ac4beae" xlink:to="loc_us-gaap_TreasuryStockMember_21c0e90c-2937-4f35-bce9-99e96e5a95a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3072e61-49e6-4140-a5d1-c51c132c83b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b7ffb966-246d-46d3-92db-0f385ac4beae" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3072e61-49e6-4140-a5d1-c51c132c83b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_30bd6fd6-8685-466d-b55f-0fb77bfd3a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b7ffb966-246d-46d3-92db-0f385ac4beae" xlink:to="loc_us-gaap_RetainedEarningsMember_30bd6fd6-8685-466d-b55f-0fb77bfd3a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2f7ec616-3586-42ab-aa31-6f9cfc13e4cd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9f52a074-38d1-4798-8cde-3ac2da7b6fa9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2f7ec616-3586-42ab-aa31-6f9cfc13e4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_af1702d8-589a-4722-91e2-1d7ca8210a1d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2f7ec616-3586-42ab-aa31-6f9cfc13e4cd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_af1702d8-589a-4722-91e2-1d7ca8210a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_831d5823-8d1b-4766-8c00-1d808a3a3ad0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_af1702d8-589a-4722-91e2-1d7ca8210a1d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_831d5823-8d1b-4766-8c00-1d808a3a3ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_28eaacff-1a60-480d-b58d-e5a6a5e03c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9f52a074-38d1-4798-8cde-3ac2da7b6fa9" xlink:to="loc_us-gaap_ClassOfStockLineItems_28eaacff-1a60-480d-b58d-e5a6a5e03c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_28eaacff-1a60-480d-b58d-e5a6a5e03c6e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_b5353a2b-69ae-4ab6-ae87-75498c62c982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:to="loc_us-gaap_CommonStockSharesIssued_b5353a2b-69ae-4ab6-ae87-75498c62c982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8a3d9ba6-80d1-41ea-8316-025a0e035f69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:to="loc_us-gaap_StockholdersEquity_8a3d9ba6-80d1-41ea-8316-025a0e035f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5b42e74a-a270-478b-93a0-72474c33d483" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5b42e74a-a270-478b-93a0-72474c33d483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_30d67578-4e12-4629-a174-8370944c6169" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_30d67578-4e12-4629-a174-8370944c6169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_268b29c6-7c45-4390-ad83-aa7f4bf88b28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_268b29c6-7c45-4390-ad83-aa7f4bf88b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4b077e9a-94cc-44dc-b723-a3198b97952c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:to="loc_us-gaap_NetIncomeLoss_4b077e9a-94cc-44dc-b723-a3198b97952c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_538e633c-d838-4e46-84e4-335b3db5bbd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_538e633c-d838-4e46-84e4-335b3db5bbd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_51576ded-f94f-4894-8290-b1b1de21de5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:to="loc_us-gaap_CommonStockSharesIssued_51576ded-f94f-4894-8290-b1b1de21de5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c472d5d2-78f9-40d2-bc89-27ccfda78966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b8468f8-1841-4336-9ee7-8d7b6309faa3" xlink:to="loc_us-gaap_StockholdersEquity_c472d5d2-78f9-40d2-bc89-27ccfda78966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_82e95706-dce7-4f0e-bb63-d800733407d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_28eaacff-1a60-480d-b58d-e5a6a5e03c6e" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_82e95706-dce7-4f0e-bb63-d800733407d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#StockholdersEquityComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_1b11c012-9e73-47b7-b905-a070f41e789c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a113b09a-d7b1-4f46-943f-97bb8a6b1af5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_1b11c012-9e73-47b7-b905-a070f41e789c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a113b09a-d7b1-4f46-943f-97bb8a6b1af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c1db9762-db72-48f6-b194-230efc6ec0a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a113b09a-d7b1-4f46-943f-97bb8a6b1af5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c1db9762-db72-48f6-b194-230efc6ec0a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_233cb239-f957-40da-9b9b-17a4431c1db6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c1db9762-db72-48f6-b194-230efc6ec0a1" xlink:to="loc_us-gaap_EquityComponentDomain_233cb239-f957-40da-9b9b-17a4431c1db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f854f69e-8942-4052-8e5a-51a878296a7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_233cb239-f957-40da-9b9b-17a4431c1db6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f854f69e-8942-4052-8e5a-51a878296a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0fcbfc22-fd3e-4d5f-8a05-c1dfa281f855" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f854f69e-8942-4052-8e5a-51a878296a7e" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0fcbfc22-fd3e-4d5f-8a05-c1dfa281f855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_da1c7df6-7c8e-4f68-9984-f708cadd48cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f854f69e-8942-4052-8e5a-51a878296a7e" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_da1c7df6-7c8e-4f68-9984-f708cadd48cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bb0e7b6b-50cb-4fb6-9794-36a59f8a7f27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a113b09a-d7b1-4f46-943f-97bb8a6b1af5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bb0e7b6b-50cb-4fb6-9794-36a59f8a7f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bb0e7b6b-50cb-4fb6-9794-36a59f8a7f27" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6ce06053-b11e-491f-8e4b-c28d9a3ce57d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:to="loc_us-gaap_StockholdersEquity_6ce06053-b11e-491f-8e4b-c28d9a3ce57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_066695de-6b31-4ef7-9f14-9439604d95ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_066695de-6b31-4ef7-9f14-9439604d95ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_231a3888-eb3b-44b0-a6d3-bf9b86a0ca65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_231a3888-eb3b-44b0-a6d3-bf9b86a0ca65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_40a8de91-d35f-4267-af41-0280022dfaa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_40a8de91-d35f-4267-af41-0280022dfaa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_5ffba87b-a207-4c02-83c2-5a5af5ac6f22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_5ffba87b-a207-4c02-83c2-5a5af5ac6f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_7ff03310-69bc-499c-80b5-65f36d008beb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_7ff03310-69bc-499c-80b5-65f36d008beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_5c28e9fa-9d14-4a48-8bb2-2b409a3cc209" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_5c28e9fa-9d14-4a48-8bb2-2b409a3cc209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_16df45f4-c7cd-4c5c-8cd6-22e7ea209b94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_16df45f4-c7cd-4c5c-8cd6-22e7ea209b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0aa79096-1347-4a33-8064-2974b1e88eed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6f045280-a096-44de-831b-f86750d930b7" xlink:to="loc_us-gaap_StockholdersEquity_0aa79096-1347-4a33-8064-2974b1e88eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlans" xlink:type="simple" xlink:href="livn-20200930.xsd#StockBasedIncentivePlans"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b840af0c-00aa-4c91-a9d1-21db54511003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7565e687-4b54-4500-95fb-f7859a9b678e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b840af0c-00aa-4c91-a9d1-21db54511003" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7565e687-4b54-4500-95fb-f7859a9b678e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansTables" xlink:type="simple" xlink:href="livn-20200930.xsd#StockBasedIncentivePlansTables"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b9a95ea1-ba2a-4430-bb5d-91959a02efaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e4f7b339-c113-4123-8f0e-1334fdca8975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b9a95ea1-ba2a-4430-bb5d-91959a02efaa" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e4f7b339-c113-4123-8f0e-1334fdca8975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#StockBasedIncentivePlansCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_469917ab-c9b9-456d-ac7b-1943fdadb3de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d4068707-e0eb-49d2-81ea-36c6b109f2cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_469917ab-c9b9-456d-ac7b-1943fdadb3de" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d4068707-e0eb-49d2-81ea-36c6b109f2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5f6c0c4c-3331-412a-9c0c-2fdd12b69ceb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d4068707-e0eb-49d2-81ea-36c6b109f2cf" xlink:to="loc_us-gaap_AwardTypeAxis_5f6c0c4c-3331-412a-9c0c-2fdd12b69ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f507150-7022-4500-b8e9-9025498bc4e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5f6c0c4c-3331-412a-9c0c-2fdd12b69ceb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f507150-7022-4500-b8e9-9025498bc4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2323a677-d9c5-4ba6-b314-99655b2aeb46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f507150-7022-4500-b8e9-9025498bc4e2" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2323a677-d9c5-4ba6-b314-99655b2aeb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_b4ab5895-2b03-4c75-9530-d65b406d2e30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f507150-7022-4500-b8e9-9025498bc4e2" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_b4ab5895-2b03-4c75-9530-d65b406d2e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MarketbasedPerformanceRestrictedStockUnitMember_0ee11906-ac8b-49f3-984d-07528abbf83d" xlink:href="livn-20200930.xsd#livn_MarketbasedPerformanceRestrictedStockUnitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f507150-7022-4500-b8e9-9025498bc4e2" xlink:to="loc_livn_MarketbasedPerformanceRestrictedStockUnitMember_0ee11906-ac8b-49f3-984d-07528abbf83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_OperatingPerformancebasedRestrictedStockUnitsMember_817bcb51-74e2-4328-b98a-73eac6e2bd1d" xlink:href="livn-20200930.xsd#livn_OperatingPerformancebasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f507150-7022-4500-b8e9-9025498bc4e2" xlink:to="loc_livn_OperatingPerformancebasedRestrictedStockUnitsMember_817bcb51-74e2-4328-b98a-73eac6e2bd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d73936c4-6f36-4c5f-acba-ee958ed949f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f507150-7022-4500-b8e9-9025498bc4e2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d73936c4-6f36-4c5f-acba-ee958ed949f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5a1b7c94-29b5-4145-9524-4b874400c7e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d4068707-e0eb-49d2-81ea-36c6b109f2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5a1b7c94-29b5-4145-9524-4b874400c7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_659f599c-88ba-4e3b-8ec0-16769cdcf440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5a1b7c94-29b5-4145-9524-4b874400c7e2" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_659f599c-88ba-4e3b-8ec0-16769cdcf440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5cc54c8b-af43-4416-830a-639de7ef0251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5a1b7c94-29b5-4145-9524-4b874400c7e2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5cc54c8b-af43-4416-830a-639de7ef0251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_de0fd291-2375-49dd-9917-b61e7adfa429" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5a1b7c94-29b5-4145-9524-4b874400c7e2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_de0fd291-2375-49dd-9917-b61e7adfa429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#StockBasedIncentivePlansExecutedAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_03b9da76-f9c0-4359-95c6-9759e15b6523" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_610a6714-5034-42b6-bd53-5c58604da29f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_03b9da76-f9c0-4359-95c6-9759e15b6523" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_610a6714-5034-42b6-bd53-5c58604da29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f4b6035b-9b59-4163-ba7e-c1ee3faf3faa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_610a6714-5034-42b6-bd53-5c58604da29f" xlink:to="loc_us-gaap_AwardTypeAxis_f4b6035b-9b59-4163-ba7e-c1ee3faf3faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06d22520-ff41-403e-85e2-8fbd9a7dd50e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f4b6035b-9b59-4163-ba7e-c1ee3faf3faa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06d22520-ff41-403e-85e2-8fbd9a7dd50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_15b2f222-0387-4e7c-b095-b071f3f072ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06d22520-ff41-403e-85e2-8fbd9a7dd50e" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_15b2f222-0387-4e7c-b095-b071f3f072ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_af5e2282-ce4e-47ce-a08b-a0b2ae183323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06d22520-ff41-403e-85e2-8fbd9a7dd50e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_af5e2282-ce4e-47ce-a08b-a0b2ae183323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_MarketbasedPerformanceRestrictedStockUnitMember_6deb26a8-8310-4b0a-bf1d-f73b5cbc47b7" xlink:href="livn-20200930.xsd#livn_MarketbasedPerformanceRestrictedStockUnitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06d22520-ff41-403e-85e2-8fbd9a7dd50e" xlink:to="loc_livn_MarketbasedPerformanceRestrictedStockUnitMember_6deb26a8-8310-4b0a-bf1d-f73b5cbc47b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_OperatingPerformancebasedRestrictedStockUnitsMember_01eb627d-a26b-4811-9b8b-241c468e3eac" xlink:href="livn-20200930.xsd#livn_OperatingPerformancebasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06d22520-ff41-403e-85e2-8fbd9a7dd50e" xlink:to="loc_livn_OperatingPerformancebasedRestrictedStockUnitsMember_01eb627d-a26b-4811-9b8b-241c468e3eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_853e8f5e-cc20-4a07-8d08-43f078eb2543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_610a6714-5034-42b6-bd53-5c58604da29f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_853e8f5e-cc20-4a07-8d08-43f078eb2543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8f4825b4-7b49-4303-8180-f5e066205886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_853e8f5e-cc20-4a07-8d08-43f078eb2543" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8f4825b4-7b49-4303-8180-f5e066205886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_81e0c200-1c2f-43e2-99fc-cc0c4e64a6bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_853e8f5e-cc20-4a07-8d08-43f078eb2543" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_81e0c200-1c2f-43e2-99fc-cc0c4e64a6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/IncomeTaxes" xlink:type="simple" xlink:href="livn-20200930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_56310f47-a650-4a30-9f32-493e28bd587c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_36f21c94-6015-4ea0-8873-2615cf37c5ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_56310f47-a650-4a30-9f32-493e28bd587c" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_36f21c94-6015-4ea0-8873-2615cf37c5ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_78402e79-1122-4684-8d12-1e4bc755bb40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f2edf8e3-ae6d-45fd-b120-362e2d4249a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78402e79-1122-4684-8d12-1e4bc755bb40" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f2edf8e3-ae6d-45fd-b120-362e2d4249a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_7bcfd027-3139-4a16-9253-b4fe88e31fb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78402e79-1122-4684-8d12-1e4bc755bb40" xlink:to="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_7bcfd027-3139-4a16-9253-b4fe88e31fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct_551e56e5-5966-4141-8b07-a42509513e6e" xlink:href="livn-20200930.xsd#livn_IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78402e79-1122-4684-8d12-1e4bc755bb40" xlink:to="loc_livn_IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct_551e56e5-5966-4141-8b07-a42509513e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_90dd9309-c1f7-4b22-876d-272572e55d1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78402e79-1122-4684-8d12-1e4bc755bb40" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_90dd9309-c1f7-4b22-876d-272572e55d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_99258a18-9965-4b90-b277-ab88a4f72833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78402e79-1122-4684-8d12-1e4bc755bb40" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_99258a18-9965-4b90-b277-ab88a4f72833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/EarningsPerShare" xlink:type="simple" xlink:href="livn-20200930.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_930b35d3-947c-4c76-b899-a4fd376bc67b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_ed4c1e76-1bbd-4c0a-8720-0b83f7f673cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_930b35d3-947c-4c76-b899-a4fd376bc67b" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_ed4c1e76-1bbd-4c0a-8720-0b83f7f673cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="livn-20200930.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_cadf9cee-39db-4899-a54f-d06b23974fff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_80408245-7510-4d72-95a2-de9fd640004b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cadf9cee-39db-4899-a54f-d06b23974fff" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_80408245-7510-4d72-95a2-de9fd640004b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_fb704c98-6c0c-4d1c-9f28-aba80a829635" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_23d2ee82-4f7c-463e-b402-7e6462f8eeaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fb704c98-6c0c-4d1c-9f28-aba80a829635" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_23d2ee82-4f7c-463e-b402-7e6462f8eeaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_dcb240b9-5c2c-44d8-bfe6-14cfca59aa2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fb704c98-6c0c-4d1c-9f28-aba80a829635" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_dcb240b9-5c2c-44d8-bfe6-14cfca59aa2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8720e15a-e60a-48f2-92f6-c977fc751f93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fb704c98-6c0c-4d1c-9f28-aba80a829635" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8720e15a-e60a-48f2-92f6-c977fc751f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/EarningsPerShareNarrativeDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#EarningsPerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/EarningsPerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_752fedb3-9f08-4040-94eb-bf149ef7277a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c169e928-b131-49d9-955b-0f642637d92f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_752fedb3-9f08-4040-94eb-bf149ef7277a" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c169e928-b131-49d9-955b-0f642637d92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dc5117f8-3f86-4a23-9506-ade8f07223b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c169e928-b131-49d9-955b-0f642637d92f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dc5117f8-3f86-4a23-9506-ade8f07223b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c03147b4-554b-4697-ac9b-a0baa5123de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dc5117f8-3f86-4a23-9506-ade8f07223b7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c03147b4-554b-4697-ac9b-a0baa5123de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_937c07dc-ece1-4927-a411-e15c95739219" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c03147b4-554b-4697-ac9b-a0baa5123de1" xlink:to="loc_us-gaap_StockCompensationPlanMember_937c07dc-ece1-4927-a411-e15c95739219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a059638f-d8d2-4bef-97c9-8ebbe135375d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c169e928-b131-49d9-955b-0f642637d92f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a059638f-d8d2-4bef-97c9-8ebbe135375d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4bc82773-2bc7-440c-a108-db1f79392ab7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a059638f-d8d2-4bef-97c9-8ebbe135375d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4bc82773-2bc7-440c-a108-db1f79392ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformation" xlink:type="simple" xlink:href="livn-20200930.xsd#GeographicandSegmentInformation"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_90d7b501-d442-458e-82f2-d7a0153e1aac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_1d696dcc-af73-48af-9cde-3141dd63c5f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_90d7b501-d442-458e-82f2-d7a0153e1aac" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_1d696dcc-af73-48af-9cde-3141dd63c5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationTables" xlink:type="simple" xlink:href="livn-20200930.xsd#GeographicandSegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f1412487-21b8-41e4-adb7-7608e48f9288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_58e31452-2500-4f5c-ba5b-8796edcb3372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f1412487-21b8-41e4-adb7-7608e48f9288" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_58e31452-2500-4f5c-ba5b-8796edcb3372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_52f395ee-bae7-4a87-99cf-3d4ca292664d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f1412487-21b8-41e4-adb7-7608e48f9288" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_52f395ee-bae7-4a87-99cf-3d4ca292664d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_fe65143b-4b98-4a3d-b531-8eff7cc5c1bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f1412487-21b8-41e4-adb7-7608e48f9288" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_fe65143b-4b98-4a3d-b531-8eff7cc5c1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_47815822-880d-44b3-863b-ee11d0ba72da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f1412487-21b8-41e4-adb7-7608e48f9288" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_47815822-880d-44b3-863b-ee11d0ba72da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#GeographicandSegmentInformationSegmentInfoDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_9e8e1204-76b3-4327-a4de-96bfc490111f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b047a770-002d-4d58-89f1-ec5c5950e2b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9e8e1204-76b3-4327-a4de-96bfc490111f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b047a770-002d-4d58-89f1-ec5c5950e2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8db685c5-1235-41a8-91d1-822f3c129bf8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b047a770-002d-4d58-89f1-ec5c5950e2b1" xlink:to="loc_srt_ProductOrServiceAxis_8db685c5-1235-41a8-91d1-822f3c129bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_36ef6964-def0-4edc-8502-24d4c83b2e26" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_8db685c5-1235-41a8-91d1-822f3c129bf8" xlink:to="loc_srt_ProductsAndServicesDomain_36ef6964-def0-4edc-8502-24d4c83b2e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CardiopulmonaryMember_0912e15c-24cf-48a5-b623-82a57d604d8a" xlink:href="livn-20200930.xsd#livn_CardiopulmonaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_36ef6964-def0-4edc-8502-24d4c83b2e26" xlink:to="loc_livn_CardiopulmonaryMember_0912e15c-24cf-48a5-b623-82a57d604d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_HeartValvesMember_f2750be3-af80-4746-b721-f7d1c4a2e77a" xlink:href="livn-20200930.xsd#livn_HeartValvesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_36ef6964-def0-4edc-8502-24d4c83b2e26" xlink:to="loc_livn_HeartValvesMember_f2750be3-af80-4746-b721-f7d1c4a2e77a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_AdvancedCirculatorySupportMember_eb0f0e0d-ba5c-4de6-8dbe-23fe3606bc88" xlink:href="livn-20200930.xsd#livn_AdvancedCirculatorySupportMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_36ef6964-def0-4edc-8502-24d4c83b2e26" xlink:to="loc_livn_AdvancedCirculatorySupportMember_eb0f0e0d-ba5c-4de6-8dbe-23fe3606bc88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d384bd76-0292-472f-8c8e-af575379efb4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b047a770-002d-4d58-89f1-ec5c5950e2b1" xlink:to="loc_srt_StatementGeographicalAxis_d384bd76-0292-472f-8c8e-af575379efb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cde765b0-f515-477f-841d-d1e4c2789627" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_d384bd76-0292-472f-8c8e-af575379efb4" xlink:to="loc_srt_SegmentGeographicalDomain_cde765b0-f515-477f-841d-d1e4c2789627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_884af861-dda3-4e0a-a104-54255c39d63d" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cde765b0-f515-477f-841d-d1e4c2789627" xlink:to="loc_country_US_884af861-dda3-4e0a-a104-54255c39d63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_7184039c-90cc-40e8-a34f-3515f8ba431a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cde765b0-f515-477f-841d-d1e4c2789627" xlink:to="loc_srt_EuropeMember_7184039c-90cc-40e8-a34f-3515f8ba431a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_LocationsExcludingTheUnitedStatesAndEuropeMember_8e4b31b2-8266-49f5-ae60-3ccc07e5af94" xlink:href="livn-20200930.xsd#livn_LocationsExcludingTheUnitedStatesAndEuropeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cde765b0-f515-477f-841d-d1e4c2789627" xlink:to="loc_livn_LocationsExcludingTheUnitedStatesAndEuropeMember_8e4b31b2-8266-49f5-ae60-3ccc07e5af94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_32c79a2e-306e-41fc-a9e4-849ecc223205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b047a770-002d-4d58-89f1-ec5c5950e2b1" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_32c79a2e-306e-41fc-a9e4-849ecc223205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_e5d9e444-c6e5-4b28-9b51-2e5aca06be3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_32c79a2e-306e-41fc-a9e4-849ecc223205" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_e5d9e444-c6e5-4b28-9b51-2e5aca06be3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember_b4d53452-1247-43ca-8523-93c101763a10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_e5d9e444-c6e5-4b28-9b51-2e5aca06be3c" xlink:to="loc_us-gaap_SegmentContinuingOperationsMember_b4d53452-1247-43ca-8523-93c101763a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_42759a07-ec45-44bd-9ec8-8e88fe94f2ef" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b047a770-002d-4d58-89f1-ec5c5950e2b1" xlink:to="loc_srt_ConsolidationItemsAxis_42759a07-ec45-44bd-9ec8-8e88fe94f2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a7ac0560-aab4-4ef5-8484-d791d9ea81a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_42759a07-ec45-44bd-9ec8-8e88fe94f2ef" xlink:to="loc_srt_ConsolidationItemsDomain_a7ac0560-aab4-4ef5-8484-d791d9ea81a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_bc69e667-cce5-4147-916e-edbe7f6744df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a7ac0560-aab4-4ef5-8484-d791d9ea81a3" xlink:to="loc_us-gaap_OperatingSegmentsMember_bc69e667-cce5-4147-916e-edbe7f6744df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_3f9ba52b-1559-43db-8632-39b2472b3918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a7ac0560-aab4-4ef5-8484-d791d9ea81a3" xlink:to="loc_us-gaap_CorporateNonSegmentMember_3f9ba52b-1559-43db-8632-39b2472b3918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_148d978e-a26e-4068-81c3-e9bedd4475be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b047a770-002d-4d58-89f1-ec5c5950e2b1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_148d978e-a26e-4068-81c3-e9bedd4475be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e24129c2-03be-4e5d-b8e5-f486803daccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_148d978e-a26e-4068-81c3-e9bedd4475be" xlink:to="loc_us-gaap_SegmentDomain_e24129c2-03be-4e5d-b8e5-f486803daccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CardiovascularSegmentMember_160e975b-fd0e-4743-b07f-6570d0f4e0f1" xlink:href="livn-20200930.xsd#livn_CardiovascularSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e24129c2-03be-4e5d-b8e5-f486803daccc" xlink:to="loc_livn_CardiovascularSegmentMember_160e975b-fd0e-4743-b07f-6570d0f4e0f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_NeuromodulationSegmentMember_a48489e7-7e97-401e-b8dd-3fba9f859d1d" xlink:href="livn-20200930.xsd#livn_NeuromodulationSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e24129c2-03be-4e5d-b8e5-f486803daccc" xlink:to="loc_livn_NeuromodulationSegmentMember_a48489e7-7e97-401e-b8dd-3fba9f859d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b047a770-002d-4d58-89f1-ec5c5950e2b1" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_c1dc1a50-9b1d-423d-9bbf-166636baa321" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_NumberOfReportableSegments_c1dc1a50-9b1d-423d-9bbf-166636baa321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_NumberofGeographicRegionsinwhichEntityOperates_5e4e2bf6-1115-46cd-9d3e-4f0758479ed4" xlink:href="livn-20200930.xsd#livn_NumberofGeographicRegionsinwhichEntityOperates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_livn_NumberofGeographicRegionsinwhichEntityOperates_5e4e2bf6-1115-46cd-9d3e-4f0758479ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c89e412d-21e1-4722-8200-1be62f5430ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c89e412d-21e1-4722-8200-1be62f5430ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations_20a2a72e-a96d-407e-94a9-b17d347e3956" xlink:href="livn-20200930.xsd#livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations_20a2a72e-a96d-407e-94a9-b17d347e3956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_10baab7f-8180-4587-97d5-22395e4cb05a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_10baab7f-8180-4587-97d5-22395e4cb05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_b9ad6dd6-5385-4032-b4da-fbd9662c52b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_RestructuringCharges_b9ad6dd6-5385-4032-b4da-fbd9662c52b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_e914bc7a-60e0-4c33-a757-922a264fe9ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_e914bc7a-60e0-4c33-a757-922a264fe9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f1835683-c02a-49a2-9d77-cfd31c340237" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_OperatingIncomeLoss_f1835683-c02a-49a2-9d77-cfd31c340237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_bdb8298c-f985-48cd-8f04-2c58731b8959" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_InvestmentIncomeInterest_bdb8298c-f985-48cd-8f04-2c58731b8959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_a21bebe2-a398-46d0-a9fa-63135e9405a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_InterestExpense_a21bebe2-a398-46d0-a9fa-63135e9405a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome_e0bb46b2-b46f-4f62-9230-1a7be65deaa3" xlink:href="livn-20200930.xsd#livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome_e0bb46b2-b46f-4f62-9230-1a7be65deaa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f8b45e52-8424-441e-b6d0-22250d13d461" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f8b45e52-8424-441e-b6d0-22250d13d461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b36fc27a-4c3e-4f04-b693-3b0c6f4cc098" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_Assets_b36fc27a-4c3e-4f04-b693-3b0c6f4cc098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_22836383-2e57-4236-ac33-b7ae4913f5e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_89919fbf-6da7-406b-a518-f958ae80efcd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_22836383-2e57-4236-ac33-b7ae4913f5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_9c6fa28c-fb64-4369-9878-087fc48e0efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b56136a9-faa4-40f4-a44f-566f05a84eb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9c6fa28c-fb64-4369-9878-087fc48e0efe" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b56136a9-faa4-40f4-a44f-566f05a84eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b86e91fb-d703-44dc-b107-4fb5d49a0a05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b56136a9-faa4-40f4-a44f-566f05a84eb6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b86e91fb-d703-44dc-b107-4fb5d49a0a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d7057f0b-b39b-4e91-8687-9a4dd7b30056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b86e91fb-d703-44dc-b107-4fb5d49a0a05" xlink:to="loc_us-gaap_SegmentDomain_d7057f0b-b39b-4e91-8687-9a4dd7b30056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_NeuromodulationSegmentMember_15b72620-f6f8-4bfa-9cbb-852a9a579e71" xlink:href="livn-20200930.xsd#livn_NeuromodulationSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d7057f0b-b39b-4e91-8687-9a4dd7b30056" xlink:to="loc_livn_NeuromodulationSegmentMember_15b72620-f6f8-4bfa-9cbb-852a9a579e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_CardiovascularSegmentMember_2e66ce7a-6bcc-4860-984a-c11b48bc758e" xlink:href="livn-20200930.xsd#livn_CardiovascularSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d7057f0b-b39b-4e91-8687-9a4dd7b30056" xlink:to="loc_livn_CardiovascularSegmentMember_2e66ce7a-6bcc-4860-984a-c11b48bc758e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_50ac128b-3124-4143-8d50-938984511c97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b56136a9-faa4-40f4-a44f-566f05a84eb6" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_50ac128b-3124-4143-8d50-938984511c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_992c5172-fc4b-490b-82b1-142bc37d4416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_50ac128b-3124-4143-8d50-938984511c97" xlink:to="loc_us-gaap_GoodwillRollForward_992c5172-fc4b-490b-82b1-142bc37d4416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c6039783-eb79-46f9-95fd-32d27ff44d8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_992c5172-fc4b-490b-82b1-142bc37d4416" xlink:to="loc_us-gaap_Goodwill_c6039783-eb79-46f9-95fd-32d27ff44d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_9a5db13c-3a02-4690-91bd-9dd8c842c319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_992c5172-fc4b-490b-82b1-142bc37d4416" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_9a5db13c-3a02-4690-91bd-9dd8c842c319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f6a21412-ef9a-4159-8bef-684ba651ef01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_992c5172-fc4b-490b-82b1-142bc37d4416" xlink:to="loc_us-gaap_Goodwill_f6a21412-ef9a-4159-8bef-684ba651ef01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationGeographicAreasDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#GeographicandSegmentInformationGeographicAreasDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationGeographicAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_daa63284-5bb3-4e5d-b318-01fd4480155b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_391ad36d-9a00-4fe1-8229-28e812af5041" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_daa63284-5bb3-4e5d-b318-01fd4480155b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_391ad36d-9a00-4fe1-8229-28e812af5041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_bb4ff9a5-92da-4abf-bdb6-7678eb3d1052" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_391ad36d-9a00-4fe1-8229-28e812af5041" xlink:to="loc_srt_StatementGeographicalAxis_bb4ff9a5-92da-4abf-bdb6-7678eb3d1052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5c705c68-545e-4bdb-8762-b05da6a3a5ec" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_bb4ff9a5-92da-4abf-bdb6-7678eb3d1052" xlink:to="loc_srt_SegmentGeographicalDomain_5c705c68-545e-4bdb-8762-b05da6a3a5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d4f92238-312a-47b4-b3a5-ad2476a5442c" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5c705c68-545e-4bdb-8762-b05da6a3a5ec" xlink:to="loc_country_US_d4f92238-312a-47b4-b3a5-ad2476a5442c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_a96ccfda-ab88-4369-94a3-1f66ecb6f6ba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5c705c68-545e-4bdb-8762-b05da6a3a5ec" xlink:to="loc_srt_EuropeMember_a96ccfda-ab88-4369-94a3-1f66ecb6f6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_LocationsExcludingTheUnitedStatesAndEuropeMember_def412e9-d9fa-4949-a778-b4ccc66bf0ea" xlink:href="livn-20200930.xsd#livn_LocationsExcludingTheUnitedStatesAndEuropeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5c705c68-545e-4bdb-8762-b05da6a3a5ec" xlink:to="loc_livn_LocationsExcludingTheUnitedStatesAndEuropeMember_def412e9-d9fa-4949-a778-b4ccc66bf0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6cd23539-e9c2-496b-882d-7882562c1119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_391ad36d-9a00-4fe1-8229-28e812af5041" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_6cd23539-e9c2-496b-882d-7882562c1119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_99b36601-1f8b-42d7-b823-844525a08f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6cd23539-e9c2-496b-882d-7882562c1119" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_99b36601-1f8b-42d7-b823-844525a08f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformation" xlink:type="simple" xlink:href="livn-20200930.xsd#SupplementalFinancialInformation"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4b138aa7-29e6-4295-bc86-48741bc1b47f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_d27bccb2-32c0-4380-95ea-1f0d85bfa168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4b138aa7-29e6-4295-bc86-48741bc1b47f" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_d27bccb2-32c0-4380-95ea-1f0d85bfa168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationTables" xlink:type="simple" xlink:href="livn-20200930.xsd#SupplementalFinancialInformationTables"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ed9e6098-7188-4a04-8774-f900db8e969f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b7f6365a-7f3f-4b4d-9794-81ddab00c871" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ed9e6098-7188-4a04-8774-f900db8e969f" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b7f6365a-7f3f-4b4d-9794-81ddab00c871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_81380341-1a08-4e6a-941f-9e236592eb69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ed9e6098-7188-4a04-8774-f900db8e969f" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_81380341-1a08-4e6a-941f-9e236592eb69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofInventoryDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#SupplementalFinancialInformationSummaryofInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_14c1e210-2660-4f10-8b1d-df181c60e5ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_1d6a814c-70e3-4043-82a8-d79c2e88ed7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_14c1e210-2660-4f10-8b1d-df181c60e5ba" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_1d6a814c-70e3-4043-82a8-d79c2e88ed7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_74fdbb03-e4cc-4fd7-8a95-c6871a6664ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_14c1e210-2660-4f10-8b1d-df181c60e5ba" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_74fdbb03-e4cc-4fd7-8a95-c6871a6664ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2f92e810-dc3d-4566-9404-4a87d4b230d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_14c1e210-2660-4f10-8b1d-df181c60e5ba" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2f92e810-dc3d-4566-9404-4a87d4b230d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a1415443-17df-46a9-b37c-a7ad01425340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_14c1e210-2660-4f10-8b1d-df181c60e5ba" xlink:to="loc_us-gaap_InventoryNet_a1415443-17df-46a9-b37c-a7ad01425340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_8a409ad9-3593-4a12-a0a8-fe5872b59a3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_14c1e210-2660-4f10-8b1d-df181c60e5ba" xlink:to="loc_us-gaap_InventoryValuationReserves_8a409ad9-3593-4a12-a0a8-fe5872b59a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4a7e9966-7524-43fe-8bbc-1cc0c9147191" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_cd584d5b-34e3-4348-8f59-2a7f3e87fe48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4a7e9966-7524-43fe-8bbc-1cc0c9147191" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_cd584d5b-34e3-4348-8f59-2a7f3e87fe48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_04b5329c-a341-473c-a27c-29d879e6bc23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4a7e9966-7524-43fe-8bbc-1cc0c9147191" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_04b5329c-a341-473c-a27c-29d879e6bc23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a83e3b11-c691-4b15-80e2-ca8faafd0130" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4a7e9966-7524-43fe-8bbc-1cc0c9147191" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a83e3b11-c691-4b15-80e2-ca8faafd0130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b007b618-5649-4b34-9a96-03ed4bfb9952" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4a7e9966-7524-43fe-8bbc-1cc0c9147191" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b007b618-5649-4b34-9a96-03ed4bfb9952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ResearchAndDevelopmentCostsPayableCurrent_2bff27fe-b9c3-4e70-ac4a-cea169805b35" xlink:href="livn-20200930.xsd#livn_ResearchAndDevelopmentCostsPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4a7e9966-7524-43fe-8bbc-1cc0c9147191" xlink:to="loc_livn_ResearchAndDevelopmentCostsPayableCurrent_2bff27fe-b9c3-4e70-ac4a-cea169805b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProvisionforAgentsReturnsandOther_4a6c403b-3467-4dbf-9a66-3b497a59afc3" xlink:href="livn-20200930.xsd#livn_ProvisionforAgentsReturnsandOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4a7e9966-7524-43fe-8bbc-1cc0c9147191" xlink:to="loc_livn_ProvisionforAgentsReturnsandOther_4a6c403b-3467-4dbf-9a66-3b497a59afc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_RestructuringRelatedLiabilities_4184b631-bb6b-446a-8fe1-327e3efbe5a9" xlink:href="livn-20200930.xsd#livn_RestructuringRelatedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4a7e9966-7524-43fe-8bbc-1cc0c9147191" xlink:to="loc_livn_RestructuringRelatedLiabilities_4184b631-bb6b-446a-8fe1-327e3efbe5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_ProductRemediation_960e9a4d-bc9e-46ce-8b1c-e30661db01da" xlink:href="livn-20200930.xsd#livn_ProductRemediation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4a7e9966-7524-43fe-8bbc-1cc0c9147191" xlink:to="loc_livn_ProductRemediation_960e9a4d-bc9e-46ce-8b1c-e30661db01da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_DerivativeContractLiabilities_13b74a02-aca9-4dda-8981-06c527d9bb2a" xlink:href="livn-20200930.xsd#livn_DerivativeContractLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4a7e9966-7524-43fe-8bbc-1cc0c9147191" xlink:to="loc_livn_DerivativeContractLiabilities_13b74a02-aca9-4dda-8981-06c527d9bb2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_livn_BusinessAcquisitionsPurchasePriceAllocation_0c5cc151-6e5f-4fe7-97af-ceda82757af7" xlink:href="livn-20200930.xsd#livn_BusinessAcquisitionsPurchasePriceAllocation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4a7e9966-7524-43fe-8bbc-1cc0c9147191" xlink:to="loc_livn_BusinessAcquisitionsPurchasePriceAllocation_0c5cc151-6e5f-4fe7-97af-ceda82757af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_22e8e12e-99bb-4878-b682-5955a82d082f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4a7e9966-7524-43fe-8bbc-1cc0c9147191" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_22e8e12e-99bb-4878-b682-5955a82d082f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_484c0611-ff50-4a79-8f44-fcae65291f85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4a7e9966-7524-43fe-8bbc-1cc0c9147191" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_484c0611-ff50-4a79-8f44-fcae65291f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_8e68c9bc-2558-4a80-b1a2-9eb496686794" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4a7e9966-7524-43fe-8bbc-1cc0c9147191" xlink:to="loc_us-gaap_ContractWithCustomerLiability_8e68c9bc-2558-4a80-b1a2-9eb496686794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="livn-20200930.xsd#NewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_e6fdfca7-6b3d-46c8-993b-22c126dd5241" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_c340d022-4836-4bae-b8f1-5ffb39cecd72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_e6fdfca7-6b3d-46c8-993b-22c126dd5241" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_c340d022-4836-4bae-b8f1-5ffb39cecd72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsTables" xlink:type="simple" xlink:href="livn-20200930.xsd#NewAccountingPronouncementsTables"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_f29a1de7-b013-4ac1-83d7-661d24a56101" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_af74abe5-abe4-4398-b621-522de1b08ccf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_f29a1de7-b013-4ac1-83d7-661d24a56101" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_af74abe5-abe4-4398-b621-522de1b08ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsDetails" xlink:type="simple" xlink:href="livn-20200930.xsd#NewAccountingPronouncementsDetails"/>
  <link:presentationLink xlink:role="http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_d1ae54eb-e436-4a9d-b008-07f9c8babcf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0b8e41c4-2ed3-444e-8fab-43ebb369cf21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_d1ae54eb-e436-4a9d-b008-07f9c8babcf9" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0b8e41c4-2ed3-444e-8fab-43ebb369cf21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2110a1c4-e473-43dd-937b-d4d8a92836e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0b8e41c4-2ed3-444e-8fab-43ebb369cf21" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2110a1c4-e473-43dd-937b-d4d8a92836e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_002a0fe1-ebbd-4c11-8ffa-5f0744f3e3ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2110a1c4-e473-43dd-937b-d4d8a92836e5" xlink:to="loc_us-gaap_EquityComponentDomain_002a0fe1-ebbd-4c11-8ffa-5f0744f3e3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9b2fa0e7-44e3-4171-b562-487a646ffc62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_002a0fe1-ebbd-4c11-8ffa-5f0744f3e3ea" xlink:to="loc_us-gaap_RetainedEarningsMember_9b2fa0e7-44e3-4171-b562-487a646ffc62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_aa1fec5f-18a4-4f8c-abc4-d4001faf992b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0b8e41c4-2ed3-444e-8fab-43ebb369cf21" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_aa1fec5f-18a4-4f8c-abc4-d4001faf992b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d0e83ec4-af97-4147-abbd-a31358689057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_aa1fec5f-18a4-4f8c-abc4-d4001faf992b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d0e83ec4-af97-4147-abbd-a31358689057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_06ae8366-dff8-4ac1-92af-031db1fe8cba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_aa1fec5f-18a4-4f8c-abc4-d4001faf992b" xlink:to="loc_us-gaap_StockholdersEquity_06ae8366-dff8-4ac1-92af-031db1fe8cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_ba849949-47d5-42da-849f-841e69848716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_aa1fec5f-18a4-4f8c-abc4-d4001faf992b" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_ba849949-47d5-42da-849f-841e69848716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>livn-20200930_g1.jpg
<TEXT>
begin 644 livn-20200930_g1.jpg
M_]C_X0F&17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    D    <@$R  (    4
M    EH=I  0    !    K    -@ "OR    G$  *_(   "<0061O8F4@4&AO
M=&]S:&]P($-#(#(P,34@*$UA8VEN=&]S:"D ,C Q-3HQ,#HP,2 Q,CHU,SHQ
M,P     #H $  P    $  0  H ( !     $   $8H , !     $   !!
M      8! P #     0 &   !&@ %     0   28!&P %     0   2X!*  #
M     0 "   " 0 $     0   38" @ $     0  "$@         2     $
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M@1J%_%"/%PDGB%:OG)ZE=]6.F_6'ZL.<[U38UN"8DN9=%=S]P^BY^#Z5C/\
MNPC];Z2SIA^J_1.HN]+IQ/JYIW;6&][V?:B^QI9_,^KZ++O\#18N[ZA]5NC=
M1ZI1U7*J<[*Q]FPAQ:T^F[U:O4K;[+-CS^<K/5^B]-ZUB?9.HU>K7.YA!+7-
M=$;Z[&0YCD[WA8-'76?][AX?2N]X6#1UUG_>X>'TO!?XP.D=#Z;E=+_9U->-
ME66 6TU -#JFN9LMLK;^=ZOL;9_A?TGT_373O=9_STK'VN&>GKB?829_1O\
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M=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4 = !U '
M  IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL=&EN4')O;V8
M   )<')O;V9#35E+ #A"24T$.P     "+0   !     !       2<')I;G1/
M=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB<F)O;VP
M %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP      $QB;'-B
M;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN=')B;V]L
M  !"8VMG3V)J8P    $       !21T)#     P    !29" @9&]U8D!OX
M         $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^
M  !"<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M      !2<VQT56YT1B-0>&Q 4@            IV96-T;W)$871A8F]O; $
M    4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M             %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R
M8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C
M=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R
M;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"
M24T#[0      $ !(     0 " $@    !  (X0DE-!"8       X
M    /X   #A"24T#\@      "@  ________   X0DE-! T       0   !:
M.$))3009       $    'CA"24T#\P      "0           0 X0DE-)Q
M      H  0         ".$))30/U      !( "]F9@ ! &QF9@ &       !
M "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4    ! "T
M   &       !.$))30/X      !P  #_____________________________
M ^@     _____________________________P/H     /______________
M______________\#Z     #_____________________________ ^@  #A"
M24T$         @ %.$))300"       ,                .$))300P
M   & 0$! 0$!.$))300M       "   X0DE-! @      !H    !   "0
M D     "   &90   !QB #A"24T$'@      !      X0DE-!!H      TL
M   &              !!   !&     L 3 !. %\ ; !O &< ;P!? '0 80!G
M     0                         !              $8    00
M               !                         !     !        ;G5L
M;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @
M;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG    00    !2
M9VAT;&]N9P   1@    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L
M:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M    !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T
M960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD
M<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE
M9G1L;VYG          !"=&]M;&]N9P   $$     4F=H=&QO;F<   $8
M W5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0
M   !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O
M;VP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M
M#T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
M   /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E
M;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T
M;&]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E
M=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M     C_P        .$))3004       $    %#A"24T$#      (9     $
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M    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !< 00!D &\
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M  #VU@ !     -,M2% @(
M                        $6-P<G0   %0    ,V1E<V,   &$    ;'=T
M<'0   'P    %&)K<'0   ($    %')865H   (8    %&=865H   (L
M%&)865H   )     %&1M;F0   )4    <&1M9&0   +$    B'9U960   -,
M    AG9I97<   /4    )&QU;6D   /X    %&UE87,   0,    )'1E8V@
M  0P    #')44D,   0\   (#&=44D,   0\   (#&)44D,   0\   (#'1E
M>'0     0V]P>7)I9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP
M86YY  !D97-C         !)S4D="($E%0S8Q.38V+3(N,0
M$G-21T(@245#-C$Y-C8M,BXQ
M                              !865H@        \U$  0    $6S%A9
M6B                      6%E:(        &^B   X]0   Y!865H@
M    8ID  +>%   8VEA96B         DH   #X0  +;/9&5S8P         6
M245#(&AT=' Z+R]W=W<N:65C+F-H               6245#(&AT=' Z+R]W
M=W<N:65C+F-H
M             &1E<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!2
M1T(@8V]L;W5R('-P86-E("T@<U)'0@              +DE%0R V,3DV-BTR
M+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M              !D97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD
M:71I;VX@:6X@245#-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I
M97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M                =FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X
M   !6%E:(       3 E6 %    !7'^=M96%S          $
M           "CP    )S:6<@     $-25"!C=7)V        !      %  H
M#P 4 !D '@ C "@ +0 R #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\
M ($ A@"+ )  E0": )\ I "I *X L@"W +P P0#& ,L T #5 -L X #E .L
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MMGFV\+=HM^"X6;C1N4JYPKH[NK6[+KNGO"&\F[T5O8^^"KZ$OO^_>K_UP'#
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MDDJ?LWQU5),RFR,HKYCY Y6N.4;C>>6MO*7/@+.C>)*^I*!V4J\C"NBOE74
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>livn-20200930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:livn="http://www.livanova.cyberonics.com/20200930"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="livn-20200930.xsd" xlink:type="simple"/>
    <context id="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib5c4b96ff27e4ddeb062ecd5ba74027a_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i3d16457137524d51a1566ec297b77d53_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibcd0778524454cafb95c52ee8c85dc02_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic94ddff991844d7bb182464410e337c2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7cb9957d3e1b407bb88290f6a94e712e_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i1f504bd55c7f46eabe71635e913521f3_D20190612-20190612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:MiamiInstrumentsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-12</startDate>
            <endDate>2019-06-12</endDate>
        </period>
    </context>
    <context id="i69653e79e7a64b74bafe17de62d7f7e7_I20190612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:MiamiInstrumentsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-12</instant>
        </period>
    </context>
    <context id="id8f318fd9c2147bba4d88a7c4b055ba5_D20190612-20190612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:MiamiInstrumentsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">livn:DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-12</startDate>
            <endDate>2019-06-12</endDate>
        </period>
    </context>
    <context id="i08c3b67a02214a92852d8412d52b746a_D20180430-20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">livn:CRMBusinessFranchiseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="i4ab5cac60220483ca5a3b38de23752fc_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">livn:CRMBusinessFranchiseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i9f970e37f06645c8bb2539c0ce87edde_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">livn:ReorganizationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie7f12aa7ec264fe2ab35709629de067f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">livn:ReorganizationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8aeacf1e4fc34783813482eebf05252b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">livn:ReorganizationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i12f68e91043344bb9a9cb86689638ce5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">livn:ReorganizationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i99471d80dbd54b8ca36fd7bd75e616dd_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">livn:ReorganizationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8925322bbe234c77aa2e0c9256cd4f36_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">livn:ReorganizationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i89e139d91fc8464a99b88353610cdeb2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">livn:ReorganizationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibf00cfbfb795463ab27948e6d4c4253d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">livn:ReorganizationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i970f46cb12124b12bfb14bea4df49ada_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">livn:ReorganizationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i013558d2b17c4355a92da0429952dd67_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4f84b9a1406f4d1a801a8a1795c932dc_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia2fad0d02b3e4a0ab6a60f67969ec28b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i197004b99655439cada3d2fa6e98f33e_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i36f208ad6ec8402f80aac6618e1de718_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9faf33d672ba42d18cdfe76fdead2b2d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8c4ddeb948eb4c4dbe320a14c7ae3792_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iac495534370345098798ba8c26b009ac_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i21d96c5da2404625a9ee4885a17ebf0c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icc2e1e69df7e4a1d8c750a08dcb83a44_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i753478d430024138b30d3d04687e7eb7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2e6560d12b2f434fa22d653edaa72cd8_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia4743b9cbc8b413f864fd07a5e2fad89_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:ProductLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iafea0951c2c545c9aa85f9c8daadd17f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:RespicardiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i60b29926fecf4b70b1dc7c7cd0baf605_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:RespicardiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i51565454f75d4bebb38194ffedb9b20a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:ALungTechnologiesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2185fe191cce4a66865bde068329982b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:ALungTechnologiesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic98b76cf08a64b6da1b29b2c251fc766_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:CeribellInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iaf583348934e447b97b6b58fd72f1047_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:CeribellInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i985d7bd469a442c080589425a8443701_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:ShiraTronicsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0c5ecded17b340c89b0e638f6ae6ffc2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:ShiraTronicsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia943f93887004f2e973f75f871756f34_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:MDStartIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iddd07ea8a3bb43fcaa80fd42e2b6af83_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:MDStartIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id7070af18fef45169cea3d61e672378d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:RainbowMedicalLtd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i128dd12840304fb7a5186325c995dc74_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:RainbowMedicalLtd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0cc59c39d408424fa8ec43642bdefae4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:HighlifeS.A.S.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i67e02e6f525d49d79d1e1378eefccbaa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:HighlifeS.A.S.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i43bc731c38504f9a9bf794876a9512db_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9cfb30f9c2da4bd98ce29047f95daaf6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">livn:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib244d5c1647445c98706515b46ea2376_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">livn:RespicardiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i90db8675b50e452bb4dbe535ff672f26_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">livn:RespicardiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i798dba76d2144cabb6adb775c4a1aa5f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">livn:ALungTechnologiesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">livn:ConvertibleNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i282f7e855f164edab83c60ade72f1e8f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">livn:ALungTechnologiesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">livn:ConvertibleNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3c6523bc48a447b5869e52fba0cea6f3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if0d8e86523634968b1908339ac891144_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iff29d74ec51a43d3b79a5db568d853f2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icfefd2b87cb44284867538a460fdec64_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibad74017afa848158b4bcf23299630ba_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia53cdeb7e70b46e0a9df7e343e1c8dc7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i549d9fe1d5694fea83f1cb9a0116d9c3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibf3cde6d556f43229f6017b4b0296fb3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i99ea2a2977bf428dbe55a0a62f1d8f39_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">livn:CappedCallMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i477ef411a1da4a87828daf96a443478a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">livn:CappedCallMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i604c8c94f78e401b9a10ebc3406a262d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">livn:CappedCallMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic71b0960ca5b40b79de0620646d77218_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">livn:CappedCallMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1920c569d03f4b2981551f7c9fa3f2dc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i651e6f1d58d6444c89e41097aa3c93d2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibb5a207f947a447b8d9aaf5128bccb8e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic60029069ad0424ebdeeedac7260aaf9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7955e6392f00489b9c7c6bd1a5a7b4a6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7bb02064dc544327a00b12a199681a45_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i223528d062ef4c2d8c27572caa395a07_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9a279cef16854d728efd76005ca4b872_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i148d72eb7ca9457d9c7534140ff8b8e6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia3dabef6c1fc45838407928a7edc982a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7dab210d1ff74635af037320edfe69b2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7515b98bfc884d4c8e81ba14f06c1998_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i874c5b66a97e468981139b4c21d7eefa_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3e3b083fb0b3450ea7ce586ffdd675e6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic8a2fef709db4b8e8534fc2dc8e08119_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i19e9ceed79d04c9eb93f32768de95ec9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6f293b751409438c9ba2c7b3dc48dffc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id6b52afe363e4fe9a4d0f3237689efc2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2aba2a40c6324508a183965eccf45b95_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaa9c677be2ba4b7080abc459f6cb49e2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7c78a1ebb503459eb3095a7afc63295b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id7db9636c721460b95675081b95ae6b6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i95ed7028bea74431b97651e632a47b6b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idcbcc74327d845ba8fc6a1532ba4b344_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib087b2c401cc4c3d8384b3a48fcd1329_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i692bbffae945465da30a96cc3773a545_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic71ba4ba85c34d5486646e473787face_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9e6eaa19ee7d48d686b0f7478549e4f3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i41752121b3454d50a55318982c498675_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1cdbf2725d5841b0b9507ecf33848425_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1a4cad9c20ed4f459594fbf97ec48b93_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id2ae71915c9d485e834f0858c4a5ae25_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9f78b59175ef4d758e415b5cbed5ac3f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4305df4a64bd48dba371c408205ef499_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">livn:EmbeddedExchangeFeatureLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i209b72ec61d040dfb2b194e845cf7edb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2c92b7d80ea24dacb640f577505291f1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">livn:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i90c6c409fa4549c790424875b8e5a217_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaf2d496c991846f780a3d8de11e7596e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1c3d799108834231aa07131c4ffa94a6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">livn:EmbeddedExchangeFeatureLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i945ca206fc8d4168be118ba472cf5c62_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifdae3dc9ec2145e495befafb9bcf5123_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">livn:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib6822c11b4df4397a32236603772252c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i79abffac68b242c5a0a7017c3bb651d2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5458476260ce4943a87b849a8aacd1c1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">livn:EmbeddedExchangeFeatureLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i90160a4003a147ac85584baddfa6bbdf_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic11bd09e203746298506602f823386cf_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">livn:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia1595ac59e1649c287f1756d28d46854_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if4a3c8bc06cb468c81b9eb54252c7358_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6716b0b0e633453e9726f2030e08c1ca_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i24d1ba33f5dd45c0b73177d207d4550c_I20200617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">livn:A2020CashExchangeableSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-17</instant>
        </period>
    </context>
    <context id="ieb3ff6598aa94f57ad92e35964f81c74_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">livn:CappedCallMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputStockPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia12648082fc04c6b8edae66b0ae67c39_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputStockPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib19ca95e55f0441faf04ebd6116fa0b8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8dabcab920e744a7b4327517400decdd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">livn:CappedCallMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i62afb2ec706c47af855bd1dcaf827f5c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5d29459e1a0a41f687a10f5ab9c54a04_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic98623a8908a479b94a28994eb16d56b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:TandemLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i34cc075f863646e699af91319f899885_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:TandemLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i383d011df36a41baa36003172177eb6b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:MiamiInstrumentsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icd04c511e4ce4ac08b831ad0578c95f0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:MiamiInstrumentsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icbc2f3772dba467592c17b9ecdbc0bc9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:DrilltexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i252c36e7add342399b1424bfe704c832_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:DrilltexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if59480dc9b4f411782c729fa14047400_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i10357ff0c2724f06bbfa2eec022e8b72_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i52334654e869489ca143b061165476f4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie2536974de9b486d9e0ef01bd6a67045_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i26486ea04b234f2e927248919c447802_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputRiskadjustedDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">livn:ValuationTechniqueMonteCarloSimulationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7d05cd06a8bf4c379ecc9d10bbb2d201_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputRiskadjustedDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">livn:ValuationTechniqueMonteCarloSimulationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6a7bf4141731447ba120d2c607bf1fc2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputCreditRiskDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">livn:ValuationTechniqueMonteCarloSimulationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6291433582a64ddb8a18340f917f581e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputCreditRiskDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">livn:ValuationTechniqueMonteCarloSimulationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i79119020499f4051aaa48c43f75c5b81_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputRevenueVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">livn:ValuationTechniqueMonteCarloSimulationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1d800c2cae0e47849fbae2bf9df0853f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:ImTheraMedicalInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">livn:ValuationTechniqueMonteCarloSimulationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i48e773110abb48db81e64c019f74f83d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:TandemLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5d623187030142ffa015b3317a9e5d79_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:TandemLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3f11911900f44e6a9bb586049722bb34_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:TandemLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iae66d9458a004d28af2aca3b7976b3f0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:TandemLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia4826f8772764dcca66860adeb782fae_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:MiamiInstrumentsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6697817a4014449f80da5eda0856fefd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:MiamiInstrumentsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0aa9d51eaa804f9bbf6db6abe1aab758_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:MiamiInstrumentsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i459d7f911ab44762922172ee4898a00b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">livn:MiamiInstrumentsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">livn:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3245df3db3cb48138c8bb4d23daee5c4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i85cd7d93641d4805ad2cd66461498397_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieafa762dc91e4ea5b61fb8d13b092c3a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i45371aa600b04a59940ecd80e4ec31cc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icb27b6a99b3143aba0d74fd775949dfe_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie42f7909e6db412aa3041faa1788bd39_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i289e4abd6f78419f8f33d7774b970fca_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:BankofAmericaMerrillLynchBancoMultiploS.A.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibee8d98cf1eb433cb1a0301b339983bc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:BankofAmericaMerrillLynchBancoMultiploS.A.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i36c4db63cfaf444f879c55013695c930_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:BankofAmericaMerrillLynchBancoMultiploS.A.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifa72db626bbd480cb89d6345d833dd4d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:MediocreditoItalianoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i586947e97ff14c64ab8231790955f4c6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:MediocreditoItalianoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1080464791c844d79de57c27a7ff3ff6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:MediocreditoItalianoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idc989c83ebe44970836e50ad98670002_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:MediocreditoItalianoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibe7864f0b2ec45bd8a718ff4690bb0d1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:BankofAmericaU.SMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i77803437d5944d49a41f07e2364e792a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:BankofAmericaU.SMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9dc1230e32264a72921d8a08c4c63984_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:BankofAmericaU.SMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic5ac265b05414cd791492f4617219f2e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:DebtFacility2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib89aab9bd0424c12919f50bff87ea646_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:DebtFacility2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0d873ce62a3742a390dae8762e636c14_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:EuropeanInvestmentBank2017Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id4afcc088bc84e9aa4e4191bfefcc218_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:EuropeanInvestmentBank2017Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i87d4c0b95a4e4fe294e383610676bf94_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:EuropeanInvestmentBank2014Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i774fcbadcb514ffb99380b94b3c9864e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">livn:EuropeanInvestmentBank2014Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5a882a55bae3450ab4104c69d32cbe64_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic874c4d0e00049b4a599f3482a07d919_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib86600fe8d314ce3bbf5074a7b1877ac_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib6ca57cb331747069aa1e6f1b22dd36d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if6b26cfd42a14eae84e4cde0f4855b55_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i222517d76090477aa98b1abaaae6b229_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic387d566a4a047a4abc670c43b8f310a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i50324d744dcd4a44b4764e5523cc1cce_I20200610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-10</instant>
        </period>
    </context>
    <context id="idf2a05cfe98047578281e694de92f942_D20200610-20200610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-10</startDate>
            <endDate>2020-06-10</endDate>
        </period>
    </context>
    <context id="i545ddcc4502f4443a3f1a3a772c175dc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i96351578f5c9420c994226ab0fb578bb_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1401125337584d3cb2556f5344879ff5_I20200617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-17</instant>
        </period>
    </context>
    <context id="ie66d4c341b7f42f0b9c74ad3972a82cb_D20200617-20200617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-17</startDate>
            <endDate>2020-06-17</endDate>
        </period>
    </context>
    <context id="i5ffd59ecf9044f8eb3cf977b8db8a6a7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i444306b422a649ef948af581cd5b4f06_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i17a5d78945d143a89628f9c4af1abbc5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">livn:CappedCallMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibec415e111624e90a65386d8ccfeb185_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0e616a092dd14267a1ec789a805bdb80_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i950b10f7b07943f2aec8cb421632f276_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">livn:ForeignExchangeandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6a94651f8023444cba196300adc7abcd_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">livn:ForeignExchangeandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i64e57c8edaa1477d881db72e4c50172e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">livn:ForeignExchangeandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0efb92ce20cb40c3829d2008a9aee0a0_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">livn:ForeignExchangeandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i649606b21180421ebd128add525a4018_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic43de1d78774468cbbd002d32d130ae7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i96a7d1296872411baf7843151d3b8798_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3e21c8f995c24e08b7f442b0d2e9f153_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib51f3bb185c74b338b8ef92535cb08f2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i249fe1f728d5471fa1555fe39c4bfefe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iceda4563a5cf43d4b3bb9b89365c4c20_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if1925dad241b4aad82804e153bd1d891_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7100fe2c632148de9c37fb8985d42d30_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic334fc4aef0a4ba39603d81e0f99657a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i54a9f60e897042dabf6cfd3734d2ec73_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7af1f95c61944858b003c6c933d18f4e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">livn:ForeignExchangeandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1948e41e49f1497390be627047b5251a_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">livn:ForeignExchangeandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7d2ccb840b50403f8fc4f14ac40d2d79_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0e3cfd47324747a59764c08500c16de3_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1ee46b672ebd4d8bae5042f234b05104_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7438dabb55a44445b30dbd44a361b2f4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iae52b02ee83b438bb79bd0edc64a3be1_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7aee89dbb9cd451d93a65f546dc5d74e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">livn:ForeignExchangeandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iecc073aeadb743fe846108c910b49974_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">livn:ForeignExchangeandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iffc8dde6780b4135bdbe52a6f7da8dda_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia84ea03c48e54abfb6747a6de26f6116_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia7abd6989d6846e99b0a4c7ee504321d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5331125ba8a94b0fbfcb5387185e5869_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iaa29b64fff8949389d46c6f12d455215_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibd587e00f53f4c9184d615617e686bcd_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6b35bd5fd55a4b69b147d5820c42e6d7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibc095689f6144f4ea7254b0bb872766c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4f55df33738d44e1ba296c8eb88269a1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i22945e43bf0c46a2a590bd5b5d61f00f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i930e2a8fddf64cb1b8979187598b1cd4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i09a77749f8b64a04b0150d233c3084e4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic2bca75c3d294e0eaa5aa2c0d20d66ac_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">livn:CappedCallMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i43f7ebc0918b4360bae6ce12a9368d0d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">livn:DerivativeLiabilitiesNoncurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2c0f04c520c14a329fc827c4e8389951_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id58204573a634e6ca3cf75d337baefe3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">livn:DerivativeLiabilitiesNoncurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i007ee0b9e8934174994f5d86e0bb6e6d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i990fa7277e80490b9cfb6a6d1b9d78f4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i75a2980d9bdb44a792b41575bc1a46ba_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">livn:DerivativeLiabilitiesNoncurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i52618d0ff8d74edb8b26a424dd5945e5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i06b91b912b3c479ca956a6a0c95f7567_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1d1c0b4a1d3f448aa2bc219f0184bf4d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if2bfe101df98424ab800c282d00e7116_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icd8a5acd53214b2b9194da6aedc036eb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5cd90438d14b4f0c8370dc4b8d777673_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8e2eef5d48ff4b9bb6fe18d873c6d803_I20150827">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:FDAWarningLetterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-08-27</instant>
        </period>
    </context>
    <context id="i9e7e31e16f08494b91383db437aa83e5_D20190329-20190329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:ProductLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-29</startDate>
            <endDate>2019-03-29</endDate>
        </period>
    </context>
    <context id="ib86a229e06c94877bea66e161b156052_D20190701-20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:ProductLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="ibc438c9935fb4d298a4744c265489040_D20200101-20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:ProductLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-31</endDate>
        </period>
    </context>
    <context id="i822d6a83e0f24f4e85072aba1aaa8ce1_I20201029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-29</instant>
        </period>
    </context>
    <context id="ia92f7ea6fe5141b3a709c569c6f57200_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:ProductLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8dfb8d93c33740aab82c128a023695f0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:ProductLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id94164334ffb44b9adc73f1e3a4a759e_D20120101-20120131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:SNIAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">livn:SNIAs.p.aMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-01-01</startDate>
            <endDate>2012-01-31</endDate>
        </period>
    </context>
    <context id="i4922d7cf37464b6088c833375aa28ff9_D20160401-20160401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:SNIAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-01</startDate>
            <endDate>2016-04-01</endDate>
        </period>
    </context>
    <context id="ifd123abeb5064944877aad0f41f3b289_D20200930-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">livn:SNIAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-30</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id9108f299f5642e3ab27bd8eabbe0df9_I20190305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-05</instant>
        </period>
    </context>
    <context id="if0767ecfc4434c7c8ba7c0a26e46ab4a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i42ece6a951c243ed95e1890dcca64a65_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">livn:RegionalInternalRevenueOfficeofLombardyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:ThreatenedLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2a8c70677248473d83cfc005358a6167_I20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">livn:RegionalInternalRevenueOfficeofLombardyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="ieed6906313d54138b062d2f1a35a9599_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">livn:RegionalInternalRevenueOfficeofLombardyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i774b2c58712345bab82956aa91ba877a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">livn:RegionalInternalRevenueOfficeofLombardyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2f8533c39b7f41078d1b3a8bcc766b96_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i1478be27f8e34765a887baf8c6538b31_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i5443a67444ea416485c37b991988f6fb_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id34d4656788a44fd81611969a787b29b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie93c1f60108b48a3a6733d851a357ebe_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i1b57b2b83dd54d149c591d8fbbb18813_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i772e55ea562149ffb5fc638d38caf1ad_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iae4dac957e404f989a0f0e8abd6471a0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if9a83943fc464403a7d5089f8b33a871_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i11762dbaa1ed49eb94d45dbf0e1eca9d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7c3477a39b584e26aca4ae04d6bcdc27_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i67841b9ab95c44768c3ad97a56b3bfa8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifdffa7f2634f4108a1118eab5e5b8ac5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i42ea28428d684a9cacaefaa3e6dd1b9e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifbbfbf1476804a928a5c7aef5fa053f0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i646772a5bff64501b5ff80d29c70951d_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i0ee5111b458142f6a8d38873421f58fc_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i901bf76852a3483e827718cf605968da_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i37e2013ed189474aab9c13d2000c9cc9_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i6767353b5d7549d18ff983e40ed7a527_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ia64252b3f99d4b618cfb4816f6ff303e_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i81d68c28a9ae4f16b06014531f6d4332_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i71221703b9ac4249a6c037f96c6fd8a2_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3f027e9798fa4ca0934d00d9bb263410_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5c602e5b577142efafee2537813d0b56_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibe68740e4f2a4fd1984ecc22362196b1_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3cbb04514b7b4f2dbc2888e6954040c0_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i5ea24a03159448d282159becae6e7f97_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ic2b13270d7694a2899d0fd79a80d5739_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="idd4e32d70c90404db0418fec4b835d7a_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ief427b70c02847b5b1c5f0f93bfab969_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="icdff871ce34c40e09563d35dccbeece4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3f92e675a9a74c8ebf70114e14995425_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9f678b8291d0499489325ab4fb979196_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i14244109275c4b71acdb26ad86c70caa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8fc22053772446cd9092b2ea318f9022_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibeb25415374f4786a2efe54934478bee_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i602472901bc5472da9591b20d9734683_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia2e3b203d4b44ef49fe6a6a87e78b48a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8ed16dbbc5fd4b1285afa69aff2e6594_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i84001a93f52c4e74984ff02516c7b75c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iecd6db286ef0474c8967169d3455a2e9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i357c72c25b924030994b1bf08eb695cb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i11b5dc862856494ba736bb256c91320d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3b2edf297198406494036b93de529988_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5433f056524a44659bef554cefff1704_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia85d1e0c436c415abf0ffabd07459791_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5223aa7b849840fb8494719b938ff2b2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia86697a40b714160b0bee988340e85a0_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie10c500eacef4aaf8fc597afbc3d45b5_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3d1519f3a2b54a76abca9ca793ca5b66_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i585b337eb45c4a659b1ee03c596606d8_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8bbc378fed9842a5b7a3214c4db31cbb_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i73b9ebabb9a742feaf7a7a83f366667e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1125b67f1c85426d9cd1a530fb32d7b6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2a275a7257a24e82a86ff4fa4e50516e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i98e7648a0a8345a3b1986dfb798ac9de_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie0977771516644bab2772f34d2437e3d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idd262b92e2af4f3f98cd4f5c03def298_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i28ed0d61b46b4daaa86046342354f4b2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iefddf94f87084dd1ade6648ea605cf0c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9b7762a5b5f04bec8a312789ceeb2bd4_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i340d4173e28147f58686dee1587f9750_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id48df069b0704c3581b5adc77e251cb0_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i4561e95c0c8449a78e98f5d3fc5b92c3_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ief162d0a6831435c9c447ec4cb5cc4f1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5acbf636460b4e198f468c31a3c1be2d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i225c9725da49473d854e8f083baa2603_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic23be7d8ac3c4b778a9d24d166906ab1_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i546f2452d51d4bdc881efe5cc5c05a8d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia56cee55c4cf43099b9e98160544d49b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6a0fca2fdff64694bb24e3e060fd6dc8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib638c02dde7843eab3f4573d6585314d_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i427900b1e7d84e50b571679ab1cabaad_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:MarketbasedPerformanceRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib7c014275f2d405ab23766c236149138_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:MarketbasedPerformanceRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i32d2a1a2778b49afb67fef2675c88931_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:MarketbasedPerformanceRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0d8cecc1dece477e9a955468c571ae1e_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:MarketbasedPerformanceRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i65ec3dbf2057421c8affe016c664ea78_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:OperatingPerformancebasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i19cf82e1376d4f11840e7da277a74cd5_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:OperatingPerformancebasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2e416e9ef1f14ac2bc887e06f9aebbf6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:OperatingPerformancebasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0a670137ff2a451782f99f45ef40a8f6_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:OperatingPerformancebasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7bb32345ef6842089919448a35175b29_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id526b3c20a2d42d5abba8504d3816294_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i97785f256ae3470b9f482c61dec5e68a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5d45641764344e17bb094a058ba9942c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic0dced88ae604075b207e4543f4c306f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i92991d08bea7415da6b40d6cf2dfe885_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id411cf0d82944320a5787d8a7f2ebfe8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:MarketbasedPerformanceRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iaaa1e1cbda504307b64e2b6e1037f051_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">livn:OperatingPerformancebasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9a0a4786b53a409786262fe990c43c5a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i20801a9a959b4964abe3933a95ed2cae_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i45c62bd5d99d4fce99db5761c61d6e17_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4379082406654f39a39e859cda18b46a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i876852bfed184662a8f0d97d8bcaa96c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibe5844e1c9474606816d00972d05d123_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i62b84cedd45d40678d48897ca51541e3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iba81a1a74dfe49b8aa3eb8f99114e275_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i048767aa111f4c9fb0f1ac8f9d147073_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i98d0d7d6789f427ea18447a9ecab0429_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i45c1d64c7a40486b9179d7e170cbe2f9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie7329b87ee254e179498f3ab5d4c1188_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1e91c84eafce45e9b7b415a5813b4a82_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0a6de0e9e7b442a3a978cd51f4294ab4_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9a14281cb8974824bd527e86f10ab2bb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i067bb22836894b95b391f0d0acb63f85_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i998e5f95302b4aeda2b81e2447e7d338_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i492977f4fcc14476974fcd6784642170_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic21d9046e8e54eb08111e039c3cd30c2_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i14ea489aa03e4679ae969ce4f20eeec8_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:CardiopulmonaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i31a3762e4349432987b7c4352fec5b98_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6a02318bfa3347cc8505a8b9b72252cb_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i512e1cbc1dbf402a8182f4c49af7e088_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i86e615fd4f804099b338c2d68fd98684_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6b2e5a703d0d4e0da33993ef6e8b10d7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaebed4d2a7214242b9cdae043b3e1395_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7d314c195032448da84bdf91257809f5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0fad8409ffa449c3a2dcd5303e70034a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i73bb4237240a4e3fb606e9efd3f84f99_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib1965860a1d8443d8fd1255f6745e510_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i37b3bf78b8684a9a85fa49b6161b9c2e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic43242093f884cfa9804e7b602317c98_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9863d6e831c3445b8abe8ec63dd71610_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifea8fbd4f8a842768f18f1cb7d62556d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3691f9031c3d4c0baaccadab036cdb47_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1d14b893f6a8433790639cb04398340d_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:HeartValvesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if9f0e21d42994c2d9c4ad4c9cc1386b3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i37a57e73f7074cc2b478dc7848ff6ebb_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6c228cdd25fa46dc846f886d32efa18b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib4cde2101963426a8246337e1a0c076a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9f2ccc2749c2492885274416414af440_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i24e4350fe7d9437184b7909a2aae9e1f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i993975a651dd4a8da309a2bc9be5ccaf_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i13437c9318a542149d8e4b9ace7af3f8_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i69ff964a5f854ebbbe1ea60e0e626bb6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i718f682704d94fc694e5d005c83a53e9_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7b0092809fe14757a77ae4181720814e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i30054fec7a044c3195b0a1f4a0c95929_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5a8df61046d04836b659e7543314d52b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5c55bcd90e9a4aacbf366789e82e6f95_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3f292902eb0549ab833ee3de080de1ba_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i83af8f7348324741a33b045e553554c3_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">livn:AdvancedCirculatorySupportMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i60f6642d17aa4014ad54b108c471cdcd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2c95775accb649a2a43367af2881bd1e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3ba01b8c48ef4056a693c9fd38968b66_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i455f04a75540413cb77b07c862e31aa6_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iaa815b9dabb542e1ae17525ed43b6edd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idb31194759654532b6d3c7273756b4f0_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iee15933e70114ffda536e4ce711dad1d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib6dd5ea4b1ca4e18a2fcdea83a107830_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id2e41838e4174c11abc94d3fb48a1fb4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icaadc304289f4da0b546e3b00fcd58c1_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1ab86d3d6d0f49dca6f89b85afbdfa63_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i92e6ec3e0d984c9f86c920f967033463_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6605f2db15da497784c8273e981148a5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1255365af20d4f3d8de0bd8332901b23_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie4a5a9acdf1b466d8d5cd9e19d1f3cb1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5546f850f727425d90f293dbf898907b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia4b98b0523e7492f935ed61439c44ac7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifd5e3ac54bd741a5a9a5b5f8105a08ae_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib713c27b02154444b1b13648efdc2cb9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i90c55e2ec6ed42bc805a2d2a55c5c015_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5bfaac3413d149e8a37153945f6a6c4d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if2d1490e739647a987879cf6b41a8714_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i576c2f526c3d4a9b9c2a3777ca6ae531_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i647ae223232c4e10957d4e6ecf102def_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8d864c92f8184a1b8fc7aa74c911e9d5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib3b6505d7e924fd996331218487159c5_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1c978d524b454407894936f54228ed99_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i685896438be142c1b5cc2e440c305db2_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5e5933b714be422fb3a8dbdb558b63d0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic8fcde1e652d443a977756769f311eb0_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iad0023589bcb4062a7f6ee3b1663620e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i177a57ba7c1e481b80517501c4f324c5_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9869e96a35ca485f87925c8da417cf1d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3d7442c704eb4389bdc5b405e968fa81_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib304e38586c34d63aeb55253400f5dfc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic91a56d11d8a4a7994c72db8fe11c1d9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4e8a04ec819f4cecb0b4d32157f3793c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i750cd8c7e43c4c11ab8974d496e7bb2f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibb3170768056425eb10ca95b859602e3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic51b2b23224546d29ccce9fe55170242_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i26b3c5a9534a4fe29e2597bb3c79e85a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6da06d9c9f8f4561b0149e510d196cdf_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i533727d94e6d4a939f7d8a3366ee1c2c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0d8d758d27874054949a7da21f2f2b51_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibdd4df75ecee4768ac486e5f62873b27_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i555f859b9cc045aa906e26d5ebfeda55_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i72a6c2813b9a4c7a8ef3258c3a0d53e6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4e3947b9663c4dd195e33fed5b54ba85_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i37c0fa19eea047a2936735006bf189fc_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i97f2df041b5e4467941d20a0fed11b0d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5c740fe5919f452f8b72fcc2fa97e743_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic1ba6be74fbf4cd8a64b5aff3d82ca29_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7e834100347f4225a07ea71d1272445b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i82d6d51022114ec88eb0d11a4a6ff932_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i621fac9415c54f6a87f88d3a519eb1f0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie26338ab822548b58c3b31da34f31dd8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i21249aea88bf443ba021a32669ad704b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic77fdf65e1a94d118f6cb9b70082f469_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i50dafb81ae7249f0b00a89f30fa949b6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idbd1000ed3de4516a0195c708a123de5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia01b97a86f2f4fb9ad100afbeb3977ab_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie035b1af1b6244959d04c1e0f44038a5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7ed94ea4037647e09c43b0db147a2453_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:NeuromodulationSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie3dabd6f2807465da694560fc9777ec8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">livn:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2dde44e6ca6c4af39265921b98826424_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i67e83bb326504f55b272768962da8016_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibedca0f603bd4bd6a1d7eb72407a0f05_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2c3b8ff212bf4e7789a78c902e1ca14e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2e0cc6d97d2c44baa25cccb561c0a434_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia8d1a426602f4eb09beb15214ebfd323_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">livn:LocationsExcludingTheUnitedStatesAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i11591753270141129f271d60eea42105_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="i25fe44ba33a444a484626a29cce0642c_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001639691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="gbpPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:GBP</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="distributor">
        <measure>livn:distributor</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="claim">
        <measure>livn:claim</measure>
    </unit>
    <unit id="non-conformity">
        <measure>livn:non-conformity</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="installment">
        <measure>livn:installment</measure>
    </unit>
    <unit id="notice">
        <measure>livn:notice</measure>
    </unit>
    <unit id="segment">
        <measure>livn:segment</measure>
    </unit>
    <unit id="geographic_region">
        <measure>livn:geographic_region</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80L2ZyYWc6Mzg4NmRjNDRkZjk3NGJkZmIzN2EyMWRhZWNiMWYwMGUvdGFibGU6N2QyZDU2YTNmOWU5NGYwZTkwMDQ3N2VjMjUyMDg5YjkvdGFibGVyYW5nZTo3ZDJkNTZhM2Y5ZTk0ZjBlOTAwNDc3ZWMyNTIwODliOV80LTEtMS0xLTA_8e475c0f-0e18-434d-adc2-a232bb62cda0">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80L2ZyYWc6Mzg4NmRjNDRkZjk3NGJkZmIzN2EyMWRhZWNiMWYwMGUvdGFibGU6N2QyZDU2YTNmOWU5NGYwZTkwMDQ3N2VjMjUyMDg5YjkvdGFibGVyYW5nZTo3ZDJkNTZhM2Y5ZTk0ZjBlOTAwNDc3ZWMyNTIwODliOV81LTEtMS0xLTA_f65a4013-b83a-4a7f-a8d1-f2839f2ce674">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80L2ZyYWc6Mzg4NmRjNDRkZjk3NGJkZmIzN2EyMWRhZWNiMWYwMGUvdGFibGU6N2QyZDU2YTNmOWU5NGYwZTkwMDQ3N2VjMjUyMDg5YjkvdGFibGVyYW5nZTo3ZDJkNTZhM2Y5ZTk0ZjBlOTAwNDc3ZWMyNTIwODliOV82LTEtMS0xLTA_1528e7da-3f81-4306-9493-012505d16d8f">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80L2ZyYWc6Mzg4NmRjNDRkZjk3NGJkZmIzN2EyMWRhZWNiMWYwMGUvdGFibGU6N2QyZDU2YTNmOWU5NGYwZTkwMDQ3N2VjMjUyMDg5YjkvdGFibGVyYW5nZTo3ZDJkNTZhM2Y5ZTk0ZjBlOTAwNDc3ZWMyNTIwODliOV84LTEtMS0xLTA_f6e2d167-139b-4fcf-b2b0-74eadecd69f8">0001639691</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80L2ZyYWc6Mzg4NmRjNDRkZjk3NGJkZmIzN2EyMWRhZWNiMWYwMGUvdGFibGU6N2QyZDU2YTNmOWU5NGYwZTkwMDQ3N2VjMjUyMDg5YjkvdGFibGVyYW5nZTo3ZDJkNTZhM2Y5ZTk0ZjBlOTAwNDc3ZWMyNTIwODliOV85LTEtMS0xLTA_c9bac9f9-acaf-49c0-ba97-68b9552cc40e">--12-31</dei:CurrentFiscalYearEndDate>
    <livn:DebtInstrumentExchangeableConversionRatio
      contextRef="i5ffd59ecf9044f8eb3cf977b8db8a6a7_D20200701-20200930"
      decimals="6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82MS9mcmFnOmQwOGIwMWJhOWFjMDQ3ODVhYTViYmQyODBlMzUzZmY4L3RleHRyZWdpb246ZDA4YjAxYmE5YWMwNDc4NWFhNWJiZDI4MGUzNTNmZjhfOTQ_4e36198b-3b4d-4e70-9fe7-0357b260d047"
      unitRef="number">0.016398</livn:DebtInstrumentExchangeableConversionRatio>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMi0wLTEtMS0wL3RleHRyZWdpb246NzBlNmI4NTFhNzBkNDhmYTgzNmM5ZmZkOGQwOTVkZGZfMTY_2f7bdef0-ddd7-4bfa-ad80-21e764af2e97">us-gaap:AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RhYmxlOmI3NzhiMTYwZjg5NTQzN2ViODlhMTA0NWE0NGFmNzdjL3RhYmxlcmFuZ2U6Yjc3OGIxNjBmODk1NDM3ZWI4OWExMDQ1YTQ0YWY3N2NfMS0wLTEtMS0wL3RleHRyZWdpb246OWNhMDIzMjU1YjY2NDBkN2I1NDUzOTBiNjY0ZTMzZDNfMTQ_421ad1dc-77dd-457b-948b-627f349609b2">us-gaap:AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <dei:DocumentType
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTE1_6d671cec-7650-4f14-948c-88b8e9190865">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTI1_17eb74cc-e4c3-4d2d-9bb8-978344f6c03e">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yNDg_a536447f-0a27-4abf-b337-dc52b2b6242e">2020-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTEy_2367b4d1-581a-4dd6-9b35-915d94bb8e50">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTI2_fac42b86-25fa-40e2-84d2-e1d1c0f4ebb2">001-37599</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8zODQ4MjkwNjk5MzQ0_fcb3c8e8-5aae-4e0b-9135-5700434a20d4">LivaNova PLC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTI3_644d362f-35c0-4a09-b6ff-be5792cf5893">X0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTIz_e5db4872-e876-4759-a24b-02bd8e8d7667">98-1268150</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTE2_742408dc-15f6-4b24-ba10-803e4d01b204">20 Eastbourne Terrace</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTE3_615e4e5a-3735-4921-b310-1ee1b67f1f42">London</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTE4_2443e641-d92f-4d1d-9547-1c2035862b3f">GB</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTEz_e6dc773c-a9d7-4488-abb6-d6b8c40eb21d">W2 6LG</dei:EntityAddressPostalZipCode>
    <dei:CountryRegion
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTE5_fd598441-2519-41cb-af15-8100f267f569">44</dei:CountryRegion>
    <dei:CityAreaCode
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTI0_20bf4d65-8f90-4a51-ba72-601dfe3fab52">0</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTE0_46348ae1-5deb-4da5-8972-e6ad07516551">203 325-0660</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGFibGU6NmUxMGQxNWUyMTA1NDY3MmE0MzA5MzVjMjg0YWFiMjgvdGFibGVyYW5nZTo2ZTEwZDE1ZTIxMDU0NjcyYTQzMDkzNWMyODRhYWIyOF8xLTEtMS0xLTA_4c0b6917-6af0-4466-92d8-469be112c85c">Ordinary Shares&#160;- &#xa3;1.00&#160;par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGFibGU6NmUxMGQxNWUyMTA1NDY3MmE0MzA5MzVjMjg0YWFiMjgvdGFibGVyYW5nZTo2ZTEwZDE1ZTIxMDU0NjcyYTQzMDkzNWMyODRhYWIyOF8xLTItMS0xLTA_3e390888-1fa8-425f-8a29-9620aa70267f">LIVN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGFibGU6NmUxMGQxNWUyMTA1NDY3MmE0MzA5MzVjMjg0YWFiMjgvdGFibGVyYW5nZTo2ZTEwZDE1ZTIxMDU0NjcyYTQzMDkzNWMyODRhYWIyOF8xLTMtMS0xLTA_48d59eb2-cc14-426a-b405-3901e2730924">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTIw_2fb80dea-ebbf-45bd-bde6-425ab4dad356">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTIx_e54fd1b6-fbaf-4b5b-9691-054244091c06">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGFibGU6OTI4ODJmY2VkNzViNDZiZjljNmY4MjY1OTdkMGViZGMvdGFibGVyYW5nZTo5Mjg4MmZjZWQ3NWI0NmJmOWM2ZjgyNjU5N2QwZWJkY18wLTAtMS0xLTA_1340b91c-1b7e-4adf-ac4d-374a82f2ee3d">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGFibGU6OTI4ODJmY2VkNzViNDZiZjljNmY4MjY1OTdkMGViZGMvdGFibGVyYW5nZTo5Mjg4MmZjZWQ3NWI0NmJmOWM2ZjgyNjU5N2QwZWJkY18xLTMtMS0xLTA_7a701c3e-2688-46cc-af8d-830bc28b3b24">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGFibGU6OTI4ODJmY2VkNzViNDZiZjljNmY4MjY1OTdkMGViZGMvdGFibGVyYW5nZTo5Mjg4MmZjZWQ3NWI0NmJmOWM2ZjgyNjU5N2QwZWJkY18yLTEtMS0xLTA_befec33f-e5d4-4b6a-8c1c-140cf23f143c">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGV4dHJlZ2lvbjoyZWZlODhlMGNiYWM0MzRiYmMwM2NhNTUwMWM2NjAzMF8yMTIy_a8af6ea1-7180-43e2-b7e3-b5cd6caafc9a">false</dei:EntityShellCompany>
    <dei:Security12bTitle
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGFibGU6YzgyNDY1OGI5OTg3NDU1OThhODIyN2UyMTIyZTFmZTUvdGFibGVyYW5nZTpjODI0NjU4Yjk5ODc0NTU5OGE4MjI3ZTIxMjJlMWZlNV8xLTAtMS0xLTA_d0dfc065-5961-424b-ab08-76286aa1b8e2">Ordinary Shares&#160;- &#xa3;1.00&#160;par value per share</dei:Security12bTitle>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ib5c4b96ff27e4ddeb062ecd5ba74027a_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xL2ZyYWc6MmVmZTg4ZTBjYmFjNDM0YmJjMDNjYTU1MDFjNjYwMzAvdGFibGU6YzgyNDY1OGI5OTg3NDU1OThhODIyN2UyMTIyZTFmZTUvdGFibGVyYW5nZTpjODI0NjU4Yjk5ODc0NTU5OGE4MjI3ZTIxMjJlMWZlNV8xLTEtMS0xLTA_58ee5959-11cb-4adf-a12a-eb4064eb811c"
      unitRef="shares">48596417</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMi0yLTEtMS0w_73888873-6a4a-4d55-96d6-4ac9e317fe47"
      unitRef="usd">240083000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMi00LTEtMS0w_b708328e-9382-47e1-9ef8-8f3124367f91"
      unitRef="usd">268610000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMi02LTEtMS0w_8bc058b9-ea56-4c10-9446-ba851a70384e"
      unitRef="usd">664686000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMi04LTEtMS0w_d377c8b8-f694-4d55-97d7-1559c16bb4f5"
      unitRef="usd">796580000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNC0yLTEtMS0w_3c494328-33f4-4842-883a-eb214c2b6909"
      unitRef="usd">86467000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNC00LTEtMS0w_f4269994-2a54-47e4-be17-5ebec55d06bc"
      unitRef="usd">86128000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNC02LTEtMS0w_78ab5cf2-a4a4-4cea-87ef-8566c6764bc7"
      unitRef="usd">212152000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNC04LTEtMS0w_a0515660-9afc-4b75-8ec6-0ef7d1abd07a"
      unitRef="usd">245324000</us-gaap:CostOfGoodsAndServicesSold>
    <livn:ProductRemediationExpense
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNS0yLTEtMS0w_4ee2cd9c-dde5-42f1-91e6-0402c67bfb59"
      unitRef="usd">1133000</livn:ProductRemediationExpense>
    <livn:ProductRemediationExpense
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNS00LTEtMS0w_4dd8cc1c-327e-4d3d-ad2a-63275283f9de"
      unitRef="usd">3076000</livn:ProductRemediationExpense>
    <livn:ProductRemediationExpense
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNS02LTEtMS0w_876a489e-8711-4a10-bff9-2f6b297bf7c1"
      unitRef="usd">6868000</livn:ProductRemediationExpense>
    <livn:ProductRemediationExpense
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNS04LTEtMS0w_6121828e-ff49-4d5e-9f4e-8c5d6c6f8825"
      unitRef="usd">11136000</livn:ProductRemediationExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNi0yLTEtMS0w_6fc0b15e-df01-492f-880d-77633f057de0"
      unitRef="usd">99199000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNi00LTEtMS0w_a220c84e-6359-4ba7-93af-7a588788ed89"
      unitRef="usd">123015000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNi02LTEtMS0w_58aadc6b-1d66-4820-a122-ccdb3a2dff72"
      unitRef="usd">317424000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNi04LTEtMS0w_cd37e210-e63b-43dd-b872-89ab6c91047c"
      unitRef="usd">375932000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNy0yLTEtMS0w_1894f19e-8cb2-44bf-b4ba-ce132a5fa62f"
      unitRef="usd">47368000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNy00LTEtMS0w_95c1b65b-9c5f-4faf-832f-8c41596b0dd1"
      unitRef="usd">45904000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNy02LTEtMS0w_be1464c1-c341-42c7-a9cc-6beb3c4d0fe0"
      unitRef="usd">108422000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfNy04LTEtMS0w_81812ebe-529d-4cd2-bdcc-1a950f7e4312"
      unitRef="usd">124023000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfOC0yLTEtMS0w_410f3ba4-cfa6-4882-8b2f-1d5773aa6413"
      unitRef="usd">1094000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfOC00LTEtMS0w_bbea17b6-0fb7-46bd-ae5c-d6e1412adda7"
      unitRef="usd">6716000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfOC02LTEtMS0w_16e2d4e6-0087-4684-85e4-5ab20b387844"
      unitRef="usd">6616000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfOC04LTEtMS0w_f245bda2-a174-4c7f-883d-e3d8de8ea3b9"
      unitRef="usd">14345000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:RestructuringCharges
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfOS0yLTEtMS0w_51e276c7-6d8a-4d46-ba78-96bbad1124c5"
      unitRef="usd">-349000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfOS00LTEtMS0w_6d61241a-d12c-4556-b2fc-531916e21bc3"
      unitRef="usd">698000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfOS02LTEtMS0w_20353d4b-d98e-459c-b9dd-66691a3e81c1"
      unitRef="usd">2025000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfOS04LTEtMS0w_58f247fc-59e8-4f7b-b68e-d543c1ecc08c"
      unitRef="usd">4563000</us-gaap:RestructuringCharges>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTAtMi0xLTEtMA_4497b3af-0cd8-4827-9d7f-e20074f54d73"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTAtNC0xLTEtMA_1a586335-7607-4365-a6ef-57c9476b6b83"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTAtNi0xLTEtMA_7dd77c0e-1da5-4e14-ae6d-e23539cd3a71"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTAtOC0xLTEtMA_a44ac694-e92e-4248-a301-5a247294b480"
      unitRef="usd">50295000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTEtMi0xLTEtMA_3f15f84a-40a8-4be9-88fc-bd1bb4551bac"
      unitRef="usd">9685000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTEtNC0xLTEtMA_437a3866-bfe2-4733-8947-32284d6a4d01"
      unitRef="usd">11146000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTEtNi0xLTEtMA_1ff6b7ed-4377-45cf-89d5-fe2477436772"
      unitRef="usd">29346000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTEtOC0xLTEtMA_a22fe9c1-576e-43b8-8f5b-c10e86a1438c"
      unitRef="usd">29690000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:LitigationSettlementExpense
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTItMi0xLTEtMA_9f88bcbd-b53b-4177-b69c-91d1f7571665"
      unitRef="usd">2994000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTItNC0xLTEtMA_7d8e20ff-579c-4ba1-82dd-9688b84d73be"
      unitRef="usd">-33834000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTItNi0xLTEtMA_c480b62a-666d-416d-9cc0-8d633fe096d2"
      unitRef="usd">3970000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTItOC0xLTEtMA_3e9e870c-dbd6-4674-9db7-2440c8e1f185"
      unitRef="usd">-33834000</us-gaap:LitigationSettlementExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTMtMi0xLTEtMA_6ecde5c0-be1c-44b0-a0b0-d3eec2e0e7c5"
      unitRef="usd">-7508000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTMtNC0xLTEtMA_015ae59d-e870-4570-8c10-ae5dd613cd3d"
      unitRef="usd">25761000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTMtNi0xLTEtMA_42a94055-c103-4c6e-bc7f-42769339656d"
      unitRef="usd">-22137000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTMtOC0xLTEtMA_dbd14566-bf92-48dc-b308-121942e12f6f"
      unitRef="usd">-24894000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTQtMi0xLTEtMA_c3e2d1f7-7dda-44d1-aaab-1c75552ca42b"
      unitRef="usd">47000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTQtNC0xLTEtMA_7ebebaf7-30e0-4b17-b09d-bc56ba8175fa"
      unitRef="usd">151000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTQtNi0xLTEtMA_b8995a7c-7182-49e8-b8e4-f8edd9e33d33"
      unitRef="usd">482000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTQtOC0xLTEtMA_4fd3ee71-4bee-45ed-86f1-c7a814ff2aae"
      unitRef="usd">624000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTUtMi0xLTEtMA_e8feb6b0-8216-421f-8634-9b6ad49ed445"
      unitRef="usd">14673000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTUtNC0xLTEtMA_3633f422-eb0d-4af4-934d-05f9ada07e12"
      unitRef="usd">4774000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTUtNi0xLTEtMA_8078332b-499f-4aff-b1c7-72aa2db8790e"
      unitRef="usd">25237000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTUtOC0xLTEtMA_fe8a1d57-f7bd-4856-a616-8a2432596371"
      unitRef="usd">10490000</us-gaap:InterestExpense>
    <livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTYtMi0xLTEtMA_b2e30b56-d158-454a-bc85-970bd1b309fb"
      unitRef="usd">3420000</livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome>
    <livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTYtNC0xLTEtMA_27f1cbfb-15a1-4aeb-9b81-f8f39286b720"
      unitRef="usd">327000</livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome>
    <livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTYtNi0xLTEtMA_f9bf53b6-0a28-40f6-9fae-ca403106354d"
      unitRef="usd">507000</livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome>
    <livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTYtOC0xLTEtMA_9d394663-ffae-4049-b0e9-376d6258a05b"
      unitRef="usd">-795000</livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTctMi0xLTEtMA_56b9bdcf-62bb-4dea-a10c-86e2a37046b4"
      unitRef="usd">-18714000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTctNC0xLTEtMA_59820116-7741-4755-a3df-d8efe4999768"
      unitRef="usd">21465000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTctNi0xLTEtMA_c3bd8974-e870-4785-a4c8-63c5815f9058"
      unitRef="usd">-46385000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTctOC0xLTEtMA_c08c2024-4ccf-4b83-9fb1-0a5fde6257b3"
      unitRef="usd">-35555000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTgtMi0xLTEtMA_42efe157-8dfd-4740-809b-8079f40939de"
      unitRef="usd">-3990000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTgtNC0xLTEtMA_fd6d1f5f-db04-4507-b535-fd1838333fc3"
      unitRef="usd">-10653000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTgtNi0xLTEtMA_d9384950-edc5-44b4-b290-efb0bec4b521"
      unitRef="usd">17581000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTgtOC0xLTEtMA_83e3529f-b9ed-40a4-9ec2-aa6eca8e192d"
      unitRef="usd">-23431000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTktMi0xLTEtMA_8f1810c8-6760-40a2-b0f5-9f2db7a4fa6e"
      unitRef="usd">-48000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTktNC0xLTEtMA_dfc905b2-45e7-48b0-bd09-dd9be88c3003"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTktNi0xLTEtMA_7b86fbec-e152-48ff-bdc2-050b6be55dd4"
      unitRef="usd">-221000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMTktOC0xLTEtMA_fdd0c4fd-a3e6-4f4e-b8ea-f35b17a12284"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjAtMi0xLTEtMA_a909fdd8-0b4e-479f-87d2-1c9b31fb8291"
      unitRef="usd">-14772000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjAtNC0xLTEtMA_1dd611b0-1c5a-4afe-bb34-d36d20188cd1"
      unitRef="usd">32118000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjAtNi0xLTEtMA_bb64ec94-a9b8-4412-8565-6d3a5245f02a"
      unitRef="usd">-64187000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjAtOC0xLTEtMA_9057c294-abe4-4cfd-a628-db4fc1e2c5cd"
      unitRef="usd">-12124000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjEtMi0xLTEtMA_b3b5526e-dd18-4a68-a279-cf4514ed193b"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjEtNC0xLTEtMA_128cdabb-331c-4bd9-b06c-9006cd7dab75"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjEtNi0xLTEtMA_86279b8a-7c37-4203-99b8-348776150362"
      unitRef="usd">-995000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjEtOC0xLTEtMA_a1f8a0b0-3a5c-4565-8da2-c89dcfdec55e"
      unitRef="usd">178000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjItMi0xLTEtMA_62d4444f-bda9-41ba-94f9-ea814f7a8224"
      unitRef="usd">-14772000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjItNC0xLTEtMA_23004a56-ac1d-48a4-8bb8-33fcb6b13313"
      unitRef="usd">32118000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjItNi0xLTEtMA_635074bc-a9e9-40e7-ba28-e8d326e22514"
      unitRef="usd">-65182000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjItOC0xLTEtMA_d6745ced-29f1-4712-b0c6-4fb84dd893e7"
      unitRef="usd">-11946000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjUtMi0xLTEtMA_ca14f938-018e-41bd-b63e-cb1f3e436fb7"
      unitRef="usdPerShare">-0.30</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjUtNC0xLTEtMA_6f249268-f626-49bf-a35a-c02367953753"
      unitRef="usdPerShare">0.66</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjUtNi0xLTEtMA_3d6ea665-6e2a-45d4-b076-8b8eb821343a"
      unitRef="usdPerShare">-1.32</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjUtOC0xLTEtMA_364db6a9-c458-43be-95a6-14302687eeca"
      unitRef="usdPerShare">-0.25</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjYtMi0xLTEtMA_a8406609-9d63-4df6-b2af-d97a3bb29357"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjYtNC0xLTEtMA_127a54e9-16db-426b-b5e8-06cd90602fd9"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjYtNi0xLTEtMA_c182d87a-9ade-4420-a085-5898b4b67d5e"
      unitRef="usdPerShare">-0.02</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjYtOC0xLTEtMA_daa81265-9396-459d-bcbb-407a1ac066d6"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjctMi0xLTEtMA_12898ac2-9844-4ba6-9c90-5d5d35346123"
      unitRef="usdPerShare">-0.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjctNC0xLTEtMA_21fcb6d1-b757-44cb-beab-6e6cb7469eca"
      unitRef="usdPerShare">0.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjctNi0xLTEtMA_541c6346-2649-4554-9731-c012cef26a36"
      unitRef="usdPerShare">-1.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMjctOC0xLTEtMA_25ea5db0-50ff-4421-a9d0-26071411febf"
      unitRef="usdPerShare">-0.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzAtMi0xLTEtMA_3897a58f-e29e-4026-ad8c-d5274e72a7fe"
      unitRef="usdPerShare">-0.30</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzAtNC0xLTEtMA_0cc79f80-5dbe-40ee-8388-4f990296a641"
      unitRef="usdPerShare">0.66</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzAtNi0xLTEtMA_85f0f279-0e54-47e0-a60c-e6e52e6925ce"
      unitRef="usdPerShare">-1.32</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzAtOC0xLTEtMA_3e67bd86-b2af-4434-882a-7af6ca25307f"
      unitRef="usdPerShare">-0.25</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzEtMi0xLTEtMA_48c3385b-7934-4020-9f6b-56ce81a9548f"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzEtNC0xLTEtMA_b33234f1-a860-4bb1-956b-ca4de2cac0ff"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzEtNi0xLTEtMA_bc25a112-0ffb-4f06-a2de-434abd09a848"
      unitRef="usdPerShare">-0.02</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzEtOC0xLTEtMA_692f9905-b21a-42c2-8150-3e1d3c9a64f9"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzItMi0xLTEtMA_f2c027d2-0863-44f0-9f7c-f3244cdceb5e"
      unitRef="usdPerShare">-0.30</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzItNC0xLTEtMA_a5469d56-3dff-4e89-8ef8-2cf30c63db49"
      unitRef="usdPerShare">0.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzItNi0xLTEtMA_c4775589-d91c-4031-9dff-aef8bbb8f354"
      unitRef="usdPerShare">-1.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzItOC0xLTEtMA_b2f9f0e1-4735-440c-bfef-42295f7edd4c"
      unitRef="usdPerShare">-0.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzQtMi0xLTEtMA_7c12ae20-5425-46ae-9a24-6d7438a1c00f"
      unitRef="shares">48652000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzQtNC0xLTEtMA_20fa9c19-c84b-4422-b11f-45da877d668f"
      unitRef="shares">48395000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzQtNi0xLTEtMA_f940caa2-b821-40ac-b59a-4eaa0ba5e816"
      unitRef="shares">48582000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzQtOC0xLTEtMA_7a902816-50d9-4dca-9274-41d27987fe23"
      unitRef="shares">48329000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzUtMi0xLTEtMA_2f1ca099-a984-421b-9980-ba0f38b9d446"
      unitRef="shares">48652000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzUtNC0xLTEtMA_8f204425-d664-4c9d-bd00-bf7bed9df27c"
      unitRef="shares">48820000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzUtNi0xLTEtMA_88b24c58-6904-4e85-961e-a63894781df1"
      unitRef="shares">48582000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8xOS9mcmFnOjE5NmM1YjQxYjAxOTRlYzI4ODY2MzJjNWU4Yjc2ZjBhL3RhYmxlOjExYjVlNTkxYWY0ZDRhMmU5ZmYwZjYwMTYwZmVjZjJjL3RhYmxlcmFuZ2U6MTFiNWU1OTFhZjRkNGEyZTlmZjBmNjAxNjBmZWNmMmNfMzUtOC0xLTEtMA_71544a00-085a-4b2d-88ee-e2cb847924d4"
      unitRef="shares">48329000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfMi0yLTEtMS0w_62d4444f-bda9-41ba-94f9-ea814f7a8224"
      unitRef="usd">-14772000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfMi00LTEtMS0w_23004a56-ac1d-48a4-8bb8-33fcb6b13313"
      unitRef="usd">32118000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfMi02LTEtMS0w_635074bc-a9e9-40e7-ba28-e8d326e22514"
      unitRef="usd">-65182000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfMi04LTEtMS0w_d6745ced-29f1-4712-b0c6-4fb84dd893e7"
      unitRef="usd">-11946000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNC0yLTEtMS0w_987ca709-b32a-4695-b8c1-94363c736385"
      unitRef="usd">1640000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNC00LTEtMS0w_a50753c0-b8ab-4143-a21a-2ee248706882"
      unitRef="usd">-870000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNC02LTEtMS0w_28a51827-8c94-486b-80ad-c4240f824f4e"
      unitRef="usd">1313000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNC04LTEtMS0w_5ac079db-e727-4308-8bde-71406b946d7d"
      unitRef="usd">-665000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNS0yLTEtMS0w_903e626a-8a28-440e-82ca-cd018d0c6a81"
      unitRef="usd">393000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNS00LTEtMS0w_5eca29ce-87c7-4d67-8e10-fd787566c1ab"
      unitRef="usd">-209000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNS02LTEtMS0w_2ca22d6e-50a9-4b73-9f18-79ea10b2d773"
      unitRef="usd">314000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNS04LTEtMS0w_dd784584-04f7-47f9-8858-be13f08d56ac"
      unitRef="usd">-159000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNi0yLTEtMS0w_67f06007-0484-4840-ab1d-f6d4d4678a14"
      unitRef="usd">1247000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNi00LTEtMS0w_d3b6d93d-7a56-43bc-84d6-852c4a1dc195"
      unitRef="usd">-661000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNi02LTEtMS0w_9fdf2e05-059b-4b1e-80a2-b6d292451a80"
      unitRef="usd">999000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNi04LTEtMS0w_98fc3fd2-36f4-4ac2-97fb-47a98398a106"
      unitRef="usd">-506000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNy0yLTEtMS0w_6e3698d1-5760-4f52-b2a3-be613fd1eae9"
      unitRef="usd">23457000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNy00LTEtMS0w_f315b07e-c3fe-43de-b2b2-3d97ae2fabe5"
      unitRef="usd">-27775000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNy02LTEtMS0w_4dd50b66-1305-4eb0-8b5b-481806973171"
      unitRef="usd">8008000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfNy04LTEtMS0w_1e775ea0-bf75-4147-8ca2-bab5b88e3269"
      unitRef="usd">-16628000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfOC0yLTEtMS0w_2dfa516d-c37c-436a-8844-94fe9655e7a4"
      unitRef="usd">24704000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfOC00LTEtMS0w_c64f1fdd-8476-4fd0-bce8-e8e4b98bd4a3"
      unitRef="usd">-28436000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfOC02LTEtMS0w_77972933-119a-4c89-94c3-306582d456b4"
      unitRef="usd">9007000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfOC04LTEtMS0w_4ed744b4-2ac6-46ac-8c2b-2cdfe9129e02"
      unitRef="usd">-17134000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfOS0yLTEtMS0w_5bdf1727-1278-41d6-8242-a36d07776d43"
      unitRef="usd">9932000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfOS00LTEtMS0w_8be83b49-c4cd-4023-83f3-4c51ef13e8cc"
      unitRef="usd">3682000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfOS02LTEtMS0w_042ef546-d713-46d0-99b9-18808f0bc9a3"
      unitRef="usd">-56175000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yMi9mcmFnOmYzY2UyY2VkODc3YzQ0NTVhODlkMGQxOTZiY2ZmYzhhL3RhYmxlOmYzMzU3ODQ2YTZjYjQ2OTU4YTY3MzY2NjNlY2YxNjZjL3RhYmxlcmFuZ2U6ZjMzNTc4NDZhNmNiNDY5NThhNjczNjY2M2VjZjE2NmNfOS04LTEtMS0w_7bf49585-3d01-4886-991c-0c44e7f22465"
      unitRef="usd">-29080000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMy0yLTEtMS0w_bd73e834-7132-4d7c-a3bf-5761dee589f6"
      unitRef="usd">227811000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMy00LTEtMS0w_345cd795-5b80-45a0-a47f-27248cfad935"
      unitRef="usd">61137000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNC0wLTEtMS0wL3RleHRyZWdpb246MThjOGMxNWIyMTM2NGQ4ZmJjNDBhNTM3MjgyNWJjNmVfNDU_fde24d94-d4a0-4e7e-9d4a-b9b66ca36779"
      unitRef="usd">16241000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNC0wLTEtMS0wL3RleHRyZWdpb246MThjOGMxNWIyMTM2NGQ4ZmJjNDBhNTM3MjgyNWJjNmVfNjk_75238c56-0c18-4daa-acb4-caacf7eb4414"
      unitRef="usd">13105000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNC0yLTEtMS0w_7202a229-cd7d-4f1a-9116-2152ff5bee48"
      unitRef="usd">191892000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNC00LTEtMS0w_49135421-d868-48a8-89db-b5f02f0eed35"
      unitRef="usd">257769000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNS0yLTEtMS0w_ca34fcd1-b8e1-4a63-a7f7-934d15f7a4ed"
      unitRef="usd">178091000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNS00LTEtMS0w_f2e3b82e-c6a5-485b-a2d5-715edfd81198"
      unitRef="usd">164154000</us-gaap:InventoryNet>
    <us-gaap:PrepaidTaxes
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNi0yLTEtMS0w_4c53dd4f-6b15-4b46-bde3-ce2a129803cc"
      unitRef="usd">43316000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNi00LTEtMS0w_beaf040f-3042-4fc5-bcb3-f22578d87698"
      unitRef="usd">37779000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNy0yLTEtMS0w_0174f6c7-b374-4bd2-b24b-5f17faf3123d"
      unitRef="usd">32026000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNy00LTEtMS0w_b80ced88-b0d3-4bbb-8d28-c2f4b899f79b"
      unitRef="usd">28604000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfOC0yLTEtMS0w_4e16d892-76a1-4e30-af3e-49b40115b7a6"
      unitRef="usd">673136000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfOC00LTEtMS0w_7e64f0bc-da45-4c39-a99d-c18a671a3f62"
      unitRef="usd">549443000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfOS0yLTEtMS0w_07aeef33-720f-4d20-b713-24d87ce7c22c"
      unitRef="usd">190509000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfOS00LTEtMS0w_7d327cfa-475a-42c4-9c20-68a40bb9f31e"
      unitRef="usd">181354000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTAtMi0xLTEtMA_3a9598a9-4df7-4b6f-9fb0-13c9d37f80e9"
      unitRef="usd">918478000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTAtNC0xLTEtMA_3f57ae20-e302-4120-b351-3e916eb0c98e"
      unitRef="usd">915794000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTEtMi0xLTEtMA_46da2dc5-6d6e-4c4f-8861-d53ce36f161f"
      unitRef="usd">583818000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTEtNC0xLTEtMA_11419dc7-05e5-48e1-a8e3-d696688214d0"
      unitRef="usd">607546000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTItMi0xLTEtMA_d8a094ea-ecfa-4786-92dc-878b36178b78"
      unitRef="usd">52834000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTItNC0xLTEtMA_5f8d4b4e-68df-45e8-9884-dc4ac3dc3307"
      unitRef="usd">54372000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Investments
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTMtMi0xLTEtMA_7f057dfe-1c81-4ad6-95c4-ddc21ca28447"
      unitRef="usd">30358000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTMtNC0xLTEtMA_e2609067-213a-4a69-9ac1-603012baa6fe"
      unitRef="usd">27256000</us-gaap:Investments>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTQtMi0xLTEtMA_4c0859c8-7720-4907-a66a-a0e6b0e526e4"
      unitRef="usd">22673000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTQtNC0xLTEtMA_c9bfb83f-1d5b-469b-915a-296041ac9424"
      unitRef="usd">68676000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTUtMi0xLTEtMA_ff715312-ef2b-48b2-a97f-af86c55baeb9"
      unitRef="usd">49942000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTUtNC0xLTEtMA_e45d6884-9364-434c-a572-b1af3f99d24d"
      unitRef="usd">7356000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTYtMi0xLTEtMA_6865815c-0532-47a4-8f76-e394da67a3ec"
      unitRef="usd">2521748000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTYtNC0xLTEtMA_4db120ee-e600-4565-8bb9-f8428fba3547"
      unitRef="usd">2411797000</us-gaap:Assets>
    <us-gaap:DebtCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTktMi0xLTEtMA_9b758d72-836e-44ce-9955-ebb5ff9476d4"
      unitRef="usd">13953000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMTktNC0xLTEtMA_511ad651-00bb-4b04-b2d6-73862f0f74e7"
      unitRef="usd">77396000</us-gaap:DebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjAtMi0xLTEtMA_39e3e57e-8b3c-466b-8bd3-764d7c56d7e2"
      unitRef="usd">71596000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjAtNC0xLTEtMA_1a6272c8-de2b-4b99-9543-2f06ddfb0f4c"
      unitRef="usd">85892000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjEtMi0xLTEtMA_14733a44-0579-49c5-9b95-ed73d69f6566"
      unitRef="usd">98308000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjEtNC0xLTEtMA_4e16cc75-f865-40a4-bcdb-a70595decd74"
      unitRef="usd">120100000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LossContingencyAccrualCarryingValueCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjItMi0xLTEtMA_92e3cb35-99e7-4497-b0e8-94c19a23eb0d"
      unitRef="usd">34790000</us-gaap:LossContingencyAccrualCarryingValueCurrent>
    <us-gaap:LossContingencyAccrualCarryingValueCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjItNC0xLTEtMA_21a4a7d3-7b6a-462a-bd8d-ea8598432d08"
      unitRef="usd">146026000</us-gaap:LossContingencyAccrualCarryingValueCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjMtMi0xLTEtMA_2e1e0e81-c772-472a-8212-323d3d2cdfac"
      unitRef="usd">10118000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjMtNC0xLTEtMA_d5abb643-c80a-4e7f-9831-abd67b84c729"
      unitRef="usd">12719000</us-gaap:TaxesPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjQtMi0xLTEtMA_acd36841-55e0-40fc-b22a-88f17265ac63"
      unitRef="usd">52994000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjQtNC0xLTEtMA_005aa986-9225-40ae-a232-3c7b065ed38f"
      unitRef="usd">70420000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjUtMi0xLTEtMA_f07c98f0-5b6d-4096-b854-203524366b1e"
      unitRef="usd">281759000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjUtNC0xLTEtMA_bfbe64ad-6050-4ed8-b200-97a866be3e3e"
      unitRef="usd">512553000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjYtMi0xLTEtMA_2c9e0638-caa2-42b3-a520-45a63b0246e4"
      unitRef="usd">637109000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjYtNC0xLTEtMA_eee1b82a-0b7d-405c-871f-ff7dc731e23f"
      unitRef="usd">260330000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjctMi0xLTEtMA_e7803fd5-306c-4aae-a89e-1a3d2e875d2d"
      unitRef="usd">79603000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjctNC0xLTEtMA_48c76a15-3bdc-4502-96fc-08139bd56597"
      unitRef="usd">114396000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LossContingencyAccrualCarryingValueNoncurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjgtMi0xLTEtMA_4e0e061d-9482-4a59-bb35-385123e171ec"
      unitRef="usd">11510000</us-gaap:LossContingencyAccrualCarryingValueNoncurrent>
    <us-gaap:LossContingencyAccrualCarryingValueNoncurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjgtNC0xLTEtMA_39e8de90-fdca-43b4-8105-efef28db41d0"
      unitRef="usd">24378000</us-gaap:LossContingencyAccrualCarryingValueNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjktMi0xLTEtMA_3061d102-cdcb-431e-beda-8c1de2494bab"
      unitRef="usd">28362000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMjktNC0xLTEtMA_ec736d2b-0e56-4b89-8c9f-ac63f6e1bc57"
      unitRef="usd">32219000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzAtMi0xLTEtMA_c0d22597-b81c-4279-90d1-29703603c61b"
      unitRef="usd">43124000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzAtNC0xLTEtMA_4d318182-d71b-4b9e-803d-e5f0711670c0"
      unitRef="usd">46027000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzEtMi0xLTEtMA_cfab0ea5-9292-499d-8898-40d994c784e4"
      unitRef="usd">23109000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzEtNC0xLTEtMA_6cfded1e-f4a6-4f60-9745-7b1e7ad7ee97"
      unitRef="usd">22797000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzItMi0xLTEtMA_afc52a9f-cc0f-494a-badc-83fdc4b78384"
      unitRef="usd">59588000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzItNC0xLTEtMA_98a8b4bb-5473-465e-ba30-9c53b4aee660"
      unitRef="usd">61000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzMtMi0xLTEtMA_b55e8c06-07af-4a93-afe7-6562955ea508"
      unitRef="usd">6792000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzMtNC0xLTEtMA_8bc13327-d785-4b24-8738-0a6b23ff46c1"
      unitRef="usd">15319000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzQtMi0xLTEtMA_b9c8ee27-75d0-480f-becb-85eb4a462ec9"
      unitRef="usd">1170956000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzQtNC0xLTEtMA_567aa86b-f8dd-494b-adee-57af0f6b1ee5"
      unitRef="usd">1028080000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzUtMi0xLTEtMA_b8816143-c6bd-4f8a-839e-9951cba0cdef"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzUtNC0xLTEtMA_2af9a29a-3903-42c1-9fa3-471df75f0dd7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjFlMWFhOWU2ZGNlNjRhNzRiN2NlYjdlMTM0ZTQ5NDBlXzIx_a79f4b9c-59b6-4c5f-9591-818d46a775b9"
      unitRef="gbpPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjFlMWFhOWU2ZGNlNjRhNzRiN2NlYjdlMTM0ZTQ5NDBlXzIx_ac81ebf2-9947-4564-a157-916336804812"
      unitRef="gbpPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjFlMWFhOWU2ZGNlNjRhNzRiN2NlYjdlMTM0ZTQ5NDBlXzY0_1293ec01-010a-4f56-b2d3-12f27981a1f3"
      unitRef="shares">49402628</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjFlMWFhOWU2ZGNlNjRhNzRiN2NlYjdlMTM0ZTQ5NDBlXzg1_52d907d4-def4-4728-941e-10129bcbb919"
      unitRef="shares">48596417</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjFlMWFhOWU2ZGNlNjRhNzRiN2NlYjdlMTM0ZTQ5NDBlXzEyNQ_97e83f5b-fab3-45f4-9d41-ffac36be14ce"
      unitRef="shares">49411016</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjFlMWFhOWU2ZGNlNjRhNzRiN2NlYjdlMTM0ZTQ5NDBlXzE0Ng_c935756b-0ae3-4daa-8045-664e5fcb9fc0"
      unitRef="shares">48443830</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzctMi0xLTEtMA_ada93424-9b70-4206-9769-6cedacd36e8e"
      unitRef="usd">76338000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzctNC0xLTEtMA_91cca2d2-0c68-46b2-b213-a7303213ff23"
      unitRef="usd">76257000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzgtMi0xLTEtMA_10f97444-2b46-44da-87be-906c00915bba"
      unitRef="usd">1758468000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzgtNC0xLTEtMA_62222782-4ff9-41c2-9feb-e1d33d2240cb"
      unitRef="usd">1734870000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzktMi0xLTEtMA_ee83454c-527b-4c45-a0f8-58cf9f3fc2df"
      unitRef="usd">-10385000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfMzktNC0xLTEtMA_6d2a8a92-ca85-4819-92e9-e4c9379ea2c0"
      unitRef="usd">-19392000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDAtMi0xLTEtMA_ddd9be1a-fae5-4e6e-83fc-8d3cb87bbc52"
      unitRef="usd">-472576000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDAtNC0xLTEtMA_092c5037-4ff6-4da7-b864-d58b635ee002"
      unitRef="usd">-406755000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOjIxNzA2NTdhNmY3NDQ2YTQ5YWQyYTM1M2Q4MDI1NjQ5XzI4_b42db590-d1d3-425f-b079-88e63171bd65"
      unitRef="shares">806211</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOjIxNzA2NTdhNmY3NDQ2YTQ5YWQyYTM1M2Q4MDI1NjQ5XzY1_99268987-e737-4f6a-bee7-a2ba52696a42"
      unitRef="shares">967186</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDEtMi0xLTEtMA_1ef42a05-d7e0-4ab8-8424-e6e75e139e75"
      unitRef="usd">1053000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDEtNC0xLTEtMA_c2917f55-2a06-46d3-8ead-96a3d71e47e0"
      unitRef="usd">1263000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDItMi0xLTEtMA_2056aeb1-ef0c-4c4d-be62-b9fd3e0be102"
      unitRef="usd">1350792000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDItNC0xLTEtMA_01605ce4-a958-43fa-b0fc-05c10b6e759e"
      unitRef="usd">1383717000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDMtMi0xLTEtMA_1789972f-885a-4db9-909e-ff4afaf9ddb9"
      unitRef="usd">2521748000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yNS9mcmFnOmU1ODc2YTkwMWQ5NzQ5NGY4ODUyZmJkNmQyY2ZjYTUxL3RhYmxlOjFmNjEzODdlYjc3NzQ2Yjk5NGU2YTM1OWY1MWEzNTVhL3RhYmxlcmFuZ2U6MWY2MTM4N2ViNzc3NDZiOTk0ZTZhMzU5ZjUxYTM1NWFfNDMtNC0xLTEtMA_d5211b53-e19b-4eca-998a-77127ecef55d"
      unitRef="usd">2411797000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMy0yLTEtMS0w_531ccb63-e41c-46cd-b024-3db204ba79f7"
      unitRef="usd">-65182000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMy00LTEtMS0w_9c952639-4c7c-4b2d-a546-6a53ec8f1bef"
      unitRef="usd">-11946000</us-gaap:NetIncomeLoss>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNS0yLTEtMS0w_1601948a-d427-46a6-a062-4e1536e3930d"
      unitRef="usd">41133000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNS00LTEtMS0w_e08917eb-74a5-474c-afb3-a904e399234b"
      unitRef="usd">-26422000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNi0yLTEtMS0w_72180580-5aaf-427d-ad57-9bafeea32828"
      unitRef="usd">-31176000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNi00LTEtMS0w_6ff4b055-ab01-4dcd-b3c7-443045f75d75"
      unitRef="usd">-2425000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNy0yLTEtMS0w_a8d2f84f-57b4-4e6c-8a6c-46a2fbeb957b"
      unitRef="usd">29346000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNy00LTEtMS0w_bd627b1f-9c7a-4b0c-9ad7-edbceda0a6f2"
      unitRef="usd">29690000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfOC0yLTEtMS0w_f7701f17-b893-4d83-a496-0c0fca31dd89"
      unitRef="usd">26845000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfOC00LTEtMS0w_fa7b3bcb-b2be-44d9-806d-23b81d12c43f"
      unitRef="usd">24127000</us-gaap:ShareBasedCompensation>
    <us-gaap:Depreciation
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfOS0yLTEtMS0w_40a12e0f-7560-452d-9f2d-799c05a406d4"
      unitRef="usd">22206000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfOS00LTEtMS0w_89fb788f-c178-4885-886a-4723170a2c0d"
      unitRef="usd">23115000</us-gaap:Depreciation>
    <livn:RemeasurementOfCappedCallAndEmbeddedExchangeFeature
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTAtMi0xLTEtMA_f9c9b9a1-8fbe-44bb-a016-8d4e4d7f299a"
      unitRef="usd">17654000</livn:RemeasurementOfCappedCallAndEmbeddedExchangeFeature>
    <livn:RemeasurementOfCappedCallAndEmbeddedExchangeFeature
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTAtNC0xLTEtMA_3202863a-bbea-4490-9f83-bd4f9a4bf3f1"
      unitRef="usd">2948000</livn:RemeasurementOfCappedCallAndEmbeddedExchangeFeature>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTEtMi0xLTEtMA_932d5273-63a6-4147-b81a-c016ea9ace61"
      unitRef="usd">9813000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTEtNC0xLTEtMA_7ca5cf58-4ac4-4e2d-9ae8-aceb4e13f93f"
      unitRef="usd">8961000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTMtMi0xLTEtMA_9410367c-fdff-43bb-ace5-be02f9ca1621"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTMtNC0xLTEtMA_fa927ef7-7482-488a-8c9d-218f4487edb5"
      unitRef="usd">50295000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTUtMi0xLTEtMA_3122a3a8-a8dd-4de1-98db-cd837ca9d293"
      unitRef="usd">-5876000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTUtNC0xLTEtMA_260c4558-fb4a-4723-bd69-eb15bd640201"
      unitRef="usd">-7638000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTctMi0xLTEtMA_a29e996d-d7c8-4d18-89c5-f7a7dc96cf31"
      unitRef="usd">-65401000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTctNC0xLTEtMA_49d15c1d-84ea-45de-9d3a-e36ae0261e89"
      unitRef="usd">-5433000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTgtMi0xLTEtMA_f44e0277-3b12-4c8e-b6a5-495fe8652c79"
      unitRef="usd">12141000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTgtNC0xLTEtMA_05c9b792-8809-4284-96cb-38d0360d5c77"
      unitRef="usd">18181000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTktMi0xLTEtMA_50c281cf-f765-467f-bfbf-2dd3cce0da50"
      unitRef="usd">15360000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMTktNC0xLTEtMA_ba0f1c87-a14d-4578-9007-9809d5038db5"
      unitRef="usd">-9575000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjAtMi0xLTEtMA_6469fec1-3ebb-4863-8be5-9572d2e984d7"
      unitRef="usd">-49547000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjAtNC0xLTEtMA_b673ff07-16cc-4e1f-8cc1-9c350d425265"
      unitRef="usd">-28964000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjEtMi0xLTEtMA_f0345b81-9dab-4e8c-bb51-4687c76aa896"
      unitRef="usd">-615000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjEtNC0xLTEtMA_d7272e53-5e25-4c2b-b09a-e55a3a80daf2"
      unitRef="usd">-14367000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <livn:IncreaseDecreaseInLitigationProvisionLiability
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjItMi0xLTEtMA_b4d4db71-c6ba-435c-8127-c6db59697da8"
      unitRef="usd">124158000</livn:IncreaseDecreaseInLitigationProvisionLiability>
    <livn:IncreaseDecreaseInLitigationProvisionLiability
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjItNC0xLTEtMA_f01449da-4b19-4e7f-9788-4af6ba9e27fc"
      unitRef="usd">140823000</livn:IncreaseDecreaseInLitigationProvisionLiability>
    <us-gaap:IncreaseDecreaseInRestructuringReserve
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjMtMi0xLTEtMA_655feeff-f15e-430c-a86f-1a5bb0c5583c"
      unitRef="usd">-1194000</us-gaap:IncreaseDecreaseInRestructuringReserve>
    <us-gaap:IncreaseDecreaseInRestructuringReserve
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjMtNC0xLTEtMA_2de4cd50-1313-4e81-87d2-2d3f76c5f3ff"
      unitRef="usd">-6766000</us-gaap:IncreaseDecreaseInRestructuringReserve>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjQtMi0xLTEtMA_276fd868-78cd-4551-bc9b-8968881b1926"
      unitRef="usd">-116407000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjQtNC0xLTEtMA_6be20588-560a-44b3-b855-1e3503cbe767"
      unitRef="usd">-94008000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjYtMi0xLTEtMA_df6e0add-b483-4fcf-b442-01008252dcd2"
      unitRef="usd">28445000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjYtNC0xLTEtMA_611a2524-1c95-44be-abd6-af9d132754cd"
      unitRef="usd">16801000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <livn:PurchasesOfInvestments
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjctMi0xLTEtMA_0fffa8f4-4830-4160-94cf-ec3ee62ad6b1"
      unitRef="usd">3175000</livn:PurchasesOfInvestments>
    <livn:PurchasesOfInvestments
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjctNC0xLTEtMA_b2ac6499-78e8-45cc-9f79-c34a72999868"
      unitRef="usd">287000</livn:PurchasesOfInvestments>
    <us-gaap:PaymentsToAcquireNotesReceivable
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjgtMi0xLTEtMA_9611fbbc-b469-427e-a32e-785e7f0013ae"
      unitRef="usd">2250000</us-gaap:PaymentsToAcquireNotesReceivable>
    <us-gaap:PaymentsToAcquireNotesReceivable
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjgtNC0xLTEtMA_10cd3260-9f3f-4abe-9796-41a9b6e7f9fe"
      unitRef="usd">0</us-gaap:PaymentsToAcquireNotesReceivable>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjktMi0xLTEtMA_803a66d4-541a-4a56-b157-b8a1f1503843"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMjktNC0xLTEtMA_998b4dfb-83ca-4f12-b2da-08d5ddcb983a"
      unitRef="usd">10750000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzAtMi0xLTEtMA_5f5a3c88-fd39-48df-8e60-345df8faff22"
      unitRef="usd">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzAtNC0xLTEtMA_0f485300-dc33-493e-a703-bf5883cc863e"
      unitRef="usd">3186000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzItMi0xLTEtMA_1cf50c4b-68e0-4e79-961b-84171d6adcc9"
      unitRef="usd">-533000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzItNC0xLTEtMA_6c742d9f-02dc-4217-bce7-b1a9af6340bb"
      unitRef="usd">-505000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzMtMi0xLTEtMA_5b0f9f2a-8406-44a7-9713-d0d96c40ecb2"
      unitRef="usd">-33337000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzMtNC0xLTEtMA_e26ce6f1-a8cd-4c93-a60d-339d71ab4fa5"
      unitRef="usd">-30519000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzUtMi0xLTEtMA_c6960f04-188f-4b6b-b0ff-b1d8416735db"
      unitRef="usd">886899000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzUtNC0xLTEtMA_1eb42d33-8596-403b-adde-75965b67952f"
      unitRef="usd">193490000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzYtMi0xLTEtMA_44b71a23-ddef-4905-9c21-6f4a59c144a0"
      unitRef="usd">481360000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzYtNC0xLTEtMA_89ed63ce-fed9-40b5-a5c4-b18259ec2781"
      unitRef="usd">12330000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzctMi0xLTEtMA_7166ff47-171e-4f23-a984-e295eb58c5cf"
      unitRef="usd">46717000</us-gaap:ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths>
    <us-gaap:ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzctNC0xLTEtMA_8597ae75-e8c6-425d-847c-2a64e88e05e5"
      unitRef="usd">0</us-gaap:ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths>
    <us-gaap:RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzgtMi0xLTEtMA_1c0eb4e4-5e97-4d68-8537-628ae5c7063d"
      unitRef="usd">44838000</us-gaap:RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths>
    <us-gaap:RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzgtNC0xLTEtMA_bc75e280-9afc-4615-b8df-00c68a828e5d"
      unitRef="usd">0</us-gaap:RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzktMi0xLTEtMA_a3277a90-1c1c-4842-8563-49ef82f5b0b6"
      unitRef="usd">43096000</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfMzktNC0xLTEtMA_c877a79c-4f1b-43c1-8348-e78352a22504"
      unitRef="usd">0</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDAtMi0xLTEtMA_529486be-6e0f-4a0c-b767-4102decc993b"
      unitRef="usd">20412000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDAtNC0xLTEtMA_4d64380c-dbac-4fc1-9ef5-2ac882f59359"
      unitRef="usd">3795000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <livn:PaymentForDispositionOfBusinessClosingAdjustment
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDEtMi0xLTEtMA_08905518-5c38-44d2-b7bc-1c232569d53b"
      unitRef="usd">14891000</livn:PaymentForDispositionOfBusinessClosingAdjustment>
    <livn:PaymentForDispositionOfBusinessClosingAdjustment
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDEtNC0xLTEtMA_5407568f-5b81-4557-bc19-ceb071be4aa5"
      unitRef="usd">0</livn:PaymentForDispositionOfBusinessClosingAdjustment>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDItMi0xLTEtMA_0c65216b-7e86-4efc-89e2-3e638504eab2"
      unitRef="usd">8860000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDItNC0xLTEtMA_8a4417b8-6b7c-4ed2-8d7c-307c1833eed7"
      unitRef="usd">17989000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDMtMi0xLTEtMA_7892fe33-5f54-4f59-89bc-389890fff9bf"
      unitRef="usd">5277000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDMtNC0xLTEtMA_85f06b46-2545-4b87-b524-3fddd85eb450"
      unitRef="usd">6183000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDQtMi0xLTEtMA_5d21ba0d-5ef0-46c9-8e30-6c555cd6a35a"
      unitRef="usd">2063000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDQtNC0xLTEtMA_498c685d-0c14-4dba-a15c-5da5b145b7e3"
      unitRef="usd">2574000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDUtMi0xLTEtMA_355ac296-7851-4d7f-8c1c-a0c98a2780f5"
      unitRef="usd">-1043000</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDUtNC0xLTEtMA_3181fa28-021c-425b-800f-5796fcca35a1"
      unitRef="usd">-2173000</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDctMi0xLTEtMA_a5054aa0-c0d6-4426-88bf-f7a410386286"
      unitRef="usd">25000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDctNC0xLTEtMA_f7b1c0b3-b758-4fe6-9d61-2c4a79222262"
      unitRef="usd">147000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDgtMi0xLTEtMA_5bfd4cc5-1b15-4bfd-b0e8-b6ecf96ad816"
      unitRef="usd">315927000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDgtNC0xLTEtMA_39619e55-82ca-4d1d-944b-169ef8c8990f"
      unitRef="usd">153741000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDktMi0xLTEtMA_591e6703-fd70-45d6-852e-bc9359bf4db4"
      unitRef="usd">491000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNDktNC0xLTEtMA_13159553-2db0-4f3d-a0ec-4ed7803fe123"
      unitRef="usd">-1105000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNTAtMi0xLTEtMA_89d929ef-d9f1-4ac7-85fc-d5a06234d104"
      unitRef="usd">166674000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNTAtNC0xLTEtMA_a8bc9386-62ca-4275-bda7-8f105c3f2c6c"
      unitRef="usd">28109000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNTEtMi0xLTEtMA_f3108375-8211-407e-b8f8-fecb629a9d80"
      unitRef="usd">61137000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic94ddff991844d7bb182464410e337c2_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNTEtNC0xLTEtMA_dbfc3c0d-c48e-4c0c-ab07-65e9ef5e95b3"
      unitRef="usd">47204000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNTItMi0xLTEtMA_e21d5c8d-1311-4ad6-8119-9bd11a02b00b"
      unitRef="usd">227811000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7cb9957d3e1b407bb88290f6a94e712e_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8yOC9mcmFnOjcxMTk0ZDE4MGNjZTQ4ZjFiMmI0MGM2NzJlYjgzZDhkL3RhYmxlOmQ0MTgzMjcwYzUzMDRjMDM5MDdhZjg5ZWUxZDE1YzlmL3RhYmxlcmFuZ2U6ZDQxODMyNzBjNTMwNGMwMzkwN2FmODllZTFkMTVjOWZfNTItNC0xLTEtMA_518f1556-df5d-4a49-8b6f-a6f13283bf54"
      unitRef="usd">75313000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8zNC9mcmFnOjZhNmE1Yjg2ODFjODRlZWVhZmE1NTcxN2FlYTFhOTJiL3RleHRyZWdpb246NmE2YTViODY4MWM4NGVlZWFmYTU1NzE3YWVhMWE5MmJfMzg0ODI5MDcwMDIyMg_6409b096-0680-46fb-8dc6-50f4b8a7673e">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Note 1. Unaudited Condensed Consolidated Financial Statements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;Basis of Presentation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The accompanying condensed consolidated financial statements of LivaNova as of, and for the three and nine months ended September 30, 2020 and 2019, have been prepared in accordance with U.S. GAAP for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. The accompanying condensed consolidated balance sheet of LivaNova at December 31, 2019 has been derived from audited financial statements contained in our 2019 Form 10-K, but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, the condensed consolidated financial statements reflect all adjustments (consisting of only normal recurring adjustments) considered necessary for a fair statement of the operating results of LivaNova and its subsidiaries, for the three and nine months ended September 30, 2020, and are not necessarily indicative of the results that may be expected for the year ending December 31, 2020. The financial information presented herein should be read in conjunction with the audited consolidated financial statements and notes thereto accompanying our 2019 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;Recent Developments Regarding COVID-19&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Due to the COVID-19 pandemic (&#x201c;COVID-19&#x201d;), we have experienced and may continue to experience significant and unpredictable reductions in the demand for our products as healthcare customers have diverted medical resources and priorities towards the treatment of COVID-19. In addition, public health bodies have delayed elective procedures during the COVID-19 pandemic, which has negatively impacted the usage of our products, including the number of Neuromodulation procedures. Further, some people are avoiding seeking treatment for non-COVID-19 emergency procedures, which has also negatively impacted the demand for our products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;We are seeing signs of stabilization in certain geographies as elective surgeries resume and expect this trend to continue on a global basis during the fourth quarter of 2020. We expect elective procedure recovery rates to vary by country, and to be impacted by COVID-19 case volumes, hospital occupancy and staffing levels, patient&#x2019;s willingness to re-book previously deferred procedures, travel restrictions, transportation limitations, quarantine restrictions, economic uncertainty and potential COVID-19 resurgence. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;We have reclassified certain prior period amounts for comparative purposes. These reclassifications did not have a material effect on our financial condition, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;Our significant accounting policies are detailed in &#x201c;Note 2. Basis of Presentation, Use of Accounting Estimates and Significant Accounting Policies&#x201d; and &#x201c;Note 3. Revenue Recognition&#x201d; of our 2019 Form 10-K.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8zNC9mcmFnOjZhNmE1Yjg2ODFjODRlZWVhZmE1NTcxN2FlYTFhOTJiL3RleHRyZWdpb246NmE2YTViODY4MWM4NGVlZWFmYTU1NzE3YWVhMWE5MmJfMjczOA_d0a93c42-6bb3-4572-9cda-05d706bff35f">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;Basis of Presentation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The accompanying condensed consolidated financial statements of LivaNova as of, and for the three and nine months ended September 30, 2020 and 2019, have been prepared in accordance with U.S. GAAP for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. The accompanying condensed consolidated balance sheet of LivaNova at December 31, 2019 has been derived from audited financial statements contained in our 2019 Form 10-K, but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, the condensed consolidated financial statements reflect all adjustments (consisting of only normal recurring adjustments) considered necessary for a fair statement of the operating results of LivaNova and its subsidiaries, for the three and nine months ended September 30, 2020, and are not necessarily indicative of the results that may be expected for the year ending December 31, 2020. The financial information presented herein should be read in conjunction with the audited consolidated financial statements and notes thereto accompanying our 2019 Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8zNC9mcmFnOjZhNmE1Yjg2ODFjODRlZWVhZmE1NTcxN2FlYTFhOTJiL3RleHRyZWdpb246NmE2YTViODY4MWM4NGVlZWFmYTU1NzE3YWVhMWE5MmJfMzg0ODI5MDcwMDIyMQ_22d393d1-4982-4c72-b654-8c2eb6ce621f">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;We have reclassified certain prior period amounts for comparative purposes. These reclassifications did not have a material effect on our financial condition, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8zNy9mcmFnOjY1MzY5MmNkYzg4ZDQ5NjQ5ZjU5OGYzMWNjZjMxOGY1L3RleHRyZWdpb246NjUzNjkyY2RjODhkNDk2NDlmNTk4ZjMxY2NmMzE4ZjVfMzg0ODI5MDY5ODczNA_ec491498-544a-41bd-b96f-70b58fc4b9e5">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Note 2. Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;Miami Instruments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;On June 12, 2019, we acquired the minimally invasive cardiac surgery instruments business from Miami Instruments, LLC (&#x201c;Miami Instruments&#x201d;) for cash consideration of up to&#160;$17.0 million. The related operations have been integrated into our Cardiovascular segment as a part of our Heart Valves business. Cash of&#160;$10.8 million&#160;was paid at closing with up to&#160;$6.0 million&#160;in contingent consideration based on achieving certain milestones. The purchase price allocation for the Miami Instruments acquisition was finalized during the second quarter of 2020 and resulted in no measurement period adjustments. In connection with this acquisition, we recognized $14.7 million in developed technology and in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) intangible assets and $1.5 million in goodwill.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i1f504bd55c7f46eabe71635e913521f3_D20190612-20190612"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8zNy9mcmFnOjY1MzY5MmNkYzg4ZDQ5NjQ5ZjU5OGYzMWNjZjMxOGY1L3RleHRyZWdpb246NjUzNjkyY2RjODhkNDk2NDlmNTk4ZjMxY2NmMzE4ZjVfMTk5_2da87bda-b4f9-48df-a90b-7b0e6e7d73bd"
      unitRef="usd">17000000.0</us-gaap:BusinessCombinationConsiderationTransferred1>
    <livn:BusinessCombinationUpfrontCosts
      contextRef="i69653e79e7a64b74bafe17de62d7f7e7_I20190612"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8zNy9mcmFnOjY1MzY5MmNkYzg4ZDQ5NjQ5ZjU5OGYzMWNjZjMxOGY1L3RleHRyZWdpb246NjUzNjkyY2RjODhkNDk2NDlmNTk4ZjMxY2NmMzE4ZjVfMzI3_6ccc8b88-e9dc-4f5d-aa82-6415687f9d9d"
      unitRef="usd">10800000</livn:BusinessCombinationUpfrontCosts>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i69653e79e7a64b74bafe17de62d7f7e7_I20190612"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8zNy9mcmFnOjY1MzY5MmNkYzg4ZDQ5NjQ5ZjU5OGYzMWNjZjMxOGY1L3RleHRyZWdpb246NjUzNjkyY2RjODhkNDk2NDlmNTk4ZjMxY2NmMzE4ZjVfMzYx_47a1cd0b-ed7b-4733-9177-eb88558e3407"
      unitRef="usd">6000000.0</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="id8f318fd9c2147bba4d88a7c4b055ba5_D20190612-20190612"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8zNy9mcmFnOjY1MzY5MmNkYzg4ZDQ5NjQ5ZjU5OGYzMWNjZjMxOGY1L3RleHRyZWdpb246NjUzNjkyY2RjODhkNDk2NDlmNTk4ZjMxY2NmMzE4ZjVfNjQ5_7cbda0c3-f3e7-40dc-9912-62e374b0de5c"
      unitRef="usd">14700000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:Goodwill
      contextRef="i69653e79e7a64b74bafe17de62d7f7e7_I20190612"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV8zNy9mcmFnOjY1MzY5MmNkYzg4ZDQ5NjQ5ZjU5OGYzMWNjZjMxOGY1L3RleHRyZWdpb246NjUzNjkyY2RjODhkNDk2NDlmNTk4ZjMxY2NmMzE4ZjVfNzQ4_c97ab84b-8dfe-4518-8722-10892427b7eb"
      unitRef="usd">1500000</us-gaap:Goodwill>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80MC9mcmFnOmVlMmEwYmY0ZDg1OTRiYmFiNWI3NjEzOWZmMGFjNTVhL3RleHRyZWdpb246ZWUyYTBiZjRkODU5NGJiYWI1Yjc2MTM5ZmYwYWM1NWFfMzg0ODI5MDY5NzczMQ_efab8da1-a45b-4e5c-9aae-7c1ed50e4171">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Note 3. Discontinued Operations &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;On April 30, 2018, we completed the sale of our Cardiac Rhythm Management (&#x201c;CRM&#x201d;) business to MicroPort Cardiac Rhythm B.V. and MicroPort Scientific Corporation (&#x201c;MicroPort&#x201d;) for total cash proceeds of $195.9 million, less cash transferred of $9.2 million, subject to a closing working capital adjustment. In March 2020, we finalized the working capital adjustment and as a result, made a $16.4 million payment to MicroPort during the first quarter of 2020 and incurred an additional $1.0 million loss on sale, net of a $0.1&#160;million tax benefit.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i08c3b67a02214a92852d8412d52b746a_D20180430-20180430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80MC9mcmFnOmVlMmEwYmY0ZDg1OTRiYmFiNWI3NjEzOWZmMGFjNTVhL3RleHRyZWdpb246ZWUyYTBiZjRkODU5NGJiYWI1Yjc2MTM5ZmYwYWM1NWFfMjIx_1bdc69b4-236a-4f29-8893-b59d506ff480"
      unitRef="usd">195900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <livn:BusinessCombinationConsiderationTransferredCashTransferred
      contextRef="i08c3b67a02214a92852d8412d52b746a_D20180430-20180430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80MC9mcmFnOmVlMmEwYmY0ZDg1OTRiYmFiNWI3NjEzOWZmMGFjNTVhL3RleHRyZWdpb246ZWUyYTBiZjRkODU5NGJiYWI1Yjc2MTM5ZmYwYWM1NWFfMjUw_7b214fd4-4cb3-438f-bc4b-754a208592a8"
      unitRef="usd">9200000</livn:BusinessCombinationConsiderationTransferredCashTransferred>
    <us-gaap:DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax
      contextRef="i4ab5cac60220483ca5a3b38de23752fc_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80MC9mcmFnOmVlMmEwYmY0ZDg1OTRiYmFiNWI3NjEzOWZmMGFjNTVhL3RleHRyZWdpb246ZWUyYTBiZjRkODU5NGJiYWI1Yjc2MTM5ZmYwYWM1NWFfMzg2_3a439553-0f80-4398-9007-c201697e18fb"
      unitRef="usd">-16400000</us-gaap:DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
      contextRef="i4ab5cac60220483ca5a3b38de23752fc_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80MC9mcmFnOmVlMmEwYmY0ZDg1OTRiYmFiNWI3NjEzOWZmMGFjNTVhL3RleHRyZWdpb246ZWUyYTBiZjRkODU5NGJiYWI1Yjc2MTM5ZmYwYWM1NWFfNDcw_d4b0610d-c62e-4847-9e8c-18efe96a3c59"
      unitRef="usd">-1000000.0</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="i4ab5cac60220483ca5a3b38de23752fc_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80MC9mcmFnOmVlMmEwYmY0ZDg1OTRiYmFiNWI3NjEzOWZmMGFjNTVhL3RleHRyZWdpb246ZWUyYTBiZjRkODU5NGJiYWI1Yjc2MTM5ZmYwYWM1NWFfNDk2_cca36e57-e490-4e6b-bb3f-0d80e317f05b"
      unitRef="usd">100000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RleHRyZWdpb246ZTg1Yzg4MTgwMmQ1NDYyMWI1Y2RhODkyOTVkOTMwYTRfMzg0ODI5MDY5NzgyOQ_76a40e67-6981-43e7-8474-50f149ea14e6">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Note 4. Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;We initiate restructuring plans to leverage economies of scale, streamline distribution and logistics, and strengthen operational and administrative effectiveness in order to reduce overall costs. Costs associated with these plans were reported as restructuring expenses in the operating results of our condensed consolidated statements of income (loss). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following table provides a reconciliation of the beginning and ending balance of the accruals and other reserves recorded in connection with our restructuring plans included within accrued liabilities and other and other long-term liabilities on the condensed consolidated balance sheet (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Employee Severance and Other Termination Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(792)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,672)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following table presents restructuring expense by reportable segment (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(401)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RleHRyZWdpb246ZTg1Yzg4MTgwMmQ1NDYyMWI1Y2RhODkyOTVkOTMwYTRfNjAy_2d2695db-4d2a-42fe-9ff4-724620aa96f4">&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following table provides a reconciliation of the beginning and ending balance of the accruals and other reserves recorded in connection with our restructuring plans included within accrued liabilities and other and other long-term liabilities on the condensed consolidated balance sheet (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Employee Severance and Other Termination Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(792)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,672)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i9f970e37f06645c8bb2539c0ce87edde_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfMS0yLTEtMS0w_b775852f-aab1-4f17-a09d-cc1e595c9e3c"
      unitRef="usd">4097000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ie7f12aa7ec264fe2ab35709629de067f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfMS00LTEtMS0w_4062e48e-a53a-407e-8ce6-daf89915a092"
      unitRef="usd">1400000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i8aeacf1e4fc34783813482eebf05252b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfMS02LTEtMS0w_f772e64b-cc4b-4851-b808-19c00ad87658"
      unitRef="usd">5497000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i12f68e91043344bb9a9cb86689638ce5_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfMi0yLTEtMS0w_58d84067-4a6b-4d3b-b089-c5f54bf431d2"
      unitRef="usd">2025000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i99471d80dbd54b8ca36fd7bd75e616dd_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfMi00LTEtMS0w_60ace299-42d9-4b2f-bcf8-b6493a320f6a"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8925322bbe234c77aa2e0c9256cd4f36_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfMi02LTEtMS0w_f2c1d173-7719-471f-95b7-62e4c6b7949b"
      unitRef="usd">2025000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i12f68e91043344bb9a9cb86689638ce5_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfMy0yLTEtMS0w_480db3ed-531f-4ab3-9d97-123a34b62dbb"
      unitRef="usd">4880000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i99471d80dbd54b8ca36fd7bd75e616dd_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfMy00LTEtMS0w_07801deb-066e-4f0a-950f-d956a0d4329d"
      unitRef="usd">792000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i8925322bbe234c77aa2e0c9256cd4f36_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfMy02LTEtMS0w_2b02b381-0c4f-4028-b794-f0b5779da860"
      unitRef="usd">5672000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i89e139d91fc8464a99b88353610cdeb2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfNC0yLTEtMS0w_2f346274-4a13-4781-a484-1bcf589444e1"
      unitRef="usd">1242000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ibf00cfbfb795463ab27948e6d4c4253d_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfNC00LTEtMS0w_7d7ff45b-933d-4ca5-8d66-ebe18895b182"
      unitRef="usd">608000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i970f46cb12124b12bfb14bea4df49ada_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjVmZDZiZGYxMGVlZDQwOWI4NTA2ZmQxNTFiNmM4ODA4L3RhYmxlcmFuZ2U6NWZkNmJkZjEwZWVkNDA5Yjg1MDZmZDE1MWI2Yzg4MDhfNC02LTEtMS0w_c3a118dd-3797-478f-98c9-46f3142623b8"
      unitRef="usd">1850000</us-gaap:RestructuringReserve>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RleHRyZWdpb246ZTg1Yzg4MTgwMmQ1NDYyMWI1Y2RhODkyOTVkOTMwYTRfNTk5_fcfa55a9-6df6-4a3e-8a46-f00d4e016054">&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following table presents restructuring expense by reportable segment (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(401)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="i013558d2b17c4355a92da0429952dd67_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfMi0yLTEtMS0w_b8914b56-c94b-4650-bbf6-3d6aade0c97d"
      unitRef="usd">9000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4f84b9a1406f4d1a801a8a1795c932dc_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfMi00LTEtMS0w_2675fc26-8014-430f-ace8-dd42bace5d46"
      unitRef="usd">783000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia2fad0d02b3e4a0ab6a60f67969ec28b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfMi02LTEtMS0w_5ff9574f-ec4c-4602-8eba-e796feb098f0"
      unitRef="usd">1265000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i197004b99655439cada3d2fa6e98f33e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfMi04LTEtMS0w_336f89a4-862b-47a0-ab41-8f80b696b279"
      unitRef="usd">1521000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i36f208ad6ec8402f80aac6618e1de718_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfMy0yLTEtMS0w_2184d5a7-b987-4201-aef2-7f7b8c7183e5"
      unitRef="usd">43000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9faf33d672ba42d18cdfe76fdead2b2d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfMy00LTEtMS0w_225405c6-a744-412f-a712-8b799687fbfd"
      unitRef="usd">-171000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8c4ddeb948eb4c4dbe320a14c7ae3792_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfMy02LTEtMS0w_db489576-9a26-4327-85fe-e4edb92a09d3"
      unitRef="usd">851000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iac495534370345098798ba8c26b009ac_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfMy04LTEtMS0w_1f569eb5-73a3-4edb-8579-99ff4640b272"
      unitRef="usd">314000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i21d96c5da2404625a9ee4885a17ebf0c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfNC0yLTEtMS0w_054d0dd2-f27a-4544-a0ec-321211e4d989"
      unitRef="usd">-401000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="icc2e1e69df7e4a1d8c750a08dcb83a44_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfNC00LTEtMS0w_faaacec1-464a-4ca5-8d5b-09eb11602cfd"
      unitRef="usd">86000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i753478d430024138b30d3d04687e7eb7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfNC02LTEtMS0w_fb84ce06-c650-4350-b1f1-ef46b92dcd52"
      unitRef="usd">-91000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2e6560d12b2f434fa22d653edaa72cd8_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfNC04LTEtMS0w_656582aa-3724-4703-bd88-a0d7c61afcb8"
      unitRef="usd">2728000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfNS0yLTEtMS0w_9e423d1d-eae9-4da9-9863-0d208c864a3d"
      unitRef="usd">-349000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfNS00LTEtMS0w_f971cc02-a84c-42e2-8f5b-f869080ead6e"
      unitRef="usd">698000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfNS02LTEtMS0w_ced6d134-2f0e-4277-a37f-10ae0ce82804"
      unitRef="usd">2025000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80Ni9mcmFnOmU4NWM4ODE4MDJkNTQ2MjFiNWNkYTg5Mjk1ZDkzMGE0L3RhYmxlOjIxMzY4NDk2NzNmYTQyNDg5MjYwYWYwOTdiNDNhNzg2L3RhYmxlcmFuZ2U6MjEzNjg0OTY3M2ZhNDI0ODkyNjBhZjA5N2I0M2E3ODZfNS04LTEtMS0w_df08941b-23f2-4741-873a-1bd2bacfac1c"
      unitRef="usd">4563000</us-gaap:RestructuringCharges>
    <livn:ProductRemediationTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RleHRyZWdpb246YWViYjFiMTc5MDJlNGRhNWEzOWM1MTlmM2E0NGQ3NDRfMzg0ODI5MDcwMTg3NA_f06925a5-4406-4566-97de-b85e20e115d3">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Note 5. Product Remediation Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;On December 29, 2015, we received an FDA Warning Letter (the &#x201c;Warning Letter&#x201d;) alleging certain violations of FDA regulations applicable to medical device manufacturing at our Munich, Germany and Arvada, Colorado facilities. On October 13, 2016, the CDC and FDA separately released safety notifications regarding 3T Heater-Cooler devices in response to which we issued a Field Safety Notice Update for U.S. users of our 3T Heater-Cooler devices to proactively and voluntarily contact facilities to facilitate implementation of the CDC and FDA recommendations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;At December 31, 2016, we recognized a liability for a product remediation plan related to our 3T Heater-Cooler device (&#x201c;3T device&#x201d;). The remediation plan consists primarily of a modification of the 3T device design to include internal sealing and the addition of a vacuum system to new and existing devices. These changes are intended to address regulatory actions and to reduce further the risk of possible dispersion of aerosols from 3T devices in the operating room. We concluded that it was probable that a liability had been incurred upon management&#x2019;s approval of the plan and the commitments made by management to various regulatory authorities globally in November and December 2016, and furthermore, the cost associated with the plan was reasonably estimable. The deployment of this solution for commercially distributed devices has been dependent upon final validation and verification of the design changes and approval or clearance by regulatory authorities worldwide. It is reasonably possible that our estimate of the remediation liability could materially change in future periods due to the various significant assumptions involved such as customer behavior, market reaction and the timing of approvals or clearance by regulatory authorities worldwide.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;In April 2017, we obtained CE Mark in Europe for the design change, and in May 2017 we completed our first vacuum canister and internal sealing upgrade on a customer-owned device. In October 2018, the FDA concluded that we could commence the vacuum canister and internal sealing upgrade program in the U.S., and on February 25, 2020, LivaNova received clearance for K191402, a 510(k) for the 3T devices that addressed issues contained in the 2015 Warning Letter along with design changes that further mitigate the potential risk of aerosolization. Concurrent with this clearance, (1) 3T devices manufactured in accordance with K191402 will not be subjected to the import alert previously issued by the FDA and (2) LivaNova initiated a correction to distribute the updated Operating Instructions cleared under K191402. We continue to implement the vacuum canister and internal sealing upgrade program in as many countries as possible until all devices are upgraded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt; As a second part of the remediation plan, we continue to offer a no-charge deep disinfection service (deep cleaning service) for 3T device users as we receive the required regulatory approvals. The deep disinfection service was rolled out in Europe in the second half of 2015, and in April 2018, the FDA agreed to allow us to move forward with the deep cleaning service in the U.S., thereby adding to the growing list of countries around the world in which we offer this service. Finally, we continue to offer the loaner program for 3T devices, initiated in the fourth quarter of 2016, to provide existing 3T device users with a new loaner 3T device at no charge pending regulatory approval and implementation of the vacuum system addition and deep disinfection service worldwide. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following table provides a reconciliation of the beginning and ending balance of the product remediation liability included within accrued liabilities and other on the condensed consolidated balance sheet (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remediation activity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;We recognized product remediation expenses of $1.1 million and $3.1 million during the three months ended September 30, 2020 and 2019, respectively, and $6.9 million and $11.1 million during the nine months ended September 30, 2020 and 2019, respectively. Product remediation expenses include internal labor costs, costs to remediate certain inspectional observations made by the FDA at our Munich facility and costs associated with the incorporation of the modification of the 3T device design into the next generation 3T device. These costs and related legal costs are expensed as incurred and are not included within the product remediation liability presented above. At September&#160;30, 2020, our balance sheet includes a&#160;$46.3 million&#160;provision related to litigation involving our 3T device. For further information, please refer to &#x201c;Note 10. Commitments and Contingencies.&#x201d;&lt;/span&gt;&lt;/div&gt;</livn:ProductRemediationTextBlock>
    <livn:ScheduleofProductRemediationTableTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RleHRyZWdpb246YWViYjFiMTc5MDJlNGRhNWEzOWM1MTlmM2E0NGQ3NDRfNDY0OQ_e37abf05-16ea-449d-9d33-5b1e6a1d7aa2">&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following table provides a reconciliation of the beginning and ending balance of the product remediation liability included within accrued liabilities and other on the condensed consolidated balance sheet (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remediation activity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</livn:ScheduleofProductRemediationTableTextBlock>
    <livn:ProductRemediationNet
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RhYmxlOmIzNzhmMDRmNzU1MzRhNmFiZDNmNDFkODA5MzM3ZjVjL3RhYmxlcmFuZ2U6YjM3OGYwNGY3NTUzNGE2YWJkM2Y0MWQ4MDkzMzdmNWNfMC0yLTEtMS0w_2789956e-af4f-417a-b034-31cbaf16372e"
      unitRef="usd">3251000</livn:ProductRemediationNet>
    <livn:ProductRemediationAdjustments
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RhYmxlOmIzNzhmMDRmNzU1MzRhNmFiZDNmNDFkODA5MzM3ZjVjL3RhYmxlcmFuZ2U6YjM3OGYwNGY3NTUzNGE2YWJkM2Y0MWQ4MDkzMzdmNWNfMS0yLTEtMS0w_af59d5b4-6b94-45b2-bd8f-b5294eb8cde0"
      unitRef="usd">2301000</livn:ProductRemediationAdjustments>
    <livn:ProductRemediationPayments
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RhYmxlOmIzNzhmMDRmNzU1MzRhNmFiZDNmNDFkODA5MzM3ZjVjL3RhYmxlcmFuZ2U6YjM3OGYwNGY3NTUzNGE2YWJkM2Y0MWQ4MDkzMzdmNWNfMi0yLTEtMS0w_8e4115b9-b110-4a36-8c94-987fd3d3a58c"
      unitRef="usd">3982000</livn:ProductRemediationPayments>
    <livn:ProductRemediationForeignCurrencyTranslationGainLoss
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RhYmxlOmIzNzhmMDRmNzU1MzRhNmFiZDNmNDFkODA5MzM3ZjVjL3RhYmxlcmFuZ2U6YjM3OGYwNGY3NTUzNGE2YWJkM2Y0MWQ4MDkzMzdmNWNfMy0yLTEtMS0w_1114fcdf-7351-4554-947b-67be249c4651"
      unitRef="usd">145000</livn:ProductRemediationForeignCurrencyTranslationGainLoss>
    <livn:ProductRemediationNet
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RhYmxlOmIzNzhmMDRmNzU1MzRhNmFiZDNmNDFkODA5MzM3ZjVjL3RhYmxlcmFuZ2U6YjM3OGYwNGY3NTUzNGE2YWJkM2Y0MWQ4MDkzMzdmNWNfNC0yLTEtMS0w_3ee73966-9c26-4336-90de-fc1827df3486"
      unitRef="usd">1715000</livn:ProductRemediationNet>
    <livn:ProductRemediationExpense
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RleHRyZWdpb246YWViYjFiMTc5MDJlNGRhNWEzOWM1MTlmM2E0NGQ3NDRfNDAzMA_238d18c1-b8af-4588-89d8-10865a2c3521"
      unitRef="usd">1100000</livn:ProductRemediationExpense>
    <livn:ProductRemediationExpense
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RleHRyZWdpb246YWViYjFiMTc5MDJlNGRhNWEzOWM1MTlmM2E0NGQ3NDRfNDAzNw_1c9598b6-b789-402c-a046-db45d6805ab9"
      unitRef="usd">3100000</livn:ProductRemediationExpense>
    <livn:ProductRemediationExpense
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RleHRyZWdpb246YWViYjFiMTc5MDJlNGRhNWEzOWM1MTlmM2E0NGQ3NDRfNDA2Mg_2fee82e2-0d19-4fa5-807a-ac82caeb2b7a"
      unitRef="usd">6900000</livn:ProductRemediationExpense>
    <livn:ProductRemediationExpense
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RleHRyZWdpb246YWViYjFiMTc5MDJlNGRhNWEzOWM1MTlmM2E0NGQ3NDRfNDA2OQ_23b71730-10ec-44b6-9262-2255c2775ce4"
      unitRef="usd">11100000</livn:ProductRemediationExpense>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ia4743b9cbc8b413f864fd07a5e2fad89_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV80OS9mcmFnOmFlYmIxYjE3OTAyZTRkYTVhMzljNTE5ZjNhNDRkNzQ0L3RleHRyZWdpb246YWViYjFiMTc5MDJlNGRhNWEzOWM1MTlmM2E0NGQ3NDRfNDU0MQ_a9f4cf8d-7a27-4807-870f-8a4a02ece91f"
      unitRef="usd">46300000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:InvestmentTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RleHRyZWdpb246YzkyNTJmMzA2OWFjNDgwM2I1MjUzMjNhNGU1YmFmODdfMzg0ODI5MDY5OTEyMg_8b9778d9-f054-4954-8463-a231a3c544de">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Note 6. Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following table details the carrying value of our investments in equity securities of non-consolidated affiliates without readily determinable fair values for which we do not exert significant influence over the investee. These equity investments are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The below equity investments are included in investments on the condensed consolidated balance sheets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.371%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity Investments Without Readily Determinable Fair Values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Respicardia Inc. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ALung Technologies, Inc. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceribell, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ShiraTronics, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MD Start II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rainbow Medical Ltd.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Highlife S.A.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Respicardia Inc. (&#x201c;Respicardia&#x201d;) is a privately funded U.S. company developing an implantable device designed to restore a more natural breathing pattern during sleep in patients with central sleep apnea by transvenously stimulating the phrenic nerve. We have a loan outstanding to Respicardia, with a carrying amount of $0.8 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$0.6 million as of September&#160;30, 2020 and December 31, 2019, respectively, which is included in prepaid expenses and other current assets on the condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;During the first quarter of 2020, we invested in ALung Technologies, Inc. (&#x201c;ALung&#x201d;). ALung is a privately held medical device company focused on creating advanced medical devices for treating respiratory failure. ALung&#x2019;s Hemolung Respiratory Assist System is a dialysis-like alternative or supplement to mechanical ventilation which removes carbon dioxide directly from the blood in patients with acute respiratory failure. During the second quarter of 2020, we provided a convertible loan to ALung for $2.0&#160;million, due July 10, 2021. As of September&#160;30, 2020, the carrying amount of the loan was $2.0 million, which is included in prepaid expenses and other current assets on the condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentTextBlock>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RleHRyZWdpb246YzkyNTJmMzA2OWFjNDgwM2I1MjUzMjNhNGU1YmFmODdfMTg5OQ_cf6ff2b3-da7b-4d42-b943-44dc6fdfdbbe">The below equity investments are included in investments on the condensed consolidated balance sheets (in thousands):&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.371%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity Investments Without Readily Determinable Fair Values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Respicardia Inc. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ALung Technologies, Inc. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceribell, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ShiraTronics, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MD Start II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rainbow Medical Ltd.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Highlife S.A.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Respicardia Inc. (&#x201c;Respicardia&#x201d;) is a privately funded U.S. company developing an implantable device designed to restore a more natural breathing pattern during sleep in patients with central sleep apnea by transvenously stimulating the phrenic nerve. We have a loan outstanding to Respicardia, with a carrying amount of $0.8 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$0.6 million as of September&#160;30, 2020 and December 31, 2019, respectively, which is included in prepaid expenses and other current assets on the condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;During the first quarter of 2020, we invested in ALung Technologies, Inc. (&#x201c;ALung&#x201d;). ALung is a privately held medical device company focused on creating advanced medical devices for treating respiratory failure. ALung&#x2019;s Hemolung Respiratory Assist System is a dialysis-like alternative or supplement to mechanical ventilation which removes carbon dioxide directly from the blood in patients with acute respiratory failure. During the second quarter of 2020, we provided a convertible loan to ALung for $2.0&#160;million, due July 10, 2021. As of September&#160;30, 2020, the carrying amount of the loan was $2.0 million, which is included in prepaid expenses and other current assets on the condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="iafea0951c2c545c9aa85f9c8daadd17f_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMS0yLTEtMS0w_76dcca31-3bd0-41a7-8432-a3c6ed22c273"
      unitRef="usd">17706000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i60b29926fecf4b70b1dc7c7cd0baf605_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMS00LTEtMS0w_be7acf77-f31e-4161-8318-78bbe8ce4894"
      unitRef="usd">17706000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i51565454f75d4bebb38194ffedb9b20a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMi0yLTEtMS0w_cbcd1bf1-8993-44af-97a7-d150a203fafc"
      unitRef="usd">3000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i2185fe191cce4a66865bde068329982b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMi00LTEtMS0w_d294bf02-4dd2-4393-b480-9771b7e05c83"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ic98b76cf08a64b6da1b29b2c251fc766_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMy0yLTEtMS0w_8edc6f04-032c-4ed2-b0f3-89209d2405ea"
      unitRef="usd">3000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="iaf583348934e447b97b6b58fd72f1047_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMy00LTEtMS0w_64507087-0b16-4d9e-bb92-94034f07bb15"
      unitRef="usd">3000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i985d7bd469a442c080589425a8443701_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfNC0yLTEtMS0w_f6df3bca-5b95-4852-9c21-8a03b562223f"
      unitRef="usd">2045000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i0c5ecded17b340c89b0e638f6ae6ffc2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfNC00LTEtMS0w_8504c162-4ce8-41f9-bd0b-95b12f88b1cb"
      unitRef="usd">2045000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ia943f93887004f2e973f75f871756f34_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfNS0yLTEtMS0xNzA4_dc2fec31-9b14-4761-9ec3-90fd1a7e6470"
      unitRef="usd">1169000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="iddd07ea8a3bb43fcaa80fd42e2b6af83_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfNS00LTEtMS0xNzA4_49750130-6a0b-468f-bf77-c8ecbc035279"
      unitRef="usd">1121000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="id7070af18fef45169cea3d61e672378d_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfNS0yLTEtMS0w_ad670935-4db8-4c81-bd97-ff2610b963b3"
      unitRef="usd">1145000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i128dd12840304fb7a5186325c995dc74_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfNS00LTEtMS0w_1804998f-7e65-497d-a9d9-6c17697c9ed9"
      unitRef="usd">1099000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i0cc59c39d408424fa8ec43642bdefae4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfNy0yLTEtMS0w_711395c1-1446-4ec0-8570-ab4b25ed538d"
      unitRef="usd">1109000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i67e02e6f525d49d79d1e1378eefccbaa_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfNy00LTEtMS0w_65afcba0-1bb5-41ed-b8f1-888d68d5a116"
      unitRef="usd">1064000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i43bc731c38504f9a9bf794876a9512db_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfOC0yLTEtMS0w_ee996330-ec03-447e-9b2c-4805d1bfc884"
      unitRef="usd">770000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i9cfb30f9c2da4bd98ce29047f95daaf6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfOC00LTEtMS0w_bd0f1c2f-df1f-4b63-b46c-af2ce169674c"
      unitRef="usd">770000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfOS0yLTEtMS0w_2b86763c-7ad7-466d-90d3-2adf03738669"
      unitRef="usd">29944000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfOS00LTEtMS0w_aa3a95e7-ceb5-4adc-bd00-79031324e595"
      unitRef="usd">26805000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMTAtMi0xLTEtMA_f5765c66-b1a3-480a-aa05-16e4d43bdd7f"
      unitRef="usd">414000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMTAtNC0xLTEtMA_3b2034df-a328-42e0-aa6b-99c1ddc3c62c"
      unitRef="usd">451000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMTEtMi0xLTEtMA_9421b9b1-9437-42a9-88ae-5b5fde3aac1b"
      unitRef="usd">30358000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RhYmxlOjIyNDNhN2U0NGQxMjRkMmY5ZTg5MWYwNjdmY2UwMTZiL3RhYmxlcmFuZ2U6MjI0M2E3ZTQ0ZDEyNGQyZjllODkxZjA2N2ZjZTAxNmJfMTEtNC0xLTEtMA_27c39834-2f1d-4e07-b6ec-a69ca9680347"
      unitRef="usd">27256000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:NotesReceivableNet
      contextRef="ib244d5c1647445c98706515b46ea2376_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RleHRyZWdpb246YzkyNTJmMzA2OWFjNDgwM2I1MjUzMjNhNGU1YmFmODdfODk0_99e4055a-2eb9-4c6c-81fa-053473207d72"
      unitRef="usd">800000</us-gaap:NotesReceivableNet>
    <us-gaap:NotesReceivableNet
      contextRef="i90db8675b50e452bb4dbe535ff672f26_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RleHRyZWdpb246YzkyNTJmMzA2OWFjNDgwM2I1MjUzMjNhNGU1YmFmODdfOTAx_aa6249f9-8c39-40a0-86e5-ddcb58fbbc27"
      unitRef="usd">600000</us-gaap:NotesReceivableNet>
    <us-gaap:NotesReceivableGross
      contextRef="i798dba76d2144cabb6adb775c4a1aa5f_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RleHRyZWdpb246YzkyNTJmMzA2OWFjNDgwM2I1MjUzMjNhNGU1YmFmODdfMTUzNA_2b361ef2-4469-46fc-ab2e-367ce15d7254"
      unitRef="usd">2000000.0</us-gaap:NotesReceivableGross>
    <us-gaap:NotesReceivableNet
      contextRef="i282f7e855f164edab83c60ade72f1e8f_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81Mi9mcmFnOmM5MjUyZjMwNjlhYzQ4MDNiNTI1MzIzYTRlNWJhZjg3L3RleHRyZWdpb246YzkyNTJmMzA2OWFjNDgwM2I1MjUzMjNhNGU1YmFmODdfMTgwNw_9b619324-d7ce-40f6-986e-fdddc617d915"
      unitRef="usd">2000000.0</us-gaap:NotesReceivableNet>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMzg0ODI5MDcwMjYwMQ_6980e13e-0803-4aa4-8302-b1326d752e9e">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Note 7. Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;We review the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain securities within the fair value hierarchy. There were no transfers between Level 1, Level 2, or Level 3 during the nine months ended September 30, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following tables provide information by level for assets and liabilities that are measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value Measurements Using Inputs Considered as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets - designated as cash flow hedges (foreign currency exchange rate &#x201c;FX&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets - freestanding instruments (FX)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets - capped call derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities - freestanding instruments (interest rate swaps)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities - freestanding instruments (FX) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities - embedded exchange feature&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities - other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value Measurements Using Inputs Considered as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets - designated as cash flow hedges (FX)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets - freestanding instruments (FX)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities - designated as cash flow hedges (FX)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities - designated as cash flow hedges (interest rate swaps)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities - freestanding instruments (FX) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following table provides a reconciliation of the beginning and ending balances of our recurring fair value measurements, using significant unobservable inputs (Level 3) (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.018%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Capped Call Derivative Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Embedded Exchange Feature Derivative Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Derivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Convertible Notes Receivable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in fair value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) (3) (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;During the nine months ended September 30, 2020, we paid $8.8 million under the contingent consideration arrangement for the acquisition of CardiacAssist, Inc., doing business as TandemLife (&#x201c;TandemLife&#x201d;). Additionally, we made final payments under contingent consideration arrangements resulting from the acquisitions of two distributors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;The contingent consideration change in fair value during the nine months ended September 30, 2020 is primarily due to a one-year delay in the projected achievement of a certain regulatory milestone and timing of sales-based earnout payments for ImThera Medical Inc. (&#x201c;ImThera&#x201d;), and the impact of an increase in discount rates utilized in the valuation of contingent consideration. Refer to the tables below for further information regarding the fair value measurements of contingent consideration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;During the nine months ended September 30, 2020, the contingent consideration change in fair value resulted in a decrease of $19.2 million and $12.0 million recorded to cost of sales - exclusive of amortization and research and development, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Changes in the fair value of the embedded exchange feature derivative and capped call derivatives are recognized in foreign exchange and other gains (losses) in the condensed consolidated statements of income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;Embedded Exchange Feature and Capped Call Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;In June 2020, the Company issued $287.5&#160;million in cash exchangeable senior notes and entered into related capped call transactions. The cash exchangeable senior notes include an embedded exchange feature that is bifurcated from the cash exchangeable senior notes. Please refer to &#x201c;Note 8. Financing Arrangements&#x201d; for further details. The embedded exchange feature derivative is measured at fair value using a binomial lattice model and discounted cash flows that utilize observable and unobservable market data. The capped call derivative is measured at fair value using the Black-Scholes model utilizing observable and unobservable market data, including stock price, remaining contractual term, expected volatility, risk-free interest rate and expected dividend yield, as applicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The embedded exchange feature and capped call derivatives are classified as Level 3 as the Company uses historical volatility and implied volatility from options traded to determine expected stock price volatility which is an unobservable input that is significant to the valuation. In general, an increase in our stock price or stock price volatility would increase the fair value of the embedded exchange feature and capped call derivatives which would result in an increase in expense. As time to the expiration of the derivatives decreases with passage of time, the fair value of the derivatives would decrease. The future impact on net income depends on how significant inputs such as stock price, stock price volatility and time to the expiration of the derivatives change in relation to other inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The stock price volatility as of September&#160;30, 2020 was 37%. As of September&#160;30, 2020, a 10% lower volatility, holding other inputs constant, would result in approximate fair value for the embedded exchange feature derivative of $42.4 million and a 10% higher volatility, holding other inputs constant, would result in approximate fair value of $76.4 million. As of September&#160;30, 2020, a 10% lower volatility, holding other inputs constant would result in approximate fair value for the capped call derivatives of $29.3 million and a 10% higher volatility, holding other inputs constant, would result in approximate fair value of $42.3 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;Contingent Consideration Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following table provides the fair value of our Level 3 contingent consideration arrangements by acquisition (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ImThera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;TandemLife&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Miami Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drilltex&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The ImThera business combination involved contingent consideration arrangements composed of potential cash payments upon the achievement of a certain regulatory milestone and a sales-based earnout associated with sales of products. The sales-based earnout is valued using projected sales from our internal strategic plan. Both arrangements are Level 3 fair value measurements and include the following significant unobservable inputs as of September&#160;30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:14pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ImThera Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ranges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Regulatory milestone-based payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected payment year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-based earnout&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Monte Carlo simulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-adjusted discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit risk discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected years of earnout&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The TandemLife business combination involved a contingent consideration arrangement composed of potential cash payments upon the achievement of certain regulatory milestones. The arrangement is a Level 3 fair value measurement and includes the following significant unobservable inputs as of September&#160;30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.939%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TandemLife Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ranges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Regulatory milestone-based payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected payment years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The Miami Instruments business combination involved a contingent consideration arrangement composed of potential cash payments upon the achievement of certain regulatory milestones. The arrangement is a Level 3 fair value measurement and includes the following significant unobservable inputs as of September&#160;30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.939%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Miami Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ranges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Regulatory milestone-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected payment years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfNTM0NQ_9ef7688f-1e23-4d7b-8da7-12f8f0f3ba0f">&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following tables provide information by level for assets and liabilities that are measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value Measurements Using Inputs Considered as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets - designated as cash flow hedges (foreign currency exchange rate &#x201c;FX&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets - freestanding instruments (FX)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets - capped call derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities - freestanding instruments (interest rate swaps)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities - freestanding instruments (FX) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities - embedded exchange feature&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities - other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value Measurements Using Inputs Considered as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets - designated as cash flow hedges (FX)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets - freestanding instruments (FX)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities - designated as cash flow hedges (FX)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities - designated as cash flow hedges (interest rate swaps)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities - freestanding instruments (FX) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:DerivativeAssets
      contextRef="i3c6523bc48a447b5869e52fba0cea6f3_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMy0yLTEtMS0w_35b1dcab-706f-4557-b9f5-ed9f6d0ce7a8"
      unitRef="usd">1787000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="if0d8e86523634968b1908339ac891144_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMy00LTEtMS0w_17596ff2-3423-431e-a413-e550959f11ef"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="iff29d74ec51a43d3b79a5db568d853f2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMy02LTEtMS0w_435e7d24-82f4-454e-a256-545a336aefc2"
      unitRef="usd">1787000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="icfefd2b87cb44284867538a460fdec64_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMy04LTEtMS0w_cb39851f-880a-4352-bcb9-57ee4fd5c21a"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ibad74017afa848158b4bcf23299630ba_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNC0yLTEtMS0w_9637e335-9108-4180-adde-1b661a88d8e6"
      unitRef="usd">4052000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ia53cdeb7e70b46e0a9df7e343e1c8dc7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNC00LTEtMS0w_19e962cc-51a7-4362-a76d-85770d100d8f"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i549d9fe1d5694fea83f1cb9a0116d9c3_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNC02LTEtMS0w_3b070539-f463-4b51-a042-e76cd034561a"
      unitRef="usd">4052000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ibf3cde6d556f43229f6017b4b0296fb3_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNC04LTEtMS0w_3c14d505-43f2-4697-bef3-920cc84b0496"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i99ea2a2977bf428dbe55a0a62f1d8f39_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNS0yLTEtMS0w_1af3b9df-3c06-4084-9286-5ed0ccf1873d"
      unitRef="usd">38999000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i477ef411a1da4a87828daf96a443478a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNS00LTEtMS0w_8a85b65a-eef9-42dc-a53e-82f9e571819c"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i604c8c94f78e401b9a10ebc3406a262d_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNS02LTEtMS0w_26c90407-c253-4d08-959d-fc980940031b"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ic71b0960ca5b40b79de0620646d77218_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNS04LTEtMS0w_6f4ce28f-785c-496c-873b-72eea0ba61c9"
      unitRef="usd">38999000</us-gaap:DerivativeAssets>
    <us-gaap:ReceivablesFairValueDisclosure
      contextRef="i1920c569d03f4b2981551f7c9fa3f2dc_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNi0yLTEtMS0w_e273e496-4b97-4992-90cc-73068cf7955f"
      unitRef="usd">2301000</us-gaap:ReceivablesFairValueDisclosure>
    <us-gaap:ReceivablesFairValueDisclosure
      contextRef="i651e6f1d58d6444c89e41097aa3c93d2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNi00LTEtMS0w_2cb70e52-0cdf-4bd3-a7d4-a0487710137a"
      unitRef="usd">0</us-gaap:ReceivablesFairValueDisclosure>
    <us-gaap:ReceivablesFairValueDisclosure
      contextRef="ibb5a207f947a447b8d9aaf5128bccb8e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNi02LTEtMS0w_0ceae1cc-cfd9-4190-815a-f869232afb75"
      unitRef="usd">0</us-gaap:ReceivablesFairValueDisclosure>
    <us-gaap:ReceivablesFairValueDisclosure
      contextRef="ic60029069ad0424ebdeeedac7260aaf9_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNi04LTEtMS0w_16b5a90e-acca-4bb9-b24c-e6d5cb41d9ba"
      unitRef="usd">2301000</us-gaap:ReceivablesFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1920c569d03f4b2981551f7c9fa3f2dc_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNy0yLTEtMS0w_fdf2e9e2-59db-44c2-ac6f-57dec6b3aa88"
      unitRef="usd">47139000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i651e6f1d58d6444c89e41097aa3c93d2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNy00LTEtMS0w_e56e9939-bd8b-48ee-adfa-bfbb9dca38f3"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibb5a207f947a447b8d9aaf5128bccb8e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNy02LTEtMS0w_fb40721b-2a79-4234-a49a-e3d803e1e4aa"
      unitRef="usd">5839000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic60029069ad0424ebdeeedac7260aaf9_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfNy04LTEtMS0w_eed3cabb-be4b-4726-bbf3-f811fec9ff31"
      unitRef="usd">41300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="i7955e6392f00489b9c7c6bd1a5a7b4a6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTEtMi0xLTEtMA_90019866-0f68-493c-9402-d635ed64b98e"
      unitRef="usd">139000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i7bb02064dc544327a00b12a199681a45_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTEtNC0xLTEtMA_189eb7cf-6afd-4f9e-bd61-47d8a19bfd6b"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i223528d062ef4c2d8c27572caa395a07_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTEtNi0xLTEtMA_505dd3e3-d113-4c12-807f-7c833668bbf5"
      unitRef="usd">139000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i9a279cef16854d728efd76005ca4b872_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTEtOC0xLTEtMA_f10a4101-a0f2-4c9c-8891-253d52e7014f"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ibad74017afa848158b4bcf23299630ba_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTItMi0xLTEtMA_87e95021-5ae4-43b2-9d1b-f8c901c30690"
      unitRef="usd">85000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ia53cdeb7e70b46e0a9df7e343e1c8dc7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTItNC0xLTEtMA_42d6423e-04d5-488b-9903-e2fa766b1459"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i549d9fe1d5694fea83f1cb9a0116d9c3_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTItNi0xLTEtMA_a8c83f1f-1041-431b-92bf-6590413aca6c"
      unitRef="usd">85000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ibf3cde6d556f43229f6017b4b0296fb3_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTItOC0xLTEtMA_ba835604-7d80-4e51-ae6b-c342c0f54f78"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i148d72eb7ca9457d9c7534140ff8b8e6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTMtMi0xLTEtMA_a2f87088-d760-45b6-9de3-edfbf948501c"
      unitRef="usd">59398000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ia3dabef6c1fc45838407928a7edc982a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTMtNC0xLTEtMA_e92769ab-c473-476f-8847-60bff359bcdc"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i7dab210d1ff74635af037320edfe69b2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTMtNi0xLTEtMA_8dc82cd6-62e5-4d89-8201-db407e9f05b9"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i7515b98bfc884d4c8e81ba14f06c1998_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTMtOC0xLTEtMA_c7abd5e2-9f9e-4747-8f32-53abc1556948"
      unitRef="usd">59398000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i874c5b66a97e468981139b4c21d7eefa_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTQtMi0xLTEtMzA3Ng_01b90eb1-78cf-4c79-818a-f54e92f7202e"
      unitRef="usd">1350000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i3e3b083fb0b3450ea7ce586ffdd675e6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTQtNC0xLTEtMzA3OA_7fac008a-2064-4f0c-b16f-337b9986b400"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ic8a2fef709db4b8e8534fc2dc8e08119_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTQtNi0xLTEtMzA4MA_f0096e54-bf5c-4051-9fae-1813a512f86e"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i19e9ceed79d04c9eb93f32768de95ec9_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTQtOC0xLTEtMjMxOA_065e284d-2056-435d-81a7-1612661c5a70"
      unitRef="usd">1350000</us-gaap:DerivativeLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1920c569d03f4b2981551f7c9fa3f2dc_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTQtMi0xLTEtMA_4c28a022-ce7b-4ff9-97a0-02f3d4138a17"
      unitRef="usd">96174000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i651e6f1d58d6444c89e41097aa3c93d2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTQtNC0xLTEtMA_33a5a19b-a281-483d-aec1-72b4a47ad32e"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ibb5a207f947a447b8d9aaf5128bccb8e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTQtNi0xLTEtMA_38950dfb-dea0-491a-97c9-d204344a103a"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic60029069ad0424ebdeeedac7260aaf9_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTQtOC0xLTEtMA_eacc933e-fba3-4206-8c8b-c5fbf38bac2c"
      unitRef="usd">96174000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1920c569d03f4b2981551f7c9fa3f2dc_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTUtMi0xLTEtMA_c8975e77-3528-4288-852a-cb1766ddcf60"
      unitRef="usd">157146000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i651e6f1d58d6444c89e41097aa3c93d2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTUtNC0xLTEtMA_196e9ff5-4d5b-4c3a-8c59-4101946d68d3"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ibb5a207f947a447b8d9aaf5128bccb8e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTUtNi0xLTEtMA_abbf1ed2-a4c6-47de-a612-df4d6f866247"
      unitRef="usd">224000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic60029069ad0424ebdeeedac7260aaf9_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc1YTI0ZGJmMzk5NDQ1ZTQ5NzIyN2YwNGYzMThhOTBjL3RhYmxlcmFuZ2U6NzVhMjRkYmYzOTk0NDVlNDk3MjI3ZjA0ZjMxOGE5MGNfMTUtOC0xLTEtMA_de8132e4-e937-4a80-be94-08a5f5a1b6fa"
      unitRef="usd">156922000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:DerivativeAssets
      contextRef="i6f293b751409438c9ba2c7b3dc48dffc_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMy0yLTEtMS0w_b6b27383-7755-4bdc-8193-b13a66e6f5e0"
      unitRef="usd">535000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="id6b52afe363e4fe9a4d0f3237689efc2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMy00LTEtMS0w_7babca43-011d-4860-84bd-042d6d4b95db"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i2aba2a40c6324508a183965eccf45b95_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMy02LTEtMS0w_792113f5-bce4-4f57-a6b4-dc560c475984"
      unitRef="usd">535000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="iaa9c677be2ba4b7080abc459f6cb49e2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMy04LTEtMS0w_86201b90-e08b-41fb-b9fc-8b3536fb0d4c"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i7c78a1ebb503459eb3095a7afc63295b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfNC0yLTEtMS0w_162df00d-876d-4437-a048-8cc675523eb1"
      unitRef="usd">26000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="id7db9636c721460b95675081b95ae6b6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfNC00LTEtMS0w_c5cd9332-a240-4fc5-a29a-68eb7ccb6885"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i95ed7028bea74431b97651e632a47b6b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfNC02LTEtMS0w_89e1eae9-f7ec-4f7b-95d9-fbcdca62d816"
      unitRef="usd">26000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="idcbcc74327d845ba8fc6a1532ba4b344_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfNC04LTEtMS0w_21d91523-12e0-490f-a71f-3a4251f245f0"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib087b2c401cc4c3d8384b3a48fcd1329_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfNS0yLTEtMS0w_9c2e12f5-de5a-4529-9a46-607867d6ec25"
      unitRef="usd">561000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i692bbffae945465da30a96cc3773a545_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfNS00LTEtMS0w_591140b5-48a7-485d-8fc2-a6717b70232d"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic71ba4ba85c34d5486646e473787face_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfNS02LTEtMS0w_5f06436e-a875-4cd4-9635-291cf89ba0c0"
      unitRef="usd">561000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9e6eaa19ee7d48d686b0f7478549e4f3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfNS04LTEtMS0w_498d35cd-d6b5-4ad2-a415-b5348724df1e"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="i6f293b751409438c9ba2c7b3dc48dffc_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfOC0yLTEtMS0w_d51e7f5c-8b1e-422e-9ca7-6df9c94d4a49"
      unitRef="usd">169000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="id6b52afe363e4fe9a4d0f3237689efc2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfOC00LTEtMS0w_9881d1d0-a5ca-4883-a225-877faf383518"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i2aba2a40c6324508a183965eccf45b95_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfOC02LTEtMS0w_a23c03e2-742d-4d21-b9ae-3d92cbe3d2ad"
      unitRef="usd">169000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="iaa9c677be2ba4b7080abc459f6cb49e2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfOC04LTEtMS0w_51ac823a-961e-4886-bfaa-af77a36a54dc"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i41752121b3454d50a55318982c498675_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfOS0yLTEtMS0w_fabb684b-1c14-423b-84ce-b472f1e67ac4"
      unitRef="usd">374000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i1cdbf2725d5841b0b9507ecf33848425_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfOS00LTEtMS0w_0fbdb451-48d5-4aa4-a4b1-57c993fc898f"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i1a4cad9c20ed4f459594fbf97ec48b93_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfOS02LTEtMS0w_39747586-8618-4f99-a1fe-6c7455710cb4"
      unitRef="usd">374000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="id2ae71915c9d485e834f0858c4a5ae25_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfOS04LTEtMS0w_826c5d1b-0b39-4a60-b922-8a635cae1d59"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i7c78a1ebb503459eb3095a7afc63295b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTAtMi0xLTEtMA_209a27e8-5fc7-40ce-846f-1cb1c482eae8"
      unitRef="usd">3137000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="id7db9636c721460b95675081b95ae6b6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTAtNC0xLTEtMA_f1ab9efc-14da-4efc-9a48-377fa11668f2"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i95ed7028bea74431b97651e632a47b6b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTAtNi0xLTEtMA_aea966c2-941a-402a-9f25-630dc500b708"
      unitRef="usd">3137000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="idcbcc74327d845ba8fc6a1532ba4b344_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTAtOC0xLTEtMA_4613f89d-71fb-4eed-b001-60929b4b0744"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib087b2c401cc4c3d8384b3a48fcd1329_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTEtMi0xLTEtMA_5e203290-44cf-435e-bab0-de43332e7f6f"
      unitRef="usd">137349000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i692bbffae945465da30a96cc3773a545_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTEtNC0xLTEtMA_e257c3e5-122f-4717-8548-e3d6d9320526"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic71ba4ba85c34d5486646e473787face_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTEtNi0xLTEtMA_04372f72-d1ed-46a1-b02c-3ddf736cf26d"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9e6eaa19ee7d48d686b0f7478549e4f3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTEtOC0xLTEtMA_39d0ee05-d399-45bd-8c81-dbbd2ea456f7"
      unitRef="usd">137349000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib087b2c401cc4c3d8384b3a48fcd1329_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTItMi0xLTEtMA_a103dad5-fd7e-4cdc-9c49-5eaed0045689"
      unitRef="usd">141029000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i692bbffae945465da30a96cc3773a545_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTItNC0xLTEtMA_3370bbab-23f0-4f33-a4e1-16c412cee641"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic71ba4ba85c34d5486646e473787face_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTItNi0xLTEtMA_0ce9c156-e612-45a0-b045-a9eddbc9149c"
      unitRef="usd">3680000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9e6eaa19ee7d48d686b0f7478549e4f3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjVmMGU3NTRmNjgwYzRiNmRhOGNmMjgwMDEwM2YyNThjL3RhYmxlcmFuZ2U6NWYwZTc1NGY2ODBjNGI2ZGE4Y2YyODAwMTAzZjI1OGNfMTItOC0xLTEtMA_e61f7362-61de-44f3-afd3-43837294979e"
      unitRef="usd">137349000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfNTMzOQ_ddacd1c6-f7e2-4b5e-8a7a-aea099b22076">&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following table provides a reconciliation of the beginning and ending balances of our recurring fair value measurements, using significant unobservable inputs (Level 3) (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.018%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Capped Call Derivative Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Embedded Exchange Feature Derivative Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Derivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Convertible Notes Receivable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in fair value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) (3) (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;During the nine months ended September 30, 2020, we paid $8.8 million under the contingent consideration arrangement for the acquisition of CardiacAssist, Inc., doing business as TandemLife (&#x201c;TandemLife&#x201d;). Additionally, we made final payments under contingent consideration arrangements resulting from the acquisitions of two distributors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;The contingent consideration change in fair value during the nine months ended September 30, 2020 is primarily due to a one-year delay in the projected achievement of a certain regulatory milestone and timing of sales-based earnout payments for ImThera Medical Inc. (&#x201c;ImThera&#x201d;), and the impact of an increase in discount rates utilized in the valuation of contingent consideration. Refer to the tables below for further information regarding the fair value measurements of contingent consideration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;During the nine months ended September 30, 2020, the contingent consideration change in fair value resulted in a decrease of $19.2 million and $12.0 million recorded to cost of sales - exclusive of amortization and research and development, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Changes in the fair value of the embedded exchange feature derivative and capped call derivatives are recognized in foreign exchange and other gains (losses) in the condensed consolidated statements of income (loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i9f78b59175ef4d758e415b5cbed5ac3f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMS0yLTEtMS0w_3972b68a-3fb0-4bb1-86c7-08303a08c8f9"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i4305df4a64bd48dba371c408205ef499_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMS00LTEtMS0w_129e79f6-54bf-4642-8203-761e86538f9b"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i209b72ec61d040dfb2b194e845cf7edb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMS02LTEtMS0zMDky_f1d070ab-469b-4795-93b3-747fa82e75f3"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i2c92b7d80ea24dacb640f577505291f1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMS02LTEtMS0w_2adba7d5-964d-4d28-942c-bf6efb03640e"
      unitRef="usd">137349000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i90c6c409fa4549c790424875b8e5a217_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMS04LTEtMS0w_3588cf8f-4d99-438e-811d-1aca5592c7e0"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="iaf2d496c991846f780a3d8de11e7596e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMi0yLTEtMS0w_fa92417d-c473-4dfb-9436-66a26fb4268c"
      unitRef="usd">43096000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i1c3d799108834231aa07131c4ffa94a6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMi00LTEtMS0w_184e0cc6-2a43-4c51-a43a-5e3957eda22d"
      unitRef="usd">74951000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i945ca206fc8d4168be118ba472cf5c62_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMi02LTEtMS0yMzU5_4dd4d7ef-e66d-4edf-a0d6-e1334f1bd23a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="ifdae3dc9ec2145e495befafb9bcf5123_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMi02LTEtMS0w_8475eda7-813a-421b-aa1e-b6a8d3681266"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="ib6822c11b4df4397a32236603772252c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMi04LTEtMS0w_2c5a09fd-bf67-4776-a2fb-a935d0d5c8bc"
      unitRef="usd">2267000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="iaf2d496c991846f780a3d8de11e7596e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMy0yLTEtMS0w_56ad2a83-3fd1-47ea-bbb6-f7adbcc70287"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i1c3d799108834231aa07131c4ffa94a6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMy00LTEtMS0w_e938c9c2-c917-41d3-8403-2cba4b1f4234"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i945ca206fc8d4168be118ba472cf5c62_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMy02LTEtMS0zMzEw_b81dd69b-e42b-4140-bcad-5cd3acde6936"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ifdae3dc9ec2145e495befafb9bcf5123_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMy02LTEtMS0w_09dbe7cf-354c-4c77-8f1a-06939e48a15c"
      unitRef="usd">9868000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="ib6822c11b4df4397a32236603772252c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfMy04LTEtMS0w_b8f46cdc-149a-44cc-ad50-6550ef8d9c20"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="iaf2d496c991846f780a3d8de11e7596e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNC0yLTEtMS0w_007e5a9e-ed58-420e-9bbb-f2d613f696be"
      unitRef="usd">-4097000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i1c3d799108834231aa07131c4ffa94a6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNC00LTEtMS0w_48954fb1-2db3-4b06-a889-2d485f63c384"
      unitRef="usd">15553000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i945ca206fc8d4168be118ba472cf5c62_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNC02LTEtMS0zMzEw_c422b9eb-ee78-4ca8-b146-169bab57d5d3"
      unitRef="usd">-1350000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ifdae3dc9ec2145e495befafb9bcf5123_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNC02LTEtMS0w_4331e47e-14ae-4d3f-b6d7-1120c530a843"
      unitRef="usd">31176000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="ib6822c11b4df4397a32236603772252c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNC04LTEtMS0w_bcb6c810-f4f8-48f0-9340-4559b5d258f2"
      unitRef="usd">34000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="iaf2d496c991846f780a3d8de11e7596e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNS0yLTEtMS0w_652ffa06-8dd7-4435-bb14-3bcd93f3b968"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
      contextRef="i1c3d799108834231aa07131c4ffa94a6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNS00LTEtMS0w_8bcbeb8b-1945-4bc0-ad90-94e93df76d27"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
      contextRef="i945ca206fc8d4168be118ba472cf5c62_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNS02LTEtMS0zMzEw_47c33321-663c-4529-8445-1864c2f920d8"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
      contextRef="ifdae3dc9ec2145e495befafb9bcf5123_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNS02LTEtMS0w_158c763e-985f-46ce-a5ed-d30c385d15a9"
      unitRef="usd">-131000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="ib6822c11b4df4397a32236603772252c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNS04LTEtMS0w_5b7f1ef0-5848-4c8c-8d5f-05cc5e836e4a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i79abffac68b242c5a0a7017c3bb651d2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNi0yLTEtMS0w_3af8c76f-d102-48f6-be44-fe7939d6269e"
      unitRef="usd">38999000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i5458476260ce4943a87b849a8aacd1c1_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNi00LTEtMS0w_7ccf4a91-7aa3-485a-aadc-f9270b413326"
      unitRef="usd">59398000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i90160a4003a147ac85584baddfa6bbdf_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNi02LTEtMS0zMDkw_cb6813bb-47b0-4a86-a1e6-7c0b28537c6d"
      unitRef="usd">1350000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ic11bd09e203746298506602f823386cf_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNi02LTEtMS0w_2b03b411-0bfd-4318-a0d4-d23b0c9d8ce6"
      unitRef="usd">96174000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ia1595ac59e1649c287f1756d28d46854_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNi04LTEtMS0w_821bcda3-5942-4fb0-a2af-564ca3bcc240"
      unitRef="usd">2301000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <livn:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue
      contextRef="i79abffac68b242c5a0a7017c3bb651d2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNy0yLTEtMS0w_c973a221-de25-46c0-9872-68e3fb8cae5f"
      unitRef="usd">0</livn:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue>
    <livn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue
      contextRef="i5458476260ce4943a87b849a8aacd1c1_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNy00LTEtMS0w_57c4f8cf-1225-4bd0-87d5-af05d0143e8f"
      unitRef="usd">0</livn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue>
    <livn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue
      contextRef="i90160a4003a147ac85584baddfa6bbdf_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNy02LTEtMS0yMzcy_41df1947-6e8f-4430-9f7f-ae1e78432eab"
      unitRef="usd">1160000</livn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue>
    <livn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue
      contextRef="ic11bd09e203746298506602f823386cf_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNy02LTEtMS0w_d8eeacb4-d8ed-4d04-8ef9-d5691101edf4"
      unitRef="usd">16571000</livn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue>
    <livn:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue
      contextRef="ia1595ac59e1649c287f1756d28d46854_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfNy04LTEtMS0w_08d2e30c-8d94-4b93-b91b-e5eace3d0ca8"
      unitRef="usd">2044000</livn:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue>
    <livn:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue
      contextRef="i79abffac68b242c5a0a7017c3bb651d2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfOC0yLTEtMS0w_76df6936-1c95-4bf9-9a04-e024239c276f"
      unitRef="usd">38999000</livn:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue>
    <livn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue
      contextRef="i5458476260ce4943a87b849a8aacd1c1_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfOC00LTEtMS0w_0bd894be-9702-4a58-b2fa-bcf9227f4b11"
      unitRef="usd">59398000</livn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue>
    <livn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue
      contextRef="i90160a4003a147ac85584baddfa6bbdf_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfOC02LTEtMS0zMDkw_f582deac-a580-461e-8092-48ac071283fa"
      unitRef="usd">190000</livn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue>
    <livn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue
      contextRef="ic11bd09e203746298506602f823386cf_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfOC02LTEtMS0w_37cdf6dc-daac-420c-889d-d334af93b0dc"
      unitRef="usd">79603000</livn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue>
    <livn:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue
      contextRef="ia1595ac59e1649c287f1756d28d46854_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmRmODhhYTQwYTE1OTQ0Y2M4MjBkOWYzYTZmMzBlOTdkL3RhYmxlcmFuZ2U6ZGY4OGFhNDBhMTU5NDRjYzgyMGQ5ZjNhNmYzMGU5N2RfOC04LTEtMS0w_86597c84-d808-4ed6-bd38-6c9cecad698a"
      unitRef="usd">257000</livn:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue>
    <us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfNzI3_a50c8af2-caa8-4f29-ad08-f9e96c453785"
      unitRef="usd">8800000</us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities>
    <livn:NumberOfDistributorsAcquired
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMzg0ODI5MDcwMzAyOQ_8e5634be-0ca7-4ac0-976c-02a63cc78135"
      unitRef="distributor">2</livn:NumberOfDistributorsAcquired>
    <livn:BusinessCombinationMilestoneAchievementPeriodOfDelay
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMzg0ODI5MDcwMzAzMg_3eac03fd-2bbf-4f46-b651-404ccf57d5c1">P1Y</livn:BusinessCombinationMilestoneAchievementPeriodOfDelay>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="if4a3c8bc06cb468c81b9eb54252c7358_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMTU0MA_ccbdaa4e-967b-44d0-86c6-e0de8657452d"
      unitRef="usd">19200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i6716b0b0e633453e9726f2030e08c1ca_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMTU0Nw_c028cc7e-d278-409d-8e90-2bc665c1e698"
      unitRef="usd">12000000.0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i24d1ba33f5dd45c0b73177d207d4550c_I20200617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMTk0NA_e7c242bd-bfcf-41c6-8c63-af24862609d3"
      unitRef="usd">287500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ieb3ff6598aa94f57ad92e35964f81c74_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMzYwMg_1d6fcad7-dedf-4f19-b7a7-95ad58e8878b"
      unitRef="number">0.37</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ia12648082fc04c6b8edae66b0ae67c39_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMzYwMg_98430bce-48d4-4b1b-b753-1adb1d7a8b4d"
      unitRef="number">0.37</us-gaap:DerivativeLiabilityMeasurementInput>
    <livn:SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue
      contextRef="ib19ca95e55f0441faf04ebd6116fa0b8_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMzc1OA_288e03da-d6f4-4c48-9b6f-28ebc4342267"
      unitRef="usd">42400000</livn:SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue>
    <livn:SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue
      contextRef="ib19ca95e55f0441faf04ebd6116fa0b8_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfMzg2Mw_c78e917c-83a7-4400-a11f-9b5cef442a0c"
      unitRef="usd">76400000</livn:SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue>
    <livn:SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue
      contextRef="i8dabcab920e744a7b4327517400decdd_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfNDAwNQ_1bdf44bc-771b-47cd-8b1b-17e473960c0c"
      unitRef="usd">29300000</livn:SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue>
    <livn:SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue
      contextRef="i8dabcab920e744a7b4327517400decdd_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfNDExMA_f668dd49-ff1e-4de0-ae29-95d37a1bf88b"
      unitRef="usd">42300000</livn:SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfNTM0NA_0ba57e07-5bb7-47ee-b5ad-5dd694b4b404">&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following table provides the fair value of our Level 3 contingent consideration arrangements by acquisition (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ImThera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;TandemLife&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Miami Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drilltex&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i62afb2ec706c47af855bd1dcaf827f5c_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfMS0yLTEtMS0w_c6e50446-bc31-435a-b016-3f939e6fb608"
      unitRef="usd">79603000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i5d29459e1a0a41f687a10f5ab9c54a04_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfMS00LTEtMS0w_9df39929-eaa2-4f90-9766-47ef52761ba4"
      unitRef="usd">113503000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic98623a8908a479b94a28994eb16d56b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfMi0yLTEtMS0w_364a385a-22ce-446f-8c31-41e1c9f51066"
      unitRef="usd">11672000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i34cc075f863646e699af91319f899885_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfMi00LTEtMS0w_6e1059f8-7745-43f3-997c-bf28b90fb688"
      unitRef="usd">17311000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i383d011df36a41baa36003172177eb6b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfMy0yLTEtMS0w_2f820e87-d10d-4719-9804-c648fb833613"
      unitRef="usd">4899000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="icd04c511e4ce4ac08b831ad0578c95f0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfMy00LTEtMS0w_acdfaba4-19f0-45f7-b97e-96b822165861"
      unitRef="usd">5338000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="icbc2f3772dba467592c17b9ecdbc0bc9_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfNC0yLTEtMS0w_c41baaad-c1d8-4503-882f-733b0b601adc"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i252c36e7add342399b1424bfe704c832_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfNC00LTEtMS0w_7ba45170-ce47-4586-b6d1-3167e4630e5a"
      unitRef="usd">294000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="if59480dc9b4f411782c729fa14047400_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfNS0yLTEtMS0w_898ab87f-519d-43bc-818e-198ba4e5587b"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i10357ff0c2724f06bbfa2eec022e8b72_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfNS00LTEtMS0w_8b39acd0-3c60-4324-9707-f623c09b7d6a"
      unitRef="usd">903000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ic60029069ad0424ebdeeedac7260aaf9_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfNi0yLTEtMS0w_b23f296f-40f7-47fd-a807-c0a51867676f"
      unitRef="usd">96174000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i9e6eaa19ee7d48d686b0f7478549e4f3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmIyMTFjMWRmYTU4OTQzZjc5YjU4NmRiYzAwMmU0YjQ1L3RhYmxlcmFuZ2U6YjIxMWMxZGZhNTg5NDNmNzliNTg2ZGJjMDAyZTRiNDVfNi00LTEtMS0w_e631adbb-a0f6-4433-b8fc-84d633f895e0"
      unitRef="usd">137349000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RleHRyZWdpb246OWZjMTRjMTZjM2Q1NGYwNGFiMDU1ZjMxNWI3MTI3ZjBfNTMzMw_fadbd4b6-e28c-49c8-9199-b8ba1b125540">Both arrangements are Level 3 fair value measurements and include the following significant unobservable inputs as of September&#160;30, 2020:&lt;div style="margin-bottom:14pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ImThera Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ranges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Regulatory milestone-based payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected payment year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-based earnout&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Monte Carlo simulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-adjusted discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit risk discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected years of earnout&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The TandemLife business combination involved a contingent consideration arrangement composed of potential cash payments upon the achievement of certain regulatory milestones. The arrangement is a Level 3 fair value measurement and includes the following significant unobservable inputs as of September&#160;30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.939%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TandemLife Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ranges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Regulatory milestone-based payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected payment years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The Miami Instruments business combination involved a contingent consideration arrangement composed of potential cash payments upon the achievement of certain regulatory milestones. The arrangement is a Level 3 fair value measurement and includes the following significant unobservable inputs as of September&#160;30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.939%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Miami Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ranges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Regulatory milestone-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected payment years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <livn:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="i52334654e869489ca143b061165476f4_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc3NmEyMTZlMjhjNzRkMDU4ZTRkNzE3MWM1YWUwZmRhL3RhYmxlcmFuZ2U6Nzc2YTIxNmUyOGM3NGQwNThlNGQ3MTcxYzVhZTBmZGFfMS02LTEtMS0w_7c93210a-e960-440e-be95-3f8a8f24085b"
      unitRef="number">0.083</livn:BusinessCombinationContingentConsiderationMeasurementInput>
    <livn:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="ie2536974de9b486d9e0ef01bd6a67045_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc3NmEyMTZlMjhjNzRkMDU4ZTRkNzE3MWM1YWUwZmRhL3RhYmxlcmFuZ2U6Nzc2YTIxNmUyOGM3NGQwNThlNGQ3MTcxYzVhZTBmZGFfMi02LTEtMS0w_430d79b0-177e-4171-8992-87a457ca6d60"
      unitRef="number">0.85</livn:BusinessCombinationContingentConsiderationMeasurementInput>
    <livn:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="i26486ea04b234f2e927248919c447802_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc3NmEyMTZlMjhjNzRkMDU4ZTRkNzE3MWM1YWUwZmRhL3RhYmxlcmFuZ2U6Nzc2YTIxNmUyOGM3NGQwNThlNGQ3MTcxYzVhZTBmZGFfNS02LTEtMS0w_bd7a8493-0ade-4800-9806-69ab3e367d10"
      unitRef="number">0.122</livn:BusinessCombinationContingentConsiderationMeasurementInput>
    <livn:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="i7d05cd06a8bf4c379ecc9d10bbb2d201_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc3NmEyMTZlMjhjNzRkMDU4ZTRkNzE3MWM1YWUwZmRhL3RhYmxlcmFuZ2U6Nzc2YTIxNmUyOGM3NGQwNThlNGQ3MTcxYzVhZTBmZGFfNS04LTEtMS0w_e6779036-6daa-4f3f-9c60-676f59d51dae"
      unitRef="number">0.125</livn:BusinessCombinationContingentConsiderationMeasurementInput>
    <livn:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="i6a7bf4141731447ba120d2c607bf1fc2_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc3NmEyMTZlMjhjNzRkMDU4ZTRkNzE3MWM1YWUwZmRhL3RhYmxlcmFuZ2U6Nzc2YTIxNmUyOGM3NGQwNThlNGQ3MTcxYzVhZTBmZGFfNi02LTEtMS0w_82ef8504-cfc2-4f66-94b1-56354c9a3cdb"
      unitRef="number">0.085</livn:BusinessCombinationContingentConsiderationMeasurementInput>
    <livn:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="i6291433582a64ddb8a18340f917f581e_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc3NmEyMTZlMjhjNzRkMDU4ZTRkNzE3MWM1YWUwZmRhL3RhYmxlcmFuZ2U6Nzc2YTIxNmUyOGM3NGQwNThlNGQ3MTcxYzVhZTBmZGFfNi04LTEtMS0w_a9e5f5b4-468f-4d23-8c19-caf36a930abe"
      unitRef="number">0.092</livn:BusinessCombinationContingentConsiderationMeasurementInput>
    <livn:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="i79119020499f4051aaa48c43f75c5b81_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc3NmEyMTZlMjhjNzRkMDU4ZTRkNzE3MWM1YWUwZmRhL3RhYmxlcmFuZ2U6Nzc2YTIxNmUyOGM3NGQwNThlNGQ3MTcxYzVhZTBmZGFfNy02LTEtMS0w_b12c7bd5-2671-4f7f-a6e0-d0646a00468b"
      unitRef="number">0.325</livn:BusinessCombinationContingentConsiderationMeasurementInput>
    <livn:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="i1d800c2cae0e47849fbae2bf9df0853f_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjc3NmEyMTZlMjhjNzRkMDU4ZTRkNzE3MWM1YWUwZmRhL3RhYmxlcmFuZ2U6Nzc2YTIxNmUyOGM3NGQwNThlNGQ3MTcxYzVhZTBmZGFfOC02LTEtMS0w_31f4b9ca-9cb3-4788-8201-d130413b8e01"
      unitRef="number">0.85</livn:BusinessCombinationContingentConsiderationMeasurementInput>
    <livn:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="i48e773110abb48db81e64c019f74f83d_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjgwMGExNDAxNzhmZTQ0YTY4Y2VlYTc0ZTA1NDdiOTM1L3RhYmxlcmFuZ2U6ODAwYTE0MDE3OGZlNDRhNjhjZWVhNzRlMDU0N2I5MzVfMS02LTEtMS0w_1a5d0c1c-03f8-4667-bd0c-8324ab3a3245"
      unitRef="number">0.076</livn:BusinessCombinationContingentConsiderationMeasurementInput>
    <livn:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="i5d623187030142ffa015b3317a9e5d79_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjgwMGExNDAxNzhmZTQ0YTY4Y2VlYTc0ZTA1NDdiOTM1L3RhYmxlcmFuZ2U6ODAwYTE0MDE3OGZlNDRhNjhjZWVhNzRlMDU0N2I5MzVfMS04LTEtMS0w_b4dabc82-623d-4ed5-9a1c-f9d0dbc8d350"
      unitRef="number">0.077</livn:BusinessCombinationContingentConsiderationMeasurementInput>
    <livn:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="i3f11911900f44e6a9bb586049722bb34_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjgwMGExNDAxNzhmZTQ0YTY4Y2VlYTc0ZTA1NDdiOTM1L3RhYmxlcmFuZ2U6ODAwYTE0MDE3OGZlNDRhNjhjZWVhNzRlMDU0N2I5MzVfMi02LTEtMS0w_6a8340e0-68e9-4664-a8fa-f7a0de0ae874"
      unitRef="number">0.70</livn:BusinessCombinationContingentConsiderationMeasurementInput>
    <livn:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="iae66d9458a004d28af2aca3b7976b3f0_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOjgwMGExNDAxNzhmZTQ0YTY4Y2VlYTc0ZTA1NDdiOTM1L3RhYmxlcmFuZ2U6ODAwYTE0MDE3OGZlNDRhNjhjZWVhNzRlMDU0N2I5MzVfMi04LTEtMS0w_8be8281e-4a49-45ce-9b71-a9997b68dea9"
      unitRef="number">1</livn:BusinessCombinationContingentConsiderationMeasurementInput>
    <livn:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="ia4826f8772764dcca66860adeb782fae_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmJmMWVhZDMzNzdjZDRlMDk4M2NlNGUwZDkxYzM5NDY0L3RhYmxlcmFuZ2U6YmYxZWFkMzM3N2NkNGUwOTgzY2U0ZTBkOTFjMzk0NjRfMS02LTEtMS0w_2de87424-19dd-4b2d-a4de-ec8fc9fe11fa"
      unitRef="number">0.076</livn:BusinessCombinationContingentConsiderationMeasurementInput>
    <livn:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="i6697817a4014449f80da5eda0856fefd_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmJmMWVhZDMzNzdjZDRlMDk4M2NlNGUwZDkxYzM5NDY0L3RhYmxlcmFuZ2U6YmYxZWFkMzM3N2NkNGUwOTgzY2U0ZTBkOTFjMzk0NjRfMS04LTEtMS0w_d292a5e0-8601-4d4f-ae4d-a60fa3d60250"
      unitRef="number">0.077</livn:BusinessCombinationContingentConsiderationMeasurementInput>
    <livn:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="i0aa9d51eaa804f9bbf6db6abe1aab758_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmJmMWVhZDMzNzdjZDRlMDk4M2NlNGUwZDkxYzM5NDY0L3RhYmxlcmFuZ2U6YmYxZWFkMzM3N2NkNGUwOTgzY2U0ZTBkOTFjMzk0NjRfMi02LTEtMS0w_4bd1dcc1-88cd-4d0a-9a11-425b39f4cd88"
      unitRef="number">0.80</livn:BusinessCombinationContingentConsiderationMeasurementInput>
    <livn:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="i459d7f911ab44762922172ee4898a00b_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81NS9mcmFnOjlmYzE0YzE2YzNkNTRmMDRhYjA1NWYzMTViNzEyN2YwL3RhYmxlOmJmMWVhZDMzNzdjZDRlMDk4M2NlNGUwZDkxYzM5NDY0L3RhYmxlcmFuZ2U6YmYxZWFkMzM3N2NkNGUwOTgzY2U0ZTBkOTFjMzk0NjRfMi04LTEtMS0w_ab576ae5-f056-48b4-a24f-b7e38e29d3ea"
      unitRef="number">0.95</livn:BusinessCombinationContingentConsiderationMeasurementInput>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMzg0ODI5MDcwNjU4Nw_427e5450-4eb7-4782-a9f0-452c259e1af8">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Note 8. Financing Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The carrying amount of our long-term debt as of September&#160;30, 2020 and December 31, 2019 was as follows (in thousands, except interest rates):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.030%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 Senior Secured Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;LIBOR (1% Floor)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;+&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 Cash Exchangeable Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank of America Merrill Lynch Banco M&#xfa;ltiplo S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.61%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mediocredito Italiano&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.77%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank of America, U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.08%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Debt Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2017 European Investment Bank&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2014 European Investment Bank&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;Revolving Credit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The outstanding principal amount of our short-term unsecured revolving credit agreements and other agreements with various banks was $4.3 million and $4.2 million, at September&#160;30, 2020 and December 31, 2019, respectively, with interest rates ranging from 3.21% to 7.20% and loan terms ranging from overnight to 10 months, as of September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;2020 Senior Secured Term Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;On June 10, 2020, we entered into a $450.0&#160;million five-year senior secured term loan (the &#x201c;Term Loan&#x201d;) through our wholly owned subsidiary LivaNova USA Inc., with funds managed by affiliates of Ares Management Corporation, as administrative agent and collateral agent, resulting in cash proceeds of approximately $421.7&#160;million, net of discounts and issuance costs. The obligations under the Term Loan are guaranteed on a senior secured basis by each of LivaNova&#x2019;s existing and future wholly owned material subsidiaries, and are secured by a perfected first priority security interest in substantially all tangible and intangible assets of LivaNova and certain U.S. and UK subsidiaries of LivaNova, subject in each case to certain exceptions contained in the Term Loan. Borrowings under the Term Loan bear interest at a variable annual rate equal to the three-month LIBOR rate (subject to a 1% floor), plus an applicable margin of 6.5% per annum. The effective interest rate of the Term Loan at September&#160;30, 2020 was 9.0%. The Term Loan will mature on June&#160;30, 2025 and includes certain affirmative, negative and financial covenants. The financial covenants under the Term Loan state (i) the net revenue of LivaNova PLC, LivaNova USA, Inc. and any restricted subsidiaries on a consolidated basis shall not be lower than $700&#160;million for each trailing 12 month period, such threshold to decrease pro rata (not below $550&#160;million) upon prepayments of the Term Loan made by LivaNova USA, Inc. out of the proceeds of certain asset sales, and (ii) the total secured leverage ratio (as defined in the debt agreement) for LivaNova PLC, LivaNova USA, Inc. and any restricted subsidiaries on a consolidated basis shall not be greater than the applicable ratio set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Test Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Secured Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 Quarters ending June 30, 2020 through each fiscal quarter thereafter until (and including) the fiscal quarter ending June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.625&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 Quarters ending September 30, 2021 and ending each fiscal quarter thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Debt discounts and issuance costs related to the Term Loan were approximately $28.3&#160;million and included various legal, bank and accounting fees. Amortization of debt discount and issuance costs was $1.1 million and $1.3 million for the three and nine months ended September 30, 2020, respectively, and was included in interest expense on the condensed consolidated statement of income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;2020 Cash Exchangeable Senior Notes &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;On June 17, 2020, our wholly-owned subsidiary, LivaNova USA, Inc., issued $287.5&#160;million aggregate principal amount of 3.00% cash exchangeable senior notes (the &#x201c;Notes&#x201d;) by private placement to qualified institutional buyers pursuant to Rule &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;144A under the Securities Act of 1933, as amended. The sale of the Notes resulted in approximately $278.0&#160;million in net proceeds to the Company after deducting issuance costs. Interest is payable semiannually in arrears on June 15 and December 15 of each year, beginning on December 15, 2020. The effective interest rate of the Notes at September&#160;30, 2020 was 9.9%. The Notes mature on December&#160;15, 2025 unless earlier exchanged, repurchased, or redeemed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Debt discounts and issuance costs related to the Notes were approximately $82.0&#160;million and included $75.0&#160;million of discount attributable to the embedded exchange feature, discussed below, and $7.0&#160;million of allocated issuance costs to the Notes related to legal, bank and accounting fees. Amortization of debt discount and issuance costs was $3.0 million and $3.4 million for the three and nine months ended September 30, 2020 and is included in interest expense on the condensed consolidated statement of income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The Notes are exchangeable at the option of the holders only under certain circumstances and solely into cash in an amount based on the trading prices of LivaNova&#x2019;s ordinary shares during a related observation period. The Notes are not exchangeable into ordinary shares of LivaNova or any other security under any circumstances. The initial exchange rate for the Notes is 16.3980 ordinary shares per $1,000 principal amount of Notes (equivalent to an initial exchange price of approximately $60.98 per share). The exchange rate is subject to adjustment in certain circumstances, as set forth in the indenture governing the Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The Company may redeem the Notes at its option, on or after June 20, 2023, in whole or in part, if the last reported sale price per ordinary share has been at least 130% of the exchange price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. Additionally, the Company may redeem the Notes at its option, prior to December 15, 2025, in whole but not in part, in connection with certain tax-related events.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;Embedded Exchange Feature&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The embedded exchange feature of the Notes requires bifurcation from the Notes and is accounted for as a derivative liability. The fair value of the Notes&#x2019; embedded exchange feature derivative at the time of issuance was $75.0&#160;million and was recorded as debt discount on the Notes. This discount is amortized as interest expense using the effective interest method over the term of the Notes. The Notes&#x2019; embedded exchange feature derivative is carried on the condensed consolidated balance sheets at its estimated fair value and is adjusted at the end of each reporting period, with unrealized gain or loss reflected in the consolidated statements of income (loss). The fair value of the embedded exchange feature derivative liability was $59.4 million as of September&#160;30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;Capped Call Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;In connection with the pricing of the Notes, the Company entered into privately negotiated capped call transactions with certain of the initial purchasers of the Notes or their respective affiliates. The capped call transactions cover, subject to anti-dilution adjustments substantially similar to those applicable to the Notes, the number of LivaNova&#x2019;s ordinary shares underlying the Notes and are expected generally to offset any cash payments the Company is required to make upon exchange of the Notes in excess of the principal amount thereof in the event that the market value per ordinary share, as measured under the capped call transactions, is greater than the strike price of the capped call transactions, with such offset being subject to an initial cap price of $100.00 per share. The aggregate cost of the capped calls derivative assets was $43.1&#160;million. The capped call transactions expire on December 15, 2025 and must be settled in cash. The capped calls are carried on the condensed consolidated balance sheets as a derivative asset at their estimated fair value and are adjusted at the end of each reporting period, with unrealized gain or loss reflected in the condensed consolidated statement of income (loss). The fair value of capped call derivative assets was $39.0 million as of September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The current and non-current classification is evaluated at each balance sheet date and may change depending on whether any exchange conditions are met. As of September&#160;30, 2020, no exchange conditions have been met and the Notes, embedded exchange feature derivative liability, and the capped call derivative assets are classified as non-current. Please refer to &#x201c;Note 7. Fair Value Measurements&#x201d; for details on the valuation of the embedded exchange feature derivative liability and capped call derivative assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;Extinguishment of Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The Company used the net proceeds from the Term Loan, together with a portion of the net proceeds of the Notes, after fees, discounts, commissions and other expenses, to repay outstanding indebtedness under the Company&#x2019;s 2017 European Investment Bank loan, 2014 European Investment Bank loan, Banca Nazionale del Lavoro S.p.A loan, and 2019 Debt Facility and related &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;expenses. The Company repaid approximately $528.0&#160;million in aggregate outstanding principal, accrued interest and associated fees, including breakage fees and legal fees. The Company recognized a loss on debt extinguishment of $1.4&#160;million during the nine months ended September 30, 2020. The loss on debt extinguishment was recognized in foreign exchange and other losses in the condensed consolidated statements of income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The remainder of the proceeds from the concurrent financing transactions were used to pay the cost of capped call transactions and for general corporate purposes.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfODU5NA_b65f6447-4cd4-4059-b6ca-76f28d1bbb94">&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The carrying amount of our long-term debt as of September&#160;30, 2020 and December 31, 2019 was as follows (in thousands, except interest rates):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.030%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 Senior Secured Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;LIBOR (1% Floor)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;+&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 Cash Exchangeable Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank of America Merrill Lynch Banco M&#xfa;ltiplo S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.61%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mediocredito Italiano&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.77%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank of America, U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.08%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Debt Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2017 European Investment Bank&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2014 European Investment Bank&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3245df3db3cb48138c8bb4d23daee5c4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMS0yLTEtMS0w_79b9c0d9-d452-4329-8d0e-cb2ef0ed9731"
      unitRef="usd">422960000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i85cd7d93641d4805ad2cd66461498397_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMS00LTEtMS0w_d52a9df1-689b-4d61-91ee-ca610f256860"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <livn:DebtInstrumentLIBORFloorRate
      contextRef="ieafa762dc91e4ea5b61fb8d13b092c3a_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMS04LTEtMS0wL3RleHRyZWdpb246ZTRiYTYyODA4NWUyNGI2ODlkNzJlNTE5ODZlZDk5OGRfMTI_42d09835-0e1b-4df5-b860-0b5ce43afecb"
      unitRef="number">0.01</livn:DebtInstrumentLIBORFloorRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i45371aa600b04a59940ecd80e4ec31cc_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMS0xMC0xLTEtMA_c577b052-f634-447d-9c58-c0683b9435ee"
      unitRef="number">0.0650</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="icb27b6a99b3143aba0d74fd775949dfe_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMi0yLTEtMS0w_944cdb45-5a0b-4398-b378-d6164b0ff6e4"
      unitRef="usd">208954000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie42f7909e6db412aa3041faa1788bd39_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMi00LTEtMS0w_8be411f2-779b-46c3-aad1-3a58aa100496"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icb27b6a99b3143aba0d74fd775949dfe_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMi04LTEtMS0w_d760bb1f-f371-4a9e-895f-17404deb856b"
      unitRef="number">0.0300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i289e4abd6f78419f8f33d7774b970fca_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMy0yLTEtMS0w_07d5cbaf-820c-4a62-aacf-f28fb63eb8f3"
      unitRef="usd">6000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibee8d98cf1eb433cb1a0301b339983bc_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMy00LTEtMS0w_e8d22c4b-d231-41dd-8dc7-b5091d2996e4"
      unitRef="usd">8422000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i36c4db63cfaf444f879c55013695c930_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMy04LTEtMS0w_a9d9b4e1-705b-44d5-91d9-cb566ae52c4a"
      unitRef="number">0.0561</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifa72db626bbd480cb89d6345d833dd4d_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNC0yLTEtMS0w_fba785e2-55bf-47ce-aff0-76fbd130c90b"
      unitRef="usd">5835000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i586947e97ff14c64ab8231790955f4c6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNC00LTEtMS0w_6d0b2f92-de94-4af4-974d-7f7846c19cab"
      unitRef="usd">6222000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1080464791c844d79de57c27a7ff3ff6_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNC04LTEtMS0w_5121ca11-7058-42d4-9ab6-842f9f5e57e0"
      unitRef="number">0.0050</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idc989c83ebe44970836e50ad98670002_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNC0xMC0xLTEtMA_7df27c41-8fc8-409e-bed5-3c5e2f26f272"
      unitRef="number">0.0277</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibe7864f0b2ec45bd8a718ff4690bb0d1_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNS0yLTEtMS0w_25887131-c7c2-4007-9822-469e21ff061e"
      unitRef="usd">2011000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i77803437d5944d49a41f07e2364e792a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNS00LTEtMS0w_687f6f3d-b52f-4c27-82d2-b925600d0802"
      unitRef="usd">2004000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9dc1230e32264a72921d8a08c4c63984_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNS04LTEtMS0w_6197d7be-c5bc-43c3-ad77-1ca65072d661"
      unitRef="number">0.0208</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic5ac265b05414cd791492f4617219f2e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNi0yLTEtMS0w_31e3e155-f986-4f52-b866-bd847d87e23b"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib89aab9bd0424c12919f50bff87ea646_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNi00LTEtMS0w_6353391e-eed9-458e-848a-a603ac6ef843"
      unitRef="usd">184275000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0d873ce62a3742a390dae8762e636c14_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNy0yLTEtMS0w_766d72a4-c376-4943-a850-572aac29bda1"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id4afcc088bc84e9aa4e4191bfefcc218_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfNy00LTEtMS0w_6c7a4cea-422b-480b-874e-d1d3afb62360"
      unitRef="usd">103570000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i87d4c0b95a4e4fe294e383610676bf94_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfOC0yLTEtMS0w_6613c565-3449-4148-84d2-2ad9f4657c6c"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i774fcbadcb514ffb99380b94b3c9864e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfOC00LTEtMS0w_32c4f31b-0084-4a2f-9416-e4d603dabd7d"
      unitRef="usd">28053000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5a882a55bae3450ab4104c69d32cbe64_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfOS0yLTEtMS0w_767d66d2-c70e-45cf-8058-94f5ac9d675a"
      unitRef="usd">1041000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic874c4d0e00049b4a599f3482a07d919_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfOS00LTEtMS0w_43a4121f-15c0-4f4e-9aa3-f404b8efc7e8"
      unitRef="usd">965000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMTAtMi0xLTEtMA_cd1c6e55-d458-4972-beeb-7dc02077291c"
      unitRef="usd">646801000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMTAtNC0xLTEtMA_687c8107-42ee-4c2f-8f03-08b0723858d1"
      unitRef="usd">333511000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMTEtMi0xLTEtMA_694d9447-b4d0-44fa-91e1-29d2714f3006"
      unitRef="usd">9692000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMTEtNC0xLTEtMA_b2b7a345-e2a6-44fa-8163-3be8725381ac"
      unitRef="usd">73181000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMTItMi0xLTEtMA_e17549c3-1bf6-4b34-b087-b984a8f3a24b"
      unitRef="usd">637109000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOjUzNDMzOTZjNmZiMDQwYjJhMDI1YTllZmVjYThjNTYwL3RhYmxlcmFuZ2U6NTM0MzM5NmM2ZmIwNDBiMmEwMjVhOWVmZWNhOGM1NjBfMTItNC0xLTEtMA_fcee3039-5b55-4db5-80fc-3d8915cdb008"
      unitRef="usd">260330000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ShortTermBorrowings
      contextRef="ib86600fe8d314ce3bbf5074a7b1877ac_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjcz_cbaf0ca2-6bf6-46f4-8738-f99233c967da"
      unitRef="usd">4300000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="ib6ca57cb331747069aa1e6f1b22dd36d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjgw_2d2cf2e9-6ede-4239-9810-b8f22b9fe883"
      unitRef="usd">4200000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="if6b26cfd42a14eae84e4cde0f4855b55_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMzQ1_484285e7-bc64-4d82-853b-582831bf47fd"
      unitRef="number">0.0321</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i222517d76090477aa98b1abaaae6b229_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMzUx_cdf3c333-ab60-4ec1-994c-95ac4addb3e2"
      unitRef="number">0.0720</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="ic387d566a4a047a4abc670c43b8f310a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMzg4_6a3b5f21-91a8-4a23-b9b1-b673535f47ac">P10M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i50324d744dcd4a44b4764e5523cc1cce_I20200610"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNDY4_9d49343a-0ff0-4d99-836e-adb5d687bc0b"
      unitRef="usd">450000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebtTerm
      contextRef="i50324d744dcd4a44b4764e5523cc1cce_I20200610"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMzg0ODI5MDcwNzM1Nw_b6c98876-d16d-475a-81e1-408ba53be7b5">P5Y</us-gaap:LongTermDebtTerm>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="idf2a05cfe98047578281e694de92f942_D20200610-20200610"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNzMy_5cb6b30a-e6bb-458b-b622-ef12ed52fda0"
      unitRef="usd">421700000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <livn:DebtInstrumentLIBORFloorRate
      contextRef="ieafa762dc91e4ea5b61fb8d13b092c3a_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMTI5OA_beee2e30-f8bd-45a3-b71a-497a1d702600"
      unitRef="number">0.01</livn:DebtInstrumentLIBORFloorRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i45371aa600b04a59940ecd80e4ec31cc_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMTMzOA_9d0decd5-6a50-456c-844c-64fa56f80076"
      unitRef="number">0.065</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i3245df3db3cb48138c8bb4d23daee5c4_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMTY0OTI2NzQ1MTk1MA_e5fa5256-6477-411a-8750-f34803532e39"
      unitRef="number">0.090</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <livn:ScheduleOfDebtCovenantsTableTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfODYwMA_049adc4a-6ce1-4047-8cef-7bc7153aca38">The financial covenants under the Term Loan state (i) the net revenue of LivaNova PLC, LivaNova USA, Inc. and any restricted subsidiaries on a consolidated basis shall not be lower than $700&#160;million for each trailing 12 month period, such threshold to decrease pro rata (not below $550&#160;million) upon prepayments of the Term Loan made by LivaNova USA, Inc. out of the proceeds of certain asset sales, and (ii) the total secured leverage ratio (as defined in the debt agreement) for LivaNova PLC, LivaNova USA, Inc. and any restricted subsidiaries on a consolidated basis shall not be greater than the applicable ratio set forth below:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Test Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Secured Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 Quarters ending June 30, 2020 through each fiscal quarter thereafter until (and including) the fiscal quarter ending June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.625&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 Quarters ending September 30, 2021 and ending each fiscal quarter thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</livn:ScheduleOfDebtCovenantsTableTextBlock>
    <livn:DebtInstrumentCovenantMinimumNetRevenue
      contextRef="i545ddcc4502f4443a3f1a3a772c175dc_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMTYzOA_7987ce4f-cf12-4fe7-8da9-7f7e3928198b"
      unitRef="usd">700000000</livn:DebtInstrumentCovenantMinimumNetRevenue>
    <livn:DebtInstrumentCovenantMinimumProRataNetRevenues
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMTcyMw_214456e3-0e0a-46e0-8015-c5cad2ab2ed6"
      unitRef="usd">550000000</livn:DebtInstrumentCovenantMinimumProRataNetRevenues>
    <livn:DebtInstrumentCovenantSecuredLeverageRatioPeriodOne
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOmQ0MzIwMjE5MTY3OTRjZjNiMzUzZWQ3MzIyMWQzYWZkL3RhYmxlcmFuZ2U6ZDQzMjAyMTkxNjc5NGNmM2IzNTNlZDczMjIxZDNhZmRfMS0yLTEtMS0w_1e48971a-b2e7-45bd-ac68-5406f3cff227"
      unitRef="number">5.625</livn:DebtInstrumentCovenantSecuredLeverageRatioPeriodOne>
    <livn:DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RhYmxlOmQ0MzIwMjE5MTY3OTRjZjNiMzUzZWQ3MzIyMWQzYWZkL3RhYmxlcmFuZ2U6ZDQzMjAyMTkxNjc5NGNmM2IzNTNlZDczMjIxZDNhZmRfMi0yLTEtMS0w_11034521-214f-44b2-a06f-be96f5a4e1e5"
      unitRef="number">4.5</livn:DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i50324d744dcd4a44b4764e5523cc1cce_I20200610"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjE0OA_d1e0879a-31bf-437b-86c5-9529c2583ba9"
      unitRef="usd">28300000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i96351578f5c9420c994226ab0fb578bb_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMTY0OTI2NzQ1MTc4OA_7698a678-1976-4f5c-9045-2446e309d277"
      unitRef="usd">1100000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i545ddcc4502f4443a3f1a3a772c175dc_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjc0ODc3OTA3OTQ1MA_4ba698b3-4534-4464-b890-eed0c0670058"
      unitRef="usd">1300000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1401125337584d3cb2556f5344879ff5_I20200617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjUxNg_0af091d6-a002-44b3-8fe8-07d3d3219456"
      unitRef="usd">287500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1401125337584d3cb2556f5344879ff5_I20200617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjU0OQ_8f1cb2f7-7b1c-4a67-a208-c46c72e9094b"
      unitRef="number">0.0300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ie66d4c341b7f42f0b9c74ad3972a82cb_D20200617-20200617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjc2OA_66c21308-4e3d-40d6-b356-403059a667ce"
      unitRef="usd">278000000.0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="icb27b6a99b3143aba0d74fd775949dfe_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMTY0OTI2NzQ1MjAxNQ_07e4629c-10f7-443a-9bf1-4fb245aef2cc"
      unitRef="number">0.099</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i1401125337584d3cb2556f5344879ff5_I20200617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMzE1OA_508bb115-b681-4ae0-98de-7b09bec286c2"
      unitRef="usd">82000000.0</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i1401125337584d3cb2556f5344879ff5_I20200617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMzE3NA_1db6cfee-52fd-4cd5-8727-db340159285f"
      unitRef="usd">75000000.0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i1401125337584d3cb2556f5344879ff5_I20200617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMzI1Nw_bc022e1c-660c-489e-9368-d518c494a105"
      unitRef="usd">7000000.0</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i5ffd59ecf9044f8eb3cf977b8db8a6a7_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMTY0OTI2NzQ1MTc5NQ_8669da83-3e9d-4157-9364-6512767a3cf4"
      unitRef="usd">3000000.0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i444306b422a649ef948af581cd5b4f06_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjc0ODc3OTA3OTQ3NQ_0fa4cdb3-f614-4ba1-b183-2d9aa0ade218"
      unitRef="usd">3400000</us-gaap:AmortizationOfFinancingCosts>
    <livn:DebtInstrumentOptionToExchangePricePerShare
      contextRef="i1401125337584d3cb2556f5344879ff5_I20200617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNDAzMw_66e946cd-813c-48ec-b23c-9416bbb02899"
      unitRef="usdPerShare">60.98</livn:DebtInstrumentOptionToExchangePricePerShare>
    <livn:DebtInstrumentRedemptionPricePercentageOfExchangePrice
      contextRef="i444306b422a649ef948af581cd5b4f06_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNDMzMg_c8c4ba4f-3efc-4843-8181-adb075736100"
      unitRef="number">1.30</livn:DebtInstrumentRedemptionPricePercentageOfExchangePrice>
    <livn:DebtInstrumentRedemptionThresholdTradingDays
      contextRef="icb27b6a99b3143aba0d74fd775949dfe_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNDM4NQ_54b61604-98f0-4e0e-be56-6987b1c8a574"
      unitRef="claim">20</livn:DebtInstrumentRedemptionThresholdTradingDays>
    <livn:DebtInstrumentRedemptionThresholdConsecutiveTradingDays
      contextRef="icb27b6a99b3143aba0d74fd775949dfe_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNDU1MQ_1f9c72f8-2c12-4c21-aa75-e7022de17cd7"
      unitRef="claim">30</livn:DebtInstrumentRedemptionThresholdConsecutiveTradingDays>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i444306b422a649ef948af581cd5b4f06_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNDc0MQ_31c8c747-f90c-47d0-8e10-5e949ae66f80"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i1401125337584d3cb2556f5344879ff5_I20200617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNTI4MA_3ac0ea3c-4d2c-40ba-8bb9-f8f6ce1df71f"
      unitRef="usd">75000000.0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="icb27b6a99b3143aba0d74fd775949dfe_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjc0ODc3OTA3OTQ5Mw_98b311a6-6ac6-4c38-bf28-80015534421b"
      unitRef="usd">59400000</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <livn:DerivativeCapPricePerShare
      contextRef="i8dabcab920e744a7b4327517400decdd_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNjYyMQ_37737e4d-a3d5-45f1-955b-a0a95269ba2d"
      unitRef="usdPerShare">100.00</livn:DerivativeCapPricePerShare>
    <us-gaap:DerivativeCostOfHedge
      contextRef="i17a5d78945d143a89628f9c4af1abbc5_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfNjY5Ng_d7b7d425-5a48-434f-abb7-5ff3d4ab97f5"
      unitRef="usd">43100000</us-gaap:DerivativeCostOfHedge>
    <us-gaap:DerivativeAssets
      contextRef="i8dabcab920e744a7b4327517400decdd_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfMjc0ODc3OTA3OTQ4NA_1d66d6f6-4b37-43a8-8571-6595595f8d22"
      unitRef="usd">39000000.0</us-gaap:DerivativeAssets>
    <us-gaap:RepaymentsOfDebt
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfODA1Mw_6aae5c73-5f42-493b-9035-e77487929542"
      unitRef="usd">528000000.0</us-gaap:RepaymentsOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV81OC9mcmFnOjhkYzY1YWM2ZWY4NjQ5Zjc4YThlMDMwODI1NWRhMGEyL3RleHRyZWdpb246OGRjNjVhYzZlZjg2NDlmNzhhOGUwMzA4MjU1ZGEwYTJfODIyNg_c9062f96-d739-46dc-962f-fa913527ad68"
      unitRef="usd">-1400000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfMzg0ODI5MDcwMjUwMA_b8d28efc-b9a5-43ca-86c7-e7289cd8daef">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Note 9. Derivatives and Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Due to the global nature of our operations, we are exposed to foreign currency exchange rate fluctuations. We enter into FX derivative contracts to reduce the impact of foreign currency exchange rate fluctuations on earnings and cash flow. We are also exposed to equity price risk in connection with our Notes, including exchange and settlement provisions based on the price of our ordinary shares at exchange or maturity of the Notes. In addition, the capped call transactions associated with the Notes also include settlement provisions that are based on the price of our ordinary shares, subject to a capped price per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;We measure all outstanding derivatives each period end at fair value and report the fair value as either financial assets or liabilities on the condensed consolidated balance sheets. We do not enter into derivative contracts for speculative purposes. At inception of the contract, the derivative is designated as either a freestanding derivative or a hedge. Derivatives that are not designated as hedging instruments are referred to as freestanding derivatives with changes in fair value included in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;If the derivative qualifies for hedge accounting, changes in the fair value of the derivative will be recorded in&#160;accumulated other comprehensive income (&#x201c;AOCI&#x201d;) until the hedged item is recognized in earnings upon settlement/termination. FX derivative gains and losses in AOCI are reclassified to our condensed consolidated statements of income (loss) as shown in the tables below. We evaluate hedge effectiveness at inception. Cash flows from derivative contracts are reported as operating activities on our condensed consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;Freestanding FX Derivative Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The gross notional amount of FX derivative contracts not designated as hedging instruments outstanding at September&#160;30, 2020 and December 31, 2019 was $332.2 million and $338.0 million, respectively. These derivative contracts are designed to offset the FX effects in earnings of various intercompany loans and trade receivables. We recorded net (losses) gains for these freestanding derivatives of $(11.7) million and $3.1 million for the three months ended September 30, 2020 and 2019, respectively, and $(4.8) million and $6.8 million for the nine months ended September 30, 2020 and 2019, respectively. These (losses) and gains are included in foreign exchange and other gains (losses) on our condensed consolidated statement of income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;Counterparty Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;We are exposed to credit risk in the event of non-performance by the counterparties to our derivatives at maturity. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The two counterparties to the capped call transactions are financial institutions. To limit our credit risk, we selected financial institutions with a minimum long-term investment grade credit rating. Our exposure to the credit risk of the counterparties is not secured by any collateral.  If a counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings, with a claim equal to our exposure at that time under the capped call transactions with that counterparty.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;To manage credit risk with respect to our other derivatives, the Company selects and periodically reviews counterparties based on credit ratings, limits its exposure with respect to each counterparty, and monitors the market positions. However, if one or more of these counterparties were in a liability position to the Company and were unable to meet their obligations, any transactions with the counterparty could be subject to early termination, which could result in substantial losses for the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The gross notional amounts of open derivative contracts designated as cash flow hedges at September&#160;30, 2020 and December 31, 2019 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description of Derivative Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts to be exchanged for British Pounds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts to be exchanged for Japanese Yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts to be exchanged for Euros&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Interest rate swap contracts were de-designated upon the repayment of the 2014 European Investment Bank loan. Refer to &#x201c;Note 8. Financing Arrangements.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;After-tax net loss associated with derivatives designated as cash flow hedges recorded in the ending balance of AOCI and the amount expected to be reclassified to earnings in the next twelve months are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description of Derivative Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;After-Tax Net Gain in AOCI as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;After-Tax Net Gain in AOCI as of Amount Expected to be Reclassified to Earnings in Next 12 Months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Pre-tax gains (losses) for derivative contracts designated as cash flow hedges recognized in other comprehensive income (loss) (&#x201c;OCI&#x201d;) and the amount reclassified to earnings from AOCI were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description of Derivative Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location in Earnings of Reclassified Gain or Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains Recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Losses) Gains Reclassified from AOCI to Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Losses Recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains (Losses) Reclassified from AOCI to Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange and other gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description of Derivative Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location in Earnings of Reclassified Gain or Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains Recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Losses) Gains Reclassified from AOCI to Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains Recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains (Losses) Reclassified from AOCI to Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange and other gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(681)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;We offset fair value amounts associated with our derivative instruments on our condensed consolidated balance sheets that are executed with the same counterparty under master netting arrangements. Our netting arrangements include a right to set off or net together purchases and sales of similar products in the settlement process.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following tables present the fair value and the location of derivative contracts reported on the condensed consolidated balance sheets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.491%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.493%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expense and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capped call derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Embedded exchange feature&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.491%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.493%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;For the classification of inputs used to evaluate the fair value of our derivatives, refer to &#x201c;Note 7. Fair Value Measurements.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfNTA4MQ_9b045889-444a-480e-afef-c77b71c06616">If the derivative qualifies for hedge accounting, changes in the fair value of the derivative will be recorded in&#160;accumulated other comprehensive income (&#x201c;AOCI&#x201d;) until the hedged item is recognized in earnings upon settlement/termination. FX derivative gains and losses in AOCI are reclassified to our condensed consolidated statements of income (loss) as shown in the tables below. We evaluate hedge effectiveness at inception. Cash flows from derivative contracts are reported as operating activities on our condensed consolidated statements of cash flows.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ibec415e111624e90a65386d8ccfeb185_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfMjE2MA_ca1218a4-1df7-487b-a91a-47b177624425"
      unitRef="usd">332200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0e616a092dd14267a1ec789a805bdb80_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfMjE2Nw_c2a748ea-91b8-4691-a20f-ad0cd9f06784"
      unitRef="usd">338000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i950b10f7b07943f2aec8cb421632f276_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfMjM4NA_125fd9a9-1a4e-457b-b919-d98317cda768"
      unitRef="usd">-11700000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i6a94651f8023444cba196300adc7abcd_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfMjM5MQ_9d3a06d3-37d8-434b-98d1-aaf64b63dc7d"
      unitRef="usd">3100000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i64e57c8edaa1477d881db72e4c50172e_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfMjQxNg_d22bfc4f-5a0f-436d-9666-ff952b541bae"
      unitRef="usd">-4800000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i0efb92ce20cb40c3829d2008a9aee0a0_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfMjQyMw_d7eba4f7-9ced-4b3a-b5ab-f61610caaf85"
      unitRef="usd">6800000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfNTEwMQ_7b215bb7-18ad-41df-b41b-5e8ad1150a2a">&lt;div style="margin-bottom:3pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The gross notional amounts of open derivative contracts designated as cash flow hedges at September&#160;30, 2020 and December 31, 2019 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description of Derivative Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts to be exchanged for British Pounds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts to be exchanged for Japanese Yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts to be exchanged for Euros&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Interest rate swap contracts were de-designated upon the repayment of the 2014 European Investment Bank loan. Refer to &#x201c;Note 8. Financing Arrangements.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i649606b21180421ebd128add525a4018_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfMS0yLTEtMS0w_ec8ee9d0-55be-4365-b499-0108f0003176"
      unitRef="usd">7610000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic43de1d78774468cbbd002d32d130ae7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfMS00LTEtMS0w_30b03886-0f92-4ca4-80c3-a7d328e538c0"
      unitRef="usd">10128000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i96a7d1296872411baf7843151d3b8798_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfMi0yLTEtMS0w_beacb10c-1618-41c1-8ae0-b62d714064c5"
      unitRef="usd">16023000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3e21c8f995c24e08b7f442b0d2e9f153_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfMi00LTEtMS0w_ca630da2-b13a-44d9-90b1-382baeb44316"
      unitRef="usd">25342000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib51f3bb185c74b338b8ef92535cb08f2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfMy0yLTEtMS0w_b0e0ff04-0532-4f69-8abe-32b99eb16348"
      unitRef="usd">36553000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i249fe1f728d5471fa1555fe39c4bfefe_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfMy00LTEtMS0w_67474fb3-bffc-4987-bc2d-75a68b1d6bea"
      unitRef="usd">48838000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iceda4563a5cf43d4b3bb9b89365c4c20_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfNC0yLTEtMS0w_a20f11ce-4f13-4a70-883a-1a221d26a948"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if1925dad241b4aad82804e153bd1d891_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfNC00LTEtMS0w_170279d5-0584-4a68-b2d1-3c0270d6f3ce"
      unitRef="usd">22442000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7100fe2c632148de9c37fb8985d42d30_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfNS0yLTEtMS0w_7a94675f-cdfd-4c7e-b028-53bb4b5911ab"
      unitRef="usd">60186000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic334fc4aef0a4ba39603d81e0f99657a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjk0ZmM3ZGEzNTcyNjQwZDRiNTdlNmE2ZTY2NzNmZTNmL3RhYmxlcmFuZ2U6OTRmYzdkYTM1NzI2NDBkNGI1N2U2YTZlNjY3M2ZlM2ZfNS00LTEtMS0w_99ceb148-b931-4d0a-aea9-b260d791c5bd"
      unitRef="usd">106750000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfNTEwMg_694060fe-2fd5-4588-b52f-4ae5ce3e334c">&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;After-tax net loss associated with derivatives designated as cash flow hedges recorded in the ending balance of AOCI and the amount expected to be reclassified to earnings in the next twelve months are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description of Derivative Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;After-Tax Net Gain in AOCI as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;After-Tax Net Gain in AOCI as of Amount Expected to be Reclassified to Earnings in Next 12 Months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Pre-tax gains (losses) for derivative contracts designated as cash flow hedges recognized in other comprehensive income (loss) (&#x201c;OCI&#x201d;) and the amount reclassified to earnings from AOCI were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description of Derivative Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location in Earnings of Reclassified Gain or Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains Recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Losses) Gains Reclassified from AOCI to Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Losses Recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains (Losses) Reclassified from AOCI to Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange and other gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description of Derivative Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location in Earnings of Reclassified Gain or Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains Recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Losses) Gains Reclassified from AOCI to Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains Recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains (Losses) Reclassified from AOCI to Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange and other gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(681)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i54a9f60e897042dabf6cfd3734d2ec73_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjVjMjU2M2JkNzJhNzRhMzM4ZDEyN2UwYjVlZTFkYWZlL3RhYmxlcmFuZ2U6NWMyNTYzYmQ3MmE3NGEzMzhkMTI3ZTBiNWVlMWRhZmVfMS0yLTEtMS0w_b201c245-d939-4b2e-821e-702e4a05a86e"
      unitRef="usd">1512000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i54a9f60e897042dabf6cfd3734d2ec73_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjVjMjU2M2JkNzJhNzRhMzM4ZDEyN2UwYjVlZTFkYWZlL3RhYmxlcmFuZ2U6NWMyNTYzYmQ3MmE3NGEzMzhkMTI3ZTBiNWVlMWRhZmVfMS00LTEtMS0w_e81eea28-5fd6-4eb2-acf7-dfdda0e15324"
      unitRef="usd">1512000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7af1f95c61944858b003c6c933d18f4e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfMy00LTEtMS0w_c02b5f6e-059c-496a-ac4a-1f466c6b3783"
      unitRef="usd">1482000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i7af1f95c61944858b003c6c933d18f4e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfMy02LTEtMS0w_ee0be224-6717-4876-b4c5-a0cd6db7ca51"
      unitRef="usd">-692000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1948e41e49f1497390be627047b5251a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfMy04LTEtMS0w_1af8fae5-8de9-4f51-b5f2-f90c756b3fe3"
      unitRef="usd">-689000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i1948e41e49f1497390be627047b5251a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfMy0xMC0xLTEtMA_7557308c-e788-4087-8199-90ae97750c0b"
      unitRef="usd">963000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7d2ccb840b50403f8fc4f14ac40d2d79_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNC00LTEtMS0w_50a4f89d-da47-45bc-ae3f-6b119ff6c533"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i7d2ccb840b50403f8fc4f14ac40d2d79_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNC02LTEtMS0w_3c1c839b-b68d-4d41-a792-aaee3b9218d4"
      unitRef="usd">534000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i0e3cfd47324747a59764c08500c16de3_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNC04LTEtMS0w_79086c82-a25e-43ae-93eb-1a0e5bbb280b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i0e3cfd47324747a59764c08500c16de3_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNC0xMC0xLTEtMA_7741ecb6-4f25-416e-83db-c50722d68022"
      unitRef="usd">-742000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1ee46b672ebd4d8bae5042f234b05104_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNS04LTEtMS0w_5c499b2e-4de5-46c3-ae2e-663368e074d7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i1ee46b672ebd4d8bae5042f234b05104_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNS0xMC0xLTEtMA_b228d960-8b25-4fba-b5a7-b276d96c62a1"
      unitRef="usd">-40000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7438dabb55a44445b30dbd44a361b2f4_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNi00LTEtMS0w_4a184715-4209-404e-91a4-54eb47d8b9e6"
      unitRef="usd">1482000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i7438dabb55a44445b30dbd44a361b2f4_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNi02LTEtMS0w_f45fc390-681c-463b-98cb-47ab2b8ed851"
      unitRef="usd">-158000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iae52b02ee83b438bb79bd0edc64a3be1_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNi04LTEtMS0w_513536c4-8fd1-412f-8f0b-784fba7c3de5"
      unitRef="usd">-689000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="iae52b02ee83b438bb79bd0edc64a3be1_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjFlMDMyODgyMDM3ZDQwOTg4YjBkY2ZhMjJlYjZiZjA3L3RhYmxlcmFuZ2U6MWUwMzI4ODIwMzdkNDA5ODhiMGRjZmEyMmViNmJmMDdfNi0xMC0xLTEtMA_2dac8350-7e3b-4626-9b5f-821bdaf05f3d"
      unitRef="usd">181000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7aee89dbb9cd451d93a65f546dc5d74e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfMy00LTEtMS0w_7fafd6c5-fb1a-4285-bc8d-aa25dfc5a78a"
      unitRef="usd">632000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i7aee89dbb9cd451d93a65f546dc5d74e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfMy02LTEtMS0w_6e9478ea-facb-4681-b3c2-4dc93986a8a3"
      unitRef="usd">-777000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iecc073aeadb743fe846108c910b49974_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfMy04LTEtMS0w_3ffff93b-837c-443d-993b-96e57f5e2f99"
      unitRef="usd">933000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="iecc073aeadb743fe846108c910b49974_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfMy0xMC0xLTEtMA_acdf49ec-b685-4cd7-b19a-410cccd669a4"
      unitRef="usd">3094000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iffc8dde6780b4135bdbe52a6f7da8dda_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNC00LTEtMS0w_bd5a0b09-8fe1-41f9-b281-59319d922371"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="iffc8dde6780b4135bdbe52a6f7da8dda_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNC02LTEtMS0w_d54b70ec-eda2-4102-9e97-362b46df0a4f"
      unitRef="usd">209000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ia84ea03c48e54abfb6747a6de26f6116_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNC04LTEtMS0w_65c33298-17bd-4e23-929a-cd233c666b48"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ia84ea03c48e54abfb6747a6de26f6116_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNC0xMC0xLTEtMA_e8534201-81d2-44b1-83ce-0c51f0cd26a9"
      unitRef="usd">-1470000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ia7abd6989d6846e99b0a4c7ee504321d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNS00LTEtMS0w_59c1f2d1-3d16-45c4-867c-3e30416eea25"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ia7abd6989d6846e99b0a4c7ee504321d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNS02LTEtMS0w_e47c0bc3-ebea-4e28-a51a-e5ebb2d7c6cd"
      unitRef="usd">-113000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5331125ba8a94b0fbfcb5387185e5869_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNS04LTEtMS0w_fd056f04-7ecb-4da4-8ae2-778eab33e4cd"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i5331125ba8a94b0fbfcb5387185e5869_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNS0xMC0xLTEtMA_0d7c57ff-be52-4028-a689-8f1eb4700f58"
      unitRef="usd">-26000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iaa29b64fff8949389d46c6f12d455215_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNi00LTEtMS0w_ca9924b0-b792-4836-a2fb-44896903dfa0"
      unitRef="usd">632000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="iaa29b64fff8949389d46c6f12d455215_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNi02LTEtMS0w_4805acfd-9df7-4af4-b2ad-aee0fe804806"
      unitRef="usd">-681000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ibd587e00f53f4c9184d615617e686bcd_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNi04LTEtMS0w_a9109df3-9745-4f60-a216-01ff6519e927"
      unitRef="usd">933000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ibd587e00f53f4c9184d615617e686bcd_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOjkwZmIyZThmMmI3ZjQ1MjdhZDllZjgwZDc3MTZjYmJmL3RhYmxlcmFuZ2U6OTBmYjJlOGYyYjdmNDUyN2FkOWVmODBkNzcxNmNiYmZfNi0xMC0xLTEtMA_12a1fc21-2915-4cc1-a329-7f276ae098bc"
      unitRef="usd">1598000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RleHRyZWdpb246NjM3ODIwMjg0ZTZkNDNkNDk0MDVjOTY0OGQxYjNiZDJfNTA4NA_12ef723a-d0c3-4c8e-8590-4f075a458fbb">&lt;div style="margin-bottom:3pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following tables present the fair value and the location of derivative contracts reported on the condensed consolidated balance sheets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.491%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.493%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expense and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capped call derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Embedded exchange feature&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.491%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.493%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;For the classification of inputs used to evaluate the fair value of our derivatives, refer to &#x201c;Note 7. Fair Value Measurements.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6b35bd5fd55a4b69b147d5820c42e6d7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfMi00LTEtMS0w_f2c09d8d-f1e2-470a-a1ee-71f5f6c5dcf9"
      unitRef="usd">1775000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ibc095689f6144f4ea7254b0bb872766c_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfMy00LTEtMS0xNjA1_1fc9042a-ef5c-4131-a4b9-3649d8bd00fd"
      unitRef="usd">12000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4f55df33738d44e1ba296c8eb88269a1_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfMy00LTEtMS0w_c44befa5-f1b9-4436-9717-7713de27a818"
      unitRef="usd">1787000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i22945e43bf0c46a2a590bd5b5d61f00f_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfNS04LTEtMS0w_305f53f0-3618-4a40-9f9c-73865477f588"
      unitRef="usd">139000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i930e2a8fddf64cb1b8979187598b1cd4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfNi00LTEtMS0w_37dd2738-5dae-40ed-807c-fcb08dd47f96"
      unitRef="usd">4052000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i09a77749f8b64a04b0150d233c3084e4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfNi04LTEtMS0w_6e612e36-fbc7-46a8-920b-4fdb9a8f1593"
      unitRef="usd">51000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i930e2a8fddf64cb1b8979187598b1cd4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfOC04LTEtMS0xNjEw_de41e291-b4f9-4333-aca0-229a33563e77"
      unitRef="usd">34000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic2bca75c3d294e0eaa5aa2c0d20d66ac_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfNy00LTEtMS0w_f5d92e13-2556-4f01-ae72-4f30b5371de6"
      unitRef="usd">38999000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i43f7ebc0918b4360bae6ce12a9368d0d_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfOC04LTEtMS0w_2ced269a-a02c-4ce5-bd60-4e62574b9f75"
      unitRef="usd">59398000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i2c0f04c520c14a329fc827c4e8389951_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfMTEtOC0xLTEtMjMwNQ_91f6cd35-139e-4c5e-9fbd-8539184001f1"
      unitRef="usd">1160000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id58204573a634e6ca3cf75d337baefe3_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfMTItOC0xLTEtMjMwNQ_c550d397-6449-4364-a9fc-36cdd8c4fc2b"
      unitRef="usd">190000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i007ee0b9e8934174994f5d86e0bb6e6d_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfOS00LTEtMS0w_459c7e28-4a73-4c1a-b9e6-fca822e3845f"
      unitRef="usd">43051000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i007ee0b9e8934174994f5d86e0bb6e6d_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfOS04LTEtMS0w_defe6e3d-26a4-45e8-a129-abd2faa88ae6"
      unitRef="usd">60972000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfMTAtNC0xLTEtMA_b0fa96e4-f2f4-444e-9b43-c65c24d3f570"
      unitRef="usd">44838000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU0ODEyNTlmZDc2ZTQ2YmQ5MGE0YzI4ZjllNWYyMGQyL3RhYmxlcmFuZ2U6ZTQ4MTI1OWZkNzZlNDZiZDkwYTRjMjhmOWU1ZjIwZDJfMTAtOC0xLTEtMA_b859cea5-2821-4419-a0b5-80deebcd125f"
      unitRef="usd">60972000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i990fa7277e80490b9cfb6a6d1b9d78f4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfMi04LTEtMS0w_52385ccd-340a-405b-98aa-71d2de1aa6f7"
      unitRef="usd">313000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i75a2980d9bdb44a792b41575bc1a46ba_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfMy04LTEtMS0w_6af53117-744b-42b6-bf75-569b12f4ff75"
      unitRef="usd">61000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i52618d0ff8d74edb8b26a424dd5945e5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfNC00LTEtMS0w_47781e1f-b730-4740-a539-ba3a51d4d6eb"
      unitRef="usd">148000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i06b91b912b3c479ca956a6a0c95f7567_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfNC04LTEtMS0w_23e5516a-df77-4293-b63d-317d233d9c9d"
      unitRef="usd">169000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i06b91b912b3c479ca956a6a0c95f7567_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfNS00LTEtMS0w_6fc94ca9-77f5-434a-bf72-7b7287092f7f"
      unitRef="usd">387000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1d1c0b4a1d3f448aa2bc219f0184bf4d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfNi00LTEtMS0w_199d947f-c93c-4f1f-8923-865132ccf075"
      unitRef="usd">535000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i1d1c0b4a1d3f448aa2bc219f0184bf4d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfNi04LTEtMS0w_3055febc-4c61-4aae-83a4-630330a4c98a"
      unitRef="usd">543000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if2bfe101df98424ab800c282d00e7116_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfOC00LTEtMS0w_5c9b1b35-40e5-4de8-9948-10d843851b8b"
      unitRef="usd">26000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if2bfe101df98424ab800c282d00e7116_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfOC04LTEtMS0w_30304eb4-be58-4d94-9992-f15f1d5b0c3a"
      unitRef="usd">3104000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="icd8a5acd53214b2b9194da6aedc036eb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfOS04LTEtMS0w_59fb1f79-50e5-449a-88d1-4921c03df32d"
      unitRef="usd">33000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i5cd90438d14b4f0c8370dc4b8d777673_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfMTAtNC0xLTEtMA_5a7b7a5e-83e3-4e73-a234-f365a14802f6"
      unitRef="usd">26000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i5cd90438d14b4f0c8370dc4b8d777673_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfMTAtOC0xLTEtMA_7baebae6-e0b4-4aba-8f31-bd454786db7d"
      unitRef="usd">3137000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfMTEtNC0xLTEtMA_fce5fa55-f656-48ed-a06a-90468641730d"
      unitRef="usd">561000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82NC9mcmFnOjYzNzgyMDI4NGU2ZDQzZDQ5NDA1Yzk2NDhkMWIzYmQyL3RhYmxlOmU2MDBiN2E0Yjk5NTRlOTViNWRkMDNjNWY0N2M4NTZlL3RhYmxlcmFuZ2U6ZTYwMGI3YTRiOTk1NGU5NWI1ZGQwM2M1ZjQ3Yzg1NmVfMTEtOC0xLTEtMA_f8e38123-b539-4b18-a4a4-293afcc76e50"
      unitRef="usd">3680000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMzg0ODI5MDcxNTg3Mw_e6f6cfc3-8b70-4e71-ace2-27300a5369e7">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Note 10. Commitments and Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;FDA Warning Letter&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;On December&#160;29, 2015, the FDA issued a Warning Letter alleging certain violations of FDA regulations applicable to medical device manufacturers at our Munich, Germany and Arvada, Colorado facilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The FDA inspected the Munich facility from August 24, 2015 to August 27, 2015 and the Arvada facility from August 24, 2015 to September 1, 2015. On August&#160;27, 2015, the FDA issued a Form 483 identifying two observed non-conformities with certain regulatory requirements at the Munich facility. We did not receive a Form 483 in connection with the FDA&#x2019;s inspection of the Arvada facility. Following the receipt of the Form 483, we provided written responses to the FDA describing corrective and preventive actions that were underway or to be taken to address the FDA&#x2019;s observations at the Munich facility. The Warning Letter responded in part to our responses and identified other alleged violations related to the manufacture of our 3T Heater-Cooler device that were not previously included in the Form 483. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The Warning Letter further stated that our 3T devices and other devices we manufactured at our Munich facility were subject to refusal of admission into the U.S. until resolution of the issues set forth by the FDA in the Warning Letter. The FDA had informed us that the import alert was limited to the 3T devices, but that the agency reserved the right to expand the scope of the import alert if future circumstances warranted such action. The Warning Letter did not request that existing users cease using the 3T device, and manufacturing and shipment of all of our products other than the 3T device were unaffected by the import limitation. To help clarify these issues for current customers, we issued an informational Customer Letter in January 2016 and that same month agreed with the FDA on a process for shipping 3T devices to existing U.S. users pursuant to a certificate of medical necessity program. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Finally, the Warning Letter stated that premarket approval applications for Class III devices to which certain Quality System regulation deviations identified in the Warning Letter were reasonably related would not be approved until the violations had been corrected; however, this restriction applied only to the Munich and Arvada facilities, which do not manufacture or design devices subject to Class III premarket approval. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;On February 25, 2020, LivaNova received clearance for K191402, a 510(k) for the 3T devices that addressed issues contained in the 2015 Warning Letter along with design changes that further mitigate the potential risk of aerosolization. Concurrent with this clearance, (1) 3T devices manufactured in accordance with K191402 will not be subjected to the import alert and (2) LivaNova initiated a correction to distribute the updated Operating Instructions cleared under K191402.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;We continue to work diligently to remediate the FDA&#x2019;s inspectional observations for the Munich facility, as well as the additional issues identified in the Warning Letter. We take these matters seriously and intend to respond timely and fully to the FDA&#x2019;s requests. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;CDC and FDA Safety Communications and Company Field Safety Notice&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;On October 13, 2016, the CDC and the FDA separately released safety notifications regarding the 3T devices. The CDC&#x2019;s Morbidity and Mortality Weekly Report (&#x201c;MMWR&#x201d;) and Health Advisory Notice (&#x201c;HAN&#x201d;) reported that tests conducted by the CDC and its affiliates indicate that there appears to be genetic similarity between both patient and 3T device strains of the non-tuberculous mycobacterium (&#x201c;NTM&#x201d;) bacteria M. chimaera isolated in hospitals in Iowa and Pennsylvania. Citing the geographic separation between the two hospitals referenced in the investigation, the report asserts that 3T devices manufactured prior to August 18, 2014 could have been contaminated during the manufacturing process. The CDC&#x2019;s HAN and FDA&#x2019;s Safety Communication, issued contemporaneously with the MMWR report, each assess certain risks associated with 3T devices and provide guidance for providers and patients. The CDC notification states that the decision to use the 3T device during a surgical operation is to be taken by the surgeon based on a risk approach and on patient need. Both the CDC&#x2019;s and FDA&#x2019;s communications confirm that 3T devices are critical medical devices and enable doctors to perform life-saving cardiac surgery procedures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Also on October 13, 2016, concurrent with the CDC&#x2019;s HAN and FDA&#x2019;s Safety Communication, we issued a Field Safety Notice Update for U.S. users of 3T devices to proactively and voluntarily contact facilities to aid in implementation of the CDC and FDA recommendations. In the fourth quarter of 2016, we initiated a program to provide existing 3T device users with a new loaner 3T device at no charge pending regulatory approval and implementation of additional risk mitigation strategies worldwide, including a vacuum canister and internal sealing upgrade program and a deep disinfection service. This loaner program is available on a global basis. We anticipate that this program will continue until we are able to address customer needs through a broader solution that includes implementation of the risk mitigation strategies described above. We are currently implementing the vacuum and sealing upgrade program in as many countries as possible until all devices are upgraded. On October 11, 2018, after review of information provided by us, the FDA concluded that we could commence the vacuum and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;sealing upgrade program in the U.S., and on February 25, 2020, LivaNova received clearance for K191402, a 510(k) for the 3T devices that addressed issues contained in the 2015 Warning Letter along with design changes that further mitigate the potential risk of aerosolization. Furthermore, we continue to offer a no-charge deep disinfection service (deep cleaning service) for 3T device users as we receive the required regulatory approvals. The deep disinfection service was rolled out in Europe in the second half of 2015, and on April 12, 2018, the FDA agreed to allow us to move forward with the deep cleaning service in the U.S. thereby adding to the growing list of countries around the world in which we offer this service. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;On December&#160;31, 2016, we recognized a liability for our product remediation plan related to our 3T device. We concluded that it was probable that a liability had been incurred upon management&#x2019;s approval of the plan and the commitments made by management to various regulatory authorities globally in November and December 2016, and furthermore, the cost associated with the plan was reasonably estimable. At September&#160;30, 2020, the product remediation liability was $1.7 million. Refer to &#x201c;Note 5. Product Remediation Liability&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%"&gt;Product Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The Company is currently involved in litigation involving our 3T device. The litigation includes a class action complaint in the U.S. District Court for the Middle District of Pennsylvania, federal multi-district litigation in the U.S. District Court for the Middle District of Pennsylvania, various U.S. state court cases and cases in jurisdictions outside the U.S. The class action, filed in February 2016, consists of all Pennsylvania residents who underwent open heart surgery at WellSpan York Hospital and Penn State Milton S. Hershey Medical Center between 2011 and 2015 and who currently are asymptomatic for NTM infection.&#160;Members of the class seek declaratory relief that the 3T devices are defective and unsafe for intended uses, medical monitoring, damages, and attorneys&#x2019; fees.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;On March 29, 2019, we announced a settlement framework that provides for a comprehensive resolution of the personal injury cases pending in the multi-district litigation in U.S. federal court, the related class action pending in federal court, as well as certain cases in state courts across the United States. The agreement, which makes no admission of liability, is subject to certain conditions, including acceptance of the settlement by individual claimants and provides for a total payment of up to $225 million to resolve the claims covered by the settlement. Per the agreed-upon terms, the first payment of $135 million was paid into a qualified settlement fund in July 2019 and the second payment of $90 million was paid in January 2020. Cases covered by the settlement are being dismissed as amounts are disbursed to individual plaintiffs from the qualified settlement fund.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Cases in state courts in the U.S. and in jurisdictions outside the U.S. continue to progress. As of October&#160;29, 2020, including the cases encompassed in the settlement framework described above that have not yet been dismissed, we are aware of approximately 85&#160;filed and unfiled claims worldwide, with the majority of the claims in various federal or state courts throughout the United States. This includes cases that have settled but have not yet been dismissed. The complaints generally seek damages and other relief based on theories of strict liability, negligence, breach of express and implied warranties, failure to warn, design and manufacturing defect, fraudulent and negligent misrepresentation or concealment, unjust enrichment, and violations of various state consumer protection statutes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;At September&#160;30, 2020, the provision for these matters was $46.3 million. While the amount accrued represents our best estimate, the actual liability for resolution of these matters may vary from our estimate. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The changes in the litigation provision liability during the nine months ended September 30, 2020 are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.375%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Litigation Provision Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total litigation provision liability at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total litigation provision liability at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion of litigation liability at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion of litigation provision liability at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%"&gt;Environmental Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Our subsidiary, Sorin S.p.A. (&#x201c;Sorin&#x201d;) was created as a result of a spin-off (the &#x201c;Sorin spin-off&#x201d;) from SNIA S.p.A. (&#x201c;SNIA&#x201d;) in January 2004. SNIA subsequently became insolvent and the Italian Ministry of the Environment and the Protection of Land and Sea (the &#x201c;Italian Ministry of the Environment&#x201d;), sought compensation from SNIA for remediation costs relating to the environmental damage at chemical sites previously operated by SNIA&#x2019;s other subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;In September 2011 and July 2014, the Bankruptcy Court of Udine and the Bankruptcy Court of Milan, respectively, held (in proceedings to which we are not parties) that the Italian Ministry of the Environment and other Italian government agencies (the &#x201c;Public Administrations&#x201d;) were not creditors of either SNIA or its subsidiaries in connection with their claims in the Italian insolvency proceedings. The Public Administrations appealed and in January 2016, the Court of Udine rejected the appeal. The Public Administrations has appealed that decision to the Supreme Court. Meanwhile, the Bankruptcy Court of Milan&#x2019;s decision has been appealed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;In January 2012, SNIA filed a civil action against Sorin in the Civil Court of Milan asserting joint liability of a parent and a spun-off company. The Public Administrations intervened in the proceeding, with a claim for environmental damages of approximately $4 billion. On April 1, 2016, the Court of Milan dismissed all legal actions of SNIA and of the Public Administrations further requiring the Public Administrations to pay Sorin approximately &#x20ac;292,000&#160;(approximately $342,000 as of September&#160;30, 2020)&#160;for legal fees. The Public Administrations appealed the 2016 Decision to the Court of Appeal of Milan, and on March 5, 2019, the Court of Appeal issued a partial decision on the merits declaring Sorin/LivaNova jointly liable with SNIA for SNIA&#x2019;s environmental liabilities in an amount up to the fair value of the net worth received by Sorin because of the Sorin spin-off, an estimated &#x20ac;572.1 million&#160;(approximately $669.1 million as of September&#160;30, 2020). Additionally the Court issued a separate order, staying the proceeding until a panel of three experts can assess the environmental damages, the costs of clean-up, and the costs that the Public Administrations has already borne for the clean-up of the sites to allow the Court to decide on the second claim of the Public Administration against LivaNova, (i.e., to refund the Public Administrations for the SNIA environmental liabilities). Both LivaNova and the Public Administrations have appealed the decision to the Italian Supreme Court (Corte di Cassazione). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;We have not recognized an expense in connection with this matter because any potential loss is not currently probable or reasonably estimable. In addition, we cannot reasonably estimate a range of potential loss, if any, that may result from this matter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%"&gt;Patent Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;On May 11, 2018, Neuro and Cardiac Technologies LLC (&#x201c;NCT&#x201d;), a non-practicing entity, filed a complaint in the United States District Court for the Southern District of Texas asserting that the VNS Therapy System, when used with the SenTiva Model 1000 generator, infringes the claims of U.S. Patent No. 7,076,307 owned by NCT. The complaint requests damages that include a royalty, costs, interest, and attorneys&#x2019; fees. On September 13, 2018, we petitioned the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office (the &#x201c;Patent Office&#x201d;) for an &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%"&gt;inter partes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;review (&#x201c;IPR&#x201d;) of the validity of the &#x2018;307 patent, and on May 18, 2020, the Patent Office issued a Final Written Decision determining that all challenged claims are unpatentable. NCT is appealing the Final Written Decision. On March 24, 2020, we were granted our request for an &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%"&gt;ex parte &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;reexamination of the &#x2018;307 patent, and in August, the Patent Office issued a Non-Final Rejection of all of the &#x2018;307 claims. The Court has stayed the litigation pending the outcome of the IPR appeal proceeding. We have not recognized an expense in connection with this matter because any potential loss is not currently probable or reasonably estimable. In addition, we cannot reasonably estimate a range of potential loss, if any, that may result from this matter. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%"&gt;Contract Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;On November 25, 2019, LivaNova received notice of a lawsuit initiated by former members of Caisson Interventional, LLC (&#x201c;Caisson&#x201d;), a subsidiary of the Company acquired in 2017. The lawsuit, Todd J. Mortier, as Member Representative of the former Members of Caisson Interventional, LLC v. LivaNova USA, Inc., is currently pending in the United States District Court for the District of Minnesota. The complaint alleges (i) breach of contract, (ii) breach of the covenant of good faith and fair dealing and (iii) unjust enrichment in connection with the Company&#x2019;s operation of Caisson&#x2019;s Transcatheter Mitral Valve Replacement (&#x201c;TMVR&#x201d;) program and the Company&#x2019;s November 20, 2019 announcement that it was ending the TMVR program at the end of 2019. The lawsuit seeks damages arising out of the 2017 acquisition agreement, including various regulatory milestone payments. We intend to vigorously defend this claim. The Company has not recognized an expense related to this matter because any potential loss is not currently probable or reasonably estimable. In addition, we cannot reasonably estimate a range of potential loss, if any, that may result from this matter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%"&gt;Tax Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;In a tax audit report received on October 30, 2009, the Regional Internal Revenue Office of Lombardy (the &#x201c;Internal Revenue Office&#x201d;) informed Sorin Group Italia S.r.l. that, among several issues, it was disallowing in part a tax-deductible write down of the investment in the U.S. company, Cobe Cardiovascular Inc., which Sorin Group Italia S.r.l. recognized in 2002 and deducted in five equal installments, beginning in 2002. In December 2009, the Internal Revenue Office issued notices of assessment for 2004. In December 2010 and October 2011, the Internal Revenue Office issued notices of assessment for 2005 and 2006, respectively. We challenged all three notices of assessment (for 2004, 2005 and 2006) before the relevant Provincial Tax Courts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The total amount of losses in dispute was &#x20ac;62.6 million (approximately $73.2 million as of September&#160;30, 2020). On May 31, 2019, we filed an application to settle the litigation according to law N. 136/2018 and paid the required settlement balance of &#x20ac;1.9 million. As per law N. 136/2018, the Italian Revenue Agency reviewed the settlement and accepted the application by default on July 31, 2020. We recognized a benefit of &#x20ac;5.4&#160;million, approximately $6.5&#160;million, during the third quarter of 2020 as compared to the previously recognized reserve for an uncertain tax position of &#x20ac;15.5 million. The difference of &#x20ac;10.1&#160;million (approximately $11.8&#160;million as of September 30, 2020) was a fully valued deferred tax asset for net operating losses, the reversal of which does not impact the condensed consolidated statement of income (loss). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Other Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Additionally, we are the subject of various pending or threatened legal actions and proceedings that arise in the ordinary course of our business. These matters are subject to many uncertainties and outcomes that are not predictable and that may not be known for extended periods of time. Since the outcome of these matters cannot be predicted with certainty, the costs associated with them could have a material adverse effect on our consolidated net income, financial position or liquidity.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <livn:LossContingencyNumberofObservedNonConformities
      contextRef="i8e2eef5d48ff4b9bb6fe18d873c6d803_I20150827"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfNDMy_6a9e4f85-0c56-43c0-8377-28357d4f069d"
      unitRef="non-conformity">2</livn:LossContingencyNumberofObservedNonConformities>
    <livn:ProductRemediationNet
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfNjY5Mg_d40f0612-9717-4a4b-80dc-c22d60a30ed2"
      unitRef="usd">1700000</livn:ProductRemediationNet>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i9e7e31e16f08494b91383db437aa83e5_D20190329-20190329"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfODA2Mg_c4e690be-8c7f-4b55-92ef-81593fc77f61"
      unitRef="usd">225000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="ib86a229e06c94877bea66e161b156052_D20190701-20190731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfODE2Mg_7ca78688-d74b-41bc-b2b5-080f4827d3c9"
      unitRef="usd">135000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="ibc438c9935fb4d298a4744c265489040_D20200101-20200131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfODI0Ng_6070fcac-b885-4836-b671-212f1f8eb0e8"
      unitRef="usd">90000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i822d6a83e0f24f4e85072aba1aaa8ce1_I20201029"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfODY1Nw_3039faaa-17b6-4fcc-9acc-8fd688737984"
      unitRef="claim">85</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ia4743b9cbc8b413f864fd07a5e2fad89_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfOTI0Ng_a2610cee-c747-47e9-b710-189ffa419983"
      unitRef="usd">46300000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTg2MzE_117f8768-dd30-4654-932e-b7c189bf009f">&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The changes in the litigation provision liability during the nine months ended September 30, 2020 are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.375%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Litigation Provision Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total litigation provision liability at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FX and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total litigation provision liability at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion of litigation liability at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion of litigation provision liability at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ia92f7ea6fe5141b3a709c569c6f57200_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RhYmxlOmM5N2RkNzc3NDhhNTRiNGJhYjBkM2QxZWY3ZDdmMzFlL3RhYmxlcmFuZ2U6Yzk3ZGQ3Nzc0OGE1NGI0YmFiMGQzZDFlZjdkN2YzMWVfMS0yLTEtMS0w_f5f7898f-f692-4dc5-ad41-1314733e8add"
      unitRef="usd">170404000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i8dfb8d93c33740aab82c128a023695f0_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RhYmxlOmM5N2RkNzc3NDhhNTRiNGJhYjBkM2QxZWY3ZDdmMzFlL3RhYmxlcmFuZ2U6Yzk3ZGQ3Nzc0OGE1NGI0YmFiMGQzZDFlZjdkN2YzMWVfMi0yLTEtMS0w_8f29382b-1b32-4907-8edb-280188452e67"
      unitRef="usd">128128000</us-gaap:LossContingencyAccrualPayments>
    <livn:LossContingencyAccrualAdjustments
      contextRef="i8dfb8d93c33740aab82c128a023695f0_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RhYmxlOmM5N2RkNzc3NDhhNTRiNGJhYjBkM2QxZWY3ZDdmMzFlL3RhYmxlcmFuZ2U6Yzk3ZGQ3Nzc0OGE1NGI0YmFiMGQzZDFlZjdkN2YzMWVfMy0yLTEtMS0w_e2361859-fbfa-404b-9e27-523870c2e000"
      unitRef="usd">3970000</livn:LossContingencyAccrualAdjustments>
    <livn:LossContingencyAccrualForeignCurrencyAdjustmentsAndOther
      contextRef="i8dfb8d93c33740aab82c128a023695f0_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RhYmxlOmM5N2RkNzc3NDhhNTRiNGJhYjBkM2QxZWY3ZDdmMzFlL3RhYmxlcmFuZ2U6Yzk3ZGQ3Nzc0OGE1NGI0YmFiMGQzZDFlZjdkN2YzMWVfNC0yLTEtMS0w_6ce23769-0623-4e28-a8d4-8c6900674a45"
      unitRef="usd">54000</livn:LossContingencyAccrualForeignCurrencyAdjustmentsAndOther>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ia4743b9cbc8b413f864fd07a5e2fad89_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RhYmxlOmM5N2RkNzc3NDhhNTRiNGJhYjBkM2QxZWY3ZDdmMzFlL3RhYmxlcmFuZ2U6Yzk3ZGQ3Nzc0OGE1NGI0YmFiMGQzZDFlZjdkN2YzMWVfNS0yLTEtMS0w_194045fd-a8c0-4cb6-8496-c29d5c38d9d6"
      unitRef="usd">46300000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualCarryingValueCurrent
      contextRef="ia4743b9cbc8b413f864fd07a5e2fad89_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RhYmxlOmM5N2RkNzc3NDhhNTRiNGJhYjBkM2QxZWY3ZDdmMzFlL3RhYmxlcmFuZ2U6Yzk3ZGQ3Nzc0OGE1NGI0YmFiMGQzZDFlZjdkN2YzMWVfNi0yLTEtMS0w_5561c814-9d5e-4bb9-8d58-73d2e0f5039a"
      unitRef="usd">34790000</us-gaap:LossContingencyAccrualCarryingValueCurrent>
    <us-gaap:LossContingencyAccrualCarryingValueNoncurrent
      contextRef="ia4743b9cbc8b413f864fd07a5e2fad89_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RhYmxlOmM5N2RkNzc3NDhhNTRiNGJhYjBkM2QxZWY3ZDdmMzFlL3RhYmxlcmFuZ2U6Yzk3ZGQ3Nzc0OGE1NGI0YmFiMGQzZDFlZjdkN2YzMWVfNy0yLTEtMS0w_fa8ca03a-22a1-4881-b7dc-f981c3b28b55"
      unitRef="usd">11510000</us-gaap:LossContingencyAccrualCarryingValueNoncurrent>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="id94164334ffb44b9adc73f1e3a4a759e_D20120101-20120131"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTA4NjI_c8790bb0-e641-464a-9e12-1a791e576e0c"
      unitRef="usd">4000000000</us-gaap:LossContingencyDamagesSoughtValue>
    <livn:ReimbursedLegalFees
      contextRef="i4922d7cf37464b6088c833375aa28ff9_D20160401-20160401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTEwNDU_663d522e-02e9-4edf-9df3-3924c6bd9017"
      unitRef="eur">292000</livn:ReimbursedLegalFees>
    <livn:ReimbursedLegalFees
      contextRef="ifd123abeb5064944877aad0f41f3b289_D20200930-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTEwNjM_63dbec7f-2e36-4648-b9cf-a8b24c9eaed7"
      unitRef="usd">342000</livn:ReimbursedLegalFees>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="id9108f299f5642e3ab27bd8eabbe0df9_I20190305"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTE0NjE_ca1dc4eb-3a71-4c39-ba3c-60dc94a62149"
      unitRef="eur">572100000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="if0767ecfc4434c7c8ba7c0a26e46ab4a_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTE0Nzk_36e15651-c073-4f3b-8757-a263d9651827"
      unitRef="usd">669100000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <livn:IncomeTaxExaminationNumberofInstallments
      contextRef="i42ece6a951c243ed95e1890dcca64a65_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTUyNjY_86493b10-9ba4-4350-a024-2fb51b1f6424"
      unitRef="installment">5</livn:IncomeTaxExaminationNumberofInstallments>
    <livn:LossContingencyNumberofAssessments
      contextRef="i42ece6a951c243ed95e1890dcca64a65_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTU1MzY_1b441153-f03a-4972-a103-8529fff3e84f"
      unitRef="notice">3</livn:LossContingencyNumberofAssessments>
    <livn:IncomeTaxExaminationOperatingLossesUnderDispute
      contextRef="i42ece6a951c243ed95e1890dcca64a65_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTcxMDk_c66bfc37-ecb0-45e6-a190-0c17da6875c1"
      unitRef="eur">62600000</livn:IncomeTaxExaminationOperatingLossesUnderDispute>
    <livn:IncomeTaxExaminationOperatingLossesUnderDispute
      contextRef="i42ece6a951c243ed95e1890dcca64a65_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTcxMjc_f08953b3-e3c0-487c-aca0-252e26853474"
      unitRef="usd">73200000</livn:IncomeTaxExaminationOperatingLossesUnderDispute>
    <livn:IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements
      contextRef="i2a8c70677248473d83cfc005358a6167_I20190531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTc2ODg_7b74060c-3e94-49c8-a6c3-38c872542913"
      unitRef="eur">1900000</livn:IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ieed6906313d54138b062d2f1a35a9599_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMzg0ODI5MDcxNzU1OA_d3a708c1-0027-4d30-8bf8-88c322498be4"
      unitRef="eur">5400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ieed6906313d54138b062d2f1a35a9599_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMzg0ODI5MDcxNzU3Mg_ee242bcc-1c4c-4521-932c-325adb549a1a"
      unitRef="usd">6500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="i774b2c58712345bab82956aa91ba877a_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMTY0OTI2NzQ2MTY4OQ_270c3534-88b7-49ae-a9ec-35bdd38f1237"
      unitRef="eur">15500000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i774b2c58712345bab82956aa91ba877a_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMzg0ODI5MDcxNzU4Ng_d6776982-eb8a-4269-85fe-ee67f3f46546"
      unitRef="eur">10100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i774b2c58712345bab82956aa91ba877a_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV82Ny9mcmFnOjkyODg3ZWE3ZTYwMDQ3MjZiYjdjY2IyOTE1YjYwY2M1L3RleHRyZWdpb246OTI4ODdlYTdlNjAwNDcyNmJiN2NjYjI5MTViNjBjYzVfMzg0ODI5MDcxNzYwMQ_10b1ee91-586e-4dc1-8544-d87f87dfa2cb"
      unitRef="usd">11800000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RleHRyZWdpb246ZjczNzE4ZTIyYzU0NDA5MDkyNDc2OTgxYzk1NjVhYWJfMzg0ODI5MDY5Nzc1MA_9f94000d-4e13-4f70-ae53-bc99aaa01ee8">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Note 11. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The tables below present the condensed consolidated statement of stockholders&#x2019; equity as of and for the three and nine months ended September 30, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ordinary Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ordinary Shares - Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additional Paid-In Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Stockholders' Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,089)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(457,804)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,333,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,758,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,053)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472,576)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,717,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(295,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,483,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,725,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(263,525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ordinary Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ordinary Shares - Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additional Paid-In Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Stockholders' Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,734,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(406,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,383,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMi0wLTEtMS0wL3RleHRyZWdpb246NzBlNmI4NTFhNzBkNDhmYTgzNmM5ZmZkOGQwOTVkZGZfMTY_2f7bdef0-ddd7-4bfa-ad80-21e764af2e97"&gt;ASU No. 2016-13&lt;/span&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,758,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,053)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472,576)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(251,579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,503,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,725,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(263,525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Refer to &#x201c;Note 17. New Accounting Pronouncements&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The table below presents the change in each component of AOCI, net of tax, and the reclassifications out of AOCI into net income for the nine months ended September 30, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in Unrealized Gain (Loss) on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments Gain (Loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of loss from accumulated other comprehensive loss, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of loss from accumulated other comprehensive loss, after tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(944)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,919)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of gain from accumulated other comprehensive loss, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of gain from accumulated other comprehensive loss, after tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive loss, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Taxes are not provided for foreign currency translation adjustments as translation adjustments are related to earnings that are intended to be reinvested in the countries where earned.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RleHRyZWdpb246ZjczNzE4ZTIyYzU0NDA5MDkyNDc2OTgxYzk1NjVhYWJfMzg0ODI5MDY5Nzc0OQ_e91b4799-2ecc-4687-b1b2-79bc1e25b33b">&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The tables below present the condensed consolidated statement of stockholders&#x2019; equity as of and for the three and nine months ended September 30, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ordinary Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ordinary Shares - Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additional Paid-In Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Stockholders' Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,089)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(457,804)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,333,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,758,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,053)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472,576)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,717,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(295,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,483,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,725,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(263,525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ordinary Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ordinary Shares - Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additional Paid-In Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Stockholders' Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,734,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(406,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,383,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMi0wLTEtMS0wL3RleHRyZWdpb246NzBlNmI4NTFhNzBkNDhmYTgzNmM5ZmZkOGQwOTVkZGZfMTY_2f7bdef0-ddd7-4bfa-ad80-21e764af2e97"&gt;ASU No. 2016-13&lt;/span&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,758,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,053)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472,576)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(251,579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,503,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,725,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(263,525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Refer to &#x201c;Note 17. New Accounting Pronouncements&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:CommonStockSharesIssued
      contextRef="i2f8533c39b7f41078d1b3a8bcc766b96_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMS0yLTEtMS0w_d25cee26-cbb8-41f9-bbfa-f0d37df666ab"
      unitRef="shares">49476000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i2f8533c39b7f41078d1b3a8bcc766b96_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMS00LTEtMS0w_c60dcd58-60d8-42ae-a4e4-56654703f9e7"
      unitRef="usd">76338000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1478be27f8e34765a887baf8c6538b31_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMS02LTEtMS0w_53fa02f0-b944-4a6f-b87b-e87dd1d68767"
      unitRef="usd">1750798000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5443a67444ea416485c37b991988f6fb_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMS04LTEtMS0w_b10cbc57-6e2d-440b-a1da-39c1f58d8e1d"
      unitRef="usd">-1057000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id34d4656788a44fd81611969a787b29b_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMS0xMC0xLTEtMA_9fae0e6d-2748-4c8f-97b0-c982980af419"
      unitRef="usd">-35089000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie93c1f60108b48a3a6733d851a357ebe_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMS0xMi0xLTEtMA_f996f700-066a-4829-ab75-9d54caf86d97"
      unitRef="usd">-457804000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1b57b2b83dd54d149c591d8fbbb18813_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMS0xNC0xLTEtMA_ebf2235a-25ea-4a12-b170-498e2095c136"
      unitRef="usd">1333186000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i772e55ea562149ffb5fc638d38caf1ad_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMi02LTEtMS0w_d9e6d363-da7b-42a8-a4bb-cd7163838591"
      unitRef="usd">7670000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iae4dac957e404f989a0f0e8abd6471a0_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMi04LTEtMS0w_4914396a-8f01-49c9-b154-b2977e7c4d5a"
      unitRef="usd">4000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMi0xNC0xLTEtMA_bc05ab71-2334-412e-90ec-c934d9cd233e"
      unitRef="usd">7674000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMy0yLTEtMS0zMTA2_cdc77a8e-8e41-410c-8872-049b3aeb4223"
      unitRef="shares">73000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:NetIncomeLoss
      contextRef="if9a83943fc464403a7d5089f8b33a871_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMy0xMi0xLTEtMA_35eeaa63-a262-4263-93d3-20a78aec9a57"
      unitRef="usd">-14772000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMy0xNC0xLTEtMA_f11ca183-d5fc-4baf-b66a-6dcab609abf0"
      unitRef="usd">-14772000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i11762dbaa1ed49eb94d45dbf0e1eca9d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNC0xMC0xLTEtMA_61276178-b5d6-4f16-8643-04b3cf1ecef6"
      unitRef="usd">24704000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNC0xNC0xLTEtMA_9da9629f-befd-48c2-950c-f378b253f299"
      unitRef="usd">24704000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesIssued
      contextRef="i7c3477a39b584e26aca4ae04d6bcdc27_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNS0yLTEtMS0w_0d3eef56-f9f7-4bfd-8540-4b6ff7f8af98"
      unitRef="shares">49403000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i7c3477a39b584e26aca4ae04d6bcdc27_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNS00LTEtMS0w_00db5d6d-c229-44fd-937a-5bedd95f121d"
      unitRef="usd">76338000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i67841b9ab95c44768c3ad97a56b3bfa8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNS02LTEtMS0w_6e691833-6c55-49b2-90eb-d7af6c49dbd5"
      unitRef="usd">1758468000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifdffa7f2634f4108a1118eab5e5b8ac5_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNS04LTEtMS0w_c0d8995e-9caf-40f1-accf-f713ad2fed04"
      unitRef="usd">-1053000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i42ea28428d684a9cacaefaa3e6dd1b9e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNS0xMC0xLTEtMA_4d296f50-933c-4087-b122-7335e4e72a5b"
      unitRef="usd">-10385000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifbbfbf1476804a928a5c7aef5fa053f0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNS0xMi0xLTEtMA_a0a3fb86-723a-41e0-a9c2-4a160e73f7ae"
      unitRef="usd">-472576000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNS0xNC0xLTEtMA_1da25a1e-795a-4607-b592-c9cb6f2e691f"
      unitRef="usd">1350792000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i646772a5bff64501b5ff80d29c70951d_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNy0yLTEtMS0w_2170aaab-a58a-4d9e-8673-e8967b91fabb"
      unitRef="shares">49380000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i646772a5bff64501b5ff80d29c70951d_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNy00LTEtMS0w_d3ee6693-e630-4258-ae46-5e8e94b9b8fa"
      unitRef="usd">76217000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0ee5111b458142f6a8d38873421f58fc_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNy02LTEtMS0w_0a57f10b-45b5-448f-8928-3d3eba4c2c63"
      unitRef="usd">1717220000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i901bf76852a3483e827718cf605968da_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNy04LTEtMS0w_ce577cd2-694f-4626-ac25-acb5f045cb73"
      unitRef="usd">-1292000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i37e2013ed189474aab9c13d2000c9cc9_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNy0xMC0xLTEtMA_0ad8ac53-ee28-4119-9149-849197b26221"
      unitRef="usd">-13174000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6767353b5d7549d18ff983e40ed7a527_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNy0xMi0xLTEtMA_7d20c004-1396-4133-b45f-10ee0cb6e2fe"
      unitRef="usd">-295643000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia64252b3f99d4b618cfb4816f6ff303e_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfNy0xNC0xLTEtMA_6abd7d6e-5e96-46f7-b237-3ecc1997730b"
      unitRef="usd">1483328000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i81d68c28a9ae4f16b06014531f6d4332_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfOC0yLTEtMS0w_f7b24591-9a97-440d-9e9e-09ced8df005b"
      unitRef="shares">1000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i71221703b9ac4249a6c037f96c6fd8a2_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfOC02LTEtMS0w_00972052-9ad3-4858-971b-fec70fdf149b"
      unitRef="usd">8262000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3f027e9798fa4ca0934d00d9bb263410_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfOC04LTEtMS0w_37801cfc-0f7b-45b5-bf61-365957984a3a"
      unitRef="usd">10000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfOC0xNC0xLTEtMA_d3f21435-8817-454d-8e2f-41ce77064fb1"
      unitRef="usd">8272000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="i5c602e5b577142efafee2537813d0b56_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfOS0xMi0xLTEtMA_95346789-0d8b-4b5b-9b46-3f61b2b47f9a"
      unitRef="usd">32118000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfOS0xNC0xLTEtMA_347b4df9-533c-4b49-9ae9-8b338741ba9a"
      unitRef="usd">32118000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ibe68740e4f2a4fd1984ecc22362196b1_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTAtMTAtMS0xLTA_f07f1f32-eb19-4678-982c-0cfe457c6c6f"
      unitRef="usd">-28436000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTAtMTQtMS0xLTA_5deb0b44-f794-4d3d-ba8c-bcb596fe064b"
      unitRef="usd">-28436000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesIssued
      contextRef="i3cbb04514b7b4f2dbc2888e6954040c0_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtMi0xLTEtMA_1b1522c0-4b81-4efa-a30c-b65773e80003"
      unitRef="shares">49381000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i3cbb04514b7b4f2dbc2888e6954040c0_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtMi0xLTEtMA_99dacb3f-480b-49df-8ec7-79611001f8fc"
      unitRef="shares">49381000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i3cbb04514b7b4f2dbc2888e6954040c0_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtNC0xLTEtMA_8509de0f-e71d-4afb-ba42-169086efd624"
      unitRef="usd">76217000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3cbb04514b7b4f2dbc2888e6954040c0_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtNC0xLTEtMA_fbdc6e9d-825d-4d8f-bad9-671428a6e376"
      unitRef="usd">76217000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5ea24a03159448d282159becae6e7f97_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtNi0xLTEtMA_b95f88a4-4f2d-4b66-aef3-d1f9351fc3e1"
      unitRef="usd">1725482000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5ea24a03159448d282159becae6e7f97_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtNi0xLTEtMA_e7f5de5e-8acb-4a01-b3b0-b54355244bda"
      unitRef="usd">1725482000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic2b13270d7694a2899d0fd79a80d5739_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtOC0xLTEtMA_b42437a8-578e-4e43-b67c-c608419e0f6c"
      unitRef="usd">-1282000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic2b13270d7694a2899d0fd79a80d5739_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtOC0xLTEtMA_bbda78e6-b068-49dc-884c-058edece54fd"
      unitRef="usd">-1282000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idd4e32d70c90404db0418fec4b835d7a_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtMTAtMS0xLTA_850bf423-ada2-436c-863f-ddc109827f94"
      unitRef="usd">-41610000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idd4e32d70c90404db0418fec4b835d7a_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtMTAtMS0xLTA_f83c9a1f-160d-444a-903e-ae3ea500756e"
      unitRef="usd">-41610000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief427b70c02847b5b1c5f0f93bfab969_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtMTItMS0xLTA_70d3641a-9681-480e-9c87-aca19ecf2dad"
      unitRef="usd">-263525000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief427b70c02847b5b1c5f0f93bfab969_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtMTItMS0xLTA_fac56d3b-f80d-4622-9496-68530fbaba82"
      unitRef="usd">-263525000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7cb9957d3e1b407bb88290f6a94e712e_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtMTQtMS0xLTA_a40a891a-d8f7-4aa7-ad57-ac3bbc35971b"
      unitRef="usd">1495282000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7cb9957d3e1b407bb88290f6a94e712e_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOjI4YjFjODM3N2JkYzQ3Y2I4MTNmMDdkNGFiMTNjYjgxL3RhYmxlcmFuZ2U6MjhiMWM4Mzc3YmRjNDdjYjgxM2YwN2Q0YWIxM2NiODFfMTEtMTQtMS0xLTA_f45e8ac1-be3f-4a64-b628-18af37aa54ab"
      unitRef="usd">1495282000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="icdff871ce34c40e09563d35dccbeece4_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMS0yLTEtMS0w_d6a77f9a-ccf7-4e2e-87ba-97e4b6ff48c5"
      unitRef="shares">49411000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="icdff871ce34c40e09563d35dccbeece4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMS00LTEtMS0w_82d7236f-5553-4d71-8127-60b10c77dd02"
      unitRef="usd">76257000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3f92e675a9a74c8ebf70114e14995425_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMS02LTEtMS0w_af15cf12-bf70-45e8-b825-cab655e8bb3b"
      unitRef="usd">1734870000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9f678b8291d0499489325ab4fb979196_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMS04LTEtMS0w_6f1073bf-7146-49df-abe6-c25e57ca315a"
      unitRef="usd">-1263000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i14244109275c4b71acdb26ad86c70caa_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMS0xMC0xLTEtMA_b341b772-1e50-4653-a31a-0519af3a4ee7"
      unitRef="usd">-19392000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8fc22053772446cd9092b2ea318f9022_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMS0xMi0xLTEtMA_437ce250-1282-41c9-a6a5-8448c5fb282b"
      unitRef="usd">-406755000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMS0xNC0xLTEtMA_8c9fbaf8-ee95-4e41-94d6-cf2b2d036fc0"
      unitRef="usd">1383717000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibeb25415374f4786a2efe54934478bee_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMi0xMi0xLTEtMA_9947b64a-bd48-4812-b219-629174bd84fa"
      unitRef="usd">-639000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i602472901bc5472da9591b20d9734683_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMi0xNC0xLTEtMA_b7eea104-96da-4bad-81a6-585faa7f295f"
      unitRef="usd">-639000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia2e3b203d4b44ef49fe6a6a87e78b48a_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMy0yLTEtMS0w_c4753247-cbd4-4468-a7d6-cca27f0e0e2d"
      unitRef="shares">65000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia2e3b203d4b44ef49fe6a6a87e78b48a_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMy00LTEtMS0w_ed2d4f33-7e43-49b3-82c2-4caefbae5314"
      unitRef="usd">81000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8ed16dbbc5fd4b1285afa69aff2e6594_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMy02LTEtMS0w_2eb5cadd-c92a-48a6-b0b8-9dbb3e1e8707"
      unitRef="usd">23598000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i84001a93f52c4e74984ff02516c7b75c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMy04LTEtMS0w_6e55e8ce-6353-4d5b-bfa4-2620622eec76"
      unitRef="usd">210000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMy0xNC0xLTEtMA_f9136b04-bb06-40bd-b511-1eb2cf2ef12d"
      unitRef="usd">23889000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNC0yLTEtMS0zMTA4_974dab07-9b8b-41f4-8704-9a39c3fbe459"
      unitRef="shares">73000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:NetIncomeLoss
      contextRef="iecd6db286ef0474c8967169d3455a2e9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNC0xMi0xLTEtMA_ed424ac7-8ac6-4bbf-a14f-af53b8a4caa4"
      unitRef="usd">-65182000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNC0xNC0xLTEtMA_5122dbf3-8bae-4ce0-8a1e-20945af40244"
      unitRef="usd">-65182000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i357c72c25b924030994b1bf08eb695cb_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNS0xMC0xLTEtMA_1d096099-f89e-4a19-abe5-7ca9435fafaa"
      unitRef="usd">9007000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNS0xNC0xLTEtMA_ccbb2ff5-4b4b-4d83-b0ed-0e9d669d040e"
      unitRef="usd">9007000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesIssued
      contextRef="i7c3477a39b584e26aca4ae04d6bcdc27_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNi0yLTEtMS0w_0d3eef56-f9f7-4bfd-8540-4b6ff7f8af98"
      unitRef="shares">49403000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i7c3477a39b584e26aca4ae04d6bcdc27_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNi00LTEtMS0w_00db5d6d-c229-44fd-937a-5bedd95f121d"
      unitRef="usd">76338000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i67841b9ab95c44768c3ad97a56b3bfa8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNi02LTEtMS0w_6e691833-6c55-49b2-90eb-d7af6c49dbd5"
      unitRef="usd">1758468000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifdffa7f2634f4108a1118eab5e5b8ac5_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNi04LTEtMS0w_c0d8995e-9caf-40f1-accf-f713ad2fed04"
      unitRef="usd">-1053000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i42ea28428d684a9cacaefaa3e6dd1b9e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNi0xMC0xLTEtMA_4d296f50-933c-4087-b122-7335e4e72a5b"
      unitRef="usd">-10385000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifbbfbf1476804a928a5c7aef5fa053f0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNi0xMi0xLTEtMA_a0a3fb86-723a-41e0-a9c2-4a160e73f7ae"
      unitRef="usd">-472576000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfNi0xNC0xLTEtMA_a8075a64-93c3-4b3f-a609-4df30586264d"
      unitRef="usd">1350792000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i11b5dc862856494ba736bb256c91320d_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOC0yLTEtMS0w_2c5d9c7e-a8cd-43c6-ab65-ec1c285f0195"
      unitRef="shares">49323000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i11b5dc862856494ba736bb256c91320d_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOC00LTEtMS0w_69dc1a22-5a10-4fba-9db3-78c187f846be"
      unitRef="usd">76144000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3b2edf297198406494036b93de529988_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOC02LTEtMS0w_3fe2017c-64fa-4bb2-bc69-d36be392af17"
      unitRef="usd">1705111000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5433f056524a44659bef554cefff1704_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOC04LTEtMS0w_b0f8f76f-a1f8-4575-8735-69164f3c623e"
      unitRef="usd">-1462000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia85d1e0c436c415abf0ffabd07459791_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOC0xMC0xLTEtMA_690fbc57-de5c-4556-9aba-be1ea7ba974f"
      unitRef="usd">-24476000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5223aa7b849840fb8494719b938ff2b2_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOC0xMi0xLTEtMA_b5718b0b-0295-49ad-bb5f-b9c0c170ba5c"
      unitRef="usd">-251579000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic94ddff991844d7bb182464410e337c2_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOC0xNC0xLTEtMA_63d72c61-a0b6-4ea2-b290-395ffea9b4b6"
      unitRef="usd">1503738000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia86697a40b714160b0bee988340e85a0_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOS0yLTEtMS0w_b65ba890-c4b2-422b-9ebc-f10f2c68eefa"
      unitRef="shares">58000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia86697a40b714160b0bee988340e85a0_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOS00LTEtMS0w_386ce3cf-2496-44c3-8fb6-e9551198ce35"
      unitRef="usd">73000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie10c500eacef4aaf8fc597afbc3d45b5_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOS02LTEtMS0w_bfde20e2-b0b7-4dc7-8179-a15aa9844a3a"
      unitRef="usd">20371000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3d1519f3a2b54a76abca9ca793ca5b66_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOS04LTEtMS0w_1e2626da-6277-43b4-8363-f6cc02b5957d"
      unitRef="usd">180000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfOS0xNC0xLTEtMA_0ce1acc5-2cd3-4450-aa89-7cd3e55a179d"
      unitRef="usd">20624000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="i585b337eb45c4a659b1ee03c596606d8_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTAtMTItMS0xLTA_04e54b02-2d93-45a1-8582-650fa4588665"
      unitRef="usd">-11946000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTAtMTQtMS0xLTA_6b71d259-bed5-48fe-a590-afc953e912e9"
      unitRef="usd">-11946000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8bbc378fed9842a5b7a3214c4db31cbb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTEtMTAtMS0xLTA_3d228988-83a1-432d-84ab-8b12f7ccbb5e"
      unitRef="usd">-17134000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTEtMTQtMS0xLTA_46fc1af0-6296-4887-b0f1-7e0c40f676a3"
      unitRef="usd">-17134000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesIssued
      contextRef="i3cbb04514b7b4f2dbc2888e6954040c0_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItMi0xLTEtMA_1b1522c0-4b81-4efa-a30c-b65773e80003"
      unitRef="shares">49381000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i3cbb04514b7b4f2dbc2888e6954040c0_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItMi0xLTEtMA_99dacb3f-480b-49df-8ec7-79611001f8fc"
      unitRef="shares">49381000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i3cbb04514b7b4f2dbc2888e6954040c0_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItNC0xLTEtMA_8509de0f-e71d-4afb-ba42-169086efd624"
      unitRef="usd">76217000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3cbb04514b7b4f2dbc2888e6954040c0_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItNC0xLTEtMA_fbdc6e9d-825d-4d8f-bad9-671428a6e376"
      unitRef="usd">76217000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5ea24a03159448d282159becae6e7f97_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItNi0xLTEtMA_b95f88a4-4f2d-4b66-aef3-d1f9351fc3e1"
      unitRef="usd">1725482000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5ea24a03159448d282159becae6e7f97_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItNi0xLTEtMA_e7f5de5e-8acb-4a01-b3b0-b54355244bda"
      unitRef="usd">1725482000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic2b13270d7694a2899d0fd79a80d5739_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItOC0xLTEtMA_b42437a8-578e-4e43-b67c-c608419e0f6c"
      unitRef="usd">-1282000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic2b13270d7694a2899d0fd79a80d5739_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItOC0xLTEtMA_bbda78e6-b068-49dc-884c-058edece54fd"
      unitRef="usd">-1282000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idd4e32d70c90404db0418fec4b835d7a_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItMTAtMS0xLTA_850bf423-ada2-436c-863f-ddc109827f94"
      unitRef="usd">-41610000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idd4e32d70c90404db0418fec4b835d7a_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItMTAtMS0xLTA_f83c9a1f-160d-444a-903e-ae3ea500756e"
      unitRef="usd">-41610000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief427b70c02847b5b1c5f0f93bfab969_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItMTItMS0xLTA_70d3641a-9681-480e-9c87-aca19ecf2dad"
      unitRef="usd">-263525000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief427b70c02847b5b1c5f0f93bfab969_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItMTItMS0xLTA_fac56d3b-f80d-4622-9496-68530fbaba82"
      unitRef="usd">-263525000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7cb9957d3e1b407bb88290f6a94e712e_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItMTQtMS0xLTA_a40a891a-d8f7-4aa7-ad57-ac3bbc35971b"
      unitRef="usd">1495282000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7cb9957d3e1b407bb88290f6a94e712e_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMTItMTQtMS0xLTA_f45e8ac1-be3f-4a64-b628-18af37aa54ab"
      unitRef="usd">1495282000</us-gaap:StockholdersEquity>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RleHRyZWdpb246ZjczNzE4ZTIyYzU0NDA5MDkyNDc2OTgxYzk1NjVhYWJfNDgy_41ae2a59-e896-49bb-bade-fe8b61e64c24">&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The table below presents the change in each component of AOCI, net of tax, and the reclassifications out of AOCI into net income for the nine months ended September 30, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in Unrealized Gain (Loss) on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments Gain (Loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of loss from accumulated other comprehensive loss, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of loss from accumulated other comprehensive loss, after tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(944)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,919)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of gain from accumulated other comprehensive loss, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of gain from accumulated other comprehensive loss, after tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive loss, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Taxes are not provided for foreign currency translation adjustments as translation adjustments are related to earnings that are intended to be reinvested in the countries where earned.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i73b9ebabb9a742feaf7a7a83f366667e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMS0yLTEtMS0w_288c8e11-1ce8-4777-98eb-51bad7f23a67"
      unitRef="usd">513000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1125b67f1c85426d9cd1a530fb32d7b6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMS00LTEtMS0w_c0c9819f-b3da-48ee-a54e-36d575724014"
      unitRef="usd">-19905000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i14244109275c4b71acdb26ad86c70caa_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMS02LTEtMS0w_3cbebec2-3b4f-4f11-8e1f-71a3991e8844"
      unitRef="usd">-19392000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i2a275a7257a24e82a86ff4fa4e50516e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMi0yLTEtMS0w_472b380d-3235-46f8-9dd7-727034602932"
      unitRef="usd">632000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i98e7648a0a8345a3b1986dfb798ac9de_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMi00LTEtMS0w_419ba7b1-be1b-4c24-970a-c4ee84663772"
      unitRef="usd">8008000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMi02LTEtMS0w_92f5ef85-7206-4162-91f6-1467822b47a6"
      unitRef="usd">8640000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i2a275a7257a24e82a86ff4fa4e50516e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMy0yLTEtMS0w_e2910d67-c065-411d-8dae-383a3fdc3e81"
      unitRef="usd">152000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i98e7648a0a8345a3b1986dfb798ac9de_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMy00LTEtMS0w_70e15612-29e8-4291-a6da-b875e98982ff"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMy02LTEtMS0w_5f8e2082-54b7-475f-b138-813fbe577d9a"
      unitRef="usd">152000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i2a275a7257a24e82a86ff4fa4e50516e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNC0yLTEtMS0w_da2280ae-5e74-4469-b998-38f7db463d2d"
      unitRef="usd">480000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i98e7648a0a8345a3b1986dfb798ac9de_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNC00LTEtMS0w_662fc593-1cc6-406b-82bb-c475b5e69844"
      unitRef="usd">8008000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNC02LTEtMS0w_27975081-16e9-40e9-b6bc-ec8a03bc816d"
      unitRef="usd">8488000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i2a275a7257a24e82a86ff4fa4e50516e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNS0yLTEtMS0w_ddd3d131-0f81-4862-9ba9-b792a54bc844"
      unitRef="usd">-681000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i98e7648a0a8345a3b1986dfb798ac9de_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNS00LTEtMS0w_f723efbe-73f2-49d2-937d-64b43929686d"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNS02LTEtMS0w_9ddb44d4-b1f0-4c9c-b8b1-dd8398736bd7"
      unitRef="usd">-681000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i2a275a7257a24e82a86ff4fa4e50516e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNi0yLTEtMS0w_103348cc-63e2-4642-8fd3-597cf03c0060"
      unitRef="usd">-162000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i98e7648a0a8345a3b1986dfb798ac9de_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNi00LTEtMS0w_83d29c46-4fd2-4b69-a21d-8c750d43342c"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNi02LTEtMS0w_ac38472b-bfaa-4027-8550-c831dbbaf093"
      unitRef="usd">-162000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i2a275a7257a24e82a86ff4fa4e50516e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNy0yLTEtMS0w_48dee3ab-2215-42b1-a5e9-a2faffb941d0"
      unitRef="usd">-519000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i98e7648a0a8345a3b1986dfb798ac9de_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNy00LTEtMS0w_6dad24b9-b3d2-4c0b-a038-a4ce1be296c8"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfNy02LTEtMS0w_52f02571-2416-4fb7-a76d-37c842af5847"
      unitRef="usd">-519000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2a275a7257a24e82a86ff4fa4e50516e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfOC0yLTEtMS0w_4012e3b5-a80b-4733-9e85-7585faee3c48"
      unitRef="usd">999000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i98e7648a0a8345a3b1986dfb798ac9de_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfOC00LTEtMS0w_0e0b024d-c389-4fef-b3db-cdace581fad6"
      unitRef="usd">8008000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfOC02LTEtMS0w_63c4e44b-e73e-4424-b0ed-de284df166b8"
      unitRef="usd">9007000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="ie0977771516644bab2772f34d2437e3d_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfOS0yLTEtMS0w_cb83ef62-6339-407e-bddc-903a91f9a840"
      unitRef="usd">1512000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idd262b92e2af4f3f98cd4f5c03def298_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfOS00LTEtMS0w_157fc030-6b9c-4ec3-9b21-18f1792869bb"
      unitRef="usd">-11897000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i42ea28428d684a9cacaefaa3e6dd1b9e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfOS02LTEtMS0w_f4073d25-fbed-4a8b-bc33-4f12324c1560"
      unitRef="usd">-10385000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i28ed0d61b46b4daaa86046342354f4b2_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTEtMi0xLTEtMA_08d8aa04-813a-4dd0-9696-7503a47188fa"
      unitRef="usd">-944000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iefddf94f87084dd1ade6648ea605cf0c_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTEtNC0xLTEtMA_f9c1841c-1d39-474a-896b-352e9a547ce3"
      unitRef="usd">-23532000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia85d1e0c436c415abf0ffabd07459791_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTEtNi0xLTEtMA_3f3281a3-578e-4e46-921b-a99570c9d2bf"
      unitRef="usd">-24476000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i9b7762a5b5f04bec8a312789ceeb2bd4_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTItMi0xLTEtMA_e7071bce-bc65-4ec1-944a-75e7bb1d60ae"
      unitRef="usd">933000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i340d4173e28147f58686dee1587f9750_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTItNC0xLTEtMA_203b7f69-d655-44ba-8ef6-ce25a3a77fd5"
      unitRef="usd">-16628000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTItNi0xLTEtMA_61a1f1f6-4d7d-4b4b-8eb8-6f0f18296bd3"
      unitRef="usd">-15695000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i9b7762a5b5f04bec8a312789ceeb2bd4_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTMtMi0xLTEtMA_44cec627-a673-4295-b426-e597d0273721"
      unitRef="usd">224000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i340d4173e28147f58686dee1587f9750_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTMtNC0xLTEtMA_aeb332cd-1156-42cc-b41e-3bb0771234c4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTMtNi0xLTEtMA_6d714485-3d0e-44ef-a27c-1ee1e7f46035"
      unitRef="usd">224000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i9b7762a5b5f04bec8a312789ceeb2bd4_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTQtMi0xLTEtMA_865da662-cef5-4948-a347-efc82ec92867"
      unitRef="usd">709000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i340d4173e28147f58686dee1587f9750_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTQtNC0xLTEtMA_0483c96d-7839-4c98-a469-75b8406270f1"
      unitRef="usd">-16628000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTQtNi0xLTEtMA_95490a53-172a-4358-8ad6-0d2ee5120c3c"
      unitRef="usd">-15919000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i9b7762a5b5f04bec8a312789ceeb2bd4_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTUtMi0xLTEtMA_4509b5e9-ad88-4834-bda0-dec6fd7d7431"
      unitRef="usd">1598000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i340d4173e28147f58686dee1587f9750_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTUtNC0xLTEtMA_5850a18c-479d-49ab-8970-62e24fb76e78"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTUtNi0xLTEtMA_97fa1df4-dc28-4880-b030-68308f4f2704"
      unitRef="usd">1598000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i9b7762a5b5f04bec8a312789ceeb2bd4_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTYtMi0xLTEtMA_1d272633-5c7b-4c26-988c-246cdaa1c9a6"
      unitRef="usd">383000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i340d4173e28147f58686dee1587f9750_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTYtNC0xLTEtMA_d1be111f-0340-4612-90e5-5bb84ff38b39"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTYtNi0xLTEtMA_a9038b67-60d3-43d6-9361-855f33152d8d"
      unitRef="usd">383000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i9b7762a5b5f04bec8a312789ceeb2bd4_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTctMi0xLTEtMA_47bc25b8-68f9-4881-b0f0-6efbeabc7acb"
      unitRef="usd">1215000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i340d4173e28147f58686dee1587f9750_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTctNC0xLTEtMA_0115e5b9-43ea-4e5a-8979-8a6c467f5bce"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTctNi0xLTEtMA_d3585bc2-406d-4d9d-b0dc-4d0411aad6df"
      unitRef="usd">1215000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9b7762a5b5f04bec8a312789ceeb2bd4_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTgtMi0xLTEtMA_f37b6237-5592-44a6-aaf5-0c7ce0a16603"
      unitRef="usd">-506000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i340d4173e28147f58686dee1587f9750_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTgtNC0xLTEtMA_d6177efc-adf0-4148-a3d4-5597e8582850"
      unitRef="usd">-16628000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTgtNi0xLTEtMA_b5a7249b-8956-4128-bdab-a2d59d4ebcac"
      unitRef="usd">-17134000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="id48df069b0704c3581b5adc77e251cb0_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTktMi0xLTEtMA_69e65fef-10c2-4620-b99e-6e9d57f8deac"
      unitRef="usd">-1450000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4561e95c0c8449a78e98f5d3fc5b92c3_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTktNC0xLTEtMA_d327c17b-0539-46ca-b097-14e1615eff45"
      unitRef="usd">-40160000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idd4e32d70c90404db0418fec4b835d7a_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmVhNmViMDA0NzBmMjRmMDQ5MzEwYzRkOWZhYzkyYTVhL3RhYmxlcmFuZ2U6ZWE2ZWIwMDQ3MGYyNGYwNDkzMTBjNGQ5ZmFjOTJhNWFfMTktNi0xLTEtMA_1ff1cd72-b49e-4358-91fd-680840683095"
      unitRef="usd">-41610000</us-gaap:StockholdersEquity>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RleHRyZWdpb246MjhhODhlNzE4YmUzNDc0MWI5Yjk4YzYyNGQxZWZlZTRfMzg0ODI5MDY5ODI4OQ_04ad643f-49af-42d2-ba4a-a2382294da93">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Note 12. Stock-Based Incentive Plans &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Stock-based incentive plans compensation expense is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.918%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service-based restricted stock units (&#x201c;RSUs&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service-based stock appreciation rights (&#x201c;SARs&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market performance-based restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating performance-based restricted stock units &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(962)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee share purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;During the nine months ended September 30, 2020, we issued stock-based compensatory awards with terms approved by the Compensation Committee of our Board of Directors. The awards with service conditions generally vest ratably over four years, subject to forfeiture unless service conditions are met. Market performance-based awards cliff vest after three years subject to the rank of our total shareholder return for the three-year period ending December 31, 2022 relative to the total shareholder returns for a peer group of companies. Operating performance-based awards cliff vest after three years subject to the achievement of certain thresholds of cumulative adjusted free cash flow for the three year period ending December 31, 2022. Compensation expense related to awards granted during 2020 for the three and nine months ended September 30, 2020 was $3.3 million and $6.6 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Stock-based compensation agreements issued during the nine months ended September 30, 2020, representing potential shares and their weighted average grant date fair values by type follows (shares in thousands, fair value in dollars):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service-based SARs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service-based RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market performance-based RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating performance-based RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RleHRyZWdpb246MjhhODhlNzE4YmUzNDc0MWI5Yjk4YzYyNGQxZWZlZTRfMTAzOA_434c8c64-c65f-4555-a904-741fdc647ec8">&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Stock-based incentive plans compensation expense is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.918%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service-based restricted stock units (&#x201c;RSUs&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service-based stock appreciation rights (&#x201c;SARs&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market performance-based restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating performance-based restricted stock units &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(962)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee share purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Stock-based compensation agreements issued during the nine months ended September 30, 2020, representing potential shares and their weighted average grant date fair values by type follows (shares in thousands, fair value in dollars):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service-based SARs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service-based RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market performance-based RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating performance-based RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ief162d0a6831435c9c447ec4cb5cc4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfMi0yLTEtMS0w_54f79543-06a1-444b-839f-a16df74a2dc5"
      unitRef="usd">4410000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5acbf636460b4e198f468c31a3c1be2d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfMi00LTEtMS0w_c207bcfa-196f-4fe0-ab76-532cee420470"
      unitRef="usd">3583000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i225c9725da49473d854e8f083baa2603_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfMi02LTEtMS0w_a7fe8ab1-90a7-4dc1-9339-34797a238752"
      unitRef="usd">13139000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic23be7d8ac3c4b778a9d24d166906ab1_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfMi04LTEtMS0w_6ff6ce14-0355-4f62-a5b1-4d1ceae135f7"
      unitRef="usd">10428000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i546f2452d51d4bdc881efe5cc5c05a8d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfMy0yLTEtMS0w_911119e9-05c9-4db6-ad1c-31c03f56f12e"
      unitRef="usd">3211000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia56cee55c4cf43099b9e98160544d49b_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfMy00LTEtMS0w_13e1faf7-6bf9-46e7-b40f-29ba88b9abfa"
      unitRef="usd">2896000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6a0fca2fdff64694bb24e3e060fd6dc8_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfMy02LTEtMS0w_972cba88-ca43-4942-b668-be0fcde953f8"
      unitRef="usd">9185000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib638c02dde7843eab3f4573d6585314d_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfMy04LTEtMS0w_76c098e0-7e9a-4cdd-a7ce-166a38028ed8"
      unitRef="usd">7804000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i427900b1e7d84e50b571679ab1cabaad_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNC0yLTEtMS0w_387696d6-2073-421f-a729-cbfc2a673a59"
      unitRef="usd">814000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib7c014275f2d405ab23766c236149138_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNC00LTEtMS0w_8de0b4f4-c1b2-4bb7-9d3c-05c46aa97747"
      unitRef="usd">757000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i32d2a1a2778b49afb67fef2675c88931_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNC02LTEtMS0w_c11a7d4a-dc37-4d84-88ed-72b2139ef42f"
      unitRef="usd">2745000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0d8cecc1dece477e9a955468c571ae1e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNC04LTEtMS0w_7e45aa8e-4f97-4277-a9e5-374274ff1e24"
      unitRef="usd">2146000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i65ec3dbf2057421c8affe016c664ea78_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNS0yLTEtMS0w_9b49a016-110d-4ddb-80dd-b0f62aa55d88"
      unitRef="usd">-962000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i19cf82e1376d4f11840e7da277a74cd5_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNS00LTEtMS0w_1aee5019-1904-4a28-bb76-0f276385a55e"
      unitRef="usd">983000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2e416e9ef1f14ac2bc887e06f9aebbf6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNS02LTEtMS0w_f3d754fa-fd4d-49a8-8a7d-a509147d2c37"
      unitRef="usd">882000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0a670137ff2a451782f99f45ef40a8f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNS04LTEtMS0w_977c8b44-e296-45cb-a54d-af5c065c0c2c"
      unitRef="usd">2752000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7bb32345ef6842089919448a35175b29_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNi0yLTEtMS0w_cca2e767-2428-4f4c-8f0c-af93baa38369"
      unitRef="usd">337000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id526b3c20a2d42d5abba8504d3816294_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNi00LTEtMS0w_2be78324-1d86-41cb-af2a-36a3968aead3"
      unitRef="usd">312000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i97785f256ae3470b9f482c61dec5e68a_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNi02LTEtMS0w_9a6291cc-f644-4894-8552-83ede90ac1bf"
      unitRef="usd">894000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5d45641764344e17bb094a058ba9942c_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNi04LTEtMS0w_6bab5827-5418-46c6-ab24-43bbab510e87"
      unitRef="usd">997000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNy0yLTEtMS0w_c936c6fb-d16c-4d3b-964d-c8244cd34386"
      unitRef="usd">7810000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNy00LTEtMS0w_f4c9348b-a30d-404f-8e43-7c356f144e46"
      unitRef="usd">8531000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNy02LTEtMS0w_97196dbe-ce0a-4811-9745-9aea5fc486e7"
      unitRef="usd">26845000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmJlNzJkYzQ1OTE1NTRlZmM4M2IwOWI0MWM1NjcyYmMxL3RhYmxlcmFuZ2U6YmU3MmRjNDU5MTU1NGVmYzgzYjA5YjQxYzU2NzJiYzFfNy04LTEtMS0w_77a18c02-9419-43cd-a3ff-6e98815f19c8"
      unitRef="usd">24127000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RleHRyZWdpb246MjhhODhlNzE4YmUzNDc0MWI5Yjk4YzYyNGQxZWZlZTRfMjc3_7a4b828f-9545-4ee5-b13d-6a44bc818f36">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i32d2a1a2778b49afb67fef2675c88931_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RleHRyZWdpb246MjhhODhlNzE4YmUzNDc0MWI5Yjk4YzYyNGQxZWZlZTRfMzg3_00881ad7-3267-4b50-99cc-ccee96ae3bad">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i427900b1e7d84e50b571679ab1cabaad_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RleHRyZWdpb246MjhhODhlNzE4YmUzNDc0MWI5Yjk4YzYyNGQxZWZlZTRfMzg0ODI5MDY5ODI5NA_accc563f-edcc-4d6e-b476-efdf4cd6730a">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i2e416e9ef1f14ac2bc887e06f9aebbf6_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RleHRyZWdpb246MjhhODhlNzE4YmUzNDc0MWI5Yjk4YzYyNGQxZWZlZTRfNjE1_e8b94243-f4e7-4755-97c2-ce7cfda01607">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i2e416e9ef1f14ac2bc887e06f9aebbf6_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RleHRyZWdpb246MjhhODhlNzE4YmUzNDc0MWI5Yjk4YzYyNGQxZWZlZTRfMzg0ODI5MDY5ODI5NQ_d30d2fbe-ef34-4e57-a3c0-bd9ceff29ed8">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RleHRyZWdpb246MjhhODhlNzE4YmUzNDc0MWI5Yjk4YzYyNGQxZWZlZTRfODIw_8d935d2e-0af5-4885-8450-5f411493c10b"
      unitRef="usd">3300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RleHRyZWdpb246MjhhODhlNzE4YmUzNDc0MWI5Yjk4YzYyNGQxZWZlZTRfODI3_6954da3f-6989-491c-9fb6-618f357e4c29"
      unitRef="usd">6600000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i6a0fca2fdff64694bb24e3e060fd6dc8_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmZjMDI1OTRjODE1ZTRhMzFhM2I0YjYyNWRkMzE1YTI5L3RhYmxlcmFuZ2U6ZmMwMjU5NGM4MTVlNGEzMWEzYjRiNjI1ZGQzMTVhMjlfMi0yLTEtMS0w_89a7b730-cb09-4dfd-b5c4-1de00f0afb30"
      unitRef="shares">1133000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ic0dced88ae604075b207e4543f4c306f_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmZjMDI1OTRjODE1ZTRhMzFhM2I0YjYyNWRkMzE1YTI5L3RhYmxlcmFuZ2U6ZmMwMjU5NGM4MTVlNGEzMWEzYjRiNjI1ZGQzMTVhMjlfMi00LTEtMS0w_c9a2c31f-742f-427c-bdef-281ee39c862a"
      unitRef="usdPerShare">15.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i225c9725da49473d854e8f083baa2603_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmZjMDI1OTRjODE1ZTRhMzFhM2I0YjYyNWRkMzE1YTI5L3RhYmxlcmFuZ2U6ZmMwMjU5NGM4MTVlNGEzMWEzYjRiNjI1ZGQzMTVhMjlfMy0yLTEtMS0w_7015c605-a9bd-4ce0-b678-6df8eab499f1"
      unitRef="shares">599000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i92991d08bea7415da6b40d6cf2dfe885_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmZjMDI1OTRjODE1ZTRhMzFhM2I0YjYyNWRkMzE1YTI5L3RhYmxlcmFuZ2U6ZmMwMjU5NGM4MTVlNGEzMWEzYjRiNjI1ZGQzMTVhMjlfMy00LTEtMS0w_196c6c39-763b-49bc-931b-00b88b17888a"
      unitRef="usdPerShare">44.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i32d2a1a2778b49afb67fef2675c88931_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmZjMDI1OTRjODE1ZTRhMzFhM2I0YjYyNWRkMzE1YTI5L3RhYmxlcmFuZ2U6ZmMwMjU5NGM4MTVlNGEzMWEzYjRiNjI1ZGQzMTVhMjlfNC0yLTEtMS0w_9838889a-93f9-4ddc-afae-c0e12efaba92"
      unitRef="shares">93000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id411cf0d82944320a5787d8a7f2ebfe8_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmZjMDI1OTRjODE1ZTRhMzFhM2I0YjYyNWRkMzE1YTI5L3RhYmxlcmFuZ2U6ZmMwMjU5NGM4MTVlNGEzMWEzYjRiNjI1ZGQzMTVhMjlfNC00LTEtMS0w_e4284637-160c-4aaf-bb35-fdbfbc069522"
      unitRef="usdPerShare">39.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2e416e9ef1f14ac2bc887e06f9aebbf6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmZjMDI1OTRjODE1ZTRhMzFhM2I0YjYyNWRkMzE1YTI5L3RhYmxlcmFuZ2U6ZmMwMjU5NGM4MTVlNGEzMWEzYjRiNjI1ZGQzMTVhMjlfNS0yLTEtMS0w_5f955cc3-6d9d-4ded-8404-f38872a35af9"
      unitRef="shares">93000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="iaaa1e1cbda504307b64e2b6e1037f051_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83Ni9mcmFnOjI4YTg4ZTcxOGJlMzQ3NDFiOWI5OGM2MjRkMWVmZWU0L3RhYmxlOmZjMDI1OTRjODE1ZTRhMzFhM2I0YjYyNWRkMzE1YTI5L3RhYmxlcmFuZ2U6ZmMwMjU5NGM4MTVlNGEzMWEzYjRiNjI1ZGQzMTVhMjlfNS00LTEtMS0w_684cf472-9267-491b-8ea5-72fc148a91ba"
      unitRef="usdPerShare">43.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfMzg0ODI5MDcwMDA1OQ_b10e2826-6d61-42dd-846a-a52169deb1eb">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Note 13. Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Our effective income tax rate from continuing operations for the three and nine months ended September 30, 2020 was 21.3% and (37.9)% compared with (49.6)% and 65.9% for the three and nine months ended September 30, 2019, respectively. Our effective income tax rate fluctuates based on, among other factors, changes in pretax income in countries with varying statutory tax rates, changes in valuation allowances, changes in tax credits and incentives, and changes in unrecognized tax benefits associated with uncertain tax positions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We continually assess the realizability of our worldwide deferred tax asset and valuation allowance positions, and when the need arises, we establish or release valuation allowances accordingly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Compared with the three months ended September 30, 2019, the change in the effective tax rate for the three months ended September 30, 2020 was primarily attributable to a discrete tax benefit due to the release of the uncertain tax position upon the settlement of tax litigation in Italy offset by a valuation allowance for certain jurisdictions outside the U.S., as compared to a U.S. federal tax benefit from a return to provision reconciliation, partially offset by the establishment of a valuation allowance for a portion of the U.S. federal and state net operating losses during the three months ended September 30, 2019. We established valuation allowances as it is more likely than not that we will be unable to realize the related historical deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Compared with the nine months ended September 30, 2019, the change in the effective tax rate for the nine months ended September 30, 2020 was primarily attributable to a $42.4 million realized discrete tax benefit related to the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;) and the discrete tax benefit due to the release of the uncertain tax position upon the settlement of tax litigation in Italy offset by the establishment of a $74.5&#160;million valuation allowance for the U.K. and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;other jurisdictions outside the U.S., as compared to a release of uncertain tax positions and a U.S. federal tax benefit from a return to provision reconciliation, partly offset by the establishment of a valuation allowance for a portion of the U.S. federal and state net operating losses and attributes during the nine months ended September 30, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;We operate in multiple jurisdictions throughout the world, and our tax returns are periodically audited or subjected to review by tax authorities. As a result, there is an uncertainty in income taxes recognized in our financial statements. Tax benefits totaling $4.0&#160;million and $12.9 million were unrecognized as of September&#160;30, 2020 and December 31, 2019, respectively. It is reasonably possible that, within the next twelve months, due to the settlement of uncertain tax positions with various tax authorities and the expiration of statutes of limitations, unrecognized tax benefits could decrease by up to approximately $0.7 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;We monitor income tax developments in countries where we conduct business. On March 27, 2020, the U.S. enacted the CARES Act which provided for a 5-year loss carryback for losses incurred in 2018-2020. We recorded a discrete tax benefit of $42.4 million to account for the effect of the CARES Act during the nine months ended September 30, 2020. Further regulations and notices as well as state legislative changes addressing conformity to the CARES Act are still pending.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfNzI_98d93a35-3d46-4330-835b-90e517f91a2e"
      unitRef="number">0.213</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfNzk_9c20b4b2-988d-48da-aed5-d4873239029f"
      unitRef="number">-0.379</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfOTY_6f14bc8c-939c-4538-96c7-b2c53caaf17b"
      unitRef="number">-0.496</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfMTAz_f7d90111-bb0d-41f8-9980-75099c280d9b"
      unitRef="number">0.659</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <livn:IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfMTA4NQ_43bda678-f511-40b3-9ba2-70e621a321bc"
      unitRef="usd">-42400000</livn:IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct>
    <us-gaap:OperatingLossCarryforwardsValuationAllowance
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfMTIzMQ_add8992e-715e-4fce-89f4-5c9c42548b71"
      unitRef="usd">74500000</us-gaap:OperatingLossCarryforwardsValuationAllowance>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfMTA5OTUxMTYzMDYwMA_9f259c3c-6681-4875-8cd8-777089a96f45"
      unitRef="usd">4000000.0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfMTc4MQ_7187ece9-d822-416d-a608-fc4215a4fcdd"
      unitRef="usd">12900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfMjA3MQ_f054fd36-0bc5-4c9f-a6eb-495123387fd8"
      unitRef="usd">700000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <livn:IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83OS9mcmFnOmYwMzlmYWZjZWQyMzQ2ZTk4MWY3YTg5M2I2ZmE0ZjFmL3RleHRyZWdpb246ZjAzOWZhZmNlZDIzNDZlOTgxZjdhODkzYjZmYTRmMWZfMjMxNQ_43bda678-f511-40b3-9ba2-70e621a321bc"
      unitRef="usd">-42400000</livn:IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RleHRyZWdpb246OWU1ZmJhNzA1MzJmNDgwZmIzNzE4NDU3YTI4NDk5ZmZfMzg0ODI5MDY5NzY0NQ_07e7e20d-2ca0-4118-a3f0-869ab57c4346">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Note 14. Earnings Per Share &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Reconciliation of the shares used in the basic and diluted earnings per share computations for the three and nine months ended September 30, 2020 and 2019 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.187%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add effects of share-based compensation instruments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average&#160;shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Excluded from the computation of diluted earnings per share were stock options, SARs and restricted share units totaling 4.1 million and 1.4 million for the three months ended September 30, 2020 and 2019, respectively, and 4.2 million and 3.2 million for the nine months ended September 30, 2020 and 2019, respectively, because to include them would have been anti-dilutive under the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RleHRyZWdpb246OWU1ZmJhNzA1MzJmNDgwZmIzNzE4NDU3YTI4NDk5ZmZfNDA1_a36fd85c-f5e4-410f-951d-7525a343a9e3">&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Reconciliation of the shares used in the basic and diluted earnings per share computations for the three and nine months ended September 30, 2020 and 2019 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.187%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add effects of share-based compensation instruments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average&#160;shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Excluded from the computation of diluted earnings per share were stock options, SARs and restricted share units totaling 4.1 million and 1.4 million for the three months ended September 30, 2020 and 2019, respectively, and 4.2 million and 3.2 million for the nine months ended September 30, 2020 and 2019, respectively, because to include them would have been anti-dilutive under the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMi0yLTEtMS0xMzQ2_8b83dfc5-e8f9-4d2d-9324-a7adbf5df443"
      unitRef="shares">48652000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMi00LTEtMS03Mjc_20fa9c19-c84b-4422-b11f-45da877d668f"
      unitRef="shares">48395000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMi02LTEtMS0xMzUz_8f69c654-b31f-4bd4-9efd-d3354292b175"
      unitRef="shares">48582000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMi04LTEtMS03MzM_7a902816-50d9-4dca-9274-41d27987fe23"
      unitRef="shares">48329000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMy0yLTEtMS0xNDEz_ddd7a3c1-dde1-4162-8b77-5f8ba9b700b1"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMy00LTEtMS0xNDE1_c265c2eb-999e-4e65-ae44-291cf04333ce"
      unitRef="shares">425000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMy02LTEtMS0xNDE3_9788738c-d076-43c9-95f3-a17190134f60"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMy04LTEtMS0xNDE5_044b05f5-2967-444c-b884-2d875f7a6ea7"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMy04LTEtMS0xNDE5_1b208725-4024-456f-bd7a-d0ea2440b485"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMi0yLTEtMS0w_695ebc30-f835-4c22-b6b9-ff3854aeabed"
      unitRef="shares">48652000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMi00LTEtMS0w_8f204425-d664-4c9d-bd00-bf7bed9df27c"
      unitRef="shares">48820000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMi02LTEtMS0w_fcb76de2-6cfe-4388-b600-29cd23019bf1"
      unitRef="shares">48582000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RhYmxlOmJhOGE2YmNjMWFkNjQzZWE4YzkzMDk0MWQ5MGIzMDZkL3RhYmxlcmFuZ2U6YmE4YTZiY2MxYWQ2NDNlYThjOTMwOTQxZDkwYjMwNmRfMi04LTEtMS0w_71544a00-085a-4b2d-88ee-e2cb847924d4"
      unitRef="shares">48329000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9a0a4786b53a409786262fe990c43c5a_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RleHRyZWdpb246OWU1ZmJhNzA1MzJmNDgwZmIzNzE4NDU3YTI4NDk5ZmZfMjU4_0c8db8b8-9b7c-4a30-af72-046162b218b8"
      unitRef="shares">4100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i20801a9a959b4964abe3933a95ed2cae_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RleHRyZWdpb246OWU1ZmJhNzA1MzJmNDgwZmIzNzE4NDU3YTI4NDk5ZmZfMjY1_4983da09-d10a-44f0-9816-3f9fb6e58884"
      unitRef="shares">1400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i45c62bd5d99d4fce99db5761c61d6e17_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RleHRyZWdpb246OWU1ZmJhNzA1MzJmNDgwZmIzNzE4NDU3YTI4NDk5ZmZfMjkw_5e1f3ad0-b6bc-4a0d-9ef3-c4b669d12f82"
      unitRef="shares">4200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4379082406654f39a39e859cda18b46a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84Mi9mcmFnOjllNWZiYTcwNTMyZjQ4MGZiMzcxODQ1N2EyODQ5OWZmL3RleHRyZWdpb246OWU1ZmJhNzA1MzJmNDgwZmIzNzE4NDU3YTI4NDk5ZmZfMjk3_e99932e6-92fc-4c6e-aea8-a6a97bbd2a31"
      unitRef="shares">3200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RleHRyZWdpb246YmRhNjliNWY3NmI4NDkzMTg4OGFmM2VlZGRlNTg0ZGJfMzg0ODI5MDcwMDE3OQ_e61373f6-c943-452b-a0de-49993d40da78">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Note 15. Geographic and Segment Information &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;We identify operating segments based on the way we manage, evaluate and internally report our business activities for purposes of allocating resources, developing and executing our strategy, and assessing performance. We have two reportable segments: Cardiovascular and Neuromodulation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The Cardiovascular segment generates its revenue from the development, production and sale of cardiopulmonary products, heart valves and related products and advanced circulatory support. Cardiopulmonary products include oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae and other related accessories. Heart valves include mechanical heart valves, tissue heart valves, related repair products and minimally invasive surgical instruments. Advanced circulatory support includes temporary life support controllers and product kits that can include a combination of pumps, oxygenators, and cannulae. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Our Neuromodulation segment generates its revenue from the design, development and marketing of neuromodulation therapy systems for the treatment of drug-resistant epilepsy, difficult-to-treat depression (&#x201c;DTD&#x201d;) and obstructive sleep apnea. Neuromodulation products include the VNS Therapy System, which consists of an implantable pulse generator, a lead that connects the generator to the vagus nerve, and other accessories. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;&#x201c;Other&#x201d; includes corporate shared service expenses for finance, legal, human resources, information technology and corporate business development.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Net sales of our reportable segments include revenues from the sale of products they each develop and manufacture or distribute. We define segment income as operating income before merger and integration, restructuring and amortization of intangibles.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;We operate under&#160;three&#160;geographic regions: U.S., Europe, and Rest of World. The table below presents net sales by operating segment and geographic region (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiopulmonary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Heart Valves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Advanced Circulatory Support&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;796,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Europe sales include those countries in which we have a direct sales presence, whereas European countries in which we sell through distributors are included in Rest of World. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;No&#160;single customer represented over&#160;10%&#160;of our consolidated net sales. No&#160;country&#x2019;s net sales exceeded&#160;10%&#160;of our consolidated sales except for the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The table below presents a reconciliation of segment income from continuing operations to consolidated (loss) income from continuing operations before tax (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,311)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,037)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75,845)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reportable segment income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merger and integration expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating (loss) income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,508)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,673)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,490)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange and other gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(795)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Loss) income from continuing operations before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Assets by segment are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,546,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,521,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,411,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Capital expenditures by segment are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.477%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The changes in the carrying amount of goodwill by segment for the nine months ended September 30, 2020 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:15pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.952%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;915,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Property, plant and equipment, net by geography are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RleHRyZWdpb246YmRhNjliNWY3NmI4NDkzMTg4OGFmM2VlZGRlNTg0ZGJfMjM1_e22077af-192b-49e5-a78c-7deb2b5eb841"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <livn:NumberofGeographicRegionsinwhichEntityOperates
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RleHRyZWdpb246YmRhNjliNWY3NmI4NDkzMTg4OGFmM2VlZGRlNTg0ZGJfMTc3OQ_0e3c0408-62fd-4d13-ae88-944ee7a10cc2"
      unitRef="geographic_region">3</livn:NumberofGeographicRegionsinwhichEntityOperates>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RleHRyZWdpb246YmRhNjliNWY3NmI4NDkzMTg4OGFmM2VlZGRlNTg0ZGJfMjc1MA_3d8f4781-a010-48ad-b804-43affa425412">The table below presents net sales by operating segment and geographic region (in thousands):&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiopulmonary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Heart Valves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Advanced Circulatory Support&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;796,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Europe sales include those countries in which we have a direct sales presence, whereas European countries in which we sell through distributors are included in Rest of World. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;No&#160;single customer represented over&#160;10%&#160;of our consolidated net sales. No&#160;country&#x2019;s net sales exceeded&#160;10%&#160;of our consolidated sales except for the U.S.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i876852bfed184662a8f0d97d8bcaa96c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMy0yLTEtMS0w_702f481f-6dc4-4ac3-b2cc-088f2c4d3617"
      unitRef="usd">33549000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe5844e1c9474606816d00972d05d123_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMy00LTEtMS0w_a2d5bb46-36e2-4f0e-b2b8-69452a5416aa"
      unitRef="usd">39054000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i62b84cedd45d40678d48897ca51541e3_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMy02LTEtMS0w_8df2f90b-4df7-4a10-81d9-0a7ef81d9536"
      unitRef="usd">96223000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba81a1a74dfe49b8aa3eb8f99114e275_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMy04LTEtMS0w_b8f67c1b-c144-4d5a-b150-ce39afc8bcfe"
      unitRef="usd">119580000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i048767aa111f4c9fb0f1ac8f9d147073_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNC0yLTEtMS0w_8eea1033-bfa5-4670-834b-050b3c0d7209"
      unitRef="usd">29947000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98d0d7d6789f427ea18447a9ecab0429_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNC00LTEtMS0w_6c026618-d508-4b33-9e72-00687c1ad2a0"
      unitRef="usd">30052000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45c1d64c7a40486b9179d7e170cbe2f9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNC02LTEtMS0w_da5df4cd-4cab-4bb7-940e-df1dbe13fba7"
      unitRef="usd">87475000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7329b87ee254e179498f3ab5d4c1188_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNC04LTEtMS0w_ff822ba2-8b95-44f6-a843-f8e55d77ded5"
      unitRef="usd">99933000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e91c84eafce45e9b7b415a5813b4a82_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNS0yLTEtMS0w_7ace39d0-34c3-432a-a9e9-93e08b2394ca"
      unitRef="usd">43704000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a6de0e9e7b442a3a978cd51f4294ab4_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNS00LTEtMS0w_9c5417b5-fcb1-474f-b137-697462c91033"
      unitRef="usd">50908000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a14281cb8974824bd527e86f10ab2bb_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNS02LTEtMS0w_e44ce631-7dd4-4328-8f90-ed25c1a8a541"
      unitRef="usd">140925000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i067bb22836894b95b391f0d0acb63f85_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNS04LTEtMS0w_e9a96c5c-b4d1-4768-9398-05e1ffa2611c"
      unitRef="usd">152650000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i998e5f95302b4aeda2b81e2447e7d338_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNi0yLTEtMS0w_4c60aaf4-53c0-4701-96d1-42dd73d74c30"
      unitRef="usd">107200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i492977f4fcc14476974fcd6784642170_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNi00LTEtMS0w_94f61f12-7890-4149-aedd-96ed890c46b0"
      unitRef="usd">120014000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic21d9046e8e54eb08111e039c3cd30c2_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNi02LTEtMS0w_82d902f9-1e69-47a5-b3d1-69d3e0a07285"
      unitRef="usd">324623000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i14ea489aa03e4679ae969ce4f20eeec8_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfNi04LTEtMS0w_12f6894a-8b5f-46b5-b087-2ace2893b177"
      unitRef="usd">372163000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i31a3762e4349432987b7c4352fec5b98_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfOC0yLTEtMS0w_b28e36ca-ab9d-4fdc-870d-5fee157eff85"
      unitRef="usd">3129000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a02318bfa3347cc8505a8b9b72252cb_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfOC00LTEtMS0w_fece0467-931a-489f-9559-c828a7e18704"
      unitRef="usd">4626000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i512e1cbc1dbf402a8182f4c49af7e088_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfOC02LTEtMS0w_4d6a14ad-c6c5-4483-b969-4876f50a7d34"
      unitRef="usd">8990000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86e615fd4f804099b338c2d68fd98684_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfOC04LTEtMS0w_2427c2f9-357d-4728-bdb3-7539763080c0"
      unitRef="usd">13660000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b2e5a703d0d4e0da33993ef6e8b10d7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfOS0yLTEtMS0w_e46c5602-c084-4f53-94ad-37b8631fa123"
      unitRef="usd">7945000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaebed4d2a7214242b9cdae043b3e1395_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfOS00LTEtMS0w_2815f9f9-c2d6-4533-bb6f-f1a4c46e1a7f"
      unitRef="usd">9572000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d314c195032448da84bdf91257809f5_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfOS02LTEtMS0w_f4317f56-f1d0-4da4-b797-a12231ea69ab"
      unitRef="usd">22822000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0fad8409ffa449c3a2dcd5303e70034a_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfOS04LTEtMS0w_79b8690d-239d-4798-9eaf-caca22c0d58b"
      unitRef="usd">30757000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73bb4237240a4e3fb606e9efd3f84f99_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTAtMi0xLTEtMA_61f80086-48cc-41f3-9b9f-99bb5d89c3ef"
      unitRef="usd">10062000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1965860a1d8443d8fd1255f6745e510_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTAtNC0xLTEtMA_40a7ed3e-4ec1-42ce-a58f-d7c840964614"
      unitRef="usd">14679000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37b3bf78b8684a9a85fa49b6161b9c2e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTAtNi0xLTEtMA_f86d034e-8d1f-4147-81cd-0094d2c2af66"
      unitRef="usd">32001000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic43242093f884cfa9804e7b602317c98_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTAtOC0xLTEtMA_c66b75cf-fcee-4323-a33f-f0555c0ff891"
      unitRef="usd">43484000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9863d6e831c3445b8abe8ec63dd71610_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTEtMi0xLTEtMA_d9fdc76e-b4d1-447f-b16d-b5704008af82"
      unitRef="usd">21136000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifea8fbd4f8a842768f18f1cb7d62556d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTEtNC0xLTEtMA_7f07fe89-4e94-481f-bb8b-4294195c74a3"
      unitRef="usd">28877000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3691f9031c3d4c0baaccadab036cdb47_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTEtNi0xLTEtMA_5e8e5720-1793-4cf3-abec-bfd2fec1daa4"
      unitRef="usd">63813000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d14b893f6a8433790639cb04398340d_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTEtOC0xLTEtMA_d50d7218-e848-4838-b760-e87d0759f99d"
      unitRef="usd">87901000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9f0e21d42994c2d9c4ad4c9cc1386b3_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTMtMi0xLTEtMA_ad0b43ea-c628-4385-9ab2-6479b3243b6a"
      unitRef="usd">12331000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37a57e73f7074cc2b478dc7848ff6ebb_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTMtNC0xLTEtMA_efd2c218-8943-46a1-b422-2a7cedcd1023"
      unitRef="usd">6313000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c228cdd25fa46dc846f886d32efa18b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTMtNi0xLTEtMA_613d687d-f3c1-4245-b8ec-376f471ee0a1"
      unitRef="usd">28075000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4cde2101963426a8246337e1a0c076a_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTMtOC0xLTEtMA_dfaa35bb-a6fb-4244-8365-39f904f38888"
      unitRef="usd">22290000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f2ccc2749c2492885274416414af440_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTQtMi0xLTEtMA_e41f2ede-4e35-46f0-81e3-aa8db6af2636"
      unitRef="usd">162000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i24e4350fe7d9437184b7909a2aae9e1f_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTQtNC0xLTEtMA_80db6075-083d-4732-8e2d-5bb773adb257"
      unitRef="usd">186000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i993975a651dd4a8da309a2bc9be5ccaf_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTQtNi0xLTEtMA_83a61158-a68c-4990-a76b-fe4af0d1b383"
      unitRef="usd">835000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i13437c9318a542149d8e4b9ace7af3f8_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTQtOC0xLTEtMA_3f99ae89-00d6-4c92-a7e3-31ab1c750f85"
      unitRef="usd">497000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69ff964a5f854ebbbe1ea60e0e626bb6_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTUtMi0xLTEtMA_85dfcf04-1102-4807-bf30-258a3641fc86"
      unitRef="usd">49000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i718f682704d94fc694e5d005c83a53e9_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTUtNC0xLTEtMA_4b7062b3-43f6-43ef-9fd4-c0fd8c8810a5"
      unitRef="usd">36000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b0092809fe14757a77ae4181720814e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTUtNi0xLTEtMA_78c59954-535f-4e41-b588-5ca5f21e2e98"
      unitRef="usd">136000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i30054fec7a044c3195b0a1f4a0c95929_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTUtOC0xLTEtMA_99d61961-5991-4a42-8db3-f1b9225b2d33"
      unitRef="usd">310000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a8df61046d04836b659e7543314d52b_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTYtMi0xLTEtMA_a39938f0-cda5-456b-93f8-534783f4108a"
      unitRef="usd">12542000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c55bcd90e9a4aacbf366789e82e6f95_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTYtNC0xLTEtMA_aaffe59e-3401-44d4-bb9d-c821403edf92"
      unitRef="usd">6535000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f292902eb0549ab833ee3de080de1ba_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTYtNi0xLTEtMA_25c4dc11-6222-4ef9-9bf1-bddcb9232dc8"
      unitRef="usd">29046000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i83af8f7348324741a33b045e553554c3_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTYtOC0xLTEtMA_292e3a60-5623-4b50-a0c2-ca393a374763"
      unitRef="usd">23097000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i60f6642d17aa4014ad54b108c471cdcd_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTgtMi0xLTEtMA_2ac785a9-7d51-4d9f-b508-a594fed8bfd2"
      unitRef="usd">49009000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c95775accb649a2a43367af2881bd1e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTgtNC0xLTEtMA_d58dd0db-881c-480b-8513-317f80943a8d"
      unitRef="usd">49993000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ba01b8c48ef4056a693c9fd38968b66_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTgtNi0xLTEtMA_9e5626b0-38c1-4414-b6f5-f3f94b42557d"
      unitRef="usd">133288000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i455f04a75540413cb77b07c862e31aa6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTgtOC0xLTEtMA_51c6002f-927d-41c1-8410-30d90e3837db"
      unitRef="usd">155530000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa815b9dabb542e1ae17525ed43b6edd_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTktMi0xLTEtMA_8a8f781e-69fb-415e-84bf-6ef50b7a4fdb"
      unitRef="usd">38054000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb31194759654532b6d3c7273756b4f0_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTktNC0xLTEtMA_9d1c15c7-e6d5-4e7e-9d04-e8dd6fc480c3"
      unitRef="usd">39810000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee15933e70114ffda536e4ce711dad1d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTktNi0xLTEtMA_cf32033c-68a1-4fe4-89d8-4c9fd68d4e80"
      unitRef="usd">111132000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib6dd5ea4b1ca4e18a2fcdea83a107830_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMTktOC0xLTEtMA_fb8caab7-0092-42ba-9a52-d10e3ce0fb2d"
      unitRef="usd">131187000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2e41838e4174c11abc94d3fb48a1fb4_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjAtMi0xLTEtMA_db7f3690-2f70-41bc-a8cf-ef61fde0369b"
      unitRef="usd">53815000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icaadc304289f4da0b546e3b00fcd58c1_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjAtNC0xLTEtMA_e857879b-ca4b-408c-8314-1825a9213949"
      unitRef="usd">65623000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ab86d3d6d0f49dca6f89b85afbdfa63_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjAtNi0xLTEtMA_67ad3b46-f955-4275-bdc8-3c941387c90a"
      unitRef="usd">173062000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92e6ec3e0d984c9f86c920f967033463_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjAtOC0xLTEtMA_1d5cb947-c5d0-47ac-9a21-5ebdb2019ef9"
      unitRef="usd">196444000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i013558d2b17c4355a92da0429952dd67_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjEtMi0xLTEtMA_96698931-d14c-4763-bd7e-b2ad3ec89666"
      unitRef="usd">140878000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f84b9a1406f4d1a801a8a1795c932dc_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjEtNC0xLTEtMA_b75415f7-9c80-4733-837a-9714c4ffeddc"
      unitRef="usd">155426000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia2fad0d02b3e4a0ab6a60f67969ec28b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjEtNi0xLTEtMA_4a9d8b6f-e246-4bd0-a3ff-8cf44aab656a"
      unitRef="usd">417482000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i197004b99655439cada3d2fa6e98f33e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjEtOC0xLTEtMA_0b1bf2c1-8cb8-4103-ae6c-9301a7fc015d"
      unitRef="usd">483161000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6605f2db15da497784c8273e981148a5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjMtMi0xLTEtMA_1f3cae68-caca-4e70-8576-968ae7a0ccf3"
      unitRef="usd">79854000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1255365af20d4f3d8de0bd8332901b23_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjMtNC0xLTEtMA_aef810c1-ec21-4db3-b92e-c453c0eeea81"
      unitRef="usd">88433000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4a5a9acdf1b466d8d5cd9e19d1f3cb1_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjMtNi0xLTEtMA_7abc1277-3b17-4f7d-a02b-b16b6f554312"
      unitRef="usd">197345000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5546f850f727425d90f293dbf898907b_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjMtOC0xLTEtMA_48bdd693-0cb7-4c2a-9082-529b7d98c166"
      unitRef="usd">245870000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4b98b0523e7492f935ed61439c44ac7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjQtMi0xLTEtMA_a6afbefe-1aec-4ecb-8801-4c57bde4ec4a"
      unitRef="usd">10475000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd5e3ac54bd741a5a9a5b5f8105a08ae_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjQtNC0xLTEtMA_d4b3dafb-da2e-4f1a-8d10-99ab12832c7e"
      unitRef="usd">10425000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib713c27b02154444b1b13648efdc2cb9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjQtNi0xLTEtMA_14ad104c-0d14-4a4c-908a-a76a1a47cc30"
      unitRef="usd">27474000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i90c55e2ec6ed42bc805a2d2a55c5c015_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjQtOC0xLTEtMA_92684d33-8eed-4ad4-a6a0-83c4fcbd9ce6"
      unitRef="usd">34080000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bfaac3413d149e8a37153945f6a6c4d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjUtMi0xLTEtMA_4de9a1a4-ad5d-4d20-bcb2-571302f297b3"
      unitRef="usd">8079000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if2d1490e739647a987879cf6b41a8714_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjUtNC0xLTEtMA_43a435bd-49eb-4f13-9abb-91b5e1238677"
      unitRef="usd">13685000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i576c2f526c3d4a9b9c2a3777ca6ae531_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjUtNi0xLTEtMA_8b7fe038-fe81-4d2c-9e37-b4c488127c1d"
      unitRef="usd">20458000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i647ae223232c4e10957d4e6ecf102def_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjUtOC0xLTEtMA_4ed6968e-cb88-4501-9050-fc8c3684a9c2"
      unitRef="usd">31511000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36f208ad6ec8402f80aac6618e1de718_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjYtMi0xLTEtMA_8a6bcbbd-6ed6-4c25-9ff5-1ccba03052a0"
      unitRef="usd">98408000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9faf33d672ba42d18cdfe76fdead2b2d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjYtNC0xLTEtMA_a1fe0869-e284-4228-b87e-5d00d8865a30"
      unitRef="usd">112543000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c4ddeb948eb4c4dbe320a14c7ae3792_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjYtNi0xLTEtMA_9f3d20f6-9025-4ef6-9514-41f4762e0a4d"
      unitRef="usd">245277000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac495534370345098798ba8c26b009ac_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjYtOC0xLTEtMA_d9e6868f-eb30-407d-9c26-245c13765bf4"
      unitRef="usd">311461000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i21d96c5da2404625a9ee4885a17ebf0c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjctMi0xLTEtMA_513fcb01-7e45-420e-a968-e1cf48be3e92"
      unitRef="usd">797000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc2e1e69df7e4a1d8c750a08dcb83a44_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjctNC0xLTEtMA_103ccbae-d220-40fb-9d06-d417cca17706"
      unitRef="usd">641000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i753478d430024138b30d3d04687e7eb7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjctNi0xLTEtMA_e1a515fd-96c5-451a-882b-f2f346c5c7b9"
      unitRef="usd">1927000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e6560d12b2f434fa22d653edaa72cd8_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjctOC0xLTEtMA_b82fcd2d-4d3c-4e33-a595-7280ec3951b4"
      unitRef="usd">1958000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d864c92f8184a1b8fc7aa74c911e9d5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjktMi0xLTEtMA_e80b333f-04b4-4636-8c3f-b4cad0edaac5"
      unitRef="usd">128863000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3b6505d7e924fd996331218487159c5_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjktNC0xLTEtMA_b3405973-d342-4ab2-bb5e-c106ba107a7f"
      unitRef="usd">138426000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c978d524b454407894936f54228ed99_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjktNi0xLTEtMA_2e952fde-0bc6-4211-ba7a-7b4ccc110bfe"
      unitRef="usd">330633000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i685896438be142c1b5cc2e440c305db2_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMjktOC0xLTEtMA_06a7db5e-fd2b-4405-85f5-1f18725cafd0"
      unitRef="usd">401400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e5933b714be422fb3a8dbdb558b63d0_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzAtMi0xLTEtMA_ba83fda5-3fff-4178-b37c-68417fee0637"
      unitRef="usd">48529000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8fcde1e652d443a977756769f311eb0_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzAtNC0xLTEtMA_5d191b8e-3c57-4da5-a438-ec7e898af8e6"
      unitRef="usd">50235000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad0023589bcb4062a7f6ee3b1663620e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzAtNi0xLTEtMA_4aaf2878-a742-4649-8b96-d39227813082"
      unitRef="usd">138606000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i177a57ba7c1e481b80517501c4f324c5_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzAtOC0xLTEtMA_bf7367f6-d755-4fec-b3da-e78929db31b0"
      unitRef="usd">165267000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9869e96a35ca485f87925c8da417cf1d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzEtMi0xLTEtMA_6f3a6c94-d2a9-43c2-bad8-b16a30d1576e"
      unitRef="usd">62691000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d7442c704eb4389bdc5b405e968fa81_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzEtNC0xLTEtMA_2b986764-ad06-4921-bae0-ac3db091c8f1"
      unitRef="usd">79949000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib304e38586c34d63aeb55253400f5dfc_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzEtNi0xLTEtMA_ec8f46b8-71ed-4aa9-8c62-31fdfb5c8a64"
      unitRef="usd">195447000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic91a56d11d8a4a7994c72db8fe11c1d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzEtOC0xLTEtMA_2fa17dca-36bc-461d-86a4-cc80a94fbe38"
      unitRef="usd">229913000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzItMi0xLTEtMA_3cc4e663-6b7a-4e5e-83c3-1594e8a1b0c4"
      unitRef="usd">240083000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzItNC0xLTEtMA_36860cdf-1d05-4163-9841-32eee3791741"
      unitRef="usd">268610000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzItNi0xLTEtMA_a07241e4-5a8a-4b60-9631-d424d85f6f80"
      unitRef="usd">664686000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjA0ZGYzNGMyOTIyMjQ4YTZiYWNhMGQ0ODFmN2JhOTU3L3RhYmxlcmFuZ2U6MDRkZjM0YzI5MjIyNDhhNmJhY2EwZDQ4MWY3YmE5NTdfMzItOC0xLTEtMA_fb9d5398-dbbc-4a5d-85f5-bb84da4cb861"
      unitRef="usd">796580000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RleHRyZWdpb246YmRhNjliNWY3NmI4NDkzMTg4OGFmM2VlZGRlNTg0ZGJfMjc0NA_9ce32a67-dfdb-4305-9944-5724aba4f6fa">&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The table below presents a reconciliation of segment income from continuing operations to consolidated (loss) income from continuing operations before tax (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,311)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,037)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75,845)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reportable segment income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merger and integration expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating (loss) income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,508)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,673)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,490)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange and other gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(795)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Loss) income from continuing operations before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Assets by segment are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,546,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,521,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,411,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Capital expenditures by segment are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.477%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations
      contextRef="i4e8a04ec819f4cecb0b4d32157f3793c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMi0yLTEtMS0w_84c7cc01-f8cc-4db7-99d2-14a4475da903"
      unitRef="usd">-7311000</livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations>
    <livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations
      contextRef="i750cd8c7e43c4c11ab8974d496e7bb2f_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMi00LTEtMS0w_f4fb2621-062d-4bec-9377-c0412eb786d5"
      unitRef="usd">36180000</livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations>
    <livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations
      contextRef="ibb3170768056425eb10ca95b859602e3_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMi02LTEtMS0w_c473ecbf-9681-4733-bfaa-9ac614ea6874"
      unitRef="usd">-8037000</livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations>
    <livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations
      contextRef="ic51b2b23224546d29ccce9fe55170242_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMi04LTEtMS0w_212b3605-2ef1-49f1-88f7-794253964a09"
      unitRef="usd">47289000</livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations>
    <livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations
      contextRef="i26b3c5a9534a4fe29e2597bb3c79e85a_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMy0yLTEtMS0w_048cfd4c-3cef-4966-ad34-7978d968b0cf"
      unitRef="usd">21154000</livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations>
    <livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations
      contextRef="i6da06d9c9f8f4561b0149e510d196cdf_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMy00LTEtMS0w_42c58451-51bb-42e3-8d44-59411c1c68c0"
      unitRef="usd">30010000</livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations>
    <livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations
      contextRef="i533727d94e6d4a939f7d8a3366ee1c2c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMy02LTEtMS0w_bf936305-0398-4fe7-8929-c323b0d763c3"
      unitRef="usd">82294000</livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations>
    <livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations
      contextRef="i0d8d758d27874054949a7da21f2f2b51_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMy04LTEtMS0w_a7dedeae-d3c3-4861-875b-729866e3e40d"
      unitRef="usd">52260000</livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations>
    <livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations
      contextRef="ibdd4df75ecee4768ac486e5f62873b27_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNC0yLTEtMS0w_8158df01-aac7-4483-bb0b-3ef098bf39b2"
      unitRef="usd">-10921000</livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations>
    <livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations
      contextRef="i555f859b9cc045aa906e26d5ebfeda55_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNC00LTEtMS0w_62a04047-a531-41e4-8302-de07d7d2d39e"
      unitRef="usd">-21869000</livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations>
    <livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations
      contextRef="i72a6c2813b9a4c7a8ef3258c3a0d53e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNC02LTEtMS0w_1a6714ee-7ba6-41d9-aeb3-61645a14e24f"
      unitRef="usd">-58407000</livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations>
    <livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations
      contextRef="i4e3947b9663c4dd195e33fed5b54ba85_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNC04LTEtMS0w_1a4a52cf-1f29-46c7-9a2f-62045c7af676"
      unitRef="usd">-75845000</livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations>
    <livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations
      contextRef="i37c0fa19eea047a2936735006bf189fc_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNS0yLTEtMS0w_ed9d360d-97ae-4fee-902c-3d724dce9b72"
      unitRef="usd">2922000</livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations>
    <livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations
      contextRef="i97f2df041b5e4467941d20a0fed11b0d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNS00LTEtMS0w_e34aac11-8718-4e07-8599-83e50ed25a89"
      unitRef="usd">44321000</livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations>
    <livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations
      contextRef="i5c740fe5919f452f8b72fcc2fa97e743_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNS02LTEtMS0w_0551f1c3-6aa9-49a3-ada0-f8847bc3fb32"
      unitRef="usd">15850000</livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations>
    <livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations
      contextRef="ic1ba6be74fbf4cd8a64b5aff3d82ca29_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNS04LTEtMS0w_e079cfbc-382a-4081-a371-adfbfc39a580"
      unitRef="usd">23704000</livn:OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i37c0fa19eea047a2936735006bf189fc_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNi0yLTEtMS0w_93f15802-dc36-4aed-8263-edb1fc634d46"
      unitRef="usd">1094000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i97f2df041b5e4467941d20a0fed11b0d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNi00LTEtMS0w_044bf8cf-446f-4070-a344-f393528c38f4"
      unitRef="usd">6716000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i5c740fe5919f452f8b72fcc2fa97e743_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNi02LTEtMS0w_a37df917-3ed8-488a-9a49-017f55da407f"
      unitRef="usd">6616000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ic1ba6be74fbf4cd8a64b5aff3d82ca29_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNi04LTEtMS0w_c49411a1-d4f5-48e8-92fb-89bad36e03d5"
      unitRef="usd">14345000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:RestructuringCharges
      contextRef="i37c0fa19eea047a2936735006bf189fc_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNy0yLTEtMS0w_45272b39-b13d-4e01-93c7-0c03abcde02a"
      unitRef="usd">-349000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i97f2df041b5e4467941d20a0fed11b0d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNy00LTEtMS0w_f14a0dfe-19b3-4da7-932a-e4c516e87908"
      unitRef="usd">698000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5c740fe5919f452f8b72fcc2fa97e743_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNy02LTEtMS0w_e4179a71-f733-4cb1-abb6-3ea0b9eaf68e"
      unitRef="usd">2025000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic1ba6be74fbf4cd8a64b5aff3d82ca29_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfNy04LTEtMS0w_13fbf31a-0d1f-4af5-bfbc-e3c43d1bb1ec"
      unitRef="usd">4563000</us-gaap:RestructuringCharges>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i37c0fa19eea047a2936735006bf189fc_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfOC0yLTEtMS0w_932b5a8f-c07a-4ec4-89d0-95277fe772e8"
      unitRef="usd">9685000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i97f2df041b5e4467941d20a0fed11b0d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfOC00LTEtMS0w_c7c28751-5658-4e67-9371-9f82a965ee82"
      unitRef="usd">11146000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5c740fe5919f452f8b72fcc2fa97e743_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfOC02LTEtMS0w_7c4272e9-0744-4585-9101-0e5f9d389f9b"
      unitRef="usd">29346000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic1ba6be74fbf4cd8a64b5aff3d82ca29_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfOC04LTEtMS0w_11dc6fa3-4c72-4132-a838-cf14f29147d1"
      unitRef="usd">29690000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss
      contextRef="i37c0fa19eea047a2936735006bf189fc_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfOS0yLTEtMS0w_1a09b2d8-5bd6-4a67-afc2-1bf89b59a63b"
      unitRef="usd">-7508000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i97f2df041b5e4467941d20a0fed11b0d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfOS00LTEtMS0w_8ea8917c-b68c-49d5-ba6a-38b6fb3cf65c"
      unitRef="usd">25761000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5c740fe5919f452f8b72fcc2fa97e743_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfOS02LTEtMS0w_737f7ba8-c5f9-4dfe-a022-9ab68efd0c16"
      unitRef="usd">-22137000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic1ba6be74fbf4cd8a64b5aff3d82ca29_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfOS04LTEtMS0w_f8828395-156c-40b1-97df-bd32ade3c761"
      unitRef="usd">-24894000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTAtMi0xLTEtMA_c3e2d1f7-7dda-44d1-aaab-1c75552ca42b"
      unitRef="usd">47000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTAtNC0xLTEtMA_7ebebaf7-30e0-4b17-b09d-bc56ba8175fa"
      unitRef="usd">151000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTAtNi0xLTEtMA_b8995a7c-7182-49e8-b8e4-f8edd9e33d33"
      unitRef="usd">482000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTAtOC0xLTEtMA_4fd3ee71-4bee-45ed-86f1-c7a814ff2aae"
      unitRef="usd">624000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTEtMi0xLTEtMA_e8feb6b0-8216-421f-8634-9b6ad49ed445"
      unitRef="usd">14673000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTEtNC0xLTEtMA_3633f422-eb0d-4af4-934d-05f9ada07e12"
      unitRef="usd">4774000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTEtNi0xLTEtMA_8078332b-499f-4aff-b1c7-72aa2db8790e"
      unitRef="usd">25237000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTEtOC0xLTEtMA_fe8a1d57-f7bd-4856-a616-8a2432596371"
      unitRef="usd">10490000</us-gaap:InterestExpense>
    <livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTItMi0xLTEtMA_b2e30b56-d158-454a-bc85-970bd1b309fb"
      unitRef="usd">3420000</livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome>
    <livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTItNC0xLTEtMA_27f1cbfb-15a1-4aeb-9b81-f8f39286b720"
      unitRef="usd">327000</livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome>
    <livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTItNi0xLTEtMA_f9bf53b6-0a28-40f6-9fae-ca403106354d"
      unitRef="usd">507000</livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome>
    <livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTItOC0xLTEtMA_9d394663-ffae-4049-b0e9-376d6258a05b"
      unitRef="usd">-795000</livn:ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3d16457137524d51a1566ec297b77d53_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTMtMi0xLTEtMA_56b9bdcf-62bb-4dea-a10c-86e2a37046b4"
      unitRef="usd">-18714000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6af99e1e8c6342c88abf5785505fc38d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTMtNC0xLTEtMA_59820116-7741-4755-a3df-d8efe4999768"
      unitRef="usd">21465000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTMtNi0xLTEtMA_c3bd8974-e870-4785-a4c8-63c5815f9058"
      unitRef="usd">-46385000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iaa6a7a822d7e4c43a4c4e167c9590ce6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ZWMyYjU4NjBmMTRhODZhMmU1ZGM5NjlhYjU1NTdjL3RhYmxlcmFuZ2U6ZTVlYzJiNTg2MGYxNGE4NmEyZTVkYzk2OWFiNTU1N2NfMTMtOC0xLTEtMA_c08c2024-4ccf-4b83-9fb1-0a5fde6257b3"
      unitRef="usd">-35555000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:Assets
      contextRef="i7e834100347f4225a07ea71d1272445b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfMS0yLTEtMS0w_a4ad9bbb-614b-4a92-96e3-1139976261eb"
      unitRef="usd">1463523000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i7e834100347f4225a07ea71d1272445b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfMS0yLTEtMS0w_f03561c1-c8f7-4f94-a3fb-7d4a3752e704"
      unitRef="usd">1463523000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i82d6d51022114ec88eb0d11a4a6ff932_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfMS00LTEtMS0w_4c47bf65-24e5-48cb-8835-9b4792cd0f38"
      unitRef="usd">1546520000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i621fac9415c54f6a87f88d3a519eb1f0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfMi0yLTEtMS0w_8d4d2464-0883-4717-98c1-bbffd6c83ef5"
      unitRef="usd">668899000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i621fac9415c54f6a87f88d3a519eb1f0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfMi0yLTEtMS0w_b2e5dd9e-b9d9-41f7-bb5d-66a3c5abd969"
      unitRef="usd">668899000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie26338ab822548b58c3b31da34f31dd8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfMi00LTEtMS0w_44e8e413-9a49-49b6-ab8e-aeb8a51c0ba2"
      unitRef="usd">749069000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i21249aea88bf443ba021a32669ad704b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfMy0yLTEtMS0w_760bd744-2956-4521-b15c-9b7214690f9f"
      unitRef="usd">389326000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i21249aea88bf443ba021a32669ad704b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfMy0yLTEtMS0w_c4418813-ef18-4e25-b206-f80a521df412"
      unitRef="usd">389326000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic77fdf65e1a94d118f6cb9b70082f469_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfMy00LTEtMS0w_f199adb5-6e97-4930-97bd-7704e589a17e"
      unitRef="usd">116208000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfNC0yLTEtMS0w_1887e9ca-06ea-4e81-ac32-06a51356666f"
      unitRef="usd">2521748000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfNC0yLTEtMS0w_786b787b-3f72-4a30-a6b1-14d83d93dcb5"
      unitRef="usd">2521748000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU1ODU2YzU2ZjZhOTRkMGFiNWJmZWE2Nzc1NmY0Mzc5L3RhYmxlcmFuZ2U6ZTU4NTZjNTZmNmE5NGQwYWI1YmZlYTY3NzU2ZjQzNzlfNC00LTEtMS0w_8eab19cd-5c36-4284-842d-2e04ec1fb633"
      unitRef="usd">2411797000</us-gaap:Assets>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i4e8a04ec819f4cecb0b4d32157f3793c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfMi0yLTEtMS0w_1a9e49d6-9580-41e3-9a88-311fdf74a054"
      unitRef="usd">7040000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i750cd8c7e43c4c11ab8974d496e7bb2f_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfMi00LTEtMS0w_c80eda15-9e84-4c9f-9ccd-0b4900645cf2"
      unitRef="usd">5178000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ibb3170768056425eb10ca95b859602e3_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfMi02LTEtMS0w_e2c65f54-db6b-4f4c-ab59-4a519e284c14"
      unitRef="usd">17777000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ic51b2b23224546d29ccce9fe55170242_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfMi04LTEtMS0w_695bfa9e-a03e-40c9-8b22-171ff2da62db"
      unitRef="usd">13564000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i26b3c5a9534a4fe29e2597bb3c79e85a_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfMy0yLTEtMS0w_fcc6091b-dd86-49d3-a99a-d7f59ce450ae"
      unitRef="usd">1210000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i6da06d9c9f8f4561b0149e510d196cdf_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfMy00LTEtMS0w_7352282c-9a67-4d95-834c-2824f0c918a2"
      unitRef="usd">136000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i533727d94e6d4a939f7d8a3366ee1c2c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfMy02LTEtMS0w_7dd4103e-c8c9-4dba-8b62-7349d8df045c"
      unitRef="usd">7285000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i0d8d758d27874054949a7da21f2f2b51_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfMy04LTEtMS0w_6cfa5794-c58b-4454-af7f-0e901c2b4382"
      unitRef="usd">666000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ibdd4df75ecee4768ac486e5f62873b27_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfNC0yLTEtMS0w_dbff32cc-7010-430e-9a3c-6d43658d4312"
      unitRef="usd">967000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i555f859b9cc045aa906e26d5ebfeda55_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfNC00LTEtMS0w_26af7064-1c32-4f02-8503-c9b0aaebd7a5"
      unitRef="usd">691000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i72a6c2813b9a4c7a8ef3258c3a0d53e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfNC02LTEtMS0w_114e3282-ac9c-4501-ad25-42f964585eb0"
      unitRef="usd">3174000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i4e3947b9663c4dd195e33fed5b54ba85_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfNC04LTEtMS0w_461a4108-fe46-4f01-9b01-458ca2980015"
      unitRef="usd">2571000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i37c0fa19eea047a2936735006bf189fc_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfNS0yLTEtMS0w_54cc7239-7dc7-4397-b04f-10de41ba1037"
      unitRef="usd">9217000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i97f2df041b5e4467941d20a0fed11b0d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfNS00LTEtMS0w_e944d8a6-29f8-4459-aad7-8f0e9ffff74a"
      unitRef="usd">6005000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i5c740fe5919f452f8b72fcc2fa97e743_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfNS02LTEtMS0w_55144a20-b61f-4255-8a41-51682bdfccc4"
      unitRef="usd">28236000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ic1ba6be74fbf4cd8a64b5aff3d82ca29_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjE4MDRhMTY0NjE5ZDQ1MWJhODgwOTE3NWE3Y2RkNmM4L3RhYmxlcmFuZ2U6MTgwNGExNjQ2MTlkNDUxYmE4ODA5MTc1YTdjZGQ2YzhfNS04LTEtMS0w_16801681-83ce-468f-bde1-d9ce22fd18da"
      unitRef="usd">16801000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RleHRyZWdpb246YmRhNjliNWY3NmI4NDkzMTg4OGFmM2VlZGRlNTg0ZGJfMjczOA_18914644-db06-4012-93f5-ab512a0e1442">&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The changes in the carrying amount of goodwill by segment for the nine months ended September 30, 2020 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:15pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.952%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;915,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i50dafb81ae7249f0b00a89f30fa949b6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjVkNjJmMzZjNzViNDQxNmM5N2U5YWMwMzRkNWI3N2EzL3RhYmxlcmFuZ2U6NWQ2MmYzNmM3NWI0NDE2Yzk3ZTlhYzAzNGQ1Yjc3YTNfMS0yLTEtMS0w_90b44ac7-1a31-47dc-be55-6adc24e4b570"
      unitRef="usd">398754000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="idbd1000ed3de4516a0195c708a123de5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjVkNjJmMzZjNzViNDQxNmM5N2U5YWMwMzRkNWI3N2EzL3RhYmxlcmFuZ2U6NWQ2MmYzNmM3NWI0NDE2Yzk3ZTlhYzAzNGQ1Yjc3YTNfMS00LTEtMS0w_18a676c1-5a92-45e9-ab68-74e76dc5664f"
      unitRef="usd">517040000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjVkNjJmMzZjNzViNDQxNmM5N2U5YWMwMzRkNWI3N2EzL3RhYmxlcmFuZ2U6NWQ2MmYzNmM3NWI0NDE2Yzk3ZTlhYzAzNGQ1Yjc3YTNfMS02LTEtMS0w_27fc7fb6-ac36-4c1c-8ef0-2a6467fbc60a"
      unitRef="usd">915794000</us-gaap:Goodwill>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ia01b97a86f2f4fb9ad100afbeb3977ab_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjVkNjJmMzZjNzViNDQxNmM5N2U5YWMwMzRkNWI3N2EzL3RhYmxlcmFuZ2U6NWQ2MmYzNmM3NWI0NDE2Yzk3ZTlhYzAzNGQ1Yjc3YTNfNC0yLTEtMS0w_8a2d969f-85aa-4681-8cb9-5e1cef7df43e"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ie035b1af1b6244959d04c1e0f44038a5_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjVkNjJmMzZjNzViNDQxNmM5N2U5YWMwMzRkNWI3N2EzL3RhYmxlcmFuZ2U6NWQ2MmYzNmM3NWI0NDE2Yzk3ZTlhYzAzNGQ1Yjc3YTNfNC00LTEtMS0w_bc62f1b7-701e-463b-9afa-647a084bf428"
      unitRef="usd">2684000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjVkNjJmMzZjNzViNDQxNmM5N2U5YWMwMzRkNWI3N2EzL3RhYmxlcmFuZ2U6NWQ2MmYzNmM3NWI0NDE2Yzk3ZTlhYzAzNGQ1Yjc3YTNfNC02LTEtMS0w_4faaa716-5b77-4a94-a90a-26d5a272705e"
      unitRef="usd">2684000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i7ed94ea4037647e09c43b0db147a2453_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjVkNjJmMzZjNzViNDQxNmM5N2U5YWMwMzRkNWI3N2EzL3RhYmxlcmFuZ2U6NWQ2MmYzNmM3NWI0NDE2Yzk3ZTlhYzAzNGQ1Yjc3YTNfNS0yLTEtMS0w_5007627e-7d0c-49da-ae52-fd36c802cbab"
      unitRef="usd">398754000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie3dabd6f2807465da694560fc9777ec8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjVkNjJmMzZjNzViNDQxNmM5N2U5YWMwMzRkNWI3N2EzL3RhYmxlcmFuZ2U6NWQ2MmYzNmM3NWI0NDE2Yzk3ZTlhYzAzNGQ1Yjc3YTNfNS00LTEtMS0w_49cac7a9-954a-4414-ad59-e552f86f2798"
      unitRef="usd">519724000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOjVkNjJmMzZjNzViNDQxNmM5N2U5YWMwMzRkNWI3N2EzL3RhYmxlcmFuZ2U6NWQ2MmYzNmM3NWI0NDE2Yzk3ZTlhYzAzNGQ1Yjc3YTNfNS02LTEtMS0w_a9e1f8fd-ee6d-43e6-8db4-e92545a6a242"
      unitRef="usd">918478000</us-gaap:Goodwill>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RleHRyZWdpb246YmRhNjliNWY3NmI4NDkzMTg4OGFmM2VlZGRlNTg0ZGJfMjczOQ_0d51cfa5-af3c-47e4-b04b-6145658ebbe1">&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Property, plant and equipment, net by geography are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2dde44e6ca6c4af39265921b98826424_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU4ZjdmMzEwYzJiZTQwZWU4ZmM0ZjIzYjFiYTg1ZjI3L3RhYmxlcmFuZ2U6ZThmN2YzMTBjMmJlNDBlZThmYzRmMjNiMWJhODVmMjdfMS0yLTEtMS0w_5d9100d8-9dcf-4f14-a0d2-e7317982a5b8"
      unitRef="usd">64620000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i67e83bb326504f55b272768962da8016_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU4ZjdmMzEwYzJiZTQwZWU4ZmM0ZjIzYjFiYTg1ZjI3L3RhYmxlcmFuZ2U6ZThmN2YzMTBjMmJlNDBlZThmYzRmMjNiMWJhODVmMjdfMS00LTEtMS0w_afb7dfc5-40f9-4fcb-a722-7df33355de36"
      unitRef="usd">61410000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ibedca0f603bd4bd6a1d7eb72407a0f05_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU4ZjdmMzEwYzJiZTQwZWU4ZmM0ZjIzYjFiYTg1ZjI3L3RhYmxlcmFuZ2U6ZThmN2YzMTBjMmJlNDBlZThmYzRmMjNiMWJhODVmMjdfMi0yLTEtMS0w_6c6a3c96-d27a-465a-9375-f5fba3f84647"
      unitRef="usd">116746000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2c3b8ff212bf4e7789a78c902e1ca14e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU4ZjdmMzEwYzJiZTQwZWU4ZmM0ZjIzYjFiYTg1ZjI3L3RhYmxlcmFuZ2U6ZThmN2YzMTBjMmJlNDBlZThmYzRmMjNiMWJhODVmMjdfMi00LTEtMS0w_43894dd9-4086-4b36-b94e-823bf850e4e2"
      unitRef="usd">110270000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2e0cc6d97d2c44baa25cccb561c0a434_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU4ZjdmMzEwYzJiZTQwZWU4ZmM0ZjIzYjFiYTg1ZjI3L3RhYmxlcmFuZ2U6ZThmN2YzMTBjMmJlNDBlZThmYzRmMjNiMWJhODVmMjdfMy0yLTEtMS0w_dcfbc90c-7f3f-4dcb-b376-39aa862d07d7"
      unitRef="usd">9143000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia8d1a426602f4eb09beb15214ebfd323_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU4ZjdmMzEwYzJiZTQwZWU4ZmM0ZjIzYjFiYTg1ZjI3L3RhYmxlcmFuZ2U6ZThmN2YzMTBjMmJlNDBlZThmYzRmMjNiMWJhODVmMjdfMy00LTEtMS0w_05df8c92-16bf-4d69-aac6-1169e88223bb"
      unitRef="usd">9674000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU4ZjdmMzEwYzJiZTQwZWU4ZmM0ZjIzYjFiYTg1ZjI3L3RhYmxlcmFuZ2U6ZThmN2YzMTBjMmJlNDBlZThmYzRmMjNiMWJhODVmMjdfNC0yLTEtMS0w_86a194bd-12ec-4fa8-8557-3c32853fde34"
      unitRef="usd">190509000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84NS9mcmFnOmJkYTY5YjVmNzZiODQ5MzE4ODhhZjNlZWRkZTU4NGRiL3RhYmxlOmU4ZjdmMzEwYzJiZTQwZWU4ZmM0ZjIzYjFiYTg1ZjI3L3RhYmxlcmFuZ2U6ZThmN2YzMTBjMmJlNDBlZThmYzRmMjNiMWJhODVmMjdfNC00LTEtMS0w_86e33674-2be9-4c02-a218-8995c6ea302b"
      unitRef="usd">181354000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:QuarterlyFinancialInformationTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RleHRyZWdpb246ZmNiMTBiOGY0ZjBiNDkxZmIzNjk4YjdhYTE1Y2JkNTNfMzg0ODI5MDY5ODA2NA_e9834ea6-bf99-4ee4-946e-73774fef5d79">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Note 16. Supplemental Financial Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Inventories consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;As of September&#160;30, 2020 and December 31, 2019, inventories include adjustments totaling $14.5 million and $12.7 million, respectively, to record balances at lower of cost or net realizable value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Accrued liabilities and other consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal and administrative costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provisions for agents, returns and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring related liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product remediation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative contract liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CRM purchase price adjustment payable to MicroPort Scientific Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Refer to &#x201c;Note 7. Fair Value Measurements&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Refer to &#x201c;Note 4. Restructuring&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Refer to &#x201c;Note 5. Product Remediation Liability&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Refer to &#x201c; Note 9. Derivatives and Risk Management&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;As of&#160;September&#160;30, 2020&#160;and&#160;December 31, 2019, contract liabilities of&#160;$9.5 million&#160;and&#160;$8.6 million, respectively, are included within accrued liabilities and other long-term liabilities on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RleHRyZWdpb246ZmNiMTBiOGY0ZjBiNDkxZmIzNjk4YjdhYTE1Y2JkNTNfNjA0_43a36819-5cff-4dd5-abe0-e29e28eb63bc">&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Inventories consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOmJhYzg0ZGY4YTM0ZDRjZTg5MWRiYjUyMTFjNTMxNjkyL3RhYmxlcmFuZ2U6YmFjODRkZjhhMzRkNGNlODkxZGJiNTIxMWM1MzE2OTJfMS0yLTEtMS0w_e66e40ad-e89b-4864-b62c-86b9fbaf852f"
      unitRef="usd">48325000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOmJhYzg0ZGY4YTM0ZDRjZTg5MWRiYjUyMTFjNTMxNjkyL3RhYmxlcmFuZ2U6YmFjODRkZjhhMzRkNGNlODkxZGJiNTIxMWM1MzE2OTJfMS00LTEtMS0w_611fbb77-4827-49d4-8f7a-20aa025d9f9b"
      unitRef="usd">45225000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOmJhYzg0ZGY4YTM0ZDRjZTg5MWRiYjUyMTFjNTMxNjkyL3RhYmxlcmFuZ2U6YmFjODRkZjhhMzRkNGNlODkxZGJiNTIxMWM1MzE2OTJfMi0yLTEtMS0w_6f32b1e8-6cdc-4d34-a820-c85908b8bf2c"
      unitRef="usd">18949000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOmJhYzg0ZGY4YTM0ZDRjZTg5MWRiYjUyMTFjNTMxNjkyL3RhYmxlcmFuZ2U6YmFjODRkZjhhMzRkNGNlODkxZGJiNTIxMWM1MzE2OTJfMi00LTEtMS0w_4d95c2d5-55a1-45bc-9335-e9f2c5d56c68"
      unitRef="usd">14581000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOmJhYzg0ZGY4YTM0ZDRjZTg5MWRiYjUyMTFjNTMxNjkyL3RhYmxlcmFuZ2U6YmFjODRkZjhhMzRkNGNlODkxZGJiNTIxMWM1MzE2OTJfMy0yLTEtMS0w_45092075-fa62-465b-97b2-1a912ee89cb2"
      unitRef="usd">110817000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOmJhYzg0ZGY4YTM0ZDRjZTg5MWRiYjUyMTFjNTMxNjkyL3RhYmxlcmFuZ2U6YmFjODRkZjhhMzRkNGNlODkxZGJiNTIxMWM1MzE2OTJfMy00LTEtMS0w_c3b29bd3-c92e-4c77-954b-8ce88215c66e"
      unitRef="usd">104348000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOmJhYzg0ZGY4YTM0ZDRjZTg5MWRiYjUyMTFjNTMxNjkyL3RhYmxlcmFuZ2U6YmFjODRkZjhhMzRkNGNlODkxZGJiNTIxMWM1MzE2OTJfNC0yLTEtMS0w_85657380-01be-466f-b877-c76a665e2440"
      unitRef="usd">178091000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOmJhYzg0ZGY4YTM0ZDRjZTg5MWRiYjUyMTFjNTMxNjkyL3RhYmxlcmFuZ2U6YmFjODRkZjhhMzRkNGNlODkxZGJiNTIxMWM1MzE2OTJfNC00LTEtMS0w_f82caeec-6a27-4d46-8b6c-08c0d2036fc3"
      unitRef="usd">164154000</us-gaap:InventoryNet>
    <us-gaap:InventoryValuationReserves
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RleHRyZWdpb246ZmNiMTBiOGY0ZjBiNDkxZmIzNjk4YjdhYTE1Y2JkNTNfMjUw_d65f73c6-97e7-44f8-8537-d5c870688f46"
      unitRef="usd">14500000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RleHRyZWdpb246ZmNiMTBiOGY0ZjBiNDkxZmIzNjk4YjdhYTE1Y2JkNTNfMjU3_34bdec84-5266-4e2b-9e15-d93d8d85babd"
      unitRef="usd">12700000</us-gaap:InventoryValuationReserves>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RleHRyZWdpb246ZmNiMTBiOGY0ZjBiNDkxZmIzNjk4YjdhYTE1Y2JkNTNfNjA1_7bcf1d56-54be-4fa7-9727-a7b7cece1cb2">&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Accrued liabilities and other consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal and administrative costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provisions for agents, returns and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring related liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product remediation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative contract liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CRM purchase price adjustment payable to MicroPort Scientific Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Refer to &#x201c;Note 7. Fair Value Measurements&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Refer to &#x201c;Note 4. Restructuring&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Refer to &#x201c;Note 5. Product Remediation Liability&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt"&gt;Refer to &#x201c; Note 9. Derivatives and Risk Management&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMS0yLTEtMS0xNTQ3_49d536e7-b8fb-47e9-9f99-da387c0ed096"
      unitRef="usd">16571000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMS00LTEtMS0xNTQ3_4a8fb9e3-2130-42c9-9c3b-7f61dca64c25"
      unitRef="usd">22953000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMi0yLTEtMS0zMDA0_ac0c789c-6145-471e-8da6-08d991b140f4"
      unitRef="usd">14034000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMi00LTEtMS0zMDA0_76963798-e7dd-4318-94f8-639854d30fa1"
      unitRef="usd">11066000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMi0yLTEtMS0xNTQ3_5cc89def-eb65-4d85-87ec-e32ea6b4087a"
      unitRef="usd">11941000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMi00LTEtMS0xNTQ3_6bbacd80-19f1-4bd7-933d-80375ab8755b"
      unitRef="usd">11110000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfNC0yLTEtMS0w_dcc12555-08ee-4fcc-b325-c55e55d8db33"
      unitRef="usd">7723000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfNC00LTEtMS0w_210b3b98-00a0-420e-812a-b3c7ff58f06e"
      unitRef="usd">6728000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <livn:ResearchAndDevelopmentCostsPayableCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfNS0yLTEtMS0w_e6759877-109d-48af-afc5-54db209bfcac"
      unitRef="usd">5328000</livn:ResearchAndDevelopmentCostsPayableCurrent>
    <livn:ResearchAndDevelopmentCostsPayableCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfNS00LTEtMS0w_fe2f6aac-db76-4898-abcf-18f603d19796"
      unitRef="usd">5160000</livn:ResearchAndDevelopmentCostsPayableCurrent>
    <livn:ProvisionforAgentsReturnsandOther
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfNi0yLTEtMS0w_07d66619-4635-4eb0-a2be-ded3f7c2af9a"
      unitRef="usd">3772000</livn:ProvisionforAgentsReturnsandOther>
    <livn:ProvisionforAgentsReturnsandOther
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfNi00LTEtMS0w_53e3f505-b59f-4163-bda0-a812692d3484"
      unitRef="usd">3922000</livn:ProvisionforAgentsReturnsandOther>
    <livn:RestructuringRelatedLiabilities
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfOC0yLTEtMS0w_3662f04a-1e8d-4701-b319-6516114778cd"
      unitRef="usd">1813000</livn:RestructuringRelatedLiabilities>
    <livn:RestructuringRelatedLiabilities
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfOC00LTEtMS0w_c9923904-8e37-45fb-b786-5ab3ed9dd1a5"
      unitRef="usd">4315000</livn:RestructuringRelatedLiabilities>
    <livn:ProductRemediation
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfOS0yLTEtMS0w_4bca347b-bfd1-4d53-b09c-63ac5f8d2a8b"
      unitRef="usd">1715000</livn:ProductRemediation>
    <livn:ProductRemediation
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfOS00LTEtMS0w_7ba4ba44-c0a8-4dda-89db-36603aa9b3c5"
      unitRef="usd">3251000</livn:ProductRemediation>
    <livn:DerivativeContractLiabilities
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMTAtMi0xLTEtMjc5Ng_ff602494-ad7b-4ab5-aae3-9df07e5987d6"
      unitRef="usd">1338000</livn:DerivativeContractLiabilities>
    <livn:DerivativeContractLiabilities
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMTAtNC0xLTEtMjc5Ng_c160455b-710e-4dba-a3f6-9ec91aca8f2a"
      unitRef="usd">3173000</livn:DerivativeContractLiabilities>
    <livn:BusinessAcquisitionsPurchasePriceAllocation
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMTAtMi0xLTEtMA_0c3f554a-3d14-49fc-8192-8eddac68b15e"
      unitRef="usd">0</livn:BusinessAcquisitionsPurchasePriceAllocation>
    <livn:BusinessAcquisitionsPurchasePriceAllocation
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMTAtNC0xLTEtMA_89ef7220-03cd-4b93-abf7-24baab68378a"
      unitRef="usd">14891000</livn:BusinessAcquisitionsPurchasePriceAllocation>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMTEtMi0xLTEtMA_52cd1847-3450-4ca4-9d04-8e978b65bdc3"
      unitRef="usd">34073000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMTEtNC0xLTEtMA_cc6a2eb2-2a31-419b-99cc-d309aa4e143e"
      unitRef="usd">33531000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMTItMi0xLTEtMA_330edc82-ced4-4adf-909f-32ac77cbf5cb"
      unitRef="usd">98308000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RhYmxlOjU2OGNiNTg5M2MxMzQ5ZGM5NGE0NzEwNmU0YTQ5ZTEwL3RhYmxlcmFuZ2U6NTY4Y2I1ODkzYzEzNDlkYzk0YTQ3MTA2ZTRhNDllMTBfMTItNC0xLTEtMA_4f298fc1-8157-4878-966a-6e96a00a614a"
      unitRef="usd">120100000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RleHRyZWdpb246ZmNiMTBiOGY0ZjBiNDkxZmIzNjk4YjdhYTE1Y2JkNTNfNDYy_10236a65-87e2-4ebd-8069-4616e7fd83cd"
      unitRef="usd">9500000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ibcd0778524454cafb95c52ee8c85dc02_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV84OC9mcmFnOmZjYjEwYjhmNGYwYjQ5MWZiMzY5OGI3YWExNWNiZDUzL3RleHRyZWdpb246ZmNiMTBiOGY0ZjBiNDkxZmIzNjk4YjdhYTE1Y2JkNTNfNDY5_1e1bbd11-9999-4198-9c9e-97047510fd18"
      unitRef="usd">8600000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RleHRyZWdpb246OWRiYzhiM2U1NTljNGFiOWI0N2E3ODFiNmRmNWVjNTNfMzg0ODI5MDY5NzY5Ng_00889461-9856-41d3-86de-a17da89fc3f4">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Note 17. New Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Adoption of New Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following table provides a description of our adoption of new Accounting Standards Updates (&#x201c;ASUs&#x201d;) issued by the FASB and the impact of the adoption on our condensed financial statements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issue Date &amp;amp; Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date of Adoption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Effect on Financial Statements or Other Significant Matters&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2016&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RhYmxlOmI3NzhiMTYwZjg5NTQzN2ViODlhMTA0NWE0NGFmNzdjL3RhYmxlcmFuZ2U6Yjc3OGIxNjBmODk1NDM3ZWI4OWExMDQ1YTQ0YWY3N2NfMS0wLTEtMS0wL3RleHRyZWdpb246OWNhMDIzMjU1YjY2NDBkN2I1NDUzOTBiNjY0ZTMzZDNfMTQ_421ad1dc-77dd-457b-948b-627f349609b2"&gt;ASU No. 2016-13&lt;/span&gt;, Financial Instruments&#x2014;Credit Losses (Topic 326)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. We adopted the update effective&lt;br/&gt;January 1, 2020, applying this standard to our accounts receivable by use of a provision matrix approach. This approach utilizes historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;We recognized the following cumulative-effect adjustments, including to retained earnings, upon adoption at January 1, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net decreased $0.6 million and accumulated deficit increased $0.6 million.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2017&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU No. 2017-04,&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;This update removes step 2 of the goodwill impairment test that compares the implied fair value of goodwill with its carrying amount. Instead, an impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge will be recorded by the amount a reporting unit&#x2019;s carrying amount exceeds its fair value.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;There was no material impact to our consolidated financial statements as a result of adopting this ASU.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2018&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU No. 2018-13, Fair Value Measurement (Topic 820): Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;This update removes, modifies and adds certain disclosure requirements related to fair value measurements.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;There was no material impact to our consolidated financial statements as a result of adopting this ASU.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2018&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU No. 2018-15, Intangibles&#x2014;Goodwill and Other&#x2014;Internal-Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;This update clarifies and aligns the accounting for implementation costs for hosting arrangements with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;There was no material impact to our consolidated financial statements as a result of adopting this ASU.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Future Adoption of New Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following table provides a description of future adoptions of new accounting standards that may have an impact on our financial statements when adopted:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issue Date &amp;amp; Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Projected Date of Adoption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Effect on Financial Statements or Other Significant Matters&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;August 2018&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU No. 2018-14, Compensation&#x2014;Retirement Benefits&#x2014;Defined Benefit Plans&#x2014;General&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Subtopic 715-20): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Changes to the Disclosure Requirements for Defined Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;This update adds and removes certain disclosure requirements related to defined benefit plans. This ASU is to be implemented on a retrospective basis for all periods presented with early adoption permitted.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;We do not expect the adoption of this update to have a material effect on our condensed consolidated financial statement disclosures.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RleHRyZWdpb246OWRiYzhiM2U1NTljNGFiOWI0N2E3ODFiNmRmNWVjNTNfNDYw_3ae676ee-1ab6-45fa-968b-3b6d2927bc4f">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Adoption of New Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following table provides a description of our adoption of new Accounting Standards Updates (&#x201c;ASUs&#x201d;) issued by the FASB and the impact of the adoption on our condensed financial statements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issue Date &amp;amp; Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date of Adoption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Effect on Financial Statements or Other Significant Matters&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2016&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RhYmxlOmI3NzhiMTYwZjg5NTQzN2ViODlhMTA0NWE0NGFmNzdjL3RhYmxlcmFuZ2U6Yjc3OGIxNjBmODk1NDM3ZWI4OWExMDQ1YTQ0YWY3N2NfMS0wLTEtMS0wL3RleHRyZWdpb246OWNhMDIzMjU1YjY2NDBkN2I1NDUzOTBiNjY0ZTMzZDNfMTQ_421ad1dc-77dd-457b-948b-627f349609b2"&gt;ASU No. 2016-13&lt;/span&gt;, Financial Instruments&#x2014;Credit Losses (Topic 326)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. We adopted the update effective&lt;br/&gt;January 1, 2020, applying this standard to our accounts receivable by use of a provision matrix approach. This approach utilizes historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;We recognized the following cumulative-effect adjustments, including to retained earnings, upon adoption at January 1, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net decreased $0.6 million and accumulated deficit increased $0.6 million.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2017&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU No. 2017-04,&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;This update removes step 2 of the goodwill impairment test that compares the implied fair value of goodwill with its carrying amount. Instead, an impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge will be recorded by the amount a reporting unit&#x2019;s carrying amount exceeds its fair value.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;There was no material impact to our consolidated financial statements as a result of adopting this ASU.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2018&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU No. 2018-13, Fair Value Measurement (Topic 820): Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;This update removes, modifies and adds certain disclosure requirements related to fair value measurements.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;There was no material impact to our consolidated financial statements as a result of adopting this ASU.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2018&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU No. 2018-15, Intangibles&#x2014;Goodwill and Other&#x2014;Internal-Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;This update clarifies and aligns the accounting for implementation costs for hosting arrangements with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;There was no material impact to our consolidated financial statements as a result of adopting this ASU.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"&gt;Future Adoption of New Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following table provides a description of future adoptions of new accounting standards that may have an impact on our financial statements when adopted:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issue Date &amp;amp; Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Projected Date of Adoption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Effect on Financial Statements or Other Significant Matters&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;August 2018&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU No. 2018-14, Compensation&#x2014;Retirement Benefits&#x2014;Defined Benefit Plans&#x2014;General&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Subtopic 715-20): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Changes to the Disclosure Requirements for Defined Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;This update adds and removes certain disclosure requirements related to defined benefit plans. This ASU is to be implemented on a retrospective basis for all periods presented with early adoption permitted.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;We do not expect the adoption of this update to have a material effect on our condensed consolidated financial statement disclosures.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RleHRyZWdpb246OWRiYzhiM2U1NTljNGFiOWI0N2E3ODFiNmRmNWVjNTNfNDY5_0d076685-0a46-4b05-acde-004305582fdd">&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following table provides a description of our adoption of new Accounting Standards Updates (&#x201c;ASUs&#x201d;) issued by the FASB and the impact of the adoption on our condensed financial statements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issue Date &amp;amp; Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date of Adoption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Effect on Financial Statements or Other Significant Matters&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2016&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RhYmxlOmI3NzhiMTYwZjg5NTQzN2ViODlhMTA0NWE0NGFmNzdjL3RhYmxlcmFuZ2U6Yjc3OGIxNjBmODk1NDM3ZWI4OWExMDQ1YTQ0YWY3N2NfMS0wLTEtMS0wL3RleHRyZWdpb246OWNhMDIzMjU1YjY2NDBkN2I1NDUzOTBiNjY0ZTMzZDNfMTQ_421ad1dc-77dd-457b-948b-627f349609b2"&gt;ASU No. 2016-13&lt;/span&gt;, Financial Instruments&#x2014;Credit Losses (Topic 326)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. We adopted the update effective&lt;br/&gt;January 1, 2020, applying this standard to our accounts receivable by use of a provision matrix approach. This approach utilizes historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;We recognized the following cumulative-effect adjustments, including to retained earnings, upon adoption at January 1, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net decreased $0.6 million and accumulated deficit increased $0.6 million.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2017&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU No. 2017-04,&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;This update removes step 2 of the goodwill impairment test that compares the implied fair value of goodwill with its carrying amount. Instead, an impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge will be recorded by the amount a reporting unit&#x2019;s carrying amount exceeds its fair value.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;There was no material impact to our consolidated financial statements as a result of adopting this ASU.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2018&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU No. 2018-13, Fair Value Measurement (Topic 820): Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;This update removes, modifies and adds certain disclosure requirements related to fair value measurements.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;There was no material impact to our consolidated financial statements as a result of adopting this ASU.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2018&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU No. 2018-15, Intangibles&#x2014;Goodwill and Other&#x2014;Internal-Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;This update clarifies and aligns the accounting for implementation costs for hosting arrangements with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;There was no material impact to our consolidated financial statements as a result of adopting this ASU.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;The following table provides a description of future adoptions of new accounting standards that may have an impact on our financial statements when adopted:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issue Date &amp;amp; Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Projected Date of Adoption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Effect on Financial Statements or Other Significant Matters&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;August 2018&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU No. 2018-14, Compensation&#x2014;Retirement Benefits&#x2014;Defined Benefit Plans&#x2014;General&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Subtopic 715-20): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Changes to the Disclosure Requirements for Defined Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;This update adds and removes certain disclosure requirements related to defined benefit plans. This ASU is to be implemented on a retrospective basis for all periods presented with early adoption permitted.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;We do not expect the adoption of this update to have a material effect on our condensed consolidated financial statement disclosures.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i11591753270141129f271d60eea42105_I20200101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RhYmxlOmI3NzhiMTYwZjg5NTQzN2ViODlhMTA0NWE0NGFmNzdjL3RhYmxlcmFuZ2U6Yjc3OGIxNjBmODk1NDM3ZWI4OWExMDQ1YTQ0YWY3N2NfMS02LTEtMS0wL3RleHRyZWdpb246OTVhYjgwZDJhMWVlNDEzZDhjYjI0OWY5NDFjNzUxZjlfMTY0_8ddfe692-e408-4a27-b0b0-f035655b828d"
      unitRef="usd">600000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:StockholdersEquity
      contextRef="i25fe44ba33a444a484626a29cce0642c_I20200101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RhYmxlOmI3NzhiMTYwZjg5NTQzN2ViODlhMTA0NWE0NGFmNzdjL3RhYmxlcmFuZ2U6Yjc3OGIxNjBmODk1NDM3ZWI4OWExMDQ1YTQ0YWY3N2NfMS02LTEtMS0wL3RleHRyZWdpb246OTVhYjgwZDJhMWVlNDEzZDhjYjI0OWY5NDFjNzUxZjlfMjAx_a29f5978-9ce8-435e-bbb7-96f01d156b85"
      unitRef="usd">600000</us-gaap:StockholdersEquity>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535325221096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Oct. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LivaNova PLC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">X0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1268150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">20 Eastbourne Terrace<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">London<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">GB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">W2 6LG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">203 325-0660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares&#160;- &#163;1.00&#160;par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LIVN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,596,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001639691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535321501864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Income (Loss) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 240,083<span></span>
</td>
<td class="nump">$ 268,610<span></span>
</td>
<td class="nump">$ 664,686<span></span>
</td>
<td class="nump">$ 796,580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales - exclusive of amortization</a></td>
<td class="nump">86,467<span></span>
</td>
<td class="nump">86,128<span></span>
</td>
<td class="nump">212,152<span></span>
</td>
<td class="nump">245,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ProductRemediationExpense', window );">Product remediation</a></td>
<td class="nump">1,133<span></span>
</td>
<td class="nump">3,076<span></span>
</td>
<td class="nump">6,868<span></span>
</td>
<td class="nump">11,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">99,199<span></span>
</td>
<td class="nump">123,015<span></span>
</td>
<td class="nump">317,424<span></span>
</td>
<td class="nump">375,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">47,368<span></span>
</td>
<td class="nump">45,904<span></span>
</td>
<td class="nump">108,422<span></span>
</td>
<td class="nump">124,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Merger and integration expenses</a></td>
<td class="nump">1,094<span></span>
</td>
<td class="nump">6,716<span></span>
</td>
<td class="nump">6,616<span></span>
</td>
<td class="nump">14,345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring expenses</a></td>
<td class="num">(349)<span></span>
</td>
<td class="nump">698<span></span>
</td>
<td class="nump">2,025<span></span>
</td>
<td class="nump">4,563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">50,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="nump">9,685<span></span>
</td>
<td class="nump">11,146<span></span>
</td>
<td class="nump">29,346<span></span>
</td>
<td class="nump">29,690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation provision, net</a></td>
<td class="nump">2,994<span></span>
</td>
<td class="num">(33,834)<span></span>
</td>
<td class="nump">3,970<span></span>
</td>
<td class="num">(33,834)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating (loss) income from continuing operations</a></td>
<td class="num">(7,508)<span></span>
</td>
<td class="nump">25,761<span></span>
</td>
<td class="num">(22,137)<span></span>
</td>
<td class="num">(24,894)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="nump">482<span></span>
</td>
<td class="nump">624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(14,673)<span></span>
</td>
<td class="num">(4,774)<span></span>
</td>
<td class="num">(25,237)<span></span>
</td>
<td class="num">(10,490)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome', window );">Foreign exchange and other gains (losses)</a></td>
<td class="nump">3,420<span></span>
</td>
<td class="nump">327<span></span>
</td>
<td class="nump">507<span></span>
</td>
<td class="num">(795)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(Loss) income from continuing operations before tax</a></td>
<td class="num">(18,714)<span></span>
</td>
<td class="nump">21,465<span></span>
</td>
<td class="num">(46,385)<span></span>
</td>
<td class="num">(35,555)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) expense</a></td>
<td class="num">(3,990)<span></span>
</td>
<td class="num">(10,653)<span></span>
</td>
<td class="nump">17,581<span></span>
</td>
<td class="num">(23,431)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Losses from equity method investments</a></td>
<td class="num">(48)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(221)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net (loss) income from continuing operations</a></td>
<td class="num">(14,772)<span></span>
</td>
<td class="nump">32,118<span></span>
</td>
<td class="num">(64,187)<span></span>
</td>
<td class="num">(12,124)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net (loss) income from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(995)<span></span>
</td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (14,772)<span></span>
</td>
<td class="nump">$ 32,118<span></span>
</td>
<td class="num">$ (65,182)<span></span>
</td>
<td class="num">$ (11,946)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic (loss) income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="num">$ (0.30)<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="num">$ (1.32)<span></span>
</td>
<td class="num">$ (0.25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share (in dollars per share)</a></td>
<td class="num">(0.30)<span></span>
</td>
<td class="nump">0.66<span></span>
</td>
<td class="num">(1.34)<span></span>
</td>
<td class="num">(0.25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted (loss) income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="num">(0.30)<span></span>
</td>
<td class="nump">0.66<span></span>
</td>
<td class="num">(1.32)<span></span>
</td>
<td class="num">(0.25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share (in dollars per share)</a></td>
<td class="num">$ (0.30)<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="num">$ (1.34)<span></span>
</td>
<td class="num">$ (0.25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in computing basic (loss) income per share (in shares)</a></td>
<td class="nump">48,652<span></span>
</td>
<td class="nump">48,395<span></span>
</td>
<td class="nump">48,582<span></span>
</td>
<td class="nump">48,329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in computing diluted (loss) income per share (in shares)</a></td>
<td class="nump">48,652<span></span>
</td>
<td class="nump">48,820<span></span>
</td>
<td class="nump">48,582<span></span>
</td>
<td class="nump">48,329<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign Currency Transaction Gain (Loss) and Other Nonoperating Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_ProductRemediationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Remediation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_ProductRemediationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535325146216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (14,772)<span></span>
</td>
<td class="nump">$ 32,118<span></span>
</td>
<td class="num">$ (65,182)<span></span>
</td>
<td class="num">$ (11,946)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent', window );">Net change in unrealized gain (loss) on derivatives</a></td>
<td class="nump">1,640<span></span>
</td>
<td class="num">(870)<span></span>
</td>
<td class="nump">1,313<span></span>
</td>
<td class="num">(665)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent', window );">Tax effect</a></td>
<td class="num">(393)<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="num">(314)<span></span>
</td>
<td class="nump">159<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Net of tax</a></td>
<td class="nump">1,247<span></span>
</td>
<td class="num">(661)<span></span>
</td>
<td class="nump">999<span></span>
</td>
<td class="num">(506)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">23,457<span></span>
</td>
<td class="num">(27,775)<span></span>
</td>
<td class="nump">8,008<span></span>
</td>
<td class="num">(16,628)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">24,704<span></span>
</td>
<td class="num">(28,436)<span></span>
</td>
<td class="nump">9,007<span></span>
</td>
<td class="num">(17,134)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income (loss)</a></td>
<td class="nump">$ 9,932<span></span>
</td>
<td class="nump">$ 3,682<span></span>
</td>
<td class="num">$ (56,175)<span></span>
</td>
<td class="num">$ (29,080)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535319499832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 227,811<span></span>
</td>
<td class="nump">$ 61,137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance of $16,241 at September 30, 2020 and $13,105 at December 31, 2019</a></td>
<td class="nump">191,892<span></span>
</td>
<td class="nump">257,769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">178,091<span></span>
</td>
<td class="nump">164,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid and refundable taxes</a></td>
<td class="nump">43,316<span></span>
</td>
<td class="nump">37,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">32,026<span></span>
</td>
<td class="nump">28,604<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">673,136<span></span>
</td>
<td class="nump">549,443<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">190,509<span></span>
</td>
<td class="nump">181,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">918,478<span></span>
</td>
<td class="nump">915,794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">583,818<span></span>
</td>
<td class="nump">607,546<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">52,834<span></span>
</td>
<td class="nump">54,372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">30,358<span></span>
</td>
<td class="nump">27,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">22,673<span></span>
</td>
<td class="nump">68,676<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">49,942<span></span>
</td>
<td class="nump">7,356<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">2,521,748<span></span>
</td>
<td class="nump">2,411,797<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current debt obligations</a></td>
<td class="nump">13,953<span></span>
</td>
<td class="nump">77,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">71,596<span></span>
</td>
<td class="nump">85,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities and other</a></td>
<td class="nump">98,308<span></span>
</td>
<td class="nump">120,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueCurrent', window );">Current litigation provision liability</a></td>
<td class="nump">34,790<span></span>
</td>
<td class="nump">146,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Taxes payable</a></td>
<td class="nump">10,118<span></span>
</td>
<td class="nump">12,719<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued employee compensation and related benefits</a></td>
<td class="nump">52,994<span></span>
</td>
<td class="nump">70,420<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">281,759<span></span>
</td>
<td class="nump">512,553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt obligations</a></td>
<td class="nump">637,109<span></span>
</td>
<td class="nump">260,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">79,603<span></span>
</td>
<td class="nump">114,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent', window );">Litigation provision liability</a></td>
<td class="nump">11,510<span></span>
</td>
<td class="nump">24,378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">28,362<span></span>
</td>
<td class="nump">32,219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">43,124<span></span>
</td>
<td class="nump">46,027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Long-term employee compensation and related benefits</a></td>
<td class="nump">23,109<span></span>
</td>
<td class="nump">22,797<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Long-term derivative liabilities</a></td>
<td class="nump">59,588<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">6,792<span></span>
</td>
<td class="nump">15,319<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">1,170,956<span></span>
</td>
<td class="nump">1,028,080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary Shares, &#163;1.00 par value: unlimited shares authorized; 49,402,628 shares issued and 48,596,417 shares outstanding at September 30, 2020; 49,411,016 shares issued and 48,443,830 shares outstanding at December 31, 2019</a></td>
<td class="nump">76,338<span></span>
</td>
<td class="nump">76,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,758,468<span></span>
</td>
<td class="nump">1,734,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(10,385)<span></span>
</td>
<td class="num">(19,392)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(472,576)<span></span>
</td>
<td class="num">(406,755)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock at cost, 806,211 ordinary shares at September 30, 2020; 967,186 ordinary shares at December 31, 2019</a></td>
<td class="num">(1,053)<span></span>
</td>
<td class="num">(1,263)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders&#8217; Equity</a></td>
<td class="nump">1,350,792<span></span>
</td>
<td class="nump">1,383,717<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders&#8217; Equity</a></td>
<td class="nump">$ 2,521,748<span></span>
</td>
<td class="nump">$ 2,411,797<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535324553976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>&#163; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>&#163; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts | $</a></td>
<td class="nump">$ 16,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in pounds per share) | &#163; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares issued (in shares)</a></td>
<td class="nump">49,402,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,411,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares outstanding (in shares)</a></td>
<td class="nump">48,596,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,443,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">806,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">967,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535322554664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (65,182)<span></span>
</td>
<td class="num">$ (11,946)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Non-cash items included in net loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax expense (benefit)</a></td>
<td class="nump">41,133<span></span>
</td>
<td class="num">(26,422)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Remeasurement of contingent consideration to fair value</a></td>
<td class="num">(31,176)<span></span>
</td>
<td class="num">(2,425)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Amortization</a></td>
<td class="nump">29,346<span></span>
</td>
<td class="nump">29,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">26,845<span></span>
</td>
<td class="nump">24,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">22,206<span></span>
</td>
<td class="nump">23,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature', window );">Remeasurement of derivative instruments</a></td>
<td class="num">(17,654)<span></span>
</td>
<td class="num">(2,948)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease assets</a></td>
<td class="nump">9,813<span></span>
</td>
<td class="nump">8,961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment of intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">50,295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="nump">5,876<span></span>
</td>
<td class="nump">7,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">65,401<span></span>
</td>
<td class="nump">5,433<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(12,141)<span></span>
</td>
<td class="num">(18,181)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other current and non-current assets</a></td>
<td class="num">(15,360)<span></span>
</td>
<td class="nump">9,575<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accounts payable and accrued current and non-current liabilities</a></td>
<td class="num">(49,547)<span></span>
</td>
<td class="num">(28,964)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable', window );">Taxes payable</a></td>
<td class="num">(615)<span></span>
</td>
<td class="num">(14,367)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_IncreaseDecreaseInLitigationProvisionLiability', window );">Litigation provision liability</a></td>
<td class="num">(124,158)<span></span>
</td>
<td class="num">(140,823)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInRestructuringReserve', window );">Restructuring reserve</a></td>
<td class="num">(1,194)<span></span>
</td>
<td class="num">(6,766)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(116,407)<span></span>
</td>
<td class="num">(94,008)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(28,445)<span></span>
</td>
<td class="num">(16,801)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_PurchasesOfInvestments', window );">Purchase of investments</a></td>
<td class="num">(3,175)<span></span>
</td>
<td class="num">(287)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireNotesReceivable', window );">Loans to investees</a></td>
<td class="num">(2,250)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(10,750)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchases of intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,186)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">533<span></span>
</td>
<td class="nump">505<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(33,337)<span></span>
</td>
<td class="num">(30,519)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt obligations</a></td>
<td class="nump">886,899<span></span>
</td>
<td class="nump">193,490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt obligations</a></td>
<td class="num">(481,360)<span></span>
</td>
<td class="num">(12,330)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths', window );">Proceeds from short term borrowings (maturities greater than 90 days)</a></td>
<td class="nump">46,717<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths', window );">Repayments of short term borrowings (maturities greater than 90 days)</a></td>
<td class="num">(44,838)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities', window );">Purchase of capped call</a></td>
<td class="num">(43,096)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="num">(20,412)<span></span>
</td>
<td class="num">(3,795)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_PaymentForDispositionOfBusinessClosingAdjustment', window );">Closing adjustment payment for sale of CRM business</a></td>
<td class="num">(14,891)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration</a></td>
<td class="num">(8,860)<span></span>
</td>
<td class="num">(17,989)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares repurchased from employees for minimum tax withholding</a></td>
<td class="num">(5,277)<span></span>
</td>
<td class="num">(6,183)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans', window );">Proceeds from share issuances under ESPP</a></td>
<td class="nump">2,063<span></span>
</td>
<td class="nump">2,574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess', window );">Change in short-term borrowing, net</a></td>
<td class="num">(1,043)<span></span>
</td>
<td class="num">(2,173)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">315,927<span></span>
</td>
<td class="nump">153,741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">491<span></span>
</td>
<td class="num">(1,105)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">166,674<span></span>
</td>
<td class="nump">28,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">61,137<span></span>
</td>
<td class="nump">47,204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 227,811<span></span>
</td>
<td class="nump">$ 75,313<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_IncreaseDecreaseInLitigationProvisionLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Litigation Provision Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_IncreaseDecreaseInLitigationProvisionLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_PaymentForDispositionOfBusinessClosingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment For Disposition Of Business, Closing Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_PaymentForDispositionOfBusinessClosingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_PurchasesOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchases Of Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_PurchasesOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remeasurement Of Capped Call And Embedded Exchange Feature</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInRestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the carrying amount (including both current and noncurrent portions of the accrual) of the liability pertaining to the exit from or disposal of business activities or restructuring pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination and to asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInRestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3505-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3098-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment of more than three months but less than one year or one operating cycle (if the normal cycle is more than one year).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from a repayment of a borrowing having initial term of repayment of more than three months but less than one year or one operating cycle (if the normal cycle is more than one year).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535317287976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Unaudited Condensed Consolidated Financial Statements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Unaudited Condensed Consolidated Financial Statements</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 1. Unaudited Condensed Consolidated Financial Statements </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Basis of Presentation </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The accompanying condensed consolidated financial statements of LivaNova as of, and for the three and nine months ended September 30, 2020 and 2019, have been prepared in accordance with U.S. GAAP for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. The accompanying condensed consolidated balance sheet of LivaNova at December 31, 2019 has been derived from audited financial statements contained in our 2019 Form 10-K, but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, the condensed consolidated financial statements reflect all adjustments (consisting of only normal recurring adjustments) considered necessary for a fair statement of the operating results of LivaNova and its subsidiaries, for the three and nine months ended September 30, 2020, and are not necessarily indicative of the results that may be expected for the year ending December 31, 2020. The financial information presented herein should be read in conjunction with the audited consolidated financial statements and notes thereto accompanying our 2019 Form 10-K.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Recent Developments Regarding COVID-19</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Due to the COVID-19 pandemic (&#8220;COVID-19&#8221;), we have experienced and may continue to experience significant and unpredictable reductions in the demand for our products as healthcare customers have diverted medical resources and priorities towards the treatment of COVID-19. In addition, public health bodies have delayed elective procedures during the COVID-19 pandemic, which has negatively impacted the usage of our products, including the number of Neuromodulation procedures. Further, some people are avoiding seeking treatment for non-COVID-19 emergency procedures, which has also negatively impacted the demand for our products. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We are seeing signs of stabilization in certain geographies as elective surgeries resume and expect this trend to continue on a global basis during the fourth quarter of 2020. We expect elective procedure recovery rates to vary by country, and to be impacted by COVID-19 case volumes, hospital occupancy and staffing levels, patient&#8217;s willingness to re-book previously deferred procedures, travel restrictions, transportation limitations, quarantine restrictions, economic uncertainty and potential COVID-19 resurgence. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Reclassifications</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We have reclassified certain prior period amounts for comparative purposes. These reclassifications did not have a material effect on our financial condition, results of operations or cash flows.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Significant Accounting Policies</span></div>Our significant accounting policies are detailed in &#8220;Note 2. Basis of Presentation, Use of Accounting Estimates and Significant Accounting Policies&#8221; and &#8220;Note 3. Revenue Recognition&#8221; of our 2019 Form 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535318414456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 2. Business Combinations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Miami Instruments </span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On June 12, 2019, we acquired the minimally invasive cardiac surgery instruments business from Miami Instruments, LLC (&#8220;Miami Instruments&#8221;) for cash consideration of up to&#160;$17.0 million. The related operations have been integrated into our Cardiovascular segment as a part of our Heart Valves business. Cash of&#160;$10.8 million&#160;was paid at closing with up to&#160;$6.0 million&#160;in contingent consideration based on achieving certain milestones. The purchase price allocation for the Miami Instruments acquisition was finalized during the second quarter of 2020 and resulted in no measurement period adjustments. In connection with this acquisition, we recognized $14.7 million in developed technology and in-process research and development (&#8220;IPR&amp;D&#8221;) intangible assets and $1.5 million in goodwill.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535318673688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Discontinued Operations</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 3. Discontinued Operations </span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On April 30, 2018, we completed the sale of our Cardiac Rhythm Management (&#8220;CRM&#8221;) business to MicroPort Cardiac Rhythm B.V. and MicroPort Scientific Corporation (&#8220;MicroPort&#8221;) for total cash proceeds of $195.9 million, less cash transferred of $9.2 million, subject to a closing working capital adjustment. In March 2020, we finalized the working capital adjustment and as a result, made a $16.4 million payment to MicroPort during the first quarter of 2020 and incurred an additional $1.0 million loss on sale, net of a $0.1&#160;million tax benefit.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535317054488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 4. Restructuring</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We initiate restructuring plans to leverage economies of scale, streamline distribution and logistics, and strengthen operational and administrative effectiveness in order to reduce overall costs. Costs associated with these plans were reported as restructuring expenses in the operating results of our condensed consolidated statements of income (loss). </span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides a reconciliation of the beginning and ending balance of the accruals and other reserves recorded in connection with our restructuring plans included within accrued liabilities and other and other long-term liabilities on the condensed consolidated balance sheet (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:49.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.146%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Severance and Other Termination Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(792)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,672)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,850&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:right"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table presents restructuring expense by reportable segment (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:34.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(401)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(349)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,563&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535317269000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Remediation Liability<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ProductRemediationAbstract', window );"><strong>Product Remediation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ProductRemediationTextBlock', window );">Product Remediation Liability</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 5. Product Remediation Liability</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On December 29, 2015, we received an FDA Warning Letter (the &#8220;Warning Letter&#8221;) alleging certain violations of FDA regulations applicable to medical device manufacturing at our Munich, Germany and Arvada, Colorado facilities. On October 13, 2016, the CDC and FDA separately released safety notifications regarding 3T Heater-Cooler devices in response to which we issued a Field Safety Notice Update for U.S. users of our 3T Heater-Cooler devices to proactively and voluntarily contact facilities to facilitate implementation of the CDC and FDA recommendations.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">At December 31, 2016, we recognized a liability for a product remediation plan related to our 3T Heater-Cooler device (&#8220;3T device&#8221;). The remediation plan consists primarily of a modification of the 3T device design to include internal sealing and the addition of a vacuum system to new and existing devices. These changes are intended to address regulatory actions and to reduce further the risk of possible dispersion of aerosols from 3T devices in the operating room. We concluded that it was probable that a liability had been incurred upon management&#8217;s approval of the plan and the commitments made by management to various regulatory authorities globally in November and December 2016, and furthermore, the cost associated with the plan was reasonably estimable. The deployment of this solution for commercially distributed devices has been dependent upon final validation and verification of the design changes and approval or clearance by regulatory authorities worldwide. It is reasonably possible that our estimate of the remediation liability could materially change in future periods due to the various significant assumptions involved such as customer behavior, market reaction and the timing of approvals or clearance by regulatory authorities worldwide.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In April 2017, we obtained CE Mark in Europe for the design change, and in May 2017 we completed our first vacuum canister and internal sealing upgrade on a customer-owned device. In October 2018, the FDA concluded that we could commence the vacuum canister and internal sealing upgrade program in the U.S., and on February 25, 2020, LivaNova received clearance for K191402, a 510(k) for the 3T devices that addressed issues contained in the 2015 Warning Letter along with design changes that further mitigate the potential risk of aerosolization. Concurrent with this clearance, (1) 3T devices manufactured in accordance with K191402 will not be subjected to the import alert previously issued by the FDA and (2) LivaNova initiated a correction to distribute the updated Operating Instructions cleared under K191402. We continue to implement the vacuum canister and internal sealing upgrade program in as many countries as possible until all devices are upgraded.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> As a second part of the remediation plan, we continue to offer a no-charge deep disinfection service (deep cleaning service) for 3T device users as we receive the required regulatory approvals. The deep disinfection service was rolled out in Europe in the second half of 2015, and in April 2018, the FDA agreed to allow us to move forward with the deep cleaning service in the U.S., thereby adding to the growing list of countries around the world in which we offer this service. Finally, we continue to offer the loaner program for 3T devices, initiated in the fourth quarter of 2016, to provide existing 3T device users with a new loaner 3T device at no charge pending regulatory approval and implementation of the vacuum system addition and deep disinfection service worldwide. </span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides a reconciliation of the beginning and ending balance of the product remediation liability included within accrued liabilities and other on the condensed consolidated balance sheet (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remediation activity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,982)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in foreign currency exchange rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,715&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We recognized product remediation expenses of $1.1 million and $3.1 million during the three months ended September 30, 2020 and 2019, respectively, and $6.9 million and $11.1 million during the nine months ended September 30, 2020 and 2019, respectively. Product remediation expenses include internal labor costs, costs to remediate certain inspectional observations made by the FDA at our Munich facility and costs associated with the incorporation of the modification of the 3T device design into the next generation 3T device. These costs and related legal costs are expensed as incurred and are not included within the product remediation liability presented above. At September&#160;30, 2020, our balance sheet includes a&#160;$46.3 million&#160;provision related to litigation involving our 3T device. For further information, please refer to &#8220;Note 10. Commitments and Contingencies.&#8221;</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_ProductRemediationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Remediation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_ProductRemediationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_ProductRemediationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Remediation [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_ProductRemediationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535317028952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTextBlock', window );">Investments</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 6. Investments</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table details the carrying value of our investments in equity securities of non-consolidated affiliates without readily determinable fair values for which we do not exert significant influence over the investee. These equity investments are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The below equity investments are included in investments on the condensed consolidated balance sheets (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.371%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity Investments Without Readily Determinable Fair Values</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Respicardia Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALung Technologies, Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceribell, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ShiraTronics, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MD Start II</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rainbow Medical Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Highlife S.A.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,944&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,805&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,256&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Respicardia Inc. (&#8220;Respicardia&#8221;) is a privately funded U.S. company developing an implantable device designed to restore a more natural breathing pattern during sleep in patients with central sleep apnea by transvenously stimulating the phrenic nerve. We have a loan outstanding to Respicardia, with a carrying amount of $0.8 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$0.6 million as of September&#160;30, 2020 and December 31, 2019, respectively, which is included in prepaid expenses and other current assets on the condensed consolidated balance sheet.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">During the first quarter of 2020, we invested in ALung Technologies, Inc. (&#8220;ALung&#8221;). ALung is a privately held medical device company focused on creating advanced medical devices for treating respiratory failure. ALung&#8217;s Hemolung Respiratory Assist System is a dialysis-like alternative or supplement to mechanical ventilation which removes carbon dioxide directly from the blood in patients with acute respiratory failure. During the second quarter of 2020, we provided a convertible loan to ALung for $2.0&#160;million, due July 10, 2021. As of September&#160;30, 2020, the carrying amount of the loan was $2.0 million, which is included in prepaid expenses and other current assets on the condensed consolidated balance sheet.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI http://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI http://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535317257592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 7. Fair Value Measurements</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We review the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain securities within the fair value hierarchy. There were no transfers between Level 1, Level 2, or Level 3 during the nine months ended September 30, 2020 and 2019.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following tables provide information by level for assets and liabilities that are measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;Value Measurements Using Inputs Considered as:</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets - designated as cash flow hedges (foreign currency exchange rate &#8220;FX&#8221;)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets - freestanding instruments (FX)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets - capped call derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - freestanding instruments (interest rate swaps)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - freestanding instruments (FX) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - embedded exchange feature</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration arrangements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,146&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,922&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;Value Measurements Using Inputs Considered as:</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets - designated as cash flow hedges (FX)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets - freestanding instruments (FX)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - designated as cash flow hedges (FX)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - designated as cash flow hedges (interest rate swaps)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - freestanding instruments (FX) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration arrangements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,029&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,680&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides a reconciliation of the beginning and ending balances of our recurring fair value measurements, using significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capped Call Derivative Asset</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Embedded Exchange Feature Derivative Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Derivative Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability Arrangements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Convertible Notes Receivable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,868)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) (3) (4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,097)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in foreign currency exchange rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,999&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,398&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,174&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,571&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,999&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,398&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,603&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:2pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">During the nine months ended September 30, 2020, we paid $8.8 million under the contingent consideration arrangement for the acquisition of CardiacAssist, Inc., doing business as TandemLife (&#8220;TandemLife&#8221;). Additionally, we made final payments under contingent consideration arrangements resulting from the acquisitions of two distributors. </span></div><div style="margin-bottom:2pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">The contingent consideration change in fair value during the nine months ended September 30, 2020 is primarily due to a one-year delay in the projected achievement of a certain regulatory milestone and timing of sales-based earnout payments for ImThera Medical Inc. (&#8220;ImThera&#8221;), and the impact of an increase in discount rates utilized in the valuation of contingent consideration. Refer to the tables below for further information regarding the fair value measurements of contingent consideration.</span></div><div style="margin-bottom:2pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">During the nine months ended September 30, 2020, the contingent consideration change in fair value resulted in a decrease of $19.2 million and $12.0 million recorded to cost of sales - exclusive of amortization and research and development, respectively.</span></div><div style="margin-bottom:6pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Changes in the fair value of the embedded exchange feature derivative and capped call derivatives are recognized in foreign exchange and other gains (losses) in the condensed consolidated statements of income (loss).</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Embedded Exchange Feature and Capped Call Derivatives</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In June 2020, the Company issued $287.5&#160;million in cash exchangeable senior notes and entered into related capped call transactions. The cash exchangeable senior notes include an embedded exchange feature that is bifurcated from the cash exchangeable senior notes. Please refer to &#8220;Note 8. Financing Arrangements&#8221; for further details. The embedded exchange feature derivative is measured at fair value using a binomial lattice model and discounted cash flows that utilize observable and unobservable market data. The capped call derivative is measured at fair value using the Black-Scholes model utilizing observable and unobservable market data, including stock price, remaining contractual term, expected volatility, risk-free interest rate and expected dividend yield, as applicable.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The embedded exchange feature and capped call derivatives are classified as Level 3 as the Company uses historical volatility and implied volatility from options traded to determine expected stock price volatility which is an unobservable input that is significant to the valuation. In general, an increase in our stock price or stock price volatility would increase the fair value of the embedded exchange feature and capped call derivatives which would result in an increase in expense. As time to the expiration of the derivatives decreases with passage of time, the fair value of the derivatives would decrease. The future impact on net income depends on how significant inputs such as stock price, stock price volatility and time to the expiration of the derivatives change in relation to other inputs.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The stock price volatility as of September&#160;30, 2020 was 37%. As of September&#160;30, 2020, a 10% lower volatility, holding other inputs constant, would result in approximate fair value for the embedded exchange feature derivative of $42.4 million and a 10% higher volatility, holding other inputs constant, would result in approximate fair value of $76.4 million. As of September&#160;30, 2020, a 10% lower volatility, holding other inputs constant would result in approximate fair value for the capped call derivatives of $29.3 million and a 10% higher volatility, holding other inputs constant, would result in approximate fair value of $42.3 million.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Contingent Consideration Arrangements</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides the fair value of our Level 3 contingent consideration arrangements by acquisition (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.301%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ImThera</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,603&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TandemLife</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miami Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drilltex</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,174&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The ImThera business combination involved contingent consideration arrangements composed of potential cash payments upon the achievement of a certain regulatory milestone and a sales-based earnout associated with sales of products. The sales-based earnout is valued using projected sales from our internal strategic plan. Both arrangements are Level 3 fair value measurements and include the following significant unobservable inputs as of September&#160;30, 2020:</span></div><div style="margin-bottom:14pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.163%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.484%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.192%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ImThera Acquisition</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ranges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory milestone-based payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected payment year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-based earnout</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monte Carlo simulation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-adjusted discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit risk discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected years of earnout</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The TandemLife business combination involved a contingent consideration arrangement composed of potential cash payments upon the achievement of certain regulatory milestones. The arrangement is a Level 3 fair value measurement and includes the following significant unobservable inputs as of September&#160;30, 2020:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:29.939%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.170%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.175%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TandemLife Acquisition</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ranges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory milestone-based payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected payment years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Miami Instruments business combination involved a contingent consideration arrangement composed of potential cash payments upon the achievement of certain regulatory milestones. The arrangement is a Level 3 fair value measurement and includes the following significant unobservable inputs as of September&#160;30, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:29.939%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.170%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.175%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Miami Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ranges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory milestone-based payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected payment years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535317265960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Arrangements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Financing Arrangements</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 8. Financing Arrangements</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The carrying amount of our long-term debt as of September&#160;30, 2020 and December 31, 2019 was as follows (in thousands, except interest rates):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.030%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.198%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Senior Secured Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422,960&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">LIBOR (1% Floor)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Cash Exchangeable Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank of America Merrill Lynch Banco M&#250;ltiplo S.A.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.61%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mediocredito Italiano</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.77%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank of America, U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.08%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Debt Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 European Investment Bank</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014 European Investment Bank</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,041&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term facilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646,801&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,511&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637,109&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,330&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Revolving Credit</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The outstanding principal amount of our short-term unsecured revolving credit agreements and other agreements with various banks was $4.3 million and $4.2 million, at September&#160;30, 2020 and December 31, 2019, respectively, with interest rates ranging from 3.21% to 7.20% and loan terms ranging from overnight to 10 months, as of September&#160;30, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">2020 Senior Secured Term Loan</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On June 10, 2020, we entered into a $450.0&#160;million five-year senior secured term loan (the &#8220;Term Loan&#8221;) through our wholly owned subsidiary LivaNova USA Inc., with funds managed by affiliates of Ares Management Corporation, as administrative agent and collateral agent, resulting in cash proceeds of approximately $421.7&#160;million, net of discounts and issuance costs. The obligations under the Term Loan are guaranteed on a senior secured basis by each of LivaNova&#8217;s existing and future wholly owned material subsidiaries, and are secured by a perfected first priority security interest in substantially all tangible and intangible assets of LivaNova and certain U.S. and UK subsidiaries of LivaNova, subject in each case to certain exceptions contained in the Term Loan. Borrowings under the Term Loan bear interest at a variable annual rate equal to the three-month LIBOR rate (subject to a 1% floor), plus an applicable margin of 6.5% per annum. The effective interest rate of the Term Loan at September&#160;30, 2020 was 9.0%. The Term Loan will mature on June&#160;30, 2025 and includes certain affirmative, negative and financial covenants. The financial covenants under the Term Loan state (i) the net revenue of LivaNova PLC, LivaNova USA, Inc. and any restricted subsidiaries on a consolidated basis shall not be lower than $700&#160;million for each trailing 12 month period, such threshold to decrease pro rata (not below $550&#160;million) upon prepayments of the Term Loan made by LivaNova USA, Inc. out of the proceeds of certain asset sales, and (ii) the total secured leverage ratio (as defined in the debt agreement) for LivaNova PLC, LivaNova USA, Inc. and any restricted subsidiaries on a consolidated basis shall not be greater than the applicable ratio set forth below:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Test Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Secured Leverage Ratio</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 Quarters ending June 30, 2020 through each fiscal quarter thereafter until (and including) the fiscal quarter ending June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.625</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 Quarters ending September 30, 2021 and ending each fiscal quarter thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00</span></td></tr></table></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Debt discounts and issuance costs related to the Term Loan were approximately $28.3&#160;million and included various legal, bank and accounting fees. Amortization of debt discount and issuance costs was $1.1 million and $1.3 million for the three and nine months ended September 30, 2020, respectively, and was included in interest expense on the condensed consolidated statement of income (loss).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">2020 Cash Exchangeable Senior Notes </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On June 17, 2020, our wholly-owned subsidiary, LivaNova USA, Inc., issued $287.5&#160;million aggregate principal amount of 3.00% cash exchangeable senior notes (the &#8220;Notes&#8221;) by private placement to qualified institutional buyers pursuant to Rule </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">144A under the Securities Act of 1933, as amended. The sale of the Notes resulted in approximately $278.0&#160;million in net proceeds to the Company after deducting issuance costs. Interest is payable semiannually in arrears on June 15 and December 15 of each year, beginning on December 15, 2020. The effective interest rate of the Notes at September&#160;30, 2020 was 9.9%. The Notes mature on December&#160;15, 2025 unless earlier exchanged, repurchased, or redeemed.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Debt discounts and issuance costs related to the Notes were approximately $82.0&#160;million and included $75.0&#160;million of discount attributable to the embedded exchange feature, discussed below, and $7.0&#160;million of allocated issuance costs to the Notes related to legal, bank and accounting fees. Amortization of debt discount and issuance costs was $3.0 million and $3.4 million for the three and nine months ended September 30, 2020 and is included in interest expense on the condensed consolidated statement of income (loss).</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Notes are exchangeable at the option of the holders only under certain circumstances and solely into cash in an amount based on the trading prices of LivaNova&#8217;s ordinary shares during a related observation period. The Notes are not exchangeable into ordinary shares of LivaNova or any other security under any circumstances. The initial exchange rate for the Notes is 16.3980 ordinary shares per $1,000 principal amount of Notes (equivalent to an initial exchange price of approximately $60.98 per share). The exchange rate is subject to adjustment in certain circumstances, as set forth in the indenture governing the Notes.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Company may redeem the Notes at its option, on or after June 20, 2023, in whole or in part, if the last reported sale price per ordinary share has been at least 130% of the exchange price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. Additionally, the Company may redeem the Notes at its option, prior to December 15, 2025, in whole but not in part, in connection with certain tax-related events.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Embedded Exchange Feature</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The embedded exchange feature of the Notes requires bifurcation from the Notes and is accounted for as a derivative liability. The fair value of the Notes&#8217; embedded exchange feature derivative at the time of issuance was $75.0&#160;million and was recorded as debt discount on the Notes. This discount is amortized as interest expense using the effective interest method over the term of the Notes. The Notes&#8217; embedded exchange feature derivative is carried on the condensed consolidated balance sheets at its estimated fair value and is adjusted at the end of each reporting period, with unrealized gain or loss reflected in the consolidated statements of income (loss). The fair value of the embedded exchange feature derivative liability was $59.4 million as of September&#160;30, 2020. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Capped Call Transactions</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In connection with the pricing of the Notes, the Company entered into privately negotiated capped call transactions with certain of the initial purchasers of the Notes or their respective affiliates. The capped call transactions cover, subject to anti-dilution adjustments substantially similar to those applicable to the Notes, the number of LivaNova&#8217;s ordinary shares underlying the Notes and are expected generally to offset any cash payments the Company is required to make upon exchange of the Notes in excess of the principal amount thereof in the event that the market value per ordinary share, as measured under the capped call transactions, is greater than the strike price of the capped call transactions, with such offset being subject to an initial cap price of $100.00 per share. The aggregate cost of the capped calls derivative assets was $43.1&#160;million. The capped call transactions expire on December 15, 2025 and must be settled in cash. The capped calls are carried on the condensed consolidated balance sheets as a derivative asset at their estimated fair value and are adjusted at the end of each reporting period, with unrealized gain or loss reflected in the condensed consolidated statement of income (loss). The fair value of capped call derivative assets was $39.0 million as of September&#160;30, 2020.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The current and non-current classification is evaluated at each balance sheet date and may change depending on whether any exchange conditions are met. As of September&#160;30, 2020, no exchange conditions have been met and the Notes, embedded exchange feature derivative liability, and the capped call derivative assets are classified as non-current. Please refer to &#8220;Note 7. Fair Value Measurements&#8221; for details on the valuation of the embedded exchange feature derivative liability and capped call derivative assets.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Extinguishment of Debt</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Company used the net proceeds from the Term Loan, together with a portion of the net proceeds of the Notes, after fees, discounts, commissions and other expenses, to repay outstanding indebtedness under the Company&#8217;s 2017 European Investment Bank loan, 2014 European Investment Bank loan, Banca Nazionale del Lavoro S.p.A loan, and 2019 Debt Facility and related </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">expenses. The Company repaid approximately $528.0&#160;million in aggregate outstanding principal, accrued interest and associated fees, including breakage fees and legal fees. The Company recognized a loss on debt extinguishment of $1.4&#160;million during the nine months ended September 30, 2020. The loss on debt extinguishment was recognized in foreign exchange and other losses in the condensed consolidated statements of income (loss).</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The remainder of the proceeds from the concurrent financing transactions were used to pay the cost of capped call transactions and for general corporate purposes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535318775048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Risk Management<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivatives and Risk Management</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 9. Derivatives and Risk Management</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Due to the global nature of our operations, we are exposed to foreign currency exchange rate fluctuations. We enter into FX derivative contracts to reduce the impact of foreign currency exchange rate fluctuations on earnings and cash flow. We are also exposed to equity price risk in connection with our Notes, including exchange and settlement provisions based on the price of our ordinary shares at exchange or maturity of the Notes. In addition, the capped call transactions associated with the Notes also include settlement provisions that are based on the price of our ordinary shares, subject to a capped price per share.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We measure all outstanding derivatives each period end at fair value and report the fair value as either financial assets or liabilities on the condensed consolidated balance sheets. We do not enter into derivative contracts for speculative purposes. At inception of the contract, the derivative is designated as either a freestanding derivative or a hedge. Derivatives that are not designated as hedging instruments are referred to as freestanding derivatives with changes in fair value included in earnings.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If the derivative qualifies for hedge accounting, changes in the fair value of the derivative will be recorded in&#160;accumulated other comprehensive income (&#8220;AOCI&#8221;) until the hedged item is recognized in earnings upon settlement/termination. FX derivative gains and losses in AOCI are reclassified to our condensed consolidated statements of income (loss) as shown in the tables below. We evaluate hedge effectiveness at inception. Cash flows from derivative contracts are reported as operating activities on our condensed consolidated statements of cash flows.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Freestanding FX Derivative Contracts</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The gross notional amount of FX derivative contracts not designated as hedging instruments outstanding at September&#160;30, 2020 and December 31, 2019 was $332.2 million and $338.0 million, respectively. These derivative contracts are designed to offset the FX effects in earnings of various intercompany loans and trade receivables. We recorded net (losses) gains for these freestanding derivatives of $(11.7) million and $3.1 million for the three months ended September 30, 2020 and 2019, respectively, and $(4.8) million and $6.8 million for the nine months ended September 30, 2020 and 2019, respectively. These (losses) and gains are included in foreign exchange and other gains (losses) on our condensed consolidated statement of income (loss).</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Counterparty Credit Risk</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We are exposed to credit risk in the event of non-performance by the counterparties to our derivatives at maturity. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The two counterparties to the capped call transactions are financial institutions. To limit our credit risk, we selected financial institutions with a minimum long-term investment grade credit rating. Our exposure to the credit risk of the counterparties is not secured by any collateral.  If a counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings, with a claim equal to our exposure at that time under the capped call transactions with that counterparty.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">To manage credit risk with respect to our other derivatives, the Company selects and periodically reviews counterparties based on credit ratings, limits its exposure with respect to each counterparty, and monitors the market positions. However, if one or more of these counterparties were in a liability position to the Company and were unable to meet their obligations, any transactions with the counterparty could be subject to early termination, which could result in substantial losses for the Company.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cash Flow Hedges</span></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The gross notional amounts of open derivative contracts designated as cash flow hedges at September&#160;30, 2020 and December 31, 2019 were as follows (in thousands):</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.372%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Derivative Contract</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts to be exchanged for British Pounds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts to be exchanged for Japanese Yen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts to be exchanged for Euros</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,186&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,750&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Interest rate swap contracts were de-designated upon the repayment of the 2014 European Investment Bank loan. Refer to &#8220;Note 8. Financing Arrangements.&#8221;</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">After-tax net loss associated with derivatives designated as cash flow hedges recorded in the ending balance of AOCI and the amount expected to be reclassified to earnings in the next twelve months are as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.372%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Derivative Contract</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After-Tax Net Gain in AOCI as of September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After-Tax Net Gain in AOCI as of Amount Expected to be Reclassified to Earnings in Next 12 Months</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pre-tax gains (losses) for derivative contracts designated as cash flow hedges recognized in other comprehensive income (loss) (&#8220;OCI&#8221;) and the amount reclassified to earnings from AOCI were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.148%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Derivative Contract</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location in Earnings of Reclassified Gain or Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains Recognized in OCI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Losses) Gains Reclassified from AOCI to Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Losses Recognized in OCI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (Losses) Reclassified from AOCI to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange and other gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(692)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(689)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(742)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(689)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.148%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Derivative Contract</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location in Earnings of Reclassified Gain or Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains Recognized in OCI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Losses) Gains Reclassified from AOCI to Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains Recognized in OCI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (Losses) Reclassified from AOCI to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange and other gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,470)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(681)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We offset fair value amounts associated with our derivative instruments on our condensed consolidated balance sheets that are executed with the same counterparty under master netting arrangements. Our netting arrangements include a right to set off or net together purchases and sales of similar products in the settlement process.</span></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following tables present the fair value and the location of derivative contracts reported on the condensed consolidated balance sheets (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:27.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.491%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.493%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expense and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capped call derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Embedded exchange feature</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term derivative liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term derivative liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,051&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,972&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,838&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,972&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:27.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.491%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.493%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term derivative liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,680&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">For the classification of inputs used to evaluate the fair value of our derivatives, refer to &#8220;Note 7. Fair Value Measurements.&#8221;</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535318586952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 10. Commitments and Contingencies</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">FDA Warning Letter</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On December&#160;29, 2015, the FDA issued a Warning Letter alleging certain violations of FDA regulations applicable to medical device manufacturers at our Munich, Germany and Arvada, Colorado facilities. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The FDA inspected the Munich facility from August 24, 2015 to August 27, 2015 and the Arvada facility from August 24, 2015 to September 1, 2015. On August&#160;27, 2015, the FDA issued a Form 483 identifying two observed non-conformities with certain regulatory requirements at the Munich facility. We did not receive a Form 483 in connection with the FDA&#8217;s inspection of the Arvada facility. Following the receipt of the Form 483, we provided written responses to the FDA describing corrective and preventive actions that were underway or to be taken to address the FDA&#8217;s observations at the Munich facility. The Warning Letter responded in part to our responses and identified other alleged violations related to the manufacture of our 3T Heater-Cooler device that were not previously included in the Form 483. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Warning Letter further stated that our 3T devices and other devices we manufactured at our Munich facility were subject to refusal of admission into the U.S. until resolution of the issues set forth by the FDA in the Warning Letter. The FDA had informed us that the import alert was limited to the 3T devices, but that the agency reserved the right to expand the scope of the import alert if future circumstances warranted such action. The Warning Letter did not request that existing users cease using the 3T device, and manufacturing and shipment of all of our products other than the 3T device were unaffected by the import limitation. To help clarify these issues for current customers, we issued an informational Customer Letter in January 2016 and that same month agreed with the FDA on a process for shipping 3T devices to existing U.S. users pursuant to a certificate of medical necessity program. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Finally, the Warning Letter stated that premarket approval applications for Class III devices to which certain Quality System regulation deviations identified in the Warning Letter were reasonably related would not be approved until the violations had been corrected; however, this restriction applied only to the Munich and Arvada facilities, which do not manufacture or design devices subject to Class III premarket approval. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On February 25, 2020, LivaNova received clearance for K191402, a 510(k) for the 3T devices that addressed issues contained in the 2015 Warning Letter along with design changes that further mitigate the potential risk of aerosolization. Concurrent with this clearance, (1) 3T devices manufactured in accordance with K191402 will not be subjected to the import alert and (2) LivaNova initiated a correction to distribute the updated Operating Instructions cleared under K191402.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We continue to work diligently to remediate the FDA&#8217;s inspectional observations for the Munich facility, as well as the additional issues identified in the Warning Letter. We take these matters seriously and intend to respond timely and fully to the FDA&#8217;s requests. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">CDC and FDA Safety Communications and Company Field Safety Notice</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On October 13, 2016, the CDC and the FDA separately released safety notifications regarding the 3T devices. The CDC&#8217;s Morbidity and Mortality Weekly Report (&#8220;MMWR&#8221;) and Health Advisory Notice (&#8220;HAN&#8221;) reported that tests conducted by the CDC and its affiliates indicate that there appears to be genetic similarity between both patient and 3T device strains of the non-tuberculous mycobacterium (&#8220;NTM&#8221;) bacteria M. chimaera isolated in hospitals in Iowa and Pennsylvania. Citing the geographic separation between the two hospitals referenced in the investigation, the report asserts that 3T devices manufactured prior to August 18, 2014 could have been contaminated during the manufacturing process. The CDC&#8217;s HAN and FDA&#8217;s Safety Communication, issued contemporaneously with the MMWR report, each assess certain risks associated with 3T devices and provide guidance for providers and patients. The CDC notification states that the decision to use the 3T device during a surgical operation is to be taken by the surgeon based on a risk approach and on patient need. Both the CDC&#8217;s and FDA&#8217;s communications confirm that 3T devices are critical medical devices and enable doctors to perform life-saving cardiac surgery procedures. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Also on October 13, 2016, concurrent with the CDC&#8217;s HAN and FDA&#8217;s Safety Communication, we issued a Field Safety Notice Update for U.S. users of 3T devices to proactively and voluntarily contact facilities to aid in implementation of the CDC and FDA recommendations. In the fourth quarter of 2016, we initiated a program to provide existing 3T device users with a new loaner 3T device at no charge pending regulatory approval and implementation of additional risk mitigation strategies worldwide, including a vacuum canister and internal sealing upgrade program and a deep disinfection service. This loaner program is available on a global basis. We anticipate that this program will continue until we are able to address customer needs through a broader solution that includes implementation of the risk mitigation strategies described above. We are currently implementing the vacuum and sealing upgrade program in as many countries as possible until all devices are upgraded. On October 11, 2018, after review of information provided by us, the FDA concluded that we could commence the vacuum and </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">sealing upgrade program in the U.S., and on February 25, 2020, LivaNova received clearance for K191402, a 510(k) for the 3T devices that addressed issues contained in the 2015 Warning Letter along with design changes that further mitigate the potential risk of aerosolization. Furthermore, we continue to offer a no-charge deep disinfection service (deep cleaning service) for 3T device users as we receive the required regulatory approvals. The deep disinfection service was rolled out in Europe in the second half of 2015, and on April 12, 2018, the FDA agreed to allow us to move forward with the deep cleaning service in the U.S. thereby adding to the growing list of countries around the world in which we offer this service. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On December&#160;31, 2016, we recognized a liability for our product remediation plan related to our 3T device. We concluded that it was probable that a liability had been incurred upon management&#8217;s approval of the plan and the commitments made by management to various regulatory authorities globally in November and December 2016, and furthermore, the cost associated with the plan was reasonably estimable. At September&#160;30, 2020, the product remediation liability was $1.7 million. Refer to &#8220;Note 5. Product Remediation Liability&#8221; for additional information.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Litigation</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Product Liability</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Company is currently involved in litigation involving our 3T device. The litigation includes a class action complaint in the U.S. District Court for the Middle District of Pennsylvania, federal multi-district litigation in the U.S. District Court for the Middle District of Pennsylvania, various U.S. state court cases and cases in jurisdictions outside the U.S. The class action, filed in February 2016, consists of all Pennsylvania residents who underwent open heart surgery at WellSpan York Hospital and Penn State Milton S. Hershey Medical Center between 2011 and 2015 and who currently are asymptomatic for NTM infection.&#160;Members of the class seek declaratory relief that the 3T devices are defective and unsafe for intended uses, medical monitoring, damages, and attorneys&#8217; fees.&#160;</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On March 29, 2019, we announced a settlement framework that provides for a comprehensive resolution of the personal injury cases pending in the multi-district litigation in U.S. federal court, the related class action pending in federal court, as well as certain cases in state courts across the United States. The agreement, which makes no admission of liability, is subject to certain conditions, including acceptance of the settlement by individual claimants and provides for a total payment of up to $225 million to resolve the claims covered by the settlement. Per the agreed-upon terms, the first payment of $135 million was paid into a qualified settlement fund in July 2019 and the second payment of $90 million was paid in January 2020. Cases covered by the settlement are being dismissed as amounts are disbursed to individual plaintiffs from the qualified settlement fund.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cases in state courts in the U.S. and in jurisdictions outside the U.S. continue to progress. As of October&#160;29, 2020, including the cases encompassed in the settlement framework described above that have not yet been dismissed, we are aware of approximately 85&#160;filed and unfiled claims worldwide, with the majority of the claims in various federal or state courts throughout the United States. This includes cases that have settled but have not yet been dismissed. The complaints generally seek damages and other relief based on theories of strict liability, negligence, breach of express and implied warranties, failure to warn, design and manufacturing defect, fraudulent and negligent misrepresentation or concealment, unjust enrichment, and violations of various state consumer protection statutes. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">At September&#160;30, 2020, the provision for these matters was $46.3 million. While the amount accrued represents our best estimate, the actual liability for resolution of these matters may vary from our estimate. </span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The changes in the litigation provision liability during the nine months ended September 30, 2020 are as follows (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.375%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Litigation Provision Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation provision liability at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128,128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation provision liability at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of litigation liability at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of litigation provision liability at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,510&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Environmental Liability</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our subsidiary, Sorin S.p.A. (&#8220;Sorin&#8221;) was created as a result of a spin-off (the &#8220;Sorin spin-off&#8221;) from SNIA S.p.A. (&#8220;SNIA&#8221;) in January 2004. SNIA subsequently became insolvent and the Italian Ministry of the Environment and the Protection of Land and Sea (the &#8220;Italian Ministry of the Environment&#8221;), sought compensation from SNIA for remediation costs relating to the environmental damage at chemical sites previously operated by SNIA&#8217;s other subsidiaries.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In September 2011 and July 2014, the Bankruptcy Court of Udine and the Bankruptcy Court of Milan, respectively, held (in proceedings to which we are not parties) that the Italian Ministry of the Environment and other Italian government agencies (the &#8220;Public Administrations&#8221;) were not creditors of either SNIA or its subsidiaries in connection with their claims in the Italian insolvency proceedings. The Public Administrations appealed and in January 2016, the Court of Udine rejected the appeal. The Public Administrations has appealed that decision to the Supreme Court. Meanwhile, the Bankruptcy Court of Milan&#8217;s decision has been appealed.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In January 2012, SNIA filed a civil action against Sorin in the Civil Court of Milan asserting joint liability of a parent and a spun-off company. The Public Administrations intervened in the proceeding, with a claim for environmental damages of approximately $4 billion. On April 1, 2016, the Court of Milan dismissed all legal actions of SNIA and of the Public Administrations further requiring the Public Administrations to pay Sorin approximately &#8364;292,000&#160;(approximately $342,000 as of September&#160;30, 2020)&#160;for legal fees. The Public Administrations appealed the 2016 Decision to the Court of Appeal of Milan, and on March 5, 2019, the Court of Appeal issued a partial decision on the merits declaring Sorin/LivaNova jointly liable with SNIA for SNIA&#8217;s environmental liabilities in an amount up to the fair value of the net worth received by Sorin because of the Sorin spin-off, an estimated &#8364;572.1 million&#160;(approximately $669.1 million as of September&#160;30, 2020). Additionally the Court issued a separate order, staying the proceeding until a panel of three experts can assess the environmental damages, the costs of clean-up, and the costs that the Public Administrations has already borne for the clean-up of the sites to allow the Court to decide on the second claim of the Public Administration against LivaNova, (i.e., to refund the Public Administrations for the SNIA environmental liabilities). Both LivaNova and the Public Administrations have appealed the decision to the Italian Supreme Court (Corte di Cassazione). </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We have not recognized an expense in connection with this matter because any potential loss is not currently probable or reasonably estimable. In addition, we cannot reasonably estimate a range of potential loss, if any, that may result from this matter.</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Patent Litigation</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On May 11, 2018, Neuro and Cardiac Technologies LLC (&#8220;NCT&#8221;), a non-practicing entity, filed a complaint in the United States District Court for the Southern District of Texas asserting that the VNS Therapy System, when used with the SenTiva Model 1000 generator, infringes the claims of U.S. Patent No. 7,076,307 owned by NCT. The complaint requests damages that include a royalty, costs, interest, and attorneys&#8217; fees. On September 13, 2018, we petitioned the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office (the &#8220;Patent Office&#8221;) for an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">inter partes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">review (&#8220;IPR&#8221;) of the validity of the &#8216;307 patent, and on May 18, 2020, the Patent Office issued a Final Written Decision determining that all challenged claims are unpatentable. NCT is appealing the Final Written Decision. On March 24, 2020, we were granted our request for an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">ex parte </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">reexamination of the &#8216;307 patent, and in August, the Patent Office issued a Non-Final Rejection of all of the &#8216;307 claims. The Court has stayed the litigation pending the outcome of the IPR appeal proceeding. We have not recognized an expense in connection with this matter because any potential loss is not currently probable or reasonably estimable. In addition, we cannot reasonably estimate a range of potential loss, if any, that may result from this matter. </span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Contract Litigation</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On November 25, 2019, LivaNova received notice of a lawsuit initiated by former members of Caisson Interventional, LLC (&#8220;Caisson&#8221;), a subsidiary of the Company acquired in 2017. The lawsuit, Todd J. Mortier, as Member Representative of the former Members of Caisson Interventional, LLC v. LivaNova USA, Inc., is currently pending in the United States District Court for the District of Minnesota. The complaint alleges (i) breach of contract, (ii) breach of the covenant of good faith and fair dealing and (iii) unjust enrichment in connection with the Company&#8217;s operation of Caisson&#8217;s Transcatheter Mitral Valve Replacement (&#8220;TMVR&#8221;) program and the Company&#8217;s November 20, 2019 announcement that it was ending the TMVR program at the end of 2019. The lawsuit seeks damages arising out of the 2017 acquisition agreement, including various regulatory milestone payments. We intend to vigorously defend this claim. The Company has not recognized an expense related to this matter because any potential loss is not currently probable or reasonably estimable. In addition, we cannot reasonably estimate a range of potential loss, if any, that may result from this matter.</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Tax Litigation</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In a tax audit report received on October 30, 2009, the Regional Internal Revenue Office of Lombardy (the &#8220;Internal Revenue Office&#8221;) informed Sorin Group Italia S.r.l. that, among several issues, it was disallowing in part a tax-deductible write down of the investment in the U.S. company, Cobe Cardiovascular Inc., which Sorin Group Italia S.r.l. recognized in 2002 and deducted in five equal installments, beginning in 2002. In December 2009, the Internal Revenue Office issued notices of assessment for 2004. In December 2010 and October 2011, the Internal Revenue Office issued notices of assessment for 2005 and 2006, respectively. We challenged all three notices of assessment (for 2004, 2005 and 2006) before the relevant Provincial Tax Courts.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The total amount of losses in dispute was &#8364;62.6 million (approximately $73.2 million as of September&#160;30, 2020). On May 31, 2019, we filed an application to settle the litigation according to law N. 136/2018 and paid the required settlement balance of &#8364;1.9 million. As per law N. 136/2018, the Italian Revenue Agency reviewed the settlement and accepted the application by default on July 31, 2020. We recognized a benefit of &#8364;5.4&#160;million, approximately $6.5&#160;million, during the third quarter of 2020 as compared to the previously recognized reserve for an uncertain tax position of &#8364;15.5 million. The difference of &#8364;10.1&#160;million (approximately $11.8&#160;million as of September 30, 2020) was a fully valued deferred tax asset for net operating losses, the reversal of which does not impact the condensed consolidated statement of income (loss). </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Other Matters</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Additionally, we are the subject of various pending or threatened legal actions and proceedings that arise in the ordinary course of our business. These matters are subject to many uncertainties and outcomes that are not predictable and that may not be known for extended periods of time. Since the outcome of these matters cannot be predicted with certainty, the costs associated with them could have a material adverse effect on our consolidated net income, financial position or liquidity.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535320603336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 11. Stockholders&#8217; Equity</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The tables below present the condensed consolidated statement of stockholders&#8217; equity as of and for the three and nine months ended September 30, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.970%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.290%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares - Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,057)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,089)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(457,804)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation of shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,772)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,772)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,403&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,338&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,758,468&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,053)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,385)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472,576)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350,792&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,717,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(295,643)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,436)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,436)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,381&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,217&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,725,482&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,282)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,610)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(263,525)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495,282&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.970%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.290%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares - Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,411&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,263)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,392)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(406,755)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,383,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMi0wLTEtMS0wL3RleHRyZWdpb246NzBlNmI4NTFhNzBkNDhmYTgzNmM5ZmZkOGQwOTVkZGZfMTY_2f7bdef0-ddd7-4bfa-ad80-21e764af2e97">ASU No. 2016-13</span> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation of shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,758,468&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,053)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,385)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472,576)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350,792&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705,111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,462)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,476)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(251,579)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,381&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,217&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,725,482&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,282)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,610)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(263,525)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495,282&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Refer to &#8220;Note 17. New Accounting Pronouncements&#8221;</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The table below presents the change in each component of AOCI, net of tax, and the reclassifications out of AOCI into net income for the nine months ended September 30, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.648%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Unrealized Gain (Loss) on Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments Gain (Loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,905)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,392)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,008&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,640&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,008&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,488&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of loss from accumulated other comprehensive loss, before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of loss from accumulated other comprehensive loss, after tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,008&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,007&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,897)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,385)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(944)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,532)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,476)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,628)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,695)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,628)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,919)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of gain from accumulated other comprehensive loss, before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of gain from accumulated other comprehensive loss, after tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,215)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,215)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(506)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,628)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,134)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,450)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,160)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,610)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Taxes are not provided for foreign currency translation adjustments as translation adjustments are related to earnings that are intended to be reinvested in the countries where earned.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535317298168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Incentive Plans<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Incentive Plans</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 12. Stock-Based Incentive Plans </span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Stock-based incentive plans compensation expense is as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.918%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service-based restricted stock units (&#8220;RSUs&#8221;)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,428&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service-based stock appreciation rights (&#8220;SARs&#8221;)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market performance-based restricted stock units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating performance-based restricted stock units </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(962)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee share purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,810&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,531&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">During the nine months ended September 30, 2020, we issued stock-based compensatory awards with terms approved by the Compensation Committee of our Board of Directors. The awards with service conditions generally vest ratably over four years, subject to forfeiture unless service conditions are met. Market performance-based awards cliff vest after three years subject to the rank of our total shareholder return for the three-year period ending December 31, 2022 relative to the total shareholder returns for a peer group of companies. Operating performance-based awards cliff vest after three years subject to the achievement of certain thresholds of cumulative adjusted free cash flow for the three year period ending December 31, 2022. Compensation expense related to awards granted during 2020 for the three and nine months ended September 30, 2020 was $3.3 million and $6.6 million, respectively.</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Stock-based compensation agreements issued during the nine months ended September 30, 2020, representing potential shares and their weighted average grant date fair values by type follows (shares in thousands, fair value in dollars):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:63.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service-based SARs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service-based RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market performance-based RSUs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating performance-based RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535318629768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 13. Income Taxes</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our effective income tax rate from continuing operations for the three and nine months ended September 30, 2020 was 21.3% and (37.9)% compared with (49.6)% and 65.9% for the three and nine months ended September 30, 2019, respectively. Our effective income tax rate fluctuates based on, among other factors, changes in pretax income in countries with varying statutory tax rates, changes in valuation allowances, changes in tax credits and incentives, and changes in unrecognized tax benefits associated with uncertain tax positions. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We continually assess the realizability of our worldwide deferred tax asset and valuation allowance positions, and when the need arises, we establish or release valuation allowances accordingly.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Compared with the three months ended September 30, 2019, the change in the effective tax rate for the three months ended September 30, 2020 was primarily attributable to a discrete tax benefit due to the release of the uncertain tax position upon the settlement of tax litigation in Italy offset by a valuation allowance for certain jurisdictions outside the U.S., as compared to a U.S. federal tax benefit from a return to provision reconciliation, partially offset by the establishment of a valuation allowance for a portion of the U.S. federal and state net operating losses during the three months ended September 30, 2019. We established valuation allowances as it is more likely than not that we will be unable to realize the related historical deferred tax assets.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Compared with the nine months ended September 30, 2019, the change in the effective tax rate for the nine months ended September 30, 2020 was primarily attributable to a $42.4 million realized discrete tax benefit related to the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) and the discrete tax benefit due to the release of the uncertain tax position upon the settlement of tax litigation in Italy offset by the establishment of a $74.5&#160;million valuation allowance for the U.K. and </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">other jurisdictions outside the U.S., as compared to a release of uncertain tax positions and a U.S. federal tax benefit from a return to provision reconciliation, partly offset by the establishment of a valuation allowance for a portion of the U.S. federal and state net operating losses and attributes during the nine months ended September 30, 2019. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We operate in multiple jurisdictions throughout the world, and our tax returns are periodically audited or subjected to review by tax authorities. As a result, there is an uncertainty in income taxes recognized in our financial statements. Tax benefits totaling $4.0&#160;million and $12.9 million were unrecognized as of September&#160;30, 2020 and December 31, 2019, respectively. It is reasonably possible that, within the next twelve months, due to the settlement of uncertain tax positions with various tax authorities and the expiration of statutes of limitations, unrecognized tax benefits could decrease by up to approximately $0.7 million.</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We monitor income tax developments in countries where we conduct business. On March 27, 2020, the U.S. enacted the CARES Act which provided for a 5-year loss carryback for losses incurred in 2018-2020. We recorded a discrete tax benefit of $42.4 million to account for the effect of the CARES Act during the nine months ended September 30, 2020. Further regulations and notices as well as state legislative changes addressing conformity to the CARES Act are still pending.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535318775048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 14. Earnings Per Share </span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Reconciliation of the shares used in the basic and diluted earnings per share computations for the three and nine months ended September 30, 2020 and 2019 are as follows (in thousands):</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,395&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add effects of share-based compensation instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average&#160;shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,652&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,820&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,582&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,329&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Excluded from the computation of diluted earnings per share were stock options, SARs and restricted share units totaling 4.1 million and 1.4 million for the three months ended September 30, 2020 and 2019, respectively, and 4.2 million and 3.2 million for the nine months ended September 30, 2020 and 2019, respectively, because to include them would have been anti-dilutive under the treasury stock method.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535318490968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Geographic and Segment Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Geographic and Segment Information</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 15. Geographic and Segment Information </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We identify operating segments based on the way we manage, evaluate and internally report our business activities for purposes of allocating resources, developing and executing our strategy, and assessing performance. We have two reportable segments: Cardiovascular and Neuromodulation.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Cardiovascular segment generates its revenue from the development, production and sale of cardiopulmonary products, heart valves and related products and advanced circulatory support. Cardiopulmonary products include oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae and other related accessories. Heart valves include mechanical heart valves, tissue heart valves, related repair products and minimally invasive surgical instruments. Advanced circulatory support includes temporary life support controllers and product kits that can include a combination of pumps, oxygenators, and cannulae. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Our Neuromodulation segment generates its revenue from the design, development and marketing of neuromodulation therapy systems for the treatment of drug-resistant epilepsy, difficult-to-treat depression (&#8220;DTD&#8221;) and obstructive sleep apnea. Neuromodulation products include the VNS Therapy System, which consists of an implantable pulse generator, a lead that connects the generator to the vagus nerve, and other accessories. </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8220;Other&#8221; includes corporate shared service expenses for finance, legal, human resources, information technology and corporate business development.</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Net sales of our reportable segments include revenues from the sale of products they each develop and manufacture or distribute. We define segment income as operating income before merger and integration, restructuring and amortization of intangibles.</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We operate under&#160;three&#160;geographic regions: U.S., Europe, and Rest of World. The table below presents net sales by operating segment and geographic region (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.514%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiopulmonary</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,580&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,014&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,623&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372,163&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Heart Valves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,877&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Advanced Circulatory Support</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,542&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,097&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,878&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417,482&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,161&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Neuromodulation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,408&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,543&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,277&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,461&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,913&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,083&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,610&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664,686&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796,580&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Europe sales include those countries in which we have a direct sales presence, whereas European countries in which we sell through distributors are included in Rest of World. </span></div><div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">No&#160;single customer represented over&#160;10%&#160;of our consolidated net sales. No&#160;country&#8217;s net sales exceeded&#160;10%&#160;of our consolidated sales except for the U.S.</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The table below presents a reconciliation of segment income from continuing operations to consolidated (loss) income from continuing operations before tax (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,311)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,037)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,921)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,869)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,407)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,845)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reportable segment income from continuing operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,321&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,850&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,704&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger and integration expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) income from continuing operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,508)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,761&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,137)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,894)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,673)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,774)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,237)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,490)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange and other gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(795)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from continuing operations before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,714)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,465&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,385)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,555)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Assets by segment are as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463,523&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546,520&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668,899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,521,748&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,411,797&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Capital expenditures by segment are as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,040&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,571&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,217&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,005&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,236&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,801&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The changes in the carrying amount of goodwill by segment for the nine months ended September 30, 2020 were as follows (in thousands):</span></div><div style="margin-bottom:15pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.952%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.302%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Neuromodulation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398,754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517,040&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915,794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,684&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398,754&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519,724&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918,478&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Property, plant and equipment, net by geography are as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,509&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535317045848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Supplemental Financial Information</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 16. Supplemental Financial Information</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Inventories consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,091&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,154&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">As of September&#160;30, 2020 and December 31, 2019, inventories include adjustments totaling $14.5 million and $12.7 million, respectively, to record balances at lower of cost or net realizable value.</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accrued liabilities and other consisted of the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,953&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and administrative costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provisions for agents, returns and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring related liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product remediation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative contract liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRM purchase price adjustment payable to MicroPort Scientific Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,308&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Refer to &#8220;Note 7. Fair Value Measurements&#8221;</span></div><div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Refer to &#8220;Note 4. Restructuring&#8221;</span></div><div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Refer to &#8220;Note 5. Product Remediation Liability&#8221;</span></div><div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Refer to &#8220; Note 9. Derivatives and Risk Management&#8221;</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">As of&#160;September&#160;30, 2020&#160;and&#160;December 31, 2019, contract liabilities of&#160;$9.5 million&#160;and&#160;$8.6 million, respectively, are included within accrued liabilities and other long-term liabilities on the condensed consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535318494728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Note 17. New Accounting Pronouncements </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Adoption of New Accounting Pronouncements</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides a description of our adoption of new Accounting Standards Updates (&#8220;ASUs&#8221;) issued by the FASB and the impact of the adoption on our condensed financial statements:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:19.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issue Date &amp; Standard</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date of Adoption</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effect on Financial Statements or Other Significant Matters</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2016</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RhYmxlOmI3NzhiMTYwZjg5NTQzN2ViODlhMTA0NWE0NGFmNzdjL3RhYmxlcmFuZ2U6Yjc3OGIxNjBmODk1NDM3ZWI4OWExMDQ1YTQ0YWY3N2NfMS0wLTEtMS0wL3RleHRyZWdpb246OWNhMDIzMjU1YjY2NDBkN2I1NDUzOTBiNjY0ZTMzZDNfMTQ_421ad1dc-77dd-457b-948b-627f349609b2">ASU No. 2016-13</span>, Financial Instruments&#8212;Credit Losses (Topic 326)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. We adopted the update effective<br/>January 1, 2020, applying this standard to our accounts receivable by use of a provision matrix approach. This approach utilizes historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We recognized the following cumulative-effect adjustments, including to retained earnings, upon adoption at January 1, 2020:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net decreased $0.6 million and accumulated deficit increased $0.6 million.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2017</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2017-04,&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This update removes step 2 of the goodwill impairment test that compares the implied fair value of goodwill with its carrying amount. Instead, an impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge will be recorded by the amount a reporting unit&#8217;s carrying amount exceeds its fair value.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There was no material impact to our consolidated financial statements as a result of adopting this ASU.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2018-13, Fair Value Measurement (Topic 820): Changes to the Disclosure Requirements for Fair Value Measurement</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This update removes, modifies and adds certain disclosure requirements related to fair value measurements.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There was no material impact to our consolidated financial statements as a result of adopting this ASU.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2018-15, Intangibles&#8212;Goodwill and Other&#8212;Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This update clarifies and aligns the accounting for implementation costs for hosting arrangements with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There was no material impact to our consolidated financial statements as a result of adopting this ASU.</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Future Adoption of New Accounting Pronouncements</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides a description of future adoptions of new accounting standards that may have an impact on our financial statements when adopted:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:22.800%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issue Date &amp; Standard</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected Date of Adoption</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effect on Financial Statements or Other Significant Matters</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">August 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2018-14, Compensation&#8212;Retirement Benefits&#8212;Defined Benefit Plans&#8212;General</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Subtopic 715-20): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Changes to the Disclosure Requirements for Defined Benefit Plans</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This update adds and removes certain disclosure requirements related to defined benefit plans. This ASU is to be implemented on a retrospective basis for all periods presented with early adoption permitted.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We do not expect the adoption of this update to have a material effect on our condensed consolidated financial statement disclosures.</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=112272810&amp;loc=SL108384541-122693<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=112272810&amp;loc=d3e31137-122693<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535319714376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Unaudited Condensed Consolidated Financial Statements (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Basis of Presentation </span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The accompanying condensed consolidated financial statements of LivaNova as of, and for the three and nine months ended September 30, 2020 and 2019, have been prepared in accordance with U.S. GAAP for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. The accompanying condensed consolidated balance sheet of LivaNova at December 31, 2019 has been derived from audited financial statements contained in our 2019 Form 10-K, but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, the condensed consolidated financial statements reflect all adjustments (consisting of only normal recurring adjustments) considered necessary for a fair statement of the operating results of LivaNova and its subsidiaries, for the three and nine months ended September 30, 2020, and are not necessarily indicative of the results that may be expected for the year ending December 31, 2020. The financial information presented herein should be read in conjunction with the audited consolidated financial statements and notes thereto accompanying our 2019 Form 10-K.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Reclassifications</span></div><div style="margin-bottom:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We have reclassified certain prior period amounts for comparative purposes. These reclassifications did not have a material effect on our financial condition, results of operations or cash flows.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives</a></td>
<td class="text">If the derivative qualifies for hedge accounting, changes in the fair value of the derivative will be recorded in&#160;accumulated other comprehensive income (&#8220;AOCI&#8221;) until the hedged item is recognized in earnings upon settlement/termination. FX derivative gains and losses in AOCI are reclassified to our condensed consolidated statements of income (loss) as shown in the tables below. We evaluate hedge effectiveness at inception. Cash flows from derivative contracts are reported as operating activities on our condensed consolidated statements of cash flows.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Adoption of New Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Adoption of New Accounting Pronouncements</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides a description of our adoption of new Accounting Standards Updates (&#8220;ASUs&#8221;) issued by the FASB and the impact of the adoption on our condensed financial statements:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:19.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issue Date &amp; Standard</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date of Adoption</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effect on Financial Statements or Other Significant Matters</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2016</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RhYmxlOmI3NzhiMTYwZjg5NTQzN2ViODlhMTA0NWE0NGFmNzdjL3RhYmxlcmFuZ2U6Yjc3OGIxNjBmODk1NDM3ZWI4OWExMDQ1YTQ0YWY3N2NfMS0wLTEtMS0wL3RleHRyZWdpb246OWNhMDIzMjU1YjY2NDBkN2I1NDUzOTBiNjY0ZTMzZDNfMTQ_421ad1dc-77dd-457b-948b-627f349609b2">ASU No. 2016-13</span>, Financial Instruments&#8212;Credit Losses (Topic 326)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. We adopted the update effective<br/>January 1, 2020, applying this standard to our accounts receivable by use of a provision matrix approach. This approach utilizes historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We recognized the following cumulative-effect adjustments, including to retained earnings, upon adoption at January 1, 2020:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net decreased $0.6 million and accumulated deficit increased $0.6 million.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2017</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2017-04,&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This update removes step 2 of the goodwill impairment test that compares the implied fair value of goodwill with its carrying amount. Instead, an impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge will be recorded by the amount a reporting unit&#8217;s carrying amount exceeds its fair value.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There was no material impact to our consolidated financial statements as a result of adopting this ASU.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2018-13, Fair Value Measurement (Topic 820): Changes to the Disclosure Requirements for Fair Value Measurement</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This update removes, modifies and adds certain disclosure requirements related to fair value measurements.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There was no material impact to our consolidated financial statements as a result of adopting this ASU.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2018-15, Intangibles&#8212;Goodwill and Other&#8212;Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This update clarifies and aligns the accounting for implementation costs for hosting arrangements with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There was no material impact to our consolidated financial statements as a result of adopting this ASU.</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Future Adoption of New Accounting Pronouncements</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides a description of future adoptions of new accounting standards that may have an impact on our financial statements when adopted:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:22.800%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issue Date &amp; Standard</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected Date of Adoption</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effect on Financial Statements or Other Significant Matters</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">August 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2018-14, Compensation&#8212;Retirement Benefits&#8212;Defined Benefit Plans&#8212;General</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Subtopic 715-20): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Changes to the Disclosure Requirements for Defined Benefit Plans</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This update adds and removes certain disclosure requirements related to defined benefit plans. This ASU is to be implemented on a retrospective basis for all periods presented with early adoption permitted.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We do not expect the adoption of this update to have a material effect on our condensed consolidated financial statement disclosures.</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535325214888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of Restructuring and Related Costs</a></td>
<td class="text"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides a reconciliation of the beginning and ending balance of the accruals and other reserves recorded in connection with our restructuring plans included within accrued liabilities and other and other long-term liabilities on the condensed consolidated balance sheet (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:49.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.146%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Severance and Other Termination Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(792)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,672)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,850&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Expense by Reportable Segment</a></td>
<td class="text"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table presents restructuring expense by reportable segment (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:34.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(401)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11.25pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(349)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 11.25pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,563&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535317083736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Remediation Liability (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ProductRemediationAbstract', window );"><strong>Product Remediation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ScheduleofProductRemediationTableTextBlock', window );">Product Liability Contingencies</a></td>
<td class="text"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides a reconciliation of the beginning and ending balance of the product remediation liability included within accrued liabilities and other on the condensed consolidated balance sheet (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remediation activity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,982)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in foreign currency exchange rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,715&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_ProductRemediationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Remediation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_ProductRemediationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_ScheduleofProductRemediationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Product Remediation [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_ScheduleofProductRemediationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535405784376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock', window );">Schedule of Long-term Investments</a></td>
<td class="text">The below equity investments are included in investments on the condensed consolidated balance sheets (in thousands):<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.371%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity Investments Without Readily Determinable Fair Values</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Respicardia Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALung Technologies, Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceribell, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ShiraTronics, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MD Start II</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rainbow Medical Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Highlife S.A.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,944&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,805&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,256&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Respicardia Inc. (&#8220;Respicardia&#8221;) is a privately funded U.S. company developing an implantable device designed to restore a more natural breathing pattern during sleep in patients with central sleep apnea by transvenously stimulating the phrenic nerve. We have a loan outstanding to Respicardia, with a carrying amount of $0.8 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$0.6 million as of September&#160;30, 2020 and December 31, 2019, respectively, which is included in prepaid expenses and other current assets on the condensed consolidated balance sheet.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">During the first quarter of 2020, we invested in ALung Technologies, Inc. (&#8220;ALung&#8221;). ALung is a privately held medical device company focused on creating advanced medical devices for treating respiratory failure. ALung&#8217;s Hemolung Respiratory Assist System is a dialysis-like alternative or supplement to mechanical ventilation which removes carbon dioxide directly from the blood in patients with acute respiratory failure. During the second quarter of 2020, we provided a convertible loan to ALung for $2.0&#160;million, due July 10, 2021. As of September&#160;30, 2020, the carrying amount of the loan was $2.0 million, which is included in prepaid expenses and other current assets on the condensed consolidated balance sheet.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535319714376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Fair Value Measurements on a Recurring Basis</a></td>
<td class="text"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following tables provide information by level for assets and liabilities that are measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;Value Measurements Using Inputs Considered as:</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets - designated as cash flow hedges (foreign currency exchange rate &#8220;FX&#8221;)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets - freestanding instruments (FX)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets - capped call derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - freestanding instruments (interest rate swaps)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - freestanding instruments (FX) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - embedded exchange feature</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration arrangements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,146&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,922&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;Value Measurements Using Inputs Considered as:</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets - designated as cash flow hedges (FX)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets - freestanding instruments (FX)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - designated as cash flow hedges (FX)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - designated as cash flow hedges (interest rate swaps)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities - freestanding instruments (FX) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration arrangements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,029&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,680&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Reconciliation of Beginning and Ending Balances of Contingent Consideration</a></td>
<td class="text"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides a reconciliation of the beginning and ending balances of our recurring fair value measurements, using significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capped Call Derivative Asset</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Embedded Exchange Feature Derivative Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Derivative Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability Arrangements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Convertible Notes Receivable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,868)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) (3) (4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,097)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in foreign currency exchange rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,999&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,398&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,174&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,571&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,999&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,398&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,603&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:2pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">During the nine months ended September 30, 2020, we paid $8.8 million under the contingent consideration arrangement for the acquisition of CardiacAssist, Inc., doing business as TandemLife (&#8220;TandemLife&#8221;). Additionally, we made final payments under contingent consideration arrangements resulting from the acquisitions of two distributors. </span></div><div style="margin-bottom:2pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">The contingent consideration change in fair value during the nine months ended September 30, 2020 is primarily due to a one-year delay in the projected achievement of a certain regulatory milestone and timing of sales-based earnout payments for ImThera Medical Inc. (&#8220;ImThera&#8221;), and the impact of an increase in discount rates utilized in the valuation of contingent consideration. Refer to the tables below for further information regarding the fair value measurements of contingent consideration.</span></div><div style="margin-bottom:2pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">During the nine months ended September 30, 2020, the contingent consideration change in fair value resulted in a decrease of $19.2 million and $12.0 million recorded to cost of sales - exclusive of amortization and research and development, respectively.</span></div><div style="margin-bottom:6pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Changes in the fair value of the embedded exchange feature derivative and capped call derivatives are recognized in foreign exchange and other gains (losses) in the condensed consolidated statements of income (loss).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</a></td>
<td class="text"><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides the fair value of our Level 3 contingent consideration arrangements by acquisition (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.301%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ImThera</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,603&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TandemLife</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miami Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drilltex</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,174&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text">Both arrangements are Level 3 fair value measurements and include the following significant unobservable inputs as of September&#160;30, 2020:<div style="margin-bottom:14pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.163%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.484%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.192%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ImThera Acquisition</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ranges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory milestone-based payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected payment year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-based earnout</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monte Carlo simulation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-adjusted discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit risk discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected years of earnout</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The TandemLife business combination involved a contingent consideration arrangement composed of potential cash payments upon the achievement of certain regulatory milestones. The arrangement is a Level 3 fair value measurement and includes the following significant unobservable inputs as of September&#160;30, 2020:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:29.939%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.170%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.175%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TandemLife Acquisition</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ranges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory milestone-based payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected payment years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Miami Instruments business combination involved a contingent consideration arrangement composed of potential cash payments upon the achievement of certain regulatory milestones. The arrangement is a Level 3 fair value measurement and includes the following significant unobservable inputs as of September&#160;30, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:29.939%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.170%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.175%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Miami Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ranges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory milestone-based payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected payment years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535318684648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Arrangements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt</a></td>
<td class="text"><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The carrying amount of our long-term debt as of September&#160;30, 2020 and December 31, 2019 was as follows (in thousands, except interest rates):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.030%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.198%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Senior Secured Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422,960&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">LIBOR (1% Floor)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Cash Exchangeable Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank of America Merrill Lynch Banco M&#250;ltiplo S.A.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.61%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mediocredito Italiano</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.77%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank of America, U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.08%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Debt Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 European Investment Bank</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014 European Investment Bank</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,041&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term facilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646,801&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,511&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637,109&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,330&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ScheduleOfDebtCovenantsTableTextBlock', window );">Schedule of Debt Covenants</a></td>
<td class="text">The financial covenants under the Term Loan state (i) the net revenue of LivaNova PLC, LivaNova USA, Inc. and any restricted subsidiaries on a consolidated basis shall not be lower than $700&#160;million for each trailing 12 month period, such threshold to decrease pro rata (not below $550&#160;million) upon prepayments of the Term Loan made by LivaNova USA, Inc. out of the proceeds of certain asset sales, and (ii) the total secured leverage ratio (as defined in the debt agreement) for LivaNova PLC, LivaNova USA, Inc. and any restricted subsidiaries on a consolidated basis shall not be greater than the applicable ratio set forth below:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Test Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Secured Leverage Ratio</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 Quarters ending June 30, 2020 through each fiscal quarter thereafter until (and including) the fiscal quarter ending June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.625</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 Quarters ending September 30, 2021 and ending each fiscal quarter thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_ScheduleOfDebtCovenantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Debt Covenants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_ScheduleOfDebtCovenantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535324967048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Risk Management (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Schedule of Notional Amounts of Derivative Contracts Designated Cash Flow Hedges</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The gross notional amounts of open derivative contracts designated as cash flow hedges at September&#160;30, 2020 and December 31, 2019 were as follows (in thousands):</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.372%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Derivative Contract</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts to be exchanged for British Pounds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts to be exchanged for Japanese Yen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts to be exchanged for Euros</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,186&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,750&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Interest rate swap contracts were de-designated upon the repayment of the 2014 European Investment Bank loan. Refer to &#8220;Note 8. Financing Arrangements.&#8221;</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Cash Flow Hedges Included in AOCI</a></td>
<td class="text"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">After-tax net loss associated with derivatives designated as cash flow hedges recorded in the ending balance of AOCI and the amount expected to be reclassified to earnings in the next twelve months are as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.372%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Derivative Contract</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After-Tax Net Gain in AOCI as of September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After-Tax Net Gain in AOCI as of Amount Expected to be Reclassified to Earnings in Next 12 Months</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pre-tax gains (losses) for derivative contracts designated as cash flow hedges recognized in other comprehensive income (loss) (&#8220;OCI&#8221;) and the amount reclassified to earnings from AOCI were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.148%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Derivative Contract</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location in Earnings of Reclassified Gain or Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains Recognized in OCI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Losses) Gains Reclassified from AOCI to Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Losses Recognized in OCI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (Losses) Reclassified from AOCI to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange and other gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(692)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(689)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(742)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(689)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.148%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Derivative Contract</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location in Earnings of Reclassified Gain or Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains Recognized in OCI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Losses) Gains Reclassified from AOCI to Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains Recognized in OCI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (Losses) Reclassified from AOCI to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange and other gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,470)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(681)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Fair Value of Derivative Instruments in Statement of Financial Position</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following tables present the fair value and the location of derivative contracts reported on the condensed consolidated balance sheets (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:27.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.491%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.493%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expense and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capped call derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Embedded exchange feature</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term derivative liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term derivative liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,051&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,972&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,838&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,972&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:27.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.491%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.493%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term derivative liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,680&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">For the classification of inputs used to evaluate the fair value of our derivatives, refer to &#8220;Note 7. Fair Value Measurements.&#8221;</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535317226904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock', window );">Litigation Provision Liabilities</a></td>
<td class="text"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The changes in the litigation provision liability during the nine months ended September 30, 2020 are as follows (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.375%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Litigation Provision Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation provision liability at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128,128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FX and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation provision liability at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of litigation liability at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of litigation provision liability at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,510&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14472-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14453-108349<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121555522&amp;loc=d3e12021-110248<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14394-108349<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121555522&amp;loc=d3e12053-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535318666744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of Stockholders Equity</a></td>
<td class="text"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The tables below present the condensed consolidated statement of stockholders&#8217; equity as of and for the three and nine months ended September 30, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.970%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.290%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares - Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,057)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,089)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(457,804)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation of shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,772)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,772)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,403&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,338&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,758,468&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,053)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,385)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472,576)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350,792&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,717,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(295,643)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,436)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,436)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,381&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,217&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,725,482&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,282)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,610)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(263,525)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495,282&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.970%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.290%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares - Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,411&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,263)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,392)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(406,755)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,383,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV83MC9mcmFnOmY3MzcxOGUyMmM1NDQwOTA5MjQ3Njk4MWM5NTY1YWFiL3RhYmxlOmM3OTU3NDJjZmFmYjQ0ODJhOWU3YmRmYmVlNzVjMTcyL3RhYmxlcmFuZ2U6Yzc5NTc0MmNmYWZiNDQ4MmE5ZTdiZGZiZWU3NWMxNzJfMi0wLTEtMS0wL3RleHRyZWdpb246NzBlNmI4NTFhNzBkNDhmYTgzNmM5ZmZkOGQwOTVkZGZfMTY_2f7bdef0-ddd7-4bfa-ad80-21e764af2e97">ASU No. 2016-13</span> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation of shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,758,468&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,053)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,385)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472,576)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350,792&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705,111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,462)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,476)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(251,579)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,381&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,217&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,725,482&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,282)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,610)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(263,525)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495,282&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Refer to &#8220;Note 17. New Accounting Pronouncements&#8221;</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The table below presents the change in each component of AOCI, net of tax, and the reclassifications out of AOCI into net income for the nine months ended September 30, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.648%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Unrealized Gain (Loss) on Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments Gain (Loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,905)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,392)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,008&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,640&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,008&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,488&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of loss from accumulated other comprehensive loss, before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of loss from accumulated other comprehensive loss, after tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,008&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,007&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,897)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,385)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(944)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,532)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,476)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,628)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,695)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,628)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,919)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of gain from accumulated other comprehensive loss, before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of gain from accumulated other comprehensive loss, after tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,215)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,215)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(506)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,628)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,134)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,450)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,160)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,610)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Taxes are not provided for foreign currency translation adjustments as translation adjustments are related to earnings that are intended to be reinvested in the countries where earned.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535319095112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Incentive Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Compensation, Stock Options, Activity</a></td>
<td class="text"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Stock-based incentive plans compensation expense is as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.918%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service-based restricted stock units (&#8220;RSUs&#8221;)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,428&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service-based stock appreciation rights (&#8220;SARs&#8221;)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market performance-based restricted stock units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating performance-based restricted stock units </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(962)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee share purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,810&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,531&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Stock-based compensation agreements issued during the nine months ended September 30, 2020, representing potential shares and their weighted average grant date fair values by type follows (shares in thousands, fair value in dollars):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:63.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service-based SARs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service-based RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market performance-based RSUs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating performance-based RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535318435480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Net Income Per Share</a></td>
<td class="text"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Reconciliation of the shares used in the basic and diluted earnings per share computations for the three and nine months ended September 30, 2020 and 2019 are as follows (in thousands):</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,395&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add effects of share-based compensation instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average&#160;shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,652&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,820&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,582&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,329&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Excluded from the computation of diluted earnings per share were stock options, SARs and restricted share units totaling 4.1 million and 1.4 million for the three months ended September 30, 2020 and 2019, respectively, and 4.2 million and 3.2 million for the nine months ended September 30, 2020 and 2019, respectively, because to include them would have been anti-dilutive under the treasury stock method.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535325366168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Geographic and Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Areas</a></td>
<td class="text">The table below presents net sales by operating segment and geographic region (in thousands):<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.514%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiopulmonary</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,580&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,014&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,623&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372,163&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Heart Valves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,877&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Advanced Circulatory Support</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,542&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,097&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,878&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417,482&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,161&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Neuromodulation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,408&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,543&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,277&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,461&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,913&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,083&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,610&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664,686&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796,580&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Europe sales include those countries in which we have a direct sales presence, whereas European countries in which we sell through distributors are included in Rest of World. </span></div><div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">No&#160;single customer represented over&#160;10%&#160;of our consolidated net sales. No&#160;country&#8217;s net sales exceeded&#160;10%&#160;of our consolidated sales except for the U.S.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The table below presents a reconciliation of segment income from continuing operations to consolidated (loss) income from continuing operations before tax (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,311)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,037)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,921)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,869)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,407)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,845)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reportable segment income from continuing operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,321&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,850&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,704&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger and integration expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) income from continuing operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,508)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,761&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,137)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,894)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,673)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,774)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,237)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,490)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange and other gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(795)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from continuing operations before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,714)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,465&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,385)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,555)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Assets by segment are as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463,523&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546,520&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668,899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,521,748&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,411,797&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Capital expenditures by segment are as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,040&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,571&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,217&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,005&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,236&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,801&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The changes in the carrying amount of goodwill by segment for the nine months ended September 30, 2020 were as follows (in thousands):</span></div><div style="margin-bottom:15pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.952%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.302%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Neuromodulation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398,754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517,040&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915,794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,684&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398,754&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519,724&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918,478&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Long-lived Assets by Geographic Areas</a></td>
<td class="text"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Property, plant and equipment, net by geography are as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,509&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535317280488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Inventories consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,091&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,154&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued Liabilities</a></td>
<td class="text"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accrued liabilities and other consisted of the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,953&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and administrative costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provisions for agents, returns and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring related liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product remediation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative contract liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRM purchase price adjustment payable to MicroPort Scientific Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,308&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Refer to &#8220;Note 7. Fair Value Measurements&#8221;</span></div><div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Refer to &#8220;Note 4. Restructuring&#8221;</span></div><div style="padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Refer to &#8220;Note 5. Product Remediation Liability&#8221;</span></div><div style="margin-bottom:9pt;padding-left:36pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:8.68pt">Refer to &#8220; Note 9. Derivatives and Risk Management&#8221;</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535318697320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Schedule of New Accounting Pronouncements and Changes in Accounting Principles</a></td>
<td class="text"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides a description of our adoption of new Accounting Standards Updates (&#8220;ASUs&#8221;) issued by the FASB and the impact of the adoption on our condensed financial statements:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:19.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issue Date &amp; Standard</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date of Adoption</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effect on Financial Statements or Other Significant Matters</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2016</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFiZjc1ZDNkMDU1NDRiMmRiNDYzOTI5MTY5MmFjNTdhL3NlYzoxYmY3NWQzZDA1NTQ0YjJkYjQ2MzkyOTE2OTJhYzU3YV85MS9mcmFnOjlkYmM4YjNlNTU5YzRhYjliNDdhNzgxYjZkZjVlYzUzL3RhYmxlOmI3NzhiMTYwZjg5NTQzN2ViODlhMTA0NWE0NGFmNzdjL3RhYmxlcmFuZ2U6Yjc3OGIxNjBmODk1NDM3ZWI4OWExMDQ1YTQ0YWY3N2NfMS0wLTEtMS0wL3RleHRyZWdpb246OWNhMDIzMjU1YjY2NDBkN2I1NDUzOTBiNjY0ZTMzZDNfMTQ_421ad1dc-77dd-457b-948b-627f349609b2">ASU No. 2016-13</span>, Financial Instruments&#8212;Credit Losses (Topic 326)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. We adopted the update effective<br/>January 1, 2020, applying this standard to our accounts receivable by use of a provision matrix approach. This approach utilizes historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We recognized the following cumulative-effect adjustments, including to retained earnings, upon adoption at January 1, 2020:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net decreased $0.6 million and accumulated deficit increased $0.6 million.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2017</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2017-04,&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This update removes step 2 of the goodwill impairment test that compares the implied fair value of goodwill with its carrying amount. Instead, an impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge will be recorded by the amount a reporting unit&#8217;s carrying amount exceeds its fair value.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There was no material impact to our consolidated financial statements as a result of adopting this ASU.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2018-13, Fair Value Measurement (Topic 820): Changes to the Disclosure Requirements for Fair Value Measurement</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This update removes, modifies and adds certain disclosure requirements related to fair value measurements.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There was no material impact to our consolidated financial statements as a result of adopting this ASU.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2018-15, Intangibles&#8212;Goodwill and Other&#8212;Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This update clarifies and aligns the accounting for implementation costs for hosting arrangements with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There was no material impact to our consolidated financial statements as a result of adopting this ASU.</span></td></tr></table></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following table provides a description of future adoptions of new accounting standards that may have an impact on our financial statements when adopted:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:22.800%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issue Date &amp; Standard</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected Date of Adoption</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effect on Financial Statements or Other Significant Matters</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">August 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2018-14, Compensation&#8212;Retirement Benefits&#8212;Defined Benefit Plans&#8212;General</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Subtopic 715-20): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Changes to the Disclosure Requirements for Defined Benefit Plans</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This update adds and removes certain disclosure requirements related to defined benefit plans. This ASU is to be implemented on a retrospective basis for all periods presented with early adoption permitted.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We do not expect the adoption of this update to have a material effect on our condensed consolidated financial statement disclosures.</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e765-108305<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e725-108305<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535322502184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 12, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 918,478<span></span>
</td>
<td class="nump">$ 915,794<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_MiamiInstrumentsLLCMember', window );">Miami Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Fair value of consideration transferred</a></td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationUpfrontCosts', window );">Cash</a></td>
<td class="nump">10,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_MiamiInstrumentsLLCMember', window );">Miami Instruments | Developed technology and in process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Intangible assets acquired</a></td>
<td class="nump">$ 14,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_BusinessCombinationUpfrontCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Upfront Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_BusinessCombinationUpfrontCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=livn_MiamiInstrumentsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=livn_MiamiInstrumentsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535320915384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations (Narrative) (Details) - CRM Business Franchise - Discontinued Operations - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 195.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationConsiderationTransferredCashTransferred', window );">Consideration transferred, cash</a></td>
<td class="nump">$ 9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax', window );">Working capital adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax', window );">Operating loss from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_BusinessCombinationConsiderationTransferredCashTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Cash Transferred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_BusinessCombinationConsiderationTransferredCashTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of an increase (decrease) to a gain (loss) previously reported in discontinued operations in a prior period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1020-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=livn_CRMBusinessFranchiseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=livn_CRMBusinessFranchiseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535322729400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Restructuring and Related Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="num">$ (349)<span></span>
</td>
<td class="nump">$ 698<span></span>
</td>
<td class="nump">$ 2,025<span></span>
</td>
<td class="nump">$ 4,563<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=livn_ReorganizationPlansMember', window );">Reorganization Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,672)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at end of period</a></td>
<td class="nump">1,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=livn_ReorganizationPlansMember', window );">Reorganization Plans | Employee Severance and Other Termination Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,880)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at end of period</a></td>
<td class="nump">1,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=livn_ReorganizationPlansMember', window );">Reorganization Plans | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(792)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at end of period</a></td>
<td class="nump">$ 608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=livn_ReorganizationPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=livn_ReorganizationPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535319712904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Restructuring Expense by Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="num">$ (349)<span></span>
</td>
<td class="nump">$ 698<span></span>
</td>
<td class="nump">$ 2,025<span></span>
</td>
<td class="nump">$ 4,563<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">783<span></span>
</td>
<td class="nump">1,265<span></span>
</td>
<td class="nump">1,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Neuromodulation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">43<span></span>
</td>
<td class="num">(171)<span></span>
</td>
<td class="nump">851<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="num">$ (401)<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
<td class="num">$ (91)<span></span>
</td>
<td class="nump">$ 2,728<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=livn_CardiovascularSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=livn_CardiovascularSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=livn_NeuromodulationSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=livn_NeuromodulationSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535325169848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Remediation Liability (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingenciesRollForward', window );"><strong>Accrual for Environmental Loss Contingencies [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ProductRemediationNet', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ProductRemediationAdjustments', window );">Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ProductRemediationPayments', window );">Remediation activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,982)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ProductRemediationForeignCurrencyTranslationGainLoss', window );">Effect of changes in foreign currency exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ProductRemediationNet', window );">Balance at end of period</a></td>
<td class="nump">$ 1,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ProductRemediationExpense', window );">Product remediation expense</a></td>
<td class="nump">1,133<span></span>
</td>
<td class="nump">$ 3,076<span></span>
</td>
<td class="nump">6,868<span></span>
</td>
<td class="nump">$ 11,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=livn_ProductLiabilityMember', window );">Product Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityContingencyLineItems', window );"><strong>Product Liability Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Litigation provision liability</a></td>
<td class="nump">$ 46,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 170,404<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_ProductRemediationAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Remediation, Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_ProductRemediationAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_ProductRemediationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Remediation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_ProductRemediationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_ProductRemediationForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Remediation, Foreign Currency Translation Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_ProductRemediationForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_ProductRemediationNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Remediation, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_ProductRemediationNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_ProductRemediationPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Remediation, Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_ProductRemediationPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForEnvironmentalLossContingenciesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForEnvironmentalLossContingenciesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=livn_ProductLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=livn_ProductLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535422961944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Investments</a></td>
<td class="nump">$ 29,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,805<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investment</a></td>
<td class="nump">414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">451<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue', window );">Total investments</a></td>
<td class="nump">30,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,256<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=livn_RespicardiaMember', window );">Respicardia Inc. | Equity Method Investee | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Outstanding loans</a></td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=livn_ALungTechnologiesInc.Member', window );">ALung Technologies, Inc. | Convertible Notes Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Outstanding loans</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableGross', window );">Notes receivable gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_RespicardiaMember', window );">Respicardia Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Investments</a></td>
<td class="nump">17,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,706<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_ALungTechnologiesInc.Member', window );">ALung Technologies, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Investments</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_CeribellInc.Member', window );">Ceribell, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Investments</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_ShiraTronicsInc.Member', window );">ShiraTronics, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Investments</a></td>
<td class="nump">2,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_MDStartIIMember', window );">MD Start II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Investments</a></td>
<td class="nump">1,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,121<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_RainbowMedicalLtd.Member', window );">Rainbow Medical Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Investments</a></td>
<td class="nump">1,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_HighlifeS.A.S.Member', window );">Highlife S.A.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Investments</a></td>
<td class="nump">1,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_OtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Investments</a></td>
<td class="nump">$ 770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 770<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 55<br> -Paragraph 79<br> -URI http://asc.fasb.org/extlink&amp;oid=121647567&amp;loc=SL82922352-210448<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919230-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 55<br> -Paragraph 80<br> -URI http://asc.fasb.org/extlink&amp;oid=121647567&amp;loc=SL82922355-210448<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919230-210447<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=livn_RespicardiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=livn_RespicardiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=livn_ALungTechnologiesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=livn_ALungTechnologiesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=livn_ConvertibleNotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=livn_ConvertibleNotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_RespicardiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_RespicardiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_ALungTechnologiesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_ALungTechnologiesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_CeribellInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_CeribellInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_ShiraTronicsInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_ShiraTronicsInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_MDStartIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_MDStartIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_RainbowMedicalLtd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_RainbowMedicalLtd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_HighlifeS.A.S.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_HighlifeS.A.S.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535325915032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 79,603<span></span>
</td>
<td class="nump">$ 114,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=livn_CappedCallMember', window );">Capped call derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember', window );">Other derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">1,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated as Hedging Instruments | Embedded exchange feature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">59,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Other derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Derivatives Not Designated as Hedging Instruments | Embedded exchange feature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Other derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Derivatives Not Designated as Hedging Instruments | Embedded exchange feature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Other derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">1,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Derivatives Not Designated as Hedging Instruments | Embedded exchange feature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">59,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesFairValueDisclosure', window );">Convertible notes receivable</a></td>
<td class="nump">2,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">47,139<span></span>
</td>
<td class="nump">561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">96,174<span></span>
</td>
<td class="nump">137,349<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">157,146<span></span>
</td>
<td class="nump">141,029<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Derivatives Designated as Hedging Instruments | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">1,787<span></span>
</td>
<td class="nump">535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Derivatives Designated as Hedging Instruments | Interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">374<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Derivatives Not Designated as Hedging Instruments | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">4,052<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">3,137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Derivatives Not Designated as Hedging Instruments | Capped call derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">38,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesFairValueDisclosure', window );">Convertible notes receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | Derivatives Designated as Hedging Instruments | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | Derivatives Designated as Hedging Instruments | Interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | Derivatives Not Designated as Hedging Instruments | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | Derivatives Not Designated as Hedging Instruments | Capped call derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesFairValueDisclosure', window );">Convertible notes receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">5,839<span></span>
</td>
<td class="nump">561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">224<span></span>
</td>
<td class="nump">3,680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | Derivatives Designated as Hedging Instruments | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">1,787<span></span>
</td>
<td class="nump">535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | Derivatives Designated as Hedging Instruments | Interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">374<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | Derivatives Not Designated as Hedging Instruments | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">4,052<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">3,137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | Derivatives Not Designated as Hedging Instruments | Capped call derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesFairValueDisclosure', window );">Convertible notes receivable</a></td>
<td class="nump">2,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">41,300<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">96,174<span></span>
</td>
<td class="nump">137,349<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">156,922<span></span>
</td>
<td class="nump">137,349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | Derivatives Designated as Hedging Instruments | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | Derivatives Designated as Hedging Instruments | Interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | Derivatives Not Designated as Hedging Instruments | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | Derivatives Not Designated as Hedging Instruments | Capped call derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">$ 38,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of receivables, including, but not limited to, trade account receivables, note receivables, and loan receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13728-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=livn_CappedCallMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=livn_CappedCallMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535325022456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Contingent Consideration Reconciliation (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>distributor</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Liabilities Measured on Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities', window );">Contingent consideration paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_NumberOfDistributorsAcquired', window );">Number of distributors acquired | distributor</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationMilestoneAchievementPeriodOfDelay', window );">Period of delay</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Remeasurement of contingent consideration to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (31,176)<span></span>
</td>
<td class="num">$ (2,425)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales - exclusive of amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Liabilities Measured on Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Remeasurement of contingent consideration to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Liabilities Measured on Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Remeasurement of contingent consideration to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Liabilities Measured on Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Total at beginning period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Total at period end</a></td>
<td class="nump">$ 96,174<span></span>
</td>
<td class="nump">96,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | Embedded Exchange Feature Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Liabilities Measured on Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Total at beginning period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Changes in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,553)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome', window );">Effect of changes in foreign currency exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Total at period end</a></td>
<td class="nump">59,398<span></span>
</td>
<td class="nump">59,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue', window );">Less current portion at period end</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue', window );">Long-term portion at period end</a></td>
<td class="nump">59,398<span></span>
</td>
<td class="nump">59,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | Other Derivative Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Liabilities Measured on Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Total at beginning period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Changes in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome', window );">Effect of changes in foreign currency exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Total at period end</a></td>
<td class="nump">1,350<span></span>
</td>
<td class="nump">1,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue', window );">Less current portion at period end</a></td>
<td class="nump">1,160<span></span>
</td>
<td class="nump">1,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue', window );">Long-term portion at period end</a></td>
<td class="nump">190<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | Contingent Consideration Liability Arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Liabilities Measured on Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Total at beginning period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,868)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Changes in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,176)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome', window );">Effect of changes in foreign currency exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(131)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Total at period end</a></td>
<td class="nump">96,174<span></span>
</td>
<td class="nump">96,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue', window );">Less current portion at period end</a></td>
<td class="nump">16,571<span></span>
</td>
<td class="nump">16,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue', window );">Long-term portion at period end</a></td>
<td class="nump">79,603<span></span>
</td>
<td class="nump">79,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | Derivative Financial Instruments, Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Assets Measured on Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">As of beginning period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Changes in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,097)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Effect of changes in foreign currency exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Total at period end</a></td>
<td class="nump">38,999<span></span>
</td>
<td class="nump">38,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue', window );">Less current portion at period end</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue', window );">Long-term portion at period end</a></td>
<td class="nump">38,999<span></span>
</td>
<td class="nump">38,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | Notes Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Assets Measured on Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">As of beginning period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Changes in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Effect of changes in foreign currency exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Total at period end</a></td>
<td class="nump">2,301<span></span>
</td>
<td class="nump">2,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue', window );">Less current portion at period end</a></td>
<td class="nump">2,044<span></span>
</td>
<td class="nump">2,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue', window );">Long-term portion at period end</a></td>
<td class="nump">$ 257<span></span>
</td>
<td class="nump">$ 257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_BusinessCombinationMilestoneAchievementPeriodOfDelay">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Milestone Achievement, Period Of Delay</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_BusinessCombinationMilestoneAchievementPeriodOfDelay</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Current Asset Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Non-current Asset Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Current Liability Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Non-current Liability Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_NumberOfDistributorsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Distributors Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_NumberOfDistributorsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, made soon after acquisition date of business combination, to settle contingent consideration liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=livn_EmbeddedExchangeFeatureLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=livn_EmbeddedExchangeFeatureLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=livn_ContingentConsiderationLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=livn_ContingentConsiderationLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DerivativeFinancialInstrumentsAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_DerivativeFinancialInstrumentsAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535322414488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 17, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember', window );">Embedded exchange feature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue', window );">10 percent decrease in stock price volatility, fair value</a></td>
<td class="nump">$ 42,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue', window );">10 percent increase in stock price volatility, fair value</a></td>
<td class="nump">76,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=livn_CappedCallMember', window );">Capped call derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue', window );">10 percent decrease in stock price volatility, fair value</a></td>
<td class="nump">29,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue', window );">10 percent increase in stock price volatility, fair value</a></td>
<td class="nump">$ 42,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 287,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=livn_A2020CashExchangeableSeniorNotesMember', window );">2020 Cash Exchangeable Senior Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 287,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=livn_MeasurementInputStockPriceVolatilityMember', window );">Measurement Input, Stock Price Volatility | Embedded exchange feature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=livn_MeasurementInputStockPriceVolatilityMember', window );">Measurement Input, Stock Price Volatility | Capped call derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis Of Fair Value, 10 Percent Decrease In Stock Price Volatility, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis Of Fair Value, 10 Percent Increase In Stock Price Volatility, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=livn_CappedCallMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=livn_CappedCallMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=livn_A2020CashExchangeableSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=livn_A2020CashExchangeableSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=livn_MeasurementInputStockPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=livn_MeasurementInputStockPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535330042904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value of Contingent Consideration by Acquisition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 79,603<span></span>
</td>
<td class="nump">$ 114,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">96,174<span></span>
</td>
<td class="nump">137,349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">96,174<span></span>
</td>
<td class="nump">137,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</a></td>
<td class="nump">96,174<span></span>
</td>
<td class="nump">137,349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_ImTheraMedicalInc.Member', window );">ImThera | Fair Value, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">79,603<span></span>
</td>
<td class="nump">113,503<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_TandemLifeMember', window );">TandemLife | Fair Value, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">11,672<span></span>
</td>
<td class="nump">17,311<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_MiamiInstrumentsLLCMember', window );">Miami Instruments | Fair Value, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">4,899<span></span>
</td>
<td class="nump">5,338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_DrilltexMember', window );">Drilltex | Fair Value, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_OtherMember', window );">Other | Fair Value, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 903<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionContingentConsiderationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=livn_ImTheraMedicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=livn_ImTheraMedicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=livn_TandemLifeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=livn_TandemLifeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=livn_MiamiInstrumentsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=livn_MiamiInstrumentsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=livn_DrilltexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=livn_DrilltexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=livn_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=livn_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535422977288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Level 3 Valuations (Details) - Level 3<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_ImTheraMedicalInc.Member', window );">ImThera | Discounted cash flow | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationContingentConsiderationMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.083<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_ImTheraMedicalInc.Member', window );">ImThera | Discounted cash flow | Probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationContingentConsiderationMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_ImTheraMedicalInc.Member', window );">ImThera | Monte Carlo simulation | Revenue volatility</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationContingentConsiderationMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.325<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_ImTheraMedicalInc.Member', window );">ImThera | Minimum | Monte Carlo simulation | Probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationContingentConsiderationMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_ImTheraMedicalInc.Member', window );">ImThera | Minimum | Monte Carlo simulation | Risk-adjusted discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationContingentConsiderationMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.122<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_ImTheraMedicalInc.Member', window );">ImThera | Minimum | Monte Carlo simulation | Credit risk discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationContingentConsiderationMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.085<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_ImTheraMedicalInc.Member', window );">ImThera | Maximum | Monte Carlo simulation | Risk-adjusted discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationContingentConsiderationMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_ImTheraMedicalInc.Member', window );">ImThera | Maximum | Monte Carlo simulation | Credit risk discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationContingentConsiderationMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.092<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_TandemLifeMember', window );">TandemLife | Minimum | Discounted cash flow | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationContingentConsiderationMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.076<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_TandemLifeMember', window );">TandemLife | Minimum | Discounted cash flow | Probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationContingentConsiderationMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.70<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_TandemLifeMember', window );">TandemLife | Maximum | Discounted cash flow | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationContingentConsiderationMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.077<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_TandemLifeMember', window );">TandemLife | Maximum | Discounted cash flow | Probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationContingentConsiderationMeasurementInput', window );">Measurement input</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_MiamiInstrumentsLLCMember', window );">Miami Instruments | Minimum | Discounted cash flow | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationContingentConsiderationMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.076<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_MiamiInstrumentsLLCMember', window );">Miami Instruments | Minimum | Discounted cash flow | Probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationContingentConsiderationMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_MiamiInstrumentsLLCMember', window );">Miami Instruments | Maximum | Discounted cash flow | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationContingentConsiderationMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.077<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=livn_MiamiInstrumentsLLCMember', window );">Miami Instruments | Maximum | Discounted cash flow | Probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessCombinationContingentConsiderationMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.95<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_BusinessCombinationContingentConsiderationMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Measurement Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_BusinessCombinationContingentConsiderationMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=livn_ImTheraMedicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=livn_ImTheraMedicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=livn_MeasurementInputProbabilityofPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=livn_MeasurementInputProbabilityofPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=livn_ValuationTechniqueMonteCarloSimulationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=livn_ValuationTechniqueMonteCarloSimulationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=livn_MeasurementInputRevenueVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=livn_MeasurementInputRevenueVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=livn_MeasurementInputRiskadjustedDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=livn_MeasurementInputRiskadjustedDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=livn_MeasurementInputCreditRiskDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=livn_MeasurementInputCreditRiskDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=livn_TandemLifeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=livn_TandemLifeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=livn_MiamiInstrumentsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=livn_MiamiInstrumentsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535324984488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Arrangements Schedule of Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 17, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term facilities</a></td>
<td class="nump">$ 646,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 333,511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion of long-term debt</a></td>
<td class="nump">9,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt obligations</a></td>
<td class="nump">$ 637,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">260,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member', window );">Bank of America Merrill Lynch Banco M&#250;ltiplo S.A.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">5.61%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=livn_MediocreditoItalianoMember', window );">Mediocredito Italiano | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=livn_MediocreditoItalianoMember', window );">Mediocredito Italiano | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">2.77%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=livn_BankofAmericaU.SMember', window );">Bank of America, U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">2.08%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term facilities</a></td>
<td class="nump">$ 422,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_DebtInstrumentLIBORFloorRate', window );">LIBOR floor rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term facilities</a></td>
<td class="nump">$ 208,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans Payable | Bank of America Merrill Lynch Banco M&#250;ltiplo S.A.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term facilities</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,422<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans Payable | Mediocredito Italiano</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term facilities</a></td>
<td class="nump">5,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,222<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans Payable | Bank of America, U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term facilities</a></td>
<td class="nump">2,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,004<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans Payable | 2019 Debt Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term facilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans Payable | 2017 European Investment Bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term facilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,570<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans Payable | 2014 European Investment Bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term facilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,053<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term facilities</a></td>
<td class="nump">$ 1,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 965<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_DebtInstrumentLIBORFloorRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, LIBOR Floor Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_DebtInstrumentLIBORFloorRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=livn_MediocreditoItalianoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=livn_MediocreditoItalianoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=livn_BankofAmericaU.SMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=livn_BankofAmericaU.SMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=livn_DebtFacility2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=livn_DebtFacility2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=livn_EuropeanInvestmentBank2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=livn_EuropeanInvestmentBank2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=livn_EuropeanInvestmentBank2014Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=livn_EuropeanInvestmentBank2014Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535405158216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Arrangements - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 17, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 10, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>claim </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>claim </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 886,899,000<span></span>
</td>
<td class="nump">$ 193,490,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_DebtInstrumentCovenantMinimumProRataNetRevenues', window );">Minimum pro rata net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">550,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 528,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=livn_CappedCallMember', window );">Capped call derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_DerivativeCapPricePerShare', window );">Derivative, cap price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.00<span></span>
</td>
<td class="nump">$ 100.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeCostOfHedge', window );">Derivative, cost of hedge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,000,000.0<span></span>
</td>
<td class="nump">$ 39,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.90%<span></span>
</td>
<td class="nump">9.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 287,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt obligations</a></td>
<td class="nump">278,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt discounts and issuance costs</a></td>
<td class="nump">$ 82,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of Debt Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="nump">$ 75,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs, net</a></td>
<td class="nump">$ 7,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_DebtInstrumentExchangeableConversionRatio', window );">Debt instrument, exchangeable, conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.016398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_DebtInstrumentOptionToExchangePricePerShare', window );">Option to exchange, price per share | $ / shares</a></td>
<td class="nump">$ 60.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice', window );">Redemption price, percentage of exchange price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_DebtInstrumentRedemptionThresholdTradingDays', window );">Redemption, threshold trading days | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays', window );">Redemption, threshold consecutive trading days | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Fair value of embedded derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,400,000<span></span>
</td>
<td class="nump">$ 59,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTerm', window );">Long-term debt, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 421,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_DebtInstrumentCovenantMinimumNetRevenue', window );">Minimum net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt discounts and issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of Debt Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_DebtInstrumentLIBORFloorRate', window );">LIBOR floor rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300,000<span></span>
</td>
<td class="nump">$ 4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.21%<span></span>
</td>
<td class="nump">3.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.20%<span></span>
</td>
<td class="nump">7.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_DebtInstrumentCovenantMinimumNetRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Minimum Net Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_DebtInstrumentCovenantMinimumNetRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_DebtInstrumentCovenantMinimumProRataNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Minimum Pro Rata Net Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_DebtInstrumentCovenantMinimumProRataNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_DebtInstrumentExchangeableConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Exchangeable, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_DebtInstrumentExchangeableConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_DebtInstrumentLIBORFloorRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, LIBOR Floor Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_DebtInstrumentLIBORFloorRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_DebtInstrumentOptionToExchangePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Option To Exchange, Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_DebtInstrumentOptionToExchangePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption Price, Percentage Of Exchange Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption, Threshold Consecutive Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_DebtInstrumentRedemptionThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption, Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_DebtInstrumentRedemptionThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_DerivativeCapPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative, Cap Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_DerivativeCapPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCostOfHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The premium (cost) of a hedge, expensed during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCostOfHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=livn_CappedCallMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=livn_CappedCallMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535318702664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financing Arrangements - Leverage Ratios (Details)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodOne', window );">Secured leverage ratio, period one</a></td>
<td class="nump">5.625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo', window );">Secured leverage ratio, period two</a></td>
<td class="nump">4.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Secured Leverage Ratio, Period One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Secured Leverage Ratio, Period Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535325129208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Risk Management Narrative (Details) - Foreign Exchange Contract - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=livn_ForeignExchangeandOtherMember', window );">Foreign exchange and other gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative</a></td>
<td class="num">$ (11.7)<span></span>
</td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="num">$ (4.8)<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 332.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 332.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 338.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=livn_ForeignExchangeandOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=livn_ForeignExchangeandOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535325043208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives and Risk Management Derivative Notional Amounts (Details) - Derivatives Designated as Hedging Instruments - Cash Flow Hedging - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 60,186<span></span>
</td>
<td class="nump">$ 106,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Foreign Exchange Contract | United Kingdom, Pounds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">7,610<span></span>
</td>
<td class="nump">10,128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Foreign Exchange Contract | Japan, Yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">16,023<span></span>
</td>
<td class="nump">25,342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Foreign Exchange Contract | Euro Member Countries, Euro</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">36,553<span></span>
</td>
<td class="nump">48,838<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Interest Rate Swap Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 22,442<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_GBP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_GBP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535324806568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Risk Management Amount of Gain (Loss) Recognized in OCI and Income Statement (Details) - Cash Flow Hedging - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gains (Losses) Recognized in OCI</a></td>
<td class="nump">$ 1,482<span></span>
</td>
<td class="num">$ (689)<span></span>
</td>
<td class="nump">$ 632<span></span>
</td>
<td class="nump">$ 933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gains (Losses) Reclassified from AOCI to Earnings</a></td>
<td class="num">(158)<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="num">(681)<span></span>
</td>
<td class="nump">1,598<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Foreign Exchange Contract | Foreign exchange and other gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gains (Losses) Recognized in OCI</a></td>
<td class="nump">1,482<span></span>
</td>
<td class="num">(689)<span></span>
</td>
<td class="nump">632<span></span>
</td>
<td class="nump">933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gains (Losses) Reclassified from AOCI to Earnings</a></td>
<td class="num">(692)<span></span>
</td>
<td class="nump">963<span></span>
</td>
<td class="num">(777)<span></span>
</td>
<td class="nump">3,094<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Foreign Exchange Contract | SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gains (Losses) Recognized in OCI</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gains (Losses) Reclassified from AOCI to Earnings</a></td>
<td class="nump">$ 534<span></span>
</td>
<td class="num">(742)<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="num">(1,470)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Interest Rate Swap Contracts | Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gains (Losses) Recognized in OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gains (Losses) Reclassified from AOCI to Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (40)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instruments | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">After-Tax Net Loss in AOCI as of period end</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Amount Expected to be Reclassified to Earnings in Next 12 Months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=livn_ForeignExchangeandOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=livn_ForeignExchangeandOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535325035688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives and Risk Management Fair Value of Derivative Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total asset derivatives</a></td>
<td class="nump">$ 44,838<span></span>
</td>
<td class="nump">$ 561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liability derivatives</a></td>
<td class="nump">60,972<span></span>
</td>
<td class="nump">3,680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total asset derivatives</a></td>
<td class="nump">1,787<span></span>
</td>
<td class="nump">535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liability derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">543<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instruments | Prepaid expenses and other current assets | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total asset derivatives</a></td>
<td class="nump">1,775<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instruments | Accrued liabilities | Interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liability derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instruments | Accrued liabilities | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total asset derivatives</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liability derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instruments | Long-term derivative liability | Interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liability derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total asset derivatives</a></td>
<td class="nump">43,051<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liability derivatives</a></td>
<td class="nump">60,972<span></span>
</td>
<td class="nump">3,137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated as Hedging Instruments | Prepaid expenses and other current assets | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total asset derivatives</a></td>
<td class="nump">4,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liability derivatives</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated as Hedging Instruments | Accrued liabilities | Interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liability derivatives</a></td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated as Hedging Instruments | Accrued liabilities | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total asset derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liability derivatives</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">$ 3,104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated as Hedging Instruments | Accrued liabilities | Other derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liability derivatives</a></td>
<td class="nump">1,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated as Hedging Instruments | Long-term derivative liability | Embedded exchange feature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liability derivatives</a></td>
<td class="nump">59,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated as Hedging Instruments | Long-term derivative liability | Other derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liability derivatives</a></td>
<td class="nump">190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated as Hedging Instruments | Other assets | Capped call derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total asset derivatives</a></td>
<td class="nump">$ 38,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=livn_DerivativeLiabilitiesNoncurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=livn_DerivativeLiabilitiesNoncurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=livn_CappedCallMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=livn_CappedCallMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535321220568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Narrative (Details)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>notice </div>
<div>installment</div>
</th>
<th class="th">
<div>Mar. 29, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2016 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jan. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2012 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>notice </div>
<div>installment</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>notice </div>
<div>installment</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 29, 2020 </div>
<div>claim</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>EUR (&#8364;) </div>
<div>notice </div>
<div>installment</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 05, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Aug. 27, 2015 </div>
<div>non-conformity</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ProductRemediationNet', window );">Product remediation</a></td>
<td class="nump">$ 1,715,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,715,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,715,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,251,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,990,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,653,000)<span></span>
</td>
<td class="nump">17,581,000<span></span>
</td>
<td class="num">$ (23,431,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=livn_RegionalInternalRevenueOfficeofLombardyMember', window );">Regional Internal Revenue Office of Lombardy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements', window );">Application pending approval, payments for legal settlements | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves', window );">Unrecognized tax benefits, net of settlement payment | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 15,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,500,000<span></span>
</td>
<td class="nump">&#8364; 5,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Deferred tax asset</a></td>
<td class="nump">11,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_ThreatenedLitigationMember', window );">Threatened Litigation | Regional Internal Revenue Office of Lombardy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_IncomeTaxExaminationOperatingLossesUnderDispute', window );">Losses under dispute</a></td>
<td class="nump">$ 73,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 62,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_IncomeTaxExaminationNumberofInstallments', window );">Number of equal installments | installment</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_LossContingencyNumberofAssessments', window );">Number of notice of assessments | notice</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="nump">$ 669,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 669,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 669,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 572,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Pending claims, number | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=livn_FDAWarningLetterMember', window );">FDA Warning Letter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_LossContingencyNumberofObservedNonConformities', window );">Number of observed non-conformities | non-conformity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=livn_ProductLiabilityMember', window );">Product Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="nump">$ 135,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Litigation provision liability</a></td>
<td class="nump">46,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 170,404,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=livn_ProductLiabilityMember', window );">Product Liability | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement, amount awarded to other party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=livn_SNIAMember', window );">SNIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ReimbursedLegalFees', window );">Reimbursed legal fees</a></td>
<td class="nump">$ 342,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=livn_SNIAMember', window );">SNIA | Pending Litigation | SNIA s.p.a</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Compensation sought</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Application Pending Approval, Payments for Legal Settlements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_IncomeTaxExaminationNumberofInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Number of Installments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_IncomeTaxExaminationNumberofInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_IncomeTaxExaminationOperatingLossesUnderDispute">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Operating Losses Under Dispute</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_IncomeTaxExaminationOperatingLossesUnderDispute</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_LossContingencyNumberofAssessments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Assessments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_LossContingencyNumberofAssessments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_LossContingencyNumberofObservedNonConformities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Observed Non-Conformities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_LossContingencyNumberofObservedNonConformities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_ProductRemediationNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Remediation, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_ProductRemediationNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_ReimbursedLegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reimbursed Legal Fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_ReimbursedLegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121555522&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=livn_RegionalInternalRevenueOfficeofLombardyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=livn_RegionalInternalRevenueOfficeofLombardyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_ThreatenedLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_ThreatenedLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=livn_FDAWarningLetterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=livn_FDAWarningLetterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=livn_ProductLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=livn_ProductLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=livn_SNIAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=livn_SNIAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=livn_SNIAs.p.aMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=livn_SNIAs.p.aMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535322458760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Product Liability (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Litigation Provision Liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueCurrent', window );">Less current portion of litigation liability at period end</a></td>
<td class="nump">$ 34,790<span></span>
</td>
<td class="nump">$ 146,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent', window );">Long-term portion of litigation provisions liability at period end</a></td>
<td class="nump">11,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=livn_ProductLiabilityMember', window );">Product Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Litigation Provision Liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Total litigation provision liability at beginning of period</a></td>
<td class="nump">170,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualPayments', window );">Payments</a></td>
<td class="num">(128,128)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_LossContingencyAccrualAdjustments', window );">Adjustments</a></td>
<td class="nump">3,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther', window );">FX and other</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Total litigation provision liability at end of period</a></td>
<td class="nump">46,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueCurrent', window );">Less current portion of litigation liability at period end</a></td>
<td class="nump">34,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent', window );">Long-term portion of litigation provisions liability at period end</a></td>
<td class="nump">$ 11,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_LossContingencyAccrualAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Accrual, Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_LossContingencyAccrualAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Accrual, Foreign Currency Adjustments, And Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow reducing loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=livn_ProductLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=livn_ProductLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535320062056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity Statement of Stockholders' Equity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning Balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,411,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="nump">$ 1,333,186<span></span>
</td>
<td class="nump">$ 1,483,328<span></span>
</td>
<td class="nump">$ 1,383,717<span></span>
</td>
<td class="nump">$ 1,503,738<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation plans</a></td>
<td class="nump">$ 7,674<span></span>
</td>
<td class="nump">8,272<span></span>
</td>
<td class="nump">$ 23,889<span></span>
</td>
<td class="nump">20,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Cancellation of shares (in shares)</a></td>
<td class="num">(73,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (14,772)<span></span>
</td>
<td class="nump">32,118<span></span>
</td>
<td class="num">$ (65,182)<span></span>
</td>
<td class="num">(11,946)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">$ 24,704<span></span>
</td>
<td class="num">(28,436)<span></span>
</td>
<td class="nump">$ 9,007<span></span>
</td>
<td class="num">(17,134)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending Balance (in shares)</a></td>
<td class="nump">49,402,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,402,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="nump">$ 1,350,792<span></span>
</td>
<td class="nump">$ 1,495,282<span></span>
</td>
<td class="nump">$ 1,350,792<span></span>
</td>
<td class="nump">$ 1,495,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (639)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning Balance (in shares)</a></td>
<td class="nump">49,476,000<span></span>
</td>
<td class="nump">49,380,000<span></span>
</td>
<td class="nump">49,411,000<span></span>
</td>
<td class="nump">49,323,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="nump">$ 76,338<span></span>
</td>
<td class="nump">$ 76,217<span></span>
</td>
<td class="nump">$ 76,257<span></span>
</td>
<td class="nump">$ 76,144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock-based compensation plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending Balance (in shares)</a></td>
<td class="nump">49,403,000<span></span>
</td>
<td class="nump">49,381,000<span></span>
</td>
<td class="nump">49,403,000<span></span>
</td>
<td class="nump">49,381,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="nump">$ 76,338<span></span>
</td>
<td class="nump">$ 76,217<span></span>
</td>
<td class="nump">$ 76,338<span></span>
</td>
<td class="nump">$ 76,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="nump">1,750,798<span></span>
</td>
<td class="nump">1,717,220<span></span>
</td>
<td class="nump">1,734,870<span></span>
</td>
<td class="nump">1,705,111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation plans</a></td>
<td class="nump">7,670<span></span>
</td>
<td class="nump">8,262<span></span>
</td>
<td class="nump">23,598<span></span>
</td>
<td class="nump">20,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="nump">1,758,468<span></span>
</td>
<td class="nump">1,725,482<span></span>
</td>
<td class="nump">1,758,468<span></span>
</td>
<td class="nump">1,725,482<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="num">(1,057)<span></span>
</td>
<td class="num">(1,292)<span></span>
</td>
<td class="num">(1,263)<span></span>
</td>
<td class="num">(1,462)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation plans</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="num">(1,053)<span></span>
</td>
<td class="num">(1,282)<span></span>
</td>
<td class="num">(1,053)<span></span>
</td>
<td class="num">(1,282)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="num">(35,089)<span></span>
</td>
<td class="num">(13,174)<span></span>
</td>
<td class="num">(19,392)<span></span>
</td>
<td class="num">(24,476)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">24,704<span></span>
</td>
<td class="num">(28,436)<span></span>
</td>
<td class="nump">9,007<span></span>
</td>
<td class="num">(17,134)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="num">(10,385)<span></span>
</td>
<td class="num">(41,610)<span></span>
</td>
<td class="num">(10,385)<span></span>
</td>
<td class="num">(41,610)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="num">(457,804)<span></span>
</td>
<td class="num">(295,643)<span></span>
</td>
<td class="num">(406,755)<span></span>
</td>
<td class="num">(251,579)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(14,772)<span></span>
</td>
<td class="nump">32,118<span></span>
</td>
<td class="num">(65,182)<span></span>
</td>
<td class="num">(11,946)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="num">$ (472,576)<span></span>
</td>
<td class="num">$ (263,525)<span></span>
</td>
<td class="num">(472,576)<span></span>
</td>
<td class="num">$ (263,525)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated Deficit | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (639)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535324995176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Comprehensive Income) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="nump">$ 1,333,186<span></span>
</td>
<td class="nump">$ 1,483,328<span></span>
</td>
<td class="nump">$ 1,383,717<span></span>
</td>
<td class="nump">$ 1,503,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income before reclassifications, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,640<span></span>
</td>
<td class="num">(15,695)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(152)<span></span>
</td>
<td class="num">(224)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive income before reclassifications, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,488<span></span>
</td>
<td class="num">(15,919)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Reclassification of loss from accumulated other comprehensive loss, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">681<span></span>
</td>
<td class="num">(1,598)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassification of tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(162)<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Reclassification of loss from accumulated other comprehensive loss, after tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">519<span></span>
</td>
<td class="num">(1,215)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">24,704<span></span>
</td>
<td class="num">(28,436)<span></span>
</td>
<td class="nump">9,007<span></span>
</td>
<td class="num">(17,134)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="nump">1,350,792<span></span>
</td>
<td class="nump">1,495,282<span></span>
</td>
<td class="nump">1,350,792<span></span>
</td>
<td class="nump">1,495,282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="num">(35,089)<span></span>
</td>
<td class="num">(13,174)<span></span>
</td>
<td class="num">(19,392)<span></span>
</td>
<td class="num">(24,476)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">24,704<span></span>
</td>
<td class="num">(28,436)<span></span>
</td>
<td class="nump">9,007<span></span>
</td>
<td class="num">(17,134)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="num">(10,385)<span></span>
</td>
<td class="num">(41,610)<span></span>
</td>
<td class="num">(10,385)<span></span>
</td>
<td class="num">(41,610)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Change in Unrealized Gain (Loss) on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">513<span></span>
</td>
<td class="num">(944)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income before reclassifications, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">632<span></span>
</td>
<td class="nump">933<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(152)<span></span>
</td>
<td class="num">(224)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive income before reclassifications, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480<span></span>
</td>
<td class="nump">709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Reclassification of loss from accumulated other comprehensive loss, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">681<span></span>
</td>
<td class="num">(1,598)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassification of tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(162)<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Reclassification of loss from accumulated other comprehensive loss, after tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">519<span></span>
</td>
<td class="num">(1,215)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">999<span></span>
</td>
<td class="num">(506)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="nump">1,512<span></span>
</td>
<td class="num">(1,450)<span></span>
</td>
<td class="nump">1,512<span></span>
</td>
<td class="num">(1,450)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustments Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,905)<span></span>
</td>
<td class="num">(23,532)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income before reclassifications, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,008<span></span>
</td>
<td class="num">(16,628)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive income before reclassifications, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,008<span></span>
</td>
<td class="num">(16,628)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Reclassification of loss from accumulated other comprehensive loss, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassification of tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Reclassification of loss from accumulated other comprehensive loss, after tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,008<span></span>
</td>
<td class="num">(16,628)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="num">$ (11,897)<span></span>
</td>
<td class="num">$ (40,160)<span></span>
</td>
<td class="num">$ (11,897)<span></span>
</td>
<td class="num">$ (40,160)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535322847672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Incentive Plans (Compensation Expense) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 7,810<span></span>
</td>
<td class="nump">$ 8,531<span></span>
</td>
<td class="nump">$ 26,845<span></span>
</td>
<td class="nump">$ 24,127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based compensation arrangement, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Share-based compensation arrangement, compensation cost</a></td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Service-based restricted stock units (&#8220;RSUs&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">4,410<span></span>
</td>
<td class="nump">3,583<span></span>
</td>
<td class="nump">13,139<span></span>
</td>
<td class="nump">10,428<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Service-based stock appreciation rights (&#8220;SARs&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">3,211<span></span>
</td>
<td class="nump">2,896<span></span>
</td>
<td class="nump">9,185<span></span>
</td>
<td class="nump">7,804<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=livn_MarketbasedPerformanceRestrictedStockUnitMember', window );">Market performance-based restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 814<span></span>
</td>
<td class="nump">757<span></span>
</td>
<td class="nump">$ 2,745<span></span>
</td>
<td class="nump">2,146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based compensation arrangement, vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=livn_OperatingPerformancebasedRestrictedStockUnitsMember', window );">Operating performance-based restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="num">$ (962)<span></span>
</td>
<td class="nump">983<span></span>
</td>
<td class="nump">$ 882<span></span>
</td>
<td class="nump">2,752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based compensation arrangement, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee share purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 337<span></span>
</td>
<td class="nump">$ 312<span></span>
</td>
<td class="nump">$ 894<span></span>
</td>
<td class="nump">$ 997<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost expensed and capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=livn_MarketbasedPerformanceRestrictedStockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=livn_MarketbasedPerformanceRestrictedStockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=livn_OperatingPerformancebasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=livn_OperatingPerformancebasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535409953480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Incentive Plans (Executed Agreements) (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Service-based stock appreciation rights (&#8220;SARs&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares (in shares) | shares</a></td>
<td class="nump">1,133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 15.73<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Service-based restricted stock units (&#8220;RSUs&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares (in shares) | shares</a></td>
<td class="nump">599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 44.42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=livn_MarketbasedPerformanceRestrictedStockUnitMember', window );">Market performance-based restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares (in shares) | shares</a></td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 39.83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=livn_OperatingPerformancebasedRestrictedStockUnitsMember', window );">Operating performance-based restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares (in shares) | shares</a></td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 43.57<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=livn_MarketbasedPerformanceRestrictedStockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=livn_MarketbasedPerformanceRestrictedStockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=livn_OperatingPerformancebasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=livn_OperatingPerformancebasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535325481768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate (percent)</a></td>
<td class="nump">21.30%<span></span>
</td>
<td class="num">(49.60%)<span></span>
</td>
<td class="num">(37.90%)<span></span>
</td>
<td class="nump">65.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">$ 74.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct', window );">Tax benefit, CARES Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Unrecognized tax benefits, potential decrease amount</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Taxes Receivable, Income Tax Expense (Benefit), CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535319550168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding (in shares)</a></td>
<td class="nump">48,652<span></span>
</td>
<td class="nump">48,395<span></span>
</td>
<td class="nump">48,582<span></span>
</td>
<td class="nump">48,329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Add effects of share-based compensation instruments (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">425<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding (in shares)</a></td>
<td class="nump">48,652<span></span>
</td>
<td class="nump">48,820<span></span>
</td>
<td class="nump">48,582<span></span>
</td>
<td class="nump">48,329<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535319226648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Narrative (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Stock Compensation Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share amount (in shares)</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535327863752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Geographic and Segment Information Segment Info (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>geographic_region</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>segment </div>
<div>geographic_region</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_NumberofGeographicRegionsinwhichEntityOperates', window );">Number of geographic regions in which entity operates | geographic_region</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 240,083<span></span>
</td>
<td class="nump">$ 268,610<span></span>
</td>
<td class="nump">$ 664,686<span></span>
</td>
<td class="nump">$ 796,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Merger and integration expenses</a></td>
<td class="nump">1,094<span></span>
</td>
<td class="nump">6,716<span></span>
</td>
<td class="nump">6,616<span></span>
</td>
<td class="nump">14,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring expenses</a></td>
<td class="num">(349)<span></span>
</td>
<td class="nump">698<span></span>
</td>
<td class="nump">2,025<span></span>
</td>
<td class="nump">4,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="nump">9,685<span></span>
</td>
<td class="nump">11,146<span></span>
</td>
<td class="nump">29,346<span></span>
</td>
<td class="nump">29,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating (loss) income from continuing operations</a></td>
<td class="num">(7,508)<span></span>
</td>
<td class="nump">25,761<span></span>
</td>
<td class="num">(22,137)<span></span>
</td>
<td class="num">(24,894)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="nump">482<span></span>
</td>
<td class="nump">624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(14,673)<span></span>
</td>
<td class="num">(4,774)<span></span>
</td>
<td class="num">(25,237)<span></span>
</td>
<td class="num">(10,490)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome', window );">Foreign exchange and other gains (losses)</a></td>
<td class="nump">3,420<span></span>
</td>
<td class="nump">327<span></span>
</td>
<td class="nump">507<span></span>
</td>
<td class="num">(795)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(Loss) income from continuing operations before tax</a></td>
<td class="num">(18,714)<span></span>
</td>
<td class="nump">21,465<span></span>
</td>
<td class="num">(46,385)<span></span>
</td>
<td class="num">(35,555)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">2,521,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,521,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,411,797<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">140,878<span></span>
</td>
<td class="nump">155,426<span></span>
</td>
<td class="nump">417,482<span></span>
</td>
<td class="nump">483,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring expenses</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">783<span></span>
</td>
<td class="nump">1,265<span></span>
</td>
<td class="nump">1,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Neuromodulation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">98,408<span></span>
</td>
<td class="nump">112,543<span></span>
</td>
<td class="nump">245,277<span></span>
</td>
<td class="nump">311,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring expenses</a></td>
<td class="nump">43<span></span>
</td>
<td class="num">(171)<span></span>
</td>
<td class="nump">851<span></span>
</td>
<td class="nump">314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">797<span></span>
</td>
<td class="nump">641<span></span>
</td>
<td class="nump">1,927<span></span>
</td>
<td class="nump">1,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring expenses</a></td>
<td class="num">(401)<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="num">(91)<span></span>
</td>
<td class="nump">2,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember', window );">Continuing Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations', window );">Total reportable segment income from continuing operations</a></td>
<td class="nump">2,922<span></span>
</td>
<td class="nump">44,321<span></span>
</td>
<td class="nump">15,850<span></span>
</td>
<td class="nump">23,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Merger and integration expenses</a></td>
<td class="nump">1,094<span></span>
</td>
<td class="nump">6,716<span></span>
</td>
<td class="nump">6,616<span></span>
</td>
<td class="nump">14,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring expenses</a></td>
<td class="num">(349)<span></span>
</td>
<td class="nump">698<span></span>
</td>
<td class="nump">2,025<span></span>
</td>
<td class="nump">4,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="nump">9,685<span></span>
</td>
<td class="nump">11,146<span></span>
</td>
<td class="nump">29,346<span></span>
</td>
<td class="nump">29,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating (loss) income from continuing operations</a></td>
<td class="num">(7,508)<span></span>
</td>
<td class="nump">25,761<span></span>
</td>
<td class="num">(22,137)<span></span>
</td>
<td class="num">(24,894)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Capital expenditures</a></td>
<td class="nump">9,217<span></span>
</td>
<td class="nump">6,005<span></span>
</td>
<td class="nump">28,236<span></span>
</td>
<td class="nump">16,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember', window );">Continuing Operations | Operating Segments | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations', window );">Total reportable segment income from continuing operations</a></td>
<td class="num">(7,311)<span></span>
</td>
<td class="nump">36,180<span></span>
</td>
<td class="num">(8,037)<span></span>
</td>
<td class="nump">47,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">1,463,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,463,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,546,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Capital expenditures</a></td>
<td class="nump">7,040<span></span>
</td>
<td class="nump">5,178<span></span>
</td>
<td class="nump">17,777<span></span>
</td>
<td class="nump">13,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember', window );">Continuing Operations | Operating Segments | Neuromodulation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations', window );">Total reportable segment income from continuing operations</a></td>
<td class="nump">21,154<span></span>
</td>
<td class="nump">30,010<span></span>
</td>
<td class="nump">82,294<span></span>
</td>
<td class="nump">52,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">668,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">668,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">749,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Capital expenditures</a></td>
<td class="nump">1,210<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">7,285<span></span>
</td>
<td class="nump">666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember', window );">Continuing Operations | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations', window );">Total reportable segment income from continuing operations</a></td>
<td class="num">(10,921)<span></span>
</td>
<td class="num">(21,869)<span></span>
</td>
<td class="num">(58,407)<span></span>
</td>
<td class="num">(75,845)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">389,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">389,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Capital expenditures</a></td>
<td class="nump">967<span></span>
</td>
<td class="nump">691<span></span>
</td>
<td class="nump">3,174<span></span>
</td>
<td class="nump">2,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">128,863<span></span>
</td>
<td class="nump">138,426<span></span>
</td>
<td class="nump">330,633<span></span>
</td>
<td class="nump">401,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Operating Segments | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">49,009<span></span>
</td>
<td class="nump">49,993<span></span>
</td>
<td class="nump">133,288<span></span>
</td>
<td class="nump">155,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Operating Segments | Neuromodulation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">79,854<span></span>
</td>
<td class="nump">88,433<span></span>
</td>
<td class="nump">197,345<span></span>
</td>
<td class="nump">245,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">48,529<span></span>
</td>
<td class="nump">50,235<span></span>
</td>
<td class="nump">138,606<span></span>
</td>
<td class="nump">165,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe | Operating Segments | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">38,054<span></span>
</td>
<td class="nump">39,810<span></span>
</td>
<td class="nump">111,132<span></span>
</td>
<td class="nump">131,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe | Operating Segments | Neuromodulation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">10,475<span></span>
</td>
<td class="nump">10,425<span></span>
</td>
<td class="nump">27,474<span></span>
</td>
<td class="nump">34,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=livn_LocationsExcludingTheUnitedStatesAndEuropeMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">62,691<span></span>
</td>
<td class="nump">79,949<span></span>
</td>
<td class="nump">195,447<span></span>
</td>
<td class="nump">229,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=livn_LocationsExcludingTheUnitedStatesAndEuropeMember', window );">Rest of World | Operating Segments | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">53,815<span></span>
</td>
<td class="nump">65,623<span></span>
</td>
<td class="nump">173,062<span></span>
</td>
<td class="nump">196,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=livn_LocationsExcludingTheUnitedStatesAndEuropeMember', window );">Rest of World | Operating Segments | Neuromodulation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">8,079<span></span>
</td>
<td class="nump">13,685<span></span>
</td>
<td class="nump">20,458<span></span>
</td>
<td class="nump">31,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=livn_CardiopulmonaryMember', window );">Cardiopulmonary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">107,200<span></span>
</td>
<td class="nump">120,014<span></span>
</td>
<td class="nump">324,623<span></span>
</td>
<td class="nump">372,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=livn_CardiopulmonaryMember', window );">Cardiopulmonary | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">33,549<span></span>
</td>
<td class="nump">39,054<span></span>
</td>
<td class="nump">96,223<span></span>
</td>
<td class="nump">119,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=livn_CardiopulmonaryMember', window );">Cardiopulmonary | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">29,947<span></span>
</td>
<td class="nump">30,052<span></span>
</td>
<td class="nump">87,475<span></span>
</td>
<td class="nump">99,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=livn_CardiopulmonaryMember', window );">Cardiopulmonary | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">43,704<span></span>
</td>
<td class="nump">50,908<span></span>
</td>
<td class="nump">140,925<span></span>
</td>
<td class="nump">152,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=livn_HeartValvesMember', window );">Heart Valves</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">21,136<span></span>
</td>
<td class="nump">28,877<span></span>
</td>
<td class="nump">63,813<span></span>
</td>
<td class="nump">87,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=livn_HeartValvesMember', window );">Heart Valves | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,129<span></span>
</td>
<td class="nump">4,626<span></span>
</td>
<td class="nump">8,990<span></span>
</td>
<td class="nump">13,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=livn_HeartValvesMember', window );">Heart Valves | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">7,945<span></span>
</td>
<td class="nump">9,572<span></span>
</td>
<td class="nump">22,822<span></span>
</td>
<td class="nump">30,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=livn_HeartValvesMember', window );">Heart Valves | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">10,062<span></span>
</td>
<td class="nump">14,679<span></span>
</td>
<td class="nump">32,001<span></span>
</td>
<td class="nump">43,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=livn_AdvancedCirculatorySupportMember', window );">Advanced Circulatory Support</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">12,542<span></span>
</td>
<td class="nump">6,535<span></span>
</td>
<td class="nump">29,046<span></span>
</td>
<td class="nump">23,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=livn_AdvancedCirculatorySupportMember', window );">Advanced Circulatory Support | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">12,331<span></span>
</td>
<td class="nump">6,313<span></span>
</td>
<td class="nump">28,075<span></span>
</td>
<td class="nump">22,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=livn_AdvancedCirculatorySupportMember', window );">Advanced Circulatory Support | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="nump">835<span></span>
</td>
<td class="nump">497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=livn_AdvancedCirculatorySupportMember', window );">Advanced Circulatory Support | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 136<span></span>
</td>
<td class="nump">$ 310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign Currency Transaction Gain (Loss) and Other Nonoperating Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_NumberofGeographicRegionsinwhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Geographic Regions in which Entity Operates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_NumberofGeographicRegionsinwhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Operating Income (Loss) Included In Segment Income (Loss) From Continuing Operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=livn_CardiovascularSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=livn_CardiovascularSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=livn_NeuromodulationSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=livn_NeuromodulationSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=livn_LocationsExcludingTheUnitedStatesAndEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=livn_LocationsExcludingTheUnitedStatesAndEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=livn_CardiopulmonaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=livn_CardiopulmonaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=livn_HeartValvesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=livn_HeartValvesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=livn_AdvancedCirculatorySupportMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=livn_AdvancedCirculatorySupportMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535325717096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Geographic and Segment Information Changes in Carrying Amount of Goodwill (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning</a></td>
<td class="nump">$ 915,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency adjustments</a></td>
<td class="nump">2,684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending</a></td>
<td class="nump">918,478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=livn_NeuromodulationSegmentMember', window );">Neuromodulation</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning</a></td>
<td class="nump">398,754<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending</a></td>
<td class="nump">398,754<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=livn_CardiovascularSegmentMember', window );">Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning</a></td>
<td class="nump">517,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency adjustments</a></td>
<td class="nump">2,684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending</a></td>
<td class="nump">$ 519,724<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=livn_NeuromodulationSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=livn_NeuromodulationSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=livn_CardiovascularSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=livn_CardiovascularSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535323078952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Geographic and Segment Information Geographic Areas (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 190,509<span></span>
</td>
<td class="nump">$ 181,354<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">64,620<span></span>
</td>
<td class="nump">61,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">116,746<span></span>
</td>
<td class="nump">110,270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=livn_LocationsExcludingTheUnitedStatesAndEuropeMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 9,143<span></span>
</td>
<td class="nump">$ 9,674<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=livn_LocationsExcludingTheUnitedStatesAndEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=livn_LocationsExcludingTheUnitedStatesAndEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535317096840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Financial Information (Summary of Inventory) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 48,325<span></span>
</td>
<td class="nump">$ 45,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">18,949<span></span>
</td>
<td class="nump">14,581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">110,817<span></span>
</td>
<td class="nump">104,348<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, Net</a></td>
<td class="nump">178,091<span></span>
</td>
<td class="nump">164,154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Provision for obsolescence</a></td>
<td class="nump">$ 14,500<span></span>
</td>
<td class="nump">$ 12,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535321368568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Financial Information (Summary of Accrued Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Contingent consideration</a></td>
<td class="nump">$ 16,571<span></span>
</td>
<td class="nump">$ 22,953<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal and administrative costs</a></td>
<td class="nump">14,034<span></span>
</td>
<td class="nump">11,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">11,941<span></span>
</td>
<td class="nump">11,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="nump">7,723<span></span>
</td>
<td class="nump">6,728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ResearchAndDevelopmentCostsPayableCurrent', window );">Research and development costs</a></td>
<td class="nump">5,328<span></span>
</td>
<td class="nump">5,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ProvisionforAgentsReturnsandOther', window );">Provisions for agents, returns and other</a></td>
<td class="nump">3,772<span></span>
</td>
<td class="nump">3,922<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_RestructuringRelatedLiabilities', window );">Restructuring related liabilities</a></td>
<td class="nump">1,813<span></span>
</td>
<td class="nump">4,315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_ProductRemediation', window );">Product remediation</a></td>
<td class="nump">1,715<span></span>
</td>
<td class="nump">3,251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_DerivativeContractLiabilities', window );">Derivative contract liabilities</a></td>
<td class="nump">1,338<span></span>
</td>
<td class="nump">3,173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_livn_BusinessAcquisitionsPurchasePriceAllocation', window );">CRM purchase price adjustment payable to MicroPort Scientific Corporation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,891<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">34,073<span></span>
</td>
<td class="nump">33,531<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">98,308<span></span>
</td>
<td class="nump">120,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability</a></td>
<td class="nump">$ 9,500<span></span>
</td>
<td class="nump">$ 8,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_BusinessAcquisitionsPurchasePriceAllocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisitions, Purchase Price Allocation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_BusinessAcquisitionsPurchasePriceAllocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_DerivativeContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Contract Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_DerivativeContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_ProductRemediation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Remediation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_ProductRemediation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_ProvisionforAgentsReturnsandOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision for Agents, Returns and Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_ProvisionforAgentsReturnsandOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_ResearchAndDevelopmentCostsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_ResearchAndDevelopmentCostsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_livn_RestructuringRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Related Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">livn_RestructuringRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>livn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140535325280424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jan. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Increase (decrease) in accounts receivable</a></td>
<td class="nump">$ 191,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 257,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="num">$ (1,350,792)<span></span>
</td>
<td class="num">$ (1,495,282)<span></span>
</td>
<td class="num">$ (1,333,186)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,383,717)<span></span>
</td>
<td class="num">$ (1,483,328)<span></span>
</td>
<td class="num">$ (1,503,738)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="nump">$ 472,576<span></span>
</td>
<td class="nump">$ 263,525<span></span>
</td>
<td class="nump">$ 457,804<span></span>
</td>
<td class="num">$ (600)<span></span>
</td>
<td class="nump">$ 406,755<span></span>
</td>
<td class="nump">$ 295,643<span></span>
</td>
<td class="nump">$ 251,579<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>85
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M7$3GKZ@:KM>ZI&E"G4[HXABDD.UJL7!AS.T=987A> 3_<%G8:/&8W^(-U]G
MEEP\@KM_*O4[7VDPUVU=\BRSTP&#T2".K I:(CB:1*G5+U98.,9#3B?HCR:/
M^4W>IR[O^W00?^Y+_1>IA=Y*8WB?H4MTMZ90'1#/%]JM'P'9U@>+ VW?YN\+
M=$I]='O,[_;,/9"W;'_,=630)).$V2*X.,XHM9TO%BX.H;1L*;!IX;)_8F-@
MHQ-D?B<XH4=1JD$241PITADE8Q@G^@1S39M3(V<A2P1RF65V<T!0-$DG]!CM
M(3M_C^Q$#Y2F>]\*3P(7AR8!$BZ.J&,-T&EI%D[<YV"C,V3^&V;WN2K75AK
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MP%K;_DV,_D#+7?>JP:/46M;=QZW("]$: /S^)*7^=F F.+P/<_=_4$L#!!0
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MY*'7/DRTV)AF\E%H:$W-L(3O$R9; WB^$D(?)VV _HMG\@]02P,$%     @
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MZ?[?<AQSX4:9&X<^,QHLK=B$0!9'X''6Z*HG:0]<SXT\\^R>\B2;L\5CEI*
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MV\(.<_AC(-(8P/>%$/IU8JZ,]A]D]!]02P,$%     @ 0W==47":U=R("
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MUMGDZ9,1N?PLRQ_!=NDI5-@ /4T_(74X^7D!YOF.TW^P@^%M?/P74$L#!!0
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MIVC9@,ZWAB; L.  XP.]_!=02P,$%     @ 0W==4> 7[E,: P  O@8  !@
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M#5H6H/.MH8;;+]C!\1]I_0]02P,$%     @ 0W==427_H&&#"0  GQ<  !D
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MZ@LM5=?0@O;EB+&ZP$6QEG:%<$B?SB#ZHWT0"^R$-D><O^%"Q*EB>857<"2
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M)Z9J5^C<RSAF8&=SIT8=$K$\]?F.>R-BMWQPNIXZX)B!_K ]'+X4%_FKO#O
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MG0W&@\W"K5I4@1=&YZ>-7-",PN?FH\/7:&NE4#49KZP1CLJSP<7X]>6$Y:/
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MX>'!0+CNQMU]!-O$6^[<!MR9XVN%8Y <"V"_M+AU]1_L8/MOS_G?4$L#!!0
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MIBC>R050$FK [5)="_8:Z,)U-X[M@J/H7D@L0(( 5,_X,4R;T.6X<*-5<5<
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M@ER9IOFT3 &)9J,5%$)E2 3MKGTNN5'0D*M3L4&:S\^H.6'=/L<!M-Z02>H
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MH!O5] *>+Q0@%6[H@.:;OE?_ E!+ P04    " !#=UU10^B@+VL/   7+
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MT0 \7QGD?[B@!>*WP*_^ U!+ P04    " !#=UU1NH.OWY<+  "_)0  &0
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M\L5JW)689U^\%%K></*,83Q/V&=IOK/W/$= X'K[[-QB$1IZ'I<"+[W <(_
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MK*/U[Z&8S_\!EY%+>:66GP$<^5$N!IG@+HE(8_0&8^$]\F;2@*O@\8JF294
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M*G-?5X+#,AJ ^PL%.\H?M$#]SM:+?P%02P,$%     @ 0W==429EI<-;&@
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M'"5ET;>\-=_)-E:JCUA5UA%29/_AR6ZTT7*LPX/R\.9\/_\=1T@$PMKV'C@
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M@;N,O$.BLR"8H&T0*S;$ET01^'25PR*MS.9-W_H>I\9(PT@-G2^@3L2_8/L
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MTZD-Y\">QSVOK,$'%F0EK(!N+L.D =O)D5B2/-(\&WB..!4(4>O\)]9TVS;
M6_<W55&XD$$)54=P))&P/'MZ^BS=_\@2.(JR<*XE\X!?5R;@ Q!%!43Y/F#M
M"!WI7)_.G@WL=34H8#$ST25HV+*7CB0%Z"S$]9N2A_VRL:UA/7U=8T"OS@(3
MP6()5R%LC)VD@MWFGMU5"B(Q<>4 \YT(';E9I0LL/.X?D6%+_8EPU =6$<)
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MLEE0U<$272%#MN3$3=-6Y0Y[S#4D%[78FJ('ZA; 2,].G-KJEJ;SL#L<P&U
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M'C;L-H.\"'P1-6J[Y/($E6/F+:<&,<Y^WG P'I(6)&E:4>;"V,*XBNI@5.-
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M-YQX"3&G0>P%X11N6LW,;8%0<\"K+N!X). >K/EBF79KT(_:E=Z 6 N=&2J
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M&GSJ+#W2?H/Q]B1X(Z.S="NH[SRKK2PZQ*];1E<]H]\<HQMF]([QOSC\P\[
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MND@7D4"_TL8@9DAUAY)$/-7A@4E<:G1MKW/X\F_BA5T<>%C9_"H*/+CLW\>
M@]DDFV'J,"8A@7TM=A.C\[XEQZ7SSLH;[9L@+G0Q%%?*:+5(5>45(.4JG<.F
M'.E$R;K(HWC\_7?/)I/QCY<75Z^N:87O#W]\PC*D]!LS<@_,#XYGV5$?I7V@
M3SC_.6-G4NOZ:OYN^+>G2;#V_X_HWXSE[$:+QVW2/X0KS/FDD[E28437-5"]
M'7'4#]<L2P2>-7._3 "E]LF4XCC!'!0%J-.N(%H35QKT?)I&Z/UF_A=8F'+D
MU0V]B<S31"&;6*(21 P>F;@('/@ 6YC+4*G)T74JP0-M-R8@.+XQ,^ 1F;70
M%B%&!4[AHSQ ^8?-@2(Z )?B=3#+QCTPR:^#PTEVTJ^LR(:MN02(0[)V5 H2
M?JGR=O5P]R3WABLHRD1P5"#O")9!<S5! 1URO=/=.'&+H*^4N>F2.=PD\C8S
M]V&]F^6T0Y'Y+-Y]S5"WM4[3,:E*$Y]B-XVN=)3ML+-_/,/L:%#S5.Z9>TAM
M4S,=:W#G%L4S4J\X&&?'76 9?O!*HPUL#K2%0IQ<S2G[;"IE.*QXOBLP\(IY
M$X#S@,R^L^*M]'DI)L<I%\,UF925"7A4<+NJ"64:VYG81(_$Q:,?[I3T3"^1
M2^_OYC+_R,]:QL'.AEL5#$-RG_U 9[$G%!A/FO:,1 CE=J.@X.3L7%_Y4J?J
M*L':UJ\B-MGSNO%<.[U:-D:N:Q[:M&X;.5!EZ#^5%Z.6.M#.&]6/X[(H@-Q
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M]9WCO)$AWLH\0#OI5DORS1LO%!LVGE"G48J;)LE/QMFP?UXNOUHEHZ"S06[
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MZ$FU%^R=LLO:W"I7]8VR0=0'W5NS-4L,D'46[&>H?39O%,#6NB5S08D:AK+
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MN3#PV=<LW%!Z.Q,&C0U2["3P]:QJ'C]E>U3(7E HXI'LY0'9'P<B'T> _%L
M" B+^" 5?0DLA;V'&ZZH/+S;>XS_.T&>32LA'"W^/2_*>/;2N. &]^.GIE^\
MVPHUYNKY*2"UVKREP=H\M:O"1""?:I_?.G2TEJ(.Q3R,(@CW 1L_]^^:'MP5
M&C2;<"/R_X5.N?[:,.Z.EZZ+_J[QCWA_8[OA9B.HW22N236)YW3',?TMJ/]P
MN@TWCY5V=(\)RRU='-%X 3I?:\K<\.$-C%?1\[\!4$L#!!0    ( $-W75&Y
M49(U= 8  %P1   9    >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;,U86V_;
M-A3^*P?>4*1 XEN2)LL-<))E2X%T0=RT#\,>:(FVV$JD2E)QTU^_[Y"2+.?2
MKD"'[24119[[]QT>^6AI[$>72>GI<Y%K=]S+O"\/!@.79+(0KF]*J;$S-[80
M'DN[&+C22I$&H2(?C(?#5X-"*-T[.0KOKNW)D:E\KK2\MN2JHA#V_E3F9GG<
M&_6:%S=JD7E^,3@Y*L5"3J6_+:\M5H-62ZH*J9TRFJR<'_<FHX/3'3X?#KQ3
M<NDZS\21S(SYR(O+]+@W9(=D+A//&@3^W<DSF>>L"&Y\JG7V6I,LV'UNM%^$
MV!'+3#AY9O+W*O79<6^_1ZF<BRKW-V;YNZSCV65]B<E=^$O+>'9OIT=)Y;PI
M:F%X4"@=_XO/=1XZ OO#9P3&M< X^!T-!2_/A1<G1]8LR?)I:..'$&J0AG-*
M<U&FWF)70<Z?O$'>)DEB*NV57M"U-1K/B43>O3L:>)C@@X.D5G<:U8V?4?<+
M71GM,T>_ZE2FZ_(#N-;Z-V[\.QU_5>%4EGW:'F[2>#@>?D7?=AOO=M"W_8R^
M3JQ3+W0J;.KHMDR%EX0EG65"+R0IO9X5I1-5YI+^G,R<MX#27U_Q9:?U92?X
MLO.C<O\-=08QC/;Z]%6]-$E-&0AAYM\X^3:3-#<Y>,N;7LR0@-*:.Y5*1P+8
M=XE5K2Y361(=W7I=]\-L.]IX\=/^>#P\G$QO77@<';XDY5PE4YK=DX?UB\GT
M-)2%%ZHHD7A6S:N5*1U,)P:(TPZR<Z4%RB5R<AZ&0BP'=,F*Z9SK_$(4Y6'K
M$)UWX@C[L- FZ=?Y7+)131>MVFFKEHRE/^"-I:E::#57B=">KH3WTCIZ76D)
MW(Y>$4*D-Z8?%ENC[9!9 0UIU *T^4PYJB(.K?Q4*8L3G5"$<^C0&[ G:&%-
M5;*7#[;=2RJD<)5%$H2' 6.]^H)%8ISGW@43WM",JR@=+,=SG$TMPWG4BN3G
M$A%C*QY%@\G#ND_OZZS+6(_:6QDRA-9*KX6NT-AI%-G*YZU,#!+SI199H2FI
MBBH7++85%4#U![2[D)!-9"3)JS3 SD")Q^T"%5)8C7?8KTKNZ$V1$,0#VP<-
M]!R[(-4=@W<SA)G*!+<7 ^7G8?\5>FJ>!QU F4AJM[")SJX2Y=F3)X[W6X,H
MZ5ZWOGM;PYU-NM1 UT+!J-OZS9AT";%@(J)EXZTI54+;N\.7!X!.4>9J?A^B
M19+>2E0+URVU@I= OK*<&B"GBY/"W(%(SLN2Q@TQ%HV46DEY5NDSY"DQ>(OJ
M-XS*%3,&Y^A.Y%7 ?JM@J7Q&"BE,A+7!O0B1/L*#39%N(J1'9N!?*2V/"Y''
MT6(3W+HI@1A*1BEV*XUL/V]RLF8IR81%FPYNSB+,;+KJ&S64'ZKG+C/:.WRD
M'9A/I$1K8LLK#_N/$ W>@I=+X4@;W,)@.9.O;DQ :MV(G,E5&E#T5"\"68-G
M#H-#2$* <<@/<@<H(=AJ 2XPG/:[V-I'[]BD"W;P74CA5:1[2$F-J?TQ8RI>
M8X'NG(]SY9+<\%&ZB<TE>L(H>T;=$T#;I,*D:'+<_9DM*3*62,ODI'1EP78M
M6!GI!$<ZI2]6AMS_,<N[:PP.L!D?/N9QO8&CTFJ1;]TZ25,S]TLPC#:FU<PW
M--_:"54)\UPMQSCLW(]<"O \#]Z+T-;.T+8='$DJRRT=619TEIL*4PHX506Q
MB;5<Z;ID(/@EASV5]DXE$N=TF%;6JIGDH..JBCENKM@.Q+HW:MV;)'C#&QF>
M GE6MEUD+FNQ#P&6B%)YF/G",D\J54V(*&XJ[_"E4/+-:F8!6JI);X7TNCJ]
M_QUJ+BK/*/^WQJAY5-_<;:X9I3K%<>TH%5IZ(>XI$W>R:<9Q7.%PGXQPF4G=
MW./_="Q"1!_B4/!#!Z3G"8@KE#&.@2[@I";:C?0ULNA4:ES0ON'F.18\(=2O
MZ3H7NN4MWEEXM2+DWFAWZWO;Y),6UG@5^B%3JKF7OZ,WIK7V6:V]9.W]J)XS
MTTYN+7]PF*<6'HZL<64]@L4AC_T5:%2XAY6!4ZMQ+[ 48U1^OYJ><*I0/DQX
MZYP:\027&O"IF0H?3-[SM;$5#D88KM@G6W"LC^C?XF$G9:[_U)?6H//%BX:Z
M"-_UR#A3)'[\MF_;GPXF\8MY=3S^[G"%24*AE+F<0W38W]OMD8W?\G$!S(3O
MYYGQZ-[A,</P(RT?P/[<X,.K7K"!]@>5D[\!4$L#!!0    ( $-W75'$AU-1
M7 D  (T:   9    >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;,U9:V_C-A;]
M*X1;#&8 QZ\\FQ?@)$V;[LXT&R=M@<5^H"7:YE0B-2053^;7]]Q+2983)\T4
M7>Q^22R)O,]S[SV4CI?6_>X72@7Q.<^,/^DL0B@.^WV?+%0N?<\6RN#)S+I<
M!ERZ>=\73LF4-^59?S08[/5SJ4WG])CO7;O38UN&3!MU[80O\URZAS.5V>5)
M9]BI;]SH^2+0C?[I<2'G:J+"77'M<-5OI*0Z5\9K:X13LY/.>'AXMD_K><$O
M6BU]Z[<@3Z;6_DX75^E)9T &J4PE@21(_+M7YRK+2!#,^%3)[#0J:6/[=RW]
MDGV'+U/IU;G-?M5I6)QT#CHB53-99N'&+G]4E3^[)"^QF>>_8AG7[NUV1%+Z
M8/-J,RS(M8G_Y><J#JT-!X-G-HRJ#2.V.RIB*R]DD*?'SBZ%H]601C_85=X-
MX[2AI$R"PU.-?>'TSL@RU4&EXMR:%,&.O[S-="KI]J4VTB1:9F(2< /Y"%Z\
MO<;S1"O_[K@?8 7)ZB>5QK.H<?2,QN_$>VO"PHOOH2]=W]^']8T+H]J%L]&+
M B>JZ(GM05>,!J/!"_*VFY!LL[SM9^2-D\26)F@S%[6;XM_CJ0\.$/K/"PIV
M&@4[K&#G&05GTFLO[$Q<.^413TGXW!3(OR!&W"X4H)[8O)#F@7Q(FKPF[;S.
MFKSZ55XA[)_Z7GZP]U)(NNP*:;#6.A$@-RR<4GS'P!:1QSPJRJ- %B!EJER3
M"EXX&@R_ZXJ%O%=BJI01Z!R%=%BO#9OI4EBA /JP$'>]24_\,!Y?LT)M@G(Z
M;QFJ36Q"7,V0329I@[R47.%>!"NH5,5PL/4O7C%V02>9P@UR[4;-RRQNGVS]
MUGMUJ*8R8R-CEUR+41 7*JG<'G;96SCKHZ\I[+^G4#N;B[K,-L8=Z@(:: R+
M+5T45/ORCZZ8ED&D%D T-F!-DI4I;,\RLB:&83TT,VL#EF*#4Y]*30&?/CP*
M,#F>J: VFM035X8EVT(;D@I%N33HT_2XRX^^!EGHM=2(V6:9?D1CJSH);=6>
MJPTJK,D>X"-<R; E*9VC!ZT-[UB71FBAR2#VWF.6L#]2S*1V*Z5U;## G&0%
MJ!,TZT<P1[0T[OER"K%:.I1[]R\B/E8+X,UIJJW3<$F;5">2!E!M56U+6 !$
MN7P 9(3Z7"!&:E5P#THZTD;&/P+::! !O+D\BM@2(&J!2 %4?F'++"4E-+H)
M9HCCQ]+$V<CE1PIKE/YY0CDFC+! *E!Z:Z7T%,2]%SKG;M,Y=U]L>3<JR:3W
M>L;!A(V;NN97BA"_JMB?7/.$ J <520"J9$+($A;9#:GP>";ZI$NIK0H76&]
M\IP1WY94ZT@U1RLJDL@W]38$5,UF5!4V5OTJT%1:FK9VVZ"MD$P"R0+I%V(&
M5N5?"NU>$]J]%^-R0<V*W=D8U)<W7T5,IXT,\:F4&44R!FNATGGLM7&P=D6R
MD&:.ISIV&:[<>YF537VT9"TUF@8CE^8%-\DWWPSW!D<06.;4TG'/$@PY*TXM
MB#3>4U?$M1)OWWQS,!H-CL8_GU_QS^'1.T&&9*R)C:,FH'*A/6N9&_TE-F,4
M("I_[D59($E>A9!Q ?210- QSD9/7/[6MG<.X,0"R:SWT4G2S9UA#66H&LK[
M,XUT?3#7SI#,=S2=4=)+4P<PR&FF:.X #SV"M*)H8G\5^P@T6&?0DVAN01SZ
M%UM_W@ ICJJ6*S28B/;XRO;".K*,N$'359E8 ZQ07^'X5?Z\#K[[#7SW7T3@
M.+7L#4G^@+- F\0Y:_ [B:HW@?MO$AW[L<W@$SWDE*"!V'N,*P00<?6)TXTL
MBI1LR3;KLD&W32I=ZL5=0?'S*QQ/[GR#8^U]&:<[P>!R/#E;<2-TJ*09@RM5
MCY.TJ;\?BBL2+"X(0F]D7APU!F$2K?S@Y]#0!.G[IJ-M/#F@&?S,E3K1*#)J
MD!C4[V5 .7GQ4XD9BZFQ)^"B^&![?+$UW(Y4#1+2*(5!KZDH*3(UQR$&T.A$
MC8&LO65>,'>V+,C*1X]11[F2OB0N@9) >P=?_,*P]8$.>YHYY52UYBG6432-
M"M4X6$WMN!0GLHRON0PYZBKFH[*V*47QDS0EL9=JH-/Z5O<):VBJ.AVV;55#
MH\6*NA4G9-A9"*G89-V]NK%]-1" $X]T'];0XP:H4/\ ;Y?=3%4"SD! ^7;0
MV\,A-,MJFMENP#@*XZS$C67#\EZC$"G=;^=W?VNPTP7;!+KFFIK8U@_6IMSS
M245$R]M;\-!$;.\.WAT".B"N>L8\@X)TJY M&C/-QBL@7SLF@;=K.,DMYAM@
MK@HQJ@MC7N_2JUV!1#(UBW,^TAS!BJEBUL95(X!I%)')1#K'YD6($)F&3ID2
M07RB!O:AEQ)WBW4<-=;.K:N250^FIZ5!M)]7.5[3A'GKYAM&:=4W*B@_%D]=
M9KA_]$0Z,)\HA=9$FE<6]IX@^I:XH5A*.KBL6$_5F%;3[\^XIF?+B =Q$!C&
M'!_$#E""L^4<M4!P.FACZP"]HRLNR<!?.(3O8[ES2"I,'8P(4^<5'X%-%(\+
M[1,,6BS%J9&;2[2$4/:,N U Z^+ D$86Q-62(F(UL4Q7&EQ;@U.QG&!(*_7Y
M2I'_?XSR[EH%,VQ&1T_KN'IP14=[([.M.Y#EB9V%);&+MY-R&NHRW]KAK/ +
ML&H?X; U'RD55W2"S9MW'^=HVQZ&T+FQ>L4@SC-;TBNMO"AYV]@YRG25,A3X
M%;D]4>Y>XXA_7O&=M6R"L+E6%C-,KM@.Y+HU>MV:A*UA^FOC 5>N=/O5F<L]
M!E@B"QV@Y@OMV2A4URXBN:FZ!^DK:++:*4-+U^$M$5Y?A?=_AYK+,A#*_ULT
M:A;%U[/-UU2JE1S?4*GFM!T/8J;A2(\/8"T/ESA.U'/\M;0('GV,I.!O)4C/
M%R!&*&$<A(YQ4A7:C0H5LL09F/\,[;IZ<H$+8@C5;7&=2=/4+>XY6+4JR/WA
M[M;7MLF-&M;JBOLAE50]E[^B-Z:5]&DEO2#IO2B>(M,PMZ9^Z(QH&*O!65]4
M%"R2/'Y]A$85S_F^1?>X2D&CLH<5>RKHZ!>8X:W7U) 87&KYI!]9X2/F/5NC
MK3#PY?<!KW_!U@K9YN-4O_6)  UUSA]"Z,4C2B1^+6CN-M]:QO$3PVIY_%#S
M'DR"#KB9FF'KH+>_VQ$N?OR(%\ ,?W"8VH#NS3\7(#_*T0(\IY>3]04I:+Y
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MRM)[YJ<E_8% [0SH?*N4/2Y<@--?DL5?4$L#!!0    ( $-W75'@;/?SV0(
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M9GOYD?4CUW/JY5(Q ZG?'0TZ2(_NPV5Y8]72?2R<*FM5YBX7 L.@I@UX/E.
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M@K<E#6:T08'^%\;X7@@$PZA?_P]02P,$%     @ 0W==4:1K'E1J"   >A0
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M-,+I=N7+A8\T .^O0^AV?VB!\7/C^?\!4$L#!!0    ( $-W75$R6N#0.00
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MJ/;B;C^,K-UEN9:&KEZWW-&_#BHK0.<;2>%T']9 __<T_P=02P,$%     @
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MN^W#@Q;9^ T>%^!,^.X=&8]F'!ZGF&6DY0/8'QOCZP4;:'X(.?\+4$L#!!0
M   ( $-W75$#JFR]_P(   4)   9    >&PO=V]R:W-H965T<R]S:&5E=#,X
M+GAM;+56WV_:,!#^5ZRH#ZVTD1\$ A4@%5 WJG6JRKH]3'LPR4&L.G9J.]!*
M^^-G.VE*1<BZ27TA]MG??7>?#Y]'.R[N90J@T&-&F1P[J5+YN>O*.(4,RP[/
M@>F5-1<95GHJ-J[,!>#$@C+J!I[7=S-,F#,96=N-F(QXH2AA<".0++(,BZ<I
M4+X;.[[S;+@EFU09@SL9Y7@#2U!W^8W0,[?VDI ,F"2<(0'KL7/AG\_]P #L
MCN\$=G)OC$PJ*\[OS621C!W/1 048F5<8/W9P@PH-9YT' ^54Z?F-,#]\;/W
M2YN\3F:%)<PX_4$2E8Z=@8,26.."JEN^^PQ50CWC+^94VE^TJ_9Z#HH+J7A6
M@74$&6'E%S]60NP!_/ ((*@ P5L!W0K0?2L@K "A5:9,Q>HPQPI/1H+OD#"[
MM3<SL&):M$Z?,'/N2R7T*M$X-9D64END1#.>K0C#YC D^HB^8B&P.1)T.@>%
M"95GVGJWG*/3DS-T@@A#WU)>2,P2.7*5CL3X<^.*=5JR!D=8KPK607[P 06>
M/VR S]KA2\@[J.L9>. UP.?M\#G$&NXWL;M:OEK#H-8PL/ZZ?]/P(GXHB"2V
MH']^T3:T4)#)7RT<W9JC:SG"(QR?.$]VA-(FL4IDWR+-_WP[&?J#,!J,W.V^
M*$W;>M$PK+>]"BRL PM; [LF."-HP:02A;X/E&Q)ME?[[+V;H/V:H]\:]R4F
M FTQ+0#Q-8IUU9,$A*U_I 1F<@U"0-)4V_T#(?W(\[QF':,ZGJ@UGAF6:1-9
MB>KMDWF#8V2#FFS03L:9(FRCC^MUYDT!# X"Z!]-=ECS#_^WFJ?#PX1[Q_A\
M[^6:\_ZM3-%O-(>M[GLY)$A!G#).^>8)Z0O-7&ZYX+&I0 $2L(A3:T]*@,&W
M5*"_=_?Z[U;G_LOMY >MJ2^8PFQ#5A00EA)TZMC0'2GNRMFKZ@ZC@P-P]UJ.
M>2!<8[$ANG-06&N<UXGT 8JRYY83Q7/;A59<Z9YFAZE^IX P&_3ZFG/U/#&-
MK7[Y3/X 4$L#!!0    ( $-W75'D67C$R0(   0'   9    >&PO=V]R:W-H
M965T<R]S:&5E=#,Y+GAM;)V576_:,!2&_\I1M(M6:LD'7Z4"I +J5FG=JK*N
M%],N3')"O#IV9CO0_OL=AS2B:T#3N"#^>M\\YQS;&6^5?C(9HH7G7$@S\3)K
MBTO?-W&&.3,=5:"DF53IG%GJZK5O"HTLJ42Y\*,@&/@YX]*;CJNQ.ST=J](*
M+O%.@RGSG.F7&0JUG7BA]SIPS]>9=0/^=%RP-2[1/A1WFGI^XY+P'*7A2H+&
M=.)=A9?SH5M?+?C.<6OVVN B62GUY#HWR<0+'! *C*US8/38X!R%<$:$\;OV
M])I7.N%^^]7]NHJ=8EDQ@W,E'GEBLXEWX4&"*2N%O5?;3UC'TW=^L1*F^H=M
MO3;P("Z-57DM)H*<R]V3/==YV!.$O0."J!9$_RKHUH)N%>B.K IKP2R;CK7:
M@G:KR<TUJMQ4:HJ&2U?%I=4TRTEGIPMN8B4MER4F\+5 S5QV#9Q\8=JU-W@*
M)PNTC MS"N<PO[^%66G(Q1BXUDS&&3=($X>,SN%AN8"3#Z?P ;B$6RZ$&Q_[
MEN@=@Q_7I+,=:72 ]*K0'>@&9Q %X46+?'Y<?LN</'3R*'@K]REG3>*B)G%1
MY=<]X'<C8Y4C+"VS2+O:GL&,"4H'#56GC\D$KI*$NRPP4:5'*%-J-+!Z<=U"
M&1K_J%59F#,@.U$F7*X/)O+'9R* &WJ;^7F$O]OP=RO^W@'^.7GRI'8'2Y4T
M*6J-25ME=E9A4'FYBV$S#4?]SFCL;UH0>@U"[_\0SB!F)FL#Z;T'&77"T9M?
M.U2_@>H?A7JD6\>5(68%MU0@EORB4^@JW+;G^BV)&71Z[0B#!F%P%*$N.D'0
MCC&0:I5#LK\K5+,KVIAVYOT]I/.P'6C8  V/ GUCS[!"B2EO3<+P?1*"SM^O
M]/?N*/=]H/.XYK2M!::D"CI# M:[.W?7L:JHKJV5LG0)5LV,/E.HW0*:3Y6R
MKQUW$S8?OND?4$L#!!0    ( $-W75%7D1AMS0,  '\/   9    >&PO=V]R
M:W-H965T<R]S:&5E=#0P+GAM;+576X^;.A#^*Q;J0RN=7;"YA*R22,WEJ'VH
MNDIZ>3@Z#]XP":B .;:3=*O^^-K 0@B$S>[9?4FPF6^^F6'F X\.C/\0(8!$
M/Y,X%6,CE#*[,4VQ#B&AXIIED*H[&\83*M62;TV1<:!!#DIBDUB69R8T2HW)
M*-^[Y9,1V\DX2N&6([%+$LKOIQ"SP]C QL/&,MJ&4F^8DU%&M[ "^36[Y6IE
M5EZ"*(%41"Q%'#9CXSV^61"B ;G%MP@.XN@:Z53N&/NA%Q^#L6'IB""&M=0N
MJ/K;PPSB6'M2<?Q7.C4J3@T\OG[P_G>>O$KFC@J8L?A[%,AP;/@&"F!#=[%<
MLL,'*!-RM;\UBT7^BPZEK66@]4Y(EI1@%4$2I<4__5D6X@B@_'0#2 D@IP#G
M#, N ?:E#$X)<"YE<$M GKI9Y)X7;DXEG8PX.R"NK94W?9%7/T>K>D6I;I25
MY.INI'!RL@0A^6XM=SQ*MZBYHFF@=F(J(4 S)J1 ;^<@:12+=^@*?5W-T=LW
M[] ;%*7H2\AV0MF+D2E55-JWN2XCF!81D#,1V.@32V4HT"(-(.C S_OQPQZ\
MJ:I1E80\E&1*>AVN(+M&MO47(A:Q.N*970S'PZYT_A_[XMGLC6+857_8N3_[
MTOX O@?TSY+%,5*3>J \^+>'QJEHG)S&.4,S"RG?0F?W%$ O!VK9VT^N;$>E
MMC]^)&TC;^@W;>9M&U5BMVFT:!LYKF=71HWDW"HYMS>Y)2@AIVGTB^;:>!O3
M5/34S*O<>J_Y: 85S: W^BE5\:X!48GN8!NEJ69C&Y0!CUCGO!;^W*,:NLYP
MT%U#OXK"?V:#S/T67>.Y-NB&%=VPGXZ*$&7T7KT2E>QI(60R!-Y%/VS17[G>
M@'3S8ZO69>O2LH.F[RGXM'1U' /V7>ND_Q^S:@9Z] +!3^YN]!LMDBQF]P!H
M!7O@12HJC\^ZC.@+</4N*P#YFZ6G3S&I(R&O.1"XUD1LO_!(E Z/:^]8YV8"
MUZJ)GRN;\Q)YV5C@6LIPOY8]83!*3XW)<'S_7,/5LH>]EYL,K]WSQ"&GD_&(
M53/06CAQOW*>F8S/[8(U"6I-Q/ZK-GRMAKA?#I_1\&U9Q(YUYMF36A5)ORKV
M-#QIR]LYNEK;2+^V/:';2T^-;A\,S_00J36-D!=K]M)5XRO(.OT*>L2H"-,\
M.E DH"JN3W("K=DNE<6W8[5;G1;?YV>DD_TIOIGACOVY.ET69\':?7$T_:0>
M<*3F)(:-HK*N!ZJBO#CM%0O)LOPX<\>D.ASEEZ$Z(0/7!NK^AC'YL- $U9E[
M\@=02P,$%     @ 0W==40B]0[@S P  I L  !D   !X;"]W;W)K<VAE971S
M+W-H965T-#$N>&ULO59;;YLP%/XK%NI#*ZT%<\FE2B*U)-,JK5O5K-O#M <G
MG 14P,PV22OMQ\\&0@A0E&527Q+;?-^Y?0=S1EO*GKD/(-!+%,9\K/E")->Z
MSI<^1(1?T01B^61%642$W+*USA,&Q,M(4:B;AM'3(Q+$VF24G3VPR8BF(@QB
M>&"(IU%$V.LMA'0[UK"V.W@,UKY0!_IDE) US$$\)0],[O32BA=$$/. QHC!
M:JS=X.L9MA0A0WP/8,LK:Z1265#ZK#9WWE@S5$00PE(H$T3^;<"%,%269!R_
M"Z-:Z5,1J^N=]8]9\C*9!>'@TO!'X E_K TTY,&*I*%XI-M/4"3D*'M+&O+L
M%VT+K*&A9<H%C0JRC" *XOR?O!2%J!"DG7:"61#,.L%^@V 5!.M8#W9!L(_U
MX!2$+'4]SSTKW)0(,ADQND5,H:4UM<BJG[%EO8)8-<I<,/DTD#PQ>00N6+H4
M*0OB-3K<S5YD.W) BU<TA[7L#H'.IR!($/(+=(F>YE-T?G:!SE 0HV\^33F)
M/3[2A0Q+&=>710BW>0CF&R%8Z)[&PN=H%GO@M?"GW?QA!U^7Y2AK8NYJ<FMV
M&IQ#<H4LXP,R#=-HB<<]FHZ';>G\G_?9R=X/BF&5#6)E]JRC&L2E7" IL^H4
M8!M /S]+/+H3$/%?'=[LTIN=>;/?\.;ZA*VAM8ER8B\CJNMO,[FT;)GAIJI,
M$]0;#@XQTR9&5MHY!,V:(-OI627H(#FG3,[I3.YK HP(5<;B=>+H#W()\P*Z
M(7R9AH1UE+!7>NF]@V#]TEO_5,%RHE,I85VM)J(_L&IJ-3'8[-75:@$Y)FY7
M:U!F-OAWM;Y RFA$/:F5^LYU%'!8NAF^@US8V-_WQJF"%<QJ&>V:'&X+YA+W
M<4VT%M3 J8%F+2 +V^VBX<KW#'?+)GSH>HVPN;=DOH<R^XL66R<K8S4O/]O
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M_P7*@OIYOJ5(5/&+]F4L[J'E5FF1EF##(.79X9\]ET+4 "0X Z E@+X6X)<
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M   7. .N=],<M-'&HCAJ3$J'E12R)^T ^ N\;-,"H%[@:9LV"]K;-!;V++$
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MBUZR*WJ_IKHFS6=<$W@:<Q?[+&+) 1%++6+IOA!+>R.66L32'1!+ZXB%D+8
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M/F#N[X0QL69@=_[ME][R;U!+ P04    " !#=UU1 ([M\*D#  "]$   &0
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M/QW5)WY:.IX>F?@;89(.+JB,!% \3J,\YN_@SI1E8M+S+.PEJT!+P+/2[VS
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M5D>/MZNOQ98/<F3Y@%O8<0E7>^B"CQQ(Y>P&KA5WM:95ZX6^='* 84+TPJB
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M6=,C -8'T/[!&#P[?C#'9R7_#5!+ P04    " !#=UU1(8P6A@(#   K"0
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M?/ 4S TW.%'EWR*WQ2@8!)#C@J]*>Z76G[$)R#LX5Z7QO[!N;*, YBMC5=6
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M4GH:/"AOB>4MZ74N)E7FPJ"I=RQT2?_S[B'NQ4@[I]NM%E_2..Z:#$M:,NA
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MRPYX<.3R0&\CF7S;!.LJ1E[3,EK3,DK0<5-NY8H*4";G/V^5"+B1U(_^,BR
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MN>$[YLXP&OK W0=16]I#$-<$L2.(NPA :SPZ2N&FDD(J1X7;EYV(LWH'&8:
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MT.!JA$ZI<A8J%T86;IQ82X/#B;M-<7X$90/P_59*<UQ8@GHBG?\$4$L#!!0
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M3J\OI-A4Y\6/0DJ15E_7G"UX7@JHYTLAY,M%:6#_3PWC_P%02P,$%     @
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M;"]W;W)K<VAE971S+W-H965T-C$N>&ULS5?;;MLX$/T50BT6"=!:-SNV6]N
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M8C7&109$).02<$<F5+$UH3PF,Y85&F)R,P--6:9ND:T,2!UNC)//J2@4HM7
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M\#$@)6QHP^V=VGV&+A\OL%#<^"_9=;Y10(K&6"4Z,"H03+8C?>KJ< ! GF%
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M"!6JD9:\P;O1WI*+H:O1:HG;&KD^_CC-1G$>/AZ>MP&G>)0=.RT&F9)CI^6
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M9\OA'K\X0%D!?+^5TIPFMJ=MOF$6_P-02P,$%     @ 0W==46V6=!FN P
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M_U2,C*-IAND:= 'NP0A-R"8'],]G)8@>)13BZX [7NN.5[GC'7'GD2;J;2
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M/V'=\9R7^8-A[4>_;BM)V_45\Z8L+]VQ+^I.\V*S<'JSZ/OL'U!+ P04
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M_R35X_G<?+W\9?F]$^\7S07G^K:B//T%4$L#!!0    ( $-W75&DR,-W^@$
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M;W!S+V%P<"YX;6Q02P$"% ,4    " !#=UU1.P":R^\    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !#=UU1
MF5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( $-W75%:RX]\7@4  /L5   8              "
M@0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !#=UU1
MC+ 0Y)0'   ;(P  &               @(&B#0  >&PO=V]R:W-H965T<R]S
M:&5E=#(N>&UL4$L! A0#%     @ 0W==48ZT5P71 P  _0P  !@
M     ("!;!4  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    (
M $-W75'_N_Y0Q@<  /H?   8              " @7,9  !X;"]W;W)K<VAE
M971S+W-H965T-"YX;6Q02P$"% ,4    " !#=UU10O4>"0(#  "/"   &
M            @(%O(0  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#
M%     @ 0W==47":U=R("   =B,  !@              ("!IR0  'AL+W=O
M<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( $-W75']/G7V9P8  "</
M   8              " @64M  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q0
M2P$"% ,4    " !#=UU1IE[!.Y(#  "L!P  &               @($"-
M>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ 0W==4> 7[E,:
M P  O@8  !@              ("!RC<  'AL+W=O<FMS:&5E=',O<VAE970Y
M+GAM;%!+ 0(4 Q0    ( $-W75%I[]X\-00  "\)   9              "
M@1H[  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ 0W==
M427_H&&#"0  GQ<  !D              ("!AC\  'AL+W=O<FMS:&5E=',O
M<VAE970Q,2YX;6Q02P$"% ,4    " !#=UU1<*A$%LH%   "#0  &0
M        @(% 20  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0
M   ( $-W75&<INT\ PP  -\G   9              " @4%/  !X;"]W;W)K
M<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ 0W==44/HH"]K#P  %RP
M !D              ("!>UL  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q0
M2P$"% ,4    " !#=UU1NH.OWY<+  "_)0  &0              @($=:P
M>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( $-W75$F9:7#
M6QH  )A*   9              " @>MV  !X;"]W;W)K<VAE971S+W-H965T
M,38N>&UL4$L! A0#%     @ 0W==41%)+(2E!@  P!0  !D
M ("!?9$  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " !#
M=UU1ZP1/>A$%  !*#   &0              @(%9F   >&PO=V]R:W-H965T
M<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( $-W75'VS=-]C@8  .<1   9
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M970R,RYX;6Q02P$"% ,4    " !#=UU1Q(=345P)  "-&@  &0
M    @(%ZO@  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    (
M $-W75'SH,])O ,  )X(   9              " @0W(  !X;"]W;W)K<VAE
M971S+W-H965T,C4N>&UL4$L! A0#%     @ 0W==4>!L]_/9 @  #08  !D
M             ("! ,P  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"
M% ,4    " !#=UU1?@;VI1$%  !1"P  &0              @($0SP  >&PO
M=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( $-W75$CI! &40D
M $D>   9              " @5C4  !X;"]W;W)K<VAE971S+W-H965T,C@N
M>&UL4$L! A0#%     @ 0W==43L8I6YC!0  RPL  !D              ("!
MX-T  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " !#=UU1
MA3[[?_\&  "H%P  &0              @(%ZXP  >&PO=V]R:W-H965T<R]S
M:&5E=#,P+GAM;%!+ 0(4 Q0    ( $-W75$+LZK&R0(  (<&   9
M      " @;#J  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%
M  @ 0W==411.)Z?(!@  714  !D              ("!L.T  'AL+W=O<FMS
M:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " !#=UU1^K4!3]@#  "]"
M&0              @(&O]   >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+
M 0(4 Q0    ( $-W75'U0^N:7@,  /8'   9              " @;[X  !X
M;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ 0W==4:1K'E1J
M"   >A0  !D              ("!4_P  'AL+W=O<FMS:&5E=',O<VAE970S
M-2YX;6Q02P$"% ,4    " !#=UU1,EK@T#D$  !)"0  &0
M@('T! $ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( $-W
M75$ 0WUF>P8  !01   9              " @60) 0!X;"]W;W)K<VAE971S
M+W-H965T,S<N>&UL4$L! A0#%     @ 0W==40.J;+W_ @  !0D  !D
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M=#0R+GAM;%!+ 0(4 Q0    ( $-W75'U["4C:@0  .T4   9
M  " @88A 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @
M0W==44A*:F&%"   /#X  !D              ("!)R8! 'AL+W=O<FMS:&5E
M=',O<VAE970T-"YX;6Q02P$"% ,4    " !#=UU1LC/*]\@&   @*   &0
M            @('C+@$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4
M Q0    ( $-W75&Q:WJI8@,  /4-   9              " @>(U 0!X;"]W
M;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ 0W==40".[?"I P
MO1   !D              ("!>SD! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX
M;6Q02P$"% ,4    " !#=UU1Y?0Q]%\$  "J&P  &0              @(%;
M/0$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( $-W75&Y
MM=AQMP4  $T<   9              " @?%! 0!X;"]W;W)K<VAE971S+W-H
M965T-#DN>&UL4$L! A0#%     @ 0W==43O9^M?G!@  %B(  !D
M     ("!WT<! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $-W75%O(@I"^00  "8=   9              "
M@9E< 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ 0W==
M49']O"K&!@  X1\  !D              ("!R6$! 'AL+W=O<FMS:&5E=',O
M<VAE970U-BYX;6Q02P$"% ,4    " !#=UU14C9S8S4#  "="@  &0
M        @('&: $ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0
M   ( $-W75%\(WV).0<  /XE   9              " @3)L 0!X;"]W;W)K
M<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ 0W==43)7;@@X!@  X"
M !D              ("!HG,! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q0
M2P$"% ,4    " !#=UU1MRKB4G,$   (%   &0              @($1>@$
M>&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( $-W75'>U<WF
M;@,  +D,   9              " @;M^ 0!X;"]W;W)K<VAE971S+W-H965T
M-C$N>&UL4$L! A0#%     @ 0W==49J>9S@> P  _PD  !D
M ("!8((! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4    " !#
M=UU1_+3L".4"   $"0  &0              @(&UA0$ >&PO=V]R:W-H965T
M<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( $-W75&J4DP0J@(  &\'   9
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M970V."YX;6Q02P$"% ,4    " !#=UU1=4A.B0($  #/#   &0
M    @(&^H0$ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    (
M $-W75%MEG09K@,  *$,   9              " @?>E 0!X;"]W;W)K<VAE
M971S+W-H965T-S N>&UL4$L! A0#%     @ 0W==467* J"+ @  '@\   T
M             ( !W*D! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !#=UU1
MEXJ[',     3 @  "P              @ &2K $ 7W)E;',O+G)E;'-02P$"
M% ,4    " !#=UU1GYK<M3(%  !X+@  #P              @ %[K0$ >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ 0W==4=MVL'$Q @  B2D  !H
M         ( !VK(! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ 0W==4:3(PW?Z 0  M"@  !,              ( !0[4! %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&     $X 3@!9%0  ;K<!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>466</ContextCount>
  <ElementCount>401</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>109</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>13</UnitCount>
  <MyReports>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Statements of Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss</Role>
      <ShortName>Condensed Consolidated Statements of Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Unaudited Condensed Consolidated Financial Statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatements</Role>
      <ShortName>Unaudited Condensed Consolidated Financial Statements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2105103 - Disclosure - Discontinued Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/DiscontinuedOperations</Role>
      <ShortName>Discontinued Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2107104 - Disclosure - Restructuring</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/Restructuring</Role>
      <ShortName>Restructuring</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2111105 - Disclosure - Product Remediation Liability</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/ProductRemediationLiability</Role>
      <ShortName>Product Remediation Liability</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2114106 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2117107 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2124108 - Disclosure - Financing Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/FinancingArrangements</Role>
      <ShortName>Financing Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2129109 - Disclosure - Derivatives and Risk Management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/DerivativesandRiskManagement</Role>
      <ShortName>Derivatives and Risk Management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2135110 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2139111 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2143112 - Disclosure - Stock-Based Incentive Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/StockBasedIncentivePlans</Role>
      <ShortName>Stock-Based Incentive Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2147113 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2149114 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2153115 - Disclosure - Geographic and Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/GeographicandSegmentInformation</Role>
      <ShortName>Geographic and Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2158116 - Disclosure - Supplemental Financial Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/SupplementalFinancialInformation</Role>
      <ShortName>Supplemental Financial Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2162117 - Disclosure - New Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Unaudited Condensed Consolidated Financial Statements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatementsPolicies</Role>
      <ShortName>Unaudited Condensed Consolidated Financial Statements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/NewAccountingPronouncements</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2308301 - Disclosure - Restructuring (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/RestructuringTables</Role>
      <ShortName>Restructuring (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/Restructuring</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2312302 - Disclosure - Product Remediation Liability (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityTables</Role>
      <ShortName>Product Remediation Liability (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/ProductRemediationLiability</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2315303 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/Investments</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2318304 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/FairValueMeasurements</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2325305 - Disclosure - Financing Arrangements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/FinancingArrangementsTables</Role>
      <ShortName>Financing Arrangements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/FinancingArrangements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2330306 - Disclosure - Derivatives and Risk Management (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementTables</Role>
      <ShortName>Derivatives and Risk Management (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/DerivativesandRiskManagement</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2336307 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/CommitmentsandContingencies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2340308 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/StockholdersEquity</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2344309 - Disclosure - Stock-Based Incentive Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansTables</Role>
      <ShortName>Stock-Based Incentive Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/StockBasedIncentivePlans</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2350310 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/EarningsPerShare</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2354311 - Disclosure - Geographic and Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationTables</Role>
      <ShortName>Geographic and Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/GeographicandSegmentInformation</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2359312 - Disclosure - Supplemental Financial Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationTables</Role>
      <ShortName>Supplemental Financial Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/SupplementalFinancialInformation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2363313 - Disclosure - New Accounting Pronouncements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsTables</Role>
      <ShortName>New Accounting Pronouncements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/NewAccountingPronouncements</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Business Combinations - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails</Role>
      <ShortName>Business Combinations - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Discontinued Operations (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails</Role>
      <ShortName>Discontinued Operations (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/DiscontinuedOperations</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2409403 - Disclosure - Restructuring Restructuring and Related Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails</Role>
      <ShortName>Restructuring Restructuring and Related Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Restructuring Restructuring Expense by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails</Role>
      <ShortName>Restructuring Restructuring Expense by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2413405 - Disclosure - Product Remediation Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails</Role>
      <ShortName>Product Remediation Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2416406 - Disclosure - Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/InvestmentsDetails</Role>
      <ShortName>Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/InvestmentsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2419407 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2420408 - Disclosure - Fair Value Measurements - Contingent Consideration Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails</Role>
      <ShortName>Fair Value Measurements - Contingent Consideration Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2421409 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2422410 - Disclosure - Fair Value Measurements - Fair Value of Contingent Consideration by Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value of Contingent Consideration by Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2423411 - Disclosure - Fair Value Measurements - Level 3 Valuations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails</Role>
      <ShortName>Fair Value Measurements - Level 3 Valuations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2426412 - Disclosure - Financing Arrangements Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails</Role>
      <ShortName>Financing Arrangements Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2427413 - Disclosure - Financing Arrangements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails</Role>
      <ShortName>Financing Arrangements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2428414 - Disclosure - Financing Arrangements - Leverage Ratios (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/FinancingArrangementsLeverageRatiosDetails</Role>
      <ShortName>Financing Arrangements - Leverage Ratios (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2431415 - Disclosure - Derivatives and Risk Management Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails</Role>
      <ShortName>Derivatives and Risk Management Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2432416 - Disclosure - Derivatives and Risk Management Derivative Notional Amounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails</Role>
      <ShortName>Derivatives and Risk Management Derivative Notional Amounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2433417 - Disclosure - Derivatives and Risk Management Amount of Gain (Loss) Recognized in OCI and Income Statement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails</Role>
      <ShortName>Derivatives and Risk Management Amount of Gain (Loss) Recognized in OCI and Income Statement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2434418 - Disclosure - Derivatives and Risk Management Fair Value of Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails</Role>
      <ShortName>Derivatives and Risk Management Fair Value of Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2437419 - Disclosure - Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2438420 - Disclosure - Commitments and Contingencies - Schedule of Product Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Product Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2441421 - Disclosure - Stockholders' Equity Statement of Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity Statement of Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2442422 - Disclosure - Stockholders' Equity (Comprehensive Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails</Role>
      <ShortName>Stockholders' Equity (Comprehensive Income) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/StockholdersEquityTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2445423 - Disclosure - Stock-Based Incentive Plans (Compensation Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Incentive Plans (Compensation Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2446424 - Disclosure - Stock-Based Incentive Plans (Executed Agreements) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails</Role>
      <ShortName>Stock-Based Incentive Plans (Executed Agreements) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2448425 - Disclosure - Income Taxes Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2451426 - Disclosure - Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails</Role>
      <ShortName>Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2452427 - Disclosure - Earnings Per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/EarningsPerShareNarrativeDetails</Role>
      <ShortName>Earnings Per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2455428 - Disclosure - Geographic and Segment Information Segment Info (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails</Role>
      <ShortName>Geographic and Segment Information Segment Info (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2456429 - Disclosure - Geographic and Segment Information Changes in Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails</Role>
      <ShortName>Geographic and Segment Information Changes in Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2457430 - Disclosure - Geographic and Segment Information Geographic Areas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationGeographicAreasDetails</Role>
      <ShortName>Geographic and Segment Information Geographic Areas (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2460431 - Disclosure - Supplemental Financial Information (Summary of Inventory) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofInventoryDetails</Role>
      <ShortName>Supplemental Financial Information (Summary of Inventory) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2461432 - Disclosure - Supplemental Financial Information (Summary of Accrued Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails</Role>
      <ShortName>Supplemental Financial Information (Summary of Accrued Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="livn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2464433 - Disclosure - New Accounting Pronouncements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsDetails</Role>
      <ShortName>New Accounting Pronouncements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="livn-20200930.htm">livn-20200930.htm</File>
    <File>livn-20200930.xsd</File>
    <File>livn-20200930_cal.xml</File>
    <File>livn-20200930_def.xml</File>
    <File>livn-20200930_lab.xml</File>
    <File>livn-20200930_pre.xml</File>
    <File>livn-20200930xex101.htm</File>
    <File>livn-20200930xex102.htm</File>
    <File>livn-20200930xex103.htm</File>
    <File>livn-20200930xex311.htm</File>
    <File>livn-20200930xex312.htm</File>
    <File>livn-20200930xex321.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>livn-20200930_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/currency/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>91
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "livn-20200930.htm": {
   "axisCustom": 0,
   "axisStandard": 41,
   "contextCount": 466,
   "dts": {
    "calculationLink": {
     "local": [
      "livn-20200930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "livn-20200930_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "livn-20200930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "livn-20200930_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "livn-20200930_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "livn-20200930.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 609,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 2,
    "http://www.livanova.cyberonics.com/20200930": 1,
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 8
   },
   "keyCustom": 52,
   "keyStandard": 349,
   "memberCustom": 47,
   "memberStandard": 59,
   "nsprefix": "livn",
   "nsuri": "http://www.livanova.cyberonics.com/20200930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.livanova.cyberonics.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107104 - Disclosure - Restructuring",
     "role": "http://www.livanova.cyberonics.com/role/Restructuring",
     "shortName": "Restructuring",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "livn:ProductRemediationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111105 - Disclosure - Product Remediation Liability",
     "role": "http://www.livanova.cyberonics.com/role/ProductRemediationLiability",
     "shortName": "Product Remediation Liability",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "livn:ProductRemediationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114106 - Disclosure - Investments",
     "role": "http://www.livanova.cyberonics.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117107 - Disclosure - Fair Value Measurements",
     "role": "http://www.livanova.cyberonics.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124108 - Disclosure - Financing Arrangements",
     "role": "http://www.livanova.cyberonics.com/role/FinancingArrangements",
     "shortName": "Financing Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129109 - Disclosure - Derivatives and Risk Management",
     "role": "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagement",
     "shortName": "Derivatives and Risk Management",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135110 - Disclosure - Commitments and Contingencies",
     "role": "http://www.livanova.cyberonics.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139111 - Disclosure - Stockholders' Equity",
     "role": "http://www.livanova.cyberonics.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143112 - Disclosure - Stock-Based Incentive Plans",
     "role": "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlans",
     "shortName": "Stock-Based Incentive Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147113 - Disclosure - Income Taxes",
     "role": "http://www.livanova.cyberonics.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i3d16457137524d51a1566ec297b77d53_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Statements of Income (Loss)",
     "role": "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss",
     "shortName": "Condensed Consolidated Statements of Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i3d16457137524d51a1566ec297b77d53_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2149114 - Disclosure - Earnings Per Share",
     "role": "http://www.livanova.cyberonics.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2153115 - Disclosure - Geographic and Segment Information",
     "role": "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformation",
     "shortName": "Geographic and Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2158116 - Disclosure - Supplemental Financial Information",
     "role": "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformation",
     "shortName": "Supplemental Financial Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2162117 - Disclosure - New Accounting Pronouncements",
     "role": "http://www.livanova.cyberonics.com/role/NewAccountingPronouncements",
     "shortName": "New Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Unaudited Condensed Consolidated Financial Statements (Policies)",
     "role": "http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatementsPolicies",
     "shortName": "Unaudited Condensed Consolidated Financial Statements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2308301 - Disclosure - Restructuring (Tables)",
     "role": "http://www.livanova.cyberonics.com/role/RestructuringTables",
     "shortName": "Restructuring (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "livn:ScheduleofProductRemediationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312302 - Disclosure - Product Remediation Liability (Tables)",
     "role": "http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityTables",
     "shortName": "Product Remediation Liability (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "livn:ScheduleofProductRemediationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:InvestmentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315303 - Disclosure - Investments (Tables)",
     "role": "http://www.livanova.cyberonics.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:InvestmentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318304 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.livanova.cyberonics.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325305 - Disclosure - Financing Arrangements (Tables)",
     "role": "http://www.livanova.cyberonics.com/role/FinancingArrangementsTables",
     "shortName": "Financing Arrangements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i3d16457137524d51a1566ec297b77d53_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)",
     "role": "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i3d16457137524d51a1566ec297b77d53_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330306 - Disclosure - Derivatives and Risk Management (Tables)",
     "role": "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementTables",
     "shortName": "Derivatives and Risk Management (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336307 - Disclosure - Commitments and Contingencies (Tables)",
     "role": "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340308 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.livanova.cyberonics.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344309 - Disclosure - Stock-Based Incentive Plans (Tables)",
     "role": "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansTables",
     "shortName": "Stock-Based Incentive Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2350310 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.livanova.cyberonics.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2354311 - Disclosure - Geographic and Segment Information (Tables)",
     "role": "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationTables",
     "shortName": "Geographic and Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2359312 - Disclosure - Supplemental Financial Information (Tables)",
     "role": "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationTables",
     "shortName": "Supplemental Financial Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2363313 - Disclosure - New Accounting Pronouncements (Tables)",
     "role": "http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsTables",
     "shortName": "New Accounting Pronouncements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Business Combinations - Narrative (Details)",
     "role": "http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails",
     "shortName": "Business Combinations - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i1f504bd55c7f46eabe71635e913521f3_D20190612-20190612",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i08c3b67a02214a92852d8412d52b746a_D20180430-20180430",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Discontinued Operations (Narrative) (Details)",
     "role": "http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails",
     "shortName": "Discontinued Operations (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i08c3b67a02214a92852d8412d52b746a_D20180430-20180430",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i3d16457137524d51a1566ec297b77d53_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409403 - Disclosure - Restructuring Restructuring and Related Costs (Details)",
     "role": "http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails",
     "shortName": "Restructuring Restructuring and Related Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i8aeacf1e4fc34783813482eebf05252b_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i3d16457137524d51a1566ec297b77d53_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Restructuring Restructuring Expense by Segment (Details)",
     "role": "http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails",
     "shortName": "Restructuring Restructuring Expense by Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "livn:ScheduleofProductRemediationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ibcd0778524454cafb95c52ee8c85dc02_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "livn:ProductRemediationNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413405 - Disclosure - Product Remediation Liability (Details)",
     "role": "http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails",
     "shortName": "Product Remediation Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "livn:ScheduleofProductRemediationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "livn:ProductRemediationAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:InvestmentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416406 - Disclosure - Investments (Details)",
     "role": "http://www.livanova.cyberonics.com/role/InvestmentsDetails",
     "shortName": "Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:InvestmentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419407 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "role": "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i874c5b66a97e468981139b4c21d7eefa_I20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420408 - Disclosure - Fair Value Measurements - Contingent Consideration Reconciliation (Details)",
     "role": "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails",
     "shortName": "Fair Value Measurements - Contingent Consideration Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib19ca95e55f0441faf04ebd6116fa0b8_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "livn:SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421409 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib19ca95e55f0441faf04ebd6116fa0b8_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "livn:SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422410 - Disclosure - Fair Value Measurements - Fair Value of Contingent Consideration by Acquisition (Details)",
     "role": "http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails",
     "shortName": "Fair Value Measurements - Fair Value of Contingent Consideration by Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i62afb2ec706c47af855bd1dcaf827f5c_I20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i52334654e869489ca143b061165476f4_I20200930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "livn:BusinessCombinationContingentConsiderationMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423411 - Disclosure - Fair Value Measurements - Level 3 Valuations (Details)",
     "role": "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails",
     "shortName": "Fair Value Measurements - Level 3 Valuations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i52334654e869489ca143b061165476f4_I20200930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "livn:BusinessCombinationContingentConsiderationMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426412 - Disclosure - Financing Arrangements Schedule of Debt (Details)",
     "role": "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails",
     "shortName": "Financing Arrangements Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfLongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427413 - Disclosure - Financing Arrangements - Narrative (Details)",
     "role": "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails",
     "shortName": "Financing Arrangements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "livn:ScheduleOfDebtCovenantsTableTextBlock",
       "span",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "livn:DebtInstrumentCovenantMinimumProRataNetRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "livn:DebtInstrumentCovenantSecuredLeverageRatioPeriodOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428414 - Disclosure - Financing Arrangements - Leverage Ratios (Details)",
     "role": "http://www.livanova.cyberonics.com/role/FinancingArrangementsLeverageRatiosDetails",
     "shortName": "Financing Arrangements - Leverage Ratios (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "livn:DebtInstrumentCovenantSecuredLeverageRatioPeriodOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i950b10f7b07943f2aec8cb421632f276_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431415 - Disclosure - Derivatives and Risk Management Narrative (Details)",
     "role": "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails",
     "shortName": "Derivatives and Risk Management Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i950b10f7b07943f2aec8cb421632f276_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i7100fe2c632148de9c37fb8985d42d30_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432416 - Disclosure - Derivatives and Risk Management Derivative Notional Amounts (Details)",
     "role": "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails",
     "shortName": "Derivatives and Risk Management Derivative Notional Amounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i7100fe2c632148de9c37fb8985d42d30_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i7438dabb55a44445b30dbd44a361b2f4_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433417 - Disclosure - Derivatives and Risk Management Amount of Gain (Loss) Recognized in OCI and Income Statement (Details)",
     "role": "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails",
     "shortName": "Derivatives and Risk Management Amount of Gain (Loss) Recognized in OCI and Income Statement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i7438dabb55a44445b30dbd44a361b2f4_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434418 - Disclosure - Derivatives and Risk Management Fair Value of Derivative Instruments (Details)",
     "role": "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails",
     "shortName": "Derivatives and Risk Management Fair Value of Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "livn:ScheduleofProductRemediationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "livn:ProductRemediationNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437419 - Disclosure - Commitments and Contingencies - Narrative (Details)",
     "role": "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails",
     "shortName": "Commitments and Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i2a8c70677248473d83cfc005358a6167_I20190531",
      "decimals": "-5",
      "lang": "en-US",
      "name": "livn:IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualCarryingValueCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438420 - Disclosure - Commitments and Contingencies - Schedule of Product Liability (Details)",
     "role": "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails",
     "shortName": "Commitments and Contingencies - Schedule of Product Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i8dfb8d93c33740aab82c128a023695f0_D20200101-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ibcd0778524454cafb95c52ee8c85dc02_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441421 - Disclosure - Stockholders' Equity Statement of Stockholders' Equity (Details)",
     "role": "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails",
     "shortName": "Stockholders' Equity Statement of Stockholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i3d16457137524d51a1566ec297b77d53_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i1b57b2b83dd54d149c591d8fbbb18813_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442422 - Disclosure - Stockholders' Equity (Comprehensive Income) (Details)",
     "role": "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails",
     "shortName": "Stockholders' Equity (Comprehensive Income) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i3d16457137524d51a1566ec297b77d53_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445423 - Disclosure - Stock-Based Incentive Plans (Compensation Expense) (Details)",
     "role": "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails",
     "shortName": "Stock-Based Incentive Plans (Compensation Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i3d16457137524d51a1566ec297b77d53_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6a0fca2fdff64694bb24e3e060fd6dc8_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446424 - Disclosure - Stock-Based Incentive Plans (Executed Agreements) (Details)",
     "role": "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails",
     "shortName": "Stock-Based Incentive Plans (Executed Agreements) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6a0fca2fdff64694bb24e3e060fd6dc8_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i3d16457137524d51a1566ec297b77d53_D20200701-20200930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448425 - Disclosure - Income Taxes Narrative (Details)",
     "role": "http://www.livanova.cyberonics.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i3d16457137524d51a1566ec297b77d53_D20200701-20200930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i3d16457137524d51a1566ec297b77d53_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451426 - Disclosure - Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details)",
     "role": "http://www.livanova.cyberonics.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails",
     "shortName": "Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i3d16457137524d51a1566ec297b77d53_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i9a0a4786b53a409786262fe990c43c5a_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452427 - Disclosure - Earnings Per Share - Narrative (Details)",
     "role": "http://www.livanova.cyberonics.com/role/EarningsPerShareNarrativeDetails",
     "shortName": "Earnings Per Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i9a0a4786b53a409786262fe990c43c5a_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455428 - Disclosure - Geographic and Segment Information Segment Info (Details)",
     "role": "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails",
     "shortName": "Geographic and Segment Information Segment Info (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ibcd0778524454cafb95c52ee8c85dc02_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456429 - Disclosure - Geographic and Segment Information Changes in Carrying Amount of Goodwill (Details)",
     "role": "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails",
     "shortName": "Geographic and Segment Information Changes in Carrying Amount of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457430 - Disclosure - Geographic and Segment Information Geographic Areas (Details)",
     "role": "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationGeographicAreasDetails",
     "shortName": "Geographic and Segment Information Geographic Areas (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i2dde44e6ca6c4af39265921b98826424_I20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460431 - Disclosure - Supplemental Financial Information (Summary of Inventory) (Details)",
     "role": "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofInventoryDetails",
     "shortName": "Supplemental Financial Information (Summary of Inventory) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461432 - Disclosure - Supplemental Financial Information (Summary of Accrued Liabilities) (Details)",
     "role": "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails",
     "shortName": "Supplemental Financial Information (Summary of Accrued Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Unaudited Condensed Consolidated Financial Statements",
     "role": "http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatements",
     "shortName": "Unaudited Condensed Consolidated Financial Statements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "ib553d4102b0c4685a6b2b1e93fdc48c2_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2464433 - Disclosure - New Accounting Pronouncements (Details)",
     "role": "http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsDetails",
     "shortName": "New Accounting Pronouncements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i11591753270141129f271d60eea42105_I20200101",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Business Combinations",
     "role": "http://www.livanova.cyberonics.com/role/BusinessCombinations",
     "shortName": "Business Combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105103 - Disclosure - Discontinued Operations",
     "role": "http://www.livanova.cyberonics.com/role/DiscontinuedOperations",
     "shortName": "Discontinued Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "livn-20200930.htm",
      "contextRef": "i6034c6f5c1764d8faf954b53477aecae_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 109,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationGeographicAreasDetails",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "Euro Member Countries, Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_GBP": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "United Kingdom, Pounds",
        "terseLabel": "United Kingdom, Pounds"
       }
      }
     },
     "localname": "GBP",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_JPY": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Japan, Yen",
        "terseLabel": "Japan, Yen"
       }
      }
     },
     "localname": "JPY",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region",
        "terseLabel": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "livn_A2020CashExchangeableSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2020 Cash Exchangeable Senior Notes",
        "label": "2020 Cash Exchangeable Senior Notes [Member]",
        "terseLabel": "2020 Cash Exchangeable Senior Notes"
       }
      }
     },
     "localname": "A2020CashExchangeableSeniorNotesMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_ALungTechnologiesInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ALung Technologies, Inc. [Member]",
        "label": "ALung Technologies, Inc. [Member]",
        "terseLabel": "ALung Technologies, Inc."
       }
      }
     },
     "localname": "ALungTechnologiesInc.Member",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_AdvancedCirculatorySupportMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Advanced Circulatory Support [Member]",
        "label": "Advanced Circulatory Support [Member]",
        "terseLabel": "Advanced Circulatory Support"
       }
      }
     },
     "localname": "AdvancedCirculatorySupportMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_BankofAmericaMerrillLynchBancoMultiploS.A.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Bank of America Merrill Lynch Banco Multiplo S.A. [Member]",
        "label": "Bank of America Merrill Lynch Banco Multiplo S.A. [Member]",
        "terseLabel": "Bank of America Merrill Lynch Banco M\u00faltiplo S.A."
       }
      }
     },
     "localname": "BankofAmericaMerrillLynchBancoMultiploS.A.Member",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_BankofAmericaU.SMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Bank of America, U.S [Member]",
        "label": "Bank of America, U.S [Member]",
        "terseLabel": "Bank of America, U.S."
       }
      }
     },
     "localname": "BankofAmericaU.SMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_BusinessAcquisitionsPurchasePriceAllocation": {
     "auth_ref": [],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Acquisitions, Purchase Price Allocation",
        "label": "Business Acquisitions, Purchase Price Allocation",
        "terseLabel": "CRM purchase price adjustment payable to MicroPort Scientific Corporation"
       }
      }
     },
     "localname": "BusinessAcquisitionsPurchasePriceAllocation",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_BusinessCombinationConsiderationTransferredCashTransferred": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Cash Transferred",
        "label": "Business Combination, Consideration Transferred, Cash Transferred",
        "terseLabel": "Consideration transferred, cash"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredCashTransferred",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_BusinessCombinationContingentConsiderationMeasurementInput": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Measurement Input",
        "label": "Business Combination, Contingent Consideration, Measurement Input",
        "terseLabel": "Measurement input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationMeasurementInput",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "livn_BusinessCombinationMilestoneAchievementPeriodOfDelay": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Milestone Achievement, Period Of Delay",
        "label": "Business Combination, Milestone Achievement, Period Of Delay",
        "terseLabel": "Period of delay"
       }
      }
     },
     "localname": "BusinessCombinationMilestoneAchievementPeriodOfDelay",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "livn_BusinessCombinationUpfrontCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Upfront Costs",
        "label": "Business Combination, Upfront Costs",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationUpfrontCosts",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_CRMBusinessFranchiseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "CRM Business Finance [Member]",
        "label": "CRM Business Franchise [Member]",
        "terseLabel": "CRM Business Franchise"
       }
      }
     },
     "localname": "CRMBusinessFranchiseMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_CappedCallMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Capped Call",
        "label": "Capped Call [Member]",
        "terseLabel": "Capped call derivatives"
       }
      }
     },
     "localname": "CappedCallMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_CardiopulmonaryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cardiopulmonary [Member]",
        "label": "Cardiopulmonary [Member]",
        "terseLabel": "Cardiopulmonary"
       }
      }
     },
     "localname": "CardiopulmonaryMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_CardiovascularSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cardiovascular Segment",
        "label": "Cardiovascular Segment [Member]",
        "terseLabel": "Cardiovascular"
       }
      }
     },
     "localname": "CardiovascularSegmentMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails",
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_CeribellInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ceribell, Inc. [Member]",
        "label": "Ceribell, Inc. [Member]",
        "terseLabel": "Ceribell, Inc."
       }
      }
     },
     "localname": "CeribellInc.Member",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_ContingentConsiderationLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contingent Consideration Liability",
        "label": "Contingent Consideration Liability [Member]",
        "terseLabel": "Contingent Consideration Liability Arrangements"
       }
      }
     },
     "localname": "ContingentConsiderationLiabilityMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_ConvertibleNotesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Convertible Notes Receivable",
        "label": "Convertible Notes Receivable [Member]",
        "terseLabel": "Convertible Notes Receivable"
       }
      }
     },
     "localname": "ConvertibleNotesReceivableMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_DebtFacility2019Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Facility, 2019 [Member]",
        "label": "Debt Facility, 2019 [Member]",
        "terseLabel": "2019 Debt Facility"
       }
      }
     },
     "localname": "DebtFacility2019Member",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_DebtInstrumentCovenantMinimumNetRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Minimum Net Revenue",
        "label": "Debt Instrument, Covenant, Minimum Net Revenue",
        "terseLabel": "Minimum net revenue"
       }
      }
     },
     "localname": "DebtInstrumentCovenantMinimumNetRevenue",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_DebtInstrumentCovenantMinimumProRataNetRevenues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Minimum Pro Rata Net Revenues",
        "label": "Debt Instrument, Covenant, Minimum Pro Rata Net Revenues",
        "terseLabel": "Minimum pro rata net revenue"
       }
      }
     },
     "localname": "DebtInstrumentCovenantMinimumProRataNetRevenues",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodOne": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Secured Leverage Ratio, Period One",
        "label": "Debt Instrument, Covenant, Secured Leverage Ratio, Period One",
        "terseLabel": "Secured leverage ratio, period one"
       }
      }
     },
     "localname": "DebtInstrumentCovenantSecuredLeverageRatioPeriodOne",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsLeverageRatiosDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "livn_DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Secured Leverage Ratio, Period Two",
        "label": "Debt Instrument, Covenant, Secured Leverage Ratio, Period Two",
        "terseLabel": "Secured leverage ratio, period two"
       }
      }
     },
     "localname": "DebtInstrumentCovenantSecuredLeverageRatioPeriodTwo",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsLeverageRatiosDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "livn_DebtInstrumentExchangeableConversionRatio": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Exchangeable, Conversion Ratio",
        "label": "Debt Instrument, Exchangeable, Conversion Ratio",
        "terseLabel": "Debt instrument, exchangeable, conversion ratio"
       }
      }
     },
     "localname": "DebtInstrumentExchangeableConversionRatio",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "livn_DebtInstrumentLIBORFloorRate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, LIBOR Floor Rate",
        "label": "Debt Instrument, LIBOR Floor Rate",
        "terseLabel": "LIBOR floor rate"
       }
      }
     },
     "localname": "DebtInstrumentLIBORFloorRate",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "livn_DebtInstrumentOptionToExchangePricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Option To Exchange, Price Per Share",
        "label": "Debt Instrument, Option To Exchange, Price Per Share",
        "terseLabel": "Option to exchange, price per share"
       }
      }
     },
     "localname": "DebtInstrumentOptionToExchangePricePerShare",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "livn_DebtInstrumentRedemptionPricePercentageOfExchangePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Redemption Price, Percentage Of Exchange Price",
        "label": "Debt Instrument, Redemption Price, Percentage Of Exchange Price",
        "terseLabel": "Redemption price, percentage of exchange price"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentageOfExchangePrice",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "livn_DebtInstrumentRedemptionThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Redemption, Threshold Consecutive Trading Days",
        "label": "Debt Instrument, Redemption, Threshold Consecutive Trading Days",
        "terseLabel": "Redemption, threshold consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionThresholdConsecutiveTradingDays",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "livn_DebtInstrumentRedemptionThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Redemption, Threshold Trading Days",
        "label": "Debt Instrument, Redemption, Threshold Trading Days",
        "terseLabel": "Redemption, threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionThresholdTradingDays",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "livn_DerivativeCapPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative, Cap Price Per Share",
        "label": "Derivative, Cap Price Per Share",
        "terseLabel": "Derivative, cap price per share"
       }
      }
     },
     "localname": "DerivativeCapPricePerShare",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "livn_DerivativeContractLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative Contract Liabilities",
        "label": "Derivative Contract Liabilities",
        "terseLabel": "Derivative contract liabilities"
       }
      }
     },
     "localname": "DerivativeContractLiabilities",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_DerivativeLiabilitiesNoncurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative Liabilities, Noncurrent",
        "label": "Derivative Liabilities, Noncurrent [Member]",
        "terseLabel": "Long-term derivative liability"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrentMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Developed Technology Rights and In Process Research and Development [Member]",
        "label": "Developed Technology Rights and In Process Research and Development [Member]",
        "terseLabel": "Developed technology and in process research and development"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsandInProcessResearchandDevelopmentMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_DrilltexMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Drilltex [Member]",
        "label": "Drilltex [Member]",
        "terseLabel": "Drilltex"
       }
      }
     },
     "localname": "DrilltexMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_EmbeddedExchangeFeatureLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Embedded Exchange Feature Liability",
        "label": "Embedded Exchange Feature Liability [Member]",
        "terseLabel": "Embedded Exchange Feature Derivative Liability"
       }
      }
     },
     "localname": "EmbeddedExchangeFeatureLiabilityMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_EuropeanInvestmentBank2014Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "European Investment Bank, 2014",
        "label": "European Investment Bank, 2014 [Member]",
        "terseLabel": "2014 European Investment Bank"
       }
      }
     },
     "localname": "EuropeanInvestmentBank2014Member",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_EuropeanInvestmentBank2017Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "European Investment Bank, 2017 [Member]",
        "label": "European Investment Bank, 2017 [Member]",
        "terseLabel": "2017 European Investment Bank"
       }
      }
     },
     "localname": "EuropeanInvestmentBank2017Member",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_FDAWarningLetterMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "FDA Warning Letter [Member]",
        "label": "FDA Warning Letter [Member]",
        "terseLabel": "FDA Warning Letter"
       }
      }
     },
     "localname": "FDAWarningLetterMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Current Asset Value",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Current Asset Value",
        "terseLabel": "Less current portion at period end"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisCurrentAssetValue",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Non-current Asset Value",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Non-current Asset Value",
        "terseLabel": "Long-term portion at period end"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNonCurrentAssetValue",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Current Liability Value",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Current Liability Value",
        "terseLabel": "Less current portion at period end"
       }
      }
     },
     "localname": "FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisCurrentLiabilityValue",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Non-current Liability Value",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Non-current Liability Value",
        "terseLabel": "Long-term portion at period end"
       }
      }
     },
     "localname": "FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisNoncurrentLiabilityValue",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Foreign Currency Transaction Gain (Loss) and Other Nonoperating Income",
        "label": "Foreign Currency Transaction Gain (Loss) and Other Nonoperating Income",
        "terseLabel": "Foreign exchange and other gains (losses)",
        "verboseLabel": "Foreign exchange and other gains (losses)"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_ForeignExchangeandOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Foreign Exchange and Other [Member]",
        "label": "Foreign Exchange and Other [Member]",
        "terseLabel": "Foreign exchange and other gains (losses)"
       }
      }
     },
     "localname": "ForeignExchangeandOtherMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_HeartValvesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Heart Valves [Member]",
        "label": "Heart Valves [Member]",
        "terseLabel": "Heart Valves"
       }
      }
     },
     "localname": "HeartValvesMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_HighlifeS.A.S.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Highlife S.A.S. [Member]",
        "label": "Highlife S.A.S. [Member]",
        "terseLabel": "Highlife S.A.S."
       }
      }
     },
     "localname": "HighlifeS.A.S.Member",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_ImTheraMedicalInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ImThera Medical, Inc.",
        "label": "ImThera Medical, Inc. [Member]",
        "terseLabel": "ImThera"
       }
      }
     },
     "localname": "ImTheraMedicalInc.Member",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income Tax Examination, Application Pending Approval, Payments for Legal Settlements",
        "label": "Income Tax Examination, Application Pending Approval, Payments for Legal Settlements",
        "terseLabel": "Application pending approval, payments for legal settlements"
       }
      }
     },
     "localname": "IncomeTaxExaminationApplicationPendingApprovalPaymentsforLegalSettlements",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_IncomeTaxExaminationNumberofInstallments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income Tax Examination, Number of Installments",
        "label": "Income Tax Examination, Number of Installments",
        "terseLabel": "Number of equal installments"
       }
      }
     },
     "localname": "IncomeTaxExaminationNumberofInstallments",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "livn_IncomeTaxExaminationOperatingLossesUnderDispute": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income Tax Examination, Operating Losses Under Dispute",
        "label": "Income Tax Examination, Operating Losses Under Dispute",
        "terseLabel": "Losses under dispute"
       }
      }
     },
     "localname": "IncomeTaxExaminationOperatingLossesUnderDispute",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income Taxes Receivable, Income Tax Expense (Benefit), CARES Act",
        "label": "Income Taxes Receivable, Income Tax Expense (Benefit), CARES Act",
        "negatedTerseLabel": "Tax benefit, CARES Act"
       }
      }
     },
     "localname": "IncomeTaxesReceivableIncomeTaxExpenseBenefitCARESAct",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_IncreaseDecreaseInLitigationProvisionLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase (Decrease) In Litigation Provision Liability",
        "label": "Increase (Decrease) In Litigation Provision Liability",
        "negatedTerseLabel": "Litigation provision liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInLitigationProvisionLiability",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_LocationsExcludingTheUnitedStatesAndEuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Locations Excluding The United States And Europe [Member]",
        "label": "Locations Excluding The United States And Europe [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "LocationsExcludingTheUnitedStatesAndEuropeMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationGeographicAreasDetails",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_LossContingencyAccrualAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency Accrual, Adjustments",
        "label": "Loss Contingency Accrual, Adjustments",
        "terseLabel": "Adjustments"
       }
      }
     },
     "localname": "LossContingencyAccrualAdjustments",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_LossContingencyAccrualForeignCurrencyAdjustmentsAndOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Accrual, Foreign Currency Adjustments, And Other",
        "label": "Loss Contingency, Accrual, Foreign Currency Adjustments, And Other",
        "terseLabel": "FX and other"
       }
      }
     },
     "localname": "LossContingencyAccrualForeignCurrencyAdjustmentsAndOther",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_LossContingencyNumberofAssessments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Assessments",
        "label": "Loss Contingency, Number of Assessments",
        "terseLabel": "Number of notice of assessments"
       }
      }
     },
     "localname": "LossContingencyNumberofAssessments",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "livn_LossContingencyNumberofObservedNonConformities": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Observed Non-Conformities",
        "label": "Loss Contingency, Number of Observed Non-Conformities",
        "terseLabel": "Number of observed non-conformities"
       }
      }
     },
     "localname": "LossContingencyNumberofObservedNonConformities",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "livn_MDStartIIMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "MD Start II [Member]",
        "label": "MD Start II [Member]",
        "terseLabel": "MD Start II"
       }
      }
     },
     "localname": "MDStartIIMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_MarketbasedPerformanceRestrictedStockUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Market-based Performance Restricted Stock Unit",
        "label": "Market-based Performance Restricted Stock Unit [Member]",
        "terseLabel": "Market performance-based restricted stock units"
       }
      }
     },
     "localname": "MarketbasedPerformanceRestrictedStockUnitMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails",
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_MeasurementInputCreditRiskDiscountRateMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement Input, Credit Risk Discount Rate [Member]",
        "label": "Measurement Input, Credit Risk Discount Rate [Member]",
        "terseLabel": "Credit risk discount rate"
       }
      }
     },
     "localname": "MeasurementInputCreditRiskDiscountRateMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_MeasurementInputProbabilityofPaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement Input, Probability of Payment [Member]",
        "label": "Measurement Input, Probability of Payment [Member]",
        "terseLabel": "Probability of payment"
       }
      }
     },
     "localname": "MeasurementInputProbabilityofPaymentMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_MeasurementInputRevenueVolatilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement Input, Revenue Volatility [Member]",
        "label": "Measurement Input, Revenue Volatility [Member]",
        "terseLabel": "Revenue volatility"
       }
      }
     },
     "localname": "MeasurementInputRevenueVolatilityMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_MeasurementInputRiskadjustedDiscountRateMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement Input, Risk-adjusted Discount Rate [Member]",
        "label": "Measurement Input, Risk-adjusted Discount Rate [Member]",
        "terseLabel": "Risk-adjusted discount rate"
       }
      }
     },
     "localname": "MeasurementInputRiskadjustedDiscountRateMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_MeasurementInputStockPriceVolatilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement Input, Stock Price Volatility",
        "label": "Measurement Input, Stock Price Volatility [Member]",
        "terseLabel": "Measurement Input, Stock Price Volatility"
       }
      }
     },
     "localname": "MeasurementInputStockPriceVolatilityMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_MediocreditoItalianoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Mediocredito Italiano [Member]",
        "label": "Mediocredito Italiano [Member]",
        "terseLabel": "Mediocredito Italiano"
       }
      }
     },
     "localname": "MediocreditoItalianoMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_MiamiInstrumentsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Miami Instruments, LLC [Member]",
        "label": "Miami Instruments, LLC [Member]",
        "terseLabel": "Miami Instruments"
       }
      }
     },
     "localname": "MiamiInstrumentsLLCMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_NeuromodulationSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Neuromodulation Segment [Member]",
        "label": "Neuromodulation Segment [Member]",
        "terseLabel": "Neuromodulation"
       }
      }
     },
     "localname": "NeuromodulationSegmentMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails",
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_NumberOfDistributorsAcquired": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number Of Distributors Acquired",
        "label": "Number Of Distributors Acquired",
        "terseLabel": "Number of distributors acquired"
       }
      }
     },
     "localname": "NumberOfDistributorsAcquired",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "livn_NumberofGeographicRegionsinwhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Geographic Regions in which Entity Operates",
        "label": "Number of Geographic Regions in which Entity Operates",
        "terseLabel": "Number of geographic regions in which entity operates"
       }
      }
     },
     "localname": "NumberofGeographicRegionsinwhichEntityOperates",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "livn_OperatingPerformancebasedRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Performance-based Restricted Stock Units [Member]",
        "label": "Operating Performance-based Restricted Stock Units [Member]",
        "terseLabel": "Operating performance-based restricted stock units"
       }
      }
     },
     "localname": "OperatingPerformancebasedRestrictedStockUnitsMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails",
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other [Member]",
        "label": "Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails",
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Operating Income (Loss) Included In Segment Income (Loss) From Continuing Operations",
        "label": "Other Operating Income (Loss) Included In Segment Income (Loss) From Continuing Operations",
        "terseLabel": "Total reportable segment income from continuing operations"
       }
      }
     },
     "localname": "OtherOperatingIncomeLossIncludedInSegmentIncomeLossFromContinuingOperations",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_PaymentForDispositionOfBusinessClosingAdjustment": {
     "auth_ref": [],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payment For Disposition Of Business, Closing Adjustment",
        "label": "Payment For Disposition Of Business, Closing Adjustment",
        "negatedTerseLabel": "Closing adjustment payment for sale of CRM business"
       }
      }
     },
     "localname": "PaymentForDispositionOfBusinessClosingAdjustment",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_ProductLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product Liability [Member]",
        "label": "Product Liability [Member]",
        "terseLabel": "Product Liability"
       }
      }
     },
     "localname": "ProductLiabilityMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails",
      "http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_ProductRemediation": {
     "auth_ref": [],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product Remediation",
        "label": "Product Remediation",
        "terseLabel": "Product remediation"
       }
      }
     },
     "localname": "ProductRemediation",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_ProductRemediationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product Remediation [Abstract]",
        "label": "Product Remediation [Abstract]",
        "terseLabel": "Product Remediation [Abstract]"
       }
      }
     },
     "localname": "ProductRemediationAbstract",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "xbrltype": "stringItemType"
    },
    "livn_ProductRemediationAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product Remediation, Adjustments",
        "label": "Product Remediation, Adjustments",
        "terseLabel": "Adjustments"
       }
      }
     },
     "localname": "ProductRemediationAdjustments",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_ProductRemediationExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product Remediation",
        "label": "Product Remediation Expense",
        "terseLabel": "Product remediation",
        "verboseLabel": "Product remediation expense"
       }
      }
     },
     "localname": "ProductRemediationExpense",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss",
      "http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_ProductRemediationForeignCurrencyTranslationGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product Remediation, Foreign Currency Translation Gain (Loss)",
        "label": "Product Remediation, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Effect of changes in foreign currency exchange rates"
       }
      }
     },
     "localname": "ProductRemediationForeignCurrencyTranslationGainLoss",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_ProductRemediationNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product Remediation, Net",
        "label": "Product Remediation, Net",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "terseLabel": "Product remediation"
       }
      }
     },
     "localname": "ProductRemediationNet",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_ProductRemediationPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product Remediation, Payments",
        "label": "Product Remediation, Payments",
        "negatedTerseLabel": "Remediation activity"
       }
      }
     },
     "localname": "ProductRemediationPayments",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_ProductRemediationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product Remediation [Text Block]",
        "label": "Product Remediation [Text Block]",
        "terseLabel": "Product Remediation Liability"
       }
      }
     },
     "localname": "ProductRemediationTextBlock",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/ProductRemediationLiability"
     ],
     "xbrltype": "textBlockItemType"
    },
    "livn_ProvisionforAgentsReturnsandOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Provision for Agents, Returns and Other",
        "label": "Provision for Agents, Returns and Other",
        "terseLabel": "Provisions for agents, returns and other"
       }
      }
     },
     "localname": "ProvisionforAgentsReturnsandOther",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_PurchasesOfInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchases Of Investments",
        "label": "Purchases Of Investments",
        "negatedTerseLabel": "Purchase of investments"
       }
      }
     },
     "localname": "PurchasesOfInvestments",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_RainbowMedicalLtd.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rainbow Medical Ltd. [Member]",
        "label": "Rainbow Medical Ltd. [Member]",
        "terseLabel": "Rainbow Medical Ltd."
       }
      }
     },
     "localname": "RainbowMedicalLtd.Member",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_RegionalInternalRevenueOfficeofLombardyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Regional Internal Revenue Office of Lombardy [Member]",
        "label": "Regional Internal Revenue Office of Lombardy [Member]",
        "terseLabel": "Regional Internal Revenue Office of Lombardy"
       }
      }
     },
     "localname": "RegionalInternalRevenueOfficeofLombardyMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_ReimbursedLegalFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reimbursed Legal Fees",
        "label": "Reimbursed Legal Fees",
        "terseLabel": "Reimbursed legal fees"
       }
      }
     },
     "localname": "ReimbursedLegalFees",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_RemeasurementOfCappedCallAndEmbeddedExchangeFeature": {
     "auth_ref": [],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Remeasurement Of Capped Call And Embedded Exchange Feature",
        "label": "Remeasurement Of Capped Call And Embedded Exchange Feature",
        "negatedLabel": "Remeasurement of derivative instruments"
       }
      }
     },
     "localname": "RemeasurementOfCappedCallAndEmbeddedExchangeFeature",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_ReorganizationPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reorganization Plans [Member]",
        "label": "Reorganization Plans [Member]",
        "terseLabel": "Reorganization Plans"
       }
      }
     },
     "localname": "ReorganizationPlansMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_ResearchAndDevelopmentCostsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Research And Development Costs",
        "label": "Research And Development Costs Payable, Current",
        "terseLabel": "Research and development costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentCostsPayableCurrent",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_RespicardiaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Respicardia [Member]",
        "label": "Respicardia [Member]",
        "terseLabel": "Respicardia Inc."
       }
      }
     },
     "localname": "RespicardiaMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_RestructuringRelatedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring Related Liabilities",
        "label": "Restructuring Related Liabilities",
        "terseLabel": "Restructuring related liabilities"
       }
      }
     },
     "localname": "RestructuringRelatedLiabilities",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_SNIAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "SNIA [Member]",
        "label": "SNIA [Member]",
        "terseLabel": "SNIA"
       }
      }
     },
     "localname": "SNIAMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_SNIAs.p.aMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "SNIA s.p.a [Member]",
        "label": "SNIA s.p.a [Member]",
        "terseLabel": "SNIA s.p.a"
       }
      }
     },
     "localname": "SNIAs.p.aMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_ScheduleOfDebtCovenantsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule Of Debt Covenants",
        "label": "Schedule Of Debt Covenants [Table Text Block]",
        "terseLabel": "Schedule of Debt Covenants"
       }
      }
     },
     "localname": "ScheduleOfDebtCovenantsTableTextBlock",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "livn_ScheduleofProductRemediationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Product Remediation [Table Text Block]",
        "label": "Schedule of Product Remediation [Table Text Block]",
        "terseLabel": "Product Liability Contingencies"
       }
      }
     },
     "localname": "ScheduleofProductRemediationTableTextBlock",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "livn_SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sensitivity Analysis Of Fair Value, 10 Percent Decrease In Stock Price Volatility, Fair Value",
        "label": "Sensitivity Analysis Of Fair Value, 10 Percent Decrease In Stock Price Volatility, Fair Value",
        "terseLabel": "10 percent decrease in stock price volatility, fair value"
       }
      }
     },
     "localname": "SensitivityAnalysisOfFairValue10PercentDecreaseInStockPriceVolatilityFairValue",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sensitivity Analysis Of Fair Value, 10 Percent Increase In Stock Price Volatility, Fair Value",
        "label": "Sensitivity Analysis Of Fair Value, 10 Percent Increase In Stock Price Volatility, Fair Value",
        "terseLabel": "10 percent increase in stock price volatility, fair value"
       }
      }
     },
     "localname": "SensitivityAnalysisOfFairValue10PercentIncreaseInStockPriceVolatilityFairValue",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "livn_ShiraTronicsInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ShiraTronics, Inc. [Member]",
        "label": "ShiraTronics, Inc. [Member]",
        "terseLabel": "ShiraTronics, Inc."
       }
      }
     },
     "localname": "ShiraTronicsInc.Member",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_TandemLifeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "TandemLife [Member]",
        "label": "TandemLife [Member]",
        "terseLabel": "TandemLife"
       }
      }
     },
     "localname": "TandemLifeMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "livn_ValuationTechniqueMonteCarloSimulationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Valuation Technique, Monte Carlo Simulation [Member]",
        "label": "Valuation Technique, Monte Carlo Simulation [Member]",
        "terseLabel": "Monte Carlo simulation"
       }
      }
     },
     "localname": "ValuationTechniqueMonteCarloSimulationMember",
     "nsuri": "http://www.livanova.cyberonics.com/20200930",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r203",
      "r216",
      "r217",
      "r218",
      "r219",
      "r221",
      "r223",
      "r227"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails",
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r203",
      "r216",
      "r217",
      "r218",
      "r219",
      "r221",
      "r223",
      "r227"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails",
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r87",
      "r151"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r159",
      "r170",
      "r257",
      "r393",
      "r394",
      "r395",
      "r418",
      "r419"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r159",
      "r170",
      "r257",
      "r393",
      "r394",
      "r395",
      "r418",
      "r419"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r159",
      "r170",
      "r257",
      "r393",
      "r394",
      "r395",
      "r418",
      "r419"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationGeographicAreasDetails",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails",
      "http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails",
      "http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r369",
      "r371",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r539",
      "r599",
      "r602"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r369",
      "r371",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r539",
      "r599",
      "r602"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r230",
      "r347",
      "r349",
      "r540",
      "r598",
      "r600"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r230",
      "r347",
      "r349",
      "r540",
      "r598",
      "r600"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r358",
      "r369",
      "r371",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r539",
      "r599",
      "r602"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r358",
      "r369",
      "r371",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r539",
      "r599",
      "r602"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r231",
      "r232",
      "r347",
      "r350",
      "r601",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationGeographicAreasDetails",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r231",
      "r232",
      "r347",
      "r350",
      "r601",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationGeographicAreasDetails",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r166",
      "r254",
      "r255",
      "r256",
      "r257",
      "r260",
      "r261",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r397",
      "r418",
      "r419",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible List]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsDetails",
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r29",
      "r47",
      "r238",
      "r239"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance of $16,241 at September 30, 2020 and $13,105 at December 31, 2019",
        "verboseLabel": "Increase (decrease) in accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForEnvironmentalLossContingenciesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accrual for Environmental Loss Contingencies [Roll Forward]",
        "terseLabel": "Accrual for Environmental Loss Contingencies [Roll Forward]"
       }
      }
     },
     "localname": "AccrualForEnvironmentalLossContingenciesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities and other",
        "totalLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r34",
      "r35",
      "r71"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Legal and administrative costs"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r96",
      "r106",
      "r453"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Change in Unrealized Gain (Loss) on Derivatives"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r50",
      "r93",
      "r95",
      "r96",
      "r583",
      "r610",
      "r614"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r516"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r92",
      "r96",
      "r99",
      "r156",
      "r157",
      "r158",
      "r454",
      "r605",
      "r606"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails",
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r89",
      "r96",
      "r99",
      "r454",
      "r511",
      "r512",
      "r513",
      "r514",
      "r516"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments Gain (Loss)"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r393",
      "r394",
      "r395"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Non-cash items included in net loss:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r373",
      "r386",
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r54",
      "r240",
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r114",
      "r141",
      "r521"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of Debt Issuance Costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r141",
      "r277",
      "r283"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 9.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangibles",
        "verboseLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share amount (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r149",
      "r211",
      "r218",
      "r225",
      "r251",
      "r451",
      "r455",
      "r508",
      "r563",
      "r581"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r31",
      "r33",
      "r82",
      "r149",
      "r251",
      "r451",
      "r455",
      "r508"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r492"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r375",
      "r387"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails",
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails",
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r465",
      "r472"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails",
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r368",
      "r370"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r368",
      "r370",
      "r435",
      "r436"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionContingentConsiderationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition, Contingent Consideration [Line Items]",
        "terseLabel": "Business Acquisition, Contingent Consideration [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r438",
      "r439",
      "r442"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Fair value of consideration transferred",
        "verboseLabel": "Consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r140",
      "r446"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Remeasurement of contingent consideration to fair value"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r437",
      "r440",
      "r443"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r437",
      "r441"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/BusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Merger and integration expenses",
        "verboseLabel": "Merger and integration expenses"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r27",
      "r64",
      "r143"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r137",
      "r143",
      "r145"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r137",
      "r509"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r490"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "terseLabel": "Amount Expected to be Reclassified to Earnings in Next 12 Months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r76",
      "r308",
      "r568",
      "r588"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 10)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r305",
      "r306",
      "r307",
      "r320"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r156",
      "r157"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Ordinary Shares"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Ordinary shares, par value (in pounds per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Ending Balance (in shares)",
        "periodStartLabel": "Beginning Balance (in shares)",
        "terseLabel": "Ordinary shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r46",
      "r333"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Ordinary shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Ordinary Shares, \u00a31.00 par value: unlimited shares authorized; 49,402,628 shares issued and 48,596,417 shares outstanding at September 30, 2020; 49,411,016 shares issued and 48,443,830 shares outstanding at December 31, 2019"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r102",
      "r104",
      "r105",
      "r112",
      "r574",
      "r594"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r344",
      "r345",
      "r348"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r344",
      "r345",
      "r348"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r216",
      "r217",
      "r218",
      "r219",
      "r221",
      "r227",
      "r229"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails",
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r116",
      "r540"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales - exclusive of amortization"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "verboseLabel": "Cost of sales - exclusive of amortization"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "terseLabel": "Current debt obligations"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Financing Arrangements"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r41",
      "r42",
      "r43",
      "r564",
      "r565",
      "r580"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r43",
      "r324",
      "r565",
      "r580"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "totalLabel": "Total long-term facilities"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r520",
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r73",
      "r326",
      "r520"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Interest rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r578"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price, percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r74",
      "r152",
      "r334",
      "r337",
      "r338",
      "r339",
      "r519",
      "r520",
      "r522",
      "r579"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument, term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r519",
      "r522"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Unamortized discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r325",
      "r521"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "terseLabel": "Debt discounts and issuance costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Unrecognized tax benefits, potential decrease amount"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r66",
      "r521"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt issuance costs, net"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r402",
      "r403"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r141",
      "r150",
      "r415",
      "r425",
      "r426",
      "r427"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "verboseLabel": "Deferred tax expense (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r402",
      "r403"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves",
        "terseLabel": "Unrecognized tax benefits, net of settlement payment"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r141",
      "r286"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r85",
      "r86",
      "r507"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeCostOfHedge": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The premium (cost) of a hedge, expensed during the period.",
        "label": "Derivative, Cost of Hedge",
        "terseLabel": "Derivative, cost of hedge"
       }
      }
     },
     "localname": "DerivativeCostOfHedge",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r84",
      "r88",
      "r469",
      "r538"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "verboseLabel": "Total asset derivatives"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r84",
      "r88",
      "r469",
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Total liability derivatives"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFinancialInstrumentsAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents types of derivative financial instruments which are financial instruments or other contractual arrangements with all three of the following characteristics: (a) it has (1) one or more underlyings and (2) one or more notional amounts or payment provisions or both. Those terms determine the amount of the settlement or settlements, and, in some cases, whether or not a settlement is required; (b) it requires no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; and (c) its terms require or permit net settlement, it can readily be settled net by a means outside the contract, or it provides for delivery of an asset that puts the recipient in a position not substantially different from net settlement. Notwithstanding the above characteristics, loan commitments that relate to the origination of mortgage loans that will be held for sale are accounted for as derivative instruments by the issuer of the loan commitment (that is, the potential lender).",
        "label": "Derivative Financial Instruments, Assets [Member]",
        "terseLabel": "Derivative Financial Instruments, Assets"
       }
      }
     },
     "localname": "DerivativeFinancialInstrumentsAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents derivative instrument obligations meeting the definition of a liability which are reported as of the balance sheet date. Derivative instrument obligations are generally measured at fair value, and adjustments to the carrying amount of hedged items reflect changes in their fair value (that is, losses) that are attributable to the risk being hedged and that arise while the hedge is in effect.",
        "label": "Derivative Financial Instruments, Liabilities [Member]",
        "terseLabel": "Other Derivative Liabilities"
       }
      }
     },
     "localname": "DerivativeFinancialInstrumentsLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r467"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "verboseLabel": "Gain (loss) on derivative"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r466",
      "r471",
      "r477",
      "r482"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivatives and Risk Management"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r463",
      "r466",
      "r477"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r463",
      "r466",
      "r477",
      "r482",
      "r483",
      "r487",
      "r489"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss)"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r85",
      "r86",
      "r507"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Noncurrent",
        "terseLabel": "Long-term derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityMeasurementInput": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of input used to measure derivative liability.",
        "label": "Derivative Liability, Measurement Input",
        "terseLabel": "Derivative liability, measurement input"
       }
      }
     },
     "localname": "DerivativeLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r459",
      "r461"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r458",
      "r460",
      "r461",
      "r463",
      "r464",
      "r473",
      "r477",
      "r484",
      "r486",
      "r489"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r146",
      "r153",
      "r458",
      "r460",
      "r463",
      "r464",
      "r485"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives Designated as Hedging Instruments"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Incentive Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax": {
     "auth_ref": [
      "r9",
      "r10",
      "r15"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax of an increase (decrease) to a gain (loss) previously reported in discontinued operations in a prior period.",
        "label": "Discontinued Operation, Amount of Adjustment to Prior Period Gain (Loss) on Disposal, before Income Tax",
        "negatedTerseLabel": "Working capital adjustment"
       }
      }
     },
     "localname": "DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax": {
     "auth_ref": [
      "r6",
      "r8",
      "r11",
      "r21"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.",
        "label": "Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax",
        "terseLabel": "Operating loss from discontinued operations"
       }
      }
     },
     "localname": "DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": {
     "auth_ref": [],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share",
        "terseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": {
     "auth_ref": [],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share",
        "terseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": {
     "auth_ref": [
      "r7",
      "r8",
      "r9",
      "r11",
      "r19",
      "r21",
      "r404",
      "r424",
      "r430"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Tax Effect of Discontinued Operation",
        "terseLabel": "Tax benefit"
       }
      }
     },
     "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r25",
      "r292"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DiscontinuedOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r368",
      "r370"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r113",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r179",
      "r181",
      "r183",
      "r184",
      "r185",
      "r189",
      "r190",
      "r575",
      "r595"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Earnings per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic (loss) income per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r113",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r181",
      "r183",
      "r184",
      "r185",
      "r189",
      "r190",
      "r575",
      "r595"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Earnings per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted (loss) income per share:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r191"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r509"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": {
     "auth_ref": [
      "r470"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.",
        "label": "Embedded Derivative, Fair Value of Embedded Derivative Liability",
        "terseLabel": "Fair value of embedded derivative liability"
       }
      }
     },
     "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmbeddedDerivativeFinancialInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument embedded in host contract.",
        "label": "Embedded Derivative Financial Instruments [Member]",
        "terseLabel": "Embedded exchange feature"
       }
      }
     },
     "localname": "EmbeddedDerivativeFinancialInstrumentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued employee compensation and related benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Severance and Other Termination Costs"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee share purchase plan"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r163",
      "r173",
      "r175",
      "r195",
      "r257",
      "r333",
      "r340",
      "r393",
      "r394",
      "r395",
      "r418",
      "r419",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r516",
      "r605",
      "r606",
      "r607"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsDetails",
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails",
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvesteeMember": {
     "auth_ref": [
      "r247",
      "r550",
      "r552",
      "r554",
      "r556",
      "r558",
      "r560"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An entity that issued voting stock held by an investor and that is accounted for under the equity method of accounting by the investor.",
        "label": "Equity Method Investee [Member]",
        "terseLabel": "Equity Method Investee"
       }
      }
     },
     "localname": "EquityMethodInvesteeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r65",
      "r212",
      "r248"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value.",
        "label": "Equity Securities, FV-NI and without Readily Determinable Fair Value",
        "totalLabel": "Total investments"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r244"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Long-term Investments"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r492",
      "r493",
      "r494",
      "r504"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r492",
      "r493",
      "r494",
      "r503",
      "r504"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "terseLabel": "Fair Value Measurements on a Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Assets Measured on Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r492",
      "r504"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r493",
      "r529",
      "r530",
      "r531"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r502",
      "r504"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r492",
      "r493",
      "r496",
      "r497",
      "r505"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r359",
      "r360",
      "r365",
      "r367",
      "r493",
      "r529"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r359",
      "r360",
      "r365",
      "r367",
      "r493",
      "r530"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r493",
      "r531"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r498",
      "r504"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Beginning and Ending Balances of Contingent Consideration"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": {
     "auth_ref": [
      "r499"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings",
        "terseLabel": "Changes in fair value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss": {
     "auth_ref": [
      "r500"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Effect of changes in foreign currency exchange rates"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": {
     "auth_ref": [
      "r501"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements": {
     "auth_ref": [
      "r501"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements",
        "terseLabel": "Payments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r498"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Total at period end",
        "periodStartLabel": "As of beginning period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r499"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "negatedTerseLabel": "Changes in fair value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome": {
     "auth_ref": [
      "r500"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Effect of changes in foreign currency exchange rates"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r501"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r501"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r498"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Total at period end",
        "periodStartLabel": "Total at beginning period",
        "terseLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r529",
      "r530",
      "r531"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r502",
      "r505"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r465",
      "r473",
      "r487"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Financial Liabilities Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r278",
      "r280",
      "r282",
      "r284",
      "r541",
      "r548"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r278",
      "r281"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r282",
      "r541"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-lived Intangible Assets Acquired",
        "verboseLabel": "Intangible assets acquired"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r359",
      "r479"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contract"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r141",
      "r327",
      "r328"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on debt extinguishment"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r271",
      "r272",
      "r562"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending",
        "periodStartLabel": "Goodwill, beginning",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Impairment of intangible assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r273",
      "r274",
      "r434"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Foreign currency adjustments"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r463",
      "r483"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r141",
      "r285"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 8.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Impairment of intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r115",
      "r142",
      "r168",
      "r169",
      "r170",
      "r171",
      "r182",
      "r185",
      "r448"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Net (loss) income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r109",
      "r211",
      "r217",
      "r221",
      "r224",
      "r227",
      "r561",
      "r571",
      "r577",
      "r596"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "(Loss) income from continuing operations before tax"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r107",
      "r113",
      "r162",
      "r168",
      "r169",
      "r170",
      "r171",
      "r181",
      "r183",
      "r184",
      "r569",
      "r572",
      "r575",
      "r591"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r107",
      "r113",
      "r162",
      "r168",
      "r169",
      "r170",
      "r171",
      "r181",
      "r183",
      "r184",
      "r185",
      "r575",
      "r591",
      "r593",
      "r595"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r9",
      "r11",
      "r19",
      "r21",
      "r449"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Net (loss) income from discontinued operations, net of tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r110",
      "r141",
      "r208",
      "r248",
      "r570",
      "r590"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Losses from equity method investments"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r368",
      "r370"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r20",
      "r22",
      "r23",
      "r24",
      "r290",
      "r291"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r406",
      "r410",
      "r412",
      "r423",
      "r428",
      "r431",
      "r432",
      "r433"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r150",
      "r174",
      "r175",
      "r209",
      "r404",
      "r424",
      "r429",
      "r597"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax (benefit) expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "terseLabel": "Accounts payable and accrued current and non-current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.",
        "label": "Increase (Decrease) in Accrued Taxes Payable",
        "terseLabel": "Taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other current and non-current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInRestructuringReserve": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the period in the carrying amount (including both current and noncurrent portions of the accrual) of the liability pertaining to the exit from or disposal of business activities or restructuring pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination and to asset retirement obligations.",
        "label": "Increase (Decrease) in Restructuring Reserve",
        "terseLabel": "Restructuring reserve"
       }
      }
     },
     "localname": "IncreaseDecreaseInRestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r108",
      "r205",
      "r518",
      "r521",
      "r576"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateContractMember": {
     "auth_ref": [
      "r359",
      "r478"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.",
        "label": "Interest Rate Contract [Member]",
        "terseLabel": "Interest rate swap contracts"
       }
      }
     },
     "localname": "InterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap Contracts"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementDerivativeNotionalAmountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r56",
      "r268"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofInventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r28",
      "r81"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Inventory, Net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r58",
      "r268"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r81",
      "r155",
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Provision for obsolescence"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r57",
      "r268"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r119",
      "r204"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTextBlock": {
     "auth_ref": [
      "r243",
      "r246",
      "r252",
      "r253"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for investment.",
        "label": "Investment [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r589"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "verboseLabel": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r70",
      "r149",
      "r219",
      "r251",
      "r452",
      "r455",
      "r456",
      "r508"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r53",
      "r149",
      "r251",
      "r508",
      "r566",
      "r585"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r72",
      "r149",
      "r251",
      "r452",
      "r455",
      "r456",
      "r508"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r492"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r68",
      "r152"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Litigation settlement, amount awarded to other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 10.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Litigation provision, net"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Loans Payable"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.",
        "label": "Long-lived Assets by Geographic Areas [Table Text Block]",
        "terseLabel": "Long-lived Assets by Geographic Areas"
       }
      }
     },
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "verboseLabel": "Less current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt obligations"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTerm": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Long-term Debt, Term",
        "terseLabel": "Long-term debt, term"
       }
      }
     },
     "localname": "LongTermDebtTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r74",
      "r323"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r308",
      "r309",
      "r310",
      "r313",
      "r314",
      "r315",
      "r318",
      "r321",
      "r322"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r308"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "periodEndLabel": "Total litigation provision liability at end of period",
        "periodStartLabel": "Total litigation provision liability at beginning of period",
        "terseLabel": "Litigation provision liability"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails",
      "http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValueCurrent": {
     "auth_ref": [
      "r308"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LossContingencyAccrualAtCarryingValue",
       "weight": 1.0
      },
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.",
        "label": "Loss Contingency, Accrual, Current",
        "terseLabel": "Current litigation provision liability",
        "verboseLabel": "Less current portion of litigation liability at period end"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails",
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValueNoncurrent": {
     "auth_ref": [
      "r308"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LossContingencyAccrualAtCarryingValue",
       "weight": 1.0
      },
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.",
        "label": "Loss Contingency, Accrual, Noncurrent",
        "periodEndLabel": "Long-term portion of litigation provisions liability at period end",
        "terseLabel": "Litigation provision liability"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails",
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualPayments": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow reducing loss contingency liability.",
        "label": "Loss Contingency Accrual, Payments",
        "negatedLabel": "Payments"
       }
      }
     },
     "localname": "LossContingencyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Loss Contingency Accrual [Roll Forward]",
        "terseLabel": "Litigation Provision Liability"
       }
      }
     },
     "localname": "LossContingencyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesScheduleofProductLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r308",
      "r311",
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Compensation sought"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r312",
      "r317",
      "r321"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "terseLabel": "Estimate of possible loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Pending claims, number"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r137",
      "r139",
      "r142"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r24",
      "r100",
      "r103",
      "r111",
      "r142",
      "r149",
      "r162",
      "r168",
      "r169",
      "r170",
      "r171",
      "r174",
      "r175",
      "r182",
      "r211",
      "r217",
      "r221",
      "r224",
      "r227",
      "r251",
      "r508",
      "r573",
      "r592"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net (loss) income",
        "totalLabel": "Net (loss) income",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss",
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r160",
      "r161",
      "r164",
      "r165",
      "r176",
      "r177",
      "r178",
      "r258",
      "r259",
      "r351",
      "r352",
      "r353",
      "r354",
      "r396",
      "r420",
      "r421",
      "r422",
      "r545",
      "r546",
      "r547",
      "r609",
      "r610",
      "r611",
      "r612",
      "r614"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/NewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r159",
      "r162",
      "r163",
      "r164",
      "r166",
      "r167",
      "r170",
      "r189",
      "r254",
      "r255",
      "r256",
      "r257",
      "r260",
      "r261",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r397",
      "r416",
      "r417",
      "r418",
      "r419",
      "r542",
      "r543",
      "r544",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Adoption of New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails",
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesReceivableGross": {
     "auth_ref": [
      "r263",
      "r264",
      "r265"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of financing receivable.",
        "label": "Financing Receivable, before Allowance for Credit Loss",
        "terseLabel": "Notes receivable gross"
       }
      }
     },
     "localname": "NotesReceivableGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
        "label": "Notes Receivable [Member]",
        "terseLabel": "Notes Receivable"
       }
      }
     },
     "localname": "NotesReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesReceivableNet": {
     "auth_ref": [
      "r47",
      "r238",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.",
        "label": "Financing Receivable, after Allowance for Credit Loss",
        "terseLabel": "Outstanding loans"
       }
      }
     },
     "localname": "NotesReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "OCI, before Reclassifications, before Tax, Attributable to Parent",
        "terseLabel": "Other comprehensive income before reclassifications, before tax"
       }
      }
     },
     "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r96",
      "r106"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "totalLabel": "Other comprehensive income before reclassifications, net of tax"
       }
      }
     },
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r211",
      "r217",
      "r221",
      "r224",
      "r227"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating (loss) income from continuing operations",
        "totalLabel": "Operating (loss) income from continuing operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "verboseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r523"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Amortization of operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsValuationAllowance": {
     "auth_ref": [
      "r411"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Operating Loss Carryforwards, Valuation Allowance",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r216",
      "r217",
      "r218",
      "r219",
      "r221",
      "r227"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails",
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r26",
      "r457"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Unaudited Condensed Consolidated Financial Statements"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r34",
      "r35",
      "r36",
      "r71"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationSummaryofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r465",
      "r487"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r449",
      "r450",
      "r453"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "negatedTerseLabel": "Tax expense"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent",
        "totalLabel": "Net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent",
        "terseLabel": "Net change in unrealized gain (loss) on derivatives"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent",
        "negatedTerseLabel": "Tax effect"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r90",
      "r93",
      "r468",
      "r474",
      "r488"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Gains (Losses) Recognized in OCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r93",
      "r97",
      "r476"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Gains (Losses) Reclassified from AOCI to Earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax": {
     "auth_ref": [
      "r91",
      "r93",
      "r475",
      "r488"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax",
        "terseLabel": "After-Tax Net Loss in AOCI as of period end"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r101",
      "r104",
      "r449",
      "r450",
      "r453"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Total other comprehensive income (loss)",
        "verboseLabel": "Other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails",
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherContractMember": {
     "auth_ref": [
      "r359",
      "r480"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is classified as other.",
        "label": "Other Contract [Member]",
        "terseLabel": "Other derivatives"
       }
      }
     },
     "localname": "OtherContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r242",
      "r266",
      "r359",
      "r502"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r117",
      "r141",
      "r286"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Other Depreciation and Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Payment of contingent consideration"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities": {
     "auth_ref": [
      "r124"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow, made soon after acquisition date of business combination, to settle contingent consideration liability.",
        "label": "Payment for Contingent Consideration Liability, Investing Activities",
        "terseLabel": "Contingent consideration paid"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForDerivativeInstrumentFinancingActivities": {
     "auth_ref": [
      "r131",
      "r136"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.",
        "label": "Payments for Derivative Instrument, Financing Activities",
        "negatedTerseLabel": "Purchase of capped call"
       }
      }
     },
     "localname": "PaymentsForDerivativeInstrumentFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r138"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Payments for legal settlements"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r120",
      "r125",
      "r154"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r135",
      "r294"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Cash payments and other"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedLabel": "Shares repurchased from employees for minimum tax withholding"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedTerseLabel": "Purchases of intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireNotesReceivable": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
        "label": "Payments to Acquire Notes Receivable",
        "negatedLabel": "Loans to investees"
       }
      }
     },
     "localname": "PaymentsToAcquireNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r44",
      "r355",
      "r356",
      "r357",
      "r367"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "terseLabel": "Long-term employee compensation and related benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r31",
      "r62",
      "r63"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementFairValueofDerivativeInstrumentsDetails",
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r30",
      "r32",
      "r269",
      "r270"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid and refundable taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/UnauditedCondensedConsolidatedFinancialStatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from long-term debt obligations"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": {
     "auth_ref": [
      "r126",
      "r388"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised",
        "terseLabel": "Proceeds from share issuances under ESPP"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r128",
      "r134",
      "r154"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": {
     "auth_ref": [
      "r127",
      "r130",
      "r144"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.",
        "label": "Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less",
        "terseLabel": "Change in short-term borrowing, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment of more than three months but less than one year or one operating cycle (if the normal cycle is more than one year).",
        "label": "Proceeds from Short-term Debt, Maturing in More than Three Months",
        "terseLabel": "Proceeds from short term borrowings (maturities greater than 90 days)"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductLiabilityContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Liability Contingency [Line Items]",
        "terseLabel": "Product Liability Contingency [Line Items]"
       }
      }
     },
     "localname": "ProductLiabilityContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductLiabilityContingencyTable": {
     "auth_ref": [
      "r308",
      "r310",
      "r313",
      "r314",
      "r315",
      "r318",
      "r319"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information and financial data about the reasonably possible loss or the recognized and additional reasonably possible loss from product liability related to an individual product.",
        "label": "Product Liability Contingency [Table]",
        "terseLabel": "Product Liability Contingency [Table]"
       }
      }
     },
     "localname": "ProductLiabilityContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/ProductRemediationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAdditions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Additions",
        "terseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAdditions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r38",
      "r39",
      "r287",
      "r587"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationGeographicAreasDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "verboseLabel": "Supplemental Financial Information"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable [Domain]"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesFairValueDisclosure": {
     "auth_ref": [
      "r55",
      "r83",
      "r567",
      "r586"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of receivables, including, but not limited to, trade account receivables, note receivables, and loan receivables.",
        "label": "Receivables, Fair Value Disclosure",
        "terseLabel": "Convertible notes receivable"
       }
      }
     },
     "localname": "ReceivablesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent",
        "negatedTerseLabel": "Reclassification of loss from accumulated other comprehensive loss, before tax"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r96",
      "r106"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "negatedTotalLabel": "Reclassification of loss from accumulated other comprehensive loss, after tax"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r94",
      "r98"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "terseLabel": "Reclassification of tax benefit"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r366",
      "r525",
      "r526"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r366",
      "r525",
      "r527",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Repayment of long-term debt obligations"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow from a repayment of a borrowing having initial term of repayment of more than three months but less than one year or one operating cycle (if the normal cycle is more than one year).",
        "label": "Repayments of Short-term Debt, Maturing in More than Three Months",
        "negatedTerseLabel": "Repayments of short term borrowings (maturities greater than 90 days)"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r400",
      "r625"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Service-based restricted stock units (\u201cRSUs\u201d)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails",
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/Restructuring"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r141",
      "r293",
      "r298",
      "r302"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Charges",
        "verboseLabel": "Restructuring expenses"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails",
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails",
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails",
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r294",
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r49",
      "r340",
      "r397",
      "r584",
      "r609",
      "r614"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r163",
      "r173",
      "r175",
      "r257",
      "r393",
      "r394",
      "r395",
      "r418",
      "r419",
      "r605",
      "r607"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit",
        "verboseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsDetails",
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r202",
      "r203",
      "r216",
      "r222",
      "r223",
      "r230",
      "r231",
      "r236",
      "r346",
      "r347",
      "r540"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Geographic Areas"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r96",
      "r515",
      "r516"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of information about a contingent payment arrangement including the terms that will result in payment and the accounting treatment that will be followed if such contingency occurs, including the potential impact on earnings per share if the contingency is to be settled in shares of common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsFairValueofContingentConsiderationbyAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r435",
      "r436"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow Hedges Included in AOCI"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r74",
      "r152",
      "r334",
      "r337",
      "r338",
      "r339",
      "r519",
      "r520",
      "r522",
      "r579"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Derivative Instruments in Statement of Financial Position"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Basic and Diluted Net Income Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r24",
      "r149",
      "r250",
      "r251",
      "r508"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r275",
      "r276"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r37",
      "r59",
      "r60",
      "r61"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock": {
     "auth_ref": [
      "r308",
      "r309",
      "r310",
      "r313",
      "r314",
      "r315",
      "r318",
      "r321",
      "r322"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.",
        "label": "Schedule of Loss Contingencies by Contingency [Table Text Block]",
        "terseLabel": "Litigation Provision Liabilities"
       }
      }
     },
     "localname": "ScheduleOfLossContingenciesByContingencyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r167",
      "r170",
      "r192",
      "r193"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Schedule of New Accounting Pronouncements and Changes in Accounting Principles"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "terseLabel": "Schedule of Notional Amounts of Derivative Contracts Designated Cash Flow Hedges"
       }
      }
     },
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r296",
      "r297",
      "r300"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails",
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r296",
      "r297",
      "r300"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Schedule of Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/RestructuringTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r294",
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Expense by Reportable Segment"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/RestructuringTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r211",
      "r214",
      "r220",
      "r275"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationGeographicAreasDetails",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r211",
      "r214",
      "r220",
      "r275"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r375",
      "r387"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails",
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r378",
      "r381",
      "r383"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Share-based Compensation, Stock Options, Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r77",
      "r147",
      "r196",
      "r197",
      "r330",
      "r331",
      "r332",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "terseLabel": "Schedule of Stockholders Equity"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentContinuingOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Component of an entity expected to operate in the foreseeable future.",
        "label": "Continuing Operations [Member]",
        "terseLabel": "Continuing Operations"
       }
      }
     },
     "localname": "SegmentContinuingOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDiscontinuedOperationsMember": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Component or group of components disposed of or classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations [Member]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "SegmentDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r198",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r216",
      "r217",
      "r218",
      "r219",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r236",
      "r598"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails",
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentOperatingActivitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operations of an entity including continuing and discontinued operations.",
        "label": "Operating Activities [Domain]",
        "terseLabel": "Operating Activities [Domain]"
       }
      }
     },
     "localname": "SegmentOperatingActivitiesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r198",
      "r200",
      "r201",
      "r211",
      "r215",
      "r221",
      "r225",
      "r226",
      "r227",
      "r228",
      "r230",
      "r235",
      "r236",
      "r237"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Geographic and Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationGeographicAreasDetails",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "SG&amp;A"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DerivativesandRiskManagementAmountofGainLossRecognizedinOCIandIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Share-based compensation arrangement, vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails",
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r372",
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails",
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost expensed and capitalized for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount",
        "terseLabel": "Share-based compensation arrangement, compensation cost"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r40",
      "r564",
      "r582"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "verboseLabel": "Short-term debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r12",
      "r198",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r216",
      "r217",
      "r218",
      "r219",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r236",
      "r275",
      "r289",
      "r295",
      "r303",
      "r598"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationChangesinCarryingAmountofGoodwillDetails",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails",
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringExpensebySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r79",
      "r156",
      "r157",
      "r158",
      "r163",
      "r173",
      "r175",
      "r195",
      "r257",
      "r333",
      "r340",
      "r393",
      "r394",
      "r395",
      "r418",
      "r419",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r516",
      "r605",
      "r606",
      "r607"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsDetails",
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails",
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOperatingActivitiesSegmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by continuing and discontinuing operations.",
        "label": "Operating Activities [Axis]",
        "terseLabel": "Operating Activities [Axis]"
       }
      }
     },
     "localname": "StatementOperatingActivitiesSegmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/GeographicandSegmentInformationSegmentInfoDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Service-based stock appreciation rights (\u201cSARs\u201d)"
       }
      }
     },
     "localname": "StockAppreciationRightsSARSMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansCompensationExpenseDetails",
      "http://www.livanova.cyberonics.com/role/StockBasedIncentivePlansExecutedAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Stock Compensation Plan"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r45",
      "r46",
      "r333",
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock-based compensation plans (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r45",
      "r46",
      "r340",
      "r374",
      "r382"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock-based compensation plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r46",
      "r51",
      "r52",
      "r149",
      "r241",
      "r251",
      "r508"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "negatedTerseLabel": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.livanova.cyberonics.com/role/NewAccountingPronouncementsDetails",
      "http://www.livanova.cyberonics.com/role/StockholdersEquityComprehensiveIncomeDetails",
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r148",
      "r340",
      "r343"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r517",
      "r528"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r517",
      "r528"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r517",
      "r528"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ThreatenedLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of threatened litigation against the entity.",
        "label": "Threatened Litigation [Member]",
        "terseLabel": "Threatened Litigation"
       }
      }
     },
     "localname": "ThreatenedLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r78",
      "r341"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r78",
      "r341"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesRetired": {
     "auth_ref": [
      "r46",
      "r333",
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common and preferred stock retired from treasury during the period.",
        "label": "Treasury Stock, Shares, Retired",
        "negatedTerseLabel": "Cancellation of shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesRetired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/StockholdersEquityStatementofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r78",
      "r341",
      "r342"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock at cost, 806,211 ordinary shares at September 30, 2020; 967,186 ordinary shares at December 31, 2019"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/RestructuringRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r401",
      "r409"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Valuation technique calculating present value of future cash flows.",
        "label": "Valuation Technique, Discounted Cash Flow [Member]",
        "terseLabel": "Discounted cash flow"
       }
      }
     },
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FairValueMeasurementsLevel3ValuationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.livanova.cyberonics.com/role/FinancingArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r185"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Add effects of share-based compensation instruments (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r180",
      "r185"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Shares used in computing diluted (loss) income per share (in shares)",
        "totalLabel": "Diluted weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss",
      "http://www.livanova.cyberonics.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r179",
      "r185"
     ],
     "calculation": {
      "http://www.livanova.cyberonics.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Shares used in computing basic (loss) income per share (in shares)",
        "verboseLabel": "Basic weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.livanova.cyberonics.com/role/CondensedConsolidatedStatementsofIncomeLoss",
      "http://www.livanova.cyberonics.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 13
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1020-107759"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868656-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3505-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3098-108585"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e31137-122693"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=SL108384541-122693"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e725-108305"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e765-108305"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "http://asc.fasb.org/topic&trid=2126967"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721491-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "321",
   "URI": "http://asc.fasb.org/topic&trid=75115024"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=117311354&loc=d3e32014-111567"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "325",
   "URI": "http://asc.fasb.org/topic&trid=2197064"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "79",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82922352-210448"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "80",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82922355-210448"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721501-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "c",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613673-111683"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL7498348-110258"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(7))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r626": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r627": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r628": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r629": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r631": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13728-122682"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(dd)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>92
<FILENAME>0001639691-20-000111-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001639691-20-000111-xbrl.zip
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MIGSX^#^CB=MS\2U-7L[?.8O^ >>+E_A-?4VR7,QG=?5-71RM;]<4;]Y<?;4
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M=(Y(DR*H*2$Z,57_&"M#\_':$FJD:(KUA8MM-4,$+(5R]L%':RH+7>&DY#!
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MKTWP41(R]PVQI9 %!]0DJ0/.?FID.-%U2-ZUA0+9<"T$#:Q-V=7D2D,+!OH
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MEU<E'_</1X)(#I43%Q_!,F03D%WE&"%:*-F7-/S=QH- 9(-[:@4;:LCB6JR
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M@&0;VA!"$U\J],W](]BP.UG&9!E?(F948800/8;:-!G7L$%4*!<?0X7J1E"
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M; 9JP,.GZ75P)LU1$VLLMY(U^"%E8ZK+CHV1U+?S#!ZE03B3:6QLPV7O.6/
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M-P<OI84(3H,(N42<!8G$L-K;W;-1#1.&!M>7"2*?J]2,WS-A$S-G)L4DM54
M#S753)BJ01<%(A+@\-=)#@B7SULI^2;6K;]V>-AOX,,#OY<.^.N!STF5B"78
MZL +ER V%\.U8@2,8?B GY6:>H2O;IR>/%\L]=8.\.BR#WT@S_0+?6?'B2SU
M?Q^()K*G<K^U695%N[<X(ESR9X] ?AP!'SU?BOK,>9\T'1$'YXL3?5A_-._0
M/_O+S'.8:S(Q)0<9DN?LU>T8$WS(&.W%BA]]/SBE=<7,^^S8$#:3Q8MP+"9Z
MZSF ]9E,=.R:11_4?Y0Q=;D:+G+;;_20$I"K(2=5UA"H#];TM7A8+&&7UU-$
MV+Y??M>1MASZGOU"2?,>DS+W <],M:88J<1SP.)P 7M3)_+V?T[UOFXNCHX7
M<WW[7NS4OQ_UJ+JHOWQI:.)FH+&0,HE++8N'% /FG A;KC&H__1V9Z"YP3P[
M6=O4CSCCNYK&'L]4DXX$IJ#9#L8$ ()]E#.'ZA.58DO.+3;:&9@>+=?J[/68
M;(@],,004\X(T#C;:*T^/TQJ2Z[L#C@W:CT].CWL*Y+.=Y<>'2_E>3];7^'6
M8]I(()/BJVW16),),G;;\BKP0Y>*24AV!K('<H(SS>5NGZTP^N(5 S85EBBH
MZ5#VK$J>+90:BN7<B,CF;/W5X;.M)Z!9IX0@&*+3G]\:A5:CS^QS1<UH>$2Y
MS- B]/8S&!1@K$5=#1AH)1<TS4CNO0T@632[!^X7CNO;A[05S+Z ;Q4B@/&8
M.)C<*Y=Y3762W3U(OWQHV3ZJUJ;HF!"M,!2AHDHO,*FQ6JE8=M$+;T/C;1_H
M5#7]3>@+A0SB(E8$% /<Z])7-X)BY<,;HMC0Z)'F56"I()50 5+,U2.7I,J(
M/#7,.P/-EH8H-@13X]8P-1<]]$&^C-;:/ET>)%#&.H)YNF%(F2]3,= )N@PN
M][Y96*JZ-VF(7B+W6C:R,^ ,8(AB4_9$U*C9[O",0N8RAIH4M=#0!-_,SD!V
MU4,4FPI+T&>&,5!K$8*QFJ"W;-B5FDP)]GRC_0X,(5V18NCSP!L:.S$B0:,/
M0<@67(O8ATUR\N!L"[G5G8%F"XIA@S 5-9JF[BTX])"]9)>2S;5%$TK,C#L#
MTY4IA@V"XY/T)?+"-A=(@"J_J_6L$<?44FO9&7"VK!@V"%GL.]^#I\ I0%'@
M6BMJ5F"$-5MR:6<@NTK%L$%\,((+CGPKA8%B=W4$V<866_/&R]7ALZTGD*WF
M'U6E;$&!9B.9:"P$;UMD\/YWNX+'+VZ_J'CZC"W"FQHVL\[99#P5K."@8*S&
MIU9Z$T_.N(. ;F66:CO@:I+IDI14<D.HJ. !FUYGE/H@CS6[!^X5SE)M!])0
MHW$2**C2!B<-FX@+/F65=H9"W#U(KW:6:CNHDL2<5.9!<PB-;<D@M3KGH[,E
MDMT]5+<^2[4ECUR)# 0+E$C!9E(ME;/$$L" J>=% W8 WRL<<]K0<& 0=(#&
MV] W>;++3E^15)0H*HC2SD"SI3&GS;7NLMXEPRD60)<U%3.-4\%L."1?=@:F
M*QUSVE1K%@;QCI.IO;P0L/HZFYOTNGX^<,*= 6< 8TX;@DP:N$2*F'$9$@6R
M-3332I^9)WVZ.P/958\Y;<K?<6LYV2H>JBK$WMC<LQI3K212900-3 :G&#95
M<\BWXB2F@ 43]+[=306Z!;%05,^Y$71"&+1BV!1,I<64^Q9#RZ9W9<K%NX J
MOZDW32XC*-4]0,6PL6KWX "L*2X%50G)8N7>3X1SK!J3< 2];T:C&#96:JU5
MYTSP?5L]Q%['N3AR@EZE7C'.[0QD5ZP8-H4/";D 5@&"!JF7<94F 8J']591
M&2X^O4[1S3,K4:.XW31S./EQ_</OMQN\.'Y;9/NCCN07IZN3?NE-U=W8;=Y$
MXR"YOJ:C!GW!O>*")6>X) \Q#[@D^Y9X,Q3@U,"]XN09"$#SN=*D-S;*2=)Z
M<^0(:E\.*5=X?R_#U1?"S,(V,JD=-L74NARP82S8FN8;H<#N ;JUK8-; !?T
M06/Q+;@*DJ!D:,VX8%7QDJK@W0/WBK<.7CVD4EG-U>4HS4 ?"B@QV5C80PCJ
MG,ON07KU6P>O'E4?4DVNND#%@?&F%/7%U$P6BB54VCU4MSXINQV@K:7 -4>-
ML[W"*V'RD32'BK58K_IW+7SS$(7OD&33)6F;-S?$2DZXN9+ZDHAU_5VCV!3/
M$EPI.>\,--L88MT<3 &\;R;$X  !8I\W;R% E=::309V!J:K&V+='#B8 ULQ
M%7RL8 -J"&L-B4V"T$? =P:<;0^Q;M">G/.(B7+/#DSK_POJ M7Q9<T!R>T,
M9%<Z5+9)DXJQ) 1#R8*-A@R):#CR8$23]8N%M79WUNM=Z3+XCVWTL+EU>6)-
M#<8(:L@"Q)9;5=^(C:IG"!1V#]"M+8._>G ]VV!+\^@H *:(5/L.^E1\Q4 Q
M[AZX5[P,_NHA#3F0]TD(0NTUY M9$>/5:&,TD?/N07KUR^"O'M5,ZF]3;L*]
MJ;K:9L+>Q[H"D[>5:/=0W?J(RW: 3IZ*$!+UE5.N";:$";-O/NI_TH"GJ#\=
MWQ_4?.\M5JL#.;F)J^=W#A>_]A;2\B/VMN4CF6JTUFG$3,W6',!%+I4M!J\I
M2E_V2[NSENH2<(^6.%\=XBBGAAVZ%#"YD-"!9*>)2VO0$"288*/L]!CV55O<
M]D>R2Y84(:-17PH!/=F2(S=*)6,MO-MP7Y&=;A]E,27I?S2IB1& >F.SY)H'
M=J"2V//.%)8:1/3<8,4I9A<=%2<.U0G[5G)E:*$:S])<V:%"B%N,GIML>Y*%
M#4=+$ FX-]R.!J('YP,TV*%AV$$8V@;'9Z4QMP(M)Y.!5:*RJ*O,@M&$VDS=
M1>"N7J9N#J]"*<6>\(=F@*1F]-:E7*H(.6+8Z<1_FS)U2P.R8!AL\N*RA=1"
MCJI216S(?:-UV,'ID^W*U.V@S)"YF5C() /5AVPI]);N25RPE7:GUL$PHN?F
MMIQ"B%:*RM*: 7H3)"FY!?:M]J5PU>\B<-L8Y-G<%FX;'1N,V5OPH99>95TJ
M5 JU0AM3YXH;O^*2'[T^EO<G/U8GRUE5G-8S6C_-9R>K!P]_^O+)_=7W,0A8
MJ44?(1H"L6IYT OF6_35DC@>42F@(8&YG7(_SJDU)A<8^P*>WI\,)#>3/2&Z
M:/R(QN.&!.9VAMVJ\R2),U;?MRJGC(4=L(V]93&^*=(U!M4Z)#"WM(  8G,0
M' ?+0%QSMGV7;*TJ>P+F,?4%^@,PUQ#>.#Y>2IVM=<V#V;/G)ZN'-QX\W,6X
MB2%6D1!4]C3HFS6HJ&RUT00 AD+CCYM; W0[L3.B:15=[TJC8J@ D0/Q8J)I
M'-5@QQ\[MVJA5Q\_*?I<C6.6E,$+DF\05!3%D(,F+CS^^+E5"[WZ& HN%6/(
M=E'4%Q102#:FHE*HH@K<$<?0P]G+^7?[N/Q%3@A7PC_*LBV61SBO\@&-M(OA
ME%(U5@$.S3&H(B+G4XPJ@:.%8GT>;S@=$K9;*D+KV*%%EWIYB(*M+^B2YF(*
M*H.+M^.-K$/"=CM!UG"N4JOE7ALP)2E80N@C2.J;4:R,-\@."=OMQ-L8I'JF
MYDQ(X&S-V)KHDZ\Q@F#*(X^W]_51J&J:/[N$[!KI#PU+[&+,M:6V[,1JI&5H
MUF8P*JVZG^[U)3F,/.8."-\MC08+V"A%FFT6L#K2<)LTH6T%A:C%D<?= >&[
MI=B+46W3I]:[. 2;LFNE:(XK#0SF-J9]9@/'=TN[5HB\\QW/F,&97(KMK0+0
M*]:!7!EO_+WX\^VCX\/%:Y$UCO?7U?!V,=!R<)%\=08UN76LV2UA#@;89QM=
M@?$&VJT!N9V(6C2%#<V%B.(A&5)OFUV-/?L)$D=5^7 H0&XG= :&$,&F"!Y
MK'I:4P!-R(2E@*OC#9U;M<BKCY'5<!7.&24:,#TLFB00P#>H7J7N\+<X#&%L
M_XOL9BBN]!+XF43321L8(X'A6)OC)CF'T4)S9<L6OLRF(+"V-L-9A0=XU20A
MY;[*)#4GI,",#I9M#]1]$900T8JMQ*@ZT9M$$<11%-N[I9I@QXG2EE.Z+^/F
MT& O>T_!(YBBKUQT34KI%=!JP#%E:7H&GAV>]EKE#Z6>+F<G,UG=?E4/3UGX
MSG)QU%<VGYZLX]']=E$:1,%\^!R7\OWK#Y_@ X&MGT>OOC[1CX>XDUF?9NR]
M\'(O:T]0(B")+][K>V%74<:4]>TH,;:314*HT1$'[FW=6U57P112M#V15 ^?
MQI1%[B@QMI.5@D_%9 <FQ@#-%_1%<BB5T6:"B&/*2G>4&%>6Y9ZJ!%JSXOQ.
MWP!]M"ZU)F>"ZOS#BW-<?';QOI_D=R=\)HMG2SQ^/JO_7LHS?6H?/O7O#ON8
MB[Q;7BO%')SF%&PSQ.@PM][<A3-5Q!+K")11[]_R9G/7#V^>"!Z>$;$N3N<G
MR]??_?3P#_GV49?X<;G@TWIR?_E0EB]G];)DOJDJ>K8X/CT\6LQQ^7H7A1))
MR'T4KA9($$W,-K*R(3DV@:WS(Q!*UXPG6UJA[2A#%68(K#$R98:<2ZH8;  K
M8]C==,UXLJ6%WY@M6DS 3:!01O1"N972FZ6Z-(;BNM>,)]N9.S"@"B4A6FL;
MU-+(-(M5B<(6DDE^_/JD?WS[=+DX_K.JGJ-BRW942LEL.+&&G=);F(OF9  )
MBU0D V>K,<:M4G:3+5L;X[$<H?:B_9 C%9L*)[')5!+7QM"BZUJR94L5%I-W
M*E22B M].4*!DIM'4IU;K<UC*"]^+=FR'=UBI=B:0;!5@2"%$O4^.R%;3X#9
MC5^WK)&\MZCK0;WS4</9_-FCY])G!OLDH7YU=6/.NT>I[8@;@Y'%2!&E$CCT
M6%*N'%07NP)(8UBA.%%J6 JHH 67;:5<$F0'Q$%5<X[-&B1'8VAG.5%J6#+)
MQ$3D7/8Q%Z 2R!?;#!NL%'W+.S"P<XTIM1TM54J6T$KPQJEV$D9'V8KK!>T2
M>S^&/8Y# G$[Z@6**RDU:+5:12YJP&FUC]1 !*<I]TC4RU! W(Y>J,YR,1!%
M#1*$3+;6BO&E^LK>5#<2O3 4$+?4VEJS4L@%T7B!7IM%]-EJEMJ<$9$ZEH&,
MH8"XI7+9%GV*3L!# >]*3I0J^.":](J\8XF)VYT_^Q]1J'[&PY>RD[4#(AKG
M;::&WD.J-8=>QI *)>>"JV,H?W>-.+*=B!ZLZUL8JF5J8!QFFUV#VDL )3%Y
M#!7UKA%'MB,8<I1H0V-HV4"OHJDY5W4<<^.28QY#)XYKQ)$MU2$B)P&3\6P8
MQ+"&G%*\-$T5R!I.X]<C5S8[MN.J!(6$@1TF9\&!H[YV7@QX\F)]&4-%HVO'
ME.UHD\3>0K4E&.\ ,F,&XE:L"RF;TL+XM<GN,65+DPX-.:LT:0T!2O7HN'+P
MQDLRQL,8-N5<.Z9LK<LX@?/)@4$0WRB:=?DU]BU#*V.HUS2JZ:D=%S-D2PPY
M&K3J?\"SID0:GD*+"8($.Y99C8E.PU \/I&GEC+UM!H+YJ !K5"TT:I,=F/H
MU3W1:3BRJ((*9Z<L:3E#;5BR 4D:\IRWJ9:QS/1,=!J&=BHY>HZ2O:T>(%!&
MDBQ5_\A)/909B78: H#;42M-,#?JX[B:2KL4<[/ZWTJ)HXJ6.(8^@D,!<$OZ
M0)]B*Z8;($,UA%@K,I+QL3+!&*J2# 7 +:V]8 N4-2!'M4#?2XGHDZUDP)?<
M.V"/)"(/ <#MQ,!6FA%G&5PI4!V7"JBF6&JU/D?:@?VH5S 7=H-?]JIR?'.V
MK+W5\F+Y^N'I\?%B^04J_VT_ZOJ$(4GR+9D$M3KUTYEKRI!;BT+3,HPA4V9+
M532J<[DRNY[_]\:&$#6%B^R=M%YG:B1Q_GI29DL%-:"R!B9E8?3@5%XXB"HP
MQ**I)HVB+MGUI<R6\OGFJL:C!*4Z*"[GH*_!1K" #6 L^?P09LVNEZ)Q(."#
M:9*X@$\V VDF4] A2A';QJ]H=IXX6]IO6GQ) 6.PS("9T7?64"W4VZQC&[^N
MV7GB;&G<Q*N?J<7;C &<A<)9@ I62=A\VX&9C)TGSI;6I9;6>EWOT'+?L48D
M5C :,1)=)(KCUSC#F@*[7D)(I4^+V24#*H1:C04DL#&A9H_!RP[4&YO8M<7U
MKZ3^R/6EKF(AA80IH8#--CF3+4RK07:$7=N15%[]%#2I"0U ];8$,F@;H*DE
ME#>U$D<LJ29V;4]W!<WN6K0&(AO(/E(,15( [RUP<#02W35 /+>C=$(-@2H7
M(P4!L5+SL9=9E>PDMM'LVAD@GEM:2=*<^GCCA#0*%*3LO8AG,=FP6!I#E]2!
MXKFE/;H>6V[)JZ]UD,"B]V3Z&O3@0]#P/I)H/D \MS1N85J,X-@F1# 6D .0
M-;E"LI4KCR1^7L%TWDW5=HO#&:]5WEV]VGL-B-[T,WQX=N=_MBSI3R_ZMK/1
M^6_[_G0UF\MJ=7&!WU6B>8FK3MGE^0&[J ^<)@TI!:R5(O29(%5Z,6%S.5MB
M.X9&>A-?M\+7+>D?0F-)W6F6!B9$C,77TMCG$C/%.!+],_%U*_YU"VT'0V@&
M,*F8,V!]I93(I)JC$V\1XTCTW<37K?C7J]>OB-D&*HQ$ 9Q8%)N""\+@*0KO
M@'[=[(3MQ-HAJ%@F;VV!%$H,$+RCR+XFEWP*D:#MP';NB;6[IV5%;"B^USJQ
M%EIC##X*5$G6,K+E\6O9B;6[IVC5MW(0!+(506Q&URH+9H_6I.S-^!7MQ-K=
MT[7L^@H,G_7?U/M^(=4"[!M!1MO.FO",6]=N8=9\HO80Q&]%Y.H-N-X\D]%H
MXA;%DS'JET.N=OSB=Z+VUJF]'86L;KKOGN3(ID'ABK'E0CE@(VX8=Z K^43M
MK5-[.S*Z.(E2O1@NN3?(SK$69UJ)R7@/<2P3_Q.UATSM+:V!B"8TQV0#(Y24
ME-_9)2\E6ZMR.XQ?:U^+.8\#4;L\6G!?M*-?WF$%W4M_^JBJPAF&YCFS&.+L
MO5,'3,Z/7T%/A-TI72R  0M6;I8@1B5LJ%S$%K;-5[+CU\4387=*[8;0*^$$
MTY)+X (7TUSQ3)K.976L-'ZU.Q%VIS0L OW_[+UY4QRYTB_\52HX]WVN)P(Q
MVDORG$,$ W@.YS'-#&#/Q?\XM!44[H73"S;^]&^JJIMN-INE@6J0)P::KDVE
MS/SEHLR45A8+RD+.-2TT$\%+PIEVG!N7]L5);-M$2[;P(C#C!+<^%A-$(T%8
M42B"A<'*O(!TWL2V+]">M3EACN864R(X_+/$$B9CCJ]WU%F]^/9L8ML7:-5J
M[(0(-#@9/*?6*4!9ZJD1P@F'B5A\JS:Q[0NT;84MC'&,$^8)UT$9EA/!-!>%
M--+Q%Y#CFY8>GI^WG\D II&G<<B!U7ANM,I5KETA+5C#*B=\\0W@Q-O/S]O/
MM.=W+ATM!)5Q%PFCX\Y2 -UY[HPT0; 7$/5-O/W\O/T\IG0$ZT I@_\<#P1K
MD7L>,R0*@JD/Q>*;THFWGY^WG\?>5EY)[C0M%%'<$*L*EQN3PU>$!.U?1S[$
M0EJ3EEDIL/!YT)077FO)&*% 13 EA7:+TCWI62GW3)FC3N?*"\HM%YSC7&FN
MF2P$IU0%KU] 1/%I9.X9+ $E%/AN3-E .'7$"N=H !HZ!I)HZ>); D\C<\\0
M5PJQG-&"EVT#R%EAF5'>>BN$LI+YU[0OQ4)J.Z=B)1\)4E#/.3,:?$LA<ZD+
M!H:*?4U5U NI\XS'F#) 3^LLQY*:O) A,$ND9)+B%]!W^"GE[QDV2\CCCG/6
MY(X$KL!/P(+D A/'"T:Y>TW+20NI_[22.FAIF'"&*U&H7%/AE#><Y*X@:5WE
M)2A)YG,.9FF.>;!@I&KKG0"T%4!X51B5JBU?@B:U#,C+P!&1CG$OF0E@Q%+!
M.,:%\(5;?$W:*"(_C[IUFA@A/2%>&6[RN"]P3KU512#$$9\:Z;\$G<R#,B#+
M3A%=<!><Q99[1HG("Y9KYA9 )U\)JI^'[=?<L#PMAV68Q-<OAO?'7Z[#?)3=
M$9P_OA!XX<6O+KR:[@_@(#BO7!XX<W5C$Z5S[KF6(;>6+L*>CHG!%X/!G\D6
MLXSD.)?@#4M.1; $.Z.%54)+3,,B](!(#+X8#/Y,=J@@EEK**.6"2T^U<R[H
M(@@!?$_Y(BQX) 9?# 9_'AN<2LN< ,QFW/ B4!VHT&"<,)?KH(1)-OC+9/#7
MDW4LO<'2Z]C&I^!"$HMC8KT@V!,MG4]&>.+P!;?"!6,YS;WF0<;<8Z:+W"O#
MF)0A$$<7(2*:.'Q!./QYS'#LE<^%\C17.8^;ZW%M<F\H*6A!K2#)#$\<OMAV
MN/6>^R(7P87 <ZF,XTH&44BJ<F;I(O2T6%0.7^_U3WKPO-!ZT7:P$*)0(E8F
M.<R%,1K+0*47P1;!&[$(^=*)PQIMA^;42$<5858;[G*C0L&H4(X9[ 4+B[#_
M6^*P1MN!/##-<ZNE9(Y[<.!%8 S@2UC!K5&+D(67.*S1=AC+'2X,T2$8S'-#
M-9,Y$QA+6Q"EBY23\'(,(IT7U!>8$RL"YS+7G'B*#08\(<1BGPRB%V.9")=S
MH*O0,=-(T$+9G!;.T<+H/.0\K5._'!/!$6ND!:(6MN#.*R.Y%::(G:.I SQ/
M)L*+T=5Y4(P3C!G/"TZI,#@/)B>>T)QR+NSGK23,+R@8^$1K\F47N!?.O8I*
MDR/W8%5%O?2"8$H)B1FO*H"!08CA1A:%9C2R*M&$,I)8-;'JW5D54)50Q,@<
M6%524A@'QK!P@A?2J+Q0RC,CP"FRI, )55\4JS[5$LNCP&J@DC%EK +MSY6-
ML4;+B#>,%_#+JP2KB5>;@JN44*Y-,$J!8\*9-9@2PZB4VO@<\V2M+F;(\E%P
MS>5YX0LI C&:@YVH"NFLMCG&BA9<ZH1K"\XK<\05@;TIK"(F@->K"VPQ-DH7
M#!? .]K*!>*5EPK]WGH"4Q<\\X$+(@W<7+@<*P-D\4&\#!(MLM,#%+$Z-TH6
M@*^%!94,! .Q"I;I/#=V$0/$#9"FYP\'!\R$):8@5E+.M= ><T<"!A,,L^E^
MER^%L*^F,"L/,=_9 !%SR?. M0.3&GM+XJ(M%VR!K.D&R.GC..?,&^L!417.
MN13>2,V%Q(6+O<N"4R^#1(L<E:8>[!$>I(M;2YB":2J%IJ )E:*24]Y<"CU+
M%\='H8&,JUC6,IAZS LA+,UI+I66U!L%4]9<V_"9:3!'Z\\&[PPN)&;6<X L
M0WP>++A3.(>OL5A8.7C,GFZ/@TB.6544E%!;\)#G2IM<.8UI(,X0'A96&IZ&
M$O,,5P;LG/0Z]]1Q;HVAPCEGA20.&\X65S<\>^.E1Q$<HSPQG$J)P8$-%FMP
M78F@(#*V\(RRA16<!I%KCM)%B- D%XSFF'!"J"YH3KS$ 5P:2LXU#KBECTVN
M.S/LK*_W$'P118BXPICAG!NNN*32Q 8; 8/MZ9YN!A[L'6S^=P3C6N]U3GK=
MJ7<P.6TW# TX#W[3]+O N(^0B?5P^OQ:?GO;#X/>J._"H/[S*!A?C<>7IZO_
MA!]CQK5%+CSS6 B@'O66P\123:2FQHG<?([DFEXS&)ZU@3"=LHN.0GEX-'S+
MY,GPMZ^E'QZ])1C_?TL7SS/]0SC5]H;#7N=M/#..#Y7=2*ZW^F0(IP].3'?U
MG[;_*SRG_EP_[LI#JTM-NSSLOG5P>>B/+YX<=[UVK__V'[CZ]UL!<X$*TRG;
M9V__[SY0>Y"UPM=LM]<QW?^[/##= 1K [!7UB8/R>WA+" RP^O-K_6XYW*<-
MM)Z\:_V"'UI;^YL;V=[^VO[FWL4Q-W"T>YOK'W:W]K<V][*UUD:V^?_6_[W6
M^F,S6]_9WM[:V]O::3WC*^!;O<+?9G $DC;L=9>SC97UE8S&DN$;AWT#TSWF
MB\A+[\&O?8_/-_U[1@KP6U'@7:_?R?X)*-+M=5NC#MS$96.PV0U%]'HQXTX6
MPI%<<J\*4VC!K6 \STUPYMIVZ%G71)#WH7R[T7.C"(_[9R=A:;S&PCZ>V8W>
MZ7NZ>WK MD?^>//TTQ_Z>.?X7?GIV)%/&ZTOVQL?2&MCM]SN[):MC8/O._M;
M8GO_0&QWWAVW]OW1>]9J'WSO?3OH'+#6WW]]_[2Q1EK[?^&#X_]\.3C^BVY_
M_W*VL[])=_;_<W3P_0,[^*B^O:>?S@[^=G*[\['S:?^0?]K__?@@WF]C&Q]T
M_G.\O=$Z/MC_0+8WX+OC@Z_;W]=._1\?N?_W?]J?:/O4'O?./OW]J;VS<=3>
M_J-5'OR]C;>_[Y8'G>VOV[1UU-K_\'7[;_ATO/9]^YTZV][?))^EESEQP:%<
M"HQX03C27#FDE%5!$XV5%$NK!*._*BR?4F$UN[T8_ !KGY+E?BHK5 #'O=DV
M_2_93C?\\A@C7>N7IIV!P>EZ/F3;>[?%I^O'.G?!*$#<S!"NAA<$P^>M[?7:
MUK3;O:'M?;M.;OX:F3Y,0/ML-YST^L-7)T);Y#.)$1[N' K<,<0]]4A;JY#.
M%>.\D ZSL+3Z/__0.1>_79:B"8_=DGW^!FT4G9;!P_@FN^-CYZ54JX?_]6%M
M=W]S]_U!MKOYY\[N?O;GA]V]#VNM_6Q_)P.C81\L@XRP;&<W(^*-_R7;>9?M
M_WLSF[$GSFV)M?7]>)AHQAMD3%P_Z:#*LN%1R/X[$9FL-J*S $:I?SM_+3<C
MS&]]]##@CD?>G)T%TP_=ZZ3YSVI F_5BVBN3Y=;&X6<CF.0\+Q V-$?<V )9
MQG+DG:"6QH5?"J*\%TZ&E8_U/_\@$O_&\'(6)_WV"K(!YFW%D;U^4G$_5W'[
M?1A^&8-&KU3';9Y]IDSFEGN"A"(&=)R7H..80)H(KSEHNR#P6,?QI..65O=W
MUUI[6Y4F>YU*;G@N-!,M5_1[G>R2^YD->Y>_NO,;/K=7H6_%$.N]3J<<Q+!?
M5I3MD'5'48$\@M*?XM=F%>A[!T]K50][=;BU13\7QG%JE414%(!;.%"DP$)'
M@7CB<%S?L#1&=0EBN=#Z82J\[!QF@[[[UU)<:3@GR>=#LG)\<KB4F?;PID/C
MFXXY1O"3;^/ )A@<\'GIUY]ZV>PI@DWDL@=]/:\_.D_OAL-R$!%FV((CKXNO
MO^]L_,6WC[]\;1U_$=O?_\*?"V>94T$A84Q /& +:AETLP#J<,8-Q9XOK;XO
M3TVK=VJR/]^OWZ2@?\)C^BEX3$U8K+KAVW((#W.W"'&^V?QFW+!BE:Q79/US
M%LG,(!N<!!?7:'Q6=K-R.,C<4>6#W2'$<\/ZP?S?^T;1PD]A#0=_:/HG_=[I
M..GFHI]8B]]6UXUK'&(F85R[6J]/7@>#_W5)8]0R[#/XC)Y)6B F' :W$6MD
M90&^8Q"YIJX02K.EU<WN8=MT?1;__]NTP^!&;7,-8Q75OR<2J(K55J[^>]SQ
M_9#Q'\>:?R:ANRQ0^^;;UG@9N<Y.>*T&V_?/07C+50X6FLHEXF"4(4.Y19A:
M#SK.YU+F2ZM:(4*E(N)*T*4)+/KT/LA]9?Q-A=X9^&P]<-KZV?&H7PY\Z2J_
M#;1H0P&I"41N!OVV5G97]E:RS<Y)NW<6;@[G+88A5[U3.6M=5*S9/S3=\GOU
M]R_-9,G$D./17%1C6:NW\BBKJ NEW=>\[X?!8/SK/0R O#K-ODD_YYQRK+Q#
M1!2@V2WER!J"D<(L<(^)I1C<5(JS33,8VMZHWPW9?NCWC0N7E?SRXX?-QM1:
MAX\[_?W>U^[K(QGX-40$'H1!+&<"<4T)L@Q(1D(@5N8%*3A=6GW?Z_I>]PEH
M=-E7';NHD737N:D3$M9GO3[Z\<^4<Q8D)\AK<$ZY)Q[!-.>(.(J94)):5BRM
MUMG/V?_&99=>YX&+-W-;3(C0O/RBO;XQ?_[9&X!V_52>O,KHR2:X?-*[/&<.
M&>USQ+E2R%@KD9=6.8Z#I<0OK?Y-,_G^CQ<6N:R-^#$C1(?KI _F;WEBVEGX
M%MQH6)[&:";84V'04-/WU82([DI5D.@LBO3-!O SI O?YVWBDLYTQ>5__J$H
MR7\;9,/0#B='O>YD+7,Y ]:M2VHRTP\FB^D?;Y\+P:M,SD>$\+%5$>>E]PIM
M0_&Y\$(K#K8%%40C3IQ%IB "*8)Q0<$X%%(OK7)^&;%_R1Z5+%&O O.]2EVZ
MA3]3; ON)9"AT'$E0H#%;G**)":^"*PP5L3U[JM$>42:Q)*[]I\1*5YI6'L3
M?^:2<64"0<('"Y:X 0KI&.66QN-<$"D$B<XORQ@5"$MYAVS"BVI$ #2.OQGV
M3JH_K],J0V/;87('V^O[T$< RVUS,@AO)Q]^\^7@I&W.WI;="EVKBWX[#?UA
MK*H<WQ*>,JW"6L%U)=:P#__[R?W'AU>J0[\._=5C6JUH?/-AO$+.C_U:W;M_
M.6>B6I&%ZV#L<9[^M<26+KW>>(+HR3"K&KAE$P5T8GS46F]Q1JJ[3!_S:_7&
M]U/=3[U@?+WBW@,KLE_URALOB8<^^'HGH_Y@%-?&A[T,SJAB=82^L;]$&S2F
M;ZVY8?/Y#9@&:WT?=B-XA5)Y*W:[RVVI6J%"S_VV)%\15"W,:./<WFZT8U&^
M26ZOE<L?GTI/OL63KY'&2UQ4<^^3RR1@7#TV']QXB>/M"""B'\]:6MTOA^TJ
M?248=Y2YMAD,SL7PY;]\WU3.P]Y9Q_;:;P:_O)Y7;XVSEBJRAV_NR'0/X8MN
M]O6HA&^FR'V'*;FJS5Z;I#UJ#&^L6,\(M974+J15^ZZT?WR0K<Z';]M__/6M
M]?<'L%;A61LP\LXF6+5K8OO[Q^/MXT-\\/>[$GZ/K_D(SQ+=3_L]^FE_\^NG
MC4WR:7_K&[P7;AV[LX/]O[YO;WSYWOI[^VQG8_?HX.^MLYUW,,;]S>'V'H;?
M:Y^YPU9JDB-I"G!4N)1(4Z\0E]H&0JA3PBVM[O2!UTS_+-L[,OTPJ.MM4!9_
ML]] ">'ZFQ/3STY->Q1BKGDVB.?>&"A,G/TSSA[C< W#B:UOP=9;YVS- M-8
M*85(88"9J2B0,E0C+2DV)L<Q,+*T^G[K8RLQZ$,S54%-7EWZF\#RYEB)+FR"
M^%/S\/84FI47.EB*G",<>%@:9#D6"#B;!)HSK"D'DV5M;V/MK^R/=L^:=A9K
MYL/P 3Q];]_[O/#AN3WMK:Z/:2\ALV>9.PKN2]:)C02^'H4JM2YZU3-)Z6_(
M+]F1&53%0#XS[38<C,6%T4W_[ZB,3CKXYC:,3X![COWT6N,1%C.CZLJQL<L^
MX^E/F#^Z\?%PK!S+/!P%ZSJ>>M(/+E2V-J'U_:K2X$'V!FX*<I8-1F!U#HYZ
M,4=^4K\U/#+#RV_QU5P<;U7:5%T\?IM?EJMTYS>T?EL+T@K'[3&\2SR_.A4N
MBD,9WZ?JBEH-HAJI&0PS/5;SWIP-5NJ/]<]'7Z)='_7[,)ZZ[C/JQ*$9C@8+
MB2</"BQ__4P+J[ /!@5K"\2%]<CZ(*.*,Y9[XYF02ZL'5Y/:QY2ZVRK0+4N(
M;R>8YYT7'F$A*K_E"*8\>_7GDZR073^P5J\AY.&_W3+<N*!P'\$/<*]3#F.J
M36@#_O5[W6BJM<^R &;;6;85+3CCJB7_#3,T6:S<O*P-IO>8#>'NCN!,4-$1
MZW?#X;C'=[:']K,WD<#Y;Y31E?$)PZ.RJG\ZB?5/-VF%;$X*H1[O.<Z'P2]/
M"^ SDQKG=(SGKP_ OWT.@A>>6(D*:P# K; HMC%$6'#*.=;$X03@=P7P9X7N
MNZ96)-2^*VH#4)JL#6\2,N,<H';<ULE70-:/ANVUWV8@.^C: X,.P#T\I3\Q
M)P'P.C '9]&6A[N![1LG[3 [[/>^#H\F1U? M _5T'PHRF[55*%*%HNI.!3>
M\H8!5H?);Y/3?GK"C<.;G!<M^?&Y-PQU<F;9K732V%>A%M&)ES+KFJS<GGN>
MIQ7<12'_R2C5E870YBVS4[(B<S;W)3^N5X1XA.54NB*UN-=M?W2,KHC\=H.]
MY:K)-?&X=BB&UU#PL7N//%<HKK*U*E")X'K8N[YN/!JT_?7Q"0MI@]5!.7@^
MW]GX3^> ?OS2^OX1QO0)QMH^;G4.^/;Q =G9]U^V__A8?OIC^W)03FP?'_+M
MSJ?C3W__!6/=PJW.?SH[8*M].CX\:QU_$"WZU]=/?\.XB?KZ?G_M/"A'&,<6
MC#1$;!X0-[X '<,]8CDWBA8T!.:75M]?KPKF&VL^'@V&97'V(/:>6X^PBL$O
M&8C/]UKSE-JUJU1\R.L]&)$>@63\(LGN#[=-HUWK.A/PQ=-OL;7DWDWF[XNB
MV_.U4ZQM@&J6)YN@)1O@9S; A86YW.28.!80E2IF2CB'3*$\4@Q;1Y5E-B[,
M_:0)XPM#VLWK'=$DLW.4V<D<_U%-\7H]PTEV?R:[9[/Y3C84P3%6H" \1]Q*
M@Y2+YCS'KJ"L()RYV\GNW#+X?IX@J.\K+.>))W=(&W\>_-@J?A!YBR5MU\8+
MR^*Z!9YJ60>LO6ZO6I49#>JH'4Q5U>'[NIZHO7[UK/99?/C7$AX=PX%=>+5>
MM$1.RT%E/79-UT5$ 9LRUIW%D^-V/-[T_2"+W=I*?U-6/WMC?KDN^'9IRYNY
MX>1=<XZ>R*VX,9MD4</2@Z/0;I\'D-\ ^U71X;K%8;4@>"'N"A2_N/1V,$FG
M?)Q5A)]*WS,W]QY;HW$2%UFA/6A1\.RS4::0P1"4$X419X$BFP>&K'!>.F,*
MI\V\VGJGA(HG$JK+T;#&UF\]8"&#JY5</,I"!N;Y(Z\-7)^KVRF];X=',X)N
M7^]?$61]L4J/;FD=[(R&E=E4M2@89CMNV(L[,M)\LH''7%SDIZ3OLQ<+O* R
MF(/OX,)M@/OWQY;8V3]D+1C?SO[1T<[&UEF+?J@TYJ?]=W#?#Y?<PI-C. >#
M^\</CK^(G0V'0=N*G3\VP9W<8E7^]?%_VMN@G5MQC#/+.A[[PF$ID-"2(!X[
MG1J+%<HE5=(88E6@K[,,YFZQD7=5DA?X.Z-N63-V]?J#I8O,#G8-MUH6!<T#
M]SY8+&EP7EB3<TQS4V\52^#C$IC3KNR8]N!?2UNM=Q<W4^J..KXW')]P3=9P
MK].)C;%[[DM-L!G<@6F&F8/3<9*46TC*-( B5 A""XU(;#52+X 2&O.1.98\
M6 7?+ZURM0R2M,Q)/N'\"6=<$P"]T2<<<QB-QNA)KW;9W_9#3*L\#3=N.3LV
MJ/#T$F,'O?9H>/,E#]^E]JZ;ZN;GF^H>]:<2?QB0[0?S!9D"!/RM:7\U9X.X
MZ\3U.^]R"M;7#S;??<!6N\^QJ\7MMO1YO_5QK;7S<:W>0.$&V[HI@]U?^_W]
M9MPT:'VGM;_9VK]YM^"+$T[RI\IBTGI%U1;\76W_?(7R^6<%X17!Z-P="@47
MWK/'PH^/*<KG/MA\1? []6!I[I+OK<.%%Q+\YAI>;YK]=/W^RG^N[>[7L["U
MDKW;:JVUUK?6WF=@\NSL;J_MSV[2_3RS\Q3,<=/4_+&9M796[N(66N.^'/9[
MHZY'XV$Z%T)17-]CZ!GN,4;OB.TW-T*ZD]Q6"N4&^MROW>.MA/='[33^:1HS
MENRH'SV/?_S<,B,XA@^'(5NSO=$P>]?K?S5]G[WO];Y475'B3@U5<>0_?S67
MK:B7Q$SW,*42F]V-S=@-+'1G<!NW=$VX\9P$E4NK6P -XV*+!Z+#)8K>"QT2
M5S2#*]9[T06/&03PJ0+G*AGUW7DZP=QT2@.X)JF-1^<G,2^UT3";. '5<S*6
MOA&HIO 4LUCBKI.=D+UYWQO$UH!-L8$37C66K>:&5X^@WI)AM:",1>DM\2JF
ME?7#$9P7.WK,$[T:P$H)O1Z=R62RMA)ZS9VQQ(WH];MI@UL8LKVC$)H49$P0
MU5A.RI.!E2!J[HRE;FM@F<%1]J[=^YJB5XFG?LY3*ME3":SFS5B,U(NV@UAS
M%^NLGB[FW@ 62JCUZ,RETU+MRR&HYK-+M73QS9;$%7/BBFW3-8>56CC?7W6C
M'+C18!"+&F+CQ;6N:9\-RLKRG6J3J&[JBO)XSFX8C-JU<;QS$NHA)>,X\=_/
M^8_=E#?R4.LX(<IS+'[1"XKFIG2O!;(T$UO,BRW^BAU"RF%5RE0I#?BB/?D[
MZIQV;S#JP[CK--1Z8Y=LMQQ\67PN2HKD\?F+X^2QO"22YK.:A"^^,9G88EYL
M ;['L \4J[3(G_V>"SXJCL5GD:0F'I]Y>",<CD;7'#Z7"=7L*L6ME6QG_]^;
MNW<L47SZ99QD[S1F+'? )L8:6DV3"C<;S3/OPZ%IUU90M8=:,H,2V]R";?A-
MBT I[MJ8L=R%I.-:S(RL+7ZT++'$O%@B1D^S=\8->_V4]9$XYA8<,S^]D+R*
M)I!4C_5"ROE('''.$1^Z=5/W$#=+WC/M4&5N;/YW5 [/LG%CU3+4\=4/@Q /
MCAV,Y%TD!KL%@_&Y-7I)IF0#2,KI6(NDA([$$><<L1$*4V7]?3CI=4%M=,M>
M?T9[+#ZK)$WQ^$PT/TV1K,LFD%2,-45*V$@<<<X1VW -^!E% /=B)M-O\5DD
M:8C'9Y[D2[PLDJJQAKBI2=("&8B)(^;%$3O5=H-;W7JS$[C5XC-'T@V/SS;)
M>WA1)!5DK!MN:D&U0*9AXHAY<<3FMZ/2EJE5<.*6VW +ORGR\..=MV[8_NGQ
M]F?^^;2,-VC.AD?E(!;+]8%1VF?9;CCI]8=9KQMW:NAD!*._EK-8O$WQ;^_+
M4]/JG9KEZF_RV^3[ND%(O;7XI4-?P^5O1H/)%W'];_QE;]2?? ODB%M#][+)
MT^+&5-6Y(*1QV[MI]Y'!R Y*7YI^&08K%VFR '._'R>^7T]WQYQ5._J9LEM/
M0.BZNOD*S$S<"?T$WG$8MTHL0:#;<4/VD6E7!P ,J@W=77M4;P#:Z<'/7K1X
M!V_O,"ECU$$18MZRRWNV(:*>8Z)(75D G"$?9_OC6PWAXMP0OE)M'[;?-S[$
M_<P'U7[WD5 ?6WNQ6T[?G)QE@[,!V!J#Y:I]3CRP7Q]XG.VE5WZZ8VKU'E<V
M_8MYUXBOT).K&]Z;0:C1^G_^07+^C-,_J2W9JV9T/*%;^VN[6VMI,A\VF16N
M7H:8DU%[$++#T(VM-GK5,3]RP\';;+OG0QMT LW>_!E/2M-_]^G_97DZC;OC
M><PV1KTTEP^:2Y:]V0B=\B2QY8.GDL],9>+,!T^GR-ZL#4[*?OCW>IK)!\VD
MG,SDWFZ:R0?-),;9F[W0W0<7*\WD/6:RLIOJR525[MD[ZW3"L+^PUOTOSSF=
M=_'=DYOZ<#=UW?1]V0/]WNEU*X._-O G+NO;;$\L*A\_)QMG1\'TAZ@]ZAYF
M'>..X(3E;(^EJ9S35&YU*^6?YO/N\[F<_3M.*!SXDJ;O/M/W__9W4[#I/H*\
M-AKVAGVX0S&J>KY.@GAL/[+D,/31>J_7#OTTN?=AR_5>MQM<;*[+%?UMW"SW
MM-<>U4DN:4JG4TJ3*=I 4S1>& L !R.876");%@.!J.Z@V<GN"/3K;X]->W3
M$!?+VL:-=TJ)9\ 7IKP0H"Z'_5[1[GU-O'\O..GWOG:S/W?WT_3=9_KVX$G9
M'C#X!)"7LS]#WP7@WC2A]YG0[1+N&^W^87]42?WYO.[W3K)_FV&:UOM,ZVX
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M2GFDP+#GOASUVG$H6<U>U=55&G <XB@F!;?+"O7@17XDP#'V%:KGFZP[ZEC
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MF[$;_&YC;1*BJL8\KJ0\'W;BIJ?B)C NP4\O!\!+X=M)Y75&7["L^\#&1:4
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M/ K][-"4W4%=MA &5PB0XI4-6ZS_*::UR]/NVS&]UT?]?NBZL_T^O%\]O#^
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M@G<BMJCFR%(-?Q86V^" DC3FP>?+0J5F,HLFQ@L2E$@"_5"!G@DH*!:8H+I
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M0:5ALDHJ>D@'^X1L"=E>"+(]6JY20K9Y(-M,:(Z*8(2WX'GBHH@A>8*,]AB
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MXN*>>FYWE976^TOVN5210';33S!)(,E)OJ3T"B;&YM@F"?GU=VK9!CM @L'
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M*[<])6-_Q+MM[!1+K#9"I1K,XAF^ X/-I"2CD410( 1YI?)9$6 P30E%C++
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MU F_^N6)N[77Y;@=0B<^5H*6X^/V,&]_C@HT^_/3<[ED\S]:O6%L$/S/>_7
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MM[VU5^.)=/73O-QM;6ZU]K8V&_!J;_?U]N;&/ORRMP__[&RU]O<:NZ\F#_7
M$[UJ7^-AOOR:SMG8^W?CU>O=C\LWKO]XW]IXO[D-8_G/Y6O[=A<(O'<*]PB#
MZYM_;/L'0$/C]2PO@N._Y/7X%[_5Z/G@>:JU]&(IK-9O>*Z./1G$YY,7?X7V
MX*1CSYZWNU7KJHM^7:GA6\:T9\PS5;'RQ/$VOOV8%)]5;_TB.D;O2?G,4';M
MV_@9N>5[@LI;7?F[QA+^C,C;-NA1&LMO=-L_N$SG2-'^QX^:2Q^]POX<8_%1
M#*U+@*Q6]!;\I;$#'SL<-+: '<)L[.6,KG[ WIQR,5PGQ'\775V_?LY.O9MX
MJ/_XM$^IRZ9"+N>8?[7R^US]:+LGL6]SP97&!EBQWRK/PDV*7BQT$CPT3N^C
MB$5E>LNZ#/;5OJQ6'-Y;HHH[1Q[6K;/F]H@NCT]SGIA*B1GW,@E/E.1!YYT%
MP9U@7"D;O8U?-JM=(H()6MPI5IBH%V?Q:^/3W'TY]FD>^1\[V:>XN<5W_FX=
M?=Y_RS_#=^\<;^.=OW=HZ^=_.I^.#N">AU_/?9K';_'._L'/G2/_'>[W<V?S
MW='.YH[8V0R'GX\.Q.>/[W_ _<BGGYWC7WV:GS??_MC=W#EK_7P!;=_YWOI[
MYSNT[WN+OCK>W>QT/N^_^KJS_^%H]^/GM'.&SRI_YA[^_D4PXKV3#$5./.+2
M!^0PY8@%1S%WN4R)6EN7HDET34[@%S(J9/0;,K)66F4UI4%%[CFS\",2J;P1
M!OLH,QD1,R8C>%'(Z+')")^3D8%!HI(9Q+WRN2Q\0%9PB:05+'J=B,N5$0EI
M&GZ7H_,U#?:NNS+L=9&W@\-&&RSN0:/=]9W3;(*WNXWN6#264G@/4 IOM!;1
M>D^6S9ABOP^S8VA_-.*/D[S_U?B'B]V8VL/[K:B[DD><'E:-WWC=FPSS:/';
MMS^V1D/]8C30926<8R5L[4W)<B)!FW!M4>!4@2RW$EDL*0(I(YB,# 8MK*US
MTB3L\K&G4D&@UEBNO9HMJ%XHJB_T;<3:$!4=4MP*Q!7WR";'D#68 Z8-9=RM
MK5/9Y+0FQO9"#S/67+.\B\?5P=TJ%*?12Q42JSKCPRIRIQTJ/S@ =MAK)-L>
M%\U\[ ..JTV C^);?'$Z@$8/!B][QZ[=K<;\O.;\\.7T5-CH]RW\M0K>>GF8
M7VYW-XYAE(:[Z9I+)O&99Z00Z3Q$VIZ21XH2C87&2%B;$$BD@&S(Y6^=33%:
M1G6.*6,@CTJ.O14EAD=11H48:DD,%PI+IL0=%@)9!P//0][.8!XL*,XP%SD.
M-2=XH2"P5BM;WU((+)C_T):?U60O+J 5<0%5*=(WXTD?WAXQ7S=,#W3ALGFX
M;'IKUNI D^8)">5XSB3LD;8R;]):FEQT!OX.7&::[(K=D.(#6A4P+T#H%# _
M$I@OA(D+DBI'$C)>600:Q2-C@T(QN%P4%EN9: 5F:>Y<N:GX?VZ%R>JH)')V
M=%+K.+L\;R]5GK0=5U.I4F6]?9'']^74\!9.FX/3=E]."92D%":)Y)3H)E>8
MUPQ9;B3"'B=O&0E!F\J=K?EE:ZL4EEP5"#^D0"D07@2$+V1)LLHQYQURU,5<
M'M8@C65 E#E- J$PG D@S)N$+BKU5/&:S!M*<R''B]=D1:3(]* 6]IJ'O::C
M9#BVA$:<D!(2(RYH0";!#V6,Q\)R8#(.[$6;%!</R>H"]R$%2 'N[8%[(3NT
M24YIG1!PK49<:X&TEA9Q11E1.)=]S'ET6).0.UL.Q1NRF&B8 +?Y5J7T:;2[
M@V'_=#9C3;&LZAG]\D=FZ[2_=9_/C/9N>FE/3L#$LIW.1C=L';L80@Q;/WRU
MD?TJVB%\LK#?/,=<]F>*1";CC3.6()TJL\LY9#&12 <>>5")&F/7UHEJ2L'K
ML4]=H%V_^)4"[;I >RI%( ,BUI)9Y%P$0<,-!IM$,^0"3\9REU@B.0+%7)%O
MM42@/& $2M8TO?/4%AW 2&S8P2#>4M,48ZT^DN9\.WLRO*_SZ+[+#=Y-[P=Q
M(P_S]%P8'W HO#<7[\V45C.,!D$50\!]$G'"\[80L<B#KHG66%C2@/=,4Y-R
M8&EUT?V@P2H%W?>+[BE5H[P5/N4")=;G6+3L:;51(X"U@P%FR>1](MTT\G+-
MW-KZ:R;9%:&Q\?>$4+]//B57U/;QB6WW)WZH=G<(IDH[I\^\@UQ[TG;JX\FU
MG['?"W9P^"N7_]WKA>_MRB;=/A_?BL@O!K_P]US\/5,)Q'""&2S#*(64$&?9
MX>2C0"YBFHRW1%)09U6-(OI7C3;Z"YR75Y\53-\#IJ<T6;*&JI@44ES3O(EF
MD?8F($ITXERK&)Q86Q>X24V=PN^**%L)5UIU5*!XRNHMO>8_X5H-:ZO7S9F^
M1OD_BO5\&Z9^/ZV^&*'4,@OFL@X!\1 ),CHXY(-F8%F;0 T#IF[J*TZK%]_8
MJN#Y44ZL%SPO"L]3RHM*[+D0&B7'1T%+R 5I4'1$P L.; S6E&I*MJB:BG6+
M7JI-KLJK4]:/,B[D))536WPC;U%5F+=S42.OY*S\W3V>DJ+=\#[GYQ@T^M''
M]K=<:Z>94YL6D;MJ(A<6PG[>,]J,HW^WNY.Q?W<^]&5]G&M]]--ZUU(3C9$!
M!>4UZ%VBD39>H*2L"MY(GQBIDLIS7*?MHH+M%1"\!=OW@.TI[<M-(,#6 6F>
MX]M$B,@$9E%DTD9,)8GYT"] NU:):9_4=FGW6^P.>WT0MV5K=-FC\Z^GM:EA
M+GPV%Y\=S(3B<PZTI11BCE#$O8[(R9R=UX@4M134*^ S0IN$7]8J)11_%7#\
MD)NB!<>+Q/&4+L'"&Z<,15IC@SC5'(&AX1#3 3.)@_!* 8YUD^B:X/@I^58J
M-W3#G_;[.8HKN^"ZN9S,Y/<2=K_B8J4:__. W2H(I+#=?&SW=5JU".RI)CZA
MI"1H%:D2<LDE1$-@,)UQL (#VXDF4%\]*@D40*^D<Z4 >P' GI(QSN)$O%;(
M$AX0%THC@[%"!E1-$!C43 [J,DVA2F*$1]XF.K%GMHI"!S5CO>^?YKR1URB<
MJ0W'XI.IN<Q9D,\YSX?7%\.^T0VS7#GU7B',>0CS:":5@N32I.@)8M$YQ+5D
M2+LHD!&*!AJ-Y@'L/@Z,R2]GL"O^FU7 ?$VD4,'\O6)^6B1)Q5("542D][DF
M8D+: P48SP0.G HJ<Y6/?!RQ)NE3GI*O9]_^B.?JJ#AUED7MW)#>JM%],QK<
MPF%S<=A,OH0$0R><!M(*%G1+U!XY)PCB4BNOI+7:R+5U>47^N^*^607HUDNT
M%%3? =53RB0HJF@4#(E(!>*>.N2PL2@*D0^ X&!SF0_"FTS>Q1HIKIM;X?,U
M*.^#4?*GDW[O6WN07TU<,V?%,5-SJ7*S?'>7.>YBV-],1OV\UF(AN[G(;GM:
MPC@>>'"*("^=19P)CS2A"GX-3AAI5+ ZA\[P)A$U27978%T_&5-@70-83^<5
MP(1SL$H0=\2 9:(2,DKGU$\)<&XB5<EG#8.;FEZ.\2WNE7M/S)V3;_OA:3\?
M:NM'N,NWXF:INW99A*TV,_+O1@-?B&XNHIM)BB2%2'GVHD1$!/V"/;):)D2L
M< Y[(33+1-<DYBY>Y.*$J2^P:^*$*<!> +"GS^<'&,T@,"*,L.Q;)4BK0!$-
M+"GI16(IK:W+II*7\VTLOQ-&UT6_7'TVOQ6'C9R-HG&:"ZW.GM"'(?A6BR 9
MU^N'V$?#WLGSW*^#7J<=&KEK5IP0'T7IP(QX"1.BLN)"#"_.WL/,V.Y>1!6>
M3XM"BG.1XMMIM4.53$%+C93V.;)0$.2\<4@;J;4F8.M1"6J'R";'"XB4N1F"
MELB/\U0IX5$T4J&$>Z.$*9TD7:18:(V$Q+E6B6/(:2$0B4Q@YEU44JVM&][$
M> '^V_MEA 6Y@.JLG/))P4$EE"ZF_^W2%]W40+S!/?X\JG>Y^R.T<"739%V]
M#+PY[?M#L$ '.:_Z23\+\>%9LW'2L>,0]OB_I^V3G*?WL?7X:B^Q#WDV[XT]
MJPHW[O<V/(QN/[X9C_N;/.JY)MADS,O*.M?*^FE:;(<D(X8YBQS7#/'D$[SB
M%,$88DT%#3[0*D*5\[L$>)6=T?J"^B&S"A10WQNHI^4R(1:PRQ&!,<QR.2+K
M@D1 UX$PJ@3W 2QHV=17I#5;^GW1)=$RHQ(Q62C?OCYQV3^ID7"IHC_.E>IN
MVKX8W$)F<Y'93(Y&#!QC=>((! I&G$B,# >9$CV+45(;I"-KZZQ)KCAH7#8_
M5P&\"Q H!:&+1NCT*3=JO>3&(*6C1EQXCTQ2!GG&K:+&&"UUMB%6,)"\YEKC
M=0^N;0Q[8Z$1'W^_<K69ZE'](ZW>,);<L;=EM)E<BP8LJ.2<1X[+G*--@0'%
M: 2"$U$E&$!F8ZZ-3L5=DA85I\@J)RVZ237)@N$%8WA*E1#L Z/96D@L(6Y=
M1$:97/';&B<!QB;%.E:2?$*ND&K2#]JYPP=5!8OL$ZE"KNP(#J%X1>I=TN)6
M)/?B= #-'H )UHK#W93C)\;OA$)X<Q'>3*I%C9F5,G D@.* \(1$C@B%G+8D
MD9R2C;.%$5[QE]37"GG4#9T"[L6!>TK-&*,=#\DAS3R .Q&*' T681U$"-X9
MS>S:.L%-=2>3I+A9[AR>TCXO(7V7=-'%4*NWAOFE4'CQ'\_%;3]G,B.*)"SS
M6J,4F$%<AX1T!,.-<1%2'M)$:1TMM8+E51(N!=%W1/1TC8O$M6 8H^ 90]RP
MB*S"#+DD- @8KR6+U9ZMOLNYMH=SNH3VX*1CSW([X^_17[]//B%_4I7#M+B,
MZBVWKLGC..'C5[W^FWX/NC(,7O5[Q]60GI\G**=I;LG.,^F0B$\">^Z0U!'G
MO"D&&4G M.1$D2!M\#Y71JQ57<0"Y-IM<!4@/PJ0I^-\O>(TF(0P#1YQ2A1R
M/L(/8HU-DG'L'  9KVP%CF7+(- ^/QA7,@@\MK%9IPP"A1?ORHLS^9*$P\DD
M:D'18(DXMPH911@*.!CI.8[>43 _69.QDD"@,$(=$P@41K@[(TPII4@E#& B
MR%8Y1;QAR$H<$&,F*&(=3U8 (^"F(*;NC/ $$@B\:G=MUY<$ B6!P*)V:,>6
M:".!*=KH]+H':!C[Q\#>;MCHN<XX/^^CB_'E6V#K&AT_Y7K8'@Q.@4[B;GH-
M [\/X[X)PUZ6T[F6T_?3 MM+(W'"'!&M$^).YNH1*2%'@N:@F)@(;FU=:]G4
MYO)Z6G9L5P71#[IA6Q"]:$1/1\M'QVE@#&F18^0Q<P@F;D0*?A5.*B-H6ELG
MAC6YN1Q@5J+E'R2?^LG(M9ZCS!8L89[TMDE=3_B=#_B@\-P=>&XFWQ'G#NQ]
MRA"0&R@7@P4RGA(D$[?">,*YQ6OK7),FDS4)I"T8KI^?KV#XH3$\I56TB4$R
M'U&*P8!6<0)9X3E8'YH*$SU5FN1R3DW&:@+A)^MI&1SV^L-&I5-<K]_O?8>G
M&33^ =@Y[5=>O<9!/UIXOS$\A*8:W CV;'!IC(K1M@)NF+T\%R;\MV-'122V
MNSN]?MR'P=\_[,>X PT]+#L=\Y'C3+HD1:1,B2M$%(F()Y ZUFB.(C4B.J&]
M\&#(<=E4Y/+>9_',K K('RJ!0<'W0^![6OP( S2M!(K:2\2I"$ASY1&UDD>M
M(Q91U/&PS%-TU%3G 1]2 A43L(8::-H$+!QY3QQY,!O@CJ/CD2,1C4(\2(VT
M8 I)JFT47F') F@@WM3L+N4BBH_GJ<N? NT'@?9TKDFO1*0:(V.31UP2@5P^
M,(RQEQH&7$<1ZICDY"EY@*827'M[<A+AB6VG4WPZJR)HID[X;,*#?;/#]K>X
MW<VE0?/?SX/W2NCJ+1EO)JV3913&T&!$/ '&TYR"F)'Y5'5,FB;AL),@9E@3
MFYH<IB[@7DHQ4V!][[">$C)> ZJ5\3F7DT.<>8(TXQI%I9F@EE*!>?'C/"I$
MLY!OM,>A9O"P@U*E8_5$S&[*PSP)*'R9![G0VARTUMJ<S>5$#=?2120CSEEW
ML4=.284XP11&PAO#W-HZQ4U.:'&]K"2*'R.+4T'QW5$\)4YXD)QIP&Z .9RK
M A($UH9 U'J=;0[#A,GYFY2I2<V=)^1>>=GI#:H, N'H=%2\IC&)"P;8- 8P
MY[/GY>6[G88;YV(MKI=E5RVCRD6C8<[V67MPTALE3M]-DXR[XXFQ<3XO"@/.
MQ8!;,U7'M,%"$(V$9QIQ'BCH&.<1\911(4T06<<0WM2F)B44"ZZ7RNM2$/T0
MB)[2-()C):1.2#A-$!<Y,[XG!OGHL"(N<FM+X,PC[QQ=G&_*4(36Y]_@Y: =
M8K\ZWE0<,,LN97XQW8#[7IZ/]<OIH7[=MJ[=:0_/BN?YKD0XD_X1>RDHD0ZI
MJ"7B,7FD3:2(1<FTP#S:G!U)-W4Y +6B,'\$#TV!^8/ ?#I0V').E--(.N4!
MYF#!Z "O&%:>:,9B# HL&-4T^BXICXH3YS9HW3NT?;A9/YZ,@V7"Z+Q4/#[I
M],XBO)5].<?M;OOX]+@QM#\:W]O#P\->)S]H<>>LF 8:O(L=.XQAO[=O?WR\
M&&@@S6JBO,@3Y&7O^"1V!Q5G%EZ<BQ=GDD,J;6B*C"&1!$<\"0/RQP$O:B#"
M7&S>N+2V+II4+2 W9''LU!#AC[%!51!^SPB?.2*5L'1<(BJX0-QIA9R@'+$4
M0M B.B[PVKIL@@JJ!\*?DHOGE^/A,/?/0VP& %JP"AI;>V_>%#_/"IX OTC;
M-=*_[_-P;\,?NCG4<*,;KN;"-QWHE4*(<Q'BVYF@G$")LS@@$1-&7'J0/)%A
M)+T0P@=IF;"YG#V6I>3'ZJ+^\9/U%=3?.^JG@WB,]E*+@+ G8.@$9Y$EPB,1
MK'"$"Z<BRZ@7BM<(]4_("?3RT'8/8JX+4IT11[-GQ)N-;AP65T_-73WS)_R?
MIL8;G!^=.C>ZVW\=!X42YZ/$F;S%3 CKJ9%(:4& $E5".I^JLM@;;:G2.(FU
M==+$O":688%\_7P_!?*UA_R4"F)$DV2I1ICFXY-4.*0Q3D@H(Y/WV?0A6041
M51/(EU*TJ^#G*J5HE\")=3U+3YV%K4:RQ";<E91GDA1:@06W%B./0R[01B72
MVB64E.4$,RVIED#*=:I;6>!;.V]4@>]#PG=*4R7EB,>.(:>$1CQ%B4R0,%">
M6V4H_$_2?#CBS@E&:^I76IJZLR?CJH(-=]9(YS752NW9Y9<N=ZTO61CQKHQX
M,%MQ-@7NO4#$D1QRD )R.&KD9/3)2!LT 4'#B&@:NJBTRZ7N[&JPP4/NRQ4V
MN#<VF/8Y&4E,% )IZBWB@01D.'>(R)RSRVMC<"ZF)5A3\<NG1^O(!BM5<_9J
MQ&ZE%'UU]BS^\*.=N;X=QL;H]: !(*XTE>V&T8OXOZ?M;P"1[N.G!7JBS+EP
M%]!H#NRFK?$,> <38+>;&3/_MW4QX._B8-AO^V$,^8V-;IC]P]0G"X_.Q:,S
MJ0^%(5$JS% *"B,N@D1:T(B<SPE(7.+!\;5U?L4)_-O9F?505(47EG.7KY#'
MXY/'=$53L+:,$ S1X( \$@O(XEB=A%,:LQ0)97FOG^ %Y#"JF?I:<M]5N^O[
M,6>0;B]:<Q5KM0::Z\:,>B?N? ,]T0/;=C25-N/H7_B]<YI'9YJE1\Q=R'8>
MLMV?2?NH33 4C%L43"*(6Z] J26/@K!84@8F<,YF2Z1LRKM'FQ;_UTHQRD/Z
MOPJCU)I1IN2;U=G*TQ+)RH=&E4 N6*"5!(+-LT2]]&OK5(-^NYR^H(Z$\@1<
M:"^OTVH-.VRX>-#N=O/^8R\U3BHH/;;;;*5IU?F E=*"<BZXM\D9X06-47LM
M@L?TRW9F4S""R..P:2''N<AQ)CME8@1KIO(& P&YA55$3B>-8-%QDAIK@LXG
MG,&X976*P2@07RS$O>$AI&0,T9P'Y7(!="XY)S@RIOP(XKI ?&D@/J5_@DN>
M>0SSF>N(N,<>68<5DB+F5-S1",?6UKEJ4KR"Q_>65N5$^/O=],T?#,H;BMA1
M!SUG,(RA=^HZ<21D[V!BUFT8_NN6\OYN/;,J2X<3@H5<E,-ASZ465CKJ2#0L
M!2"<T=+QF-Z[LG3,M73,)/B,E 3A=4"$975H\[8I(089%PBQ><AQKL%"51/^
MO%C;^4[@>F1776'6PJP+8%;EG3%"!1:) \O,.:VIP4E:PZ,B-([L[L*L2\.L
MTSGDB4Y$"(E"$@&8E1NDG4S(RD08U<PEP=?6E6@R<N=,.C4@UDK,_VMHX>O@
MW]#^MO[?\&/2Y#% .'VF!(!H4K[@>3^GNFM_BW]];X?AX01 4Q>.GP5?7&(=
MM/QT>/TE4^W.>6-B?_0D[6Z WS*&%TT+!/^)%TB5QS7&AO6^=PS??99]F]W>
M$.X^[#6&A[ED8&Y?3NZ:<]CGL<DY "<G,6P'6@M_.)[9S?ZUE^OZY'JVQ=,_
M<^LK9B$N*1%8P$)P[FAP7#)##9&&6B^4_<+(VN2BP_[D"4[L042N'^U79!,\
M\'/;^6[/!FO_FNF7XW87_3(#?SMY+G78^G^[/MSRBJ>H5>]?BI*@^?%>;W_8
M:.U^V&B\>?VRL=':;.R]?[&WO;F]\6Y[:Z_&<^GJIVG!TG#>Z@>>S%4#&@_S
MY5<__?YN8__?6XV7NZW-K=;>UF9^M;?[>GMS8Q]^>;7=VFB]W-YXW=C;AS_L
M;+7VEV^ __&^:T]#&\COGY?;?D.JX.=4,5I76Z?'T!B_@.B467&UVS^PW?;/
M*@?9RW/:AE] 5+WIQP'TI!V5Z7DUX?&]<QK?; ]\IS<X[<=]:-.+3L]_?5R5
M];-UKK(^'[:.01$='=#=S5='NYOO.I\_?CC\#']K[?L?H'XZG_9?'<*U;5!,
MG?CO=V>?/X831[F$Z^BG_0_MW<U/?.?C#F_]_0&N?77\:1_:^W.+?8+[['S<
M@G;^)^W\/,"[F]#N3?]]9W/[;.?@B^38.&PDPE+G](/)(1V\1 (G[K154K&X
M-J[X<AK#1I; -' ?-"AFSS W&)05)2X*35Q(G$J^UH@@8T_RG.^?QEF^/[;]
M U@=QC)#WL.L)W^<]2+3&FB!!GG6.)_\C9?G@N#EM" XGTB-BYG4F 7*_<[Y
M%W;0'NRF#5 RIU61AC?0-G\V^OED9_*1_[F[\25@:YCG%$GG&.)"461\L B+
MH+!T*3&1ZC4;+Z]Q>3968YQ]T],DUKAV*;G4[,?7G=5C[!_^HKCG$-GYZ5^#
M'=SJ?;,-FW]M5H[\7&LAZ_5A3KQ4_:4+W]LXKE(P99<^W&\OGL!=7.PW&&XV
M,I"J#V9;OMDXM-]BP\78;9STXXGMP^?;W:J9_5 5#\_5&QKOG^T]:_R]L?&F
M^L)V7I_;QU,-;7=''H \+OG>N4GM+ICQIY4!69D5K^ 3#8+1V^H3&]EX UN0
MX/QH[^+!:6=T^1[ZGV>-FW:5LYVJD8/#&(>S?31L;$8_?FS2K)X6'G8P>E:P
M/,',&U>NF%#<E?V>^<I"EU;=TCOMCVXT>9;_VVRXTVS7PBP!^RF'_W9. [2]
MT\FM&77#;->D7F\X,K7Z>0.F/SKB/MO!^<$[$2CXJB8]:VQWJSOW3MK=?%?X
M(IB;8'KDMYOSFF_0C-3)Q\=RFR\JLPX:_ZBJEPV&X[B77K=S!L\(C]*!2_QI
MOS];RG7PS_-R9_!-7>C[P<#VSZKGL8UDV_V++YWT3>^DJJ0#]P%@GW9^G>;0
M6VWXV^#4P6W;MM^.@^8M9_P(+3EE=QZF2>L XS ^H>TKJW_2JDE;AH<PB8[M
M&4R91OQQ$GW5A>.O/XNVG[\M-_Z7B4;Q: )?#8^3$8?!K0ZAIT89-$\[(7\)
M&([5-(-^/#KMCMQU%?SR%TYFZ9\'M.J3D3&?OP*@-P.ERY/XV2^FY,R*7<L5
MX5W,1@)T_+?8Z9V,'ALXQ/:K\7BY^V%[$Q&S="O$YFF<.& FS]" 9H1X#,KI
M'[G (\5_3=ZI?B5__;/9^!Y'-)XG*8 $"#%4DR#/W8DVS?>]>+\Z(]1.,/&A
M%_-'3[LP+P$(E<<,)F*8$'=[Q#70A,ERD^?/2;^7/S'(2]%AM)WAH<_8\L %
M/9@U@U%[H,=C/T_3XWSKBC<&<'5.EY]O=M)O]_K5B6UHW'<8N\$(V "#X80E
M)@];D5[V"^96-1LGIP[TW?BK&ZX7\DU&WQD[]@R^,F9.RZ ^R<EUPFFN612J
M+(57=R_TXF';'U9+1!=F4KXVLP/ IL)]ONAT "1;<>%4%S3'I#^Y<_>TH@+X
M5"N>PO("G^I,D#]IR;/&J]-^!F>S,8#^:IS$'O!]14_V6Z]=W6L0X]?JGN?=
MD3L?<(G.VPYX[Q_ <)Y-W7KZ.6QGT+OV8:X9T6?+IZL^CGH..JSJ-YC9U3H"
MC)BKLXW,X8I683+"4MXXB+V#OCTYS',&>NE\IH#M>Y#Q,:A6@./1XC(B?N@Q
M4* P%%G;]"Y E=?TQD&G!SH$M$A6J5-S+/7R(#?^]]0""*H9,5H;/DZ6DRLF
M:5Y:>X":L^H$=Z6;ON55U&4D@X'3/QNM9/!W6##.!Q3>/I\5/A\_^M;KP!/
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M.;_,Y"R^< B#PB"@%JC/]KB6"]H$>&RP/AV(SK.JJGR450?.,*:<,.T8#BS
M JM5A'55W< H+ZOJO8%U*D^UT]Q'+)'/(:.<Y;A1D@B*H/O!.@\^B/^?O3=O
M:NO8UH>_RB[J_JJ2*IKT/#BWJ"+&\?5Y YPXY/C:_U ]@FPA<;4E$_CT[^J]
M)21&"Q @H"L5#-(>>ECK64.O 31_\P*$ZNOAT]LHOU$*B0.ACB;.>+*4!BE8
M#-8JZH,NI^W+Q;A3DQWV36AJ+6**<L059L@%K4$G#LI+8I//A1KHJJ+WKGE3
M"D7>BOTN=](N]<Q*A9ZEU=18()(+19@2E =!+!%21D^-<DH%P8K_X^D ?[;M
MM(F<PEX%%&TTB =KD-&2(1PHUEZ#K<7 K&+\<H[/K8\YG[XD3ZEN5K!S^;5G
M:9,QD43M)>/4:VU=$DH+@47R3,\3(5(0<]&(.>.(,HIXCRFR.H?;TTB13L*A
MI*7!&L<<B+>R+DTI"ED4S0*6#PZ6=ZEX5UP-3X:C,S4A8Y"!,(YHPA%P5"ED
MF4J(8!NQCYIJS!?;RZX@:4'2@J37!E-9:975E 85N>?,PH](I/)&&.!'69RV
MRX6D4Z=M2%@;3ARB+%'$5<Z.4LPBXD).;D_6$Y_[Z FYJ"2#IT?2.:KK7E%M
M]_JBNKE&:4-UQ"4E\J&B$)P[&AR7S%!#I*'6"V7WN%EYV$J\W<[WWIM_#_H!
M&.1C/(RATV11+4NYW9V_)NSQ>_?SX8=_/G\%DMS=./FR^Q'8XC\'6Z==>/8[
M\>4KD/GFQV_;IW]>*K?[^=-_.I]AG%N[7@!K=;???SS8_O3N=.?3%MG:[1X"
MF>/M]W\RN#]MG0)+;,*X-_WQUNX^V][82QAV0UB!.,<2<2$E,BI$Y+2(%$="
M8 -;=.OT1C%L9$CB%%"+Y(X*1G&AE3/1A"!9(,EB:^)-Q7K/5ZV5#U"NE_RH
M)%E3KG>[/XR56*O&Q%'-4$?U1\>Z3K<S/)FS]JZ<R/0G+T*\TZLVHV]K2%*3
M.U\1L5H=QVH GW:^QU#!F'[?W*@^V4$OER+^(PZ'<.U/PX-8Y<;E%/]Z_JOF
M0_+KSY7M=N-^_MP#EMA.K_K>Z;<YB7753\U#!W%_-/G('AUU 7$RD W[55Y;
M@!^0<=\[/E8PSQ% Z;@<LAU6_=&@V@*!Z@]6J_<1)%_OI&G\NS'X;H-=K=[F
M];.A7\%=>6<ZL5ZK8+([?MC/<R6LF:M<K?)$WFZ^;>[.8ZKCD1W88>SF6LO=
M:&M8@]JF.#RI>OUA)\&PV@'#X'/!-A@/VZW^)\(M _2VW^_"T]M1UQ5,>A#K
MHWZNW0R3.CZ \>;%[=3U*"]M]7LG=D/U5_MXH+ \U[^/ CPKR_/J[[6_UJH1
M;&VS8GG.U[X*'G\TZ&?!\CT//<_F>[\[Z@WM *BFX4?X<F8Y\AWCO_+K.H='
MW9C+2;<4#:^[N#! $?U#N"*T\U][=K2^,9S2.B.3_6]IO;_?@R?E+>E.>+G9
M 9M7M>'WP0R_'W5MWED@7;@%UO&&G:E^&G,)?-]^,F&0M2I7 +_T6-BINE,/
M:W@Q:&_-YL%FV.JP'\Z(;[(]9\^$?_*)31Y+I^>[HP ;FHLZ]H"%Z@@R/',-
M[&.^*2L DX?8ZKOUH]%A59_4PWB8[^_!8N=+XS\PBGS?F,*:X0(=^P/; XVQ
MLH/V'4TA6K@/'@NT7D]XNC\ (O1CUNXU5PPB+"00]FB08Z";L0PZ];<\CJ-^
M77<RZ^=*XT#ND^'%01_4E[I*@_[A=+8-8^7;^W"M;08YZ/</UZI/,2]?,_\\
M5\")SK ZMGDM^ZZ%EOSA["8?V%"Y&'MYW48#&&(U G[-@&/W&W[(VT74KPU
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M*_@O8&>3Q.(>>;4% Q\9 Z<M:UQ4UB>E4&(D @9*@C0C&BGM7-0^<FWX<\/
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MT9^PL<? ZLCU&I"EFB"N64 V>H(4==QR90.CB[-'"E<O+U<_; .[PM6/Z&D
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M#8D4&Z=H])($S'%(CCIB>-1<^*1BF+..4H'$)8;$257FTZW-;R=["39:8>L
M$0W\4$8@PQS (E?):AJ52*S 8H'%5PZ+WE"G@L;14AZL=Y+C))026%!#$EE
MJ%/!QB7"QN,]:L$>4 '04/*FVYY&AE./7)(1;&H&!+"X^*B"BP47EV?6M_$G
M8B_!8C;)<L&-5P9SRK423D=A*5'%G_B<T7#:#8 )K7W28#>'G''/=$2:D("(
M]58(0[V*^'EIB0OJ$[#4\+4!0VU4A%+N_R%!T"8:N)'>&))+QBN-+0LZ1$+
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M?4YCW!IG1/:F"?1Q2?.S/XRAWXH[*1/I1%+22Z72G>TOHK'US4F1)%AFB/O
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MD]-BGDBI'S"\GOM1XH($1J-&&,FO$K,.(-([B7"9'[%UOEXB1'/0"K'6M:<
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M\IWTNUGG+3[ZJ0^WFX;:&SJV#/".T[)YY4FGU\R7?E78=R#MQK'^[-N:^.(
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M%I13@5.!A.4:<<83@HU72*3$ @=>52DWQV$SZO2G3)=;A J =',Z17WDA"F
M_!A$2G8> 1&=MDH=/,/VE:N6R0;W,R<NV?1E*^,2FD%47FMFY!L^LITQ9RK,
M#(-C<N,?SI7WP^E[,N-6L<87RX>7; 9>9"9+&62>#^Z80AD6D1:*("D S8U(
M.E"ZMLEF#=NXH\VP<IIW 0/];G<XX@Z>&0W_]BT@\V9J#OQ[H!3%S!=VP*\%
MDTYA01D)*6#'@GI8:GHAGHR"++5A&+#0W8>Z8&;49@EG&1..X^E&;>NF;5Z'
M9<[\^J$%WBPR$(YC^3P3NO%\?H/UT==OAH "-@<;57J')K9PH_9WJQ@NT,VY
MWEGKFZATKJF-6K;[:X7A7ZN7"FJA3 ]JH N7:8A@H;1Z0TPN3V BO6U.=T@Q
M/.VF)UH!E_O/+!7ZS=[A$,:S(W4E66]H,/6SF!H.4AE56(X\ZJ.68F#A=0Y*
M%BJ$H:T5,G),#5/?G[:;R]2?G,>^/B[>6@?V.3YN OD6[)?%;W'U@6<SFY2=
M6C'R($\PR#9I**==9N]I#.ULM(TMJL'CC.Q-BHFJO>UW.R<1]O=#^T<<9&Z]
MSAGVK>*!X#/\ML_ K][6&O:BB%5ERF[5_K(_.MU.[?/&R<;6X&-Y^7 Y4] #
M\)8?D_PPK'2U&<!T6[JJ'<!MQ>9R==L!K&9Y_Y 52_5TB!B9)YOA >64Q80,
MT'Z8$I0'02P14D9/#1@N*@BVR$J33Z.9*>5DKQ>KE.[ FG*RK+51>,7 &N04
M<<,<,ICE=!:5HXO4" Z*J*!W*LH?^Q,F$7KD0EL?90J,1Y-FZZO7Z_C215J*
MA'$25L&WME D!N[ HBYJ4 (U382^<] NPV*E%993"S+XQBLR^A?.4LJTV0/D
MA-_F(-+W8$WV_H*'B+V=]K2.\>*I]L-YX^";-UC29"0*BAG$9?#(P N >H8P
M094-LF@Y=S7B,DVS@PR\0EVY0_E+27(W4=<PLCL@Q691: ,0.N%O'FLVK>*$
M[^HDF!&6O%;17 X!O5LD^AS;9J&571XY-5(IX7&'=EX:EGQ="I#D<OU2,>UD
M-__@:Z7+\EJ'5#$W$LR60=  OE .5X\YJ (*T954^QMUL+OJ[K,4@7R9@DV)
M2TH$%K 0N4EU<%PRP%@B#;5>*/M-\K4)O>$1AEM>=<Z,TSYZ6^V0/::P_ULY
MHE1T[LD)($!M8,4MR=A+VAAASMY%X^+@O+[]@3?>?Z&Y>SC\)QIPC;V+[X C
MA]_K7S]<[!U_O((YC:,Z RPYJQ\=X/W=_>\-6&MC^SNN;_]SM)/K+M]__+EW
MU&CN;^=JX ,,GQ7U;0^?_Y)'8#H=J,XYZ<Y8@3CS-G?;52 U097S00<;T^6.
M3J#?695DT(3F8P\FD$A\HA9.A^+\^>D1F$]K[UX9951P=.$L,!NU,?64;/:I
MV?M>J]LVB.I,2"MG &_W1^'+@U;' 5BT1[EFN;DD6(3%V+@BGA:',<G. )&&
M$%^BF#^_7+S6ZOO3$E% :?D:RU!Q&2A^]_]-NCTRP61!U2M-W= O*Q9J3=!Q
MROY9<]PJBZAHB^*BWL#7TCO,0[_/BD44/N]6KS/Y(#E0>GH^" !V\YG.2)',
M^S&PX\>*VI1T*SW\A3PLTHY+BWZJ8G$48RQV]U(LV)Y.1&>[9>^;O*[I3*4/
M.4Y=NMO6;PR!3BJ8HX#^(,"<-V!0S'K-LHO0;MZL.Z]_.K ^7-:X5*D,P*T<
MCWR-P\AU[F8PI>&'"3@H?+'CE/9\F)>B+64TI1S)-?$.?+59J$7CN;\#QV:.
MJPR\AH,)D'<."16D'CIE[>J8[6;R7-85<BY%OW2JC+6$VE9.&O9QJI9W^+WU
MP:C+R5RX$+/.7WJG1X]E0>,!L^7JGA7%<+7#'*J<1M81Z>753U_SL!331=_)
M@? N/MD==/(H2*]WW1V'*2<%BQ4*Z,1!3-9V#_%C]:CUEZE/O;^!]/SY2U6.
M&KM@H'W\9ASF0FNPQ3BWB&L<D4TQ(:^44\1C*8F\K.!\2)=99]A/M>3%@B,F
M&I^L3Q+L)?3H7+E6,8*^J%48Y-DVVZ7M!Q?L'_<'1>\%9X))==*-AP F9;9L
M:6(-XB-;.V\^C!K!EL,%BU+^O#BX*-AF98[1I,TW$KM%IM%8KOPG)]P"NIT6
MT?1IV9\CR ,7Q\@LS/<>L/5$8">G/O6[][ 7BUKDP\Y9>[B!10^C7MF8J-1,
M!E&UP=Z/4H@+Y[J=0,&-LJMXUB8&EMQ,2"W7/JC8S?'*4H_*16\C Z,H![[K
M\XQTF Q)]YK8^W3!HG>38 R'/\:0VIOACJT<SF8;_Z";/2*YL*SH?CRN&[I.
MN[V;/)O4,&YHBCG5EI.1]3+N,F\^A(N>$Q$)(9+R:+"5@FDPUKQ/T1$M%IH/
MT1ALU7)U=__UAO716PK&M+>$$FTYRE44(#N40]80D"+*$:7@.#@5:YN,T0VZ
MN+9&.()$LMC0$ BG4ED2O=+&:BQ<<!KG\R:&4$:J\U[D>3?.OGEJ%=?1(D.<
M1EP:DGNX)V0#]L$D+)7.3:S8K)##\+RG1W\4?ME>O%X&E6 SD)UE%FR6?X!/
MI8CK34EM0*[AX*,B4.$',88<VBU%=*[&+:1RA/ME&5I(SY&JD4/?OY5B_/>!
M8!]TL(%%7JN3Y\C$;_.,1!+8Y:ZR#BO#6:*@NVKO."62T425O$/8;!2:N(YR
M<R0B!R)VVA/4O#R= 9^ A.M%^A85*1AK$+$\(BX LIPA!@6C6:X MZJ(/Y -
M=86"?[\W9$EKN!0D:4P9J-G>66(DP]@&KZSS(9\W,8/SAE\6(ZLJ"KA" 2(;
M/(%9+ -#3(4BJ=;E!K.Y%T"2W$D&9Q)R"[8;9E]-MV"[2^>U?*RSAA[-!1MY
M<)_R.@9K"5B\06L2G**1>X$)_#M/1+,BFKL2S<<\QR90ZI+G"0F+\Y ^&9"1
M4J*4C*!.<.)LS&-*K_:ENC]JX)B<H3Y2#+(!>Z:I"7"JVAH;([9X@!JD0HU'
M)H#S^MFWH&+N9Z20\3'DW%^+G+ N]W&4!'L #PVJKIQ! %=0X\[M&J^"QE!=
M&JDH^6,#_T-WV@%X0_2Z_,+H&G>TXA_2]?&I:AN+K@'=W#/BO/:F&T/SM AX
MK9RM_O5*Y,J73S,,]8P+VN"4<O+P2>P6S)\=ZFX8=A_M1K-L")*/?5*/!5M]
M&+*9IW)U238I.S1.SSHSGO/F&!-L[#AP,3$.*N<I=6JMYC'L<\$@XRTO8HF]
M.*@5F?WM87+M<;/=/.X?@PW2/D!%W7YSG)]Z4)@CPRL7#K:-VDZ_6QYUCM@,
MES]QWJ,XQM1S-DOO3*^<4YX/O:BO[+2RP[1K6QNUVH>4HUJ33.%B9NBIWHC-
MS/P_BA#E(.,CFU;%$P\\LP4&V"R[AC<K5U=V_BNK2Z>_6NY$T1%KW)JH,_F8
M=EB*F5MNW%Y>.0P'VM.IYUF]:,=NKFS-T?>I$RZ>;@#\PZTJL7N"7:>KF$MJ
M+(W<,HB7IWJW<G[=CV8\ZUTFEU%0=(KXX*(%P??*[@[#T[F\GB)4.+GQI38+
M0BU306^RH':8OPS<]-_.62S*EYL);EQ&B#NCMC"]*Q1=) _EY,2)TH/AY:Y,
M#LK-.8IDH_:PI/DXQF']6,>UF@?#-(#\\5FT%*=9 _YHA:+L;<P;>4C+>6TB
M%K ^:-A5?KB<?967/%%[/8P*#,7_8,4S,IBJD7+SY)"KU<TAOSVA:#H!2='$
ML&-.82(YU\YP!I8@S57## <OGCKEZ+K.$KW#VKM6YZQ6%/->BI \;I3WLS^,
MH=^*.VG:@]O;23OCX,38POE[B%*[&3U>;DCX[5G]XS?E*!&YSIAHFV<5A(0<
M6+A(1/B;$($MM7?/>6/+(VNOBW@5'MS.26S/]D-/![Q&@<PRU'KCV+=K(ES%
M#*LL$5I%%/:W4FOJP[.%WN^O[JC#L&(?RV$V(\#OP@.@0N<[Z<57PU_^",W>
M2<N>OVJVBUTIOO0'B.+3K",,T/VT<S) /6,VM& 9^$Z[\%\87GZ B1L%)O[G
M-%Q]3^@-;JY_&V^0>[XG&+W7-V]:+-$;3-WOLD^T6'ZGR_ZG.+7RY( ",C']
M/VML;2P20\:^5_3D9XU,"_A63*>7R:*DMD?GV"M9JX7DW0:0Z39'V5LSXNXC
M9AGLR@T/C//CKMWIHS/V9J#\+-/N7'4;O>3=N(*S4YMQ"U,XZ[^#: ##$PW6
MZ\%\3>F/ :0".+Z"+:@5?K':\&&6DY6N"+]B>V[(5W;C9NMEW<7K//H7I-S?
M>4-Z=R"J:[?O.FI;V+;CVBIL_K\N[^'BGG_RN;OYEDOUX'-%MXS$$E1/HC&G
M)+I *.B;05!A.2;ZFCP>MLB\#K::"O_AWO'/UL[1=[Q_7&?[[]]>-';]>>/H
MX]D^K _6TFH<OZ7[NWNT<=$XWM]M' ^_ _?J[],O<F?WT_'>1?B^MULGC8L/
M</W7WQOO/Y &_4+W=O=;C2/8!;K?@O]2_3,^_VOW[2G\>_8M>AVC"1@)X6*.
MBPDP%8Q!8)SI!*3%P(1;VU3KDEQ7A/IHG)'?G9-#*H2K$.X1$<YS%B()2BO%
MN=3>N8 Q#8P&PK"-ZIK,M0KA?CW"X1'",>PPTUHBG$R>&F$YTM@S9!4<G(Z"
M:5\TYE\':;4J$#>W,IR*_SU;??=/"PO, 8B]V+Z7MGMI?ZZUK>A\>SP3^E<:
M HT$OB'42*TH)\39I#1G1)# G%:F4O*6!0*;$TJ>B]8[@CTBDFC$B2=(Y[GL
M3M*@",>2YQ $D>N8LH="X&RD>51%KF+>NW;[B91XG8P1GO*(M5.)<^IPH-$D
M(EBEORP-\X[U%V\EP\%2Y BSB/-@D,&.(*:IL]%Q0%^PT*A89_QJD<;3,>]]
M_77/547)S>T>Q1-W)WB;L;G/#]Z<((FY7#+F%7>,::<CZ/R"">^P3K32398$
MWLXG=1,<<4J8(RP8F&=)&M!-7$2,.F.B(Y+Q/%!=K@OQ8-UD-L0\I9.I8MXA
M\U)N4B1)41T$5R19(H1(D1G/78KEQ)U*-UD*YAWK)E)QQ9-CR*4\)=AHA9RG
M 2EAI78D2+ \UC:Y7M=L4;Z5572?%'D@3\%_'X;-'HL61;TS>S*AI0QW?J$+
MDQOB#BN;D0.9G66(%=^^O(VV%_,%UC9_([]?2M&KS,3'<'/'8+F0S J?. N@
M2CEGG#9,"L\]Q7?3HRYBMQ-L[[!"X4= X<:;"14JEW 3XB-H3X0A;A5&6H.M
M2"RE)-!<O HJ5-&/F_ZQ1"9BQ;@+9MQ$P-H)-E!.'+<V:*HQCT0P%TC0AE0Z
MU-)P[UB'(@I398(  TASX%ZID:.!(.;A=1QD8AY$'Z7K_%GY=^Z0OO98(?MQ
M_FTM=/HY_39S\?51NQ<4S7_8UCP;(%7PC12IEXP2KD,TGJD$&I 6@=/ [J@!
M54#ZZ$ ZF<JD<I,.)1+R(07$O8K(8:H1B#_'G3"$6+>V*?$ZT7*Q@?X'<<UJ
MI#E5F%EAYBU6(V,\>6YCPI8[RXS$+&@2<3)&Y@;KE?*Y+)@Y5CZ-\=&!B$/.
M,()XP!;9: UHH!('98@7KIAI*M>56' "Z). 9J&U_J<HG[JU/LOD6MWRGBB#
MU2LF)UXI;O:*JDO%<8CHQ9?'Z3M5QTUXQQ9Z=W.'NT]OE-Z0Q2[<Z'XLBNA"
M1!/%>47/UM-B=,5@5-"P5<+M\\$V:I]FC=?3&[5WH\D66]UN#L@6/2XW!IUE
M;Z[B_E5%KKG4-E?:EH6V'P9M8#ZTM\8=<W=R^X WD_UR/Q3-7'*OGZKH]>";
M-!Q+T-H13<5X9@V@)F@"BSH*'UD$\>1O*GI=CA+7K5SDCD[MSZ*383'OYG(/
M_<F&+[=4MDYT8!Y.UBUF.PT:M0-SE7V.!T,N!^UC1S/?RSR&RQV01\T:!Q=M
MP\;53L]BZ\>H*Y)=1'VLJ>ICJ_K8JC[V!5>$EF"X"V#8 ##,C>W&K=FG1P-7
M!;1WV:[26JJ]G<;W3Y?P_>T$OC<RMA-:JQ>X7A7DWB'[;ZFJ;5^0&^;%.%H$
MMR9)'+51F--@79(^!:88#S1ZQ6[K(CN/Q^4FHV,LK-[^+.V5_,%.&X 1/M3-
M(\^W8_GOZYB[66Z%HWYIMO4*J *D>B:>FW^.ZD=?:)W^^;UQ\>=AX^+38?VB
MSO>WWYXWZ)>SO:-_6ON[[[[O?=UO7?;<-+[6SQN[>_EZK'[\EC7>O[VH7\ ]
M=C^P_=W7S<;7?UKUKY\.]X__F2[<=6 2>\H%"B;/X70T(DU)1 K3R"T65DLP
M<,BZ( ^.&L[%9ZOASJZ0LD+*Q2+EE =GV(-YM_,Z3JI77\%^;[9W"UNY5*DJ
M )P/ ,>NZZA)C#;']U*0B$='D?5)H9!"L#AGO5"^2@!XLVMZ.;Q3?W=CX9NZ
MU( ZU[?<I_':].BNFR:"E4.TAH/!)N>"7?)=7>NL*B9E%;;08KJW/:IW2DAR
M'^\4T1N</8YWZFZ>F3D7JRA;E<6R#<*KQ5:+A<7J13HIYW!"_>*/4C+6PJ<B
MMC?+OB7WD>T6$U]*W:OV]NKPAGE<7,M_AN;R$=ZNNRSY^=W1QWO[X[ZH/9NO
ME^)J/5T50KEI=_[J^$'?\O;8L0_;-.7T+T(%H,-GDW6QF_5<6.A]8?!\FK)7
MP)9X7"1Z?MOXVU\#BW&TGV,B'!MH$S&HBAIG,W4QD*(BQX5P]8@HYR3'90B
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M!9JLU=KF- .)^T;=5&7);<_H>VR-IAYRW.2"W2+.'@A9.R5?;U\>AIIR0K#
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M<2*4<)Y8+IVM^O(^]>5QMSNP38*1/&*/<X<X=1*YI 02TCA"$T^ENX6\W^[
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MO7&[G[T5<L..]HX&LP\+G&A183PYAI?_<SAH[> L]F>P_U;O=>R%02A9+A/
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M":(,@N6.EXJ@H<OJ@S6,EC_^8#/I,@# 2@];%B_7W#^ 2P$7 1CTCNRT-QP
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M2H59?K%:GWTY3ONC6>/TU_'D]_C>#I?\-GW$?/5+YBOEK=)2:Q04>"V<.(_
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M\2R!_*."R,0E)0(+6  8.1H<E\Q00Z2AU@M0& H_N:-1NK.Q__1A/ RP>;_
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MD>BH!V\FD1R. HM7Z],A]ON3\+O.-+T/^7QF1SX.AW:>:#J]:!?1>AQXT>/
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M)+4QT4R29I& RYYX!YPP9:E1*4?%H4K 2Y: [&-0R49BN$0)B":C!$1+E&;
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MYPGW>BI%VMQ@\?UL\&*4C$XI3D+*DH %0YP 35(.AJ=0BISTRKJFE?'G]2#
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MT"W\WB>TI)_.BK5[_VWOXUYG;_=#WCH[H#N;..[-3Q+_A9WW^Q1<5"!R8<'
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M#[SC''TZS65T8$&+:"0DDZD1WCFNJ+AQRZOBW0+A';_ .Z=S,LXS8JG3!&+
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MK#!J &.!&"DY,2+%9*D+S.>5=7RY:NW+U5H902HH;0P$0&+H,%,+CDKCG;7
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M&G9'.?A)6B&\9N 3:F39"V>B1\!+XY6(M'I95HBY3S?GO2S>&9&CDT3@-B;
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M:Q>NEM>R(LM+V(DK(8SS!BUJ,%Z:(+Q@T0G(^)]HJN;Y0."=TSPAF01,$.L
MP6N](KA>B;CD#9)LH-[QM0T-MDW59? ^'%:?@M^[R6*K-4+NDJ$XXV!=<L;X
M#""\HYPYP96R+FH*U>_W, QU,J=>:$5]+/W5N96*@.2H3:(VB+:QY@R4I=GF
MNN:/:\T# #,&I5+*S!!(7!+/J2+94(<;(&8HQ22%L6U<M[OR]"Z1/[<2]EF/
M.:USS$HFYBQ$QDQ6P2,54&IX1C:H*N4#@7>F4F9FD4F])"I9C2JEH,26\G0:
MR35)8QW3:6V#,=7F5S20KF7H[Q)IVX,CUVNY9H?77/!E.IQZ:E'4-^!\+Z6(
MP"CW-( RTBG//4M6Y!C !%X5MH?@_,[S.84-M36=;'"$JN1083.,N" X_NDD
M$U+A/S=3TNN:+_V:ZU*4S6A/1-:<@$,YCZO$"(-H1+0B!B_7-G@;%?:VALN2
MOJ:&5ME99>==R\X0J=9&EB@V""Y[*X/D*9E@9 RT!G\\%(_.["63G&<V1"*#
M*$UO#! #/!*>T%X*+'M5FNOQ-C#D47OKHGE+0YNKD!_TW!UVB\74=.V*W:/C
M87HJV4*@UKDRBT^58>N*V3O(ZY'B>@DX2S'8.TE"8NN@Q>K,+.CKI7?=-F/*
MKFCBS_;>,*76%GYN;]1ZB4P86^<RHQ:1%+6J<]/!5ZX[-8O+N+N)2%SR";QF
M5MV/0T2?VK1=R+^K>ZKNJ47OJ:<0V_+]G,Z:OU+S5\Y<&)",*Y:P839#2,%3
M#U%P)G46VHJPR%Z^?PY+V>2CDS][KG^TV8\O__>X>U@LO4V<V:9TRN/P<^R_
MA*T7;_=P#+2S_U)^>/$7VWK_Q]Z;%[M?\#XXAI=BA[_]U#G8@HM^CJWMW2^=
M5R^_=LJXMGN?.B_^QG&7^VWB,P6VLQWW/[SZB^^<[IV/$V;.)K!1$2L-)<!2
M"3HTA@C&<LP:')6PMJ';%%8CP:7FZE6N6WCNN:0AFJ 3B "!,>=+*;<(5B7M
M/<^+K*Y:N6[17#?SZ09#4W1,$IM,*?AD,[$A1(*BRU*J0(;,US9DF^E%1<!4
MKJM<MP1/?9.C*2^8IEH9*A5PF3RCP5GIC;2*\B06V2ZZ<MVBN8Z?<5WB0<DL
M@42O/ '4T8GSTA)HDO2X03E6"C/HMM:+ZOA4R:Z2W1(\]4WBEB7SW'/!.4A0
MD:,V$)+-24KD0 Y\D0VV*]DMFNS@C.P4"JB,ABQQ5)0V6,$2XSDG3+.<>72*
M1X]D)]HHTU:"[)Y"U/.URS0\^8Q=KGS)V;92@(.<.,IO:='R%$&C)2-=];4M
M+TW-)U#E$!2US),8C2)@HR#.6D>BSM*&!)*ZDH/1YNS6OK::@+^\<%;1415M
ML-EDD(IYRL FR6AD5H5X'7=2Q>S=8G;F,])"<FYX(-8I32!:28Q 8PI?@XR*
M!C,E%9^)RPF/%;&/!K%2",UUM)!4!&>%S3H:)X12*;' 0W6*+#.89TX1'4OV
M"IH(P:") -$[M!,4)UJ@,#8Q4Y"A'';Q*YJP5#@_&CA37&LM3>3::* 2+%BG
MH^,L\\R]9-<P^RMF[Q:S<[9]R$YJ"R1(XTE)F" NZTQHPA4*W(,PO!2R6B8!
M_!1BA;Y?!^?)ET3P*&IBUC+APX)6Q@4P*LFLN-'"<WT-F[URS!URS+FDR>AS
M%CP$@LM!"0B:4-T7@:"V)Q0*"A"ELHE5BSHI6:+SD(K8,R5?RFRD]38$U .=
MLU0EKJ),/J?HI*QF^8,C=F:6<X5* %5 6$EH1TN<$R.I(,%ZZESR43N)6H%E
M%;&/%[&:.Q6X8<);!T$[DY#%2SU+1Z,4XSY^U2Q?5C#/S/)2 5]PPXD+-A"0
MN%XN<DF 9ZM &J1@NK8AVDPOZO2NPGD)X8R;P(+V5BD1($9F91("9:_T$KPS
MLI[&+S.<9Q8[*.: 44-R E5D,R,HE1D"VP3'K4%&'I<@T<LDG9_"D7M3:&RA
M-0F>:+S4(J?FT?"WT(%FQVQ*CH)&I NEA:14^<R,S34E:(GY>[ZGEX00-!>6
MZ!@T 6$U\10R830F8-XQ*O3:AFUS=B]E3Y8DKK36B:IUHNZ;4:W.O)Q*,B\3
M@-(66.34452*&?,TUL2C96;4F;<J68!HG"+<9E/.L"QQ+FIB,DVV['X-;FU#
MM2E=U+GSPQ>26@9>K=IIU4[/W/M! Q*GM"5A7?)LO.8Y!)Z=U4E#36Q::BZ=
M.0NE9 ".4^(5RP2XE,0X8$0R9;B/N*0!UC:X:?.%Q>15];2JIU4]O2)]"HU!
MY9$\L\\0BH(#7KJ<132\>/JJPW:9*77FL$7FI/@O(T:$1$"93'Q,C$0;$N<Y
M,A-1/66JC1][-/KI%85.)X_6.3Y Z(0I$B9_7HCAIP*"RC(PK5"USRY;B9M?
M@-8N!9>NU";.[^AW82_%XUYZDU\-!O%+M]?;QLO_UAN$3ZNY@7OI_[T]^? ^
M'GH.:N?@[5YGO]?MO,?['KR&SHM/I[A!X<VKWP^V^#^]#Z_>]CK;N_3#JS_R
MUGXX?;/YD1G+0$%)6::* &6<6)%ER5MFW-&$<I^OM1*B_!"G\6AXG-:6L#CM
M]EYJA3W7W\5+-H5G\4\W')[@?FVY X3"46N06[N3)9\O6XM<V'R\7\HH'HS+
M**;+911;94.UOJ2%%+F52UGD%M:MY*M2X%6M<WN]FJEUL#<=K*#7VP:+JR;Z
M$Q]=C8*&%])M%ULO<[6FXOME#I_23%P^$'X*H>LO4IA(4U:DZ;6*Q]Y?H9''
M;E#?^/D?C;TL:739&^:2YF S]90Z8[.@V=G2Y'D!;3^FIL0C,8;_^=39_^-@
MZQ0_<?H/CNFOKVCXR@[_6^Z\W_JR=8J&\/O7HL-?GEXTAG%\?.M@YQ0_CV-]
M33LO7J+A^TE\V.[AV#9/.Z_^8CO[0>QL=_+6_.FWI1[ !4V8$XR CH'X)"51
M+@8."8T\78(1K6EK>>?%1.[;BU@YK7+:S3@M^HC?H2F*F$ RY9#!9-#4..2Q
MF&3EM ?C-#K7"- IK0(CTEE.0"9+G%>&:$A:Q2"5@KRV(=F]E/FMG%8Y;;DY
M[1[:LU5.^SE.FYT#<YV#SEZ5EJ:*0&"!F)0IX4Z!PC>"HFYMPS+9UG9E]+0?
M6-]3#RP^2?H^#3Z-3];I6N1T/8H4A]\'0_RSWPK'PV'JAY.6B_O'HZ-RP'(G
MO=5K596IU$3-WUOMC,H\ \I,5PP#%)[)"ZNU\S<,L#I-PT%TH[UO2<[M(3[6
MV)>]V8]_'@_#GANES1#*$1O.\N9LW:N0O8&0/5<8P3@>K;*9&.E<B0Q@Q 1O
MB4PLI*QC!H'L\G__C^&,_[I$!5CN#MR/&\.)"NF9R\PK5'ZMM)&B9I5H!J#"
M.+G((,D*Y#L'\LP#@.HPQU75I<))"?$1GEB7'5&@'37@,W!3<C*5N:&NO-QH
M?:*B^*>BDRJ,EQ7&,Z,7LG-.,T6DUYJ LT"<I8Z4.C6.:ZZI3#\%XUH.[9;H
MO!RB]8"'RC6,^QXFZ-%("YU*95N'&AY*"YVH#2 \C9Z5)&Z0HK@[%R0D*O/?
MA/G/)653JA77B>A(0ZD=[XA+DI,<A0J&\N"=OZ-CZ15((JRT66GSWFUE$9V/
M*G-#-2@9G;(@%<W!:JU3,)4V'XPV9W8OV.""=I:@ >0( $.%.4I+DBPIH+AX
MVIIR\FW;FE?:K+19:?/.#]>E%*4*/_<T@#+2*<\]2U;D&, $7FGSP6ASYF=P
M-K%L<B0IJ4A )$5,]$"2Y1)PR= N* 61F6G#HGOE/N64P/\,^KO_Z7Y.<7,T
M2D>CWTY>I<'NT!WN=</F,+G1=AG:D\X2_.LCC9*5E@#$98&&D$Y0JE-YHAAJ
M7](D[Q-;_BS!:3ISNW58$II;KA];:9K2W&[UTU')#-R=+/])R]TLVV_I4OH4
M7[="KD[BV8IER7W[[9HE=Z.$J)]RXS[:V?A^HM13<.O_C8IL2< ^<D?IY^*'
M:C_JVH_ZVHU>8TP 206G J!^8[F2EC-OC>$*."S -OIF'95..GH<]M+!W_!A
M/Z*]]/++SND?W0_;?WWY\!Y?.]BB'_9?G^[@V'>V=QG^+B[:2Q^V]PXZ:"%M
M;?^VOW7P1Z_SXK=>>6WG].W!UGZG.Z[$\@_^'L\GC<EH<;&C(3:&3" 7-Q.-
MG"0MF+:&.^G-VH:"MN)WGE^Q@AZDRFY/@=V43D9X+Y#4*&0I?0E84,8J'ETI
M0+2 M(K*;HMCMYD3W66O8PZ2 ,T6V2UXXC3G!%\40D@9DU#(;JP-MV]<?2_L
M]A0"X5\>%RS4D/<[]66G&!S-B@H?P4?E6-3):PY4X\M45GUMB1BM.Z>OJ:"<
M"%:1R'6):Y>.6*$ER3)[)[(!!7IM@S'5UK!,C44K@A=M<07A3<Z<<9\A:6VL
MTR98RA,+CD&J.LE2(7CN8%\8"S&B.D*-(N"%(MY"(H8+GXVD"1(O"*9MKF^M
ME-18V!OA[VT:-44.WP^&O7@73K-K\=>3Z)G&$PU!1:LC#P#>.2Y#"%XJ%J@#
M43U&R\1?)_,MAT/V*&<"T5ED A%M*B^T(L(Z9] BICHV3788B"5JDE;QN^BD
M61.9 ZX4Y:A_>&I]\DQRU#Q\CH*+JG\L%7YG^@>5,:.BR E3ON!7E98N01&T
M&6PRAJ,:X@M^U5+U+'T*CH\KFQPNPFKZT?=J..3]3="C$0#W$ Y9!<""!,#Y
MT@C*,0L^$L93()"=(49*3400W$A<OB0 #5!+VY+:1],UH5)II=*EI=*[+]M6
MJ71Q5$KGJ#0)@8HRX3Y9 KA4Q'&&?&IQ!55R J4C4JEA;7'[W,:EH=)K1)N7
MO\L6[_:/F\(*D]C>\9/ZX;\WOMGF8X(AX.M:(LX.!Z.F2=*S82HE&CZG643O
M?Y\/CYY,")U]Q7E\]N.C;W_E?$L1=654XW)$77-S?L+F?Y8':F#+?-8RBDBE
M!/ \>E#"<HMV'7=!:O?1F+7IE_:&L\#.W43\,+E/Q&5\XF>N]\6=C-;^?7ZJ
M<)XN+,VW9O7J&;MJV<<_[S8SX:]C-\2GZIW\WNV[?NBZWNO^F#5QBRQ+1L*;
MYU/B^["_LX\$MH^$]&H'_XO$]_Y#=^MT1[YY]5KLO'_YM?.^T_WPXN_3BQD)
M'PZ0J+9_Z[YYM8.$]QN.[=/7#P>O3SO[GV!G/^[M;+]D._R/3YU2C_)TE[YY
M@>-^@==]L<D[FQ^3-0*24\1GBU26$A +*A$MM(:<LHS:?B\[X1*6%HX4]J/(
MWP8IG<%1:C&UWGIW?'C82T7$N5[K;/%;<ZM_?C/>5\^LU_W/.*;!\.1Y4^CO
M:*E28^Y[(W;V-^E'$$XHPRR1(1>/5"R=LQ(EB=O$3?)*^+#\B3'3=>WB)7'W
MC+JC$G\]R$UGK''Z2^FD]7/MKNPR=KNJJ3$U-685DD%J:LS2I<8<=&/LI8<Z
MY7=?6J@!X)?1CJZI,35X?-7]Y&<J)>[LK>G&[J2C-_EMP@?\G):G<.%/*I@3
M%T^Y3LFIWH&=[2WZX<7;_0_;N_B]M]V=_;]/MK;+N+:^HJ)Y<M'%LX-C?O/B
M[:</^WM[3>&!5YW>FZ*8OOJCV]E^_77K_1;;.FW&>CY!)BF5@+I(DK&>@%%
MO.*!&.5M]BX;R?/:!IBVX'(E0L@KQU6.6T$'=N6X17/<S(VM&,N^J<MJN"XE
M^H"8K!WAU#G*9;39>N0XV>8KPG'W%"WRH%KL^\'P$^GVR>%P$-*HMHAX-$I<
M6=C7_3_'RUH9[J<9[ES:3!9EO0Q1(08"40!QAE."\LE2XXW//)2#NK:%184\
M+%'00L7Q0R@J%<>+PO%<\DS$!>-1$BD=(R!](%8(29)% ,LH55 &<0QM:=@2
MX?@I>-5^[_:[H[T46[N#0;P3MUH-OG\(=62ZKJ4V9:6QGZ>Q^1P:D-1R6M)V
MG>(EB]<3JSTGS*'L06ED@Y_D !JFER@*OP)YA?61"N1% 7FFCP3AN?51D&!Y
M(A"T+O6Z/3&AI-(P&91"><PHM 4LJMSL"CE([@B&_%HPO'IVESL(_%$[QQ<\
M.X]'"-RC-K=,X=ZKP/;G,V>DDEH82BCSI1>ARL0;I/R@E5-*)I3B%-E>FS:U
MBS(_%X261YLV4QGS*3+F/:K-E3%OS)@S_3@;'EQ*@2A73A8C*&*\"H2:0".G
M0N4@D#$5M-D2),C<5W;,CU-0'CR:>7-40I?/(B?'*S$-GVR*_E^*(VRWNG,A
MT-U^Z!W'--_%OG54$MQ+$/1_W;UV)'\&Z_^XWCA?Z9)EK%83^3^?(;+_]Y>/
M4<FL15#$ZH3HA5PRA84F40:CJ3(F@RK>]O7+40$MW).]LK)EJ]QHN7^.VNMR
MWW:YQ4<!'F?, )%<*0*)>V(3DR1:$4TTTCL?<;GY^F67Y'2YVZUA&AVF4#+U
M>B=M1#R^$)!O6][U7#\@,;BC5F_P!7D#^24,2KVM8=,U9)B0&TZ;#(?/N"YI
M_6'2<S9#&!ZG^)^N\]U>]PBI[*DGZ+"/VH?,HE0$IS65B@$:&0'EN=->!Q0#
MK+BKESY!9[*RK=YL:1MV&ASMX6Z\1<I.3<RIB3DU,:<FYCR&Q)RS&3C+U[]O
M-\#SIFS +J[/F).12QL=K36=CH4.2JW+:XSJBC($Q7HDHOGVQ2ETHU0NL+;Q
M+_;+A83W&H!? _!7] CAM^,1CG T>CXX\-U^ \D95)_/(W6J.T\SW!^'^VS_
M;_[F5:?;*2XSOO5UZ_0O^>'5ENR\>DD[IR^_= [^ICO;^-KVRR^7NIEN[\ .
M?\W>O/ATNG/Z\K3SHO=IY_13^;S8VM[D'[;?[N%K/53*YY./ON+SB(]@HQ0*
M[6]OLB]M(RVQI41#=,+H0%.DMACAJBWUK<\<:@)2Y;_E>>KE.A"H_'=?_$?/
M\Y]#WK-)$,X$)< #\E\0GNBL6 Q.0>!R;8/SMI6+*CC]*)*3'A2Z_TF[KM=X
M5UP\*'%G1\-&;6X\?C57:=5UP8DK[<_A(",CXGA<[_>41I7O?H+O9FE*IULO
M-NE'%VC0QH:F+SCJ>RP1$YTBU$1KF6= ,S0I#E0LZL1TB0)%*HSO4:6I,%XD
MC.DY&&MEE=#6D*1C)""8(;8<H"IAC80H:':LA/BWJ5JF/EU/H<O/F\-&4>_O
MMGK)C=+\@5!-6UIQS>1L;?]3EK9:8HO13,:6F S!V)@R25ZA9A*-)$:G0)+@
M"9<2J-&NH30+B_)$+9&_J<+X'C63"N.[T$S&,%8>]VTTE#";&0$?=<FACL10
MH:7S1DOI&QBSA35%KFZ3ZY]]EIF^M4I2K:SE44FFB_J^>[3W_'B$TY*&E=%N
MP6CG<G)B"(Q+*0DUJ<2FA4"\X)($*9.4T40OQ-J&;FM^:^]P]98L,8[O7B>I
M.%X\CF>9(IQ1+[PUA%)7CGEH(H9QAV ..F=I,BV9U IQ?.L\ZNHNN6E3Y.2&
M8:\YSHGI<^H-FLY!MSC+J:;6PZLGO>[G_K/IVF[VXXO9RCXO"_NG.RD!RI78
M?H+8SA<0UM*6+&%&;21@7"8N!TDD1,^I]3FXL+8AV^+VQ%:=)DN,Y+M34"J2
M[Q+)<\FLB6?E7"#1:X5(1F7%^9 ),UE1$9G5)1)/MA&S2X3DI^ W^7,X^-PM
M!YBC@I:6*R%9HY*+=G0\[,]E^51?RBHK*V>KC!_?;);X[7B!<7W?E.6MU'83
M:INOCTMU5$HQ2T )22!Y2ASWB<041=:!NVS=VH9H:\V7R/JJ"%XQ):4B>,$(
MGBDG4B21)97$2YL),"6(CPYA;!A7ED<!!@J"+5\F!#^9K#94SX^&QP$W>XD[
M:;+(+J0BKV!Z&[_#]+9J.=ZC#VBV-=^.=^9<^8-*R3>@Y#?S1U-"*9XI.,*2
MB00T9<0+U+&49(HQ0$$;2CV-MF&+2ERHGI]EQ._=>WXJ?A>'W[GBOM9R82D0
MDX0F(+,G7AM%I/,B11LC<W)M ]J"+:HKTBKZ>QY,I4)C(N*V1V7J(,7NRM8(
M$+=1HJIENR1*U&0SOIWMQ<J[-^'=^1,S\,$)T,BV.3("4:(I2TM"E'!!9A.Y
M,R5 L:UOS[O5&;7$D+U[9U2%[*T@.U.5M'> _P<2J#,(V>B(L=$3-(&H<,YZ
M$63Q/G'Y!-LR/;RJ] *_]GF:@'TYQ'@5U2:HOJ='H#;--N8TNK):KC^9YK&]
M>;35I5\;2MX/LK/[,6=%.5@@+J(R!<Y+XEP2Q,9,=2I!2;%4#FH+42./'C.&
M[UB/JAA>)(8[S\]A." ,04I/-*,)%2OOB!-9$9N"92XXDWES,,_T,OF0GT+,
MT?.W6ZW#XV'8*RGDA\-NF*]UWSH<Q]R5 MA;W3 <_#D8'K7>A2Z^U\W=T'H^
M&!X.QN6B:E#2\FLPIPF-13?:.T=\TXI@F^%_C[MC)7;TYV1'_%DVQ&:O-PC5
MLKR5*K/YD0:1I01'1&1 P.9 #+.<F(1F9E#&,YE*MS?#&?]UB:S+"N454V0J
MGN]!K=G\:&S*FG-*J B1@+>".)\UX>"=\\H(;5Q3X,HLK(G:*CJ+'J0R3M,*
MP4T:):2OAZD_JD5Q5D%!^7XUC;*LEQN;U(20G^&RE_.ZB>0A,@.:")"4H% "
M8F,3,6"U\4KZ6/J;"6C3I;+/*HA71S6I(+X3$,\I)"$HQY/GA#O!"##KB;4A
MD"BH=0X2 X$&AA!M*9:IKM5MG2S7:*"R1'U>Z2,OW+[X"7H\Y'IO!8TKK]Z2
M5U_/*T="T!2#X22D" 1<S,12FXG@+F@=?);!KVU8TQ9T434]%@>?1]LPNQ+I
MTR72>RLI78GTUD0ZIZ!"YM;DP(AA4A,PVA"KE",J6>4H=8I!\9AQVL8M\6B8
M](I&VG,]12=W((6IGHG2.'OZ2G/I9UQ?Z*5-F%E\ZU%SK<ZC<WW@%GIW>XV[
M_WINHLRZ:F8!^2 -R^%D.3;A]-?.X"BU]'KK=]<=MDI;Y-3:2FYT7&+K^T>C
MYE/LU_,15ZNZ&'PE%@/66^<2>Q[5$HB56 *YWIKFF,P%";?.:O[]:$D.W'"W
MVY]2J)U;DI58)%CV16HUJV376[,(I'&ME[?=T:?6ENN[W8:^KERG?Y]K*/Z=
M=2NK-'FER#IQ884>L)_UJ#7(8^%^UDAW_.>TF^[X+YR1\2^7&LRVKXX&GE[U
MO^[>1I>+JK]YIEZJU50O?[Y!^XN=DX\X[T(YU=3CYZ5\2ZGFK4HU%Z:2SM&(
MDFELUR_GR[1P8_;PEPM;Y49+_W-615WZ!2R]_,@2\SXR1BS^4YS7:!L$FXC5
M%+1D-$=FUC:00K^Y]*5.UN@PA<*?O9-VRPU3J]L/O>.88NL+SGBW?W8D/$\3
M9U6U6KT!4O51&AZ<IY%^"]\M>R668^38M',N5D)3^L*[GNN'U!KMI70T6K\V
M.4\H$/BZ+@D"E[,')HW:Q[;QW!<G=$YG7W$>AW-\].VO7!8$ESN(+X<LX/;"
M!,[]+ _4X(+YK&44D4H)X'GTH(3EEBG+79#:?;1L;?JEO>%,L=Q-Q ^3^T1<
MQB=^YGI?W,EH[=_GIPKGZ<+2?&M6KYZQC?_Q0[SD%4]Q;B^<IQY%!02596!:
M033992O!2P%:NQ1<^OBBD3J,,C(3/^>I!1=@,P0T@$NW"53W^OAK&%L]F_WX
M?,_U=]/H=7_^,PB.[F$OC;9Q'+_U!N'3P_*.W'HWX9W]WJ>=@RWDB4ZOL_VW
MW#E]N[>SW\/[Q+W.Z>[7G?T/GS[L_X/7O\P[;]Z_[>Z<[G6W.(YON[??>?5[
M]\W[U[3#7XHW+W[O=@[>'G3>_[-?>&?K=)>^>8'C1O[I(*=U=C]2:HQ%:4.L
MD0I9* IB5$S$,1V=L3F(#&NMA$1]6'8 <LD/D+9P'+$+.-)7XJC1*!D:PN5Z
MLS5OG=\8K?/;],$VZ)_(IN%D_/.I;D8<]Y>/PB6E54J$.:]*I09'K#*>"*\B
MMUS[ 'D5MM]F'!PVZM8@?W\'WN<&?!?V4CSNI3>Y<N7/;$_YD:*"K- H(M0!
M;D]/)7$!V9%2$"B,#<]QHE1W^ZAE;1:5F%)N(XKFR*D!%X-/Q@80@CJM&//J
M>]MY.722;53^\J#7&WPI^[?QX[8.2P' 6)1'- 5&8=@]V^Z#XV'+S6W__OGM
M_^X(U4TWC*/6WX=%@1RU_C7Q FR^^WOJG_REU1V-BIKJ3QK5\_?-=[\U:FKY
MHWMP6 Q=O'3Y:W:K?G/KF9::NWU43+NNA_.%-VIV][/K^WAPLL>/>J9V-FYR
MG/2>.QRE9]-??HW=T6'/G3SK]INI:[YTT2%^-#B<J%'6KFNJBR8UB?B87'ZB
M9*TW2M8%W_[D/;L.7'_S;;K.?O(]*<1/??-[@P6Y3LVJ#-:L<P,K,E9.UU$4
M7.NR/X@K^DX\\\0D>IC3T4L2M3$\7A=":+U (+?^KSLX_/6,2*X1U'R#0*G5
MFI07,^I]TM-0=@7*@ZG6]93GXF7.J4C'?NOW,_GW[DS^M0;#UC@WX!V.M"0P
MNOY1:\L=X6.<3P_XV2R)FYPF_RA0!2_RD,4V_CCNI^)>5Y>4A@<*$)F_*5XD
MD.Y7LM>-J.\\6S4]?!R%<?!:=(K^O;WSY</^KL1[G7;X/]TW+WI[6]N;M//^
M)46=_*!S&O<O1F'L[ ?QYM7KKYW]WP[>O/B$S[4E/KQ_#6_>O_RZ]>(OME/&
M_1Z?@W=RJ6PSK7!SV0;H[&V]>'VZM?\WV]G?X9T7OWWJ\-=XO;]Q?G[K=O9W
MZ(?M+9P+O,[V7Q^!,Q=9#$0W[<"E]L0"6JB*ZRS *FH]1_OOW=^MSF"]V3VD
M5 5M-E![#I.O^^5,^.Q0GO%?GP]3[!ZU_C,8C8I6O#TX1!M0<'4?]5$>!-@/
M@:%BRZ!1W(]C.NP6UW9WU#IN;)'6,/WO<7>(GY@S'APNQU'K7Z4;1:M,S&&1
M-!?>'OW2.AA'6<26.\(;#/!Q3QM/^>BHY=T(;W$T:/EB-Z51$1K-YXK]TD_-
MY]$Z:M*T0GEK_-%B8#1_K[?>3^R<-+: )J--#=5W/Z?&X_J'ZQ^[X4F+C8\,
MVRUW>-@[:2RV\H2CB;I4+MZ8:&.3;(3/'%+W<V/IH+5U/&HDJ1L;>*7">^O
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M7WQ]<.BZPZ)6W$,1\[O:NP]C4,Z;CP>#$KJ*ELQABT]/J':G<]P]F^/645F
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MY\G<I>>?P_5&@V\^S#>6= 6%Q?N]+DY>LT"]HV[1(:8;HQ&6TRH*YTOM7=H
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M:'T)4!^BY(J LG!5.IR+,];'Q=PZQ 7)M@+VN(#&"?J33*[EI%K V/=9'"T
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MCY^F798!T^[M,KMMN]^I.A7CV<%TKOK.>PJGH_=?_)09CI3,J%+GL4/7MK"
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M#D*7KSL.0&)COX<.N?D6GE5M/I 02OXG6F^C:=76 PFV_^L;ON*X:L.!Q($
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M_5?BCH<"JH,=HMOZ-I+21+16/]93\VA<:Z/M%<*<BN:4L4D%5(=JD6*?#8$
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M0M&50'UQ_KY.0DP: R6A.6FC$62..*- $A,M< X8<)DV3N=N.+<B8%_W%YZ
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M6JEL&1_#6=4%N=_9_K[QQK::"ZBY)WR_R^L ?9+O__  'VW/GIJ+>/?Q-E9
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MLAUZA2TP([QW%.VCY1A6J(#CUI)$'+C,RC@!]#&'?+<NMR&%>I:D:"CZ.K1
M0_AU6.P@1B:OBBLU_02S>3<NU2 7]TP'PB2CRHO)8G&51VI' LWH3*6<(V@3
MI=J.#H]VM0T-]/.E05U15UL59MT\(@RT<Y\ Q7UKS .0"8),$E=[7_PACD8N
M*8/#3B;R: 6]^U#UYK7@H8ZV4;UYOJJO*>9J\[Z4=/T$9Y"6SX,. J4I9 3!
M@V-$,B2>,VB=E'0^:6UX$F';B7ZG[6W4:Y^O>@\49AV-WI1#O_) 5AF6$\TB
M<D[ EAHV%EW6P)(FEAN7DV'!<+>5<A_L9AL]N^>KYWHBKJ/RJSV1E6=-IQ_G
MZ&E@O/*Q&T9X-5JT4 BIN =)@R8L.UT>_R[E2'0@,1H!2E/.J=F* #MTNM6N
M%'V^?&@E_[KE8#8/G'(0T:E$K#2E$*WB&(#@ET:!XIHKJOF=%;]BV9<M-WXW
ML.9Y;V96U$M?!SN_PI\(N"35H0N#!F^,_XS[/[C[4'.5CV*V1EXU >B!7O=/
MIGJ\T?YDUSR%ZH&^#S@JW*+5_F3X:%[DY70N?P0T*O_\V_\#4$L#!!0    (
M $-W75&9[K"HAH$  "^U!0 5    ;&EV;BTR,#(P,#DS,%]D968N>&UL[+UM
M<ULWLB[Z??^*W)RO%PG>7Z;V[%..D\SXE&.[[,S,N9]4#:!A<8<F/23EQ/O7
MWP8ERA)%2HODPJ+$.%7C,25ZK0?]-(#N1J/[/__W'Q_&WWS"V7PTG?SU6_$=
M__8;G*1I'DW>__7;?_SZ,_/?_N__^H__^,__A['_^\/;E]_\.$T7'W"R^.;Y
M#&&!^9O?1XOS;_Z5<?[;-V4V_?#-OZ:SWT:?@+'_6OZCY]./GV>C]^>+;R27
M?/VWL[\((R-WEK.@"V<Z1LXB!\E$CDI E-SX_/^^_TN)VEK0R)(L@6E># .A
M)/.9YQBBM*C,\J'CT>2WO]0_(LSQ&QK<9+[\^-=OSQ>+CW_Y_OO??__]NS_B
M;/S==/;^>\FY^G[U[6^OOO['G>__KI;?%B&$[Y>_O?[J?+3IB_18\?W__>7E
MNW2.'X"-)O,%3-*7%]#K\^+Z']Y$8[Z__"5]=3[ZRWSY[U].$RR6]#PXA&^V
M?J-^8JNOL?HC)B13XKL_YOG;__J/;[ZYE!S,TFPZQK=8OKGZZS_>OKB+=#19
M?)]''[Z_^L[W,!X3XN43%I\_XE^_G8\^?!SCZF?G,RQ;T:^&7$&9"N=_U:=]
M?S"F<P(R2Q<1&?T4)U7!>\2XZ>F'8[Y^%LM8X&*\Z!'QW6?WBG?Z 49]"OC.
MHWM NWP0^X ?(L[ZA'KKN3=PKD"N(ZR/'-,R.)E^@N_29_I7T\DHS;]+TP_?
M+Y$^G]*2_ ;>X\,HZ3D35M=6'A1?POGRCV] (<Y'DU%=1E[2QZLGU'<=# K_
M6. D8_[VFU'^Z[<CG=%H PEE=+ID#9(GESPM\4KXJ,/91G@'2(K>/9ECIK_,
MI^-1KIO2NP7]67>I^;2\H-WL [Z<SN?[R;+[X_N6]IX#6^=#:)5MMJ$4T)!E
MB!@ D]?<Z*)U.=MSB.T8>S[]\'&&YW7V?\+&]&U[U\!<=AKR&K%6:(ZTDDOP
M2LLH@L#D%%ABEZ@.ZF%B.PR^7Y9_@'&U@]Z=(R[ZX_/V4P=@[IYAK'/$C33!
M0I'*:6UED$4E[:W4.1-=:3-'6P?4D(TW,".E.,?%*$$'6VX?:FZ_8FB>[AG@
M&FG1%6&#ECX*H05 =+RNF#R9Y)-2K@-I6X?:<-6$^?G/X^GOC=;)ZZ</O3)N
M'M8:94:5:"1M;Q 5K8K:.ZZ5+D)Z(T506^;9@P/<FZU_3. BCQ;+U]U][\^C
M":G*",9? .Q#VNXOZ9>[ P>YOE1F'4KPD:Q%16:)\-IE!\D)F0 ,Q[.#ACL<
MDV_H=VF$PS!Z_;(C,[MYT&L,YT#<9D?N0:8]$,AL$2ED+ZS)T8D NS.\:?A[
M,_W#Q7PTP?F<K*)(KZH"W(O$C<_IEY^'H:Z)WAM-6UCT)L6D=301(YCB,\TM
MK67@9P^![E6JKV VH[]]PA]Q :-Q;U*^\]SV4K]_*&LL*%DP6BET=$D;E0&T
MLL7K+*7-LN2-+-QY0QW3:E3C:;KUPG$-%4ZO8QMCB#A>_O3L8L[> WR\?L6S
M].^+T7PE$'Q!,VI^IHTLM )[5K0P3%L(+/ (3&8,"#F L'9CC&09'RDPC\L@
MR=6[OJ^$?8_CQ7SUDR6%C(NKN./_Z@+JDL3#!WQ#IG55&66<+3_\.H/)O.!L
MAEF<@0\F!>.9X9$$(#)GD)-C1A@5.)"OE4U+ 70!>5L@7_3ZV6PEFJMXUYX!
ML1K%;Z0SB^E W%PJ!PWSVV^F,WK:7[_E^^I177HV ?W'1Q+49/%\.E_,SR2Y
M>"8HS9!+P72(GGE9ZJ%&L*F@$LK!0RM:EQ>= />]R_,NUZ+-FK$83=YC17A#
M0Y_1XDP_75HC;^O?7I?7%XL:29G_$\87^/?1^_.SE+7,7%HF(4:FO8PL0O9,
M9!=B*MP9WG19[6<8)Z![CX#?N]HJ#]76GRL12/,*\XO)@D".XAB?S>>XN)3<
M<O7T05A:)9&5*#337#D&VFKFC 0'!;$HW4('NX [(<WJG8N[^J(.U9>_3:?Y
M]]%X?!9-XN1Q)U:<4;3*9L5B <7 9@%>TN\X;Z$3*P GQ/M>,KW+K3Z4VYIQ
MD"_&M$QM&.K\A\\W/OT*I)IG/,J<I!7,Q"#)JD+%0G"%H>/ #:$FNZJ%#NP*
MM$==N9&L,*"&-&5FDPWTS>4Q]5_2>#I'<C\7LPO\\D/:[L@[_6F\W-K(Z<;W
M]2]]&4XW!O/LC]'\3.GL(@>RW94*-"N$9\ M,++:(RUV-@3<?/C>OV-9\?2H
M3/=DF=Q5KK8ZL,7(.82+AK;U35B7.R/^N%S$.P$\6\N/::TTMQ#VN6]M2_CI
MM#+MSF<''3F<C*-HC>'>RF)I;8X:R:ARP*(PP++RT9LB97!-#-PC:<NM=*O'
MHBR[<-"CDBQ#"K^,X,/HQ61.V]S26WOY\ODO2VOPS.ND!8V-H=1D;D?IZZ[M
M&<:H1(Q1@Q2=@C-;7_$H#-E#N)CV+L@>(W"W?:N7FWRK'S[_ O\]G3T? XED
MJ>?!B)!HXW3!.W+)+2<SO 26@XM QEH6(K=S=SMA_%,8(:TX:Q9&V0CU"]!7
M\.%Z9^P MZ69LB/>XQ@MS?COKF>]D=? K-D5MO0:@J1%/6@5:05.=04.I!W)
MTG*?C<]M(LF/0M<>,'D>JZKMPEG?1M&/^ G'TX^8?\5T/IF.I^\_OZV7<>8P
M(?!O9M-$R_];G".]\IQ^=O7]NN]?[?D0?,HVDMT@969:F4!F!!8FO0.+J@@=
M0R?CZ6 HPQM939F>'HVFK:;9?WZ_)MJ7]+&'') ?1_.T/%ZYP/SZX]7)REY9
M'UN>U&^>1Q>X:YD=+H,SR=(:HD%;+KW0Q:$Q/!DKHH2SAX'W+-T^<FPZ/GD(
MZ>^49P,A*\=U-L(4G63TUF&)Q5F?M0N2;V&CYTR;RX3ZZV2UF_G!SR;Y6<Y+
M.<&X@AE/YQ<SI'V*/GR<SF'\M]GTXN.<'C&^J%<Q-P/^$I@N-/N+,I85Y\@S
M0Q,9;6+((KEY9*NKY-==W'[L@@''.&@>D%(" RW:S.J@:"5WR ( V0?66.=U
M]@'3GR\/Z+%J]$%I1;M0/4!:T3:@-3_]QL>S%&S66B06M4P$&S6#DBWI5)#9
M6) .XKX91QTQ?%7 KKE-+4AMX(UN%,FS#].+R>)U>9;_^V*^J&+_=?IF-IK.
MWB#]F?]&O-5+8Z\G*SG_@&4ZN[I.]BO\<18,&IZ]9,))9)HL)!;K37ZRDZS2
M2J(337S6)J/YJO/;%MWC*T^#F.#&0=U%_;IL_.(KI*'745C4P14;630T%*U
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M!*N@5FD9'6"U/+;9@NLXIS4],/>0+AP@]@&U0HL<N /#LL1Z945JYAT4LCL
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M-PS92/[W1R1W$=Z0$4FPUB6 PG@I9&':>H=4V<(DV4"EWBLPLELGI$<3D1R
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MWAH^RR1LJ7VN16UFRIE?IIA:!1YY#+E-1ZM#0)^P63,8ESWF1'RQ_V\B6GD
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MCF.7]D?E5AWIB8>FR\X&C('^,S7=#9=+K'>&>>LT<ZI6.E.:<]XD[V%X'7G
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M0GFR;,FJ95'8R%!;&TC@FINVE\%;C>P$E/MQ:L$CB@K,;X_]NM+MY=Q5M)]
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M&C-!U. T6=:^Q>S?!.:K;3'MF;$&0>=U3%=SIPNJEK;%9EC'L2P.I^T!/3A
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MA0L5(/#(.W%Z^[DG1>0!(NLQ)W0)Y?6"%OU5\4+A=#'%,Z21,<UK[]10[1Y
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ME <BH^EEZ$Z,OTT@3FXFBZ_7*&6,@D[^Y*V@D]_KU<EOB\[)E**4:GPQ^C3
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MCUX=\/+O7;=:\]6@XOWUI\\WTZ^(2UQOEZV\-NDG3@7RUC6S1=E:"U/H$XC
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MWBKCG1<ZDS=7HDE2<B0CD6=5GB)CF(O2)U[P=K8J^/GU]N'?F-!F24Q\N]T
M$ 63*4SXFLE'&RRKIR[+FG-1H(0@8XM;H:.1'SUQ<?7L^3M,2#I"G\8;7*Q&
MHRZN,T>OD,1  G"KAAH08V90Y^9ZZP,W3>J3G@(U_A7KN-KU:'3C4 2UN']=
M3-/_?)S>T-/F]5YX\?6:6R!(UK)<:M83),&"A,*X$F2\%B3+I4N0[("<XFTH
MWYNB'$E&@RS2;TM]OX#;#+,\_\?G# M\70^0^236I=>Y[.!UJ!$?[;*I6010
MNT<N^R.C#63ZNC9E@1WQ?6^*U(*V!D5#APII=<?,HR?+D20B,=?<78W,%XA,
M*XQ1V9"*;)(&<A3JL1)"3JM_XQ%[ZKR11VGFJWW[U?33Y^GM?9JY%()#71%J
MIVH_J\R"<I%DF3V$.I\7VY;I[$)UJGR2$95C7\'.T20U.&JW,*VO;[J :EFX
MLQ/5B0MXCF=OVDKTH^D%YQ)X3:O"ZBSH) 1]!@68*=QI712J[7O-%Z</70M[
M1E*'/A)OH ;O:ICE%O-KF-W2KKAIF!FB+,"1/$>-M$[A!(O&2D:F&UAM2TFV
M2V9B;SW8#6=\.WL KJ:#"WJOG[[G=GO]X_I+A#G^W__S_P%02P,$%     @
M0W==49KO)YH-/@  -V$  !0   !L:79N+3(P,C P.3,P7V<Q+FIP9^VZ!U23
MW;(P_(3>D8[42)$F'4*3+EVD@X*(D 0()8&0 -)B1T%!4%!!0 6DBX!T 14!
M$1&1WJ6)=)!>\X5@>\]YSWO.O?=;WW_7^M_)>I[,GID]>_;L\LPN^&[\,/55
MO4"$*P"8F@+B  !0 90@9H"4@($(/P#$!9 3<0!P 7'_Q#U HM]E2 @OV;TW
M($1XT" Y(LY*>.+#$0#9=_E<PM,-T&R?!P"1 S_^M6$H%SC8W!V%0?FYHWS
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MHT\X>\.M]4Y:_RQL/X,Y&H5RM8)CL#YF+AY0 ID., ?0 (KP<P7 @!4 !S
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MTD_*>2]^D8*BO*4#G7VD9:5DI(&CFH$^SE!/. ;L B?$S>H"\Y4U F $3%W
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M@]Y;>YX\90^F_ "0 -0 !2 + ,Y0/Q]3*WUKXF&FGBYX;X$*_ *"CM7._>/
M-DE#<S 8^*\!$]0'C2&H,2?@\C!"9$/ +Q-PKP",SQY][ZR-U<5S#R<AGK*A
M"082\+U#3U:W??P(468?U]K#8=Y(& '?L]D'Y@W;P]\0\&O^V+WC6M+C!/RJ
M/P(>0,#;";B0%]8;0<#W[@RP>L.=_0" >(XGA(%#W0GXWDD]'=K:4I> 'P4
M*CJWWW"7WW ,/)!X"T07Y7..>)((%H6*@6555)3!AO  +S@&(VE.:!1G- RL
MB_+V<4:> X#].A.!^9\6_[\YZB^9_R'LM>T^MF1!;#,0^_M?M#^30ST& .45
M@F]N_:*YW > TBL P-G[BR;T$  8">U6TO);?=CW^LMOVVD(.%1JSZ$_X=\*
M_ ?P6WE2>^I^N@=\;/\D&;SG-RC*"X5%@_T(8P(.EOS'3OS?SOCG=APAQ/MP
M-)RP] #;$GH9 NE&:&XD#$'<'T0@_U4C_C>S_0/L]VL"L*3M JQ.4L"!%E:
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M>R>_K]YH /^8Q8@)'B82DC1%$.EM"'&<8)BQ@,F A#Q@W,4F=YM^:E9X0WI
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M1>=VI'-B#B>6V<XTW,[8Y195=N^/(*]O7*J-PJL>:<_FK^L7@#/?G((YPZE
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M#O=\^P2C['@K'3?[W>YACZ#\#8&\73ZRO.["]G:Y*'.Q[@AQ5]!%65<C,JD
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MUX_F:N\_J@N]]]^?Y**4,R8H58P+&*8R@2B*4LA,RI?"(F7:1" !=6HCY"K
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MXDPA"E-F?/4LP! '/(%AIGB:)AF*E%-@K<6<4]O@IVM!N*8 6&!MYW'TC.#
M5' &O &.[!QP&2!ENW7:UTC9ML'A3,JVU4>[YA]]DG]><V[*6.2+^R_%<J%_
MY+(**;M>B+=5U?_R9M%\)E_P_&DNRT:.$D9"DB2%@3DZU$Y2"(F*E.EDS1"A
MC >.72%[%6]J1-9,P-'Z@9WP8%_#JES%6D>0+_8?W*CIFP+5R\);4N6K+>?
MK-I8D-N57BQ:B!+\]B2T7=!8NW-+-U*F59^8#Y.-U8N$KY2QU2>ZY[.Z>IW%
M[951%JM-.>O/Q:TLON6\CF"EC%*,HA2F6&K_DH04DC!14*$P8"R+ R:L*@N=
MFV!JM+TIE5[7$*K$=(JY.PMD.XGV <_ -.B!C#6?75*_A9'T1QMLI/]UR$1G
MQQZ%2RYIMF&#B\_YF8"-#-%9)B,ATC" '#&]E:FIA)$&!(8BB22+4YIFF4LY
MC,;83KMXM)H8WBGD3=3LC!]/+ ;>LC8 .-L<)U3MTV!H#C_JV_Z$7H>OZE./
M^![C7@NAE[I\JW_\7-PM_US,D PI9HQ!'E$,D6!\71TZ%G$L).4TL^J%VS+'
MU-ZVZ[/+M9Q7P$BJ<01&5M=3W6- ;4]V.\$TSNFN&T(>A[QG,>A\T'L\\LB'
MO6=5.S[P/?^HY^MW/Z/O'7VDVH2_73[?/ZS^1N?_/W=OU]RVCJT-_A5<O%6S
M=Y71AR1 $CQWCI/T2;W922;Q/CU3^T*%3UNG9<DMRD[<O_X%2$JB+(D"2(#F
MS$UB)R*QU@/QX5H+Z^-)SD1$<69J8@I)),2X2AJ)%22YC%%..).14_.EBRM.
MC0),_KI<EO7DJ[*2T_%E?1%CRU>X3^1"O]B/2G0;<4$M[Q6H)/;XTK<%QZLI
M<''1<0T$6PR.S ;K"_NQC+E']?S<2GZ_G/_KJ?8X8YYHDR)'4$1I#+%I(5^H
MG, X+01G/$-"6=D3W<M,C4]V4H+KQ\?UBO+[RF/=R=RK@NX,PG;$,ARWP&PR
M%#)G-NE&Q">%G%EI5-[HUO8U65SX](!Q--^E&?/)-T]K343-*6@4ITR[%00F
M,=$<@60&&8T4Q(E$25+D242<..+<0E-CB4K.'M-H3F%HQP(^D G, _5,F@,9
M QP=7P+"^VB:4VN-/YVF0^.3 VJZ/M^W\.OA8;[9'2?L#)*Y+/?MPJ]96<U^
MG\6"XBCB&M*4%Q!'4CLFJ$B@R"*!,B(%+YR8P6GUJ=%%2_CZR*\M_D&#_*T&
MC@:&V][8,4XPQ /3D$^P>]2B]0#-;YV:BP CU[#UP.:XOJW/3?K.T5UQ*475
M9OQ363Y1K>97557&EW\N]7T^Z7]8FM)X+4I=,$]+*=HAB6_ZJUG.1(&XPJF
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M;D$]S@X<=[$>:=V^H9A2ZHONKY?BO7R6B]6C$?7#KT>Y+.4LBA)$F:(PU<)
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ML]\:.U_6,](CE?!LAX=IA[01&WS;@5Q)?E6A_.$BRNX#PYP!\SH:S'[U<8>
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MA1J_*&6$. 4+;1>>&JMMI;7N$.V,M%T$,01^@?EO*W)]R-<(?04:L<%?E>#
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MU^>^XSEX [0^</R&W*>?5=I4!"WO/IM&#=MNZ2\W3VM32#8K1*QP)@E,TIQ
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MS;.DLH@FB,60**P-#TXY9(0CS7%YC%(4XX+9SX1Q67ER!%?)"M9:6" ::<U
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M],50[]8LX$JR!*<<"B*,+987D& 9PP)+A6*9XDA9S==U6W9JE'DNB:KN6^E
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MM$42U)1RF1P!'B,[R5:D2>0;.>)GFT'D>MM^K\YW3^5\*4W5ZP.;+RMS:U<
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MK?Z+(YRH9LMN:7[6RR\K_OAU+C_J+ZY@T'SQA_WA:Y,7V-01TNL94@4EN*R
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MHO15++;)Z?N9K-_)'G?@ ^:^B7P!1IHP7_Z+$#;OCC ZO9/UD/+'F^%'0/'
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MAT^KZ@N%QP^"]^5P^6'$A<TX2L]G;Q8;NY*\5VKE8O>;?][-%QK.$%&(588
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MN!\ N]>\*5R]SG[8*9]MM4_IT,>@EM3-#U)@7.<_!IN3)4'40^+H[5?]1Z?
MU&JYL!]ELU/Q?O6Z#KNKPZ1W5\P7<O[XH)LS:$TD$:X!.S&J=-O+CNZ( ++
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MKO<5:L4?"@34S+*LHG2IR6'S-^CJ)M)L![LA-=,!T.[6 UZ;\-LKAQDRU[J
ML<[6YE.Q'K<F8$)SF2G2UJ5--Z9O4=9-#-H.;,-JIP.XO:TM>3;-T#:E/V\7
M)"1<3Y>;0W]:6N1JY.<XIR_6]0;%ZO;BNF$ZL)#12@,Q2(K0/$DS!E^@."RY
M2*-E:>(A#D)]-W%O.]B>7LL=0/LE+J=?2(]?<#L[.:9D:EI!<8XU<BL0LA-0
M,,=@LF2Z3>;E&W2-6TMXHBU[.,UT +3-FGIDR41N3<P>O%6%?-M _J[5#$)P
M1BEA5/'M.B<>#J]F=8FGV:2'T4<'R+K%Q 3)S#IKZQ57SXAT7DL(&/FQJ1#M
M&GG@3:!TBX;=:GW8=PV>0T7>0:;XQ>+3I^G%+9%-*\>K4+RRHHTH/# )AIL*
M?#3@!"*$*$61REIKFA0=/D'3;FCZOLL.AU))![;H"0E)Y-YF1:3K0.LDUV%N
M-C,H,@LK5$G6-&FM>F35-/^^#R0&4D@'T*JK9#'?\'/1YHPKIZR2&@Q+M>82
M \3H(T3TD@<M3&HSJO8^(6-WO1Q&P5MLTL'2[N)&X;.<-S<0PNQMF.97\Q?A
M\Y0VT5N,372R6BKGP5@DXRH*1:T\6V#("_="\1C:%"M^D[2Q+W0TP=3 &NG
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M%3T)=^/F,+MV?(9%QO<:/5X(,&P58%A?_\IB'NYNJD>T96Y"QTGBU4&%=8I
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M)0ZW^@-Y^I^6,@!N%J>S&IRQ]9I1;>LH%6.LR>GG4T2-NQD.I_I',76D'CK
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MD8U]AXW!].ZP\SI<7OZLA37?:ENBVHLC&)L#:,SUI)E(UEM5X#)5J\Y:;)/
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M3(1H2%P9);E^1SAM&R@;=LA.*I0\KC0Z.%N_W2R[OIONC1TII68F6=!2V]K
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M-28[\"H4H-]E'I-.')M453Q#4R_!E<-OK;$8WR^&;@Z8T=$H6_/D?&W?IVV
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M=Q+^3NG6NTBB UAM2?DUS@L5:S=SJ1.H6F9,;G^"8)5)V2M=6C4#/[%TZT.
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M#U^C[X((#]+YUP&!:!,Y(9E.O%4:E-89(AESM9:.N)E\"K9-9DBS+77HES9
M]I.LDSX@TH$9M*4@RB2#01$0@]8*E'0.O*9?D@L\9X=%Q/\Q4U)Z <NPNL5=
M)-<E_FZ>"H)5BHOHP" B*%^[G:/SX,B=1AEULJ:)"WE2=8L["7MHW>(NG.\
M04.JY$SV/B$/$(+WH)RK<]D-,<O33C/+7+?)Z#S=NL6=0+!'W>(N$ND 9.\6
M9,??[NJV%["47 LZ=T6@ T6^*;@L-6CEO2<F">.;-+W80,NT4=@F(#J4XQV
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MEK=_=.Z+E@5+@6+J*Y82$GP=(&\P&^9Y]KQ-NNQA9 _#[XF%YH\HR0YP^^#
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MSB5RV&56U$?&;4#=7Z)K3 IB4\E=%Q;WIAB+[BPC3X^N6!E6L]I3#)BNQ34
M".[\XL^SR>3GV?Q//%PCYWA4S'"";@4>38>'U/+ "),\1&&2E*R*-?,*+8.X
MOSH4^*Q;[@\(0*.HJ7#&"@+!.")U1O=4Y40$3]SDC#:?K5)9MR.@7ZB<+,D]
MR&C%UJ/A\ WFXUGI@CE?=@J*]0OKQFJ[FJ9/JWF\]0NXBNL.OB6VD?YWM4D6
M68S06$N!B4B$IQPWZO (L=+V)R4;K>11L"IY.D?0VN^U5PMJM80U)"65M>=E
M4"&![#PJ:^6(#9")MC)XK1AD6N7ENI62JO;J5TU)M6'KB4KJ_30-X>WEV83*
M>B\M>Q8Z\[M*D^W6?D5)WFO!K20JE-EZZR8'@ED\;1E1:BE3JL[XWP&]H@C'
M?!(:%:U?CQN']4@O1[@%R[C/BLK_G]#8&8JZ>$5I([&^9YGL'=D1@LRHV15Q
M/*%^]R&3D((F1AL+021&59.2H3-,QAG4:TDKV3>:C--&$'VC:6\'?Q4-55%;
MHJ0"(D-IA6<T)X&JY+477D&3_EX_WF2<5M)M-!FG#:N',1DGR>PX%[:$4Y '
M)DC4S\@2G[@TVBN)SL5+</R DW%:B>[E9)PV?!S29!SO=(P9X>^#M=LL!^D%
M85EKB$%G'?YE)N,< X&3&-KW ]F'MB-:$F1T.\&15(I"I)..>&,L"3+&J'7(
M%)H-]6R[\A GXQP#E_IL'T#XIU$<7\?$A1*.0&FD)YU&[EF>B,&?2O/(6)WX
MXX_YSG:,Z5M-7 . X-[DY8^P'#D7A-8(#99M()(G0X(M@Y6E5%QY:K.KXM4?
M(FI8[OOI$&B:3-Y6'AU6S]<+9I9AO9.US^$G/X^G?AK'?O*$I\?$+=_\SJY#
ME.TVT5$T\IV?E,G'7VX!EMM>,#^-%W$R6ZQP3P]1)1F8L-X;PAUH1(Q3)$2+
MGZR1+$06I*G2 Z,9>:<JK_]9^3FJPLG]:VS_'3G]#O_ZCU'B)L08.!$\HLX7
MEA*GP.,IHLFJD#W352JJFI'7KT*K@*/G*JV"E'X(Y;8V2(YZFFGXS>=6=*]M
MZ+SJ#A+"DSI+#"L^I:<2/0TC27:4IF#!:7?!ZN[1WBW-+*9EVOVF9'QCVSX>
MI6"R%EIY8K+(Z'!)-'>-0UZPE'R@--KG*;Q=O\8<)O B5%X;+.U_D.E04@/P
M%A[W=17C?(7KCWT83];#^9[MS.*%085$6Q7M4B)!>^(DR\0!QPT[#D'7<5L;
MD]BO\WI6%'8JK0LH4'WKIOJR^OK5S^]GC\?SA$2)XQ<[]P7=<-OGO;.9C PX
MHX2C:TMDQD^VM#]/F5D6-075*+ ^T#O[@=.?_9__C6O,42(+].5+__<%S.]@
M,6))>XM<((:"()*61%WN;9GK%3E8"\E4&2OT-FD7<4^WP<]K3<$ZE,X ;NB'
M'?UM-O_CU^FG^2S"XMF6C,PI!"H(R%*-DI,AUJ-'%S5:&UYK+7U=P.VG[2+N
MY$X0UY%\A@0YO'+&"S0Y2OKELRWQC#:$14:E*!*12FNT+]"6D=Z:) ,7Z.-7
MA=Q^VOI-?3TGY#J2SY @5Z+BGDFF).IE9A+Z4*6(*@@3B3<^42:Y$K+*&/6G
M1/3;+_^<(&K+\0$TUGJ@_:]^LMIV3]_BWGI)G4^.".7P=O>,$T_Q=L^@K.%!
M.2^JY.[N)ZG?KO;G1-)ITOB1O-"7[ODYW-']J_;FES9DQ)G?T+P!Y_!&-*H4
M4HH,"/80"8N11L>D875>P<_CH+XR9F+3A?$&Q55F48_3MA/C3BJ[4.8H)F5E
M4H$(65PC(2VQ63G"O<D"K,D@JQAUQY-\$0YM&[PU&!I20YH#, &WJ@(=J(S[
MQ0VA:@%8['9#95"".[1)2E13&H&?.)HHW"5K'.@0N:B!S<-D781[>PK^.I3*
M ##V,'[@ WC\RN<GQEL!(C"&CKG#W02FB*7 2?0V>Y_1%!95'(_#9%V$/WL*
MQCJ4RB!&C+PV(._%K@*E)FAFB=+2X:Z$),X[3:@ ],]S<*Y1I5-KK#4A[B*<
MWU,0U[F$^LYG+QX7KGY[-4T_P1U,9NL4P_4PL4_^OCP-[G;%0\X<[WX27"QE
MB882'TOG(O!,.TM5$.HMCZ3=DA?A !^#IHJ<[QM/>-_?C<MUCR[=53$U%Y]A
MN9I/'^86(,-TE%04ZU(;(E/(>#J0?R)(9SQZ]CDV&R+QYE+]CFZKC9]N.=TW
M;KZ;0[=EUQ/G?R29E4$+1D+0@4BI/?HD@)<4-R @!U#>-=4^AQ;J=RC;&71.
M9USN&S&(_X1;^0Q?(8W7$AHY3:%TYR,A.BB#K0M?6"0@J-8L!<I2LUJKE]_=
M[WBU,^B24WC9-Q1^@OGX#LF^@YU]]A343 0C2Q,@'SV:8RDAJ)UEA.JHN$DN
M!-X,%0>7Z7=H6FV =,?AOK&RBXM=Q;^O\/I<%Q7N.DE]FH\C7$TFVV+#$8TJ
M1J88T:#*0"4HTW1]1L,K><N-PL^F$7):+-KS^+3:0*K%_B'$B(K1]?+=XL&*
MYV"!<2 .ST,IE[ D:,N)<DKA=A*UO$I&^F&R>IZF=HX@47=B&0#(]F]$6AFI
M9HSDK"A!CCFTW:0D.7K0BCN6;97Y 2="ZP>(<9\HC 'D11P,:XTL:!L=\H0K
M53+/+26!E6&[@(ZDUE8;5V6PZ$&J>AY/UG>LL950+B!#XB/\^=C'$]V1*7Z,
ML.EE>D3JPZ&OZSJGH3'I'24K'%CO:IJV\Z5^G3[]F_$TCI%K3XI)=$ZHBPS1
MH63YZ6CQ_A.!<!X9URDA6JMD,G1 ^ZFZ[@02'JMDRG3Q1#E'@T%H(H,'$FQF
M1.4<A(L0DZGR"-,%\?VF/IP;O<^UZMG%?]G*]_C2Y+>_](R*N&)!<A> SMQY
MEM"_#925=,?(B!4)\:U9XM(KS>HT?1Z .GXL3>SD9/IL)"ZB"/XH!I<K[AS'
MD\EY A:HC;&*E]WM-BY?1;=!]/YJU;-#XK*5]0FYP@V^]8SJNF:N;Q?H3LR#
MDA (R'+_>Y<0Y]02:K*+-O@0<Y62]@'HZP,D_#;?4/ J 9NF:S18D"Q*PB&5
M*7L2_>'L YY*"$%H%S,_]T7W-M67KXW;X+6%P=RQP <07GWH?%RZK2WOKV=?
MO\VFL)L1R1FCOFP&I"F)T2D1)TP@22;K79GL#75'M+Y&U6#1V34Z]@UK/5E4
M \#=LSULVZ52RCTM^1?(#?1S(T,C*F>/;B8U4F8!XGGOV&[P]BHU QG>>KJT
M9UVS?@#X^5P,IBFD]WX^Q6.VV';!=8%G3]$*E^M*#F88"4J7L(7Q6NJ<HZX2
MIGJ=G'X1U(&<9YTS?1!IY\?J\ \/?4Z]9QFBRH39,K,RVXC.%A[')"EEV6?G
M>)7BV9,I[[<,I[_+\[PB'X""W.YE\1DBH%.*_/L(R]UK;:)@!2#Q2+8I S(-
M[@75@1=,**NMHZK* -M#1%VF67<D/EZ^JW<CK$&HUR_+6?SC=C9!B2TVE]"(
M:H^;T)JD7$:"E^B8XSX3*E@*R#<;ZW2Z>DG*92K ;F!VHF#:@\MMP#6%FY(O
M\'O7R@TYA&;R-/EY6OSE6\(UWI>0V6(<"L<6RU'P5KHR"D&:I$K7<$_P?V3\
MP4 [BP9*G;')#>GKMUYQ$"JO4Q'6#V9O?U%^!+^ __RW?P)02P,$%     @
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MT"[D9/^Y\QS5S)\[S\@Q'V*> 4P2FMI5@HZV#K>_]D%^QRDD6X;C)B# 1JF
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MH=!I,)184F\$0+>*F#P\AJHM=>$V@ 7"%2.O __#5W.F8X;_W]:R:?^XIS3
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M)[3(QIZ*C;$';Z_%M@@2NR[^:'*AWMK8@!P=()W1Q-8N(X)09C!=<AOVGKH
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MI32_\24\E.+OTNFD\TOB2E8IGBN33H/EXE/.X^+!Q:&J'PR_M7&.TTP-L>;
M].JC/H9>]S1E.EERQ[$^2Z3]7B:@2RAKHYU;M"1]RMJTYQ:?7)YKP9@)>+5#
M83B9$HK""QNT"BIRZCI8#"EG)Y^1[_$91E2X%]AV(L &;3L5&A7!Q:%\KU?"
M?/6)<B^+RNZ!63>#U"<K^ Z1I;" QA6<^Y&1/K7MU6?,#&(403/4:2[O<8'I
M(2A6ILSMOJBPQ?:@Q<U/!AY0.4 ]W7^XP<(TG?A6K*,6I><L YK';&759%O]
M6$,6,<3MS)V?!UN>OANTN ^H>,/"SC-]I3QF-L8[='CE[OA[C\B[&\AR3>-A
ML(B>;L$C\*>WC?=Z.J!O]DQ<3&+!(59#;!9<"<LLYS4Y7Q3Q\L%R8=R-Z4"2
M\%BSX*0V,.AV0*#'6\D7 @+=%^SN8L*&/WMLK.[!O<2^XA5+%]&<C*A5&EH@
MO*9TQB#NPZ-((\*VB8>P6X*7?;RE6OR=+0)\IF<DWK$I9P-,'38G:UV6 $6N
MU.;LPX%B4037ZNI,WA..OE;BQF9;F)>O59W:RRIBW\N\M LIW?"J&*#!I_1_
M!=^I03'3-N.Q[)C!-^O":\,T,:6NIV5*A'/?DR%?BE_MVR<W;UDZ]$F[W?4A
MMH<2J^%5FL:+-LBWSS_$;(2WMQII%((C28=JFGS7.IKZL7J0NL7NHPTVF([,
MJ)3("\U[U8\4F"I!"[H(H32YEX,<[_2IGFA;M_A [+9BP4^8C!;^S+!.X\#T
MI[5[?,D\\5+H8QVXKM;)N-%W15[>GOF2F1><&R<!B1$60S)U6C<8\>G[H=][
MG'+EC [X)^OCUFB82@Z&VA(!4X"AN8UZJ\V[KH9E.C!-73I63X<N:,F/M6UM
M&Z$1RFP0RC</6P [E.)2CQJ6.$;5>7BX3BF&9XH' N18E]W9%*XOO)?5+?%Z
MA0&<;;I*;;=JN_B>F,7Z-B5M*(WH\DP8L)REI!1Q^_J%RXP9Q:V5Z$F.F=BJ
ML]T)INZ'7:X4J@RR)#_!YF86L$R*^.DA0X'H+ZGG!__K@^ZR6 LB8D'FTW*6
M""_!HD$AFDP #?X@\NXH)C0*1IDZ-YB1G22\-=?M.*HSUF=@K_O4RNTA+Q@;
M-6FF C//6?5<$-]3I; 5#)2"[[5%8+"6:ZE$VP')3^P+6R%3^_!!4 I')NY9
MS_C'0XY.C(9!N59=EIATI4R_1BZ=G+E'6[;:O4%O/MDL].8[)HF$HY)D@FG8
M5XPV,;O.UUMFUTUU68&P#3.%HG0EDDB2S@F0_E8''N1(:#&9=W.69OJ*R9$4
MFY \ VTF$=B*1K^$W1$DSD=JU'&.=\)G 20_B 'Z8;PMSC=(Q+H;R=OVWHBR
M(M*EC/4W,J6Y1)]A3NM2HB!XAVRI$<8GKYA&M[0 >4,I*F_6)97?\LTRGG3R
M!\HB3X<N^81ZV+,')1N(2*932P;;PP++/2Y@".C\\NRD4JD1RTLI:Y2:ARWJ
M<*$DMFC6_(95;I\CWMIXQFB\D!HL["DR)5EQW1!HP$&QE&'Q%'5\7U3@T\U2
M@<<^X.<=7-),Z2A]B[1BGX3Y^\)%00+.#-RWU&O,TN'NUG"NSM1Y,5/1\I<C
M'REEB)Z):;('C<DSO#'\ERZZ1I]<50')F=<%H?#;]F!Y3&Q4KF%Q:C@W@8H0
MB:J&:3EL)A5YIC:H2$/O0,LQW<N\.\3/;$!R^!.T+G$ZJM!7-+-D0XFV04EE
MD:D"]I*;H4,/(YN;;D!)3S8AK;P.$-W'$L"# !OV'EP@0XQS$B:T_4U: U)#
MB:H2M:^'D?1.'6O[?;*F6->^A9O9N/#-Y6^G[Z*W[][\<79Q]N;\GC0D/-RX
MAH1>I7:1KX&Z[JEO<QF=:7&M2XZ<$C>>KHW/93NE=3NI?5KO- DLJJ282EJH
M;#(/?Z6"B8O=B)Q]);<+BB._QDBYDM/VA)5F8PQ!XK>P@X.K)]0H"2W6&5B7
M+AE.KR=5Z29.B &"W/+YAZ\H)IF$=Y57P-[;BL!D"D9I+JGH0<I%9J2T [+'
M=K3$,:4;LD/,H)$O0VYX0%:FL(RV@VIM\[* ]SW1)OHMSQ,N:EG@5P5:"F;8
M_#2BLY.PCRD-YKF*PYE@XLE (FAJ^K+L=Y )&=H-(O&]'=)]:(=TN&GMD"AB
M!8(;78I[C+*X!B<*C0MM=$$:552..<UT<H5%[ZI"<F[F-32.?2GMW2C5D>?:
M&+P$9AM(K%PV(W- C2BG8O2V[Z@N:#/IE\ESOQP?>!]$*&*K! ,V7L]E"+UM
MO@%U'$FHJ#> WEB^6#P#V.66KN<4""WE[[;'#\R8I_$8(3NHJY@K,T'[52'G
M;M7&"86 )Q@GXJZ+DAEEO,'TM9KSC7\\5F1]8$:R5.>&D2GG9_'?>&&1EA=<
MI$&I))F%BVQTJ$,@<9.(Z[&NQR9>$CQ21S-0='DMY?+$9.K^"B-B@E0YX;$2
M<8!%I<D5EPEF>H9>8EVKX9@_N5(EG(GC[D@8"&8\,SZ_.)5)] A>V&B@\@](
MTSV<;SNB%W@&$J_I)!A_9R5SQ(M1]^$BY<A702S0ALY9.@V%])\!89>]-W9@
MQ .O]EIH. H7DT>\F>?MEI4!M;^3!SK8JM23@3UCL0I8)&MFCF@!RP)3PYO6
M3H\&L1#: FV3O*RT8"/ KI,E2R4MG,H8ZA(.%<]CMF.ZIB3[0.<:T]R6,]U^
MD"'!,Q&E4_>76XPC\DA7I6:_9RX<I%=Z8&2&I6(AN+?-1T]/\#KLHA21J":-
M( 9:IA]GB\E%OR=1NL--HT4]LGTXUX&GIRL>"+3(& <2X$A'%EO7V_?!--$+
MXV$4E;.D*%61A80H =HM!'[ .#[DQ36=(!YQH&W\Y1W<K?BA[=34VW,;'EHD
MCBF';N4Y"UYDC\!85;M']P+7T'D.3HTM:>=]7_;>AA%GL2^WZGUW1,GW6EH8
M@?Z_ I<OM^B0A=TKVV E:TJH))$>2JTKB$W.%:6#0*(/7,[;^:*0:M">9M,2
MA!EV8R;-0IR-TS/\5G*M?W#!!J][C]!,(?B"?X3(IHS+I4($A8?BI>P@S.JK
MN:L1XQ%U6"/,A@2YC0W% YK9C*)" XV3=;9)$,6\1]25QXV)F]60(+4G0"J!
MX([A,GM((.K%D31PUO.OJ-,W&5NS5$78_(*4K/MX8.LNX(?T]18L8E/F-CF'
M!SH%8K8E#D2&(5R]108=_*W&Q.44,Q I@HURTN%HZM.RDK6#UODX^)1YN\ C
MPJ=2*Q)GE[S/Z0$7->6!W^(3LJ]!]+]2Y;9I_%5IG:U<M_$@3!\E/Q-.^P9L
M51#Z5!.,,\_F%HAC.B"!"#':'ZM]N8E].WK'MW&@SHZ>O#<"N&$0G%^)+ \M
MG]?J>L5R2,:MB0?1V5<+B^D)N*#7CG^5&?[HDE#.8DR"I@GU=&MG&'0.<CET
M%J#?Z4^>M^@,#_&!$K7B@V-"(:"!U(-:O*B<PAFC>[ %698..;:#+WAOI'WC
MT!8H!!.AF?/8,4'X5ZV%;_:CODKVJ]2ME@4T0^T.-I;L@=-BL ?#C-#M($HA
M9D.L6[,$1T,W;$M4>H11-1NDLV%<1W1*Z#/*+,+-)TTF-; .#2?&S\U,J/P<
M9A-M]RA@C%OXU'"&Q$CT@LK]T:#^:7@M]+/O&M$8]&&1)\B&3URT=L#39I"E
MU=@SZ_YF?WYD2!1W^Z@HL>?%E3G872,@1-W-XT# ?$> 1X]0O-@NC_76I0EY
MS':!"2<H$_5754ND0J'IY!Z#@&@[Y1@,D$<2B'S;7J=,K6ZO4T!;LGAD]T4_
M/]LL_7R$:\81GXNF0NR8B?=X_<E6;2TO%MFVD@[D4^+&6#K&T6;T.;G#FQ'5
MH%"=0UZXN2J:"KG !+ZX6RNJQ>_IZLUK#,A=LLLNWK$?_>%C*M:KBLNC&!@7
MU]A0=N6T+C8-)\D:MZ4&GH/;V:YYP?NP&W V.]#PI==AK\3><TAXJ'!S<^-<
M/^C.B7'I4GTM[)6FO3CSW9M&O%Y6SS,0[\WY]'RSSJ<+EWW'0^F(TN*K=AS:
ME:6<K#<0:,SA2 6"5\H8Q*>Q0"YC-E0LSYMB41ZC.K1EQNH1\32G8BL^#CGS
M:K//53A1?+MV/0B,_2), P4 #8P>FTJ1WL9SAU[/MX7'KC4+ [P<%Q@N'C]V
MVZYB0A74- M]1#-5?,-[T@F/@!(PG^OBWFS:_;W-VK6OK1M:^7:^XPF)]I]$
M;SG;ORD=!#Q?J&CO:7+R6W6W7E[5>VFY5>AN=T,-=&YY$!KFKJ#:"JEXMA1&
MXGRACXE9:%,6>B*%2-&I99*OA'VF[ZLO&>'HPT51-"%A! 9V5/$$)- TK3X
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M"9E5JGB=Z#3/" \"\T$2Y[<EN(7P>98(R:%?:.E)/,X]S#1[(UCLY(V0+)+
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MD5^GY.J]WGCXW?>X-YUH-TNG;II8&CR]NAN^],O%N_'2,X=$WV!,#ILJ7HU
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M=9M:C[#ZPT&1S.$_XWJ2_?S_ 5!+ P04    " !#=UU1G8A"4(M)  #GNP$
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M8+W ^YB]W$.=)5T&3)"X-)AD Q""-G><>Q#Q03;*NZMS82CB:.N(N^JB6"6
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MXS+XIJ;E$XUNX\MVZR@O#SW,>S()6 RM1[T!L C\3U_PMP#/B)LZQ \3E?P
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MZ-(J8,1\,NKITLM6P@&,-D'#LRPV;A.@]$==<QJ$]RO?7W&'NWM>3A3#/N,
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MV)[WYO?2YI&,-N\W[_$W8S';&W-:?7FT ?=8\"F8Y.RLX5;>MB2G [C#,?O
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M+[+BUDC7-J)F9\##O%!PD/!95L<14,B?LI0_=8\BW#=O4GTJ*<2T3$[/>VW
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M8>0G:D'>&1Z[&D8MPX'#E*9P$9@ T5B5TP'? #3\2)4@XG@(,,KV4)4]@S1
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MKJ7(ZXMII"*8F?>27(?+_9OM<K+"O\,4CDZA+Q-]I>,O]@Z)R= @F*#0U6)
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M\UU,6L)'A!-DCY)$</-9G0K_$&I^EA-BU:X &:?2[(K[P=N+25@R+M ^M)O
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MQ;5N8EW:K$ZV6(%R5(CV$,['PEI?1I1="2NE*]YM MZ;K?),PVQ3UUYHLGY
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M+D/3.)DQ1IST9AC$-]7JE/4PF# QH6W74JI0MT6\7AGNBOLBJ3YER<L;K_G
M=)<SV,M&-9AE2_+B]3Z>I $W\;/% 30/VXS#@)-R&F8@;L6>6['+V3WSS\JS
M]HKZT^\@AQCU"3Q3ZV\($$23Q9P?\3B5&6>I4CKU(A82"K9DL@5L<M"T*$9+
M'3[#.B/22NJ#;O5 <EW)GX"FW$J29!M/G?\QXF>?/'L9;0VW?9G$&=D2BYBJ
M:9'7%TCJVSE@&[#&:R52$PN_!2;G_$%Z,1U5@(SC=".FZ$WZGW-6]!J8<"9?
MAO&Q6Z^V_:[U%B20,Z;7!(=@E"#1WF/FU71;E*2H;VHVHUH([2:WAY!P_I4F
MW($!+8S(4W\3L/]D4*^W&X@WG@P,=&!MLFT3B1_3[%G;;:*UC\L9YR4'@W!2
M!RTHG2G'\W$)>,V45\BI YB<&14,< ML3#OG)=5FTQ,&CI)"*LVSDE205$D+
M&)<F&D<BK_EFNT,#$9! QZ4U/6@_( L(0XG\@HW^G=!H]FG?<ZX6ADJ)ZN>H
M"1%J@+Q9\T6[1Y5"C &/6W3LGL/M:ZJO&ZERC)YQ Q]-E3*<8\[R!F)$%071
M1%DCC^; )(OH@35W;+>-C^S3_/D+)IWVMD0ND?<#L1NB4>'!Y62Q^NQ:;'FT
M]?-VLR:H;PF9AOT3GSSHV;^XKGX^G(P>V-)B2G0L@U<[U8PBNA*=Y6(&3R\%
M2NTVZGX[MNUL0BSLC=>LD@KIOW VW$CM1=WC^D*62T<*ZAMM7?Y_(_K?JN^R
M]W%3L.K/-CV?B7=(XK\^2)36CY^,GHV>/=Y[_OC9\SWU/'XTF8P.GCQ]/)JH
M??W/'QYL> XT>.VON^N65A7\_=>C5T?GT:M/.ET?L4?W=K^1&3I_%YV=OWO]
MMVAX<G)Z^/IH>'[T[C@Z/?KEU_/HE]/A\7ET_.[\Z/7AYYC KRV-SD[PA=Y&
M)Z?O_C@Z@_<ZBWY^=XJN^5GOZVS*V&GN#]]$L#XGPU-8@:,3^. L>O?[^=G1
MF\/H_-=#C+;V:Z1>!OI/T38;Y8+#YL7@S&9ZLX=<_^,DSSKFQP1'2QO@Y'PL
M&FU8#YY(F4' LWO2X7&Y<.M(I_D5I\I*W7.[@BD")7K$YB%&V%KA;>3=\BJH
M\*.-KBC8B.HTQZ;1Z(T<>;:X\_<*=@RX5I.8MTKX:LQK:0D;>]>2GM&Y> &%
M9PL:WW=#CJ+/"XV4 M(G=:SFU/_A/YJ;17,)J:$*W<RML!GGV]1$Q'H"O@^=
MMD9-A2E.4H9_PI +TT0W RJRDEX%@_+%PZV(W(K::.6)B/?""DR_KMD/LVC#
M,$V@I]RGJ*%2J=+EXD,DD2&_XPZ)38\81Y137>7RPG0!*?BC@U\&]&_-$0[\
M5F1NM)0ZP#;LC"N5Y\B0,'3F9+ZBE_I-+:*#O?T?J$L!O)XENL@GW#8$*_$_
M\'GG 4P*+IU/J2&R(S4-8T<E8B,NB @7[H'E+Q+:\></PRH%QAURTU#2+SLG
MN)H4N!!0J\SK@AM&]JVC%#5P<?^8EVTY)<!($V%NZ_$2T<1CB(!Y:AS-81I;
M6V6;L3F@E*&OXZBH&@?4*:%4+SA<>DL.7\"LV)Q+V,L&C(;4D025L4Q/N =L
M^M4@"R50!YYZ;9-=06K6:$E+!V+J0+G)M3515$GL.D%USJ09#^3]B[MY/":>
M4-BW8<0,.1LQ>2>25NOW02$5_&FBJ56@HHX]5$Q>,O/8E9S %'0CW,D<4$\T
MF%0T<9*8F?"^M[, (_P9 4(XNG9_ 16-X;7_HX7.DQ ($H6WT 0'".5#I5VP
M?:J9-)L"K"!9"CKBT55>O">2E>:BMFJ*O#AIK^FY\F[?VPR'\]&CY9;C[V?G
MI\.W1\.;^VM?^X .8<'FBU;AW%>SQ+K]81#21":R=G.+C=(6&X0KK^@OE?I(
MEWP-.Z-[#<Y;]:\>S[IAQ AFILV;#':JRL@59>EW"R:KYQ@1@(($_ 684UF3
MOS8Q]H@K^6S7=C>H/]N=7JSOQ7:$)?M=,N,A*S"5"R>9P#4PU;( VRG*">3&
M79W<#9R6I2)23$%QDMPP.ELV19]S6U(XV&&;(.=9_/UWCW]XB1EMR5JCM0>/
MY3RL2=WV@FH\!!XG@+C&&2^"\592QBH.YX!N+.:W&:;@?\KW")RIL%T5#6%,
M%WG=\SJ:C_O='O#OERJM.?UO7IE?RO#0\?=C2E9C!4-)RA.4!/^YU8]QT#%M
M^+QS]2%Z:RJ1E]5C?NOGYA_><L%$3NI42/K,PI6\=&0;I83A@BFB39MDN/X<
MDEAA_WIV'6UEOPS?.S2X'##Y[-UA*:PW0K+O IO.DFC0RM*PRBH?OV<8P0 M
M>;!P*JS#E0-'5FIX2&'J'"T'FNS4J!7AK$WS$:\<:816X9Y*F/ACRA!P.M.,
M\#*B@O?F9P\:;XR&^A6-Z-P2Z,OQI*TRK!$/ER9P$N,\A44OO]F\X=IR@-_.
M]NB5+0)F)TV#TH(<07+FZ-1:O%8'W9=O[FQ)7Q]!4(X1#LG(+Q/H9"C63%<<
MJ"4OWNN@%DUP+ NMB$@?@5]&=Y7CJ8ZI^]BYT:3H,$D_&(2'A25<W$Z&;0RX
M,XB<P2HO=2OLU'X5XA=46Y(*P;%P(SG2KJ8:P A('TM'K!*"##-,2S2_#'Z1
M]=HUI#Y=M@[<,:MG(UUX $&\@;%QZ/8LWDUD"]S;][IBY)'W*R^D)&2XQC8Z
MH2N1XI<NI4 ]!J,D?A4:E2L8%WT(1FY0P>2Y;;/,WIEFRMQ8],UGWVJ;W'$;
M=]^8"FF-5.A:5B6K%5(YXU^#"I3H#>LJRR/_^]D;FP#J;.:-500D1[@VEF&B
M-YG(.8;GLHN=5$_@E9YM=#"1IN+I.K.%X6P]WMU_@I/1A3N[TB-8&1UM3:MJ
M3LM";A#]Z^KJ:C=-+E667ZK=<3ZC#]F<S8L=XR>6]#&9DSM^DP%&"^;%_2I_
M_54^'IZ]&?Z_:Q<W4V6L_FV7MES,1GE*?X1ES[8_PB+_ZDFSW-6L="F@";?Z
M&YZ:D(1(/.L@>Q+/L\6;\FWXNY5O Q<3R#0K7PEZ$P26,L@HZ$@D<G4#S3O^
M$6[C$F%(0(41<8).*TQ3450\2)85Q.%=1OO\^ZY[[N\^L3=G38IA\7+*.3 \
M[S/0EV=X/)E6P+T[W"[Z[WVCXGG/<'\J-$W@,K0I^6IC<> ;_#<\<N]+0WR^
MC0#ZZ^'Q\$U_]+P7(?H5CPF\P8.??L\(QN]XR.RAL1VL @J^06>%J%=R:EC0
M8_Q%,C)EZ&(6;@D#!C+@Y_G['4W9&^HB; ((.(KM@="^-<'1USS<8UR3&&60
M2F)0]NJ-M[Z1K?;KT?%=WFG@0%0I[S)<WKZM,[]VZW1NV2_N#'P;F^SGT^'Q
MZJC:O?4X.%TOY<H;G^[N/_+9*5(M"TUZS9*44Q^,>:K&;E]: L/E/<HVQ/ST
M19[KWDQA7.DF4V=J-DHNZKQN=)01F$F:\I11<P3VE(5AE$(U'D&(C?JB"!\T
MP RN=X5I-29&$_;,,,34W&UHPF( P9K;S<R3B7F [9/6);4N<VVR;#\-2N6'
M?;)L5PW\RXU[:NP&NH.. O&/=A1R8>5-:8-JG2W8N)58, AT=+M&!8NCL?7+
M# NC8VS[PTL TSZ?H@G'(9J!);T<)44U=>RJ$>$CDHDIV3>7<WO70<3M5Q7&
M3@;1O_)11'TV!UP<)K&Z"6<!N"]&H2GI-$WFEF;0?_T!2G*P;;G"# 7SW#)U
M.[98:><Y,Z50C0=1ATUL*C[&$&"*?[+@HP'%KO"_=<9_HGU75Y8/-NDF.INH
M2]0C'=W55MXV :;@OCE>P Z^]'RXOC@@;(WX*#Q )Z\[-5"UK7ZYJ+@@")^I
MO"5IT^ZG*H6TB+>B0N%F&R4;![1++?6"#;(!UWK';VEQ R'@=0:3'].KWV=K
M5LW6K&<?K]#%+6C4!HHJB[O1:2$D;:8I@%Y67I]FVXP-[H][T&$PK^G79E#S
MS;W6XN;9TKL7NX/V.S#-/<&KXV0"1Y!(I+D''#CRXX7@8IFQ79K"E8RD6\(%
M=,VY<) [3@7]N\;4E8I2.'?N9**BD_8OK.>T52$]ARKLFN8A"9E>9%K#ML#E
M(#@MEFICUSP^^I>Z(;&D(>!_A%[%!TIX'.=YR>7UWH!8\A"FD21/\/,M>6+*
M=<7"FETC,'2;W_SC5(^C1!S0H&"VR#K#CG1D=?A6FIVP:\RUAF(LO[1!=0.-
M078&\W6Z3FK)39NI?<P8SZ=?M[_D#4Y2HS%AHRTA'3%'@=.V/G'\&*#'F?%Z
M!DLOF-7[&](<$!1W4C,^R.]UZ/P)AL\.3#^U,0*(3 4(TD0,&N?9=3[L7+B/
M../>= ;-%%7%@Z=7=\,7*%:SCV+78%;KJBA17")?]-<CS]Q,>8!^&A-6O>5V
M&-[H%/$FRA>#FPA@F>./$)A4>F(<:*^5WI=KH_?Q-?;?0!3EE\/3WX;'__@F
MPRAO7,T6;$/QA(),O''I0TJ@FV5TNU]Y S)[- <_&S(.[!AB8)9Q7H\$\!JO
M/$=>"%-JN#C&87QX"5Y:\Z?,&1'(I5%\I"E6B1=];/'!>C?4N1]9P\;T6.<I
M_:+AEL0R744>,:J9BU99ZX:^=O<>ZF,YNVYO!<%QU_@$[-+2EK[:)D'*KUX-
M64 M?Y'?KNJC<R+KWT)3K>)&.SO8*P?^N\_%3!3><IB!F$(,O/O*FTNH(+^.
M\FA3MM>*%,,':XH@T:)%T;IJI*^;(,P&'>=L\.%^.B1I3'&AUUY/Q0%<%+W5
M%R"/7V.393Q5!%O;*K?7.;'?IAKPMN673<]LQB3<3"FL*=*\NB1YM+X1?D5)
M<N.4O'AO6"-JLD'D-9\XEQMW\KD$;-8YB=^HZG^U(.)?"93UT'<TV %]-D;;
M=9H]YL_AI:QI)OID1]^_E["9=U6,=44_Q$TI)+I ^>(!Q98P/,E[G#/-I6[G
M12G\'*:*;='\I"ZX&,@+99*"?;T8:0IBPJ(>9>/=0:2BJRD\>K&37V'RN'3\
MC7#OM\FE.LXOX<2]?3VP47[P)_;W]KQ[1:_2RW@0_9K#"J)B/_][],,/>T^>
M#8BL:KC+8)+7Z(U@S(4?W(66Q; 9N67.3/#32I<ZBS$5Z0_DR>-G&/77[U5T
M&L-MSVI$9,+X!K K2GV9I)B5?3V,GC]Y^G0_'-%ONB@P4OIVD8VGL,L372!<
M_F>=93!GWW_W"#;SV2S!M#",.2_F.76UO&;27JGL/?YW.(.=.%;PDOS#)G^J
M?6NN$KO/=7TJ.^%&R1/,"ERSG6VRP;;K]3;VGWF1QL3GP!6"KVE!!M'!P5[T
M!TCJ1716@=R%XX0#_D=>O(<__0,V_L&S_8\&>PQ<8H(D.]<J?E2>@N'I=T,5
M]/<A6"ZM"\T*D_O!8B*/<>(T^:F2SP8,32&@R@"94JCE.[\Y)4CK,@2Z!'@4
M(>C@K44B2._,5))ZV4+*8GB8&*RV;@3*3#VLO0#_,H8A(E<UUCP%>YS*A7CO
M$R(E_-9G?/,P3%S0<#<VS'B)[8!=?]NI K0ER/9=*4_P#1^^B%CN^PVK98@8
M_-[L\Y+2Y#PQH)^Q,_)%H>;3: OA */\4NKBW/6-GD#=4 )4_ 9A(]4/",C%
M7)"^U*F002D/!L H /<83$0EW[)XW-*]"^06Q\"**0/M)9^OSSP/3-K9TT W
M5S\6@8"V&1.2H;Q*9I2[X]Z)W_ :1%N3[6C9,1D[WUDX+3P]Y*6L"3=J6 (-
M^6(03$I,W @6]!+LQZRB7#9ZB,2/9C.KF9]7Y[GMYLAJ)I%G"8_%C%DRV,@O
M1S4-7A(91[=:TEAB7%QQ:WML8F@_:S>'7\K"8GVX5E^NSYF/0U/X2]*B;TP%
MPS&8-"V(,UI!?=OYG_W_;/[;GF",E:PZD(UB[BUYH6_JU;I*04RKRVO?]'9!
M$H[.AV^_34#">5_"_0WV(NM#).SO[I,AU<PEWS#U8$&,'Y=\:)4T=^<0^^3L
MYYOJ@Y7 LON[:\IKM8J9#_9Q$C::==MMOPW Z?O;FHML5-E7+J%=NA-.0,6D
M3K:3GMOR7N,<Y36C8?+E&5LI'41AB(=MH:>)))6LH86M#%"=CS>MC[J^\WGD
M*-8L]W'B82 3@?S2G2^?9)YUIK,+M./%,T5#'&FO,*YP 7>?U&F$@:]+O'JT
M$$2%X1!!/Y:1GJ; D; 6\^FBQ,^I&3,B[%)T(E12\ O4WO4-(R\$C-X([',K
MVLYL:)!V0_7Y[\='V(?C;T?'O[QY]]LFV6+W6GS-6OS@7HO?:_';H\652_1S
M.&9@(BGY/,F\RO\&K0!SG6!8;X>:2JCX4A>E-IT%7'/1G2K?P1ZCHNL3*4_Z
M*-KO+W'J5V=!=C!;%TT.<+:EC]BF$%U3LMY8,&XDBOL;[#/\-E?9>ML*GS=X
M5#S8C.$E\K^VQQBY"Z<)LX!1";A!C4B.U_86-S\P72Q%[C3NRY5TV--^"1D@
MYRBB#%X#_K;U?&\;3S(<>.KX2YEE)$+B46,JD"@M;:\ _#2\83ZFE@'QP(HN
MJ0R$V<QC;E0U2<)&R <'!]'6_O;6F(X1 C!F?-NM0U5DU(6<.N_JC*#;V]$0
MY,[!WMXCBM]F/N,A3;*P]U(5YP@[(-%$87Z"Q:''GHV"#1OC7#EX9*-=NE=F
M ,*0A1Y&FI_O?::96KYA.-.E,I,)HWO"$ZEZC;_.J6<J.$B%E-#^^MOI:YHQ
M2V_I=7:-:VV,.J'^:;]WNZV&Q^KM3XC4JXYS),A,*C\O@->9SM&CA;2S5MMA
M>VS:HEB%13O8,"Z,\JQNT"'P53CV#J*B1JE[8XS2:GC4?K1IZ<WDGS[K9S\/
M)MS<GC;*A]MFO?;CL&.X8>^+<'MS1UU*@0A_*&CE*6:M.L]PQ]; ZLJ>4MP*
M*=Q2:?*-+V6J(L(.XLW9JYEHB(E.JB1U6RZA"C>5T&%%4;*,F/R&WO1M\+0?
MCO)X ?^95K/TI_\/4$L#!!0    ( $-W75$0K =!W <  *8A   7    ;&EV
M;BTR,#(P,#DS,'AE>#,Q,2YH=&WE6FUO&[D1_MY?P5/0G WH7?*;[!AP+!].
M@&/G7!5I/Q74<E9BO;O<([F2=;^^#\G5FV4["IK>M6J R-KE<#B<>>:9X:XN
M?NC?7P___OF&36R:L,]__7@[N&:56J/QI7/=:/2'??;S\-,MZ]:;+3;4/#/2
M2I7QI-&XN:NPRL3:O-=HS&:S^JQ35WK<&#XTG*IN(U'*4%U84;F\<'?P25Q<
M_NGBAUJ-]554I)19%FGBE@0KC,S&[(L@\\AJM5+J6N5S+<<3R]K-=I-]4?I1
M3GD8M](F=+G0<]$(UQ<-O\C%2(GYY8604R;%AXKL-(_$$1UW.VW!NTTZ.^T>
M\Z/C9H=.F_%HQ,_^T8*1#8B'.<;.$_I02656FY!;O]=MUT^.<GL^D\).>JUF
M\\\5+WIY$:O,8CV-^>%K4+.MC.LQ](V4M2KMM=I09NG)UG@BQUG/[[(2M"UF
M1"I1NO>NZ?^=NY%:S%.9S'L_#F5*AMW1C#VHE&<_5@TB4S.D91P$C?R-8"86
M\9>SL(L3Z$ED1HM=M4ZZV,?-WWX>?!P,6:=5;VUNXE7SCS>MCQ !TN&.S 2N
M>JW3_(_:S_7-PW#PT^#Z:CBXO_O6#6V;_T)P=_7+/PMC93S__1W3?>Z8M@/L
MH,KZT$L9^Q3U71*+*HM(.Q.9G7#[_MW1Z?E>[+15?_^N==P\#Y\#-N%38IJF
MDF;@&CN1AOU2< W0)G/V0+G2EJF,_:1TREK-VB\L5AIBQ'Y=2N6P1 E&V)M@
M?Z'<4CHB'1;H-*N!H53,;L%0=PHL]?GVFO%,,&D-BU1F5"*%ISI3C(P4DFM)
M!BX_VP^7MS=<_I$;[!0N3>?L,5.SA,28JL'S.OA;*"R>*>N<8[G,X*PY*S*K
M"X+M\)2O#_ H9RFNM.0)BWF$6YJI5%IF59#;$L@H(F.XGCN1E#^2#^52I\$]
M 6.P9.*+"]9P I'4*"80RS =E@C2;#:1T001<Q^K^3/25"IQ&TBE25!U7 &;
M23O!!DU.D3?0Z2V1$ZDII@DVFJ^[87\ T-D- ,1BF<'%+EHKEU9]JB@,Z[5Q
MF2$/$5MT'/@>)87+/81MS7]5A%SZ_(37'6 <D))DA8@R&.;9T@"=\*U,U4D4
M"00  X58^>6,MR?B9L+B1,W, B.:QM)8]$&6<7<SV TKJVNA-@MCMJS=GVAW
M-Z(]W'#-^W>G[=;)N2GC6988EQXJCB4NO=,&C&ORX8&[Y2@A3[H$3(P2:29.
MW(FEH 9'#^Y:2!,ERA28YTA#JR3$*=<J(H';AAT@+((0Y^#[FZ=HPK,QL2OD
MXT.10*+5X;76T0$=^JFM(Q&NPJ5TC4P6\.'T,Y>T:[ )872V[+Q0O+%0C(46
MQ64=3)!P16I_2O !/UQ'2)\,C/35#USZ]4!6'<U'O#"[3W%\.R($I5PI,+@J
M-!0@,:?2^'2'%&5>C^MY5D2Q3C::$NZC7%+X*E+5DHC<X)N5'8*AT'CZRYRF
MPCCR]TEA?*7PY(!3$@S"\<5/RM%OR*A(N.,T;,L;L2HBF!%*TGHEQ;<1.4'0
M#N:3V!^:.1B]@:*=DW4+3+NG^<Z8 @ZG4CBH<(/>VO$9-X"9ZR8<?K@6BU@"
M79*/9"+MW-65EY9UR/9A]Q$-H-P07>M&/&T^E1O*"YT#4<;7P2A26G@#?%\R
MI@SE+0&P,.(Z6.%%T',%\ #9,D_VJ2D]B#;@<S/E2>$SU?F6XAB-@9S"*^:%
M K^L8CLP3[A\N>9[M& B6,.$SF*D"ONZ!;MP(U]*DVN;XJ_WF6RT:,A\ E#P
M!.SQP78+[$? Q29?!%]NQ\2=-<J"[4=>#/PWL(2K)"J*"NT\OT;;+VA-E;&X
M[YZ90)>)H*@\93)V\,J<&!A" C\3+RU'ETK^G.2.4%FQ-.PPF#7A9EGD7.I[
MS)'PG.@=4O+5'*>A1TK*0],S^>J_[:/]PMG1=VA__4,)L4!H=96ACC#64;)*
M5A?F;ZAZ6]W+TC2.#L8J;9:%QM^ RA0G:TOT!AV.%$J9&Q<2]GDE!X 2V,<X
M=L-?UT<M$H!^+23,]V OLLB?K0[WMLN]PLG3=0H2<79MO3L@1)(0F+)(++O-
M&?%'Q_JA4GO>]SV&?[JQ.(5^4[C+QC <JE[(:2XPT= RI5^%1MF98 KBBP:B
M&DJ/0=TQ18KHP#]^,R67OGA>WZ]T?]:&7J%ZQ!HI4X73R6<YPN8?!97QK0;N
ME=E4)5-R!)SQ<?E$2Y?$0&F>J#EA=#91@0WX!GH0[>]2GNK?+P;MDS\B!OZQ
M?A^N]<2Q'HE[$-#R,6S[K'P,N^-^W0N=\HY5N;_<>JF!S5K?S)<:1D@(TC5L
M.N&YH=[BRSF(/$_XO"<S;[J?=#YUW(^27:K$*N4;I+-6O=T^=2^1K,9_L5!?
MOE^J^_=+#2NVQ[HG]5;GY-7A9KWUZMA;:H^:]>/CSDYJ&][D8#:V;W*>?:AT
M*HL).1?NI--KLI;'RD+?&Z+M_,D)KWL_H=@^=U\(V^\//_^V[_V[+I+.?[+^
MU:?!S1W[=-V_O[NZ[2_A]GV]4T+-01.RS#]F8(N-ON&Z1=[^-WGOV7NG_Y#'
M_L><<CV1%+.;)XH*=PAD]Z$]_+]QCM?8DQ:K13NXZ^!S>$*!TK;EL\-MIS4\
M!:\5@5U>YSY[W9^K\'N'7G@@.*6M'P"LDM67E.9J"A\A8PN[/>4KOQDH/\,O
M&/QO*2[_!5!+ P04    " !#=UU15C^MH=P'  "/(@  %P   &QI=FXM,C R
M,# Y,S!X97@S,3(N:'1MY5IM<]LV$OY^OP*UYU)[1N^2+4=V/./8SM@SN21U
MU<G=IQN(6$HX@P0+@%+47W\/ $J6_%:Y=:]WNLR$%LG%8K'[[+,+DB??77P^
M'_[CRR6;N$RQ+S^]_WA]SG;JS>;7[GFS>3&\8%?#OWUDO4:KS8:&YU8ZJ7.N
MFLW+3SML9^)<,6@V9[-98]9M:#-N#F^:7E6OJ;2VU!!.[)R>^"LX$A>G?SGY
MKEYG%SHI,\H=2PQQ1X*55N9C]E60O67U>B5UKHNYD>.)8YU6I\6^:G,KISS>
M=](I.EWH.6G&\Y-FF.1DI,7\]$3(*9/BW8[D[5&_QP][_98XZAV(P[?][D&K
M<Y@FZ8BW>ZW6/]LPL@GQ.,:ZN:)W.YG,ZQ/R\P]ZG4;_H'#',RG<9-!NM?ZZ
MLR[*S1C2(^V<S@:'D'3TS=5E+F#<H'U4.,BG.G<PS6"J^#/.^'#>QY5Q)<?Y
M(/BC4K88D&BES6"W%?X=^SOUE&=2S0??#V5&EGVB&;O1&<^_KUG$L&[)R#0*
M6OD+84&8))S.XGK[T*-D3HOUM_L]K/CR[U?7[Z^'K-MN=-;7L*GU"=Q!YD\R
M__SR9GC]X?K\;'C]^=-OL_]?I74RG3\=S!<J>@HF?YQK>O==T_%8OJZQX80+
M=@6S=%YC"1EO'G,3[M[L'AP=;\4JVXTWN^W#UG$\7K,)GQ(S-)4T P6YB;3L
MAY(;(%3-V0T5VCBF<_9!FXRU6_4?6*H-Q(C]O)0J8(D6C+ VP7ZDPE$V(A,G
MZ+9JD;ATRCZ"N#YID->7C^>,YX))9UFB<ZN5%($!;3FR4DAN)%FX_.UVN+RS
MYO+WW&*E<&DV9[>YGBD28ZI%SYOH;Z$Q>:Z==X[C,H>SYJS,G2D)ML-3H6S
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MR](TC@[&:6.7A29<@,H,.VM'] P=CC1*F;\O).P+2O8 );"/]>R&O[Z/6B0
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M+3(P,C P.3,P7V1E9BYX;6Q02P$"% ,4    " !#=UU1FN\GF@T^   W80
M%               @ & @0, ;&EV;BTR,#(P,#DS,%]G,2YJ<&=02P$"% ,4
M    " !#=UU1YA4XRJL8 0"<N0L %0              @ &_OP, ;&EV;BTR
M,#(P,#DS,%]L86(N>&UL4$L! A0#%     @ 0W==44-,_:2$M   )3P( !4
M             ( !G=@$ &QI=FXM,C R,# Y,S!?<')E+GAM;%!+ 0(4 Q0
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M:79N+3(P,C P.3,P>&5X,S$R+FAT;5!+ 0(4 Q0    ( $-W75%7RI %"P8
M #<>   7              "  0A[!@!L:79N+3(P,C P.3,P>&5X,S(Q+FAT
7;5!+!08     #0 - &H#  !(@08    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
